SMAD1	228.2697784602969
C/EBPΑ	192.94361038169467
CALMODULIN	179.03917522934788
HSN3	169.7765564480627
INTRON	150.66235270286276
PHYLOGENETIC	145.55987837479154
sα	136.71874400193016
SΑ I2	134.82234617436444
BOI1	133.46181284302227
RRNA	131.9329190103253
P27	129.64442338150337
I2	128.21726355004893
P66	128.1731404889818
III1-C	120.35944440105247
SNIP1	112.92131444941245
TYROSINE	109.15143377739246
CAS	108.94178816124558
RAB24	106.81935907999194
MYOSIN	106.22532011679996
P51	103.58043874761614
GSK3Β	101.93146371797872
P53	99.10089040922142
CCAF	98.11534625067239
BLM	94.26902623484882
MYOSIN-II	92.56660979788253
BOI1-PH	91.15010181549405
MYOSIN II	87.65767226361145
AZ	85.85801306886883
THIAMINE	83.8585728352895
SKP2	78.64163783424496
BASE	77.94196466600752
SPARC-NULL	77.90797525196642
PLASMINOGEN ACTIVATOR INHIBITOR 1	75.94770919170236
M/Z VALUE	75.35373178560197
ELK-1	72.46748977457861
OOCYTE	71.36073014994969
WG	70.70278599578168
SCF	70.46926330887764
PIP	68.44596107877146
CD98	68.20040842935333
CPLA	68.19991503029888
DFZ2	64.91187550064363
BASE PAIR	64.48265417020946
RESVERATROL	64.40891976982624
IDO	64.24010593182302
GENETIC PROGRAMMING NEURAL NETWORK	64.1382815364774
ALM	63.501936105853844
WTPAI-1	62.822393228141436
PROTEIN PHOSPHATASE TYPE 5	60.93768984788952
COVARIATION	60.694637694400136
LYSOSOME	60.68804675319425
GNRH	58.72136281629497
EGF-LIKE	57.96623963171221
MOLEGO	57.75442892361863
V-CRK	57.6276792207572
CAS SD	56.49424461786214
BUTANEDIONE MONOXIME	56.23262732734945
NUCLEOTIDE	56.230571933213085
YEARS OF HEALTHY LIFE	56.20594116544625
TAG	55.72954377175933
GAD1	54.99933132904811
CEE	54.82626937938472
WOUND	54.680937142391386
FIBRONECTIN	54.54533484684809
HF	54.391190771185606
INTEIN	53.74662081444937
LYSOSOMAL	52.83543184534412
EPITHELIAL	52.7871722812128
SMAD4	52.66083531969133
THDP	52.632866855876
ASBT	52.630704008992126
PROBE SET	52.31192632020513
MICROEXTENSION	52.202031318777955
PROHB-EGF	51.846367512332314
HUGENEFL	51.75589787270354
PROTEASOME	51.62016715313721
AHAB	51.271015668198956
MNOC	51.271015668198956
SN50-TREATED	50.83103367982917
USM	50.0796751744313
SUBSTRATE DOMAIN	49.82456729286779
TBID	49.69182234949795
ALM MIGRATION	49.651505343204406
CONTACT SITE	49.5860164286604
PHYLOGENETIC TREE	49.57193523950889
BINDING ACTIVITY	49.549384308206925
PROTEIN PHOSPHATASE 5	49.44845233341012
PHOSPHATIDYLSERINE	49.37232945289784
TRANSGENE	49.219878101787785
C/EBPΒ	49.05482197735385
ATCOP1	49.05482197735385
QRNA	48.78175048094284
UPA	48.60868853127945
probes	48.40500340499899
BACK PROPAGATION           NN	47.84814947432027
TOP67	47.798645561140916
MICROARRAY	47.78573744042473
PIGMENT EPITHELIUM DERIVED FACTOR	47.588013305464145
THROMBIN	47.19026779137623
IRIDOCORNEAL	47.09359188711113
ANGLE	47.0861223158582
OXIDATIVE	46.86467778352693
SRC	46.43430313338094
RRNA INTRON	45.76885941240883
P35-C/EBPΒ	45.69981892747789
CHEMOKINE	45.30348291742838
RGS3	45.0418747733099
TYROSINE PHOSPHORYLATION	44.89068476983029
RAB	44.86881282364651
SPARC-NULL MOUSE	44.836383159637876
VO	44.64128005768665
AA RELEASE	44.10972087414525
HYAL-2	44.06663784412394
CYTOSKELETON	43.91618042121489
P35	43.705922356193845
FASTGROUP	43.11972728605057
OXYBURST	43.0292576464218
MITOCHONDRIA	42.96050838604785
MOESIN	42.817446938328224
TENASCIN	42.71523579856315
IRIDOCORNEAL ANGLE	42.43710166470149
MHCK-C	41.56734680243992
NOCTURNIN	41.56134689986275
WOX1	41.29427530602891
TOPOISOMERASE	41.26430764209289
TRABECULAR MESHWORK	41.23237612296763
ARR	41.121213356365516
SERINE	40.941454683648104
LIPOPOLYSACCHARIDE	40.881062103485306
L1	40.638658395410395
ZD DOMAIN	40.127630551393494
MCNTCP	39.970011198937534
ACTIN	39.696903114287615
L929 CELL	39.36658366324931
F-BOX	39.215418913139416
MMCOP1	39.06430331552696
MITOCHONDRIA           ISOLATION BUFFER	39.00281632840273
CONTAMINATION	38.98841253176972
TPA	38.809747107473015
CHR	38.61816986945256
EGF-LIKE MODULE	38.526787251157856
GHFT1-5 CELL	38.34249188318884
DOXAZOSIN	37.965102880465686
DODECYLTRIMETHYLAMMONIUM CHLORIDE	37.95820617393909
HYAL-1	37.811297431882295
SERUM RESPONSE FACTOR	37.54621951263591
ISI	37.3651639858079
GNRH RECEPTOR	37.14714563388134
EXTRACELLULAR DOMAIN	37.03359284280661
SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE	36.94640112008629
MORI	36.866414503306004
REPLACEMENT	36.72797429825948
CYTOKINESI	36.568459873520005
PH DOMAIN	36.526227438884945
ALEXA-CALMODULIN	36.38379831719863
IDO EXPRESSION	36.3402247051918
WILD-TYPE L1	36.268389358103896
GENE SET	36.03615660078205
NN	35.89931270620299
BMP	35.76566486645649
YEARS OF UNHEALTHY LIFE	35.55731158205185
UNCONJUGATED BILIRUBIN	35.530653286593484
GREEN H	35.39633509929577
PROLIFERATION	35.21993675361659
LNCAP	35.175394929540836
ANALYSIS	35.00723707066491
ALM MIGRATION DEFECT	35.00614554104697
REPLACEMENT MUTATION	35.00614554104697
SELECTED VARIANT	34.81566635467058
OXYBURST GREEN H	34.80022218799858
SECONDARY STRUCTURE	34.510239404566455
EPITHELIUM	34.430793696913625
GFP-MHCK-C	34.430793696913625
LERISETRON	34.39131013812574
CHLORTHALIDONE	34.357060181975
SECTORING	34.34820138687899
POLYMERASE	34.14714624377411
B. MORI	34.07566152148174
MHCK-A	34.045921039156646
DONOR	33.919171336295214
GP120	33.919171336295214
PHYLOGENETIC GROUP	33.658298177371435
OXIDATIVE ACTIVITY	33.658298177371435
MUTANT VERSION	33.43870969150008
LH SECRETION	33.300936013714896
MESENCHYMAL	33.249393533007876
OSTEOCLAST	33.17341597286685
ANTIGENIC	33.090823662832214
CIRCADIAN	33.090823662832214
TM	33.02579365749072
GLUCOCORTICOID         RECEPTORS	32.90339924430167
HFF BSA	32.8561129648078
PROHB-EGF EXTRACELLULAR DOMAIN	32.842877388717895
SERUM         RESPONSE ELEMENT	32.8344049683104
ERK1	32.82582243351992
CYCLIN	32.78854331510987
PHOSPHOLIPID	32.72294425700903
TGF-Β1	32.473584131415315
OCL	32.342409869035464
CHINESE           HAMSTER OVARY	32.16848430802725
TF	32.130599160941884
GRANULATION	31.990815488756123
EPITHELIAL CELL	31.989163483123292
SCD39	31.952948709438566
TPR DOMAIN	31.914837928615096
NETSEARCH	31.832245618580462
FIBULIN-1	31.832245618580462
ciliary	31.641766432204076
HPB-ALL	31.641766432204076
contacts	31.30866273403273
PRIMARY MOTOR NEURON	31.21524899550306
P66 IN	31.025591060876653
TRYPTOPHAN	30.772315014212644
PROSEQUENCE	30.730987082563146
INHIBITORY ACTIVITY	30.708769990630874
HELICASE	30.48194757275872
BODY MASS INDEX	30.38317400286849
AXONAL	30.27013686466514
SECONDARY STRUCTURE DIAGRAM	30.231451433686797
NCRNA	30.14338716180371
MAS4	29.997065368254134
RHOA	29.997065368254134
PHPP	29.997065368254134
KKTK	29.997065368254134
CHLOROPLAST	29.97428468063855
DX2	29.824003418590742
DISCOIDEUM	29.806856060890368
TAG EXPRESSION	29.666299555338195
GENOME	29.521884462308183
D. DISCOIDEUM	29.512095567896942
RING FINGER	29.469853917285395
TRANSACTIVATION	29.434043673010866
BMP TYPE I	29.39387635714436
EPISTASIS	29.31128404710974
ANDROGEN	29.220814407480976
NITROCEFIN	29.197779910658134
DLA DX2	29.12080486073335
BLASTOCYST	29.11808734403469
OMIMID	29.009003699387396
SN50-TREATED EXPLANT	28.70673092967608
ULTRAMICROEXTENSION	28.66257353684927
P10	28.56287025331299
DSH	28.56287025331299
LH	28.351059545219414
FIBROSARCOMA	28.277700879092297
C/EBPΑ-GFP	28.13137908554272
PARABASAL	28.048786775508095
COREGENE	27.95831713587933
STANDARD	27.94759973580969
MODULE	27.74650642778575
HSCOP1	27.74650642778575
dermal	27.74650642778575
migration	27.63508099583968
ARP3	27.473434931374737
E15	27.300372981711345
WNT	27.300372981711345
IQ PEPTIDE	27.197470852622324
INTRACELLULAR	27.16212597287125
NB	27.088562273617768
HUGENEFL CHIP	27.06724220838464
SYMBOL	27.04783629308976
TRAINING SET	26.938834936621266
ARCHAEA	26.891638181715667
BINDING ACTIVITY DNA	26.838408076413252
GFP-MYOSIN II	26.83395363378379
TNF-ALPHA	26.78486039208908
PHEROMONE	26.78486039208908
MITOCHONDRIAL	26.684328448898327
P53 PROTEIN	26.670673262170748
MISSING DATA	26.640633484542086
UBIQUITINATION	26.54786300290636
CLASSIFICATION	26.449371962501882
HELIX	26.3558303415053
DEPENDENT PROTEIN KINASE	26.320419374228443
CRE	26.304586294684274
ARABIDOPSIS	26.223472397611676
SMAD	26.20950854795572
COVARIATION ANALYSIS	26.176048347460007
SELECTION	25.991561540482536
NEURAL PRECURSOR	25.986898350835823
CDC42	25.960049273198578
C. ELEGAN	25.901248207559192
GFP-MYOSIN-II	25.813836401172427
ORGANISM NAME	25.786892328099267
CILIARY BODY	25.74834748662843
STANDARD USM	25.74834748662843
OKADAIC ACID	25.733912017729633
DNA DAMAGE	25.583251725477037
RT	25.538336984993933
POSITIONS	25.519433383044227
ORTHOLOG	25.428963743415462
EXPLANT	25.32895419666784
FIBROBLAST	25.261579420715428
LAYERS	25.217153035321882
MEC-3	25.090403332460447
TNF	25.04053129844681
LRP6	24.94408153891087
T CELL	24.925103874344785
NF-ΚB	24.922992924133652
BLASTODERM	24.859315334221794
CODON	24.827176087199177
ESTRADIOL-TREATED	24.771212961426034
SCE	24.771019589247476
IQ2	24.755958426662712
TNF CYTOTOXICITY	24.70283288054757
GNRH-STIMULATED	24.665636168406014
INTRON POSITION	24.661081892259773
scores	24.626440031333573
DLA DX2 MUTANT	24.60290531811324
CDNA MICROARRAY	24.43216755921963
topoisomerases	24.420131784155927
GRANULATION TISSUE	24.4170099790224
GFP-C/EBPΑ	24.33501900688741
PARAFORMALDEHYDE	24.275545836639065
TITRATING	24.252426696852787
IN SILICO DELETION STRAIN	23.832717850504405
RASMC	23.823396646269007
OVARIAN	23.77010189377263
IQ3	23.75056044845846
IQ1	23.748205551810504
DLA DX2 MUTANT EMBRYO	23.679492912916498
APE1	23.67707485271943
IQ	23.65467713133347
BASE VECTOR DOCUMENT	23.63833736924114
CRNA	23.560238930495146
FIBROSARCOMA PAI-1	23.551227000134887
NOCODAZOLE-TREATED	23.551227000134887
METABOLIC NETWORK	23.502538750168917
P53 ACTIVATION	23.32672740553397
P-VALUE	23.309187431276506
FZ	23.29220219496246
HSP70	23.24685979280343
PHYLOGENY	23.19392964628214
PROTEASOMAL	23.142322355771327
INTRON TYPE	23.138199303160587
IQ DOMAIN	23.123226126894984
LNCAP CELL	23.066344795630293
GFP-HYAL-2	23.066344795630293
ANTISENSE	23.045718384395705
RECIPIENT	22.98375248559567
NEURAL NETWORK	22.934688823480414
GR-GFP	22.907361675340944
CORRELATION	22.89902227777057
LYSOTRACKER	22.839339449006708
inputs	22.825240118462222
S2 CELL	22.79327329921928
EUCARYA	22.79327329921928
GARPIKE	22.79327329921928
S CANAL	22.777155036500083
KINASE	22.690063416071325
PAI-1S	22.681472137873325
GLYCINE-CONJUGATED BILE ACID	22.57993385897749
PROTEOLYSI	22.562475049929077
GSK3Α	22.55472243501189
DENDRITIC           CELLS	22.543534419061416
OUTPUT	22.53782300796884
ESTIMATOR	22.52667607989412
NOCODAZOLE-TREATED CELL	22.49259777196966
ZEBRAFISH	22.44103112413295
FETAL         BOVINE SERUM	22.386462730599614
DIFFERENTIAL EXPRESSION	22.3014689265433
extracellular	22.29199496303828
insertion	22.272792582770123
RRNA INTRONS TABLE	22.271816477268935
CPT	22.23533869179892
DNASE	22.23419224752288
ANGLE DEVELOPMENT	22.21560200803266
EPISTASIS MODEL	22.126522020890093
MESENCHYME	22.118839808004022
INSMUTANT	22.096772885937735
REPROGRAMMING	22.007715567465066
BOOTSTRAPPING	22.007715567465066
INTRONS TABLE	21.998522883710695
ALTERED EXPRESSION	21.99848558876339
ENDOGENOUS CA	21.97494809795351
COP9/SIGNALOSOME	21.94577293924825
LYSOSOMAL PH	21.90705000418467
BIOPSY	21.817474744960958
CD39	21.811565435094266
IONO	21.809615991277735
ACIDOPHILUM	21.796543694459274
TRABECULAR	21.79590485937149
KINASE DOMAIN	21.786628073615926
WILCOXON TEST	21.777735820992778
TOPOISOMERASE I	21.76402882320166
PROBE PAIR	21.75053673557969
P300	21.734957925310265
NUCLEOLUS	21.713312549336866
POSITION	21.6228429097081
PERIPHERAL ALPHA-1 ANTAGONIST	21.582102914738854
NEO	21.539542974817763
PLASMIN	21.536698537370157
INFECTION	21.475127174017835
ARS CONSENSUS SEQUENCE	21.466986835174755
GLU351	21.41103220161452
PERIPHERAL ALPHA-1	21.372144460160584
TRANSLOCATION	21.287443159051858
BPAEC	21.284282498753086
QUASI	21.284282498753086
ADP	21.28355113736281
PAIRWISE	21.244452598577645
CYTOSKELETON-ASSOCIATED	21.220281613096383
CBP	21.162686576054735
MONOCYTE DERIVED CELLS	21.157079721329023
BOI2	21.137960705203508
BUSM	21.137960705203508
PLASMA         MEMBRANES	21.12825021665462
FORMALDEHYDE	21.074023651273173
CSN	21.022595346317583
LATERAL INHIBITION	21.00847090500281
CORONARY SYNDROME	20.99619363935566
EXPONENTIAL GROWTH	20.990387523852654
DBD	20.964898755540116
SRC KINASE DOMAIN	20.953032369328568
RECIPIENT OOCYTE	20.908461358255188
MODE ESTIMATOR	20.796660196909233
OVERESTIMATION	20.796660196909233
MEK1	20.790578663144476
BDM TREATMENT	20.729020811701005
IMMUNOPRECIPITATE	20.66310673306558
COMMON PROBE	20.64762353840648
IMPLEMENTATION	20.59732090859892
MP-RELEASE	20.523588700498216
LUCIFERASE	20.467066782356774
endothelial	20.422555227276117
PROMOTER	20.371743240073478
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL	20.36806542956941
GFP-N346	20.350526750834828
RNA TYPE	20.345988597699733
NEURAL TUBE	20.316575754744946
NUCLEAR IMPORT/LOCALIZATION SIGNALS	20.286640798555666
DOXAZOSIN GROUP	20.278434901614098
BACT517	20.250517204087203
ADAPTOR	20.250517204087203
BOOLEAN	20.250517204087203
GFP-BLM	20.250517204087203
LIPID	20.247348231645148
MUTATIONS	20.236713898480005
IDO-EXPRESSING	20.23625787957575
MATCH ONLY INTEGRAL DISTRIBUTION	20.202310359216746
SUBCELLULAR	20.187277317900538
INTEGRIN	20.178078647566135
ENDONUCLEASE	20.172815551781863
PHOSPHORYLATE	20.163112836262687
ROBUST         PARAMETRIC MODE	20.161239089034805
TC	20.140624744903967
PAPERS	20.138716042741247
RELEASE	20.08192636132001
FACTOR	19.999536615800068
TRANSCRIPTS	19.97127811039325
TERNARY	19.971268125240528
GSTCDC6	19.963248074635995
UNIVERSAL SEQUENCE MAPS	19.945963970101594
PROTEASOMAL DEGRADATION	19.945963970101594
STATIN	19.909048623004576
BIOSYNTHETIC PRECURSOR	19.87942756015189
HSPG	19.865644546330234
SRC*	19.865644546330234
H-3E	19.865644546330234
DETERGENT	19.81613562342826
DNTP	19.771378547870448
TITRATING SEQUENCE	19.734153262008018
LGL	19.692582596666842
TCF	19.692582596666842
TUMOR NECROSIS         FACTOR	19.657460620608514
PREDICTION ERROR	19.634143715260397
REFERENCE PAPER	19.579888219022028
STRUCTURE MODEL	19.566213206131497
TAURINE-CONJUGATED BILE ACID	19.52648903832674
COS1	19.52358731555605
POLYMERIZATION	19.52234255391444
ALA MYOSIN-II	19.461081765597
SCE FREQUENCY	19.461081765597
RRNA SEQUENCE	19.45811074613266
MESENCHYMAL CELL	19.455766256776972
RATIO METHOD	19.395592851053003
HERITABILITY	19.395592851053003
ES CELL	19.389994851468654
CHLORTHALIDONE GROUP	19.37788975968606
COMMON NAME	19.303587507099245
ARABIDOPSIS GENE REGULATORY INFORMATION SERVER	19.256599554179097
T. ACIDOPHILUM	19.230730811531583
P51 INSMUTANT	19.19540178965002
THERMOPLASMA	19.15043492793921
DEXAMETHASONE	19.09213834977389
IL-1BETA	19.076209107840036
HEMAGGLUTININ	19.017397736859024
THERAPY	18.95249200055498
EXPRESSED GENE	18.90959643281334
CULLIN	18.898235161246596
BALB/C	18.864398399746456
ABASIC	18.864398399746456
WOUND SITE	18.84877575976862
mitochondrial	18.783858578726353
CYTOSKELETAL	18.721196109049234
NUCLEOLAR	18.659630218927212
AFFINITY CHROMATOGRAPHY	18.591819839189508
SN50	18.591326903335442
GENE EXPRESSION CHANGE	18.55332629728367
PROLIFERATION ARREST	18.542586286089517
Γ AMINO BUTYRIC ACID	18.53970667680971
REEPITHELIALIZATION	18.504003182786004
RELAXATION	18.483150538236483
DLA	18.41826495367205
HTK	18.41826495367205
SMG	18.41826495367205
OXIDIZED OXYBURST	18.409002686018077
C/EBPΑ EXPRESSION	18.40831420505966
BOI1 LOCALIZATION	18.404645837286342
SUBCELLULAR LOCALIZATION	18.394175416777827
HIV-1 RT	18.37798675583345
COMPARATIVE ANALYSIS	18.36873536456477
CARBON CATABOLITE REPRESSION 4	18.35250859258477
POLYMERASE ACTIVITY	18.335280263463915
HALF RANGE MODE	18.303425892998057
EXON	18.257326152920015
MEDIAN	18.2201173920678
CADHERIN-LIKE	18.16461040139129
TCA	18.12468159863977
C3 EXOENZYME	18.119130525029032
LEUKEMIC LGL	18.119130525029032
CUTOFF SCORE	18.119130525029032
BACT517 SITE	18.119130525029032
gene expression	18.109517763158856
MYOCARDIAL	18.107921597510078
P51 SUBUNIT	18.10242246912792
GRANISETRON	18.083468092975103
OVARIAN CANCER	18.067683995238202
ABASIC SITE	18.048786291620488
IAP ELEMENT	18.048786291620488
RHYTHMICITY	18.048786291620488
PLM AXONAL	17.972808731479454
ECTOCERVIX	17.972808731479454
MICROPODIA	17.972808731479454
POLAR BODY	17.972808731479454
MYOFIBROBLAST	17.96853022401135
PSEUDOPODIAL	17.91818982740127
CONSERVATION	17.91436960252809
VIBRISSAE	17.89021642144483
CONSENSUS	17.89021642144483
MNOC MRNA	17.883477268940993
THPERCENTILE	17.882088151059204
BUTAIT	17.861803171444055
transcriptional	17.854954539465908
BOI1-GFP	17.799746781816065
CYCLIN E	17.783928076602315
inclusions	17.768668446690562
PI3K	17.718856099700655
PGAD424	17.699737235068444
IMMUNOGOLD	17.688950743902996
TRNA	17.684045698803818
ACC	17.63541964729053
LTR	17.626117590724366
IRIDOCORNEAL ANGLE DEVELOPMENT	17.612107098673622
PAIRWISE ALIGNMENT	17.594144749310185
PBS(+)	17.587936073722485
WOUNDS	17.587936073722485
APOPTOTIC	17.563089901199163
GNRH-STIMULATED LH SECRETION	17.547636921843736
COMPARATIVE STRUCTURE MODEL	17.53161150845583
GRANULATION TISSUE FORMATION	17.526344356687243
INACTIVATION	17.517313952087854
ELECTROPORATION	17.500395848807646
GLUTARALDEHYDE	17.494534831714635
PERCENT SEQUENCE IDENTITY	17.463781747427337
WTP53	17.46118637086105
QUERY	17.46118637086105
EA485	17.46118637086105
PGBT9	17.46118637086105
OXIDIZED OXYBURST GREEN H	17.450573726587994
errors	17.43306383872462
EXPERIMENTAL VARIABILITY	17.427958146222412
ARREST	17.417068430614563
AMINOPEPTIDASE         N	17.400172224550552
alignments	17.374690861501737
COLLAGEN	17.34874117437969
GR	17.32289762468155
PJC4	17.31486457731147
GLIA	17.31486457731147
NEURAL PRECURSOR CELL	17.311582456656875
CONSENSUS SEQUENCE	17.29621689341521
CASPASE	17.258980468173668
INCLUSION BODY	17.23718845338742
HIGHEST FOLD CHANGE	17.222830709764875
TISSUE HETEROGENEITY	17.219839035839673
BOI1 MUTANT VERSION	17.21953713841264
N-TERMINAL DELETION	17.201210397314124
MYR	17.201112217734636
INTERMEDIATE LAYER	17.17891863641799
COILED-COIL DOMAIN	17.17891863641799
BOI1-PH PROTEOLYSI	17.17891863641799
ADI	17.14180262764808
PTA	17.14180262764808
GQΑ	17.14180262764808
COMMON PROBE PAIR	17.113653108350775
CORRELATION COEFFICIENT	17.090014625675654
MIGRATION DEFECT	17.078909089670365
SUBTREE-NEIGHBOR	17.078909089670365
YEAST TWO-HYBRID SYSTEM	17.045701794551654
HEPARIN-BINDING	17.024653593431996
WILD-TYPE MOUSE	17.010055511856102
WT	17.002951141253728
LYSOSOME SUBSET	17.00194546653616
INTERPHASE	16.972649381458744
AXON	16.96960323619597
PP5 EXPRESSION	16.96645963010723
MOID ALGORITHM	16.964493549239442
BOUND VO	16.95986275389813
CARBOXYL	16.95020928763948
degradation	16.941534729931874
THYMIDINE KINASE	16.93308428037599
NEURON	16.915772139455022
SPECIFICATION	16.905847140006973
RS	16.858742506579006
TRANSGENIC	16.85159844210777
HPB-ALL CELL	16.840358225462975
POLAR CORTEX	16.840358225462975
proapoptotic	16.840358225462975
DMSO	16.83165197347714
ECM MOLECULE	16.82070736134913
GENBANK ACCESSION	16.81144406045368
FLAG-MHCK-C	16.77001399205443
BOOLEAN USM	16.77001399205443
OSCILLATORY	16.77001399205443
GONADOTROPE	16.77001399205443
PROTEIN KINASE	16.76718712457262
WEIGHT MATRIX	16.728351717356528
ZN(II)	16.72499320127402
cutoff	16.71915494963956
ADENO-RGS3	16.694036431913396
SORT ORDER	16.694036431913396
DONOR CELL	16.694036431913396
FIBULIN-1C	16.694036431913396
PS VESICLE	16.67090764158616
TISSUE FORMATION	16.666104155115995
SUBUNIT	16.638629474487367
APN	16.63053297893093
YOL	16.623760688654176
GENE	16.616871227833172
MYRISTOYL	16.611444121878773
EXOENZYME	16.611444121878773
REFERENCE	16.611444121878773
RIBOSOMAL RNA	16.580178941118145
VITRONECTIN	16.565994653961948
lymphocytes	16.565994653961948
ESTROGEN	16.520974482250004
GRANZYME	16.520974482250004
PRO-N3-F	16.520974482250004
COENZYME	16.520974482250004
secretion	16.518595341838086
QUERY SEQUENCE	16.506538762806994
RNA SEQUENCE	16.470386482060835
RNASE H	16.46832767363299
HUMAN         IMMUNODEFICIENCY VIRUS TYPE 1	16.434450088006727
MOLEGOS	16.420964935502383
P53-GST	16.420964935502383
SCANNER	16.420964935502383
ANNEXIN	16.420964935502383
NORMALIZATION	16.400448238484483
FLUX           BALANCE ANALYSIS	16.37198336919019
PRESERVATION	16.339582302755773
DSRNAI	16.309163774156428
MHCK-B	16.309163774156428
HUAPE1	16.309163774156428
MYOCARDIAL INFARCTION	16.30591278902675
ACTIN CYTOSKELETON	16.300082564922487
RELAXATION ACTIVITY	16.282859161367455
TITRATION	16.207173188155686
NUCLEAR           ENVELOPE	16.201765734281786
PERI-CENTROMERIC CHROMATIN	16.18329135446436
PAC-1	16.18241407129499
ENDOTHELIAL	16.173086015491972
TGF-Β	16.167494324158618
REPLICATION	16.144225164202506
BOI1-PH MUTANT VERSION	16.064761915020878
CONT	16.03609227774541
XNOC	16.03609227774541
MHCK	16.03609227774541
SERINE PHOSPHORYLATION	16.02898035333721
MAB	16.006405283037083
VASCULAR CELL ADHESION MOLECULE 1	16.00168844495011
FUNCTIONAL STABILITY	15.988113074894592
MDCK CELL	15.975630206494376
HYPERVARIABLE DOMAIN	15.970275348420042
C-TERMINAL MUTATION	15.93872673275495
RECEPTOR ACTIVATION	15.92822043151293
PP5	15.90042557306343
ACTIN POLYMERIZATION	15.873651566466187
OTH	15.863030328082022
IGM	15.863030328082022
STRUCTURE DIAGRAM	15.848955185299861
AUTOPHOSPHORYLATION	15.847753604237433
FILAMENTOUS ACTIN	15.844248340409617
PROMOTER SEQUENCE	15.843928052147856
P66 WT	15.824494255532233
ADP-RIBOSYLATION	15.797633888518206
SCANNER SETTING	15.74337839227983
GAD1 EXPRESSION	15.742715918561636
WOX1 EXPRESSION	15.742715918561636
ADAPTOR PROTEIN	15.73572486326169
GOLGI	15.733176948721386
CCAF TREATMENT	15.67930211492735
predictions	15.672515944457635
INTRACELLULAR MEMBRANE	15.668396462557347
ERK PATHWAY	15.6589214911567
XK	15.651219619988442
INTRA-PATIENT	15.62457193885481
ACTIN DYNAMIC	15.620242974205937
DONOR NUCLEUS	15.610012098125836
IQ4	15.58550819888066
PROLONGATION	15.559083024310816
PNN ANALYSIS	15.557948194229724
CLONE	15.548734778429584
FUNCTIONAL SNP	15.534580571219504
RNA MOLECULE	15.534230855658638
accession	15.515464866940707
CARDIOLIPIN	15.488738790902264
NG/ML	15.482893229807177
query	15.469964656194533
heterogeneity	15.460254648171684
GFP-HYAL-1	15.412761230761234
MICROVILLI	15.412761230761234
TRANSCRIPTIONAL	15.391685065134913
PARTICIPANT	15.361586074611417
SEDIMENTATION	15.347470204614432
GTPASE	15.334167001544728
ESTRADIOL	15.33016892072661
CELL ADHESION	15.329186328156426
RRNA GENE	15.32753817424856
RNA MODEL	15.325442921247596
RNA CLASS	15.325442921247596
TARGETING VECTOR	15.284935162981757
DOXAZOSIN PARTICIPANT	15.244069735071054
LISTERIA	15.239699281097838
DAMAGE	15.22620703916863
P21	15.224771596655069
INSERTION MUTANT	15.185558702170123
DENDROGRAM	15.15376270017353
TOPIIIΑ	15.13968973435022
BIOSYNTHETIC	15.063772212358185
filamentous	15.035492177554673
STRUCTURAL ELEMENT	15.03309237188527
FUSION	15.027888573004265
AVERAGE DIFFERENCE INTENSITY	14.998509850095669
ACTIN FILAMENT	14.991453620405826
MISMATCH	14.982472514067888
SPECIES D2	14.97614283792856
REAL TIME PCR	14.97111096653419
T-CELL	14.968984565924801
CLASS	14.901138870142832
CURRENT STRUCTURE MODEL	14.825447900432275
REPRESENTATION	14.803101186136313
ORNITHINE DECARBOXYLASE	14.789562411286466
NUCLEOLAR LOCALIZATION	14.781996616360328
NUCLEAR EXPORT SIGNALS	14.759015272561076
RCCA	14.754817076593252
PMID	14.754817076593252
BDUS	14.754817076593252
L929	14.754817076593252
ORIGINAL DISTRIBUTION	14.73796264952495
LAMINA	14.736316168890033
GCDCA	14.706273350208118
chromatin	14.698308735190398
NUCLEOTIDE FREQUENCY	14.694233551631003
RECOMBINATION	14.693510854493788
FUNCTIONAL TAXONOMY	14.659949439140657
CLINICAL PROTEOMICS	14.659949439140657
RHYTHMIC EXPRESSION	14.65923755625204
UBIQUITYLATION	14.652950788485683
CA SUBSTRATE DOMAIN	14.635390244948777
INDIVIDUAL PROFILE	14.613637192338699
PHEROMONE RESPONSE	14.60924944807993
P27 UBIQUITYLATION	14.598472532356638
NUCLEATION	14.582825178896066
TET	14.58175512692986
TPR	14.58175512692986
CAP	14.58175512692986
P18	14.58175512692986
KBP	14.58175512692986
FILAMENT ASSEMBLY	14.564948942372736
ANDROGEN-MEDIATED	14.564948942372736
GΑ	14.560460461126828
AFFYMETRIX	14.558043870782473
MICROARRAY ANALYSIS	14.539763504150109
retinoblastoma	14.521695145229991
REFERENCE GENOME	14.50462780745847
HEPARIN	14.500424785859046
P27 UPREGULATION	14.491680671899276
METABOLIC PATHWAY	14.468119721991032
CARBOXYTERMINUS	14.459372149352706
III1-C RECEPTOR	14.452263518324445
HUMAN BILE ACID           BINDER	14.452169438224338
RIBOSOMAL	14.445483913718812
ANNOTATION	14.424476916746624
PALMITOYLATION	14.401826484245122
ANTIGENIC SITE	14.401826484245122
EFFECTOR	14.373403935015919
GP	14.369944418836283
DEXTRAN	14.360613678103922
NF-ΚB ACTIVATION	14.354166077023624
TERNARY COMPLEX	14.342349065948847
PROLIFERATIVE	14.340565695927685
RAS-DEPENDENT	14.340565695927685
INPUT ALIGNMENT	14.337843238244835
CELL CYCLE	14.28992269121827
LACZ	14.277162410125415
RIBOSYLATION	14.27507678138369
POSTERIOR TM	14.27507678138369
ALM POSITION	14.27507678138369
HIGHLIGHT 2A	14.27507678138369
BOOTSTRAPPED	14.27507678138369
PGK PROMOTER	14.270571035913798
QUERY GENOME	14.266859468602268
NOCODAZOLE	14.262374013251168
STRUCTURAL RNA	14.259973118761533
HEPARITINASE	14.246810217554026
PROFILE HMM	14.20473254797514
TOMOGRAPHIC	14.20473254797514
CAS CHIMERA	14.20473254797514
BIFURCATION	14.20473254797514
IΚBΑ	14.193134444203428
GENE SUBSET	14.184174549541025
RANK VALUE	14.128754987834109
astrocytes	14.128754987834109
ECTODERMAL	14.128754987834109
NORMAL BLM	14.128754987834109
OBSERVED R	14.115477348942548
MARKOV	14.096549296652881
COVERSLIP	14.068130917235365
FRAGMENTATION	14.065844754591662
LFC MODEL	14.046162677799483
TETRACYSTEINE	14.042681897512775
CONTRACTION	14.023630702127077
S PHASE	14.01091539606166
HUMAN           IMMUNODEFICIENCY VIRUS	13.984570083471738
CYTOSOLIC	13.972803988616983
NEURAL CELL	13.964646042802249
CYTOCHALASIN D	13.957516876084174
STEPWISE	13.955693038170715
FILOPODIA	13.948756918628286
PIPERAZINE	13.939959025547871
SPECIES D1	13.931384008150932
RELATIONAL DATABASE MANAGEMENT SYSTEM	13.907684074676528
PHARYNGEAL	13.884080004603543
PROTEOMICS	13.884080004603543
ATCISDB	13.855683491423095
PATHWAY	13.855683491423095
MHB-EGF	13.855683491423095
PROFILE	13.855683491423095
NEAREST	13.855683491423095
AA	13.836662749755805
EFFECT SIZE	13.827188266823583
HYPERVARIABLE	13.808161518064782
RECEPTOR BMP TYPE I ACTIVATION	13.765594478563896
ATTFDB	13.74388233007714
MEMORY	13.74388233007714
LTBP-3	13.74388233007714
MAP	13.707472470865781
integrins	13.671327160997674
PB/IM	13.617132627215705
C-CRK	13.617132627215705
CPBG	13.59594217392195
leucine	13.59292161879754
ESTRADIOL-TREATED MOUSE	13.53843663739733
PROTEOLYSIS	13.536550745927144
TRANSACTIVATION DOMAIN	13.499687878967148
GENE-GENE INTERACTIONS	13.499687878967148
ARP2	13.470810833666125
DELTA-NOTCH SIGNALING	13.459289749542645
BMP TYPE I ACTIVATION	13.455120568016325
ATTENUATED SRC KINASE	13.452101459364478
OLIGONUCLEOTIDE ARRAY	13.445061975782519
WILCOXON TEST P-VALUE	13.441082988023636
CAS SUBSTRATE DOMAIN	13.417095568932524
conditions	13.393412595509151
SELECTIVE ADVANTAGE	13.392948514029086
RESVERATROL-TREATED	13.372938176105713
INTRON DISTRIBUTION	13.35994779147087
GUANINE-NUCLEOTIDE	13.326625929303754
RING FINGER DOMAIN	13.326625929303754
GUANINE NUCLEOTIDE	13.317057084813229
NCBI	13.312550862458155
RATIO	13.298561779910782
STM	13.297748884002733
pgk	13.297748884002733
TPI	13.297748884002733
SH3	13.297748884002733
PLM	13.297748884002733
EXP	13.297748884002733
CELL SURFACE HSPG	13.27793767933779
BLASTODERM MARGIN	13.27793767933779
GENOMIC STABILITY	13.272880622774167
E. COLI TOPOISOMERASE I	13.27185317194113
DERMAL FIBROBLAST	13.269312445807955
GLUCOCORTICOID RECEPTOR	13.250574060033792
P19 CELL	13.239403424854933
SIMILARITY SCORE	13.226616382556134
NEGATIVE ENTROPY	13.226616382556134
PHOSPHATE           BUFFERED SALINE	13.176477406706796
FUNGI	13.175636381050136
MATRIX ASSEMBLY	13.172360886317762
SPARC-NULL CELL	13.172360886317762
TRABECULAR BEAM	13.172360886317762
DE-LOCALIZATION	13.172360886317762
PARABASAL LAYER	13.172360886317762
BUSM COORDINATE	13.172360886317762
T-CELL IMMUNITY	13.150847923995391
TEST SET	13.123005820882058
SCFG	13.11800800276148
non-functional	13.114815221210177
TYPE MYOSIN-II	13.114815221210177
MICROPARTICLES	13.114815221210177
IMMUNOGLOBULIN	13.114815221210177
GST-P35-C/EBPΒ	13.114815221210177
GENE SELECTION	13.114815221210177
DOWNREGULATION	13.114815221210177
RNASE H ACTIVITY	13.102553555931571
ADHESIVE ORGAN	13.093193599588556
TN	13.085938175909156
ULTRASTRUCTURAL	13.079516892302184
CARBOXYL GROUP	13.055388715909654
GIANT VACUOLE	13.05355443289274
SIGNAL METHOD	13.048496969338554
N-BENZYL GROUP	13.044592494587116
TN PRODUCTION	13.02406846613343
GENECHIP	13.003879736931875
INTRANUCLEAR	12.988065518348744
CCAF-INDUCED	12.988065518348744
HTK PROMOTER	12.983559772878852
P66 SUBUNIT	12.953858283982749
CSN SUBUNIT	12.95075597033575
NEDDYLATION	12.933457796957063
LEPISOSTEUS	12.917721284940196
EGF	12.904458209975754
PYROCOCCUS	12.889276461285876
PEPTIDE	12.85622330612516
GC CONTENT	12.841743724799164
PHALLOIDIN	12.841743724799164
TESTICULAR	12.841743724799164
COPY ARRAY	12.841743724799164
GFP-MHCK-A	12.841743724799164
HEPARAN SULFATE	12.835918931781032
YDXP MOTIF	12.828466085907605
PHOSPHORYLATION	12.81884180103863
GRANZYME B	12.807601224792295
ΜM IONO	12.774724850263253
ALIGNMENT	12.759151414764538
MISFOLDED	12.759151414764538
DELETIONS	12.759151414764538
TAG LEVEL	12.759151414764538
TAURINE	12.752949567237021
PSEUDOPODIA	12.750604898814347
WOUND REPAIR	12.704252154428218
BSA	12.696331184295854
CELL-SURFACE RECEPTOR	12.689899665375231
SEQUENCING	12.673069803201038
GFP-N280	12.668681775135772
CRW SITE	12.668681775135772
PERICYTE	12.668681775135772
GFP-N200	12.668681775135772
NETSCAPE	12.668681775135772
MIMOSINE	12.668681775135772
GFP-MHCK	12.668681775135772
BIND PIP	12.668681775135772
maturation	12.667341583350794
BLOOD PRESSURE	12.655982773542652
NON-LINEAR	12.655027482175683
CLINICAL PROTEOMICS PROGRAM DATABANK	12.64553034433101
MP	12.643094386725425
assemblies	12.614219394411723
D2	12.613026052672355
STAUROSPORINE	12.603494314078903
TRITON X-100	12.58796266892846
GENES	12.587432484382447
TXT	12.584471021116034
FOCI	12.583460123452557
sedimentation	12.572646898170788
OXIDASE	12.56867222838815
NLS-GFP	12.56867222838815
AQUEOUS	12.56867222838815
WT TBID	12.550025610732607
MIN ADI	12.532673080106786
TRUNCATION	12.524976739314965
AMINO ACIDS	12.514775425335294
W89	12.509288691031333
advantages	12.48142086570066
ISL1	12.48108181902385
RECEPTOR ACTIVATION BMP TYPE I	12.475242989389137
RASMCS	12.456871067042194
CYTOTOXIC	12.456443953633292
FOCAL         ADHESION KINASE	12.439717630286854
ECO RI	12.428299638470765
PLM AXONAL MORPHOLOGY DEFECT	12.421147097885964
MYOSIN II HEAVY CHAIN KINASE	12.418330219346132
positional	12.41788333992897
ATTENUATED SRC KINASE DOMAIN	12.415299026087169
BOOTSTRAP	12.395509610987231
retraction	12.359777794537111
TOMOGRAPHIC RECONSTRUCTION	12.355658183341966
FILE	12.331004054756765
PH-20	12.33012136418076
SMAD7	12.33012136418076
INTRA-PATIENT VARIABILITY	12.321137551138346
CHAOS GAME REPRESENTATION	12.321137551138346
ORTHOLOGY BOOTSTRAP VALUE	12.307048995576377
MICROARRAY DATA	12.30658436868777
STANDARD PARAMETRIC MODE	12.26740751291193
STOICHIOMETRY	12.26508098999743
DISTAL	12.253446919420522
NORTHERN BLOT ANALYSIS	12.249946646579344
HOMOLOGOUS RECOMBINATION	12.228682146100397
MYOSIN-II CONCENTRATION	12.216601377444437
POSITIONAL COVARIATION	12.209336389792387
HEPARIN-BINDING REGION	12.209336389792387
CADHERIN-LIKE RECEPTOR	12.20372139586164
SECONDARY MOTOR NEURON	12.203313450546776
RNA SECONDARY STRUCTURE	12.190360854618499
PACI	12.18379957063118
AXIN	12.18379957063118
LOGP	12.18379957063118
MG/L	12.18379957063118
FLUX	12.18379957063118
GSK3	12.18379957063118
PJC1	12.18379957063118
SORT	12.18379957063118
REVERSE TRANSCRIPTASE	12.181423309562865
PROGRAMMED CELL DEATH	12.181423309562865
ADHESIVE	12.176684073957771
HELICE	12.17086960325741
INTERTRABECULAR SPACE	12.168938260367884
DISCRIMINANT ANALYSIS	12.167589955761013
RETINOBLASTOMA CELL	12.155795874596395
MACROPHAGE	12.146657674641695
ELECTRON MICROSCOPIC	12.126744079757763
LYSOPHOPHATIDIC ACID	12.109836282151559
C-TERMINAL DELETION	12.097753768943402
T-TEST	12.09446960574599
METALLO-Β-LACTAMAS	12.087145771249233
PROBABILISTIC MODEL	12.082586686930952
EXPRESSION ANALYSIS	12.080565618521387
P53 PHOSPHORYLATION	12.067069681858857
BIOLOGICAL SEQUENCE	12.062021994354856
LINE OF OPTIMALITY	12.036274440128995
MAJOR PHYLOGENETIC	12.036274440128995
CELLULAR MYOSIN-II	12.036274440128995
SPIKING EXPERIMENT	12.036274440128995
CONSERVATION RATIO	12.02763058393922
WILD-TYPE BOI1-GFP	12.020838982647255
ATORVASTATIN	12.015738731824502
P14	12.010737620967786
myc	12.010737620967786
MDC	12.010737620967786
BDM	12.010737620967786
COVARIATION-BASED	11.987586190163029
DOTMAC/PFA METHOD	11.987586190163029
ATP DEPENDENT	11.978343669528927
XENOPUS NOCTURNIN	11.96522867693438
DIFFERENTIAL GENE	11.954592578408128
references	11.948259048986328
ENDOGENOUS C-CRK	11.936264893381374
EXTRACHROMOSOMAL	11.936264893381374
ESTROGEN-TREATED	11.936264893381374
SV40-TRANSFORMED	11.936264893381374
TRANSGENIC ARRAY	11.936264893381374
ANGLE MESENCHYME	11.936264893381374
SIGNALING NETWORK	11.92852024119044
carboxyl-terminal	11.925602217474808
XENOPUS	11.92301255468175
IΚBΑ DEGRADATION	11.906479714799644
OBJECTIVE FUNCTION	11.901157410080312
ECFP	11.886817894025148
PB/IM INTERFACE	11.882009397143001
ANTIGENIC DRIFT	11.882009397143001
MODE ESTIMATION	11.882009397143001
LYSOTRACKER RED	11.882009397143001
INTERTRABECULAR	11.882009397143001
INTRON SEQUENCE	11.877455120996764
ZN(II) ION	11.871279030706424
RRNAS,	11.843714830594024
MULTIPLE ALIGNMENT	11.837091514704278
KPNI	11.827354121368126
ARABIDOPSIS TF	11.824463732035419
CELL MIGRATION	11.824463732035419
PROTEIN PHOSPHATASES TYPE 1	11.809653796124275
DIFFERENCE CALL	11.80403455371358
finger domains	11.794742369806315
LEUCINE ZIPPER	11.767320874892562
CHELERYTHRINE	11.763202943717982
BOI1 FUNCTION	11.763202943717982
ACTINOMYCIN D	11.763202943717982
PRAZOSIN	11.762143572925332
PRIMARY MOTOR	11.751041416572118
SMG PHENOTYPE	11.749081652408552
PHYLOBROWSER	11.697714029173984
SOMITE STAGE	11.697714029173984
PECTORAL FIN	11.697714029173984
ORGANISM	11.695839209486639
BLOT ANALYSIS	11.643666656773304
PROTEIN KINASE C	11.634543459233027
OUTPUT PAGE	11.627369795765436
RANK NUMBER	11.627369795765436
SYNERGISTIC	11.627369795765436
NUCLEOPLASM	11.627369795765436
KKTK MUTANT	11.620174496313496
INCORPORATION	11.61223575058132
PROTΑ	11.606313919413342
U BASE PAIR	11.599959131186615
CD9 ANTIGEN	11.59944194883607
GENBANK	11.57097778121399
NCRNA GENE	11.551392235624405
OSTEOBLAST	11.551392235624405
INTERGENIC	11.551392235624405
MUSCLECHIP	11.551392235624405
TRANSITION	11.551392235624405
PG E	11.54746906835389
M/Z REGION	11.542856610622689
YQXP MOTIF	11.538114596732846
POP1	11.536607881376069
M/Z	11.49028396549672
Y152	11.483717971295542
T LYMPHOCYTE	11.483256792701436
TREATMENT	11.481970291350915
RNAS	11.474562198893342
FLAG-COP1	11.468799925589778
ANAEROBIC	11.468799925589778
EUKARYOTA	11.468799925589778
LOGNORMAL	11.468799925589778
OPTIC CUP	11.468799925589778
ADENOSINE	11.468799925589778
NONCODING	11.468799925589778
APOPTOSIS	11.463149814348393
LACTACYSTIN	11.449696135561632
EXPRESSION	11.449398991701397
HEART FAILURE	11.448717222527888
SOMATIC CELL	11.445528407890249
K	11.424928396227802
CRW RDBM	11.378330285961013
CLUSTALX	11.378330285961013
GFP-COP1	11.378330285961013
proteasome	11.340220172072419
GREEN FLUORESCENT PROTEIN	11.28443001295377
TELEOST	11.278320739213392
BS CELL	11.278320739213392
RECIPIENT OOCYTE MATURATION STAGE	11.27335757508471
BIPARTITE	11.272554374040944
MICROBIAL	11.272554374040944
EST CLONE	11.266513527504685
selections	11.248077877494076
RESAMPLED INFERENCE OF ORTHOLOGS	11.245842234960152
LOXP	11.205995539275209
EXPRESSION LEVEL	11.189772698366447
STEPWISE DISCRIMINANT ANALYSIS	11.18730302787542
GNRH-A	11.166519577867433
WNT/WG	11.166519577867433
POSITIVE RATE	11.16133127023241
PHOSPHATASE	11.15970726310534
CONTAINING ANTIBIOTIC	11.15641954326413
CYTOMETRY	11.145191192567346
ENDOGENOUS	11.140690492429728
CO-EXPRESSION	11.140343064377046
CONSENSUS SEQUENCE AR	11.135857898009325
STATISTICAL SIGNIFICANCE	11.108333433605814
DUCHENNE MUSCULAR DYSTROPHY	11.094855995816001
FIBRONECTIN MATRIX ASSEMBLY	11.091154676962569
GENE SYMBOL	11.090745999168048
METALLO-Β-LACTAMASE	11.05833978876093
PST I	11.039769875006002
RRNAS	11.039769875006002
BEAMS	11.039769875006002
SCORE	11.039769875006002
UNIVERSAL SEQUENCE MAP	11.027601408553604
INTER-PATIENT VARIABILITY	11.02702623478751
CALMODULIN BIND	11.01154564170643
PHORBOL MYRISTATE ACETATE	11.010285598577575
PLASMINOGEN	10.997416236826965
MAJOR PHYLOGENETIC GROUP	10.991202633582587
copies	10.989320633521896
MONKEY CV-1 CDNA LIBRARY	10.98451954393594
BINARY COMPLEX	10.976635109286576
PLASMINOGEN ACTIVATOR	10.975987803725676
PSEUDOPODIAL EXTENSION	10.969743621449908
SMAD1 IMMUNOPRECIPITATE	10.953973831871737
CELLULAR GENE	10.953551884939179
GSTORC4	10.940377294368915
PHYLOGENETIC RELATIONSHIP	10.93096790141047
EXTRACHROMOSOMAL ARRAY	10.915225073441555
HOST PROTEIN	10.903141591271353
BZIP	10.89344808145642
PJC3	10.89344808145642
VASP	10.89344808145642
H-4A	10.89344808145642
YDXP	10.89344808145642
RAC1	10.89344808145642
ASCI	10.89344808145642
U/UG	10.89344808145642
U/ΜG	10.89344808145642
HYDRODYNAMIC	10.886195110193928
RNASE PROTECTION ASSAY	10.879751578323962
OSCILLATORY BEHAVIOUR	10.874826944017052
PHOSPHATIDYLINOSITIDE	10.874826944017052
IGG	10.868461246288371
DOMAINS	10.86483505128414
AFFYMETRIX GENECHIP	10.848714357860148
TRANSGENE EXPRESSION	10.845972007764534
MATURATION	10.843089742940975
GLUCOSE	10.838566877225
ACTIN MICROFILAMENT	10.833402128224947
LYSOSOMAL POPULATION	10.83263276340693
INTERCELLULAR BRIDGE	10.83263276340693
EXPRESSION POTENTIAL	10.831910003014931
HYAL-2-INCREASED TNF	10.824524705918499
CONSERVATION DIAGRAM	10.823713900169656
INFLAMMATORY CYTOKINE	10.823129093090685
PUBMED IDENTIFICATION	10.81999589000424
JUN N TERMINAL           KINASE	10.819853423856191
ASSOCIATION	10.789168149663757
MC57 CELL	10.786000778118387
sulfates	10.784753785630462
POST-MITOTIC NEURON	10.779820557924397
P53 TRANSCRIPTIONAL	10.77753105806489
EYFP-CPLA	10.76310748064211
PROTEASOME INHIBITOR	10.762532374972787
EQUATOR	10.75671270398342
NF-ΚB TRANSLOCATION	10.754655981369766
D. DISCOIDEUM CELL	10.747903547498476
CORTICAL MYOSIN-II	10.74216312377816
PHYLOGENETIC LEVEL	10.74216312377816
IN SILICO ANALYSIS	10.741304320381264
CROSS HYBRIDIZATION	10.73956092655372
CONFOCAL	10.725629242628791
rules	10.72072537672364
AZT	10.720386131793028
BL6	10.720386131793028
PML	10.720386131793028
DLB	10.720386131793028
CD9	10.720386131793028
RCL	10.720386131793028
LRP	10.720386131793028
M.O	10.720386131793028
g/l	10.720386131793028
YSL	10.720386131793028
SRE	10.720386131793028
CYTOTOXICITY	10.705964438163555
SUPERFICIAL LAYER	10.693474873812198
REGULATORY MODULE	10.693474873812198
SELECTED MUTATION	10.693474873812198
LEUKEMIC LGL CELL	10.693474873812198
CYLINDRICAL SHAPE	10.693474873812198
COVARIATION SCORE	10.693474873812198
LIMIT FOLD CHANGE	10.691153601946928
FN	10.683948240530075
METABOLIC BEHAVIOR	10.681857150361129
ΜM EGTA	10.673324465855698
donors	10.66675806891337
N-TERMINAL REGION	10.645695600166723
MATURATION STAGE	10.64215357703054
RETRACTION FIBER	10.64215357703054
NON-NEUTRALIZING	10.64215357703054
NEURAL CELL FATE	10.64215357703054
CROSS-VALIDATION	10.64215357703054
REPORTER STRAINS	10.634773178797898
NON-FUNCTIONAL SNP	10.634114921405978
NF-ΚB INHIBITION	10.63337478755382
P27 ACCUMULATION	10.626804159847318
TRANSGENIC MOUSE	10.609302982323808
MAMMALIAN	10.606611977761421
EFFECT	10.605049698786628
GROWTH FACTOR	10.599234761366795
ERK ACTIVATION	10.595432370353077
POSSIBLE HELICE	10.587898080792169
ACIDIC LYSOSOME	10.587898080792169
HELICASE DOMAIN	10.587898080792169
glucocorticoids	10.587898080792169
TREATED HPB-ALL	10.587898080792169
SECONDARY MOTOR	10.587898080792169
POLARIZED GROWTH	10.585594999119632
NB LOCALIZATION	10.583705811211399
CONNECTIONS MAP	10.581028395344688
COX-2	10.5777985759729
FN ACCUMULATION	10.572852205302905
REPLICATE	10.565825665051818
ACID SUBSTITUTION	10.557504951882112
IMPORT	10.543997517011894
EVGFP	10.540792533818504
Β-GALACTOSIDASE	10.537688456467812
OMIM	10.5325226890325
POOLING SCHEME	10.530352415684584
PHOSPHOHISTONE	10.530352415684584
GENETIC EFFECT	10.526874154815019
propidium	10.52434073780433
SRC KM/CAS(SD)	10.523900802781359
GREEN FLUORESCENT           PROTEIN	10.497659705102196
LD	10.477490147153935
NETWORK MODEL	10.469091627367147
FILAMENTATION	10.469091627367147
PROMYELOCYTIC	10.469091627367147
AVERAGE SCORE	10.469091627367147
NADPH OXIDASE	10.469091627367147
DEVELOPING TM	10.469091627367147
GENE DELETION	10.469091627367147
ACYL COENZYME	10.469091627367147
NON-ESSENTIAL	10.469091627367147
NEGATIVE BIAS	10.469091627367147
GENOMIC LOCUS	10.46444056713428
SELECTION MAP	10.462525424685452
MUTANT EMBRYO	10.461494895653464
ERK1 ACTIVATION	10.458568266869392
GREEN           FLUORESCENT PROTEIN	10.457812438748736
N(T)KXD MOTIF	10.454621662198226
TERTIARY STRUCTURE	10.45376373834852
D1	10.452243933168559
C-TERMINAL DOMAIN	10.442991105249188
PROLINE	10.436517120182721
PMA TREATMENT	10.43145790571149
P19	10.423037878604594
Y142	10.41402983194643
EXPRESSION VALUE	10.408071055059684
CROSSLINKING	10.403602712823153
DAUNORUBICIN	10.403602712823153
BS CELL LINE	10.403602712823153
TNF-MEDIATED	10.403602712823153
MASS BALANCE	10.403602712823153
antiapoptotic	10.377975169976855
CONTROL GROUP	10.377844962821907
TOUCH	10.3751874992543
DIMER	10.350005686165444
MISSING COMPLETELY         AT RANDOM	10.34815677371788
USM COORDINATE	10.343445557578674
REPRODUCIBILITY	10.342958809489343
BMP-INDUCED	10.333258479414603
OUTPUT FILE	10.333258479414603
MIB-INDUCED	10.333258479414603
NM-MYOSINII	10.333258479414603
GENEFINDING	10.333258479414603
DELTA-NOTCH	10.333258479414603
MMCOP1 CDNA	10.322735902017046
PROTEIN EXPRESSION	10.322044133104413
endogenous	10.311546153202421
CYTOCHROME C	10.279646304497778
LAST OBSERVATION CARRIED FORWARD	10.275220009519744
WHOLE GENOME	10.268767988711966
SERUM         RESPONSE ELEMENT TRANSACTIVATION	10.265166490027116
DORSAL LIP	10.25728091927357
RAB FAMILY	10.25728091927357
CHR SAMPLE	10.25728091927357
KM/CAS(SD)	10.25728091927357
INTERACTOR	10.25728091927357
CONTAINING ANTIBIOTIC Β-LACTAM	10.256494534553063
SRC KINASE	10.248735744812594
MODE	10.247119419212108
RNAI	10.247119419212108
EXPECTED R	10.24400328038201
BINARY USM	10.243752758893491
GLUCOCORTICOID         RECEPTORS ACCUMULATION	10.24114244168124
STOCHASTIC CONTEXT FREE GRAMMAR	10.239459938402465
chromatography	10.239145191956261
consensus	10.219452258501963
Β-CATENIN	10.174688609238945
INFLUENZA	10.174688609238945
noncoding	10.174688609238945
N-PEPTIDE	10.174688609238945
OPERCULUM	10.174688609238945
YOLK MASS	10.174688609238945
OTH MODEL	10.174688609238945
TRANSWELL	10.174688609238945
COAGULANT	10.174688609238945
G1 ARREST	10.174688609238945
SEDIMENTATION COEFFICIENT	10.17463921640211
RNA STRUCTURE	10.171431000407752
TK MUTANT	10.167961936647151
C-TERMINUS	10.16514630133145
ADHESION	10.161990122714377
CALMODULIN CONCENTRATION	10.150494041277165
HMM	10.142824602729517
CAMPTOTHECIN	10.14244173486074
T ANTIGEN	10.136650616815412
BASELINE CHARACTERISTIC	10.133954655031076
SEPHAROSE	10.120163911665145
morphologic	10.111939866673103
GENE PRODUCT	10.109137889588736
layers	10.10725037352858
FORELIMB	10.084218969610177
AGGRECAN	10.084218969610177
QUIN2-AM	10.084218969610177
VERSICAN	10.084218969610177
SPECTRIN	10.084218969610177
ACIDIC PHOSPHOLIPID	10.08285333187896
ALGORITHM	10.072900721802405
BLASTOMERE	10.06578770636363
HOMOLOG	10.055486186166778
GREEN           FLUORESCENCE PROTEIN	10.046456346757632
CDK2	10.040791549190649
SINGLE BASE	10.037221582832249
HYBRIDIZATION	10.032711618879139
NORMAL LYMPHOBLAST	10.029587118084976
OLIGONUCLEOTIDE	10.02656490328233
GENOMIC	10.006365713780788
Β-LACTAM CARBONYL	10.006312189017391
CYTOSKELETON-ASSOCIATED TRANSCRIPT	10.001686002986713
noise	9.995229110953378
EQUATORIAL LIGAND	9.993823935359597
MITOGENIC	9.992272739422678
objectives	9.991195712206501
MUTANT DERIVATIVE	9.985758715290075
NIDOGEN	9.984209422862557
CAS(SD)	9.984209422862557
VEGETAL	9.984209422862557
CORNEAL	9.984209422862557
EQUATORIAL OXYGEN	9.983785300688522
MACROSCOPIC FOCI	9.980072677270664
HIV-1 INFECTION	9.954198135154204
TEMPLATE PRIMER	9.949002841224937
blood pressure	9.937623467570083
RNA	9.936152282822192
MMP EXPRESSION	9.927299318461491
BALANCED DIFFERENTIAL EXPRESSION	9.920537958236583
SIGNALING PATHWAY RAS-DEPENDENT	9.919093692952087
STATIN THERAPY	9.917980610427225
SELECTED GENE	9.917843250165037
LIPID-LOWERING	9.899528229474845
LOCALIZATION SIGNAL	9.897607077631765
TRANSCRIPTIONAL ACTIVITY	9.88503875688534
BINDING LOOP	9.874248616139363
BY/SNJ	9.872408261516602
INPUTS	9.872408261516602
BAM HI	9.872408261516602
PPD118	9.872408261516602
CLONAL	9.872408261516602
RAW264	9.872408261516602
HLA-DR	9.872408261516602
MM BDM	9.872408261516602
STROMA	9.872408261516602
SOMITE	9.872408261516602
CORNEA	9.872408261516602
BENZIMIDAZOLE	9.869784591548425
SYNERGIZE	9.859939343588412
ΜM CPT	9.856271342201198
NEUROTROPHIC	9.831944672560946
P53 TRANSCRIPTIONAL ACTIVITY	9.820473072267491
BAND SHIFT	9.801087719364574
DNA-BINDING	9.800191830340124
NACHR	9.798892762633335
MICROARRAY EXPERIMENT	9.796678570541605
MICROTUBULE	9.789380788538258
ΔN3	9.765262294174256
GONADOTROPE RESPONSIVENESS	9.763135138779322
SUPPRESSED GNRH-STIMULATED	9.763135138779322
CELL DEATH	9.759752154719768
EXPRESSING CELL	9.752338070365706
HIGH-ENERGY PHOSPHATE BOND	9.750867566410435
ANISOMYCIN	9.74593445012271
PAPER	9.745658558655167
INDUCIBLE	9.729753986994314
LOGARITHMIC TRANSFORMATION	9.729595453276595
HEPARINASE	9.729388469350152
HOST	9.726579903103733
PROTEIN-PROTEIN INTERACTION	9.717816546028619
FUNCTIONAL CHARACTERIZATION	9.715477917685394
AGONIST	9.715084487374863
ENDOTHELIAL CELL	9.713872959073761
PRIMARY DERMAL FIBROBLAST	9.712310639812074
Β-LACTAM	9.694423846988107
GENE EXPRESSION VALUE	9.692904201687929
ESTRADIOL-TREATED ANIMAL	9.692790905370776
MITOSIS PROMOTING FACTOR	9.689571426111774
STANDARD ERROR	9.685240906242054
NONFATAL	9.684357398215722
STATISTICAL PROPERTY	9.673909299670303
tests	9.661316448647996
MASS BALANCE CONSTRAINT	9.655562103659927
PROTEIN         KINASE B	9.654664189650509
MEAN	9.641748242071808
CARBOXYL-TERMINAL DOMAIN	9.64056379739143
ENHANCED GREEN           FLUORESCENT PROTEIN	9.63895881488292
SUPRACHIASMATIC NUCLEUS	9.638255807300517
ACS	9.631912642744371
ESTROGEN-TREATED MOUSE	9.616813345229744
LYSOTRACKER RED DND-99	9.616813345229744
GPNN	9.599336765105589
PPT1	9.599336765105589
LRP5	9.599336765105589
acyl	9.599336765105589
MDM2	9.599336765105589
NGN1	9.599336765105589
BEX1	9.599336765105589
ESTS	9.599336765105589
VEX1	9.599336765105589
BPNN	9.599336765105589
HEPARITINASE TREATMENT	9.580671676537834
MULTIPLE CLONING SITE	9.579860629768401
ORGANELLE	9.579570079891667
FOLATE	9.577072443117668
SHAM-TRANSFECTED CELL	9.57641521580524
PERIOCULAR MESENCHYME	9.57641521580524
STRATIFIED EPITHELIUM	9.57641521580524
RESVERATROL TREATMENT	9.569029808530045
SPARC-NULL FIBROBLAST	9.567230318432536
GSK3Β PHOSPHORYLATION	9.566445933257455
NTPDAS	9.55865139048609
TYR228	9.55865139048609
MIRACL	9.554105935940635
TOUCH RECEPTOR NEURON	9.550867710429085
YR	9.549672316005566
PHOSPHOENOLPYRUVATE	9.545649253754833
PRODUCTION CAPABILITY	9.542275125570848
SEQUENCE ALIGNMENT	9.537570760057225
BIOLOGICAL REPLICATE	9.53422103519512
TISSUE-SPECIFIC CELL	9.53422103519512
CIRCADIAN OSCILLATOR	9.53422103519512
ACTIVATED BMP TYPE I	9.53422103519512
STRUCTURAL VARIATION	9.53422103519512
DETERGENT EXTRACTION	9.520285311386878
FORMALDEHYDE SOLUTION	9.518217342686377
CLASSIFICATION ERROR	9.512467710226158
FLUORESCEIN-DEXTRAN	9.490063642368309
ARACHIDOYL COENZYME	9.490063642368309
CLASSIFICATIONERROR	9.490063642368309
CDC37	9.489129440614219
RECEPTOR BMP TYPE I	9.486244235913718
REGULATORY ELEMENT	9.482832839468335
REGULATORY NETWORK	9.482832839468335
IONIZING RADIATION	9.482625037253767
MIDDLE-LAYER NEURON	9.481408829712587
CONDITION DEPENDENT	9.479907995148011
SUBDOMAIN	9.474292707076815
DOCUMENTATION	9.468190154258636
BILE	9.468107948481014
ACTIN INCORPORATION	9.467268982443434
N-TERMINAL MUTATION	9.466043156462487
TRANSGENE INTRODUCTION	9.460507805432432
BBMV	9.450574288107905
POP2	9.447496951797524
G418	9.446269948386671
EPITHELIUM SURFACE	9.44375139556635
PROPOSED BASE PAIR	9.44375139556635
OVER-DETERMINATION	9.44375139556635
POSITIVE SELECTION	9.44375139556635
NONCODING SEQUENCE	9.44375139556635
PROTEIN INTERACTION	9.436504699529378
TNF SUPPLEMENTATION	9.433274083770765
FBA	9.426274815442195
IAP	9.426274815442195
ZWF	9.426274815442195
C57	9.426274815442195
CRK	9.426274815442195
DLD	9.426274815442195
TTT	9.426274815442195
GTPAS	9.425974653869421
DRIFT	9.425974653869421
ARCHAEAL	9.406580975435007
cell lines	9.404355302980905
GNRH-STIMULATED IP	9.40259017561504
BIOLOGICAL SAMPLE	9.395063145600385
MONKEY FIBULIN-1C	9.395063145600385
CELLULAR LOCATION	9.395063145600385
EXPRESSION CHANGE	9.390892756844062
ARP3 LOCALIZATION	9.390706296868649
UCB	9.370105146816305
NEAREST NEIGHBOR	9.359506734001528
NEIGHBORING CELL	9.359506734001528
AVERAGE POSITION	9.346526623515633
REFRACTIVE INDEX	9.343741848818729
BLASTOCYST STAGE	9.343741848818729
CINNAMYL-ALCOHOL	9.343741848818729
ARABIDOPSIS GENE	9.343741848818729
BLASTN ALIGNMENT	9.343741848818729
SN50-TREATED E15	9.343741848818729
CHF	9.34336779299639
MEC-3 EXPRESSION	9.343066010082676
CONFLUENCE	9.337957258876507
FIBROBLAST MODEL	9.335274996023921
CEE CYTOTOXICITY	9.334264746542724
PRIMARY CATEGORY	9.330761537530192
HEPATOCYTE	9.324109398260783
ACTIN NUCLEATION	9.31132193329505
Α-KETOGLUTARATE	9.289486352580358
STRUCTURE ENTRY	9.289486352580358
B-CELL IMMUNITY	9.289486352580358
TRAINED NETWORK	9.289486352580358
EVACUATION ZONE	9.289486352580358
SELECTION FRAME	9.289486352580358
MOLECULAR CLOCK	9.289486352580358
PM LOCALIZATION	9.285294082999588
IMPORT MACHINERY	9.281196249085134
MULTIPLE TISSUE	9.269846891481256
activation domain	9.267888378694272
DERMATAN SULFATE	9.251076848786678
IA	9.250787465471381
CATALYTIC DOMAIN	9.247545040045162
MICROARRAY SUITE	9.243746817717676
CONTROL SUBJECT	9.242363200595603
SEQUENCE SIMILARITY	9.24094918759899
TK SUBSTITUTION	9.239435787177293
SIDE EFFECT	9.235420532243841
CR	9.235234868957654
P107	9.232837246713217
MHCA	9.232837246713217
FATE	9.232837246713217
BI-DIRECTIONAL	9.231940687472774
TNF-RESISTANCE	9.231940687472774
RECONSTRUCTION	9.231940687472774
UNIDIRECTIONAL	9.231940687472774
MYRISTOYLATION	9.231940687472774
EPISTASISMODEL	9.231940687472774
STOPPED-FLOW FLUORESCENCE STUDY	9.229152776417173
PROTEIN PRODUCT	9.228984543744508
PROBE RESPONSE	9.227879773767189
ROSA26 GENOMIC	9.227178782710869
INHIBITORY RNA	9.226476206598456
PRIMARY DERMAL	9.21948932560507
WILD-TYPE BOI1	9.21765497318706
CAS SD CHIMERA	9.214596514031038
QR	9.214464107348618
BS	9.214464107348618
GC COMPOSITION	9.204354480576221
SEQUENCE ENTRY	9.194381541289994
GFP-EXPRESSING	9.194381541289994
DOWN-REGULATION	9.193958987515662
CYTOCHALASIN B	9.193845449377536
UPREGULATION	9.179727582520588
VARIABLE REGION	9.179442739264015
costs	9.178121309390635
GIBBS SAMPLER	9.170679899155337
AMINOTERMINUS	9.170679899155337
EMBRYONIC SMG	9.170679899155337
MODE ESTIMATE	9.170679899155337
BRDU-POSITIVE	9.170679899155337
UNBUDDED CELL	9.170679899155337
PROPOSED BASE	9.170679899155337
GROWING RASMC	9.170679899155337
MUSCLE BIOPSY	9.170679899155337
NOMINAL VALUE	9.170679899155337
INCYTEGENOMIC	9.170679899155337
PSI ALGORITHM	9.168126375890232
RNA ALIGNMENT	9.165342616920897
ARTERIAL FLOW	9.16330840746551
CELL MONOLAYER	9.160250940770268
S PHASE ENTRY	9.157436202221069
CAS SD DOMAIN	9.153739452128308
APOPTOTIC CELL	9.149562943440575
GLUCOCORTICOID	9.149388951039938
PERMEABILIZATION	9.132489684250126
CORONARY REVASCULARIZATION	9.130356633560371
HYALURONIDASE	9.126170866182525
HETERODIMER	9.122979638641638
MISCLASSIFIED	9.111014538983795
DEOXYCHOLATE	9.105190984611339
SYNAPTOJANIN	9.105190984611339
HNF3ΑLOXPNEO	9.105190984611339
ANGLE RECESS	9.105190984611339
DENUDED AREA	9.105190984611339
TRANSPOSABLE	9.105190984611339
VEGETAL POLE	9.105190984611339
FUNCTIONAL GROUP	9.104478347749552
EGF RECEPTOR	9.09856949779037
INPUT NEURON	9.09768880742502
COS7	9.096044870708186
CHLORTHALIDONE PARTICIPANT	9.083881187400724
DISTAL HINGE	9.08211610629584
DFZ2 PLASMID	9.082038150625854
WITHDRAWAL	9.067535579888904
LACTATE DEHYDROGENASE	9.058848285355413
PHASE ENTRY	9.034846751202792
DMD PATIENT	9.034846751202792
RATIOMETRIC	9.034846751202792
RAS-RELATED	9.034846751202792
CONTAMINANT	9.034846751202792
BZIP DOMAIN	9.034846751202792
CROSSLINKED	9.034846751202792
NEOEPIDERMI	9.034846751202792
UTILIZATION	9.034846751202792
PROHB-EGFEX	9.034846751202792
RAB PROTEIN	9.027917899770346
THIAMINE TRANSPORTER	9.027065431423978
T CELL LINE	9.026339993230055
TAIL SYMBOL	9.025709863009851
PERFORMANCE	9.024280019983216
MITOMYCIN C	9.024274066293819
HISTOLOGICAL	9.02189367325922
JNK PATHWAY	9.010972946569623
INTERACTIONS	9.010270521976953
ARCHITECTURE	9.010270521976953
NORMAL PBMC	9.005243233457664
TKT	9.004404178579321
PPP	9.004404178579321
RI	8.99772986943852
TETRACYSTEINE MOTIF	8.991851729545157
shapes	8.99172976813066
FUSION PROTEIN	8.984607664556982
SERPIN	8.983225792602248
WILD-TYPE	8.976520699779229
AFFINITY COMPONENT	8.975738541485828
LAMELLIPODIA	8.965757657390593
cytoskeleton	8.965757657390593
TOPOISOMERASE III	8.965002155093696
RAB GTPASE	8.95886919106176
GPNN MODEL	8.95886919106176
GR-INDUCED	8.95886919106176
INGRESSION	8.95886919106176
GFP-MHCK-B	8.95886919106176
LOGP VALUE	8.95886919106176
INHIBITION	8.95886919106176
COS-1 CELL	8.95886919106176
ZYMOGRAPHY	8.95886919106176
P20-C/EBPΒ	8.95886919106176
CHI-SQUARE	8.95886919106176
BOI1-S-GFP	8.95886919106176
FIB-1C EGF	8.95886919106176
DORSAL FIN	8.95886919106176
IMPORTIN-Β	8.95886919106176
FORM STABLE DIMER	8.95198966924939
BDU NEURON	8.951805225543097
NEURAL CREST	8.949852703983963
IMMUNOFLUORESCENCE MICROSCOPY	8.949236315616291
BOVINE SERUM           ALBUMIN	8.946716360132825
CLINICAL BENEFIT	8.942511601862158
IMMUNOBLOT	8.936300439389862
TOTAL COST	8.931710384238114
REVASCULARIZATION	8.929554727403495
RECRUITMENT	8.926165426368073
PERSPECTIVE	8.926165426368073
MEAN RATIO	8.918064739834039
GUIDE TREE	8.916693161641511
LABELED CRNA	8.914463586617485
TRMA LYMPHOBLAST	8.913616064217752
HOSPITALIZED HF	8.909459994552755
FACTORS	8.907830779555246
LATRUNCULIN	8.904033761334361
CYTOKERATIN	8.904033761334361
AFFINITY UPTAKE	8.902709550359251
DROSOPHILA	8.888841601144993
LEUCINE	8.876444798113425
CELL FATE	8.876276881027135
CCR4 GENE	8.876276881027135
YOLK PLUG	8.876276881027135
CROSSOVER	8.876276881027135
BL6 MOUSE	8.876276881027135
P27 LEVEL	8.876276881027135
FIBRILLAR	8.876276881027135
A549 CELL	8.876276881027135
HNF3ΑLACZ	8.876276881027135
POSTNATAL	8.876276881027135
RADIATION	8.876276881027135
REFERENCE ORGANISM CURRENT STRUCTURE MODEL	8.873669550889728
WG SIGNAL	8.871798652394594
GAL4	8.867010500518349
RGS3 CDNA	8.866439634718214
MTT ASSAY	8.863965736476823
PRESENTATION	8.857226559541804
METAL ION	8.855310628792969
KINETIC STUDY	8.854778506847197
EVOLUTION	8.854138482173399
SD DOMAIN	8.853776512775836
IDO ANTISENSE	8.84993400635878
PHYSICAL INTERACTION	8.849523482598384
CYTOKINESIS	8.839113001882133
NF-ΚB P50	8.83055573799719
ACCESSION	8.826860769456506
NON-NEURAL	8.822771043020023
RESORPTION	8.822771043020023
GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR	8.811571492927403
NUCLEAR LOCALIZATION           SEQUENCE	8.806696937610559
COLLAGENASE	8.795603629405083
LDH ACTIVITY	8.791508212074646
BAYESIAN	8.785807241398366
ANTIZYME	8.785807241398366
INGROWTH	8.785807241398366
NN MODEL	8.785807241398366
dermatan	8.785807241398366
LYMPHOMA	8.785807241398366
UNBUDDED	8.785807241398366
PATHWAYS	8.785807241398366
MESHWORK	8.785807241398366
SYNDECAN	8.785807241398366
B. MORI APN	8.781843940707457
TYPE ENZYME	8.777448037469359
DECATENATION	8.77564423323274
KDA PROTEIN	8.766872970005554
CEPHALOSPORIN	8.758308362140248
ENVIRONMENTAL CONDITION	8.751216933486212
SALT ELUATE	8.7259587710714
HI	8.724824698470975
IMPUTATION	8.720200585477663
HEMATOXYLIN	8.718970295589104
EMBRYO	8.717497615376852
ITERATIVE	8.710374949364612
E10	8.709697272441584
Y-79 CELL	8.708779117966358
CYPROTERONE ACETATE	8.70758065788963
glutathione	8.705832059317721
K S VALUE	8.696682464421269
SPECIES T	8.693000590285365
IMMUNOFLUORESCENT	8.688088541103584
CLUSTAL	8.685797694650747
SYMBOLS	8.685797694650747
LIBRARY	8.685797694650747
PORCINE	8.685797694650747
DISPLAY	8.685797694650747
GDN-HCL	8.685797694650747
EFFECTS	8.685797694650747
FLUORESCEIN-DEXTRAN PH-DEPENDENCE	8.671510709416456
TRANSDUCE	8.664555007686715
COVARIATE	8.662653363051195
INTRACELLULAR LOCALIZATION	8.66201414007839
PERIPHERAL BLOOD MONONUCLEAR CELLS	8.661322829805682
CALF SERUM	8.653945748001275
CORONARY HEART DISEASE	8.653565159474406
ACETYL LEUCYL LEUCYL NORLEUCINAL	8.643995369291899
PHYLOGENETIC/CELL LOCATION GROUP	8.643995369291899
FOLD-CHANGE	8.639437026517696
HEPARIN/H	8.63190285977442
PROTEIN-PROTEIN INTERACTION DATA	8.62977464856164
PROTEASOME-MEDIATED DEGRADATION	8.615658555495646
STABLE TYROSINE PHOSPHORYLATION	8.605231060620609
CYTOPLASMIC LOCALIZATION SIGNAL	8.603754957009688
TRANSCRIPTION ACTIVATION DOMAIN	8.601693026638824
EVOLUTIONARY DISTANCE	8.595284922144817
FILAMENT	8.587258958488183
PROLIFERATIVE NEURAL PRECURSOR	8.586449704184314
ALTERED PSEUDOPODIAL EXTENSION	8.586449704184314
PASSING	8.583349762859665
dropouts	8.580496095779793
Β-GALACTOSIDASE ACTIVITY	8.579329336992394
TRANSDUCTION	8.577671204059866
DFZ2ΔC	8.57399653330479
ROSA26	8.57399653330479
KLENOW	8.57399653330479
BOWFIN	8.57399653330479
LRP6ΔN	8.57399653330479
SINGLE NUCLEOTIDE POLYMORPHISM	8.564348284431947
TRANSLATION	8.564049096327816
SV40-TRANSFORMED BS CELL LINE	8.556313434364036
METABOLIC PATHWAY UTILIZATION	8.556313434364036
SIGNAL	8.555480445026276
RECEPTOR ACTIVATED BMP TYPE I	8.552867036930722
GENE EXPRESSION DATA	8.550006935376414
IMMUNOFLUORESCENCE	8.526794416710292
CONSTITUTIVE EXPRESSION	8.525684598161904
TERTIARY STRUCTURE BASE PAIR	8.525188915866877
CROSS-VALIDATION CONSISTENCY	8.525188915866877
EPIDERMAL	8.525119308937898
SEQUENCE ALIGNMENT ALGORITHM	8.523050837175981
SEM	8.521592066073552
COARSE ORIGINAL DISTRIBUTION	8.519158942784717
SPARC-NULL DERMAL FIBROBLAST	8.518546762776374
P65	8.516319266325503
BTR175	8.514781801248045
P50	8.513136753714042
replication	8.512138502310668
GEL SHIFT	8.50582878099166
CONTROL GFP-EXPRESSING CELL	8.491163743255012
FUNCTIONAL RELATIONSHIP	8.486441951117497
EXPRESSION PROFILE	8.471899794438508
THREONINE558-PHOSPHOMOESIN	8.45970000132288
SPATIAL DISTRIBUTION	8.457353410669237
GHFT1-5 CELL PROLIFERATION	8.455693872221165
GSK3Β PHOSPHORYLATION SITE	8.452636853595338
margins	8.451160544750051
HETEROGENEOUS DISTRIBUTION	8.450838517595585
MRNAS	8.447246830443355
VINGA	8.447246830443355
ERROR	8.447246830443355
HYAL2	8.447246830443355
PBIGT	8.447246830443355
SPARC	8.447246830443355
APAF1	8.447246830443355
diets	8.447246830443355
BASES	8.447246830443355
TRANSFORMING GROWTH FACTOR	8.442997655311604
FIXATIVE	8.438586840414125
COS-7 CELL	8.433127992716582
TRANSITION PROBABILITY	8.43307723849129
RESVERATROL-TREATED BPAEC	8.425179369119256
MEMBRANE-LOCALIZATION TAG	8.425179369119256
COORDINATE REPRESENTATION	8.425179369119256
NEOMYCIN PHOSPHOTRANSFERASE	8.423609401645926
AR	8.42091134070698
BASE PAIR FREQUENCY TABLE	8.419585383822593
IN SITU RNA HYBRIDIZATION	8.41922985451614
SD	8.417281197194665
ratios	8.416443311198618
PHYLOGENETIC DISTRIBUTION	8.416414599530015
INTRON DISTRIBUTION TABLE	8.408345592468548
PEDF	8.40713042562551
EPITOPE	8.405544783136532
ENHANCED           CHEMILUMINESCENCE	8.400861968662877
CHAIN PHOSPHORYLATION	8.40045441942518
VECTOR	8.395221519679183
RESVERATROL CONCENTRATION	8.39294284368086
AVERAGE NEGATIVE ENTROPY	8.389355767914333
E-TP	8.388791164640665
C/EBPΒ C-TERMINAL DOMAIN	8.385625260201524
GUANINE NUCLEOTIDE STATE	8.382417849511173
CDNA MICROARRAY ANALYSIS	8.377912175864823
TRANSCRIPTIONAL MODULATOR	8.376424180143584
ACR1	8.369403945885256
C. ELEGAN TRANSFORMATION	8.367493257597397
IMMUNOHISTOCHEMISTRY	8.367388824394187
PROTEOME	8.366280569774345
SENSE	8.36534361448907
C-TERMINAL HYPERVARIABLE	8.364958247472552
CYTOSKELETAL ASSOCIATION	8.361706122513503
TRANSPORTER	8.353439649201793
CYSTEINE-HISTIDINE PAIR	8.352126966203484
ARABIDOPSIS TF SEQUENCE	8.352126966203484
TERTIARY STRUCTURE BASE	8.352126966203484
INTERMEDIATE EPITHELIAL	8.352126966203484
APICAL ECTODERMAL RIDGE	8.352126966203484
CORRESPONDING PROBE SET	8.352126966203484
STANDARD USM COORDINATE	8.352126966203484
INDUCED WOX1 EXPRESSION	8.351625198922038
CONSERVATION INFORMATION	8.351590166040992
LUCIFERASE REPORTER	8.348534676631235
DEVELOPMENTAL STAGE	8.346906553864013
CELL PROLIFERATION	8.344959006050033
PROTEIN-INTERACTION MAP	8.344322165884535
ANTI-FLAG	8.340077506760093
REPAIR	8.331880281544404
COMPARATIVE INFORMATION	8.324103696092774
INTRANUCLEAR INCLUSION	8.313378207773301
STATISTICAL COMPARISON	8.313378207773301
MODE ESTIMATION METHOD	8.313378207773301
SOUTHERN BLOT ANALYSIS	8.312467137231678
CONTROL GFP-EXPRESSING	8.310765693527877
CYTOPLASMIC LOCALIZATION	8.310125033082745
INTENSITY DISTRIBUTION	8.30492666399317
words	8.303638444732416
RTNF	8.300925036893776
PJC8	8.300925036893776
ARGO	8.300925036893776
BMP2	8.300925036893776
YQXP	8.300925036893776
PARP	8.300925036893776
HRMB	8.300925036893776
MGSA	8.300925036893776
ENOS	8.300925036893776
Y187	8.300925036893776
H-4B	8.300925036893776
serine	8.299015462524412
TRIMER	8.299015462524412
B-CELL	8.299015462524412
PARTICULATE FRACTION	8.29674114929497
POLYPEPTIDE CROSSLINKING	8.295346973551512
TWO-HYBRID INTERACTION	8.294154046344701
SOMITE STAGE EMBRYO	8.293228084735516
CONFOCAL MICROSCOPY	8.293228084735516
SELECTION CRITERION	8.293228084735516
AVERAGE	8.289621072429926
IP	8.28679554241779
BUFFER B	8.284030327019556
HISTONE	8.273512331818257
NON-NEUTRALIZING FACE	8.272980078348798
ASSEMBLY INTERMEDIATE	8.272980078348798
INHIBITOR LACTACYSTIN	8.272980078348798
CRE-MEDIATED EXCISION	8.272980078348798
BASAL EPITHELIAL CELL	8.272980078348798
UBIQUITIN-INDEPENDENT	8.272980078348798
COVARIATION ALGORITHM	8.27002350190693
BOI1-GFP LOCALIZATION	8.268340527624636
C-TERMINAL TRUNCATION	8.267594885543968
PROBE RESPONSE FACTOR	8.266820115784341
C-TERMINAL YDXP MOTIF	8.258220661031856
IMMUNOBLOT ANALYSIS	8.255228741612578
GENE-GENE INTERACTION	8.254013361551912
HNF3ΑΔPGK-NEO ES CELL	8.251817215396484
FLOW CYTOMETRY	8.249168073349841
MITOGENIC STIMULATION	8.247495222258335
RETINA	8.246825588757808
ALM/BDU CELL DIVISION	8.241235783920327
CYTOTOXIC INTERACTION	8.239421226209792
CYTOSKELETON FRACTION	8.232191123534388
UROTHELIAL CARCINOMA	8.230785897738675
YOLK SYNCYTIAL LAYER	8.230785897738675
EXPERIMENTAL PROGRAM	8.230785897738675
P35-C/EBPΒ SYNERGIZE	8.230785897738675
OTHER MICROEXTENSION	8.230785897738675
RENAL CELL CARCINOMA	8.230785897738675
NEAREST CONTACT SITE	8.230785897738675
TRANSDUCTION PATHWAY	8.230785897738675
RHODAMINE-PHALLOIDIN	8.230785897738675
COCKE YOUNGER KASAMI	8.230785897738675
OLIGODEOXYNUCLEOTIDE	8.230785897738675
D. DISCOIDEUM MYOSIN	8.228810512747032
MYC EPITOPE	8.227969810805279
CLUSTERING ALGORITHM	8.227871236550024
REFERENCE SEQUENCE	8.227869377630054
NORMALIZATION FACTOR	8.226204289911308
COLONY HYBRIDIZATION	8.225718361808406
DEVELOPMENTAL SIGNAL	8.225013170724258
AMPLITUDE RHYTHMICITY	8.222718278837053
PROAPOPTOTIC PROTEIN	8.222435879494299
SYNERGISTIC EFFECT	8.222351045725949
ZD	8.222000200354529
SOMATIC CELL NUCLEUS	8.21970656452467
TERTIARY INTERACTION	8.212088071245438
ACTIN STRESS FIBER	8.205782831523173
BLASTOCYST FORMATION	8.205779739129495
ANTI-FLAG ANTIBODY	8.203996970019823
PHOSPHORYLATE SERINE	8.200031196920488
LOCALIZATION SIGNALS	8.199980171021695
CYTOSOLIC FRACTION	8.197698790188205
CELL CYCLE ARREST	8.196620224904217
OPTIMAL UTILIZATION	8.186628504911866
CONSENSUS STRUCTURE	8.186628504911866
CELLULAR METABOLISM	8.186628504911866
GLUCOSE-OXYGEN PHPP	8.186628504911866
MICROBIAL DIVERSITY	8.186628504911866
PATHWAY UTILIZATION	8.186628504911866
METANEPHRIC ADENOMA	8.186628504911866
IMMUNOPRECIPITATION	8.185644833145759
SMAD1 PROTEIN LEVEL	8.181145604286591
KKTK MUTANT VERSION	8.180934760104561
PROTEIN PHOSPHATASE	8.178404153973954
SUPPLEMENTATION	8.175965856863058
PROMOTER ACTIVATION	8.173334058481839
MISSING INTERACTION	8.168212079659126
INTERACTION DATASET	8.168212079659126
DIAGNOSTIC ACCURACY	8.165202566264165
EXTRACTION BUFFER	8.160673230298336
WOUND CONTRACTION	8.15915750790344
SINGLE NUCLEOTIDE	8.157574450255254
REPORTER	8.15358306769337
INDUCIBLE CELL LINE	8.142705330684079
METABOLIC GENOTYPE	8.140316258109907
NEGATIVE SELECTION	8.140316258109907
HERITABILITY VALUE	8.140316258109907
PHOSPHOTRANSFERASE	8.140316258109907
DIMETHYLSULPHOXIDE	8.140316258109907
IMMUNOLOCALIZATION	8.140316258109907
LIMITED PROTEOLYSI	8.140316258109907
FASTGROUP ANALYSIS	8.139028053014561
SΑ I2 LOCALIZATION	8.137361093600584
CACODYLATE BUFFER	8.135785429953625
NUCLEOTIDE PATTERN	8.130747413619382
FINAL CELL DENSITY	8.13002595312208
mesenchymal	8.128422743039282
ΔLZ	8.127863087230383
P12	8.127863087230383
IVM	8.127863087230383
CIS	8.127863087230383
PDF	8.127863087230383
PKN	8.127863087230383
CY5	8.127863087230383
CGR	8.127863087230383
PCMV5	8.12652759449364
ANTI-COP1 ANTIBODY	8.124058221389328
DISTRIBUTION TABLE	8.12218032780119
TRITON	8.114471817256456
REFERENCE ORGANISM	8.110509857455513
GENBANK DATABASE	8.106058804546436
WEIGHT LOSS	8.101728372521023
excitation	8.101296761545095
PLATELET	8.100080201801182
alignment algorithm	8.098782156456291
Β-ACTIN	8.097172807386249
CELL MOTILITY	8.095458736453011
RAS-RELATED GTPAS	8.091628008143942
EXPERIMENTAL BIAS	8.091628008143942
SEGMENT DYSGENESI	8.091628008143942
CLUSTERING METHOD	8.091628008143942
C/EBPΑ-EXPRESSING	8.091628008143942
ALA GFP-MYOSIN-II	8.091628008143942
SPARC-NULL DERMAL	8.091628008143942
HYAL-2-EXPRESSING	8.091628008143942
HELICASE ACTIVITY	8.091628008143942
BOVINE TESTICULAR	8.091628008143942
PLASTIC COVERSLIP	8.091628008143942
negative control	8.086729719656232
AVERAGE INTENSITY	8.086660711569563
DIETARY TREATMENT	8.08469261628526
CACL	8.083991755377657
EARLY-BORN NEURON	8.083257707624842
MEMORY REQUIREMENT	8.078574428182945
PROTEOLYSIS ASSAY	8.076510828380798
BIND PHOSPHOLIPID	8.076456838453073
WILD-TYPE BOI1-PH	8.076456838453073
APOPTOTIC NUCLEUS	8.075797222379556
IONOPHORE	8.071918779787872
DISTAL PIPERAZINE NITROGEN	8.06651696969441
LAMININ	8.064818767427143
C/EBPΑ REGULATION	8.064222024186241
DIPHTHERIA TOXIN	8.057573106793845
MYOSIN II ABSENCE	8.052757556098763
LIPID STIMULATION	8.0501183910626
BASAL EPITHELIAL	8.040306711362286
MICROVASCULATURE	8.040306711362286
ENDOGENOUS RAB24	8.040306711362286
SMAD1 INTERACTOR	8.040306711362286
ANTI-PHOSPHO-P44	8.040306711362286
VIRAL QUASISPECY	8.040306711362286
SN50-TREATED SMG	8.040306711362286
ANDROGEN-INDUCED	8.040306711362286
FORMAZAN PRODUCT	8.040306711362286
EXPRESSION RATIO	8.039630872626233
ANDROGEN CONTROL	8.03793068572044
PROAPOPTOTIC P53	8.03476528278894
IDO-EXPRESSING RAW CELL	8.034457964291404
SERUM-FREE MEDIUM	8.033575492592407
CALMODULIN STOICHIOMETRY	8.033276185584056
PEDF-RECEPTOR INTERACTION	8.03237800613476
SIMULATED GENOME	8.031306873229678
CONFIDENCE RATING	8.019322858978946
N-TERMINAL A-BOX	8.017502434010648
PBMC	8.012118873543569
VELOCITY SEDIMENTATION	8.01210522340266
CALMODULIN INTERACTION	8.011828698519057
HNF3ΑΔPGK-NEO ES	8.011044079773217
MOBILIZATION	8.01048139635078
PARAMETER VALUE	8.010161007655086
APN ENZYMATIC ACTIVITY	8.010089855270476
excitation filters	8.007333855190296
NORTHERN ANALYSIS	8.004377040793672
EXPRESSION DATA	7.998877769042221
PUBMED	7.9944017167914385
LIPID-LOWERING THERAPY	7.993001212982989
EXTRACELLULAR MATRIX PROTEIN	7.990944426188757
CSN5	7.988129131927183
POLYADENYLATION	7.986051215123915
G1 PROLONGATION	7.986051215123915
ANGLE STRUCTURE	7.986051215123915
DORSAL FIN FOLD	7.986051215123915
P27 DEGRADATION	7.986051215123915
PAIRED POSITION	7.986051215123915
MYRISTOYL GROUP	7.986051215123915
DIVERGENCE TIME	7.986051215123915
MOLEGO APPROACH	7.986051215123915
QUASISPECIATION	7.986051215123915
TGF-Β1-MEDIATED	7.986051215123915
CCAF-INDUCED TN	7.986051215123915
MNOC EXPRESSION	7.985388741405721
ENOS EXPRESSION	7.985388741405721
DEFINED GENOMIC	7.981185187931949
C-TERMINAL YDXP	7.981185187931949
NP40 LYSIS BUFFER	7.978337529974304
NORMAL BLM CDNA	7.9783024704011645
CDNA EXPRESSION	7.973765624321597
AFFYMETRIX CHIP	7.973474406381605
EXTRACELLULAR SIGNAL REGULATED KINASE	7.97194461054405
CONSENSUS CODON	7.971453133548021
TARGETING MOTIF	7.970912463860024
GEL FILTRATION	7.965987159629098
CRE RECOMBINASE	7.964994809774056
INTERACTION MAP	7.962043320698447
FLUORESCEIN           ISOTHIOCYANATE	7.96070010549054
DELETION ALLELE	7.958801462848912
RNA INFORMATION	7.955801525451763
ARABIDOPSI	7.9534559187659735
CO-TRANSFECTION	7.950891516395309
PRIMARY	7.948913793927494
TGF Β INDUCED FACTOR 2	7.944696976550929
CARRYING INSERTION	7.9364908259536335
BINARY COMPLEX E-TP	7.9358206991838784
CHONDROITINASE ABC	7.9348338798859235
TRYPSINIZATION	7.932887702432049
SECONDARY PREVENTION	7.932176405560936
SUBENDOTHELIAL	7.928505550016331
AGGRESOME-LIKE	7.928505550016331
SMAD-REGULATED	7.928505550016331
SΑ I2 FUNCTION	7.928505550016331
BLOOM SYNDROME	7.928505550016331
ENDOGENOUS ARR	7.928505550016331
IMMUNOELECTRON	7.928505550016331
SEGMENT LENGTH	7.928505550016331
CELL CARCINOMA	7.928505550016331
NON-SYNONYMOUS	7.928505550016331
BRANCHIAL ARCH	7.928505550016331
TGF-Β1-INDUCED	7.928505550016331
TET-RESPONSIVE	7.928505550016331
REDUCED NUMBER	7.928505550016331
AGAR	7.927404964254439
BEM1	7.927404964254439
MAS4 ALGORITHM	7.925891170931363
RETROVIRAL	7.9255798823999495
BOI1-PH ABILITY	7.923624509912091
LACZ TRANSGENE	7.919414640925423
PROTEASE INHIBITOR COCKTAIL	7.919099946297876
segments	7.91683317194126
RASMC ADHESION	7.916384337895119
C3	7.916052379136806
TH	7.916052379136806
IG	7.916052379136806
BLM C-TERMINUS	7.914219835730616
WORKING BUFFER	7.913517259618205
GNRH SECRETION	7.908752463596578
REPRESSOR	7.907829751983437
ΜM RESVERATROL	7.906989657595794
entropy	7.905168757172283
PRODUCTION	7.904951776122387
TOUCH RECEPTOR	7.902501409229583
KK SUBSTITUTION	7.8951260213083465
R LIGAND	7.887844731388123
MAMMALIAN COP1	7.88676641958155
CALMODULIN BOUND	7.885048147406911
ALLHAT	7.884763540649584
AZT RESISTANCE	7.876892646790525
EJECTION FRACTION	7.874329785302189
IMMUNOLABELING	7.8731610435834805
SPHERICAL CAP	7.867244761698894
INPUT EXAMPLE	7.867244761698894
CONTAINED PIP	7.867244761698894
PH-DEPENDENCE	7.867244761698894
FUNCTIONALSNP	7.867244761698894
OSTEOSCLEROSI	7.867244761698894
MSN50-TREATED	7.867244761698894
EURYARCHAEOTA	7.867244761698894
MONKEY LTBP-3	7.867244761698894
BOI1-PH(KKTK)	7.867244761698894
RRNA POSITION	7.864273742234554
MUTUAL CHANGE	7.864042392358231
RETROVIRAL LTR	7.863548285059066
DNA REPLICATION	7.862415255935207
LIBRARY CLONE	7.862070072168287
INCREASED TNF	7.860141324252334
INTENT TO TREAT	7.8593583044606365
EGFP	7.84992129438752
SINGLE CHANGE	7.846787985942294
MEK1 INHIBITION	7.844760222884743
WOUND CLOSURE	7.842493992386974
segmentations	7.842493992386974
IMPORT SIGNAL	7.837769231922154
LOCALIZATION PATTERN	7.837416737578454
revascularization	7.834911655271677
CYSTEINE PAIR	7.8346873400688235
LATRUNCULIN B	7.830036279835955
DECARBOXYLASE	7.822473111641862
CELL CYCLE S PHASE	7.818105547407719
SMAD1 ABILITY	7.807575887147783
EXERCISE	7.804854748652631
FLUORESCENCE INTENSITY	7.802259199397934
OVER-FITTING	7.801755847154897
CANCER GROUP	7.801755847154897
GFP-LABELLED	7.801755847154897
MPF ACTIVITY	7.801755847154897
ELK-1(1-209)	7.801755847154897
CNMCRESEARCH	7.801755847154897
BIOGEOGRAPHY	7.801755847154897
KKTK VERSION	7.801755847154897
NON-SURVIVOR	7.801755847154897
CYTOCHALASIN	7.801755847154897
PROLINE-RICH	7.801755847154897
INTERSTITIAL	7.801755847154897
ELK-1(1-140)	7.801755847154897
PRODELHB-EGF	7.801755847154897
RETINAL CELL	7.801755847154897
OCL FUNCTION	7.801755847154897
LOXP ELEMENT	7.801755847154897
CHEMOATTRACT	7.801755847154897
SPLICEOSOMAL	7.801755847154897
MINIMAL ESSENTIAL           MEDIUM	7.8010202200790335
LENS	7.795634938638925
RAB24 MUTANT	7.794352657028673
DIFFERENTIATION	7.792825303222598
EXTRACELLULAR	7.78153048358169
ΜM CALYCULIN	7.781276187427448
SUCROSE	7.777677363638299
COLLAGEN GEL	7.7686746039136025
NOREPINEPHRINE	7.763918805240177
GEL ELECTROPHORESI	7.761519002665707
DATASET	7.758284717333981
PROSTAGLANDIN	7.756545182241364
HETERODIMERIC	7.75111894530302
MOUSE EMBRYO	7.750071985684533
WOUND TISSUE	7.750071985684533
BINDING SITE TRANSCRIPTION FACTOR	7.748399139333678
N-TERMINAL TRANSACTIVATION DOMAIN	7.74740645818609
HF DIAGNOSIS	7.747049042014842
MULTICELLULAR	7.739849068584919
GENE TRANSCRIPTION	7.739752511649302
GENOMIC SEQUENCE	7.7357627932446125
RANDOMIZATION	7.734840234487985
FUSION RATE	7.731411613746349
NOVEL NCRNA	7.731411613746349
RADIAL GLIA	7.731411613746349
OSCILLATION	7.731411613746349
ENUCLEATION	7.731411613746349
HU-POSITIVE	7.731411613746349
CHROMOPHOBE	7.731411613746349
GENOME-WIDE	7.731411613746349
WORD LENGTH	7.731411613746349
CONSTRAINTS	7.731411613746349
MEROBLASTIC	7.731411613746349
ENDOTHELIUM	7.731411613746349
PERVANADATE	7.731411613746349
OSTEICHTHYE	7.731411613746349
PATH LENGTH	7.731411613746349
EPR SPECTRUM	7.73140090391191
TAT PROTEIN	7.72857407805563
ADDITIONAL FILE	7.728183931302162
MUTANT SN50	7.724216314294409
LIMIT CYCLE	7.722548285080144
RGD PEPTIDE	7.721084805230607
HIV-1 GP120	7.717832018450419
GENOMIC PCR	7.713907426710474
MORPHOGENESI	7.70965870973969
OPTIMIZATION	7.70965870973969
LYMPHOBLAST	7.708164699138685
transgenic	7.705551753420257
MITOCHONDRION	7.701885505890049
P60	7.6918928797226
RAS	7.6918928797226
ODC	7.6918928797226
BASE COMPOSITION	7.690208635158626
EXTRACELLULAR SIGNAL REGULATED KINASE ACTIVATION	7.6897559950938295
DIVIDING CELL	7.68735452581733
CSN MUTANT	7.686296530991445
LEU2	7.683733689741233
INTERACTING PROTEIN	7.679209982984595
ACTIN STRESS	7.663760189739153
MAJOR HISTOCOMPATIBILITY COMPLEX	7.662887606806337
TREATMENT GROUP	7.662295953977671
MONKEY CD9	7.655434053605317
AUTOPHAGIC	7.655434053605317
DOTMAC/PFA	7.655434053605317
NEW SOMITE	7.655434053605317
RETROVIRUS	7.655434053605317
IAP INSERT	7.655434053605317
ANGIOGENIC	7.655434053605317
HERBIMYCIN	7.655434053605317
ADENO-ΒGAL	7.655434053605317
MICROSPIKE	7.655434053605317
BLASTOPORE	7.655434053605317
BIND SMAD1	7.655434053605317
NOVAFECTOR	7.655434053605317
MH2 DOMAIN	7.655434053605317
QUERY PAGE	7.655434053605317
POLYPHENOL	7.655434053605317
subdomains	7.655434053605317
BLASTODISC	7.655434053605317
DIMERIZATION	7.65142007822225
BLAST MATCH	7.650797852698332
TRMA CELL	7.639940858985369
EGTA	7.637045217903216
PARTICULATE	7.6276048793107325
NG/ML CCAF	7.626754353599548
CLINICAL PROTEOMICS PROGRAM DATABANK WEBSITE	7.621448440995132
blot analyses	7.618781882733103
Β-LACTAMAS	7.614383890351979
CARBAPENEM	7.614383890351979
MOTILITY	7.608625490041314
TYPE P51	7.605841007407577
protein kinases	7.605284149006253
TISSUE PLASMINOGEN ACTIVATOR	7.604865817353225
DNA TRAP	7.60377860464817
HF EVENT	7.602704360326326
RISK GROUP	7.6016596160945
NP FRACTION	7.596803283929648
HOMO SAPIEN	7.588480298484752
CELL GROWTH	7.587017809879617
MAB 6B12	7.583773023098294
POLYPEPTIDE	7.583451199952451
MARITIMA	7.574299467920767
SIGNALING PATHWAY RAS-DEPENDENT ACTIVATION	7.5742225261742835
CARCINOMA	7.572841743570692
RAB24(WT)	7.572841743570692
OTHER RAB	7.572841743570692
CALYCULIN	7.572841743570692
LOGARITHM	7.572841743570692
CROSSLINK	7.572841743570692
IL-1-BETA	7.572841743570692
SNP NOISE	7.572841743570692
BRANCHIAL	7.572841743570692
RECURSION	7.572841743570692
C-FOS SRE	7.572841743570692
MTT VALUE	7.572841743570692
GOLGI MEMBRANE	7.572561608182154
ACCURACY	7.572080929573765
INCREASING AMOUNT	7.571033149980297
S6 KINASE	7.570175514962878
JUN N TERMINAL           KINASE ACTIVATION	7.568086379627113
GROWTH ARREST	7.566970353852234
DIFFERENTIAL GENE EXPRESSION	7.561349020624052
PARALLEL	7.5602652396576735
NOVEL CBP	7.559787284632438
MUTANT RECEPTOR	7.5597372578922215
ECFP-CPLA	7.553912665294389
NON-MUSCLE	7.543573620605251
ESTIMATION	7.543573620605251
falciparum	7.543573620605251
OVEREXPRESSION	7.539786719898856
MAJOR HISTOCOMPATIBILITY           COMPLEX	7.538814026172881
STRUCTURAL CLASS	7.5345569414270885
KK MUTANT	7.531520754792523
TOBACCO BUDWORM	7.515774104276547
PROTEASOME-MEDIATED DEGRADATION PATHWAY	7.512223163912177
TETRAPLOID	7.509921684725022
TAMULUS	7.508745898550565
QUASI FIND	7.503344735392905
VANADYL	7.494115475466986
OBESITY	7.487071197686001
MODERATE	7.482372103941923
MZ VALUE	7.482372103941923
BLASTULA	7.482372103941923
BIT-WISE	7.482372103941923
DATABANK	7.482372103941923
endoderm	7.482372103941923
UNITS/NG	7.482372103941923
MEC-3GFP	7.482372103941923
PERFORIN	7.482372103941923
TXT FILE	7.482372103941923
PYRUVATE	7.482372103941923
GENOMICS	7.482372103941923
ANAPHASE	7.482372103941923
UNGAPPED	7.482372103941923
drainage	7.482372103941923
BLM CDNA	7.472925862913807
RECOMBINASE	7.469179726285045
OPTIMAL METABOLIC PATHWAY UTILIZATION	7.464752634149653
MESENCHYMAL DIFFERENTIATION	7.452513850249829
RAB24 C-TERMINAL HYPERVARIABLE DOMAIN	7.451035756962606
FLUORESCEIN ISOTHIOCYANATE	7.449420483172687
MOLECULAR BIOCHEMICAL	7.442196236351891
SER224	7.441613394822853
SUBMANDIBULAR         SALIVARY GLAND	7.440096370790277
DENATURING GRADIENT GEL ELECTROPHORESIS	7.438408209134089
ASN233	7.434946728156186
OLIGONUCLEOTIDE MICROARRAY	7.432950991275359
ionophore	7.427014244339182
genotypes	7.427014244339182
PSEUDOPOD	7.427014244339182
AHAB FIND	7.426077977931533
MM HG	7.418186008234581
PROTEOMICS PROGRAM DATABANK WEBSITE	7.414782530149041
SEXTA	7.408687438949424
NOTI	7.407187829830455
REGULATING SUBCELLULAR LOCALIZATION	7.406739260546748
UM	7.40364938375883
filtration	7.402725267396207
PRIMARY ANTIBODY	7.395013457843271
GRAPHICAL USER INTERFACE	7.389457170438131
STEADY-STATE	7.388395535602067
KRUPPEL	7.382362557194303
TAILBUD	7.382362557194303
LRP/ARR	7.382362557194303
PLATEAU	7.382362557194303
ADENOMA	7.382362557194303
CHORION	7.382362557194303
CONTACT	7.382362557194303
STROMAL	7.382362557194303
NONLINEAR	7.381992768936647
COMPUTATIONAL ANALYSIS	7.376879757255798
PI ASSAY	7.375638064492568
TRANSCRIPTION FACTOR	7.373660982842086
GHFT1-5 PITUITARY PROGENITOR CELL	7.362034917894807
UBIQUITIN-INDEPENDENT DEGRADATION	7.362034917894807
STRUCTURED         SINGULAR VALUE	7.362034917894807
COVARIATION-BASED STRUCTURE MODEL	7.362034917894807
CONSERVED RNA SECONDARY STRUCTURE	7.358531309276675
TCDCA	7.358028402761918
orders	7.338379969190122
6B12	7.33466632307945
CCR5	7.328149610892758
SECONDARY STRUCTURE CONSERVATION	7.327736293981914
G PROTEIN	7.327379706929138
SUBCELLULAR LOCALIZATION PATTERN	7.326664658577802
PROPIDIUM IODIDE	7.3237588607599005
SUBSET	7.32373938363089
SWISSPROT	7.315320097431893
cytotoxic	7.315320097431893
GENE EXPRESSION LEVEL	7.305599831229731
ECTODERM	7.299337893335992
ENDOSOME	7.299337893335992
MOUSE            NOCTURNIN CDNA	7.296619931520235
ZNCL	7.291221575168171
C-TERMINAL HYPERVARIABLE DOMAIN	7.288727558926056
DMEM	7.287243531101449
EPITHELIAL CELL DIFFERENTIATION	7.285551295183163
EXTRACELLULAR PROTEIN	7.282444181178467
CAS SD TYROSINE PHOSPHORYLATION	7.281957609096227
FLUORESCEIN-CONJUGATED DEXTRAN	7.276973912662665
CINNAMYL-ALCOHOL DEHYDROGENASE	7.276973912662665
MESENCHYMAL-EPITHELIAL NETWORK	7.276973912662665
SΑ I2 SUBCELLULAR LOCALIZATION	7.27118400364695
SC-URA	7.270561395848348
PPACPL	7.270561395848348
RHYTHM	7.270561395848348
NON-CN	7.270561395848348
CAUDAL	7.270561395848348
GUTELL	7.270561395848348
TBS-TX	7.270561395848348
HIS-UB	7.270561395848348
MIG-13	7.270561395848348
STANZA	7.270561395848348
SSPE-T	7.270561395848348
RESIN	7.267513359388393
TRANSCRIPTION FACTOR TITRATION	7.265851025721182
MHCK C	7.261989967276919
S O	7.261033824290313
BAYESIAN POSTERIOR PROBABILITY	7.257650241165081
AFFYMETRIX MICROARRAY	7.2552042383196245
ORC	7.252747470731346
precursor	7.251510720684146
SMAD1 PROTEASOMAL DEGRADATION	7.246837642842386
Β-CATENIN DESTRUCTION COMPLEX	7.246837642842386
INDICATED EXPRESSION PLASMID ΜG	7.245036748113104
NORMAL GFP-BLM FUSION PROTEIN	7.242199425114698
SUBMITOCHONDRIAL LOCALIZATION	7.241756415857374
REACTIVE OXYGEN SPECIES	7.240044878469992
U BASE	7.2372280625150145
FLOW	7.231121385403515
CELLULAR PROLIFERATION	7.224911086355189
IN VITRO TRANSCRIPTION	7.222861334395032
DETERGENT CONCENTRATION	7.219875593035883
MYOFIBROBLAST DIFFERENTIATION	7.216443800447374
INTERMEDIATE EPITHELIAL CELL	7.2157131243452275
SUPPRESSED GNRH-STIMULATED IP	7.215382428173263
VOL	7.212205869074582
CLUSTERING ANALYSIS	7.209999127478761
SMAD-REGULATED TRANSCRIPTION	7.204380813500866
NM PMA	7.200407549694502
PROBABILITY DENSITY FUNCTION	7.196749295956402
INDICATED EXPRESSION PLASMID	7.195290136562463
NON-SPECIFIC CELL ATTACHMENT	7.1923469786518535
CHONDROITINASE ABC TREATMENT	7.190546470455567
IMMOBILON P MEMBRANE	7.184509630097404
PROTEOMICS PROGRAM DATABANK	7.1835333386260976
MICROEXTENSION PRESERVATION	7.1835333386260976
SECONDARY STRUCTURE ELEMENT	7.1835333386260976
WTPAI-1 INHIBITORY ACTIVITY	7.1835333386260976
MICROEXTENSION CYTOSKELETON	7.1776448768138215
INCLUSION BODY ACCUMULATION	7.1716119128711835
MODEL GENE-GENE INTERACTION	7.16995407658521
PCR PRODUCT	7.169931505756497
PAIRWISE SEQUENCE ALIGNMENT	7.169751832256941
IMMUNOFLUORESCENT MICROSCOPY	7.164061644391453
CHEMOTAXI	7.162947360742941
DETERGENT EXTRACTION BUFFER	7.161277073235657
SEQUENCE CONSERVATION	7.160250324133559
QUANTITATION	7.153120338081559
NEAREST NEIGHBOR STATISTIC	7.15022420980123
PHYLOGENETIC/CELL LOCATION	7.15022420980123
MORPHOLOGICAL PRESERVATION	7.15022420980123
ANTI-BOI1 IMMUNOREACTIVITY	7.15022420980123
PHEROMONE RESPONSE NETWORK	7.146970500886131
PHEROMONE RESPONSE PATHWAY	7.146970500886131
BT	7.145974651072194
ORIGINAL DISTRIBUTION TYPE	7.144316553983034
HG	7.144069889167433
HNF3Α	7.143811692986913
TIAF1	7.143811692986913
MSN50	7.143811692986913
SMAD2	7.143811692986913
OFTHE	7.143811692986913
WOESE	7.143811692986913
GPMAB	7.143811692986913
THY-1	7.143811692986913
KNIRP	7.143811692986913
HUVEC	7.143811692986913
PY967	7.143811692986913
PHAGE	7.143811692986913
EA471	7.143811692986913
RAB24 HYPERVARIABLE DOMAIN	7.137404596675743
INCREASED TNF CYTOTOXICITY	7.137113241831982
HYBRIDIZATION SOLUTION	7.134669335427204
FALSE-POSITIVE INTERACTION	7.130067585390087
PK	7.128196873294416
CCAF-INDUCED TN PRODUCTION	7.126036260507858
TOTAL LYSOSOMAL POPULATION	7.125944639487807
PRELIMINARY EXPERIMENT	7.124883924063313
ISOLATION	7.120724476946618
POLY-GLN PROTEIN AGGREGATE	7.119570118461648
SECONDARY STRUCTURE MODEL	7.115703577597607
INTRACISTERNAL A-PARTICLE	7.115703577597607
ISOLATED SMAD1 INTERACTOR	7.115703577597607
IMMUNOELECTRON TOMOGRAPHY	7.115703577597607
1-D WESTERN BLOT ANALYSIS	7.1149949505481045
COLONY-SECTORING ANALYSIS	7.114286323498602
ALM POSITION DISTRIBUTION	7.109860397871446
PLASMINOGEN ACTIVATOR INHIBITOR 1 GLU351	7.103711473735899
MACROPHAGE DIFFERENTIATION	7.101109377994557
DISTRIBUTED CONTAMINATION	7.098721836518452
BUDWORM	7.097839527840852
TRANSPORT FLUX CONSTRAINT	7.096872339965277
SOYBEAN TRYPSIN INHIBITOR	7.091319539124974
MAP KINASE	7.090396056033164
fixation	7.087598993669802
PUNCTATE	7.087598993669802
TRANSCRIPTIONAL MACHINERY	7.086980065460318
DIALYZED FETAL BOVINE SERUM	7.0804971288100855
secondary structure base	7.079879976392684
IN SILICO REPRESENTATION	7.079879976392684
MOUSE IRIDOCORNEAL ANGLE	7.079879976392684
PROGRAM DATABANK WEBSITE	7.079879976392684
CUSTOMIZED GIBBS SAMPLER	7.079879976392684
EXPRESSING GFP-MYOSIN II	7.079879976392684
PRACTICAL IMPLEMENTATION	7.079879976392684
REPORTED GENE EXPRESSION	7.079372095277812
signal transduction	7.077496221107941
RNA STRUCTURE DEFINITION	7.075599065902574
BOI1 KKTK MUTANT VERSION	7.075310104444491
NADPH OXIDASE ACTIVATION	7.074103706385752
ALEXA-CALMODULIN FLUORESCENCE	7.074038409842694
RAS-DEPENDENT ACTIVATION	7.071215571382286
ES	7.069848793344378
LUCIFERASE ACTIVITY	7.0679656488588884
EXPERIMENTAL GROUP	7.066911256920533
BOOTSTRAP STANDARD ERROR	7.065952747598192
INPUT MULTIPLE ALIGNMENT	7.064823512831071
POSSIBLE MECHANISM	7.064408399980811
ELECTRON TRANSPORT CHAIN	7.0612643735485605
TRANSCRIPTION ACTIVATION	7.060360052402745
IMMUNOPRECIPITATION ASSAY	7.056827380035754
HALF-MAXIMAL STIMULATION	7.0533986258679455
EVOLUTIONARY INFORMATION	7.051515253955626
CORRESPONDING PROBE	7.046940841718678
SIGNALING MECHANISM	7.046940841718678
REACHING CONFLUENCE	7.046940841718678
PHYLOGENETIC GROUP NAME	7.042651174681833
APOPTOTIC FRAGMENTATION	7.042651174681833
COMPARATIVE PERSPECTIVE	7.042651174681833
D. DISCOIDEUM MYOSIN II	7.041108365316459
PCMV5 EXPRESSION VECTOR	7.038651210647262
ARTERIAL FLOW CONDITION	7.036809846141236
ROCKVILLE	7.0355102857012035
OLIGONUCLEOTIDE ADAPTER	7.034712958972817
LEF-LUCIFERASE REPORTER	7.034431960186656
BAM HI RESTRICTION SITE	7.034051440997065
HISTOLOGICAL EXAMINATION	7.030401663570146
GAL4 DEPENDENT REPORTER	7.03001353852162
PEPTIDE PHOSPHORYLATION	7.019457182206028
PAIRWISE COMPARISON	7.018092289639899
MEASUREMENT VARIABILITY	7.017549249331699
GENOTYPE	7.011099184491516
MEDIATED TRANSFORMATION	7.010252178008986
AFFINITY UPTAKE COMPONENT	7.004857220976618
TRANSESTERIFICATION DOMAIN	7.00437729753362
ENDOTHELIAL CELL SHAPE	7.003902416251652
CIS- REGULATORY MODULE	7.003902416251652
SYNERGY	7.001603336922621
TUBULIN	7.001603336922621
RNA STRUCTURAL ELEMENT	6.99972667626921
PROTEIN STABILITY	6.999561300951942
MYOSIN-II LOCALIZATION	6.999199890609887
ORF	6.999051897156809
GFP-BLM FUSION PROTEIN	6.998179038056876
OBSERVED INTRACELLULAR	6.997829618237452
YOLK	6.9974898994373325
CORT	6.9974898994373325
RECQ	6.9974898994373325
RHO3	6.9974898994373325
his3	6.9974898994373325
ALK3	6.9974898994373325
PRF4	6.9974898994373325
Y190	6.9974898994373325
PDGF	6.9974898994373325
TBSE	6.9974898994373325
P102	6.9974898994373325
ura3	6.9974898994373325
KI67	6.9974898994373325
B/PB	6.9974898994373325
H-2C	6.9974898994373325
RPMB	6.9974898994373325
H-2B	6.9974898994373325
THTO	6.9974898994373325
ZT12	6.9974898994373325
LOGNORMAL DISTRIBUTION	6.995450872471521
RESTRICTION SITE PST I	6.99541174495402
DIFFERENTIATING NEURON	6.994868007383236
USM REPRESENTATION	6.994522173760355
BASELINE	6.994348579494819
WINDOW	6.993049844488434
CLEFT PALATE PHENOTYPE	6.992854313840276
EE MONOCLONAL ANTIBODY	6.99240407769185
WEBSITE	6.987191350215784
AMINO-ACID SUBSTITUTION	6.985787629500918
TARGETED ES CELL CLONE	6.9847784295227235
ΜM RESVERATROL-TREATED	6.9792400262722225
CELL-CELL CONTACT	6.978965862946566
DEFAULT PARAMETER	6.978965862946566
LINEAR PROGRAMMING	6.978681295289393
STRUCTURE ANALYSIS	6.976692989498171
GLUTAMATE DECARBOXYLASE	6.971207233300683
HEART	6.968533669012949
T. ACIDOPHILUM A-ATPASE	6.965198287340625
CELLULAR MORPHOGENESI	6.963504286827148
BMP SIGNALING PATHWAY	6.963504286827148
MONOCYTE-DERIVED CELL	6.963504286827148
COORDINATE DIFFERENCE	6.963504286827148
HYGROMYCIN-RESISTANCE	6.963504286827148
MSN50-TREATED EXPLANT	6.963504286827148
CLOSTRIDIUM BOTULINUM	6.963504286827148
IRIDOCORNEAL JUNCTION	6.963504286827148
FUNCTIONAL ANNOTATION	6.963504286827148
FLUX BALANCE ANALYSIS	6.962605417089233
GSK3Β KINASE ACTIVITY	6.961180041763021
MICROARRAY EXPRESSION	6.960463192765796
DEFINED GENOMIC LOCUS	6.959914158290594
NEOMYCIN	6.959575589834881
OVEREXPRESSED	6.9584314731818715
CYTOSKELETON FILAMENT	6.958021181425867
GR-GFP FUSION PROTEIN	6.957857554523898
DEPHOSPHORYLATION	6.953244718605974
INTERSTITIAL COLLAGEN	6.951754775252974
TAQ DNA POLYMERASE	6.951340515869967
HALF-LIFE	6.948191199834508
DROSOPHILA EXPRESSION	6.947939781863697
INCREASED EXPRESSION	6.946710672106083
TRANSFECTED CELL LINE	6.945319113134457
KLENOW DNA POLYMERASE	6.94496403059018
deletions	6.9449557120255605
protease inhibitors	6.943971514956165
SINGLE COPY TRANSGENE	6.943331820977797
TRANSIENT EXPRESSION	6.940419818386518
ACETATE	6.939868368384703
EXPRESSED PROTEIN	6.937389541246295
STRUCTURE INFORMATION	6.93620693019577
MMP	6.928819508203592
transcripts	6.928187273073352
BILE ACID TRANSPORTER	6.927525458856347
FUNCTIONAL ATTRIBUTE	6.9213101062170255
SIGNALING TECHNOLOGY	6.9213101062170255
PPP OXIDATIVE BRANCH	6.9213101062170255
METABOLIC CAPABILITY	6.9213101062170255
PROTEASOME-DEPENDENT	6.9213101062170255
EXPRESSING CELL LINE	6.9213101062170255
BOI1-PH KKTK VERSION	6.9213101062170255
INTRAOCULAR PRESSURE	6.9213101062170255
AVERAGE ALM POSITION	6.9213101062170255
COMBINATORIAL ACTION	6.9213101062170255
PGKLOXP-NEO CASSETTE	6.9213101062170255
CIRCADIAN EXPRESSION	6.920587345825026
BIFURCATION ANALYSIS	6.919980916464824
MITOCHONDRIAL UPTAKE	6.919966214004378
HYDRODYNAMIC ANALYSIS	6.919827506751198
CDK2 KINASE ACTIVITY	6.919018811872189
PHYSIOLOGICAL AGONIST	6.918445494529154
DEVELOPMENTAL CHANGE	6.917654834398471
INTERGENIC REGION	6.9173107551639434
POISSON DISTRIBUTION	6.913089955767925
transactivation domain	6.912203166237229
MITOCHONDRION GENOME	6.911685433658816
ADENO-RGS3 INFECTION	6.911058539277629
CEE CYTOTOXIC EFFECT	6.90913475294314
SINGLE SITE MUTATION	6.908180339095907
NON-NEURAL TISSUE	6.906919761599953
METABOLIC PROCESS	6.906919761599953
INTENSITY READING	6.906919761599953
GEL ELECTROPHORESI SD	6.906671956479764
IDO-EXPRESSING CLONE	6.905578507983983
TM CHANNEL FORMATION	6.904639333810905
POLAR BODY FORMATION	6.904639333810905
expression plasmid	6.904561673849971
PRENATAL DEVELOPMENT	6.903991925173774
HYPERVARIABLE REGION	6.903472379742476
cacodylate	6.899880089783252
NONSPECIFIC EFFECT	6.898761007824277
N-TERMINAL EXTENSION	6.896922589552603
WILD-TYPE FIBROBLAST	6.896328881232273
ANDROGEN RECEPTOR	6.895517068974876
MISFOLDED PROTEIN	6.8946430182236265
DEVELOPMENTAL ABILITY	6.894417158771004
BASELINE SUBTRACTION	6.891580562092777
CYTOTOXIC POTENTIAL	6.890803134651007
CLUSTER ANALYSIS	6.883870098137978
CALMODULIN AFFINITY	6.88275333646838
SH3-DOMAIN MUTATION	6.877152713390217
DEGRADATION CHAMBER	6.877152713390217
INTERNAL REFLECTION	6.877152713390217
ANAEROBIC CONDITION	6.877152713390217
LONGITUDINAL DOMAIN	6.877152713390217
THROMBIN INHIBITION	6.877152713390217
relative expression	6.877152713390217
PHYLOGENETIC DOMAIN	6.877152713390217
GST-P35-C/EBPΒ BEAD	6.877152713390217
IN VITRO MATURATION	6.877152713390217
LYSOSOMAL OXIDATIVE	6.877152713390217
GFP-MYOSIN-II IMAGE	6.877152713390217
BIFURCATION DIAGRAM	6.877152713390217
PHARYNGEAL ENDODERM	6.877152713390217
ADENOVIRUS-MEDIATED	6.877152713390217
CORNEAL ENDOTHELIUM	6.877152713390217
CONSENSUS BASE PAIR	6.877152713390217
secondary structure	6.877152713390217
TAIL BUD MESENCHYME	6.877152713390217
BINDING SITE C/EBPΑ	6.877152713390217
MICROTUBULE NETWORK	6.877152713390217
ROBUSTNESS ANALYSIS	6.875843527869269
MATRIX	6.874986841207166
REDUCED GLUTATHIONE	6.874770057471085
RNA STRUCTURE MODEL	6.873152424298432
POSTERIOR TERMINATION	6.8730330477060075
SPLICEOSOMAL INTRON	6.872258766401048
GENOMIC INSTABILITY	6.871923764077385
RING FINGER PROTEIN	6.871669812764942
COMPLEX CARRIER DNA	6.870558992250596
NOMINAL LIMIT CYCLE	6.8701390328748015
SRE-DRIVEN REPORTER	6.869378700252555
COARSE DISTRIBUTION	6.8690562757445415
P27 PHOSPHORYLATION	6.867472674992908
MAXIMUM PATH LENGTH	6.863372894024636
ACCESSION NUMBER	6.86263821318001
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	6.862457174749744
WHOLE CCAF MOLECULE	6.862039363118289
CONTAMINATION LEVEL	6.861465865451721
METABOLIC PHENOTYPE	6.861276867283787
COMPARATIVE SUPPORT	6.857631302622311
SUBTILISIN DIGESTION	6.857603940236492
MYOCARDIAL ISCHEMIA	6.857409298204581
TRYPSIN INHIBITOR	6.8564847749890365
P66 INSAND P66 IN	6.848891520082559
CULLIN NEDDYLATION	6.848115414720013
DNA-BINDING PROTEIN	6.8480125652009765
RELATIVE RISK	6.847829095213997
DNA FRAGMENT	6.84739304687212
CONCENTRATION RATIO	6.847374290184937
LYMPHOCYTE MOTILITY	6.84575917330331
ONCOGENE ACTIVATION	6.8424361701519425
MICROARRAY TECHNOLOGY	6.838858325691779
G1 PHASE	6.837802937913997
ammonium sulfate	6.835923764843092
MESOBILIRUBIN XIIIΑ	6.835140125836991
AFFINITY THIAMINE	6.834759951518535
SYSTEMATIC ERROR	6.831277384423591
LYSOSOMAL MEMBRANE	6.830840466588258
SIGNALING ACTIVITY	6.830840466588258
IMMUNOGOLD-LABELED	6.830840466588258
neighbor statistic	6.830840466588258
PHYLOGENETIC EVENT	6.830840466588258
CCAF-TREATED WOUND	6.830840466588258
SELECTION PRESSURE	6.830840466588258
POST-FERTILIZATION	6.830840466588258
METABOLIC FUNCTION	6.830840466588258
electron transport	6.830840466588258
ELEVATED FREQUENCY	6.830840466588258
SEQUENCE/STRUCTURE	6.830840466588258
P27 DOWNREGULATION	6.830840466588258
COAGULANT FIXATIVE	6.830840466588258
CLUSTER DENDROGRAM	6.830840466588258
PUPILLARY MEMBRANE	6.830840466588258
MISMATCH INTENSITY	6.830840466588258
NON-ESSENTIAL GENE	6.830840466588258
BRDU-POSITIVE CELL	6.830840466588258
PUNCTATE STRUCTURE	6.830840466588258
RENILLA LUCIFERASE	6.830840466588258
ANGLE MORPHOGENESI	6.830840466588258
NON-PROBE-SPECIFIC	6.830840466588258
CATALYTIC FRAGMENT	6.830840466588258
NOCTURNIN FUNCTION	6.830840466588258
AMPLITUDE CIRCADIAN	6.828349186470453
MORPHOLOGIC CHANGE	6.8272979025760545
RESPONSE PATHWAY	6.824743218200314
TOLUIDINE BLUE-O	6.824726620816183
LFC	6.8244279497739395
RB1	6.8244279497739395
A20	6.8244279497739395
ANN	6.8244279497739395
RAC	6.8244279497739395
AVM	6.8244279497739395
NAC	6.8244279497739395
CY3	6.8244279497739395
2-P	6.8244279497739395
ΔN1	6.8244279497739395
KNI	6.8244279497739395
DEX	6.8244279497739395
FAF	6.8244279497739395
GFP-FUSION PROTEIN	6.82274791544511
TREATED FIBROBLAST	6.82206497807072
ARABIDOPSIS GENOME	6.821512564225191
BAM HI RESTRICTION	6.820169039193474
DONOR CELL NUCLEUS	6.820102757035743
CORTICAL ENRICHMENT	6.8185884810865
METABOLIC REACTION	6.817842186603634
NONIONIC DETERGENT	6.8173344412917345
CYTOTOXIC FUNCTION	6.816898763056363
WILD-TYPE GFP-N346	6.8154050091065175
CELLULAR PHENOTYPE	6.815219039739267
SPEED CENTRIFUGATION	6.815133162916138
COX-2 EXPRESSION	6.813963888944551
DEPENDENT REPORTER	6.8131981390026
EXTRACELLULAR MATRIX	6.813166443948782
FILAMENTOUS GROWTH	6.812757085438101
C/EBPΑ INTERACTION	6.812719174785795
INTEGRIN DEPENDENT	6.811135371292999
AB	6.807782168640683
INFLAMMATORY AGENT	6.805417360147744
WILDTYPE RECEPTOR	6.804214144060886
OPTIMAL PRODUCTION	6.798222141343825
LIPID ACCUMULATION	6.797047688423029
ΜM STAUROSPORINE	6.796657486609795
DENDRITIC	6.795690173258263
THIAMINE UPTAKE	6.795236177413037
DISULFIDE BRIDGE	6.791367220804645
ECTOCERVIX EXHIBIT	6.7888799996476035
AXONAL MORPHOLOGY	6.782152216622293
EUCARYA ORGANELLE	6.782152216622293
PROAPOPTOTIC WOX1	6.782152216622293
EXPRESSING C/EBPΑ	6.782152216622293
PERIPHERAL TISSUE	6.782152216622293
BOOTSTRAPPED MODE	6.782152216622293
ADENYLATE CYCLASE	6.782152216622293
ALTERED PSEUDOPOD	6.782152216622293
C/EBPΑ INHIBITION	6.782152216622293
BPNN ARCHITECTURE	6.782152216622293
PHARYNGEAL REGION	6.782152216622293
MASS SPECTROMETER	6.782152216622293
ENDOTHELIAL-LINED	6.782152216622293
MATERNAL/GAP GENE	6.782152216622293
NON-LINEAR SYSTEM	6.782152216622293
STANDARD APPROACH	6.782152216622293
SUCCESSION SCHEME	6.782152216622293
MATURATION MEDIUM	6.782152216622293
POLYMORPHIC NOISE	6.782152216622293
PLM AXONAL DEFECT	6.782152216622293
BIOCHEMICAL LEVEL	6.782152216622293
COMPARISON RESULT	6.782152216622293
DUPLICATE PROFILE	6.782152216622293
PREDICTED NETWORK	6.782152216622293
GR-GFP EXPRESSION	6.781463735663874
PNN ANALYSIS SHOW	6.781308117762196
TK MUTANT VERSION	6.776645643919681
RAB24 MUTANT FORM	6.776645643919681
PHOSPHORYLATE P53	6.77650713022569
FLUX DISTRIBUTION	6.774321935491522
NORMAL FIBROBLAST	6.7735269830924585
CLUSTAL X	6.773060947175904
DENSITY DEPENDENT	6.772330418903349
MDCK	6.771767590563045
P66 INSAND P66	6.766948105870904
TWO-SAMPLE T TEST	6.764574585532182
BINDING AFFINITY DNA	6.763390066523787
oxidation	6.759832539038713
digestion	6.759832539038713
CHANNEL FORMATION	6.758332062341301
PATTERN FORMATION	6.758332062341301
WILD-TYPE CPLA	6.757761614372897
TRANSPORT PATHWAY	6.756917003671143
LNCAP CELL LYSATE	6.755602669663271
immunoblot	6.755543290936121
SIGNALING EVENT	6.751310295364754
INTERCONNECTION	6.751310295364754
ELONGATED SHAPE	6.751310295364754
REGULATORY GENE	6.751310295364754
CRITICAL PERIOD	6.7498836250938625
CHEMOATTRACTANT	6.7498836250938625
PROSTATE CANCER	6.7498836250938625
GENE TRANSCRIPT	6.7498836250938625
ACID TRANSPORT	6.749361913635767
PALM SUBDOMAIN	6.749313845021254
QUALITY CONTROL	6.747715494300547
PROFILING STUDY	6.74742791021541
LEUKEMIA             INHIBITORY FACTOR	6.747328090330296
ASTROCYTE LINEAGE	6.7452137165053925
fusions	6.743298479487475
SIGNAL SEQUENCE	6.743143465762572
GENE REGULATION	6.737462585659037
EXPRESSED IDO	6.736261541729235
JUXTAPOSITIONING	6.730830919840637
THROMBOSPONDIN-1	6.730830919840637
POSITION COGNATE	6.730830919840637
SMAD1 MH2 DOMAIN	6.730830919840637
CARBOXY TERMINUS	6.730830919840637
AQUEOUS DRAINAGE	6.730830919840637
PHOSPHOLIPASE CΒ	6.730830919840637
POTENTIAL HELICE	6.730830919840637
TRANSPOSABLE IAP	6.730830919840637
OXIDATIVE BRANCH	6.730830919840637
LYSOSOMAL HYAL-1	6.730830919840637
ENVELOPING LAYER	6.730830919840637
DOTMAC-INSOLUBLE	6.730830919840637
DENSITY FUNCTION	6.730830919840637
PROGRAM DATABANK	6.730830919840637
MONOCYTE-DERIVED	6.730830919840637
BACKGROUND MODEL	6.730830919840637
EMBRYONIC SHIELD	6.730830919840637
STATIONARY PHASE	6.730830919840637
HOPF BIFURCATION	6.730830919840637
ANTIGENIC SITE D	6.730830919840637
DELETION VERSION	6.730830919840637
SECONDARY SEARCH	6.730830919840637
EXPRESSED C/EBPΑ	6.730830919840637
PCMV5 EXPRESSION	6.730155081104584
BALANCE ANALYSIS	6.729588021181488
CASEIN KINASE II	6.728688376487295
CONTROL SPECIMEN	6.728454894198789
PMA	6.728360371006733
P66 INSMUTANT	6.727940683473607
BLOCKING SOLUTION	6.7275005176189255
IN SILICO STRAIN	6.7268877283499116
MIGRATION FACTOR	6.726546750318607
INTRON ALIGNMENT	6.7261847638501715
GENOMIC LOCATION	6.725866723410348
VAP MOTOR NEURON	6.7253531858485935
BLOCKING BUFFER	6.724187611162702
PREDICTIVE ABILITY	6.723671617551397
FORCE REQUIREMENT	6.721467537858814
PREDICTIVE	6.719069167903299
WILD-TYPE EMBRYO	6.715938330549771
FINAL MATURATION	6.715938330549771
PALATE PHENOTYPE	6.7157589017631345
INTERACTION DATA	6.7133469575704385
HB	6.712026116526636
OXYGEN LIMITATION	6.711353424731567
R91	6.711292511369733
MULTIPLE SUBPEAK	6.710795244158031
UBC3	6.709322832350056
P66 WTSUBUNIT	6.708913618884604
CYTOPLASMIC DOMAIN	6.704546821664248
LH CONCENTRATION	6.702560241864757
RASMC ATTACHMENT	6.7010457412589055
ARABIDOPSIS COP1	6.69457070243679
B. MORI BBMV	6.692705769813863
PHARMACIA/UPJOHN	6.685729120768106
REGULATED GENE	6.684318409894488
COLLAGENASE MMP-1	6.68281606553869
PERFECT MATCHES	6.676575423602265
L929 CELL DEATH	6.676575423602265
EGF-LIKE DOMAIN	6.676575423602265
FUNCTIONAL LINK	6.676575423602265
POTENTIAL HELIX	6.676575423602265
GSK3Β-DEPENDENT	6.676575423602265
POSITION NUMBER	6.676575423602265
CILIARY PROCESS	6.676575423602265
INTERPHASE CELL	6.676575423602265
OVERREPRESENTED	6.676575423602265
MOUSE NOCTURNIN	6.676575423602265
EGF-LIKE REPEAT	6.676575423602265
SHOWED MODERATE	6.676575423602265
GENETIC NETWORK	6.676575423602265
ORTHOLOGY VALUE	6.676575423602265
TABULAR DISPLAY	6.676575423602265
MOLECULAR LOCUS	6.676575423602265
OSTEOPROTEGERIN	6.676575423602265
COARSE ORIGINAL	6.676575423602265
STATIONARY RING	6.676575423602265
NN ARCHITECTURE	6.676575423602265
INTRAEPITHELIAL	6.676575423602265
BONE RESORPTION	6.676575423602265
STANDARDIZATION	6.676575423602265
SYNCYTIAL LAYER	6.676575423602265
LACZ EXPRESSION	6.675912949884072
CONTROL PROFILE	6.674246384946282
QUASI ALGORITHM	6.673903879261578
GIBBS ALGORITHM	6.673903879261578
RHYTHMIC CHANGE	6.673225044224191
COMPARATIVE RNA	6.670991457972142
EXPRESSION PLASMID	6.670563477478121
CDK2 ACTIVATION	6.669040929885675
HALF PROTEASOME	6.6684814377780075
FREQUENCY TABLE	6.666957863975794
CATEGORIZATION	6.666493831676168
CORRESPONDENCE	6.666493831676168
SAMPLING ERROR	6.666493831676168
TARGETING ROLE	6.666493831676168
CLEAVED DNA	6.66611276321604
CSN COMPLEX	6.665873786629476
PHOSPHOLIPASE C	6.66489695834155
CONTROL MEDIUM	6.662975951559505
TRANSWELL ASSAY	6.662029292494613
VALIDATION	6.661271633195106
BINARY APPROACH	6.661151035522075
HYALURONIC ACID	6.661077934156767
SMG DEVELOPMENT	6.660701781500322
MACROPHAGE CELL	6.6598919018012435
DIAGNOSIS	6.6591598504828475
inserts	6.655602209062527
NONFATAL MI	6.653458891471209
LIPID TREATMENT	6.652988375538752
EXPRESSION VECTOR	6.652322144401903
T. MARITIMA	6.651776873417509
ACE-INHIBITOR	6.651375854970964
EXOGENOUS ACTIN	6.6493382520069835
CELL ATTACHMENT	6.647379260450477
TOTAL MYOSIN-II	6.645609796017036
ARCHAEAL INTRON	6.6405791256002535
CHD	6.634614354468761
DRUG GROUP	6.632290291937698
HELA	6.629848159710848
OXIDATIVE BURST	6.622075919052261
PMA STIMULATION	6.620847761203247
STRUCTURE DATA	6.6190297584946824
BASE PAIR TYPE	6.6190297584946824
GSK3Β ACTIVITY	6.6190297584946824
NEUTRALIZATION	6.6190297584946824
POSITIVE DONOR	6.6190297584946824
VIRAL SEQUENCE	6.6190297584946824
SELECTED MODEL	6.6190297584946824
PORCINE OOCYTE	6.6190297584946824
LAMINA PROPRIA	6.6190297584946824
SCORING MATRIX	6.6190297584946824
HUMAN U87 CELL	6.6190297584946824
ACIDIC RESIDUE	6.6190297584946824
C/EBPΑ-INDUCED	6.6190297584946824
PROTEOBACTERIA	6.6190297584946824
CONSENSUS BASE	6.6190297584946824
PHAGOLYSOSOMAL	6.6190297584946824
B/PB INTERFACE	6.6190297584946824
PROPAGATION NN	6.6190297584946824
PARABASAL CELL	6.6190297584946824
FULL-THICKNESS	6.6190297584946824
CIS-REGULATORY	6.6190297584946824
STRUCTURE LINK	6.6190297584946824
BUD MESENCHYME	6.6190297584946824
INOSITOL-BASED	6.6190297584946824
SUPER-ORTHOLOG	6.6190297584946824
AMBIGUOUS BASE	6.6190297584946824
SΑ I2 SEQUENCE	6.6190297584946824
LIPOSOME-BASED	6.6190297584946824
PRECURSOR CELL	6.6190297584946824
PHOSPHOPROTEIN	6.6190297584946824
ISOLATED SMAD1	6.6190297584946824
P27 EXPRESSION	6.618381460277502
SCFG ALGORITHM	6.616415379409715
PRIMING KINASE	6.615946906856917
SV40	6.615042136311189
PLUG	6.615042136311189
PFAM	6.615042136311189
PNPP	6.615042136311189
CCR4	6.615042136311189
C-TERMINAL	6.614648968980745
SEPHAROSE BEAD	6.613886591711372
KR	6.612617241680363
DD	6.612617241680363
SN50 TREATMENT	6.612499146249784
ALLN TREATMENT	6.612499146249784
LAMIN BETA	6.612373833600358
LTBP-3 PROTEIN	6.61153999840106
PROTEIN FAMILY	6.61153999840106
RAT FIBROBLAST	6.610907931083514
DATABASE TABLE	6.6096179937888
INFARCTION	6.6091615016104655
S PHASE ARREST	6.6054704364607835
SERUM RESPONSE	6.60529142543426
E. COLI MUTANT	6.6049556844206085
SN50 PHENOTYPE	6.60457192716938
SCALING FACTOR	6.604365922436522
TM DEVELOPMENT	6.6034957779121575
CHANGE P-VALUE	6.602636315871731
CYTOPLASM	6.601356552806337
MM SODIUM ACETATE	6.600053193050781
WHOLE MOLECULE	6.598384597204359
BODY FORMATION	6.596599851952626
TRANSPORT FLUX	6.595267382257059
AZ INTERACTION	6.594850862617673
BEHAVIOR	6.589180480926266
ASBT CELL	6.5861216980208965
JNK ACTIVATION	6.585850034992378
L1 MUTANT	6.584027226021741
CALCIUM IONOPHORE	6.583204267606763
GENERALIZATION	6.5808079813427955
SIMVASTATIN	6.577768079054687
NON-CONSENSUS	6.5762016538353825
CONTRACTILITY	6.5762016538353825
MAPPING STUDY	6.572490781194431
CHLOROTOXIN	6.564552222918469
FETAL CALF SERUM	6.562538182207955
CDK2 ACTIVITY	6.561476467026629
INTERCELLULAR	6.561476467026629
GLYB CELL	6.559544758569138
VIRAL VARIANT	6.557768970177244
ULTRA-PARALOG	6.557768970177244
OVERABUNDANCE	6.557768970177244
MASIA PROGRAM	6.557768970177244
PERIVITELLINE	6.557768970177244
P. FALCIPARUM	6.557768970177244
DEHYDROGENASE	6.557768970177244
INTRONS RANGE	6.557768970177244
SCANNING MODE	6.557768970177244
MICROINJECTED	6.557768970177244
EXPRESSED DLA	6.557768970177244
PRE-ASSEMBLED	6.557768970177244
OCULAR REGION	6.557768970177244
PH-DEPENDENCY	6.557768970177244
CRENARCHAEOTA	6.557768970177244
MATRICELLULAR	6.557768970177244
MAXILLARY ROW	6.557768970177244
LATERAL NASAL	6.557768970177244
PLATEAU PHASE	6.557768970177244
ANAPHYLATOXIN	6.557768970177244
DEUTEROSTOMIA	6.557768970177244
CLOSED CIRCLE	6.557768970177244
EXPRESSED DLB	6.557768970177244
AMINOTERMINAL	6.557768970177244
C/EBPΑ DOMAIN	6.557768970177244
P27 HALF-LIFE	6.557768970177244
RHYTHMIC GENE	6.557768970177244
DLBCL PATIENT	6.557768970177244
WOX1-MEDIATED	6.557768970177244
III1-C COLUMN	6.557768970177244
PHOSPHOLIPASE	6.557768970177244
TN EXPRESSION	6.557135762625281
CONTROL WOUND	6.555542821689718
VECTOR PPACPL	6.553354404532488
FIBULIN-1 MAP	6.551202767495549
CELLULAR FUNCTION	6.5510233535832025
MAMMALIAN PP5	6.550974377837055
ELK-1 PROTEIN	6.5504535518589595
OUTPUT NEURON	6.550070663584911
DNA STRUCTURE	6.548971468324287
JURKAT T CELL	6.54878761248619
CYTOTOXIC EFFECT	6.547150242887545
TEST SEQUENCE	6.546991340947979
MOLE	6.545282561310354
LOCATED CLOSE	6.544959492814593
MICROINJECTION	6.543481572738667
TARGET PROTEAS	6.542839282304206
ISOLATABLE	6.54266622941967
WTSUBUNIT	6.5415736852255675
ANTISERUM	6.5415736852255675
FATAL HF	6.540944928562687
MORI APN	6.537383515499235
SINGLE INTRON	6.536161482317732
ONCOGENE	6.532921536705883
TRANSIENT TRANSFECTION EXPERIMENT	6.530568324649483
PH VALUE	6.530413453624186
CDNA SEQUENCE	6.530354872436129
GENE PRESENCE	6.528829039839403
M. SEXTA	6.528275485027647
ABC TREATMENT	6.527712248464584
TRANSCRIPTOME	6.524202481332847
GENE FUNCTION	6.5236695848188635
A-ATPASE	6.522849468175744
MURINE	6.5226277653397045
MEAN YOL	6.5164730099686565
PHOSPHATIDYLINOSITOL-4-PHOSPHATE	6.5143379937583425
EJECTION	6.512540036157128
SYSTOLIC	6.506677810107327
V-CRK ABILITY	6.498100095626132
GSK3Β ABILITY	6.498100095626132
trap	6.497598535876992
CDK2 COMPLEX	6.4922800556332465
MIB-ARRESTED	6.4922800556332465
LEADING EDGE	6.4922800556332465
gastrulation	6.4922800556332465
PINEAL GLAND	6.4922800556332465
spectrometer	6.4922800556332465
WD-40 DOMAIN	6.4922800556332465
POST-MITOTIC	6.4922800556332465
CCAF-TREATED	6.4922800556332465
OXALOACETATE	6.4922800556332465
BLEBBISTATIN	6.4922800556332465
PREOVULATORY	6.4922800556332465
NEURAL PLATE	6.4922800556332465
TAIR WEBSITE	6.4922800556332465
CONTACT PLOT	6.4922800556332465
SSV APPROACH	6.4922800556332465
CRE-MEDIATED	6.4922800556332465
MYCRAB24(WT)	6.4922800556332465
PHASE ARREST	6.4922800556332465
FLUOROGRAPHY	6.4922800556332465
BLM FUNCTION	6.4922800556332465
SUBSELECTION	6.4922800556332465
cleft palate	6.4922800556332465
nucleic acid	6.4922800556332465
OVERTRAINING	6.4922800556332465
CONTROL DIET	6.490110622629225
cell divisions	6.490097271540647
OTHER INTRON	6.48803787744711
STRAIN PY967	6.486879552197704
C3 TREATMENT	6.486063965964581
NATURAL KILLER	6.485696425161349
PROTEIN LEVEL	6.485609290879999
CRE REPORTER	6.485541374355268
Β-ACTIN MRNA	6.484863130460407
DNA HELICASE	6.483706687333833
MARKOV TABLE	6.483321573463699
ONLINE TABLE	6.483321573463699
PEPTIDE SN50	6.481654879106574
MAPK CASCADE	6.4803820715018166
KERATINOCYTE	6.479677647517245
RESTING CELL	6.479677647517245
HETEROLOGOUS	6.479677647517245
NITRIC OXIDE	6.479677647517245
NEGATIVE EFFECT	6.479452222432945
CHLORATE	6.479320755208255
TUMOR GROWTH	6.47634970031083
TUMOR	6.47419960481366
GENE EXPRESSION MEASUREMENT	6.474109101746052
RNA ISOLATION	6.473257177377624
CADHERIN	6.471938692775171
ΜM THICKNESS	6.471800395905797
OTHER SPECIES	6.469229244638478
JNK ACTIVITY	6.467716475490939
MOUSE GENOME	6.466994472570495
TOTAL CORTEX	6.4634364577388705
PROAPOPTOTIC	6.4576220052660185
KDA FRAGMENT	6.455802403685389
REGENERATION	6.455370921290477
DENSITOMETRY	6.455370921290477
COP1	6.45427181686723
STOCK SOLUTION	6.452050721547279
SHAPE CHANGE	6.449359073638908
STRANDED RNA	6.448895665541044
MOTOR NEURON	6.445035442352361
MITOGEN ACTIVATED PROTEIN KINASE	6.439431586695067
P51 IN	6.438338811544062
OTHER SERPIN	6.437889271032423
MCARDLE	6.432356043703345
fragmentation	6.4294825142640235
MORPHOGENETIC	6.4294825142640235
COTRANSFECTED	6.4294825142640235
TREATMENT EFFECT	6.427868790564104
COMPUTATIONAL STUDY	6.427705803497815
PCNA	6.4253379670135224
endothelium	6.4219358222247
PFAM FAMILY	6.4219358222247
FASTA_GROUP	6.4219358222247
FLUORESCEIN	6.4219358222247
CELLULAR FN	6.4219358222247
TRANSDUCING	6.4219358222247
POWER CURVE	6.4219358222247
MIB-TREATED	6.4219358222247
DEFINED IVM	6.4219358222247
CENTROMERIC	6.4219358222247
CHONDROSTEI	6.4219358222247
IRIS STROMA	6.4219358222247
JACOBBERGER	6.4219358222247
MÜLLER GLIA	6.4219358222247
OPTIC NERVE	6.4219358222247
CYK/OUTSIDE	6.4219358222247
PHAGOCYTOSI	6.4219358222247
MARKER GENE	6.4219358222247
NEURAL KEEL	6.4219358222247
PROBE ARRAY	6.4219358222247
ERROR MODEL	6.4219358222247
GAL4 FUSION	6.4219358222247
MINUTE HAND	6.4219358222247
STROMELYSIN	6.4219358222247
DOXYCYCLINE	6.4219358222247
CHEMOTACTIC	6.4219358222247
ADDING CELL	6.4219358222247
HEMISEGMENT	6.4219358222247
PURIFIED C3	6.4219358222247
PREFIXATION	6.4219358222247
FITCH GROUP	6.4219358222247
INNERVATION	6.4219358222247
ACROCENTRIC	6.4219358222247
BENZAMIDINE	6.4219358222247
HU-NEGATIVE	6.4219358222247
HYAL-2 CELL	6.4219358222247
BOI1-PH(TK)	6.4219358222247
BOI1-PH(KK)	6.4219358222247
RECQ FAMILY	6.4219358222247
PMT SETTING	6.4219358222247
PALINDROMIC	6.4219358222247
calculations	6.42011368296502
extraction	6.419334888435033
ANIMAL RRNA	6.419121799625353
STOP EFFECT	6.418718048556752
SUBTILISIN	6.418382914531864
INTRON DATA	6.417812769613958
P53 BEARING	6.41701829436006
TNF KILLING	6.415207750009898
CARRIER DNA	6.413603204640349
C/EBPΑ CDNA	6.411413244827142
MONKEY CDNA	6.411413244827142
BLOCKING AGENT	6.407771489559831
G1	6.406671717975803
ALANINE MUTATION	6.404882896317053
MURINE L929	6.404102377799924
MULTIPLE TRANSCRIPTION FACTOR COMBINATORIAL ACTION	6.402203751223462
endonuclease	6.401861033548868
maps	6.400380166579952
AMMONIUM SULFATE FRACTIONATION	6.397980177520607
EQ	6.39667615910056
NE FRACTION	6.393054341497745
H-RA	6.387407539558533
NON-SPECIFIC CELL ATTACHMENT FACTOR POLY-L-LYSINE	6.383798234578427
PP5 ACTIVITY	6.382239774960729
CHARACTERIZED TRANSCRIPTIONAL REGULATORY ELEMENT	6.380258079413455
CASPASE ACTIVATION	6.379836725134322
RATIO IMAGE	6.375997394496568
NON-TREATED	6.375997394496568
subtraction	6.375997394496568
PROPAGATION	6.375997394496568
VECTASHIELD	6.375997394496568
SUBTRACTION	6.375997394496568
ORTHOLOGOUS	6.375997394496568
SECONDARY ANTIBODY	6.37530995626342
DC PRECURSOR	6.3751306734160895
NON EGF-LIKE	6.3751306734160895
hydroxyl	6.373090038222216
ELECTROSPRAY IONIZATION MASS         SPECTROMETRY	6.370822823707034
BID	6.370806409041929
ECM	6.370806409041929
GHFT1-5 PITUITARY PROGENITOR CELL PROLIFERATION	6.3615553684876005
HIGH-ENERGY PHOSPHATE BOND PRODUCTION CAPABILITY	6.35786002381716
ANTI-Β1 MAB	6.355637778589066
FUNCTIONAL SIGNIFICANCE	6.34631716964939
PROTEOLYTIC	6.346067820111534
GLYOXYLATE	6.345958262083668
ANTI-MOUSE	6.345958262083668
GΑ-PROTEIN	6.345958262083668
GENEFINDER	6.345958262083668
ANTI-NF-ΚB	6.345958262083668
IG-RELATED	6.345958262083668
AD-SKP2-ΔF	6.345958262083668
CRD DOMAIN	6.345958262083668
HUNTINGTIN	6.345958262083668
SCFG-BASED	6.345958262083668
GFP-FUSION	6.345958262083668
NEURAL NET	6.345958262083668
PADDLEFISH	6.345958262083668
PLM DEFECT	6.345958262083668
ENDOSTATIN	6.345958262083668
CYK/INSIDE	6.345958262083668
HUMAN APE1	6.345958262083668
confluence	6.345958262083668
GENEFECTOR	6.345958262083668
CENTROMERE	6.345958262083668
reactivity	6.345958262083668
THTYPE III	6.345958262083668
OPTIMALITY	6.345958262083668
SGRAI SITE	6.345958262083668
SPARC PLAY	6.345958262083668
TUMOR TYPE	6.345958262083668
GENESPRING	6.345958262083668
YEAST CCR4	6.345958262083668
MODEL RULE	6.345958262083668
NON-NORMAL	6.345958262083668
CARCINOMAS	6.345958262083668
NEUROBLAST	6.345958262083668
ANALYZABLE	6.345958262083668
WOUND EDGE	6.345958262083668
SYNDECAN-1	6.345958262083668
WNT SIGNAL	6.341317533927395
RNASEP RNA	6.341060772328585
RAT STRAIN	6.340873208891156
GΑ PROTEIN	6.33924563481491
ALA MUTANT	6.338987501665599
DECREASED ACCUMULATION TN-C KNOCKOUT MICE SHOW	6.337937917996704
HYAL2 CDNA	6.33576405592048
BOVINE GROWTH HORMONE POLYADENYLATION SEQUENCE	6.335443415147086
SINGLE CHIP	6.333199128291747
EXOGENOUS BOVINE TESTICULAR HYALURONIDASE PH-20	6.333169890942351
BULK LIPID	6.331123934494477
HOMOLOGOUS	6.330924116075241
SCANNING ELECTRON MICROSCOPY	6.330316251674206
CUTOFF	6.3276493589276175
MOMULV LTR	6.327573839003047
ΜG/ML SN50	6.327188824907117
GRANZYME H	6.326041803746329
TOTAL ERK1	6.318799455260023
MUTANT FORM	6.314447449918383
SUBCELLULAR DISTRIBUTION	6.310062714178668
TRANSCRIPTIONAL REGULATION	6.309580349146387
BETA-BLOCKER	6.309186990131031
RADIOLIGAND	6.307225684461577
O	6.3025608562011595
DNA CLEAVAGE	6.300631171230578
U5-PB	6.296268970998279
ATPΓS	6.296268970998279
F-BOX PROTEIN	6.289628631069192
TRANSFORMING GROWTH FACTOR Β-BINDING PROTEIN	6.288741075780876
BOVINE BRAIN	6.287498385343594
ERK	6.286655766552899
CYTOPLASMIC DISTRIBUTION	6.284899066403921
SIGNAL INTENSITY	6.284086078861534
GLYCOSYLPHOSPHATIDYLINOSITOL (GPI)-ANCHORED	6.283529844404076
PBMCS	6.282900614226576
CA SUBSTRATE DOMAIN TYROSINE PHOSPHORYLATION	6.279011041222627
SRF-DEPENDENT TRANSCRIPTION TRANSACTIVATION	6.275074335402799
JNK	6.270500301716697
COMPUTATION	6.270449245487026
ECORI	6.268639481265849
PROTEASE	6.268349413756576
DEPOSITION	6.264014190222158
MISMATCHED	6.264014190222158
GROUP NAME	6.264014190222158
HOMOZYGOUS	6.264014190222158
PERCENTILE	6.264014190222158
METABOLITE	6.264014190222158
TF FAMILY	6.263365952049043
UNWOUNDED	6.263365952049043
CYTOPLAST	6.263365952049043
MELATONIN	6.263365952049043
MODELLING	6.263365952049043
DOMAIN G2	6.263365952049043
ABI PRISM	6.263365952049043
OTHER PP5	6.263365952049043
BOTULINUM	6.263365952049043
PREIMMUNE	6.263365952049043
PAIR-SCFG	6.263365952049043
HUMAN U87	6.263365952049043
PACI SITE	6.263365952049043
GENE RANK	6.263365952049043
TBS-TWEEN	6.263365952049043
OMIM GENE	6.263365952049043
GDP-BOUND	6.263365952049043
MAXILLARY	6.263365952049043
FOREBRAIN	6.263365952049043
NEOMARKER	6.263365952049043
EUCLIDEAN	6.263365952049043
RECURSIVE	6.263365952049043
V3 REGION	6.263365952049043
SUBFAMILY	6.263365952049043
C-PEPTIDE	6.263365952049043
MYRISTATE	6.263365952049043
CIPHERGEN	6.263365952049043
GTP STATE	6.263365952049043
PRIMORDIA	6.263365952049043
LOXP SITE	6.263365952049043
SYNERGISM	6.263365952049043
VIBRISSAL	6.263365952049043
VAP MOTOR	6.263365952049043
VARIABLES	6.263365952049043
TRENDLINE	6.263365952049043
CO-LOCALIZATION	6.260237044702725
INDEPENDENT EXPERIMENT	6.259280257188504
PIXEL MAP	6.257551781261417
GAD1 MRNA	6.256626799545203
GLYB	6.256318896658777
CDC6	6.256318896658777
NT	6.25496253491224
MOUSE MAB	6.254607897318315
TEST CASE	6.253822692411422
P53 PROTEIN BASAL TRANSCRIPTIONAL ACTIVITY	6.252668045407711
ΜG/ML TET	6.245253744621622
gap genes	6.244206023084282
HYDROXYL GROUP	6.244138686337008
ADMINISTRATION	6.2435260561631925
examinations	6.2424550853674265
ENRICHMENT	6.240779853837816
CURRENT COVARIATION-BASED STRUCTURE MODEL	6.240376378448639
RESTRICTED MESENCHYMAL-EPITHELIAL NETWORK	6.240376378448639
RNASE MRP	6.235316506492524
SΑ I2 OBSERVED INTRACELLULAR LOCALIZATION	6.235275376295128
DEVELOPMENTAL PROCESS	6.234581734194334
SUBSTRATE DOMAIN TYROSINE PHOSPHORYLATION	6.231963720766455
W183	6.229462143404531
ENHANCED CHEMILUMINESCENCE	6.228879134462462
GLYCERALDEHYDE-3-PHOSPHATE	6.228879134462462
proteomics	6.225580121250225
RELATEDNES	6.225580121250225
UP-REGULATION	6.223467406533911
epithelial	6.221979217955049
INTRODUCTION	6.219104097403387
GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE	6.218040929860079
S218	6.217152798163001
AFFYMETRIX OLIGONUCLEOTIDE	6.215455934356979
TRANSFECTION EFFICIENCY	6.213326915996193
SECONDARY STRUCTURE CONSERVATION DIAGRAM	6.212648612437301
PRIMARY SEQUENCE ALIGNMENT	6.212583265073705
TIME	6.209095665205158
BP WINDOW	6.20619851062909
BASAL LAYER	6.2047699411884265
AMERSHAM	6.204021922587653
BEHAVIORAL	6.202540253830124
METABOLIC BEHAVIOR COMPUTATIONAL ANALYSIS	6.201710034097385
PHENYLMETHYLSULFONYL           FLUORIDE	6.195167226214057
operations	6.191070442433863
MONOLAYER	6.189196639874023
SINGLE COPY	6.184772750761645
YEAST TWO-HYBRID SCREEN	6.179048685059586
CELL LYSATE	6.177237778675679
GLUTATHIONE-S-TRANSFERASE	6.1754094222303255
STRUCTURAL CHARACTERISTIC	6.1754094222303255
YHL	6.1745703655695126
4F2	6.1745703655695126
DUCHENNE	6.172896312420274
MAMMALIA	6.172896312420274
PLM AXON	6.172896312420274
PSIBLAST	6.172896312420274
GAL4-SRF	6.172896312420274
B6 MOUSE	6.172896312420274
MATURITY	6.172896312420274
GERMLINE	6.172896312420274
G1 BLOCK	6.172896312420274
CYANELLE	6.172896312420274
BLOCKAGE	6.172896312420274
DISPLAYS	6.172896312420274
VINCULIN	6.172896312420274
METAPHAS	6.172896312420274
GRAPHPAD	6.172896312420274
GFP-ΔN70	6.172896312420274
MYCRAB24	6.172896312420274
STELLATE	6.172896312420274
ABLATION	6.172896312420274
MAXIMAL RAS-STIMULATED TRANSACTIVATION	6.17172868305812
TRANSPOSABLE INTRACISTERNAL A-PARTICLE	6.17172868305812
ENHANCED WOX1-MEDIATED L929 CELL DEATH	6.17172868305812
GAD1 RNA	6.168358159285182
LIBRARY CLONE Β-GALACTOSIDASE ACTIVITY	6.168204227366142
BHK	6.166554726744736
P27 MRNA	6.166425023923741
STANDARD TRITON X-100 PERMEABILIZATION	6.166067057425261
JURKAT T	6.161441387955145
FLUORESCENCE DISTRIBUTION	6.161092612691679
RPM METHOD	6.1600713176018305
6AA	6.158739037649826
TARGETING MOTIF INTRACELLULAR MEMBRANE	6.1583488049682025
HEPARIN-BINDING EGF-LIKE GROWTH FACTOR	6.157861075101806
ARACHIDONIC ACID	6.156287506477004
REGULATORY MECHANISM	6.1543226351273566
SERUM RESPONSE ELEMENT	6.148720402692206
METABOLIC PATHWAY OPTIMAL UTILIZATION	6.147696696451533
COORDINATE REPRESENTATION WORD LENGTH	6.147696696451533
ADENOVIRUS	6.147218143966525
FLOORPLATE	6.147218143966525
HY5	6.146540361377465
oxidative	6.142281516667828
cytoplasm	6.142281516667828
LEUPEPTIN	6.142281516667828
ORTHOLOGY	6.142281516667828
HUMAN PP5	6.142281516667828
PROTEOMIC	6.142281516667828
TRANSCRIPTIONAL ACTIVITY INCREASE P53	6.1411118930227175
KDA HSPG	6.141069456421353
DUAL EXCITATION RATIOMETRIC MEASUREMENT	6.141001785526727
GCA	6.139389636859097
BOOTSTRAP MODE OF           THE MODES	6.138300425840222
METHIONINE	6.128513701563734
FILOPODIAL	6.128513701563734
E. COLI CONDITION DEPENDENT PHENOTYPE	6.128119714850381
AFFINITY-PURIFIED POLYCLONAL ANTIBODY	6.123599918551536
MESENCHYMAL CELL DEVELOPED HIERARCHY	6.1230404330921555
SUBCELLULAR FRACTIONATION	6.119625726469283
ASPARAGINE	6.118708454363679
GENE EXPRESSION ANALYSIS	6.11756624704733
TABULAR DISPLAY NUCLEOTIDE FREQUENCY	6.117230919239635
HL-60 CELL	6.115416414444192
ANDROGEN-MEDIATED CELL CYCLE CONTROL	6.1152603539185675
AFFINITY-PURIFIED ANTI-BOI1 ANTIBODY	6.109879486349978
SPINAL CORD	6.109025769667939
DIFFERENTIAL LOCALIZATION	6.107118205090426
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE	6.1056798933236855
GENBANK ACCESSION NUMBER	6.104866747127737
POLYCLONAL	6.1017542364647674
PG	6.099117180092869
PS	6.09849032649535
CORONARY REVASCULARIZATION PROCEDURE	6.094999224887722
PROTEOGLYCAN	6.094620605103615
GR-INDUCED TRANSCRIPTIONAL ACTIVITY	6.093688256508573
monoclonal antibodies	6.093457648222538
CYTOSKELETAL NETWORK	6.092252784921863
cell differentiation	6.092252784921863
POTENTIAL GSK3 PHOSPHORYLATION SITE	6.091986147970888
OBSERVED INTRACELLULAR LOCALIZATION	6.089564614233871
IN VIVO COIMMUNOPRECIPITATION ASSAY	6.088457102476492
IN SITU HYBRIDIZATION	6.086360469551427
DROSOPHILA EXPRESSION VECTOR PPACPL	6.085821151058226
U/ML	6.082365533463069
INTRACELLULAR CALCIUM	6.081265631542654
CYTOPLASMIC	6.080019958206654
OLIGONUCLEOTIDE PROBE	6.077722652336534
JENSSEN	6.072886765672654
PROTIST	6.072886765672654
APLYSIA	6.072886765672654
CRITICA	6.072886765672654
RPM-BME	6.072886765672654
NEURITE	6.072886765672654
CHELATE	6.072886765672654
AD-SKP2	6.072886765672654
SER/THR	6.072886765672654
HRM-BME	6.072886765672654
BIPOLAR	6.072886765672654
RAS/RAF	6.072886765672654
ERP/NET	6.072886765672654
AEROBIC	6.072886765672654
PROPRIA	6.072886765672654
DNASE-1	6.072886765672654
HITACHI	6.072886765672654
SC	6.071886037260208
OH	6.071886037260208
POTENTIAL AGGRESOME-LIKE STRUCTURE	6.0717191363105005
INTRAMOLECULAR SECONDARY STRUCTURE	6.0717191363105005
SCANNING MICROSCOPY CONFOCAL LASER	6.0717191363105005
DENEDDYLATION	6.071638582298389
CANALICULAR	6.069254615621422
ORIGIN RECOGNITION         COMPLEX	6.067101299419335
HYBRIDIZATION SIGNAL	6.067012775991733
PH-20-INCREASED TNF SUSCEPTIBILITY	6.065452560551177
ORIGINAL DISTRIBUTION THPERCENTILE	6.06536592586326
antigen	6.065226473890426
SIMILARITY	6.064144716773759
GENOMIC DNA SOUTHERN BLOT ANALYSIS	6.063984246117195
NORMALIZATION PROCEDURE	6.062257063411056
INTER-ARRAY VARIABILITY	6.062257063411056
TP	6.060881885975221
HS	6.060881885975221
ANDROGEN-MEDIATED P27 ACCUMULATION	6.059032203791624
PROTEIN/PROTEIN INTERACTION DOMAIN	6.057267913385435
HOMODIMER	6.055553201794801
HIERARCHICAL CLASSIFICATION SCHEME	6.054906372078167
ZN	6.053739028832364
NADP-DEPENDENT ALCOHOL DEHYDROGENASE	6.053068066246242
CYTOPLASMIC COMPARTMENT	6.053006447411186
MESENCHYMAL-EPITHELIAL INTERACTION	6.050042301922901
nonspecific	6.046590041908027
TISSUE-TYPE PLASMINOGEN ACTIVATOR	6.044978980196685
GRAPHICAL USER INTERFACE COREGENE	6.044978980196685
HIGH-RESOLUTION CRYSTAL STRUCTURE	6.044978980196685
MG/ML LIPID VESICLE/PBS SUSPENSION	6.044072165980572
VESICLE CO-SEDIMENTATION ANALYSIS	6.043959748598684
CARBOXYL-TERMINAL WD REPEAT DOMAIN	6.042997330746933
CYTOLYTIC	6.041884278414975
TRANSCRIPTIONAL COMPLEX	6.039742220883118
KINASE INACTIVE SRC KINASE DOMAIN	6.038507201637174
RRNA INTRON OBSERVED DISTRIBUTION	6.035443693401202
LOCALIZATION PATTERN DISTRIBUTION	6.035168511753547
RECEPTOR-MEDIATED PHOSPHORYLATION	6.033674775200664
OTHER INOSITOL-BASED PHOSPHOLIPID	6.032766401584912
IN VITRO PHOSPHORYLATION REACTION	6.031613670154396
CHLORAMPHENICOL ACETYL TRANSFERASE	6.03117070492664
HYAL-2-INCREASED TNF CYTOTOXICITY	6.030990026514108
ADENOVIRUS-MEDIATED GENE TRANSFER	6.030111493191049
IMMUNOFLUORESCENCE FLOW CYTOMETRY	6.028894595503635
non-specific	6.01835428154308
C/EBPΑ ANTI-PROLIFERATIVE ACTION	6.017463640072128
ACETYL-LEUCYL-LEUCYL-NORLEUCINAL	6.017463640072128
UNDERSTANDING NOCTURNIN FUNCTION	6.017463640072128
PHYLOGENETIC GROUP/CELL LOCATION	6.017463640072128
PHOSPHATIDYLINOSITOL-3-PHOSPHATE	6.017463640072128
CIPHERGEN WCX2 PROTEINCHIP ARRAY	6.017463640072128
BIOLOGICAL SIGNIFICANCE	6.014847656411725
RNA STRUCTURAL ALIGNMENT PROBLEM	6.013988597147776
PAIR-WISE COMPARISON	6.013425294486017
MIB-INDUCED G1 CELL CYCLE ARREST	6.012589424176319
BOOTSTRAP ESTIMATE USING THE MEAN	6.012507421585349
ENO	6.012385254177453
THIAMINE MITOCHONDRIAL UPTAKE	6.012363540034415
SΑ I2 INTRACELLULAR LOCALIZATION	6.011485504079353
PROTEASOME INHIBITOR LACTACYSTIN	6.0107475175094205
E. COLI IN SILICO REPRESENTATION	6.010680356283794
ANTIANDROGEN CYPROTERONE ACETATE	6.009666762154502
acceptor	6.008938459633952
SYSTEMIC	6.008938459633952
ALPHABET	6.008938459633952
HYBRIDOMA BANK DEVELOPMENTAL STUDY	6.005504327638182
REAL-TIME POLYMERASE CHAIN REACTION	6.005323779848001
WILD-TYPE CELL	6.004089444468857
CONTROLLING BEHAVIORAL RHYTHMICITY	6.002786802957936
EXCITATION RATIOMETRIC MEASUREMENT	6.002027788276377
EXTRACELLULAR MATRIX COMPONENT	5.99789795721979
CORTICAL MYOSIN-II CONCENTRATION	5.994469457738793
HETEROTRIMERIC G PROTEIN COMPLEX	5.992879371754276
EMBRYONIC DEVELOPMENT	5.9916378001660995
EXPERIMENTAL TREATMENT	5.990010882979617
DNA-BINDING TRANSCRIPTION FACTOR	5.9899955095851745
BOI1-PH KK MUTANT VERSION ABILITY	5.98913714953342
NEW SECONDARY STRUCTURE DIAGRAM	5.989126826275875
DIFFERENTIATING EPITHELIAL CELL	5.989126826275875
ORIGINAL KERNEL DOCUMENT METHOD	5.989126826275875
IRIDOCORNEAL ANGLE MORPHOGENESI	5.989126826275875
FLAG-MHCK-C AUTOPHOSPHORYLATION	5.989126826275875
CLEAVAGE FURROW CORTEX INCREASE	5.989126826275875
SPONTANEOUS AXONAL REGENERATION	5.989126826275875
DUAL COLOR IMMUNOHISTOCHEMISTRY	5.989126826275875
PARALLEL PLATE PERFUSION CHAMBER	5.985666997314313
METABOLISM GENE DELETION STRAIN	5.98554924179406
PCNA-DEFINED CELL PROLIFERATION	5.984923164509743
HYDROXYPHOSPHORIBOSYL TRANSFERASE	5.98463447411498
LATE-BORN NEURON REDUCED NUMBER	5.984156979852861
CLONE FUNCTIONAL CHARACTERIZATION	5.983457778448192
MAMMALIAN PERIOCULAR MESENCHYME	5.983278253383865
GR-GFP CYTOPLASMIC LOCALIZATION	5.981576534473291
hybridization	5.979987710056315
TYROSINE-PHOSPHORYLATED PROTEIN	5.979681500832957
GSK3Β-DEPENDENT PHOSPHORYLATION	5.9780097042497395
ENDOGENOUS PROTEASOME COMPONENT	5.97721298290404
SUBCELLULAR LOCALIZATION SIGNAL	5.976985097461703
OBSERVED INTERACTION	5.975377185032291
HISTOLOGY	5.974220981096197
LEUKOCYTE	5.974220981096197
CROSS HYBRIDIZATION DISTRIBUTION	5.973441208155066
RG	5.971825029295971
ERK2	5.97159177306896
RIBOSOMAL RNA SEQUENCE	5.97045310841617
BASAL TRANSCRIPTIONAL MACHINERY	5.968811909516121
T LYMPHOCYTE ACTIN CYTOSKELETON	5.966441588748592
SPARC-NULL FIBROBLAST MONOLAYER	5.961917152822738
PLASMINOGEN ACTIVATOR INHIBITOR 1 DISTAL HINGE	5.961177046813394
SMG GR	5.961085604326699
URACIL	5.961085604326699
HITRAP	5.961085604326699
ARG356	5.961085604326699
B6 EYE	5.961085604326699
SHIELD	5.961085604326699
EVENTS	5.961085604326699
CMV-RA	5.961085604326699
HEPTAD	5.961085604326699
UNC-86	5.961085604326699
OSSEUS	5.961085604326699
T7 TAG	5.961085604326699
SILVER	5.961085604326699
CAS(SD	5.961085604326699
P0-17D	5.961085604326699
SC-LEU	5.961085604326699
TIMP-1	5.961085604326699
RNASEP	5.961085604326699
FUMABC	5.961085604326699
'-RACE	5.961085604326699
BLASTN	5.961085604326699
SCLERA	5.961085604326699
DNASE1	5.961085604326699
SPREAD	5.961085604326699
GADD45	5.961085604326699
THR235	5.961085604326699
NORTHERN HYBRIDIZATION	5.960441944879439
PROSEQUENCE ARTIFICIAL REMOVAL	5.959917974964545
BPNN ARCHITECTURE OPTIMIZATION	5.959917974964545
TGF-Β1-MEDIATED TNF-RESISTANCE	5.959917974964545
PAPILLARY UROTHELIAL CARCINOMA	5.959917974964545
RAS-STIMULATED TRANSACTIVATION	5.959917974964545
GENETIC BACKGROUND PAG-3(LS20)	5.959917974964545
INDUCED WOX1 EXPRESSION HYAL-2	5.959512788578807
DENSITY INDEPENDENT EXPRESSION	5.959377726450228
AFFYMETRIX GENECHIP EXPRESSION	5.959377726450228
INTRINSIC EXPRESSION POTENTIAL	5.959377726450228
SMALL-SCALE GROWTH CULTURE	5.959261136459722
EXPERIMENTAL FOLD CHANGE VALUE	5.957868794636676
REGULATORY INFORMATION	5.95704423673492
ALTERED NUCLEOLAR LOCALIZATION	5.956499171545741
BASAL TRANSCRIPTIONAL ACTIVITY	5.9560420059722965
PROLIFERATION ASSOCIATED GENE,	5.955751308297878
TRITON X-100-INSOLUBLE FRACTION	5.95572440335786
MAINTAINING SIGNAL SPECIFICITY	5.955602980358288
HUMAN GENOME MUTATION DATABASE	5.954522291511307
ONTHE AVERAGE PREDICTIVE ABILITY	5.954387910300089
TRANSCRIPTIONAL TRANSACTIVATOR	5.954104021476172
NF-ΚB SN50-MEDIATED INHIBITION	5.952900431104895
POTENTIAL GSK3 PHOSPHORYLATION	5.952571785800173
3T3 CELL	5.95196850376326
PHENOTYPE PHASE PLANE ANALYSIS	5.95013667390337
VESICLE CO-SEDIMENTATION ASSAY	5.948055578760512
ZEBRAFISH PRIMARY MOTOR NEURON	5.947209765422845
POSITIVE CONTROL	5.947092735607462
MODELING GENE-GENE INTERACTION	5.94594173457321
KINETIC STUDY STEADY-STATE	5.944949185444849
ΜM CEE	5.944948685011295
PROPER MULTIPLE IMPUTATION	5.944912724024982
RAB24 C-TERMINAL HYPERVARIABLE	5.942616387662957
P38	5.941902515640118
ATP HYDROLYSI	5.940986575935154
CAP-DEPENDENT TRANSLATION	5.939900291711958
TOXIN	5.939826439122559
COILED-COIL STRUCTURE	5.939664832402756
MITOCHONDRIAL SURFACE	5.939664832402756
INDIVIDUAL PROBE PAIR	5.939664832402756
UBIQUITOUS EXPRESSION	5.938467261811222
EXTRACELLULAR MATRIX FORMATION	5.938250195703308
ΜG/ML G418	5.937981504349954
PHYLOGENETIC ANALYSIS	5.9374624447575215
POLYCLONAL ANTI-SMAD1 ANTIBODY	5.937122379755157
PROGRAMMING ALGORITHM	5.934835413742781
DEVELOPING IRIDOCORNEAL ANGLE	5.929781705144265
SECONDARY STRUCTURE BASE PAIR	5.929781705144265
TGF-Β1-INDUCED TNF-RESISTANCE	5.929781705144265
SV40 POLYADENYLATION SEQUENCE	5.929781705144265
WOX1-MEDIATED L929 CELL DEATH	5.929781705144265
CINNAMYL-ALCOHOL DEHYDROGENAS	5.929781705144265
QUANTITATIVE HISTOMORPHOMETRY	5.929781705144265
CLINICAL PROTEOMICS DATA BANK	5.929781705144265
DIVERGENCE-MATCHED TRANSITION	5.929781705144265
ELEVATED EXPRESSION	5.928220586003742
RNA SAMPLE	5.9281742886206175
CONTROL SUBSTRATE SPECIFICITY	5.92789976922389
PERFORMED MICROARRAY ANALYSIS	5.927112163958938
OBSERVED DISTRIBUTION	5.926044536458494
TRANSCRIPTIONAL STOP SEQUENCE	5.925941242888151
EPITHELIAL CELL PROLIFERATION	5.925653208218943
RECEPTOR TYROSINE KINASE	5.925456168887619
SIGNAL TRANSDUCTION	5.92473176148017
SIMILARITY SCORE DISTRIBUTION	5.923693599079273
GLYCERALDEHYDE-3-PHOSPHATE           DEHYDROGENASE	5.923522690619582
origins	5.922888789874555
BINDING DOMAIN C-TERMINAL SRC	5.922837459163884
PGBT9 BAM HI RESTRICTION SITE	5.922442155054803
coronary revascularization	5.922262728475839
ENCOMPASSING SEQUENCE	5.921808027434211
PRIMARY MOTOR NEURON IDENTITY	5.9171899121796425
CHROMATIN	5.916076210401227
DONOR CELL NUCLEUS ACTIVATION	5.915984203899148
IMPROVEMENT	5.915961525654539
STRUCTURAL PAIRWISE ALIGNMENT	5.915727247526146
SIGNAL TRANSDUCTION PATHWAY	5.914958201594665
MEDIATED ACTIVATION	5.913193794105491
LYMPHOCYTE ACTIN CYTOSKELETON	5.911464519109752
POSTNATAL DEVELOPMENT	5.910969645801738
CONDITION DEPENDENT PHENOTYPE	5.910207356604955
MEDIATED TRANSFORMATION V-CRK	5.906738931607582
TNF-MEDIATED IΚBΑ DEGRADATION	5.906190294142423
mutations	5.903254770113071
MULTIPLE TRANSCRIPTION FACTOR	5.902891414564268
SULFATE FRACTIONATION	5.902719779653946
DNA POLYMERASE ACTIVITY	5.902662790585394
CONSTRUCTION	5.901943031139675
INTRACELLULAR BILE ACID	5.901860231605259
SALI RESTRICTION ENDONUCLEASE	5.8996961619847585
WITHIN-TREATMENT VARIABILITY	5.898657186647107
TARGETED MUTATION HOMOZYGOUS	5.898657186647107
ESTROGEN-TREATED MOUSE MODEL	5.898657186647107
STRUCTURAL ALIGNMENT PROBLEM	5.898657186647107
NORMAL PITUITARY GONADOTROPE	5.898657186647107
HUMAN IMMUNODEFICIENCY VIRUS	5.898657186647107
FIBULIN-1C CARBOXYL-TERMINUS	5.898657186647107
WTPAI-1 FUNCTIONAL STABILITY	5.898657186647107
SEQUENCE SELECTION CRITERION	5.898657186647107
PROBABILISTIC NEURAL NETWORK	5.898657186647107
VIBRISSAE ECTODERMAL PLACODE	5.898657186647107
STANDARD DEVIATION PARAMETER	5.898657186647107
LYSOSOMAL OXIDATIVE ACTIVITY	5.898657186647107
SPECIALIZED MESENCHYMAL CELL	5.898657186647107
THROMBIN AMIDOLYTIC ACTIVITY	5.898657186647107
STRAIN-TO-STRAIN VARIABILITY	5.898657186647107
SPECTROFLUORIMETRIC ANALYSIS	5.897194626111903
POST-TRANSCRIPTIONAL CONTROL	5.89586123758978
CI	5.89468142737516
C/EBPΑ-GFP EXPRESSION VECTOR	5.894430659144548
CIS-REGULATORY RNA STRUCTURE	5.894188251678428
HYAL-2-INCREASED TNF KILLING	5.892709440470611
NEGATIVE CONTROL PROTEIN III	5.892665282947599
RIBOSOME	5.892624285475775
SURVIVAL	5.891879027257371
SEQUENCE INFORMATION	5.891772281710884
CONSERVED N(T)KXD NUCLEOTIDE	5.891414543701559
PROPIDIUM IODIDE-STAINED DNA	5.891290991280107
NEGATIVE CONTROL RAD PEPTIDE	5.890412388031548
TARGETING SIGNAL SUBCELLULAR	5.890201564198885
PURIFIED WILD-TYPE MYOSIN II	5.888264685800926
NF-ΚB-MEDIATED TRANSCRIPTION	5.887324875802745
NUCLEOTIDE SEQUENCE	5.886226349218637
LDL RECEPTOR RELATED PROTEINS	5.8841887390994
SRC KINASE DOMAIN C-TERMINUS	5.884046810213297
STABLE TRANSFECTED CELL LINE	5.883862541635222
CARDIOVASCULAR ENDPOINT	5.883601860927841
AFFINITY-PURIFIED POLYCLONAL	5.883559061737541
MIB-INDUCED P27 UPREGULATION	5.881440026662515
SEDIMENTATION ANALYSIS	5.881205177976322
N-TERMINAL SEQUENCE ANALYSIS	5.879792440993815
CLUSTALW	5.878469325004314
THIAMINE CONCENTRATION	5.874612545158595
PROTEOLYTIC CLEAVAGE	5.874309404327565
PROSTATE CANCER CELL	5.874309404327565
XHOI	5.873540064096224
requirements	5.872363209554736
MONOCLONAL ANTIBODY	5.8721351712634515
files	5.870089609302042
HEPARAN SULFATE PROTEOGLYCAN	5.86891845576463
CO-TRANSFECTED	5.867695977513819
VIDEO TIME-LAPSE MICROSCOPY	5.866477400927977
PRE-APICAL ECTODERMAL RIDGE	5.866477400927977
REFERENCE STRUCTURE DIAGRAM	5.866477400927977
JAAGSIEKTE SHEEP RETROVIRUS	5.866477400927977
COPY EXTRACHROMOSOMAL ARRAY	5.866477400927977
BONE MORPHOGENETIC PROTEINS	5.866477400927977
IMAGEQUANT SOFTWARE VERSION	5.866477400927977
MORPHOGENETIC CELL MOVEMENT	5.866477400927977
GENERATING TRANSGENIC MOUSE	5.866477400927977
RGS3-EXPRESSING GONADOTROPE	5.866477400927977
CELL SURFACE HSPGS FUNCTION	5.866477400927977
INTERCELLULAR THY-1 VESICLE	5.866477400927977
T. ACIDOPHILUM INTEIN	5.864920273161418
MAPK PATHWAY	5.86384821204641
interaction domains	5.863257523834991
SOUTHERN BLOT HYBRIDIZATION	5.862797112295304
AFFYMETRIX SOFTWARE	5.8625932903120255
TERMINAL CYTOPLASMIC DOMAIN	5.862527822883157
NOCODAZOLE TREATMENT	5.862416740042516
INDICATED EXPRESSION VECTOR	5.86229300148341
CLOSURE	5.861534548768151
somites	5.861534548768151
trypsin	5.861534548768151
GUANINE	5.861534548768151
TGF-Β CELL-SURFACE RECEPTOR	5.8608449591944956
CYTOSKELETAL PROTEIN	5.8606700702148125
METABOLIC FLUX DISTRIBUTION	5.8605075318095405
SER/THR PROTEIN PHOSPHATASE	5.860413215562496
TRITON X-100-EXTRACTED CELL	5.859586647743399
EMBRYONIC FIBROBLAST	5.859519035039053
METALLO-Β-LACTAMASE L1	5.859373040030784
PHOSPHORYLATION TARGET SITE	5.859339871458551
MULTICELLULAR AGGREGATE	5.8585964814444385
PHOSPHORYLATION SITE	5.858255945650777
OVERESTIMATION DISTRIBUTION	5.857522597250322
NODE	5.8572664125588005
C-TERMINAL DELETION PROTEIN	5.856557675090173
OPPOSITE QUADRANT COMPARISON	5.855988572772249
GENE-SPECIFIC TRANSCRIPTION	5.8552580452810306
SRF-DEPENDENT TRANSCRIPTION	5.8552580452810306
PROTEIN PHOSPHATASE TYPE 5 CELLULAR ROLE	5.855187504687723
DONOR NUCLEUS REPROGRAMMING	5.854407882927659
PHOSPHATIDYLINOSITIDE ABILITY	5.854117616040174
EMBRYONIC GENOME ACTIVATION	5.853517631097127
FIBRONECTIN RECEPTOR	5.853316266502652
transient transfection	5.852452215195991
variations	5.852371752786286
SINGLE PARAMETER ROBUSTNESS	5.852174197156834
TRYPSIN	5.852141360180253
GENERAL ALIGNMENT ALGORITHM	5.852139297773039
SEQUENCE ALIGNMENT RETRIEVAL	5.851924895260359
SRF DEPENDENT TRANSCRIPTION	5.85150961316315
CATALYTIC EFFICIENCY	5.851508903247897
SEGMENT LENGTH DETERMINATION	5.849092635176313
ΜM RESVERATROL-TREATED CELL	5.849056768182613
PROTEIN KINASE C ACTIVATION	5.848639832881474
BINDING ACTIVITY P35	5.847004426865435
PROTEIN/PROTEIN INTERACTION	5.846108507866645
COLLECTION	5.84588242964106
DECATENATION ACTIVITY	5.844333731327601
MULTIPLE COMPARATIVE GENOME	5.84392639993087
METABOLIZE BILE ACID	5.84356835488891
ACTIVATED B CELL-LIKE GROUP	5.843344158094036
N-TERMINAL DELETION PROTEIN	5.842701826517761
DIFFERENTIAL DISPLAY SCREEN	5.841322806778449
DIFFERENTIAL GENE SELECTION	5.841322806778449
EVOLUTIONARY DISTANCE FIXED	5.8380057174400495
DNA-BINDING TRANSCRIPTIONAL	5.837695342983422
HIV-1 RT P51 SUBUNIT	5.837034379165549
ACKAB	5.834335901465263
RANKL	5.834335901465263
IMAGE	5.834335901465263
BPSEQ	5.834335901465263
EA489	5.834335901465263
UNC-5	5.834335901465263
PEGFP	5.834335901465263
WAVE1	5.834335901465263
calls	5.834335901465263
ACNAB	5.834335901465263
C-RAF	5.834335901465263
C/EBP	5.834335901465263
HYAL1	5.834335901465263
IP-LB	5.834335901465263
MET14	5.834335901465263
Α-PML	5.834335901465263
TGFΒ1	5.834335901465263
PJC10	5.834335901465263
F-ΔN3	5.834335901465263
GFP-MYOSIN-II CONCENTRATION	5.833541936554231
ULTRASTRUCTURAL ALTERATION	5.833168272103109
MITOCHONDRIAL CONTACT SITE	5.833168272103109
INFLUENZA SELECTED VARIANT	5.833168272103109
SECONDARY STRUCTURE HELICE	5.833168272103109
ADENOVIRUS SPLICE ACCEPTOR	5.833168272103109
INTEGRATED OPTICAL DENSITY	5.833168272103109
ORIGINAL NON-LINEAR SYSTEM	5.833168272103109
ANDROGEN-INDUCED G1 ARREST	5.833168272103109
REPETITIVE SEQUENCE FAMILY	5.833168272103109
SECOND-ORDER RATE CONSTANT	5.833168272103109
HETEROGENEOUS FLUORESCENCE	5.833168272103109
AFFYMETRIX DIFFERENCE CALL	5.833168272103109
HYGROMYCIN-RESISTANCE GENE	5.833168272103109
LOAD-DEPENDENT RECRUITMENT	5.833168272103109
PATHOPHYSIOLOGICAL PROCESS	5.833168272103109
INTER-INDIVIDUAL VARIATION	5.833168272103109
COMPENSATORY ANTIAPOPTOTIC	5.833168272103109
P53-GST PREPHOSPHORYLATION	5.833168272103109
EMBRYONIC SMG MORPHOGENESI	5.833168272103109
DIFFERENTIATING EPITHELIAL	5.833168272103109
GR-INDUCED GENE EXPRESSION	5.832648838832222
PROPRIETARY MAS4 ALGORITHM	5.8310735640760685
HORSERADISH PEROXIDASE	5.830863683645896
ACTIN FILAMENT GROWING END	5.830504917575653
MACHINERY	5.8300128435434395
LOCALIZATION POLAR PATTERN	5.829881191814523
CA TYROSINE PHOSPHORYLATION	5.829272344551055
TARGET GENE	5.829146107759063
INACTIVE SRC KINASE DOMAIN	5.8274388277230695
BONE MORPHOGENETIC PROTEIN	5.827167282927925
PUTATIVE NOCTURNIN PROTEIN	5.827167282927925
PROPIDIUM IODIDE-BOUND DNA	5.8259514991051375
DOTMAC-RESISTANT COMPONENT	5.825656780037394
PARTHENOGENETIC ACTIVATION	5.824306788375814
SEQUENCE COMPOSITION	5.824073150020031
POLYCLONAL GOAT ANTI-NF-ΚB	5.82330703123735
SUBJECT	5.823196846082647
STATISTICAL METHOD	5.822801706748219
OTHER PROTEASOME COMPONENT	5.821814267594537
CRNA HYBRIDIZATION SOLUTION	5.821130218769843
LATENCY-ASSOCIATED PEPTIDE	5.819752397902018
ATP DEPENDENT MANNER	5.817008589604808
GFP FUSION PROTEIN	5.81688772551773
MEDIATED AA RELEASE	5.815355429451276
PROTEIN INTERACTION DOMAIN	5.813729533320497
TRANSPORT BILE ACID	5.81291150502022
NITROCEFIN HYDROLYSI	5.811861714191562
SERINE DEGRADATION PATHWAY	5.811065490852269
HIGH-THROUGHPUT SEQUENCING	5.809717760288194
DIMETHYL SULFOXIDE	5.809356866801555
GENETIC BACKGROUND	5.809356866801555
INTRACELLULAR ACCUMULATION	5.809105129601281
CELLULAR ADHESION MOLECULE	5.806915007686789
immunohistochemical	5.805913116755432
PROLINE-RICH REGION	5.805913116755432
EXPERIMENTAL RESULT	5.805913116755432
MECHANICAL PROPERTY	5.805913116755432
IMMUNOHISTOCHEMICAL	5.805913116755432
COMPARISON ANALYSIS	5.803774628166163
DENSITY LIPOPROTEIN	5.803593045524028
DEVELOPMENTAL STUDY	5.8014979603142045
MULTIPLE IMPUTATION	5.8005767703109825
THIAMINE DIPHOSPHATE	5.7993819569028755
CONTAINING GST-P35-C/EBPΒ	5.798647639899486
SMAD1 SIGNALING MECHANISM	5.798647639899486
SISTER CHROMATID EXCHANGE	5.798647639899486
GALACTOSE/RAFFINOSE PLATE	5.798647639899486
STUDIED SEGMENTATION GENE	5.798647639899486
ANTI-PROLIFERATIVE ACTION	5.798647639899486
HUMAN TRACHEAL EPITHELIAL	5.798647639899486
SELECTING KERNEL DOCUMENT	5.798647639899486
FIBULIN-1 EGF-LIKE MODULE	5.798647639899486
'-AZIDO-3'-DEOXYTHYMIDINE	5.798647639899486
CONFORMATIONAL TRANSITION	5.798647639899486
CIRCADIAN CLOCK MECHANISM	5.798647639899486
ENDOGENOUS RAB24 FUNCTION	5.798647639899486
RELATIVE EXPRESSION LEVEL	5.7981338757177285
SRC* TRANSIENT EXPRESSION	5.7981338757177285
INCREASED ENOS EXPRESSION	5.7981338757177285
ALPHA-1 ANTAGONIST	5.797962683251036
TRYPTOPHAN DEPLETION	5.797539889926877
SMALL-SCALE GROWTH	5.797232392858434
CO-SEDIMENTATION ANALYSIS	5.79723038580048
SIMULATED MICROARRAY DATA	5.797030331225281
CATALYTIC MECHANISM	5.795151096555212
NOVEL C-TERMINAL SEQUENCE	5.794873919659674
MYC PROMOTER BINDING PROTEIN, CLONE 14	5.794289833719796
FIBROBLAST DIFFERENTIATION	5.793914170375865
BLM DNA HELICASE ACTIVITY	5.793294132988145
CYTOSKELETON PRESERVATION	5.792884139896864
INTERACTING PROTEIN SMAD1	5.792712145455592
BEARING	5.792534414516497
PROTEIN DEGRADATION	5.792479053856435
NUCLEOTIDE FREQUENCY DATA	5.791629355763451
MULTIPLICITY OF INFECTION	5.791360455988125
P66 PALM SUBDOMAIN	5.791204495606955
RELATIONAL DATABASE TABLE	5.791188992837268
MURINE HYALURONIDASE HYAL1	5.791015427739685
epithelial cell proliferation	5.790330253444486
CPLA TRANSLOCATION	5.789947589670431
IMMOBILIZED CDNA FRAGMENT	5.789633635156048
GENE PRESENCE SIGNIFICANCE	5.789397602288078
EVOLUTIONARY CONSERVATION	5.789137864895159
PRIMARY MOTOR NEURON FATE	5.786562418554546
GENETIC ALGORITHM	5.786511889843709
DISTANCE CALCULATION	5.786015381605232
BOOTSTRAP ORTHOLOGY VALUE	5.78455908433752
BLASTOCYST FORMATION RATE	5.780872359517566
ANTI-FIBRONECTIN ANTIBODY	5.780760915753417
LEUCINE ZIPPER DIMERIZATION	5.779727740300698
YEAST CENTROMERIC PLASMID	5.779371068944769
AVM TOUCH RECEPTOR NEURON	5.778507176166827
ALM TOUCH RECEPTOR NEURON	5.778507176166827
OLIGO	5.775715974201309
FOLATE TRANSPORTER	5.775669042378808
KB HINDIII/ECORV FRAGMENT	5.775593639888997
DIAGNOSTIC CLASSIFICATION	5.7754530667182005
CORRESPONDING GENE	5.77403802382205
COMPARISON SURVIVAL METHOD	5.774000826908554
MESOBUTHUS TAMULUS	5.77302848270361
HETEROOLIGOMERIZATION	5.772082394529468
CELL SURFACE PROTEOGLYCAN	5.769830139886374
ADIPOCYTE DIFFERENTIATION	5.7694765509291575
EXCLUSIVE	5.768766100931751
STRUCTURAL ALIGNMENT	5.768110579758368
primer	5.767807645029425
ACHBP	5.765912649430229
DNA-BINDING TRANSCRIPTION	5.765024054021436
DESTABILIZING PERTURBATION	5.764491773216572
ZIMMERMANN FUSION MEDIUM	5.762824038694562
AGGRESOME-LIKE STRUCTURE	5.762824038694562
MEMBRANE-BOUND PRECURSOR	5.762824038694562
DIVERGENCE TIME ESTIMATE	5.762824038694562
DORSAL/VENTRAL ASYMMETRY	5.762824038694562
SPARC-NULL MICE RELATIVE	5.762824038694562
GLUTATHIONE-COUPLED BEAD	5.762824038694562
MORPHOLOGICAL DIFFERENCE	5.762824038694562
CORTICAL MYOSIN-II LEVEL	5.762824038694562
NORMAL AXONAL MORPHOLOGY	5.762824038694562
OTHER COAGULANT FIXATIVE	5.762824038694562
L-Α-PHOSPHATIDYLINOSITOL	5.762824038694562
SN50-MEDIATED INHIBITION	5.762824038694562
NON-BOOTSTRAPPED VERSION	5.762824038694562
MATRIX INTER-Α-INHIBITOR	5.762824038694562
RESVERATROL-TREATED CELL	5.762824038694562
HUGENEFL INTENSITY LEVEL	5.762824038694562
POTENTIAL AGGRESOME-LIKE	5.762824038694562
METABOLISM GENE DELETION	5.762824038694562
DORSAL BLASTODERM MARGIN	5.762824038694562
POLYMERIZATION INHIBITOR	5.762824038694562
TERM ULTRAMICROEXTENSION	5.762824038694562
PRESERVED MICROEXTENSION	5.762824038694562
AVERAGE PREDICTION ERROR	5.762824038694562
UBIQUITINATION SUBSTRATE	5.762824038694562
MNOC RHYTHMIC EXPRESSION	5.762316157579691
TAG EXPRESSION POTENTIAL	5.762316157579691
thaliana	5.762221732631317
PARAFFIN	5.762221732631317
NM LYSOTRACKER RED DND-99	5.762071582190536
CULLIN REGULATION	5.761375470482254
LYSOSOMAL STORAGE DISEASE	5.7613544045884
SCFG ALIGNMENT ALGORITHM	5.76077591681302
EXPERIMENTAL FOLD CHANGE	5.760255492400496
C/EBPΑ EXPRESSION VECTOR	5.758775336699735
EXPRESSION VECTOR PPACPL	5.758775336699735
REGULATORY RNA STRUCTURE	5.758543128204453
SALT CONCENTRATION	5.7583778789921265
SINGLE-STRAND DNA	5.757838474134498
TYROSINE KINASE ACTIVITY	5.7575984849788036
STRUCTURAL PROTEIN	5.757421331542496
GENOMIC CROSS-NETWORKING	5.757228277125347
ACTIN-BASED CYTOSKELETON	5.757126536005907
CONSERVED PROTEIN DOMAIN	5.756956511057328
INTERACTING PROTEIN SMAD	5.756956511057328
TRANSFORMATION	5.756360643710745
CORONARY DISEASE	5.756269310059702
FETAL BRAIN CDNA LIBRARY	5.756140949047917
LACZ TRANSGENE INTRODUCTION	5.7560687419478045
CONDENSED CHROMATIN	5.755564841548446
TRANSCRIPTIONAL ACTIVATION	5.755245469672623
ACTIVATED PROTEIN KINASE	5.75454138467678
ATP CONCENTRATION	5.753130449884811
chemiluminescence	5.749475780969415
MARKED DIFFERENCE	5.749475780969415
MAPK SIGNAL TRANSDUCTION	5.748974981542273
THIN-LAYER CHROMATOGRAPHY	5.748596192508291
POLYMERASE CLEFT	5.7481460795374115
REPORTED MURINE SEQUENCE	5.747722224339089
IMMUNOFLUORESCENCE STUDY	5.746690785144107
PROTEIN         KINASE C	5.745588166166035
NEURAL PATTERN FORMATION	5.745252301430484
PAI-1S COMPLEX FORMATION	5.745252301430484
DC PRECURSOR TRANSFORMATION	5.744231248277778
FIBRONECTIN ACCUMULATION	5.740149875496799
DISTRIBUTION QUANTITATION	5.739831422919051
BLINDED MEDICATION	5.7397828819737065
HIV-1 RT SUBUNIT	5.739626875942933
C-TERMINAL REGION	5.739185202986139
PRIMARY BPAEC PREPARATION	5.738728721686681
AMINOPEPTIDASE N	5.738025888178392
TB	5.736871473159836
GFP FUSION	5.736765432649655
EXCESS EARLY-BORN NEURON	5.735758562047138
COLLAGEN GEL CONTRACTION	5.735596669065671
FLUORESCENCE IMAGE	5.734179131852789
EUCLIDEAN DISTANCE	5.734179131852789
MEMBRANE INTEGRITY	5.734179131852789
ADVANCED DIFFERENTIATION	5.733986985209034
ENTERING DIFFERENTIATION	5.733986985209034
KK MUTANT VERSION ABILITY	5.733940345078377
ECTOPIC EXPRESSION	5.733034941934438
MYOSIN HEAVY CHAIN	5.731051932828988
SHOWED MIGRATION DEFECT	5.725595236983712
ECTOCERVICAL EPITHELIUM	5.725595236983712
HRP-CATALYZED OXIDATION	5.725595236983712
SPECIALIZED MESENCHYMAL	5.725595236983712
PROTEASE-SENSITIVE SITE	5.725595236983712
FORM SDS-STABLE COMPLEX	5.725595236983712
MEASUREDTHE CONSISTENCY	5.725595236983712
PSEUDOPODIAL RETRACTION	5.725595236983712
PREDICTION ERROROF GPNN	5.725595236983712
NON-SYNONYMOUS MUTATION	5.725595236983712
NOMINAL PARAMETER VALUE	5.725595236983712
BOVINE TESTICULAR PH-20	5.725595236983712
NORMAL SV40-TRANSFORMED	5.725595236983712
DEVELOPMENTAL MECHANISM	5.725595236983712
GUANIDINE-HYDROCHLORIDE	5.725595236983712
UBIQUITINATION ACTIVITY	5.725595236983712
RHOA IMMUNOLOCALIZATION	5.725595236983712
ENVIRONMENTAL PARAMETER	5.725595236983712
TN-C KNOCKOUT MICE SHOW	5.725595236983712
PROLIFERATIVE PRECURSOR	5.725595236983712
NEW SECONDARY STRUCTURE	5.725595236983712
OPTIMAL NN ARCHITECTURE	5.725595236983712
SIGNALING NETWORK MODEL	5.725595236983712
IN SILICO GENE DELETION	5.725595236983712
THECLASSIFICATION ERROR	5.725595236983712
EXPECTED SAMPLE BIOLOGY	5.725595236983712
IMMUNOGOLD-LABELED TBID	5.725595236983712
ENDOGENOUS CPLA	5.725134245429486
PLASMINOGEN ACTIVATOR INHIBITOR 1 RCL	5.724864518942552
EXPERIMENTAL EXPRESSION	5.724842586061544
SUBSTITUTION ERROR MODEL	5.724453102219941
TESTICULAR HYALURONIDASE	5.723653707710054
HIGH-DENSITY MICROARRAY	5.723225922601174
RABBIT POLYCLONAL	5.7228785947972565
NORMALIZATION ALGORITHM	5.722560036859677
ROSA26 GENOMIC SEQUENCE	5.7219096368330975
RAB24 C-TERMINAL DOMAIN	5.7219096368330975
APLYSIA BAG CELL NEURON	5.721020009210535
HYBRIDIZATION CONDITION	5.7203181276771495
TET-RESPONSIVE PROMOTER	5.720099549185162
RGS3-GST FUSION PROTEIN	5.7197983421885965
DETERMINED DNA SEQUENCE	5.718623907323184
LIMIT CYCLE OSCILLATION	5.718179897758523
ΜM INTERMEDIATE	5.718148385594855
E. COLI EXONUCLEASE III	5.717855476667421
NON-NORMAL DISTRIBUTION	5.71703513340809
GEL SHIFT ASSAY	5.71599343463475
MODIFIED TYRODES BUFFER	5.713994659460465
TRANSFORMATION PHENOTYPE	5.713040732069253
ACID SUBSTITUTION MATRIX	5.712572053959237
IMMUNOFLUORESCENCE CELL	5.7125139519420935
MM TRIS/HCL	5.711380665206547
SRC-1	5.711039695382072
STIMULATED LH SECRETION	5.710306821544124
CONTACT INHIBITION	5.7087237926793835
HOECHST	5.708611516015381
PHOSPHOTYROSINE DEPENDENT	5.708405555320853
P-NITROPHENYL PHOSPHATE	5.70781971089845
TRANSCRIPT ABUNDANCE	5.707812104336878
NUCLEOTIDE DISTRIBUTION	5.706753532987925
DISRUPTED INCORPORATION	5.706640721923407
DEPENDENT TRANSCRIPTION	5.704133156153638
CALMODULIN MOLE	5.703688192929079
SERUM SAMPLE COLLECTION	5.703003175006182
MATHEMATICAL RELATIONSHIP	5.702589306522446
IMMUNOGLOBULIN MOLECULE	5.701626946971971
FLAG-MHCK-C PURIFICATION	5.70097614766639
MAXIMUM LIKELIHOOD	5.700957241047001
RATIOMETRIC MEASUREMENT	5.700493311633578
BLOCKING AGENT INTEGRIN	5.700426948314741
PRIMARY ANTIBODY ABSENCE	5.700352623879764
COMMON	5.700054550645762
MODELING STUDY	5.699137960155955
simulations	5.6989321677704785
EXPRESSING IDO	5.698388531366922
TRITON X100	5.696753499648647
MASTER	5.696750996020727
ANLAGE	5.696750996020727
benefits	5.694438447131937
P53 PROTEIN STABILIZATION	5.693401870493462
ARABIDOPSIS COP1 MUTANT	5.692654517956405
PAIRWISE SURVIVAL METHOD	5.691637892172142
transcription	5.691356664254913
EXPERIMENTAL MEAN VALUE	5.69035730383637
WASH	5.688014107915684
ISL2	5.688014107915684
cop1	5.688014107915684
H-4C	5.688014107915684
BMP1	5.688014107915684
USER	5.688014107915684
BCL2	5.688014107915684
PVA3	5.688014107915684
GPCR	5.688014107915684
TGFΒ	5.688014107915684
MATΑ	5.688014107915684
COLL	5.688014107915684
BIGT	5.688014107915684
GAS3	5.688014107915684
TNFΑ	5.688014107915684
DEME	5.688014107915684
BIAS	5.688014107915684
TIGR	5.688014107915684
UVEA	5.688014107915684
u/ml	5.688014107915684
POB1	5.688014107915684
chk2	5.688014107915684
MM/L	5.688014107915684
UMP1	5.688014107915684
CD68	5.688014107915684
DALI	5.688014107915684
H-3F	5.688014107915684
HNOC	5.688014107915684
P120	5.688014107915684
BMP7	5.688014107915684
TCEF	5.688014107915684
GAD2	5.688014107915684
PI4K	5.688014107915684
GAS2	5.688014107915684
trp1	5.688014107915684
LIST	5.688014107915684
JAB1	5.688014107915684
FASL	5.688014107915684
ALLN	5.688014107915684
BFGF	5.688014107915684
MAPS	5.688014107915684
STAINING PATTERN	5.687691345527807
PRO-APOPTOTIC FUNCTION	5.686846478553531
C/EBPΑ-EXPRESSING CELL	5.686846478553531
MICROBIAL BIOGEOGRAPHY	5.686846478553531
PHYLOBROWSER INTERFACE	5.686846478553531
IONOPHORE-CLAMPED CELL	5.686846478553531
WORD LENGTH LIMITATION	5.686846478553531
DEHYDROGENASE ACTIVITY	5.686846478553531
STRUCTURAL ENVIRONMENT	5.686846478553531
ACROCENTRIC CHROMOSOME	5.686846478553531
CHROMOSOMAL COORDINATE	5.686846478553531
SEA URCHIN COELOMOCYTE	5.686846478553531
RECOMBINATIONAL REPAIR	5.686846478553531
NEURAL TUBE FLOORPLATE	5.686846478553531
HYAL-2-EXPRESSING CELL	5.686846478553531
GAL4-ACTIVATION DOMAIN	5.686846478553531
RETINOBLASTOMA-RELATED	5.686846478553531
DOMINANT-NEGATIVE FORM	5.686846478553531
EMERGING DAUGHTER CELL	5.686846478553531
MORPHOLOGICAL CATEGORY	5.686846478553531
BRANCHING MORPHOGENESI	5.686846478553531
BIOCHEMICAL EXPERIMENT	5.686846478553531
BIOCHEMICAL LITERATURE	5.686846478553531
ZEBRAFISH NEURAL PLATE	5.686846478553531
EMBRYONIC GUT ENDODERM	5.686846478553531
TRANSMISSION FREQUENCY	5.686846478553531
genefinding algorithms	5.686846478553531
EXPRESSING MHC CLASS I	5.686846478553531
SYSTEMATIC VARIABILITY	5.686846478553531
ENDOGENOUS COUNTERPART	5.686846478553531
GRAPHIC REPRESENTATION	5.686846478553531
background subtraction	5.686846478553531
GAP GENE WEIGHT MATRIX	5.686846478553531
MEMBRANE FRAGMENTATION	5.686846478553531
NORMAL ULTRASTRUCTURAL	5.686846478553531
BOOLEAN USM COORDINATE	5.686846478553531
SPECIALIZED ECTODERMAL	5.686846478553531
C/EBPΑ TERMINAL DOMAIN	5.686846478553531
EXPRESSED ROSA26 LOCUS	5.686846478553531
SURFACE HSPGS FUNCTION	5.686846478553531
MID-HINDBRAIN JUNCTION	5.686846478553531
MEMBRANE MICROPARTICLE	5.686846478553531
behavioral rhythmicity	5.686846478553531
EXPERIMENTAL TECHNIQUE	5.686846478553531
zones	5.686718304997916
INDEPENDENT EXPRESSION	5.686103372799767
FERTILIZATION	5.6859030733055045
CONTROL UNWOUNDED SKIN	5.6851048023899144
KINASE INACTIVE DOMAIN	5.684490685361125
DISCRIMINATING CONTROL	5.684233964308106
SHAM EXPRESSION VECTOR	5.682897242325432
SRC KM/CAS(SD) CHIMERA	5.681916411348455
HYBRIDIZATION PROTOCOL	5.681636293893621
HUMAN INSULIN RECEPTOR	5.68153058000197
CYTOSKELETON STRUCTURE	5.681288948249627
P53-GST FUSION PROTEIN	5.6811231003587555
PURIFIED SPARC ADDITION	5.680912084642237
NOTOCHORD	5.679932156459948
BIOCHEMICAL ANALYSIS	5.679475213031899
MYOSIN-II DISTRIBUTION	5.6783949347734
BMP-INDUCED ACTIVATION	5.6783949347734
INVOLVING DISTRIBUTION	5.6783949347734
SECONDARY DISTRIBUTION	5.6783949347734
COMPETING FLAG PEPTIDE	5.678316315761491
DEATH-INDUCING PROTEIN	5.678261411261367
PROTEIN UBIQUITINATION	5.678261411261367
ANGIOGENESI	5.677830195083436
MHCK-C PHOSPHORYLATION	5.6767418780009775
AMINO ACID SUBSTITUTION	5.675948181738868
AMINOPEPTIDASE	5.675368729386724
BINARY EXPRESSION TREE	5.674816577860528
EPITHELIAL CELL GROWTH	5.67405718287509
JURKAT T CELL ADHESION	5.671994457913787
TERNARY COMPLEX FACTOR	5.67171926321182
TNF CYTOTOXIC FUNCTION	5.671428813839474
EGF-LIKE GROWTH FACTOR	5.670916797600623
CONTAMINATION LOCATION	5.670471612479527
ELK-1 N-TERMINAL A-BOX	5.670130469436319
DECREASED ACCUMULATION	5.66996931597419
BIOLOGICAL PROCESS	5.669494025977034
BEARING PLASMID PPB799	5.668258792739796
PRODUCTIVE INTERACTION	5.6676223171249305
EXPERIMENTAL EVIDENCE	5.667575255689292
ANDROGEN ADMINISTRATION	5.667547034611528
MURINE L929 FIBROBLAST	5.665909296318774
CLASSIFICATION PROBLEM	5.664480807818306
questions	5.663939036141156
MYOSIN-II TOTAL AMOUNT	5.663690102287263
ΜG/ML OXYBURST GREEN H	5.662107951971688
TRNA CRYSTAL STRUCTURE	5.660266985795727
ANNOTATION INFORMATION	5.659178601394006
NUCLEOCYTOPLASMIC	5.658764907124508
STATISTICAL POWER	5.658764907124508
FURROW INGRESSION	5.658764907124508
PARAXIAL MESODERM	5.658764907124508
FOLD-CHANGE VALUE	5.658764907124508
HOUSEKEEPING GENE	5.658764907124508
OPTIMAL CONDITION	5.658764907124508
APOPTOSIS PATHWAY	5.658764907124508
REGULATORY REGION	5.658764907124508
HEPARITINASE DIGESTION	5.658190462924024
PERFORMANCE COMPARISON	5.658190462924024
PARSING ALGORITHM	5.654229759690045
MULTIPLE TRANSCRIPTION	5.654227800753978
ELUATE	5.654114742512713
COLLAGENASE I	5.654110772845571
INTRANUCLEAR AGGREGATE	5.651577536240292
ΜM NITROCEFIN	5.649701804056061
MEK INHIBITION	5.647035396053391
IMPAIRED WOUND REPAIR	5.646448349129027
FUNCTIONAL ASSIGNMENT	5.646448349129027
sulfate proteoglycans	5.646448349129027
HYDROXYPHOSPHORIBOSYL	5.646448349129027
RHYTHMIC GENE PRODUCT	5.646448349129027
LISTERIA MONOCYTOGENE	5.646448349129027
UNDERGOING CYTOKINESI	5.646448349129027
SIMULATED POWER CURVE	5.646448349129027
GENERATING TRANSGENIC	5.646448349129027
INTERCELLULAR CONTACT	5.646448349129027
LIGHT-RESPONSIVE GENE	5.646448349129027
MITOCHONDRIAL CONTACT	5.646448349129027
DOMINANT-NEGATIVE RAB	5.646448349129027
RING FINGER STRUCTURE	5.646448349129027
CHONDROITIN-4-SULFATE	5.646448349129027
STIMULATED PROTEOLYSI	5.646448349129027
CYTOSKELETAL FILAMENT	5.646448349129027
DEVELOPMENTAL PATHWAY	5.646448349129027
AMINO-TERMINAL DOMAIN	5.646448349129027
PHOTO-MULTIPLIER TUBE	5.646448349129027
OPTIMAL BIOMASS YIELD	5.646448349129027
NON-TREATED RECIPIENT	5.646448349129027
DEVELOPMENTAL PROFILE	5.646448349129027
BDUS AVERAGE POSITION	5.646448349129027
CHONDROITIN-6-SULFATE	5.646448349129027
TRIMER-BURIED PORTION	5.646448349129027
PREOVULATORY LH SURGE	5.646448349129027
finger-like dendritic	5.646448349129027
DNA-BINDING-DEFECTIVE	5.646448349129027
HEMATOPOIETIC LINEAGE	5.646448349129027
PROSEQUENCE-LESS HSN3	5.646448349129027
NADPH OXIDASE COMPLEX	5.646448349129027
TRANSCRIPTS ASSOCIATE	5.646448349129027
REGULATORY CONSTRAINT	5.646448349129027
ACANTHAMOEBA MYOSINIC	5.646448349129027
AUTONOMIC INNERVATION	5.646448349129027
MYOSIN-II RECRUITMENT	5.646448349129027
FUNCTIONAL IMPORTANCE	5.646448349129027
DEXAMETHASONE-INDUCED	5.646448349129027
BIOLOGICAL LITERATURE	5.646448349129027
PARALOGOUS COMPARISON	5.646448349129027
SUBENDOTHELIAL MATRIX	5.646448349129027
OXYBURST FLUORESCENCE	5.646448349129027
PAI-1S NEUTRALIZATION	5.646448349129027
FILAMENTATION PATHWAY	5.646448349129027
MYOSIN-II HEAVY CHAIN	5.646448349129027
ASP355-PRO357 SEGMENT	5.646448349129027
ANDROGEN-MEDIATED P27	5.646448349129027
FUNCTIONAL ANTAGONISM	5.646448349129027
FOLD CROSS-VALIDATION	5.646448349129027
AMINO-TERMINAL REGION	5.646448349129027
blot hybridization	5.645933484399913
BLASTODERM EXPRESSION	5.6457151948411735
WESTERN BLOT ANALYSIS	5.6455494793911125
SUBCLONING	5.645524593342965
QUANTITATIVE ANALYSIS	5.645100044522154
CONTROL ALM MIGRATION	5.644729997008968
MOLECULAR CLOCK STUDY	5.644592528839363
SΑ I2 PM LOCALIZATION	5.644128573766946
BLM C-TERMINAL DOMAIN	5.6428582205924736
GFP-N346 LOCALIZATION	5.641808798404866
BEX1 EXCITATION FILTER	5.641562898299495
VEX1 EXCITATION FILTER	5.641562898299495
FIBRILLAR FIBRONECTIN	5.641278564036391
OTHER TRANSCRIPTIONAL	5.6411883933661695
CONSTITUTIVE PROMOTER	5.641095021370379
DONOR CELL CELL CYCLE	5.641030909660695
CORTICAL CYTOSKELETON	5.640965243727746
CYTOPLASMIC INCLUSION	5.640931810158226
AZ TARGETING ACTIVITY	5.640863704738833
CATALYTIC SITE	5.6408627194215235
ANTI-APOPTOTIC SIGNAL	5.6405926054965905
MOTOR NEURON IDENTITY	5.6405060674133525
final concentration	5.6403447502093815
REHOSPITALIZATION	5.640332374669077
GR PROTEIN EXPRESSION	5.640312847300541
DNA HELICASE ACTIVITY	5.639657604466232
ANION-EXCHANGE	5.638830267848262
ULTRAFILTRATION	5.638309054357175
CONTROL PROLIFERATION	5.638216368503866
YEAST TWO-HYBRID TEST	5.638129154727083
DISTRIBUTION QUARTILE	5.638109986076388
CORTICAL DISTRIBUTION	5.638109986076388
MATRICELLULAR PROTEIN	5.637978250674151
ENDOGENOUS PROTEASOME	5.637490800701191
CDNA EXPRESSION ARRAY	5.6373841067013135
HPB-ALL CELL ADHESION	5.637309840126892
PRIOR PHOSPHORYLATION	5.636479066581243
RESULTING PCR PRODUCT	5.635773276666356
PHENOTYPE PHASE PLANE	5.635548199837324
SYMBOL REPRESENTATION	5.63527906034864
ANTI-III 1-C ANTIBODY	5.635103993126377
phosphorylation targets	5.634240688988144
INHIBITORY CONFORMATION	5.634026241692379
ANTI-GFP ANTIBODY	5.6326629300408895
POLYCLONAL POPULATION	5.632529696956544
PURIFIED CSN	5.632461312572605
BLASTP THRESHOLD SCORE	5.631271175514487
carbonyl	5.631029666156653
GROWTH FACTOR PATHWAY	5.630731994040111
TARGETED MUTATION	5.630520869931739
OVERLAP-EXTENSION PCR	5.63043574043502
Β-GALACTOSIDASE ASSAY	5.630350263876155
NON-APOPTOTIC NUCLEUS	5.629590354261733
ACETYLCHOLINE	5.628613171063705
EXERCISE TIME	5.6278787931322
MULTIPLE MOUSE STRAIN	5.627680861023051
WG EXPRESSION PLASMID	5.627620814917074
REPULSIVE INTERACTION	5.627481632332142
REPLICATION PROTEIN A	5.6259092317852595
PG SYNTHESIS	5.6257957752440735
ADJUSTED YOL	5.625095893824577
ΜM BILE ACID	5.623387876464541
STABLE TRANSFECTANT	5.622519988436132
EXERCISE TEST	5.622489978517567
MOLECULAR MECHANISM	5.622428838818354
TARGETING MOTIF GOLGI	5.6215712968454365
THDP-UTILIZING	5.6203687293867235
ORG	5.620258904078546
PHARMACOLOGICAL AGENT	5.619839161152221
BACTERIAL SPECIES	5.619395967693424
PLASMID PGKNEOTPALOX2	5.618940202098951
N-TERMINAL YQXP MOTIF	5.618786907383848
molecular concentration	5.618429324911988
T LYMPHOCYTE MOTILITY	5.614494960131048
NITRIC OXIDE SYNTHASE	5.612940482787864
TEMPLATE-PRIMER	5.612356909333363
INTRON MEAN FREQUENCY	5.608763097453532
nucleotides	5.607440025323893
SMAD1 CO-LOCALIZATION	5.60711302777201
TETRAPLOID AGGREGATION	5.605935375599628
LIMITED DOCUMENTATION	5.605325058619417
C-MYC ORIGIN	5.605265920272194
CELLULAR SENSITIVITY	5.604254168518905
MONOCLONAL ANTI-HSN3	5.604254168518905
LGL LEUKEMIA LIBRARY	5.604254168518905
BINDING PROTEIN-BETA	5.604254168518905
ACCEPTOR COMPARTMENT	5.604254168518905
SECONDARY STRUCTURES	5.604254168518905
NO-CHANGE EXPERIMENT	5.604254168518905
TRANSITION PARAMETER	5.604254168518905
GENE-SPECIFIC PRIMER	5.604254168518905
LGL LEUKEMIA PATIENT	5.604254168518905
SPREADING MORPHOLOGY	5.604254168518905
FILOPODIAL EXTENSION	5.604254168518905
SΑ I2 PALMITOYLATION	5.604254168518905
CHROMOSOMAL SEQUENCE	5.604254168518905
MULTIPROTEIN COMPLEX	5.604254168518905
CYSTEINE-RICH-DOMAIN	5.604254168518905
ALTERNATIVE SPLICING	5.604254168518905
BOOTSTRAPPED VERSION	5.604254168518905
DEGENERATIVE DISEASE	5.604254168518905
PRECURSOR HL-60 CELL	5.604254168518905
DEVELOPING VIBRISSAE	5.604254168518905
PROFILING EXPERIMENT	5.604254168518905
SV40 POLYADENYLATION	5.604254168518905
RE-EPITHELIALIZATION	5.604254168518905
IN VIVO RIBOSYLATION	5.604254168518905
APOPTOSIS TRANSCRIPT	5.604254168518905
SIGNALING PATHWAY WG	5.604254168518905
POLYPHOSPHOINOSITIDE	5.604254168518905
VASCULAR ENDOTHELIUM	5.604254168518905
MITOCHONDRIAL PELLET	5.604254168518905
CYTOKINESIS PROGRESS	5.604254168518905
ENVIRONMENTAL SAMPLE	5.604254168518905
TYPE EGF-LIKE MODULE	5.604254168518905
THEORETICAL PROPERTY	5.604254168518905
PROFILING TECHNOLOGY	5.604254168518905
MOLECULAR CLOCK DATA	5.604254168518905
FRDABCD GENE PRODUCT	5.604254168518905
HEXAMETHYLDISILAZANE	5.604254168518905
SURROUNDING SEQUENCE	5.604254168518905
ARP3 DE-LOCALIZATION	5.604254168518905
PHENYLMETHYLSULFONYL	5.604254168518905
PROTEOLYTIC FRAGMENT	5.604254168518905
TREATED HPB-ALL CELL	5.604254168518905
NETWORK ARCHITECTURE	5.604254168518905
PARAMETER ESTIMATION	5.604254168518905
ANAPHYLATOXIN TYPE I	5.604254168518905
PURIFIED FLAG-MHCK-C	5.604254168518905
BOOLEAN USM APPROACH	5.604254168518905
NUMERICAL SIMULATION	5.604254168518905
STUDIED SEGMENTATION	5.604254168518905
ARTIFICIAL SUBSTRATE	5.604254168518905
PREVENTED DETACHMENT	5.604254168518905
DETAILED EXPLANATION	5.604254168518905
ONION EPIDERMAL CELL	5.604254168518905
GONADOTROPE FUNCTION	5.604254168518905
OTHER INOSITOL-BASED	5.604254168518905
DFZ2 CARBOXYTERMINUS	5.604254168518905
INTER-ARRAY VARIANCE	5.604254168518905
CANDIDATE NCRNA GENE	5.604254168518905
PPT1 GENE EXPRESSION	5.6037723282575715
INDICATED EXPRESSION	5.603531408126905
KEY SIGNAL TRANSDUCER	5.603379481460156
PHASE PLANE ANALYSIS	5.603368042017436
LEUCINE REPEAT DOMAIN	5.603366806690389
C/EBPΑ LEUCINE ZIPPER	5.603366806690389
TOMOGRAPHIC ANALYSIS	5.602924978766703
THEORETICAL ANALYSIS	5.602924978766703
RRNA STRUCTURE MODEL	5.601993366684361
SEQUENCE ANALYSIS	5.601767294998264
DICTYOSTELIUM MYOSIN	5.601291091031438
MARKED GENOMIC LOCUS	5.600714937075542
BALANCED SALT SOLUTION	5.600496007704741
P53 BEARING MUTATION	5.600303398535615
INTERACTING TYROSINE	5.600254678277974
TRANSCRIPTIONAL READ	5.599068782915838
FUNCTIONAL HALF LIFE	5.5989453213538605
G1 CELL CYCLE ARREST	5.5989135318498775
EXPERIMENTAL DATA	5.596541193492387
MOUSE NOCTURNIN CDNA	5.5958002697158005
EARLIEST-BORN NEURON	5.59546711114228
STATIC CELL ADHESION	5.59524521575398
CODON USAGE	5.5952138331836245
CONSERVED NUCLEOTIDE	5.594380888182438
junction	5.594121363192793
C/EBPΑ GROWTH ARREST	5.5918150287179635
NEUROBLASTOMA	5.591600523315835
SINGLE TISSUE SAMPLE	5.591124401397785
FAILURE	5.591041667426567
INCLUDING DNA DAMAGE	5.58868520515895
BRISTOL MYERS SQUIBB	5.586881655010305
membrane localization	5.586134189714933
S. CEREVISIAE STRAIN	5.583967188054591
INTEGRAL DISTRIBUTION	5.583278932063575
TRANSLATION INITIATION	5.582532516896912
FRACTION DETERMINATION	5.581592276578365
BDM APPLICATION LEAD	5.581385288423329
POP1 MUTANT	5.580602970010805
REACTIVE CENTER LOOP	5.579479548415364
GFP-GR TRANSLOCATION	5.579306299323731
GR-GFP TRANSLOCATION	5.579306299323731
TUMOR SUPPRESSOR	5.57927230240891
SURFACE ECTODERM	5.57927230240891
CURRENT DATA SET	5.57927230240891
IMMUNOREACTIVITY	5.57927230240891
AFFYMETRIX ARRAY	5.57927230240891
POTENTIAL TARGET	5.57927230240891
CLONAL CELL LINE	5.57927230240891
BACKGROUND LEVEL	5.57927230240891
INDIVIDUAL PROBE	5.57927230240891
DYNAMICAL SYSTEM	5.57927230240891
MUTATION PROBABILITY	5.578402391019558
ANTI-RESORBING AGENT	5.578022217821038
MISSING VALUE	5.5778337391696935
DETAILED INFORMATION	5.57734380530299
FIBRONECTIN MOLECULE	5.576141253982979
CIRCADIAN REGULATION	5.575483641947051
SPECTROSCOPY	5.5735379625883805
SERINE PHOSPHORYLATE	5.573499467700716
TRANSFORMATION PLATE	5.573141854900505
STRAND CDNA TEMPLATE	5.570498530035589
TARGETING SIGNAL	5.570455004802067
PROTEASOME-DEPENDENT DEGRADATION	5.569292651774559
HOMOTYPIC AGGREGATION	5.566620785198609
PAIRWISE INTERACTION	5.566580037265508
DNA-DEPENDENT ATPASE	5.564906242472105
alcohol dehydrogenases	5.564580811867634
DNA FRAGMENTATION	5.563541926237563
DOWNLOAD	5.562208292819548
NEUROMODULIN	5.560846779514854
ΜG/ML CYTOCHALASIN B	5.560375110624227
phosphorylation	5.5601657511317
MEASURE SPECIFICITY	5.560096775692095
GENE-SPECIFIC PROBE	5.560096775692095
DEVELOPED HIERARCHY	5.560096775692095
INACTIVE GFP-C/EBPΑ	5.560096775692095
MYSTACIAL VIBRISSAE	5.560096775692095
STRIKING DIFFERENCE	5.560096775692095
HEALING PROGRESSION	5.560096775692095
CHICKEN CHEMOTACTIC	5.560096775692095
BACK PROPAGATION NN	5.560096775692095
AXONAL REGENERATION	5.560096775692095
PERFORIN TRANSCRIPT	5.560096775692095
PHOSPHATIDYLCHOLINE	5.560096775692095
NON-MUSCLE MYOSINII	5.560096775692095
CONSERVED NONCODING	5.560096775692095
NONMUSCLE MYOSIN-II	5.560096775692095
IMMUNOGOLD PARTICLE	5.560096775692095
UBIQUITIN-DEPENDENT	5.560096775692095
MELTING TEMPERATURE	5.560096775692095
DELTAAMUTANT EMBRYO	5.560096775692095
AMIDOLYTIC ACTIVITY	5.560096775692095
ANALYTICAL FUNCTION	5.560096775692095
COMPUTER SIMULATION	5.560096775692095
INCREASED INTENSITY	5.560096775692095
CHLOROFORM/METHANOL	5.560096775692095
CONSENSUS DETECTION	5.560096775692095
BIOCHEMICAL NETWORK	5.560096775692095
ANAEROBIC SYNTHESIS	5.560096775692095
ANALYZABLE POSITION	5.560096775692095
DIHYDROTESTOSTERONE	5.560096775692095
POSITIVE PROBE PAIR	5.560096775692095
ANTI-DIGOXYGENIN-AP	5.560096775692095
QUALITATIVE NETWORK	5.560096775692095
NON-EXPRESSING CELL	5.560096775692095
GLUTATHIONE-COUPLED	5.560096775692095
DOMINANT-SUPPRESSOR	5.560096775692095
METABOLIC BYPRODUCT	5.560096775692095
EXPRESSING GFP-NFAT	5.560096775692095
PREDICTED BASE PAIR	5.560096775692095
HL-60 PROMYELOCYTIC	5.560096775692095
DEGRADATIVE PATHWAY	5.560096775692095
MARROW STROMAL CELL	5.560096775692095
STELLATE PROJECTION	5.560096775692095
REGULATORY PROPERTY	5.560096775692095
IMPROVED REACTIVITY	5.560096775692095
PREDICTED STABILITY	5.560096775692095
FUNGI/METAZOA GROUP	5.560096775692095
SCANNING MICROSCOPY	5.560096775692095
SMAD1 CO-EXPRESSION	5.560096775692095
PANNICULUS CARNOSUS	5.560096775692095
ARITHMETIC OPERATOR	5.560096775692095
C/EBPΑ PROLONGATION	5.560096775692095
BOI1-PH CO-SEDIMENT	5.560096775692095
5'TACCACTACAATGGATG	5.560096775692095
IMMUNO-FLUORESCENCE	5.560096775692095
ANTIAPOPTOTIC TIAF1	5.560096775692095
DEAE DEXTRAN METHOD	5.560096775692095
SELECTIVE INHIBITOR	5.560096775692095
RHYTHMIC PHYSIOLOGY	5.560096775692095
DEGRADATION PATHWAY	5.560096775692095
GFP-LABELLED MHCK-A	5.560096775692095
IN VITRO EXPERIMENT	5.560096775692095
INTERQUARTILE RANGE	5.560096775692095
SPECTROFLUORIMETRIC	5.560096775692095
STRUCTURAL SCAFFOLD	5.560096775692095
BOVINE SOMATIC CELL	5.560096775692095
GLUTAMINE PEN-STREP	5.560096775692095
REPETITIVE SEQUENCE	5.560096775692095
BUSM IMPLEMENTATION	5.560096775692095
QUADRANT COMPARISON	5.560096775692095
GSK3Β PHOSPHORYLATE	5.560096775692095
INTEGRATED FUNCTION	5.560096775692095
SPECIALIZED PROGRAM	5.560096775692095
BIOCCLUSIVE BANDAGE	5.560096775692095
LABELING EXPERIMENT	5.560096775692095
NEURAL NET ANALYSIS	5.559223985344797
TWO-HYBRID ANALYSIS	5.558787590171148
CHI-SQUARE ANALYSIS	5.558787590171148
DIFFERENCE ANALYSIS	5.558787590171148
HF OUTCOME	5.5586373833540845
SNP	5.558165551907845
acetylcholine	5.55811288963919
STATISTICAL CONTROL	5.557594030721852
ΚB RESPONSE ELEMENT	5.557123972021856
QUANTITATIVE CHANGE	5.55649651550949
CYTOSKELETAL CHANGE	5.55649651550949
RNA SEQUENCE FAMILY	5.556096486600311
COMPARATIVE RNA WEB	5.556096486600311
BY/SNJ MOUSE STRAIN	5.5559432840393495
MHCK-C LOCALIZATION	5.555591834745655
MHCK-A LOCALIZATION	5.555591834745655
C-TERMINAL SUBDOMAIN	5.555438671415935
DIMERIC FIBRONECTIN	5.555076984351777
CYTOPLASMIC SPECKLE	5.55474029103017
SMAD FAMILY PROTEIN	5.554613875066821
GAL4 FUSION PROTEIN	5.554613875066821
PHYLOGENETIC SIGNAL	5.554410927895618
MUTANT GFP-BLM GENE	5.55440303088479
STRUCTURAL MOTIF	5.554045034255999
BINDING PROFILE DNA	5.5535030545524755
N-TERMINAL DOMAIN	5.553271580571791
CO-IMMUNOPRECIPITATION	5.552810854761178
HPB-ALL T CELL LINE	5.552523814618339
T CELL LINE HPB-ALL	5.552523814618339
PH-20-INCREASED TNF	5.552110744014316
LENGTH DISTRIBUTION	5.552000338046421
FLAG-MHCK-C PROTEIN	5.551872424754183
MONKEY CDNA LIBRARY	5.551770107592041
COX-2 MRNA	5.551378728337802
CRE REPORTER STRAIN	5.550760608614242
MHC PHOSPHORYLATION	5.550416737294787
NUCLEOTIDE CATEGORY	5.5503720876711835
NUCLEOTIDE IDENTITY	5.5503720876711835
CONTROL RAD PEPTIDE	5.550256525700561
ACTIN FILAMENT ORGANIZATION	5.550191237370908
STERILE ALPHA MOTIF	5.549251547487703
ASSOCIATED GENE	5.549221643475409
BINARY USM APPROACH	5.549046920540451
KKTK MUTANT PROTEIN	5.548920130259515
POSSIBLE EXON VALUE	5.548613592887445
PROFILING RESULT	5.548088755195013
ACTIVATION TYROSINE	5.548061039909399
PHOSPHOCREB PEPTIDE	5.547839145675039
TARGETED ES CELL	5.547406279478917
NON-IONIC DETERGENT	5.546370783745912
SIGNAL DISTRIBUTION	5.546314490249943
SELECTIVE PRESSURE	5.545429867801165
TRANSIENT ENRICHMENT	5.544795080270408
ANTI-Β1 INTEGRIN MAB	5.544309145028439
GARPIKE DEVELOPMENT	5.543039232302664
SEGMENT DEVELOPMENT	5.543039232302664
GLYCINE	5.542116404116378
OPTIMAL INTERACTION	5.541680350439354
GENETIC INTERACTION	5.541680350439354
M-MULV LTR PROMOTER	5.541614966681061
STRUCTURAL PAIRWISE	5.541406063254739
LYSOSOMAL ENZYME	5.540190714860547
BOI1 BIND PH DOMAIN	5.539806178902085
AUTOCATALYTIC	5.539508648707721
GLASS COVERSLIP	5.538739902505349
MG/ML G418	5.5385508453889365
TNF-ALPHA SECRETION	5.538406319283311
IG-RELATED MOLECULE	5.537426750284205
LENGTH DETERMINATION	5.536687022781976
N-TERMINAL SUBDOMAIN	5.536360001916557
EXOGENOUS SUBSTRATE	5.535695012232214
PROTEIN TRANSLATION	5.535604582447595
ANTI-HA	5.5353470695642795
ECTOPIC	5.5353470695642795
DEPENDENT PHENOTYPE	5.534065282365368
INFORMATION DENSITY	5.533591411933948
KINETIC INFORMATION	5.533591411933948
CENTROMERIC PLASMID	5.533386737310333
CELLULAR REGULATION	5.531759243932233
EXPERIMENTS	5.527891820687062
SPATIAL PROXIMITY	5.526597753320155
SEQUENCING REACTION	5.5254608598330295
DC PROTEIN ASSAY KIT	5.5235375874042285
HYALURONIDASE HYAL1	5.5234941305022724
degradation pathways	5.522851845321557
MAPK	5.522213594967029
IN VIVO INTERACTION	5.521407244019184
GENOMIC APPLICATION	5.521080769280966
MALTOPHILIA	5.5195897675152645
INDUCTION CONDITION	5.518265181189441
NCK	5.5149521582522905
AS3	5.5149521582522905
WRN	5.5149521582522905
7-B	5.5149521582522905
MIT	5.5149521582522905
GZΑ	5.5149521582522905
ΔH1	5.5149521582522905
PFF	5.5149521582522905
CRD	5.5149521582522905
U87	5.5149521582522905
non	5.5149521582522905
FAK	5.5149521582522905
MTT	5.5149521582522905
V12	5.5149521582522905
UNC	5.5149521582522905
BPA	5.5149521582522905
IIB	5.5149521582522905
TCU	5.5149521582522905
CPU	5.5149521582522905
IPP	5.5149521582522905
PP7	5.5149521582522905
SBH	5.5149521582522905
RIA	5.5149521582522905
CTG	5.5149521582522905
ODN	5.5149521582522905
TLL	5.5149521582522905
5-C	5.5149521582522905
MRP	5.5149521582522905
ΔN2	5.5149521582522905
HFC	5.5149521582522905
DMD	5.5149521582522905
ECTODERMAL PLACODE	5.513784528890136
AMERSHAM-PHARMACIA	5.513784528890136
MITOCHONDRIAL GENE	5.513784528890136
GENETIC SUPPRESSOR	5.513784528890136
PLM AXON OUTGROWTH	5.513784528890136
LEPISOSTEUS OSSEUS	5.513784528890136
MYOSIN-II ACTIVITY	5.513784528890136
SEQUENCE SELECTION	5.513784528890136
LABELED GΑ-PROTEIN	5.513784528890136
HPB-ALL MORPHOLOGY	5.513784528890136
PROLIFERATIVE CELL	5.513784528890136
SUBGERMINAL CAVITY	5.513784528890136
Q-BRIGHT SATELLITE	5.513784528890136
MATHEMATICAL MODEL	5.513784528890136
TRANSIENT INCREASE	5.513784528890136
prediction errorof	5.513784528890136
BONE MORPHOGENETIC	5.513784528890136
ARTIFICIAL REMOVAL	5.513784528890136
SYNTHETIC ANDROGEN	5.513784528890136
EXPRESSING GFP-BLM	5.513784528890136
TRIMMING CRITERION	5.513784528890136
PRE-ASSEMBLED FORM	5.513784528890136
NUMEROUS INCLUSION	5.513784528890136
THY-1 GLYCOPROTEIN	5.513784528890136
POSSIBLE STRUCTURE	5.513784528890136
DISEASE CLASSIFIER	5.513784528890136
RESULTING FRAGMENT	5.513784528890136
NUCLEO-CYTOPLASMIC	5.513784528890136
FUNCTIONAL OUTCOME	5.513784528890136
TARGETING ACTIVITY	5.513784528890136
MYOSIN-II NET FLUX	5.513784528890136
CANDIDATE POSITIVE	5.513784528890136
STANDARD INTERFACE	5.513784528890136
AFFYMETRIX DEFAULT	5.513784528890136
INACTIVE GDP-BOUND	5.513784528890136
DEVELOPMENTAL TIME	5.513784528890136
UNWINDING ACTIVITY	5.513784528890136
LISTERIA BACTERIUM	5.513784528890136
PREPHOSPHORYLATION	5.513784528890136
PROLIFERATIVE ZONE	5.513784528890136
BIOCHEMICAL SYSTEM	5.513784528890136
USM GENERALIZATION	5.513784528890136
AUTOPHAGIC VACUOLE	5.513784528890136
UTERINE ECTOCERVIX	5.513784528890136
DEFINED IVM MEDIUM	5.513784528890136
PUBLISHED DATA SET	5.513784528890136
RB1 DOWNREGULATION	5.513784528890136
UNCERTAINTY MATRIX	5.513784528890136
MUSCULAR DYSTROPHY	5.513784528890136
VITELLINE ENVELOPE	5.513784528890136
experimental means	5.513784528890136
BIOLOGICAL NETWORK	5.513784528890136
INCREASED RECOVERY	5.513784528890136
MUTUAL ORIENTATION	5.513784528890136
KNOCKOUT MICE SHOW	5.513784528890136
SHUFFLED ALIGNMENT	5.513784528890136
DEVELOPMENTAL RATE	5.513784528890136
DEFECTIVE ASSEMBLY	5.513784528890136
Β-CATENIN-MEDIATED	5.513784528890136
GFP-BLM EXPRESSION	5.513084054320463
GEL-SHIFT ANALYSIS	5.512496323794791
CED-8 GENE CONTROL	5.512142770829401
MISMATCHED CONTROL	5.511321891799033
NO-PRIMARY CONTROL	5.511321891799033
INTERCELLULAR ADHESION MOLECULE 1	5.511042178168856
CLUSTALW ALGORITHM	5.510959739285635
ACTIN LEADING EDGE	5.510591968893913
LEADING EDGE ACTIN	5.510591968893913
BIOCHEMICAL CHANGE	5.510241964877934
X-GAL	5.509934811861804
AVIAN	5.509934811861804
BGLII	5.509934811861804
CLADE	5.509934811861804
SSDNA	5.509934811861804
POOLING RNA SAMPLE	5.509848346654356
LIVER MITOCHONDRIA	5.509186733044512
BINDING DOMAIN SRC	5.509137294379506
SRC BINDING DOMAIN	5.509137294379506
BILIRUBIN	5.508416697108242
STATISTICAL SIGNAL	5.5081897999647165
INSTRUCTIVE SIGNAL	5.5081897999647165
NUTRITIONAL SIGNAL	5.5081897999647165
CIS-REGULATORY RNA	5.507880255536465
TOPOISOMERASE IIIΑ	5.507333889942544
STABLE LIMIT CYCLE	5.506883246503091
MIMOSINE TREATMENT	5.506728319755627
LOCALIZATION STUDY	5.506692134067757
SCORE DISTRIBUTION	5.505817841157626
RT QUASISPECIATION	5.505780958344049
CELL CYCLE CONTROL	5.505241488442355
protein interactions	5.505155688104742
CHLOROPLAST GENOME	5.5044566265270705
DROSOPHILA S2 CELL	5.504337691524263
MIGRATED CLOSE ALM	5.504337691524263
NUCLEOTIDE SEGMENT	5.504215684399611
N(T)KXD NUCLEOTIDE	5.504215684399611
PERIPHERAL BLOOD T	5.503849062005338
HOLTFRETER SOLUTION	5.503587428732368
MANIPULATION MEDIUM	5.501532543388379
GST-PULLDOWN ASSAY	5.498404001862068
EXTREME C-TERMINUS	5.498349071408397
MOST-TYPICAL CODON	5.498349071408397
RHYTHMIC PHENOTYPE	5.498163102041146
HSP70 ACCUMULATION	5.497875591117546
normal distribution	5.497349383938113
MM SODIUM VANADATE	5.496835791263128
FITC-CONJUGATED	5.4952348562298985
JAVASERVER PAGE	5.4952348562298985
ANTI-RABBIT IGG	5.4952348562298985
PIXEL INTENSITY	5.4952348562298985
HEALING PROCESS	5.4952348562298985
BANDING PATTERN	5.4952348562298985
TERMINAL DOMAIN	5.4952348562298985
PROGNOSIS ACCURACY	5.492701952817516
identities	5.492667497350652
OPTIMAL SOLUTION	5.49164073935143
differential genes	5.489847696364607
segmentation genes	5.489847696364607
FILAMENT FORMATION	5.489549418077685
PROMOTED FORMATION	5.489549418077685
ELUTION	5.489181225345655
OVERLAPPING WINDOW	5.4890877969193514
K562 CELL	5.487942509977532
PACCMVPLPA PLASMID	5.487502533718525
PERFUSION	5.4859812518448985
leukotrienes	5.484699681073703
PEAK CONCENTRATION	5.484483321467172
S-PHASE	5.484285005348288
BINDING PROTEIN CA	5.484223875339421
ADAPTOR PROTEIN CA	5.484223875339421
CATENATION	5.484167147831858
RESEARCH GENETICS	5.482542035385372
PREIMMUNE SERUM	5.479081635381811
SURVIVAL PREDICTION	5.47900783865618
N-TERMINAL PEPTIDE	5.478087789937815
INDIVIDUAL GENE	5.477983466876848
NITROGEN	5.47639726668128
CORTICAL ASTROCYTE	5.476202545456333
DMSO-WATER	5.474208918663188
DNA MANIPULATION	5.473116371159936
SPREADING ASSAY	5.471474483926662
ACETATE PRODUCTION	5.471230736760905
IDO CDNA	5.470934366976607
defaults	5.470741048926165
classification schemes	5.470334360463921
NON EGF-LIKE MODULE	5.469997956763301
repeats	5.469570229278389
BIOLOGICAL SUBJECT	5.466420933329728
NOMINAL PARAMETER	5.465096278924173
TCF FAMILY MEMBER	5.465096278924173
TETRATRICOPEPTIDE	5.465096278924173
RUNNING LAKEWATER	5.465096278924173
MEMBRANOUS FLANGE	5.465096278924173
DISEASE PATHOLOGY	5.465096278924173
DNA-FRAGMENTATION	5.465096278924173
EGG CIRCUMFERENCE	5.465096278924173
POST-MITOTIC CELL	5.465096278924173
P. FALCIPARUM PP5	5.465096278924173
RETINAL CELL TYPE	5.465096278924173
PHEROMONE PATHWAY	5.465096278924173
ORIGINAL DATA SET	5.465096278924173
EXPERIMENTAL DIET	5.465096278924173
MICROPLATE READER	5.465096278924173
TITRATING ELEMENT	5.465096278924173
REPORTED MUTATION	5.465096278924173
GFP-C/EBPΑ FUSION	5.465096278924173
RECRUITING DOMAIN	5.465096278924173
MIB-ARRESTED CELL	5.465096278924173
MYR-BOI1-PH(KKTK)	5.465096278924173
EQUATORIAL REGION	5.465096278924173
PROPOSED APPROACH	5.465096278924173
CHIMERIC APPROACH	5.465096278924173
HNF3ΑLOXPNEO CELL	5.465096278924173
OSTEOCLASTOGENESI	5.465096278924173
CLASSIC BIPARTITE	5.465096278924173
E15 SMG PRIMORDIA	5.465096278924173
EPITHELIAL MARGIN	5.465096278924173
ORIGINAL APPROACH	5.465096278924173
COMMERCIAL SOURCE	5.465096278924173
SEQUENCE DATA SET	5.465096278924173
SECONDARY CULTURE	5.465096278924173
yeast centromeric	5.465096278924173
MODULE PREDICTION	5.465096278924173
INTEGRIN-BLOCKING	5.465096278924173
GFP-BLM CELL LINE	5.465096278924173
PHYLOBROWSER PAGE	5.465096278924173
CYLINDRICAL STAGE	5.465096278924173
GLYOXYLATE BYPASS	5.465096278924173
SKP2-MEDIATED P27	5.465096278924173
CALCULATED VOLUME	5.465096278924173
SUBSTRATE COMPLEX	5.465096278924173
IONOPHORE-CLAMPED	5.465096278924173
NON-RODENT MAMMAL	5.465096278924173
AEROBIC CONDITION	5.465096278924173
MUTATION POSITION	5.465096278924173
SUBCATEGORIZATION	5.465096278924173
NEURODEGENERATIVE	5.465096278924173
DORSOVENTRAL AXIS	5.465096278924173
OTHER PP5 HOMOLOG	5.465096278924173
NON-FUNCTIONALSNP	5.465096278924173
RAB GTPASE FAMILY	5.465096278924173
CELL LINE HPB-ALL	5.465096278924173
REFERENCE ARTICLE	5.465096278924173
CLUSTERING RESULT	5.465096278924173
HEPARIN-SEPHAROSE	5.465096278924173
cellular adhesion	5.465096278924173
PHYSICAL PROPERTY	5.465096278924173
FASTGROUP PROGRAM	5.465096278924173
UM CYTOCHALASIN D	5.465096278924173
CARBOXYL-TERMINUS	5.465096278924173
VIBRISSAL PLACODE	5.465096278924173
TGF-Β1 INHIBITION	5.465096278924173
INTESTINAL PORTAL	5.465096278924173
LEARNING MOMENTUM	5.465096278924173
HLA-DR EXPRESSION	5.4644077979657535
SHOWED EXPRESSION	5.4644077979657535
NEIGHBOR ANALYSIS	5.463830130634025
CONTROL CELL LINE	5.463482631245752
ACETYL TRANSFERASE	5.462938316009109
alignment problems	5.462938316009109
BUFFER S	5.462632673576281
BUFFER H	5.461850675437183
PROMOTER ID ENTRY	5.461744856822836
CLONING RING ASSAY	5.4608451346256235
TBID LOCALIZATION	5.460739430192436
ANGIOGENIC FACTOR	5.4607319698350185
TITRATION ENDPOINT	5.460591567722292
OTHER RAB PROTEIN	5.459793619262374
MOTOR NEURON FATE	5.459516078578105
DNA SEQUENCE DATA	5.458719315069122
GENE SYMBOL ENTRY	5.458103805651014
REMAINING ADHERENT	5.458017714762558
C/EBPΑ ACTIVATION	5.457265997793401
APOPTOSIS PROTEIN	5.457142289431475
MYOSIN-II PROTEIN	5.457142289431475
TRITON EXTRACTION	5.456058135278548
GST BEAD	5.455870212188956
CHEMICAL CROSSLINKER	5.455606447897662
TRANSLATIONAL	5.45560126049279
SITE-SPECIFIC DNA	5.455530833141597
YEAST GENOMIC DNA	5.455347944026707
CONTINGENCY TABLE	5.455101155363129
RNA HYBRIDIZATION	5.454465908904812
ACIDIC AMINO ACID	5.454359021386242
HPLC	5.453973158210204
SUBSTRATE PEPTIDE	5.453241597491306
HYDROGEN PEROXIDE	5.453171556762182
PROMOTER REGION	5.452710059791426
PLATELET ADHESION	5.452223771307676
DROSOPHILA EMBRYO	5.451168647732554
EC	5.451159604401758
TARGETED ALLELE	5.450723758781837
INTRAEPITHELIAL T	5.450448253015747
CHROMOGENIC ASSAY	5.449979099161028
INDUCED PHENOTYPE	5.449742324056304
OPTIMAL PHENOTYPE	5.449742324056304
EXCHANGE	5.449740158219059
CRNA AMPLIFICATION	5.448955607466827
CALCIUM PHOSPHATE	5.448836269303335
COMMON NAME FIELD	5.448519000822929
MOTILITY INCREASE	5.448437739655766
SMAD1 INTERACTION	5.447285262096317
TRANSFER FUNCTION	5.446627028865722
RHOA INACTIVATION	5.446216601086645
COVALENT	5.445664595922022
OTHER DNA-BINDING	5.444868052669679
ΜG/ML MUTANT SN50	5.444762734097848
SAMPLE COLLECTION	5.444374681297618
SEQUENCING PRIMER	5.444374681297618
RELATIVE CONTRIBUTION	5.443388004433659
CARBOXYL TERMINUS	5.443312035265487
REDISTRIBUTION	5.442161215059443
REORGANIZATION	5.442161215059443
DIGITAL CAMERA	5.442161215059443
DROSOPHILA GENOME	5.4420004588546185
CLONE E6	5.441882773019927
DISCRIMINATION	5.440071164444929
bioinformatics	5.440071164444929
transformation	5.440071164444929
RDBMS INFORMATION	5.439462233584427
WOUNDED MONOLAYER	5.439351263691181
ISCHEMIA	5.438220499350845
CPT CONCENTRATION	5.436296770358453
PICOLINIC	5.436051035697972
MANGANESE	5.436051035697972
MONOCYTE CHEMOTACTIC PROTEIN 1	5.435236874906031
SMAD1 DISSOCIATION	5.435204018074003
SATURATION DENSITY	5.435204018074003
BP ECORI FRAGMENT	5.4344805851335884
effectors	5.433580358290274
KK MUTANT VERSION	5.43127018946527
internal controls	5.426912660825803
HYBRID TRANSCRIPT	5.426478756074685
PHAGOLYSOSOMAL PH	5.425849122549965
NEURONAL IDENTITY	5.425580674147953
CODON PROBABILITY	5.425299442488702
cell migration	5.424906733031083
MAXIMAL INDUCTION	5.424639826415186
PROTEIN AGGREGATE	5.424465923943448
carboxyl	5.424452650106867
SULFATION	5.423695922774267
WILDTYPE	5.421612420115152
RNA INTERFERENCE	5.418603553598977
TYPE IA	5.418491885749481
rapid degradation	5.417897084330355
CATALYTIC SUBUNIT	5.417406860221946
AFFYMETRIX MICROARRAY SUITE	5.41550837379439
POLYUBIQUITYLATION	5.415218893505038
LYSOSOMAL STORAGE	5.415120661118953
TRABECULAR BEAMS	5.413774982142516
CORT/GR FUNCTION	5.413774982142516
VOLUME INDICATOR	5.413774982142516
RHYTHMIC PATTERN	5.413774982142516
TRAINING SESSION	5.413774982142516
NEIGHBORING GENE	5.413774982142516
TRIMER INTERFACE	5.413774982142516
histomorphometry	5.413774982142516
ORTHOLOGOUS GENE	5.413774982142516
GENERIC MISMATCH	5.413774982142516
NOVEL NCRNA GENE	5.413774982142516
SHOWED MIGRATION	5.413774982142516
COLLECTIVE SCORE	5.413774982142516
PERI-CENTROMERIC	5.413774982142516
ALBRECHT-BUEHLER	5.413774982142516
CLONAL VARIATION	5.413774982142516
insulin receptor	5.413774982142516
FORMED PSEUDOPOD	5.413774982142516
CARDIOPROTECTIVE	5.413774982142516
deletion mutants	5.413774982142516
MONKEY PROHB-EGF	5.413774982142516
DOTMAC-RESISTANT	5.413774982142516
HISTOGRAM METHOD	5.413774982142516
SECONDARY PALATE	5.413774982142516
GR-HSP90 COMPLEX	5.413774982142516
SMG MORPHOGENESI	5.413774982142516
SINGLE-CHAIN TPA	5.413774982142516
TRITC-PHALLOIDIN	5.413774982142516
BMP-INDUCED GENE	5.413774982142516
FORCE GENERATION	5.413774982142516
VALUABLE INSIGHT	5.413774982142516
ZEBRAFISH EMBRYO	5.413774982142516
TRAINING EXAMPLE	5.413774982142516
NON-LINEAR MODEL	5.413774982142516
QUICKTIME FORMAT	5.413774982142516
SYSTEM PARAMETER	5.413774982142516
PERIVASCULAR MDC	5.413774982142516
LIGAND-ACTIVATED	5.413774982142516
MULTIDIMENSIONAL	5.413774982142516
HYAL-2 MIGRATION	5.413774982142516
TARGETING DOMAIN	5.413774982142516
BIT SCAN REVERSE	5.413774982142516
CONTINUOUS SPACE	5.413774982142516
SPECTRAL OVERLAP	5.413774982142516
DOMAIN STRUCTURE	5.413774982142516
IN VITRO SETTING	5.413774982142516
EXPRESSING SΑ I2	5.413774982142516
RAS/MAPK PATHWAY	5.413774982142516
CHI-SQUARE VALUE	5.413774982142516
PHOTOMORPHOGENIC	5.413774982142516
HU-NEGATIVE CELL	5.413774982142516
PREHYBRIDIZATION	5.413774982142516
ENDOGENOUS SΑ I2	5.413774982142516
SHEEP RETROVIRUS	5.413774982142516
MATING PHEROMONE	5.413774982142516
SEGMENTED VOLUME	5.413774982142516
MIB-TREATED CELL	5.413774982142516
WEIGHTED AVERAGE	5.413774982142516
PARALLEL CULTURE	5.413774982142516
CONSENSUS COLUMN	5.413774982142516
SUBSTRATE S-2444	5.413774982142516
TEST DATA	5.41333488503533
EXPRESSION SCORE	5.4130991434064635
ROUTINE ANALYSIS	5.412532083483368
CANALICULAR STAGE	5.411997185006127
CONTROL ACTIVITY	5.411398956500669
GENETIC ELEMENT	5.41136560540544
MINING ALGORITHM	5.411049540965102
GFP-3XASP MYOSIN	5.411004267855843
PERIODIC SOLUTION	5.410444579920805
TITRATION EFFECT	5.410148960402132
ADMISSION	5.407222438875994
DOTMAC TREATMENT	5.406966941323835
GAGASE TREATMENT	5.406966941323835
genomic	5.406682610232215
G418-RESISTANT	5.406101200294524
unidirectional	5.406101200294524
CELLULAR LEVEL	5.406101200294524
COLOCALIZATION	5.406101200294524
overexpression	5.406101200294524
TRANSCRIPTOMIC	5.406101200294524
MISMATCH PROBE	5.406101200294524
FALSE-POSITIVE	5.406101200294524
RECONSTITUTION	5.406101200294524
NOTCH ACTIVATION	5.406088484444005
GFP-COP1 PROTEIN	5.405967047675216
PROTEIN POSITION	5.405967047675216
INACTIVE PROTEIN	5.405967047675216
SECONDARY NEURON	5.405558381154452
LATE-BORN NEURON	5.405558381154452
OTHER PROTEASOME	5.405517704911937
FETAL FIBROBLAST	5.405308129347709
EMBRYONIC GENOME	5.404775144009907
ISOPROPYL-Β-D-THIOGALACTOPYRANOSIDE	5.404654229770698
MEMBRANE TOPOLOGY	5.404411600160692
IODIDE-BOUND DNA	5.404385181729852
TARGET TRANSGENE	5.404297879866511
METABOLIC RESEARCH	5.404021275686648
CELL DEATH ASSAY	5.403881921640874
INDEPENDENT TEST	5.402271740759227
L929 CELL GROWTH	5.402143392180334
LABELING STUDY	5.402080401234483
IMMOBILIZED CDNA	5.401917375503343
CYCLIN E COMPLEX	5.40053712499508
PROBE SET SUBSET	5.398330815470508
REGULATORY MOTIF	5.398330815470508
ENDPOINT	5.397927463344182
COMMON PROBE SET	5.397502104088107
GROWTH CONDITION	5.396327597199242
POLAR RELAXATION	5.395644873440593
WT KINASE DOMAIN	5.395279791724694
RHO INACTIVATION	5.395241982136106
INFORMATION	5.394944889542382
MAB 4F2	5.394467169669634
RECRUIT MYOSIN-II	5.394297487033446
THALIANA SEQUENCE	5.394297487033446
THALIANA PROTEOME	5.394297487033446
VACUOLAR	5.394253803977336
BIOASSAY	5.394253803977336
MULTIPLE PATIENT	5.39373930645991
CATIONIC DETERGENT	5.39223030122143
M/Z VALUE SUBSET	5.39171188689679
ΜM DEXAMETHASONE	5.39134506770933
OTHER N-TERMINAL	5.390970704790878
EXPRESSING GFP	5.390544537264602
CAUSED FORMATION	5.390392225125082
MATRIX FORMATION	5.390392225125082
acid substitutions	5.390300869036212
FOCAL ADHESION	5.3863018109837135
TEST DEVELOPMENT	5.3860778572584795
III1-C SEPHAROSE	5.385975482132901
TERAZOSIN	5.384159561418413
COMPLETER	5.384159561418413
culturing	5.384159561418413
TURBIDITY	5.384159561418413
AZ TRANSLOCATION	5.382724647050191
S. CEREVISIAE	5.382664062216955
MAMMALIAN ENZYME	5.382597139473143
PROBE PRODUCTION	5.382303850056159
KDA CORE PROTEIN	5.381935440991431
CANCER DIAGNOSIS	5.381698635977576
CYTOPLASM VOLUME	5.381069688013557
OTHER POLYPEPTIDE	5.380137728655301
gene activation	5.376538596368402
BP DNA FRAGMENT	5.3764797603502945
FINANCIAL IMPLICATION	5.375034631765606
GRADIENT NOVEX GEL	5.373175208854824
ANTI-MOUSE SECONDARY ANTIBODY	5.371588692268119
B2 BOX	5.371396652302732
TRIS/HCL	5.370560422588233
response factors	5.3698810347589125
ΜM ATP	5.369262576467424
polymerization	5.369027362584513
ELEVATED LEVEL	5.369027362584513
EXCISION WOUND	5.368514061301792
CLONTECH	5.367702024399094
NP-40	5.367530605829531
MATRIGEL	5.366571069853275
P51 WT	5.361057971375816
TXT OUTPUT FILE	5.359519485904144
PROBE INTENSITY	5.359519485904144
EXPRESSED SΑ I2	5.359519485904144
OVARIAN DATASET	5.359519485904144
ACTINOPTERYGIAN	5.359519485904144
CAS(SD) CHIMERA	5.359519485904144
TIRF MICROSCOPE	5.359519485904144
NON-FLUORESCENT	5.359519485904144
OVER-ESTIMATION	5.359519485904144
LENS EPITHELIAL	5.359519485904144
INACTIVE DOMAIN	5.359519485904144
AQUEOUS OUTFLOW	5.359519485904144
POPULATION SIZE	5.359519485904144
CONTROLLING ALM	5.359519485904144
OCULAR LOCATION	5.359519485904144
MITOTRACKER RED	5.359519485904144
DIAGNOSTIC RULE	5.359519485904144
PROLINE/GLYCINE	5.359519485904144
ACIPENSERIFORME	5.359519485904144
NF-ΚB-INHIBITED	5.359519485904144
USM STATE SPACE	5.359519485904144
AVERAGE LINKAGE	5.359519485904144
ATTRIBUTE FIELD	5.359519485904144
SPHERICAL STAGE	5.359519485904144
METALLOPROTEASE	5.359519485904144
STRINGENCY WASH	5.359519485904144
CANDIDATE NCRNA	5.359519485904144
ISL1 LIM DOMAIN	5.359519485904144
SYNDECAN FAMILY	5.359519485904144
GTP-BOUND STATE	5.359519485904144
BINDING PROFILE	5.359519485904144
immunoglobulins	5.359519485904144
SUPERVISED STEP	5.359519485904144
ULTRASONIC BATH	5.359519485904144
ONION EPIDERMAL	5.359519485904144
SMAD1-DEPENDENT	5.359519485904144
ACTIN-DEPENDENT	5.359519485904144
GAD1 TRANSCRIPT	5.359519485904144
SELECTIVE FORCE	5.359519485904144
TOP-RIGHT FRAME	5.359519485904144
AXON MORPHOLOGY	5.359519485904144
SURROUNDING P10	5.359519485904144
SEARCH STRATEGY	5.359519485904144
PEPTIDE-TREATED	5.359519485904144
MOLECULAR EVENT	5.359519485904144
CELLULAR SYSTEM	5.359519485904144
C3 RIBOSYLATION	5.359519485904144
SELECTION MODEL	5.359519485904144
BINDING SITE TF	5.359519485904144
MUSCLE MYOSINII	5.359519485904144
DSH-INDEPENDENT	5.359519485904144
FORCE GENERATOR	5.359519485904144
PSIBLAST SEARCH	5.359519485904144
RGS3-EXPRESSING	5.359519485904144
OTHER COAGULANT	5.359519485904144
GAP GENE WEIGHT	5.359519485904144
NEUROEPITHELIAL	5.359519485904144
CONCEPTUALIZING	5.359519485904144
ANTICANCER DRUG	5.359519485904144
PLASMID VECTOR	5.358985818882555
TARGETED DELIVERY	5.358898091088083
RGS3 EXPRESSION	5.358857012185951
EXPRESSION UNIT	5.358857012185951
activator	5.358730110747151
MOLEGO ANALYSIS	5.358301166130299
CYCLOOXYGENASES 1	5.357137207106171
MYOSIN ACTIVITY	5.356803563750489
reporter strains	5.35625877522607
STRIKING EFFECT	5.3559651703900135
P53 TARGET GENE	5.355898256365938
FORMAMIDE	5.355807201512322
SYSTEM RESPONSE	5.35536977743587
I2 LOCALIZATION	5.355327216323374
EXCHANGE FACTOR	5.355320037779572
MISMATCH SIGNAL	5.354228271870163
ranks	5.352932219901831
TYROSINE KINASE	5.352703339569253
SMAD ACTIVATION	5.351984992187553
NEGATIVE MUTANT	5.351571641490602
NEURON IDENTITY	5.351465371931237
INHIBITED NF-ΚB	5.350914300975196
NOVEL EXTRACELLULAR MATRIX PROTEIN	5.350713869478376
POXVIRUS GENOME	5.350697623656841
CUT GENOMIC DNA	5.350139392545358
LOG PHASE GROWTH	5.349674176610155
SERUM PROTEOMIC	5.3496304629011195
GENOME ANALYSIS	5.349479303882996
ACETATE EXCRETION	5.349132740482466
DYSPNEA	5.348049107939652
GOAT ANTI-MOUSE SECONDARY ANTIBODY	5.346329469515139
CLOSE AGREEMENT	5.346117968391848
T CELL RECEPTOR	5.345383932250245
ΜM FEATURE SIZE	5.3448619174432626
CONFIDENCE LIMIT	5.3427975353094554
MULTIPLE REGION	5.339880024805043
N-TERMINAL YQXP	5.337166173491056
EMMPRIN	5.336727947220215
RAS STIMULATION	5.336491526235128
OPTICAL DENSITY	5.336004381275747
REDUCED COMPOUND	5.335588888365473
AFFINITY COLUMN	5.3341708791367
CO-ACTIVATOR CBP	5.333886723769456
CONTROL PLASMID	5.3323342542946115
MISSENSE ALLELE	5.332269733629142
ONLINE RESOURCE	5.3283182407996685
BDM APPLICATION	5.328077464048373
ANTI-MOUSE IGG	5.327279872603087
MITOSI	5.325917246850634
MOUSE ASTROCYTE	5.323976330762837
MINIMUM VALUE	5.323873977773572
SUBPOPULATION	5.323873977773572
CELLULAR ROLE	5.323873977773572
PERFECT MATCH	5.323873977773572
NEURONAL MARKER	5.321496575752978
MIDGUT	5.321396652302732
CA LOCALIZATION	5.321045269912888
SERINE PROTEASE	5.320430186088968
ABC TRANSPORTER	5.31988348259505
BSA/PB	5.319125566815455
INTERNAL LOOP	5.31121311414576
LINKER REGION	5.31121311414576
FOCAL CONTACT	5.31121311414576
CO-SEDIMENTED	5.31121311414576
USM PROCEDURE	5.31121311414576
stabilization	5.31121311414576
SEARCH RESULT	5.31121311414576
documentation	5.31121311414576
TRUNCATED BID	5.31121311414576
POLY-L-LYSINE	5.31121311414576
SERUM INDUCTION	5.310702245365402
GENE SEQUENCE	5.310412253049933
HOMOLOGOUS UNIT	5.310272945648116
STUDIES	5.309837986668449
ANALYSIS SHOW	5.309310965426977
BINDING ENERGY	5.30805628528923
repeat domains	5.307999545576728
USM ALGORITHM	5.30704206254346
STUDY	5.306294197843056
OPPOSITE STRAND	5.306204753192183
PCNA TRANSCRIPT	5.30501998135414
EGFP C-TERMINUS	5.304046775915746
N-TERMINUS	5.303687183602108
DP	5.303141450158714
B6	5.303141450158714
ZT	5.303141450158714
HA	5.303141450158714
RB	5.303141450158714
CΒ	5.303141450158714
NUCLEOLAR RNA	5.302494932518002
TRANSCRIPTIONAL ACTIVATION DOMAIN	5.302434039664849
SCFG ALIGNMENT	5.301973820796561
TRAINING ERROR	5.301973820796561
MICROSATELLITE	5.301973820796561
REDUCING NOISE	5.301973820796561
BMP-RESPONSIVE	5.301973820796561
PFAM ALIGNMENT	5.301973820796561
POSITIVE PROBE	5.301973820796561
MEC-3 SEQUENCE	5.301973820796561
administration	5.301973820796561
DUMMY VARIABLE	5.301973820796561
RAB24 FUNCTION	5.301973820796561
PREDICTED GSK3	5.301973820796561
CIRCULATING MP	5.301973820796561
METABOLIC FLUX	5.301973820796561
OMIM GENE LIST	5.301973820796561
MEASURED LEVEL	5.301973820796561
OPTIMIZATIONOF	5.301973820796561
INITIALIZATION	5.301973820796561
PRE-PROCESSING	5.301973820796561
CORNEAL STROMA	5.301973820796561
CROSS-REACTIVE	5.301973820796561
CONFOCAL LASER	5.301973820796561
AXON OUTGROWTH	5.301973820796561
STOICHIOMETRIC	5.301973820796561
ESSENTIAL GENE	5.301973820796561
APOPTOTIC BODY	5.301973820796561
MYOSIN-II FLUX	5.301973820796561
CLUSTALX CLADE	5.301973820796561
LOGODDSPOSTCOD	5.301973820796561
GLYCINE-SERINE	5.301973820796561
PERIODIC ORBIT	5.301973820796561
PPASE ACTIVITY	5.301973820796561
DUMBBELL SHAPE	5.301973820796561
SIGNATURE GENE	5.301973820796561
PATHWAY MEMBER	5.301973820796561
REPEAT REMOVER	5.301973820796561
SQUARED WEIGHT	5.301973820796561
POWER TODETECT	5.301973820796561
PH-20-MEDIATED	5.301973820796561
LOGODDSPOSTRNA	5.301973820796561
SPHERICAL CELL	5.301973820796561
SMAD1-MEDIATED	5.301973820796561
HUMAN THROMBIN	5.301973820796561
INTRALYSOSOMAL	5.301973820796561
FINDINGS RAISE	5.301973820796561
GRK/Β ARRESTIN	5.301973820796561
MISMATCH VALUE	5.301973820796561
CROSSOVER RATE	5.301973820796561
DEVELOPING GUT	5.301973820796561
(GPI)-ANCHORED	5.301973820796561
WEEK-OLD CHICK	5.301973820796561
PORCINE EMBRYO	5.301973820796561
PHYSICAL MODEL	5.301973820796561
MUTATION RATIO	5.301973820796561
SCORING MODULE	5.301973820796561
ANTI-Β-TUBULIN	5.301973820796561
GLYCERALDEHYDE	5.301973820796561
REQUIRED FORCE	5.301973820796561
DEVELOPING EYE	5.301973820796561
SPREAD HPB-ALL	5.301973820796561
HELIX JUNCTION	5.301973820796561
CATALYTIC FACE	5.301973820796561
AMINO-TERMINUS	5.301973820796561
DITHIOTHREITOL	5.301973820796561
TUNEL-POSITIVE	5.301973820796561
DORSAL MIDLINE	5.301973820796561
DIMENSIONALITY	5.301973820796561
MM GAP CUVETTE	5.301973820796561
OSTEOSCLEROTIC	5.301973820796561
EPIDERMAL CELL	5.301973820796561
JASPLAKINOLIDE	5.301973820796561
NON-EXPRESSING	5.301973820796561
SECONDARY FATE	5.301973820796561
GST-P20-C/EBPΒ	5.301973820796561
ISL1-CRE MOUSE	5.301973820796561
PROFILING DATA	5.301973820796561
DIACYLGLYCEROL	5.301973820796561
NOCTURNIN GENE	5.301973820796561
HSPGS FUNCTION	5.301973820796561
MARROW STROMAL	5.301973820796561
BJ-ADEASY CELL	5.301973820796561
ANNOTATED GENE	5.301973820796561
IMPROVED POWER	5.301973820796561
USER INTERFACE	5.301973820796561
PURIFIED SPARC	5.301973820796561
DIBUTYRYL CAMP	5.301973820796561
TENTATIVE BASE	5.301973820796561
MHCK-B DISPLAY	5.301973820796561
SYSTEM DEFAULT	5.301973820796561
RAS EXPRESSION	5.301325522579381
PLANE ANALYSIS	5.300781570423983
CONTINUOUS DATA	5.300062912570737
REPORTER GENE	5.299918054054577
ALGORITHM ARGO	5.2993594417115935
OTHER PROTEIN	5.2992637468872115
DESENSITIZATION	5.29732763097672
domain organization	5.29655773032537
REGULATORY RNA	5.2965093399222445
RNA ANNOTATION	5.2965093399222445
MAP TRANSCRIPT	5.2952511317209305
SIOUX BIOCHEMICAL	5.295179178386429
CONTROL VECTOR	5.29517484450606
ACETONITRILE	5.29503657152455
MAMMALIAN APE1	5.295017299057431
REPORTER MOUSE	5.294894174778862
DNA SUBSTRATE	5.294676374747271
UNC-86 PROTEIN	5.294484060702939
TAGGED PROTEIN	5.294484060702939
MOSAIC PROTEIN	5.294484060702939
JNK2	5.2942713545667175
CAPO	5.2942713545667175
BRDU	5.2942713545667175
FRAGMENTED DNA	5.292966656006387
DETERMINED DNA	5.292966656006387
ADENOVIRAL DNA	5.292966656006387
BUFFER SOLUTION	5.291616224657631
Α1(I) COLLAGEN	5.291584210406951
C-TERMINAL SRC	5.290760303131431
REQUIREDTO USE	5.290706215162758
NON-DNA DAMAGE	5.290033522289098
RELIGATION	5.289505617663515
CYCLIN E LEVEL	5.289275408098148
MIGRATED CLOSE	5.2888590666982
C-TERMINAL DNA	5.288204751244482
AGED PHENOTYPE	5.2875159894712604
E. COLI GENOME	5.287329536224219
TYRODES BUFFER	5.286985530398435
GSK3Β ANTIBODY	5.2869267988529876
ASPARTIC ACID	5.286434928416908
GROWTH HORMONE	5.285237419122921
OPTIMAL GROWTH	5.285237419122921
SINGLE DENSITY	5.284308205654606
LIPID ANALYSIS	5.284229846286052
DLA DX2 ALLELE	5.284196043018784
SURVIVAL METHOD	5.284058633450291
MUTANT PEPTIDE	5.2830332523211085
MURINE PROFILE	5.282696712362826
GP120 MOLECULE	5.281328659506238
T-CELL EPITOPE	5.280921189217614
ΜM PERVANADATE	5.280457928376023
RESULTS WINDOW	5.2791166779394185
ONCOGENE V-CRK	5.277731396554137
PLASMID PPB799	5.277649496472237
PPD118 PLASMID	5.277649496472237
IMPORT COMPLEX	5.276973820796561
REPRODUCTION RATE	5.276299500548902
P27 REGULATION	5.276167369183658
BASELINE ARRAY	5.275307154129894
GFP-BLM ALLELE	5.275307154129894
PHE158	5.271396652302732
LUMEN FORMATION	5.268474752835796
OVEREXPRESSING	5.268308751133504
ASTROCYTE LINE	5.267191212100909
MOLECULAR DYNAMIC	5.267084014846911
LAMIN	5.266928989374257
cyclin	5.266698421112945
DIVALENT CATION	5.263706077084375
GENE PROMOTER	5.262247226536566
ANTI-NF-ΚB P65	5.259868557638666
CANCER SUBJECT	5.258138204358205
MEAN FREQUENCY	5.2564453655120085
MEAN INTENSITY	5.2564453655120085
MUTANT ALLELE	5.256259509285461
UG/ML	5.251874702430863
SURFACE AREA	5.250507353372132
CONTAINING GST	5.250360917570755
PNPP HYDROLYSI	5.250360917570755
P300 REPRESSOR	5.249923909923121
BASES OPPOSITE	5.249799907753083
ABSENCE FILTER	5.249728922837377
XENOPUS RETINA	5.248921189217614
total phenotypic	5.2469779820848235
EPIDERMAL GROWTH FACTOR RECEPTOR	5.245641270221287
FAS RECEPTOR	5.245105893736689
STIMULATION	5.244048391186132
HOSPITALIZATION	5.243963217571113
HYBRIDOMA BANK	5.242756238480344
IC	5.2408318609253515
MUTATION RATE	5.240713032479123
CANCER SAMPLE	5.240713032479123
HEPTAD REPEAT	5.240713032479123
CURRENT PULSE	5.240713032479123
GNATHOSTOMATA	5.240713032479123
ELK-1(89-428)	5.240713032479123
FUNCTIONALAND	5.240713032479123
TGF-Β-INDUCED	5.240713032479123
AUTOPHAGOSOME	5.240713032479123
CONSENSUS SET	5.240713032479123
STUDYING GENE	5.240713032479123
VOLUME MARKER	5.240713032479123
GAP CHARACTER	5.240713032479123
HOMEOTIC GENE	5.240713032479123
OPTIMAL VALUE	5.240713032479123
SHARED MOLEGO	5.240713032479123
PHOSPHOMOESIN	5.240713032479123
INHIBITOR P27	5.240713032479123
LEF-DEPENDENT	5.240713032479123
PCNA-POSITIVE	5.240713032479123
TWOFUNCTIONAL	5.240713032479123
GOLD PARTICLE	5.240713032479123
STOP SEQUENCE	5.240713032479123
EXPRESSED DLD	5.240713032479123
PGKNEOTPALOX2	5.240713032479123
incorporation	5.240713032479123
ALIGNMENT GAP	5.240713032479123
THREE-MYC TAG	5.240713032479123
SARCOPTERYGII	5.240713032479123
PHOSPHOROLYSI	5.240713032479123
CELL GEOMETRY	5.240713032479123
preincubation	5.240713032479123
BIOMASS YIELD	5.240713032479123
MEASURED GENE	5.240713032479123
TELENCEPHALON	5.240713032479123
ERROR MESSAGE	5.240713032479123
APURINIC SITE	5.240713032479123
NEURAL TISSUE	5.240713032479123
CELL ABLATION	5.240713032479123
HEALING WOUND	5.240713032479123
MICROFILAMENT	5.240713032479123
WNT/Β-CATENIN	5.240713032479123
PTX-MKC2 CELL	5.240713032479123
METAL CHELATE	5.240713032479123
STANDARD BEAD	5.240713032479123
OLFACTORY PIT	5.240713032479123
TET-ON SYSTEM	5.240713032479123
EMBRYOLOGICAL	5.240713032479123
POLAR PATTERN	5.240713032479123
PHOTORECEPTOR	5.240713032479123
LOOP-8 INSERT	5.240713032479123
COLOR DISPLAY	5.240713032479123
TWO-CHAIN TPA	5.240713032479123
TYPE EGF-LIKE	5.240713032479123
AXONAL DEFECT	5.240713032479123
INCREASED P27	5.240713032479123
INTERNAL CAMP	5.240713032479123
ORTHOSTRAPPER	5.240713032479123
RIO PROCEDURE	5.240713032479123
NON-RESPONDER	5.240713032479123
SMG PRIMORDIA	5.240713032479123
PH-20-INDUCED	5.240713032479123
ARGININE-RICH	5.240713032479123
anticoagulant	5.240713032479123
GABA-MEDIATED	5.240713032479123
TREATED HUVEC	5.240713032479123
ENHANCING CEE	5.240713032479123
GR-RESPONSIVE	5.240713032479123
ON-CHIP CACHE	5.240713032479123
NESTED HELICE	5.240713032479123
PRIMITIVE MDC	5.240713032479123
LIMITED RANGE	5.240713032479123
DIAMETER DISH	5.240713032479123
DONOR PROFILE	5.240713032479123
NEGATIVE FORM	5.240713032479123
PHAGOLYSOSOME	5.240713032479123
BIDIRECTIONAL	5.240713032479123
ADHERED BPAEC	5.240713032479123
RNA-GENERATED	5.240713032479123
GROUPING STEP	5.240713032479123
TRUNCATED NEO	5.240713032479123
DEREPLICATING	5.240713032479123
SEQUENCE UNIT	5.240713032479123
PP5 ASSOCIATE	5.240713032479123
MICROPARTICLE	5.240713032479123
SINGLE SUBJECT	5.240472589216249
PMOLE	5.237837927820575
MATRIX EFFECT	5.237315736309029
GENE RESPONSE	5.236746646087642
ACTIN NETWORK	5.236384067830249
PREDICTED RNA	5.235375750244685
AMBION	5.235363209628252
COMPONENT DSH	5.234608515923485
ECM COMPONENT	5.234608515923485
CANCER PATIENT	5.234401133533646
CPT TREATMENT	5.234334435588334
ITERATIVE MAP	5.234146829797428
CCAF RECEPTOR	5.233918440138934
GAL4 REPORTER	5.233798181867426
RANK SUM TEST	5.23352794632628
TEST PLATFORM	5.229935403249858
CYCLE CONTROL	5.2291290622057085
PRIMARY BPAEC	5.22855150533326
DROSOPHILA S2	5.227903555116472
RESULTING PCR	5.2268833312557295
PALMITIC ACID	5.225900177140323
GLUTAMIC ACID	5.225900177140323
POSSIBLE EXON	5.225391892888501
LIPID BILAYER	5.224546588635226
LENGTH CAS SD	5.223772585452094
TNF CYTOTOXIC	5.221006722143502
ΜG/ML HOECHST	5.220258107894785
SD RAT STRAIN	5.220078126260029
COMMON LETTER	5.217843428992634
MAPK ANTIBODY	5.213807232237031
MULTIPLE CHIP	5.209919983940855
EST DATABASE	5.209775996934016
gene product	5.209775996934016
BCL-2 FAMILY	5.209775996934016
INVAGINATION	5.209775996934016
microtubules	5.209775996934016
SCORE CUTOFF	5.209775996934016
compensation	5.209775996934016
manipulation	5.209775996934016
FILAMENT ORGANIZATION	5.2096906430269705
DENDRITIC CELL	5.209237166346404
HYPOTONIC LYSI	5.207856173737738
ARCHAEAL RRNA	5.207689008433178
EXCESS NEURON	5.206968788582734
TRNA SEQUENCE	5.20674007077818
CELL APOPTOSI	5.206138779420641
ACETONE	5.205354765303188
BASELINE CHIP	5.202645893342424
transcriptional activation domains	5.202511842514114
SATURABLE	5.200405226458578
FLAG EPITOPE	5.199657038403772
INTERSECTION	5.199657038403772
MRNA ABUNDANCE	5.199625819698574
GP120 MONOMER	5.197303136972362
CXCR4	5.1957276039897105
MG/DL	5.1957276039897105
SPOTTED CDNA	5.192091288563688
MEDLINE RECORD	5.187688106510847
IMMUNOGOLD ELECTRON MICROSCOPY	5.183306436929911
IL-6	5.182190770923628
CD14	5.182190770923628
JNK1	5.182190770923628
CYCLE ARREST	5.181099992556372
CHO CELL	5.181032438926319
SERUM ABSENCE	5.180232102686013
CDNA LIBRARY	5.1776260432152705
PIGMENT EPITHELIUM DERIVED FACTOR BINDING AFFINITY	5.176386369194246
P53-MEDIATED	5.175224117935126
DECREASED GR	5.175224117935126
USM DISTANCE	5.175224117935126
PH-DEPENDENT	5.175224117935126
CYTOCHEMICAL	5.175224117935126
ALLN-INDUCED	5.175224117935126
GUT ENDODERM	5.175224117935126
COCLUSTERING	5.175224117935126
DE-LOCALIZED	5.175224117935126
ANGLE REGION	5.175224117935126
intranuclear	5.175224117935126
SUCCINYL-COA	5.175224117935126
CONSTRICTION	5.175224117935126
GENE-BY-GENE	5.175224117935126
DEGENERATIVE	5.175224117935126
BLASTN QUERY	5.175224117935126
POLAR REGION	5.175224117935126
VOLUME RATIO	5.175224117935126
COMPARE PJC3	5.175224117935126
AGAR OVERLAY	5.175224117935126
TETRACYCLINE	5.175224117935126
ROSA26 LOCUS	5.175224117935126
DENATURATION	5.175224117935126
MYERS/MILLER	5.175224117935126
MULTIPROTEIN	5.175224117935126
PROCESSIVITY	5.175224117935126
PGR(ALA)-GFP	5.175224117935126
AVM POSITION	5.175224117935126
ANTI-CLEAVED	5.175224117935126
DISAGREEMENT	5.175224117935126
TUMOR TISSUE	5.175224117935126
BOI1-PH BIND	5.175224117935126
GNRH-TREATED	5.175224117935126
JUKES-CANTOR	5.175224117935126
SPLICED FORM	5.175224117935126
SEGMENTATION	5.175224117935126
P53-POSITIVE	5.175224117935126
MM COVERSLIP	5.175224117935126
CELL-SURFACE	5.175224117935126
REDUCED GENE	5.175224117935126
CHANGED GENE	5.175224117935126
HUMAN LTBP-3	5.175224117935126
ERROROF GPNN	5.175224117935126
P53-REPORTER	5.175224117935126
RHO FUNCTION	5.175224117935126
BLM ACTIVITY	5.175224117935126
BLOCKED ERK1	5.175224117935126
NEEDED FORCE	5.175224117935126
USING MOLEGO	5.175224117935126
QUASI REJECT	5.175224117935126
PROGRAM CODE	5.175224117935126
TRANSREPRESS	5.175224117935126
FUSION PULSE	5.175224117935126
PUBMED PAPER	5.175224117935126
GFP-BLM GENE	5.175224117935126
KORARCHAEOTA	5.175224117935126
REPROGRAMMED	5.175224117935126
S. CERVISEAE	5.175224117935126
RADIOGRAPHIC	5.175224117935126
TGF-Β1 BLOCK	5.175224117935126
EXTERNAL YSL	5.175224117935126
LINE HPB-ALL	5.175224117935126
SCORING DATA	5.175224117935126
PAIR-GRAMMAR	5.175224117935126
oscillations	5.175224117935126
KIT PROTOCOL	5.175224117935126
USM APPROACH	5.175224117935126
LENGTH SMAD1	5.175224117935126
BALB/C MOUSE	5.175224117935126
POLYMORPHISM	5.175224117935126
LONGNOSE GAR	5.175224117935126
SUPERSHIFTED	5.175224117935126
FRDABCD GENE	5.175224117935126
WD-40 REPEAT	5.175224117935126
LIPOFECTMINE	5.175224117935126
VIRAL ORIGIN	5.175224117935126
SEARCH QUERY	5.175224117935126
CAS FUNCTION	5.175224117935126
LFC FUNCTION	5.175224117935126
SUBCONFLUENT	5.175224117935126
EUTELEOSTOMI	5.175224117935126
ORDERED LIST	5.175224117935126
DAN EQUATION	5.175224117935126
BIPARTITE NL	5.175224117935126
DT-SENSITIVE	5.175224117935126
MOUSE LTBP-3	5.175224117935126
MEASURED TAG	5.175224117935126
JUXTANUCLEAR	5.175224117935126
C/EBPΑ BLOCK	5.175224117935126
RESULTS/PAGE	5.175224117935126
3-D DISTANCE	5.175224117935126
NET ANALYSIS	5.174089287854035
SSV ANALYSIS	5.174089287854035
RIO ANALYSIS	5.174089287854035
LIPID ABSENCE	5.17351781350891
H PREINCUBATION	5.1733128453582955
ECORV	5.172739418961119
MM ALGORITHM	5.172735650665807
CHAIN KINASE	5.172289740345871
P27 DEPLETION	5.171767904321325
INTRON ENTRY	5.170981939748989
INPUT VECTOR	5.170922021977999
NCOA	5.170236841579197
INCREASE P53	5.170164510065281
STRAIN EA485	5.169823614499583
EMBRYOGENESI	5.169570178514547
SURVIVAL RATE	5.168585821483274
SRE REPORTER	5.168485436657147
ENHANCED TNF	5.168301654440476
TN ANTISENSE	5.167208633888689
CELLULAR DNA	5.166650749635712
SYMBOL ENTRY	5.165823241584366
GLYCOPROTEIN	5.164929064344851
TEST DATASET	5.164721069874277
FLAG PEPTIDE	5.164598941408453
SN50 PEPTIDE	5.164598941408453
GB ACCESSION	5.164026015223191
PRIMARY FATE	5.163372429461795
TWO-SAMPLE T	5.162095307859065
GPGRAF MOTIF	5.161122803408986
PCU3	5.161004832648049
GENERAL MODE	5.1608567408707575
proliferation	5.16020690189972
MICROARRAY R	5.159180275387529
SINGLE ERROR	5.15840930124465
ES CELL LINE	5.1574119311652655
TYPE ES CELL	5.1574119311652655
POLY T MOTIF	5.157070701533659
ARCHAEA RRNA	5.152290080882107
PLASMID PTRE	5.15207128394964
PLASMID PRF4	5.15207128394964
LTR PROMOTER	5.151193475429042
P105 SUBUNIT	5.1506605377928185
GAL4 SUBUNIT	5.1506605377928185
TOUCH NEURON	5.149591679215197
CSN1	5.14869548740652
ACH2	5.14869548740652
ACR4	5.14869548740652
CDC2	5.14869548740652
WAF1	5.14869548740652
CCRA	5.14869548740652
CDNA FRAGMENT	5.1462580815276056
MRNA SPECIES	5.146205179020115
INCREASING G	5.1455564172437676
P NEUROBLAST	5.144765278558665
RASMC LYSATE	5.139530165540836
LEPTOMYCIN B	5.13896359486791
GABA RECEPTOR	5.136246175248721
SECONDARY AB	5.13617432386274
FLOW CHALLENGE	5.13442665098524
INTERVENTION	5.133476762223936
HIERARCHICAL CLUSTER ANALYSIS	5.133225988510166
TRIMMED MEAN	5.131888370854795
PHOSPHOTYROSINE	5.1318262227657945
HHBS	5.131462404068379
GRADIENT NOVEX	5.131135703689787
SACI	5.130772573559287
EMPTY PLASMID	5.130135122978792
RESULTS SHOW	5.1269861108342365
MARKOV MODEL	5.126664823742086
TN-C ABSENCE	5.125495400585802
MUTANT PROTEIN	5.125235350541691
ACID	5.122839758990013
DNA SYNTHESIS	5.120015814223344
CONTAINING PROTEASE INHIBITOR	5.11991006766308
CLONING RING	5.118818859830569
BMI	5.117370888000363
salt solution	5.117337539986222
CYTOSOL	5.117073124277537
assay buffer	5.116649426826547
CRY	5.115159527909995
ACETYLATION	5.1048798845265795
SAOS-2 CELL	5.1048798845265795
H3 SEROTYPE	5.1048798845265795
CD4-INDUCED	5.1048798845265795
DORSAL ROOT	5.1048798845265795
BIOPHYSICAL	5.1048798845265795
SUBSEQUENCE	5.1048798845265795
STIPULATION	5.1048798845265795
TYPE ANIMAL	5.1048798845265795
BEST-SO-FAR	5.1048798845265795
ESCHERICHIA	5.1048798845265795
hematoxylin	5.1048798845265795
HOLOBLASTIC	5.1048798845265795
DYE HOECHST	5.1048798845265795
SB/LE MOUSE	5.1048798845265795
DEREPLICATE	5.1048798845265795
TUMORIGENIC	5.1048798845265795
BER PATHWAY	5.1048798845265795
PRSETB-EFII	5.1048798845265795
PERIODICITY	5.1048798845265795
DISASSEMBLE	5.1048798845265795
MOVING CELL	5.1048798845265795
MEMBRANE MP	5.1048798845265795
PAG-3(LS20)	5.1048798845265795
ATTENUATION	5.1048798845265795
CORTEXILLIN	5.1048798845265795
HOMEODOMAIN	5.1048798845265795
HYAL-1 CELL	5.1048798845265795
ROHON-BEARD	5.1048798845265795
SMG EXPLANT	5.1048798845265795
ERROR LEVEL	5.1048798845265795
GROWING END	5.1048798845265795
RDBMS QUERY	5.1048798845265795
ELK-1 A-BOX	5.1048798845265795
EXONUCLEASE	5.1048798845265795
FIRST-LEVEL	5.1048798845265795
SINGLE-PASS	5.1048798845265795
RCCA SAMPLE	5.1048798845265795
CHLOROQUINE	5.1048798845265795
DORSAL SKIN	5.1048798845265795
NEURAL FOLD	5.1048798845265795
MKHB-EGF EX	5.1048798845265795
GR-MEDIATED	5.1048798845265795
ANTI-MHCK-C	5.1048798845265795
WHT4-1 CELL	5.1048798845265795
GROUP LEVEL	5.1048798845265795
HUMAN MYOIE	5.1048798845265795
SPLICESOMAL	5.1048798845265795
TAXONOMICAL	5.1048798845265795
SEDIMENTING	5.1048798845265795
DASHED LINE	5.1048798845265795
COILED COIL	5.1048798845265795
CYTOKINETIC	5.1048798845265795
N-GLYCANASE	5.1048798845265795
POSSIBLE NN	5.1048798845265795
PP5 HOMOLOG	5.1048798845265795
DUPLICATION	5.1048798845265795
oscillators	5.1048798845265795
C/EBPΑ BIND	5.1048798845265795
neuroblasts	5.1048798845265795
BS-C-1 CELL	5.1048798845265795
TRANSIT-LT1	5.1048798845265795
SMAD1 LEVEL	5.1048798845265795
CY5 CHANNEL	5.1048798845265795
COATED WELL	5.1048798845265795
ETHYL ETHER	5.1048798845265795
HALF-SAMPLE	5.1048798845265795
UVEOSCLERAL	5.1048798845265795
NON-COGNATE	5.1048798845265795
HL-5 MEDIUM	5.1048798845265795
BLAST SCORE	5.1048798845265795
WD40 DOMAIN	5.1048798845265795
CELL-MATRIX	5.1048798845265795
CONTROL ALM	5.10277137186667
CONTROL E15	5.10277137186667
MYOSIN TAIL	5.10242112059426
P24	5.101891367367782
ΚB RESPONSE	5.101123092934557
PARENCHYMAL	5.100818377173207
REPLICATING	5.100818377173207
genome-wide	5.100818377173207
CRNA SAMPLE	5.100818377173207
CARPINTERIA	5.100818377173207
DECALCIFIED	5.100818377173207
annotations	5.100818377173207
SUBCATEGORY	5.100818377173207
assessments	5.100818377173207
BASAL LEVEL	5.100818377173207
chromogenic	5.100818377173207
PROMOTER ID	5.100500665925229
VEX1 SIGNAL	5.100089671299212
BEX1 SIGNAL	5.100089671299212
PROBING RNA	5.099824639009993
POOLING RNA	5.099824639009993
RNA FEATURE	5.099824639009993
ECM PROTEIN	5.097951033094132
ΔN4 PROTEIN	5.097951033094132
P27 PROTEIN	5.097951033094132
NEURON FATE	5.097588377692803
NF-ΚB BOUND	5.097089485119966
AA SEQUENCE	5.0969219496488565
DNA COMPLEX	5.0965472669422285
DNA HELICAS	5.0965472669422285
GFP VARIANT	5.0960693137691
SERUM LEVEL	5.095927207789141
SYMBOL PAIR	5.095742996333638
COLLAGEN IV	5.095268352791148
RAD PEPTIDE	5.094553076010837
CLASSIFICATIONOF GALAXY OPTIMIZING NN ARCHITECTURE	5.0935183129567
SIMILARITY OVER-DETERMINATION RESULTING EXPRESSION	5.093056364843399
T ALIGNMENT	5.092119747567472
POST-TRANSCRIPTIONAL CONTROL FUNDAMENTAL MECHANISM	5.091894256056945
MAP PROTEIN	5.091731806677089
DIFFERENT PROBE COMPARISON ANALYSIS MOID ALGORITHM	5.091710024477363
WASH BUFFER	5.091014068252514
EXTRACELLULAR         SIGNAL-REGULATED KINASES 1/2	5.090973473796816
TEST VECTOR	5.090490487142185
GROWTH CONE	5.0893968731536035
CELL CULTURE PRIMARY RAT AORTIC SMOOTH MUSCLE CELL	5.089082173098225
PROMOTER ACTIVATION ELECTROPHORETIC MOBILITY SHIFT	5.086616790760931
GENOMIC DNA	5.086432449415957
VIRAL STOCK	5.086377685935874
CHONDROITIN	5.085762410518879
SELECTED MYCRAB24 PROTEIN GUANINE NUCLEOTIDE STATE	5.08575343588196
DIASTOLIC BLOOD PRESSURE	5.0856024171159415
XENOPUS EYE	5.085403886010047
ΜM INTERVAL	5.084975318805527
FITC-CONJUGATED GOAT ANTI-MOUSE SECONDARY ANTIBODY	5.0849408488040115
AUTOSOMAL RECESSIVE DISORDER	5.084909540356357
BOVINE TESTICULAR PH-20-INCREASED TNF CYTOTOXICITY	5.084190320690651
REQUIRING ACTOMYOSIN INTERACTION REGULATED PROCESS	5.083957827056254
WINDOW SIZE	5.08373451470863
CDNA INSERT	5.083630277141298
SENSITIVE SER/THR PROTEIN PHOSPHATASE OKADAIC ACID	5.082756055268492
GLYCINE-CONJUGATED BILE ACID CYTOTOXICITY	5.08272880475404
POLYMERASE CHAIN REACTION	5.082620783116414
FUSION PROTEIN TRANSCRIPTIONAL ACTIVATION PROPERTY	5.082394363861135
ARR PLASMID	5.0823772105649105
INSULIN-LIKE GROWTH FACTOR I CELL SURFACE RECEPTOR	5.082197845366977
USM ALGORITHM IMPLEMENTATION	5.081270218499073
DECREASED CELL PROLIFERATION	5.077949337304302
GRANULATION TISSUE FORMATION SPARC-NULL FIBROBLAST	5.076102481188197
GENETIC PROGRAMMING NEURAL NETWORK FUNCTIONAL SNP	5.075086417923251
INDUCED LUCIFERASE ACTIVITY MAXIMAL DEXAMETHASONE	5.075086417923251
WOUNDING EXPERIMENT FULL-THICKNESS EXCISION WOUND	5.075086417923251
MYOSIN-II CROSS-BRIDGE LOAD-DEPENDENT RECRUITMENT	5.075086417923251
NEURAL TUBE PROSPECTIVE TRUNK LONGITUDINAL DOMAIN	5.075086417923251
CROSS-VALIDATION CONSISTENCYTHAT EMPIRICAL CUTOFF	5.075086417923251
FUNGI DIVERGENCE TIME ESTIMATE PUBLISHED DATA SET	5.075086417923251
TERMINAL-RESTRICTION FRAGMENT LENGTH POLYMORPHISM	5.075086417923251
CONNECTIVE-TISSUE CONTRACTION IN VITRO EQUIVALENT	5.075086417923251
ENHANCED WOX1-MEDIATED L929 CELL DEATH GFP-HYAL-2	5.075086417923251
ESTROGEN ANTIRESORPTIVE ACTION PARACRINE MEDIATOR	5.075086417923251
INTRODUCING C3 EXOENZYME ELECTROPORATION PROCEDURE	5.074904632244404
CLUSTERING ANALYSIS NEAREST-NEIGHBOR HIERARCHICAL	5.074241049019828
RT-PCR DATA	5.074042886875404
NEURON BIRTH	5.072538067697365
PH INCREASE	5.070691039304624
ELEVATED PH	5.070691039304624
DIRECTED NUCLEOLAR LOCALIZATION C-TERMINAL DOMAIN	5.0700581141402585
FLUORESCENCE INTENSITY HETEROGENEOUS DISTRIBUTION	5.069858376133416
MG ESTRADIOL	5.069464258989081
TERMINAL RESTRICTION FRAGMENT LENGTH POLYMORPHISM	5.066682824824034
proteolytic	5.066230710647885
CANCER CELL	5.066230710647885
INCLUDING ACTIN CYTOSKELETAL PROTEIN LOCALIZATION	5.06599666423458
EXCESS	5.065954040326872
EXHIBITING NEGATIVE BIAS STANDARD PARAMETRIC MODE	5.0642817982242585
MONOCLONAL ANTI-MYC ANTIBODY	5.063963474745157
JUNCTION PROTEIN ADHEREN TYROSINE PHOSPHORYLATION	5.063802471481943
TRANSFORMING GROWTH FACTOR Β	5.0631456911269845
PHASE GROWTH	5.063086375128454
MEAN LENGTH	5.062761058466437
CONSERVED PROTEIN DOMAIN MODEL MULTIPLE ALIGNMENT	5.062461026997222
PROTEOLYTIC FRAGMENT N-TERMINAL SEQUENCE ANALYSIS	5.06200169236495
BINDING PROTEIN INTRACELLULAR BILE ACID	5.0613045027724315
BOOTSTRAPPED MODE ESTIMATOR INCREASED PERFORMANCE	5.060905354568323
TOTAL RNA ΜG	5.060501042635038
LEFT VENTRICULAR           HYPERTROPHY	5.058734644340747
TARGETED ES	5.058400960720194
DIFFERENTIAL EXPRESSION DATA VARIABLE RELIABILITY	5.057095606576022
FEATURE KEY	5.056822225849422
DETERMININGSIGNIFICANCE CRITICAL RELEVANCE VALUE	5.05628951124585
EGF-LIKE MODULE NUMEROUS CALCIUM-BINDING TYPE II	5.05628951124585
LABELED GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE	5.05628951124585
CONSTITUTIVE EXPRESSION LEADING BACKGROUND LEVEL	5.055923621055265
COVARIATION ANALYSIS METHOD DETAILED EXPLANATION	5.055616622281346
S1 NUCLEASE	5.055540688284698
TNE	5.055452805470034
PROGRAMMING ALIGNMENT ALGORITHM STANDARD DYNAMIC	5.0548139932877385
INCLUDING FILAMENTOUS ACTIN CYTOSKELETAL ELEMENT	5.053788079139578
N-TERMINAL TRANSACTIVATION DOMAIN PHOSPHORYLATION	5.053325273441364
ULTRASTRUCTURAL IMMUNOGOLD BIOLOGICAL APPLICATION	5.053269397377207
EC-SPECIFIC INTEGRIN COMPLEX INCREASED PRODUCTION	5.052863305707938
LEF-LUCIFERASE REPORTER DUAL LUCIFERASE ACTIVITY	5.052293860846009
DIVERGENCE TIME ESTIMATE NON-NORMAL DISTRIBUTION	5.052128142626661
STANDARD NORMAL DISTRIBUTION INTERQUARTILE RANGE	5.052128142626661
FLUOROPHORE	5.051942365195952
INTEGRIN-MEDIATED ADHESION CHEMOKINE UPREGULATION	5.051564398961329
STANDARD TRITON X-100 PERMEABILIZATION PROCEDURE	5.0514862293822125
ASTROCYTE-SPECIFIC INTERMEDIATE FILAMENT PROTEIN	5.05100562013781
RABBIT POLYCLONAL ANTI-PROTEIN DISULFIDE ISOMERASE	5.050019572953655
CONTAINING GST-P35-C/EBPΒ GLUTATHIONE AGAROSE BEAD	5.04968884510097
INTRON CONSERVATION DATA EQUIVALENT PRESENTATION	5.04925905863285
IN VITRO DNA HELICASE ACTIVITY EPITOPE-TAGGED GENE	5.049133400690139
TRANSCRIPTION FACTOR BASIC-LEUCINE ZIPPER FAMILY	5.048756394328308
ISI ABILITY	5.048364077922242
EXCESS ROHON-BEARD SENSORY NEURON CAUSE FORMATION	5.048152633153138
INHIBITORY NEUROTRANSMITTER Γ-AMINO BUTYRIC ACID	5.047730108493585
MODELING MULTIPLE SEQUENCE ALIGNMENT PROFILE HMM	5.047250302133098
OXIDIZED OXYBURST GREEN H FLUORESCENCE INTENSITY	5.04583792570923
MYOSIN II HEAVY CHAIN KINASE IN VITRO REGULATION	5.045161551545755
dysfunction	5.0444238819046445
NEIGHBOR JOINING	5.044076863502707
INCREASED JNK ACTIVITY SRC* TRANSIENT EXPRESSION	5.043847277614396
DISULFIDE	5.043696427360781
GERM-LINE TRANSFORMATION C. ELEGAN TRANSFORMATION	5.043426369502946
RECRUIT DSH	5.043205889224227
NAMED SERUM RESPONSE FACTOR TRANSCRIPTION FACTOR	5.041617655012293
EXPRESSED DELTA GENE BRDU-POSITIVE CELL FRACTION	5.041606308150501
(SNPS) FUNCTIONAL SINGLE NUCLEOTIDE POLYMORPHISM	5.041321043085184
PLATELET NM-MYOSINII S1 FRAGMENT ATPASE ACTIVITY	5.039689934217101
BUFFER (20 MM 2-[MORPHOLINO]ETHANE-SULFONIC ACID	5.039270932939824
HEK	5.039195623978509
GDP	5.039195623978509
E12	5.039195623978509
PASSING PB/IM INTERFACE EXHIBIT HLA-DR EXPRESSION	5.038414902922321
AVERAGE SINGLE NUCLEOTIDE SUBSTITUTION PROBABILITY	5.037260843629593
EMERGING DAUGHTER CELL CROSS-SECTIONAL DIAMETER	5.037112843503812
BETTER SCE CORRECTION TET-INDUCIBLE SYSTEM SHOW	5.037112843503812
DIVIDING DICTYOSTELIUM DISCOIDEUM CELL GEOMETRY	5.037112843503812
PCNA-POSITIVE EPITHELIAL CELLS/TOTAL EPITHELIAL	5.037112843503812
CLINICAL PROTEOMICS PROGRAM DATABANK MODEL RULE	5.037112843503812
POTENTIAL INTEREST CONSERVED NONCODING SEQUENCE	5.037112843503812
CIRCULATING MP POSSIBLE PATHOPHYSIOLOGICAL ROLE	5.037112843503812
NOLLER-WOESE-GUTELL COMPARATIVE STRUCTURE MODEL	5.037112843503812
RAB PROTEINS PLAY POSTTRANSLATIONAL PRENYLATION	5.037112843503812
NUMEROUS CELLULAR PROCESS SPARC-NULL MOUSE LENS	5.037112843503812
YIELDED MODERATE ACTIVATION GROWTH FACTOR ABSENCE	5.0370508392982645
CONTAINING MULTIPLE TPR REPEAT N-TERMINAL DOMAIN	5.036962022620488
variance	5.03647822229734
3-D ORGANELLAR PROTEIN QUANTITATIVE DEMONSTRATION	5.035930674553546
HIND III/ECORV RESTRICTION ENDONUCLEASE FRAGMENT	5.035725310514338
NF-ΚB P50 NUCLEAR LOCALIZATION           SEQUENCE	5.035568630732682
BEDNARCZUK SINGLE-STRAND DNA PROTOCOL MODIFICATION	5.035081020016074
TOTAL INTERNAL REFLECTION           FLUORESCENCE	5.034911268102764
GEL FILTRATION CHROMATOGRAPHY SUBCELLULAR FRACTION	5.034888408079368
SPATIAL-TEMPORAL EXPRESSION FEATURE DIFFERENTIAL	5.033914260391989
BMP-INDUCED GAL4-SMAD1 TRANSCRIPTIONAL ACTIVITY	5.033848477315374
TGF-Β/BMP FAMILY LIGAND REGULATION CHARACTERISTIC	5.033355720173938
AFFYMETRIX FLUIDICS STATION	5.03322246393878
PH-20-INCREASED TNF SUSCEPTIBILITY TGF-Β1 BLOCK	5.033029418162638
GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR AFFINITY	5.0328715839966485
(TET)-RESPONSIVE TRANSCRIPTIONAL TRANSACTIVATOR	5.03276035525256
DIFFERENTIAL LOCALIZATION FUNCTIONAL SIGNIFICANCE	5.032422316377284
CORTEXILLIN ACTIN-FILAMENT CROSSLINKING PROTEIN	5.031856239787848
CHICKEN EMBRYO FIBROBLAST ANGIOGENIC FACTOR CEF	5.031389855640312
STAUROSPORINE APOPTOSI PH-20-MEDIATED INHIBITION	5.031316696246847
CHROMA TECH	5.030871090163757
WEEK OLD DBA	5.030182025666265
BINDING SITE TRANSCRIPTION FACTOR JUXTAPOSITION	5.029618629567174
BINDING PROTEIN DNA TITRATION OPTIMAL CONDITION	5.029394056291922
MIB-ARRESTED LNCAP CELL PROMOTING S PHASE ENTRY	5.028955880049892
DME MEDIUM	5.028902324385547
TELEOSTEAN	5.028902324385547
SMAD1 BIND	5.028902324385547
PRONUCLEAR	5.028902324385547
MIBOLERONE	5.028902324385547
RENAL CELL	5.028902324385547
MUCIN-LIKE	5.028902324385547
GAL4-SMAD1	5.028902324385547
POSITIONAL	5.028902324385547
GLIAL FATE	5.028902324385547
IPP FAMILY	5.028902324385547
EXTENSIONS	5.028902324385547
PCRII-TOPO	5.028902324385547
PSEUDOKNOT	5.028902324385547
LTBP-3 EGF	5.028902324385547
BPSEQ FILE	5.028902324385547
HISTOLOGIC	5.028902324385547
PROCESSIVE	5.028902324385547
T7 EPITOPE	5.028902324385547
TELEOSTOMI	5.028902324385547
PLECKSTRIN	5.028902324385547
HA SURFACE	5.028902324385547
POTENTIATE	5.028902324385547
NON-CANCER	5.028902324385547
TIME FRAME	5.028902324385547
DUTY RATIO	5.028902324385547
GERM LAYER	5.028902324385547
ARR DSRNAI	5.028902324385547
LACKED PIP	5.028902324385547
ASCOMYCOTA	5.028902324385547
RAT C/EBPΑ	5.028902324385547
EGF-MODULE	5.028902324385547
RIO OUTPUT	5.028902324385547
EUCARYOTIC	5.028902324385547
CELLS/WELL	5.028902324385547
RESAMPLING	5.028902324385547
ONCOCYTOMA	5.028902324385547
COLOR CODE	5.028902324385547
DYSTROPHIN	5.028902324385547
SUCCESSION	5.028902324385547
PFA POWDER	5.028902324385547
PROBE CELL	5.028902324385547
GENEORDER2	5.028902324385547
PENETRANCE	5.028902324385547
PRE-FORMED	5.028902324385547
LIM DOMAIN	5.028902324385547
PEGFP-N280	5.028902324385547
RMSD VALUE	5.028902324385547
SC-URA-LEU	5.028902324385547
ROOT LEVEL	5.028902324385547
ALM DEFECT	5.028902324385547
PRESENCEOF	5.028902324385547
VARIABILTY	5.028902324385547
ANTI-HUMAN	5.028902324385547
NORMAL PLM	5.028902324385547
SEMI-THICK	5.028902324385547
MILLIMOLAR	5.028902324385547
ANTICANCER	5.028902324385547
CACODYLATE	5.028902324385547
PEGFP-COP1	5.028902324385547
C/EBPΑ DBD	5.028902324385547
CYTOCHROME	5.028902324385547
ALKALINITY	5.028902324385547
PELVIC FIN	5.028902324385547
COLOCALIZE	5.028902324385547
REFRACTIVE	5.028902324385547
HLA-DR MDC	5.028902324385547
ced-8 gene	5.028902324385547
Β-ARRESTIN	5.028902324385547
CYTOPATHIC	5.028902324385547
ETHYLATION	5.028902324385547
DEPENDENCY	5.028902324385547
REACTIVITY	5.028902324385547
VERTEBRATA	5.028902324385547
STTYPE III	5.028902324385547
PY967 CELL	5.028902324385547
BLAST LIST	5.028902324385547
NON-RODENT	5.028902324385547
ANTI-LAMIN	5.028902324385547
FASTA FILE	5.028902324385547
EARLY-BORN	5.028902324385547
CAUDAL FIN	5.028902324385547
ANTAGONISM	5.028902324385547
GAD1 PROBE	5.028902324385547
EE EPITOPE	5.028902324385547
microarray	5.028902324385547
WOUND SCAB	5.028902324385547
CCAF-INDUCED FN ACCUMULATION POSSIBLE MECHANISM	5.028845786064624
BIOTINYLATED GOAT ANTI-MOUSE SECONDARY ANTIBODY	5.028664377280692
PRIMARY MOTOR NEURON LATERAL INHIBITION PATTERN	5.027599122275165
SERUM         RESPONSE ELEMENT MAXIMAL INDUCTION	5.027035389105349
DIAGNOSTIC TEST DEVELOPMENT OVARIAN CANCER OPTIMUM	5.0266074172391795
COMPUTATIONAL IMPLEMENTATION BINARY ENVIRONMENT	5.026519051345105
MHC KINASE	5.026139347506379
TARGETING DOMAIN RAB24 C-TERMINAL HYPERVARIABLE	5.025455636398887
MULTIPLE NON-MUSCLE MYOSIN MILLIMOLAR INHIBITOR	5.024829527883033
DT RECEPTOR	5.0244355428278595
P53 TARGET	5.024138254617148
STRAND RNA	5.024004834630464
CALLED RNA	5.024004834630464
ALM NEURON	5.021838358866885
CD8 T CELL	5.020661031280442
IONIC	5.019716279238355
PRACTICAL IMPLEMENTATION PERFORMANCE COMPARISON	5.019566875240953
COMPUTATIONAL COMPARISON PERFORMANCE COMPARISON	5.019566875240953
PHOSPHORYLATION REACTION	5.019539022025595
QUASI TEST	5.01901277265942
DECREASED UBIQUITYLATION NORTHERN BLOT ANALYSIS	5.018581428605861
BINDING MOLEGOS FORM INDIVIDUAL Β-STRAND METAL ION	5.018499539176835
TRITONX-100	5.018286135499831
progression	5.018286135499831
DESCRIPTION	5.018286135499831
MULTIPLE COMPONENT ACTIVATED PROTEIN EXPRESSION	5.01824333230564
P53-POSITIVE EPITHELIAL CELLS/TOTAL EPITHELIAL	5.017540752815669
BACK PROPAGATION           NN PREDICTION ERROR	5.017540752815669
GENE FUNCTION CATEGORIZATION SUBJECTIVE NATURE	5.017540752815669
BACTERIAL HYDROXYNEUROSPORENE METHYLTRANSFERAS	5.017540752815669
UNIVERSAL SEQUENCE MAPS BOOLEAN IMPLEMENTATION	5.017540752815669
GENERATING TRANSGENIC MOUSE TRADITIONAL METHOD	5.017540752815669
INDUCED NORMAL GFP-BLM CELL LINE SCE FREQUENCY	5.017540752815669
PHILLIPS CM10 TRANSMISSION ELECTRON MICROSCOPE	5.017540752815669
INDEPENDENT UNIDIRECTIONAL SIMILARITY ESTIMATE	5.017540752815669
MOUSE IRIDOCORNEAL ANGLE DEVELOPMENTAL PROFILE	5.017540752815669
SYNTHETIC FOOT-AND-MOUTH DISEASE VIRUS VACCINE	5.017540752815669
MOUSE NOCTURNIN WIDESPREAD RHYTHMIC EXPRESSION	5.017178680692445
DOTMAC-INSOLUBLE MATERIAL BIOCHEMICAL ANALYSIS	5.016708418612878
MORPHOGENETIC CELL MOVEMENT EXPERIMENTAL STUDY	5.01616599281549
CELL ASSAY	5.0161444507175
INTEGRIN DEPENDENT ACTIN STRESS FIBER FORMATION	5.016011192509421
MODEL SYSTEM	5.015978201166697
transmission	5.015978201166697
GFP SIGNAL	5.015725971227557
GLB BUFFER	5.015469209628747
SUBSTRATE DOMAIN TYROSINE PHOSPHORYLATION KINAS	5.0151764317613665
N-TERMINAL TRANSESTERIFICATION DOMAIN	5.015061293997393
RECONSTRUCTED MITOCHONDRIA VOLUME SEGMENTATION	5.014570028081242
INTERMEDIATE FILAMENT CYTOSKELETON COMPARTMENT	5.014155927057655
BUD GROWTH	5.013902481286296
HEPES-BUFFERED SYNTHETIC OVIDUCTAL FLUID MEDIUM	5.013471959949643
MOLECULAR TIME ESTIMATE INVOLVING DISTRIBUTION	5.013422808114677
CAS SD ACT	5.013357771536892
YIELDED INDEPENDENT GAL4-LTBP-3 FUSION PROTEIN	5.013357749889441
TRANSCRIPTION-INDEPENDENT PROLIFERATION ARREST	5.012886617398402
COUPLE AGONIST-ACTIVATED HEPTAHELICAL RECEPTOR	5.012684263684607
LYSOPHOPHATIDIC ACID INCREASED LEVEL OBSERVATION	5.011967059370261
SUBSTRATE DOMAIN LEAD TYROSINE PHOSPHORYLATION	5.010613795903633
TERMED GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR	5.01024503538697
PHOSPHOCREB PEPTIDE (SEQUENCE KRREILSRRPS(P)YR	5.00974778188443
BOI1-S-P-GFP LOCALIZATION PATTERN DISTRIBUTION	5.009529238605725
BMP-RESPONSIVE GENE TRANSCRIPTIONAL ACTIVATION	5.009146250718078
EUKARYOTIC TRANSLATION INITIATION FACTOR-3 COMPLEX	5.009067354169425
HIGH-ENERGY PHOSPHATE BOND ANAEROBIC CONDITION	5.008989614058583
PREVENTED DETACHMENT PHOSPHATE BUFFERED SALINE	5.008989614058583
MOUSE IRIDOCORNEAL ANGLE POSTNATAL DEVELOPMENT	5.008865082911636
PPP ENZYME	5.008332867414197
WG PLASMID	5.007101876746027
EXPERIMENTAL DATA COLLECTION ADDITIONAL DETAIL	5.006643265009383
EXPECTED SIZE PROTEIN TYROSINE PHOSPHORYLATION	5.0064307929774055
TRANSFORMING GROWTH FACTOR Β-BINDING PROTEIN-3	5.005898345172451
MORPHOLOGICAL CHANGE NORMAL INTEGRIN DEPENDENT	5.0055241433199855
BLM ALLELE	5.00500257438074
EXCESS DYE	5.00500257438074
DX2 ALLELE	5.00500257438074
GLUTATHIONE-S-TRANSFERASE (GST)-PULLDOWN ASSAY	5.004290545222024
CAUSED PLM TOUCH RECEPTOR NEURON AXONAL DEFECT	5.004022784242086
SELECTED BECAUSETHEY EXHIBIT INTERACTION EFFECT	5.003938498384516
TRANSFORMANT	5.003480058663315
ELECTROPHORESI	5.003424293608288
LYSOSOMAL OXIDATIVE BURST ACTIVITY DISTRIBUTION	5.003027846109123
BN	5.002424575218741
GREEN           FLUORESCENT PROTEIN C-TERMINUS	5.002338851835168
BACKGROUND HIGH-THROUGHPUT DNA SEQUENCING MAKE	5.0016127972502895
CHARACTERIZED CLONAL MOUSE ASTROCYTE CELL LINE	5.001352455712129
CORRESPONDING CODON-CODON EMISSION PROBABILITY	5.001352455712129
IRIDOCORNEAL ANGLE MESENCHYMAL DIFFERENTIATION	5.000408966003641
ENCODING TAG REPLICATION-DEFECTIVE RETROVIRUS	4.997556587986735
ARABIDOPSIS GENE GENERATED TRANSCRIPT PROFILE	4.997556587986735
AG-6730 TIME-LAPSE VIDEOCASSETTE RECORDER SVH	4.997556587986735
OPTIMAL SEQUENCE ALIGNMENT PROGRAMMING METHOD	4.997556587986735
CORRESPONDING PROBE PAIR PAIR-WISE COMPARISON	4.997556587986735
SEARCHFOR COMPLEX DISEASE SUSCEPTIBILITY GENE	4.997556587986735
UNIVERSAL SEQUENCE MAPS SPARSE IMPLEMENTATION	4.997556587986735
HL-60 CELL CYTOSKELETON-ASSOCIATED POPULATION	4.997556587986735
REFERENCE STRUCTURE DIAGRAM SCHEMATIC VERSION	4.997556587986735
AUTOPHAGOSOME-LYSOSOME PATHWAY BASAL ACTIVITY	4.997556587986735
GR-HSP90-HSP70-COMPLEX ASSEMBLY/STABILIZATION	4.997556587986735
BIOLOGICAL SEQUENCE CHAOS GAME REPRESENTATION	4.997556587986735
CONTAINING FIREFLY LUCIFERASE-CODING SEQUENCE	4.997556587986735
ADISEASE-DETECTION METHOD WORST-CASE SCENARIO	4.997556587986735
INCLUDED LACTATE OPTIMAL METABOLIC BY-PRODUCT	4.997556587986735
ORIGINAL CGR REPRESENTATION BI-DIMENSIONALITY	4.997556587986735
COVARIATION-BASED COMPARATIVE STRUCTURE MODEL	4.997556587986735
ENHANCED WOX1-MEDIATED L929 CELL DEATH HYAL-2	4.997556587986735
RECOMBINATION EVENT RECONSTITUTING ADENO-RGS3	4.997556587986735
BASE PAIR INTERACTION HETEROGENEOUS COLLECTION	4.9972764515909835
DOWNREGULATE ISL1 EXPRESSION ALTERNATING CELL	4.997196484981764
COMPARATIVE RNA SEQUENCE/STRUCTURE INFORMATION	4.996874707760475
GLUCOCORTICOID         RECEPTORS TRANSLOCATION	4.996711055843282
SINGLE NUCLEOTIDE FREQUENCY	4.996671169603931
GROUP I/II INTRON SECONDARY STRUCTURE DIAGRAM	4.995493602340801
RESVERATROL-MEDIATED ENDOTHELIAL SHAPE CHANGE	4.995280117145883
ACTIN STRESS FIBER MORPHOLOGICAL PRESERVATION	4.995094720351642
LOCALIZATION TRANSMISSION ELECTRON MICROSCOPE	4.994708080883311
CONTAINING LYSOSOMAL PROTEAS AUTOPHAGIC VACUOLE	4.994334101834363
UNRAVELING TRANSCRIPTIONAL REGULATORY NETWORK	4.994327175863666
CYTOSKELETON AFFECTED ULTRASTRUCTURAL FEATURE	4.99419017050087
GLUCOCORTICOID         RECEPTORS LOCALIZATION	4.993758578515503
SHAPING RT QUASISPECIATION SELECTIVE PRESSURE	4.9934420777262325
STANDARD TRITON X-100 PERMEABILIZATION METHOD	4.992829278325733
BINDING CASSETTE CONSERVED N(T)KXD NUCLEOTIDE	4.992637394907758
OXIDATIVE ACTIVITY HETEROGENEOUS DISTRIBUTION	4.992437151257078
GENETIC PROGRAMMING NEURAL NETWORK DISADVANTAGE	4.992195164750891
PERMUTATION	4.992157155345753
BINDING AB	4.9921334782243045
INCLUDED CONTROL RNA TRANSCRIPT HYBRIDIZATION	4.99073047726079
CAS SUBSTRATE DOMAIN TYROSINE PHOSPHORYLATION	4.990667303119616
GNRH-STIMULATED INOSITOL TRISPHOSPHATE PRODUCTION	4.990654091030175
OCL IDENTIFICATION SENSITIVE HISTOLOGIC METHOD	4.9904621467515655
AFFYMETRIX HIGH-DENSITY OLIGO NUCLEOTIDE ARRAY	4.990254810561223
CHARACTERIZING MEASUREMENT VARIABILITY SUPPORT	4.990035231791096
IMMUNOFLUORESCENCE MICROSCOPY STANDARD METHOD	4.989733223406907
DNA CONTENT	4.9895236763245565
SMAD1           NUCLEAR INTERACTING PROTEIN-1	4.988739780285659
fold changes	4.988448216098337
INVOLVING ANDROGEN ADMINISTRATION RECENT STUDY	4.988241180311886
TGF-Β1-MEDIATED GROWTH SUPPRESSION PH-20 BLOCK	4.987884580693163
P53 DECREASED GSK3Β-DEPENDENT PHOSPHORYLATION	4.987745072209447
POLYPEPTIDE FRACTIONATION FUNCTIONAL SIGNIFICANCE	4.986454771954946
REGULATORY INFORMATION SERVER ARABIDOPSIS GENE	4.98544326717934
SCORING/PARSING ALGORITHM GENERAL DESCRIPTION	4.985261006547887
IMMUNOBLOTTING	4.984289202503428
SERUM         RESPONSE ELEMENT SERUM INDUCTION	4.983187095277333
adenovirus	4.983135182587495
TUMOR CELL	4.983135182587495
HUNTSVILLE	4.983135182587495
identifier	4.983135182587495
CONGRUENCY	4.983135182587495
CELL SHAPE	4.983135182587495
INPUT DATA	4.983135182587495
MUTATIONAL	4.983135182587495
CHAIN GENE	4.983135182587495
LIPOFECTIN	4.983135182587495
intergenic	4.983135182587495
TIME LAPSE	4.983135182587495
NUCLEIC ACID SEQUENCE INFORMATION DETERMINATION	4.981016351330847
CIS-REGULATORY ELEMENT ANNOTATION INFORMATION	4.980797052658398
GUANINE NUCLEOTIDE RAS-RELATED GTPAS AFFINITY	4.978858569849333
AFFECTING HIV QUASISPECIATION SELECTIVE FORCE	4.9782362789374215
CONTAINING GFP-BLM POOLED MACROPREP Q FRACTION	4.978188713515194
INCLUDING CASPASE ACTIVATION MULTIPLE PATHWAY	4.977735926292909
ADULT SIZE	4.977688574375246
ANTIANDROGEN CYPROTERONE ACETATE MOLAR EXCESS	4.977636683139339
CONTAINING DELETION ALLELE INDUCIBLE CELL LINE	4.977204912532682
USM COORDINATE FLOATING POINT REPRESENTATION	4.977142623391165
CHAOS GAME REPRESENTATION ITERATIVE FUNCTION	4.977142623391165
PROFILING TECHNOLOGY MASSIVELY-PARALLEL GENE	4.977142623391165
ANALYZABLE POSITION AVERAGE NEGATIVE ENTROPY	4.977142623391165
PHYLOGENETIC GROUP/CELL LOCATION COMBINATION	4.977142623391165
INFORMATIVE GENE MARKER WEIGHTED COMBINATION	4.977142623391165
JUXTANUCLEAR GOLGI-LIKE FLUORESCENCE PATTERN	4.977142623391165
EMBEDDING MEDIUM OPTIMAL CUTTING TEMPERATURE	4.977142623391165
P27 DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI	4.977142623391165
TRYPSIN-STIMULATED PHOSPHOHYDROLASE ACTIVITY	4.977142623391165
GENETIC DISORDER RECESSIVE PLEIOTROPIC HUMAN	4.977142623391165
SENSITIVE MITOTRACKER RED MEMBRANE POTENTIAL	4.977142623391165
AVERAGE ALM POSITION CORRELATION COEFFICIENT	4.977142623391165
PHOSPHATASE-CONJUGATED GOAT ANTI-CHICKEN IGY	4.977142623391165
BACKGROUND PLASMINOGEN ACTIVATOR INHIBITOR-1	4.977142623391165
DENSITY-DEPENDENT REDUCTION INTAG EXPRESSION	4.97669500897009
AFFYMETRIX GENE EXPRESSION ANALYSIS SOFTWARE	4.976125984974298
BI-DIRECTIONAL OVER-DETERMINATION PROBABILITY	4.976089577931942
MICROARRAY EXPRESSION DATA	4.976054016852352
FILAMENT ASSEMBLY LEVEL REGULATING MYOSIN II	4.975919243112968
APE1 CONTROL SPECIFICITY MOLEGOS DISTINCTIVE	4.975883691891209
GENE EXPRESSION POST-TRANSCRIPTIONAL CONTROL	4.975121344595145
IN SITU HYBRIDIZATION DATA	4.97507211075435
SECONDARY STRUCTURE DIAGRAM RETRIEVAL MULTIPLE	4.974892819519728
ELECTRON MICROSCOPY MOUSE LIVER MITOCHONDRIA	4.97479217149497
GENE EXPRESSION ANALYSIS COMPARING ALGORITHM	4.974681916489055
INDUCED ACTIN POLYMERIZATION CHEMOATTRACTANT	4.974082478263155
ACTIN MICROFILAMENT LATRUNCULIN B DEPOLYMERIZ	4.973934381869061
ENDOTHELIAL CELL CYTOSKELETON REORGANIZATION	4.973795010084464
RAB24 PUTATIVE DOMINANT-NEGATIVE MUTANT FORM	4.972846519647565
MUTANT METABOLIC NETWORK OPTIMAL UTILIZATION	4.972846519647565
RNA STRUCTURE ANALYSIS PHYLOGENETIC ANALYSIS	4.9728071897644535
III1-C RECOMBINANT PROTEIN PRODUCTION PROTEIN	4.9724675102849085
E3 LIGAS REGULATING SUBCELLULAR LOCALIZATION	4.972025676004247
CCAAT/ENHANCER         BINDING PROTEIN ALPHA	4.971971354152024
LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN FAMILY	4.971971354152024
ATTRACTING NON-PHYSIOLOGICAL PROTEIN PARTNER	4.971971354152024
CASPASE GENE EXPRESSION REGULATORY MECHANISM	4.971763111894253
ACTIN LEADING EDGE COMPONENT DE-LOCALIZATION	4.971242281066222
PEROXIDASE IMMUNOHISTOCHEMISTRY BIOPSY SAMPLE	4.971106164883508
CONTAINING HOMOLOGOUS GENE SEQUENCE ALIGNMENT	4.970787485087084
REGULATORY SEQUENCE ENDOGENOUS TRANSCRIPTION	4.970764376328743
REGULATORY GENE CELL CYCLE	4.969921656230728
REPLACEMENT MUTATION TESTED INDIVIDUAL CODON	4.9692518205967975
REVEALED BRDU-POSITIVE CELL WILD-TYPE EMBRYO	4.9692518205967975
BOI1-P-GFP LOCALIZATION PATTERN DISTRIBUTION	4.969219187003769
DIFFERENTIAL INTERFERENCE-CONTRAST MICROSCOPY	4.96879496286478
L929 FIBROBLAST HYAL-2-INCREASED TNF KILLING	4.9686393457329245
GLUCOCORTICOID RECEPTOR NUCLEAR TRANSLOCATION	4.968372391550107
AZ ABILITY	4.967511350383299
NON-IONIC DETERGENT TREATMENT CAUSES REMOVAL	4.9666309468115255
CDNA ARRAY	4.966483460422976
RGS3 FUNCTIONAL PROTEIN DOMAIN IDENTIFICATION	4.966464994308036
SRF DEPENDENT TRANSCRIPTION MAXIMAL INDUCTION	4.966127797593431
STRUCTURE CONSERVATION DIAGRAMS CONSERVATION	4.966095499479051
RESTRICTION	4.965966563277056
EXCESSIVE INTRAOCULAR MACROPHAGE RECRUITMENT	4.965870047970641
HUMAN HEPARIN-BINDING EGF-LIKE GROWTH FACTOR	4.965628211266342
CONSERVED PROTEIN-PROTEIN INTERACTION DOMAIN	4.965562828934022
D. DISCOIDEUM MYOSIN II ENZYME PHOSPHORYLATE	4.9653550535795254
PROXIMAL GENE BASAL TRANSCRIPTIONAL APPARATUS	4.965348584412666
CONTAINING PROTEASE INHIBITOR MM RIPA BUFFER	4.9653337279888845
CO-IMMUNOPRECIPITATION EXPERIMENT	4.965187539869177
UNDERGOING SUICIDE DENDRITIC           CELLS	4.964297130470102
PP5 ACTING	4.963721188008799
REPORTER GENE DEPENDENT MAKING TRANSCRIPTION	4.963021042793898
LANGERHAN IG-RELATED MOLECULE CHARACTERISTIC	4.962888269956179
SQ	4.962424575218741
MULTIPLE PROTEIN DYNAMIC PML-DEPENDENT DEPOT	4.962389753189412
DIFFERING BASE COMPOSITION SPURIOUS ARTIFACT	4.9619052110985935
HIGH         DENSITY LIPOPROTEIN	4.9616512881761805
OPPOSITE UNIDIRECTIONAL COMPARISON EXPRESSION	4.960880879763058
AFFYMETRIX GENECHIP EXPRESSION ANALYSIS MANUAL	4.960663188323001
MULTIPLE CYTOPLASMIC PROTEASOMAL DEGRADATION	4.960504779295153
GENERAL PRIMARY SEQUENCE ALIGNMENT ALGORITHM	4.960483516025423
BIOCHEMICAL SUBCELLULAR FRACTIONATION METHOD	4.959770130142276
MATCH-ONLY INTEGRAL DISTRIBUTION PRIMARY GOAL	4.959613479134233
ECTOCERVIX EXHIBIT STAGE-SPECIFIC INTERACTION	4.95894772407499
RATE CONSTANT	4.958499785156619
MYOSIN II HEAVY CHAIN KINASE CO-LOCALIZATION	4.958489891767448
PC VESICLE	4.957203074371124
TRANSFECTED 3T3 CELL REPRESENTATIVE PHOTOGRAPH	4.9569075809206256
FLAG-MHCK-C AUTOPHOSPHORYLATION STOICHIOMETRY	4.956411485381715
REPLACEMENT MUTATION OBSERVED OVERABUNDANCE	4.95627996449823
WOUNDING EXPERIMENT FULL-THICKNESS EXCISION	4.95627996449823
DIVERGENCE TIME ESTIMATE PUBLISHED DATA SET	4.95627996449823
CHROMOGENIC PLASMINOGEN ACTIVATOR SUBSTRATE	4.95627996449823
ASPARAGINE CLOSTRIDIUM BOTULINUM RIBOSYLATE	4.95627996449823
SECONDARY STRUCTURE ELEMENT CHANGING LENGTH	4.95627996449823
YIELDED RATIO IMAGE CORRECTED NLS-GFP IMAGE	4.95627996449823
INTERNAL REFLECTION FLUORESCENCE MICROSCOPY	4.95627996449823
MICROTUBULE POLYMERIZATION/DEPOLYMERIZATION	4.95627996449823
MOUSE NEONATAL SUBMANDIBULAR SALIVARY GLAND	4.95627996449823
GENETIC PROGRAMMING NEURAL NETWORK THEPOWER	4.95627996449823
OXYBURST FLUOROPHORE FLUORESCENCE INTENSITY	4.95627996449823
SECONDARY STRUCTURE DIAGRAM STANDARD FORMAT	4.95627996449823
HIGH-THROUGHPUT YEAST TWO-HYBRID EXPERIMENT	4.95627996449823
ENHANCED CHEMILUMINESCENCE DETECTION SYSTEM	4.95627996449823
SUPPLEMENTARY WEBSITE SUPPLEMENTARY WEBSITE	4.95627996449823
PRESUMPTIVE RADIAL GLIA CELL REDUCED NUMBER	4.95627996449823
SUSPENDED HL-60 PROMYELOCYTIC LEUKEMIA CELL	4.95627996449823
CCAAT/ENHANCER BINDING         PROTEIN-BETA	4.95627996449823
SUBMEMBRANOUS CYTOSKELETON INTEGRAL COMPONENT	4.956186473101845
NEAREST CONTACT SITE EXPERIMENTAL MEAN VALUE	4.956186019763848
NEIGHBORING GENE FALL BLASTODERM EXPRESSION	4.955923928641094
CIRCADIAN RHYTHM MOLECULAR-GENETIC ANALYSIS	4.9554615065107
PAIRWISE RNA SECONDARY STRUCTURE INTERACTION	4.955458640373974
SUCROSE GRADIENT	4.954949921412105
STATISTICAL CHARACTERISTIC SIMULATION STUDY	4.954590163545514
GENE EXPRESSION STUDY QUANTITATIVE STANDARD	4.95457208787892
EXPRESSING TAG MOLONEY SARCOMA VIRUS VECTOR	4.954211469923342
EXTRACELLULAR DOMAIN HEPARIN-BINDING REGION	4.9538282443659405
mutant	4.953740049948984
N-TERMINAL TRANSCRIPTIONAL ACTIVATION DOMAIN	4.95373691992481
PERIPHERAL NERVE-LIKE REGENERATIVE RESPONSE	4.9534922218097375
RENAL CELL CARCINOMA RNA EXPRESSION PROFILE	4.953482424099829
SIGNALING PATHWAY MULTIPLE PHOSPHATIDYLINOSITOL	4.953440178034078
NONCODING RNA GENE COMPUTATIONAL GENEFINDER	4.953278951877285
CONSERVED RNA SECONDARY STRUCTURES FUNCTION	4.953278951877285
WG EXPRESSION PLASMID TRANSIENT TRANSFECTION	4.952910613291309
USING FLOW CYTOMETRY MEMBRANE MICROPARTICLE	4.952135169708548
LIGAND-ACTIVATED TRANSCRIPTIONAL STIMULATOR	4.952022714035959
BINDING DOMAIN CONSERVED GUANINE NUCLEOTIDE	4.951416330759783
CASPASE-3 CYTOCHROME C-DEPENDENT ACTIVATION	4.951218348741245
OBSERVED NORMAL LIGAND-DEPENDENT TRANSLOCATION	4.951146093716186
CYTOSKELETON PRODUCES CHANGE REORGANIZATION	4.950700809216563
MATURATION/MEIOSIS/MITOSIS-PROMOTING FACTOR	4.950637649673234
SIGNALING COMPONENT TEMPORAL CO-LOCALIZATION	4.94881185384753
FILAMENTOUS ACTIN RHOA DEPENDENT RETRACTION	4.948766731690352
TYR	4.948699760038454
RECEPTOR PHOSPHORYLATE INTRACELLULAR REGION	4.947867451261123
CRITICAL SUBSTRATE TYROSINE PHOSPHORYLATION	4.947765621348971
TRANSCRIPTION FACTOR MULTI-TIERED HIERARCHY	4.947117175334774
signal transduction pathway	4.94674934093746
ASSISTED LASER INACTIVATION SAW CHROMOPHORE	4.946516670104755
PRECURSOR	4.946310014350922
CEES SHOW	4.946310014350922
INHIBITOR	4.946310014350922
RATIONALE	4.946310014350922
MICE SHOW	4.946310014350922
MATP NODE	4.946310014350922
HYPOCOTYL	4.946310014350922
EUMETAZOA	4.946310014350922
CDNA/CRNA	4.946310014350922
PRONUCLEI	4.946310014350922
SEQUENCER	4.946310014350922
GENOTOXIC	4.946310014350922
PIGMENTED	4.946310014350922
PRESENTIN	4.946310014350922
CRE MOUSE	4.946310014350922
POSTERIAD	4.946310014350922
HUMAN EST	4.946310014350922
AVIAN OCL	4.946310014350922
lakewater	4.946310014350922
BILATERIA	4.946310014350922
AGGRESOME	4.946310014350922
BIOMARKER	4.946310014350922
OTHER DMD	4.946310014350922
FIBRILLIN	4.946310014350922
MACROPREP	4.946310014350922
MATΑ URA3	4.946310014350922
PROPIDIUM	4.946310014350922
CHR TUMOR	4.946310014350922
GENE DATA	4.946310014350922
RESCANNED	4.946310014350922
FLAG-N280	4.946310014350922
ROOT NODE	4.946310014350922
PSALEOTPA	4.946310014350922
W303 CELL	4.946310014350922
OTHER ECM	4.946310014350922
monocytes	4.946310014350922
GENE NAME	4.946310014350922
BOI1 BIND	4.946310014350922
CERVISEAE	4.946310014350922
CMV-ELK-1	4.946310014350922
LAG PHASE	4.946310014350922
GROUP_SEQ	4.946310014350922
III/ECORV	4.946310014350922
U/ML RTNF	4.946310014350922
P81 PAPER	4.946310014350922
HALF-MOON	4.946310014350922
CUTANEOUS	4.946310014350922
MESANGIAL	4.946310014350922
ASCI SITE	4.946310014350922
BRYOPHYTA	4.946310014350922
REFOLDING	4.946310014350922
WOUND BED	4.946310014350922
NN METHOD	4.946310014350922
RBI/SIGMA	4.946310014350922
FUTURE TM	4.946310014350922
SUCCINATE	4.946310014350922
HYPERFILM	4.946310014350922
ECORI CUT	4.946310014350922
TETRAPODA	4.946310014350922
NEO LOCUS	4.946310014350922
AUTOPHAGY	4.946310014350922
OPERCULAR	4.946310014350922
MATL NODE	4.946310014350922
VITELLINE	4.946310014350922
RPMI-1640	4.946310014350922
imidazole	4.946310014350922
endpoints	4.946310014350922
RHO GTPAS	4.946310014350922
COELOMATA	4.946310014350922
MECHANISM	4.946310014350922
SHORELINE	4.946310014350922
OTHER TCF	4.946310014350922
INFERENCE	4.946310014350922
SUBMENTAL	4.946310014350922
NOTI SITE	4.946310014350922
NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE	4.945769240868891
DISPLAYED MOTILITY MOCK-ELECTROPORATED CELL	4.945511625093662
GNRH-STIMULATED LH SECRETION PITUITARY CELL	4.945431859616591
C/EBPΑ-REGULATED TRANSCRIPTIONAL ACTIVATION	4.945273893026645
TESTICULAR PH-20-INCREASED TNF CYTOTOXICITY	4.945046628619374
SPECIFIEDBY NONLINEAR GENE-GENE INTERACTION	4.944766645638
PLM TOUCH RECEPTOR AXON DISRUPTED EXTENSION	4.944379054406805
RRNA SITE	4.94367926787287
REGULATORY MODULE GENOME-WIDE IDENTIFICATION	4.943666490324152
SRF DEPENDENT TRANSCRIPTION TRANSACTIVATION	4.9435893696301285
PROTEIN NUCLEASE AREA CLUSTAL-W MISALIGNMENT	4.943546610900881
DECREASED RESORPTION CELLULAR FUNCTIONAL BASIS	4.943074586139386
BMP-INDUCED TRANSCRIPTION RESPONSE REPRESSOR	4.94285343797211
TARGET PROTEASE SPECIFICITY SOLE DETERMINANT	4.942742117101399
CHLORTHALIDONE TREATMENT GROUP	4.942532444282827
TARTRATE-RESISTANT ACID         PHOSPHATASE	4.94239850327528
DROSOPHILA STAT TRANSCRIPTION FACTOR D-STAT	4.9417473028771965
P53 BLOCK	4.941712763030473
OTHER RNA	4.941584014871909
REGARDING POSSIBLE CROSS-PRODUCT RELATIONSHIP	4.9414496298889805
GENE EXPRESSION MEASUREMENT REPRODUCIBILITY	4.940992073470513
RECEPTOR-LIGAND PROTEIN-PROTEIN INTERACTION	4.94092887268459
chemokines	4.940824487089173
HALF LIFE	4.940132457889069
WORK FLOW	4.939782784881794
PROMEGA DUAL-LUCIFERASE REPORTER ASSAY SYSTEM	4.939748236470971
XNOC MRNA	4.939570861847082
MRNA BAND	4.939570861847082
PPT1 MRNA	4.939570861847082
BIOSYNTHETIC PRECURSOR PRODUCTION CAPABILITY	4.939560926834802
DNA POLYMERASE	4.939351580937899
HRM METHOD	4.939278261867519
TRANSFECTED CELL	4.939121452497146
RRNAS, EXTRACTION SUBCELLULAR FRACTIONATION	4.9390072007275165
CELL-TYPE DEPENDENT REGULATION	4.93822303757471
MAB F7-26	4.937551959620194
CONTAINING UNINFECTED SF9 CELL MICROTITER PLATE	4.936929176916819
VESICLE CO-SEDIMENTATION ASSAY YEAST CYTOSOL	4.936547682746675
MNOC CDNA	4.936472768042
SULFUR MUSTARD (BIS-2-(CHLOROETHYL)SULFIDE	4.934948442781042
GNRH RECEPTOR-EXPRESSING HETEROLOGOUS CELL	4.934948442781042
GENERATED USINGTHE HARDY-WEINBERG EQUATION	4.934948442781042
DETERMINING REGION IDENTIFYING SPECIFICITY	4.934948442781042
SPANNING ANTIGENIC SITE D SELECTED VARIANT	4.934948442781042
GLUCOSE-6-PHOSPHATE DEHYDROGENASE ZWF CODE	4.934948442781042
DUCHENNE MUSCULAR DYSTROPHY PATIENT SAMPLE	4.934948442781042
'-CTAGCACCATGGGCTGCACCGTGTCGGCCGAGGACAAG-3	4.934948442781042
GLUCOCORTICOID HORMONE-RESPONSIVE ELEMENTS	4.934948442781042
UNIVERSAL SEQUENCE MAPS ORIGINAL PROPONENT	4.934948442781042
DUAL COLOR IMMUNOHISTOCHEMISTRY EXPERIMENT	4.934948442781042
TERTIARY COVARIATION-BASED STRUCTURE MODEL	4.934948442781042
GLUCOCORTICOID HORMONE RESPONSIVE ELEMENTS	4.934948442781042
EXHIBITED FRAGMENTATION INTERMEDIATE LAYER	4.934948442781042
MITOCHONDRIAL PERMEABILITY TRANSITION PORE	4.934948442781042
INHIBITOR ACETYL-LEUCYL-LEUCYL-NORLEUCINAL	4.934948442781042
INTESTINAL EPITHELIUM BRUSHBORDER MEMBRANE	4.934948442781042
FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING	4.934948442781042
PROBE-SPECIFIC BACKGROUND SUBTRACTION MAS4	4.934948442781042
NUMERICAL REPRESENTATION SCALE-INDEPENDENT	4.934948442781042
VECTORIAL SECRETION INTRACELLULAR COMPONENT	4.934792334359158
GLYCERALDEHYDE 3 PHOSPHATE           DEHYDROGENASE	4.934654389861982
POMBE SCHIZOSACCHAROMYCE	4.934574078800909
HYGROMYCIN-RESISTANCE GENE EXPRESSION UNIT	4.934506025307895
SCE ASSAY	4.933998869800611
XENOPUS NOCTURNIN LEUCINE ZIPPER-LIKE DOMAIN	4.93395086072726
CONSERVATION RATIO STATISTICAL SIGNIFICANCE	4.933626070475871
HISTONE PHOSPHOPROTEIN SUBSTRATE PREPARATION	4.933535555317031
AVERAGE R	4.933497304652265
PROTEIN CONFORMATIONAL CHANGE	4.933315404682741
GLUCOSE REPRESSIBLE ALCOHOL DEHYDROGENASE II	4.932954127742709
EXON TYPE	4.932743615846461
TRANSGENE INTEGRATION EVENT GENOMIC LOCATION	4.932667189459277
BACKGROUND EXPRESSION	4.9324668243178955
GENOMIC SEQUENCE CHAOS GAME REPRESENTATION	4.932348713438834
GIVING ORIGIN EXPOSED CYTOPLASMIC FILAMENT	4.932285305406098
GTPASE RHOA FIBRONECTIN IMMUNOLOCALIZATION	4.9318287675703925
RNA SEQUENCE FAMILY COMPUTATIONAL ANALYSIS	4.931314245876435
BIOLOGICAL SEQUENCE UNIVERSAL SEQUENCE MAP	4.931278236650866
INTERACTING PROTEIN RANK CANDIDATE PATHWAY	4.93085945947393
UNDERLYING SUBENDOTHELIAL MATRIX COMPONENT	4.930683261828983
METASTATIC	4.929907433350648
detachment	4.929907433350648
MYC-TAGGED	4.929907433350648
UNTRANSFORMED EXPRESSION DATA DISTRIBUTION	4.929474291097169
MEGABASE-SIZED GENOME INTENSIVE COMPARISON	4.92905696981129
MITOCHONDRIAL MEMBRANE DAMAGE HYAL-2 CAUSE	4.928429718460282
biases	4.927742539607726
ΜM III1-C	4.92770182471522
MINI-EDTA-FREE PROTEASE INHIBITOR COCKTAIL	4.9276692006228595
BINDING DOMAIN-SRF FUSION PROTEIN GAL4 DNA	4.927443123337636
UNDERSTANDING SMAD-REGULATED TRANSCRIPTION	4.926542851374364
CHROMOSOMAL	4.926233840935823
LIMITING TUMOR GROWTH EFFICACIOUS APPROACH	4.925811318733114
IN VITRO GST-P35-C/EBPΒ C/EBPΒ INTERACTION	4.925792163336787
NON-PROBE-SPECIFIC CROSS HYBRIDIZATION DATA	4.925700327939122
TUMOR GENE EXPRESSION PATTERN VISUALIZATION	4.92562404948893
C-TERMINAL DNA BINDING/DIMERIZATION DOMAIN	4.925552031072063
P53 TARGET GENE TRANSCRIPTIONAL ACTIVATION	4.925481761440398
CYCLIN D2	4.925343762116756
EXTRACELLULAR MATRIX COMPONENT FIBRONECTIN	4.925126340360012
ACTIVATING PEPTIDE HUMAN THROMBIN RECEPTOR	4.9250563280584965
SENSE ODN	4.9250212043900765
TABULAR DISPLAY TABLE NUCLEOTIDE FREQUENCY	4.92497523320812
REVERSE ANDROGEN-MEDIATED P27 ACCUMULATION	4.924900409127109
SERPIN BODY-PROTEASE BODY INTERACTIONS PLAY	4.924897946804918
BIOLOGICAL CHARACTERISTIC	4.924274502871988
PHASE-CONTRAST MICROSCOPE	4.924274502871988
RESULTING CELL SUSPENSION	4.924274502871988
REPRESENTATIVE	4.923260899247271
CONTAINING FRAGMENT N-TERMINAL RING FINGER	4.923005936115273
FOLD CHANGE/ABSOLUTE EXPRESSION CALCULATION	4.922550961517236
XNOC MAMMALIAN HOMOLOGUE INITIATED ANALYSIS	4.922514895382508
COMPUTATIONAL APPROACH	4.922498488894579
homozygous	4.922119298094797
DIVERGENCE	4.922119298094797
PHOSPHATAS	4.922119298094797
mismatches	4.922119298094797
epithelium	4.922119298094797
BINDING MOTIF CONSERVED N(T)KXD NUCLEOTIDE	4.922025474947942
CHARACTERIZING MUTATION MULTIPLE ALIGNMENT	4.921832691144677
THIAMINE PROGRESSIVE DEPLETION	4.9214907433144734
BINARY USM SYMBOL-PAIR DISTANCE CALCULATION	4.921363208391206
ANTI-PHOSPHORYLATED C-RAF(SER259) ANTIBODY	4.921257078220197
CONTROLLING TRANSLATION RIBOREGULATORY RNA	4.921109264269925
FALSE-POSITIVE PROTEIN-PROTEIN INTERACTION	4.919687977040617
CLASSIC EPITHELIAL-MESENCHYMAL INTERACTION	4.919687977040617
SHOWING P	4.918634561401823
SECONDARY STRUCTURE UNKNOWN TARGET SEQUENCE	4.918621543266255
ANTIHYPERTENSIVE	4.918460295897625
I0 ΜM ATP	4.918268705470003
MM SUCROSE	4.9180701200557655
UNITS/ML PENICILLIN/STREPTOMYCIN	4.918008837332121
FICOLL-HYPAQUE DENSITY GRADIENT CENTRIFUGATION	4.917710044291762
RETINOBLASTOMA FAMILY PROTEIN INACTIVATION	4.917705143383514
KINETIC CONSTANT STEADY-STATE	4.9171186707572065
QUANTIFICATION	4.916470041077547
RESIDUE DROSOPHILA RRP-1 N-TERMINAL REGION	4.915846025795749
FACILITATED CHARACTERIZATION SYNCHRONIZATION	4.915769712768309
ΜM P-AMIDINOPHENYLMETHANESULFONYL FLUORIDE	4.915371018883729
TRANSCRIPTIONAL REGULATOR	4.91486344214918
EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR	4.914430592650129
CARDIOPROTECTIVE PROPERTY RED WINE EXHIBIT	4.91374676659216
THYMIDINE KINASE PROMOTER	4.913730572655824
CANDIDATE NCRNA GENE COMPUTATIONAL SCREEN	4.913126498542794
CONCERNING VARIABILITY LINGERING QUESTION	4.913126498542794
IMMUNOGOLD ELECTRON MICROSCOPY MYC-TAGGED	4.913126498542794
TTGCACTGCTGCCGGGCTCGGCCCAGTCCCCGAGGGGACAA	4.913126498542794
AG-6730 TIME-LAPSE VIDEOCASSETTE RECORDER	4.913126498542794
UBIQUITIN-INDEPENDENT DEGRADATION PATHWAY	4.913126498542794
GENETIC PROGRAMMING NEURAL NETWORK OUTPUT	4.913126498542794
ZEISS AXIOPLAN EPIFLUORESCENCE MICROSCOPE	4.913126498542794
ENTERING EPITHELIUM MONOCYTE-DERIVED CELL	4.913126498542794
EMPIRICAL DIFFERENCE CALL DECISION MATRIX	4.913126498542794
IMMUNOHISTOCHEMISTRY RENAL CELL CARCINOMA	4.913126498542794
RING-FINGER TYPE UBIQUITINATION E3 LIGASE	4.913126498542794
REGULATORY MECHANISM POST-TRANSCRIPTIONAL	4.913126498542794
LATERAL INHIBITION COORDINATES TRANSITION	4.913126498542794
PROTEASOME-SPECIFIC INHIBITOR LACTACYSTIN	4.913126498542794
GLUCOSE-6-PHOSPHATE         DEHYDROGENASE	4.913126498542794
GLUCOCORTICOID HORMONE-RESPONSIVE ELEMENT	4.913126498542794
DEVELOPING METHOD-SPECIFIC IMPLEMENTATION	4.913126498542794
USM COORDINATE WORD LENGTH REPRESENTATION	4.913126498542794
CO-OPERATIVE PROPERTY MOLECULAR MECHANISM	4.913126498542794
COMPUTATIONAL METHOD DETAILED DESCRIPTION	4.913126498542794
FUNCTIONAL GENOMIC-DERIVED MOLECULAR DATA	4.913126498542794
TTGCACTGCTGCCGGGCTCGGCCCAGTCCCTGTGGGGACAA	4.913126498542794
CHEMOTACTIC DICTYOSTELIUM DISCOIDEUM CELL	4.913126498542794
PHOSPHATASE ACTIVITY PHOSPHATASE ACTIVITY	4.913126498542794
PAI-1 YIELD GDN-HCL ACTIVATABLE INHIBITOR	4.913126498542794
REGULATORY PROTEIN-LIKE MODULE COMPLEMENT	4.913126498542794
LEUKEMIC LGL CELL GENE EXPRESSION PROFILE	4.912833345395591
GLYOXYLATE BYPASS CONSTITUTIVE EXPRESSION	4.912686768821991
MITOGEN ACTIVATED PROTEIN KINASE ACTIVATION	4.912628329790975
HERPES SIMPLEX VIRUS THYMIDINE KINASE HNF	4.911732467777295
PH CHANGE	4.911512274708713
developments	4.911175095745041
ACTIN STRESS FIBER FLUORESCENCE INTENSITY	4.910721505853728
PGK PROMOTER RESULT CRE-MEDIATED DELETION	4.910557852505064
CONDITION-SPECIFIC GENE EXPRESSION CHANGE	4.910462889824163
MMCOP1 NUCLEAR IMPORT/LOCALIZATION SIGNALS	4.910225526487493
RNA SECONDARY STRUCTURE CONSENSUS PATTERN	4.910161326545688
RNA SECONDARY STRUCTURE ALIGNMENT PROBLEM	4.910161326545688
RESVERATROL-ELICITED MORPHOLOGICAL CHANGE	4.910161326545688
SMAD1 TRANSCRIPTIONAL REGULATORY ACTIVITY	4.90997169345285
SIGNALING PATHWAY WNT CANDIDATE COMPONENT	4.909735083071104
ALTERED EXPRESSION MAP TRANSCRIPTS EXHIBIT	4.9097226264834655
DLA DX2 MUTANT EMBRYO LONGITUDINAL DOMAIN	4.909609475090671
RECEPTOR LOCALIZATION STRIKING PERTURBATION	4.909460583028804
NON-PSEUDOKNOTTED RNA SECONDARY STRUCTURE	4.909420033546412
STANDARD DEVIATION	4.9092527951851626
LNCAP CELL PROLIFERATION ANDROGEN CONTROL	4.909176610665795
MOLECULAR WEIGHT MARKER PRECISION PROTEIN	4.909062356421074
CONTAINING HSP70 COMPLEX PROTEIN ASSEMBLY	4.909062356421074
RESPONSIVE TRANSCRIPTIONAL TRANSACTIVATOR	4.908920091756202
promoters	4.908672806858766
APOPTOSI CHARACTERISTIC MORPHOLOGIC CHANGE	4.9085541937325745
HIGH-DENSITY OLIGONUCLEOTIDE GENECHIP HTTP	4.908444535435863
ORIGINAL ROSA26 LACZ PROMOTER TRAP STRAIN	4.9084203503649215
GAL4-LUC INHIBITED BMP-INDUCED ACTIVATION	4.908125332870257
SRF-P35-C/EBPΒ INTERACTION RAS STIMULATION	4.908124412859844
CONTAINING ROSA26 GENOMIC SEQUENCE VECTOR	4.908090013903643
SΑ I2 INTRACELLULAR GOLGI/ER LOCALIZATION	4.908025496389281
SECONDARY STRUCTURE DIAGRAM REPRESENTATIVE	4.907651284687856
PROPIDIUM IODIDE-STAINED DNA FLUORESCENCE	4.907017090937704
GFP-COP1 SUBCELLULAR LOCALIZATION PATTERN	4.906842982697811
STOCK SOLUTION SPECTROFLUORIMETRIC ANALYSIS	4.906404163793486
DNA REPAIR	4.905692432974269
INTERSTITIAL COLLAGEN ELEVATED EXPRESSION	4.905639671737962
HIGH-THROUGHPUT DNA MICROARRAY TECHNOLOGY	4.9056328397247695
INHIBITED NB-ΚB ACTIVATION SN50 TREATMENT	4.905581882899653
IMMUNOFLUORESCENCE MICROSCOPY HEK293 CELL	4.9054838721277205
DECREASED GSK3Β-DEPENDENT PHOSPHORYLATION	4.905154025073993
BLOCK COLLAGEN-INDUCED AGGREGATION RESPONSE	4.905034694489181
DAMAGE MITOCHONDRIAL FUNCTION INDEPENDENT	4.905027595923834
MASS SPECTROMETRY	4.904644392232862
INCLUDING MAJOR HISTOCOMPATIBILITY COMPLEX	4.904618267121947
BOVINE EMBRYO EMBRYONIC GENOME ACTIVATION	4.904441020892791
DNA REPAIR PROTEIN MULTIFUNCTIONAL FAMILY	4.904174830337002
TRANSCRIPTION FACTOR COMBINATORIAL ACTION	4.904073139135627
TRANSCRIPTION FACTOR ENERGETIC PREFERENCE	4.904073139135627
MARGINAL ORTHOLOGY BOOTSTRAP VALUE EXHIBIT	4.904041110381249
PITUITARY PROGENITOR GHFT1-5 CELL S PHASE	4.903929439636518
POLYCLONAL ANTI-PROTEIN DISULFIDE ISOMERASE	4.9038961349640084
SINGLE LIVING CELL HOMOGENEOUS POPULATION	4.903540668061301
ZWF STRAIN PHENOTYPE PHASE PLANE ANALYSIS	4.903484098169245
SURROUNDING PEPTIDE CONFORMATIONAL CHANGE	4.903331087329101
GFP-LABELED PROTEIN CORTICAL DISTRIBUTION	4.903045155218108
RIBOSOMAL SUBUNIT	4.902911034119786
C. ELEGAN ACID CED8 TRANSMEMBRANE PROTEIN	4.902881874888814
DETAILED DESCRIPTION	4.902671864966218
UNDERLYING IRIDOCORNEAL ANGLE DEVELOPMENT	4.902590062125896
ANDROGEN CONTROL NORMAL BIPHASIC MECHANISM	4.902507375775709
THIAMINE INTRACELLULAR POOL	4.902092144970934
IDENTIFICATION SENSITIVE HISTOLOGIC METHOD	4.901860978425665
SIMPLE TRANSCRIPTION ACTIVATION MECHANISM	4.901859438234342
GHFT1-5 CELL PROLIFERATION S PHASE ARREST	4.901668495988726
MAMMALIAN MATCHMAKER TWO-HYBRID ASSAY KIT	4.901627485378566
GENETIC PROGRAMMING NEURAL NETWORK ABILITY	4.901596278710822
CYTOSOL ΜL	4.901469375511675
RNA SECONDARY STRUCTURE BRANCHING TOPOLOGY	4.900768394708075
BINDING MOTIF FUNCTION N(T)KXD NUCLEOTIDE	4.900282039672841
PREDICTED RNA MAXIMUM LIKELIHOOD LOCATION	4.899947181125072
DEVELOPING NEURON SPECIALIZED GROWTH CONE	4.8997680249706095
RABBIT POLYCLONAL ANTI-Β-COATOMER PROTEIN	4.899698221268026
RIBOSOMAL RNA COMPARATIVE STRUCTURE MODEL	4.8993087970362845
E. COLI DNA TOPOISOMERASE I	4.899232373929756
TARGETING DOMAIN C-TERMINAL HYPERVARIABLE	4.899044049536543
LACKING HELICASE ACTIVITY MISSENSE ALLELE	4.898656459196921
gene lists	4.898540051632051
phosphatase	4.898243263553182
NON-REDUNDANT PROTEIN-PROTEIN INTERACTION	4.897958742415045
REMOVE POSSIBLE GENOMIC DNA CONTAMINATION	4.897903230068812
QUANTITATIVE THREE-DIMENSIONAL EXAMINATION	4.8966366419485
CONTAINING PLASMID EXTRACHROMOSOMAL ARRAY	4.896627720572416
INFLUENCE OSTEOGENIC CELL DIFFERENTIATION	4.896481514632664
NONMUSCLE MYOSIN-II UBIQUITOUS REQUIREMENT	4.895952502647919
ACTIVATED PROTEIN KINASE CONSENSUS MITOGEN	4.8955798954347145
FUNCTIONAL SINGLE NUCLEOTIDE POLYMORPHISM	4.89513727528812
MEDIATED BIPARTITE NLS VARIANT RING FINGER	4.894508208568914
NORMAL HUMAN SKELETAL MUSCLE TISSUE SAMPLE	4.894508208568914
FINGER-LIKE DENDRITIC PROCESSES DEPENDENT	4.894234139738279
MEDIATED TRANSFORMATION ATTENUATING V-CRK	4.894197668003135
ETHANOL	4.894131477724352
BACKGROUND HIGH-THROUGHPUT DNA SEQUENCING	4.893782298853064
MACROMOLECULE INTRACELLULAR INCORPORATION	4.893569748514584
DIVERGENCE-MATCHED TRANSITION PROBABILITY	4.892155427027036
T. MARITIMA TOPOISOMERASE I	4.892151371312062
PB/IM INTERFACE EXHIBIT HLA-DR EXPRESSION	4.891701841932357
AUTOMATED ANNOTATION CONSENSUS DETECTION	4.890791049954233
TAILBUD MESENCHYMAL STEM CELL POPULATION	4.890791049954233
ANTIRESORPTIVE ACTION PARACRINE MEDIATOR	4.890791049954233
UTERINE ECTOCERVIX STRATIFIED EPITHELIUM	4.890791049954233
DEMONSTRATED SKP2-INDEPENDENT PROTEOLYSI	4.890791049954233
CHARACTERISTIC FILAMENTOUS ORNAMENTATION	4.890791049954233
FUNCTIONALLY-DESCRIPTIVE KERNEL DOCUMENT	4.890791049954233
BACKGROUND PLASMA MEMBRANE MICROPARTICLE	4.890791049954233
BOUNDED SCALE INDEPENDENT REPRESENTATION	4.890791049954233
BACKGROUND ARABIDOPSIS SEEDLINGS DISPLAY	4.890791049954233
DOTMAC/PFA-EXTRACTED CELL MICROEXTENSION	4.890791049954233
CANONICAL WNT/Β-CATENIN SIMPLIFIED MODEL	4.890791049954233
MEASURING LACTATE DEHYDROGENASE ACTIVITY	4.890791049954233
TARGETING SEQUENCE ENDOPLASMIC RETICULUM	4.890791049954233
ENVELOPE SURFACE GLYCOPROTEIN--THE MAJOR	4.890791049954233
glyceraldehyde-3-phosphate dehydrogenase	4.890791049954233
INTERACTIVE DOMAIN MAJOR PROTEIN-PROTEIN	4.890791049954233
IMAGING SYSTEM ZEISS AXIOCAM HRC DIGITAL	4.890791049954233
WITH/WITHOUT SECONDARY STRUCTURE DIAGRAM	4.890791049954233
DELTA-NOTCH SIGNALING GENETIC DISRUPTION	4.890791049954233
FUNDAMENTAL RELEVANCE BOOLEAN EQUIVALENT	4.890791049954233
GUI-BASED INTERACTIVE COMPUTATIONAL TOOL	4.890791049954233
PURDUE MACROMOLECULAR STRUCTURE FACILITY	4.890791049954233
GENERATEAPPROPRIATE NETWORK ARCHITECTURE	4.890791049954233
CORRESPONDING GENE FUNCTIONAL RELATEDNES	4.890791049954233
FITNESS-PROPORTIONATESELECTION TECHNIQUE	4.890791049954233
PROTEASOME-DEPENDENT DEGRADATIVE PATHWAY	4.890791049954233
ADAPTOR MOLECULE TYROSINE PHOSPHORYLATION	4.890710576977507
GENE EXPRESSION DATA PRINCIPAL PARAMETER	4.890441466977068
METABOLIC PROCESS COMPUTATIONAL ANALYSIS	4.889987425897187
MICROBIAL BIOGEOGRAPHY DETAILED ANALYSIS	4.889987425897187
CLASSICAL STEPWISE DISCRIMINANT ANALYSIS	4.889987425897187
MICROSCOPIC OBSERVATION SPECIMEN PREPARATION	4.88978456952648
MINING ALGORITHM BLASTP PROTEIN SIMILARITY	4.889727199863519
SINGLE NUCLEOTIDE           POLYMORPHISMS	4.889140867536564
PROGRAMMING SEQUENCE ALIGNMENT ALGORITHM	4.889028854718031
ENDOTHELIAL CELL SHAPE REVERSIBLE CHANGE	4.889023077028732
MITOCHONDRIAL MARCHANTIA POLYMORPHA RRNA	4.888740739147093
P21 INHIBITOR GENE PROMOTER TRANSCRIPTION	4.888521561095307
GENE DELETION CONDITION-DEPENDENT EFFECT	4.888446564118243
CONTAINING CELL LINE C-TERMINAL DELETION	4.88822327975291
CONTAINING RAB24 PCMV5 EXPRESSION VECTOR	4.888004261362252
RESVERATROL-INDUCED MORPHOLOGCIAL CHANGE	4.887844428411731
RAS-RAF-MAPK SIGNAL TRANSDUCTION PATHWAY	4.887300876865056
HERPES SIMPLEX THYMIDINE KINASE PROMOTER	4.88657610219961
PRE-ESTRADIOL TREATMENT ENDOSTEAL MARGIN	4.8863891581805365
MISFOLDED PROTEIN AUTOPHAGIC DEGRADATION	4.8857426544735745
NOVEL NCRNA E. COLI IN-DEPTH QRNA SCREEN	4.885655509551587
OTHER POTENTIAL DOMINANT-NEGATIVE MUTANT	4.885548519126532
SECONDARY STRUCTURE DIAGRAM CONSERVATION	4.8853987325314545
MAPPED CYTOPLASMIC LOCALIZATION SEQUENCE	4.88473776053967
DI-DEOXY CHAIN TERMINATION REACTION METHOD	4.8847052525463655
ENTERING INTERMEDIATE LAYERS SHOW T CELL	4.884592983951039
EXCISED SPECIMEN RADIOGRAPHIC EXAMINATION	4.88456721036015
LUCIFERASE GENE INCREASING TRANSCRIPTION	4.884564355470655
substitutions	4.884311174590777
PROTEOBACTERIA GAMMA SUBDIVISION E. COLI	4.883601293390528
TAKES PLACE BESTSOLUTION PERIODIC EXCHANGE	4.883565556958574
STIMULATED LH SECRETION CALCIUM IONOPHORE	4.883533986515003
TUMOR PROMOTER PHORBOL MYRISTATE ACETATE	4.883280020856872
NORMAL DIPLOID SMOOTH MUSCLE CELL GROWTH	4.883270384092617
TUMOR NECROSIS         FACTOR ACTIVATION	4.8830511460718755
ANDROGEN RECEPTOR TRANSCRIPTIONAL TARGET	4.8829670100131946
GENE-SPECIFIC TRANSCRIPTION PREREQUISITE	4.882488790642795
NN BINARY EXPRESSION TREE REPRESENTATION	4.882302119923817
INTRON DISTRIBUTION STATISTICAL ANALYSIS	4.882013471529524
EPITHELIAL CELL GROWTH TGF-Β1 INHIBITION	4.881766250920294
PRACTICAL IMPLEMENTATION PRESENTED CONSIDERATION	4.8811353536321525
BACKGROUND MAMMALIAN PROTEIN PHOSPHATASE	4.881053682801593
RELEASE CYTOSKELETON-ASSOCIATED COMPONENT	4.880477797360117
MITOCHONDRIAL CREATINE KINASE LOCALIZATION	4.880413710512251
EXTRACELLULAR MATRIX PROTEIN FIBRONECTIN	4.880254045668246
NF-ΚB ACTIVATION PHYSIOLOGICAL INHIBITOR	4.880145048542295
STIMULATED LH SECRETION CALCIUM IONPHORE	4.880139558748744
INCREASING TNF CYTOTOXICITY PH-20 EFFECT	4.880091669139075
INCLUDED TRANSCRIPTION ACTIVATION DOMAIN	4.879594477661643
MRNA BACKGROUND SUBCELLULAR LOCALIZATION	4.879294587271905
FIBROSARCOMA PAI-1 UPA COMPLEX FORMATION	4.878696132370431
RNASEP RNA STRUCTURAL PAIRWISE ALIGNMENT	4.878666015777213
PROMOTED FORMATION NAC FORCED EXPRESSION	4.878346549393265
GPNN MODEL DISADVANTAGE ISTHE INTERPRETATION	4.877718508182139
SCIENTIFIC ENDEAVOR EXPANDING COLLECTION	4.877639056240138
NORMAL TRANSMEMBRANE-DEPENDENT PH GRADIENT	4.877134620765054
LYSOSOMAL OXIDATIVE ACTIVITY MEASUREMENT	4.876217219081858
BIOSYNTHETIC PRECURSOR OPTIMAL PRODUCTION	4.876206801240932
KEY ROLE PROTEIN-PROTEIN INTERACTION PLAY	4.8758374565300295
GENERAL PATIENT POPULATION REPRESENTATIVE	4.875756939383053
HUMAN CARBOXYL ESTER LIPASE-LIKE PROTEIN	4.8756911696255445
FOCAL         ADHESION KINASE ACTIVATION	4.87557302990715
THERAPEUTIC INTERVENTION POTENTIAL TARGET	4.874367464580636
STANDARD TWO-HYBRID TECHNIQUE REQUIREMENT	4.874367464580636
EPITHELIAL CELL ADVANCED DIFFERENTIATION	4.8742501989641145
DENDRITIC           CELLS DIFFERENTIATION	4.874107559516258
MATCH ONLY INTEGRAL DISTRIBUTION ACCURACY	4.872228569890012
DNA HISTOGRAM CELL CYCLE SUBSET ANALYSIS	4.871916826490745
4 MORPHOLINEETHANESULFONIC	4.871697287691589
IMMUNOFLUORESCENCE CELL COMPOUND TREATMENT	4.8716202521760215
HOMOLOGOUS BZIP-TYPE TRANSCRIPTION FACTOR	4.871384797239831
PROMOTER ANNOTATION RELATIVE INFORMATION	4.871330406327341
NORTHERN BLOTTING NORTHERN BLOT ANALYSIS	4.870975466538717
E. COLI METABOLISM COMMON CHARACTERISTIC	4.870975379424998
ROBUST         PARAMETRIC MODE RECOMMENDATION	4.870594557091246
BOUND VO EQUATORIAL LIGAND	4.869762620194117
SIGNALING SPECIFICITY PRIMARY DETERMINANT	4.869672790578693
DETERMINING DIFFERENTIAL GENE EXPRESSION	4.869413032697713
PROTEASOME INHIBITOR LACTACYSTIN ADDITION	4.868595347549832
YOLK SYNCYTIAL LAYER EXTERNAL APPEARANCE	4.868086555542534
CATALYTIC SUBUNIT A-ATPASE	4.8680646505559775
5'CGCTAATGAAAGGAAGAGGAAAAAGATGCCAGCCTCC	4.86791734630821
CONFOCAL MICROSCOPY IMMUNOCYTOCHEMISTRY	4.86791734630821
AFFYMETRIX ARRAY RESULT REPRODUCIBILITY	4.86791734630821
PLACED ARR GENETIC EPISTASIS EXPERIMENT	4.86791734630821
CORTEXILLIN ACTIN-FILAMENT CROSSLINKING	4.86791734630821
CONFLICTING RESULT POSSIBLE EXPLANATION	4.86791734630821
BPNN AREUNIVERSAL FUNCTION APPROXIMATOR	4.86791734630821
AFFECTED SPECIFICATION DLA DX2 MUTATION	4.86791734630821
FIBROSARCOMA PAI-1 FUNCTIONAL STABILITY	4.86791734630821
MOUSE PITUITARY PROGENITOR GHFT1-5 CELL	4.86791734630821
INHIBITORY ACTIVITY(CONVERT TO LATENCY)	4.86791734630821
NEUTRAL SPHINGOMYELIN PHOSPHODIESTERASE	4.86791734630821
LOW-LIGHT LEVEL FLUORESCENCE MICROSCOPY	4.86791734630821
AUTOMATING NN ARCHITECTURE EXCELLENTWAY	4.86791734630821
PRESERVATION FIXATION/EXTRACTION METHOD	4.86791734630821
MOLECULAR BIOLOGY ESTABLISHED TECHNIQUE	4.86791734630821
'-CCGGCTTGTCCTCGGACACGGTGCAGCCCATGGTG-3	4.86791734630821
GPNN ALLOWSOPTIMAL NETWORK ARCHITECTURE	4.86791734630821
SPURIOUS SECONDARY STRUCTURE PREDICTION	4.86791734630821
EMPIRICAL ABSOLUTE CALL DECISION MATRIX	4.86791734630821
RODAMINE-CONJUGATED GOAT ANTI-MOUSE IGG	4.86791734630821
SIMULATED DATA CONTAININGFUNCTIONAL SNP	4.86791734630821
CONVENTIONAL IMMUNO-ELECTRON MICROSCOPY	4.86791734630821
PUTATIVE CINNAMYL-ALCOHOL DEHYDROGENASE	4.86791734630821
CALCULATED CROSS-VALIDATION CONSISTENCY	4.86791734630821
DIGITAL CAMERA HAMAMATSU MODEL C4742-95	4.86791734630821
SEGMENTED VOLUME GRAPHIC REPRESENTATION	4.86791734630821
MM OBLONG FULL-THICKNESS EXCISION WOUND	4.86791734630821
OPTIMAL SCFG-BASED STRUCTURAL ALIGNMENT	4.86791734630821
IN VITRO ELECTRON MICROSCOPY PHOTOGRAPH	4.86791734630821
PHOTOLITHOGRAPHIC FABRICATION TECHNIQUE	4.86791734630821
TOTAL ERK1 RELATIVE CHANGE QUANTIFICATION	4.867772845041619
INTRODUCED TAG TAG EXPRESSION POTENTIAL	4.867570017166906
MNOCIN BALB/C MOUSE RHYTHMIC EXPRESSION	4.867570017166906
EXPRESSION VALUE SYSTEMATIC VARIABILITY	4.867483184881579
DESCRIBING EXPRESSION ANALYTICAL METHOD	4.867483184881579
GENE EXPRESSION SPATIO-TEMPORAL PATTERN	4.867483184881579
MAMMALIAN CELL NEOPLASTIC TRANSFORMATION	4.867291668667907
BIFURCATION ANALYSIS SOFTWARE TOOL AUTO	4.867278591970849
ABSOLUTE ANALYSIS BIO-INFORMATIC METHOD	4.867118903386509
COMPARATIVE ANALYSIS UNDERLYING PREMISE	4.867118903386509
GTPΓ S-DEPENDENT TRYPSIN PROTECTION ASSAY	4.867001019987357
RESULTING CHIMERIC MOUSE	4.866734740824071
INTERPRETING AFFYMETRIX MICROARRAY DATA	4.8665506238580525
IN SILICO GENE DELETION SYSTEMIC EFFECT	4.8663644326836835
SERINE/THREONINE PROTEIN PHOSPHATASE TYPE	4.866305822777551
REMAINING SERINE RESIDUE PHOSPHORYLATION	4.866254904371342
transitions	4.86618727875633
THROUGHPUT MICRO-ARRAY EXPRESSION STUDY	4.865834707341698
Y140	4.86552581198676
CURRENT COMPARATIVE RNA STRUCTURE MODEL	4.864989722261971
ACTIN POLYMERIZATION NEGATIVE REGULATOR	4.864949173452466
PRE-FORMED ACTIN FILAMENT REARRANGEMENT	4.864949173452466
STEROID-RESPONSIVE GENE PROMOTER REGION	4.864747197193052
ECTOCERVIX EXHIBIT STRATIFIED EPITHELIUM	4.864614751785404
EXHIBIT FRAGMENTATION INTERMEDIATE LAYER	4.864614751785404
SPARC-NULL EMBRYONIC FIBROBLASTS EXHIBIT	4.864614751785404
TRANSIENT EPITHELIAL CELL PROLIFERATION	4.864568876305324
TGF-Β1-MEDIATED L929 CELL PROLIFERATION	4.864568876305324
GEL FILTRATION CHROMATOGRAPHY SUBCELLULAR	4.864539699705003
NEURAL PRECURSOR CELL DLA MUTANT EMBRYO	4.8644448588978095
SIGNALING PATHWAYS FALL TYROSINE KINASE	4.86434370076049
BINDING DOMAIN ISOLATED C/EBPΑ BZIP DNA	4.863895983493417
REPRESENTATIVE CONFOCAL MICROSCOPY FIELD	4.863829462840339
CRW SITE CONSERVATION DIAGRAM INTERFACE	4.863631304704516
TRANSIENT TRANSFECTION	4.863540231600979
UNDERSTANDING TRANSCRIPTIONAL REGULATION	4.863418195820097
ALIGNED GENOME AVERAGE PERCENT IDENTITY	4.8632921215560225
ETHANOL-WATER-ACETIC ACID	4.8631801180179925
SMAD1 TRANSCRIPTIONAL MODULATOR FUNCTION	4.863145447945272
VOLTAGE DEPENDENT ANION CHANNEL OPENING	4.862962384916656
PHOSPHOGLYCERATE KINASE PROMOTER HSV-TK	4.862682629946571
NORMAL SV40-TRANSFORMED FIBROBLAST LINE	4.862478207217228
WHOLE GENOME STUDY COMPUTATIONAL METHOD	4.861973339524116
IMMUNOLOCALIZATION STUDY	4.861811150578045
HETEROGENEOUS FLUORESCENCE DISTRIBUTION	4.861333565042934
DECREASING P53 TRANSCRIPTIONAL ACTIVITY	4.861242655272557
UPREGULATE P53 TRANSCRIPTIONAL ACTIVITY	4.861242655272557
MULTIPROTEIN COMPLEX MAPK FAMILY MEMBER	4.861220406302437
OLIGODEOXYNUCLEOTIDE ANTISENSE SEQUENCE	4.860397975073659
ARABIDOPSIS           GENOME INITIATIVE	4.860208638387896
SMAD1 RECEPTOR-MEDIATED PHOSPHORYLATION	4.860045828211434
Q-WAVE MYOCARDIAL INFARCTION	4.85985148695448
ENDOGENOUS FAK TYROSINE PHOSPHORYLATION	4.859611218047458
PLAY KEY ROLE SMAD FAMILY PROTEIN SUBSET	4.859338419560953
TRANSCRIPTION FACTOR GENETIC DEFICIENCY	4.858978629523638
REAL-TIME         POLYMERASE CHAIN REACTION	4.858868079433463
EXOCRINE PANCREATIC CELL GOLGI MEMBRANE	4.85817634266345
AFFYMETRIX HIGH-DENSITY OLIGO NUCLEOTIDE	4.857860107759772
INDICATED ANTI-MOUSE SECONDARY ANTIBODY	4.857840445986045
MONOCLONAL ANTIBODY ANTI-HA ANTI-MAB414	4.857840445986045
REGULATORY ELEMENT SURFACTANT PROTEIN C	4.857781751811134
SHOWED LOCALIZATION KKTK MUTANT PROTEIN	4.857539713442184
BINARY EXPRESSION TREE REPRESENTATIONOF	4.857374596193622
TERNARY COMPLEX FORMATION	4.857090943351956
GAL4 DEPENDENT REPORTER TRANSACTIVATION	4.856982448104504
TWO-SAMPLE T TEST SIMULATED POWER CURVE	4.856832755953828
GROWTH POLARIZATION COORDINATED PROCESS	4.856709078516123
MUTANT BEHAVIOR IN SILICO REPRESENTATION	4.856500369909121
MACROPHAGE ACTIVATION LIPOPOLYSACCHARIDE	4.8564192889686115
BINDING SITE T7 RNA POLYMERASE PROMOTER	4.856406367113315
P53 TRANSCRIPTIONAL ACTIVITY ACTIVATION	4.8563048193236
TYROSINE-PHOSPHORYLATED PROTEIN FRACTION	4.856002269389953
TODETECT	4.8558403747221535
RGS-GAIP	4.8558403747221535
PANEL FN	4.8558403747221535
TRIMERIC	4.8558403747221535
P120 PKN	4.8558403747221535
THEPOWER	4.8558403747221535
NOMARSKI	4.8558403747221535
BRASSICA	4.8558403747221535
NIDOGEN1	4.8558403747221535
SMG CORT	4.8558403747221535
SEROTYPE	4.8558403747221535
PERIODIC	4.8558403747221535
BLOSUM62	4.8558403747221535
APURINIC	4.8558403747221535
BOI1(TK)	4.8558403747221535
MYOSINII	4.8558403747221535
inositol	4.8558403747221535
LH STORE	4.8558403747221535
ID ENTRY	4.8558403747221535
POXVIRUS	4.8558403747221535
MUTATING	4.8558403747221535
ISOGENIC	4.8558403747221535
MTT DATA	4.8558403747221535
MONENSIN	4.8558403747221535
MATHWORK	4.8558403747221535
METAZOAN	4.8558403747221535
TKT LINE	4.8558403747221535
CORIMBIA	4.8558403747221535
LH SURGE	4.8558403747221535
NEO GENE	4.8558403747221535
APOSTAIN	4.8558403747221535
EUTHERIA	4.8558403747221535
FIREWALL	4.8558403747221535
AX2 CELL	4.8558403747221535
NET FLUX	4.8558403747221535
drawings	4.8558403747221535
TAG LINE	4.8558403747221535
NFAT-GFP	4.8558403747221535
adapters	4.8558403747221535
hindlimb	4.8558403747221535
HTK LINE	4.8558403747221535
ANTI-TAG	4.8558403747221535
MOBYDICK	4.8558403747221535
MP COUNT	4.8558403747221535
SGAL-LEU	4.8558403747221535
NOTATION	4.8558403747221535
ANTI-P44	4.8558403747221535
CAS(5'SD	4.8558403747221535
OVERDOSE	4.8558403747221535
GFP-NFAT	4.8558403747221535
ARRESTIN	4.8558403747221535
WUBLASTN	4.8558403747221535
SDS/PAGE	4.8558403747221535
PKS-COP1	4.8558403747221535
GEOMETRY	4.8558403747221535
PARAXIAL	4.8558403747221535
MYOSINIC	4.8558403747221535
BANDPASS	4.8558403747221535
VIMENTIN	4.8558403747221535
GOLGI/ER	4.8558403747221535
CRANIATA	4.8558403747221535
NN INPUT	4.8558403747221535
BOI2-GFP	4.8558403747221535
ADJUVANT	4.8558403747221535
ATAXIN-1	4.8558403747221535
Q-BRIGHT	4.8558403747221535
PULLDOWN	4.8558403747221535
PIRIFORM	4.8558403747221535
DFZ2ΔCRD	4.8558403747221535
IGG FITC	4.8558403747221535
RGS3-GST	4.8558403747221535
C3 SCORE	4.8558403747221535
DOUNCING	4.8558403747221535
GAL4-LUC	4.8558403747221535
PAIR-HMM	4.8558403747221535
A PRIORI	4.8558403747221535
POLY-GLN	4.8558403747221535
FN LEVEL	4.8558403747221535
PODOSOME	4.8558403747221535
OVER-FIT	4.8558403747221535
IN-FRAME	4.8558403747221535
CHORDATA	4.8558403747221535
MKHB-EGF	4.8558403747221535
CAS(3'SD	4.8558403747221535
P2 SIGNAL	4.855345995252449
GESTATION	4.855206266799121
sepharose	4.855206266799121
PELLETING	4.855206266799121
estimates	4.855206266799121
DYNAMICAL	4.855206266799121
INVARIANT	4.855206266799121
PROLACTIN	4.855206266799121
CELL-CELL	4.855206266799121
CONSTRAST	4.855206266799121
EUKARYOTIC DNA REPLICATION	4.855040544633258
EXPRESSING NORMAL TRANSFECTED CELL LINE	4.854994607804609
CELL CYCLE CONTRACTION FORCE REQUIREMENT	4.85481151539677
P53 ACTIVATION NON-DNA DAMAGE MECHANISM	4.854722132353393
INHIBITING GNRH-STIMULATED LH SECRETION	4.854688822840017
SUPPRESSED GNRH-STIMULATED LH SECRETION	4.854688822840017
MULTIPLE PARAMETER SENSITIVITY ANALYSIS	4.8542479075796185
SELECTED BECAUSETHEY EXHIBIT INTERACTION	4.853310103100333
MAMMALIAN BRAIN SUPRACHIASMATIC NUCLEUS	4.853275589276956
MITOCHONDRIA-SPECIFIC LIPID CARDIOLIPIN	4.853137892502367
OLIGONUCLEOTIDE GENECHIP	4.853058101251774
SUPERNATANT AMMONIUM SULFATE FRACTIONATION	4.853056968501483
INTEGRATING PROTEIN-PROTEIN INTERACTION	4.852941659363086
CAUSED PLM TOUCH RECEPTOR NEURON AXONAL	4.852788550685355
MYC	4.852339939860155
VECTOR V	4.852086783654484
METABOLIC PHENOTYPE CONDITION DEPENDENT	4.852041321668855
CAUSED FORMATION NEGATIVE DELTA PROTEIN	4.851887729312062
HUMAN APE1 TOTAL SEQUENCE DECOMPOSITION	4.85168234023361
ENDOTHELIAL CELL MONOLAYER DEGENERATION	4.85168234023361
TYPE P53	4.851425852336921
B Β-STRAND	4.851361324349833
DICTATE COMMON STRUCTURE PROTEIN FAMILY	4.851360156377027
MESENCHYMAL CELL ASSOCIATION INVESTIGATION	4.850648395728554
GLU351 NON-COGNATE PROTEASE SUBSTITUTION	4.8505871050878016
BIPHASIC	4.850249679494882
MONKEY CD9 ANTIGEN EXTRACELLULAR DOMAIN	4.849830192977256
ACTIN STRESS FIBER ORGANIZED PRODUCTION	4.849369066122882
HYDROXYPHOSPHORIBOSYL         TRANSFERASE	4.849288089663945
FINAL DRAFT OFTHE MANUSCRIPT PREPARATION	4.849030997732713
XNOC MRNA AMPLITUDE CIRCADIAN REGULATION	4.848707731092664
OLIGONUCLEOTIDE SEQUENCES REPRESENTATIVE	4.848697176055619
GFP GENE	4.8479310221152785
VEX1 GFP	4.8479310221152785
TOTAL PHENOTYPIC VARIANCE THEPROPORTION	4.84762358871496
MAB 33B6	4.847430430178135
DIVERGENCE-MATCHED EMISSION PROBABILITY	4.847211831314517
G PROTEIN REGARDING DEGRADATIVE PATHWAY	4.847205804996824
LIPOPOLYSACCHARIDE CEE CYTOTOXIC EFFECT	4.847205759315986
ERROR RATE	4.846877805926178
MOID USE	4.846482830792893
WOUNDED SPARC-NULL FIBROBLAST MONOLAYER	4.846243201142627
SDS-PAGE SAMPLE BUFFER	4.845238164076646
ACIDIC PHOSPHOLIPID BOI1 BIND PH DOMAIN	4.845039600946875
LYSOSOMAL MEMBRANE DIFFERING STABILITY	4.844478803152274
GAME REPRESENTATION ITERATIVE FUNCTION	4.844478803152274
METABOLIC NETWORK REGULATORY STRUCTURE	4.844478803152274
CRANIAL PARAXIAL MESODERM-DERIVED CELL	4.844478803152274
DORSAL CUTANEOUS BIOPSY FULL-THICKNESS	4.844478803152274
TRAFFICKING ACTIVITY NUMEROUS MEMBRANE	4.844478803152274
EXPRESSING MHC CLASS I EPITHELIAL CELL	4.844478803152274
UPREGULATE POSITIVE FEEDBACK MECHANISM	4.844478803152274
CELLULAR REARRANGEMENT PRODUCING FORCE	4.844478803152274
YIELDED INDEPENDENT GAL4-LTBP-3 FUSION	4.844478803152274
PROGRAMMING APPROACH EXPENSIVE DYNAMIC	4.844478803152274
FIBROSARCOMA PAI-1 INHIBITORY ACTIVITY	4.844478803152274
PROLIFERATING HL-60 PROMYELOCYTIC CELL	4.844478803152274
SUPERSIGNAL CHEMILUMINESCENT SUBSTRATE	4.844478803152274
ANTIAPOPTOTIC MATRIX INTER-Α-INHIBITOR	4.844478803152274
PROTEOMICS PROGRAM DATABANK MODEL RULE	4.844478803152274
MEASURED INTERPHASE CORTICAL STIFFNESS	4.844478803152274
MICROFILAMENT POLYMERIZATION INHIBITOR	4.844478803152274
EXPRESSING GFP-MHCK D. DISCOIDEUM CELL	4.844478803152274
LATERAL INHIBITION MOLECULAR MECHANISM	4.844478803152274
IN SILICO PTA METABOLIC CHARACTERISTIC	4.844478803152274
SENSITIVE FLUORESCENT DETECTION METHOD	4.844478803152274
COMPLEX MULTIGENEIC BIOLOGICAL PROCESS	4.844478803152274
RAB24 POTENTIAL DOMINANT-NEGATIVE FORM	4.844478803152274
UNDERLYING DYNAMICAL SYSTEM TRAJECTORY	4.844478803152274
PRESERVE MOESIN-ACTIN FILAMENT COMPLEX	4.844478803152274
CONTINUOUS DATA MODE ESTIMATION METHOD	4.844478803152274
HLA-DR DUAL COLOR IMMUNOHISTOCHEMISTRY	4.844478803152274
AUTOMATED AVIDIN-BIOTIN COMPLEX METHOD	4.844478803152274
ESTROGEN-STIMULATED PREOVULATORY SURGE	4.844478803152274
UNDERLYING ADENOSINE MOLECULAR NETWORK	4.844478803152274
STORM PHOSPHORLMAGER MOLECULAR DYNAMIC	4.844478803152274
CROSSBRIDGE LOAD-DEPENDENT RECRUITMENT	4.844478803152274
MEDIATED RECOMBINATION CRE RECOMBINASE	4.844478803152274
THY-1 GLYCOPROTEIN CARBOHYDRATE MOIETY	4.844478803152274
AFFECTING HA VARIATION SELECTIVE FORCE	4.844478803152274
SMAD1 OBSERVED PROTEASOMAL DEGRADATION	4.844478803152274
ZEISS AXIOSKOP FLUORESCENCE MICROSCOPE	4.844478803152274
CONVENTIONAL IMMUNOELECTRON MICROSCOPY	4.844478803152274
UNIVERSAL SEQUENCE MAPS IMPLEMENTATION	4.844478803152274
OSTEOSCLEROTIC ESTRADIOL-TREATED MOUSE	4.844478803152274
TRAFFICKING PATHWAY INCLUDING MEMBRANE	4.844478803152274
PROBLEM WHILEDECREASING SUSCEPTIBILITY	4.844478803152274
PROGRAMMING PROBLEM UNDERLYING DYNAMIC	4.844478803152274
PROBABILISTIC           NEURAL NETWORK	4.844478803152274
ZEISS AXIOPHOT FLUORESCENCE MICROSCOPE	4.844478803152274
REVERSE TRANSCRIPTASE SELECTED VARIANT	4.844478803152274
INTERESTING QUESTION LEPISOSTEUS RAISE	4.844478803152274
DIVIDING DICTYOSTELIUM DISCOIDEUM CELL	4.844478803152274
IMMORTALIZED HUMAN TRACHEAL EPITHELIAL	4.844478803152274
RECOMBINATION EVENT ELEVATED FREQUENCY	4.844478803152274
ANTIGENIC SITE D TRIMER-BURIED PORTION	4.844478803152274
PROGRESSIVE NEURODEGENERATIVE DISORDER	4.844478803152274
PITUITARY PROGENITOR GHFT1-5 CELL LINE	4.844478803152274
MM ISOPROPYL-Β-D-THIOGALACTOPYRANOSIDE	4.844478803152274
POST-TRANSFECTION CELL SYNCHRONIZATION	4.844478803152274
SN50-AND MSN50 PEPTIDE-TREATED EXPLANT	4.844478803152274
MNOC EXPRESSION ENDOGENOUS RHYTHMICITY	4.8440475285902895
FLAG-MHCK-C INCREASED EXPRESSION LEVEL	4.8440475285902895
COMPARATIVE SEQUENCE ANALYSIS PARADIGM	4.843685669308029
COVARIATION ANALYSIS METHODS ASSOCIATE	4.843685669308029
DEVELOPMENTAL PROGRAM	4.843466674021384
CAENORHABDITIS ELEGAN	4.843466674021384
DIMENSIONAL STRUCTURE	4.843466674021384
BUFFER D	4.843392868980187
MICROSCOPIC OBSERVATION	4.843349199595512
MOLECULAR CHARACTERIZATION	4.843341116226757
D. DISCOIDEUM MYOSIN FILAMENT ASSEMBLY	4.843064337213434
NEURONAL INTRANUCLEAR INCLUSION DISEASE	4.842998499775103
MAPPING ALGORITHM QUASI--THE SELECTION	4.8427396109644025
LNCAP CELL ANDROGEN RESPONSE MECHANISM	4.842317614078208
NORMALIZATION ALGORITHM GENERALIZATION	4.842159880235112
BASE VECTOR DOCUMENT PUBMED IDENTIFIER	4.8420734119229465
QUERY SEQUENCE EXHIBIT SUBTREE-NEIGHBOR	4.84190981230521
MONKEY CD9 TERMINAL CYTOPLASMIC DOMAIN	4.841882740666963
BOI1-GFP LOCALIZATION OBSERVED PATTERN	4.841749609257461
RNA STRUCTURE PREDICTION MFOLD PROGRAM	4.841570645723374
EXTRACELLULAR MATRIX INTER-Α-INHIBITOR	4.841310988810079
FLUORESCEIN ISOTHIOCYANATE VISUALIZATION	4.841206521928681
POST-TRANSCRIPTIONAL	4.8411688497827186
COMPUTATIONAL METHOD	4.8411688497827186
PROSTATE EPITHELIAL CELL PROLIFERATION	4.84115259809297
MAXIMAL DEXAMETHASONE-INDUCED RESPONSE	4.840876821362165
INHIBITOR CAMPTOTHECIN TOPOISOMERASE I	4.840507215021761
EXPRESSED HUMAN PP5-GFP FUSION PROTEIN	4.840492806685653
GENECHIP HYBRIDIZATION REPRODUCIBILITY	4.840447039444026
HERPES VIRUS THYMIDINE KINASE PROMOTER	4.84031887577503
GLUTARALDEHYDE-FIXED CELL CYTOSKELETON	4.84017825519681
TOXIN C3	4.840021669508404
MAPPED MHC PHOSPHORYLATION TARGET SITE	4.839787296291767
CHLORTHALIDONE TREATMENT	4.839762410970277
SIGNALING PATHWAY MITOGENIC ACTIVATION	4.839573800299844
SIGNALING PATHWAY PHEROMONE ACTIVATION	4.839573800299844
ALM POSITION INTERMEDIATE DISTRIBUTION	4.839573800299844
PHOSPHOLIPID-BINDING PROTEIN ANNEXIN V	4.839496307568998
SPAWNING CYCLE MAKE LEPISOSTEUS EMBRYO	4.839379949887712
TIME PERIOD FETAL         BOVINE SERUM	4.839328550157222
PUTATIVE DOMINANT-NEGATIVE MUTANT FORM	4.8393047063933565
COGNATE PROTEASE SPECIFICITY IMPROVEMENT	4.838665314867372
ISI MISMATCHED OLIGONUCLEOTIDE CONTROL	4.838413927830466
IQ-PEPTIDE CONCENTRATION	4.838348628199168
INTER-ARRAY VARIANCE NONSPECIFIC SOURCE	4.8381531685047765
NEURAL CELL FATE SPECIFICATION CONSEQUENCE	4.837891880671935
VESICLE CO-SEDIMENTATION STUDY PROTEIN	4.83785879123211
Γ AMINO BUTYRIC ACID NEURAL PROGENITOR	4.837752827676903
Β-CATENIN DEGRADATION-RESISTANT MUTANT	4.837580007473717
RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR	4.837578562762351
CHLORAMPHENICOL ACETYLTRANSFERASE REPORTER	4.837516108584123
BINDING SITE NAME TRANSCRIPTION FACTOR	4.837375378611059
EXTRACELLULAR MATRIX PROTEIN SYNTHESIS	4.837120446812352
CONTAINING CDNA FRAGMENT INCYTEGENOMIC	4.836912080742482
CASPASE MITOCHONDRIA-DERIVED ACTIVATOR	4.836415275735779
INTERMEDIATE FILAMENT PROTEIN MRNA UTR	4.836345849728598
DECREASED NF-ΚB-MEDIATED TRANSCRIPTION	4.836284918479622
DIFFERENTIAL SENSITIVITY	4.8360281873312365
STATISTICAL INFORMATION RETRIEVAL METHOD	4.836004573676001
REGULATORY GENE INITIATE SINGLE MASTER	4.83507728979853
MAMMALIAN COP1-REPORTER FUSION PROTEIN	4.834868544008226
BINDING SITE INFORMATION	4.834547477003061
INFECTED SF9 INSECT CELL	4.834280451017943
SECONDARY PALATE DEFECTIVE DEVELOPMENT	4.834144962191328
MAMMALIAN COP1 SUBCELLULAR LOCALIZATION	4.833760953335984
RESPONDER	4.833606488668663
C/EBPΑ TRANSCRIPTION ACTIVATION DOMAIN	4.8334283867953545
ENDOPLASMIC RETICULUM	4.833321138451856
GRK2 ADENOVIRUS-MEDIATED GENE TRANSFER	4.832909394250345
FUNCTIONAL CHANGE TEMPORAL DEVELOPMENT	4.831963844119653
CD14 PRIMITIVE MDC SIMILAR ASSOCIATION	4.831956619399598
BIOTIN/AVIDIN/PHYCOERYTHRIN AMPLIFICATION	4.831732527222262
ALLN-INDUCED JUXTANUCLEAR ACCUMULATION	4.831418856907153
RNA SEQUENCE FAMILY MULTIPLE ALIGNMENT	4.831342315450918
INHIBITED GNRH-STIMULATED LH SECRETION	4.831338239955022
CONSERVED ALPHA-HELIX-INITIATION MOTIF	4.831338239955022
RC20-HRP ANTI-PHOSPHOTYROSINE ANTIBODY	4.831132275014626
QUIKHYB HYBRIDIZATION SOLUTION PROTOCOL	4.830409497844194
ATPASE CATALYTIC SUBUNIT	4.830349026946422
EXPERIMENTAL VARIABILITY RELATIVE CONTRIBUTION	4.829986041970556
P21 GENE	4.829786036723037
EXTENSIVE GRANULATION TISSUE FORMATION	4.829557509428291
PROMOTING GRANULATION TISSUE FORMATION	4.829557509428291
POLYCLONAL GOAT ANTI-NF-ΚB P50 ANTIBODY	4.8294505736482005
BIGDYE TERMINATOR CYCLE SEQUENCING KIT	4.828995699946468
AUTOMATED DNA SEQUENCING	4.8287049627048715
CRE EXPRESSION PLASMID CO-TRANSFECTION	4.827865990463943
BINDING DOMAIN PLASMID VECTOR GAL4 DNA	4.827691994764262
SIGNALING MOLECULE OTHER INTRACELLULAR	4.82722033947349
DIPHTHERIA TOXIN CELL-SURFACE RECEPTOR	4.827179782222723
TYROSINE-PHOSPHORYLATED CAS SD CHIMERA	4.827171719916868
HEPTAFLUOROBUTYRIC ACID	4.826864402460369
column chromatography	4.826847448699294
OPTIMAL METABOLIC PHENOTYPES- ONE GLUCOSE	4.82630626246756
X100	4.8261130829125936
CELLULAR DISTRIBUTION	4.825903324497019
MODE ESTIMATION FORMULATING RECOMMENDATION	4.825759810408297
TESTING TEST CASE SOFTWARE PERFORMANCE	4.825301510534491
DEPENDENT ACTIN STRESS FIBER FORMATION	4.825261004455937
STABLE TYROSINE PHOSPHORYLATION ABSENCE	4.8246231233234225
SAMPLE BUFFER SD ADDITION	4.824383859755708
CAS SD STABLE TYROSINE PHOSPHORYLATION	4.824032417830837
DIFFERENTIAL GENE PERMISSIVE SELECTION	4.823811121230381
LACK RADIAL GLIA DLA DX2 MUTANT EMBRYO	4.823633342500498
DIVALENT	4.823516640829483
SPATIAL INFORMATION ANTERIOR-POSTERIOR	4.82306874759813
OTHER DNA-BINDING TRANSCRIPTION FACTOR	4.822928265106975
FIBROBLAST TN SUPPORTS DIFFERENTIATION	4.822750897660706
NF-ΚB INTERACTING PROTEIN P105 SUBUNIT	4.822277175039995
GLUTARALDEHYDE-PARAFORMALDEHYDE SOLUTION	4.821416205918483
BINDING ASSAY RADIOLIGAND	4.821269043938056
CALCULATION	4.821098946085931
RRNA SEQUENCE CONSERVATION INFORMATION	4.821075786587639
UNITS/NG DNA-DEPENDENT ATPASE ACTIVITY	4.820999708616007
TRYPSIN MG/ML SOYBEAN TRYPSIN INHIBITOR	4.820895200088612
BFGF DENSITY-DEPENDENT DOWN-REGULATION	4.82082578939722
STATISTICAL SIGNIFICANCE STANDARD TEST	4.820507187380045
BIOLOGICAL PROCESS UNDERSTANDING CELL	4.820446816545686
HORSERADISH PEROXIDASE-CONJUGATED IGG	4.820446816545686
B-LYMPHOID CELL LINE ADP-RIBOSYLATION	4.820446816545686
'-CCGGCTCGAGTCACTTGGTGTCGGTGGCGCATG-3	4.820446816545686
PROSPECTIVE TRUNK LONGITUDINAL DOMAIN	4.820446816545686
ALM MIGRATION DEFECT COLD SENSITIVITY	4.820446816545686
REVERSE TRANSCRIPTASE QUASISPECIATION	4.820446816545686
NEONATAL SUBMANDIBULAR SALIVARY GLAND	4.820446816545686
CELLULAR PROCESS BRANCHED FINGER-LIKE	4.820446816545686
GNRH RECEPTOR-EXPRESSING HETEROLOGOUS	4.820446816545686
PROBE-SPECIFIC BACKGROUND SUBTRACTION	4.820446816545686
HUMAN PROSTATE CANCER CELL LINE LNCAP	4.820446816545686
INDEPENDENT UNIDIRECTIONAL SIMILARITY	4.820446816545686
SUBTILISIN-DERIVED CATALYTIC FRAGMENT	4.820446816545686
PERFORMED ADP-RIBOSYLATION EXPERIMENT	4.820446816545686
SPIKING EXPERIMENT SPIKING EXPERIMENT	4.820446816545686
RESVERATROL-INDUCED CELLULAR PROPERTY	4.820446816545686
CYTOSKELETON-ASSOCIATED TRANSCRIPTOME	4.820446816545686
MHCK-C AUTOPHOSPHORYLATION/ACTIVATION	4.820446816545686
CDK2 INHIBITOR P27 INCREASED RECOVERY	4.820446816545686
METABOLIC GENOTYPE-PHENOTYPE RELATION	4.820446816545686
COUPLE AGONIST-ACTIVATED HEPTAHELICAL	4.820446816545686
PROTEASOME-MEDIATED DEGRADATION EVENT	4.820446816545686
BIOCHEMICAL SYSTEM MATHEMATICAL MODEL	4.820446816545686
FINDING OVERREPRESENTED WEIGHT MATRIX	4.820446816545686
STABLE HYGROMYCIN-RESISTANT CELL LINE	4.820446816545686
CELL CULTURE A549 LUNG CARCINOMA CELL	4.820446816545686
MOUSE IRIDOCORNEAL ANGLE MORPHOGENESI	4.820446816545686
GENETIC REPROGRAMMING COMPLEX PROCESS	4.820446816545686
INTESTINAL CRYPT CELL LINE RIE-1 CELL	4.820446816545686
ENDOTHELIAL MP INCREASED PLASMA COUNT	4.820446816545686
PEROXIDASE/FLUORESCEIN ISOTHIOCYANATE	4.820446816545686
INDIVIDUAL DUCHENNE DYSTROPHY PROFILE	4.820446816545686
DISSECTING SCOPE LEICA MODEL MZFL III	4.820446816545686
METABOLIC PATHWAY INTEGRATED FUNCTION	4.820446816545686
MEESMANN CORNEAL EPITHELIAL DYSTROPHY	4.820446816545686
OLFACTORY BULB INTERNAL GRANULE LAYER	4.820446816545686
5'TAGCGATTACTTTCCTTCTCCTTTTTCTACGGT3'	4.820446816545686
METABOLIC NETWORK IN VIVO UTILIZATION	4.820446816545686
SECONDARY STRUCTURE ELEMENT END POINT	4.820446816545686
IMMUNOGOLD-LABELED SEMI-THICK SECTION	4.820446816545686
INVERTED MICROSCOPE NIKON DIAPHOT-TMD	4.820446816545686
AUTOPHAGIC PROCESS POSSIBLE REGULATOR	4.820446816545686
MYSTACIAL VIBRISSAE EPIDERMAL PLACODE	4.820446816545686
BIOLOGICAL SYSTEM INTEGRATED FUNCTION	4.820446816545686
CONTAINING PROTEIN TOTAL PHOSPHOTYROSINE	4.820381231167165
SALI RESTRICTION ENDONUCLEASE CUT-SITE	4.820239791308693
CASPASE EFFECTOR SUPPRESSED ACTIVATION	4.820221334500253
CDNA CLONE	4.820095435208356
GAD1 EXPRESSION COMPREHENSIVE PICTURE	4.82001850194124
GENE EXPRESSION CIRCADIAN OSCILLATION	4.82001850194124
PH DOMAIN PHOSPHOLIPID-BINDING PORTION	4.819893809235675
MM TRIS(HYDROXYMETHYL) AMINOMETHANE PH	4.819893809235675
HYGROMYCIN-RESISTANCE EXPRESSION UNIT	4.819875730406425
SYMMETRICAL LOGARITHMIC TRANSFORMATION	4.8197256492225655
PROBABILISTIC NEURAL NETWORK ANALYSIS	4.819659126200103
ANALYSIS TECHNIQUES OFFER TIME-SERIES	4.819659126200103
STATISTICAL ANALYSIS MEANS DIFFERENCE	4.819659126200103
EPITHELIAL CELL APOPTOSI	4.8195321794683545
GENE EXPRESSION QUANTITATIVE ANALYSIS	4.8192308115956575
EXPERIMENTAL DATA CONTINUOUS EVALUATION	4.81921232808441
MACROSCOPIC FOCI GROWTH	4.819204346923094
EPIFLUORESCENT ILLUMINATION ATTACHMENT	4.8191362884147155
D. DISCOIDEUM MYOSIN II PHOSPHORYLATE	4.819042058480872
STATISTICAL ANALYSIS ONE-WAY ANALYSIS	4.81887143585452
DISCOVERING MODULE EXISTING ALGORITHM	4.818719560918606
CONTROL CELL TYPE-SPECIFIC EXPRESSION	4.818512689343273
AUTOPHOSPHORYLATION MESSENGER CONTROL	4.818439066415064
GROUP I/II INTRON SECONDARY STRUCTURE	4.818091205528923
IMMEDIATE-EARLY RESPONSE GENE PRODUCT	4.817763871256924
IMMUNOFLUORESCENT MICROSCOPIC OBSERVATION	4.817740361114297
BOI1-S-GFP LOCALIZATION POLAR PATTERN	4.817736353869346
DEFECTIVE FIBRONECTIN MATRIX ASSEMBLY	4.817426586706336
UNDERSTANDING HUMAN GENOMIC VARIATION	4.8173007437963635
MODELLING SIGNAL TRANSDUCTION NETWORK	4.817025844235743
SHOWED ANNEXIN REMAINING ADHERENT CELL	4.8170107871786625
transcriptional activation	4.8168388405484155
SIGNALING NETWORK MOLECULAR COMPONENT	4.8163175960622
INCLUDING COMPONENT SEGMENT STRUCTURE	4.8163175960622
TERTIARY COMPLEX STRUCTURAL COMPONENT	4.8163175960622
AFFYMETRIX OLIGONUCLEOTIDE DATA MODEL	4.815929378751787
NUMEROUS COMPONENT ALTERED EXPRESSION	4.815889281457754
EXOGENOUS ACTIN DECREASE INCORPORATION	4.815886155193031
GLUCOSE INDEPENDENT ACTIVATION DOMAIN	4.815575478095122
SURVEYED GAD1 TRANSCRIPT DISTRIBUTION	4.815575478095122
ENDOGENOUS MHCK CELLULAR DISTRIBUTION	4.815575478095122
RT QUASISPECIATION SELECTION PRESSURE	4.815552925602295
SER/THR PROTEIN PHOSPHATASE INHIBITOR	4.815498517218489
SENSITIVE SER/THR PROTEIN PHOSPHATASE	4.815498517218489
PROBABILITY DENSITY FUNCTION DERIVATIVE	4.815439575548333
BDM TREATMENT POSSIBLE OSMOTIC EFFECT	4.815156724528937
NOVEL PROTEIN KINASE CATALYTIC DOMAIN	4.814858765995262
DESTROYED MICROEXTENSION TRITON X-100	4.814824048227748
FLOW CYTOMETRY ANALYSIS MICROPARTICLE	4.814672897691742
EXTRACELLULAR SIGNAL-REGULATED KINASE	4.814585058648586
RECOMBINANT PROTEIN PRODUCTION PROTEIN	4.814431064457844
INCLUDING CYTOCHROME C MEMBRANE SPACE	4.814406356866987
DEMONSTRATED TRANSCRIPTION START SITE	4.814343580727138
IQ1 CALMODULIN AFFINITY	4.814325133967842
ENDOGENOUS CA TYROSINE PHOSPHORYLATION	4.813910141757324
MASTER TRANSCRIPTIONAL CO-ACTIVATOR CBP	4.813481963306551
BACKGROUND GENOMICS SEQUENCING PROJECT	4.813147014536453
CANCER THERAPY ANIMAL XENOGRAFT MODEL	4.812896241947311
NOVEL PROTEIN SUBFAMILY REPRESENTATIVE	4.812886667094562
KEY GENE	4.8126984514119275
TRANSCRIPTIONAL ACTIVATION DOMAIN B42	4.812502569828341
ACTIVATED LEF-DEPENDENT TRANSCRIPTION	4.812309168787622
CD98 IMMUNOPRECIPITATE	4.812236053149761
CORE GLYCOSAMINOGLYCAN ATTACHMENT DOMAIN	4.811618135413434
INCREASED P27 UBIQUITYLATION ACTIVITY	4.811174181073998
OTHER ENDOGENOUS PROTEASOME COMPONENT	4.8110845245583755
PUBLISHED WORK SUPPORT EXTENSIVE BODY	4.811050545934376
PEROXIDASE IMMUNOHISTOCHEMISTRY BIOPSY	4.810688783502196
NON-REDUNDANT GENBANK CDS TRANSLATION	4.810659034658904
CONJUGATED RABBIT ANTI-MOUSE ANTIBODY	4.810505621149707
PARALLEL MURINE MYOGENIC CELL CULTURE	4.810258089376795
ABNORMAL ANTERIOR SEGMENT DEVELOPMENT	4.810183899615857
SMG DEVELOPMENT OBSERVED INTERRUPTION	4.810183899615857
BINARY EXPRESSION TREE REPRESENTATION	4.810046044924519
PROSTAGLANDIN SYNTHESIS	4.80986872024924
CONSTITUTIVE TYROSINE PHOSPHORYLATION	4.809521122944905
MYCRAB24(WT) SUBCELLULAR DISTRIBUTION	4.80940511605774
PRONOUNCED INTRACELLULAR DISTRIBUTION	4.809284676784791
SRP-RNA STRUCTURAL PAIRWISE ALIGNMENT	4.809201279909809
MECHANISTIC STUDY BASELINE INFORMATION	4.809043984833487
PROGRAMMING ALGORITHM GENERAL DYNAMIC	4.808747103901886
EXTENSIVE CRANIAL NEURAL CREST CONTRIBUTION	4.808737642507284
EXHIBIT CALCIUM-DEPENDENT SELF-ASSOCIATION	4.8086217888222835
AFFECTING FN DEGRADATION MAJOR ENZYME	4.808316385223707
WINSCONSIN E. COLI GENOME PROJECT HTTP	4.808310698752846
ALEXA-CALMODULIN BOUND	4.808249748227538
GELATIN-AGAROSE AFFINITY CHROMATOGRAPHY	4.808170404328245
WORSENING HEART FAILURE	4.808048596138764
BONDING NETWORK HYDROGEN	4.807858226177329
METASTATIC LESION ANEUPLOID DERIVATIVE	4.807775850773741
MULTIPLE ALIGNMENT PROGRAM WCONSENSUS	4.807749153557428
CORTICAL ASTROCYTE ASTROCYTE CELL LINE	4.807456694666101
INTERNAL         RIBOSOMAL ENTRY SITE	4.807233310998531
QUANTITATIVE COMPARISON	4.806937949889581
OLYMPUS AX70 MICROSCOPE	4.806937949889581
PHYSIOLOGICAL INHIBITOR	4.806937949889581
MOLECULAR WEIGHT MARKER	4.806937949889581
BIOLOGICAL PLAUSIBILITY	4.806937949889581
TRANSDUCTION LABORATORY	4.806937949889581
PHYSIOLOGICAL SUBSTRATE	4.806937949889581
OLYMPUS BX60 MICROSCOPE	4.806937949889581
PROAPOPTOTIC WOX1 HYAL-2 UPREGULATION	4.806537863338154
DETERMINING SERPIN INHIBITORY ACTIVITY	4.806465031045937
GENE EXPRESSION PROFILE	4.80608386877348
GENE EXPRESSION PATTERN	4.80608386877348
PROLIFERATIVE NEURAL PRECURSOR SUBSET	4.805765143715513
PROHB-EGF PROTEIN-PROTEIN INTERACTION	4.805672806150543
CONSERVED PROTEIN-PROTEIN INTERACTION	4.805672806150543
NUCLEAR         LOCALIZATION SEQUENCE	4.80564682986853
RETARDED GRANULATION TISSUE FORMATION	4.805627931819904
CONTAINING NEO G418-SENSITIVE ES CELL	4.8056105997909855
IMMUNOPRECIPITATE IMMUNOBLOT ANALYSIS	4.805578517734943
INSECT-SELECTIVE TOXIN	4.805376964705783
SD RAT STRAIN ADULT IRIDOCORNEAL ANGLE	4.805081954865396
E10 SENSE STRAND HYBRIDIZATION RESULT	4.805034140145228
YEAST PROTEIN-PROTEIN INTERACTION MAP	4.804924794279697
INCLUDING INTEGRIN AFFINITY REGULATION	4.804829496060323
BILE ACID CYTOTOXICITY	4.804656014624535
BINDING MOLEGOS FORM INDIVIDUAL Β-STRAND	4.804513971189773
PACCMVPLPA PLASMID CORRESPONDING SITE	4.804376336826173
INDUCING DIFFERENTIATION OPTIMAL DOSE	4.804233926303778
QUANTITATIVE DESCRIPTION MAKING SENSE	4.804184040487648
TRANSIENT OVEREXPRESSION VARYING LEVEL	4.804161166069795
CDK2 ACTIVITY ENHANCED P21 INHIBITION	4.803865162525726
MAMMALIAN HOMOLOGUE INITIATED ANALYSIS	4.803578385114675
DISTRIBUTION	4.803522576910048
TRANSLOCATION KINETICS	4.803468472156365
PITUITARY-SPECIFIC TRANSCRIPTION FACTOR PIT-1	4.803136166693602
TOUCH NEURON-SPECIFIC GENE ACTIVATION	4.802991187097831
GENE PRODUCT DOMINANT-NEGATIVE ALLELE	4.802828809149479
CYCLIN DEPENDENT SERINE/THREONINE KINAS	4.802653199389645
P53 N-TERMINAL TRANSACTIVATION DOMAIN	4.8024826496914494
BACTERIAL CODING-REGION IDENTIFICATION	4.801473323597629
CHANGE/ABSOLUTE EXPRESSION CALCULATION	4.800898290848316
VARIABLE CONFORMATION N-TERMINAL REGION	4.800446854788785
CYCLIN E-ASSOCIATED H1 KINASE ACTIVITY	4.800262706918836
EMBRYONIC SMG DEVELOPMENTAL HOMEOSTASI	4.800129402361547
GLUCOCORTICOID RECEPTOR INCORPORATION	4.799936767119045
CIRCADIAN DIFFERENTIAL DISPLAY SCREEN	4.799920982686027
RNA STRUCTURE ALIGNMENT	4.799738932831735
ENZYME NITRIC           OXIDE SYNTHASE	4.79964470945673
DNA-BINDING TRANSCRIPTIONAL REGULATOR	4.799570550860257
SINGLE-STRAND DNA PROTOCOL MODIFICATION	4.799264564369705
BIOLOGICAL INFORMATION REPRESENTATION	4.799183704170953
FIBROBLAST GROWTH FACTOR-LIKE PROTEIN	4.799075299823261
PROMOTING POSTMITOTIC DIFFERENTIATION	4.798829629556474
OSTEOCLAST PROGENITOR DIFFERENTIATION	4.798829629556474
UBIQUITYLATION NORTHERN BLOT ANALYSIS	4.798641152464277
GUANINE-NUCLEOTIDE DECREASED AFFINITY	4.798595024426359
BIOCHEMICAL SUBCELLULAR FRACTIONATION	4.798282226595619
phenotype	4.797911047906885
MHCK-C AUTOPHOSPHORYLATION REGULATION	4.797713903776386
WILD TYPE	4.797247909837225
METASTASI	4.797247909837225
RHODAMINE	4.797247909837225
HYPOTONIC	4.797247909837225
CHAPERONE	4.797247909837225
PUBLICATION	4.797123259393887
SUBCELLULAR COMPARTMENT	4.796738568303111
FUNCTIONAL ELEMENT COMPARTMENTALIZATION	4.796483319579969
MOTOR NEURONAL IDENTITY SPECIFICATION	4.795863550411443
MICROTUBULE POLYMERIZATION INHIBITOR	4.795790553186309
IDENTIFIED ANDROGEN-MEDIATED PATHWAY	4.795790553186309
STANDARD USM ORIGINAL IMPLEMENTATION	4.795790553186309
BODY-PROTEASE BODY INTERACTIONS PLAY	4.795790553186309
NON-EXTRACTABLE MEMBRANE CONSTITUENT	4.795790553186309
POSTERIOR CORNEAL SURFACE MESENCHYME	4.795790553186309
IMMUNOGOLD-LABELED TBID 3-D DISTANCE	4.795790553186309
E15 PRIMORDIA INDEPENDENT EXPERIMENT	4.795790553186309
N-P-TOSYL-GLY-PRO-LYS-P-NITROANILIDE	4.795790553186309
ARTIFICIAL LIPOSOME PERMEABILIZATION	4.795790553186309
UROKINASE-TYPE PLASMINOGEN ACTIVATOR	4.795790553186309
BACKGROUND GLUCOCORTICOIDS INFLUENCE	4.795790553186309
NON-INTEGER DIMENSION GENERALIZATION	4.795790553186309
AZ-DEPENDENT PROTEASOMAL DEGRADATION	4.795790553186309
VARYING FITNESS REPLACEMENT MUTATION	4.795790553186309
INDICATING MODE SUGGESTED CONVENTION	4.795790553186309
SINGLE-PARAMETER BIFURCATION DIAGRAM	4.795790553186309
SPARC-NULL MICE RELATIVE NEOEPIDERMI	4.795790553186309
ACUTE         LYMPHOBLASTIC LEUKEMIA	4.795790553186309
TARGETING ROLE POTENTIAL PROTEASOMAL	4.795790553186309
CHEMOTACTIC DICTYOSTELIUM DISCOIDEUM	4.795790553186309
CELLULAR SYSTEM METABOLIC CAPABILITY	4.795790553186309
IMMUNOPRECIPITATING ENDOGENOUS C-CRK	4.795790553186309
FIBROBLAST-DERIVED VASCULAR PERICYTE	4.795790553186309
REVEALED ABNORMALITY SPARC-NULL LENS	4.795790553186309
SV40 POLYADENYLATION SEQUENCE TRIMER	4.795790553186309
TRANSCRIPTION-INDEPENDENT INHIBITION	4.795790553186309
BONE MARROW OCL PRECURSOR POPULATION	4.795790553186309
LABELED CRNA AFFYMETRIX NOMENCLATURE	4.795790553186309
PROGRAMMED CELL DEATH PAPERS MENTION	4.795790553186309
INCLUDED10 DEME GP PARAMETER SETTING	4.795790553186309
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY	4.795790553186309
STRUCTURAL NCRNA GENEFINDING PROGRAM	4.795790553186309
TBID-IMMUNOGOLD COMPLEX MAXIMAL SIZE	4.795790553186309
FITC-CONJUGATED ANTI-MOUSE SECONDARY	4.795790553186309
ANAPHYLATOXIN TYPE I CONTAINING HALF	4.795790553186309
FLUORESCENCE MICROSCOPY HPB-ALL CELL	4.795790553186309
INDIVIDUAL NEURAL FATE SPECIFICATION	4.795790553186309
CONTAINING INSULIN SERUM-FREE MEDIUM	4.795790553186309
PROFILING HUMAN MUSCLE BIOPSY SAMPLE	4.795790553186309
PLASMINOGEN ACTIVATOR INHIBITOR TYPE	4.795790553186309
'-GAACACGGTATTGTCACCAACTGGGACGATATGG	4.795790553186309
BIOLOGICAL SYSTEM MATHEMATICAL MODEL	4.795790553186309
PROLIFERATIVE EPIDERMAL KERATINOCYTE	4.795790553186309
BROAD GENE EXPRESSION CHARACTERISTIC	4.795365275429953
EMBRYONIC SHIELD EXTERNAL EXPRESSION	4.795365275429953
EXPRESSION VALUE INTERESTING PORTION	4.795365275429953
AROMATIC BENZIMIDAZOLE	4.794460387323114
AFFYMETRIX MICROARRAY SUITE SOFTWARE	4.794451796167574
AVERAGE SINGLE NUCLEOTIDE SUBSTITUTION	4.794252244910717
TOTAL PHENOTYPIC VARIANCEATTRIBUTABLE	4.793752865945372
PROFILING STUDY EXTENSIVE EXPRESSION	4.7937505285027395
MYOSIN FILAMENT HYPERPHOSPHORYLATION	4.793465889835947
TETRASPANIN PROTEIN EXTRACELLULAR DOMAIN	4.793463412863521
PRIMARY T LYMPHOCYTE INDUCED ADHESION	4.793349139049427
CANONICAL PHEROMONE RESPONSE PATHWAY	4.793126630590653
PREDICTED PHEROMONE RESPONSE NETWORK	4.793126630590653
TRANSCRIPTIONAL ACTIVITY BASAL LEVEL	4.7927394325389585
OCL NORMAL ULTRASTRUCTURAL APPEARANCE	4.792628910130621
PROLIFERATION TANG C/EBPΑ INHIBITION	4.7925105984904075
INTER-ARRAY COMPARISON SIGNAL METHOD	4.792393836349129
INCLUDING COMPONENT HYBRID TRANSCRIPT	4.792293040521917
HOSPITALIZED HF EVENT	4.79172388611431
BOI1 MUTANT VERSION REDUCED FUNCTION	4.7917088317869645
OTHER CIRCADIAN REGULATORY COMPONENT	4.791690609816432
SRC KM/CAS(SD) CHIMERA CO-EXPRESSION	4.791558353578694
CHILLED ETHANOL SOLUTION GRADED SERIES	4.791545848159383
PLATEAU GROWTH PHASE LEVEL PREDICTIVE	4.791466089495858
TIME ESTIMATE INVOLVING DISTRIBUTION	4.790953753634748
REALITY PROBE INTENSITY DISTRIBUTION	4.790953753634748
SECONDARY MOTOR NEURON SPECIFICATION	4.7906201812518825
SYSTEMATIC RNA GENEFINDING ALGORITHM	4.790490894254112
DERMAL GRANULATION TISSUE FIBROBLAST	4.790462707994997
P38 MAPK	4.790093881177508
POTENTIAL THR PHOSPHORYLATION TARGET	4.79000771295111
COILED-COIL DOMAIN CONFORMATION CHANGE	4.789827971469034
INFLAMMATORY CYTOKINE GENE EXPRESSION	4.789816203547741
RECEPTOR ACTIVATION-INDUCED DECREASE	4.789705999547535
(GPI)-ANCHORED CELL-SURFACE RECEPTOR	4.789705999547535
HIGH-INTENSITY SIGNAL SCALING FACTOR	4.789697983174415
Β-CATENIN-MEDIATED BRANCH ACTIVATION	4.789341487117562
SPOTTED CDNA MICROARRAY	4.789264463975668
TGF-Β1-INDUCED ANTIAPOPTOTIC PROTEIN	4.789239600175574
DEVELOPMENTAL MECHANISM CONSERVATION	4.788793316501718
SITUHYBRIDIZATION FIBROBLAST CULTURE	4.7886867595978915
GFP	4.788684222571366
SOFTWARE IMPLEMENTATION TEST VERSION	4.788552032478111
PHOSPHORYLATION EXPERIMENT MYOSIN II	4.788264215438338
DIFFERENTIATION ALLOWANCE/STIMULATION	4.788021036061869
TLX2 PROMOTER BMP-INDUCED ACTIVATION	4.787848471082415
EXTRACELLULAR COMPONENT	4.787529528455504
NON-MAMMALIAN VERTEBRATE PINEAL GLAND	4.787413052677797
GRANULAR LYMPHOCYTE LEUKEMIA PATIENT	4.787326153971078
INDIVIDUAL PROFILE P-VALUE THRESHOLD	4.787187393328206
CYCLIN-DEPENDENT KINASE DOWNREGULATION	4.787160472798762
LIM HOMEODOMAIN TRANSCRIPTION FACTOR	4.78703473752494
BLINDING DISEASE GLAUCOMA RISK FACTOR	4.78656232012887
DNA CONTENT FLOW CYTOMETRIC ANALYSIS	4.7864772740307995
UNTRANSFECTED GHFT1-5 CELL DISTRIBUTION	4.786443053150424
BINDING DOMAIN SERUM RESPONSE FACTOR	4.786424093040874
WILD-TYPE EMBRYO LONGITUDINAL DOMAIN	4.78641925405516
VITROUBIQUITYLATION ASSAY CELL LYSATE	4.786266863362096
EXTRACELLULAR LIGAND-BINDING PROTEIN	4.786115833798525
IMMUNOFLUORESCENCE MICROSCOPY HEK293	4.785935290250266
MONOCLONAL ANTIBODY F7-26 ANTI-SSDNA	4.785919843129676
MONOCLONAL ANTIBODY ANTI-HUMAN PAI-1	4.785919843129676
POTENTIAL EXAMPLE GENERAL POPULATION	4.785888803160944
ATP INCREASING AMOUNT	4.785871738492456
STANDARD CALCIUM PHOSPHATE PROCEDURE	4.7857466727778055
SEDIMENTATION PROFILE	4.785324091766541
mitochondrial permeability transition	4.785210801753271
BACKGROUND FREQUENCIES REPRESENTATIVE	4.785210801753271
POWER TODETECT GENE-GENE INTERACTION	4.784788608713682
FOCAL ADHESION CYTOSKELETON BACKBONE	4.78465858573355
ENCODING RAT C/EBPΑ CDNA START CODON	4.784568681556908
THIAMINE DIPHOSPHOKINASE	4.784416166150265
STANDARD SIGMOIDAL TRANSFER FUNCTION	4.784382015113606
THROMBIN RECEPTOR ACTIVATING PEPTIDE	4.783904448403586
POLYACRYLAMIDE DISCONTINUOUS MINI-GEL	4.783356274658933
MODELING MULTIPLE SEQUENCE ALIGNMENT	4.783182919520379
CDK4	4.782806354607835
SIMPLE EUKARYOTIC NONMUSCLE MYOSIN-II	4.782693943553813
INCREASED TAG EXPRESSION MAKES SENSE	4.782532355563517
MACROPHAGE COLONY STIMULATING FACTOR	4.782384643861711
IMMUNOFLUORESCENCE LOCALIZATION CELL	4.782346963745347
SPARC-NULL PRIMARY DERMAL FIBROBLAST	4.782294727429325
TRANSFORMING GROWTH FACTOR Β-BINDING	4.7821157721592025
CYCLIN CAUSED TRANSIENT UPREGULATION	4.781980217624616
MAMMALIAN CELL TUMORIGENIC PHENOTYPE	4.781742931607631
CARBOXYL-TERMINAL FIBULIN-TYPE MODULE	4.781295688998559
INCLUDING FALSE-POSITIVE INTERACTION	4.7811212938894725
PRODUCTIVE ELECTROSTATIC INTERACTION	4.7811212938894725
DELAYED GRANULATION TISSUE FORMATION	4.781076737728057
DROSOPHILA MELANOGASTER	4.781021488481335
FRACTIONATION FUNCTIONAL SIGNIFICANCE	4.78080629990422
CARDIOVASCULAR DISEASE INCREASED RISK	4.780806299904219
ENDOGENOUS C-CRK REDUCED ASSOCIATION	4.780355472264417
ELECTRON MICROSCOPY TRANSFECTED CELL	4.779967656160852
INCREASING ARRAY INFORMATION DENSITY	4.779956289137126
DENATURING GRADIENT GEL ELECTROPHORESI	4.779866154756153
CELL GROWTH POB1 CAUSE OVEREXPRESSION	4.779568214371146
COLLAGEN ACCUMULATION MCP-1 INCREASE	4.779316300614429
CARBOXYL TERMINAL CYTOPLASMIC DOMAIN	4.779134372991984
OXIDATIVE ACTIVITY MUTUAL REGULATION	4.778861754755846
BACKGROUND PATHOLOGIC CLASSIFICATION	4.778724122248281
C-TERMINAL MAPK SITE PHOSPHORYLATION	4.778684059834305
LOW-DOSE CHLORTHALIDONE	4.778675140792672
SINGLE NUCLEOTIDE POLYMORPHISM (SNP)	4.778392555865617
LEUKOTRIENE B4 RECEPTOR	4.777937535176232
MACROPHAGE COLONY-STIMULATING FACTOR	4.777916007420178
GOAT ANTI-RABBIT POLYCLONAL ANTIBODY	4.777846108493609
ECM MOLECULE PRODUCTION/ACCUMULATION	4.777733168193816
MULTIPLE COMPARATIVE GENOME SEQUENCE	4.777519688390764
RECOMMENDED SIGNAL AMPLIFICATION STEP	4.777385327594276
FILAMENT NUCLEATION TEMPORAL CONTROL	4.776802325431115
GROWING RASMC AFFINITY CHROMATOGRAPHY	4.776240066041126
MUTANT PROTEIN STRIKING ACCUMULATION	4.776116424384395
TRIMMED DATA SET MEAN STANDARD ERROR	4.775879717091944
REDUCED AFFINITY GΑ CAUSE C-TERMINUS	4.7752753991193595
USM REPRESENTATION STORAGE REQUIREMENT	4.775159571664246
BINDING AFFINITY DNTP	4.775144568098497
CRW SITE PROJECT INTRON DISTRIBUTION	4.775105162930473
MISSING DATA PROCESS	4.77499738707114
THERMODYNAMIC THEORY	4.77499738707114
CALLED THY-1 DIFFERENTIATION PROTEIN	4.774779401270456
QUANTITATIVE COMPARATIVE INFORMATION	4.774678201120732
GOAT ANTI-MOUSE FITC ELECTROPORATION	4.77437044088654
SENSITIVITY ANALYSIS	4.77433279219504
S. CEREVISIAE PHENYLALANINE TRNA SEQUENCE	4.773994774750078
EXTRACTION SUBCELLULAR FRACTIONATION	4.773783115226707
PIXEL	4.773679197709159
SIDE	4.7733671223513605
CYTOPLASMIC CONCENTRATION MEASUREMENT	4.773214423500537
GABA ACT	4.77279217234997
P53 N-TERMINAL PRIOR PHOSPHORYLATION	4.772170916130993
CESIUM CHLORIDE GRADIENT CENTRIFUGATION	4.7721515801986545
GFP-MYOSIN-II RELATIVE CONCENTRATION	4.772071106797864
CHARGED HEPARAN SULFATE PROTEOGLYCAN	4.771936337216111
UNDERSTANDING PROBE-SPECIFIC BEHAVIOR	4.7712802842772
BOI1-PH(KK) CO-SEDIMENTATION BEHAVIOR	4.7712802842772
CO-TRANSFECTED WG SYNERGISTIC EFFECT	4.770691769426362
COMPETING FLAG PEPTIDE CONCENTRATION	4.770678278841333
'-GATCGGTACCATTAGCACGGTGCCTTAACCA-3	4.770476712545075
CONSENSUS SEQUENCE SER-X-X-X-SER(P)	4.770476712545075
STATISTICAL METHOD NEAREST NEIGHBOR	4.770476712545075
PROLIFERATIVE UNDIFFERENTIATED CELL	4.770476712545075
SLOWLY-TIME-VARYING PARAMETER VALUE	4.770476712545075
COILED-COIL STRUCTURE CHARATERISTIC	4.770476712545075
RING FINGER UBIQUITINATION ACTIVITY	4.770476712545075
CELLULAR CLEARANCE PROPOSED PATHWAY	4.770476712545075
THROMBOTIC THROMBOCYTOPENIC PURPURA	4.770476712545075
OPTIMIZATION TECHNIQUE FORSELECTING	4.770476712545075
TWO-DIMENSIONAL ELECTRON MICROGRAPH	4.770476712545075
NOVEL SΑ I2 SEQUENCE TARGETING ROLE	4.770476712545075
PROLIFERATIVE NEURAL PRECURSOR CELL	4.770476712545075
MITOCHONDRIAL MEMBRANE PRESERVATION	4.770476712545075
PURIFIED THREONINE558-PHOSPHOMOESIN	4.770476712545075
CORTICAL GFP-MYOSIN-II FLUORESCENCE	4.770476712545075
OSCILLATORY MOLECULAR NETWORK MODEL	4.770476712545075
BACKGROUND EMBRYOLOGICAL LITERATURE	4.770476712545075
MISMATCH-SUBTRACTED MATCH INTENSITY	4.770476712545075
NORMAL ECTOCERVICAL EPITHELIUM SHOW	4.770476712545075
AUTOMATIC KERNEL DOCUMENT SELECTION	4.770476712545075
NATURAL AUTOANTIBODY IMMUNOGLOBULIN	4.770476712545075
NOTCH1 TARGETED MUTATION HOMOZYGOUS	4.770476712545075
VIMENTIN TRANSCRIPT MISLOCALIZATION	4.770476712545075
BOI1 LIPID-BINDING-IMPAIRED VERSION	4.770476712545075
VESICLE CO-SEDIMENTATION EXPERIMENT	4.770476712545075
LATER-BORN CELL TYPE REDUCED NUMBER	4.770476712545075
SPECIALIZED OCL-EXTRACELLULAR SPACE	4.770476712545075
VIRAL VARIATION SELECTIVE ADVANTAGE	4.770476712545075
WW DOMAIN-CONTAINING OXIDOREDUCTASE	4.770476712545075
5'CGCGGATCCTCAACACACATAGGAGCCCTGAAG	4.770476712545075
ALKALINE PHOSPHATASE-CONJUGATED IGG	4.770476712545075
TAG EXPRESSION-CELL DENSITY PROFILE	4.770476712545075
SIMULATED DATA CONTAININGFUNCTIONAL	4.770476712545075
SIMPLIFYING INDEPENDENCE ASSUMPTION	4.770476712545075
FUNDAMENTAL DIFFERENCE GROWING LIST	4.770476712545075
MIGRATION DEFECT GENETIC SUPPRESSOR	4.770476712545075
ZEBRAFISH NEURAL PLATE STAGE EMBRYO	4.770476712545075
QUANTITATIVE HISTOMORPHOMETRIC DATA	4.770476712545075
HEMAGGLUTININ TRIMER-BURIED PORTION	4.770476712545075
AXIOPLAN EPIFLUORESCENCE MICROSCOPE	4.770476712545075
SCANNING ELECTRON MICROSCOPE S-4200	4.770476712545075
MNOC BACTERIAL ARTIFICAL CHROMOSOME	4.770476712545075
FLUORESCENCE ACTIVATED CELL SORTING	4.770476712545075
METRIC OVER-ESTIMATION USM DISTANCE	4.770476712545075
OVERESTIMATION STATISTICAL PROPERTY	4.770476712545075
CHAOS GAME REPRESENTATION TECHNIQUE	4.770476712545075
BINDING PROTEIN-BETA CCAAT-ENHANCER	4.770476712545075
ADENOVIRUS SPLICE ACCEPTOR SEQUENCE	4.770476712545075
PROSTATIC INTRAEPITHELIAL NEOPLASIA	4.770476712545075
SELECTED GENE FUNCTIONAL CATALOGING	4.770476712545075
DIFFERENTIATED MACROPHAGE-LIKE CELL	4.770476712545075
MHCK-A IN VITRO AUTOPHOSPHORYLATION	4.770476712545075
GENERALIZED NORMALIZATION PROCEDURE	4.770476712545075
HUMAN OSTEOSARCOMA CELL LINE SAOS-2	4.770476712545075
ENVIRONMENTAL PARAMETER COMBINATION	4.770476712545075
BUSM COORDINATE WORD REPRESENTATION	4.770476712545075
FIBRONECTIN-CONTAINING MATRIX FIBER	4.770476712545075
RECOMMENDED NORMALIZATION PROCEDURE	4.770476712545075
STOP SEQUENCE CRE-MEDIATED EXCISION	4.770476712545075
CORRESPONDING GENE EXPRESSION VALUE	4.770054552628898
PROFILING DATA AFFECTING EXPRESSION	4.770054552628898
ANTISENSE EXPRESSION	4.769941868329207
RGS3 ADENOVIRUS-MEDIATED EXPRESSION	4.769913832656838
BOUND VO EPR SPECTRUM	4.769795330388434
KINETIC ANALYSIS FIBROSARCOMA PAI-1	4.769700340955563
FASTGROUP ANALYSIS QUALITY SEQUENCE	4.769700340955563
classification	4.769599155471763
COVARIATION ANALYSIS IMPLEMENTATION	4.769441550425725
MULTIPARAMETRIC ROBUSTNESS ANALYSIS	4.769441550425725
GENE EXPRESSION ANALYSIS EXPERIMENT	4.769278181039385
SMAD1 YEAST TWO-HYBRID SCREEN STUDY	4.769194385562766
AFFYMETRIX MICROARRAY SUITE VERSION	4.769147770359965
AFFYMETRIX CUSTOM MUSCLE MICROARRAY	4.769147770359965
DISCOIDEUM MYOSIN FILAMENT ASSEMBLY	4.768745997141211
CAMPTOTHECIN PHASE CONTRAST MICROSCOPY	4.7684512589395975
SH3-DOMAIN MUTATION STRIKING EFFECT	4.768211732820888
BASE VECTOR DOCUMENT AVERAGE WEIGHT	4.768122157351571
STEADY-STATE KINETICS	4.7678222151508445
SONICATION	4.767791898098545
REFERENCED	4.767791898098545
VIRAL SEQUENCE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1	4.7677789004914946
ACTIVATED NK CELL INTERLEUKIN 2 CYTOLYTIC ACTIVITY	4.7677789004914946
MICROSCOPY MOUSE LIVER MITOCHONDRIA	4.767705726712294
ONLINE RESOURCE UNIFIED PUBLIC DOMAIN	4.767592794357063
ACTIN NETWORK CONTINUED CONTRACTION	4.767590588796804
DNA-BINDING TRANSCRIPTIONAL MODULATOR	4.76753781013988
C-TERMINAL DELETION NEGATIVE NATURE	4.767375847446487
GHFT1-5 CELL IMPAIRED PROLIFERATION	4.767220804191557
COMPLEX SIGNAL TRANSDUCTION PATHWAY	4.76710489806894
DIVERSE SIGNAL TRANSDUCTION PATHWAY	4.76710489806894
SMAD PROTEASOMAL DEGRADATION SUBJECT	4.767034785989359
RNA SEQUENCE/STRUCTURE QUERY SYSTEM	4.766918342759809
PROGRAMMING RNA STRUCTURE ALIGNMENT	4.766918342759809
EXPRESSING COS-1 CELL GNRH RECEPTOR	4.766852744986378
EXPRESSED MEC-3GFP RESULTING STRAIN	4.766782064768034
TYPE IA TOPOISOMERAS	4.76673918036996
CARBOXYL-TERMINAL WD40 REPEAT DOMAIN	4.766635400333845
TRANSCRIPTIONAL REGULATORY ACTIVITY	4.766438376602728
PAIRWISE PROTEIN-PROTEIN INTERACTION	4.766233556262682
C/EBPΑ-INDUCED PROLIFERATION ARREST	4.766135501407051
MNOC MRNA EXAMINED BRAIN EXPRESSION	4.766079670301253
FINAL CONCENTRATION	4.765992407584124
GTPASE-MEDIATED SIGNAL TRANSDUCTION	4.765980959910228
BUTANEDIONE MONOXIME MAMMALIAN CELL	4.765946753096702
REPRESSED ACTIVATION DOMAIN GLUCOSE	4.765675373037583
OPTIMAL METABOLIC FLUX DISTRIBUTION	4.765675373037583
LEXINGTON	4.765461273764736
AGREEMENT	4.765461273764736
ENDOGENOUS C-CRK IMMUNOPRECIPITATION	4.764920391342524
PREDICTED GSK3 PHOSPHORYLATION SITE	4.764736268065043
ALIGNED NUCLEOTIDE SEQUENCE DATASET	4.764709790000098
AFFYMETRIX OLIGONUCLEOTIDE GENECHIP	4.764540013552906
BINDING COMPLEX HIGH-AFFINITY LIGAND	4.764459642658288
GENOMIC SOUTHERN BLOT HYBRIDIZATION	4.76441593076147
ANDROGEN-MEDIATED CELL CYCLE ARREST	4.764237846238933
PHEROMONE-INDUCED CELL CYCLE ARREST	4.764237846238933
HYAL-2-INCREASED TNF SUSCEPTIBILITY	4.76416222361704
LYSOSOME HETEROGENEOUS DISTRIBUTION	4.764074926535086
RETINOBLASTOMA-RELATED PROTEIN P107	4.763973786557163
RETINOBLASTOMA-RELATED P107 PROTEIN	4.763973786557163
Γ AMINO BUTYRIC ACID POTENTIAL ROLE	4.763892885226745
SIGNALING PLAY Γ AMINO BUTYRIC ACID	4.763892885226745
C/EBPΑ DNA-BINDING-DEFECTIVE MUTANT	4.763723717441482
MASTER TRANSCRIPTION CO-ACTIVATOR CBP	4.763714183565323
STATISTICAL ANALYSIS	4.763357136617332
SIGNALING COMPONENT DSH CYTOPLASMIC	4.7632303311485265
GSK3 IMMUNOKINASE ASSAY SAOS-2 CELL	4.763061120565532
BACKGROUND SUBCELLULAR LOCALIZATION	4.762433442942781
INCLUDING CELL DEATH TM DEVELOPMENT	4.762384357802351
INTRACELLULAR MEMBRANE LOCALIZATION	4.762314734328026
INTRACELLULAR GOLGI/ER LOCALIZATION	4.762314734328026
PROTEIN-1 SMAD1 NUCLEAR INTERACTING	4.762207738948839
P53 PROTEIN PHYSIOLOGICAL REGULATOR	4.762138087246414
INVADING PATHOGEN CYTOTOXIC KILLING	4.762074368406964
INCYTEGENOMICS CDNA MICROARRAY DATA	4.761740964626844
OLIGONUCLEOTIDE MICROARRAY ANALYSIS	4.761732928520076
TISSUE PLASMINOGEN ACTIVATOR ABSENCE	4.761518373506678
CONDITIONAL PROBABILITY	4.761114641312683
SV MOUSE	4.760928143439657
CERVICAL DISLOCATION	4.760921201787648
SCIENTIFIC COMMUNITY	4.760921201787648
NUCLEASE AREA CLUSTAL-W MISALIGNMENT	4.760804369763353
EVOLUTIONARY RELATIONSHIP	4.76076920546563
SACCHAROMYCE MIP MAMMALIAN MODIFICATION	4.760699752774797
USM PROCEDURE GENERAL APPLICABILITY	4.760647555251436
TRANSCRIPTIONAL ACTIVATION PROPERTY	4.760036590592738
AFFINITY-PURIFIED RABBIT POLYCLONAL	4.759790654359169
CDNA MICROARRAY ANALYSIS MICROARRAY	4.759635650852222
BOI2 DISPLAY TWO-HYBRID INTERACTION	4.759555426663254
SAMPLE SYNTHETIC PAIRWISE ALIGNMENT	4.7593927692139495
RHO RESULT CONCLUSIONS INACTIVATION	4.758900149510344
SHEAR-SPECIFIC TRANSCRIPTION FACTOR	4.758887880382511
REGULATING INTEGRIN DEPENDENT EVENT	4.758600904716695
STANDARD NUCLEOTIDE FREQUENCY TABLE	4.758581021334653
DEXAMETHASONE-INDUCED TRANSCRIPTION	4.758445642416602
ALIGNED BASE PAIR JOINT PROBABILITY	4.758396820682747
P53 GSK3Β-DEPENDENT PHOSPHORYLATION	4.75820754549473
TRANSFECTION HUMAN EMBRYONAL KIDNEY	4.758170917193196
MULTIPLE ALIGNMENT CONSENSUS COLUMN	4.757961509264285
TRANSFECTED CELL LINE SCE FREQUENCY	4.757911196889287
ACTIVATED RAW265 LIPOPOLYSACCHARIDE	4.757847734689006
LH SECRETION ESTABLISHED STIMULATOR	4.757613864728707
MAMMALIAN WNT-1 DROSOPHILA ORTHOLOG	4.757406665612065
BINARY REPRESENTATION FINITE-LENGTH	4.7573711694868885
TARTRATE-RESISTANT ACID PHOSPHATASE	4.757309057908414
chimeric	4.757230085006487
MONKEY FIBULIN-1C CARBOXYL TERMINUS	4.757119139812693
CYCLIN-DEPENDENT KINASE INHIBITOR P21	4.7570260450148085
SWITCHING BANDPASS EXCITATION FILTER	4.75691701604969
GROWTH FACTOR REGULATING EXPRESSION	4.756480025567804
STIMULATED NEUTROPHIL CHEMOATTRACTANT	4.7563813351049316
PROGRESSIVE DEPLETION	4.7561806954109915
TESTING PROTEIN-PROTEIN INTERACTION	4.75591499803598
BILAYER	4.755830827974533
OLD DBA	4.755830827974533
SRP-RNA	4.755830827974533
ANTI-HU	4.755830827974533
AP-SITE	4.755830827974533
errorof	4.755830827974533
GND-HCL	4.755830827974533
PRE-AER	4.755830827974533
MM NACI	4.755830827974533
PROSITE	4.755830827974533
GAM IGG	4.755830827974533
LACTATE	4.755830827974533
PM-ONLY	4.755830827974533
P50-LUC	4.755830827974533
CRISTAE	4.755830827974533
e-value	4.755830827974533
PP5 ACT	4.755830827974533
CMV-LAP	4.755830827974533
MATCHES	4.755830827974533
METAZOA	4.755830827974533
FLYBASE	4.755830827974533
CYOABCD	4.755830827974533
ANTI-T7	4.755830827974533
UNC-129	4.755830827974533
THEBPNN	4.755830827974533
end cut	4.755830827974533
OUTFLOW	4.755830827974533
MIDLINE	4.755830827974533
TF GENE	4.755830827974533
HBP-ALL	4.755830827974533
PENTIUM	4.755830827974533
HTK-TAG	4.755830827974533
TYPE 2A	4.755830827974533
EE-Α I2	4.755830827974533
MEIOTIC	4.755830827974533
dextran	4.755830827974533
GST-JNK	4.755830827974533
MYC-TAG	4.755830827974533
OVERLAY	4.755830827974533
PAIRING	4.755830827974533
OUTBRED	4.755830827974533
CORT/GR	4.755830827974533
SC CELL	4.755830827974533
CYCLASE	4.755830827974533
PUBGENE	4.755830827974533
HIRUDIN	4.755830827974533
TITRATE	4.755830827974533
AMNIOTA	4.755830827974533
ANTI-FN	4.755830827974533
SUBPEAK	4.755830827974533
REMOVER	4.755830827974533
RAS S17	4.755830827974533
E15 SMG	4.755830827974533
VESSEL WALL INJURY DIAGNOSTIC MARKER	4.755806343560073
DEPENDENT REGULATION	4.755456711509333
MM ATP CONCENTRATION	4.7548417639360565
GΑ PROTEIN ANTAGONIZING INTERACTION	4.75467823217232
CRANIOFACIAL MORPHOGENESI LABELING STUDY	4.7543239397931405
MONOCYTE DERIVED CELLS CD68 EPITOPE	4.753806461775063
COMPLEMENTARY CLASSIFICATION SCHEME	4.753535400786932
IMMUNOFLUORESCENT LOCALIZATION STUDY	4.75322166928059
BIOCHEMICAL FRACTIONATION TECHNIQUE	4.7531118679929785
INCREMENTAL BENEFIT	4.752918690657735
ALM TOUCH RECEPTOR NEURON MIGRATION	4.752824003574831
FIBRONECTIN DISRUPTED INCORPORATION	4.752332221911048
TRANSFORMATION EXPERIMENT C. ELEGAN	4.752304200804509
TET-REGULATED GFP GENE TRANSFECTION	4.751969186996019
SURROUNDING MEASUREMENT VARIABILITY	4.75170390762389
COMPLEMENTARY MEASUREMENT TECHNIQUE	4.75170390762389
MRNA LEVEL	4.75155269084515
PROTEIN         KINASE C ACTIVATION	4.751348605830025
UNDERSTANDING MAMMALIAN DEVELOPMENT	4.75094950870937
P66 WT P66 WTSUBUNIT	4.750942635500612
CCAF-INDUCED TN PRODUCTION DECREASE	4.750818397957796
POSTULATED CYTOSKELETAL ASSOCIATION	4.750047483660256
ZN(II) CONCENTRATION	4.749859475071204
DNA SEQUENCING MOUSE NOCTURNIN CDNA	4.749694240410597
TRABECULAR MESHWORK DIFFERENTIATION	4.749170154812441
PCR REACTION OLIGONUCLEOTIDE PRIMER	4.7489701523977645
PHOSPHATIDYLSERINE BINDING AFFINITY	4.748938920852552
GUANINE NUCLEOTIDE REDUCED AFFINITY	4.748556446230706
RESIDUE DROSOPHILA RRP-1 N-TERMINAL	4.747692026013796
ABC	4.747606990215075
CO-SEDIMENTATION ASSAY YEAST CYTOSOL	4.747579066737513
UNDERGOING APOPTOSI EPITHELIAL CELL	4.747426033936097
INTERACTION NETWORK COMPLEX TOPOLOGY	4.747303412189084
CANALICULAR MEMBRANE	4.747125939454658
bovine serum albumin	4.7466835355242365
ARABIDOPSIS THALIANA GENOME SEQUENCE	4.746394592777998
INDUCED PRE-B LYMPHOBLASTOID ADHESION	4.746371103629814
BINDING SITE ZN(II)	4.746338439837093
NEOMYCIN PHOSPHOTRANSFERASE ACTIVITY	4.745810291153513
protein conformational	4.745755657461973
STRUCTURE DIAGRAM RETRIEVAL MULTIPLE	4.745697722995782
GNRH-STIMULATED IP ATTENUATION RGS3	4.745669791756366
BACKGROUND HETEROTRIMERIC G PROTEIN	4.745302946499742
MCARDLE RH-7777 CELL	4.745267842946892
INTERFACE EXHIBIT HLA-DR EXPRESSION	4.7447659440578835
JACKSON IMMUNORESEARCH	4.744699808978766
INCREASED PLASMA LEVEL	4.744699808978766
FUNDAMENTAL DIFFERENCE	4.744699808978766
COMPUTATIONAL STRATEGY	4.744699808978766
DEMONSTRATED DIFFERENCE CHR SAMPLE	4.744469256404654
CONTAINING PGBT9 Y190 TRANSFORMANT	4.744469256404654
PHYLOGENETIC DOMAINS/TWO ORGANELLE	4.744469256404654
AMINOTERMINAL CYSTEINE-RICH-DOMAIN	4.744469256404654
envelope surface glycoprotein--the	4.744469256404654
PROLIFERATIVE NEUROEPITHELIAL CELL	4.744469256404654
INTERACTING SNP WITHTWO FUNCTIONAL	4.744469256404654
MYOINOSITOL-LABELED PITUITARY CELL	4.744469256404654
SYNAPTOJANIN(AN IPP FAMILY MEMBER)	4.744469256404654
CONTRACTED TYPE I SPARC-NULL MOUSE	4.744469256404654
POSSIBLE PAIR-WISE DATA COMPARISON	4.744469256404654
PARALLEL TISSUE CULTURE EXPERIMENT	4.744469256404654
PROBE SET HUGENEFL INTENSITY LEVEL	4.744469256404654
RASMC CELL SURFACE RADIOIODINATION	4.744469256404654
LEU2 URA3 LEU2 HIS3 TRP1 MET14 GAL	4.744469256404654
HUMAN TISSUE PLASMINOGEN ACTIVATOR	4.744469256404654
STOCHASTIC MODEL SCALE INDEPENDENT	4.744469256404654
EPISTASIS MODEL SNP BEINGIMPORTANT	4.744469256404654
GFP-C/EBPΑ FUSION CARBOXY TERMINUS	4.744469256404654
TYPE PLASMINOGEN         ACTIVATOR	4.744469256404654
CORRESPONDING CODON-CODON EMISSION	4.744469256404654
BINDING SITE BLOCKING NON-SPECIFIC	4.744469256404654
NON-CONSERVATIVE RESIDUE VARIATION	4.744469256404654
MUSCLECHIP INTER-ARRAY VARIABILITY	4.744469256404654
ETHANE-1-HYDROXY-1,1-DIPHOSPHONATE	4.744469256404654
MOLECULAR WEIGHT REDOX-ACTIVE IRON	4.744469256404654
TNF-TREATED HYAL-2-EXPRESSING CELL	4.744469256404654
REPLACEMENT MUTATION OVERABUNDANCE	4.744469256404654
NUMERICAL PROCEDURE IMPLEMENTATION	4.744469256404654
BIOTIN-LABELED GOAT ANTI-MOUSE IGG	4.744469256404654
MODELING NONLINEAR EPISTASIS MODEL	4.744469256404654
PROFILING TECHNOLOGY PARALLEL GENE	4.744469256404654
PROLIFERATING KI67 EPITHELIAL CELL	4.744469256404654
PERFORMED RANDOMVARIABLE SELECTION	4.744469256404654
COATED GLASS COVERSLIP POLY-LYSINE	4.744469256404654
TWO-STEP GENE REPLACEMENT STRATEGY	4.744469256404654
NUMERICAL USM THEORETICAL PROPERTY	4.744469256404654
CYTOSKELETAL INTERMEDIATE FILAMENT	4.744469256404654
ALTERNATING CURRENT FIELD PREPULSE	4.744469256404654
INHIBITORY ACTIVITY RESIDUAL PAI-1	4.744469256404654
CYTOSKELETON-ASSOCIATED POPULATION	4.744469256404654
PROPOSED COORDINATE REPRESENTATION	4.744469256404654
TNF/TNF RECEPTOR-SIGNALING COMPLEX	4.744469256404654
PREPARED SLIDE CONFOCAL MICROSCOPY	4.744469256404654
GENE TREE INTERNAL NODE ANNOTATION	4.744469256404654
OVARIAN CANCER POTENTIAL BIOMARKER	4.744469256404654
ARCHITECTUREOPTIMIZATION PROCEDURE	4.744469256404654
THREONINE558-PHOSPHORYLATED MOESIN	4.744469256404654
COMPENSATORY ANTIAPOPTOTIC PATHWAY	4.744469256404654
THESEMODEL BIOLOGICAL PLAUSIBILITY	4.744469256404654
STUDYING MECHANISM POTENTIAL MODEL	4.744469256404654
EQUIVALENT STANDARD USM COORDINATE	4.744469256404654
PHYLOGENETIC TREE SELECTED PORTION	4.744469256404654
EVALUATING THECLASSIFICATION ERROR	4.744469256404654
CALCULATED NEUTRAL DRIFT FREQUENCY	4.744469256404654
SOMATIC CELL TRANSCRIPTS ASSOCIATE	4.744469256404654
CORTICAL ACTIN-MYOSIN-II STRUCTURE	4.744469256404654
VIRAL QUASISPECY SELECTED MUTATION	4.744469256404654
ZEBRAFISH VENTRAL NEURAL PRECURSOR	4.744469256404654
NON-SPECIFIC IMMUNOGOLD BACKGROUND	4.744469256404654
'-GAGCAGCGGTTTGCATTTCTTGTTCGAAGTCC	4.744469256404654
PERINUCLEAR/INTRACELLULAR MEMBRANE	4.744469256404654
3'CACAGCCAGGATGGATCCTCAATGGTCATAGG	4.744469256404654
TRANSCRIPTION/TRANSLATION PROTOCOL	4.744469256404654
HRP-CONJUGATED GOAT ANTI-MOUSE IGG	4.744469256404654
FASTGROUP GRAPHICAL USER INTERFACE	4.744469256404654
RING CHROMOSOME ELEVATED FREQUENCY	4.744469256404654
GSK3Β POTENTIAL ROLE CLARIFICATION	4.744469256404654
2-D WESTERN BLOT ARRAY METHODOLOGY	4.744469256404654
PURIFIED PROTEIN-FREE PGR(ALA)-GFP	4.744469256404654
ZEBRAFISH EMBRYO NEUROGENIC REGION	4.744469256404654
BRING GROWTH- ACTIVATING SUBSTANCE	4.744469256404654
SIGNALING PATHWAY WNT DEREGULATION	4.744469256404654
TRANSFERASE-MEDIATED DUTP NICK END	4.744469256404654
MICROPLATE READER MOLECULAR DEVICE	4.744469256404654
OVARIAN CANCER SUSCEPTIBILITY GENE	4.744469256404654
REPRESENTATIVE FIELD SCREEN CAPTURE	4.74442944571693
PROBE SET MEASURE EXPRESSION LEVEL	4.744134091088514
R STATE	4.744090365006228
PROFILING PROCEEDS GENE EXPRESSION	4.74405029975948
PERIODIC ORBIT ANALYTIC EXPRESSION	4.74405029975948
TRANSITION PROBABILITY DISTRIBUTION	4.743941773431206
CONDITION-SPECIFIC GENE EXPRESSION	4.743910647544422
IN VIVO FOOTPRINTING ANALYSIS SHOW	4.743852871903736
GEL RETARDATION ASSAY	4.743847201952064
GENE CHIP	4.743801029676399
HISTOLOGICAL ANALYSIS WOUND TISSUE	4.743698775778507
PERFORMED ULTRASTRUCTURAL ANALYSIS	4.743441948903126
HORIZONTAL TRANSFER	4.743370174521259
NEURAL NETWORK POSSIBLE DISADVANTAGE	4.743311278051873
DIVISION FURROW SYMMETRIC PLACEMENT	4.743058536936502
FIBRILLAR FIBRONECTIN CONCENTRATION	4.7429620532838355
CA SUBSTRATE DOMAIN PHOSPHORYLATION	4.7428901733059545
GARPIKE RECENT EMBRYOLOGICAL STUDY	4.742878510250364
SIMPLEX VIRUS THYMIDINE KINASE HNF	4.742875445228872
SETTING SIMPLE FOLD CHANGE CUT-OFF	4.7427741990271315
HIGH-DENSITY MICROARRAY EXPERIMENT	4.742710778513007
GENE EXPRESSION BACKGROUND CONTROL	4.7425773866536565
EXOGENOUS PEPTIDE NONSPECIFIC EFFECT	4.74245342673943
COVALENT MODIFICATION	4.742242549327903
CLUSTERING ALGORITHM SUBSEQUENTIAL	4.7422165657722175
MODIFIED T7-PCMV6 VECTOR XHO1 SITE	4.742132567138465
COMPARISON ANALYSIS MOID ALGORITHM	4.74200925780418
FINAL DIALYSIS BUFFER	4.741977703780124
CALCULATING EXPRESSION FOLD CHANGE	4.741931478037578
BIOCHEMICAL CHANGE ENOS EXPRESSION	4.741931478037578
EXPRESSION CHANGE T-TEST DETECTION	4.741931478037578
RRNA SEQUENCE COMPARATIVE ANALYSIS	4.741733024827388
LACKED FILOPODIAL ACTIN MICROSPIKE	4.741605032027124
INTRON COMPARATIVE STRUCTURE MODEL	4.741589075345354
OTHER UNIDIRECTIONAL PROMOTER GENE	4.741410129184866
GR-RESPONSIVE GENE PROMOTER REGION	4.741410129184866
CONTAINING ROSA26 GENOMIC SEQUENCE	4.741391920094271
PRIMARY DERMAL FIBROBLAST MONOLAYER	4.74129360645867
BLOCKED GHFT1-5 CELL PROLIFERATION	4.741238053278752
STRUCTURAL RNA PREDICTED STABILITY	4.740937886868149
TBID SUBMITOCHONDRIAL LOCALIZATION	4.740934264950676
TGF-Β-INDUCED ANTIAPOPTOTIC FACTOR	4.7409282118831175
APPLIED PHOTOPHYSICS	4.740694066927777
FROG DELTA-1 PROTEIN NEGATIVE FORM	4.740597106608371
BACKGROUND HYBRIDIZATION INTENSITY	4.740552646555076
PHOSPHOPROTEIN SUBSTRATE PREPARATION	4.740549210939535
FIBRONECTIN HEPARIN-BINDING REGION	4.740530265927364
TRANSCRIPTIONAL REGULATORY ELEMENT	4.740461562605086
INTERMEDIATE FILAMENT CYTOSKELETON	4.740291539231771
CALMODULIN MOLECULE	4.740069085739039
GNRH RECEPTOR RESPONSIVENESS LEVEL	4.7399736694468775
IN VITRO GSK3 PHOSPHORYLATION SITE	4.739911746761509
PHOSPHORYLATE INTRACELLULAR REGION	4.739904201215742
MONOCLONAL ANTI-PHOSPHORYLATED P53	4.739889034919433
STANDARD IMMUNOPRECIPITATION METHOD	4.739832869217846
ENHANCED TNF SUSCEPTIBILITY HYAL-2	4.739769324585161
NEURAL PRECURSOR CELL DISTRIBUTION	4.739704348569223
CONTAINING EQUIVALENT CELL PROTEIN	4.739629069159301
INTERACTING RING-H2 FINGER PROTEIN	4.739629069159301
ENHANCED GREEN FLUORESCENT PROTEIN	4.739629069159301
ELUDED POSITIONAL CLONING CHH LOCUS	4.739605877785793
NON-RECEPTOR SERINE/THREONINE KINASE	4.739269225290914
POSSIBLE FUTURE PROTEIN EXPRESSION	4.739210112514128
TN ANTISENSE INHIBITION EXPERIMENT	4.739027230087346
CRITICAL CDK2 PHOSPHORYLATION SITE	4.738772369350722
INCREASED NUCLEOTIDE EXCHANGE RATE	4.738746092196415
DETERMINED PROTEIN-INTERACTION MAP	4.738676623349816
UNLIGANDED GLUCOCORTICOID RECEPTOR	4.738475140460952
TRIS(HYDROXYMETHYL) AMINOMETHANE PH	4.738389499785766
INDIVIDUAL TRANSCRIPT DISTRIBUTION	4.738116045957413
DETAILED PHYLOGENETIC DISTRIBUTION	4.738116045957413
THDP-UTILIZING ENZYME	4.737881425974484
EXTRACELLULAR STIMULUS	4.737731706229913
HSN3-CONTAINING PROTEASOME COMPLEX	4.7376442729044
INCYTE GLASS SLIDE CDNA MICROARRAY	4.737533686255703
MEAN SIGNAL INTER-ARRAY VARIABILITY	4.7374576024921895
DEVELOPED DNA MICROARRAY TECHNIQUE	4.7373296021808144
OTHER EXTRACELLULAR MATRIX PROTEIN	4.737321066926515
FLAG-PEPTIDE AFFINITY CHROMATOGRAPHY	4.737266133751742
PRIMARY MOUSE ASTROCYTE GROWTH RATE	4.7371516454500195
OOCYTE MRNA POLARIZED LOCALIZATION	4.736782371578999
CALCIUM-DEPENDENT FIBULIN-1 EXHIBIT	4.736758567783723
BIOLOGICAL REACTION FIXATIVES STOP	4.736694933094214
METABOLIC REACTION IDENTIFYING SET	4.736694933094214
NORMAL LIGAND-DEPENDENT TRANSLOCATION	4.7366688792770075
SUBSTRATE DOMAIN CONTROLS ADHESION	4.736636036705499
AB-DEPENDENT CELLULAR CYTOTOXICITY	4.736636036705499
MISMATCHED CONTROL OLIGONUCLEOTIDE	4.736613719840259
MISMATCHED OLIGONUCLEOTIDE CONTROL	4.736613719840259
HUMAN APE1 PROTEIN PREPARED MUTANT	4.736576053829472
C-TERMINAL DELETION FUSION PROTEIN	4.736551732848919
CELLULAR FUNCTION PRIMARY CATEGORY	4.736422680526923
OBSERVED PROBE SIGNAL DISTRIBUTION	4.7363581187948265
BINARY EXPRESSION TREE FORM TOLOOK	4.736330430708979
CRE-DEPENDENT LACZ REPORTER STRAIN	4.736227488059921
GUANINE NUCLEOTIDE EXCHANGE FACTOR	4.736090308805263
SYMBOL REPRESENTATION THCOORDINATE	4.735959091793227
GENECHIP HYBRIDIZATION	4.735831314571135
Β-GALACTOSIDASE FILTER PAPER ASSAY	4.735270101597817
BINDING SITE SERUM RESPONSE FACTOR	4.73524201453501
FORM SD	4.735213429591168
MUTANT RAT GLUCOCORTICOID RECEPTOR	4.734947353473253
GENE EXPRESSION QUANTITATIVE ASSAY	4.734851144952643
PEPTIDE (SEQUENCE KRREILSRRPS(P)YR	4.734850791285691
SENSITIVE PHOSPHATASE OKADAIC ACID	4.734668450714716
GARPIKE DEVELOPMENT BLASTULA PHASE	4.734430567081465
ADULT SD RAT TRANSECTED OPTIC NERVE	4.734375583917604
HETERODIMERIC ENZYME	4.734332488089715
MAXIMAL TRANSCRIPTIONAL ACTIVATION	4.734108352157845
SINGLE POINT MUTATION	4.733918174837095
AFFECTING TYROSINE PHOSPHORYLATION	4.733782270974634
INCREASED TYROSINE PHOSPHORYLATION	4.733782270974634
TYPE ES	4.733585740245113
BMP-INDUCED TRANSCRIPTION RESPONSE	4.733010299452926
RHO CAUSES RETRACTION INACTIVATION	4.732980534179227
MARGINAL ORTHOLOGY BOOTSTRAP VALUE	4.732980534179227
GAD1 MUTANT CLEFT PALATE PHENOTYPE	4.732973613262223
TRANSCRIPTION FACTOR JUXTAPOSITION	4.7329683581472555
KB BAND	4.732776827964043
F-BOX-DEPENDENT P27 UBIQUITYLATION	4.732375864588414
DETERGENT TREATMENT CAUSES REMOVAL	4.732170901649948
SELECTING MULTIPLE KERNEL DOCUMENT	4.732049016160948
CONTAINING FORMALDEHYDE AGAROSE GEL	4.731960559874898
PET-GST-PPT1 RESTRICTION DIGESTION	4.731704009487512
FITC-CONJUGATED SECONDARY ANTIBODY	4.731503927247432
ANTI-MOUSE IMMUNOGLOBULIN ANTIBODY	4.731503927247432
OLIGONUCLEOTIDE PRIMER	4.731359167818568
PRIMARY MOTOR NEURON SPECIFICATION	4.7313291583580135
REICHERT ULTRACUT S ULTRAMICROTOME	4.731325379282342
ECM MOLECULE PRECOCIOUS DEPOSITION	4.731127514465448
TRYPTOPHAN CATABOLISM	4.731001327188859
VASCULAR ENDOTHELIAL GROWTH FACTOR	4.7309977303326605
JUXTANUCLEAR AGGREGATE ACCUMULATION	4.730977632440731
SPECIALIZED MESENCHYMAL CELL CONTRIBUTION	4.7309011896162305
CONSERVATION DIAGRAMS CONSERVATION	4.730682789734141
ELAPSED EXECUTION TIME MEASUREMENT	4.730496486130486
INTRAOCULAR MACROPHAGE RECRUITMENT	4.730401433271478
IMMUNOFLUORESCENCE MICROSCOPY FIXED	4.730162106712937
PROTEIN-PROTEIN INTERACTION DOMAIN	4.730018033479588
BROWSE PROTEIN-PROTEIN INTERACTION	4.730018033479588
PROMOTED FORMATION MOUSE FOREBRAIN	4.7299741395781805
ES CELL LOSING GERMLINE COMPETENCY	4.729957186225167
DUPLICATION INFERENCE SPECIES TREE	4.729802802499853
FUNCTIONAL RELATIONSHIP IDENTIFICATION	4.729797524339887
BRIDGING HYDROXIDE	4.729762567256755
NEGATIVE SUPERCOIL	4.729762567256755
acidophilum intein	4.729762567256755
OTHER PROTEASOME INTEGRAL COMPONENT	4.729676507843568
INTRACELLULAR RECOGNITION MECHANISM	4.72931918624523
WT TBID TOMOGRAPHIC RECONSTRUCTION	4.729263594635706
NUCLEAR IMPORT/LOCALIZATION SIGNAL	4.729065976490766
SIGNALING NETWORK SINGLE COMPONENT	4.729014014323745
PERIOD GENE HOMOLOGUE IDENTIFICATION	4.728998748469755
PROLIFERATION TRANSCRIPTION FACTOR	4.728660087312721
TRIGGER ZYGOTIC GAP GENE EXPRESSION	4.728463357687102
INDIVIDUAL TRANSFECTION EXPERIMENT	4.7281860280536545
HOMOLOGOUS UNIT PAIRWISE COMPARISON	4.728010520023414
DROSOPHILA S2 CELL ASSAY MAKES USE	4.727831905602307
PHOSPHORYLATION STATUS	4.727500304673057
G2	4.727008160365285
SA	4.727008160365285
INTRACELLULAR POOL	4.726900363220406
BLM ALLELE CONSTITUTIVE EXPRESSION	4.726817216421339
MACROPHAGE DIFFERENTIATION INDUCTION	4.726726387420863
IG-RELATED MOLECULE CHARACTERISTIC	4.726680267152379
GENERAL PRIMARY SEQUENCE ALIGNMENT	4.726668105052503
CARBOXYL ESTER LIPASE-LIKE PROTEIN	4.726372851206885
POSSIBLE GENOMIC DNA CONTAMINATION	4.72633911535802
III1-C POTENTIAL ADHESIVE RECEPTOR	4.72600089917271
METHANOL-FREE FORMALDEHYDE SOLUTION	4.725795241182955
CONTROL TOUCH RECEPTOR NEURON FATE	4.725772162425423
RECOGNIZING SPECIFICITY DETERMINANT	4.7256642104751485
PANEL B	4.725641066056035
PIPERAZINE NITROGEN	4.725571886780281
N-TERMINAL DELETION FUSION PROTEIN	4.725492555483482
GFP-BLM ALLELE PLASMID TRANSFECTION	4.724966518488849
TENASCIN CCAF INCREASES PRODUCTION	4.724960105455815
DISPLAY INTEGRATION POSITION EFFECT	4.724799621440647
SCFG-RELATED PROBABILITY PARAMETER	4.72448886992565
PROTEIN PHOSPHORYLATION ACTIVATION	4.724066613558368
subcellular localization	4.723989431726286
SHOWED DIFFERENTIAL EXPRESSION A20	4.723972921113102
AQUEOUS STOCK SOLUTION FORMALDEHYDE	4.723941975609413
EPITHELIAL-MESENCHYMAL INTERACTION	4.722792422017054
SUBCELLULAR FRACTIONATION APPROACH	4.722788925753444
AMINO-TERMINAL HALF OVER-EXPRESSION	4.722573693091015
DETAILED SECOND-LEVEL VISUALIZATION	4.722573693091015
DETECTED MULTIPLE ANTI-HA ANTIBODY	4.722325019293032
P53-REGULATED GROWTH TRANSCRIPTION	4.72208841242767
TRANSCRIPTIONAL TERMINATION SEQUENCE	4.72175002547726
WEIGHT MODIFICATION	4.721544994780744
SALI RESTRICTION ENDONUCLEASE SITE	4.720922550942629
INCREASED CHIP INFORMATION DENSITY	4.720916613990921
G PROTEIN COUPLED RECEPTOR KINASES	4.720886585089604
PP5 EXPRESSION INDUCED SUPPRESSION	4.720550640662015
ACTINOPTERYGIAN EVOLUTION PHYLOGENY	4.72052764230835
PROTEASE TREATMENT	4.7204718918963176
SEQUENCED	4.720405422191621
SUPPRESSED GNRH-STIMULATED IP RGS3	4.719850565921595
PROAPOPTOTIC WOX1 HYAL-2 INDUCTION	4.719850565921595
MUTANT PURIFICATION	4.719751556902396
EXPRESSING EGFP-CPLA	4.719254491838174
RNA SEQUENCE/STRUCTURE INFORMATION	4.7189622148329375
HYBRIDIZATION SIGNAL QUANTIFICATION	4.7186222929499655
SYNTHETIC DATA SETS REPRESENTATIVE	4.718619631397442
LIPOPOLYSACCHARIDE TERNARY MIXTURE	4.718419961091385
POLYCLONAL ANTIBODY ELECTROPORATION	4.718375427892395
TRANSCRIPTION FACTOR BINDING ENERGY	4.718372977042911
PROTEIN         KINASE B KEY TARGET	4.718061327731487
NOTE THATTHE OPTIMAL ARCHITECTURE	4.717729100290839
HL-60 PROMYELOCYTIC LEUKEMIA CELL	4.717729100290839
C/EBPΑ DNA-BINDING-DEFECTIVE FORM	4.717729100290839
BACT517 SITE DETECTION STRINGENCY	4.717729100290839
NORMAL SV40-TRANSFORMED CELL LINE	4.717729100290839
RESVERATROL-INDUCED MORPHOLOGCIAL	4.717729100290839
ENTERING INTERMEDIATE LAYERS SHOW	4.717729100290839
CRANIAL PARAXIAL MESODERM-DERIVED	4.717729100290839
USING MOLEGO STRUCTURAL ALIGNMENT	4.717729100290839
ANGIOGENESIS INHIBITOR ENDOSTATIN	4.717729100290839
GP120 THREE-DIMENSIONAL STRUCTURE	4.717729100290839
PERMITTING NONCANONICAL BASE PAIR	4.717729100290839
NORMAL DIPLOID SMOOTH MUSCLE CELL	4.717729100290839
ANTERIOR-POSTERIOR CELL MIGRATION	4.717729100290839
MOLECULAR EVENT CURRENT KNOWLEDGE	4.717729100290839
ENHANCED SIGNAL-PROPAGATION SPEED	4.717729100290839
CHAOS GAME         REPRESENTATION	4.717729100290839
REPRESENTATION ITERATIVE FUNCTION	4.717729100290839
P27 TIME-DEPENDENT DOWNREGULATION	4.717729100290839
TCF FAMILY MEMBER ELK-1 SYNERGIZE	4.717729100290839
CYTOSKELETAL MATERIAL MARKED LOSS	4.717729100290839
PLASMINOGEN ACTIVATOR INHIBITOR-1	4.717729100290839
MEASURED GENE TRANSCRIPTS DISPLAY	4.717729100290839
POSITIVE Β-GALACTOSIDASE ACTIVITY	4.717729100290839
SMOOTH MUSCLE CELLS/MYOFIBROBLAST	4.717729100290839
STANDARD USM OVERESTIMATION ERROR	4.717729100290839
CONTAINING HEPES-BUFFERED TCM-199	4.717729100290839
IMPLEMENTATIONOF CROSS-VALIDATION	4.717729100290839
SΑ I2 RESULTING RAPID DEGRADATION	4.717729100290839
PITUITARY PROGENITOR GHFT1-5 CELL	4.717729100290839
ESSENTIAL GLYCOLYTIC GENE PRODUCT	4.717729100290839
TERMED PSEUDOPOD CELLULAR PROCESS	4.717729100290839
DEVELOPMENTAL GANGLION CELL DEATH	4.717729100290839
BI-DIRECTIONAL OVER-DETERMINATION	4.717729100290839
SECONDARY STRUCTURE DIAGRAMS FILE	4.717729100290839
HES1 TARGETED MUTATION HOMOZYGOUS	4.717729100290839
BIOTIN-CONJUGATED ANTI-RABBIT IGG	4.717729100290839
SECONDARY STRUCTURE-AWARE SCORING	4.717729100290839
C. ELEGAN ANTERIOR-POSTERIOR AXIS	4.717729100290839
PROCESSING SYSTEM METAMORPH IMAGE	4.717729100290839
INHIBITION COORDINATES TRANSITION	4.717729100290839
USING EPI-FLUORESCENCE MICROSCOPY	4.717729100290839
QUASI SOFTWARE EXECUTABLE VERSION	4.717729100290839
POST-TRANSLATIONAL PALMITOYLATION	4.717729100290839
PORCINE OOCYTE DEFINED IVM SYSTEM	4.717729100290839
P35-C/EBPΒ TRANSACTIVATION DOMAIN	4.717729100290839
HIGH-THROUGHPUT TWO-HYBRID SCREEN	4.717729100290839
CELL WALL INTEGRITY NETWORK MODEL	4.717729100290839
INVERTED MICROSCOPE OLYMPUS IMT-2	4.717729100290839
GLUCOSE-6-PHOSPHATE DEHYDROGENASE	4.717729100290839
MARROW MICROENVIRONMENT INFLUENCE	4.717729100290839
OPTIMAL KERNEL DOCUMENT CANDIDATE	4.717729100290839
ENDOGENOUS ARR INDEPENDENT ACTION	4.717729100290839
PREPARING CELL STANDARD PROCEDURE	4.717729100290839
PROLIFERATING HL-60 PROMYELOCYTIC	4.717729100290839
PHYLOGENETIC GROUPS/CELL LOCATION	4.717729100290839
FLUOSTAR GALAXY MICROPLATE READER	4.717729100290839
POLYVINYLIDENEDIFLUORIDE MEMBRANE	4.717729100290839
PHOSPHOENOLPYRUVATE CARBOXYKINASE	4.717729100290839
DIVIDING DICTYOSTELIUM DISCOIDEUM	4.717729100290839
INCLUDING FLUORESCEIN FLUOROPHORE	4.717729100290839
RETAINED TRAP ACTIVITY OSTEOCLAST	4.717729100290839
GP120 CARBOHYDRATE-BUILDING MODEL	4.717729100290839
MM OBLONG FULL-THICKNESS EXCISION	4.717729100290839
TIME-LAPSE VIDEOCASSETTE RECORDER	4.717729100290839
RESULTS	4.717625207466665
INDUCED WOX1 EXPRESSION L929 CELL	4.71739656978731
PATHWAY MEMBER EXPRESSION PROFILE	4.717313437161427
HB-EGF EXPRESSION INCREASED LEVEL	4.717313437161427
METAL CHELATE RESIN CHROMATOGRAPHY	4.717259124818115
THROUGHPUT MICRO-ARRAY EXPRESSION	4.717174882784956
DATA ANALYSIS SECTION OFTHE PAPER	4.717117561332038
FASTGROUP ANALYSIS INCREASE SPEED	4.716964676592338
BLOTTING ANALYSIS HPB-ALL WESTERN	4.716964676592338
MOLECULAR CLOCK ANALYSES ANALYSIS	4.716964676592338
CONTEMPORANEOUS PROTEOME ANALYSIS	4.7167098686928375
CONVENTIONAL BIOCHEMICAL ANALYSIS	4.7167098686928375
CELLULAR FUNCTION DIVERSE SPECTRUM	4.716523715856317
trials	4.7162936939376285
NORMALIZATION MAS4 MAS4 ALGORITHM	4.716052864010792
STANDARD SCFG ALIGNMENT ALGORITHM	4.716052864010792
MICROARRAY RESULT REPRODUCIBILITY	4.715984446203443
CONTAINING GSTCDC6	4.71582086372486
PARSING ALGORITHM STORMO/HAUSSLER	4.715494118584109
BMP SMAD1-REGULATED GENE RESPONSE	4.715125403327923
BLM STABLE NUCLEOLAR LOCALIZATION	4.715098698743688
QUARTILE	4.715075994324345
concepts	4.715075994324345
OPTRONIC	4.715075994324345
TRITON-X	4.715075994324345
ABSTRACT	4.715075994324345
EXPONENT	4.715075994324345
ISOLATED MOUSE LIVER MITOCHONDRIA	4.715000758260549
CHARACTERISTIC MORPHOLOGIC CHANGE	4.714926213396334
GLYCOSAMINOGLYCAN-DEGRADING ENZYME	4.714805752298018
FIBRONECTIN FIBRILLAR MATRIX FORM	4.714798081424013
INTERACTING REGION C-TERMINAL CRK	4.714675955637896
EXTRACELLULAR MATRIX GLYCOPROTEIN	4.714675955637896
BINDING DOMAIN C-TERMINAL F-ACTIN	4.714675955637896
SMG EPITHELIAL CELL PROLIFERATION	4.714523298405249
THIAMINE TRANSPORT	4.714426932741617
RNA SECONDARY STRUCTURES FUNCTION	4.714225491672708
RNA SECONDARY STRUCTURE ALIGNMENT	4.714225491672708
RNA SECONDARY STRUCTURE CONSENSUS	4.714225491672708
DISCUSSION MYOSIN-II LOCALIZATION	4.714221898227971
SCALING FACTOR POST-HYBRIDIZATION	4.714215892744987
GFP-MHCK DIFFERENTIAL LOCALIZATION	4.714164426755506
TEMPORAL LOCALIZATION DIFFERENTIAL	4.714164426755506
AFFYMETRIX GENECHIP HYBRIDIZATION	4.713843279823457
LYSOSOMAL PH MEASUREMENT VALIDATION	4.713726508693172
CYTOSKELETON STRUCTURAL INTEGRITY	4.713584225125631
PROLIFERATION CANDIDATE MECHANISM	4.713454697776719
PROLIFERATION CONTINUING BLOCKAGE	4.713454697776719
ENDOPLASMIC RETICULUM PROTEIN PDI	4.712926962884688
ASSOCIATED ENDOGENOUS PROTEIN ΔN3	4.712926962884688
BCL-2 FAMILY PROAPOPTOTIC PROTEIN	4.712926962884688
BINDING DOMAIN-SRF FUSION PROTEIN	4.712926962884688
GLU351 MUTANT IMPROVED REACTIVITY	4.712742297357699
SIMPLEX THYMIDINE KINASE PROMOTER	4.712717419263919
ROHON-BEARD SPINAL SENSORY NEURON	4.712675619485967
EXPRESSED DLA POST-MITOTIC NEURON	4.712675619485967
MYOSIN-II MONOMER CYTOPLASMIC POOL	4.712595057547523
INSTITUTIONAL REVIEW BOARD APPROVAL	4.71259389737142
RNA SECONDARY STRUCTURE ALGORITHM	4.71254925539266
REDUCED FUSION PROTEIN EXPRESSION	4.712511299755277
COMPARING MRNA EXPRESSION PROFILE	4.712317382274793
CAS PHOSPHORYLATION REDUCED LEVEL	4.7120769977928285
MAPPED MHC PHOSPHORYLATION TARGET	4.7120769977928285
MOUSE BALB/C RETINAL CDNA LIBRARY	4.711894844726541
ASYNCHRONOUS LNCAP CELL INFECTION	4.711833372685155
ANTI-RABBIT HORSERADISH PEROXIDASE	4.7116443357605755
SERUM PROTEOMIC POSSIBLE STRENGTH	4.711524322447761
P38 PHOSPHORYLATION	4.711476026269258
PROAPOPTOTIC INCREASED ACTIVATION	4.711425833910569
CYTOCHROME C-DEPENDENT ACTIVATION	4.711425833910569
BDM TREATMENT UN-DESCRIBED EFFECT	4.711311807430243
PAIRWISE COMPARISON SURVIVAL METHOD	4.711305507377375
PUTATIVE DOMINANT-NEGATIVE MUTANT	4.711080029713318
ΜL/ML PROTEASE INHIBITOR COCKTAIL	4.710890056268246
PSEUDOPODIA FIBROBLAST RETRACTION	4.710785908389729
COMPUTER ANALYSIS SEQUENCE HOMOLOGY	4.710725397193726
EXPRESSION FOLD CHANGE CALCULATION	4.710598599240957
SERINE/THREONINE PROTEIN PHOSPHATAS	4.710543495627635
DISTRIBUTION STATISTICAL ANALYSIS	4.710406602312567
P21 POST-TRANSCRIPTIONAL STABILIZATION	4.71021316624858
ENTERING GENBANK ACCESSION NUMBER	4.710186037030626
T7 TAG ANTIBODY (AB)-AGAROSE BEAD	4.710011056879762
LYSOSOMAL OXIDATIVE BURST ACTIVITY	4.710003089728372
VASCULAR CELL ADHESION MOLECULE-1	4.709957459356074
PROTEIN PHOSPHATASE TYPE 5 PHYSIOLOGICAL SUBSTRATE	4.709931087920875
ENCODING TRANSCRIPTION RETROVIRUS	4.709831820819022
BLASTN PRIMARY SEQUENCE ALIGNMENT	4.709745780420108
IN SILICO DELETION STRAIN E. COLI	4.709604704022865
TRANSCRIPTIONAL MODULATOR FUNCTION	4.709128683808466
DOSE-DEPENDENT MANNER	4.708952079428891
SINGLE GENE EXPRESSION TIME POINT	4.7083353758141575
MONOCLONAL 16A11 ANTI-HU ANTIBODY	4.708081546026993
CARDIOVASCULAR HEALTH STUDY CONTRIBUTION	4.708046588776755
SEQUESTERING PROTEIN ACTIN MONOMER	4.708043039218202
MRNA SPATIAL DISTRIBUTION PROFILE	4.708005595619002
CYTOSKELETAL PROTEIN LOCALIZATION	4.707819048353103
ISL1-CRE MOUSE STRAIN CONSTRUCTION	4.707803121642652
COMPARATIVE EXON FINDING APPROACH	4.707671682610555
RNA GENE	4.70766314981876
EXCESS NEURON INDICATING FORMATION	4.70764753407113
SECONDARY STRUCTURE RETRIEVAL PAGE	4.707541220680066
ANTI-NF-ΚB P65 ANTIBODY EXPERIMENT	4.707535127950199
DIAMINOBENZIDINE REACTION PRODUCT	4.707444823565135
GFP PRIOR FLUORESCENCE ACTIVATION	4.7068953611997495
PH-20-ENHANCED CYTOTOXIC FUNCTION	4.7066983841253665
SΑ I2 GOLGI MEMBRANE LOCALIZATION	4.7062988099314005
INTRA-PATIENT TISSUE HETEROGENEITY	4.706173515653229
FIBULIN-1 CARBOXYL-TERMINAL DOMAIN	4.706173515653229
TARGETING FUNCTION GOLGI MEMBRANE	4.706071638888692
INCREASED ADHESIVE STATE INDUCTION	4.705877795647426
ACTIVATED RAS RESULT TRANSFECTION	4.705612683715379
PYRENE-ACTIN POLYMERIZATION ASSAY	4.7055599828129155
DEATH CERTIFICATE	4.705418442273773
INHIBITED LH SECRETION ADENO-RSG3	4.705064203952704
PEPTIDE PHOSPHORYLATION LAG PHASE	4.704919858699417
INDUCED MP-RELEASE NM CAMPTOTHECIN	4.704700602547406
SUPPRESSED OSTEOCLAST DEVELOPMENT	4.7044494031595905
JUXTACRINE GROWTH FACTOR ACTIVITY	4.7043634770227785
GENECHIP EXPRESSION ANALYSIS MANUAL	4.704160013969023
HOMOLOGOUS RESIDUE	4.703726855841771
N-TERMINAL DELETION PROTEINS SHOW	4.70370371704138
TRANSCRIPTION ACTIVATION FUNCTION	4.703528554438752
MONOCLONAL ANTI-Β-TUBULIN REAGENT	4.703481091910437
VARIOUS INTEGRIN-BLOCKING REAGENT	4.703481091910437
YEAST PROTEIN-PROTEIN INTERACTION	4.703391481794836
THATEXHIBIT GENE-GENE INTERACTION	4.703391481794836
ADENOVIRAL-MEDIATED GENE TRANSFER	4.702861613285202
MEMBRANE TRANSPORT PATHWAY ASPECT	4.702493606181101
TARGETING KEY TRANSCRIPTION FACTOR	4.702272641143798
DISTAL MAIN INTRAPULMONARY ARTERY	4.702185818421309
PHENOTYPE PHASE PLANE CONSTRUCTION	4.702126497164437
OTHER TRANSCRIPTIONAL FACTOR P300	4.702054635662244
PROTEASOME INHIBITOR LLNL ADDITION	4.7020417816556535
ASSOCIATED PROTEIN S PHASE KINASE	4.701873668476519
PHYSIOLOGICAL CONCENTRATION ABSENCE	4.701569934024961
INCLUDING RIBOSOMAL RNA ALIGNMENT	4.701402284130345
MULTIPLE TETRATRICOPEPTIDE REPEAT	4.701298964500825
NADP-DEPENDENT ALCOHOL DEHYDROGENAS	4.701017334336689
E. COLI BL21(DE3)	4.700698522814392
RING FINGER PROTEIN OTHER SUBUNIT	4.7006505309673505
SUBSTRATE PEPTIDE PHOSPHORYLATION	4.700650111502276
MAIN EFFECTSWHEN ALLELE FREQUENCY	4.700631490234356
SPREADING MORPHOLOGY T LYMPHOCYTE	4.700612471758209
OVEREXPRESSING IDO	4.700610948299904
NORMAL SERUM CREATINE KINASE LEVEL	4.700272837445725
ANDROGEN-INDUCED P27 UPREGULATION	4.699731616020857
OPPOSITE UNIDIRECTIONAL COMPARISON	4.699513386826895
AUTOMATED DNA SEQUENCING FACILITY	4.699443616734413
IONIC STRENGTH	4.699195542300834
SENSE STRAND HYBRIDIZATION RESULT	4.699032325657394
PHOSPHORYLATE EXOGENOUS SUBSTRATE	4.698731755783636
INCLUDING HUMAN MAMMALIAN SPECIES	4.698717696694269
TGF-Β1-MEDIATED GROWTH SUPPRESSION	4.698715387366912
LIGAND-ACTIVATED GR TRANSLOCATION	4.698598907220648
OBJECTIVE FUNCTION NUMERICAL VALUE	4.698514367502944
CHIMERIC MOUSE-MONKEY CD9 ANTIGEN	4.698373315321235
TOTAL MYOSIN-II FRACTIONAL AMOUNT	4.698299997953926
GERMINAL CENTER B CELL-LIKE TUMOR	4.698188974512001
SERINE OTHER KINASE PHOSPHORYLATE	4.698065315155119
TRANSBLOTTED IMMOBILON P MEMBRANE	4.697211968223059
POLYMERASE DOMAIN	4.697143258806026
COMPARATIVE STRUCTURE INFORMATION	4.697094053670946
ANGLE MESENCHYMAL DIFFERENTIATION	4.696750437644847
REGULATING TISSUE DIFFERENTIATION	4.696750437644847
COLD OLIGONUCLEOTIDE MOLAR EXCESS	4.6962474876557705
EPITHELIAL-EPITHELIAL INTERACTION	4.696222672546835
SUBCELLULAR FRACTIONATION SOLUBLE	4.696219203768167
AGGRESSIVE PROSTATE CANCERS DISPLAY	4.696055950178947
EXPRESSION VARIATION SIGNIFICANCE	4.695802870214353
PREDICTING ENHANCER ALGORITHM ARGO	4.695780420235396
EXCESS ROHON-BEARD SENSORY NEURON	4.695578009429484
ACTIN CYTOSKELETON RHO REGULATION	4.695232661626094
HOMOLOGOUS BZIP-TYPE TRANSCRIPTION	4.694983900649175
SEMIDOMINANT ROL-6(SU1006) ALLELE	4.694932286882195
NITRIC OXIDE MACROPHAGE SECRETION	4.694596279428326
INCREASE CHIP INFORMATION DENSITY	4.6943616106844654
VISUALIZATION	4.694163819921053
CILIARY BODY POSTERIOR TERMINATION	4.692770006390231
ACID CYTOTOXICITY	4.69253830876414
NUCLEIC ACID SEQUENCE INFORMATION	4.6925290560520905
UBIQUITIN-CONJUGATING ENZYME	4.6924688144207
MEDIATED ACTIVATION IL-8 RECEPTOR	4.691995330155736
RELATIVE CONCENTRATION	4.691789469462049
GENE REGULATION GENERAL MECHANISM	4.691505133557828
BACKGROUND GLUTAMATE DECARBOXYLASE	4.691444384594989
MITOCHONDRIAL ISOLATION BUFFER SD	4.691438607189764
PHOSPHORYLATION MULTIPLE TYROSINE	4.690695991952239
DIMERIC FIBRONECTIN CONCENTRATION	4.690637875058484
OTHER HIV PROTEIN QUASISPECIATION	4.690625732376232
EXHIBITED DIFFERENTIAL EXPRESSION	4.690615488522458
FORELIMB APICAL ECTODERMAL RIDGE	4.690213760166282
MOLEGO STRUCTURE DEFINITION MAKE	4.690213760166282
PHYSICAL LINK FUNCTIONAL OUTCOME	4.690213760166282
BI-DIRECTIONAL OVERDETERMINATION	4.690213760166282
HIGHCROSS-VALIDATION CONSISTENCY	4.690213760166282
ECTOPIC UNC-6 GENETIC SUPPRESSOR	4.690213760166282
SECONDARY STRUCTURE BASE PAIRING	4.690213760166282
MODEL PARAMETER JUDICIOUS CHOICE	4.690213760166282
CORRECTED SCE FREQUENCY RELATIVE	4.690213760166282
NUMEROUS CALCIUM-BINDING TYPE II	4.690213760166282
EQUATORIAL CONTRACTILE APPARATUS	4.690213760166282
WITH/WITHOUT SECONDARY STRUCTURE	4.690213760166282
5'CTAGGGAAGGAATTCGACCCATGTCTTCGG	4.690213760166282
MESENCHYMAL STEM CELL POPULATION	4.690213760166282
DESCRIBING OSCILLATORY BEHAVIOUR	4.690213760166282
PHOSPHOHISTONE DEPHOSPHORYLATION	4.690213760166282
HIDDEN MARKOV             MODELS	4.690213760166282
GAD1 GENE LEAD TARGETED MUTATION	4.690213760166282
INTRAEPITHELIAL MESENCHYMAL CELL	4.690213760166282
OBSERVED PROTEASOMAL DEGRADATION	4.690213760166282
CONVENTIONAL ELECTRON MICROSCOPY	4.690213760166282
DOMAIN-CONTAINING OXIDOREDUCTASE	4.690213760166282
POTENTIAL DOMINANT-NEGATIVE FORM	4.690213760166282
GHFT1-5 CELL C/EBPΑ PROLONGATION	4.690213760166282
TRANSMISSION ELECTRON MICROSCOPE	4.690213760166282
RCCA TUMOR SUB-TYPE PATHOBIOLOGY	4.690213760166282
PREDICTION ERROR FITNESS MEASURE	4.690213760166282
YEAST TWO-HYBRID SYSTEM STRATEGY	4.690213760166282
AFFYMETRIX PROBE ARRAY CARTRIDGE	4.690213760166282
SHUFFLED RNA-GENERATED ALIGNMENT	4.690213760166282
UNLOADED D. DISCOIDEUM MYOSIN-II	4.690213760166282
AFFECTED ULTRASTRUCTURAL FEATURE	4.690213760166282
CONTAINING X-GAL GALACTOSE PLATE	4.690213760166282
RHYTHMICITY SUSTAINED GENERATION	4.690213760166282
BIOLOGICAL SIGNIFICANCE/FUNCTION	4.690213760166282
RECONSTRUCTED EMBRYOS EXPERIMENT	4.690213760166282
CLOSTRIDIUM BOTULINUM RIBOSYLATE	4.690213760166282
MODIFIED YEAST TWO-HYBRID SYSTEM	4.690213760166282
GROWING HL-60 PROMYELOCYTIC CELL	4.690213760166282
NIKON EPIFLUORESCENCE MICROSCOPE	4.690213760166282
CHICKEN CHORIOALLANTOIC MEMBRANE	4.690213760166282
PROSEQUENCE PROTEOLYTIC CLEAVAGE	4.690213760166282
CELLULAR ACTIVITY PHYSICAL MODEL	4.690213760166282
ENDOTHELIAL-LIKE TRABECULAR CELL	4.690213760166282
AVERAGE WITHIN-GROUP COEFFICIENT	4.690213760166282
CYTOSKELETON-ANCHORED POPULATION	4.690213760166282
CROSS-VALIDATION CONSISTENCYTHAT	4.690213760166282
CELL CULTURE A549 LUNG CARCINOMA	4.690213760166282
MOLECULAR SCAFFOLD SELF-ASSEMBLY	4.690213760166282
SKP2-MEDIATED P27 DOWNREGULATION	4.690213760166282
CONCOMITANT ARP3 DE-LOCALIZATION	4.690213760166282
SMAD7 NF-ΚB-DEPENDENT INHIBITION	4.690213760166282
ECTOCERVIX STRATIFIED EPITHELIUM	4.690213760166282
NEIGHBORING LENS EPITHELIAL CELL	4.690213760166282
DUAL-EXCITATION RATIOMETRIC MODE	4.690213760166282
CYTOCHALASIN B-CONTAINING MEDIUM	4.690213760166282
MITOCHONDRIAL MEMBRANE INTEGRITY	4.690213760166282
INTERNAL REFLECTION FLUORESCENCE	4.690213760166282
CATEGORIZATION SUBJECTIVE NATURE	4.690213760166282
APPROXIMATE-MATCH PATTERN SEARCH	4.690213760166282
SPARC-NULL CELL IMPEDED INGROWTH	4.690213760166282
SCALE-INDEPENDENT REPRESENTATION	4.690213760166282
DETECTED HISTOLOGICAL DIFFERENCE	4.690213760166282
YELLOW PHYLOGENETIC LEVEL BUTTON	4.690213760166282
RAS-ASSOCIATED ADENYLATE CYCLASE	4.690213760166282
HEALING WOUND GRANULATION TISSUE	4.690213760166282
ORNITHINE DECARBOXYLASE ANTIZYME	4.690213760166282
CORNEAL ENDOTHELIUM BASAL LAMINA	4.690213760166282
TRANSMISSION ELECTRON MICROSCOPY	4.690213760166282
NORMAL RAT PITUITARY GONADOTROPE	4.690213760166282
ELONGATED DENDRITIC-LIKE PROCESS	4.690213760166282
INDUCED NORMAL GFP-BLM CELL LINE	4.690213760166282
WOX1 APOPTOSIS-INDUCING FUNCTION	4.690213760166282
SIGNALING PATHWAY SMAD1-MEDIATED	4.690213760166282
ITERATIVE MODEL BUILDING PROCESS	4.690213760166282
GUANIDINE THIOCYANATE EXTRACTION	4.690213760166282
SIMPLE CASE PARAMETER ESTIMATION	4.690213760166282
PLATELET NM-MYOSINII S1 FRAGMENT	4.690213760166282
DLA MISSENSE MUTATION HOMOZYGOUS	4.690213760166282
USINGTHE HARDY-WEINBERG EQUATION	4.690213760166282
MICROVASCULAR METABOLIC FUNCTION	4.690213760166282
TRIMERIC LIGAND-RECEPTOR COMPLEX	4.690213760166282
CYLINDRICAL INTERCELLULAR BRIDGE	4.690213760166282
TRANSTHYRETIN REGULATORY ELEMENT	4.690213760166282
CYTOCHROME C-APAF1-CASP9 PATHWAY	4.690213760166282
OXALOACETATE ANAEROBIC SYNTHESIS	4.690213760166282
STRUCTURAL ELEMENT TERTIARY-LIKE	4.690213760166282
INTERSECTING STREET TRAFFIC GRID	4.690213760166282
EPI-FLUORESCENT LAMP INPUT POWER	4.690213760166282
PERI-CENTROMERIC HETEROCHROMATIN	4.690213760166282
QUASI FILE CONVERTER PERL SCRIPT	4.690213760166282
POSSIBLE PATHOPHYSIOLOGICAL ROLE	4.690213760166282
SPECIALIZED ECTODERMAL STRUCTURE	4.690213760166282
REPLICATION-DEFECTIVE RETROVIRUS	4.690213760166282
MOESIN CYTOSKELETON-BINDING SITE	4.690213760166282
DEFINED PRIORTO NETWORK EVOLUTION	4.690003246145191
GNRH RECEPTOR POTENTIAL MODULATOR	4.689953931384853
CHROMATIN CONDENSATION	4.689932966321112
ECTOCERVIX EXHIBIT DIFFERENTIATION	4.689862071129229
GENE EXPRESSION ARRAY TECHNOLOGY	4.689801486030038
INCREASING GENE EXPRESSION LEVEL	4.689801486030038
UPREGULATE DELTA GENE EXPRESSION	4.689801486030038
EXPRESSION TREE REPRESENTATIONOF	4.6896640613179565
CONSTITUTIVE EXPRESSION RELATIVE	4.6896640613179565
LIGHT-RESPONSIVE GENE EXPRESSION	4.6896640613179565
IN SILICO GENE DELETION ANALYSIS	4.689607207219486
E. COLI CYTOPLASM	4.689592829968788
HYGROMYCIN-RESISTANCE EXPRESSION	4.689389211893793
LYSOSOMAL PH SPATIAL DISTRIBUTION	4.689306593090402
RRNA-BASED PHYLOGENETIC ANALYSIS	4.6892028385882885
SERIOUS CROSS HYBRIDIZATION ISSUE	4.689168319855577
IN VITRO STUDY WOUND CONTRACTION	4.688961461620743
PURIFIED D. DISCOIDEUM MYOSIN II	4.688861610573923
MEMBRANE FRACTION	4.68884116417253
CASEIN ZYMOGRAM POSITIVE CONTROL	4.68876434055339
PROTEOLYSIS-STIMULATION ANALYSIS	4.688697377799293
BACKGROUND AFFYMETRIX MICROARRAY	4.688483330628442
regulators	4.688441119018629
PLASMID DNA GENERAL DNA TECHNIQUE	4.688270092459643
INTERNAL HERPES THYMIDINE KINASE	4.688253273522255
MICROARRAY DATA CLUSTER ANALYSIS	4.688157746829407
PERFORMED MICROARRAY ANALYSIS SM	4.688157746829407
PHYLOGENETIC INFERENCE ALGORITHM	4.68799700075833
BACKGROUND EXPRESSION MICROARRAY	4.687933631780116
CONTROL ELECTROPORATION CONDITION	4.687866189302017
VARYING DEGREE HTK PROMOTER SHOW	4.6878054937325535
IMPUTATION METHOD	4.687718744301092
OTHER TRANSCRIPTIONAL CO-ACTIVATOR	4.687436690795421
TRMA MITOCHONDRIA	4.687425841497761
IN SITU HYBRIDIZATION TECHNOLOGY	4.6873231562792075
POPULATION GROWTH/DENSITY EFFECT	4.687264506345267
C/EBPΑ ANTI-PROLIFERATIVE EFFECT	4.687264506345267
GLYCOGEN SYNTHASE KINASE (GSK)-3Β	4.687256481211365
GENOMIC INSTABILITY SHOW FEATURE	4.6871855084750615
EMBRYONIC SMG CELL PROLIFERATION	4.687034095890501
GNRH SIGNAL TRANSDUCTION PATHWAY	4.686920903958352
NERVE-LIKE REGENERATIVE RESPONSE	4.686770468903168
NESTED RNA STRUCTURE CORRELATION	4.686738717241931
GENE TRANSFER	4.6866831258472645
OUTCOME MEASURE	4.68665172360817
measurements	4.686553200732591
DEPOLYMERIZE ACTIN MICROFILAMENT	4.686455708205986
HUMAN PAPILLOMA VIRUS E7 PROTEIN	4.686403372549663
IN VITRO RGS3 PROTEIN GΑ-PROTEIN	4.686403372549663
ALTERED HYBRIDIZATION EFFICIENCY	4.686359621650183
HYBRIDIZATION MAXIMAL DISRUPTION	4.686359621650183
CYTOPLASMIC CARBOXYTERMINAL TAIL	4.686077611514859
RNA SEQUENCE STRUCTURAL ANALYSIS	4.685980526058436
PREDICTED TYROSINE KINASE DOMAIN	4.685971900050842
ECM COMPONENT EXPRESSION PATTERN	4.685826905685311
RHO-MEDIATED SIGNAL TRANSDUCTION	4.6858232852223765
HYBRIDIZATION PROTOCOL STUDY GNF	4.6857577830972845
NADPH OXIDASE COMPLEX ACTIVATION	4.6855248543218115
INTERACTING PROTEIN TARGET SMAD1	4.685450775645509
EXPRESSED MYC-TAGGED RAB PROTEIN	4.685450775645509
DIMINISHED GR PROTEIN EXPRESSION	4.685038501509265
ROSA26 LACZ PROMOTER TRAP STRAIN	4.684918989992838
P27 DEGRADATION MAJOR DETERMINANT	4.68463695179442
AFFYMETRIX OLIGONUCLEOTIDE ARRAY	4.684416081714715
PROGNOSIS CLASSIFICATION ACCURACY	4.684367909936726
CELL DENSITY DEPENDENT MECHANISM	4.6843323002342006
HYAL-2-INCREASED TNF SENSITIVITY	4.6840471385405245
ORIGINAL DISTRIBUTION PERCENTILE	4.683961885706989
MYOSIN-II PERCEIVED DISTRIBUTION	4.683961885706989
INHIBITED BMP-INDUCED ACTIVATION	4.683961885706989
INTRINSIC HISTONE ACETYLTRANSFERASE	4.683652489784593
BLOCK COLLAGEN-INDUCED AGGREGATION	4.683646609328862
DENSITY-DEPENDENT DOWN-REGULATION	4.6835338801778725
MIGRATING MESENCHYMAL CELLS REACH	4.6835338801778725
PHYLOGENETIC GROUP REPRESENTATIVE	4.6835338801778725
PROTEASOME ASSEMBLY INTERMEDIATE	4.683497637603575
SV40-TRANSFORMED FIBROBLAST LINE	4.683327177640055
DERMAL FIBROBLAST ULTRASTRUCTURE	4.683327177640055
CHEMOATTRACT RESIDENT FIBROBLAST	4.683327177640055
MOTIF TRIGGER CARBOXYLTERMINAL SSV	4.683196071202374
EXPRESSION PROFILE REPRESENTATIVE	4.68297966267199
CD3 T CELL MARKER STUDIED CHANGE	4.682976084558323
SUBSTRATE DOMAIN PHOSPHORYLATION	4.682739067286575
PGADA424 BAM HI RESTRICTION SITE	4.682676778179244
DONOR CELL NUCLEUS ORIGINAL SIZE	4.68262996462653
PRIMARY ANTIBODY PRIMARY ANTIBODY	4.682467352021684
BOI1-PH TK MUTANT VERSION ABILITY	4.682404401695353
CYTOSKELETAL DEPENDENT MECHANISM	4.682371813590174
THREE-BY-THREE CONTINGENCY TABLE	4.682233426297654
CONTAINING COMPLEX CLOSE SMAD/AZ	4.681873657147839
OSTEICHTHYIAN DIVISION GINGLYMODI	4.681734131750875
NORMAL ULTRASTRUCTURAL APPEARANCE	4.681734131750875
TRANSCRIPTION FACTOR BZIP FAMILY	4.681725669065949
TRANSCRIPTION FACTOR STAT FAMILY	4.681725669065949
SERINE-THREONINE KINASE RECEPTOR	4.6817012703322165
PROMOTED L929 CELL GROWTH TGF-Β1	4.681699178005194
ANCHORAGE INDEPENDENT MANNER SHOW	4.6815223966418165
DLA DX2 MUTANT EMBRYO OBSERVATION	4.68123727051022
SEQUENCE ALIGNMENT RETRIEVAL PAGE	4.681091364455518
SCFG ALIGNMENT MEMORY REQUIREMENT	4.681091364455518
LNCAP CELL TRANSFORMED PHENOTYPE	4.6810195502122145
CELL LYSATE IMMUNOLOGICAL TECHNIQUE	4.680939232823328
VERTEBRATE PROTEIN NETRIN HOMOLOG	4.6808689440287825
OPEN-LABEL DIURETIC	4.680846609107495
IMPROVED MOTIF DEFINITION METHOD	4.680792532682485
MAMMALIAN CELL	4.680264459172423
MEDIATING INTERCELLULAR ADHESION	4.679936057456685
MODEL WITHEIGHT NON-FUNCTIONAL SNP	4.679845193886624
PLASMODIUM FALCIPARUM	4.67981245326682
TECHNOLOGICAL ADVANCE	4.67981245326682
MORPHOLOGICAL FEATURE	4.67981245326682
EXPERIMENTAL PROTOCOL	4.67981245326682
VOLUME EXPANSION	4.6797577938829455
CONTROLLED TRIAL	4.6797577938829455
AGGRECAN CARBOXYL-TERMINAL DOMAIN	4.679734411276432
INTEIN-FREE HOMOLOG	4.679713400278089
ADHEREN TYROSINE PHOSPHORYLATION	4.679697235991359
RECRUIT OTHER RING FINGER PROTEIN	4.6796921702529515
ABI PRISM SEQUENCING ANALYSIS V.	4.679680450456071
UBIQUITINATION PRIMARY SUBSTRATE	4.679656120028797
BIOCHEMICAL DETERGENT EXTRACTION	4.67961487924701
GROWTH CURVE EXPONENTIAL PORTION	4.679570532464922
FILAMENTOUS GROWTH NETWORK MODEL	4.679570532464922
SENSE TRANSFECTED	4.679540074429989
PROGRAMMING RECOGNITION ALGORITHM	4.679499150044145
WESTERN IMMUNOBLOT ANALYSIS CELL	4.679480151647002
DIVIDING CELL MECHANICAL CONSIDERATION	4.679315517448873
INDUCED NF-ΚB TNF SUPPLEMENTATION	4.67917085368818
N-TERMINAL BLM DELETION SCE DATA	4.679084935201047
SINGLE BATCH DEVELOPMENTAL STAGE	4.678979615090966
ELECTRON MICROSCOPY SUPPORT GRID	4.678908287185726
HOMEODOMAIN TRANSCRIPTION FACTOR	4.6788963053658374
REGULATING EXPRESSION	4.678564517708644
BOUND CALMODULIN	4.678319888710034
NORMAL GFP-BLM GENE TRANSFECTION	4.6781961314074225
BOI1-PH CO-SEDIMENT PHOSPHOLIPID	4.6781007534014005
MURINE MACROPHAGE-LIKE CELL LINE	4.677954813560859
AMERICAN TYPE CULTURE COLLECTION	4.677805314212013
TRITON X-100-RESISTANT COMPONENT	4.677698060357355
PERFORIN TRANSCRIPT UP-REGULATION	4.6774994295697025
CO-IMMUNOPRECIPITATION COS-7 CELL	4.6774994295697025
SΑ I2 INTRACELLULAR ACCUMULATION	4.6774811509345335
LABELED THIAMINE	4.677347432610435
SIGNAL QUANTITATION PHOSPHOIMAGER	4.677307566040458
PRESUMPTIVE PRIMARY MOTOR NEURON	4.677283251401838
MICROSOFT	4.677261862462866
NOVEL CHIMERIC MOLECULE APPROACH	4.677084823801765
RECONSTRUCTED EMBRYO DEVELOPMENT	4.677042335334566
GROWTH FACTOR PATHWAY TRANSCRIPT	4.6769571097724985
TRITON X-100 NON-IONIC DETERGENT	4.67685240496486
GENOME DATA VISUALIZATION TOOLKIT	4.676819537156436
HIGHEST FOLD CHANGE DETERMINATION	4.676768730446135
TOPOISOMERASE I.	4.6766459095535104
PROTEIN ACTION RG MOLECULAR LOCUS	4.676583513879046
PCDNA3	4.676583392646585
TRIGGER PAIR RULE GENE EXPRESSION	4.676362305651749
PH-20-INCREASED TNF CYTOTOXICITY	4.676338861508326
REGULATORY NETWORK IDENTIFICATION	4.676280348638759
CELL-TYPE ENHANCED IDENTIFICATION	4.676280348638759
REGULATORY ELEMENT IDENTIFICATION	4.676280348638759
INTERNAL STRUCTURE IDENTIFICATION	4.676280348638759
POSITIVE SELECTION IDENTIFICATION	4.676280348638759
CORRESPONDING OMIM IDENTIFICATION	4.676280348638759
MANNOSE RECEPTOR	4.67613177214256
S. CEREVISIAE EXPRESSION DATASET	4.676051586459091
REQUIRING ACTOMYOSIN INTERACTION	4.6759930394360225
PROTEIN-PROTEIN INTERACTION PLAY	4.6759930394360225
ACTIN CYTOSKELETAL RESEARCH ASPECT	4.675955190738967
PAIRWISE RNA SECONDARY STRUCTURE	4.675914328217994
RECEPTOR-REGULATED SMAD BMP TYPE I	4.67553692305209
LEUCINE ZIPPER DIMERIZATION DOMAIN	4.675229189421051
BINDING MOTIF N(T)KXD NUCLEOTIDE	4.675160654998444
POST TNF STIMULATION HYAL-2 CELL	4.675049082196461
INVOLVING ANDROGEN ADMINISTRATION	4.674985075149631
B. MORI RECEPTOR	4.674964420414175
TRANSFECTED GHFT1-5 CELL CULTURE	4.674874676222814
IMMUNOCYTOCHEMISTRY	4.674535051119626
GOAT ANTI-MOUSE IGG	4.674535051119626
CARBON CATABOLITE REPRESSION 4 AMINO-TERMINAL HALF	4.674485989816153
DENDRITIC NETWORK REORGANIZATION	4.674438681588762
VITERBI HMM ALIGNMENT ALGORITHM RUN	4.6743974300322275
ANDROGEN-MEDIATED GROWTH CONTROL	4.674090230413945
LABELING SINGLE STRAND PCR PROBE	4.674022956897179
DOCUMENTED PATHWAY UNKNOWN MEMBER	4.673763817288454
SKELETAL MUSCLE PRODUCING MOLECULE	4.67368390333831
PROTEIN TYROSINE PHOSPHORYLATION	4.6733465899636615
HIV	4.673038144836416
EXTRACELLULAR MATRIX INTERACTION	4.672964787744802
homologous	4.672636579878324
ROL-6 TRANSFORMATION MARKER GENE	4.672466796766571
CYCLIN SKP2-INDUCED UPREGULATION	4.672363013354877
PRIVATE GENOME SEQUENCING EFFORT	4.672315246397714
CAUCHY-DISTRIBUTED CONTAMINATION	4.672044250018959
SHOWING P GENE EXPRESSION CHANGE	4.671936039161597
LOCALIZATION SEQUENCE	4.671915261067905
CARBOXYTERMINUS-INDEPENDENT MANNER	4.671482079913703
BIOSYNTHETIC PRECURSOR PRODUCTION	4.671197011171994
PERMEABILIZATION/FIXATION BUFFER	4.6711506675526975
STANDARD PROCEDURE	4.671097031574183
GROWTH SUBSTRATE	4.671034101411308
PHYLOGENETICALLY DISTANT SPECIES	4.6709704019015055
lamins	4.670883201973842
PARAMETRIC EVOLUTIONARY DISTANCE	4.670832949342471
INDEPENDENT MUTATION PROBABILITY	4.670552068026184
TRANSITION PROBABILITY PARAMETER	4.670552068026184
CHONDROITIN SULFATE	4.66999561224151
CROSS GENE ERROR MODEL REFERENCE	4.669863908801281
GENERAL CYTOPLASMIC LOCALIZATION	4.669800355786685
CORRESPONDING SAMPLE INFORMATION	4.669746955632516
REMAINING BIOSYNTHETIC PRECURSOR	4.669658354747089
GFP-MHCA-CONTAINING PLASMID P102	4.669588910809861
ENDOTHELIAL CELL DIFFERENTIATION	4.6694061411836625
INTERACTING PROTEIN P105 SUBUNIT	4.669039605189863
CONTROL CELL	4.6687112041382095
CELLULAR TYROSINE INCREASE TOTAL	4.668661694114375
GENE SYMBOL DETAILED INFORMATION	4.6685828384434265
INTERMEDIATE ADP	4.667493308584586
BOI1-PH MUTANT VERSION PH DOMAIN	4.667455351514119
CD98 INTERACTION	4.667325613631525
MYOSIN-II CELLULAR CONCENTRATION	4.667219577832947
STRUCTURAL CHARACTERISTIC APPRECIATION	4.667081199989362
EXOGENOUS DFZ2 STIMULATORY EFFECT	4.667055748746624
NON-COGNATE PROTEASE SUBSTITUTION	4.666738676829872
REPRESENTATIVE PICTURE	4.666657058191609
GROWTH FACTOR-LIKE GROWTH FACTOR	4.666313882071138
MICROARRAY SIGNIFICANCE ANALYSIS	4.666274647211906
ORTHOLOGY DETERMINATION PROCEDURE	4.665918160725739
TRANSCRIPT ABUNDANCE NORMALIZATION	4.665689446858866
EXHIBIT CIRCADIAN CLOCK ACTIVITY	4.665517338606814
SEMI-COMPLETE/PARTIAL COLLECTION	4.665396868257743
PRO-APOPTOTIC PROTEIN	4.66539510998969
CORRESPONDING PROTEIN	4.66539510998969
RECEPTOR COOPERATIVE STIMULATION	4.665207410866975
EXHIBIT THY-1 SURFACE EXPRESSION	4.66510506447057
TOTAL ANTI-BOI1 IMMUNOREACTIVITY	4.66451950339229
ACID TRANSPORTER	4.664271040969359
N-TERMINAL PRIOR PHOSPHORYLATION	4.66419102567785
NEGATIVE CONTROL	4.664115340247112
PROTEIN DEPLETION	4.663959734173511
NON-LINEAR DIFFERENTIAL EQUATION	4.663870910502849
CD98 ASSOCIATION	4.663803109468264
TRANSCRIPTION-INDEPENDENT FASHION	4.663736647480892
CONJUGATING ENZYME MIB UBIQUITIN	4.663310202042272
REGULATING T LYMPHOCYTE MOTILITY	4.6632612699453455
ARABIDOPSIS COP1 MUTANT SEEDLING	4.663148212079678
MICROSCOPIC APPEARANCE	4.662549544992284
CDNA PROBE	4.662480376364238
GLUTAMATE DECARBOXYLASE KDA ISOFORM	4.662036417743119
PHARYNX SIDEWALL VENTRAL FUSION	4.661876946370028
APOPTOTIC RETINAL GANGLION CELL	4.661876946370028
PROGRAMMED CELL           DEATH	4.661876946370028
NOVEL NCRNA EXPERIMENTAL SCREEN	4.661876946370028
BIOMEDICAL INFORMATIC TOOLMAKER	4.661876946370028
5'CCGTCGACTCAGAGCTCTGCAGACACAAA	4.661876946370028
RHODAMINE-CONJUGATED PHALLOIDIN	4.661876946370028
AFFYMETRIX NORMALIZATION METHOD	4.661876946370028
ELEVATED SCE FREQUENCY RELATIVE	4.661876946370028
ERROR ARCHITECTURE OPTIMIZATION	4.661876946370028
EQUIVALENT FUNCTION REPLACEMENT	4.661876946370028
PURINE NUCLEOSIDE PHOSPHORYLASE	4.661876946370028
NORMALIZATION METHOD COMPARISON	4.661876946370028
DICHLOROMETHYLENE DIPHOSPHANATE	4.661876946370028
MOESIN F-ACTIN-BINDING ACTIVITY	4.661876946370028
DEFECTIVE ASSEMBLY INTERMEDIATE	4.661876946370028
COMPUTATIONAL BIOLOGY COMMUNITY	4.661876946370028
IMMUNOGLOBULIN ANCESTRAL MEMBER	4.661876946370028
MARROW OCL PRECURSOR POPULATION	4.661876946370028
ORNITHINE         DECARBOXYLASE	4.661876946370028
VIDEO CAMERA SYSTEM DEI-470 CCD	4.661876946370028
DEVELOPED BOLEAN IMPLEMENTATION	4.661876946370028
STOCHASTIC CONTEXT-FREE GRAMMAR	4.661876946370028
SPHINGOMYELIN PHOSPHODIESTERASE	4.661876946370028
DIFFERENCE CALL DECISION MATRIX	4.661876946370028
GENOTYPE DUMMY VARIABLEENCODING	4.661876946370028
ALTERED BRUSH BORDER MORPHOLOGY	4.661876946370028
ZWF SYSTEMIC METABOLIC FUNCTION	4.661876946370028
MAINTAINING CELL WALL INTEGRITY	4.661876946370028
NEIGHBORING CELL MICROEXTENSION	4.661876946370028
TAGGING EXPERIMENT CELL LINEAGE	4.661876946370028
INVERTED MICROSCOPE NIKON TE300	4.661876946370028
CELLOIDIN-IMBEDDED HAND SECTION	4.661876946370028
MULTI GENETIC CELLULAR FUNCTION	4.661876946370028
CLASSICAL REDUCTIONIST APPROACH	4.661876946370028
5'CCGTCGACTCACTCAGCAGGTGGCGCGCA	4.661876946370028
CAPTURING FLUORESCENCE EMISSION	4.661876946370028
FUNCTIONALLY-DESCRIPTIVE KERNEL	4.661876946370028
FIBULIN-1 AMINO-TERMINAL REGION	4.661876946370028
SANTO CRUZ BIOTECHNOLOGY SC-163	4.661876946370028
GONADOTROPE GNRH-RESPONSIVENESS	4.661876946370028
STAINING EMBRYO Β-GALACTOSIDASE	4.661876946370028
PROGRAMMING MATRIX SCFG DYNAMIC	4.661876946370028
FLUORESCENCE MICROSCOPY HPB-ALL	4.661876946370028
RESULTING LYSED-CELL SUSPENSION	4.661876946370028
UROKINASE PLASMINOGEN ACTIVATOR	4.661876946370028
FORM MITOCHONDRIAL CONTACT SITE	4.661876946370028
PLASMINOGEN ACTIVATOR INHIBITOR	4.661876946370028
B-CELL-SELECTED ANTIGENIC DRIFT	4.661876946370028
APPLET-GENERATED GRAPH COREGENE	4.661876946370028
LACKED TRANSACTIVATION ACTIVITY	4.661876946370028
SCFG-BASED STRUCTURAL ALIGNMENT	4.661876946370028
DIVIDING CELL EQUATORIAL REGION	4.661876946370028
DUAL-COLOR IMMUNOHISTOCHEMISTRY	4.661876946370028
TUMOR CELL BACKGROUND METASTASI	4.661876946370028
SEQUENCE/STRUCTURE QUERY SYSTEM	4.661876946370028
SEQUENCE SIMILARITY INDEPENDENT	4.661876946370028
osteogenic cell differentiation	4.661876946370028
CURRENT PUBLIC AFFYMETRIX ARRAY	4.661876946370028
UNDERSTANDING OSTEOCLASTOGENESI	4.661876946370028
TARGETING SEQUENCE HETEROLOGOUS	4.661876946370028
P160 RHO-ASSOCIATED COILED-COIL	4.661876946370028
INVOLVING TRANSITION CYTOKINESI	4.661876946370028
BOEHRINGER MANNHEIM BIOCHEMICAL	4.661876946370028
PRECIPITATION-RESUSPENSION WASH	4.661876946370028
FEATURESOF NETWORK ARCHITECTURE	4.661876946370028
RED BLOOD CELL AUTOFLUORESCENCE	4.661876946370028
CLEAVAGE STAGE ZEBRAFISH EMBRYO	4.661876946370028
POLYMERIZATION/DEPOLYMERIZATION	4.661876946370028
REGULATORY CELL DEATH GENE CED9	4.661876946370028
SURROUNDING P10 CRITICAL PERIOD	4.661876946370028
OPTIMAL REPROGRAMMING CONDITION	4.661876946370028
BRANCHED PSEUDOPODIAL STRUCTURE	4.661876946370028
UMBILICAL VEIN ENDOTHELIAL CELL	4.661876946370028
PROSTATE CANCER CELL LINE LNCAP	4.661876946370028
GENERALIZED DELTA LEARNING RULE	4.661876946370028
CALLED ROULETTE WHEEL SELECTION	4.661876946370028
IONOPHORE-CLAMPED CELL LYSOSOME	4.661876946370028
CDK2 ACTIVITY C/EBPΑ INHIBITION	4.661876946370028
CRE-EXPRESSING TRANSGENIC MOUSE	4.661876946370028
D. DISCOIDEUM CELL AVERAGE SIZE	4.661876946370028
ALLOWED ISOLATION TET-ON SYSTEM	4.661876946370028
JAVA TECHNOLOGY TAKES ADVANTAGE	4.661876946370028
PHENOTYPIC VARIANCEATTRIBUTABLE	4.661876946370028
ENDOGENOUS CELLULAR COUNTERPART	4.661876946370028
EXTRACTION SUBCONFLUENT CULTURE	4.661876946370028
HUAPE1 RECENT CRYSTAL STRUCTURE	4.661876946370028
PAI-1 YIELD GDN-HCL ACTIVATABLE	4.661876946370028
binding	4.6616019635179455
NITRIC OXIDE SYNTHASE EXPRESSION	4.661537803578647
REPLICATE GENE EXPRESSION VALUE	4.661468162405737
ALKALINE PHOSPHATASE EXPRESSION	4.6613319010843055
GFP-HYAL-2 TRANSIENT EXPRESSION	4.6613319010843055
NO-CHANGE EXPRESSION EXPERIMENT	4.6613319010843055
GFP-HYAL-1 TRANSIENT EXPRESSION	4.6613319010843055
CONSTITUTIVE EXPRESSION LEADING	4.6613319010843055
OPTIMAL VALUE WILD-TYPE FRACTION	4.66127549156579
THERMOPLASMA ACIDOPHILUM	4.661189642160657
HRD DOMAIN NMR STRUCTURAL ANALYSIS	4.661134071880659
IONIC INTERACTION	4.661113537914482
PHYLOGENETIC STRUCTURE ANALYSIS	4.660874582908655
OVER-EXPRESSION	4.660807043510442
AVIAN OSTEOCLAST IN VITRO STUDY	4.660635249356033
COMPLEX TRANSCRIPTION REGULATION	4.660499308348206
TARGETED YEAST TWO-HYBRID STUDY	4.660324825102534
REPEATING MICROARRAY EXPERIMENT	4.660161166057322
GENETIC EFFECT ARANGE NN METHOD	4.660122374502426
P27 EXPRESSION ANDROGEN CONTROL	4.660031013083982
PHOSPHOROLYTIC CLEAVAGE CONTROL	4.659960747274355
INHIBITING GSK3 KINASE ACTIVITY	4.659933056535979
STUDY INTER-PATIENT VARIABILITY	4.659807451346702
MIXY CHI-SQUARE-BASED ALGORITHM	4.659678953289698
PROGRAMMING ALIGNMENT ALGORITHM	4.659678953289698
MONKEY CD9 EXTRACELLULAR DOMAIN	4.659624984709601
SΑ I2 NOVEL C-TERMINAL SEQUENCE	4.659474853932238
DISPLAY NE LOCALIZATION PATTERN	4.65929007759087
GSK3Β-DEPENDENT KINASE ACTIVITY	4.659285093257963
IN SILICO DELETION STRAIN ACKAB	4.659014878784577
DEMONSTRATING CYTOPATHIC EFFECT	4.658952659924023
EXTRACELLULAR MATRIX DEPOSITION	4.658874330822791
TRANSCRIPTION FACTOR INFORMATION	4.658429500832072
HISTOCHEMICAL TRAP LOCALIZATION	4.658427787997817
GFP-MHCK-C SPATIAL LOCALIZATION	4.658427787997817
DIRECTED NUCLEOLAR LOCALIZATION	4.658427787997817
GFP-MHCK-C LOCALIZATION PATTERN	4.658427787997817
UROSPORA PENICILLIFORMIS INTRON	4.658129949809688
COLONY HYBRIDIZATION EXPERIMENT	4.658055435673544
YEAST TRANSCRIPTIONAL APPARATUS	4.657966563331766
BASAL TRANSCRIPTIONAL APPARATUS	4.657966563331766
DLA DX2 MUTANT ZEBRAFISH EMBRYO	4.657953528721639
SHARING BI-DIRECTIONAL PROMOTER	4.657897148248247
CORRESPONDING C-TERMINAL REGION	4.657873458973712
DISTINCTIVE GENOMIC INSTABILITY	4.657873458973712
CASE-FATALITY RATE	4.657730432341967
INCLUDING RETINA MULTIPLE TISSUE	4.657641775849328
EXPRESSING RECEPTOR TARGET CELL	4.657490516701021
OBSERVED INTRACELLULAR MEMBRANE	4.657422735227107
C-JUN N	4.657336729715432
ABASIC DNA SITE INITIATE REPAIR	4.657333377460064
FINE FILOPODIAL STRUCTURE ABSENCE	4.657235515407858
CYCLIN DEPENDENT SERINE/THREONINE	4.65721466007314
INCREASED P27 PROTEIN STABILITY	4.657154283648569
NOCTURNINGENE LABORATORY STRAIN	4.657106833727609
TRANSFECTED HNF3ΑLOXPNEO ES CELL	4.657023929411409
INCLUDED CONTROL RNA TRANSCRIPT	4.656994172649805
MUTANT VERSION REDUCED FUNCTION	4.65697267430954
RESTORED G1 PROLONGATION MUTANT	4.65697267430954
RB-BINDING DEFECTIVE MUTANT TAG	4.65697267430954
VIRUS THYMIDINE KINASE PROMOTER	4.656948207944642
DECREASED GR PROTEIN EXPRESSION	4.656745499684278
SUBENDOTHELIAL MATRIX COMPONENT	4.656622369162363
NONIONIC DETERGENT CONCENTRATION	4.656620696913675
UNDERGOING APOPTOSI MITOCHONDRIA	4.6565911004547615
transcription factors	4.656551457851193
POSTERIOR PROBABILITY CALCULATION	4.656457032631242
JOINT GENOME INSTITUTE ESTIMATE	4.656433355593742
FLUORESCENCE LOCALIZATION STUDY	4.656358292974491
MICROSCOPIC FIELD REPRESENTATIVE	4.656297341224613
BINDING SITE GUANINE NUCLEOTIDE	4.656292746237897
DNA TITRATION OPTIMAL CONDITION	4.656197485232572
MEGASCRIPT T7 TRANSCRIPTION KIT	4.656052010897327
SPAWNING CYCLE MAKE LEPISOSTEUS	4.655835755807922
ACTIVATION CELLULAR COMPARTMENT	4.6556779981434735
OXIDATIVE ACTIVITY DISTRIBUTION	4.6556779981434735
LOGNORMAL ORIGINAL DISTRIBUTION	4.6556779981434735
TYROSINE KINASE ACTIVITY CHANGE	4.655603621753687
ENZYME CONCENTRATION	4.655443475314607
AMINOTERMINAL TRUNCATION MUTANT	4.655337916956046
PROTEIN KINASE CATALYTIC DOMAIN	4.65521039381452
GENERATING CONSERVATION DIAGRAM	4.655151087544216
SPARC-NULL EMBRYONIC FIBROBLAST	4.655048663298138
RIBOGREEN RNA QUANTIFICATION KIT	4.654942074484116
ANTISENSE INHIBITION EXPERIMENT	4.6547970949744375
INTENSITY DISTRIBUTION ANALYSIS	4.654675634682101
RELEASING ACTIVITY CYTOCHROME C	4.654670669056659
SMG PHENOTYPE E15 SMG PRIMORDIA	4.654583846438426
SUBSTRATE LEVEL PHOSPHORYLATION	4.654465531685939
FAS RECEPTOR CYTOPLASMIC DOMAIN	4.654414666628241
DNA BINDING/DIMERIZATION DOMAIN	4.654304331520087
LIMITED TRANSFORMATION PHENOTYPE	4.654292195694579
REDUCED TRANSFORMATION PHENOTYPE	4.654292195694579
E. COLI RRNA REFERENCE SEQUENCE	4.653616671082054
CDK INHIBITION C/EBPΑ ENHANCEMENT	4.653613062579027
SEQUENCE-SPECIFIC DNA P53 POSSE	4.652845728342633
PHOSPHOTYROSINE DEPENDENT ADAPTOR	4.652830657494555
CLEAVED COMPLEX	4.652630045763759
BONDING NETWORK	4.652630045763759
COMPETING CAUSE	4.652630045763759
CLINICAL STATUS	4.652630045763759
TIME-OF-FLIGHT MASS SPECTROMETRY	4.652528850231094
CYTOSKELETON-MODULATING PROTEIN	4.65243162092711
MRNA MOLECULE MINISCULE FRACTION	4.652275989325664
TRANSFORMED PHENOTYPE	4.651981986782694
P53-DNA DAMAGE RESPONSE PATHWAY	4.651787393771266
GR-GFP CYTOPLASMIC DISTRIBUTION	4.6515768647131015
BLOCKED TNF CYTOTOXICITY TGF-Β1	4.6515588674895225
INHIBITED IL-1-MEDIATED CYTOKINE	4.6514521385186605
PAIRWISE ALIGNMENT TRAINING SET	4.651144192924584
NEURON PROGENITOR PROLIFERATION	4.651046822706545
INFLUENCE OSTEOCLAST LYMPHOCYTE	4.6510287869735585
ADHESIVE ORGAN WRAP CURVED MASS	4.650970148274118
BINARY REPRESENTATION	4.650756746119871
GENERAL APPLICABILITY	4.650756746119871
ASSISTED LASER INACTIVATION SAW	4.650667181660343
DLA DX2 MUTANT EMBRYO PHENOTYPE	4.650660428790036
INDIVIDUAL TRANSCRIPTION FACTOR	4.650655301274447
OTHER RAB PROTEIN N(T)KXD MOTIF	4.650625639719737
INSTALLING FASTGROUP INSTRUCTION	4.6503120908231415
HYDROPHOBIC TRANSMEMBRANE DOMAIN	4.6503120908231415
INDUCIBLE TRANSFECTION EFFICIENCY	4.6502810480207755
APOPTOSIS-RELATED CYSTEINE PROTEAS	4.650097609552929
GREEN FLUORESCENCE PROTEIN CDNA	4.649982159308249
GLYCOGEN SYNTHASE         KINASE	4.649914868039057
SKP2 COMPLEMENTARY DNA FRAGMENT	4.649891992583375
MAMMALIAN COP1 N-TERMINAL REGION	4.649759444570606
EIGHT-SUBUNIT COMPLEX HOMOLOGOUS	4.649350604814874
ENDOTHELIAL CELL SHAPE MODULATION	4.649338660064906
SYMBOL-PAIR DISTANCE CALCULATION	4.649102949327895
IDENTIFIED PRIMARY MOTOR NEURON	4.649055902874083
FIBROBLAST PROTEIN CHEMOATTRACT	4.648751779669527
TRANFORMING GROWTH FACTOR ALPHA	4.648732522248326
REGULATING CPLA	4.64862272925273
STATISTICAL INFORMATION RETRIEVAL	4.648243739223851
NUCLEOTIDE PATTERN DISTRIBUTION	4.648232397967299
MACROPHAGE ESTABLISHED FUNCTION	4.648150703868373
CASPASE CASCADE	4.647985201625975
NUCLEOTIDE DISSOCIATION INHIBITOR	4.647985075370733
TRANSCRIPTION C/EBPΑ ACTIVATION	4.647911417513208
SIMPLE TRANSCRIPTION ACTIVATION	4.647911417513208
NONLINEAR GENE-GENE INTERACTION	4.647776613401871
ACID CED8 TRANSMEMBRANE PROTEIN	4.647591451194809
PLASMINOGEN ACTIVATOR INHIBITOR 1 REACTIVE SITE	4.647202437662478
MAXIMUM CORRELATION COEFFICIENT	4.646051396191649
MEASURE TRANSFECTION EFFICIENCY	4.645989090875986
AFFYMETRIX OLIGONUCLEOTIDE CHIP	4.645780873966378
MULTIPLE INDEPENDENT EXPERIMENT	4.64571872696868
ANTISENSE CLONE	4.645620524265345
DESIGNATED CLASSIFICATION ERROR	4.645472412648537
SINGLE COPY TRANSGENE INTRODUCTION	4.6449292966156275
TOUCH RECEPTOR NEURON CELL FATE	4.644783555745253
ACTIVATED PROTEIN KINASE MITOGEN	4.644355959453402
PLASMINOGEN ACTIVATOR INHIBITOR 1 TARGET PROTEAS	4.6441984243734105
GAPPED	4.644029666628578
T7-ΔN3	4.644029666628578
FBOOTH	4.644029666628578
routes	4.644029666628578
BS-C-1	4.644029666628578
LH RIA	4.644029666628578
ΜMOL/L	4.644029666628578
THUNIT	4.644029666628578
PGAD10	4.644029666628578
MORULA	4.644029666628578
CAUCHY	4.644029666628578
LABIAL	4.644029666628578
PAB416	4.644029666628578
RNEASY	4.644029666628578
DORSAL	4.644029666628578
IMAGES	4.644029666628578
BICOID	4.644029666628578
CAVITY	4.644029666628578
FUGENE	4.644029666628578
MM GAP	4.644029666628578
POWDER	4.644029666628578
TIGARD	4.644029666628578
OÖCYTE	4.644029666628578
UNC-40	4.644029666628578
EXOIII	4.644029666628578
RESGEN	4.644029666628578
MG-132	4.644029666628578
ABLETO	4.644029666628578
TIMP-2	4.644029666628578
BICHIR	4.644029666628578
LOOP-5	4.644029666628578
BRUCEI	4.644029666628578
GAMETE	4.644029666628578
CIS DB	4.644029666628578
palate	4.644029666628578
THERIA	4.644029666628578
APPLET	4.644029666628578
PEG202	4.644029666628578
PPB799	4.644029666628578
ASP355	4.644029666628578
SLP-76	4.644029666628578
MM GTP	4.644029666628578
SV40-6	4.644029666628578
MNOCIN	4.644029666628578
DELTAA	4.644029666628578
FIBRONECTIN IMMUNOBLOT ANALYSIS	4.643843276526209
MONOCYTE DERIVED CELLS ABBREVIATION	4.6430818984219675
FILOPODIA ACCELERATED FORMATION	4.643019398260277
MATCH-ONLY INTEGRAL DISTRIBUTION	4.642851074868601
NORMAL BLM CDNA DELETION ALLELE	4.64268752924615
IMMUNOFLUORESCENCE LOCALIZATION	4.642493647912111
HIV-1 RT MUTANT	4.642457684536058
SEQUENCING MOUSE NOCTURNIN CDNA	4.64240142173859
MEDIATED SUPPRESSION PROTEIN PHOSPHATASE TYPE 5	4.642280179163927
USM COORDINATE SPATIAL PROXIMITY	4.641761733106755
ELECTRON MICROSCOPY TRANSFECTED	4.641597975035924
SKP1	4.641435063797573
PC LIPID VESICLE FILE GENERATION	4.641093429285244
JNK PATHWAY MEDIATED ACTIVATION	4.640955496105408
MUSCLE MYOSINII ATPASE ACTIVITY	4.639622266431682
H1 FUSION PROTEIN CO-LOCALIZATION	4.639332902206782
FLAG-MHCK-C PROTEIN PURIFICATION	4.639236247110073
BOVINE Α-THROMBIN CONCENTRATION	4.6390774249266
CELL SURFACE PROTEOGLYCAN SERVE	4.638947882191126
ANTI-MHCK-C POLYCLONAL ANTIBODY	4.638878953085726
AVERAGE DIFFERENCE DETERMINATION	4.638825246618299
DEPENDENT PROTEIN KINASE ABILITY	4.638759112827126
SUBCELLULAR FRACTIONATION STUDY	4.638653540523586
CHARACTERISTIC BIPHASIC RESPONSE	4.638318441843641
OTHER DNA-BINDING TRANSCRIPTION	4.638096416154496
EXTRACHROMOSOMAL PLASMID VECTOR	4.637626779699626
PHAGOCYTE RECOGNITION DETERMINANT	4.637611267088983
TRMA INDIVIDUAL	4.63749129449987
POTENTIAL CYTOTOXIC INTERACTION	4.6369284540054005
GENOMIC DNA ISOLATION TOTAL RNA	4.636888742717564
NORMAL TRANSMEMBRANE PH GRADIENT	4.636338981294994
MULTIPLE CULLIN	4.636217633212192
INDUCED DENDRITIC FORMATION BMP	4.636002636172928
PROLIFERATION C/EBPΑ REGULATION	4.635976965810957
ANTI-PROTEIN DISULFIDE ISOMERASE	4.635947489859611
LOW DENSITY LIPOPROTEIN	4.635592102449839
SHOWING DIFFERENTIAL EXPRESSION	4.635212060984069
A-ATPASE INTEIN	4.634406595966475
INTERCELLULAR ADHESION MOLECULE	4.634329196145054
MACROPHAGE ACTIVATION	4.634191741255318
BOVINE TESTICULAR HYALURONIDASE	4.633852534595815
XNOC AMPLITUDE CIRCADIAN RHYTHM	4.633852534595815
CRE SV40 PA CASSETTE COATING IRE	4.6336863952635
BOOTSTRAPPED MODE ESTIMATE MEAN	4.63316901235742
MITOGEN-ACTIVATED PROTEIN KINAS	4.633160533322045
RAT AORTIC SMOOTH MUSCLE CELLS	4.6326680950586985
OPTIMAL EXPERIMENTAL CONDITION	4.6326680950586985
PHYLOBROWSER INTERFACE DISPLAY	4.6326680950586985
POLY-L-LYSINE-COATED COVERSLIP	4.6326680950586985
LIPID-BINDING-IMPAIRED VERSION	4.6326680950586985
BESTSOLUTION PERIODIC EXCHANGE	4.6326680950586985
MOLECULAR WEIGHT MACROMOLECULE	4.6326680950586985
SN50-AND MSN50 PEPTIDE-TREATED	4.6326680950586985
FILAMENT ASSEMBLY PREREQUISITE	4.6326680950586985
CACAGCCAGGATGGATCCATGGTCATAGGT	4.6326680950586985
AVERAGE FLUORESCENCE INTENSITY	4.6326680950586985
LEPISOSTEUS DEVELOPMENTAL RATE	4.6326680950586985
P27 PROTEOLYTIC DOWNREGULATION	4.6326680950586985
REPRESENTATIVE/TYPICAL EXAMPLE	4.6326680950586985
MIB-INDUCED RB1 DOWNREGULATION	4.6326680950586985
NON-BOOTSTRAPPED MODE ESTIMATE	4.6326680950586985
TCGGCACTGGTGGAATTCGAGAGCCTGGAG	4.6326680950586985
STANDARDIZED FACTORY SYNTHESIS	4.6326680950586985
INCONSISTENT SEQUENCE FIDELITY	4.6326680950586985
DELINEATING NOCTURNIN FUNCTION	4.6326680950586985
GENERAL-PURPOSE MODE ESTIMATOR	4.6326680950586985
MYOSIN-II BIOPHYSICAL PROPERTY	4.6326680950586985
OPTIMIZATIONOF NN ARCHITECTURE	4.6326680950586985
FINDING OVERREPRESENTED WEIGHT	4.6326680950586985
BOI1-PH(TK) MYR-TAGGED VERSION	4.6326680950586985
TRUNCATED CARBOXYTERMINUS FAIL	4.6326680950586985
FUNCTIONAL MICROTUBULE NETWORK	4.6326680950586985
HPB-ALL PSEUDOPODIAL EXTENSION	4.6326680950586985
DIVIDING CELL SEQUENTIAL IMAGE	4.6326680950586985
NEURAL CELL FATE SPECIFICATION	4.6326680950586985
IMMUNOGOLD ELECTRON TOMOGRAPHY	4.6326680950586985
BUTANEDIONE MONOXIME TITRATION	4.6326680950586985
ANTI-CHIMERA IMMUNOPRECIPITATE	4.6326680950586985
POLE-TO-POLE DISTANCE INCREASE	4.6326680950586985
ASSOCIATED BUSM IMPLEMENTATION	4.6326680950586985
HEURISTIC NORMALIZATION SCHEME	4.6326680950586985
INHIBITING NON-MUSCLE MYOSINII	4.6326680950586985
MICROSCOPY IMMUNOCYTOCHEMISTRY	4.6326680950586985
BINDING SITE REGULATORY MODULE	4.6326680950586985
CONTAINING LYSINE-RICH HISTONE	4.6326680950586985
BINDING SITE MATERNAL/GAP GENE	4.6326680950586985
COCKE YOUNGER KASAMI DP MATRIX	4.6326680950586985
CELL CYCLE-DEPENDENT VARIATION	4.6326680950586985
BACKPROPAGATION NEURAL NETWORK	4.6326680950586985
SELECTED PARAMETER COMBINATION	4.6326680950586985
LYSOSOMAL DISORDER PATHOGENESI	4.6326680950586985
EMBRYO ANTERIOR-POSTERIOR AXIS	4.6326680950586985
2-D WESTERN MULTIPROTEIN ARRAY	4.6326680950586985
CONSERVED PALINDROMIC SEQUENCE	4.6326680950586985
GENE SEQUENCE BASE PAIR REGION	4.6326680950586985
ANNOTATION CONSENSUS DETECTION	4.6326680950586985
EXPRESSED DLD HU-NEGATIVE CELL	4.6326680950586985
AUTOPHOSPHORYLATION/ACTIVATION	4.6326680950586985
GLASS-GLASS DOUNCE HOMOGENIZER	4.6326680950586985
GENERATION BIOINFORMATICS TOOL	4.6326680950586985
POSITION WEIGHT MATRIX METHODS	4.6326680950586985
CONTROVERSIAL DIFFERENT THEORY	4.6326680950586985
INDIVIDUAL AVERAGE COPY NUMBER	4.6326680950586985
MICROPARTICLES INCREASED COUNT	4.6326680950586985
SIZE TOTHE ORIGINAL POPULATION	4.6326680950586985
SILICON GRAPHICS IRIX PLATFORM	4.6326680950586985
NON-REDUCIBLE METHYLENE BRIDGE	4.6326680950586985
INTRA-PATIENT TISSUE VARIATION	4.6326680950586985
REGULATORY PROTEIN-LIKE MODULE	4.6326680950586985
REGULATED BI-DIRECTIONAL ARRAY	4.6326680950586985
BACTERIAL ARTIFICAL CHROMOSOME	4.6326680950586985
COMPUTATIONAL GENEFINDING TOOL	4.6326680950586985
CIPHERGEN H4 PROTEINCHIP ARRAY	4.6326680950586985
ELONGATED PSEUDOPODIAL PROCESS	4.6326680950586985
CELLULAR DEVELOPMENTAL PROCESS	4.6326680950586985
NORMAL ULTRASTRUCTURAL FEATURE	4.6326680950586985
PURIFIED HUMAN PLATELET TGF-Β1	4.6326680950586985
PROSTATE CANCER CELL METASTASI	4.6326680950586985
'-CGCAAGCTTACTCAAGGCACGGAATC-3	4.6326680950586985
UNDERGOING RADICAL NEPHRECTOMY	4.6326680950586985
ULTRAMICROEXTENSIONS EXTENSION	4.6326680950586985
normal ectocervical epithelium	4.6326680950586985
PRO-HSN3 ASSEMBLY INTERMEDIATE	4.6326680950586985
FN-DEGRADING METALLOPROTEINASE	4.6326680950586985
EXPRESSED HUMAN PP5-GFP FUSION	4.6326680950586985
METAMORPH ACQUISITION SOFTWARE	4.6326680950586985
DIFFERENTIATED MACROPHAGE-LIKE	4.6326680950586985
AUTOPHAGOSOME-LYSOSOME PATHWAY	4.6326680950586985
INCREASED HYDROSTATIC PRESSURE	4.6326680950586985
STRUCTURAL ELEMENT DEFINED SET	4.6326680950586985
GENERATED STABLE CELL LINE KHK	4.6326680950586985
EXPERIMENTAL LITERATURE MODULE	4.6326680950586985
PHOSPHOHISTONE PROCEDURE YIELD	4.6326680950586985
INTERESTING SEQUENCE STRUCTURE	4.6326680950586985
genomic-derived molecular data	4.6326680950586985
SPHERICAL PRECURSOR HL-60 CELL	4.6326680950586985
CONTROLLING ALM CELL MIGRATION	4.6326680950586985
COATED COVERSLIP POLY-L-LYSINE	4.6326680950586985
USM STATE SPACE DIMENSIONALITY	4.6326680950586985
MITOCHONDRIA-DERIVED ACTIVATOR	4.6326680950586985
CYTOSKELETON-ASSOCIATED SAMPLE	4.6326680950586985
POSSIBLE TNF-MEDIATED RECOVERY	4.6326680950586985
TRANSCRIPTION C/EBPΑ REGULATION	4.632414046946821
REPORTED GENE EXPRESSION LEVEL	4.632262908672961
NGN1 EXPRESSION ELEVATED LEVEL	4.632262908672961
RECEPTOR SUBTYPE	4.632237824758957
WIDESPREAD RHYTHMIC EXPRESSION	4.632127846544382
EXPRESSION TREE REPRESENTATION	4.632127846544382
NOTCHAND DELTAGENES EXPRESSION	4.632127846544382
BOOSTED DECISION TREE ANALYSIS	4.631922938575837
ADENOVIRUS-MEDIATED EXPRESSION	4.631857722287223
RIGOROUS PHYLOGENETIC ANALYSIS	4.63167455308155
COMPARATIVE STRUCTURE ANALYSIS	4.63167455308155
EXPRESSION ANALYSIS EXPERIMENT	4.631134304567233
STANDARDIZED MICROARRAY SYSTEM	4.63096741478659
CHARACTERIZING CONTROL ELEMENT	4.63076875982603
GFP SIGNAL SHOW CO-LOCALIZATION	4.630674586917988
APPLYING FOLD CHANGE THRESHOLD	4.63061891473083
VESICLE CO-SEDIMENTATION STUDY	4.630616813007417
ADVANCED COVARIATION ALGORITHM	4.630489445821226
ALGORITHM DETAILED DESCRIPTION	4.630489445821226
HYPERPHOSPHORYLATION MYOSIN II	4.630453255634556
NON-PHOSPHORYLATABLE MYOSIN II	4.630453255634556
CYTOTOXIC INTERACTION TIME COURSE	4.6303124090688
IN SILICO GENE DELETION STRAIN	4.629831215626075
IN SITU HYBRIDIZATION APPROACH	4.629827185967789
IAP TRANSCRIPTIONAL START SITE	4.629761118314512
EXTRACELLULAR MATRIX SYNTHESIS	4.629691904582508
POST-TRANSCRIPTIONAL REGULATION	4.629332468180619
FUNDAMENTAL RNA STRUCTURE RULE	4.62925279451225
NUCLEOLAR LOCALIZATION PATTERN	4.629249291639895
CHANGING GLYCINE POINT MUTATION	4.628978723852473
CONTINUED ACTIN POLYMERIZATION	4.628974650922041
ACTIN INTENSITY IMMUNOLABELING	4.628974650922041
GENOMIC SOUTHERN BLOT ANALYSIS	4.628946748099646
WTP53 TRANSCRIPTIONAL ACTIVITY	4.62879212606645
SMAD1 TRANSCRIPTIONAL ACTIVITY	4.62879212606645
APLYSIA BAG CELL NEURON SYSTEM	4.628727208359191
C-TERMINAL LEUCINE-RICH REPEAT	4.6286998410904445
CYTOPLASMIC GREEN FLUORESCENCE	4.628603054408292
PRIMARY RESPONSE GENE REPRESSOR	4.628536078966236
BACKGROUND SIGNAL TRANSDUCTION	4.628353100452442
EXPLOITABLE STATISTICAL SIGNAL	4.628353100452442
OTHER STEROID HORMONE RECEPTOR	4.628320268971742
MICROARRAY ANALYSIS MICROARRAY	4.628273192537332
TNF KILLING HYAL-2 ENHANCEMENT	4.6281226405132445
LTBP PROTEIN PROPOSED FUNCTION	4.627986995000184
RGS3 FUNCTIONAL PROTEIN DOMAIN	4.627986995000184
ΜM III	4.627892747313174
CULTURING MEDIUM	4.6276337313649165
DEXAMETHASONE-INDUCED RESPONSE	4.627591952926719
MNOC MRNA CIRCADIAN EXPRESSION	4.6273927788028315
THEBPNN MODEL PREDICTIVE ABILITY	4.627138030394243
RAB24 GUANINE NUCLEOTIDE STATE	4.627133039708145
MRNA ABUNDANCE RHYTHMIC INCREASE	4.627116006745579
LOCALIZATION CONTROL MYOSIN II	4.627018361501988
TRANSGENE VARIABLE COPY NUMBER	4.62698627687688
FIBRONECTIN IMMUNOLOCALIZATION	4.626953809344413
LEF-LUCIFERASE REPORTER SYSTEM	4.626768390043949
MEASURE INDEPENDENT CELL CYCLE	4.626680071106603
CAS SUBSTRATE DOMAIN SUBFRAGMENT	4.626620474650653
GFP-LABELLED MHCK DISTRIBUTION	4.626523701817531
SMAD-REGULATED GENE ACTIVATION	4.626523701817531
NFAT-GFP CELLULAR DISTRIBUTION	4.626523701817531
CLUSTALX SOFTWARE DISTRIBUTION	4.626523701817531
REGULATING PROTEIN DEGRADATION	4.626426628314014
NUMEROUS MITOCHONDRIAL PROTEIN	4.626426628314014
COOMASSIE-STAINED PROTEIN BAND	4.626426628314014
MUTANT PEPTIDE-TREATED EXPLANT	4.626186613577217
NA OIL EMERSION PHASE OBJECTIVE	4.626005699299035
VOLUME ASSUMPTION CONSERVATION	4.626001428392032
MG/ML SOYBEAN TRYPSIN INHIBITOR	4.625936433413691
TRANSCRIPTIONAL FACTOR LEF/TCF	4.625367468532204
DETAILED NUCLEOTIDE OCCURRENCE	4.62528802125796
PROTEASOMAL DEGRADATION SUBJECT	4.625022925406679
PARAMETER DEPENDENT PREDICTION	4.624960965964286
SUBNUCLEAR LOCALIZATION SIGNAL	4.624934297033638
TRYPTOPHAN 2, 3 DIOXYGENASE	4.624883669029049
PLECKSTRIN N-TERMINAL PH DOMAIN	4.624780773583306
NAD COFACTOR ANAEROBIC SYNTHESIS	4.624569078343697
COMPARING HYBRIDIZATION SIGNAL	4.624565221664563
LOCATED CLOSE CONTAMINANT DATA	4.624471373747223
CDNA EXPRESSION ARRAY ANALYSIS	4.624408747450763
HUMAN UNIGEM-V CDNA MICROARRAY	4.62428358011528
RELEASE CYTOSKELETON-ASSOCIATED	4.62423221413601
OTHER SRC SUBSTRATE ACTIVATION	4.624027542063307
MIGRATING FORM	4.623857213209967
coli cytoplasm	4.623857213209967
APOPTOSIS ASSAY APOPTOTIC CELL	4.623771297905674
TET INDUCIBLE EXPRESSION SYSTEM	4.623635206510548
COLLAGEN EXPRESSION STIMULATOR	4.623469837886374
INCREASED FN ACCUMULATION CCAF	4.623465641070968
HIGH-THROUGHPUT DNA MICROARRAY	4.623461444128111
NUCLEIC ACID SEQUENCE DATABASE	4.623189422072916
EXPRESSED PROTEIN LOCALIZATION	4.62300782489521
SUBCELLULAR LOCALIZATION STUDY	4.622896934319796
MM TRIS PH	4.622844531683481
CELL SURFACE INTEGRIN RECEPTOR	4.622702291443652
ANALYSIS MEAN FITC-FLUORESCENCE	4.62259733755851
P53 ACTIVATION CELLULAR EFFECT	4.622563627948132
codes	4.622426949153164
SPATIAL POINT PATTERN STATISTICS	4.622380922282944
RAB24 SUBCELLULAR DISTRIBUTION	4.622222626548714
BINDING SITE T7 RNA POLYMERASE	4.622143646829332
ANTISENSE OLIGODEOXYNUCLEOTIDE	4.622141779269225
GABA RECEPTOR EXPRESSION PATTERN	4.621784319782886
CALMODULIN-BINDING	4.621714364884571
SINGLE TISSUE SAMPLE REPLICATE	4.621627085594976
CONSENSUS TREE BOOTSTRAP VALUE	4.621556983947587
ACTIVATED TRANSCRIPTION FACTOR	4.621545208117215
POTENTIAL TRANSCRIPTION FACTOR	4.621545208117215
INCLUDING TRANSCRIPTION FACTOR	4.621545208117215
MANUSCRIPT PREPARATION	4.621474412999043
DNA SEQUENCE DATA VISUALIZATION	4.62140856027148
PERMIT HOMOLOGOUS RECOMBINATION	4.6213597245277915
PLASMINOGEN ACTIVATOR INHIBITOR 1 DEGLYCOSYLATION	4.621292390565531
TRANSCRIPTIONAL CO-ACTIVATOR CBP	4.621292235800562
APOPTOSI	4.621073577879697
A POSTERIORI PARAMETER MAXIMUM	4.620903389176346
WOUND BIOPSY NORTHERN ANALYSIS	4.620811827464726
LEF-DEPENDENT LUCIFERASE ASSAY	4.6208056988546655
CLOSTRIDIUM BOTULINUM TOXIN C3	4.620763333153937
TRANSFORMING GROWTH FACTOR BETA	4.620708110474113
CONTAINING MULTIPLE TPR REPEAT	4.620656083046686
PROTEASOME INHIBITOR TREATMENT	4.620625258121944
PRACTICAL APPLICATION	4.620583511774965
PROTEIN TRANSLOCATION MACHINERY	4.620361937898775
OBSERVED R LOWER-THAN-EXPECTED	4.620322416046353
INTRACELLULAR RNA LOCALIZATION	4.620280546540437
MITOCHONDRIAL ISOLATION BUFFER	4.62017785306026
STABILIZING BUFFER MICROTUBULE	4.62017785306026
ANTI-RABBIT SECONDARY ANTIBODY	4.620128910105721
MONOCLONAL ANTI-PAC-1 ANTIBODY	4.620128910105721
ANTI-PAI-1 MONOCLONAL ANTIBODY	4.620128910105721
BIND P	4.620029666628578
GRANULATION TISSUE DEVELOPMENT	4.619723111239928
INDUCIBLE CELL LINE CONSTRUCTION	4.619584621785093
T-CELL IMMUNITY ESCAPE VARIANT	4.619510200321856
CYCLIN-DEPENDENT KINASE	4.61947668304265
RAB24(WT) HYPERVARIABLE DOMAIN	4.619334761725365
MODE METHOD CONFIDENCE INTERVAL	4.618945932588255
ANDROGEN-INDUCED GROWTH ARREST	4.618721093663998
PROHB-EGF PHYSICAL INTERACTION	4.618691854667364
DISPLAY TWO-HYBRID INTERACTION	4.618691854667364
TERTIARY STRUCTURE INTERACTION	4.618691854667364
TERTIARY BASE-BASE INTERACTION	4.618691854667364
DETERMINANT	4.618564435163136
P53 TRANSCRIPTIONAL ACTIVATION	4.6182180539769995
OTH MODEL MUTATION PROBABILITY	4.61817534143551
UNPROGRAMMED TRANSLATION LYSATE	4.617894189002166
INCREASED TNF CYTOTOXIC EFFECT	4.6178842113407335
IODIDE	4.617708278591268
OBSERVED WILCOXON TEST P-VALUE	4.617574822023085
CORE GLYCOSAMINOGLYCAN ATTACHMENT	4.617314565038478
STAUROSPORINE-MEDIATED APOPTOSI	4.6172362904465025
COLI BL21(DE3)	4.6171905465433
CYCLIN D2 INCREASED EXPRESSION	4.617111393521446
CHONDROITIN SULFATE PROTEOGLYCAN	4.6169851283604055
PHOSPHOTYROSINE DEPENDENT FASHION	4.616835688954589
MICROARRAY PAIRWISE COMPARISON	4.616783017623469
EXACERBATED MULTIPLE SCLEROSIS	4.616652079042683
MULTIPLE PARAMETER SENSITIVITY	4.616652079042683
IDENTIFIED MULTIPLE TRANSCRIPT	4.616652079042683
PURIFIED PP5 CATALYTIC SUBUNIT	4.616539062800634
CLASSIFICATION SCORE THRESHOLD	4.616407932457072
BACKGROUND GENOMICS SEQUENCING	4.616407932457072
SITE-SPECIFIC HLA-DR SECRETION	4.616207189708904
INOSITOL TRISPHOSPHATE PRODUCTION	4.61593200896922
MHCK B	4.615458238057149
INPUT ALIGNMENT GC COMPOSITION	4.615426715748353
COMPROMISING ANALYSIS ACCURACY	4.615414390479924
HYBRIDIZATION SOLUTION PROTOCOL	4.614789677144934
CYTOPLASMIC EXTRACTION REAGENT	4.614714165519403
CEREVISIAE FUNCTIONAL CATEGORY	4.614650077040681
SINGLE HYBRIDIZATION CONDITION	4.61415887031919
MISFOLDED PROTEIN ACCUMULATION	4.614156689663707
PROLIFERATIVE PRECURSOR SUBSET	4.61414957654018
WNT-RECEPTOR COMPLEX FORMATION	4.6139765062736515
PEROXIDASE-CONJUGATED ANTIBODY	4.613859317629232
NEOMYCIN PHOSPHOTRANSFERASE PGK	4.613835097614234
DESCRIBING PATIENT CASE REPORT	4.613437325827929
ADENINE NUCLEOTIDE TRANSPORTER	4.613166809136748
COMMON NORMALIZATION CRITERION	4.613155899936747
distribution	4.612974715020606
REACTIVE OXYGEN           SPECIES	4.612839506681918
ACTIN POLYMERIZATION MACHINERY	4.612714488320415
ELEMENT ANNOTATION INFORMATION	4.612553152529963
NUCLEIC ACID PREPARATION TISSUE	4.61248994981607
PITUITARY CELL DIFFERENTIATION	4.612218197308187
FUNCTIONAL MECHANISM	4.612040285465343
NEGATIVE CORRELATION	4.612040285465343
CELLULAR COMPARTMENT	4.612040285465343
NON-TRANSFECTED CELL	4.612040285465343
AMOEBA D. DISCOIDEUM	4.612040285465343
BIOCHEMICAL FUNCTION	4.612040285465343
EXPONENTIAL INCREASE	4.612040285465343
PERFORMED EXPERIMENT	4.612040285465343
PHOSPHATASE ACTIVITY	4.612040285465343
PROTEIN PHOSPHATASES TYPE 1 CATALYTIC SUBUNIT	4.611838434012545
MESENCHYMAL-NEURAL INTERACTION	4.611703734471696
ENDOGENOUS CA SUBSTRATE DOMAIN	4.611700353123214
ZEBRAFISH DELTAA MUTANT ALLELE	4.611140317280921
TRNA SECONDARY STRUCTURE MODEL	4.610928964623915
AFFECTING EXPRESSION	4.610810041834283
DECREASED EXPRESSION	4.610810041834283
CNBR-ACTIVATED SEPHAROSE CL-4B	4.610445872836476
T LYMPHOCYTE INTEGRIN FUNCTION	4.610364911746404
TOUCH NEURON DEDIFFERENTIATION	4.610226934686503
POTENTIAL PHYSIOLOGIC REGULATOR	4.610139570786865
IMPORTIN-Β FOCAL CONCENTRATION	4.610069225002201
CYCLIN MOLECULAR CONCENTRATION	4.610069225002201
PEROXIDASE	4.609566853932249
STRUCTURAL MOTIF IDENTIFICATION	4.608658871485663
ENZYME PROTEIN	4.608636923327091
WILD-TYPE PROTEIN DISTRIBUTION	4.608377473168084
ACTIVATED PRIMARY T LYMPHOCYTE	4.608200788107179
SUPPORT STRESS FIBER FORMATION	4.607538292358803
SIGMA STAT STATISTICAL SOFTWARE	4.607342955890478
RABBIT ANTISERA	4.607213791972089
MICROSCOPE	4.60716903638747
SF9	4.60714339916242
TRANSLOCATION INHIBITING NF-ΚB	4.60700253255103
RETROVIRAL VECTOR INCORPORATION	4.606984901262183
GR-RESPONSIVE REPORTER PLASMID	4.606498119773679
SHOWED DIFFERENTIAL EXPRESSION	4.606237878906842
VASCULAR ENDOTHELIUM HOMEOSTASI	4.605828122821602
BMP FUNCTIONAL CHARACTERIZATION	4.605828122821602
MAMMALIAN CIRCADIAN REGULATION	4.605365617265337
MAMMALIAN OVEREXPRESSION SYSTEM	4.605074897524903
TOXIC BILE ACID	4.604981828680932
DIETHYLPYROCARBONATE-TREATED H	4.604890317280921
TESTICULAR HYALURONIDASE PH-20	4.604890317280921
CATALYTIC DOMAIN HOMOLOGY MODEL	4.604770597848989
OPTIMAL INTERACTION DETERMINANT	4.604383975815991
EXOGENOUS CYTOCHROME C ADDITION	4.604255619009234
LIGAND-DEPENDENT	4.603940975674903
STRANDED OLIGO	4.6038572132099675
RELATIVE PROTEIN CONCENTRATION	4.603827758257516
MHCK DIFFERENTIAL LOCALIZATION	4.603359324002355
IMMUNOPRECIPITATION COS-7 CELL	4.603256330352816
CYTOSKELETON FRACTION RELATIVE	4.602611430855693
RETARDED WOUND REPAIR PROCESS	4.602531825238419
ELECTROPORATE SUSPENSION CELL	4.602531825238419
DETERMINING PATIENT PROGNOSIS	4.602531825238419
POSTTRANSLATIONAL PRENYLATION	4.602531825238419
ENDOGENOUS REGULATORY ELEMENT	4.602531825238419
PROGRAMMED CELL DEATH UNDERGO	4.602531825238419
PHOTO-MULTIPLIER         TUBE	4.602531825238419
comparative sequence analysis	4.602531825238419
PROFILING HUMAN MUSCLE BIOPSY	4.602531825238419
SECONDARY STRUCTURES FUNCTION	4.602531825238419
PHENYLMETHYLSULFONYL FLUORIDE	4.602531825238419
NOMINAL MODEL PARAMETER VALUE	4.602531825238419
GATCGAGCCCCATTGCGCAATCATAGATC	4.602531825238419
USM COORDINATE REPRESENTATION	4.602531825238419
SPECIALIZED ECTODERMAL TISSUE	4.602531825238419
PHOTO MULTIPLIER         TUBE	4.602531825238419
CELLULAR MEMBRANE COMPARTMENT	4.602531825238419
CONTAINING DOMAIN LTBP-3 GENE	4.602531825238419
CELLULAR OXIDATIVE METABOLISM	4.602531825238419
DEMONSTRATED SKP2-INDEPENDENT	4.602531825238419
PHOSPHATIDYLINOSITOL-4-KINASE	4.602531825238419
WEBSITE SUPPLEMENTARY WEBSITE	4.602531825238419
OBSERVED REPLACEMENT MUTATION	4.602531825238419
HRP-CONJUGATED ANTI-MOUSE IGG	4.602531825238419
SELECTED REPLACEMENT MUTATION	4.602531825238419
REDUCED SUBSTRATE SPECIFICITY	4.602531825238419
DISPLAYED BETTER PRESERVATION	4.602531825238419
CAENORHABDITIS ELEGAN HOMOLOG	4.602531825238419
LDL-RECEPTOR-RELATED PROTEINS	4.602531825238419
IDENTIFIED PROLIFERATIVE CELL	4.602531825238419
JUN-N-TERMINAL KINASES/STRESS	4.602531825238419
DIFFERENTIATED SECRETORY CELL	4.602531825238419
SUFFERED PROTEOLYTIC CLEAVAGE	4.602531825238419
FUNCTIONAL TAXONOMY SIGNATURE	4.602531825238419
LEICA DM IRB PHASE MICROSCOPE	4.602531825238419
INCLUDING PANNICULUS CARNOSUS	4.602531825238419
NORMAL BLM-CONTAINING COMPLEX	4.602531825238419
TARGETING PATHWAY AZ-INVOLVED	4.602531825238419
ANGLE MESENCHYME MORPHOGENESI	4.602531825238419
PHOTOLITHOGRAPHIC FABRICATION	4.602531825238419
POSSIBLE REPLACEMENT MUTATION	4.602531825238419
DIFFUSE LARGE B-CELL LYMPHOMA	4.602531825238419
BURN WOUND GRANULATION TISSUE	4.602531825238419
GP MUSTBE OPERATING PARAMETER	4.602531825238419
VARYING SUBSTRATE SPECIFICITY	4.602531825238419
HYOBRANCHIAL PHARYNGEAL POUCH	4.602531825238419
INDIVIDUAL PROFILE DATABASING	4.602531825238419
BIOLOGICAL MEANINGFUL PATTERN	4.602531825238419
INCREASED GROUPING EFFICIENCY	4.602531825238419
DETERMINEWHAT INPUT RELEVANCE	4.602531825238419
filament hyperphosphorylation	4.602531825238419
'-GAACTGAGCACTACAATGGGACTCC-3	4.602531825238419
HYAL-1 LYSOSOMAL HYALURONIDAS	4.602531825238419
TNF-TREATED HYAL-2-EXPRESSING	4.602531825238419
ΔN4 SHOW NUCLEOLAR MORPHOLOGY	4.602531825238419
BOUNDED LENGTH SEGMENT LENGTH	4.602531825238419
RECENT RAPID DATA ACQUISITION	4.602531825238419
SKP2-MEDIATED P27 DEGRADATION	4.602531825238419
SYNTHETIC ANDROGEN MIBOLERONE	4.602531825238419
CILIARY BODY POSTERIOR ASPECT	4.602531825238419
THIOCYANATE PROCEDURE LITHIUM	4.602531825238419
MORPHOLOGICAL GLAND INTEGRITY	4.602531825238419
GENETIC ANNOTATION INITIATIVE	4.602531825238419
DIVERSE FUNCTION FAMILY SERVE	4.602531825238419
NUCLEOTIDE/STRUCTURAL ELEMENT	4.602531825238419
WEREIDENTIFIED FUNCTIONAL SNP	4.602531825238419
POSTNATAL DEVELOPMENTAL STAGE	4.602531825238419
CULTURED EXPLANT MORPHOGENESI	4.602531825238419
PRODUCED FORCE ECHINODERM EGG	4.602531825238419
NOCODAZOLE-TREATED DONOR CELL	4.602531825238419
TISSUE CULTURE LNCAP-FGC CELL	4.602531825238419
IMMUNOGOLD-LABELED SEMI-THICK	4.602531825238419
PEGFP-COP1 SALI-XBAI FRAGMENT	4.602531825238419
ARABIDOPSIS SEEDLINGS DISPLAY	4.602531825238419
EXTENSIVE SEQUENCE SIMILARITY	4.602531825238419
IMMUNOHISTOCHEMICAL PROCEDURE	4.602531825238419
VIRAL ORIGIN TRANSPOSABLE IAP	4.602531825238419
HALOTHANE ANESTHESIA OVERDOSE	4.602531825238419
NESTED HELICE COOPERATIVE SET	4.602531825238419
FAMILY MEMBER ELK-1 SYNERGIZE	4.602531825238419
ACTIVITY-DEPENDENT PLASTICITY	4.602531825238419
INDUCING ALM MIGRATION DEFECT	4.602531825238419
BIOLOGICALLY-ACTIVE STRUCTURE	4.602531825238419
VIRAL PARTICLE/PITUITARY CELL	4.602531825238419
PROBE ACTIN-DEPENDENT PROCESS	4.602531825238419
STANDARD TWO-HYBRID TECHNIQUE	4.602531825238419
EXPERIMENTAL PROGRAM PARALLEL	4.602531825238419
RENAL CELL         CARCINOMAS	4.602531825238419
INTRA-PATIENT VIRAL DIVERSITY	4.602531825238419
NORMAL PSEUDOPODIAL EXTENSION	4.602531825238419
CYTOKINESI MECHANICAL PROCESS	4.602531825238419
GENE FUNCTION INTERRELATEDNES	4.602531825238419
PYRUVATE, PHOSPHOENOLPYRUVATE	4.602531825238419
RIGOROUS STATISTICAL APPROACH	4.602531825238419
RECONSTITUTING UBIQUITINATION	4.602531825238419
TYPE UBIQUITINATION E3 LIGASE	4.602531825238419
'-GGAGTCCCATTGTAGTGCTCAGTTC-3	4.602531825238419
SIGNALING NETWORK GR-MEDIATED	4.602531825238419
INTERMEDIATE EPITHELIAL LAYER	4.602531825238419
SIGNALING ACTIVITY MEASURE WG	4.602531825238419
SNIP1 PROTEASOMAL DEGRADATION	4.602531825238419
BOI1-PH STIMULATED PROTEOLYSI	4.602531825238419
LO NON-ESSENTIAL GENE PRODUCT	4.602531825238419
NEAREST-NEIGHBOR HIERARCHICAL	4.602531825238419
EXPRESSING CELL GFP-MYOSIN II	4.602531825238419
PROGRESSIVE NEURODEGENERATIVE	4.602531825238419
MÜLLER GLIA EXPRESSING MARKER	4.602531825238419
INTERTRABECULAR SPACE OPENING	4.602531825238419
USER-FRIENDLY GUI ENVIRONMENT	4.602531825238419
C-RAF ANTI-APOPTOTIC FUNCTION	4.602531825238419
SUBSTRATE SELECTION MECHANISM	4.602531825238419
ABNORMAL LYSOSOMAL PHYSIOLOGY	4.602531825238419
DIVERSE DEVELOPMENTAL CONTEXT	4.602531825238419
AUTOMATED CONSENSUS DETECTION	4.602531825238419
OVERDOSE HALOTHANE ANESTHESIA	4.602531825238419
HISTOPATHOLOGICAL ABNORMALITY	4.602531825238419
D. DISCOIDEUM CELL CYTOKINESI	4.602531825238419
BETWEEN-TREATMENT-VARIABILITY	4.602531825238419
FLOATING POINT REPRESENTATION	4.602531825238419
SECONDARY STRUCTURE CONSENSUS	4.602531825238419
MYOSIN-II MECHANICAL PROPERTY	4.602531825238419
CLEAVAGE FURROW CORTEX VOLUME	4.602531825238419
INTERMEDIATE FILAMENT EXTRACT	4.602531825238419
BETWEEN-TREATMENT VARIABILITY	4.602531825238419
FALL RELATIVE PUTATIVE MODULE	4.602531825238419
BI-DIRECTIONAL OVERESTIMATION	4.602531825238419
UNDERLYING GRANULATION TISSUE	4.602531825238419
CALCULATED AVERAGE DIFFERENCE	4.602531825238419
SCALE INDEPENDENT METHODOLOGY	4.602531825238419
FCS-COATED GLASS CULTURE DISH	4.602531825238419
PROLIFERATIVE NEUROEPITHELIAL	4.602531825238419
FLAG-MHCK-C AUTOPHOSPHORYLATE	4.602531825238419
PROLIFERATING KI67 EPITHELIAL	4.602531825238419
PUBLISHED ELECTRON MICROGRAPH	4.602531825238419
CORRECTED GFP-MYOSIN-II IMAGE	4.602531825238419
SIMILARITY OVER-DETERMINATION	4.602531825238419
CONNECTIVE-TISSUE CONTRACTION	4.602531825238419
REGARDING DEGRADATIVE PATHWAY	4.602531825238419
PROPOSED RECURSIVE DEFINITION	4.602531825238419
TIME-DEPENDENT DOWNREGULATION	4.602531825238419
CYCLOSTOME POSSIBLE EXCEPTION	4.602531825238419
UBIQUITIN-INDEPENDENT PATHWAY	4.602531825238419
NEURAL TUBE DORSOVENTRAL AXIS	4.602531825238419
PSEUDO-PHYLOGENETIC STRUCTURE	4.602531825238419
LEUKOCYTE HOMOTYPIC AGGREGATION	4.602531133201105
CO-IMMUNOPRECIPITATION APPROACH	4.602531133201105
SEQUENCE/STRUCTURE INFORMATION	4.602495681265595
TUMOR GENE EXPRESSION PATTERN	4.602130350658971
TAG EXPRESSION RELATIVE LEVEL	4.602130350658971
COLLAGEN GEL CONTRACTION ASSAY	4.602049365016228
CELL TYPE-SPECIFIC EXPRESSION	4.601996525799155
GENE EXPRESSION REPROGRAMMING	4.601996525799155
INDIVIDUAL EXPRESSION PROFILE	4.601996525799155
UNTRANSFORMED EXPRESSION DATA	4.601996525799155
UBIQUITOUS EXPRESSION PATTERN	4.601996525799155
C/EBPΑ-INDUCED DIFFERENTIATION	4.601993248432931
INTRACELLULAR DOMAIN	4.601986506387667
PHAGOLYSOSOMAL PH ALKALIZATION	4.601870993609423
STATISTICAL ANALYSIS SOFTWARE	4.601547384838938
STEPWISE DISCRMINANT ANALYSIS	4.601547384838938
STEPWISE DICRIMINANT ANALYSIS	4.601547384838938
strains	4.6014484829313265
RECOMBINANT PROTEIN PRODUCTION	4.601269395609611
SERINE/THREONINE PROTEIN KINASE	4.601250834046186
GENOME SEQUENCE DATA	4.601118554237077
PROTEASE-SENSITIVITY ANALYSIS	4.601055164639198
YEAST TWO-HYBRID SCREEN STUDY	4.601007457142916
YEAST TWO-HYBRID SYSTEM STUDY	4.601007457142916
MNOC MRNA MULTIPLE HYBRID FORM	4.6009805633711665
CALF SERUM FINAL CONCENTRATION	4.6007419839909796
MICROARRAY SUITE DOCUMENTATION	4.60066438448356
ANDROGEN-MEDIATED P27 CONTROL	4.600649889318044
BACULOVIRUS EXPRESSION SYSTEM	4.600642624261563
COLONY-SECTORING ASSAY PLASMID	4.600535428584395
ENDOTHELIAL CELL SHAPE CHANGE	4.60050141691449
THEORETICAL CELL SHAPE CHANGE	4.60050141691449
RHOA IMMUNOLOCALIZATION STUDY	4.6004993344444145
PHEROMONE-RESPONSIVE G PROTEIN	4.600452602339987
AUTOPHOSPHORYLATION REGULATION	4.6004100305425695
SECONDARY STRUCTURE ALGORITHM	4.600373134035636
PROPRIETARY GENETIC ALGORITHM	4.600373134035636
PURIFIED DICTYOSTELIUM MYOSIN	4.6003372753777825
MICROARRAY EXPRESSION DATASET	4.6003114250133095
STRUCTURAL COMPONENT	4.600179967959647
TYROSINE PHOSPHORYLATION KINAS	4.600110147050282
FOUR-COMPARISON SURVIVAL METHOD	4.5997920956702325
INTRON POSITION NUMERIC ORDER	4.599771827293914
SODIUM CHLORATE	4.599733467818167
IN SILICO PGI DELETION STRAIN	4.599720933714795
GLYCEROL GRADIENT	4.599691484799199
RESVERATROL COLLECTIVE EFFECT	4.599659827377325
C-TERMINAL MUTATION CELL LINE	4.599582898863188
BINDING DOMAIN C-TERMINAL BLM	4.599582898863188
B. MORI MIDGUT	4.599355788708543
OTHER PCMV5 EXPRESSION VECTOR	4.599331369692651
LAMININ CARBOXYL-TERMINAL SEGMENT	4.5992750698341585
SMAD1-REGULATED GENE RESPONSE	4.5991787312889185
CELLULAR RESPONSE ATTENUATION	4.5991787312889185
LOCALIZATION OBSERVED PATTERN	4.599144340581744
GFP-MHCK LOCALIZATION PATTERN	4.599144340581744
STABLE NUCLEOLAR LOCALIZATION	4.599144340581744
IMMUNOPRECIPITATE IMMUNOBLOTTING	4.599095022711052
ACTIN FILAMENT POLYMERIZATION	4.598872215775529
POLYCLONAL GOAT ANTI-NF-ΚB P65	4.598659997892707
OTHER UNIDIRECTIONAL PROMOTER	4.598623189096101
ENDOTHELIAL CELL CYTOSKELETON	4.598528434280531
TRANSCRIPTIONAL MODULATOR ROLE	4.59848909576342
UNCONVENTIONAL MYOSIN	4.598405370217106
MODULATING CELL PROLIFERATION	4.598403328313097
ASSOCIATED GENE PROLIFERATION	4.598403328313097
MODELLING SIGNAL TRANSDUCTION	4.5982563591668875
SIGNAL TRANSDUCTION MECHANISM	4.5982563591668875
MOLECULAR SIGNAL TRANSDUCTION	4.5982563591668875
extensions	4.598017149488228
CONTACT SITE 3-D DISTRIBUTION	4.597965745689676
EXPRESSION PLASMID CONSTRUCTION	4.597950640872701
MOUSE GFP-N280 FUSION PROTEIN	4.597893607510731
SMAD1 INCREASED PROTEIN LEVEL	4.597893607510731
SUPPRESSING PP5 PROTEIN LEVEL	4.597893607510731
NM CPT	4.597875820474732
HETEROLOGOUS PROTEIN	4.5978273362250475
PROGRAMMED CAPILLARY REGRESSION	4.597821148028968
TENASCIN MRNA INCREASED LEVEL	4.597706309351678
PORCINE FIBROBLAST DONOR CELL	4.597502184314168
CANCER GENE EXPRESSION RESEARCH	4.597412364064677
INCLUDING COMPLEX CARRIER DNA	4.596953917417103
CLASSICAL LEUCINE ZIPPER MODEL	4.596953809344413
EXCESSIVE MYOSIN LOCALIZATION	4.596949790721108
BIOLOGICAL FUNCTION	4.596834695088978
WNT TARGET GENE TRANSCRIPTION	4.5968110442795425
GLUCOCORTICOID RECEPTOR RAB24	4.596787829516231
STEADY-STATE P27 PROTEIN LEVEL	4.596736995000184
MARKOV CHAIN TRANSITION TABLE	4.596703358990905
NEUTRAL JUKES-CANTOR EVOLUTION	4.596632059022663
FIBROBLAST MIGRATION	4.596627893173678
MIB-INDUCED CELL CYCLE ARREST	4.5965986560044225
REGULATING TNF SUSCEPTIBILITY	4.596526738801586
NF-ΚB P65 SPATIAL DISTRIBUTION	4.596480852759401
INDEPENDENT ACTIVATION DOMAIN	4.596443719173427
SIMILAR SHORT-TIME ACTIVATION	4.596443719173427
INTERMEDIATE FILAMENT PROTEIN	4.596347534934835
ASSOCIATED ENDOGENOUS PROTEIN	4.596347534934835
RETINOBLASTOMA FAMILY PROTEIN	4.596347534934835
PROTEIN PHOSPHATASE INHIBITOR	4.596347534934835
RETINOBLASTOMA PROTEIN FAMILY	4.596347534934835
PREEXISTING PROTEIN HALF-LIFE	4.596347534934835
DENOTED MATRICELLULAR PROTEIN	4.596347534934835
CORTICAL GFP-LABELLED PROTEIN	4.596347534934835
GST-P35-C/EBPΒ FUSION PROTEIN	4.596347534934835
DIFFERING PROTEIN ENVIRONMENT	4.596347534934835
P20-C/EBPΒ-GST FUSION PROTEIN	4.596347534934835
PROTEIN COILED-COIL STRUCTURE	4.596347534934835
PROTEASOME INHIBITOR COCKTAIL	4.595991632089393
ALTERED FIBROBLAST MORPHOLOGY	4.595825637339418
GRANULATION TISSUE FIBROBLAST	4.595825637339418
SN50-INDUCED NF-ΚB INHIBITION	4.595578567258928
CROSS HYBRIDIZATION BACKGROUND	4.595546882937486
MOUSE NOCTURNIN CDNA FRAGMENT	4.59548794422839
CHARACTERIZED PPT1 ACTIVITY C	4.595454401937866
ADENOVIRUS GENOME PERMUTATION	4.595403485223474
MICROBORE HPLC	4.595285784638539
POTENTIAL THR PHOSPHORYLATION	4.595252932587712
NUCLEOTIDE POLYMORPHISM (SNP)	4.595219358359619
INCREASED NUCLEOTIDE EXCHANGE	4.595219358359619
AMPLITUDE CIRCADIAN EXPRESSION	4.595090809507345
MEDIATED CELL ADHESION III1-C	4.595025467192378
FIXED MEASUREMENT NOISE EFFECT	4.595002646523684
BASAL TRANSCRIPTION APPARATUS	4.59490411729325
FUNCTIONAL ACTIN CYTOSKELETON	4.594868824817641
INITIATING POLY-GLN POLYPEPTIDE	4.594618358111916
E. COLI STOICHIOMETRIC MATRIX	4.594274831387774
TYROSINE KINASE RECEPTOR GENE	4.594093084225377
COMPLEMENTARY OLIGONUCLEOTIDE	4.594063113596732
RECEPTOR           RADIOASSAY	4.593915831655138
MISSENSE	4.593861823402424
adhesion	4.593861823402424
insights	4.593861823402424
RECOVERY	4.593861823402424
CAMP-DEPENDENT PROTEIN KINASE	4.593802026233287
WILD-TYPE FIBROBLAST MONOLAYER	4.59379312344261
KDA N-TERMINAL	4.593758036563261
MHCK-C METHIONINE START CODON	4.5936850461127285
GFP EXPRESSION VECTOR PTX-GFP	4.5934335169421905
BINDING VALUE	4.593226819051249
AROMATIC RING	4.593226819051249
CARDIAC DEATH	4.593226819051249
CHARGED ASPARTIC ACID RESIDUE	4.593139983891714
MITOCHONDRIAL MEMBRANE DAMAGE	4.59267272810332
INDUCED CELL DEATH MACROPHAGE	4.5924212205233435
HUGENEFL CHIP REPRODUCIBILITY	4.592369371268394
TYROSINE PHOSPHORYLATION SITE	4.5922907823273915
LIPID VESICLE FILE GENERATION	4.592281763906584
RHOA SUBCELLULAR DISTRIBUTION	4.592182044927934
KDA POLYPEPTIDE	4.592174757033889
TRANSCRIPTION FACTOR ACTIVITY	4.59151083214915
NUCLEUS RRNA INTRON/RRNA GENE	4.591416678709199
P66 INSOR P66	4.591392598114343
ELECTROPORATION CONTROL BUFFER	4.59106763347385
GENE ISOFORM PROBE SPECIFICITY	4.5910014283920315
L929 CELL STABLE TRANSFECTION	4.590828999308371
PREFABRICATED MICROARRAY CHIP	4.590684270482549
MUSCLE BIOPSY MULTIPLE REGION	4.590629852120372
MAMMALIAN PROTEIN PHOSPHATASE	4.590603539212647
INTERNAL RIBOSOMAL ENTRY SITE	4.590146334462451
ANTI-FLAG MONOCLONAL ANTIBODY	4.590107508472558
MONOCLONAL ANTI-HSN3 ANTIBODY	4.590107508472558
ACID METHYLTRANSFERASE FAMILY	4.590009370109479
ANTISENSE NOTCH RNA TREATMENT	4.589888625994556
EXPRESSING STRAIN GENERAL CRE	4.589670670625612
BINDING DOMAIN DNA	4.589663678644743
POST-TRANSCRIPTIONAL STABILIZATION	4.589371506361384
P21 PROTEIN C/EBPΑ STABILIZATION	4.589187998355184
MACROPHAGE CONSPICUOUS NUMBER	4.589051018951652
N-TERMINAL DELETION CELL LINE	4.588985194702205
MEDIATED DEGRADATION RNAASE H	4.588770168820678
LIPOSOME-BASED REAGENT FUGENE	4.588770168820678
EXPONENTIAL POPULATION GROWTH	4.588712588668302
TRANSFORMING GROWTH FACTOR-Β1	4.588712588668302
AZ INTRACELLULAR LOCALIZATION	4.588653482562038
SECONDARY BODY AXIS FORMATION	4.588641555209297
RELATIVE CHANGE QUANTIFICATION	4.588269187954873
DISPLAYED TRANSIENT ENRICHMENT	4.588223650614254
COMMON MODE ESTIMATION METHOD	4.588031738476311
GENERAL GENEFINDING ALGORITHM	4.587909747091266
FUNCTIONAL IMPORTANCE SUPPORT	4.587852725059495
REGULATING INTEGRIN DEPENDENT	4.587473282189377
NUCTRAP GEL FILTRATION COLUMN	4.587442902465667
BRANCHED DENDRITIC PROJECTION	4.587169976213963
FINGER-LIKE DENDRITIC PROCESS	4.587169976213963
RHODAMINE-PHALLOIDIN EXCITATION	4.5871451816387925
MAXIMUM COORDINATE DIFFERENCE	4.586989248578382
OBTAINED SIGNAL QUANTIFICATION	4.586686433785775
MITOCHONDRIA ISOLATION BUFFER	4.586642388668988
POSSIBLE SIGNAL CONTAMINATION	4.5864606536659664
ARABIDOPSIS TF CLASSIFICATION	4.586420617724966
UNKNOWN STRUCTURE RNA SEQUENCE	4.586395651655107
TYPE HIV-1 RT	4.586036087124797
BINDING PROTEIN IDENTIFICATION	4.586022587909973
PERIPHERAL BLOOD T LYMPHOCYTE	4.585999468251588
MRNA SUBCELLULAR DISTRIBUTION	4.585748023745612
UNLIMITING REGULATOR MOLECULE	4.585485128256442
GENERIC MODEL ORGANISM SYSTEM	4.585448389685361
APOPTOTIC NUCLEUS QUANTITATION	4.585158015512006
TARGETED ES CELL PGK/LOXP-NEO	4.585148680289693
CAUSED TRANSIENT UPREGULATION	4.585148680289693
MHCK-B CYTOSOLIC LOCALIZATION	4.585089882963626
BINDING DOMAIN PLASMID VECTOR	4.584669409544571
ALPHA-HELIX-TERMINATION MOTIF	4.584182950014764
PROTEIN TRANSLATION APPARATUS	4.584114951452398
NORTHERN HYBRIDIZATION FILTER	4.584099546036474
PEPTIDE PHOSPHORYLATION STUDY	4.584003332379035
SCHIZOSACCHAROMYCE	4.583933308718305
CONFLICTING RESULT	4.583933308718305
PROLIFERATING CELL	4.583933308718305
ANTI-PHOSPHOTYROSINE ANTIBODY	4.5838953500896285
NO CHANGE	4.583783514236935
B UD- EM ERGENCE PROTEIN BEM1	4.583712072752066
DIFFUSE LARGE B CELL LYMPHOMA	4.583658696436945
HUMAN LAMIN B LEADER SEQUENCE	4.583658696436945
BINDING PROTEIN C-MYC PROMOTER	4.583361748451861
FUNCTIONAL SIGNIFICANCE UNKNOWN	4.583208419032414
KD DNA-ACTIVATED PROTEIN KINASE	4.583147620680827
TBID PREFERENTIAL ASSOCIATION	4.583103604413372
PEDF ACTIVITY	4.582667655279334
EXPRESSED PROTEIN PURIFICATION	4.582566979191206
GEL AUTORADIOGRAPHIC EXPOSURE	4.582413261541417
DIFFERENTIATION OPTIMAL STAGE	4.582269263641744
MMCOP1 CDNA N-TERMINAL REGION	4.581941313692176
INDIVIDUAL SIGNIFICANCE LEVEL	4.581889340611807
ΜM CALMODULIN	4.58137208567835
CELLULAR REGULATION ASSOCIATE	4.581223454010948
T LYMPHOCYTE CYTOARCHITECTURE	4.580488682589312
FUSION PROTEIN OVER-EXPRESSION	4.58044961681976
SENSE CONTROL	4.580092542974844
SIGNALING MOTIF IDENTIFICATION	4.579918375642312
12CA5 MONOCLONAL ANTI-HA ANTIBODY	4.579849470603369
PH-20-MEDIATED ERK ACTIVATION	4.579720693653134
DENDRITIC PROCESSES DEPENDENT	4.579533450109321
S. MALTOPHILIA	4.579412768765523
MULTIPLE PHOSPHORYLATION SITE	4.579383635096984
PEDF RECEPTOR	4.579270359109239
POSITION-INDEPENDENT EVOLUTION	4.578614041004644
ENZYME LIPID INSENSITIVE FORM	4.57806890563908
HEAT SHOCK FACTOR-1 ACTIVATION	4.578059800127822
Β-CATENIN DROSOPHILA HOMOLOGUE	4.57729468886562
GFP-MHCK-C PUNCTATE AGGREGATE	4.577125690313358
GOAT ANTI-RABBIT SECONDARY AB	4.577125690313358
BINDING PROTEIN ENDOGENOUS CA	4.5771179455639475
MEDIATED BIPARTITE NLS VARIANT	4.577112539503143
ACTIVATED NF-ΚB TRANSLOCATION	4.577101378222521
SIGNIFICANCE LEVEL	4.576984333505073
AFFINITY CHROMATOGRAPHY COLUMN	4.57690854113513
FINE VESSEL BRANCHING NETWORK	4.5764571078153296
PAC-1 DIFFERENTIAL EXPRESSION	4.576343729369968
BINDING SITE GIBBS SAMPLER FIND	4.576275106768795
SEQUENCE ANALYSIS APPLICATION	4.576141249913878
THY-1 DIFFERENTIATION PROTEIN	4.57608497333816
DISULFIDE-LINKED	4.5755096688468875
SELF-ASSOCIATION	4.5755096688468875
gaps	4.575166469536694
EXPERIMENTAL PROCEDURE	4.57516400400086
HYBRIDIZATION BUFFER	4.574972058728359
IMMUNOFLUORESCENT LOCALIZATION	4.574908310983125
MG/ML COOMASSIE BRILLIANT BLUE	4.574607985769081
MIN EPPENDORF CENTRIFUGE SPIN	4.574400742087957
CONTROL SPECTRUM ORDERED LIST	4.574340933782533
MEAN AVERAGE DIFFERENCE VALUE	4.574337212089876
PEPTIDE PHOSPHORYLATION ASSAY	4.574282095271766
AMPLITUDE CIRCADIAN REGULATION	4.574125681677575
SIGNALING ACTIVITY TAKES PLACE	4.573844565646934
CELLULAR HOMOTYPIC AGGREGATION	4.573844565646934
AFFECTING HIV QUASISPECIATION	4.57381184662748
DNA-DEPENDENT ATPASE ACTIVITY	4.573389494000849
FUNCTIONAL GENOMIC	4.573095916410453
SERINE PHOSPHORYLATION STATUS	4.572475018516968
STORM PHOSPHORIMAGER INSTRUMENT	4.572198828692545
HEMATOPOIETIC DIFFERENTIATION	4.572137982843407
GFP-HYAL-2 STABLE TRANSFECTANT	4.572062034452638
TREATMENT RESPONSE STRATIFICATION	4.571893730808751
DETECTING NEGATIVE SELECTION	4.571407306741261
FOCAL CONTACT REDISTRIBUTION	4.571407306741261
SCANNING CONFOCAL MICROSCOPE	4.571407306741261
MULTIDIMENSIONALSEARCH SPACE	4.571407306741261
MISSENSE MUTATION HOMOZYGOUS	4.571407306741261
CONSIDERED MAJOR CONTRIBUTOR	4.571407306741261
IN VITRO ELECTRON MICROSCOPY	4.571407306741261
AVERAGE INTENSITY DIFFERENCE	4.571407306741261
THATTHE OPTIMAL ARCHITECTURE	4.571407306741261
SMALL-WORLD COUPLING DISPLAY	4.571407306741261
RELATIVE LUCIFERASE ACTIVITY	4.571407306741261
COMPUTATIONAL IMPLEMENTATION	4.571407306741261
RESIDUAL INDIVIDUAL VARIANCE	4.571407306741261
LOCALIZED STIFFNESS INCREASE	4.571407306741261
ROYAL INSTITUTE OFTECHNOLOGY	4.571407306741261
TESTING CORRECTION PROCEDURE	4.571407306741261
INDUCED CELL MIGRATION MEC-3	4.571407306741261
PROGENITOR GHFT1-5 CELL LINE	4.571407306741261
STATISTICAL GROUP COMPARISON	4.571407306741261
INFLUENCE MATRIX CONTRACTION	4.571407306741261
OPTIMAL FUNCTIONAL STABILITY	4.571407306741261
MORPHOLOGICAL CHARACTERISTIC	4.571407306741261
GENERATED TRANSCRIPT PROFILE	4.571407306741261
RAB24 DOMINANT-NEGATIVE FORM	4.571407306741261
CONSERVED NONCODING SEQUENCE	4.571407306741261
IN VITRO AUTOPHOSPHORYLATION	4.571407306741261
PHYSICAL PROPERTY SIMILARITY	4.571407306741261
OCL ESTRADIOL-TREATED ANIMAL	4.571407306741261
NOCTURNIN STRUCTURAL FEATURE	4.571407306741261
'-CGCAGATCTAGAAAACTTTTTAGA-3	4.571407306741261
EXPLOREWHETHER GPNN OVER-FIT	4.571407306741261
LIMITED PROTEOLYSIS INCREASE	4.571407306741261
RHODAMINE-CONJUGATED GAM-IGG	4.571407306741261
SIZE-DEPENDENT WOUND CLOSURE	4.571407306741261
WITHIN-TREATMENT-VARIABILITY	4.571407306741261
PRESUMPTIVE RADIAL GLIA CELL	4.571407306741261
HBP-ALL SPREADING MORPHOLOGY	4.571407306741261
COMPARING RELATIVE SCE EVENT	4.571407306741261
MHCK-C AMINO-TERMINAL DOMAIN	4.571407306741261
LACZ GENE TARGETED INSERTION	4.571407306741261
COOLED INTERLINE CAMERA ORCA	4.571407306741261
COPY NUMBERS- CHARACTERISTIC	4.571407306741261
CONTAINING Β-MERCAPTOETHANOL	4.571407306741261
PHOTOLITHOGRAPHIC TECHNOLOGY	4.571407306741261
MASIA CONSENSUS MACRO OUTPUT	4.571407306741261
HUGENEFL AFFYMETRIX GENECHIP	4.571407306741261
DIGITAL CAMERA SONY DKC-5000	4.571407306741261
INCREASED GROUPING FREQUENCY	4.571407306741261
BIDIRECTIONAL USM COORDINATE	4.571407306741261
STANDARD AFFYMETRIX PROTOCOL	4.571407306741261
SEGMENT ASP355-ARG356-PRO357	4.571407306741261
MICROEXTENSION FRAGMENTATION	4.571407306741261
MOLECULAR WEIGHT CONTAMINANT	4.571407306741261
ANAMNIOTE PROLIFERATIVE CELL	4.571407306741261
SMAD PROTEASOMAL DEGRADATION	4.571407306741261
GENETIC EPISTASIS EXPERIMENT	4.571407306741261
BX60 FLUORESCENCE MICROSCOPE	4.571407306741261
CYTOKERATIN IMMUNOREACTIVITY	4.571407306741261
GPNN MODEL PREDICTIVEABILITY	4.571407306741261
MICROVESSEL ENDOTHELIAL CELL	4.571407306741261
BASE PHYLOGENETIC LEVEL NAME	4.571407306741261
IRIDOCORNEAL ANGLE STRUCTURE	4.571407306741261
PERMITTING NONCANONICAL BASE	4.571407306741261
POTENTIAL ROLE CLARIFICATION	4.571407306741261
PRE-AUTOPHOSPHORYLATION STEP	4.571407306741261
ANTI-DIGOXYGENIN-AP LABELING	4.571407306741261
EACHDATA SET EPISTASIS MODEL	4.571407306741261
NORMAL PREOVULATORY LH SURGE	4.571407306741261
NON-COLLAGENOUS GLYCOPROTEIN	4.571407306741261
TRANSCRIBED HAPO-4 PROBE SET	4.571407306741261
OPTIMAL STRUCTURAL ALIGNMENT	4.571407306741261
ALPHABETICAL/NUMERICAL ORDER	4.571407306741261
DATA SETSPER EPISTASIS MODEL	4.571407306741261
PHYLOGENETIC GROUP HOMINIDAE	4.571407306741261
MASS SPECTROMETER INSTRUMENT	4.571407306741261
ANDROGEN DIHYDROTESTOSTERONE	4.571407306741261
DIVIDING CELL REQUIRED FORCE	4.571407306741261
NEURAL CREST PROGENITOR CELL	4.571407306741261
PROPOSED IMPLEMENTATION LEAD	4.571407306741261
PH-20-INDUCED DOWNREGULATION	4.571407306741261
L-Α-PHOSPHATIDYLETHANOLAMINE	4.571407306741261
CONVENTIONAL FIXATION METHOD	4.571407306741261
RRNAS, POSITIONAL DEPENDENCY	4.571407306741261
REQUIRED C/EBPΑ GHFT1-5 CELL	4.571407306741261
PAML PACKAGE EVOLVER PROGRAM	4.571407306741261
P35-C/EBPΒ-ARE COTRANSFECTED	4.571407306741261
fragment length polymorphism	4.571407306741261
EGF-LIKE MODULE SPECIFIC/ALL	4.571407306741261
EQUIVALENT BOOLEAN OPERATION	4.571407306741261
MOUSE ENDOTHELIAL LE-II CELL	4.571407306741261
NECK SQUAMOUS CELL CARCINOMA	4.571407306741261
AMMONIUM SULFATE PRECIPITATE	4.571407306741261
STAINING PATTERN PERINUCLEAR	4.571407306741261
PROGRESSIVE TISSUE PATHOLOGY	4.571407306741261
BASE EXCISION REPAIR PATHWAY	4.571407306741261
microfilament polymerization	4.571407306741261
EXPRESSING GFP-TAGGED C/EBPΑ	4.571407306741261
P35-C/EBPΒ-SRF-ELK-1 COMPLEX	4.571407306741261
WT-PAI-1 INHIBITORY ACTIVITY	4.571407306741261
CONTAINING MYR-BOI1-PH(KKTK)	4.571407306741261
THETRADITIONAL BPNN APPROACH	4.571407306741261
SPURIOUS SECONDARY STRUCTURE	4.571407306741261
PERIOCULAR MESENCHYME RESULT	4.571407306741261
OPTIMAL METABOLIC BY-PRODUCT	4.571407306741261
NORMAL PLM AXONAL MORPHOLOGY	4.571407306741261
LYSOSOMAL MEMBRANE INTEGRITY	4.571407306741261
REDUCED PROBE SET SIMULATION	4.571407306741261
MESENCHYMAL CELL PACKED MASS	4.571407306741261
ALIGNMENT PROGRAM WCONSENSUS	4.571407306741261
SINGLE-PARAMETER BIFURCATION	4.571407306741261
EXPERIMENTAL REPRODUCIBILITY	4.571407306741261
EVOLUTIONARY DIVERGENCE TIME	4.571407306741261
ELK-1 TRANSACTIVATION DOMAIN	4.571407306741261
SCANNING ELECTRON MICROSCOPE	4.571407306741261
MOLEGO STRUCTURAL SIMILARITY	4.571407306741261
DEFINED SIMILARITY THRESHOLD	4.571407306741261
FLUORESCENCE LEVELS DECREASE	4.571407306741261
ECTOCERVICAL EPITHELIUM SHOW	4.571407306741261
UNDERSTANDING CELL MIGRATION	4.571407306741261
PROTEASOME-DEPENDENT PATHWAY	4.571407306741261
RECEPTOR-INDUCED DEGRADATION	4.571407306741261
CELL SURFACE RADIOIODINATION	4.571407306741261
MULTI LOCUS SEQUENCE TYPING,	4.571407306741261
COREGENE PLATFORM LIMITATION	4.571407306741261
TGF-Β1-INDUCED ANTIAPOPTOTIC	4.571407306741261
Β-ACTIN-CRE TRANSGENIC MOUSE	4.571407306741261
SMAD4 CONSTITUTIVE REDUCTION	4.571407306741261
FOOT-AND-MOUTH DISEASE VIRUS	4.571407306741261
AFFYMETRIX DEFAULT PARAMETER	4.571407306741261
MOTIVATION FORTHIS STATISTIC	4.571407306741261
NEURAL CREST ECTO-MESENCHYME	4.571407306741261
A PRIORI CANDIDATE GENE LIST	4.571407306741261
BACKGROUND SUBTRACTION MODEL	4.571407306741261
RETINAL CIRCADIAN OSCILLATOR	4.571407306741261
BMP CRITICAL REGULATORY ROLE	4.571407306741261
MICROFILAMENT POLYMERIZATION	4.571407306741261
OTHER P53-REGULATORY PATHWAY	4.571407306741261
RAB24 PHYSIOLOGICAL FUNCTION	4.571407306741261
TRUNCATED COILED-COIL DOMAIN	4.571407306741261
PHOSPHOLIPID-BINDING PORTION	4.571407306741261
CURRENT COMPARATIVE SEQUENCE	4.571407306741261
AFFYMETRIX GENECHIP PLATFORM	4.571407306741261
RHODAMINE-CONJUGATED GAM IGG	4.571407306741261
STRUCTURAL INTERRELATIONSHIP	4.571407306741261
MODELING NONLINEAR EPISTASIS	4.571407306741261
WITHINA RANGE SELECTED MODEL	4.571407306741261
BRYOPHYTA PHYLOGENETIC GROUP	4.571407306741261
BINNING GENE EXPRESSION DATA	4.571009665688131
MNOC GENE ALTERED EXPRESSION	4.571009665688131
DOWNREGULATE ISL1 EXPRESSION	4.570877118670422
GENERATED EXPRESSION PROFILE	4.570877118670422
SIGNATURE EXPRESSION PROFILE	4.570877118670422
RGS3 EXPERIMENTAL EXPRESSION	4.570877118670422
WIDESPREAD NEURAL EXPRESSION	4.570877118670422
CONSTITUTIVE LACZ EXPRESSION	4.570877118670422
TETRACYCLINE EXPRESSION UNIT	4.570877118670422
SCION IMAGE ANALYSIS PROGRAM	4.570676026473659
ANALYSIS SECTION OFTHE PAPER	4.570676026473659
PROMOTING GENERAL ASSOCIATION	4.570640217469003
SPLICING-DEPENDENT REGULATION	4.570569268397213
SN50-TREATED EXPLANTS EXHIBIT	4.570465829701934
EMBRYONIC FIBROBLASTS EXHIBIT	4.570465829701934
OLIGONUCLEOTIDE GENECHIP HTTP	4.570463637155231
AVERAGE FOLD-CHANGE ANALYSIS	4.570432266384458
FUNCTIONAL TAXONOMY ANALYSIS	4.570432266384458
COMPARATIVE ANALYSIS PROGRAM	4.570432266384458
IMMUNOHISTOCHEMICAL ANALYSIS	4.5699447462060565
IMAGING STUDY DETAILED RATIO	4.569897494250304
NUMEROUS RECENT CANCER STUDY	4.569897494250304
NG/ML EPIDERMAL GROWTH FACTOR	4.569805648711208
FILAMENT REGULATED MYOSIN II	4.569777110530095
INDIVIDUAL MICROARRAY RESULT	4.569738296334591
FUTURE MICROARRAY GENERATION	4.569738296334591
DESCRIBING MICROARRAY RESULT	4.569738296334591
SSU RRNA CONSENSUS STRUCTURE	4.569541568872208
AFFYMETRIX HIGH-DENSITY OLIGO	4.56950384983584
BIOCHEMICAL EXTRACTION STUDY	4.569394223419986
ANIMAL CARCINOGENICITY STUDY	4.569394223419986
DETAILED DOSE-RESPONSE STUDY	4.569394223419986
RECURSIVE DISTANCE ALGORITHM	4.569269228050364
AFFYMETRIX DEFAULT ALGORITHM	4.569269228050364
MOID NORMALIZATION ALGORITHM	4.569269228050364
PARSING ALGORITHM CYK/INSIDE	4.569269228050364
NORMALIZATION MOID ALGORITHM	4.569269228050364
EXTRACELLULAR MATRIX MODULATION	4.569196213145307
CHLORIDE GRADIENT CENTRIFUGATION	4.568963165086968
LYSOSOMAL ENZYME INACTIVATION	4.568902247369491
PERIODIC QUANTITATIVE CHANGE	4.568725945760054
MEDIATED PROCESS OTHER ACTIN	4.568688807796325
MOLONEY SARCOMA VIRUS VECTOR	4.56863505216747
IN SITU HYBRIDIZATION RESULT	4.5686193007210285
ALTERED EXTRACELLULAR MATRIX	4.568486538529589
GΑ EXTREME C-TERMINAL REGION	4.568486538529589
GENEORDER ANALYSIS ALGORITHM	4.568294187693561
IMPROVING ANALYSIS ALGORITHM	4.568294187693561
TYPE GSK3Β EXPRESSION VECTOR	4.568237411114342
PHEROMONE RESPONSE NETSEARCH	4.568086230196009
MAJOR PHYLOGENETIC GROUP RNA	4.568055605514751
RNA POSTERIOR LOG-ODDS SCORE	4.568055605514751
SHOWED POSITIVE LOCALIZATION	4.568052167872469
SIMILAR LOCALIZATION PATTERN	4.568052167872469
ARP3-GFP LOCALIZATION RETURN	4.568052167872469
DUAL LOCALIZATION EXPERIMENT	4.568052167872469
MATERNAL TRANSRIPTION FACTOR	4.5680464227716655
EMISSION PROBABILITY	4.568036788632615
RECEPTOR TGF-Β FAMILY TYPE I	4.567993817631272
INDUCED ACTIN POLYMERIZATION	4.5677826414813465
FILAMENTOUS ACTIN MICROSPIKE	4.5677826414813465
IMMUNOFLUORESCENT IMAGES SHOW	4.567765535340967
TCF TRANSCRIPTIONAL ACTIVITY	4.567603515581874
PROMOTER SEQUENCE ANNOTATION	4.567535992661885
REMAINING C-TERMINAL PORTION	4.567512949125698
HIGH-THROUGHPUT GENOMIC DATA	4.567512949125698
REGULATORY DOMAIN C-TERMINAL	4.567512949125698
SMAD1 CYTOPLASMIC INTERACTOR	4.567417964793611
EXPOSED CYTOPLASMIC FILAMENT	4.567417964793611
PROHB-EGF CYTOPLASMIC DOMAIN	4.567417964793611
ACTIN NUCLEATION ARP2 SUBUNIT	4.567291852019359
GFP-C/EBPΑ EXPRESSION VECTOR	4.567180779238702
EXPRESSION VECTOR PK7-GR-GFP	4.567180779238702
SIGNAL TRANSDUCTION CATEGORY	4.567172665450552
EXOGENOUS ACTIN INCORPORATION	4.5670425342651075
EXTRACELLULAR LIGAND-BINDING	4.567026154423753
REVISITED DARWINIAN EVOLUTION	4.566825905884279
FORM COMPLEX ADAPTOR PROTEIN	4.566813377570416
BEARING MUTATION RAB PROTEIN	4.566813377570416
SM CORE SPLICEOSOMAL PROTEIN	4.566813377570416
DORSAL SPINAL SENSORY NEURON	4.566572931770217
PICOLINIC ACID	4.566274274821342
C3 TRANSFERASE ELECTROPORATION	4.566241524430447
compositions	4.56607593011908
CIS- REGULATORY DNA SEQUENCE	4.56588266021601
SELECTED GQ-COUPLED RECEPTOR	4.565718158224613
TRANSCRIPTIONAL CO-MODULATOR	4.565701620002181
TRANSCRIPTIONAL CO-REPRESSOR	4.565701620002181
HYBRIDIZATION PROTOCOL STUDY	4.565676882059676
HOMOLOG PROTEIN PHOSPHATASE T1	4.565486995000184
ENHANCING TNF SUSCEPTIBILITY	4.565459560564766
ACTIVATION OPTIMAL CONDITION	4.565377333659099
RHOGTPASE PATHWAY ACTIVATION	4.565377333659099
SHOWED DISTRIBUTION BOI2-GFP	4.565377333659099
STANDARD NORMAL DISTRIBUTION	4.565377333659099
COMPRISING ACTIVATION DOMAIN	4.565377333659099
ADENYLATE CYCLASE ACTIVATION	4.565377333659099
JNK1 CONSTITUTIVE ACTIVATION	4.565377333659099
SPATIAL DISTRIBUTION PROFILE	4.565377333659099
SPATIAL DISTRIBUTION PATTERN	4.565377333659099
PROBE INTENSITY DISTRIBUTION	4.565377333659099
GAD1 TRANSCRIPT DISTRIBUTION	4.565377333659099
DEFINED DISTRIBUTION PATTERN	4.565377333659099
FIBROBLAST MIGRATION MODULATION	4.565370545620655
RELATIONSHIP QUANTATIVE ASPECT	4.565328027718631
PRINCIPLE COMPONENT ANALYSIS	4.565320922014032
PRINCIPAL COMPONENT ANALYSIS	4.565320922014032
TARGET PROTEIN PHOSPHORYLATE	4.565282067846801
PROTEIN POTENTIAL IMPORTANCE	4.565282067846801
MISFOLDED ENDOGENOUS PROTEIN	4.565282067846801
HIGHER-ORDER PROTEIN COMPLEX	4.565282067846801
anti-rabbit	4.56511402544524
CORRESPONDING MUTANT VERSION	4.565046522635842
MRNA CENTROSOMAL SEGREGATION	4.565034721552158
E. COLI IN-DEPTH QRNA SCREEN	4.564864785947116
CONSERVATION RATIO PARAMETER	4.564864785947116
ACTIN LEADING EDGE COMPONENT	4.564855299518506
FIBROBLAST CCAF CHEMOATTRACT	4.564765153650758
CYTOSKELETON PRODUCES CHANGE	4.5647607816423905
ACTIVATED PROTEIN EXPRESSION	4.5647518797759625
DEVELOPED CHIMERIC ANTISENSE	4.5645204427474235
OTHER TRANSCRIPTIONAL FACTOR	4.564242631612279
MHCK-C PHOSPHORYLATION LEVEL	4.564197917436418
CONSERVED GUANINE NUCLEOTIDE	4.5641646637957125
EC-SPECIFIC INTEGRIN COMPLEX	4.564056159781547
GROWING POLYCLONAL CELL LINE	4.563858244286478
DISRUPTED MNOC TRANSCRIPTION	4.563852432845019
INCREASED GENE TRANSCRIPTION	4.563852432845019
DISADVANTAGE ISTHE INTERPRETATION	4.56385060978249
LOCALIZATION SIGNAL SEQUENCE	4.56381752658176
TRANSGENE ECTOPIC EXPRESSION	4.563442435949804
BINDING FACTOR DNA TITRATION	4.563361997238814
PROTEIN FAMILY REPRESENTATIVE	4.563319559532255
DENSITY DEPENDENT EXPRESSION	4.563313510815919
P53 TRANSCRIPTIONAL RELATIVE	4.563256325685432
E. COLI METABOLIC CAPABILITY	4.563229155748579
ENDOTOXIN-STIMULATED MONOCYTE	4.562898254755324
SEVEN-TRANSMEMBRANE RECEPTOR	4.562873583966289
DNA-DEPENDENT PROTEIN KINASE	4.5627608652286336
DNA-ACTIVATED PROTEIN KINASE	4.5627608652286336
HOMOLOGOUS RECOMBINATION LEAD	4.562739083789529
APROTININ PROTEASE INHIBITOR	4.562683945682401
LEUPEPTIN PROTEASE INHIBITOR	4.562683945682401
FINAL DRAFT OFTHE MANUSCRIPT	4.562645002106245
BRANCHED NETWORK FINAL MODEL	4.562645002106245
MATRIX COMPONENT FIBRONECTIN	4.5625573790598954
SOFTWARE IMPLEMENTATION TEST	4.562383140128647
SINGLE-TRANSMEMBRANE PROTEIN	4.5622194483995715
APOPTOSIS-ASSOCIATED PROTEIN	4.5622194483995715
LDL-RECEPTOR-RELATED PROTEIN	4.5622194483995715
ACID CLASSIC LEUCINE-RICH NE	4.562105144474704
INOSITOL PHOSPHATE ACCUMULATION	4.561893843281401
DNA-BINDING-DEFECTIVE MUTANT	4.561866130583133
DEGRADATION-RESISTANT MUTANT	4.561866130583133
CYTOSKELETON-ASSOCIATED MRNA	4.561848428957608
P66 HOMODIMER	4.561798148766965
SITUHYBRIDIZATION FIBROBLAST	4.561444077105507
RABBIT POLYCLONAL ANTI-CDC42	4.561341890134884
SEQUENCED CHH CRITICAL REGION	4.561246855985194
MISMATCH SIGNAL DISTRIBUTION	4.56114269236839
OPTIMAL GROWTH GLUCOSE RATIO	4.561141845244172
INCREASED L929 GROWTH TGF-Β1	4.561141845244172
TRANSCRIPTION CO-ACTIVATOR CBP	4.56110919801721
gel filtration	4.560699318473125
CROSS HYBRIDIZATION COMPONENT	4.560590049656167
STARVED RAT FIBROBLAST SERUM	4.560489937170631
sucrose	4.560169164880466
MACHINE	4.560169164880466
LINEAGE	4.560169164880466
VITERBI	4.560169164880466
REMOVAL	4.560169164880466
NECROSI	4.560169164880466
SHEAR-SPECIFIC TRANSCRIPTION	4.560074995896899
SMAD1-MEDIATED TRANSCRIPTION	4.560074995896899
CO-TRANSFECTED GROWTH HORMONE	4.559992610057364
MAPK CASCADE SHARE COMPONENT	4.559906781907803
CELL PROLIFERATION ASSAY E15	4.5596093780627625
PREDICTED BASE PAIR ACCURACY	4.559439280898313
CCAF-INDUCED FN ACCUMULATION	4.559365857426884
COLL INCREASING ACCUMULATION	4.559365857426884
VENTRAL HYPOTHALAMIC NUCLEUS	4.559216274205587
MONOCLONAL ANTIBODY ANTI-MYC	4.559101624996788
MONOCLONAL ANTIBODY FACILITY	4.559101624996788
ABLATED PRIMARY MOTOR NEURON	4.558935747963823
INCORPORATED PHOSPHATE NMOLE	4.558885735843376
ANTERIOR SEGMENT DEVELOPMENT	4.558703382869135
INSULIN-LIKE GROWTH FACTOR I	4.558621182266975
BONDED COIL STRUCTURE HYDROGEN	4.558594020984624
PATHOGEN INFECTION TREATMENT	4.558546334596073
PHOSPHORIMAGER CASSETTE	4.5584946664366335
BLM SHOW N-TERMINAL DELETION	4.557990027768893
INCLUDING CASPASE ACTIVATION	4.557942650938481
LIPID VESICLE/PBS SUSPENSION	4.55787105682234
MEDIATING TISSUE INTERACTION	4.557691330233619
YEAST TWO-HYBRID INTERACTION	4.557691330233619
SYSTEM CELL-CELL INTERACTION	4.557691330233619
MESENCHYMAL CELL INTERACTION	4.557691330233619
ENDOTHELIAL CELL INTERACTION	4.557691330233619
VARYING STRENGTH INTERACTION	4.557691330233619
IN VITRO FILOPODIA FORMATION	4.557649669557311
IMMUNOFLUORESCENCE PROCEDURE	4.5575850797113775
PERFORMED IMMUNOFLUORESCENCE	4.5575850797113775
DOMINANT-NEGATIVE SUPPRESSION	4.557493676962174
PAIRWISE RESIDUE CORRELATION	4.557487049732442
MYOSIN II IN VIVO REGULATION	4.55744020629979
ANNOTATING TRANSFER RNA GENE	4.5573884520460375
REDUCING NOISE COMMON METHOD	4.557045675729723
MARGINAL ORTHOLOGY BOOTSTRAP	4.556868371643161
CSN FUNCTION	4.555949796395849
TOUCH RECEPTOR-SPECIFIC GENE	4.555829876279011
CONSERVED DNA-BINDING DOMAIN	4.555829876279011
GENERAL LOCALIZATION PATTERN	4.5557077890155915
MEDIATED REGRESSION MACROPHAGE	4.555570589389764
EXPERIMENTAL DATA COLLECTION	4.555449938950663
PROTEIN PHOSPHATASE REACTION	4.555443690712749
MULTIPLE MAMMALIAN CELL LINE	4.555352119598559
INTERVENTION POTENTIAL TARGET	4.555349003234735
REGULATORY INFORMATION SERVER	4.5550778375910355
AZ INTERACTION MAPPING STUDY	4.555067094651418
ACTIN STRESS FIBER FORMATION	4.554931170612376
CATALYTIC REGULATOR MOLECULE	4.554523382111209
CONTAINING UNINFECTED SF9 CELL	4.554400617855051
PURIFIED APN	4.554136770242488
DOUBLE-STRAND RNA INTERFERENCE	4.554040286922693
TRANSIENT TRANSFECTION STUDY	4.5539394498905095
MUTANT STRAIN	4.553862343184372
ΜM RESVERATROL-TREATED BPAEC	4.553811285045517
CEREVISIAE YEAST SACCHAROMYCE	4.553721614025492
SWITCHING BANDPASS EXCITATION	4.553601491308672
LYMPHOCYTE INTEGRIN FUNCTION	4.553503706887766
COLLAGEN MG/ML BOVINE TYPE I	4.553438705880186
SAMPLE CENTRIFUGATION PROTOCOL	4.553303015693619
bridges	4.553019670613128
ANTI-DIGOXYGENIN-AP ANTIBODY	4.552948784124552
ANTI-PHOSPHO-MOESIN ANTIBODY	4.552948784124552
NORMAL BLM CDNA TRANSFECTION	4.552839604894237
COS-1 CELL CDNA TRANSFECTION	4.552839604894237
CONSIDERED TOTAL CELL NUMBER	4.552820599939713
MRNA SPECIES SPATIAL CONTEXT	4.552707610840615
PHOTOMORPHOGENIC DEVELOPMENT	4.552351420933072
POSITIVE PROBE PAIR FRACTION	4.552258465392544
MESENCHYMAL CELL ASSOCIATION	4.552164598523188
MHB-EGF PHYSICAL ASSOCIATION	4.552164598523188
ANTI-BOI1 IMMUNOREACTIVE BAND	4.551719555388297
DISCARD MISMATCH INFORMATION	4.551666942276169
RETINAL CELL DIFFERENTIATION	4.551338224550633
CONTROL WILD-TYPE FIBROBLAST	4.551218114765853
PROTEASOME INTEGRAL COMPONENT	4.550797101353856
CHROMATOGRAPHIC	4.550443474732501
THREE-DIMENSIONAL EXAMINATION	4.550382390392241
PSEUDOPREGNANT SURROGATE MOTHER	4.549779299273174
FUNDAMENTAL PHYSICOCHEMICAL LAW	4.549779299273174
FUNCTIONAL SINGLE NUCLEOTIDE	4.549717456994762
CELL CYCLE C/EBPΑ REGULATION	4.549702111717225
INTRAEPITHELIAL T LYMPHOCYTE	4.549574645581712
MODEL WITHEIGHT NON-FUNCTIONAL	4.549334761725365
ΜG/ML EE MONOCLONAL ANTIBODY	4.549332782093617
TYPE MYOSIN-II CONCENTRATION	4.549229270150939
ΜL AFFINITY MATRIX BED VOLUME	4.549158766859549
PROTEIN PHOSPHATASE 5 PHYSIOLOGICAL SUBSTRATE	4.549029226060747
PH-20-INDUCED ERK ACTIVATION	4.548813989876455
ANTISERA	4.548634125566631
REMODELING COMPLEX CHROMATIN	4.548451093428472
NEURAL DEVELOPMENT VERTEBRATE	4.548420457770601
INSTITUTIONAL ANIMAL CARE	4.5477146187761885
DENATURING POLYACRYLAMIDE GEL	4.547646971643965
BLOCKED ERK1 DERMATAN SULFATE	4.547485199567453
COMPLEMENTARY CLASSIFICATION	4.547471255055365
ANDROGEN CONTINUOUS PRESENCE	4.547175748244428
CARRYING ENDOTHELIAL ANTIGEN	4.546718549027507
FUMABC PRODUCTION CAPABILITY	4.546718549027507
TOTAL SEQUENCE DECOMPOSITION	4.546625031005864
CO-TRANSFECTED JNK ACTIVATION	4.546415369335018
TRMA PATIENT	4.546381047253112
INTERGENIC SEQUENCE FRACTION	4.545875518276305
NORMAL MITOTIC CELL DIVISION	4.5455815667643735
MUTANT PROTEIN INCORPORATION	4.545569200488026
CRANIAL NEURAL CREST CONTRIBUTION	4.545477058677016
DIFFERENTIAL EXPRESSION DATA	4.545469270926171
SPARC-NULL FIBROBLAST ABILITY	4.545382911270025
CANCER SPECTRUM ORDERED LIST	4.544883573792025
EXOENZYME C3 ELECTROPORATION	4.544703140234548
C3 EXOENZYME ELECTROPORATION	4.544703140234548
CELL LYSATE GAGASE TREATMENT	4.5444006320983386
MAXIMUM LIKELIHOOD PHYLOGENY	4.544330067320115
WOUND CONTRACTION TAKES PLACE	4.544247162763279
SPREADING 3T3 CELL FILOPODIA	4.544146803432324
transactivation	4.54410037540988
DERMAL FIBROBLAST PREPARATION	4.5436762024932404
BIO-RAD PROTEIN ASSAY REAGENT	4.543369952768706
G PROTEIN FAMILY G QΑ MEMBER	4.542854346537623
SUSPENSION CULTURE	4.542735895405209
DIFFERENTIAL INTERFERENCE CONTRAST	4.5426331747744
Β-ACTIN PROMOTER/CMV ENHANCER	4.542480960870093
INCREASING SATURATION DENSITY	4.542480960870093
CALPAIN-DEPENDENT DISSOCIATION	4.541759004149608
DENSITY GRADIENT CENTRIFUGATION	4.541652817394085
SERINE BLOCK PHOSPHORYLATION	4.541637500904884
SERINE PRIOR PHOSPHORYLATION	4.541637500904884
MM IMIDAZOLE	4.541604916149832
FOUR-PAIRWISE SURVIVAL METHOD	4.541557101418273
SEQUENCE IDENTITY	4.541529752050105
MEK INHIBITOR	4.541134944443135
structure alignment	4.541114812021826
AMINO-TERMINAL HALF	4.541114812021826
EXPERIMENTAL SAMPLE	4.541114812021826
DEGRADATION PRODUCT	4.541114812021826
REGULATORY SEQUENCE	4.541114812021826
EXPERIMENTAL SYSTEM	4.541114812021826
EXPERIMENTAL DESIGN	4.541114812021826
PHYLOGENETIC EVENTS	4.541114812021826
ELECTRON MICROGRAPH	4.541114812021826
VENTRAL NEURAL TUBE	4.541114812021826
PERIVITELLINE SPACE	4.541114812021826
NEURONAL IDENTITY EARLY-BORN	4.540976977466169
SINGLE PARAMETER PERTURBATION	4.540762515675236
GENE OVEREXPRESSION PHENOTYPE	4.540551615830147
STANDARD INDUCTION CONDITION	4.540252445816762
DNA POLYMERAS HYDROXYL GROUP	4.540056920239123
MITOCHONDRIAL CREATINE KINASE	4.539935452168546
PUPILLARY MEMBRANE REGRESSION	4.5396213959001726
LIGNIN BIOSYNTHESIS PATHWAY	4.539227521022131
'-POLYPHOSPHATE PHOSPHATASE	4.539227521022131
MYCRAB24-POSITIVE INCLUSION	4.539227521022131
5'CGAATTCTATCTGAATGACCGCTGC	4.539227521022131
AVERAGE CLASSIFICATIONERROR	4.539227521022131
HISTIDINE-TAGGED P35-C/EBPΒ	4.539227521022131
GUANINE-NUCLEOTIDE EXCHANGE	4.539227521022131
HETEROZYGOUS ISL1-CRE MOUSE	4.539227521022131
MECHANISM/PATHWAY DISCOVERY	4.539227521022131
RECONSTRUCTED MITOCHONDRION	4.539227521022131
COULTER ESP ELITE CYTOMETER	4.539227521022131
COMMITTED OSTEOCLASTOGENESI	4.539227521022131
SPATIAL MECHANICAL PROPERTY	4.539227521022131
UNDERLYING DYNAMICAL SYSTEM	4.539227521022131
RESULTING DATA PRESENTATION	4.539227521022131
IMMUNOHISTOCHEMICAL FEATURE	4.539227521022131
POLYMORPHONUCLEAR LEUCOCYTE	4.539227521022131
COSTAR TISSUE CULTURE PLATE	4.539227521022131
ATTENUATED ENDOTHELIAL CELL	4.539227521022131
SEGMENTATION GENE HIERARCHY	4.539227521022131
PURIFIED C3 C3 RIBOSYLATION	4.539227521022131
TIME-LAPSE VIDEO MICROSCOPY	4.539227521022131
ACTIVATION-INDUCED DECREASE	4.539227521022131
MM PMSF/LEUPEPTIN/APROTININ	4.539227521022131
TABULAR PRESENTATION FORMAT	4.539227521022131
PROGRAM DATABANK MODEL RULE	4.539227521022131
PROBABILISTIC FORMALIZATION	4.539227521022131
GENERATED MEC-3GFP DELETION	4.539227521022131
SEASONAL INFLUENZA EPIDEMIC	4.539227521022131
UPDATED PUBLIC EST DATABASE	4.539227521022131
REPETITIVE HMM ARCHITECTURE	4.539227521022131
PHYSICO CHEMICAL CONSTRAINT	4.539227521022131
SPARC DEFICIENCY COMPROMISE	4.539227521022131
MINIMUM CLASSIFICATIONERROR	4.539227521022131
THEI THINPUT SQUARED WEIGHT	4.539227521022131
CLINICAL OUTCOME DIFFERENCE	4.539227521022131
PRECIPITATED PHOSPHOHISTONE	4.539227521022131
MOUNTING MEDIUM VECTASHIELD	4.539227521022131
CARBOHYDRATE-BUILDING MODEL	4.539227521022131
RAT C/EBPΑ CARBOXY TERMINUS	4.539227521022131
EMBRYONIC TRANSCRIPT INSERT	4.539227521022131
INTRAEPITHELIAL MESENCHYMAL	4.539227521022131
GENERATION HUMAN U95 SERIES	4.539227521022131
GFP-N346 RING FINGER DOMAIN	4.539227521022131
RESULTING RAPID DEGRADATION	4.539227521022131
RELATIVE OXIDATIVE ACTIVITY	4.539227521022131
UNWINDING ACTIVITY UNITS/NG	4.539227521022131
HIGHLIGHT POTENTIAL PITFALL	4.539227521022131
RGS3 ACTION MOLECULAR LOCUS	4.539227521022131
zygotic gap gene expression	4.539227521022131
PROBE SET AVERAGE INTENSITY	4.539227521022131
ENDOTHELIAL-LIKE TRABECULAR	4.539227521022131
ANDROGEN-MEDIATED G1 ARREST	4.539227521022131
BMP CELLULAR RESPONSIVENESS	4.539227521022131
UNDERSTANDING GENE FUNCTION	4.539227521022131
RHOA SPATIAL REDISTRIBUTION	4.539227521022131
RAB MUTATION POTENTIAL ROLE	4.539227521022131
UBIQUITIN/PROTEASOME SYSTEM	4.539227521022131
UDP-GLUCORONOSYLTRANSFERASE	4.539227521022131
THREONINE558-PHOSPHO-MOESIN	4.539227521022131
REGULATORY ELEMENT DATABASE	4.539227521022131
HITRAP METAL CHELATE COLUMN	4.539227521022131
REEPITHELIALIZATION PROCESS	4.539227521022131
BASIC-LEUCINE ZIPPER FAMILY	4.539227521022131
SIGNALING PATHWAY INHIBITOR	4.539227521022131
AMINO-TERMINAL FLAG EPITOPE	4.539227521022131
RELEASING SUBSTRATE/PRODUCT	4.539227521022131
RECESSIVE PLEIOTROPIC HUMAN	4.539227521022131
EVALUATED USING100 DATA SET	4.539227521022131
PROTEIN-INTERACTION DATASET	4.539227521022131
MEASURING SCALE-INDEPENDENT	4.539227521022131
OTHER PHENOTYPIC DIFFERENCE	4.539227521022131
FORMAL STATISTICAL APPROACH	4.539227521022131
ALTERNATIVE SPLICING RESULT	4.539227521022131
CARBOHYDRATE GROUPS THOUGHT	4.539227521022131
SORTING NEXIN FAMILY MEMBER	4.539227521022131
OSTEOCLAST FUNCTIONAL STATE	4.539227521022131
CONSERVED CYSTEINE-CYSTEINE	4.539227521022131
OTHER PHOSPHATIDYLINOSITIDE	4.539227521022131
OVERLAPPING QRNA ANNOTATION	4.539227521022131
PAIR-WISE COMPARISON METHOD	4.539227521022131
UBIQUITIN-DEPENDENT PATHWAY	4.539227521022131
CONTINUOUS COORDINATE SPACE	4.539227521022131
CRE-MEDIATED EXCISION EVENT	4.539227521022131
AUTOPHAGY POSSIBLE MEDIATOR	4.539227521022131
INCREASING CORT/GR FUNCTION	4.539227521022131
HORMONE-RESPONSIVE ELEMENTS	4.539227521022131
TEXAS RED DONKEY ANTI-MOUSE	4.539227521022131
HUMAN LUNG REPLICATE SAMPLE	4.539227521022131
GRAM-NEGATIVE BACTERIA BIND	4.539227521022131
SIGNALING CENTER ECTODERMAL	4.539227521022131
EPIDERMAL COVERING PROGRESS	4.539227521022131
ACTIVATED P53-POSITIVE CELL	4.539227521022131
blood cell autofluorescence	4.539227521022131
DISPLAY ULTRAMICROEXTENSION	4.539227521022131
postmitotic differentiation	4.539227521022131
TESTED REPLACEMENT MUTATION	4.539227521022131
CLEAVAGE FURROW PROGRESSION	4.539227521022131
SYSTEMIC METABOLIC FUNCTION	4.539227521022131
HYAL-1-EXPRESSING L929 CELL	4.539227521022131
MHCK-A-EXPRESSING CELL LINE	4.539227521022131
GAIN-OF-FUNCTION EXPERIMENT	4.539227521022131
ORIGINAL CGR REPRESENTATION	4.539227521022131
MITOCHONDRIAL DEHYDROGENASE	4.539227521022131
BOOTSTRAPPED MODE ESTIMATOR	4.539227521022131
DIGESTED PEGFP-N1 AGEI-NHEI	4.539227521022131
INDUCED LUCIFERASE ACTIVITY	4.539227521022131
CHEMOKINE-CONTAINING PELLET	4.539227521022131
TITRATION OPTIMAL CONDITION	4.539227521022131
ECTOPIC RECOMBINATION EVENT	4.539227521022131
NEIGHBORING LENS EPITHELIAL	4.539227521022131
MOUSE EPITHELIAL MTD-1 CELL	4.539227521022131
SENSITIVE HISTOLOGIC METHOD	4.539227521022131
NON-SPECIFIC GENE PROBE SET	4.539227521022131
EXPRESSING GAIN-OF-FUNCTION	4.539227521022131
THREE-DIMENSIONAL STRUCTURE	4.539227521022131
BOI1-PH DEGRADATION PRODUCT	4.539227521022131
GLYCOSAMINOGLYCAN-DEGRADING	4.539227521022131
CROSS-VALIDATIONCONSISTENCY	4.539227521022131
sigmoidal transfer function	4.539227521022131
CELLULAR FUNCTION SIGNATURE	4.539227521022131
OPTIMAL CUTTING TEMPERATURE	4.539227521022131
APOPTOSIS-INDUCING FUNCTION	4.539227521022131
PPT1 MESSAGE RELATIVE LEVEL	4.539227521022131
HNF3ΑLACZ TRANSGENIC EMBRYO	4.539227521022131
MUSCLE MYOSIN-II DUTY RATIO	4.539227521022131
IMPROVED CHEMICAL STABILITY	4.539227521022131
LASER DESORPTION/IONIZATION	4.539227521022131
CLEAVAGE FURROW CORTEX PEAK	4.539227521022131
TET-RESPONSIVE GFP-BLM GENE	4.539227521022131
MULTI LOCUS SEQUENCE TYPING	4.539227521022131
GENOTYPE-PHENOTYPE RELATION	4.539227521022131
ESTRADIOL EXPOSURE INCREASE	4.539227521022131
POSITIVE FEEDBACK MECHANISM	4.539227521022131
GROWING HL-60 PROMYELOCYTIC	4.539227521022131
DOUBLING TIME REDUCING CELL	4.539227521022131
DIVIDING D. DISCOIDEUM CELL	4.539227521022131
LABELED LIVER MITOCHONDRION	4.539227521022131
OPEN READING         FRAMES	4.539227521022131
STIMULATED LUCIFERASE LEVEL	4.539227521022131
BIOLOGICAL SAMPLE REPLICATE	4.539227521022131
DIMENSIONAL PARAMETER SPACE	4.539227521022131
CONSTRUCTED HYAL-1-PEGFP-N1	4.539227521022131
MULTI-LOCUS SEQUENCE TYPING	4.539227521022131
DIVERGENCE-MATCHED EMISSION	4.539227521022131
AUTOMATED ANNOTATION METHOD	4.539227521022131
VIDEO TIME LAPSE MICROSCOPY	4.539227521022131
BINDING/DIMERIZATION DOMAIN	4.539227521022131
EMPIRICAL OBSERVATIONS SHOW	4.539227521022131
DYNAMIC PML-DEPENDENT DEPOT	4.539227521022131
CYTOSKELETAL REORGANIZATION	4.539227521022131
MAXIMAL SRE TRANSACTIVATION	4.539227521022131
INFLATED SUBGERMINAL CAVITY	4.539227521022131
FOLLICULAR LYMPHOMA PATIENT	4.539227521022131
IDENTIFIED PROTEOLYSIS SITE	4.539227521022131
AVERAGECLASSIFICATION ERROR	4.539227521022131
BOTTOM MIDDLE-RIGHT DISPLAY	4.539227521022131
NOCTURNIN RHYTHMIC FUNCTION	4.539227521022131
TUMOR NECROSIS FACTOR-ALPHA	4.539227521022131
YEAST TWO-HYBRID EXPERIMENT	4.539227521022131
CIRCADIAN REGULATORY SYSTEM	4.539227521022131
LABELING QUALITY IMMUNOGOLD	4.539227521022131
HUMAN PRE-OCL CELL LINE FLG	4.539227521022131
three-dimensional structure	4.539227521022131
CHARACTERIZED PPT1 ACTIVITY	4.539227521022131
APOPTOSIS-INDUCING ACTIVITY	4.539227521022131
REVEALED BRDU-POSITIVE CELL	4.539227521022131
SECTORING DIMINISHED AMOUNT	4.539227521022131
ABI PRISM BIGDYE TERMINATOR	4.539227521022131
IGM ECTOCERVICAL EPITHELIUM	4.539227521022131
HYAL-2-EXPRESSING L929 CELL	4.539227521022131
SOCIAL AMOEBA D. DISCOIDEUM	4.539227521022131
METALLOPROTEASE TN TENASCIN	4.539227521022131
ENDOGENOUS SΑ I2 COS-7 CELL	4.539227521022131
UPRIGHTED-STAGED MICROSCOPE	4.539227521022131
MONOCYTE CHEMOTACTIC PROTEIN	4.539111984670222
EXPRESSION TREE FORM TOLOOK	4.538833843469851
UPREGULATE DELTA EXPRESSION	4.538702617619092
RHYTHMIC EXPRESSION PATTERN	4.538702617619092
HYAL-1 TRANSIENT EXPRESSION	4.538702617619092
TEMPORAL EXPRESSION PATTERN	4.538702617619092
GRK EXPERIMENTAL EXPRESSION	4.538702617619092
BACKGROUND EXPRESSION LEVEL	4.538702617619092
NLS-GFP EXPRESSION CASSETTE	4.538702617619092
REPRESENTATIVE GENE SEQUENCE	4.538694702770537
CONCLUSION SINGLE SITE MUTATION	4.538640258631058
SPATIAL-TEMPORAL EXPRESSION	4.538440165917572
MOBILITY GEL-SHIFT ANALYSIS	4.538262199413561
COVARIATION ANALYSIS METHOD	4.538262199413561
K-NEAREST NEIGHBOR ANALYSIS	4.538262199413561
GLUTARALDEHYDE CONCENTRATION	4.538140251855779
ORIGINAL MALE CONTROL GROUP	4.537843480852579
IMMUNOCYTOCHEMICAL ANALYSIS	4.537779538609276
RESISTED ELUTION PROTEOGLYCAN	4.537740103156804
REGULATING FURROW MYOSIN II	4.537613573847669
FILAMENT ASSEMBLY MYOSIN II	4.537613573847669
IQ3 AFFINITY	4.537478507371013
MM PROBENECID	4.537414096256841
GFP-EXPRESSING CONTROL CELL	4.537382134129395
NCRNA GENEFINDING ALGORITHM	4.537110753703992
TANGENTIAL CLEAVAGE DIVISION	4.536972986772078
CHELATE RESIN CHROMATOGRAPHY	4.536972986772078
MUTANT PROTEIN CONCENTRATION	4.536743247151062
SΑ I2 OBSERVED LOCALIZATION	4.536736248716937
THYMIDINE KINASE PROTEOLYSI	4.53673144857762
OBSERVED MORPHOLOGIC CHANGE	4.536572886598564
NEURAL NETWORK INPUT VECTOR	4.536482898990985
non-ionic detergent treatment	4.53647587443326
SMAD1 DOSE-DEPENDENT EFFECT	4.5364113001553905
RESAMPLING SMOOTHING EFFECT	4.5364113001553905
CLASSIC LEUCINE ZIPPER MODEL	4.5363580882012
FLANKING ARM ROSA26 GENOMIC	4.536335865667888
SΑ I2 C-TERMINAL DISRUPTION	4.536335865667888
ANDROGEN RESPONSE MECHANISM	4.535939547421367
MHCK-A LOCALIZATION PATTERN	4.535905824615206
PRINCIPAL FACTOR EXTRACTION	4.535900136778893
DIPHOSPHOKINASE	4.535845393156607
SUPERSATURATION	4.535845393156607
REPORT LYMPHOCYTE CHROMOSOME	4.535691312331537
ACTIN FILAMENT DENATURATION	4.535638984737641
INCLUDING FILAMENTOUS ACTIN	4.535638984737641
HTK-TAG VECTOR TRANSDUCTION	4.535568024980603
COLONY HYBRIDIZATION SCREEN	4.535547232389458
MODIFICATION	4.535377640264458
GENOMIC REGULATORY SEQUENCE	4.535371980549807
SRC ACTIVITY ELEVATED LEVEL	4.535309794413156
GNRH-A TREATMENT COS-1 CELL	4.535261822250598
C/EBPΑ PROLIFERATION ARREST	4.535179203526191
C/EBPΑ BLOCKS PROLIFERATION	4.535179203526191
TYPE HIV-1RT	4.5350999956322
NONSPECIFIC KINASES FUNCTION	4.535059968996012
MICROARRAY EXPRESSION STUDY	4.535057225286798
INDEPENDENT SIGNAL DETECTOR	4.535035088663876
DIVERSE SIGNAL TRANSDUCTION	4.535035088663876
POST-TRANSCRIPTIONAL EFFECT	4.53500318972202
OCL ESTROGEN RECEPTOR LEVEL	4.53500318972202
IN SITU HYBRIDIZATION STUDY	4.53497254116451
GAL4 FUSION PARTNER PROTEIN	4.5346793819980205
DECREASED P27 PROTEIN LEVEL	4.5346793819980205
REMOVE NON-NE BOUND PROTEIN	4.5346793819980205
BOI1-PH KKTK MUTANT VERSION	4.534504483943534
BOI1-PH MAKE MUTANT VERSION	4.534504483943534
FUNCTIONAL GENOMIC ANALYSIS	4.534406658941237
CODON PROBABILITY APPROXIMATION	4.5342875436961245
DNA SEQUENCE	4.534282402796684
DEFINED CONDITION	4.5342763065805185
UNIVERSAL IMAGING	4.5342763065805185
PEROXIDASE/FITC VISUALIZATION	4.534198083026186
SIGNALING PATHWAY COMPONENT	4.534167124152206
ACTIVATED PATHWAY COMPONENT	4.534167124152206
LGIC RECEPTOR	4.534089108148582
HEMAGGLUTININ SELECTION MAP	4.533784405061203
RAT GLUCOCORTICOID RECEPTOR	4.5335950792886495
MYOSIN-II CORTICAL RECEPTOR	4.5335950792886495
CONTROL REPORTER GENE Β-GAL	4.533544382626801
LEF/TCF-RESPONSIVE PROMOTER	4.533478431087068
SHOWED LOCALIZATION	4.533446745302882
ENHANCED TNF SUSCEPTIBILITY	4.533339059209855
ENCOUNTER DATA DISTRIBUTION	4.5332576519036945
ACCOUNT LENGTH DISTRIBUTION	4.5332576519036945
REPRESSED ACTIVATION DOMAIN	4.5332576519036945
BMP-INDUCED GENE ACTIVATION	4.5332576519036945
YIELDED MODERATE ACTIVATION	4.5332576519036945
C-RAF ANTECEDENT ACTIVATION	4.5332576519036945
CORRESPONDING HUMAN PROTEIN	4.53316333565665
ANTIBODY-BOUND PROTEIN BAND	4.53316333565665
NOVEL TRANSMEMBRANE PROTEIN	4.53316333565665
INCLUDING PROTEIN SYNTHESIS	4.53316333565665
EXPRESSING POLY-GLN PROTEIN	4.53316333565665
SRC KINASE DOMAIN N-TERMINUS	4.5328466309717435
OTHER ENDOGENOUS PROTEASOME	4.532814344790939
PHOSPHORYLATE INTRACELLULAR	4.532793109108054
MICROMAX DIGITAL CAMERA SYSTEM	4.532668095058699
NONPARAMETRIC RANK SUM TEST	4.532526857580575
BIOCHEMICAL ACTIVITY MHCK C	4.532287548171948
AUTOMATED GENOME ANNOTATION	4.532237620309717
DNA-PK PHOSPHORYLATION SITE	4.532089991552705
ALIGNED NUCLEOTIDE SEQUENCE	4.532057069368806
CELL CYCLE NEGATIVE CONTROL	4.532025539541048
HOMOLOGOUS NEMATODE SEQUENCE	4.531994530872919
MG/ML POLYMYXIN B ANTIBIOTIC	4.531952995160645
PREVENTING DNA DENATURATION	4.531934748460356
FOCAL CONTACT ADHESION SITE	4.531866943756786
SULFUR MUSTARD CYTOTOXICITY	4.531866943756786
CO-TRANSLATIONAL MODIFICATION	4.531757592232892
GRAVITY- INDUCED EGG ROTATION	4.531757592232892
AFFYMETRIX GENE CHIP LAYOUT	4.53175370410655
UBIQUITIN COVALENT ATTACHMENT	4.531503921146851
SIMILAR CRE REPORTER STRAIN	4.531483046204065
H PRIOR	4.531402982751888
BLOSUM62 SUBSTITUTION MATRIX	4.531351056981191
PROTEIN CONFORMATION DISORDER	4.5312219496339745
PLASMINOGEN ACTIVATOR INHIBITOR 1 ACTIVATION	4.531184994496607
RELATING CYTOPLASMIC SIGNAL	4.531085510619056
GLASS SLIDE CDNA MICROARRAY	4.531081158172433
TARGET PROTEASE SPECIFICITY	4.530591110364126
PHYLOGENY FIELD HEADER LINE	4.530552554959403
HYDROLYZE	4.530482278008581
LIQUID SCINTILLATION SPECTROSCOPY	4.530469561576975
PHENOTYPE E15 SMG PRIMORDIA	4.530448037295996
GAD1 CLEFT PALATE PHENOTYPE	4.530448037295996
HYPERGEOMETRIC DISTRIBUTION	4.530272717344476
MUTANT FUNCTIONAL HALF LIFE	4.53016700091217
NITRIC OXIDE SYNTHASE ENZYME	4.530069658280988
GENERAL BACKGROUND CURVE B.	4.530061519144531
INTRON SPATIAL DISTRIBUTION	4.529649123773609
SRC/CAS CHIMERA CONSTRUCTION	4.529646535714805
INCLUDING COMPONENT	4.529432991629684
MOLECULAR COMPONENT	4.529432991629684
SIGNALING COMPONENT	4.529432991629684
MAMMALIAN EXPRESSION VECTOR	4.529410679844083
MOUNTING SOLUTION DABCO/DAPI	4.529320915667815
FINAL COLLAGEN CONCENTRATION	4.529049417052117
IN VITRO INTERACTION DOMAIN	4.529043074491464
SIGNAL TRANSDUCTION PROTEIN	4.528970903298395
DISTINCTIVE NUCLEAR SPECKLE	4.528946079762601
PERIPHERAL BLOOD LYMPHOCYTE	4.528780250064867
E. COLI WHOLE GENOME SCREEN	4.528556272601179
MAXIMUM	4.528462461683625
C/EBPΒ TRANSCRIPTION FACTOR	4.528420566347595
NAMED SERUM RESPONSE FACTOR	4.5283894127256685
INTEGRIN AVIDITY/CLUSTERING	4.5283107097971245
FETAL BOVINE SERUM	4.528123703924914
STANDARD IMMUNOPRECIPITATION	4.528111213250598
ENCODING MHCK-C CDNA CLONING	4.528083347296095
LEF-DEPENDENT TRANSCRIPTION	4.5280081653751845
GENE PROMOTER TRANSCRIPTION	4.527915223967459
P27 UBIQUITYLATION ACTIVITY	4.527863822787913
OPTIMAL MAXIMUM PATH LENGTH	4.527796977504184
OIL EMERSION PHASE OBJECTIVE	4.527790501446963
MEASURE P53 PHOSPHORYLATION	4.527786132420809
INVOLVING FINAL ENLARGEMENT	4.52766089960516
BINDING SITE MULTIPLE LEF-1	4.52755669580861
GENOTYPE PHENOTYPE RELATION	4.527521542720618
HIV-1 REVERSE TRANSCRIPTASE	4.5273425522267114
SKEWED DISTRIBUTION	4.527333493955521
PLATELET ACTIVATION	4.527333493955521
FRAME PROTEOMIC TRANSLATION	4.527232506219346
CONTAINING RESTRICTION SITE	4.527232506219346
AVERAGE DIFFERENCE	4.5271057495414855
PURIFIED ANTI-COP1 ANTIBODY	4.527044496582939
MONOCLONAL Β-ACTIN ANTIBODY	4.527044496582939
ACCUMULATING MUTANT PROTEIN	4.526865952885189
HEPARAN-SULFATE PROTEOGLYCAN	4.526799210417547
BLASTP THRESHOLD SCORE RANGE	4.526799210417547
IN VITRO ENZYMATIC ACTIVITY	4.526771159496162
BLOCKED V-CRK CAS SD DOMAIN	4.526588871278709
CHARGED ANALOG ASPARAGINE NON	4.526313420463236
REPORTER GENE TRANSCRIPTION	4.526015819623131
INCREASING TNF CYTOTOXICITY	4.5259784819445095
INCLUDING CARDIOLIPIN LIPID	4.52582619413902
GENE-GENE INTERACTION MODEL	4.525648258981243
WESTERN IMMUNOBLOT ANALYSIS	4.525561595504731
ANALYZED PAIRWISE ALIGNMENT	4.5254460146529745
PAIRWISE ALIGNMENT MEGABASE	4.5254460146529745
DETECTING TRANSFER RNA GENE	4.525348399742394
MOLAR RATIO	4.5253102450749765
WEIGHT GAIN	4.5253102450749765
PLASMID SELECTION ΜG/ML G418	4.525125875332711
COMMON PROBE PAIRS INCREASE	4.525009040060781
BINDING REGION ACCESSORY DNA	4.524991905252606
ELECTRON MICROSCOPY SUPPORT	4.524833503258789
NORTHERN BLOTTING ISOLATION	4.524833503258789
FUNCTIONAL SUBGROUP ALIGNMENT	4.524818941938233
CYTOKINESI FORCE REQUIREMENT	4.5246750153545126
ADE3 BEARING PLASMID PPB799	4.52445663286127
GRADIENT CENTRIFUGATION	4.524352738308486
WILD-TYPE BOI1 LOCALIZATION	4.5243392031982355
BINDING SITE AFFINITY C/EBP	4.524164014060495
IMMUNOFLUORESCENCE ANALYSIS	4.524095085101874
MAXIMUM LIKELIHOOD POSITION	4.523986796331534
MAXIMUM LIKELIHOOD LOCATION	4.523986796331534
MAXIMUM LIKELIHOOD DISTANCE	4.523986796331534
DISTENDING TOXIN CYTOLETHAL	4.523805359132837
NUCLEAR IMPORT/LOCALIZATION	4.523805359132837
N-TERMINAL LIPID MODIFICATION	4.523620080744003
MURINE MACROPHAGE-LIKE CELL	4.523619549953447
LYMPHOCYTE CYTOARCHITECTURE	4.523556614586235
SSPE-T HYBRIDIZATION BUFFER	4.523411760738866
AMBION HYBRIDIZATION BUFFER	4.523411760738866
CONSERVED CYTOPLASMIC MOTIF	4.5232829281745275
HYPOTHALAMIC GNRH SECRETION	4.523234167951752
ANTI-CD98 MAB	4.523166544657425
POST-MITOTIC PRIMARY NEURON	4.522764523572617
PROLIFERATION TRANSCRIPTION	4.521935689131276
NOVEL TUMOR REJECTION ANTIGEN	4.521909290942029
INOSITOL-BASED PHOSPHOLIPID	4.5218775888966745
P53 PROTEIN PHOSPHORYLATION	4.521721947055329
DNASE ENDONUCLEASE ACTIVITY	4.521721283201851
DOMINANT-NEGATIVE PHENOTYPE	4.521668553569862
LIPOPOLYSACCHARIDE NANOGRAM	4.521562135585303
MYOSIN-II N-TERMINAL REGION	4.521516131977394
ACTIVATION PROTEIN KINASE C	4.521389952975628
TIME-DEPENDENT ACCUMULATION	4.521345382389759
FUSION PROTEIN ACCUMULATION	4.521241909901736
GOLGI MEMBRANE LOCALIZATION	4.521184670084517
CONTAINING PROTEASE	4.521177838552572
OPTIMUM OUTCOME CLASSIFICATION	4.521169837218977
RELEASE MP ENDOTHELIAL CELL	4.521100726264192
SPECIFIC IMMUNOREACTIVE BAND	4.521080223709379
INSECT NEUROBLAST FORMATION	4.521066844404831
CYTOPLASM TOTAL FLUORESCENCE	4.520968086715101
MYOSIN-II TOTAL CORTEX GAIN	4.520826077858769
RESULTING TOTAL CELL COLONY	4.520826077858769
V-SRC-TRANSFECTED MDCK CELL	4.520720926754978
CALCIUM           PHOSPHATE	4.520632378457049
EUKARYOTIC EXPRESSION VECTOR	4.520448487851954
OTHER ANTI-RESORPTIVE AGENT	4.520176615158885
AREPRESENT NON-FUNCTIONAL SNP	4.519961886731971
PRESENCEOF NON-FUNCTIONAL SNP	4.519961886731971
MICROEXTENSION IMMUNOSTAINING	4.519961886731971
GALAPAGOS FINCH INVESTIGATION	4.519961886731971
REPORTED HF	4.5199472889617285
SHANNON INFORMATION CONTENT	4.519683919317594
PROTEIN INTERACTION NETWORK	4.519584073615762
PROTEIN INTERACTION DATASET	4.519584073615762
GEL PROGRESSIVE CONTRACTION	4.519499679417552
PROTEIN IMMUNOBLOT ANALYSIS	4.51949741013925
FUNGAL CELL DIFFERENTIATION	4.519358478097273
NEURAL CELL DIFFERENTIATION	4.519358478097273
TN SUPPORTS DIFFERENTIATION	4.519358478097273
SYSTEMATIC MUTAGENESIS STUDY	4.519067140388103
POSITIVE RNA CLASSIFICATION	4.519004818136909
HEPARITINASE DIGESTION CELL	4.5189859335424325
BASE PAIR HIGHER-ORDER ORGANIZATION	4.518985860411264
NORMAL SERUM CREATINE KINASE	4.518972553701169
SINGLE DISTRIBUTION SUBPEAK	4.518954448132551
INTRA-MOLECULAR INTERACTION	4.518858627960799
DETECTGENE-GENE INTERACTION	4.518858627960799
UNKNOWN FUNCTION SINGLE GENE	4.518512839392475
OPTIONAL RESEARCH EFFORTS FOCUS	4.518172819828572
CYTOPLASMIC PROTEIN	4.517998248515957
DIAGNOSTIC TEST DEVELOPMENT	4.517716006025293
P27 DISPLAY DOWN-REGULATION	4.517636494377119
CONDITIONAL KNOCKOUT ALLELE	4.517636494377119
MURINE MACROPHAGE CELL LINE	4.5176072957917865
MULTIPLE ENDOGENOUS PROTEIN	4.517602235371958
BIOLOGICAL SPECIES EVOLUTION	4.517481986797189
PJC18	4.517279963767142
HER-1	4.517279963767142
INTRA	4.517279963767142
PI(%)	4.517279963767142
HA-UB	4.517279963767142
INDEL	4.517279963767142
SACII	4.517279963767142
A-BOX	4.517279963767142
GAD44	4.517279963767142
GAPAC	4.517279963767142
DSRNA	4.517279963767142
DRIVE	4.517279963767142
PCMV6	4.517279963767142
C-BOX	4.517279963767142
TYPHI	4.517279963767142
MMP-2	4.517279963767142
NODAL	4.517279963767142
PFKAB	4.517279963767142
129X1	4.517279963767142
B-BOX	4.517279963767142
FRISA	4.517279963767142
IP-10	4.517279963767142
NUP62	4.517279963767142
FLUOR	4.517279963767142
UNC-6	4.517279963767142
ABDIL	4.517279963767142
IRS-1	4.517279963767142
ΔEDRR	4.517279963767142
TAXOL	4.517279963767142
129P3	4.517279963767142
RAISE	4.517279963767142
SMAD3	4.517279963767142
YOLKY	4.517279963767142
PECFP	4.517279963767142
AP-PH	4.517279963767142
FGF-2	4.517279963767142
AREAS	4.517279963767142
Β-COP	4.517279963767142
TORRE	4.517279963767142
HSC73	4.517279963767142
PROBE	4.517279963767142
5-E12	4.517279963767142
F. S.	4.517279963767142
EA363	4.517279963767142
TNF-Α	4.517279963767142
MYOIE	4.517279963767142
MACRO	4.517279963767142
VAB-8	4.517279963767142
PJC19	4.517279963767142
GAD67	4.517279963767142
GAPPY	4.517279963767142
MASIA	4.517279963767142
GAD25	4.517279963767142
ideas	4.517279963767142
LOCATED CLOSE CONTAMINATION	4.5170423619108915
GR-GFP NUCLEAR ACCUMULATION	4.517024654007687
MONOCLONAL PRIMARY ANTIBODY	4.516963083363478
ADDITIONAL PRIMARY ANTIBODY	4.516963083363478
ORGANISM NAME GENUS/SPECIES	4.516891976216947
PHOSPHOENOLPYRUVATE SYNTHASE	4.516886300123388
CARBOXYL-TERMINAL TRUNCATION	4.516886300123388
DISPLAY INTEGRATION POSITION	4.516886300123388
Γ-SCINTILLATION SPECTROMETRY	4.516886300123388
UBIQUITIN	4.516744083616668
REMODELING SYSTEM CHROMATIN	4.516500124553698
ACTIVATED B CELL-LIKE TUMOR	4.51609427818819
POTENTIAL ADHESIVE RECEPTOR	4.5160888414683695
adherent	4.5159600005937754
mesoderm	4.5159600005937754
TWEEN-20	4.5159600005937754
CHROMOSOMAL DNA REPLICATION	4.515941395389977
ADHESION INDEPENDENT GROWTH	4.515862564458776
NEAR-PERFECT CLASSIFICATION	4.515530052753215
DIFFERENTIATION UPREGULATION	4.515477943478431
PLASMIN AMINO-TERMINAL SITE	4.5152374914165625
POLYCLONAL RABBIT ANTI PAX-2	4.5147893383303925
BACKGROUND HETEROTRIMERIC G	4.513991256112377
BRDU-POSITIVE CELL FRACTION	4.513950221535288
LUCIFERASE REPORTER PLASMID	4.513800872506613
LIGAND-DEPENDENT TRANSLOCATION	4.513786976177579
polyubiquitylation	4.513666162512387
MONOCLONAL ANTIBODY REAGENT	4.513550104929807
CALORIC RESTRICTION	4.5134245710923055
METABOLIC OBJECTIVE FUNCTION	4.513251566348863
LIPOPOLYSACCHARIDE RECEPTOR	4.513113472985081
DERMAL FIBROBLAST MONOLAYER	4.5130233677796845
MEASUREMENT REPRODUCIBILITY	4.512968164291711
INTRACELLULAR INCORPORATION	4.51296461525039
MOLECULAR CONCENTRATION TAKE	4.5128819324056915
GENOME SEQUENCE INFORMATION	4.51269401860518
MONOCLONAL ANTIBODY 9E10 MOUSE	4.512152595232854
NEURONAL DEVELOPMENT	4.5119519524120815
CODING-REGION IDENTIFICATION	4.511929844976309
JNK MAPK PATHWAY ACTIVATION	4.511488617442521
PHOSPHATE BUFFERED SALINE ΜL	4.51115201873532
P51 WTMUTANT	4.510967518727238
CO-IMMUNOPRECIPITATION STUDY	4.51065955710513
IMPORT/LOCALIZATION SIGNALS	4.510651162227263
NM-MYOSINII ATPASE ACTIVITY	4.510651162227263
JNK ACTIVATION CAS SD BLOCK	4.510470224658931
TRANSCRIPTION FACTOR BREAKDOWN	4.5104340970061045
PROTEIN PHOSPHATASE 5 C-TERMINAL TRUNCATION	4.510203282434654
RIO OUTPUT MANUAL INSPECTION	4.5100711742961535
PRE-B LYMPHOBLASTOID ADHESION	4.50995340933725
NUCLEOTIDE BASE COMPOSITION	4.509721524563622
PHENANTHROLINE	4.509571498924253
SERUM VARYING CONCENTRATION	4.5094350915550185
PHOSPHATIDYLSERINE AFFINITY	4.509100507098859
CONTAINING LYSOSOMAL PROTEAS	4.509097584892263
BOOTSTRAP MEAN OF THE MODES	4.508473473313139
SUBSTRATE-CHROMOGEN SOLUTION	4.508277720131092
SERINE PROTEASE SPECIFICITY	4.508255565558941
MISFOLDED PROTEIN AGGREGATE	4.508250612604714
ONLINE BIOINFORMATIC DATABASE	4.50816618123105
REQUIREDCOMPUTATIONAL RESOURCE	4.5076680950586985
SELECTIVE LIPID STIMULATION	4.507580256129152
PROTEIN PHOSPHATASE TYPE 5 CELL HOMOGENATE	4.506918497464436
PHYSIOLOGICAL CONCENTRATION	4.506292056648385
INDUCED DENDRITIC FORMATION	4.506003337443195
EXPRESSED SΑ I2 SOLUBILIZE	4.505918392197263
5'CGAATTCTGCGCGCCACCTGCTGA	4.505918392197263
DIMERIC CYANINE DYE YOYO-1	4.505918392197263
OPTIMIZING NN ARCHITECTURE	4.505918392197263
INDIVIDUAL PARAMETER VALUE	4.505918392197263
SYNTHETIC FREQUENCY MATRIX	4.505918392197263
nucleotide exchange factor	4.505918392197263
CHARACTERISTIC MORPHOLOGIC	4.505918392197263
CORRESPONDING GENE PRODUCT	4.505918392197263
DIGITAL CAMERA RT220 COLOR	4.505918392197263
second-level visualization	4.505918392197263
REFRACTIVE INDEX ENCOUNTER	4.505918392197263
SIGNALING PLAY DELTA-NOTCH	4.505918392197263
touch receptor neuron fate	4.505918392197263
HYAL-2 FUNCTIONAL PROPERTY	4.505918392197263
OPTIC VESICLE INVAGINATION	4.505918392197263
CONTRIBUTED DISCUSSION PWL	4.505918392197263
TISSUE-TEK CRYOMOLD BIOPSY	4.505918392197263
PERCENTAGE DIFFERENCE CALL	4.505918392197263
DIVIDING SEA URCHIN EMBRYO	4.505918392197263
DYNAMIC MYOSIN-II FILAMENT	4.505918392197263
4-MORPHOLINEETHANESULFONIC	4.505918392197263
GENERATED SPARC-NULL MOUSE	4.505918392197263
FZ CARBOXYLTERMINAL REGION	4.505918392197263
CANDIDATE SMAD1 INTERACTOR	4.505918392197263
NEUROEPITHELIAL MORPHOLOGY	4.505918392197263
DOMAIN-EXCHANGE EXPERIMENT	4.505918392197263
CILIARY BODY POSTERIOR END	4.505918392197263
INDIVIDUAL PATIENT PROFILE	4.505918392197263
ASSOCIATED MUTATIONAL DATA	4.505918392197263
PERFORMED GENE REPLACEMENT	4.505918392197263
5'TACTAGACTGATGGGTGGGATC3'	4.505918392197263
TAIR CORRESPONDING GENE ID	4.505918392197263
MULTI-FUNCTIONAL REGULATOR	4.505918392197263
FOUR-DIMENSIONAL HYPERCUBE	4.505918392197263
INCLUDING MHC PRESENTATION	4.505918392197263
COLOR IMMUNOHISTOCHEMISTRY	4.505918392197263
BOOTSTRAPPED MODE ESTIMATE	4.505918392197263
CONTAINING EGF-LIKE MODULE	4.505918392197263
MARKOV CHAIN ACCOMMODATION	4.505918392197263
MHCK-C AUTOPHOSPHORYLATION	4.505918392197263
WORD LENGTH REPRESENTATION	4.505918392197263
LACKING PPT1 BUDDING YEAST	4.505918392197263
NARROW PERIVITELLINE SPACE	4.505918392197263
CONSENSUS ALIGNMENT COLUMN	4.505918392197263
POSSIBLE NN ARCHITECTURESI	4.505918392197263
CELLULAR CONTRACTILE EVENT	4.505918392197263
INDIVIDUAL FORCE GENERATOR	4.505918392197263
D. DISCOIDEUM CELLS DIVIDE	4.505918392197263
DIVIDING CELL POLAR RUFFLE	4.505918392197263
CD4-BINDING           SITE	4.505918392197263
serpin inhibitory activity	4.505918392197263
SUPERVISED LEARNING METHOD	4.505918392197263
SRF TRANSACTIVATION DOMAIN	4.505918392197263
CANDIDATE TUMOR SUPPRESSOR	4.505918392197263
ANTIGENIC SITE DEMARCATION	4.505918392197263
MACROPINOCYTOTIC EXTENSION	4.505918392197263
CELLULAR DEBRIS ENGULFMENT	4.505918392197263
OPTIMAL SEQUENCE ALIGNMENT	4.505918392197263
GENERATED STABLE CELL LINE	4.505918392197263
MAIN INTRAPULMONARY ARTERY	4.505918392197263
CORRESPONDING RADIO BUTTON	4.505918392197263
MODEL GENE-GENEINTERACTION	4.505918392197263
CYTOSKELETAL REARRANGEMENT	4.505918392197263
PRE-CASTRATION CELL NUMBER	4.505918392197263
MITOCHONDRIA-LIKE MEMBRANE	4.505918392197263
SPARSER USM REPRESENTATION	4.505918392197263
SOMATIC MUTATION FREQUENCY	4.505918392197263
IN VITRO HELICASE ACTIVITY	4.505918392197263
PATHWAY ACTIVITY PROBATIVE	4.505918392197263
GENE CATEGORIZATION SYSTEM	4.505918392197263
SMAD1 TRAPPING/DEGRADATION	4.505918392197263
FIXATION/EXTRACTION METHOD	4.505918392197263
PROTEOLYTIC DOWNREGULATION	4.505918392197263
DOTMAC EXTRACTION FIXATION	4.505918392197263
P. FALCIPARUM PP5 INCREASE	4.505918392197263
GENETIC LYSOSOMAL DISORDER	4.505918392197263
EVE AUTOREGULATORY ELEMENT	4.505918392197263
NUMEROUS SLENDER EXTENSION	4.505918392197263
FREQUENTLY ASKED QUESTIONS	4.505918392197263
GGAAGCTTGTTATTGCAGTCCTTCGG	4.505918392197263
HNPP FLUORESCENT DETECTION	4.505918392197263
PHOSPHORYLATION-CONTROLLED	4.505918392197263
AUTOMATING NN ARCHITECTURE	4.505918392197263
TRUNK-TAIL PROJECTION BEND	4.505918392197263
PELVIC LYMPH NODE METASTAS	4.505918392197263
'-POLYPHOSPHATE PHOSPHATAS	4.505918392197263
CONNECTIVE TISSUE MESHWORK	4.505918392197263
BIS-2-(CHLOROETHYL)SULFIDE	4.505918392197263
CHEMOTACTIC CELL MIGRATION	4.505918392197263
DNA-BINDING-DEFECTIVE FORM	4.505918392197263
CELL TRANSCRIPTS ASSOCIATE	4.505918392197263
GENETIC REGULATORY NETWORK	4.505918392197263
CHEMILUMINESCENT DETECTION	4.505918392197263
INDIVIDUAL TRABECULAR BEAM	4.505918392197263
LIMITED TRYPTIC PROTEOLYSI	4.505918392197263
INCLUDING HU-POSITIVE CELL	4.505918392197263
LOSING GERMLINE COMPETENCY	4.505918392197263
VARYING HERITABILITY VALUE	4.505918392197263
STAGE-SPECIFIC PROGRESSION	4.505918392197263
THIRD-CLEAVAGE ORIENTATION	4.505918392197263
DUCHENNE DYSTROPHY PROFILE	4.505918392197263
LATERAL INHIBITION PATTERN	4.505918392197263
CONSERVED SEQUENCE ELEMENT	4.505918392197263
INACTIVE GFP-C/EBPΑ FUSION	4.505918392197263
ENDOCYTIC/PHAGOCYTIC EVENT	4.505918392197263
CANCER SUSCEPTIBILITY GENE	4.505918392197263
DISPLAY PHYLOGENETIC LEVEL	4.505918392197263
APOPTOTIC RETINAL GANGLION	4.505918392197263
RELATIONAL DATABASE SYSTEM	4.505918392197263
MOLEGO STRUCTURAL PROPERTY	4.505918392197263
FUNGI MOLECULAR CLOCK DATA	4.505918392197263
LIGHT-RESPONSIVE MECHANISM	4.505918392197263
EXPRESSING CELL GFP-MHCK-C	4.505918392197263
DEPOLYMERIZING MICROTUBULE	4.505918392197263
ASSUMPTION PRODUCES RESULT	4.505918392197263
DYSTROPHIN-DEFICIENT MOUSE	4.505918392197263
FLUORESCEIN-ISOTHIOCYANATE	4.505918392197263
SELECTED BAIT TRANSFORMANT	4.505918392197263
ULTRASTRUCTURAL MORPHOLOGY	4.505918392197263
STREPTAVIDIN-PHYCOERYTHRIN	4.505918392197263
PARABASAL EPITHELIAL LAYER	4.505918392197263
CONNECTIVITY OFTHE NETWORK	4.505918392197263
ALTERED ALM CELL MIGRATION	4.505918392197263
SV40-TRANSFORMED CELL LINE	4.505918392197263
logarithmic transformation	4.505918392197263
INVOLVING GENE DUPLICATION	4.505918392197263
BPNN AREUNIVERSAL FUNCTION	4.505918392197263
DUAL SPECIFICITY PHOSPHASE	4.505918392197263
REPLACEMENT POINT MUTATION	4.505918392197263
NEURAL PRECURSOR CELL EXIT	4.505918392197263
MATING PHEROMONE DETECTION	4.505918392197263
TRANSCRIPTS-ALPHA SPECTRIN	4.505918392197263
MOLECULAR WEIGHT BIOMARKER	4.505918392197263
ENZYME-CATALYZED OXIDATION	4.505918392197263
FCS-COATED GLASS COVERSLIP	4.505918392197263
TWO-DIMENSIONAL PROJECTION	4.505918392197263
ANDROGEN RE-ADMINISTRATION	4.505918392197263
YEAST-TWO-HYBRID TECHNIQUE	4.505918392197263
NEIGHBORING PRECURSOR CELL	4.505918392197263
ONE-DIMENSIONAL DEFINITION	4.505918392197263
ATAXIA TELANGIECTASIA GENE	4.505918392197263
POSTMENOPAUSAL OSTEOPOROSI	4.505918392197263
ISL1 CELL-SPECIFIC PATTERN	4.505918392197263
ANNOTATED ARABIDOPSIS GENE	4.505918392197263
NETWORK ROUND-ROBIN SERIES	4.505918392197263
FIBULIN-1C EGF-LIKE MODULE	4.505918392197263
STATISTICAL CHARACTERISTIC	4.505918392197263
BIND PROSEQUENCE-LESS HSN3	4.505918392197263
GRANULATION TISSUE FILLING	4.505918392197263
MITOCHONDRIAL-ENCODED GENE	4.505918392197263
CONTINUOUS CELLULAR TISSUE	4.505918392197263
OSTEOCLAST SEALING PATTERN	4.505918392197263
NON-NEUTRALIZING FACE FORM	4.505918392197263
ULTRASTRUCTURAL IMMUNOGOLD	4.505918392197263
COUNTERACTED HYAL-1 TGF-Β1	4.505918392197263
FORM MITOCHONDRIAL CONTACT	4.505918392197263
APOPTOTIC CELL DESTRUCTION	4.505918392197263
C/EBPΑ ANTI-MITOTIC ACTION	4.505918392197263
ASSOCIATED DISTANCE METRIC	4.505918392197263
EMBRYONIC KIDNEY CELL LINE	4.505918392197263
ACHIEVED RATE STANDARD USM	4.505918392197263
NF-ΚB-DEPENDENT INHIBITION	4.505918392197263
'-DIAMIDINO-2-PHENYLINDOLE	4.505918392197263
PHOSPHATASE-CONJUGATED IGG	4.505918392197263
OPTIMA TLX ULTRACENTRIFUGE	4.505918392197263
KELL BLOOD GROUP PRECURSOR	4.505918392197263
CHROMOPHOBE CELL CARCINOMA	4.505918392197263
(SEQUENCE KRREILSRRPS(P)YR	4.505918392197263
EVOLUTIONARY DIVERGENT SET	4.505918392197263
ACTIN-CONTAINING STRUCTURE	4.505918392197263
DETERMINED INTERCONNECTION	4.505918392197263
CRE-MEDIATED RECOMBINATION	4.505918392197263
PROGRAMMED CELL DEATH GENE	4.505918392197263
CELLULAR FUNCTION CATEGORY	4.505918392197263
APE1 SUBSTRATE SPECIFICITY	4.505918392197263
CLUSTALW DEFAULT PARAMETER	4.505918392197263
GLUTATHIONE-SEPHAROSE BEAD	4.505918392197263
CARDIOPROTECTIVE MECHANISM	4.505918392197263
HUMAN PLATELET NM-MYOSINII	4.505918392197263
CONSERVED NONCODING REGION	4.505918392197263
HERITABILITY VARYINGDEGREE	4.505918392197263
NEURODEGENERATIVE DISORDER	4.505918392197263
TRABECULAR MESHWORK ASPECT	4.505918392197263
INCUBATING LYSOTRACKER RED	4.505918392197263
CYCLIN B1 EXPRESSION LEVEL	4.505528817244099
GENE EXPRESSION DIFFERENCE	4.505398958926377
MONITORING GENE EXPRESSION	4.505398958926377
INCREASING GENE EXPRESSION	4.505398958926377
XNOC UBIQUITOUS EXPRESSION	4.505398958926377
MHCK-A ELEVATED EXPRESSION	4.505398958926377
COMPLEX EXPRESSION PATTERN	4.505398958926377
GFP-BLM MAXIMAL EXPRESSION	4.505398958926377
INCREASED SMAD7 EXPRESSION	4.505398958926377
INCREASED EXPRESSION LEVEL	4.505398958926377
AVERAGE EXPRESSION PROFILE	4.505398958926377
CLUSTERING EXPRESSION DATA	4.505398958926377
DISPLAYED EXPRESSION LEVEL	4.505398958926377
SMAD1 INCREASED EXPRESSION	4.505398958926377
DESCRIBING GENE EXPRESSION	4.505398958926377
REDUCTION INTAG EXPRESSION	4.505398958926377
SECONDARY MOTOR NEURON BIRTH	4.505236799325111
Β-GALACTOSIDASE EXPRESSION	4.505139242290933
SEQUENCE ANALYSIS ANALOGUE	4.504963130414441
ANALYSIS METHODS ASSOCIATE	4.504963130414441
PROTEIN INTERACTION TOPOLOGY	4.504833799952412
MOLECULAR-GENETIC ANALYSIS	4.504485499523029
EXPRESSION ANALYSIS RESULT	4.504443697143553
ASSEMBLY DYNAMIC MYOSIN II	4.504321264316181
FILAMENT DRIVING MYOSIN II	4.504321264316181
PRESENTING MICROARRAY DATA	4.504283237461871
AFFYMETRIX HUFL MICROARRAY	4.504283237461871
GENE MICROARRAY TECHNOLOGY	4.504283237461871
CARBON CATABOLITE REPRESSION	4.5042603828013545
MAPK PHOSPHATASE-1 MODULATION	4.504135981851569
GNRH-TREATED CONTROL GROUP	4.504092236481383
TEMPERATURE CONTROL REGIME	4.504092236481383
Β-ACTIN ENDOGENOUS CONTROL	4.504092236481383
SECTORING POSITIVE CONTROL	4.504092236481383
VIRUS THYMIDINE KINASE HNF	4.504065846947916
MINUTE HAND REGIONS CHANGE	4.503948164770191
SETTING SIMPLE FOLD CHANGE	4.503948164770191
SIMPLE FOLD CHANGE CUT-OFF	4.503948164770191
LANDMARK COMPARATIVE STUDY	4.503946144024112
GENETIC EPIDEMIOLOGY STUDY	4.503946144024112
STUDY NM-MYOSINII FUNCTION	4.503946144024112
RECENT EMBRYOLOGICAL STUDY	4.503946144024112
REGION DETECTION ALGORITHM	4.503823684170222
ALGORITHM SCANNING VERSION	4.503823684170222
EXPRESSION MICROARRAY DATA	4.503763804190982
MARCHANTIA POLYMORPHA RRNA	4.503481203390137
SΑ I2 CHANGED LOCALIZATION	4.503453081980823
OTHER KINASE PHOSPHORYLATE	4.5034483318648
POTENTIAL KINASE SUBSTRATE	4.5034483318648
BOROSILICATE GLASS COVER SLIP	4.503447899030681
MICROARRAY ANALYSIS ASPECT	4.5033279756790465
ARITHMETIC PROPOSED CHANGE	4.5032914222945
LEADING EDGE ACTIN NETWORK	4.503255037669807
INTRON OBSERVED RAW NUMBER	4.5032402000401275
SERIOUS CROSS HYBRIDIZATION	4.5031606924219405
PROBE-SPECIFIC EFFECT MOID	4.503131519778679
MKCD9 EXTRACELLULAR DOMAIN	4.503056871410325
EXPRESSION-PROFILING STUDY	4.502960019937535
2-D BD SIGNAL TRANSDUCTION	4.5028068356134066
PRODUCE INDUCIBLE CELL LINE	4.502792663558673
RNA STRUCTURE QUERY SYSTEM	4.502634679818809
MAJOR IMMUNOREACTIVE SPECIES	4.5025198810309535
ENRICHED FILAMENTOUS ACTIN	4.502367252827322
INTACT ACTIN MICROFILAMENT	4.502367252827322
GFP-BLM ALLELE TRANSFECTION	4.5023357668334105
TARGETING VECTOR HNF3ΑLACZ	4.502297032557295
FIBRONECTIN FIBRILLAR FORM	4.5022556455899805
TRANSCRIPTIONAL START SITE	4.502191760474738
LOCATING PROMOTER SEQUENCE	4.502125607248895
C-TERMINAL DELETION FUSION	4.502103031148011
CYTOPLASMIC Β-CATENIN RISE	4.502009973561445
CYTOPLASMIC INCLUSION BODY	4.502009973561445
PROLIFERATION C/EBPΑ BLOCK	4.501912263095549
PHOTOPHYSICS	4.501907670670672
MATING SIGNAL TRANSMISSION	4.501769650085456
CONDITION-DEPENDENT EFFECT	4.5017380835693865
EXTRACELLULAR GLYCOPROTEIN	4.501626111016855
TISSUE-SPECIFIC CRE STRAIN	4.501372430096027
DORSAL ROOT GANGLIA NEURON	4.501182081929227
POLYAMINE-INDUCIBLE FACTOR	4.500979328921177
PRINCIPLE COMPONENT METHOD	4.500910730820119
RECONSTRUCTED MITOCHONDRIA	4.500804184833373
RESVERATROL TREATMENT LEAD	4.500685897044003
TREATMENT ENDOSTEAL MARGIN	4.500685897044003
NON-SPECIFIC HYBRIDIZATION	4.500455488876743
GROWTH FACTOR CONCENTRATION	4.500392306986834
IN VITRO TRANSCRIPTION KIT	4.500367174042462
TRANSCRIPTIONAL ATTENUATOR	4.5003284446134755
TRANSCRIPTIONAL STIMULATOR	4.5003284446134755
SRC KINASE INACTIVE FUSION	4.500188947817224
SUBMEMBRANOUS CYTOSKELETON	4.500091295322043
CYTOPLASMIC PHOSPHOPROTEIN	4.500055764243535
CORTICAL DISTRIBUTION SHOW	4.500010736379067
GFP-MYOSIN II DISTRIBUTION	4.500010736379067
MEDIATED ACTIVATION III1-C	4.500010736379067
INHIBITED NB-ΚB ACTIVATION	4.500010736379067
SHAPING RT QUASISPECIATION	4.4999833861206495
DISCUSSION ADAPTOR PROTEIN	4.499917403022079
PRO-APOPTOTIC PROTEIN TBID	4.499917403022079
INTERACTING PROTEIN HYAL-2	4.499917403022079
MISFOLDED POLY-GLN PROTEIN	4.499917403022079
GREEN FLUORESCENCE PROTEIN	4.499917403022079
TARGETING PROTEIN ANTIZYME	4.499917403022079
KERATINOCYTE PROLIFERATION	4.4999091985446915
UBIQUITIN TRANSFER REACTION	4.499735197480346
E. COLI GENOME PROJECT HTTP	4.49960940653366
LETHALITY MULTICOPY SUPPRESSOR	4.499334761725365
DERMATAN SULFATE PROTEOGLYCAN	4.499110892159635
MONKEY KIDNEY CDNA LIBRARY	4.499083290412348
RECEPTOR MUTANT BMP TYPE I	4.498835091466696
SAMPLE NUCLEOTIDE SEQUENCE	4.498822665375038
SKP2-ΔF OVEREXPRESSING CELL	4.498744346062734
RECOMBINANT ADENOVIRAL DNA	4.498701619199292
COMPLEMENTARY DNA FRAGMENT	4.498701619199292
DNA REPAIR COMPLEMENTATION	4.498701619199292
CYTOTOXICITY ENHANCING CEE	4.498634521103237
MNOC ALTERED TRANSCRIPTION	4.4985167679908615
MNOC MAXIMAL TRANSCRIPTION	4.4985167679908615
DENSITY DEPENDENT DECREASE	4.498508211199872
ACTIN CYTOSKELETON NETWORK	4.498482521577174
REPEATED FREEZE-THAW CYCLE	4.498241977152062
IMMUNOFLUORESCENT EXAMINATION	4.498232955546063
TRANSGENE LEVEL EXPRESSION	4.498115087832351
DRIVE TRANSGENE EXPRESSION	4.498115087832351
REGULATORY PROTEIN CONTROL	4.498091247306198
RESTRICTION ENZYME	4.4979842994134005
ACS ELEMENT	4.497899580496154
BASE PAIR CONFIDENCE RATING	4.497883001914662
P53 C-TERMINAL ACETYLATION	4.497844023465125
INVADING EPITHELIUM T CELL	4.497629849228198
INTRODUCTION CIRCADIAN RHYTHM	4.497442812593849
UPA SPECIFICITY DETERMINANT	4.497438437193076
B4 RECEPTOR	4.497422873286087
STATIC CELL ADHESION STUDY	4.497155334973374
TRANSFECTED HNF3ΑLOXPNEO ES	4.4969705527139885
POLY-UBIQUITINATED PROTEIN	4.496916908434488
ICE COLD SONICATION BUFFER	4.496911638244931
GNU GENERAL PUBLIC LICENSE	4.496847911212249
VESICULAR TRANSPORT	4.496700762214081
BINDING SITE T7 POLYMERASE	4.496553415076371
ISOLATION TOTAL RNA	4.496546316934074
ENTERING GENBANK ACCESSION	4.496492206075582
GENBANK DATABASE ACCESSION	4.496492206075582
RHYTHMIC EXPRESSION ABSENCE	4.496401830722742
HSN3-CONTAINING PROTEASOME	4.496398877500119
MATRIX PROTEIN FIBRONECTIN	4.496254656414798
RELEASE CYTOSOLIC COMPONENT	4.4962165581057985
AFFYMETRIX CHIP TECHNOLOGY	4.496057151331505
PRIMARY PHYLOGENETIC GROUP	4.4959420395704255
C-TERMINAL DELETION MUTANT	4.495871274767567
PLATEAU GROWTH PHASE LEVEL	4.49586116432685
ACCUMULATION	4.495781572506406
SRC KINASE INACTIVE MUTANT	4.4955151305318894
PHOSPHORYLATION EXPERIMENT	4.495323670605951
BINDING SITE SINGLE C/EBPΑ	4.495302781959281
ADENOMATOUS POLYPOSIS COLI	4.495235381259358
ELK-1 TRANSCRIPTION FACTOR	4.495224059140138
CDNA MICROARRAY EXPERIMENT	4.495169768415315
P PTA	4.494821124390682
GR-DEPENDENT TRANSCRIPTION	4.494815955887662
REDUCED P27 UBIQUITYLATION	4.494673117525784
PLASMINOGEN ACTIVITY ASSAY	4.4945130424414925
INDUCED STELLATE PHENOTYPE	4.4943344044332685
SN50-TREATED SMG PHENOTYPE	4.4943344044332685
PREVENTED P27 ACCUMULATION	4.494121202204485
PUNCTATE BODY ACCUMULATION	4.494121202204485
BOUNDED LENGTH RESTRICTION	4.494048380044034
BIOCHEMICAL BEHAVIOR MHCK-C	4.494037000137223
ANTI-FLAG EPITOPE ANTIBODY	4.493862329696806
BINARY EQUIVALENT BIT-WISE	4.493824417550578
GENERAL PATIENT POPULATION	4.493824417550578
TRAINING GRANT 1-T15-LM07438-01	4.493730475724747
TARGETING PP5 LEAD COMPOUND	4.49368394919281
NF-ΚB SPATIAL DISTRIBUTION	4.493263571576178
ELECTROCARDIOGRAM	4.493022066601594
RGS3 EXPRESSION IMMUNOBLOT	4.492830710764134
OVEREXPRESSED NOTCH PROTEIN	4.492680160697254
ANAEROBIC GROWTH CONDITION	4.492508755036712
SIMULATED GROWTH CONDITION	4.492508755036712
IMMUNOFLUORESCENCE PATTERN	4.492376547346397
PAIRWISE COMPARISON METHOD	4.492280505893555
EXPERIMENTAL EVIDENCE ABSENCE	4.492217701929078
WT TBID INCREASED DISTANCE	4.491779113014741
SINGLE CELL-OOCYTE COMPLEX	4.491764245213287
SINGLE PARAMETER VARIATION	4.491764245213287
HEAT INACTIVATION PROTOCOL	4.491674377613388
DEPHOSPHORYLATION REACTION	4.491460181905361
HSP90 S. CEREVISIAE HOMOLOG	4.49139797840601
INTEGRIN-MEDIATED ADHESION	4.491350650009211
MITOTIC	4.4913008053995025
SAPONIN	4.4913008053995025
PHORBOL	4.4913008053995025
NUCLEOTIDE FREQUENCY TABLE	4.491281716477693
MAP KINASE PHOSPHORYLATION	4.4909987920677255
SYNERGISTIC TOXIC INTERACTION	4.4908229496629595
TAG EXPRESSION MAKES SENSE	4.490736955945459
TEMPORAL NORTHERN ANALYSIS	4.490719115830566
TOUCH NEURON-SPECIFIC GENE	4.490656948000255
CONCENTRATION RANGE	4.490427591337281
T7 RNA POLYMERASE PROMOTER	4.49042511398664
PHYLOGENETIC TREE ACCURACY	4.490284717653986
TRANSCRIPTIONAL CO-ACTIVATOR	4.490210995454357
INDUCIBLE EXPRESSION SYSTEM	4.490122807667816
STATIC CELL ADHESION ASSAY	4.490080508786408
TARGETING KEY TRANSCRIPTION	4.489687509074577
FACILITATED CHARACTERIZATION	4.489625796814452
GNRH-INDUCED DESENSITIZATION	4.489625796814452
CHIMERIC MOLECULE APPROACH	4.489376955906313
RECOGNIZING GP120 MOLECULE	4.489376955906313
CROSS HYBRIDIZATION BEHAVIOR	4.48933186749759
HPRT-NEGATIVE ES CELL LINE	4.489050480190044
E11	4.488924157343003
COS	4.488924157343003
ASPARTIC ACID CLOSE ANALOG	4.488924013442417
IΚBΑ DEGRADATION ED PERIOD	4.488749267475629
CHEMILUMINESCENCE	4.488683335201561
CELLULAR PROPERTY	4.488683335201561
NF-ΚB TRANSCRIPTION FACTOR	4.488476894337249
WILD-TYPE GFP-N346 PROTEIN	4.488471319874324
KB HIND III/ECORV FRAGMENT	4.488437101571599
N-TERMINAL HISTAG SEQUENCE	4.488391577377262
MMCOP1 N-TERMINAL FRAGMENT	4.488391577377262
N-TERMINAL DELETION FUSION	4.488391577377262
MULTIPLE NON-MUSCLE MYOSIN	4.488389953670551
FUNCTIONAL GENOMICS RESEARCH	4.488327677609265
AMERSHAM PHARMACIA BIOTECH AB	4.488261959291384
ULTRASTRUCTURAL EXAMINATION	4.488090878968156
COBBLESTONE-LIKE APPEARANCE	4.488090878968156
SMAD FAMILY PROTEIN SUBSET	4.488063886643494
DECREASED COLONY FORMATION	4.487946971927889
INCREASED LEVEL OBSERVATION	4.487922111172598
POOLED MACROPREP Q FRACTION	4.487883006439481
POLYAMINE SYNTHESIS ENZYME	4.487529602877918
CURRENT INVESTIGATION	4.487318393418292
MEMBRANE TRANSPORT PATHWAY	4.486879362802976
LABELING SINGLE STRAND PCR	4.486794189176879
TOTAL PROTEIN CONCENTRATION	4.486671101856337
MISMATCH PROBE INFORMATION	4.4865784586027795
ENDOTHELIAL CELL MONOLAYER	4.486494735946526
FLUORESCENCE INCORPORATION	4.486296535372538
CELL CYCLE SUBSET ANALYSIS	4.486090870903863
RAS-RELATED GTPAS AFFINITY	4.486043023010462
SINGLE NORMAL DISTRIBUTION	4.48585658939509
SINGLE SCAFFOLDING PROTEIN	4.485763256038104
SRF-P35-C/EBPΒ INTERACTION	4.48576176778612
EPISTASISMODEL INTERACTION	4.48576176778612
MODELNONLINEAR INTERACTION	4.48576176778612
MODELGENE-GENE INTERACTION	4.48576176778612
ARABIDOPSIS THALIANA	4.485530232071253
ION EXCHANGE CHROMATOGRAPHY	4.485508220278562
TKT LINE ASTROCYTE LINEAGE	4.485016849057883
P27 SHOWED DOWN-REGULATION	4.484552370321452
CONTAINING DELETION ALLELE	4.484552370321452
PROTEIN MULTIPLE ATTRIBUTE	4.48451846833681
FLOW RATE	4.484406989162277
HUMAN CD98	4.484148931817981
MODELED CONFIDENCE INTERVAL	4.484101495545505
MOESIN POLYCLONAL ANTIBODY	4.484001088831046
RABBIT POLYCLONAL ANTIBODY	4.484001088831046
PROTEASE INHIBITOR ADDITION	4.483847650617194
VIRAL MRNA	4.483829618412849
GFP-346 DOMAIN COMPOSITION	4.483815610946423
DIFFERING BASE COMPOSITION	4.483815610946423
TRANSFORMATION MARKER GENE	4.483558601862112
SHOWED DNA	4.4832851715031365
POSSIBLE EXON VALUE SUBSET	4.4831384424032
PROLONGED IΚBΑ DEGRADATION	4.48302622590175
PROTEIN PHOSPHATASE TYPE 5 MUTANT FORM	4.482912535264987
MULTIPLE TETRATRICOPEPTIDE	4.48281999016936
PHOSPHOR	4.482695624550584
G PROTEIN TRANSDUCING STEP	4.482687696074092
SENSE STRAND HYBRIDIZATION	4.482553974918731
HUMAN CDNA	4.482224361922866
CO-IMMUNOPRECIPITATION DATA	4.482074803432394
NEUROHORMONAL	4.481601373462434
PEDF-AFFINITY	4.481601373462434
THURINGIENSIS	4.481601373462434
PROTEIN DISULFIDE ISOMERASE	4.481344871708623
CONSTANT DMSO CONCENTRATION	4.4812855003646135
GRADIENT GEL ELECTROPHORESIS	4.481266160908571
DISPLAY PUNCTATE AGGREGATE	4.481265290032865
TEP BUFFER	4.48060490762606
ESTABLISHMENT AXIS FORMATION	4.480369115005499
DIAGNOSTIC EVALUATION EOSIN	4.480342902899372
INCREASE SATURATION DENSITY	4.480342902899372
RETINA RHYTHMIC PHYSIOLOGY	4.48027916594629
CONTAMINATION DISTRIBUTION	4.479887783748334
MM ELECTROPORATION CUVETTE	4.479755916430963
POLY-UBIQUITINATED SPECIES	4.478642619589844
CONVENTIONAL PROTEIN KINAS	4.478551381146267
GENE FUNCTION FLYBASE LINKS	4.478502758583036
COMPOUND HETEROZYGOTE MOUSE	4.478502758583036
SIMULTANEOUS ADMINISTRATION	4.478502758583036
DETECTED MULTIPLE ANTIBODY	4.478463395011535
SINGLE PAIRWISE COMPARISON	4.478126358909578
integrin affinity regulation	4.477942723967765
TRANSGENE INTEGRATION EVENT	4.477889377144257
FIXED POINT REPRESENTATION	4.477743418295094
STORAGE PHOSPHOR SCREEN GP	4.477639833832218
ANTI-ATHEROSCLEROTIC AGENT	4.477639833832218
DECREASE ENDOTHELIAL INJURY	4.4775388734649555
KINETIC INFORMATION ABSENCE	4.477383132421245
TRITON X-100 CONCENTRATION	4.477371291205601
STOICHIOMETRIC INFORMATION	4.476908491805536
UNDERGOING DIFFERENTIATION	4.476425417215315
EPITHELIUM DIFFERENTIATION	4.476425417215315
BACKGROUND DIFFERENTIATION	4.476425417215315
LYSATE LUCIFERASE ACTIVITY	4.475872423934404
RABBIT RETICULOCYTE LYSATE	4.475872423934404
RETICULOCYTE LYSATE SYSTEM	4.475872423934404
MORPHOGENETIC SIGNIFICANCE	4.475872423934404
UBIQUITIN-CONJUGATING ENZYME CDC34	4.47577127211597
PROPIDIUM IODIDE ASSAY USE	4.475570473323571
UCB DIACID	4.475371590002057
UNDERGOING APOPTOSI	4.4749522894468665
TISSUE-SPECIFIC REGULATION	4.47490319915173
T CELL RECEPTOR BETA CHAIN	4.474577289043899
BANDING PATTERN POLYPEPTIDE	4.474454441087096
ANION-EXCHANGE CHROMATOGRAPHY	4.474163985617059
PHARMACIA PGEX-5X-1 SYSTEM	4.473869359383547
REVEALING GENE RELATIONSHIP	4.473800167552398
TOTAL PLASMID EQUAL AMOUNT	4.4730917569289135
NEUTRALIZING ANTI-GP120 AB	4.4730475893114
TRANSACTIVATE	4.472943762663506
EXCESS MATRIX ACCUMULATION	4.472755180328673
CI/MOL FINAL CONCENTRATION	4.472744151209699
LTR LINE ASTROCYTE LINEAGE	4.472690297975684
TUMORIGENIC TRANSFORMATION	4.472378706694536
LYSOSOMAL LUMEN PH MODULATION	4.472304672224445
PATTERN RECOGNITION METHOD	4.4721825681828244
LYSOSOMAL ENZYME SECRETION	4.471702920006947
MACROPHAGE-LIKE CELL LINE	4.47139775999364
NETSEARCH-GENERATED MODEL	4.47139775999364
T-25 TISSUE CULTURE FLASK	4.47139775999364
NUMEROUS CELLULAR PROCESS	4.47139775999364
PORCINE EMBRYO BLASTOCYST	4.47139775999364
CYTOSKELETON-BINDING SITE	4.47139775999364
C/EBPΑ-EXPRESSING MOUSE L	4.47139775999364
SENSITIVE MITOTRACKER RED	4.47139775999364
CYTOKINESI PHYSICAL MODEL	4.47139775999364
NORMAL HUMAN KERATINOCYTE	4.47139775999364
SEQUENCE SER-X-X-X-SER(P)	4.47139775999364
acid sequence information	4.47139775999364
FIBULIN-1 TERMINAL DOMAIN	4.47139775999364
REPEATED SEQUENCE ELEMENT	4.47139775999364
LIVING D. DISCOIDEUM CELL	4.47139775999364
NON-REDUNDANT GENBANK CDS	4.47139775999364
INTERCELLULAR BRIDGE FORM	4.47139775999364
HIDDEN MARKOV MODELS, SEE	4.47139775999364
ANDROGEN-MEDIATED PATHWAY	4.47139775999364
RECURSIVE LENGTH FUNCTION	4.47139775999364
ADISEASE-DETECTION METHOD	4.47139775999364
ALLOWED MINIMUM THRESHOLD	4.47139775999364
FLOATING POINT COORDINATE	4.47139775999364
RESULTING MATCH INTENSITY	4.47139775999364
VARYINGHERITABILITY VALUE	4.47139775999364
UNLIGANDED GLUCOCORTICOID	4.47139775999364
BOI1 PROLINE-RICH STRETCH	4.47139775999364
STRUCTURAL SINGULAR VALUE	4.47139775999364
D. DISCOIDEUM CELL CORTEX	4.47139775999364
PUBLISHED STRUCTURE MODEL	4.47139775999364
SMAD FUNCTIONAL MECHANISM	4.47139775999364
TIME-EXPENSIVE TOMOGRAPHY	4.47139775999364
GRK/Β ARRESTIN SYSTEM ACT	4.47139775999364
'-GCCCAGGTCGAGGACAGCATG-3	4.47139775999364
MISMATCH-SUBTRACTED MATCH	4.47139775999364
PEROXIDASE-CONJUGATED IGG	4.47139775999364
INDIVIDUAL PRECURSOR CELL	4.47139775999364
NORMAL GRANULATION TISSUE	4.47139775999364
APPENDING C/EBPΑ FRAGMENT	4.47139775999364
STRUCTURE DEFINITION MAKE	4.47139775999364
INDUCED ΔH1 SCE FREQUENCY	4.47139775999364
VASCULAR ENDOTHELIAL CELL	4.47139775999364
NON-SYNONYMOUS DIFFERENCE	4.47139775999364
IMMUNOELECTRON MICROSCOPY	4.47139775999364
MEMORY-EFFICIENT APPROACH	4.47139775999364
ENVIRONMENTAL TEMPERATURE	4.47139775999364
TREATED HUVEC CULTURE CPT	4.47139775999364
HALF PROTEASOMES ASSEMBLY	4.47139775999364
HERITABILITY VALUESTESTED	4.47139775999364
SUPERSCRIPT CHOICE SYSTEM	4.47139775999364
QUAIL-CHICK CHIMERAS SHOW	4.47139775999364
ORDER INHIBITION CONSTANT	4.47139775999364
FILAMENTOUS ORNAMENTATION	4.47139775999364
STIMULATED MIGRATION CCAF	4.47139775999364
REPLACEMENT OVERABUNDANCE	4.47139775999364
SPANNING ANTIGENIC SITE D	4.47139775999364
5'CCCTATGACGATAAACGTAGC3'	4.47139775999364
TAG-SPECIFIC FLUORESCENCE	4.47139775999364
PROLIFERATIVE NEURAL CELL	4.47139775999364
'-PHOSPHODIESTER ACTIVITY	4.47139775999364
PROSPECTIVE NEUROECTODERM	4.47139775999364
CONFOCAL MICROSCOPY FIELD	4.47139775999364
MYOSIN-II AVERAGE DENSITY	4.47139775999364
WTPAI-1 TPA RATE CONSTANT	4.47139775999364
PHASE-TRANSITION BOUNDARY	4.47139775999364
OTHER ULTRAMICROEXTENSION	4.47139775999364
BLINDING DISEASE GLAUCOMA	4.47139775999364
CORRESPONDING SENSITIVITY	4.47139775999364
BEST-SO-FAR SOLUTIONSFROM	4.47139775999364
INCLUDINGBOOLEAN OPERATOR	4.47139775999364
MECHANOSENSITIVE SCAFFOLD	4.47139775999364
MEDIAN ABSOLUTE DEVIATION	4.47139775999364
GLUTARALDEHYDE-FIXED CELL	4.47139775999364
ALTERNATING CURRENT FIELD	4.47139775999364
FALSE-POSITIVE PERCENTAGE	4.47139775999364
PHAGOCYTOSIS EVENT RESULT	4.47139775999364
ENDOTHELIAL-LINED CHANNEL	4.47139775999364
GENE CO-OCCURRENCE METHOD	4.47139775999364
FORMED GRANULATION TISSUE	4.47139775999364
STATISTICAL JUSTIFICATION	4.47139775999364
IN VITRO HUMAN SKIN MODEL	4.47139775999364
CYTOSKELETON-LOCALIZATION	4.47139775999364
CRE-EXPRESSING TRANSGENIC	4.47139775999364
TRIAL-AND-ERROR PROCEDURE	4.47139775999364
NON-HOMOLOGOUS CHROMOSOME	4.47139775999364
L-Α-PHOSPHATIDYL-L-SERINE	4.47139775999364
ERROR RATE MAXIMAL TYPE I	4.47139775999364
PAIRED GENE CONSENSUS SET	4.47139775999364
REMAINING EXPERIMENTSWERE	4.47139775999364
TIME-LAPSE CINEMATOGRAPHY	4.47139775999364
THICKNESS CIRCULAR LESION	4.47139775999364
UVEOSCLERAL OUTFLOW ROUTE	4.47139775999364
PROCESSED NON-DECALCIFIED	4.47139775999364
COMPETITION-GROUP EPITOPE	4.47139775999364
AUTORADIOGRAPHIC EXPOSURE	4.47139775999364
soybean trypsin inhibitor	4.47139775999364
INTRAEPITHELIAL NEOPLASIA	4.47139775999364
EMBEDDED DIMERIC SEQUENCE	4.47139775999364
SEQUENCE DISTANCE MEASURE	4.47139775999364
SELECTIVE LYSOSOMAL PROBE	4.47139775999364
NON-OVEREXPRESSION SYSTEM	4.47139775999364
REVEALED HUMAN TRANSCRIPT	4.47139775999364
OSCILLATORY NETWORK MODEL	4.47139775999364
EXPRESSED ISL1 FLOORPLATE	4.47139775999364
ENVIRONMENTAL COMPARTMENT	4.47139775999364
OTHER FASTGROUP PARAMETER	4.47139775999364
CARDIOPROTECTIVE PROPERTY	4.47139775999364
MATURING RECIPIENT OOCYTE	4.47139775999364
CLONAL SELECTION INCREASE	4.47139775999364
VARIABLE SELECTION ASWELL	4.47139775999364
PS-CONTAINING MEMBRANE MP	4.47139775999364
FLANKED NEO CASSETTE LOXP	4.47139775999364
ECTOCERVIX LAMINA PROPRIA	4.47139775999364
5'GCTTTCCTCAGCCAAGACAGA3'	4.47139775999364
'-CATGCTGTCCTCGACCTGGGC-3	4.47139775999364
UNIDIRECTIONAL COMPARISON	4.47139775999364
Β-CATENIN-MEDIATED BRANCH	4.47139775999364
ERROR-PRONE SEQUENCE DATA	4.47139775999364
CONSERVED REGION INCREASE	4.47139775999364
STIMULATING CDK2 ACTIVITY	4.47139775999364
NONOVERLAPPING PREDICTION	4.47139775999364
fusion protein expression	4.47139775999364
PROBABILISTIC COUNTERPART	4.47139775999364
HI-Q FITC EMISSION FILTER	4.47139775999364
ATM-INDEPENDENT MECHANISM	4.47139775999364
CHARGED ANALOG ASPARAGINE	4.47139775999364
OSTEOCLAST PROPER SEALING	4.47139775999364
FILOPODIA-LIKE PROJECTION	4.47139775999364
SAMPLE CLUSTER DENDROGRAM	4.47139775999364
ARCHITECTURE OPTIMIZATION	4.47139775999364
LOCALIZED MMCOP1 DELETION	4.47139775999364
CONDITIONAL MISEXPRESSION	4.47139775999364
SECONDARY STRUCTURE HELIX	4.47139775999364
PEROXIDASE-FITC TECHNIQUE	4.47139775999364
ESSENTIAL GLYCOLYTIC GENE	4.47139775999364
CONVENTIONAL MARKOV CHAIN	4.47139775999364
GFP-MYOSIN-II RATIO IMAGE	4.47139775999364
DOTMAC-INSOLUBLE MATERIAL	4.47139775999364
MODEL SELECTION CRITERION	4.47139775999364
SEQUENCE SPACE QUASISPECY	4.47139775999364
IRIDOCORNEAL ANGLE RECESS	4.47139775999364
WOUND KERATINOCYTE MARKER	4.47139775999364
BLOTTING TECHNIQUE RRNAS,	4.47139775999364
STAT STATISTICAL SOFTWARE	4.47139775999364
COVERSLIP-CONTAINING DISH	4.47139775999364
GLUCOCORTICOIDS INFLUENCE	4.47139775999364
DIFFERENTIATED HL-60 CELL	4.47139775999364
5'AATCTGCAGCTATGAAATCCC3'	4.47139775999364
CHARACTERIZED RING FINGER	4.47139775999364
MAJOR PHYLOGENETIC BRANCH	4.47139775999364
ITERATIVE COMPARISON REST	4.47139775999364
GENETICALGORITHM APPROACH	4.47139775999364
BACKGROUND CELL MIGRATION	4.47139775999364
METABOLIC PATHWAY LEADING	4.47139775999364
COMPUTATIONAL GENEFINDING	4.47139775999364
PH-20-MEDIATED INHIBITION	4.47139775999364
DETERMINED CELL MIGRATION	4.47139775999364
LOXP CONDITIONAL DELETION	4.47139775999364
KERNEL DOCUMENT SELECTION	4.47139775999364
SPLICE           ACCEPTOR	4.47139775999364
OBSERVED STATE TRANSITION	4.47139775999364
ZEISS AXIOCAM HRC DIGITAL	4.47139775999364
DOSE-DEPENDENT INHIBITION	4.47139775999364
DOTMAC/PFA-EXTRACTED CELL	4.47139775999364
TRABECULAR BEAMS INCREASE	4.47139775999364
DELTA/EPSILON SUBDIVISION	4.47139775999364
CLEAVAGE FURROW MYOSIN-II	4.47139775999364
TOTHE ORIGINAL POPULATION	4.47139775999364
NON-EXCLUSIVE EXPLANATION	4.47139775999364
INCREASED REPRODUCIBILITY	4.47139775999364
TREATED HPB-ALL CELL BODY	4.47139775999364
CAUSING RAPID DEGRADATION	4.47139775999364
PLANT O-METHYLTRANSFERASE	4.47139775999364
NEURAL TUBE VENTRAL TRUNK	4.47139775999364
DERMAL GRANULATION TISSUE	4.47139775999364
PROHB-EGF EGF-LIKE MODULE	4.47139775999364
PORCINE TETRAPLOID EMBRYO	4.47139775999364
CHEMILUMINSCENT DETECTION	4.47139775999364
BACKGROUND ATHEROSCLEROSI	4.47139775999364
IDENTIFIED ARABIDOPSIS TF	4.47139775999364
BETTER THROMBIN INHIBITOR	4.47139775999364
POSTERIOR CORNEAL SURFACE	4.47139775999364
POWDERED AMMONIUM SULFATE	4.47139775999364
CYTOSKELETAL ARCHITECTURE	4.47139775999364
DIFFERENTIATING CELL TYPE	4.47139775999364
MATING PHEROMONE EXPOSURE	4.47139775999364
ELECTRON MICROGRAPHS SHOW	4.47139775999364
MSN50-TREATED SMG EXPLANT	4.47139775999364
SHOW MEROBLASTIC CLEAVAGE	4.47139775999364
PARALLEL TRACK DEPOSITION	4.47139775999364
STRUCTURE MODELS INCREASE	4.47139775999364
IMMUNOPRECIPITATING GSK3Β	4.47139775999364
IMMUNOHISTOCHEMICAL STAIN	4.47139775999364
NETWORK CONSTRUCTIONSTILL	4.47139775999364
CARTILAGE-HAIR HYPOPLASIA	4.47139775999364
CONTROLLING ALM MIGRATION	4.47139775999364
NON-SPECIFIC FLUORESCENCE	4.47139775999364
HUMAN-INFECTIVE INFLUENZA	4.47139775999364
RESIDUAL SPECTRAL OVERLAP	4.47139775999364
OTHER LATE-BORN CELL TYPE	4.47139775999364
TET-INDUCIBLE SYSTEM SHOW	4.47139775999364
priorto network evolution	4.47139775999364
SYNCHRONIZED GHFT1-5 CELL	4.47139775999364
EXPRESSING NORMAL GFP-BLM	4.47139775999364
ALLOWING GAPPED ALIGNMENT	4.47139775999364
AMINO-TERMINAL HYALURONIC	4.47139775999364
RAT CAROTID ARTERIAL WALL	4.47139775999364
INFECTED GROUP ADENO-ΒGAL	4.47139775999364
POPULATION GROWTH/DENSITY	4.47139775999364
FUNCTIONAL RESPONSIVENESS	4.47139775999364
HIGH-RESOLUTION TECHNIQUE	4.47139775999364
pair rule gene expression	4.47139775999364
CONTAINING POLY-GLN TRACT	4.47139775999364
TRANSCRIPTOME COMPARTMENT	4.47139775999364
CASE PARAMETER ESTIMATION	4.47139775999364
ALLN-INDUCED JUXTANUCLEAR	4.47139775999364
RAB24 BIOLOGICAL FUNCTION	4.47139775999364
NON-BOOTSTRAP MODE METHOD	4.47139775999364
DEVELOPMENTAL PROGRESSION	4.47139775999364
OXIDATIVE ACTIVITY RESULT	4.47139775999364
PROSTATE TUMOR SUPPRESSOR	4.47139775999364
CONTINUOUS LOGP CRITERION	4.47139775999364
LACKING HELICASE ACTIVITY	4.47139775999364
RNA-STRUCTURE-CONSTRAINED	4.47139775999364
COMPUTED CHI-SQUARE VALUE	4.47139775999364
ROTHMUND-THOMSON SYNDROME	4.47139775999364
STRUCTURED SINGULAR VALUE	4.47139775999364
CURRENT PUBLIC AFFYMETRIX	4.47139775999364
WTPAI INHIBITORY ACTIVITY	4.47139775999364
TRUNCATED CARBOXYTERMINUS	4.47139775999364
MOLECULAR WEIGHT POSITION	4.47139775999364
GSK3Α AUTOPHOSPHORYLATION	4.47139775999364
MEMBRANE SKELETON UNDERGO	4.47139775999364
VARIOUS INTEGRIN-BLOCKING	4.47139775999364
SIMILAR PHYLOGENETIC TREE	4.47139775999364
IL-1ALPHA DECREASED LEVEL	4.47139775999364
BACTERIAL-SPECIFIC PRIMER	4.47139775999364
BOOTSTRAPPED VERSION RPMB	4.47139775999364
TRIAL-AND-ERROREXPERIMENT	4.47139775999364
TISSUE/ORGAN MORPHOGENESI	4.47139775999364
EXTENSIVE VARIABLE REGION	4.47139775999364
BUMP-LIKE TOOTH PRIMORDIA	4.47139775999364
HPB-ALL CELL HPB-ALL CELL	4.47139775999364
CELLULAR FUNCTION SPECTRUM	4.471270789155407
ADDITION P. FALCIPARUM PP5	4.471226140182416
PGE ERK-MEDIATED STIMULATION	4.471196160774608
EXAMINED BRAIN EXPRESSION	4.4708839958118824
STABLE GFP-BLM EXPRESSION	4.4708839958118824
CHK1 INCREASED EXPRESSION	4.4708839958118824
INCREASED GENE EXPRESSION	4.4708839958118824
GFP-COP1 EXPRESSION LEVEL	4.4708839958118824
MONITORED GENE EXPRESSION	4.4708839958118824
OBSERVED EXPRESSION LEVEL	4.4708839958118824
GENE EXPRESSION TECHNIQUE	4.4708839958118824
CIRCADIAN GENE EXPRESSION	4.4708839958118824
EMBRYONIC GAD1 EXPRESSION	4.4708839958118824
THEBINARY EXPRESSION TREE	4.4708839958118824
GAD1 LOCALIZED EXPRESSION	4.4708839958118824
RELATIVE EXPRESSION SCORE	4.4708839958118824
CYTOSKELETON MRNA FRACTION	4.4707764635972795
HIV BREAKTHROUGH INFECTION	4.470682074261142
NUCLEOTIDE-DEPENDENT MANNER	4.470644259914447
COMPARABILITY COMMON PROBLEM	4.4704769554657355
MODULAR ANALYSIS APPROACH	4.470452923927637
COMPARATIVE ANALYSIS IDEA	4.470452923927637
MICRO-ARRAY ANALYSIS SHOW	4.470452923927637
ANALYSIS TECHNIQUES OFFER	4.470452923927637
MONITOR Β-CATENIN-MEDIATED WG	4.470419923628102
IVM MEDIUM SUPPLEMENTATION	4.470308355737578
AMPLITUDE CIRCADIAN RHYTHM	4.470308355737578
KDA DOMAIN	4.470147991947114
DOMAIN-BY-DOMAIN ANALYSIS	4.469980505894635
EXPRESSION ARRAY ANALYSIS	4.46993915974588
MYOSIN II ENDOGENOUS COPY	4.469818063149067
AFFECTED MYOSIN II MHCK-C	4.469818063149067
MICROARRAY SUITE SOFTWARE	4.469780451319436
REPORTING MICROARRAY DATA	4.469780451319436
FEATURING MICROARRAY DATA	4.469780451319436
PH DOMAIN COMMON ATTRIBUTE	4.4696401955227225
QUALITY CONTROL CRITERION	4.469591534921594
CONTROL SPECIMEN MIDSHAFT	4.469591534921594
NEGATIVE FEEDBACK CONTROL	4.469591534921594
SINGLE-STRAND DNA PROTOCOL	4.469566134823185
ANALYSIS ONE-WAY ANALYSIS	4.469508087861633
EXPERIMENTAL DISTANCE MEAN	4.469439818262951
SEPHAROSE A/G AGAROSE BEAD	4.468992332651024
PLASMID CONSTRUCTION	4.468979894436315
NON-CANCER CONTROL SUBJECT	4.468970008740322
POPULATION MEAN EXPRESSION	4.468920384992065
IN SITU HYBRIDIZATION C57	4.468696119367411
RAW GENOMIC SEQUENCE WORK	4.468567469813782
SΑ I2 C-TERMINAL SEQUENCE	4.468567469813782
EXTRACELLULAR MATRIX GENE	4.468567469813782
IMMUNO-FLUORESCENCE STUDY	4.468471675376924
IMMUNOHISTOCHEMICAL STUDY	4.468471675376924
SCORING/PARSING ALGORITHM	4.468289990384384
P53 TUMOR SUPPRESSOR GENE	4.468238366304495
SLIGHT MITOGENIC RESPONSE	4.468179562022633
DIVERSE RESPONSE PROPERTY	4.468179562022633
BMP-INDUCED GENE RESPONSE	4.468179562022633
SHOW LOCALIZATION PATTERN	4.468146554863956
MHCK-A POLAR LOCALIZATION	4.468146554863956
DIRECTING PM LOCALIZATION	4.468146554863956
N-TERMINAL MYC EPITOPE TAG	4.4681201789178635
ENVIRONMENTAL TEMPERATURE FLUCTUATION	4.468086668621536
PRIMARY NEONATAL ASTROCYTE	4.468073315384584
IN SILICO STRAIN ISOGENIC	4.468025499353808
ACTIVATED P53 QUANTITATION	4.467923560499938
CONTROLLING ACTIN DYNAMIC	4.467885377720575
PRE-FORMED ACTIN FILAMENT	4.467885377720575
ACTIN FILAMENT ELONGATION	4.467885377720575
COLONY BLOT HYBRIDIZATION	4.467795572492002
ACCOMPANYING PGK PROMOTER	4.467646369459389
EXTREME C-TERMINAL REGION	4.4676240397538285
MOSQUITO GENOMIC SEQUENCE	4.4676240397538285
CONTAINING ROSA26 GENOMIC	4.4676240397538285
C-TERMINAL MUTATIONS LEAD	4.4676240397538285
CYTOPLASMIC VOLUME MARKER	4.467531997796759
HPB-ALL CELL C3 TREATMENT	4.467516219175548
DISTANCE METRIC PIXEL MAP	4.46740205621031
CONTAINING HOMOLOGOUS GENE	4.467305099650615
EXPRESSION VECTOR PMEXNEO	4.4673021596520615
SUBTRACTED ELEMENT SIGNAL	4.4672942972086025
PRO-N3-F INCREASED SIGNAL	4.4672942972086025
TNFR1 SIGNAL TRANSDUCTION	4.4672942972086025
ANTI-PROLIFERATIVE EFFECT	4.467263075209151
OTHER MAMMALIAN CELL TYPE	4.467263075209151
CALLED HNF3ΑLOXPNEO CLONE	4.467199183832791
LRP5 INTRACELLULAR DOMAIN	4.467199183832791
P53 PROAPOPTOTIC FUNCTION	4.467185235074781
PERKIN ELMER LIFE SCIENCE	4.467152324723851
USM COORDINATE CALCULATION	4.4670710796957875
ENCODED RNA MITOCHONDRIAL	4.46706726135779
N-TERMINAL DELETION ALLELE	4.46702555550145
BOI1-PH TK MUTANT VERSION	4.466774952699871
ACTIN FITC-LABELED MONOMER	4.466757216367637
CONSTITUTIVE LEVEL	4.466728218511992
METAMORPH SOFTWARE	4.466728218511992
METASTATIC DISEASE	4.466728218511992
immunolocalization	4.466728218511992
STOCHASTIC CONTEXT	4.466728218511992
REFERENCE STANDARD	4.466728218511992
RESULTING CHIMERIC	4.466728218511992
CORRESPONDING SITE	4.466728218511992
LYSOSOMAL DISORDER	4.466728218511992
CONSERVED POSITION	4.466728218511992
UNDERLYING DYNAMIC	4.466728218511992
TARGETING SEQUENCE	4.466728218511992
ESSENTIAL FUNCTION	4.466728218511992
RECESSIVE DISORDER	4.466728218511992
UNIDIRECTIONAL USM	4.466728218511992
INTERMEDIATE LEVEL	4.466728218511992
NEGATIVE REGULATOR	4.466728218511992
OTH SUBSTITUTION PARAMETER	4.466674678547814
ELECTROPORATION EFFICIENCY	4.466674678547814
MULTIDIMENSIONAL RESPONSE	4.466570463037129
INTRANUCLEAR LOCALIZATION	4.466520952299114
FLUORESCENCE LOCALIZATION	4.466520952299114
E-COLI GENOME KBP SEGMENT	4.466266586430154
TYROSINE KINASE SUBSTRATE	4.466111675808995
POSSIBLE ONE-TO-ONE COMPARISON	4.4660014283920315
FIBRIN-PLASMA FIBRONECTIN	4.465963602848311
III1-C SIGNALING RECEPTOR	4.465884846947653
STEROID RECEPTOR MOVEMENT	4.465884846947653
ZIPPER DIMERIZATION DOMAIN	4.465857101180117
REDUCED STEADY-STATE LEVEL	4.465857101180117
APOPTOSIS-RELATED CYSTEINE	4.465857101180117
REPORTER STRAINS FUNCTION	4.465787273265424
LIGHT-RESPONSIVE PROMOTER	4.465770674192263
CYTOSKELETON ARCHITECTURE	4.465634259991018
MEDIATED ACTIVATION V-CRK	4.46555458026748
OPTIMAL FLUX DISTRIBUTION	4.46555458026748
AVM POSITION DISTRIBUTION	4.46555458026748
GHFT1-5 CELL DISTRIBUTION	4.46555458026748
INCREASED ERK1 ACTIVATION	4.46555458026748
CONTROL EXPRESSION VECTOR	4.465495934580015
C/EBPΑ-GFP FUSION PROTEIN	4.465462265549747
GFP-HYAL-2 FUSION PROTEIN	4.465462265549747
NE-BOUND GFP-COP1 PROTEIN	4.465462265549747
BASEMENT MEMBRANE PROTEIN	4.465462265549747
GFP-C/EBPΑ FUSION PROTEIN	4.465462265549747
TWO-HYBRID FUSION PROTEIN	4.465462265549747
SELECTED MYCRAB24 PROTEIN	4.465462265549747
PERCUTANEOUS	4.465298488727811
LRP6 AMINOTERMINAL MUTANT	4.465234016935281
INHIBITED THROMBIN MUTANT	4.465234016935281
ORIENTING MRNA TRANSCRIPT	4.465222581419401
LACZ PROMOTER TRAP STRAIN	4.46521195645312
PROTEASOME INHIBITOR LLNL	4.465120680782863
RNA GENEFINDING ALGORITHM	4.464995414951619
CHICKEN EMBRYO FIBROBLAST	4.464961364051626
FUTURE PROTEIN EXPRESSION	4.4649485013679895
HPB-ALL HUMAN T CELL LINE	4.464839294473415
COMPARING MRNA EXPRESSION	4.4647088172376455
CRYSTAL STRUCTURE SOLUTION	4.464685718401838
ENCODING HUMAN RAB11 CDNA	4.464637256436062
LGL LEUKEMIA CDNA LIBRARY	4.464637256436062
NUCLEIC ACID SINGLE-STRAND	4.464631615759084
ORIGINAL REFERENCE GENOME	4.464556195242326
MHC PHOSPHORYLATION LEVEL	4.4644116993844
NUCLEOTIDE IDENTITY RANGE	4.464379475857606
VIRAL NUCLEOTIDE SEQUENCE	4.464379475857606
concentration	4.464336332879335
DNA DAMAGE-INDUCIBLE GENE	4.4642597507785196
CD14 CELL SHOWS ASSOCIATION	4.464214579185602
GFP-HYAL-2 CO-LOCALIZATION	4.464115305918502
CO-LOCALIZATION EXPERIMENT	4.464115305918502
P14 ARFGENE TRANSCRIPTION	4.4640769170341885
RHOA DEPENDENT RETRACTION	4.464068453631923
LATERAL INHIBITION ABSENCE	4.464058430971183
ULTRASTRUCTURAL COMPONENT	4.46396824827151
GENE SYMBOL CO-OCCURRENCE	4.463570784681438
GAMMA SUBDIVISION E. COLI	4.463472947490035
T CELL SHOW FRAGMENTATION	4.463199678093358
MHCK-A DISPLAYS ENRICHMENT	4.46318634844564
COLLAGEN DISC CONTRACTION	4.463164188561323
CONTAINING PROTEIN KINASE	4.463019163429174
RADIOCHEMICAL	4.4629971325309645
SΑ I2 FUNCTION C-TERMINUS	4.4629068894540636
OTHER WILD-TYPE RAB GTPAS	4.4629068894540636
RRNA CONSERVATION DIAGRAM	4.462647320636047
DNA MICROARRAY TECHNOLOGY	4.462642442104314
INTERMEDIATE DISTRIBUTION	4.462632990404399
CONTAMINATED DISTRIBUTION	4.462632990404399
QUANTITATIVE DISTRIBUTION	4.462632990404399
APPROXIMATED DISTRIBUTION	4.462632990404399
CYTOPLASMIC COMPONENT DSH	4.462578989982005
RECEPTOR NEURON CELL FATE	4.462578456980418
GTPASE-ACTIVATING PROTEIN	4.462494518327799
MITOGEN-ACTIVATED PROTEIN	4.462494518327799
THREONINE OPERON DNA SEQUENCE	4.462482874706602
T-CELL RECEPTOR BETA CHAIN	4.462379622219207
PROTEIN EXPRESSION CHANGE	4.462350202186479
PHOSPHORYLATION MYOSIN II	4.462305436924971
DENSITY DEPENDENT CONTROL	4.462262228559877
BLASTP THRESHOLD SCORE SET	4.462215165633103
POLY(A) MRNA LOCALIZATION	4.461971376289717
Β-ACTIN MRNA LOCALIZATION	4.461971376289717
BIS(2-ETHANESULFONIC ACID) PH	4.461923596622366
FIBROBLAST MULTIPLICATION	4.461743166080619
CONTACT SITE VISUALIZATION	4.461712829695585
SPARC-NULL PRIMARY DERMAL	4.461530289172031
PRESUMPTIVE PRIMARY MOTOR	4.461530289172031
IGEPAL NONIONIC DETERGENT	4.461491744364133
PROBE SIGNAL DISTRIBUTION	4.461451117482441
PROMOTED L929 CELL GROWTH	4.461450296599993
ELK-1 IN VIVO INTERACTION	4.461429442379042
CONTROL EXPRESSION	4.461344140997395
REGULATING P53 ACTIVATION	4.461342055348619
SMAD1 NUCLEAR INTERACTING	4.461334506020807
APURINIC/APYRIMIDINIC ENDONUCLEAS	4.461264949443591
OPTIMAL METABOLIC BEHAVIOR	4.46119881152696
LOCATED CLOSE CONTAMINANT	4.4610045632676
OXIDATIVE PHOSPHORYLATION	4.460918669079782
ESCHERICHIA COLI SEROTYPE	4.460831343322167
TRANSCRIPTION FACTOR NAME	4.460820144772433
NFAT TRANSCRIPTION FACTOR	4.460820144772433
PREPARING CDNA MICROARRAY	4.460766446575998
CYTOSKELETON LOCALIZATION	4.460757452296492
PRIMARY SEQUENCE ANALYSIS	4.4605854531060265
HOUSEKEEPING CONTROL CDNA	4.460577530178155
BMP-INDUCED TRANSCRIPTION	4.4604164955544645
P68 KINASE	4.460333101559725
P53 BLOCK PHOSPHORYLATION	4.460199174465541
LEUCINE ZIPPER-LIKE DOMAIN	4.460134059606239
APOPTOSIS ASSAY APOPTOTIC	4.4601168881023865
INCREASED FN ACCUMULATION	4.459729324405509
STARTING BUFFER CONDITION	4.459519820878167
MONOCLONAL ANTIBODY F7-26	4.459473277229594
PAC-1 MONOCLONAL ANTIBODY	4.459473277229594
ANTI-MOUSE ALEXA ANTIBODY	4.459473277229594
GENERAL PRESENTATION MODE	4.459435778856123
GENERAL PURPOSE ESTIMATOR	4.459435778856123
BINARY USM IMPLEMENTATION	4.459435778856123
MRNA DISTRIBUTION PATTERN	4.4593794016932415
DEGRADING HYALURONIC ACID	4.45937908700239
ACID CLASSIC LEUCINE-RICH	4.45937908700239
INTEGRAL COMPONENT	4.459364873270652
PENTOSE PHOSPHATE PATHWAY	4.459264075777592
RULE DEVELOPMENT STRATEGY	4.459087371638524
PERFORMED RGS3 IMMUNOBLOT	4.458966681556611
HIV-1 GP120 SELECTION MAP	4.458677491986157
ENHANCED TNF CYTOTOXICITY	4.45842988498774
INCREASE TNF CYTOTOXICITY	4.45842988498774
NICKEL CHELATION CHROMATOGRAPHY	4.4583312187467925
STUDENT-NEWMAN-KEULS TEST	4.45828082895319
GONADOTROPE DESENSITIZATION	4.458261171103337
GROWTH NON-ESSENTIAL GENE	4.4581344754687775
GROWTH CONTACT INHIBITION	4.4581344754687775
GRANULATION TISSUE GROWTH	4.4581344754687775
BLASTN PAIRWISE ALIGNMENT	4.457908717434312
SAMPLE SYNTHETIC PAIRWISE	4.457908717434312
FREQUENCIES REPRESENTATIVE	4.457844842976688
CYTOPLASMIC VOLUME	4.457756813456181
SIGMOID TRANSFER FUNCTION	4.457615477378673
SINGLE REFERENCE SEQUENCE	4.457398091217555
C3 EXOENZYME INACTIVATION	4.457309204431675
ABILITY CORRESPONDING LOSS	4.456970778445405
NORMAL INTEGRIN DEPENDENT	4.456945026662392
AUGMENTED WG DFZ2 PLASMID	4.456940331777603
TRANSFECTION GHFT1-5 CELL	4.456421736364779
SMAD1 DNA-BINDING COMPLEX	4.456302879034392
LIGAND BOUND GR TRANSLOCATE	4.4562470827969
UBA80 UBIQUITIN PRECURSOR	4.456059413212468
DNA MANIPULATION TECHNIQUE	4.455969575447669
TRANSFORMANT POOLED STOCK	4.4555481349864285
SINGLE PARAMETER DNA DATA	4.455544501500236
ULTRASTRUCTURAL APPEARANCE	4.455314656175605
ULTRACUT S ULTRAMICROTOME	4.455279497274442
Y187 S. CEREVISIAE STRAIN	4.455174452050664
HYAL-2 ENZYMATIC ACTIVITY	4.455141734345218
HUAPE1 ENZYMATIC ACTIVITY	4.455141734345218
OTHER IG-RELATED MOLECULE	4.4550368567603895
MHC	4.454917542578563
GROWTH FACTOR INDEPENDENT	4.454877703207022
ENDOTHELIAL GROWTH FACTOR	4.454877703207022
MULTIPLE PHOSPHATIDYLINOSITOL	4.454872971242654
BACKGROUND GENOMIC CLONING	4.4546229825350965
MIP MAMMALIAN MODIFICATION	4.454560314769071
LUCIFERASE REPORTER ASSAY	4.454506401374171
NF-ΚB-INHIBITED PHENOTYPE	4.454211419624374
OTHER N-TERMINAL DELETION	4.454062232642003
N-TERMINAL SEQUENCE CAUSE	4.454062232642003
ALLN-INDUCED ACCUMULATION	4.453895106611443
PREFERENTIAL ACCUMULATION	4.453895106611443
BRDU-POSITIVE CELL SUBSET	4.453787065541182
GFP-GR TRANSLOCATION CELL	4.453663913831725
P19 CELL LUCIFERASE ASSAY	4.453613797247429
ACTIN CYTOSKELETAL RESEARCH	4.453387454661407
OKADAIC ACID OKADAIC ACID	4.4533697505067655
ALIGNMENT IDENTITY WINDOW	4.453283902842542
ANTISENSE OLIGONUCLEOTIDE	4.45325945769119
9E10 MOUSE ANTI-MYC ANTIBODY	4.453136032197161
COMPONENT ANALYSIS	4.453040892775065
COMMON CLUSTER DENDROGRAM	4.452842101448613
INTEGRIN DEPENDENT SIGNAL	4.452841563877352
LABELED CDNA PROBE	4.45278214809348
V-CRK INDUCED ASSOCIATION	4.452751142338097
BUDDING TRANSPORT VESICLE	4.45256652236131
METABOLITE TRANSPORT FLUX	4.45256652236131
CATALYZED METABOLIC REACTION	4.452526916371464
CULLIN SUBUNIT DENEDDYLATION	4.4525163374713195
SIGNALING MOLECULE CHANGE	4.452438557578879
PROTEASOME PATHWAY	4.452160788520379
RADIO-LABEL INCORPORATION	4.451990055903177
HIV-INFECTED	4.451700792577604
GROWTH INHIBITION	4.45124592998372
FUNCTIONAL SNPSARE UNKNOWN	4.4509771930880335
DIPHTHERIA TOXIN RECEPTOR	4.450789965988405
ALIGNED TRNA TRAINING SET	4.450724336071191
OTHER DNA-BINDING PROTEIN	4.450367384590497
CLINICAL TEST DEVELOPMENT	4.45034275094489
GFP-TAGGED VARIANT ALLELE	4.450264926650692
FORGE P27 DOWN-REGULATION	4.450264926650692
CCAF RESULT CONCENTRATION	4.449906743034709
CORRESPONDING REGION	4.4498375845368106
XENOPUS NOCTURNIN EXON II	4.44956158931807
NUCLEOTIDE MAXIMUM NUMBER	4.449462181733172
HUMAN PLATELET AGGREGATION	4.449361275467173
BOOLEAN USM APPROACH PLACE	4.449361275467173
GENOMIC DNA CONTAMINATION	4.44916486981927
IDENTIFIED GENES FUNCTION	4.44915267226422
PRIVATE GENOME SEQUENCING	4.4490931464548025
OBJECTIVE CORRELATION PLOT	4.448942333861766
INHIBITED CELL ATTACHMENT	4.448755438554767
GRAVITATION SEDIMENTATION	4.448755438554767
GNRH RECEPTOR MEASUREMENT	4.448750117210127
RNA POSTERIOR PROBABILITY	4.448690884537835
MM TRIS HCL	4.44833653753275
complex formation	4.448316607091914
GROUP B PROTEIN KINASE C.	4.448256744903861
FUNCTIONAL CLASSIFICATION	4.448203186812354
PATHOLOGIC CLASSIFICATION	4.448203186812354
STRUCTURAL CLASSIFICATION	4.448203186812354
TGF-Β1 CONTINUED PRESENCE	4.44791683405703
STUDIED MAMMALIAN SPECIES	4.447899456868549
GENOME-WIDE IDENTIFICATION	4.4476474234450505
HYAL-2 STABLE TRANSFECTANT	4.4476474234450505
HYAL-1 STABLE TRANSFECTANT	4.4476474234450505
TAXONOMICAL IDENTIFICATION	4.4476474234450505
BIOCHEMICAL FRACTIONATION	4.447623322482824
MMP PRODUCTION/ACTIVATION	4.447623322482824
PRINCIPAL SURFACE ANTIGEN	4.447473797718604
CCAF INCREASES PRODUCTION	4.447473797718604
TOTAL PHENOTYPIC VARIANCE	4.447383176649381
RESTRICTION SITE	4.447344048270015
SYSTEMATIC ERROR FRACTION	4.446656881933603
EXTREME N-TERMINAL GLYCINE	4.4465884910985
EPITHELIAL CELL CYTOPLASM	4.446535603119583
CONTAINING N-TERMINAL GFP	4.446514792162378
CRNA PREPARATION TOTAL RNA	4.446472200067498
SKP2-INDUCED UPREGULATION	4.446372036298043
ALANINE SUBSTITUTION MUTANT	4.446165456037135
C-TERMINAL SERINE RESIDUE	4.445762488019743
COMPLEMENTARY MEASUREMENT	4.445695665387352
N-TERMINAL GLYCINE-SERINE	4.445394468966184
BOI1-PH KK VERSION ABILITY	4.445170907273082
TRANSPORTER 3	4.445128038464297
PROTEIN PH DOMAIN PORTION	4.444980626243116
VIS STUDY	4.444960869489106
ANTI-FLAG ANTIBODY ABILITY	4.444914715944946
DIAGRAM RETRIEVAL MULTIPLE	4.444735124920968
DELETERIOUS MUTANT ALLELE	4.444101183592331
ENZYMATIC STABILITY ASSAY	4.443860862453964
CORRESPONDING PROBABILITY	4.443833194763708
ECM MOLECULE ACCUMULATION	4.443368421172258
APOPTOSI HALLMARK FEATURE	4.443345326352557
MESENCHYMAL CELL APOPTOSI	4.443345326352557
CULLIN/RING	4.443078251338508
TYPE CD98	4.442963866076849
BIOTECHNOLOGY INFORMATION	4.442704473342654
DATABASE MANAGEMENT SYSTEM	4.441820326569828
COMPUTATIONAL PERFORMANCE	4.4416797131051196
APOPTOSI POSITIVE CONTROL	4.441539101280511
LATRUNCULIN B DEPOLYMERIZ	4.441207998075142
ADHESION DEPENDENT GROWTH	4.441199335769357
STOICHIOMATRIC RELATIONSHIP	4.441086490817534
SERINE PROTEASE INHIBITOR	4.441083074922376
SIGNALING KINASE APOPTOSI	4.440902224231986
EXPERIMENTAL EVIDENCE SHOW	4.4407339186778385
REGULATION CHARACTERISTIC	4.440721066431295
WOX1 EXPRESSION INDUCTION	4.440694233893384
COMPONENT	4.440619948083027
KEY GENE INCLUDING MODULE	4.44052186712245
ACID SEQUENCE INFORMATION	4.440250229235066
EXHIBIT DIMINUTION T CELL	4.440117699927517
LIMITED EFFECTOR MOLECULE	4.439187231753178
III1-C RESIN MG PROTEIN/ML	4.439149573835352
CALCIUM IONOPHORE IONOMYCIN	4.439095223538019
comparisons	4.438910896116692
AGAROSE GEL ELECTROPHORESI	4.43849676901226
TEMPLATE ALIGNING PROTEIN	4.438484180431089
NEOPLASTIC TRANSFORMATION	4.438224126257617
TRANSFORMATION EXPERIMENT	4.438224126257617
PGEX-2T GST FUSION VECTOR	4.438034689311428
FINE FILOPODIAL STRUCTURE	4.43803012839951
AGAR TRANSFORMATION ASSAY	4.43800113227837
ACTIN DYNAMIC RELATIONSHIP	4.43762173199153
BMP KEY SIGNAL TRANSDUCER	4.43744427003367
MONOCYTE/MACROPHAGE CHEMOTAXI	4.437391948225523
RNASIN RIBONUCLEASE INHIBITOR	4.437391948225523
E. COLI METABOLIC RESEARCH	4.436860357205801
METABOLIC NETWORK SUBJECT	4.436658855868244
DIPHTHERIA TOXIN AFFINITY	4.436644429413044
MISMATCH VALUE INTRODUCTION	4.4361794393073035
RISK OMISSION PATH LENGTH	4.435736103727414
OXIDE SYNTHASE EXPRESSION	4.435662606906969
SF-900 SERUM-FREE MEDIUM	4.435574158788717
DEVELOPMENTAL TIME FRAME	4.435574158788717
TUMOR-NORMAL SAMPLE PAIR	4.435574158788717
PHYLOGENETICALLY DISTANT	4.435574158788717
COLLAGEN-GEL CONTRACTION	4.435574158788717
PATHOPHYSIOLOGICAL MODEL	4.435574158788717
SEGMENTATION CAVITY FORM	4.435574158788717
SELECTED EPISTASIS MODEL	4.435574158788717
PROTEIN/DNA CONTACT PLOT	4.435574158788717
POSTERIOR CELL MIGRATION	4.435574158788717
ANTIGENIC SITE SUBREGION	4.435574158788717
G418-RESISTANT CELL LINE	4.435574158788717
GALAXY MICROPLATE READER	4.435574158788717
DESTROYED MICROEXTENSION	4.435574158788717
FLUORESCENCE VIDEO IMAGE	4.435574158788717
PROSPECTIVE DIENCEPHALON	4.435574158788717
ABROGATED CELL MIGRATION	4.435574158788717
PHYSIOLOGICAL IMPORTANCE	4.435574158788717
RETRACTING LAMELLIPODIUM	4.435574158788717
PMSF/LEUPEPTIN/APROTININ	4.435574158788717
OTHER PHYLOGENETIC GROUP	4.435574158788717
VARIABLE SCANNER SETTING	4.435574158788717
DEMONSTRATING CYTOPATHIC	4.435574158788717
EMBRYONIC TISSUE EXTRACT	4.435574158788717
INCLUDED NETWORK ELEMENT	4.435574158788717
HIERARCHICAL ARRANGEMENT	4.435574158788717
POSITIONAL WEIGHTMATRICE	4.435574158788717
CHARACTERISTIC STRUCTURE	4.435574158788717
COMPUTATIONAL GENEFINDER	4.435574158788717
INTERPHASE GFP-MYOSIN II	4.435574158788717
MOUSE          NOCTURNIN	4.435574158788717
CHORIOALLANTOIC MEMBRANE	4.435574158788717
GRAPHICAL REPRESENTATION	4.435574158788717
HAMAMATSU MODEL C4742-95	4.435574158788717
THE SV40 POLYADENYLATION	4.435574158788717
HYAL-1 TGF-Β1 INHIBITION	4.435574158788717
DORSAL-VENTRAL MIGRATION	4.435574158788717
PP5 PHOSPHATASE ACTIVITY	4.435574158788717
CHEMOATTRACTANT PROPERTY	4.435574158788717
Ρ-INDEPENDENT TERMINATOR	4.435574158788717
PROBE SET CHARACTERISTIC	4.435574158788717
THROMBOCYTOPENIC PURPURA	4.435574158788717
CONFORMATIONAL STABILITY	4.435574158788717
AFFECTED ULTRASTRUCTURAL	4.435574158788717
RAS/MAPK PATHWAY LEADING	4.435574158788717
PHYLOGENETIC GROUPS/CELL	4.435574158788717
AFFECTING FN DEGRADATION	4.435574158788717
AVERAGE PERCENT IDENTITY	4.435574158788717
MODERN LINUX WORKSTATION	4.435574158788717
'-TGATGTCCAGGGCGTCAATA-3	4.435574158788717
QUANTITATIVE DESCRIPTION	4.435574158788717
IDENTIFIED PROLIFERATIVE	4.435574158788717
INTRODUCING C3 EXOENZYME	4.435574158788717
EXPRESSED MYC-TAGGED RAB	4.435574158788717
EMISSION SPECTRA OVERLAP	4.435574158788717
TRIAL-AND-ERROR APPROACH	4.435574158788717
TRANSLATED SUBPOPULATION	4.435574158788717
CIRCULAR GLASS COVERSLIP	4.435574158788717
GENE ONTOLOGY CONSORTIUM	4.435574158788717
CYTOSKELETAL COMPARTMENT	4.435574158788717
TRANSITION STATE COMPLEX	4.435574158788717
ANTI-MOUSE IGG RHODAMINE	4.435574158788717
MISMATCH PROBE INTENSITY	4.435574158788717
REGULATORY GENE INITIATE	4.435574158788717
2-D WESTERN MULTIPROTEIN	4.435574158788717
ITERATIVE BLAST APPROACH	4.435574158788717
SUBBRANCH THERMOPROTEALE	4.435574158788717
CRITICAL RELEVANCE VALUE	4.435574158788717
NOCODAZOLE-TREATED DONOR	4.435574158788717
PERMEABILIZATION PROCESS	4.435574158788717
CLEAVAGE STAGE ZEBRAFISH	4.435574158788717
MORPHOLINEETHANESULFONIC	4.435574158788717
CODING-REGION GENEFINDER	4.435574158788717
UBIQUITINATION E3 LIGASE	4.435574158788717
BACKGROUND SPECIFICATION	4.435574158788717
LAMININ-COATED COVERSLIP	4.435574158788717
TWO-DIMENSIONAL ELECTRON	4.435574158788717
DISSIMILAR SEQUENCE UNIT	4.435574158788717
COMPETITIVE TUMOR/NORMAL	4.435574158788717
DETECTTHE FUNCTIONAL SNP	4.435574158788717
5'CGATGATCTGACTACCACCC3'	4.435574158788717
ORNITHORHYNCHUS ANATINUS	4.435574158788717
CELLULAR PLASMA MEMBRANE	4.435574158788717
NEURAL CELL POST-MITOTIC	4.435574158788717
SECONDARY STRUCTURE LINK	4.435574158788717
CELL ABLATION EXPERIMENT	4.435574158788717
IMPOSED CONSTRAINTS- EQN	4.435574158788717
PHYSIOLOGICAL ANTAGONIST	4.435574158788717
OTHER ECM MOLECULES PLAY	4.435574158788717
INCREASED DT-SENSITIVITY	4.435574158788717
BACTERIAL ANCESTRAL GENE	4.435574158788717
MUCOPOLYSACCHARIDOSIS IX	4.435574158788717
CLUSTALX OUTPUT CLUSTALX	4.435574158788717
SMAD1 CONSTITUTIVE LEVEL	4.435574158788717
DIMENSIONALITY REDUCTION	4.435574158788717
CRE RECOMBINASE ACTIVITY	4.435574158788717
VALIDATING MODEL QUALITY	4.435574158788717
randomvariable selection	4.435574158788717
INTENSITY IMMUNOLABELING	4.435574158788717
PHOSPHOMOLYBDATE COMPLEX	4.435574158788717
COMPUTATIONAL COMPLEXITY	4.435574158788717
ENHANCED TRANSACTIVATION	4.435574158788717
ATCISDB DATABASE ATCISDB	4.435574158788717
FUNCTIONAL GENOMICS TOOL	4.435574158788717
measurement noise effect	4.435574158788717
METABOLIC CHARACTERISTIC	4.435574158788717
PUTATIVE TUMOR BIOMARKER	4.435574158788717
GENE TRANSCRIPTS DISPLAY	4.435574158788717
POLYPHENOLIC CONSTITUENT	4.435574158788717
GENE SELECTION CRITERION	4.435574158788717
CROSS-SECTIONAL DIAMETER	4.435574158788717
SEMI-HIERARCHICAL SYSTEM	4.435574158788717
EXTRAORDINARY EFFICIENCY	4.435574158788717
FIBRONECTIN-BINDING SITE	4.435574158788717
BONE MARROW STROMAL CELL	4.435574158788717
MOESIN DEPHOSPHORYLATION	4.435574158788717
SUSPENDED PRECURSOR CELL	4.435574158788717
NEOPLASIA CURRENT THEORY	4.435574158788717
C3 RESULT MICROINJECTION	4.435574158788717
ENDOTHELIAL-LINED VESSEL	4.435574158788717
FORM POLYUBIQUITIN CHAIN	4.435574158788717
NORMAL GFP-BLM CELL LINE	4.435574158788717
POSSIBLE STRUCTURE MODEL	4.435574158788717
PLASMA MEMBRANE BLEBBING	4.435574158788717
ELONGATED DENDRITIC-LIKE	4.435574158788717
FASTA-FORMATTED DOCUMENT	4.435574158788717
C/EBPΑ-INDUCED REDUCTION	4.435574158788717
CELL-SPECIFIC DIFFERENCE	4.435574158788717
COMBINING CYTOCHALASIN D	4.435574158788717
AUXOTROPHIC TRANSFORMANT	4.435574158788717
ARABIDOPSIS ROOT CULTURE	4.435574158788717
REMAINING BOUND MATERIAL	4.435574158788717
INFECTED EPITHELIAL CELL	4.435574158788717
'-AGTGACTGTCCTTCCTCTGT-3	4.435574158788717
5'CGAAAGGAGTCGGTTCTGTC3'	4.435574158788717
WTPAI-1 MOLECULAR WEIGHT	4.435574158788717
TET-RESPONSIVE ACTIVATOR	4.435574158788717
PATHOPHYSIOLOGIC PATHWAY	4.435574158788717
WITHIN-GROUP VARIABILITY	4.435574158788717
REMAINING MODE ESTIMATOR	4.435574158788717
'-ACCAGTCGACTCTACAGTGC-3	4.435574158788717
MASSIVE STRUCTURAL ARRAY	4.435574158788717
SONIC DISMEMBRATOR MODEL	4.435574158788717
ANTI-REPRESSION FUNCTION	4.435574158788717
THROMBIN VARIABLE REGION	4.435574158788717
INCREASED GROUPING SPEED	4.435574158788717
BINDING PROTEINS ACT GTP	4.435574158788717
FASTA FORMATTED DOCUMENT	4.435574158788717
MATRIX METALLOPROTEINASE	4.435574158788717
MEMBRANE-BOUND PROHB-EGF	4.435574158788717
EXOCRINE PANCREATIC CELL	4.435574158788717
PATHWAY INCLUSION CUTOFF	4.435574158788717
FINITE LENGTH COORDINATE	4.435574158788717
INTERMEDIATE LAYERS SHOW	4.435574158788717
IMAGING CHAMBER ALUMINUM	4.435574158788717
HUMAN DIPLOID WI-38 CELL	4.435574158788717
COMPUTATIONAL COMPARISON	4.435574158788717
MEMBRANE-BOUND ORGANELLE	4.435574158788717
'-AACACAGTGAGACGCTGTCT-3	4.435574158788717
ANTI-PHOSPHORYLATED ERK1	4.435574158788717
BOUND GUANINE-NUCLEOTIDE	4.435574158788717
AUTOMATED CELL HARVESTER	4.435574158788717
DIFFERENTIATED SECRETORY	4.435574158788717
MARKOV MODEL FORMULATION	4.435574158788717
AVERAGE SIMILARITY SCORE	4.435574158788717
ELECTRO CELL MANIPULATOR	4.435574158788717
USM OVERESTIMATION ERROR	4.435574158788717
POSSIBLE NN ARCHITECTURE	4.435574158788717
HEMATOXYLIN COUNTERSTAIN	4.435574158788717
CATALYTIC DOMAIN RESIDUE	4.435574158788717
POWERPC JAVA ACCELERATOR	4.435574158788717
THICK-SECTIONED MATERIAL	4.435574158788717
SMAD SIGNALING MECHANISM	4.435574158788717
MOCK-ELECTROPORATED CELL	4.435574158788717
SMAD1 SIGNALING FUNCTION	4.435574158788717
DELTA-NOTCH PATHWAY GENE	4.435574158788717
10E-15 E-VALUE THRESHOLD	4.435574158788717
PLASTIC MICROPIPETTE TIP	4.435574158788717
HEMISPHERICAL PROPORTION	4.435574158788717
PROGRESSIVE DEGENERATION	4.435574158788717
HL-60 PROMYELOCYTIC CELL	4.435574158788717
TIME-VARIATIONS APPROACH	4.435574158788717
NP-40-INSOLUBLE MATERIAL	4.435574158788717
INTEGRIN-BLOCKING RESULT	4.435574158788717
CURRENT DATABASE VERSION	4.435574158788717
DEFINED BACKGROUND MODEL	4.435574158788717
HEPARIN-SEPHAROSE COLUMN	4.435574158788717
BIOLOGICAL SEQUENCE DATA	4.435574158788717
TETRATRICOPEPTIDE REPEAT	4.435574158788717
SEGMENTATION GENE RESULT	4.435574158788717
TERTIARY STRUCTURE MODEL	4.435574158788717
CORONAL CRYOSTAT SECTION	4.435574158788717
ORIGINAL APPROACH EMPLOY	4.435574158788717
INTERMEDIATE SAMPLE SIZE	4.435574158788717
FORMING POSTERIOR REGION	4.435574158788717
LABELED PHALLOIDIN TRITC	4.435574158788717
WOX1-MEDIATED CELL DEATH	4.435574158788717
TGF-Β CELLULAR SYNTHESIS	4.435574158788717
HUMAN LUNG MELANOMA LINE	4.435574158788717
INCREASING NEGATIVE BIAS	4.435574158788717
PROSTATE CANCERS DISPLAY	4.435574158788717
HAVING SWISSPROT HOMOLOG	4.435574158788717
RESTORED G1 PROLONGATION	4.435574158788717
OLYMPUS IX-70 MICROSCOPE	4.435574158788717
CORRESPONDING PROBE PAIR	4.435574158788717
F-ACTIN-BINDING ACTIVITY	4.435574158788717
DICTYOSTELIUM DISCOIDEUM	4.435574158788717
CASCADE BLUE FLUOROPHORE	4.435574158788717
ROULETTE WHEEL SELECTION	4.435574158788717
HEXAMERIC MOLECULAR MASS	4.435574158788717
CORTICAL ACTIN-MYOSIN-II	4.435574158788717
SN50-SUPPLEMENTED MEDIUM	4.435574158788717
MULTI-STRANDED STRUCTURE	4.435574158788717
RUNNING LAKEWATER SYSTEM	4.435574158788717
MYOSIN-II ASSEMBLY-STATE	4.435574158788717
EXPONENT DIFFERENT VALUE	4.435574158788717
SIGNALING PATHWAY WNT/WG	4.435574158788717
DUAL LUCIFERASE ACTIVITY	4.435574158788717
EXHIBITING NEGATIVE BIAS	4.435574158788717
CRANIAL SENSORY GANGLION	4.435574158788717
EXCHANGE FLUX CONSTRAINT	4.435574158788717
HETEROLOGOUS CELL SYSTEM	4.435574158788717
CLASSIFYING BREAST TUMOR	4.435574158788717
HUMAN KERATINOCYTE HACAT	4.435574158788717
CAS SUBSTRATE DOMAIN ACT	4.435574158788717
AUTOPHOSPHORYLATION STEP	4.435574158788717
NUMERICAL REPRESENTATION	4.435574158788717
TITRATING SEQUENCE BOUND	4.435574158788717
EXPRESSING CELL GFP-MHCK	4.435574158788717
STANDARD PRINTING FORMAT	4.435574158788717
MORPHOLOGICAL ALTERATION	4.435574158788717
NEW COMPUTATIONAL METHOD	4.435574158788717
CAS ACT SUBSTRATE DOMAIN	4.435574158788717
INACTIVE GDP-BOUND STATE	4.435574158788717
ELECTROPORATE SUSPENSION	4.435574158788717
DONOR CELL PERPENDICULAR	4.435574158788717
OCL PRECURSOR POPULATION	4.435574158788717
PARSIMONIOUS EXPLANATION	4.435574158788717
CCAF CHICKEN CHEMOTACTIC	4.435574158788717
AVERAGE DIFFERENCE VALUE	4.435574158788717
ultrastructural analysis	4.435574158788717
PHOSPHOPROTEIN SUBSTRATE	4.435574158788717
POLYVINYLIDENEDIFLUORIDE	4.435574158788717
INPUT-OUTPUT SPECIFICITY	4.435574158788717
NODAL PHENOTYPIC OUTCOME	4.435574158788717
TNF-ALPHA POTENTIAL ROLE	4.435574158788717
RECENT CRYSTAL STRUCTURE	4.435574158788717
TRANSPOSABLE IAP ELEMENT	4.435574158788717
HUMAN PAPILLOMA VIRUS E7	4.435574158788717
CALCULATED FOLD INCREASE	4.435574158788717
INTERNAL NODE ANNOTATION	4.435574158788717
CRITICAL REGULATORY ROLE	4.435574158788717
GLUTATHIONE-AGAROSE BEAD	4.435574158788717
VESICLE CO-SEDIMENTATION	4.435574158788717
MEASURED GENE EXPRESSION	4.435066277673845
RHYTHMIC GENE EXPRESSION	4.435066277673845
MEASURE EXPRESSION LEVEL	4.435066277673845
BLOCKING WOX1 EXPRESSION	4.435066277673845
THY-1 SURFACE EXPRESSION	4.435066277673845
NGN1 EXAMINED EXPRESSION	4.435066277673845
SHOWING EXPRESSION LEVEL	4.435066277673845
EXPRESSION PATTERNS SHOW	4.435066277673845
DETECTED GAD1 EXPRESSION	4.435066277673845
HOMEOTIC GENE EXPRESSION	4.435066277673845
RHYTHMIC MNOC EXPRESSION	4.435066277673845
FAF INCREASED EXPRESSION	4.435066277673845
TYPE-SPECIFIC EXPRESSION	4.4348123371164085
LARGE GRANULAR LYMPHOCYTIC	4.434698319277891
INSTITUTIONAL REVIEW BOARD	4.434698319277891
AVERAGE LINKAGE ANALYSIS	4.434640141954511
DOTMAC-INSOLUBLE FRACTION	4.434286442903583
BIOINFORMATICAL ANALYSIS	4.434173133537408
EXPRESSION ANALYSIS IDEA	4.434132260839639
IN SILICO DELETION STUDY	4.434127869644674
MICROARRAY CORE FACILITY	4.433975369768941
CUSTOM MUSCLE MICROARRAY	4.433975369768941
APE1 CONTROL SPECIFICITY	4.433788616635577
QUALITY CONTROL PROTOCOL	4.433788616635577
INTERNAL CONTROL INVALID	4.433788616635577
CD4	4.433739194409894
LOG AVERAGE RATIO CHANGE	4.433647749068167
MOBYDICK ALGORITHM LOGIC	4.433526036907174
MYOSIN FILAMENT ASSEMBLY	4.4334920149490085
MYOSIN S1 MICROINJECTION	4.4334920149490085
DESCENDING ETHANOL SERIES	4.433358659976332
PREFABRICATED MICROARRAY	4.433175975259053
ATTENUATED KINASE DOMAIN	4.433159032408169
ECTOPIC EXPRESSION STUDY	4.433137892148454
MICROARRAY DATA ANALYSIS	4.433041352934735
EPITHELIAL ORIGIN CHANGE	4.433005612494651
ENDOTHELIAL SHAPE CHANGE	4.433005612494651
EXOGENOUS HEPARIN ADDITION	4.4329545288327
TGF-Β1 INHIBITORY EFFECT	4.43284926619849
III1-C BIOLOGICAL EFFECT	4.43284926619849
CARBOXYLATE	4.432799252121449
DIOXYGENASE	4.432799252121449
WHOLE CELL LYSATE	4.432761211157412
DIFFERENTIATION PREPARATION	4.432718993553883
IMMUNOHISTOLOGICAL STUDY	4.43268158050063
ELECTROPORATION PROCEDURE	4.432582351812715
ALGORITHM IMPLEMENTATION	4.432501975966402
SHOWED EXPRESSION CHANGE	4.432497731379779
CORE RNA PAIR-SCFG STATE	4.432363475921134
ARP3 SHOWED LOCALIZATION	4.432360182913064
MOUSE LIVER MITOCHONDRIA	4.432240513598546
MODIFIED T7-PCMV6 VECTOR	4.432033337908761
PADTRACK1 SHUTTLE VECTOR	4.432033337908761
FIBRONECTIN DIMERIC FORM	4.431992871384419
QUANTITATIVE DEMONSTRATION	4.43195908570407
PROMOTER GENE ANNOTATION	4.431865725086041
DEFINED GENOMIC LOCATION	4.431843651075907
C/EBPΒ C-TERMINAL REGION	4.431843651075907
DNA-BINDING DOMAIN	4.431697017817874
PLASMINOGEN ACTIVATOR INHIBITOR 1 ASSAY	4.431686777391264
LNCAP CELL PROLIFERATION	4.431657125690266
NON-PARAMETRIC WILCOXON TEST	4.431532724245753
GR-GFP EXPRESSION VECTOR	4.4315254567938895
EXPRESSION VECTOR PQE-12	4.4315254567938895
TOXIC BILE	4.431431868739987
RNA STRUCTURAL ALIGNMENT	4.431293248298607
SCFG-BASED RNA ALIGNMENT	4.431293248298607
RNA STRUCTURE EQUIVALENT	4.431293248298607
RNA STRUCTURE PREDICTION	4.431293248298607
FUNCTIONAL NONCODING RNA	4.431293248298607
RNA GENEFINDING APPROACH	4.431293248298607
PREDICTING RNA STRUCTURE	4.431293248298607
FUNCTIONAL RNA STRUCTURE	4.431293248298607
GRANZYME B OVER-EXPRESSION	4.431189941301567
DLA DX2 MUTANT ZEBRAFISH	4.431004286840524
PPT1 MRNA BAND INTENSITY	4.430995808413904
HUMAN TOPOISOMERASE IIIΑ	4.430897104342805
HIV-1 LTR	4.430807391551834
HP KAYAK XU800 PC WORKSTATION	4.430786353145007
MITOSIS-PROMOTING FACTOR	4.430744939900216
AZT RESISTANCE SELECTABLE	4.4304955019105146
TK MUTANT VERSION ABILITY	4.43046490268335
TREATMENT CAUSES REMOVAL	4.430458033925434
ENCODING TERMINATION CODON	4.430374243422073
ISOLATED C/EBPΑ BZIP DNA	4.43028195439777
BACKGROUND HYBRIDIZATION	4.430232750018102
HYBRIDIZATION EXPERIMENT	4.430232750018102
HYBRIDIZATION EFFICIENCY	4.430232750018102
P68	4.430131372604757
REGULATING GNRH RECEPTOR	4.430124373608264
MAMMALIAN FEMALE MEIOSIS	4.430124373608264
SUPPRESSED GNRH RECEPTOR	4.430124373608264
NUCLEOLAR CO-LOCALIZATION	4.430050912148741
OPPOSITE FORT TICONDEROGA	4.430050912148741
INTEGRATED LEU2 REPORTER	4.430027917233388
GAL4-LUC REPORTER SYSTEM	4.430027917233388
CELL CYCLE MITOTIC PHASE	4.429944889665195
HFF BOVINE SERUM ALBUMIN	4.429888143000643
SUBMEMBRANE CYTOSKELETON	4.429876656100061
ACIDIC ACTIVATION DOMAIN	4.429797888781785
HUMAN FIBULIN-1C PROTEIN	4.429706631151482
COMPLEX PROTEIN ASSEMBLY	4.429706631151482
CDC42-GST FUSION PROTEIN	4.429706631151482
BINDING PROTEIN ANTI-RAN	4.429706631151482
MOLECULAR WEIGHT PROTEIN	4.429706631151482
PROTEIN TRANSDUCING STEP	4.429706631151482
GR PROTEIN REUTILIZATION	4.429706631151482
PROGENITOR PROLIFERATION	4.429698609141041
GNRH RECEPTOR EXPRESSION	4.429616492493391
MUTANT METABOLIC NETWORK	4.429480996191127
C/EBPΑ EXPRESSION ABSENCE	4.4294808937522285
SMAD1 IMMUNOPRECIPITATION	4.429442870268669
E. COLI IN VIVO PROPERTY	4.429306905831195
WILDTYPE METABOLIC BEHAVIOR	4.429263920202188
PROTEIN EXPRESSION LEVEL	4.42919875003661
RIBOSOMAL PROTEIN SUBUNIT	4.429161511500971
signal amplification step	4.429132093307744
NOCTURNIN MOUSE HOMOLOGUE	4.429132093307744
PROMOTING COMPLEX S-PHASE	4.429132093307744
LIPID SERUM CONCENTRATION	4.429120638603673
GPNN USE CURRENT VERSION	4.428953821157532
SIMULATED GENOME HIGH-GC	4.428810936172686
REFERENCE GENOME SERVING	4.428810936172686
FLOW CYTOMETRIC ANALYSIS	4.428727639164396
IN VITRO PHOSPHORYLATION	4.42866809492368
MORI BBMV	4.428654232414931
PCNA DECREASED EXPRESSION	4.428618329125986
LITHIUM ACETATE PROTOCOL	4.428370419757083
ANCHORAGE DEPENDENT CELL	4.428328779647074
TRANSFACINFO TABLE STORE	4.428200920015162
CELL-SURFACE PROTEOGLYCAN	4.428171509973972
CHD DEATH	4.4278177751522145
ANTI-Β-TUBULIN MOUSE MAB	4.427640927196918
SHEP TRIAL	4.427572089992442
OLIGONUCLEOTIDE SEQUENCE	4.427539219099587
MISMATCH OLIGONUCLEOTIDE	4.427539219099587
TRABECULAR BEAM COLLAGEN	4.427434869233494
NEURONAL	4.427423187442946
GENOME SEQUENCING PROJECT	4.427231594720717
HMM ALIGNMENT ALGORITHM RUN	4.427231286553354
OTHER PROTEASE INHIBITOR	4.427217821512022
WNT/Β-CATENIN ACTIVATION	4.426909753778319
LOOP-LENGTH DISTRIBUTION	4.426909753778319
CHEMOTACTIC PEPTIDE FMLP	4.4268291546619425
MULTI-FUNCTIONAL PROTEIN	4.426772867332865
BINARY DECIMAL POINT SET	4.426705404603545
CONTAINING CDNA FRAGMENT	4.426663372593189
NON-PALMITOYLATED MUTANT	4.426434414892332
INTRON DISTRIBUTION DATA	4.426306382955867
REACHED MAXIMUM INDUCTION	4.426290703950708
NON-DNA DAMAGE MECHANISM	4.4262200498968935
USING REACTION CONDITION	4.42614971825109
NORMAL BIPHASIC MECHANISM	4.426113117115894
MINIMAL FORCE REQUIREMENT	4.426113117115894
COMPLEX MEMBRANE TOPOLOGY	4.426113117115894
GENE PROMOTER ACTIVATION	4.426089455079109
MAKING PLATELET ADHESION	4.42607832097429
DOMAIN CONTROLS ADHESION	4.42607832097429
CYTOPLASMIC SMAD PROTEIN	4.425885135445676
VERTEBRATE PROTEIN NETRIN	4.425838203031717
INTRON CONSERVATION DATA	4.425815400005278
AUTOMATED CHARACTERIZATION	4.4257958101629695
DIFFERENTIAL DISTRIBUTION	4.425701825339051
LIPOPOLYSACCHARIDE ABSENCE	4.42564715973248
CONTAINING COMPLEX CLOSE	4.425299973612453
UNIGEM-V CDNA MICROARRAY	4.425064583573413
ENDOGENOUS TRANSCRIPTION	4.424718639809176
GR-INDUCED TRANSCRIPTION	4.424718639809176
INCREASING TRANSCRIPTION	4.424718639809176
PROMEGA ACCESS RT-PCR SYSTEM	4.424710367515785
TRANSCRIPTIONAL PROMOTER	4.42454588065547
BIO-RAD PROTEIN ASSAY KIT	4.424522003083969
P53 PHOSPHORYLATION SITE	4.424503807244263
ELUDED POSITIONAL CLONING	4.424435908120421
BL21(DE3) STRAIN E. COLI	4.424406447401644
GNRH RECEPTOR ACTIVATION	4.424348103601331
EXPRESSION ANALYSIS MANUAL	4.424321115109261
DYSPLASTIC SMG PHENOTYPE	4.424247798022112
TRITON X-100 LYSIS BUFFER	4.424063283103156
PGAD424 RESTRICTION SITE	4.423968134793307
ECHOCARDIOGRAM	4.423857213209967
ubiquitylation	4.423857213209967
REPRESENTATIVE MORPHOLOGY	4.4238488849720055
REPRESENTATIVE PHOTOGRAPH	4.4238488849720055
MONOCLONAL ANTIBODY 3G10	4.423786222191498
RABBIT ANTI-MYC ANTIBODY	4.423786222191498
ANTI-BOI1 ANTIBODY AP-PH	4.423786222191498
LABELING EXPERIMENT ACID	4.423693110528013
TRYPTOSE PHOSPHATE BROTH	4.423579416286283
PLASMID DNA CONCENTRATION	4.423492162864872
ANTI-Β1 INTEGRIN MAB 33B6	4.423460287118094
POB1 CAUSE OVEREXPRESSION	4.423368593305121
GROWTH FACTOR EGF FAMILY	4.423325993448773
PROTEASE LEVELS/ACTIVITY	4.423039652873674
BLOCKED TNF CYTOTOXICITY	4.422754777739241
EXTRACELLULAR ACTIVATION	4.4227129326014065
EXTRACTED MEMBRANE LIPID	4.422607428531776
LYSOSOMAL MEMBRANE LIPID	4.422607428531776
CYCLIN E KINASE ACTIVITY	4.422571290864875
INFLUENCE N3 INTERACTION	4.422435263699573
INFECTED SF9 CELL NUCLEUS	4.422070593491747
INDICATED CONTROL BUFFER	4.422046690719846
COMMON NAME RADIO BUTTON	4.421816774247816
SINGLE BASE PRESENTATION	4.42173479894561
SEQUENTIAL CHROMATOGRAPHY	4.421346312602446
NORTHERN BLOT EXPRESSION	4.421139048879352
DENDRITIC CELL PRECURSOR	4.42099915191076
TRANSCRIPTION CO-ACTIVATOR	4.4208566493944685
NEGATIVE CONTROL REAGENT	4.42073183964074
NUCLEAR           BODIES	4.420652127937475
MODEL MULTIPLE ALIGNMENT	4.420517695227104
MULTIPLE MRNAS ASSOCIATE	4.420517695227104
MULTIPLE KERNEL DOCUMENT	4.420517695227104
SELF-ASSOCIATION SITES MAP	4.4204094180934375
ACTINOPTERYGIAN EVOLUTION	4.419993570781062
SUBSTITUENT	4.4195833959852315
DNA-PROTEIN	4.4195833959852315
SALT WASH	4.4194142975360915
CD68 MUCIN-LIKE MOLECULE	4.419400602769307
DECREASED UBIQUITYLATION	4.4190813878478705
UBIQUITYLATION SUBSTRATE	4.4190813878478705
ANAEROBIC PYRIMIDINE BIOSYNTHESI	4.41888240863293
INCREASING CONTAMINATION	4.4187868740810705
PLASMINOGEN ACTIVATOR INHIBITOR 1 P357	4.418724555561285
INCREASED ADHESIVE STATE	4.418635637281902
TKT LINE CHARACTERIZATION	4.418565676636269
TGFΒ GUIDANCE SYSTEMS ACT	4.418565676636269
CARBOXYL-TERMINAL SEGMENT	4.418565676636269
ULTRASTRUCTURAL EVALUATION	4.418511939068943
MMCOP1 N-TERMINAL REGION	4.418437138982994
N-TERMINAL DELETION GENE	4.418437138982994
MOESIN N-TERMINAL DOMAIN	4.418437138982994
P27 PROTEIN ACCUMULATION	4.418171809757271
PHYLOGENETIC TREE SUBSET	4.418165122795602
S. CEREVISIAE EXPRESSION	4.4181277561670305
PARAMETRIC	4.4180147787886614
COMPLEX TISSUE FORMATION	4.418002421524638
INCREASED BONE FORMATION	4.418002421524638
SATISFACTORY INTERPRETATION	4.417777996143941
DICTATE COMMON STRUCTURE	4.417230979400849
MOTOR NEURON DEVELOPMENT	4.417230102114543
PRO-INFLAMMATORY CYTOKINE	4.417056188540344
MAMMALIAN GROWTH HORMONE	4.41701296574734
INTRALYSOSOMAL PH ELEVATION	4.416772202977248
TRANSFECTED GHFT1-5 CELL	4.416677918715788
APOPTOSI INDUCTION	4.416673023896218
HUMAN LTBP-3 INFORMATION	4.416664343830678
FITC-ACTIN INCORPORATION	4.416388690551407
MACROPHAGE SUBPOPULATION	4.416388690551407
CAUSE LETHALITY COP1 MUTANT	4.416223207540428
CONSTITUTIVE INTERACTION	4.4158658161550015
ANTAGONIZING INTERACTION	4.4158658161550015
DEMONSTRATED INTERACTION	4.4158658161550015
NON-COVALENT INTERACTION	4.4158658161550015
DIPHTHERIA TOXIN CORECEPTOR	4.415850225907779
RHO PROTEIN INACTIVATION	4.41577940235699
INSSUBUNIT	4.415622214990037
HYDROPHOBIC TRANSMEMBRANE	4.415457907027011
ADHESION MOLECULE	4.415388727265691
MNOC RHYTHMIC REGULATION	4.415357213764454
SIGNAL ADHESION INTEGRIN	4.414979989312485
IN VITRO ATPASE ACTIVITY	4.414836924738094
INTERNAL CONTROL PLASMID	4.414732779940411
CONCLUSIONS INACTIVATION	4.414683315596979
VITRONECTIN MOLAR EXCESS	4.414683315596979
ARP2 NUCLEATION ACTIVITY	4.414683315596979
SPONTANEOUS INACTIVATION	4.414683315596979
E. COLI MUTANT PHENOTYPE	4.4146754500686685
AMERSHAM PHARMACIA BIOTECH UK	4.414584168008707
ACTIN FILAMENT FORMATION	4.414530259221302
UNTRANSFECTED GHFT1-5 CELL	4.414349727015215
P53 PROTEIN ACCUMULATION	4.4140075220778545
REMAINING SERINE RESIDUE	4.413962941693815
PH DOMAIN SHARED FEATURE	4.413860170960348
H	4.413783912461857
BAYESIAN SCORE EVALUATION	4.413762759967416
CONCENTRATION MEASUREMENT	4.413459139948954
TRANSIT-LT1 TRANSFECTION	4.413367356970728
MEDIATED CELL ATTACHMENT	4.413191112511854
BLOCKED RASMC ATTACHMENT	4.413191112511854
NONSPECIFIC HYBRIDIZATION	4.41316239538381
CRY TOXIN	4.413078342190602
POLYMERIZATION MACHINERY	4.412645184553882
HETEROGENEOUS COLLECTION	4.412645184553882
PCR AMPLIFICATION PRODUCT	4.412627911515574
GENOMIC CLONE SEQUENCING	4.412407169605318
SINGLE NUCLEOTIDE CHANGE	4.4122283342483835
CELL-SURFACE CD9 ANTIGEN	4.411924147628258
POTENTIAL TARGET ANTIGEN	4.411924147628258
MOUSE-MONKEY CD9 ANTIGEN	4.411924147628258
GENOME SCALE MEASUREMENT	4.411872414665872
MYC EPITOPE TAG SEQUENCE	4.411469339721327
USE CLASSIFICATION ERROR	4.411461059123915
PURIFIED MAPK PREPARATION	4.4114402969729385
OPTIMAL GROWTH PHENOTYPE	4.411136390161189
SEQUENCING REACTION COST	4.410863735427868
BLOCKING ANTIBODY ANTI-Β1	4.410705200284327
PREHYBRIDIZATION SOLUTION	4.410223768737736
MULTIDIMENSIONAL SOLUTION	4.410223768737736
FLUORESCENCE MEASUREMENT	4.410166376528495
MARKOV PROBABILITY TABLE	4.41003496941365
chi-square-based algorithm	4.409771293756111
PROTEIN-FREE PLASMID DNA	4.409462049572288
MUTANT VERSION PH DOMAIN	4.409290299012155
ERK-MEDIATED STIMULATION	4.409092808263979
PROAPOPTOTIC STIMULATION	4.409092808263979
TEMPLATE CHECK ALIGNMENT	4.408904997267349
CROSS-PRODUCT RELATIONSHIP	4.408800110943575
TRANSCRIPTIONAL INITIATION	4.408759779431425
ENRICHED KINASE FRACTION	4.408701459891012
DIFFERENTIAL GENE EFFECT	4.408510419761514
TRNA SECONDARY STRUCTURE	4.408325232886449
TOLERABILITY	4.408188164896947
C-TERMINAL IDENTIFICATION	4.408102179607698
TERMINATION SEQUENCE LEAD	4.407999259964794
WOUND CLOSURE TIME COURSE	4.407999259964794
PREFERENTIAL ASSOCIATION	4.407924513387887
SEMI-QUANTITATIVE ASSESSMENT	4.407844286887643
APOPTOSI REGULATORY STEP	4.407842951012073
SOLUBILITY	4.407655631655102
ΜG/ML ANTI-RHOA ANTIBODY	4.40737980083673
PHYLOGENETIC INFORMATION	4.407209436351659
histone	4.407165719619404
PRELIMINARY RESEARCH RESULT	4.407150544842024
FIBROBLAST INCORPORATION	4.4068446505145715
PULSE PRESSURE ABBREVIATION	4.406737130245924
TERMINAL DIFFERENTIATION	4.406737105303189
INDUCING DIFFERENTIATION	4.406737105303189
SUPPORTS DIFFERENTIATION	4.406737105303189
CLOSE ASSOCIATION	4.40671455164601
NEURONAL FATE EARLY-BORN	4.406424145032803
MYOSIN ATPASE EXPERIMENT	4.4058423695481785
INDICATED OVER-EXPRESSION	4.4058131047913855
HEPES-BUFFERED TCM-199 ΜL	4.405679802646666
WILD-TYPE BOI1 PH DOMAIN	4.405466528606524
HETEROTRIMERIC G PROTEIN	4.405288762485814
CO-SEDIMENTATION BEHAVIOR	4.405050492521592
MAPK POLYCLONAL ANTIBODY	4.404351711818415
DOMINANT-NEGATIVE ALLELE	4.40423789400111
BINDING SITE EPITOPE CD4	4.40423789400111
DATA SETS REPRESENTATIVE	4.40423789400111
CALCIUM	4.404167431744665
OLYMPUS	4.404167431744665
figures	4.404167431744665
subunit	4.404167431744665
GENETIC	4.404167431744665
HORMONAL SIGNAL TRANSDUCTION	4.4036096455969345
MACROPHAGE LPS STIMULATION	4.403561288260252
ANTI-RABBIT SECONDARY AB	4.4034344000321965
U/ML FINAL CONCENTRATION	4.403137710370552
GAG LYASE	4.402782414754181
GERM-LINE TRANSFORMATION	4.402780393313313
MULTIPLE PHOSPHORYLATION	4.402630367648741
DIVISION FURROW DECREASE	4.402588616907025
PORCINE FOLLICULAR FLUID	4.402588616907025
ABSORBANCE LINEAR INCREASE	4.402534415378821
RAS GTPASE KEY COMPONENT	4.401379604426834
polymerase chain reaction	4.400954982183811
GAG LYAS	4.400790490172764
YEAST AC	4.400790490172764
MASS SPECTROMETRY METHOD	4.400756086802486
BINDING SITE NONSPECIFIC	4.400756086802486
WEEK OLD SPRAGUE-DAWLEY RAT	4.400428064018485
NICOTINIC	4.399899555071984
SMAD1 MH2 DOMAIN ABILITY	4.399679891850185
PROBABILITY DISTRIBUTION	4.399660827876051
CONSERVED GLYCINE	4.399447924413013
CYTOKINE GENE EXPRESSION	4.399253403630865
IDO GENE	4.399145971313909
IDO PLAY	4.399145971313909
OUTPUT RELATIVE DEPENDENCE	4.399088282818206
PURIFIED GLYCOSAMINOGLYCAN	4.399088282818206
MNOCMRNA ABUNDANCE RHYTHM	4.398942331389244
INDIVIDUAL AVERAGE COPY	4.398345357077866
FUNCTIONAL BRUSH BORDER	4.398345357077866
EXPERIMENTAL COMPARISON	4.398345357077866
GROUP-SPECIFIC VARIABLE	4.398345357077866
REDUCING PROBE SET SIZE	4.398345357077866
excision repair pathway	4.398345357077866
GARPIKE CLEAVAGE FURROW	4.398345357077866
PROMYELOCYTIC CELL TYPE	4.398345357077866
CELLULAR RESPONSIVENESS	4.398345357077866
MOLECULAR TIME ESTIMATE	4.398345357077866
RASMC CELL SURFACE HSPG	4.398345357077866
DOTMAC-INSOLUBLE PELLET	4.398345357077866
CASPASE-ACTIVATED DNASE	4.398345357077866
PROLIFERATING CELL KI67	4.398345357077866
'-HEXAFLUOROFLUORESCEIN	4.398345357077866
COMPLEMENTARY TECHNIQUE	4.398345357077866
DEVELOPMENTAL CHARACTER	4.398345357077866
PEROXIDASE/FLUORESCENCE	4.398345357077866
CELLULAR MICROEXTENSION	4.398345357077866
MELATONIN OUTPUT RHYTHM	4.398345357077866
UNWINDING G4 QUADRAPLEX	4.398345357077866
FORALL CROSS-VALIDATION	4.398345357077866
SIMPLE LEGO STYLE BLOCK	4.398345357077866
DOTMAC/PFA-TREATED CELL	4.398345357077866
TNF-MEDIATED CELL DEATH	4.398345357077866
P53-MEDIATED CELL DEATH	4.398345357077866
USECLASSIFICATION ERROR	4.398345357077866
PHOSPHODIESTER BACKBONE	4.398345357077866
POTENTIALFALSE-POSITIVE	4.398345357077866
SIGNALING PATHWAYS FALL	4.398345357077866
SYNTHETIC WEIGHT MATRIX	4.398345357077866
PROLONGING GHFT1-5 CELL	4.398345357077866
NEURAL NETWORK SOFTWARE	4.398345357077866
CHROMOSOME CONDENSATION	4.398345357077866
INDEPENDENCE ASSUMPTION	4.398345357077866
GENOME-WIDE SEARCH AHAB	4.398345357077866
DEVELOPMENTAL POTENTIAL	4.398345357077866
CLASSIFICATIONOF GALAXY	4.398345357077866
THIN-SECTION MICROSCOPY	4.398345357077866
INFORMATIVE GENE MARKER	4.398345357077866
GENERALIZABILITYOF BPNN	4.398345357077866
SUPERFICIAL RESEMBLANCE	4.398345357077866
COMMUNICATIONS FUNCTION	4.398345357077866
STUDYING CELL MIGRATION	4.398345357077866
SURFACE RADIOIODINATION	4.398345357077866
FILTER WHEEL CONTROLLER	4.398345357077866
SEALING PODOSOME REGION	4.398345357077866
BLM FUNCTIONAL LOCATION	4.398345357077866
GENE/PROTEIN DIFFERENCE	4.398345357077866
LENS CELL-ECM INTERFACE	4.398345357077866
BINDING SITE OCCURRENCE	4.398345357077866
BRANCHED MICROEXTENSION	4.398345357077866
ENDOTHELIAL CELL LINING	4.398345357077866
GROUP-SPECIFIC VARIANCE	4.398345357077866
INCLUDING PARP CLEAVAGE	4.398345357077866
DATABASE SCHEMA ATCISDB	4.398345357077866
ORIGINAL IMPLEMENTATION	4.398345357077866
CELLULAR SUSCEPTIBILITY	4.398345357077866
FLUORESCEIN FLUOROPHORE	4.398345357077866
IMAGING DEVICE PHOSPHOR	4.398345357077866
ARABIDOPSIS TF FUNCTION	4.398345357077866
TBID-IMMUNOGOLD COMPLEX	4.398345357077866
PROTEIN-FREE IVM MEDIUM	4.398345357077866
CONVENTIONAL MICROSCOPY	4.398345357077866
REVERSE BUSM COORDINATE	4.398345357077866
PROTEOLYSIS-STIMULATION	4.398345357077866
NON-SPECIFIC SIMILARITY	4.398345357077866
PERFORMING DENSITOMETRY	4.398345357077866
CAENORHABDITIS BRIGGSAE	4.398345357077866
AFFYMETRIX NOMENCLATURE	4.398345357077866
VECTOR-TRANSFECTED CELL	4.398345357077866
SPATIO-TEMPORAL PATTERN	4.398345357077866
C/EBPΑ INTERNAL SEGMENT	4.398345357077866
IN VITRO GST-P35-C/EBPΒ	4.398345357077866
THIN-SECTIONED MATERIAL	4.398345357077866
ASSOCIATED GENE PROFILE	4.398345357077866
MESENCHYME MORPHOGENESI	4.398345357077866
GRAPHPAD PRIZM SOFTWARE	4.398345357077866
YEAST PROTEOME DATABASE	4.398345357077866
TRANSFERRING ANNOTATION	4.398345357077866
FUTURE FOREBRAIN REGION	4.398345357077866
INTER-PATIENT VARIATION	4.398345357077866
BPAEC-COVERED COVERSLIP	4.398345357077866
DEVELOPING CILIARY BODY	4.398345357077866
ATOMIC FORCE MICROSCOPY	4.398345357077866
IDENTIFYING SPECIFICITY	4.398345357077866
LAMELLIPODIUM EXTENSION	4.398345357077866
2-D PHASE DIAGRAM SCORE	4.398345357077866
EXHIBITED FRAGMENTATION	4.398345357077866
DEVELOPING GUT ENDODERM	4.398345357077866
CARBOXYLTERMINAL REGION	4.398345357077866
MYELO-MONOCYTIC LINEAGE	4.398345357077866
INVESTIGATING LYSOSOMAL	4.398345357077866
SOFTWARE IMPLEMENTATION	4.398345357077866
COOLED INTERLINE CAMERA	4.398345357077866
NEURAL NETWORK STRATEGY	4.398345357077866
ARP2 POSSIBLE MECHANISM	4.398345357077866
BACKGROUND FLUORESCENCE	4.398345357077866
ASYNCHRONOUS LNCAP CELL	4.398345357077866
EXTRACTION SUBCONFLUENT	4.398345357077866
POWERBLOT WESTERN ARRAY	4.398345357077866
COLD WATER FISH GELATIN	4.398345357077866
POSITIONED HEAD-TO-HEAD	4.398345357077866
FREQUENCY WEIGHT MATRIX	4.398345357077866
STRUCTURE CHARATERISTIC	4.398345357077866
STATISTICAL CORRELATION	4.398345357077866
MUTUAL EXCHANGE PATTERN	4.398345357077866
RETURNED ESTROGEN LEVEL	4.398345357077866
SPARC CAUSES ALTERATION	4.398345357077866
TRIAL-AND-ERROR PROCESS	4.398345357077866
F-ΔN3 IMMUNOPRECIPITATE	4.398345357077866
GRK/Β ARRESTIN PARADIGM	4.398345357077866
THEOPTIMAL ARCHITECTURE	4.398345357077866
SIGNATURE GENE GROUPING	4.398345357077866
OUTPUT FIELD SORT ORDER	4.398345357077866
CIRCULAR EXCISION WOUND	4.398345357077866
STANDARD TRYPSINIZATION	4.398345357077866
GLUTARALDEHYDE FIXATIVE	4.398345357077866
ANTI-APOPTOTIC GENE A20	4.398345357077866
MULTIDIMENSIONAL OBJECT	4.398345357077866
NON-SPECIFIC GENE PROBE	4.398345357077866
CENTROSOMAL SEGREGATION	4.398345357077866
POSITIVE/NEGATIVE RATIO	4.398345357077866
DARK-FIELD ILLUMINATION	4.398345357077866
EVOLUTIONARY CONSTRAINT	4.398345357077866
SUBNUCLEAR ARCHITECTURE	4.398345357077866
Β-GALATOSIDASE ACTIVITY	4.398345357077866
P53-INDEPENDENT PATHWAY	4.398345357077866
MATERNAL/GAP GENE INPUT	4.398345357077866
CELL FATE SPECIFICATION	4.398345357077866
NITROCELLULOSE MEMBRANE	4.398345357077866
PROPOSED IMPLEMENTATION	4.398345357077866
FLUORESCENCE MICROSCOPE	4.398345357077866
NEURAL CREST DERIVATION	4.398345357077866
REGENERATION EPITHELIUM	4.398345357077866
INCLUDING P. FALCIPARUM	4.398345357077866
ESTRADIOL-TREATED FEMUR	4.398345357077866
COMMERCIALBPNN SOFTWARE	4.398345357077866
PRODUCTION/ACCUMULATION	4.398345357077866
DISCOIDEUM CELLS DIVIDE	4.398345357077866
MANUFACTURERS DIRECTION	4.398345357077866
PRESUMED CENTROMERIC G1	4.398345357077866
COMMERCIAL FORMALDEHYDE	4.398345357077866
CATASTROPHIC DISRUPTION	4.398345357077866
STRUCTURE-FUNCTION DATA	4.398345357077866
PHYSIOLOGICAL REGULATOR	4.398345357077866
ELUTE IMMUNOPRECIPITATE	4.398345357077866
MARKOV CHAIN TRANSITION	4.398345357077866
CYLINDRICAL SHAPE STAGE	4.398345357077866
CHARGED HEPARAN SULFATE	4.398345357077866
UNIDIRECTIONAL DISTANCE	4.398345357077866
PHOSPHOROLYTIC CLEAVAGE	4.398345357077866
FLAG-COP1 CO-EXPRESSION	4.398345357077866
VICARIANCE BIOGEOGRAPHY	4.398345357077866
COMPLEX DE-LOCALIZATION	4.398345357077866
MESODERM CELL MIGRATION	4.398345357077866
PUTATIVE ANTIGENIC SITE	4.398345357077866
EQUIVALENT PRESENTATION	4.398345357077866
MULTIPLE-STEP PROCEDURE	4.398345357077866
CHARACTERIZING MUTATION	4.398345357077866
CORRECTED NLS-GFP IMAGE	4.398345357077866
ACTIN-DEPENDENT PROCESS	4.398345357077866
PROSTATE CANCER PATIENT	4.398345357077866
GRAM-NEGATIVE BACTERIUM	4.398345357077866
ALLINPUT SQUARED WEIGHT	4.398345357077866
MDM2 RING FINGER DOMAIN	4.398345357077866
EXPERIMENTAL LITERATURE	4.398345357077866
HARDY-WEINBERG EQUATION	4.398345357077866
CONSTITUTIVE INTERACTOR	4.398345357077866
TIME-DEPENDENT INCREASE	4.398345357077866
MITOCHONDRIAL PERIPHERY	4.398345357077866
HERITABILITY VALUESWILL	4.398345357077866
OSTEOGENIC CELL LINEAGE	4.398345357077866
AFFYMETRIX YG_S98 ARRAY	4.398345357077866
AFFYMETRIX ARRAY RESULT	4.398345357077866
RHOA EXCLUSIVE FUNCTION	4.398345357077866
COATED COVERSLIP MM PLL	4.398345357077866
TGF-Β SIGNALING PATHWAY	4.398345357077866
MODIFIED TROWELL METHOD	4.398345357077866
UNGAPPED SEED ALIGNMENT	4.398345357077866
STATISTICAL UNCERTAINTY	4.398345357077866
INCLUDING SURFACE LAYER	4.398345357077866
CHALLENGING ENVIRONMENT	4.398345357077866
SPHERICAL OPTIC VESICLE	4.398345357077866
HIERARCHICAL COMPARISON	4.398345357077866
HUMAN FIBROSARCOMA CELL	4.398345357077866
PROTEIN-INTERACTION SET	4.398345357077866
REDUCED GTPASE ACTIVITY	4.398345357077866
NON-CANONICAL BASE PAIR	4.398345357077866
DIFFERENT C/EBPΑ DOMAIN	4.398345357077866
marrow microenvironment	4.398345357077866
WTPAI-1 HARVESTING TIME	4.398345357077866
SPONTANEOUS OSCILLATION	4.398345357077866
PURPLE FORMAZAN PRODUCT	4.398345357077866
SYNAPTOJANIN IPP DOMAIN	4.398345357077866
COREGENE MATCHING VALUE	4.398345357077866
OBSERVED MICROEXTENSION	4.398345357077866
DORSAL CUTANEOUS BIOPSY	4.398345357077866
NORMALIZATION TECHNIQUE	4.398345357077866
SHOULDBE FUNCTIONAL SNP	4.398345357077866
GENE-GENE INTERACTIONSA	4.398345357077866
SIGNALING ACTIVITY DFZ2	4.398345357077866
SUBGERMINAL CAVITY ROOF	4.398345357077866
CYTOSKELETON-MODULATING	4.398345357077866
BIDIRECTIONAL GENE PAIR	4.398345357077866
CCAF-INDUCED DIFFERENCE	4.398345357077866
F-ACTIN-RICH PROTRUSION	4.398345357077866
OPTIMAL ARCHITECTUREFOR	4.398345357077866
INITIALIZATION APPROACH	4.398345357077866
MELATONIN NORMAL RHYTHM	4.398345357077866
INTRA-PATIENT VARIATION	4.398345357077866
CANONICAL WNT/Β-CATENIN	4.398345357077866
OTHER TCF FAMILY MEMBER	4.398345357077866
TIRF-RESOLVED STRUCTURE	4.398345357077866
OSTEOGENESIS IMPERFECTA	4.398345357077866
MACINTOSH IIVX COMPUTER	4.398345357077866
HYOBRANCHIAL PHARYNGEAL	4.398345357077866
HEURISTIC NORMALIZATION	4.398345357077866
REGULATORY PROTEIN-LIKE	4.398345357077866
PROLIFERATIVE EPIDERMAL	4.398345357077866
FILAMENT POLYMERIZATION	4.398345357077866
5'TCGACATTGACCAGGCGAT3'	4.398345357077866
FILAMENT ASSEMBLY LEVEL	4.398345357077866
POSTERIOR TM DIFFERENCE	4.398345357077866
ROLLER PERISTALTIC PUMP	4.398345357077866
POOLING STRATEGY RRNAS,	4.398345357077866
HIS-UB MOLECULAR WEIGHT	4.398345357077866
MASSIVELY-PARALLEL GENE	4.398345357077866
MATΑ URA3 LEU2 HIS3 GAL	4.398345357077866
5'GGGATACTGCTATTTGCAT3'	4.398345357077866
NF-ΚB-INHIBITED EXPLANT	4.398345357077866
L-Α-PHOSPHATIDYLCHOLINE	4.398345357077866
'-GTTTGGAAGAGGCTTCAAC-3	4.398345357077866
APPROPRIATEARCHITECTURE	4.398345357077866
SUPRIM SOFTWARE PACKAGE	4.398345357077866
PHYSIOLOGICAL CONDITION	4.398345357077866
PROGRESSIVE CONTRACTION	4.398345357077866
STREPTAVIDIN-PEROXIDASE	4.398345357077866
ELK-1 TCF FAMILY MEMBER	4.398345357077866
CONCERNING LAMELLIPODIA	4.398345357077866
TGF-Β FAMILY TRANSCRIPT	4.398345357077866
MAINTAINABILITY QUALITY	4.398345357077866
MULTIFUNCTIONAL COMPLEX	4.398345357077866
UNDERGOING CHEMOTHERAPY	4.398345357077866
MODERN BIOPHYSICAL TOOL	4.398345357077866
HSN3 PRE-ASSEMBLED FORM	4.398345357077866
DETERMININGSIGNIFICANCE	4.398345357077866
STEROID-RESPONSIVE GENE	4.398345357077866
DIVERSE STRUCTURE MODEL	4.398345357077866
LONGITUDINAL EXPERIMENT	4.398345357077866
DIFFERENT SET CONDITION	4.398345357077866
TCF FAMILY MEMBER ELK-1	4.398345357077866
PERFORMED EXPERIMENT YM	4.398345357077866
INTERMEDIATE CELL SHAPE	4.398345357077866
differential expression	4.398345357077866
microscopic observation	4.398345357077866
SMAD7 PROMOTOR ACTIVITY	4.398345357077866
CHROMOSOME CONSTITUTION	4.398345357077866
DEMONSTRATED DIFFERENCE	4.398345357077866
MACHINE LEARNING METHOD	4.398345357077866
TARGETING STRATEGY LOXP	4.398345357077866
GLUTARALDEHYDE FIXATION	4.398345357077866
PRESERVE MICROEXTENSION	4.398345357077866
GROWING THROMBOTIC PLUG	4.398345357077866
MINIMUM ERROR RATE AREA	4.398345357077866
STREPTAVIDIN CONJUGATED	4.398345357077866
FEEDBACK LOOP MECHANISM	4.398345357077866
ANTI-APOPTOTIC FUNCTION	4.398345357077866
BLASTOCYST-DERIVED CELL	4.398345357077866
DIRECTIONAL CONCORDANCE	4.398345357077866
NUMEROUS INCLUSION BODY	4.398345357077866
MHCK-C CATALYTIC DOMAIN	4.398345357077866
BACKPROPAGATION NETWORK	4.398345357077866
D. DISCOIDEUM MYOSIN-II	4.398345357077866
CELLOIDIN-IMBEDDED HAND	4.398345357077866
MIB-ARRESTED LNCAP CELL	4.398345357077866
probability calculation	4.398345357077866
MICROTRABECULAR LATTICE	4.398345357077866
MOUSE ANTI-HUMAN TIMP-1	4.398345357077866
GRANULATION-LIKE TISSUE	4.398345357077866
COMPARATIVE METHOD QRNA	4.398345357077866
AFFYMETRIX RATIO METHOD	4.398345357077866
CONTAINING FORMALDEHYDE	4.398345357077866
TPI OPTIMAL UTILIZATION	4.398345357077866
SIGNALING PATHWAY TGF-Β	4.398345357077866
UNTANGLE INVASIVE EVENT	4.398345357077866
ELECTRONIC COMPENSATION	4.398345357077866
PLASMID DNA TOTAL AMOUNT	4.398185380974345
DIFFERENTIAL GROWTH RATE	4.398123904490817
submicromolar	4.3978822892708225
(D)WITHDRAWAL	4.3978822892708225
thermodynamic	4.3978822892708225
NEO EXPRESSION CASSETTE	4.3978435897964205
AFFECTED TAG EXPRESSION	4.3978435897964205
FORELIMB AER EXPRESSION	4.3978435897964205
REDUCED WOX1 EXPRESSION	4.3978435897964205
SHOWED EXPRESSION LEVEL	4.3978435897964205
MEASURED TAG EXPRESSION	4.3978435897964205
TARGET G PROTEIN SUBUNIT	4.397697402793343
RECONSTITUTE EXPRESSION	4.397592706155699
CLOCK ANALYSES ANALYSIS	4.39742258386579
INCREASE ANALYSIS SPEED	4.39742258386579
NEURAL NETWORK ANALYSIS	4.39742258386579
STRUCTURAL RNA EVOLUTION	4.397416205284977
IMMUNOCHEMICAL ANALYSIS	4.396961197259752
TRANSCRIPTOMIC ANALYSIS	4.396961197259752
NEN LIFE SCIENCE PRODUCT	4.396828316424471
NORMAL ANDROGEN CONTROL	4.39658130914253
LIMIT FOLD CHANGE MODEL	4.396442137327958
TWO-HYBRID SCREEN STUDY	4.396440185307702
GIBBS SAMPLER ALGORITHM	4.396321890328509
ALOCAL SEARCH ALGORITHM	4.396321890328509
DISASSEMBLING MYOSIN II	4.396288277924034
PHOSPHORYLATE MYOSIN II	4.396288277924034
DICTYOSTELIUM MYOSIN II	4.396288277924034
PULLING FILAMENT MYOSIN	4.396288277924034
H-RA CONTROL EXPRESSION	4.396079541861084
RRNA REFERENCE SEQUENCE	4.395991057361884
ZYGOTIC GAP GENE FACTOR	4.395959814514626
REDUCED KINASE ACTIVITY	4.395959303801167
KINASE CATALYTIC DOMAIN	4.395959303801167
HERPES THYMIDINE KINASE	4.395959303801167
ENDOGENOUS LEVEL CHANGE	4.3958077307446555
IN VITRO ACTIN ASSEMBLY	4.395772583565526
P35 BIND	4.395757265786571
POSSIBLE OSMOTIC EFFECT	4.395653266533069
INDEPENDENT MAIN EFFECT	4.395653266533069
TYROSINE ELEVATED LEVEL	4.395568761448703
RNA STEM LOOP STRUCTURE	4.3951733241613535
NORMALIZATION FACTOR NF	4.395164633660212
GDP-GTP EXCHANGE FACTOR	4.395164633660212
INCREASED AZT RESISTANCE	4.3951402687401915
LACKED FILOPODIAL ACTIN	4.394914992394745
ORIENTED ACTIN FILAMENT	4.394914992394745
AFFECTING ACTIN DYNAMIC	4.394914992394745
TARGETING VECTOR ROSA26	4.3948471603247405
PROTEIN IMPORT MACHINERY	4.394835482836005
SERINE-THREONINE KINASE	4.394766277162818
TEMPORAL CO-LOCALIZATION	4.394700769935316
RT-PCR	4.394676677048082
BLM C-TERMINAL MUTATION	4.394659756927251
HUMAN GENOMIC VARIATION	4.394659756927251
SURVIVAL PROBABILITY PLOT	4.394499690839365
L929 CELL PROLIFERATION	4.3944754769197205
TRANSCRIPTION REGULATION	4.394393222272782
IMMUNOFLOURESCENCE FIXED	4.394251611816048
REGULATING P53 FUNCTION	4.394231198770203
PHOSPHATE-BUFFERED SALINE	4.394192656714217
CONSERVED RNA STRUCTURE	4.394115979855849
PREDICTED RNA STRUCTURE	4.394115979855849
ΔN4 FUSION PROTEIN SHOW	4.393997685981529
MAJOR HSPG CORE PROTEIN	4.393997685981529
ALA MYOSIN-II ENRICHMENT	4.393792472405241
ALL-OR-NOTHING RESPONSE	4.393630782265912
SEQUENCE UNIT COMPONENT	4.393508006880184
WNT CANDIDATE COMPONENT	4.393508006880184
SIGNALING COMPONENT DSH	4.393508006880184
ORDER PATHWAY COMPONENT	4.393508006880184
DISCUSSION MITOCHONDRIA	4.393405084535552
WARMED SAMPLE SOLUTION UL	4.393261889344054
CHICKEN TYROSINE KINASE	4.393182708172005
INFLUENZA SELECTION MAP	4.393142156865233
DNA HELICAS RECQ FAMILY	4.393116859832469
BINDING DOMAIN LEXA DNA	4.393116859832469
RECQ FAMILY DNA HELICAS	4.393116859832469
BINDING DYE HOECHST DNA	4.393116859832469
CONTROL PEGFP-N1 VECTOR	4.393083112389403
HUMAN THROMBIN RECEPTOR	4.3929611759882725
GNRH RECEPTOR TRANSDUCE	4.3929611759882725
TRANSCRIPTIONAL CASCADE	4.3929455242990585
GAL4-DEPENDENT PROMOTER	4.392849669279316
AGGREGATING PROTEOGLYCAN	4.392842888623798
transcription regulation	4.392842888623798
ADDITIONAL DOCUMENTATION	4.392842888623798
C-TERMINAL LEUCINE-RICH	4.392816956851943
FAVOR CELL CYCLE ARREST	4.392783852658974
INDUCED TNF SENSITIVITY	4.3927164404842
MICROPODIA CYTOSKELETON	4.392716440484199
CYTOSKELETON TRANSCRIPT	4.392716440484199
SEQUENCE W. TAIL SYMBOL	4.392612201288021
NOVEL PROTEIN SUBFAMILY	4.39254846228275
RGS3 FUNCTIONAL PROTEIN	4.39254846228275
RSG3-GST FUSION PROTEIN	4.39254846228275
OTHER PRO-DEATH PROTEIN	4.39254846228275
LIM HOMEODOMAIN PROTEIN	4.39254846228275
BOI1 NTERACTING PROTEIN	4.39254846228275
INCREASED PROTEIN LEVEL	4.39254846228275
GFP-N280 FUSION PROTEIN	4.39254846228275
PRO-DEATH BCL-2 PROTEIN	4.39254846228275
GST-3FN1 FUSION PROTEIN	4.39254846228275
PROTEIN FAMILY DATABASE	4.39254846228275
ANALYZING YEAST PROTEIN	4.39254846228275
RECEPTOR-G PROTEIN PAIR	4.39254846228275
SPLICESOMAL RRNA INTRON	4.392541582012004
DECREASED PROLIFERATION	4.392540536840648
PROLIFERATION CANDIDATE	4.392540536840648
MUTANT GTPASES FUNCTION	4.392325543498528
TRANSLATED ELK-1 MUTANT	4.392325543498528
ANTI-PHOSPHORYLATED P53	4.392174119616372
TECHNOLOGICAL IMPROVEMENT	4.392149634957582
HUVEC CULTURE SUPERNATANT	4.392149634957582
BPAEC INCREASED ADHERENCE	4.392149634957582
MOUSE DERMAL FIBROBLAST	4.392059257328594
NORMAL HUMAN FIBROBLAST	4.392059257328594
RGS3 PROTEIN EXPRESSION	4.392046695001305
BASE VECTOR CONSTRUCTION	4.39202959562671
HUMAN PROTEIN HOMOLOGOUS	4.391952095262798
MRNA EXPRESSION PROFILE	4.3918126077317785
D. DISCOIDEUM CELLS USE	4.391804714557057
TRITON X-100 EXTRACTION	4.391758327021448
SALMONELLA TYPHI GENOME	4.3916635496105645
FLOW CYTOMETRY ANALYSIS	4.3915812553251925
DECREASED DNA SYNTHESIS	4.391374027417338
DNA DECREASED STABILITY	4.391374027417338
DNA STRAND-BREAK REPAIR	4.391374027417338
REGULATORY DNA SEQUENCE	4.391374027417338
CAUSE DNA FRAGMENTATION	4.391374027417338
DECREASED DNA STABILITY	4.391374027417338
ORDER-FREE MARKOV TABLE	4.39106087678018
MARKOV TRANSITION TABLE	4.39106087678018
BINDINGSITE TABLE STORE	4.39106087678018
ARABIDOPSIS THALIANA COP1	4.391001111406335
CORRESPONDING M/Z VALUE	4.390974156776636
POSTERIOR ADULT MESHWORK	4.390808066234992
HSP90 CHAPERONE FUNCTION	4.390808066234992
ADULT IRIDOCORNEAL ANGLE	4.390808066234992
CASPASE GENE EXPRESSION	4.390807444054338
DEXAMETHASONE TREATMENT	4.390763551053744
CODING SELECTION SYMBOL	4.3907011493580725
OXIDATIVE BURST RESPONSE	4.390611125726296
ANTI-VINCULIN MOUSE MAB	4.390507625112002
MUTATOR OLIGONUCLEOTIDE	4.39040714136885
PERIPHERAL BLOOD T CELL	4.390338708474806
TRANSCRIPTIONAL CONTROL	4.390299452396053
(GPI)-ANCHORED RECEPTOR	4.390269085443475
FLUORESCENCE ACTIVATION	4.389785253502245
ASYMMETRIC DISTRIBUTION	4.389785253502245
POPULATION DISTRIBUTION	4.389785253502245
GFP-MHCK-A DISTRIBUTION	4.389785253502245
UNDERLYING DISTRIBUTION	4.389785253502245
TRANSCRIPT DISTRIBUTION	4.389785253502245
P53-REPORTER ACTIVATION	4.389785253502245
GSK3Β PEPTIDE SUBSTRATE	4.389705624631773
LYSOSOMAL PH MEASUREMENT	4.389683653510743
KINESIN-RELATED PROTEIN	4.389650014885192
NON-INTERACTING PROTEIN	4.389650014885192
AUTOFLUORESCENT PROTEIN	4.389650014885192
USE PENETRANCE FUNCTION	4.389624500383453
AMPLIFIED CDNA FRAGMENT	4.389541838234691
CD9 CDNA REPRESENTATION	4.389541838234691
ENCODING PROHB-EGF CDNA	4.389541838234691
ENDOTHELIAL CELL DAMAGE	4.3891038522225925
GENERATING CONSERVATION	4.389057644698316
INHIBITED CELL ADHESION	4.388963829421756
CHEMOATTRACT FIBROBLAST	4.388916207453958
MISMATCH-FREE GENE CHIP	4.388819498227046
G418 CONTINUOUS PRESENCE	4.388712099637439
PRIMARY CANCER SPECIMEN	4.388708301431122
C-TERMINAL ELK-1 MUTANT	4.388639943347913
SEQUENCES REPRESENTATIVE	4.388569761607306
COMPARABLE RESULT	4.388525295764347
CELLULAR ACTIVITY	4.388525295764347
STRUCTURAL DOMAIN	4.388525295764347
REGULATORY DOMAIN	4.388525295764347
SCALE-INDEPENDENT	4.388525295764347
GRAPHPAD SOFTWARE	4.388525295764347
MEMORY COMPLEXITY	4.388525295764347
ASSEMBLY PROPERTY	4.388525295764347
TRANSGENIC ANIMAL	4.388525295764347
BIOLOGICAL SYSTEM	4.388525295764347
BACKGROUND NOISE	4.388282270001747
TRANSCRIPT LEVEL	4.388282270001747
MECHANICAL FORCE	4.388282270001747
GOAT ANTI-RABBIT	4.388282270001747
P53-GST PHOSPHORYLATION	4.3881109632712
AS3 OVEREXPRESSION MIMIC	4.388094969716585
CONTROL OLIGONUCLEOTIDE	4.387761069465844
OLIGONUCLEOTIDE CONTROL	4.387761069465844
ACTIN DEPENDENT PROCESS	4.38775683256465
COLI GENOME PROJECT HTTP	4.387657503936052
CIRCADIAN TRANSCRIPTION	4.387620515992936
EPR TUBE	4.387502777793214
E. COLI KNOCKOUT STRAIN	4.387312081733366
TESTED INDIVIDUAL CODON	4.387288556626022
BMP RECEPTOR ACTIVATION	4.387254440271191
Α- 32P	4.386998062766079
CASEIN	4.386998062766079
BINNED	4.386998062766079
OBJECT	4.386998062766079
TRIZOL	4.386998062766079
MCI/ML	4.386998062766079
EXPORT	4.386998062766079
caudal	4.386998062766079
ESCAPE	4.386998062766079
ENDING	4.386998062766079
P27 ACCUMULATION RESULT	4.38694939096799
QUASI INDEPENDENT MOTIF	4.386879045498175
EPITHELIAL CELL NUCLEUS	4.3868078261715935
ANTI-LAMIN A/C ANTIBODY	4.386699322746143
GEL ELECTROPHORESIS TBID	4.386642017012564
PROMOTING S PHASE ENTRY	4.386538943036066
MM Β-GLYCEROL PHOSPHATE	4.386495006354358
TM DEVELOPMENT PROCEEDS	4.3863224284312
SHOWED DYNAMIC MOTILITY	4.386204556581723
RADIOGRAPHIC EXAMINATION	4.386095845966179
CCAF C-TERMINAL PEPTIDE	4.386020024481159
HYPERVARIABLE REGION V3	4.3859617405718
DAMAGE RESPONSE PATHWAY	4.385960802347957
ACTIN MRNA LOCALIZATION	4.385708724046496
REPORTER GENE DEPENDENT	4.385707720917653
LIPID METABOLISM RESULT	4.38553471931297
CONTROL WILD-TYPE MOUSE	4.385524508690684
TRIZOL REAGENT PROTOCOL	4.385445756550714
G/L YEAST NITROGEN BASE	4.385445756550714
SPECIALIZED GROWTH CONE	4.385391783326751
MAINTAINING CELL GROWTH	4.385391783326751
NORMALIZED GROWTH YIELD	4.385391783326751
CONTROLLING CELL GROWTH	4.385391783326751
INHIBITING LEVEL GROWTH	4.385391783326751
USE SELF-ORGANIZING-MAP	4.3852640720362475
ARP3 IMMUNOFLUORESCENCE	4.3852640720362475
INTRACELLULAR COMPONENT	4.384938528880979
PROBENECID	4.384893964983856
ELECTRON TRANSFER CHAIN	4.384884904353881
EMITTING SINGLE RESIDUE	4.384672594374008
AFFYMETRIX U95 CHIP USE	4.384660320418941
HYAL1 GENE INACTIVATION	4.384585783182237
H DLA DX2 MUTANT EMBRYO	4.384413788508542
POLYCLONAL TRANSDUCTANT	4.384056568801636
SENSE STRAND GAD1 PROBE	4.384056568801636
NON-MUSCLE MYOSIN	4.383720915458588
COS-7 CELL TRANSFECTION	4.3837190383699145
DNA-BINDING DYE HOECHST	4.383602956475407
LEXA DNA-BINDING DOMAIN	4.383602956475407
MULTIPLE COPY OCCURENCE	4.383470142055565
CONTAINING MULTIPLE TPR	4.383470142055565
PROLIFERATION ASSAY E15	4.383458024512189
MURINE ARRAY EXPERIMENT	4.383425337191039
NORMAL AXON GUIDANCE CUE	4.3833470508093715
PLM TOUCH RECEPTOR AXON	4.383250420808826
CAS SD GENERATED FUSION	4.383243385729005
DICHROISM	4.383126553284652
CYTOLYTIC EFFECTOR CELL	4.3828658364452835
ONE-STEP RT-PCR TEMPLATE	4.382791443277676
INCREASED TNF CYTOTOXIC	4.382729652979307
CATIONIC DETERGENT DOTMAC	4.382243619328075
CONFIDENCE RATING SYSTEM	4.382235835745981
EPIDERMAL GROWTH FACTOR	4.382211059909097
SINGLE PARAMETER CHANGE	4.3821349680407975
CONTAINING LACZ ES CELL	4.382051124833042
EXON RRNA INTRONS TABLE	4.382010671695507
MULTIFUNCTIONAL CYTOKINE	4.381854847724247
DIGESTION REACTION ALIQUOT	4.3818187538584334
SIMULATED CONTAMINATION	4.381760156400099
WILD-TYPE GFP-MYOSIN-II	4.381760156400099
MULTIPLE CYCLES CONTROL	4.3817060941202275
N-TERMINAL BLM DELETION	4.381414631385979
ELK-1 N-TERMINAL DOMAIN	4.381414631385979
OTHER N-TERMINAL DOMAIN	4.381414631385979
INCREASING ACCUMULATION	4.381251407913052
NEURAL PRECURSOR SUBSET	4.38114588970833
CONTROLLING TRANSLATION	4.38114588970833
SHARED MUTANT PHENOTYPE	4.381135528583409
RUFFED BORDER FORMATION	4.380985147022633
PERMEABILIZATION BUFFER	4.380944490792996
LIPOPOLYSACCHARIDE NG/ML	4.38087813297762
INDUCTION	4.380813400536456
TOTAL CELL VOLUME RATIO	4.380754992722659
ANNOTATING TRANSFER RNA	4.380655527131864
DEGRADING ENZYME MATRIX	4.380581972745395
FUNCTIONAL AREAS COMMON	4.380222991459233
COMMON CHEMICAL FEATURE	4.380222991459233
COMMON TARGET INTENSITY	4.380222991459233
EMERSION PHASE OBJECTIVE	4.379865243610748
OTHER DNA REPAIR ENZYME	4.379794321583116
CELL CYTOSKELETON	4.379760941388389
U/ML CHONDROITINASE ABC	4.379582301765645
PROTEIN PHOSPHORYLATION	4.379415621078526
MYRISTATE INCORPORATION	4.379390842017561
DFZ2 EXPRESSION PLASMID	4.379017145783821
OVERLAPPING CLONE	4.378948352240949
N BINARY REPRESENTATION	4.378922939680381
HETEROTYPIC INTERACTION	4.378874261942542
CELL-MATRIX INTERACTION	4.378874261942542
INCLUDING RIBOSOMAL RNA	4.378636459223267
GEL FILTRATION ANALYSIS	4.3785642846179735
CONTROL INTERACTION MAP	4.378397378839681
RNA POLYMERASE PROMOTER	4.3783902238608645
TRANSGENIC STRAIN	4.378269136388226
LYMPHOCYTE CYTOSKELETON	4.377736259226862
HOMOZYGOUS INACTIVATION	4.377705996234423
III1-C SEPHAROSE COLUMN	4.377705996234423
MAIN EFFECTSWHEN ALLELE	4.377705996234423
ELEVATED BASELINE LEVEL	4.377705996234423
SIGNALING MOLECULE	4.377679541831715
BONDING DISTANCE HYDROGEN	4.377474056247201
FUNDAMENTAL PHYSICOCHEMICAL	4.377294821184544
Γ-PHOSPHATE	4.377292656349333
DENOMINATOR	4.377292656349333
ACETYLTRANSFERASE REPORTER	4.37722592636342
SERINE PROTEASES DOMAIN	4.376994294136373
CYTOPLASMIC BULK TURNOVER	4.376962712041265
SUPERFECT	4.376836677614402
NON-MAMMALIAN VERTEBRATE	4.376818662311953
INDIVIDUAL TRANSFECTION	4.376405879015938
NOVAFECTOR TRANSFECTION	4.376405879015938
GFP-C/EBPΑ TRANSFECTION	4.376405879015938
TOUCH RECEPTOR-SPECIFIC	4.376231756174177
BLOCKED CELL ATTACHMENT	4.376231756174177
IMPAIRED NFΚ B FUNCTION	4.376231756174177
VECTOR TRANSFECTED CELL	4.376178391722631
INDEPENDENT REPLICATION	4.375412733918485
GLUTATHIONE AGAROSE BEAD	4.375339691004758
CONCENTRATION MYOSIN II	4.375299097405279
NUCLEOLAR ANTIGEN ANA-N	4.374980042915477
NEUTRALIZING DETERMINANT	4.374923323715929
HISTONE ACETYLTRANSFERASE	4.3747362366336375
ADAPTOR PROTEIN P130 CA	4.37452345034699
RNA ISOLATION TOTAL RNA	4.374410926889633
PROTEIN INTERACTION MAP	4.374364531979902
NCRNA SEQUENCE FRACTION	4.374182202919688
PARAFORMALDEHYDE ABSENCE	4.374180660429323
ENHANCED P21 INHIBITION	4.3740637560855795
MITOCHONDRIAL PROTEIN ΜG	4.373301354533789
FN SUPPORT ACCUMULATION	4.373189817072361
MULTIPLE PATHWAY	4.373129223701164
SERINE PROTEINASE INHIBITOR	4.372951798583537
matrix protein synthesis	4.372901629213502
DAUGHTER CELL SEPARATION	4.372901629213502
WILDTYPE POLYUBIQUITYLATION	4.3726681726177565
PHOSPHORYLATE EXOGENOUS	4.372546156023562
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY	4.372411835376253
DNA ISOLATION TOTAL RNA	4.37235446256075
AUTOPHAGOSOME FORMATION	4.372305041995017
COMPLEMENTARY DNA	4.372243511534701
COOPERATIVE STIMULATION	4.372182786994628
CONTAINING UNINFECTED SF9	4.372156946878577
EXTERNAL PROBE TEMPLATE	4.371997236852194
ACTIVATED PROTEIN KINAS	4.371909101439307
CA INCREASED EXPRESSION	4.371877942283702
PROBABILITY DETERMINATION	4.371789444730928
ONCOGENE RESEARCH PRODUCT	4.37168006153557
NUCLEIC ACID SEQUENCING	4.371505360604772
CODON-CODON PROBABILITY	4.371424451629896
M/Z VALUE MANUAL BINNING	4.371222900742738
RAB5	4.3709581702175635
CED9	4.3709581702175635
P122	4.3709581702175635
RELA	4.3709581702175635
RMSD	4.3709581702175635
PPAS	4.3709581702175635
RAC2	4.3709581702175635
TAIR	4.3709581702175635
SMAI	4.3709581702175635
N3-F	4.3709581702175635
RAB6	4.3709581702175635
BGJB	4.3709581702175635
USES	4.3709581702175635
AMIA	4.3709581702175635
LIM5	4.3709581702175635
NADP	4.3709581702175635
IM/S	4.3709581702175635
OMIC	4.3709581702175635
RGS7	4.3709581702175635
ZVAD	4.3709581702175635
DIFF	4.3709581702175635
FALL	4.3709581702175635
LLNL	4.3709581702175635
V333	4.3709581702175635
TIRF	4.3709581702175635
HEAT	4.3709581702175635
CHK1	4.3709581702175635
RGS2	4.3709581702175635
TN-C	4.3709581702175635
PTRE	4.3709581702175635
P357	4.3709581702175635
SAP1	4.3709581702175635
PP1Γ	4.3709581702175635
GRK2	4.3709581702175635
TILT	4.3709581702175635
F-AZ	4.3709581702175635
RAGA	4.3709581702175635
CD59	4.3709581702175635
PTD1	4.3709581702175635
JEOL	4.3709581702175635
GI3Α	4.3709581702175635
CIP8	4.3709581702175635
BURN	4.3709581702175635
ADE3	4.3709581702175635
SMCS	4.3709581702175635
GLTA	4.3709581702175635
SALI	4.3709581702175635
SIP2	4.3709581702175635
ΜSEC	4.3709581702175635
BMPS	4.3709581702175635
ICDA	4.3709581702175635
V/MM	4.3709581702175635
BEGL	4.3709581702175635
RDNA	4.3709581702175635
GI1Α	4.3709581702175635
CD47	4.3709581702175635
SAP2	4.3709581702175635
LEXA	4.3709581702175635
MTSB	4.3709581702175635
RGS4	4.3709581702175635
CYAN	4.3709581702175635
CED3	4.3709581702175635
WRKY	4.3709581702175635
RIPA	4.3709581702175635
TPIA	4.3709581702175635
CED8	4.3709581702175635
PAX2	4.3709581702175635
GFAP	4.3709581702175635
SWAI	4.3709581702175635
MLST	4.3709581702175635
ACT1	4.3709581702175635
GI2Α	4.3709581702175635
HAND	4.3709581702175635
LIM1	4.3709581702175635
F266	4.3709581702175635
W280	4.3709581702175635
W303	4.3709581702175635
C-FO	4.3709581702175635
N346	4.3709581702175635
N332	4.3709581702175635
OPPOSITE DIRECTION	4.370773190523756
QUALITATIVE INFORMATION	4.370322086967157
PROSPECTIVE INFORMATION	4.370322086967157
IDENTIFYING INFORMATION	4.370322086967157
GENOMIC ANALYSIS IMPLICATION	4.370262284944555
HOMOOLIGOMER	4.3701146156763695
REATTACHMENT	4.3701146156763695
DIFFERENTIATION PROCESS	4.369855441803175
CALIBRATED LYSOSOMAL PH	4.3697418950393985
LYSOSOMAL POPULATION PH	4.3697418950393985
AB NEUTRALIZING SPECTRUM	4.369557357018567
MOTOR NEURONAL IDENTITY	4.369546248924224
JOINT CODON PROBABILITY	4.3693412863273755
NHEI RESTRICTION ENZYME	4.369115661165703
THERAPEUTIC INTERVENTION	4.36842501995813
POLYPLOIDY	4.367822714980422
CO-ELUTION	4.367822714980422
ECO RI RESTRICTION SITE	4.367632022489409
DISPLAY DOWN-REGULATION	4.367386315812701
HTK-TAG ASTROCYTE CLONE	4.367323916362988
HYBRIDIZATION TOTAL RNA	4.367144087844531
QIAGEN RNA MINIPREP COLUMN	4.36704261791462
RECEPTOR SUBUNIT MUTANT	4.366967787399151
DIFFERENT CONCENTRATION	4.366861586299732
INHIBITOR CONCENTRATION	4.366861586299732
CHEMOKINE CONCENTRATION	4.366861586299732
INDICATED CONCENTRATION	4.366861586299732
TRANSFORMATION ARTIFACT	4.365946360405019
CELLULAR TRANSFORMATION	4.365946360405019
HYDROXYL	4.365822826016054
CELLULAR FUNCTIONAL BASIS	4.365733593278898
ADDRESS OSTEOCLASTOGENESI	4.365733593278896
CLONE C2	4.36537125684317
ILLUMINATION ATTACHMENT	4.365174955722333
EXPERIMENTAL VALIDATION	4.365174955722333
BP BAMHI/ECORI FRAGMENT	4.364876123277688
FINE STRUCTURE ANALYSIS	4.364834119376143
CHAPERONE OVEREXPRESSION	4.364355375180518
TRANSIENT OVEREXPRESSION	4.364355375180518
LATRUNCULIN B TREATMENT	4.363806018523532
TERNARY COMPLEX FACTORS	4.363271933422341
ANTI-BOI1 IMMUNOREACTIVE	4.363259701586546
MAP TRANSCRIPTS EXHIBIT	4.363084835248569
NON-LINEAR DIFFERENTIAL	4.362276571137868
homologous recombination	4.362066740606299
STORAGE PHOSPHOR SCREEN	4.361922955589437
ADOBE PHOTOSHOP SOFTWARE	4.361841771053171
PRIMARY MOUSE ASTROCYTE	4.361787395983153
COMMON NAME INFORMATION	4.361540811385427
ERK POLYCLONAL ANTIBODY	4.361497999963594
TGF-Β/BMP FAMILY LIGAND	4.361379337656774
FIBROSARCOMA PREPARATION	4.36135668955491
GENERAL MECHANISM	4.361240041575043
EXPERIMENTAL OBSERVATION	4.361111747412225
HOMOLOGOUS EST SEQUENCE	4.361045307360801
COLOR DEVELOPMENT	4.3604453254336075
SPATIAL REDISTRIBUTION	4.359596598647685
DEVELOPMENTAL FUNCTION	4.359596598647685
CORRESPONDING DOCUMENT	4.359596598647685
ANTICOAGULANT FUNCTION	4.359596598647685
5'GACGTCGATACTTTAGGG3'	4.359596598647685
APPLET INCOMPATIBILITY	4.359596598647685
TRUNCATED NEO SEQUENCE	4.359596598647685
PROFILE HMM START NODE	4.359596598647685
A POSTERIORI PARAMETER	4.359596598647685
APOPTOTIC T-LYMPHOCYTE	4.359596598647685
'-EXONUCLEASE ACTIVITY	4.359596598647685
PHYLOGENETIC PLACEMENT	4.359596598647685
OVARIAN CANCER PATIENT	4.359596598647685
MH2-CONTAINING COMPLEX	4.359596598647685
DUMMY VARIABLEENCODING	4.359596598647685
TRANSECTED OPTIC NERVE	4.359596598647685
NORMAL GABAERGIC INPUT	4.359596598647685
TRITON-EXTRACTION CELL	4.359596598647685
DEVELOPMENTAL SEQUENCE	4.359596598647685
FOCAL CONTACT ASSEMBLY	4.359596598647685
EGF-ADJOINING SEQUENCE	4.359596598647685
HEAD-TO-HEAD DIRECTION	4.359596598647685
INACTIVE GDP-BOUND RAB	4.359596598647685
PHYLOGENETIC INFERENCE	4.359596598647685
CLUSTAL-W MISALIGNMENT	4.359596598647685
OVERESTIMATION PROBLEM	4.359596598647685
GOOD COVARIATION SCORE	4.359596598647685
HEPES-BUFFERED TCM-199	4.359596598647685
PSEUDOPODIAL STRUCTURE	4.359596598647685
OSTEOSCLEROTIC FEATURE	4.359596598647685
EXTRACTED GENBANK DATA	4.359596598647685
RAB PROTEINS ASSOCIATE	4.359596598647685
AMINO-ACID SUBSITUTION	4.359596598647685
SQL DATABASE INTERFACE	4.359596598647685
INDEPENDENT OCCURRENCE	4.359596598647685
GRAPHPAD PRISM VERSION	4.359596598647685
MID-SHAFT MARROW SPACE	4.359596598647685
PSEUDOKNOT ARRANGEMENT	4.359596598647685
USER-DEFINED CRITERION	4.359596598647685
DIAMETER GLASS PIPETTE	4.359596598647685
IDENTIFIED PROTEOLYSIS	4.359596598647685
SHARING BI-DIRECTIONAL	4.359596598647685
CORRESPONDING POSITION	4.359596598647685
INFORMED CONSENT PRIOR	4.359596598647685
MATHEMATICAL FRAMEWORK	4.359596598647685
INCREASE/DECREASE CALL	4.359596598647685
elongated pseudopodial	4.359596598647685
INHIBITING NM-MYOSINII	4.359596598647685
DEHYDRATED WOUND CRUST	4.359596598647685
APPLYING USM TECHNIQUE	4.359596598647685
MULTIDIMENSIONALSEARCH	4.359596598647685
PHOSPHOTRANSFERASE PGK	4.359596598647685
HYAL-2-EXPRESSING L929	4.359596598647685
PAG-3(LS20) BACKGROUND	4.359596598647685
P27 INCREASED RECOVERY	4.359596598647685
CHEMOATTRACT LEUKOCYTE	4.359596598647685
ENVIRONMENTAL VARIABLE	4.359596598647685
SUPERFICIAL BLASTOMERE	4.359596598647685
CORRESPONDING FORMULAE	4.359596598647685
HETEROLOGOUS CELL LINE	4.359596598647685
THEORETICAL CAPABILITY	4.359596598647685
ELAPSED EXECUTION TIME	4.359596598647685
THIOCYANATE EXTRACTION	4.359596598647685
CONCERNING VARIABILITY	4.359596598647685
5'GTTGAAGTGAACTTGCGGGG	4.359596598647685
WET-TRANSFER APPARATUS	4.359596598647685
INDIVIDUAL NEURAL FATE	4.359596598647685
ASYMMETRIC INHERITANCE	4.359596598647685
TRUNCATED NEO CASSETTE	4.359596598647685
GR-HSP90-HSP70-COMPLEX	4.359596598647685
LYMPHOBLASTIC LEUKEMIA	4.359596598647685
CONSIDERED ORTHOLOGOUS	4.359596598647685
QUALITATIVE DIFFERENCE	4.359596598647685
AFFECTING APE FUNCTION	4.359596598647685
STIMULATED ERK1 III1-C	4.359596598647685
CONSTANT NORMALIZATION	4.359596598647685
SMAD1 CO-PRECIPITATION	4.359596598647685
REVEALED BRDU-POSITIVE	4.359596598647685
EVOLUTIONARY PARAMETER	4.359596598647685
INCREASED PLASMA COUNT	4.359596598647685
LYSOSOMAL HYALURONIDAS	4.359596598647685
INITIATE REPROGRAMMING	4.359596598647685
BIND LPA FAMILY MEMBER	4.359596598647685
1DE8 CRYSTAL STRUCTURE	4.359596598647685
P53-DEPENDENT ACTIVITY	4.359596598647685
CELL-MARKING TECHNIQUE	4.359596598647685
AFFECTED ALM MIGRATION	4.359596598647685
SCE FREQUENCY RELATIVE	4.359596598647685
HEPARIN-BINDING DOMAIN	4.359596598647685
NONLINEAR ORGANOGENESI	4.359596598647685
BACKGROUND SUBTRACTION	4.359596598647685
EXPRESSING TISSUE GAD1	4.359596598647685
STIMULATING PROTEOLYSI	4.359596598647685
LABELED CRNA SYNTHESIS	4.359596598647685
CELLULAR BLOOD ELEMENT	4.359596598647685
ZEBRAFISH NEURAL CREST	4.359596598647685
INDUCED CELL MIGRATION	4.359596598647685
NULLSPACE INTERSECTION	4.359596598647685
NUMEROUS MITOCHONDRIAL	4.359596598647685
APPLET-GENERATED GRAPH	4.359596598647685
SAMPLE SIZE OF200 CASE	4.359596598647685
CORRESPONDING FRAGMENT	4.359596598647685
PHOTOLITHOGRAPHIC MASK	4.359596598647685
MORPHOLOGIC SIMILARITY	4.359596598647685
SELECTED GP120 VARIANT	4.359596598647685
OTHER SMAD1 INTERACTOR	4.359596598647685
AMINO-ACID PROSEQUENCE	4.359596598647685
DELAYED CELL MIGRATION	4.359596598647685
INDIVIDUAL GENE RESULT	4.359596598647685
GAPING RED WOUND FIELD	4.359596598647685
MYOSIN-II CROSS-BRIDGE	4.359596598647685
decision tree analysis	4.359596598647685
MAINTAINING SIMPLICITY	4.359596598647685
ORTHOLOGOUS COMPARISON	4.359596598647685
EPITHELIAL-MESENCHYMAL	4.359596598647685
VIDEOCASSETTE RECORDER	4.359596598647685
DIFFERENTIATED EXAMPLE	4.359596598647685
REPRODUCTIVE POTENTIAL	4.359596598647685
VESICLE/PBS SUSPENSION	4.359596598647685
CLEAVAGE SITE INCREASE	4.359596598647685
MORPHOLOGICAL FUNCTION	4.359596598647685
MM SODIUMORTHOVANADATE	4.359596598647685
BRIDGED NL RING FINGER	4.359596598647685
MANUFACTURERS PROTOCOL	4.359596598647685
CYTOSKELETAL SOLUBILIZ	4.359596598647685
ΔN3-CONTAINING COMPLEX	4.359596598647685
RAPID DATA ACQUISITION	4.359596598647685
SUPEROSE-6 FPLC COLUMN	4.359596598647685
NEURAL-TUBE FLOORPLATE	4.359596598647685
INTER-ARRAY COMPARISON	4.359596598647685
INCREASED OVER-FITTING	4.359596598647685
AFFECTING HA VARIATION	4.359596598647685
MOLECULAR WEIGHT SMEAR	4.359596598647685
DOWNREGULATE P27 LEVEL	4.359596598647685
GPNN IMPLEMENTATIONARE	4.359596598647685
ACIDIC SURFACE RESIDUE	4.359596598647685
C/EBPΑ MICE HOMOZYGOUS	4.359596598647685
FINGER-LIKE PROJECTION	4.359596598647685
RETAINED TRAP ACTIVITY	4.359596598647685
INTERNAL GRANULE LAYER	4.359596598647685
NADPH OXIDASE ACTIVITY	4.359596598647685
CONTAINING BOI1-PH(TK)	4.359596598647685
HSP70 CHAPERONE FAMILY	4.359596598647685
CORRESPONDING INCREASE	4.359596598647685
MULTIFUNCTIONAL FAMILY	4.359596598647685
EXPRESSED SEQUENCE TAG	4.359596598647685
TECHNIQUE FORSELECTING	4.359596598647685
CONSENSUS MACRO OUTPUT	4.359596598647685
ASSEMBLY/STABILIZATION	4.359596598647685
HUMAN EMBRYONAL KIDNEY	4.359596598647685
INDUCING ALM MIGRATION	4.359596598647685
NON-COAGULANT FIXATIVE	4.359596598647685
RANK CANDIDATE PATHWAY	4.359596598647685
MATHEMATICAL TECHNIQUE	4.359596598647685
'-CYCLIC MONOPHOSPHATE	4.359596598647685
Β-ACTIN-CRE TRANSGENIC	4.359596598647685
TAILBUD CAUDAL PORTION	4.359596598647685
INCREASING CELL NUMBER	4.359596598647685
INDIVIDUAL REPLACEMENT	4.359596598647685
BOOLEAN IMPLEMENTATION	4.359596598647685
METABOLIC PATHWAY GENE	4.359596598647685
SHUFFLED RNA-GENERATED	4.359596598647685
MULTI-TIERED HIERARCHY	4.359596598647685
NONADHESIVE JELLY FILL	4.359596598647685
CELLULAR REARRANGEMENT	4.359596598647685
PROGRAM DNASIS VERSION	4.359596598647685
TUMOR ASSOCIATED GENE,	4.359596598647685
STAUROSPORINE-MEDIATED	4.359596598647685
tissue differentiation	4.359596598647685
CURRENT FLY ANNOTATION	4.359596598647685
TRANSCRIBED TRANSCRIPT	4.359596598647685
SYNDECAN FAMILY MEMBER	4.359596598647685
RECOGNIZING NET CHARGE	4.359596598647685
STANDARD T-TEST METHOD	4.359596598647685
'-GGCTGGAAGGTGTCAAAG-3	4.359596598647685
H3 HEMAGGLUTININ QUASI	4.359596598647685
CANCER CELL LINE LNCAP	4.359596598647685
WATSON-CRICK BASE PAIR	4.359596598647685
INTERESTING DIFFERENCE	4.359596598647685
CYTOSKELETAL STRUCTURE	4.359596598647685
NEAR-UNIVERSAL FEATURE	4.359596598647685
E. J. COREY LABORATORY	4.359596598647685
COORDINATES TRANSITION	4.359596598647685
BRYOPHYTA PHYLOGENETIC	4.359596598647685
MONOCYTE-DERIVED CELLS	4.359596598647685
CONTRIBUTED DISCUSSION	4.359596598647685
CORRESPONDING DATA SET	4.359596598647685
COMPARING RELATIVE SCE	4.359596598647685
PHOSPHATIDYLINOSITOL-4	4.359596598647685
PALMITOYLATION PM SITE	4.359596598647685
DIVIDING D. DISCOIDEUM	4.359596598647685
DISCOVERED CORRELATION	4.359596598647685
ANTIBIOTIC-FREE MEDIUM	4.359596598647685
CRYPTOCOCCUS NEOFORMAN	4.359596598647685
RGS3 EXPRESSED VARIANT	4.359596598647685
OBSERVED OVERABUNDANCE	4.359596598647685
CONSTITUTIVE REDUCTION	4.359596598647685
CULTURE SYSTEM E15 SMG	4.359596598647685
ANNOTATED POLYMORPHISM	4.359596598647685
GFP-ARP3 GFP-ARP3 CELL	4.359596598647685
LTBP-3 EGF-LIKE MODULE	4.359596598647685
QUASI SELECTED VARIANT	4.359596598647685
'-AACCATGCAGGTACAGTC-3	4.359596598647685
ANIMAL CARCINOGENICITY	4.359596598647685
UBIQUITINATION UNDERGO	4.359596598647685
FORTHE EPISTASIS MODEL	4.359596598647685
UNIX COMPUTER PLATFORM	4.359596598647685
STACKED RING STRUCTURE	4.359596598647685
MEMBER ELK-1 SYNERGIZE	4.359596598647685
BODY INTERACTIONS PLAY	4.359596598647685
QUANTIFYING ROBUSTNESS	4.359596598647685
MIB-TREATED LNCAP CELL	4.359596598647685
WHOLE UNGAPPED SEGMENT	4.359596598647685
DONOR VESICLE MEMBRANE	4.359596598647685
METRIC OVER-ESTIMATION	4.359596598647685
GENOME-WIDE TECHNOLOGY	4.359596598647685
RABBIT ANTI-CHICKEN TN	4.359596598647685
COATED GLASS COVERSLIP	4.359596598647685
POLYGLUTAMINE DISORDER	4.359596598647685
SPINOCEREBELLAR ATAXIA	4.359596598647685
ENDOGENOUS RHYTHMICITY	4.359596598647685
DEVELOPING VASCULATURE	4.359596598647685
ENDOTHELIAL CELL DEATH	4.359596598647685
OVERESTIMATED DISTANCE	4.359596598647685
PROTEOLYSIS EXPERIMENT	4.359596598647685
HIERARCHICAL STRUCTURE	4.359596598647685
PROBABILISTIC NATUREOF	4.359596598647685
MHCK-B DISPLAY DYNAMIC	4.359596598647685
PROSTATE BIOPSY SAMPLE	4.359596598647685
PROTHROMBINASE COMPLEX	4.359596598647685
INPUT FREQUENCY MATRIX	4.359596598647685
EXPERIMENTAL RATIONALE	4.359596598647685
INHIBITOR CAMPTOTHECIN	4.359596598647685
RADIOGRAPHIC TECHNIQUE	4.359596598647685
YEAST TWO-HYBRID SYTEM	4.359596598647685
ATTFDB DATABASE ATTFDB	4.359596598647685
NON-PROLIFERATING CELL	4.359596598647685
IDENTIFIED ARABIDOPSIS	4.359596598647685
ANIMAL XENOGRAFT MODEL	4.359596598647685
HOMOGENEOUS POPULATION	4.359596598647685
GELATINOLYTIC ACTIVITY	4.359596598647685
INFRACLASS NEOPTERYGII	4.359596598647685
DECARBOXYLASE ANTIZYME	4.359596598647685
ACTIVATED P53-POSITIVE	4.359596598647685
STATISTICAL HYPOTHESIS	4.359596598647685
LEFT-MOST BIT POSITION	4.359596598647685
HIGH-THROUGHPUT SCREEN	4.359596598647685
CORRESPONDING MISMATCH	4.359596598647685
INVESTIGATIONS DEALING	4.359596598647685
OPTIMIZATION PROCEDURE	4.359596598647685
SELECTED CELL LOCATION	4.359596598647685
FILOPODIA CONDENSATION	4.359596598647685
LRP6 LRP AMINOTERMINUS	4.359596598647685
COMPLETENESS CRITERION	4.359596598647685
yeast two-hybrid study	4.359596598647685
NEURAL CREST PRECURSOR	4.359596598647685
INSTITUTE OFTECHNOLOGY	4.359596598647685
SIMILAR STAGE-SPECIFIC	4.359596598647685
REMAINING HALF PORTION	4.359596598647685
DIAPHOT-TMD MICROSCOPE	4.359596598647685
ESTABLISHED STIMULATOR	4.359596598647685
CONSERVED MOLEGOS FORM	4.359596598647685
MONKEY LTBP-3 SEQUENCE	4.359596598647685
EPIFLUORESCENCE OPTICS	4.359596598647685
PROSEQUENCE-PROCESSING	4.359596598647685
RESOLVING PHYLOGENETIC	4.359596598647685
WEUSE PREDICTION ERROR	4.359596598647685
ACCELERATED TIME FRAME	4.359596598647685
LINKING RAB24 MUTATION	4.359596598647685
QUALITATIVE EXPERIMENT	4.359596598647685
CYLINDRICAL PROJECTION	4.359596598647685
IMMUNOLOCALIZATION SMG	4.359596598647685
CODING ANNOTATION QRNA	4.359596598647685
RESCUE G1 PROLONGATION	4.359596598647685
AUTOPHAGIC DEGRADATION	4.359596598647685
BIOCHEMICAL EXTRACTION	4.359596598647685
CAUSED RAPID CESSATION	4.359596598647685
SUCCINIMIDYLPROPIONATE	4.359596598647685
ALA MYOSIN-II INCREASE	4.359596598647685
TUBULIN IMMUNOLABELING	4.359596598647685
DELAMINATED NEUROBLAST	4.359596598647685
USER-DEFINED PARAMETER	4.359596598647685
BOUND GDP GUANINE RING	4.359596598647685
MEDIATED RECOMBINATION	4.359596598647685
NUTRITIONAL EXPERIMENT	4.359596598647685
HYAL-1-EXPRESSING L929	4.359596598647685
FUNCTIONAL SPECIFICITY	4.359596598647685
NEURAL PRECURSOR STATE	4.359596598647685
RABBIT MUSCLE MYOSINII	4.359596598647685
LATERAL PLATE MESODERM	4.359596598647685
GP120 TRIMER INTERFACE	4.359596598647685
UNDERLINING ASSUMPTION	4.359596598647685
AFFECTED SPECIFICATION	4.359596598647685
ATTENUATED ENDOTHELIAL	4.359596598647685
HUMAN/MOUSE COMPARISON	4.359596598647685
ECTOPIC INVASION EVENT	4.359596598647685
expression microarrays	4.359596598647685
EXPERIMENTAL REPLICATE	4.359596598647685
ACUTE MYELOID LEUKEMIA	4.359596598647685
DELETION PROTEINS SHOW	4.359596598647685
USER-FRIENDLY WEB-PAGE	4.359596598647685
NON-TRANSCRIBED REGION	4.359596598647685
THEORETICAL CELL SHAPE	4.359596598647685
SEQUENCE DECOMPOSITION	4.359596598647685
EGFP-CPLA	4.359539519521215
OTHER PCMV5 EXPRESSION	4.359101194811843
REDUCED TAG EXPRESSION	4.359101194811843
GENE EXPRESSION RHYTHM	4.359101194811843
C/EBPΑ EXPRESSION LEAD	4.359101194811843
PHOSPHATASE EXPRESSION	4.358853492893921
GR(ALA)-GFP EXPRESSION	4.358853492893921
EXPRESSION CORRELATION	4.358853492893921
DOING CLUSTER ANALYSIS	4.3586855281060615
MATCH CLUSTER ANALYSIS	4.3586855281060615
ANALYTIC SOLUTION MATCH	4.358515011590519
REMAINING ADHERENT CELL	4.358398207058299
FOLD CHANGE CALCULATION	4.358281620120214
TRANSCIPTOMIC ANALYSIS	4.358229992835249
RATIO-IMAGING ANALYSIS	4.358229992835249
C-JUN N RAPID ACTIVATION	4.358217267805254
QUALITY CONTROL METHOD	4.357854922484068
CONTROL SAMPLE PROFILE	4.357854922484068
CONTROL CELL MIGRATION	4.357854922484068
MISMATCH CONTROL PRIOR	4.357854922484068
AFFYMETRIX CONTROL SET	4.357854922484068
CONTROL ELECTROPORATION	4.357790255054251
CHILLED ETHANOL SOLUTION	4.357654978743742
SCFG PARSING ALGORITHM	4.357598793636478
S. CEREVISIAE CYTOPLASM	4.357329139185491
KINASE INACTIVE FUSION	4.3572408054552785
MITOCHONDRIAL HOMEOSTASI	4.357233496819698
WTPAI-1 CHARACTERIZATION	4.357233496819698
MESENCHYMAL CELLS REACH	4.3570666353909795
BLASTODERM MARGIN REACH	4.3570666353909795
PROPORTIONAL HAZARD COX	4.3570666353909795
GFP-EXPRESSING CONTROL	4.35698408440226
CHARACTERIZING CONTROL	4.35698408440226
COLONY-SECTORING STUDY	4.356775083262626
BENCHMARKING ALGORITHM	4.356599891130874
DEMONSTRATED ALGORITHM	4.356599891130874
MYERS/MILLER ALGORITHM	4.356599891130874
INTRACELLULAR AGGREGATE	4.356472583486927
NEW NONCODING RNA GENE	4.356464793660853
INHIBITORY FACTOR HPRT	4.356456213373218
NORTHERN BLOTTING	4.356389329719168
MITOCHONDRIA PREPARATION	4.356356221769654
STAINING ACTIN NETWORK	4.356209738074669
MOUSE NOCTURNIN INTRON	4.35619086977064
activated transcription	4.356128482625369
including transcription	4.356128482625369
CONCENTRATION DEPENDENT	4.356124346554589
PM MATCH HYBRIDIZATION	4.356123142207744
MM HYBRIDIZATION VALUE	4.356123142207744
C-TERMINAL ALPHA HELIX	4.355957739520129
CYTOSKELETON STABILIZATION	4.355870647660313
AXIN CYTOPLASMIC LEVEL	4.355868986858481
CYTOPLASMIC SMAD1 FORM	4.355868986858481
SMG CELL PROLIFERATION	4.3557757965637505
BD SIGNAL TRANSDUCTION	4.355639780955585
ANTI-RESORPTIVE EFFECT	4.355609674734015
MICROARRAY FOLD CHANGE	4.355531643603553
TYROSINE CO-EXPRESSION	4.355484524656007
GENE EXPRESSION RESEARCH	4.355482113133889
POSSIBLE RNA SECONDARY	4.355420858665243
RNA SEQUENCE ALIGNMENT	4.355420858665243
ANTI-HA ANTIBODY	4.355241865864038
GENE EXPRESSION SIGNAL	4.355144377119742
BOI1 TK MUTANT VERSION	4.355138996216429
PHYSIOLOGICAL RESPONSE	4.354941814382993
RNA EXPRESSION PATTERN	4.3549254548294005
RNA EXPRESSION PROFILE	4.3549254548294005
POLARIZED LOCALIZATION	4.35489407300592
CONDUCTED LOCALIZATION	4.35489407300592
INDEPENDENT MANNER SHOW	4.354638475291751
C3 EXOENZYME TREATMENT	4.35460616327275
CCAF TREATMENT LEADING	4.35460616327275
RNA STRUCTURE ANALYSIS	4.354509788123619
PENICILLIFORMIS INTRON	4.354488005332119
NYLON FILTER DNA ARRAY	4.354434409547589
HYAL-2-PEGFP-N1 VECTOR	4.3544158500593
FIBRONECTIN TRANSCRIPT	4.354356641504004
ASSEMBLING FIBRONECTIN	4.354356641504004
BACKGROUND FIBRONECTIN	4.354356641504004
TRANSCRIPTIONAL TARGET	4.354265246902661
INVERSE CORRELATION	4.354205685747566
C-TERMINAL ACETYLATION	4.35413830995635
CYTOPLASMIC COMPETENCE	4.3540051809638785
CYTOPLASMIC GR-COMPLEX	4.3540051809638785
CYTOPLASMIC INTERACTOR	4.3540051809638785
CYTOPLASMIC EXTRACTION	4.3540051809638785
SMAD ACTIVATION DOMAIN	4.353962236127598
GAL4 ACTIVATION DOMAIN	4.353962236127598
SEQUENCE W TAIL SYMBOL	4.3539361511159305
PROTEIN UMP1 ASSOCIATE	4.353873220452909
OTHER BH3-ONLY PROTEIN	4.353873220452909
3-D ORGANELLAR PROTEIN	4.353873220452909
LENGTH ADAPTOR PROTEIN	4.353873220452909
CONTAINING PROTEIN CIZ	4.353873220452909
BACKGROUND RAB PROTEIN	4.353873220452909
SHARED PROTEIN ELEMENT	4.353873220452909
NAMED ANTIZYME PROTEIN	4.353873220452909
ECM PROTEIN DEPOSITION	4.353873220452909
CHAPERON PROTEIN HSC73	4.353873220452909
NEGATIVE DELTA PROTEIN	4.353873220452909
TENASCIN PROTEIN LEVEL	4.353873220452909
MISFOLDED PROTEIN LEAD	4.353873220452909
IMPAIRED PROLIFERATION	4.353865395521783
PROLIFERATION BLOCKAGE	4.353865395521783
FACSCAN FLOW CYTOMETER	4.353829350219105
MULTIPLE SEQUENCE	4.35378371085064
DETECTED MULTIPLE	4.35378371085064
ANGLE DEVELOPMENT REVIEW	4.353768591597768
POLYADENYLATION SIGNAL	4.353661372109534
INTRACELLULAR LOCATION	4.353523800633485
STARVED RAT FIBROBLAST	4.353390219628096
RNA SEQUENCE/STRUCTURE	4.353332988674022
PHOTOMULTIPLIER TUBE VOLTAGE	4.353323280269771
CUT GENOMIC DNA PVU II	4.3532835318910745
shifts	4.353201611119378
CLASSIFICATION ACCURACY	4.3530394430312835
RGS3 COMPLEMENTARY DNA	4.352713679847557
UNWINDING ACTIVITY DNA	4.352713679847557
MODIFIED PCDNA3 PLASMID	4.3525980076172965
CELL DENSITY DEPENDENT	4.352529219070465
BIOLOGICAL INTERPRETATION	4.352525572439554
PRESENCEOF NON-FUNCTIONAL	4.352525572439554
PORCINE CLONING OUTCOME	4.352480110759103
GREEN GFP FLUORESCENCE	4.3523188803925725
TET-REGULATED GFP GENE	4.3523188803925725
PREIMMUNE RABBIT SERUM	4.3522014978400705
HUMAN AUTOIMMUNE SERUM	4.3522014978400705
CONTROL FUSION PROTEIN	4.352131544289292
POINT PATTERN STATISTICS	4.352010786021764
REPRESENTATIVE SEQUENCE	4.351906795180119
ANTI-Β-ACTIN MOUSE MAB	4.351858265313134
HEPARAN SULFATE CONTRIBUTION	4.351695787534909
JAVASERVER PAGE CONTRIBUTION	4.351695787534909
ACTIVATED HUMAN T CELL	4.351691490887821
TRANSMEMBRANE RECEPTOR	4.3516227508203436
SΑ I2 NOVEL C-TERMINUS	4.351409165610683
KINASE INACTIVE MUTANT	4.351297335546936
OBSERVED WILCOXON TEST	4.351164483703831
RECEPTOR MUTANT TYPE I	4.3511520723027575
RETICULAR DISTRIBUTION	4.351145054867554
C-DEPENDENT ACTIVATION	4.351145054867554
PERCEIVED DISTRIBUTION	4.351145054867554
VIRAL INFECTION	4.351109390435104
RESTRICTION SITE KPN I	4.351105927350053
PEPTIDE SUBSTRATE MH-1	4.351066435855645
MYRISTOYL GROUP ABILITY	4.351062457691069
TGF-Β1-INDUCED PROTEIN	4.351011531355521
FALSE-POSITIVE PROTEIN	4.351011531355521
ANTI-APOPTOTIC PROTEIN	4.351011531355521
USE BIFURCATION THEORY	4.350986340430368
EMBRYONIC CDNA LIBRARY	4.350904726608403
REPRESENTING RGS3 CDNA	4.350904726608403
REPORTED CDNA SEQUENCE	4.350904726608403
RELEASING CYTOCHROME C	4.35086333674155
INCLUDING CYTOCHROME C	4.35086333674155
RABBIT ANTI-HUMAN MMP-1	4.350716062823766
MUTANT PEPTIDE-TREATED	4.350681393785171
TRANSFECTED CELL LYSATE	4.350652487289665
SAMPLE PREPARATION	4.350572131999916
MONOLAYER LYSATE SAMPLE	4.350558200579553
NF-ΚB SECONDARY EFFECT	4.3505036142831734
NON-DNA DAMAGE PATHWAY	4.350472295163662
ACTIN CENTRIPETAL FLOW	4.350442489646088
STRUCTURE CONSERVATION	4.3504266736462425
REACTION RATE CONSTANT	4.350403691378069
FOCAL CONTACT ADHESION	4.350334048141177
MEDIATED CELL ADHESION	4.350334048141177
AQUEOUS PRIMARY SOURCE	4.350081760773296
IMAGE MOUSE CDNA CLONE	4.350041295611123
IMMUNODETECTABLE NF-ΚB	4.3499440460145875
TRITON X-100-INSOLUBLE	4.349841359284449
PROTEIN PHOSPHATASE 5 CELLULAR ROLE	4.349818687702013
ENDOGENOUS P53 PROTEIN	4.349811238170986
TRANSLOCATION MACHINERY	4.349712785006884
THR235 PHOSPHORYLATION	4.349491998095131
PHOSPHORYLATION MODULE	4.349491998095131
MODEL NODE SINGLE TYPE	4.34947207577543
EVOLUTIONARY APPEARANCE	4.349462660343395
MICROSCOPIC EXAMINATION	4.349462660343395
TISSUE-SPECIFIC FASHION	4.349462660343395
DSH-INDEPENDENT FASHION	4.349462660343395
EXCHANGE CHROMATOGRAPHY	4.349462660343395
CRNA SAMPLE PREPARATION	4.349462660343395
INHIBITORY RNA ADDITION	4.349432827514374
TAG EXPRESSION P-VALUE	4.349079418853981
GENOMIC DNA EXTRACTION	4.349074820720001
INTRAEPITHELIAL T CELL	4.349056454967866
TRANSCRIPTION STRENGTH	4.349007770701447
ENCODING TRANSCRIPTION	4.349007770701447
CYTOSKELETAL DEPENDENT	4.348995529281855
INHIBITOR STUDY PASSAGE	4.348810891053603
METHIONINE START CODON	4.348680021265015
EMERGING SMG PHENOTYPE	4.348548496236309
INDUCED PHENOTYPE FORM	4.348548496236309
MULTIPLE EXPERIMENT	4.348476796753365
TRANSCRIPTIONAL SIGNAL	4.34833002036451
CONSERVED DOMAIN MOTIF	4.348275703584176
BINDING MOTIF FUNCTION	4.348275703584176
INDIVIDUAL MOTIF SCORE	4.348275703584176
BAMH1 RESTRICTION SITE	4.348275703584176
HYPOCOTYL CELL NUCLEUS	4.348205387465769
COLD SONICATION BUFFER	4.34814314041013
GENERAL PUBLIC LICENSE	4.348062101790525
ACID PHENOL EXTRACTION	4.3480074359286425
MUTANT GFP-BLM PROTEIN	4.347929750544567
IMPAIRED CELL MOTILITY	4.3476097685804405
FLANKING EXON SEQUENCE	4.3476097685804405
TYPE L1	4.347483711589118
NON-FATAL	4.347184406597511
PARALYSIS	4.347184406597511
LIPID INSENSITIVE FORM	4.3469484262319025
AFFORDED BETTER GROWTH	4.346807302969244
SUPPRESSED CELL GROWTH	4.346807302969244
REGULATING CELL GROWTH	4.346807302969244
SRF INTERACTION DOMAIN	4.3467804910286185
METABOLIC STOICHIOMETRY	4.346746954969258
GNRH RECEPTOR MODULATION	4.3465610008413105
HF CASE	4.346191622593965
SINGLE CELL SUSPENSION	4.346097234818012
COREPRESSOR BINDING SITE	4.346041973681268
DECREASED SUPPORT CELL	4.346011524571474
PUBLISHED WORK SUPPORT	4.346011524571474
INTERCELLULAR ADHESION	4.345702772887924
BIORAD CONFOCAL MICROSCOPE	4.345673228128677
motor neuron specification	4.345673228128677
INTRACELLULAR RECEPTOR	4.345549952806143
ANTI-MHCK-C POLYCLONAL	4.345489021722389
TRANSCRIPTION REPRESSOR	4.345403641540439
TRANSCRIPTION MODULATOR	4.345403641540439
UNKNOWN TARGET SEQUENCE	4.345272714909012
MAXIMUM LIKELIHOOD FIT	4.345212402566991
TRANSFECTION CELL LINE	4.345155771873761
LIVER RNA POOLED STOCK	4.345002387409051
REPEATED MULTIPLE TIME	4.3449100320788085
TYPE TISSUE COLLECTION	4.344686151490868
MATCHING STEP ACCURACY	4.344686151490868
INDICATED PLASMID	4.344555477357936
INHIBITED LH SECRETION	4.344502071896339
HIGH-TITER VIRUS STOCK	4.344313390311948
P53 PROTEIN ACTIVATION	4.3441768756508985
PROSTATISM	4.343922964975614
TRANSCRIPTION PROMOTER	4.343581779576333
T-CELL IMMUNITY ESCAPE	4.343509010925857
COLONY-SECTORING ASSAY	4.3432800061184285
PHOSPHOLIPID INFLUENCE	4.343221732573681
ΜM ARACHIDOYL COENZYME	4.343155005328065
ARACHIDOYL COENZYME ΜM	4.343155005328065
HIV-1 RT SELECTION MAP	4.343085578103716
ADHESIVE ORGAN PRODUCE	4.343074211257699
SN50-TREATED PHENOTYPE	4.343024445030621
N-TERMINAL RING FINGER	4.3428805895304725
INCREASED ACCUMULATION	4.342719436068344
PROMOTING ACCUMULATION	4.342719436068344
GENE TRANSCRIPT SUBSET	4.342615256052421
CONTAINING RESTRICTION	4.342615256052421
SUPPORT VECTOR MACHINE	4.342557692179217
ECTOPIC BONE FORMATION	4.342456551916017
PAIRWISE RNA ALIGNMENT	4.342413872847595
PHOSPHOMOESIN ANTIBODY	4.342349090807982
QUERY SEQUENCE SPECIES	4.34225395089082
ACID METHYLTRANSFERASE	4.342212854569121
MURINE HYAL-2 HOMOLOGUE	4.342146615504153
TRANSFER RNA ALIGNMENT	4.342131112286341
DETECTING TRANSFER RNA	4.342131112286341
VARIABLE WINDOW LENGTH	4.342130074835414
ROBUST PARAMETRIC MODE	4.342130074835414
CONJUGATING ENZYME MIB	4.342058490721429
ENHANCED IDENTIFICATION	4.342056191141203
VIDEO IMAGES EVALUATION	4.342056191141203
POSITIVE IDENTIFICATION	4.342056191141203
INCORPORATED PHOSPHATE	4.342046502951145
NEUROBLAST DEVELOPMENT	4.341790919033234
PRONUCLEAR DEVELOPMENT	4.341790919033234
RESTRICTED DEVELOPMENT	4.341790919033234
TARGETING SIGNAL GOLGI	4.341745955195823
COMMON REFERENCE POINT	4.341704062059505
CHEMICAL WARFARE AGENT	4.341616353546818
NUCTRAP GEL FILTRATION	4.340977461588919
REPORTER LYSIS BUFFER ΜL	4.340898421054707
MACROPHAGE RECRUITMENT	4.3408824659916805
DECREASE INCORPORATION	4.3408824659916805
RNA MULTIPLE ALIGNMENT	4.340734292096367
MESENCHYMAL RELATIONSHIP	4.340615780644453
ORTHOLOGOUS RELATIONSHIP	4.340615780644453
HYBRIDIZATION REACTION	4.34059705308335
CRE EXPRESSION PLASMID	4.340513508998108
LIPOSOME-BASED REAGENT	4.340492588228013
ES CELL CLONE GENOTYPE	4.340472611918757
DETERMINATION MTT ASSAY	4.340420266389781
DISCUSSION INTERACTION	4.340372437219084
FIBULIN-1C INTERACTION	4.340372437219084
hybridization condition	4.340297154705682
ESTROGEN ADMINISTRATION	4.340297154705682
EXPRESSION MAKES SENSE	4.340291092244781
ASTRAZENECA	4.340288259167922
MULTICENTER	4.340288259167922
INCREASED JNK ACTIVITY	4.339876329827379
transcriptional factors	4.339582115258768
FINAL REACTION MIXTURE	4.339487113995399
BALLOON CATHETER INJURY	4.339375754668028
EXOENZYME INACTIVATION	4.339218987533369
PURIFIED PRIMING KINAS	4.339218987533369
EXPRESSING EXOGENOUS AR	4.338929015255832
CELLULAR ORGANISM	4.33865914155631
COMMON FACTOR EXPONENT	4.338563676785038
WILD-TYPE LOCALIZATION	4.338519206931916
TRUNK-TAIL BUD PROJECT	4.338516311288047
FOLDING PROJECT RRNAS,	4.338516311288047
SPECIFICITY DETERMINANT	4.338424632048515
GROWTH FACTOR RECEPTOR	4.338351019143217
G418-SENSITIVE ES CELL	4.338146481685247
BLOCK RASMC ATTACHMENT	4.337763443882346
GENOME SEQUENCING	4.337648518497698
DNA REPLICATION SYSTEM	4.337619153096212
MURINE MACROPHAGE-LIKE	4.337500393824933
ADHESIVE PROTEIN PRIOR	4.337350833062923
MEASURING ASSAY BUFFER	4.337265412057293
OUTCOME CLASSIFICATION	4.33723092791246
PRECISE CLASSIFICATION	4.33723092791246
JUXTAPOSITION ACCURACY	4.33723092791246
DISEASE CLASSIFICATION	4.33723092791246
tyrosine kinases	4.336794532642167
FRACTIONATION APPROACH	4.3366717861440796
AMERSHAM PHARMACIA	4.336573834394614
subnuclear localization	4.336427274547536
KB PAC-1 CDNA FRAGMENT	4.33640510370651
TNF CYTOTOXICITY ASSAY	4.336214427111062
ARCHAEAL INTRONS RANGE	4.3360839704388585
CONCENTRATION SHOWS AREA	4.335988571539965
COMMON PROTEIN PARTNER	4.3359806838647295
RELEASABLE LH FRACTION	4.335739883196778
EXPERIMENTAL VERIFICATION	4.335543831360398
TRANSIENT UPREGULATION	4.335465217064942
CHEMOKINE UPREGULATION	4.335465217064942
OCL THE FINE STRUCTURE	4.335465217064942
CYTOSOLIC LOCALIZATION	4.335383594279446
CYTOMETRIC MEASUREMENT	4.3348130175627055
MEASUREMENT TECHNOLOGY	4.3348130175627055
PURIFIED PRIMARY STOCK	4.334798552437559
GFP STABLE TRANSFECTANT	4.334684990839973
N-TERMINAL PROSEQUENCE	4.334522584971866
JNK PATHWAY ACTIVATION	4.334241967307292
EXPRESSION MEASUREMENT	4.3340699118089425
TRANSLOCATION ACTIVITY	4.333946458783511
LAMELLIPODIA FORMATION	4.333886528550184
QUADRIRADIAL FORMATION	4.333886528550184
EXOGENOUS CYTOCHROME C	4.333881994146286
PLATELET PROTEIN KINAS	4.333495609338593
V-SRC-TRANSFECTED MDCK	4.333396812929278
PARAMETRIC STATISTICAL	4.333396812929278
P53 PROTEIN N-TERMINAL	4.333095229053773
AGONIST-SPECIFIC MANNER	4.332785034398693
NUCLEOTIDE TRANSPORTER	4.33277279924729
INCREASED OCL APOPTOSI	4.332546672389743
TOTAL SIGNAL INTENSITY	4.332483404689317
CONTROL GROUP MEAN AGE	4.332197059000543
FUNCTIONAL MODIFICATION	4.332004554366799
AUXOTROPHIC REQUIREMENT	4.332004554366799
INFORMATION REDUNDANCY	4.33192872148816
COORDINATE INFORMATION	4.33192872148816
PROGNOSTIC INFORMATION	4.33192872148816
FUNCTIONAL INFORMATION	4.33192872148816
BIOLOGICAL INFORMATION	4.33192872148816
REMAINING BIOSYNTHETIC	4.331808947128163
TXT DOCUMENTATION FILE	4.331808947128163
CRE-EXPRESSION PLASMID	4.331715069927084
GFP-DYNACORTIN PLASMID	4.331715069927084
CYTOSOLIC DISTRIBUTION	4.331634576141081
DIFFERENTIATION MEDIUM	4.331467994348782
GLUCOCORTICOID ADDITION	4.331320628565654
NUCLEOTIDE SUBSTITUTION	4.331200211476785
EXPRESSION INFORMATION	4.331185615734397
DECREASED SIGNIFICANCE	4.330940583018178
QIAGEN PLASMID MAXI KIT	4.3306425680325535
KDA CATALYTIC FRAGMENT	4.33031140902232
WILD-TYPE DFZ2 PLASMID	4.3300923354512815
QUERY SEQUENCE EXHIBIT	4.329920465956933
generations	4.329871890398454
CONTINUOUS PRESENCE	4.3298673474454725
PH DOMAIN GENERAL ROLE	4.32976519271344
MOLECULAR PROBE	4.329709171418749
MULTIPLE PROTEIN	4.329634421017989
PROPIDIUM IODIDE ASSAY	4.329614859875176
SHOWED DOWN-REGULATION	4.3290301819762105
CDNA/CRNA AMPLIFICATION	4.3286875142312455
P21 GENE TRANSCRIPTION	4.32856371988237
CONCENTRATION INCREASE	4.328512107117372
CELLULAR CONCENTRATION	4.328512107117372
HYBRID RESISTANCE STUDY	4.328348452319803
ΜL FIBROBLAST SUBSTRATE	4.327875879095935
LIMITED TRANSFORMATION	4.327608488177537
TRANSFORMATION PROCESS	4.327608488177537
ENHANCED CELL DIVISION	4.327421423204028
FLUID PHASE ENDOCYTOSI	4.327421423204028
VITERBI DP ALGORITHM RUN	4.3272098919652615
CATENANE	4.326969865841933
SPECIFIC IMMUNOREACTIVE	4.3269014156967165
IONOPHORE CONCENTRATION	4.326480228127778
PEROXIDASE VISUALIZATION	4.325974414950287
HYBRID MRNA TRANSCRIPT	4.3258544503739795
SINGLE DELETION ALLELE	4.325719623703695
CONTRACTION TAKES PLACE	4.325500554101008
NEUTRAL PHOSPHOLIPID PC	4.325370474095692
PHOSPHATE ACCUMULATION	4.3251693403718035
T7 TAG AB AGAROSE BEAD	4.324838800425941
BOOTSTRAPPED MODE MEAN	4.324805555281779
INTERESTING OBSERVATION	4.32477931842797
EXHIBIT DIFFERENTIATION	4.324769459378177
FINAL CELL RELATIONSHIP	4.324745038918618
HINDIII	4.324728249267845
ΜG/ML PROPIDIUM IODIDE	4.324489228714152
epidermal growth factor	4.324413318235681
SUCCESSFUL APPLICATION	4.324327656334446
NEAR-PERFECT DIAGNOSIS	4.324327656334446
BIOLOGICAL APPLICATION	4.324327656334446
TOTAL RNA PCR REACTION	4.324087853131558
CONTROL	4.323689566859628
SERINE/THREONINE KINASE	4.323322335781668
NG/ML TRITC-PHALLOIDIN	4.322916898641916
TRANSLATIONAL ACTIVATION	4.322455537819628
P53 DEPENDENT APOPTOSI	4.3214173105306
RANDOMIZATION PROCEDURE	4.320947753914954
DESENSITIZATION PROCESS	4.320947753914954
MEAN BACKGROUND SIGNAL	4.320848737589679
GFP-BLM ALLELE PLASMID	4.320631301719635
WARMED SAMPLE SOLUTION	4.320271384216548
detergent	4.3194780344757
G418-RESISTANT COLONY	4.319198469223181
BINDING SITE PLANT TF	4.319198469223181
CARDIOLIPIN STRUCTURE	4.319198469223181
STANDARD VALUE SYSTEM	4.319198469223181
BLOTTING CELL EXTRACT	4.319198469223181
CONCEPTUAL FOUNDATION	4.319198469223181
STATISTICAL INDICATOR	4.319198469223181
SPINNER FLASK CULTURE	4.319198469223181
ZYMOGRAPHY ZYMOGRAPHY	4.319198469223181
RECRUITMENT MECHANISM	4.319198469223181
DOWNLOADABLE DATABASE	4.319198469223181
STANDARD USM SEQUENCE	4.319198469223181
QUANTITATIVE APPROACH	4.319198469223181
PMA-INDUCED OXIDATION	4.319198469223181
NEUROENDOCRINE RHYTHM	4.319198469223181
MATURE/SOLUBLE HB-EGF	4.319198469223181
NEISSERIA MENINGITIDI	4.319198469223181
USING TIRF MICROSCOPY	4.319198469223181
BOOTSTRAPPED ESTIMATE	4.319198469223181
POLAR CORTEX INCREASE	4.319198469223181
V-CRK CO-TRANSFECTION	4.319198469223181
PITUITARY GONADOTROPE	4.319198469223181
PURIFIED C3 EXOENZYME	4.319198469223181
FUNCTIONAL ALTERATION	4.319198469223181
NEURAL PRECURSOR POOL	4.319198469223181
REVEALED NOVEL NON-CN	4.319198469223181
PHOSPHORYLATE P53-GST	4.319198469223181
SHOW BROAD CONNECTION	4.319198469223181
ARITHMETIC DIFFERENCE	4.319198469223181
MITOCHONDRIAL-ENCODED	4.319198469223181
EMBRYO RECONSTRUCTION	4.319198469223181
EXPERIMENTAL DISTANCE	4.319198469223181
SPLICING INTERMEDIATE	4.319198469223181
GRAY LEVEL/PIXEL AREA	4.319198469223181
DMD PATIENT AGE GROUP	4.319198469223181
ORIGINAL TRANSFORMANT	4.319198469223181
SIGNALING SPECIFICITY	4.319198469223181
BIOMEDICAL INFORMATIC	4.319198469223181
TWO-DIMENSIONAL SPACE	4.319198469223181
OLFACTORY PIT ANLAGEN	4.319198469223181
LEUKOCYTE IMMIGRATION	4.319198469223181
MYRISTOYLATION RESULT	4.319198469223181
FLUOROGENIC SUBSTRATE	4.319198469223181
CONTINUED CONTRACTION	4.319198469223181
SCE FREQUENCY BS CELL	4.319198469223181
MATHEMATICAL OPERATOR	4.319198469223181
SPATIAL POINT PATTERN	4.319198469223181
COPY EXTRACHROMOSOMAL	4.319198469223181
BRANCHED PSEUDOPODIAL	4.319198469223181
FLUORESCENCE DECREASE	4.319198469223181
UPPER PARABASAL LAYER	4.319198469223181
CAMERA LUCIDA DRAWING	4.319198469223181
BOLEAN IMPLEMENTATION	4.319198469223181
FORAN EPISTASIS MODEL	4.319198469223181
TERMINAL CELL DENSITY	4.319198469223181
CROSSOVER ARESELECTED	4.319198469223181
CORTICAL GFP-LABELLED	4.319198469223181
DENOTED MATRICELLULAR	4.319198469223181
STAPHYLOCOCCUS AUREUS	4.319198469223181
ANTAGONISTIC ACTIVITY	4.319198469223181
G1-G3 GLOBULAR DOMAIN	4.319198469223181
OPTRONICS ENGINEERING	4.319198469223181
nucleotide occurrence	4.319198469223181
POTENTIAL PROTEASOMAL	4.319198469223181
CO-OPERATIVE PROPERTY	4.319198469223181
PRECOCIOUS DEPOSITION	4.319198469223181
CYTOSKELETAL MESHWORK	4.319198469223181
MAXIMAL DEXAMETHASONE	4.319198469223181
PROLIFERATING CULTURE	4.319198469223181
LATERAL SPECIFICATION	4.319198469223181
EXPERIMENTAL WEAKNESS	4.319198469223181
ASSOCIATED ENDOGENOUS	4.319198469223181
CELL AUTOFLUORESCENCE	4.319198469223181
ORGAN SYSTEM LOCATION	4.319198469223181
IN VITRO GST-PULLDOWN	4.319198469223181
COMPETITIVE TITRATION	4.319198469223181
SPARC-DEFICIENT MOUSE	4.319198469223181
ANALYZED SN50-TREATED	4.319198469223181
NULLPOINTER EXCEPTION	4.319198469223181
EMPIRICAL REPLACEMENT	4.319198469223181
ECTOPIC RECOMBINATION	4.319198469223181
MEC-3GFP FLUORESCENCE	4.319198469223181
HINDIII-NDEI FRAGMENT	4.319198469223181
PRE-OCL CELL LINE FLG	4.319198469223181
sample centrifugation	4.319198469223181
FIBRILLAR MATRIX FORM	4.319198469223181
GP120 QUASISPECIATION	4.319198469223181
KAPLAN MEIER ESTIMATE	4.319198469223181
ANNOTATED ARABIDOPSIS	4.319198469223181
AGGRECAN BINDING SITE	4.319198469223181
FLOATING POINT NUMBER	4.319198469223181
EVALUATING ROBUSTNESS	4.319198469223181
BIOCHEMICAL PARAMETER	4.319198469223181
GOAT ANTI-CHICKEN IGY	4.319198469223181
TIME-LAPSE MICROSCOPY	4.319198469223181
OBSERVED CONTACT SITE	4.319198469223181
LEUCINE-REPEAT DOMAIN	4.319198469223181
RESTRICTED DETACHMENT	4.319198469223181
MONOFUNCTIONAL ANALOG	4.319198469223181
ANTI-RABBIT IGG TRITC	4.319198469223181
FUNDAMENTAL RELEVANCE	4.319198469223181
SV40-TRANSFORMED CELL	4.319198469223181
PROTEASOMAL SUBSTRATE	4.319198469223181
NEIGHBORING PRECURSOR	4.319198469223181
BLOCKED HYAL-1 TGF-Β1	4.319198469223181
ENDOGENOUS OSCILLATOR	4.319198469223181
BIOMEDICAL LITERATURE	4.319198469223181
POSSIBILITIES WARRANT	4.319198469223181
RED UPPER-CASE LETTER	4.319198469223181
UNIX CLOCK() FUNCTION	4.319198469223181
CIS-REGULATORY REGION	4.319198469223181
INTERPHASE MORPHOLOGY	4.319198469223181
FORMING DAUGHTER CELL	4.319198469223181
STRUCTURAL ANNOTATION	4.319198469223181
CONVENTIONAL APPROACH	4.319198469223181
MYRISTOYL GROUP CAUSE	4.319198469223181
SIGNALING PATHWAY BMP	4.319198469223181
OSTEOCLAST MORPHOLOGY	4.319198469223181
HINDIII-STYI FRAGMENT	4.319198469223181
INCLUDING CARDIOLIPIN	4.319198469223181
POSITIONAL DEPENDENCY	4.319198469223181
CONVENTIONAL FIXATION	4.319198469223181
compromising analysis	4.319198469223181
DYNAMIC PML-DEPENDENT	4.319198469223181
CROSS-BRACE STRUCTURE	4.319198469223181
MUCOLIPIDOSIS TYPE IV	4.319198469223181
SMAD1 HETERO-OLIGOMER	4.319198469223181
MAXIMAL INTERNAL FLUX	4.319198469223181
SIGNALING EVENTS LEAD	4.319198469223181
OSTEOCLAST POPULATION	4.319198469223181
HSN3 ASSEMBLY PATHWAY	4.319198469223181
PGK/LOXP-NEO CASSETTE	4.319198469223181
SUB-OPTIMAL CONDITION	4.319198469223181
FUNCTIONAL OSTEOCLAST	4.319198469223181
BOI1-GFP KKTK VERSION	4.319198469223181
POSTNATAL TIME PERIOD	4.319198469223181
HORMONE INSENSITIVITY	4.319198469223181
OPTIMAL REPROGRAMMING	4.319198469223181
MHCK-C AMINO-TERMINUS	4.319198469223181
EMISSION FLUORESCENCE	4.319198469223181
INTESTINAL EPITHELIUM	4.319198469223181
STATISTICAL MECHANICS	4.319198469223181
FILOPODIAL PROJECTION	4.319198469223181
IMMUNOGOLD MICROSCOPY	4.319198469223181
NORMAL BLM-CONTAINING	4.319198469223181
SPARSE IMPLEMENTATION	4.319198469223181
FLANKING LOXP ELEMENT	4.319198469223181
MULTI-SUBUNIT COMPLEX	4.319198469223181
INDIVIDUAL TRANSCRIPT	4.319198469223181
TUMOR SUPPRESSOR GENE	4.319198469223181
BLM FUNCTIONAL DOMAIN	4.319198469223181
NK CYTOLYTIC FUNCTION	4.319198469223181
PHARYNGEAL MESENCHYME	4.319198469223181
BLOCKING NON-SPECIFIC	4.319198469223181
TET INCREASING AMOUNT	4.319198469223181
TRANSITIONS GUARANTEE	4.319198469223181
cellular cytotoxicity	4.319198469223181
ANTIRESORPTIVE ACTION	4.319198469223181
DISSECTING MICROSCOPY	4.319198469223181
PATH LENGTHS INCREASE	4.319198469223181
MAJOR PROTEIN-PROTEIN	4.319198469223181
DORSAL BLASTOPORE LIP	4.319198469223181
ARCHITECTURAL FEATURE	4.319198469223181
BOI1 CRITICAL FEATURE	4.319198469223181
TREATED HUVEC CULTURE	4.319198469223181
EMBRYONIC FIBROBLASTS	4.319198469223181
GPNN SOFTWARE PACKAGE	4.319198469223181
PARALLEL WESTERN BLOT	4.319198469223181
QUASI CURRENT VERSION	4.319198469223181
SILICON GRAPHICS IRIX	4.319198469223181
SUPPLEMENTARY WEBSITE	4.319198469223181
HIGHLIGHTS DIFFERENCE	4.319198469223181
QUALITATIVE INDICATOR	4.319198469223181
OPTIMIZATIONPROCEDURE	4.319198469223181
EXPRESSING GFP-MHCK-C	4.319198469223181
ERROR FITNESS MEASURE	4.319198469223181
NETWORKED ENVIRONMENT	4.319198469223181
OSTEOCLAST PROGENITOR	4.319198469223181
MESENCHYME RESORPTION	4.319198469223181
PERCENTAGE DIFFERENCE	4.319198469223181
LIPOSOME-BASED FUGENE	4.319198469223181
NON-BOOTSTRAPPED MODE	4.319198469223181
SELECTED TRANSFORMANT	4.319198469223181
CRNA EQUIMOLAR AMOUNT	4.319198469223181
INTERESTING DISCOVERY	4.319198469223181
EPIGENETIC PROGRAMING	4.319198469223181
HPB-ALL CELLS DISPLAY	4.319198469223181
MONOCLONAL ANTI-PAC-1	4.319198469223181
TRABECULAR CELL DEATH	4.319198469223181
JAW RHYTHMIC MOVEMENT	4.319198469223181
FACSTARTPLUS ANALYZER	4.319198469223181
COLLAGEN/CELL MIXTURE	4.319198469223181
CORRESPONDING GENE ID	4.319198469223181
BLASTN-TYPE ALIGNMENT	4.319198469223181
EXPRESSING C/EBPΑ-GFP	4.319198469223181
CDK2-INTERACTION SITE	4.319198469223181
SECRETED GLYCOPROTEIN	4.319198469223181
MAKE ENDOTHELIAL CELL	4.319198469223181
RETURNED BLAST RESULT	4.319198469223181
BIFUNCTIONAL VESICANT	4.319198469223181
LIEBOVITZ L-15 MEDIUM	4.319198469223181
RING FINGERS FUNCTION	4.319198469223181
BIO-INFORMATIC METHOD	4.319198469223181
MATHEMATICAL FUNCTION	4.319198469223181
DEVELOPMENTAL CASCADE	4.319198469223181
DOMAINS/TWO ORGANELLE	4.319198469223181
INCIDENT FLUORESCENCE	4.319198469223181
ENVELOPING CELL LAYER	4.319198469223181
MOUSE GFP-N280 FUSION	4.319198469223181
POSSIBLE SEGMENTATION	4.319198469223181
RESULTING SPHEROPLAST	4.319198469223181
WITHIN-GROUP VARIANCE	4.319198469223181
CELL-MATRIX INTERFACE	4.319198469223181
FUNDAMENTAL MECHANISM	4.319198469223181
UNIFIED PUBLIC DOMAIN	4.319198469223181
RESIDUAL UPA ACTIVITY	4.319198469223181
RESIDUAL KERATINOCYTE	4.319198469223181
NON-CONSENSUS VARIANT	4.319198469223181
NUMEROUS LAMELLIPODIA	4.319198469223181
EXPRESSING COS-1 CELL	4.319198469223181
MEMBRANE VESICULATION	4.319198469223181
SEMI-CONSERVED REGION	4.319198469223181
ANTI-APOPTOTIC MEMBER	4.319198469223181
PROAPOPTOTIC FUNCTION	4.319198469223181
COIMMUNOPRECIPITATION	4.319198469223181
FUNCTIONAL RELATEDNES	4.319198469223181
INCREASING IMPORTANCE	4.319198469223181
SUBSTRATE UPTAKE RATE	4.319198469223181
HISTOCHEMICAL PURPOSE	4.319198469223181
MESENCHYMAL CELL TYPE	4.319198469223181
FUNCTIONAL NCRNA GENE	4.319198469223181
INTERCELLULAR VESICLE	4.319198469223181
PALINDROMIC STRUCTURE	4.319198469223181
DIFFERENTARCHITECTURE	4.319198469223181
BONDED COIL STRUCTURE	4.319198469223181
DESORPTION/IONIZATION	4.319198469223181
INTRAPULMONARY ARTERY	4.319198469223181
FRACTAL MEMORY LENGTH	4.319198469223181
SCANNED AUTORADIOGRAM	4.319198469223181
KIDNEY MESANGIAL CELL	4.319198469223181
FUNCTIONAL DIVERGENCE	4.319198469223181
HETEROGENOUS VARIANCE	4.319198469223181
TUNED PARAMETER VALUE	4.319198469223181
OBSERVED INTERRUPTION	4.319198469223181
IN VITRO RIBOSYLATION	4.319198469223181
CONTAMINANT ORGANELLE	4.319198469223181
DORSOVENTRAL POSITION	4.319198469223181
NEIGHBORING GENE FALL	4.319198469223181
DMD DUPLICATE PROFILE	4.319198469223181
XERODERMA PIGMENTOSUM	4.319198469223181
GENETIC REPROGRAMMING	4.319198469223181
OSTEOCLAST MATURATION	4.319198469223181
FLUORESCENCE RECOVERY	4.319198469223181
FOLD-CHANGE THRESHOLD	4.319198469223181
RHO CAUSES RETRACTION	4.319198469223181
INDIVIDUAL TRABECULAR	4.319198469223181
COMPENSATORY MUTATION	4.319198469223181
VARIATION INDEPENDENT	4.319198469223181
MEDIATED RIBOSYLATION	4.319198469223181
GENE SELECTION METHOD	4.319198469223181
IMMUNODIAGNOSTIC WORK	4.319198469223181
FINGER-LIKE EXTENSION	4.319198469223181
STIMULATED LUCIFERASE	4.319198469223181
PRENATAL MORPHOGENESI	4.319198469223181
PARAMETER SENSITIVITY	4.319198469223181
UNFOLD-TRAP MECHANISM	4.319198469223181
GENE         ONTOLOGY	4.319198469223181
SIGNALING PATHWAY FGF	4.319198469223181
CORRECTION EFFICIENCY	4.319198469223181
QUANTITATIVE STANDARD	4.319198469223181
STATISTICAL PROCEDURE	4.319198469223181
REDUCING MPF ACTIVITY	4.319198469223181
SENSITIVE PHOSPHATASE	4.319198469223181
DISCUSSING GENE TREND	4.319198469223181
Β-CATENIN-MEDIATED WG	4.319198469223181
DYSTROPHIN DEFICIENCY	4.319198469223181
REQUIREDCOMPUTATIONAL	4.319198469223181
VERSICAN BINDING SITE	4.319198469223181
A PRIORI EQUIPROBABLE	4.319198469223181
FUNCTIONAL CATALOGING	4.319198469223181
BLUE FORMAZAN PRODUCT	4.319198469223181
LIBRARY DEREPLICATION	4.319198469223181
OSTEOMEASURE SOFTWARE	4.319198469223181
STRUCTURED NCRNA GENE	4.319198469223181
H. BRDU-POSITIVE CELL	4.319198469223181
POLYMORPHIC VARIATION	4.319198469223181
SPECIFICITY PHOSPHASE	4.319198469223181
ORDER EPISTASIS MODEL	4.319198469223181
SMAD4 CONSTANT AMOUNT	4.319198469223181
ΜF CAPACITANCE TIMING	4.319198469223181
MANUFACTURING PROCESS	4.319198469223181
MORPHOLOGICAL PROCESS	4.319198469223181
PROLINE-RICH SEQUENCE	4.319198469223181
RAB24 GTPASE ACTIVITY	4.319198469223181
GR-GFP REDISTRIBUTION	4.319198469223181
DETECTED HISTOLOGICAL	4.319198469223181
RABBIT ANTI-MOUSE IGG	4.319198469223181
ASSOCIATED GENE TUMOR	4.319198469223181
TIME-LAPSE EXPERIMENT	4.319198469223181
DIFFERENT METHODOLOGY	4.319198469223181
RESCUE CELL MIGRATION	4.319198469223181
UNWOUNDED DORSAL SKIN	4.319198469223181
INFORMATIVE SUB-STATE	4.319198469223181
LO NON-ESSENTIAL GENE	4.319198469223181
MOLECULAR PERSPECTIVE	4.319198469223181
E10 PRENATAL B6 STAGE	4.319198469223181
DORSAL AXON MIGRATION	4.319198469223181
MM POTASSIUM CHLORIDE	4.319198469223181
CYTOSKELETAL MATERIAL	4.319198469223181
SERIES REPRESENTATION	4.319198469223181
BIND NON-SPECIFICALLY	4.319198469223181
HEMATOPOEITIC LINEAGE	4.319198469223181
INCLUDING HU-POSITIVE	4.319198469223181
FULL LENGTH HUMAN BID	4.319198469223181
CONSTRAINING APPROACH	4.319198469223181
trunk-tail projection	4.319198469223181
CHROMOPHOBE CARCINOMA	4.319198469223181
MEMBRANE PRESERVATION	4.319198469223181
DETERMINING STRUCTURE	4.319198469223181
CRE-MEDIATED DELETION	4.319198469223181
FLUORESCENT DETECTION	4.319198469223181
microarray expression	4.319198469223181
ALIGNED PSEUDO-GENOME	4.319198469223181
PROBE ACTIN-DEPENDENT	4.319198469223181
TRIPLICATE EXPERIMENT	4.319198469223181
SUBSTRATE DOMAIN LEAD	4.319198469223181
MAKING EXCISION WOUND	4.319198469223181
TUMOR SUPPRESSOR PTEN	4.319198469223181
CELLULAR SYSTEMS LEAD	4.319198469223181
CASEINOLYTIC ACTIVITY	4.319198469223181
DATA FILE SUPPLEMENT1	4.319198469223181
HIGH-GC PARAMETER SET	4.319198469223181
REGARDING DEGRADATIVE	4.319198469223181
ELUCIDATING MECHANISM	4.319198469223181
TIME LAPSE MICROSCOPY	4.319198469223181
DISRUPTED MICROTUBULE	4.319198469223181
BASAL ACTINOPTERYGIAN	4.319198469223181
EXPRESSING GFP-MHCK-B	4.319198469223181
SUSTAINED RHYTHMICITY	4.319198469223181
SIGNIFICANCE/FUNCTION	4.319198469223181
TPR DOMAIN PROTEOLYSI	4.319198469223181
APURINIC/APYRIMIDINIC	4.319198469223181
SINGLET/PAIR EMISSION	4.319198469223181
DAMAGE-INDUCIBLE GENE	4.319198469223181
SEQUENCE ENTRY OUTPUT	4.319198469223181
ASSESSING VARIABILITY	4.319198469223181
FORMED MICROEXTENSION	4.319198469223181
GENE DISCOVERY METHOD	4.319198469223181
SUSTAINED OSCILLATION	4.319198469223181
PLM AXONAL MORPHOLOGY	4.319198469223181
BIND RB FAMILY MEMBER	4.319198469223181
FOLD-CHANGE CRITERION	4.319198469223181
ASCII TEXT CONVERSION	4.319198469223181
RHOA STAINING PATTERN	4.319198469223181
SUBCORTICAL STRUCTURE	4.319198469223181
EMBRYONIC SMG EXPLANT	4.319198469223181
RED DONKEY ANTI-MOUSE	4.319198469223181
ESTABLISHED TECHNIQUE	4.319198469223181
PRODUCTION/ACTIVATION	4.319198469223181
ZEBRAFISH NEUROGENESI	4.319198469223181
DISTRIBUTED MYOSIN-II	4.319198469223181
PROGRESSIVE ALIGNMENT	4.319198469223181
ZEBRAFISH NEURAL CELL	4.319198469223181
PHOSPHATASE INHIBITOR	4.319198469223181
BLOOD GROUP PRECURSOR	4.319198469223181
DECREASED DEGRADATION	4.319198469223181
COMPREHENSIVE PICTURE	4.319198469223181
TARGET SEQUENCE GROUP	4.319198469223181
CONTACT SITE MEMBRANE	4.319198469223181
GFP-MYOSIN-II DYNAMIC	4.319198469223181
BACKGROUND AFFYMETRIX	4.319198469223181
PATHOLOGICAL VARIABLE	4.319198469223181
VASCULAR NETWORK SHOW	4.319198469223181
TWO-HYBRID EXPERIMENT	4.319198469223181
DEVELOPMENTAL NETWORK	4.319198469223181
PARALLEL CELL CULTURE	4.319198469223181
ESTABLISHED CELL LINE	4.319198469223181
POLARIZED RECRUITMENT	4.319198469223181
TREE REPRESENTATIONOF	4.319198469223181
DUPLICATION INFERENCE	4.319198469223181
INTERESTING CANDIDATE	4.319198469223181
FLANKING NONCONSERVED	4.319198469223181
SPARC-NULL MOUSE LENS	4.319198469223181
BETTER SCE CORRECTION	4.319198469223181
SIGNALING PATHWAY WNT	4.319198469223181
OTHER EGF-LIKE MODULE	4.319198469223181
SPECTRAL COMPENSATION	4.319198469223181
SIGNALING ACTIVITY WG	4.319198469223181
COORDINATED VARIATION	4.319198469223181
CHR SAMPLE RELATEDNES	4.319198469223181
MATERNAL TRANSRIPTION	4.319198469223181
DEVELOPMENTAL PATTERN	4.319198469223181
ZEBRAFISH NEURAL TUBE	4.319198469223181
STATISTICAL THRESHOLD	4.319198469223181
THIOCYANATE PROCEDURE	4.319198469223181
INCLUDING FLUORESCEIN	4.319198469223181
SΑ I2 MISLOCALIZATION	4.319198469223181
C-APAF1-CASP9 PATHWAY	4.319198469223181
PUNCTATE MICROCLUSTER	4.319198469223181
MONOPHYLETIC ANCESTRY	4.319198469223181
OTHER STEROID HORMONE	4.319198469223181
C-CODE IMPLEMENTATION	4.319198469223181
ACTIVATED C-RAF LEVEL	4.319198469223181
MOLECULAR WEIGHT BAND	4.319198469223181
SPECIFICIED CELL TYPE	4.319198469223181
ALLOWANCE/STIMULATION	4.319198469223181
MMCOP1 CO-FRACTIONATE	4.319198469223181
ADENO-Β GALACTOSIDASE	4.319198469223181
YEAST TWO-HYBRID DATA	4.319198469223181
TNF-MEDIATED RECOVERY	4.319198469223181
SYSTEMATIC DIFFERENCE	4.319198469223181
REFERENCED TIME POINT	4.319198469223181
REDUCTIONIST APPROACH	4.319198469223181
GERMLINE TRANSMISSION	4.319198469223181
RED LOWER-CASE LETTER	4.319198469223181
EXPERIMENTAL PLATFORM	4.319198469223181
TERTIARY BASE PAIRING	4.319198469223181
DUPLICATED PROBE PAIR	4.319198469223181
INDIVIDUAL DATA POINT	4.319198469223181
CELL-SPECIFIC PATTERN	4.319198469223181
K-A31 TUMOR CELL LINE	4.319198469223181
AFFYMETRIX EXPERIMENT	4.319198469223181
STRUCTURE PERSPECTIVE	4.319198469223181
ERROR-FREE PREDICTION	4.319198469223181
CIRCADIAN OSCILLATION	4.319198469223181
LFC-SELECTED DATA LIE	4.319198469223181
POLAR CORTICAL REGION	4.319198469223181
GNRH PERMITS RECOVERY	4.319198469223181
CCAF-INDUCED INCREASE	4.319198469223181
NON-INTEGER DIMENSION	4.319198469223181
ESTABLISHED PROCEDURE	4.319198469223181
AVERAGE BRANCH LENGTH	4.319198469223181
MOLECULAR CHRONOMETER	4.319198469223181
CAROTID ARTERIAL WALL	4.319198469223181
AGING EPITHELIAL CELL	4.319198469223181
LENS CULINARIS LECTIN	4.319198469223181
factor concentrations	4.319198469223181
STAUROSPORINE APOPTOSI	4.319021709260772
PP5 EXPRESSION ABLATE	4.318709699697945
NAC FORCED EXPRESSION	4.318709699697945
GENE EXPRESSION SCORE	4.318709699697945
TF EXPRESSION PATTERN	4.318709699697945
TUMOR GENE EXPRESSION	4.318709699697945
PP5 EXPRESSION RESULT	4.318709699697945
GENE EXPRESSION PANEL	4.318709699697945
DELTA GENE EXPRESSION	4.318709699697945
GENE EXPRESSION RATIO	4.318709699697945
BROAD GENE EXPRESSION	4.318709699697945
DISCUSSION EXPRESSION	4.318465314935327
INDIVIDUAL EXPRESSION	4.318465314935327
ANALYTICAL EXPRESSION	4.318465314935327
DELTAGENES EXPRESSION	4.318465314935327
DESCRIBING EXPRESSION	4.318465314935327
GFP-C/EBPΑ EXPRESSION	4.318465314935327
EXPRESSION DIFFERENCE	4.318465314935327
KAPLAN MEIER ANALYSIS	4.318299599485266
DATA CLUSTER ANALYSIS	4.318299599485266
P35-C/EBPΒ TRANSACTIVATE	4.31806316583519
PRIMARY RAT HEPATOCYTE	4.317906585329639
HISTOLOGICAL ANALYSIS	4.317850164616309
IN SILICO STUDY BUILD	4.317806604005933
WTMUTANT	4.31774228780058
Y187 NEGATIVE CONTROL	4.317480117103122
MEC-3 CONTROL ELEMENT	4.317480117103122
Y187 POSITIVE CONTROL	4.317480117103122
BOOLEAN USM ALGORITHM	4.317227418261936
SEDIMENTING MYOSIN II	4.317194676551616
MYOSIN MOTOR ACTIVITY	4.317194676551616
DISASSEMBLE MYOSIN II	4.317194676551616
NEURONAL SPECIFICATION	4.316945784687488
RRNA INTRON/RRNA GENE	4.316905155177018
COMMERCIAL MICROARRAY	4.316890529449683
INDIVIDUAL MICROARRAY	4.316890529449683
MICROARRAY GENERATION	4.316890529449683
DESCRIBING MICROARRAY	4.316890529449683
KINASE INACTIVE C-SRC	4.316874224159054
GENE EXPRESSION STUDY	4.3168538794082805
BALB/C MOUSE INTRON I	4.316678378996966
COLLAGEN CONCENTRATION	4.3166031136090055
WG SYNERGISTIC EFFECT	4.316576114466047
ULTRASTRUCTURAL STUDY	4.316414738788684
CYK/OUTSIDE ALGORITHM	4.3162418927813135
RESPONSE GENE PRODUCT	4.3161368367656125
SOLE MITOGENIC FACTOR	4.316100139116293
ANGIOGENIC FACTOR CEF	4.316100139116293
MIGRATION FACTOR BIND	4.316100139116293
CELL MIGRATION FACTOR	4.316100139116293
TUMOR NECROSIS FACTOR	4.316100139116293
FACTOR RELATIVE LEVEL	4.316100139116293
PEAK FORCE REQUIREMENT	4.3159302891170075
MODIFIED PCMV6 VECTOR	4.315790889595267
YIELD BETTER STATISTICS	4.315787913704093
DOSE-DEPENDENT EFFECT	4.31526493708748
P53 POTENTIAL PARTNER	4.315190883880052
EXTRACELLULAR PORTION	4.315159574619559
INCREASED RATE ALANINE	4.31513635621645
PROTEIN PHOSPHATASES TYPE 1 ISOFORM	4.315088998597819
AUTOANTIBODIES EXHIBIT	4.3150823996115575
RNA ALIGNMENT PROBLEM	4.315078649591071
STRUCTURAL RNA REGION	4.315078649591071
EFFECTOR MOLECULE	4.315053147588473
IN VITRO RGS3 PROTEIN	4.314963419995744
TM MACROPHAGE ABUNDANCE	4.314945490812524
ISL1-CRE MOUSE STRAIN	4.314920869264735
REGENERATIVE RESPONSE	4.314606020536829
TEMPORAL LOCALIZATION	4.31455891849902
GFP-NFAT LOCALIZATION	4.31455891849902
OBSERVED LOCALIZATION	4.31455891849902
ARP3-GFP LOCALIZATION	4.31455891849902
GFP-N280 LOCALIZATION	4.31455891849902
GFP-MHCK LOCALIZATION	4.31455891849902
GOLGI/ER LOCALIZATION	4.31455891849902
COMPONENT ERROR MODEL	4.314486425518955
CONTAINING GST PROTEIN	4.314432682812297
SRC KM/CAS(SD) FUSION	4.314334424109141
RNA ANALYSIS CIRCULAR	4.314179779853156
PRESENTATION MODE MAP	4.3141300524656945
BIDIMENSIONAL CGR MAP	4.3141300524656945
HYBRIDIZATION PATTERN	4.31405805790948
MAMMALIAN PP5 HOMOLOG	4.313953759708912
SRE-CAT REPORTER GENE	4.313860932991846
C-TERMINAL DISRUPTION	4.313813276418352
PROFILE REPRESENTATIVE	4.313746973640473
NUCLEOSOMAL REPRESSION	4.313746973640473
CYTOSKELETON BACKBONE	4.3137153638219
CYTOPLASMIC Β-CATENIN	4.31368193025238
ACTIVATION DOMAIN B42	4.3136395605214215
FORMULATING RECOMMENDATION	4.313624195314959
TAGGED C/EBPΒ PROTEIN	4.313551736919931
RETICULUM PROTEIN PDI	4.313551736919931
LENGTH FUSION PROTEIN	4.313551736919931
C/EBPΑ FUSION PROTEIN	4.313551736919931
EXPRESSED RAB PROTEIN	4.313551736919931
DIFFERENT RAB PROTEIN	4.313551736919931
C-CRK ADAPTOR PROTEIN	4.313551736919931
NORMAL FUSION PROTEIN	4.313551736919931
BINDING PROTEIN ALPHA	4.313551736919931
BLOCKED PROLIFERATION	4.31354401677811
HSCOP1 N TERMINAL END	4.31354401677811
SUBCELLULAR ORGANELLE	4.313361615086333
HIGH-INTENSITY SIGNAL	4.313342725590744
ELK-1 DELETION MUTANT	4.313334592613478
A-BOX DELETION MUTANT	4.313334592613478
MRNA TRANSCRIPT LEVEL	4.313323713436094
ENCODING Β-ACTIN MRNA	4.313323713436094
MYOSIN II MUTANT FORM	4.31329771726223
PROFESSOR SHMUEL SHALTIEL	4.312901509921525
WHOLE GENOME SEQUENCE	4.31268974698425
OCL RESPONSE MODULATION	4.312644863829457
GFP CONTROL CELL LINE	4.312524512328307
CELL SURFACE INTEGRIN	4.312421597378901
REPEATED DNA SEQUENCE	4.312407724560386
HUMAN U95 SERIES CHIP	4.31223914313694
PARTICULATE COMPONENT	4.312130403666842
TABULAR DISPLAY TABLE	4.312102685762699
EXPRESSING GFP FUSION	4.3120182121500745
TREATMENT VARIABILITY	4.311813061947986
WHOLE GENOME ANALYSIS	4.311790877246335
linker	4.311726111506282
NONFAT	4.311726111506282
N-TERMINAL MYC EPITOPE	4.31153041858537
ΜM FINAL CONCENTRATION	4.311515433591854
CONTROL HYBRIDIZATION	4.3114805297293906
EXPRESSING CD8 T CELL	4.311399224471359
MYOSIN-II QUANTITATION	4.311333835482199
HISTOLOGIC EXAMINATION	4.311333835482199
NON-INTEGRIN RECEPTOR	4.311331404951778
ANTIBODY CONCENTRATION	4.311264599277669
SINGLE DIFFERENTIATION	4.311218948604272
PULSE PRESSURE	4.310930361421179
TEST SEQUENCE DATASET	4.310879274821237
DNA MICROARRAY ANLYSI	4.310869098044721
COMPRISING ACTIVATION	4.310860106170542
SOFTWARE DISTRIBUTION	4.310860106170542
ANTECEDENT ACTIVATION	4.310860106170542
DISTRIBUTION FUNCTION	4.310860106170542
STANDARD DISTRIBUTION	4.310860106170542
GFP-NFAT DISTRIBUTION	4.310860106170542
BINOMIAL DISTRIBUTION	4.310860106170542
SUPPRESSED ACTIVATION	4.310860106170542
SHORT-TIME ACTIVATION	4.310860106170542
G PROTEIN SUBUNIT	4.310838554678965
HITRAP HEPARIN COLUMN	4.31082150263789
ANTIAPOPTOTIC PROTEIN	4.310728370768305
RECOMBINATION PROTEIN	4.310728370768305
PROTEIN (GFP)-LABELED	4.310728370768305
ACTIN-BINDING PROTEIN	4.310728370768305
ELK-1(89-428) PROTEIN	4.310728370768305
STRAND CDNA SYNTHESIS	4.310622996320704
CONTAINING CDNA PECFP	4.310622996320704
SPOTTED CDNA FRAGMENT	4.310622996320704
LABELED CDNA FRAGMENT	4.310622996320704
TYROSINE LOCALIZATION	4.310501912260404
PROTEASOME MATURATION	4.310240920795345
SAN DIEGO CALIFORNIA USA	4.3102290996382875
BINDING PROTEIN ACTIN	4.310210232243249
INCLUDED CONSERVATION	4.310151345311067
ADHESION PERIOD PLATE	4.310059960221046
JUKES-CANTOR EVOLUTION	4.310029436477727
ACTIVATING FIBROBLAST	4.310013571850477
FIBROBLAST RETRACTION	4.310013571850477
STANDARD DENSITY CHIP	4.309919367774859
LIPID TPR DOMAIN BIND	4.309839375520994
ABLATED PRIMARY MOTOR	4.30981105141554
DISTRIBUTION ANALYSIS	4.309511801563669
MEGABASE-SIZED GENOME	4.309435385864785
COLI METABOLIC RESEARCH	4.309399540109694
SCE FREQUENCIES CLOSE	4.309310902106117
RAPID PHOSPHORYLATION	4.309229186675397
BLOCK PHOSPHORYLATION	4.309229186675397
SMAD1 PHOSPHORYLATION	4.309229186675397
LEVEL PHOSPHORYLATION	4.309229186675397
ESCHERICHIA COLI K-12	4.3091461093208325
CDNA MICROARRAY PROBE	4.309084369805038
SLIDE CDNA MICROARRAY	4.309084369805038
SEQUENCE-SPECIFIC DNA	4.309012352228989
INTRODUCING TRANSGENE	4.308917646595779
MAXIMAL TRANSCRIPTION	4.308751443920509
ALTERED TRANSCRIPTION	4.308751443920509
ENVIRONMENT DEPENDENT	4.30873936643461
OTHER QRNA IMPROVEMENT	4.308652570861894
CELLULAR HETEROGENEITY	4.308652570861894
AMPLIFIED PRODUCT PCR	4.30852339676051
HIV-1RT	4.3085200501130565
PREDICTED START CODON	4.308428083613522
YEAST CCR4 C-TERMINUS	4.308428083613522
FINAL SELECTION LEVEL	4.308428083613522
GΑ EXTREME C-TERMINUS	4.308428083613522
WILD-TYPE DORSAL SKIN	4.308428083613522
FINAL INPUT PARAMETER	4.308428083613522
PRELOADING	4.308073339968403
PEGFP-CPLA	4.308073339968403
expansions	4.308073339968403
STANDARD MOTIF FINDER	4.3080291804427935
XHOI RESTRICTION SITE	4.3080291804427935
FLAG ANTIBODY EPITOPE	4.307854113220531
RABBIT WAVE1 ANTIBODY	4.307854113220531
IDURONIC ACID RESIDUE	4.307764505353211
CHARGED GLUTAMIC ACID	4.307764505353211
DISSIMILAR AMINO ACID	4.307764505353211
CHARGED ASPARTIC ACID	4.307764505353211
ASPARTIC ACID RESIDUE	4.307764505353211
FOCAL ADHESION KINASE	4.307735715156919
MUTANT FUSION PROTEIN	4.307687860310227
P120 PROTEIN KINASE N	4.307565783752577
MEAN FITC-FLUORESCENCE	4.307410033598827
CHEMOKINE UNKNOWN ROLE	4.307197027210871
IL-1-MEDIATED CYTOKINE	4.307197027210871
COMPONENT FIBRONECTIN	4.306960618574205
E. COLI GENOME SCREEN	4.306777657617221
PRIMARY RESPONSE GENE	4.306749418957971
RECEPTOR LOCALIZATION	4.3066918542276165
LIMITING TUMOR GROWTH	4.3065804442411535
POLARIZED CELL GROWTH	4.3065804442411535
INCREASED L929 GROWTH	4.3065804442411535
INCLUDING CELL GROWTH	4.3065804442411535
BASE PAIR INTERACTION	4.306553991358591
software package	4.306093181027621
EMBEDDING MEDIUM	4.306093181027621
PATHWAY ACTIVITY	4.306093181027621
OSMIUM TETROXIDE	4.306093181027621
METASTATIC TUMOR	4.306093181027621
CRYOSTAT SECTION	4.306093181027621
EMBRYONIC TISSUE	4.306093181027621
MULTI-FUNCTIONAL	4.306093181027621
tumor suppressor	4.306093181027621
FLUIDICS STATION	4.306093181027621
PLYMOUTH MEETING	4.306093181027621
SEQUENCE ELEMENT	4.306093181027621
SENSITIVE METHOD	4.306093181027621
DESCENDING ORDER	4.306093181027621
SPECIFIED LENGTH	4.306093181027621
AZ CYTOPLASMIC SIGNAL	4.306032303097496
SINGLE BASE FREQUENCY	4.305879885125432
INFLAMMATORY REACTION	4.30559377161098
CROSSLINKED POLYPEPTIDE	4.3054682332823715
PARAMETRIC PERTURBATION	4.3054682332823715
ASSOCIATED DISADVANTAGE	4.3054682332823715
REPRESENTATIVE PROTEIN	4.305161906348309
AQUEOUS STOCK SOLUTION	4.304988175880811
MULTIPLE OUTPUT VALUE	4.304708581075651
MULTIPLE BRAIN REGION	4.304708581075651
LYMPHOCYTE MORPHOLOGY	4.304606333881062
IDENTIFIED RELATIONSHIP	4.304530080516761
REGULATORY RELATIONSHIP	4.304530080516761
RECOGNIZED RELATIONSHIP	4.304530080516761
E. COLI MUTANT STRAIN	4.3040530918703075
MUTANT E. COLI STRAIN	4.3040530918703075
HOMOLOG IDENTIFICATION	4.304021295608641
GENETIC ANALYSIS	4.30397758618264
CIRCUMSTANTIAL EVIDENCE	4.303894044743465
CD9 CARBOXYL TERMINUS	4.303733300142644
intracellular distribution	4.3037042565869035
CHIMERIC CAS MOLECULE	4.303633524858253
HELPER T-CELL EPITOPE	4.303326322008946
EXPRESSION CALCULATION	4.303278189854877
ERRATIC CONTAMINATION	4.303042890808692
WILD-TYPE COUNTERPART	4.303042890808692
S. CEREVISIAE HOMOLOG	4.30289734505721
TUMORIGENIC PHENOTYPE	4.302848245285626
BLM N-TERMINAL DOMAIN	4.30270631625839
HSCOP1 N-TERMINAL END	4.30270631625839
STRIKING ACCUMULATION	4.302547320918677
ADDRESSED TRANSLATION	4.3024445360526
PROTEOMIC TRANSLATION	4.3024445360526
CDK7-CYCLIN H COMPLEX	4.3024445360526
UPA COMPLEX FORMATION	4.302287957237922
hybridization behavior	4.3022845673886705
SKP2-ΔF OVEREXPRESSING	4.3022845673886705
PROTEIN SAMPLE BUFFER	4.302251660214714
HIGH-DETERGENT BUFFER	4.302248354165356
NEUTRALIZING ANTIBODY	4.302181935219205
GAD1 MRNA TRANSLATION	4.302154424655706
RHODAMINE-PHALLOIDIN ΜL	4.302070289728878
INTERNAL CONTROL	4.30204883874562
FUNCTIONAL STUDY	4.301725291363059
BASE PAIR PROBABILITY	4.301716104175617
DEFECTIVE DEVELOPMENT	4.301631238325872
VIBRISSAL DEVELOPMENT	4.301631238325872
REGULATED DEVELOPMENT	4.301631238325872
LOW-LEVEL COMMON NAME	4.301545544516617
KERATINOCYTE MOTILITY	4.301459010571977
CURRENT VERSION	4.3014420015518295
MAMMALIAN CELL GROWTH	4.301335734726885
ARCHAEA RRNA SEQUENCE	4.301033007962783
GENERAL DNA TECHNIQUE	4.301027694482255
CRW RDBMS INFORMATION	4.301000231468929
TESTED AZ INTERACTION	4.300969346968397
TOXIC MISFOLDED PROTEIN	4.300817969645225
BLOCKED INCORPORATION	4.300734951035193
STIMULATED MACROPHAGE	4.300734951035193
MACROPHAGE MATURATION	4.300734951035193
GROWTH CHARACTERISTIC	4.300271431750139
MOLECULAR INTERACTION	4.3002317524262965
CELL-CELL INTERACTION	4.3002317524262965
TRANSIENT INTERACTION	4.3002317524262965
CYTOSOLIC ENVIRONMENT	4.299949269410172
SECONDARY EFFECT	4.299921163023349
CNS	4.299838459093062
AFFECTED JNK ACTIVITY	4.299742288767022
SUPER-ORTHOLOG ABSENCE	4.29971137414847
GLUCOCORTICOID ABSENCE	4.29971137414847
MG/ML ACRIDINE ORANGE	4.299423334989052
PURIFICATION PROCEDURE	4.299268144690828
STOCK PROTEIN SOLUTION	4.299264797686035
SEPHAROSE BEAD COLUMN	4.299093749418483
INACTIVATION PROTOCOL	4.299093749418483
THROMBIN MOLAR EXCESS	4.299093749418483
TWO-HYBRID ASSAY MONITOR	4.2990774039843345
NUMEROUS T LYMPHOCYTE	4.299071385992671
TRANSGENE SINGLE COPY	4.29902600337383
BIOINFORMATIC APPLICATION	4.298967773651449
RIBOSOMAL PROTEIN L16	4.298473197066407
RIBOSOMAL PROTEIN S16	4.298473197066407
SERINE PROTEASES SHOW	4.298400483218321
PERFUSION CHAMBER	4.298142891262279
MICROARRAY STUDY	4.298103954268716
RHO GTPAS RELATIONSHIP	4.297846261937636
ATPASE ACTIVITY	4.297695854330894
TOUCH NEURON-SPECIFIC	4.297657698003862
CONSERVED DNA-BINDING	4.297657698003862
TUMOR REJECTION ANTIGEN	4.297582439752565
NONCODING SEQUENCE KB	4.297266047618057
ACTIVITY ASSAY BUFFER	4.297166335682717
TRIS HCL	4.297140191372349
CLASSIFICATION SCHEMA	4.297132313339977
CLASSIFICATION SYSTEM	4.297132313339977
COLLECTION TECHNOLOGY	4.297132313339977
DEGRADATION MACHINERY	4.297132313339977
MOLECULAR SIGNAL	4.296905063610257
DETAILED VISUALIZATION	4.296355736568772
PITUITARY CELLS TOTAL	4.296352196717843
DIMENSION MAKES TOTAL	4.296352196717843
glucocorticoid receptors	4.296301870843796
ABUNDANT MRNA SPECIES	4.296213313602308
ΜG PHOSPHOCREB PEPTIDE	4.296046885846992
REPLICATING HELA CELL	4.296000715602376
CELL-SURFACE MOLECULE	4.29585105267579
CYTOSKELETAL MOLECULE	4.29585105267579
ACTIN NUCLEATION ARP2	4.295752244741802
CELL LYSI KINASE ASSAY	4.29573072218615
PROTEIN IDENTIFICATION	4.295436228316477
PROTEIN PHOSPHATASE TYPE 5 ABILITY	4.295419564665994
ECFP CHROMA FILTER SET	4.295407123637589
OTHER GLYCOSAMINOGLYCAN	4.29514855286065
BGL II	4.294885136125975
SMAD1-DEPENDENT MANNER	4.294867716284563
DSH-INDEPENDENT MANNER	4.294867716284563
MEASUREMENT THRESHOLD	4.294746782974224
REPLICATE MEASUREMENT	4.294746782974224
UBIQUITOUS REQUIREMENT	4.294097134351668
EUKARYOTIC CHLOROPLAST	4.294097134351668
PARAMETER PERTURBATION	4.294097134351668
RESULTING PLASMID DNA	4.294068959873669
ACCELERATED FORMATION	4.293832701245291
CONCOMINANT FORMATION	4.293832701245291
CHELERYTHRINE ADDITION	4.2934218821424315
MULTIPLE PROTEIN MRNA	4.293187092985313
TBID TEST ASSOCIATION	4.293139816170034
PHOSPHORYLATION ASSAY	4.293131101422525
ADHERENT CELL APOPTOSI	4.293106134749131
CLINICAL TRIAL	4.2930609754590545
PROBABILITY PARAMETER	4.292974921651836
POSTERIOR PROBABILITY	4.292974921651836
statistical approaches	4.292906235000832
SODIUM DODECYLSULFATE	4.292589281246375
PRODUCEAN ASSOCIATION	4.292589281246375
CHANGE	4.292426119732533
EXTENSIVE INFORMATION	4.291901112591803
FREQUENCY INFORMATION	4.291901112591803
CO-TRANSFECTED PLASMID	4.291845830790377
WOUND FIBROBLAST	4.2916813623374415
AXONAL GUIDANCE DEFECT	4.2916712282666305
HOMOLOGY-BASED CLONING	4.2916712282666305
AVERAGED LYSOSOMAL PH	4.291335949928627
ELEVATED LYSOSOMAL PH	4.291335949928627
ALGORITHM MODIFICATION	4.291100426834857
RELATIVE SIGNIFICANCE	4.290926206997825
INCREASED PERFORMANCE	4.290926206997825
AMPLIFICATION PROTOCOL	4.290822161136868
tyrosine kinase domain	4.290800390184822
COLLAGEN ACCUMULATION	4.290797809344503
ESTABLISHED G PROTEIN	4.2900527137715825
SURVIVAL CLASSIFICATION	4.289959670397195
EXHIBIT NEGATIVE BIAS	4.289919751060999
SIGNIFICANCE ANALYSIS	4.289577902390953
DISCRIMINATION ABILITY	4.289571716818489
GEL FILTRATION BUFFER	4.289528597772556
GFP FLUORESCENCE	4.2891936079206845
QIAGEN MAXIPREP COLUMN	4.2890587140212055
SYSTEMATIC MUTAGENESIS	4.2890587140212055
QIAGEN RNEASY MINI-KIT	4.2890587140212055
GΑ SUBUNIT C-TERMINUS	4.288971903157362
SIGNALOSOME SUBUNIT CSN5	4.288958834789232
RHO EFFECTOR MOLECULE	4.288554985004731
AVERAGE CONCENTRATION	4.288530252571947
DILUTED CONCENTRATION	4.288530252571947
MOLECULAR COMPOSITION	4.288001490215891
SUBCELLULAR LOCATION	4.287490739386115
CONTROLLING CHROMATIN	4.287454174794711
ADENOVIRUS PREPARATION	4.287202453899456
NUCLEOTIDE SEQUENCING	4.2871170470166025
ADDITIONAL VALIDATION	4.286887312394202
MAMMALIAN MODIFICATION	4.286123286524328
MICROARRAY VALIDATION	4.284579372620704
CYTOSKELETAL FRACTION	4.283892619810053
FIBRONECTIN SEPHAROSE	4.283871604423498
CYTOPLASM COMPARTMENT	4.283719551920774
CONSERVED DOMAIN ORGANIZATION	4.283641028247999
SENSE OLIGONUCLEOTIDE	4.283628580337947
COMPUTER	4.283570300683746
CONTINUING IMPROVEMENT	4.283180556968999
ATHEROSCLEROTIC PLAQUE	4.283180556968999
ETHANOL GRADED SERIES	4.283009973574725
STANDARD METHOD	4.282140961093433
MARKED INCREASE	4.282140961093433
BINDING PARTNER	4.282140961093433
GOAT ANTI-MOUSE	4.282140961093433
MULTIFUNCTIONAL	4.282140961093433
TARGET SEQUENCE	4.282140961093433
CRITICAL RESEARCH AREA	4.28196760392648
INTERNAL RESEARCH DATA	4.28196760392648
BOUND PROTEIN ELUTION	4.28180744249146
STATISTICAL CONFIDENCE	4.281554683741793
HYDROCHLOROTHIAZIDE	4.281307467920233
AFFYMETRIX RECOMMENDATION	4.281202259907102
LUCIFERASE ASSAY	4.280834032611559
TRANSLATION MACHINERY	4.280378380169394
CHARACTERIZATION STUDY	4.28035904158394
P27 LEVEL DETERMINANT	4.280286108310863
LAMIN CO-LOCALIZATION	4.2798631478661635
NUCLEAR TRANSLOCATION	4.2795313147633625
PROTEIN PHOSPHATASE 5 TPR DOMAIN	4.279406345249637
P53-MEDIATED APOPTOSI	4.2791669474881635
TNF-MEDIATED APOPTOSI	4.2791669474881635
POTENTIATING APOPTOSI	4.2791669474881635
MITOCHONDRIA FRACTION	4.279080319856801
CLEAVAGE GROOVE REACH	4.278989029613785
PERIOD GENE HOMOLOGUE	4.278989029613785
CYTOPLASMIC AGGREGATE	4.278885299821172
EXPERIMENTAL OBJECTIVE	4.27808615419042
FIBROBLAST PREPARATION	4.277892885370073
PROTEIN PHOSPHATASE T1	4.277457178774223
HNF3ΑLACZ TRANSGENIC	4.277004288613059
OVERESTIMATION ERROR	4.277004288613059
SYNERGISTIC ACTIVITY	4.277004288613059
SPARC-NULL MICE SCAB	4.277004288613059
FLANKED NEO CASSETTE	4.277004288613059
LACKING WHITE SECTOR	4.277004288613059
ROUND-ROBIN TRAINING	4.277004288613059
FILOPODIAL PRECURSOR	4.277004288613059
MITOCHONDRIAL VOLUME	4.277004288613059
INTERACTING POSITION	4.277004288613059
UNDERLYING ADENOSINE	4.277004288613059
INCREASED PROTEOLYSI	4.277004288613059
BRANCHED FINGER-LIKE	4.277004288613059
PROTEASE-SENSITIVITY	4.277004288613059
FLUORESECENT DEXTRAN	4.277004288613059
IMMUNO-ISOLATE SΑ I2	4.277004288613059
MULTI-UBIQUITINATION	4.277004288613059
SM CORE SPLICEOSOMAL	4.277004288613059
APOPTOSIS-ASSOCIATED	4.277004288613059
DOTMAC/PFA-EXTRACTED	4.277004288613059
TE/CCD-512TKB CAMERA	4.277004288613059
PARTICULATE MATERIAL	4.277004288613059
G-25 SEPHADEX COLUMN	4.277004288613059
CONSENSUS RGS DOMAIN	4.277004288613059
WEIGHTED COMBINATION	4.277004288613059
EMBRYONIC TRANSCRIPT	4.277004288613059
PRO-APOPTOTIC MEMBER	4.277004288613059
STABILITY ROBUSTNESS	4.277004288613059
NORMAL TRANSMEMBRANE	4.277004288613059
HUMAN SALIVARY GLAND	4.277004288613059
METABOLIC BY-PRODUCT	4.277004288613059
SUPPRESSIVE ACTIVITY	4.277004288613059
TRANSGENIC OFFSPRING	4.277004288613059
SPEARMAN CORRELATION	4.277004288613059
RAPID SOLUBILIZATION	4.277004288613059
EGF-LIKE MODULE BIND	4.277004288613059
OSTEOCLAST PRECURSOR	4.277004288613059
FINANCIAL LIMITATION	4.277004288613059
SN50-TREATED SECTION	4.277004288613059
GENOTYPIC DIFFERENCE	4.277004288613059
GENERATED SPARC-NULL	4.277004288613059
TRI-HYDROXY STILBENE	4.277004288613059
INCLUDING CORRECTION	4.277004288613059
MODEL PALMITOYLATION	4.277004288613059
MODEL NONLINEAR DATA	4.277004288613059
CELLULAR DYSFUNCTION	4.277004288613059
CRITICAL POINT DRYER	4.277004288613059
OUTPUT FIELD SORTING	4.277004288613059
STANDARD GP OPERATOR	4.277004288613059
GHFT1-5 CELL CULTURE	4.277004288613059
OVERESTIMATION NOISE	4.277004288613059
INSTALLING FASTGROUP	4.277004288613059
RECIRCULATING SYSTEM	4.277004288613059
GENERALIZED DECREASE	4.277004288613059
SMAD-RESPONSIVE GENE	4.277004288613059
EVOLUTIONARY HISTORY	4.277004288613059
GENETIC EPIDEMIOLOGY	4.277004288613059
EPISTASIS EXPERIMENT	4.277004288613059
NM-MYOSINII FUNCTION	4.277004288613059
STIMULATED MIGRATION	4.277004288613059
REEPITHELIALLIZATION	4.277004288613059
OTHER P53-REGULATORY	4.277004288613059
REDUCED PROCESSIVITY	4.277004288613059
ENDOTHELIAL-LINED SC	4.277004288613059
INDEPENDENT MUTATION	4.277004288613059
ANTIBIOTIC SELECTION	4.277004288613059
CYTOSKELETAL ELEMENT	4.277004288613059
EVALUATETHE APPROACH	4.277004288613059
GROWING GHFT1-5 CELL	4.277004288613059
COMPUTATIONAL RESULT	4.277004288613059
FASTGROUP EXECUTABLE	4.277004288613059
RRR-ALPHA-TOCOPHEROL	4.277004288613059
MODELING FLEXIBILITY	4.277004288613059
POST-TRANSLATIONALLY	4.277004288613059
BIOMEDICAL COMMUNITY	4.277004288613059
INCREMENTAL INCREASE	4.277004288613059
DEGREE-OF-ROBUSTNESS	4.277004288613059
MISFOLDED ENDOGENOUS	4.277004288613059
MUSCLE GROUP PROFILE	4.277004288613059
ESTABLISHED FUNCTION	4.277004288613059
OVERLAPPING FUNCTION	4.277004288613059
SCFG-BASED ALIGNMENT	4.277004288613059
EXISTING MOUSE MODEL	4.277004288613059
ENERGETIC PREFERENCE	4.277004288613059
COCKE-YOUNGER-KASAMI	4.277004288613059
FITC EMISSION FILTER	4.277004288613059
OBTAIN/DEVELOP PROBE	4.277004288613059
TECHNICAL LIMITATION	4.277004288613059
FASTA FORMATTED FILE	4.277004288613059
CALLED ORTHOSTRAPPER	4.277004288613059
STRUCTURE SIMILARITY	4.277004288613059
IDENTIFIED NOCTURNIN	4.277004288613059
fold-change analysis	4.277004288613059
HEPARAN SULFATE STUB	4.277004288613059
SELECTION STRINGENCY	4.277004288613059
PROBE SET SIMULATION	4.277004288613059
INDIVIDUAL PARAMETER	4.277004288613059
PHYSIOLOGICAL RHYTHM	4.277004288613059
RAB PROTEINS BEARING	4.277004288613059
BLM REGULATORY DEPOT	4.277004288613059
phosphatidylinositol	4.277004288613059
DEGREE OF ROBUSTNESS	4.277004288613059
likelihood phylogeny	4.277004288613059
ADVANCED COVARIATION	4.277004288613059
EXTRACTION PROCEDURE	4.277004288613059
recursive definition	4.277004288613059
BIOLOGICAL VARIATION	4.277004288613059
PARABASAL EPITHELIAL	4.277004288613059
DIRECTING PROTRUSION	4.277004288613059
T7-TRANSCRIBED DSRNA	4.277004288613059
CALIBRATED LYSOSOMAL	4.277004288613059
REQUIRING ACTOMYOSIN	4.277004288613059
AUTOMATED ANNOTATION	4.277004288613059
GP PARAMETER SETTING	4.277004288613059
CORTICAL GFP-PROTEIN	4.277004288613059
ANAEROBIC PYRIMIDINE	4.277004288613059
OSTEOCLAST STRUCTURE	4.277004288613059
CRENARCHAEOTA BRANCH	4.277004288613059
THERMAL DENATURATION	4.277004288613059
LENS EPITHELIAL CELL	4.277004288613059
PRECISION COORDINATE	4.277004288613059
SELECTED INTERLEUKIN	4.277004288613059
PLEIOTROPIC FUNCTION	4.277004288613059
SEPHADEX G-50 COLUMN	4.277004288613059
NON-NEURAL CELL TYPE	4.277004288613059
HALOTHANE ANESTHESIA	4.277004288613059
EXPOSED SIDE-BY-SIDE	4.277004288613059
RECOMBINATION SYSTEM	4.277004288613059
DYSTROPHIN-DEFICIENT	4.277004288613059
NUMEROUS TISSUE TYPE	4.277004288613059
MULTI-LOCUS SEQUENCE	4.277004288613059
RECOMBINASE ACTIVITY	4.277004288613059
REJECT NEUTRAL DRIFT	4.277004288613059
BIOCHEMICAL DATABASE	4.277004288613059
RADIOACTIVE MATERIAL	4.277004288613059
TECHNICAL CONSTRAINT	4.277004288613059
EPI-FLUORESCENT LAMP	4.277004288613059
CELL DEATH GENE CED9	4.277004288613059
generated expression	4.277004288613059
ANNOTATION AGREEMENT	4.277004288613059
PROLINE-RICH STRETCH	4.277004288613059
OTHER PATIENT BIOPSY	4.277004288613059
HUMAN ANGIOTENSIN II	4.277004288613059
ALGORITHMIC STRATEGY	4.277004288613059
QUASI--THE SELECTION	4.277004288613059
INSERTIONAL MUTATION	4.277004288613059
ADDED GLUTARALDEHYDE	4.277004288613059
DEVELOPING NEOCORTEX	4.277004288613059
TEN-RESIDUE SEQUENCE	4.277004288613059
HYPERPHOSPHORYLATION	4.277004288613059
RECONSTRUCTED EMBRYO	4.277004288613059
ERRONEOUS RIO RESULT	4.277004288613059
RESULTING COORDINATE	4.277004288613059
PROTEOMIC ANNOTATION	4.277004288613059
DETECTING DIFFERENCE	4.277004288613059
UNDERLYING PARAMETER	4.277004288613059
mismatch information	4.277004288613059
OMIM REFERENCE PAPER	4.277004288613059
GR NUCLEOCYTOPLASMIC	4.277004288613059
MOLECULAR WEIGHT RAC	4.277004288613059
ENGINEERING APPROACH	4.277004288613059
INTENSIVE COMPARISON	4.277004288613059
EXPECTED FZ SEQUENCE	4.277004288613059
EXTENSIVE ALTERATION	4.277004288613059
MITOCHONDRIAL DOMAIN	4.277004288613059
HAEMONCHUS CONTORTUS	4.277004288613059
IN-DEPTH QRNA SCREEN	4.277004288613059
DOMAIN/TWO ORGANELLE	4.277004288613059
dissimilar sequences	4.277004288613059
SYSTEMATIC DEVIATION	4.277004288613059
MECHANICAL STABILITY	4.277004288613059
SIMILAR PHYLOGENETIC	4.277004288613059
GASTROCNEMIUS MUSCLE	4.277004288613059
INCLUDING CELL DEATH	4.277004288613059
SURROUNDING MEMBRANE	4.277004288613059
MIDTRANSVERSAL PLANE	4.277004288613059
CONDITIONAL KNOCKOUT	4.277004288613059
REGULATORY APPARATUS	4.277004288613059
COMPUTATIONAL SCREEN	4.277004288613059
MAJOR CLUSTALX GROUP	4.277004288613059
LIVING D. DISCOIDEUM	4.277004288613059
LRP6 CARBOXYTERMINUS	4.277004288613059
NITROCELLULOSE PAPER	4.277004288613059
DAY-NIGHT DIFFERENCE	4.277004288613059
comparative analysis	4.277004288613059
TREATED HBP-ALL CELL	4.277004288613059
SPECIFIED TIME POINT	4.277004288613059
DEVELOPMENTAL SWITCH	4.277004288613059
ECTODERMAL STRUCTURE	4.277004288613059
CHLOROQUINE ANALOGUE	4.277004288613059
sequence information	4.277004288613059
PRE-FORMED PSEUDOPOD	4.277004288613059
GENE SELECTION MODEL	4.277004288613059
CONTAININGFUNCTIONAL	4.277004288613059
IMPACT CELL FUNCTION	4.277004288613059
BINDING SITE NIDOGEN	4.277004288613059
STEM CELL POPULATION	4.277004288613059
NOISE-FILTERING LOOK	4.277004288613059
U133 GENECHIP SERIES	4.277004288613059
ALKALINE PHOSPHATASE	4.277004288613059
GUARANTEE ROBUSTNESS	4.277004288613059
ARP2 DE-LOCALIZATION	4.277004288613059
INTERESTING QUESTION	4.277004288613059
BOI1 BINDING PARTNER	4.277004288613059
LABELING SPECIFICITY	4.277004288613059
ESTIMATING PARAMETER	4.277004288613059
BACKGROUND METASTASI	4.277004288613059
RESULTING LYSED-CELL	4.277004288613059
PKC-RELATED KINASE-2	4.277004288613059
HUAPE1 Β-BARREL CORE	4.277004288613059
SUSTAINED GENERATION	4.277004288613059
INTERMEDIATE DENSITY	4.277004288613059
ANATOMICAL CHARACTER	4.277004288613059
COMPUTED CORRELATION	4.277004288613059
proteasome inhibitor	4.277004288613059
CO-OCCURRENCE METHOD	4.277004288613059
TRANSCRIPT ASSOCIATE	4.277004288613059
PATHWAY INTERMEDIATE	4.277004288613059
GENETEX MS-JAB11-PX1	4.277004288613059
TPA CATALYTIC CENTER	4.277004288613059
ANTI-MOUSE TEXAS RED	4.277004288613059
LDL-RECEPTOR-RELATED	4.277004288613059
alkaline phosphatase	4.277004288613059
OPTIMAL ARCHITECTURE	4.277004288613059
MECHANICAL PARAMETER	4.277004288613059
PLM AXONAL OUTGROWTH	4.277004288613059
DENATURING CONDITION	4.277004288613059
UNDER-REPRESENTATION	4.277004288613059
EARLY-BORN CELL TYPE	4.277004288613059
ASSAYED SIDE-BY-SIDE	4.277004288613059
SEGMENTATION PROCESS	4.277004288613059
OSTEOBLAST CELL LINE	4.277004288613059
BINDING SITE EPITOPE	4.277004288613059
INTERESTING DOCUMENT	4.277004288613059
ARITHMETIC OPERATION	4.277004288613059
USM COORDINATE STORE	4.277004288613059
GLUTARALDEHYDE-FIXED	4.277004288613059
UNIT BLOCK STRUCTURE	4.277004288613059
BOI1 BOI1-PH SEGMENT	4.277004288613059
PAIRED PERFECT-MATCH	4.277004288613059
REVEALED ABNORMALITY	4.277004288613059
CELL SYNCHRONIZATION	4.277004288613059
CRESCENTIC NEPHRITIS	4.277004288613059
OXYBURST FLUOROPHORE	4.277004288613059
SELECTED TISSUE TYPE	4.277004288613059
DIFFERENTIATED STATE	4.277004288613059
LATER-BORN CELL TYPE	4.277004288613059
NUCLEOTIDE-SEQUENCED	4.277004288613059
GC CONTENT ALIGNMENT	4.277004288613059
STIMULATING DECREASE	4.277004288613059
DISCRIMINATED CANCER	4.277004288613059
REACHING FUNDAMENTAL	4.277004288613059
SELF-ORGANIZING-MAPS	4.277004288613059
DESCRIBING FILOPODIA	4.277004288613059
NOVEL SΑ I2 SEQUENCE	4.277004288613059
EARLY/MID CYTOKINESI	4.277004288613059
ATTRIBUTE SORT ORDER	4.277004288613059
ENCODING HUMAN RAB11	4.277004288613059
CAPTURED COLOR IMAGE	4.277004288613059
STRIKING PERIODICITY	4.277004288613059
SYNDECAN-1 THROUGH-4	4.277004288613059
COMPLICATED PROTOCOL	4.277004288613059
EXODEOXYRIBONUCLEASE	4.277004288613059
GENEFINDING APPROACH	4.277004288613059
FINANCIAL EFFICIENCY	4.277004288613059
LEICA MODEL MZFL III	4.277004288613059
ORIGINAL PROPOSITION	4.277004288613059
STRIKING RHYTHMICITY	4.277004288613059
BIOLOGICAL RATIONALE	4.277004288613059
ARGININE-RICH INSERT	4.277004288613059
MATHEMATICAL FORMULA	4.277004288613059
METASTATIC POTENTIAL	4.277004288613059
AXON GENEPIX SCANNER	4.277004288613059
BINDING PROTEINS ACT	4.277004288613059
COORDINATES INCREASE	4.277004288613059
BIOCHEMICAL PROPERTY	4.277004288613059
SPREADING EXPERIMENT	4.277004288613059
PROGRAMMING APPROACH	4.277004288613059
DORSAL WEIGHT MATRIX	4.277004288613059
CONTAINING LYSOSOMAL	4.277004288613059
FUSION CHAMBER SLIDE	4.277004288613059
HUMIDIFIED INCUBATOR	4.277004288613059
CELL-SURFACE CONTACT	4.277004288613059
DEVELOPMENTAL MODULE	4.277004288613059
ACTIN-RICH FILOPODIA	4.277004288613059
FUNCTIONAL NONCODING	4.277004288613059
LUCIFERASE SYNTHESIS	4.277004288613059
CONSENSUS DENDROGRAM	4.277004288613059
5'AAATGCATCTGCGAGGGC	4.277004288613059
GTPASE CASCADE CDC42	4.277004288613059
MILLIMOLAR INHIBITOR	4.277004288613059
EXPRESSING PRECURSOR	4.277004288613059
DISCRETE-TIME SYSTEM	4.277004288613059
SUBSELECTION PROCESS	4.277004288613059
STRUCTURAL INTEGRITY	4.277004288613059
ALGEBRAIC DIFFERENCE	4.277004288613059
REGULATORY STRUCTURE	4.277004288613059
RGS3 REGULATORY ROLE	4.277004288613059
CONCOMITANT INCREASE	4.277004288613059
DEXAMETHASONE RESULT	4.277004288613059
UNDERLYING MECHANISM	4.277004288613059
ANNOTATION CONSENSUS	4.277004288613059
B-LYMPHOID CELL LINE	4.277004288613059
IDENTIFIED VARIATION	4.277004288613059
DISPLAY PHYLOGENETIC	4.277004288613059
DECREASED RESORPTION	4.277004288613059
GOAT ANTI-MOUSE FITC	4.277004288613059
CONTAINING CELL LINE	4.277004288613059
ANAPHYLATOXIN REPEAT	4.277004288613059
MAS4 USES DIFFERENCE	4.277004288613059
G/L AMMONIUM SULFATE	4.277004288613059
INDIVIDUAL STRUCTURE	4.277004288613059
CARRYING ENDOTHELIAL	4.277004288613059
ACTIVATED RAS RESULT	4.277004288613059
signal contamination	4.277004288613059
DELETERIOUS RELATIVE	4.277004288613059
BACKGROUND CHEMOKINE	4.277004288613059
ITERATIVE COMPARISON	4.277004288613059
EXONUCLEASE ACTIVITY	4.277004288613059
FLEXIBILITY OFTHE GP	4.277004288613059
CAPTURED VIDEO IMAGE	4.277004288613059
INVOLVING TRANSITION	4.277004288613059
DETECTION STRINGENCY	4.277004288613059
TEMPORARY INHIBITION	4.277004288613059
ENDOTOXIN-STIMULATED	4.277004288613059
MUS MUSCULUS CLUSTER	4.277004288613059
ALPHABETIC CHARACTER	4.277004288613059
APOPTOTIC MORPHOLOGY	4.277004288613059
BATH-TYPE SONICATION	4.277004288613059
CYTOCHEMICAL PURPOSE	4.277004288613059
RESPONSIVENESS LEVEL	4.277004288613059
INFLUENCE OSTEOCLAST	4.277004288613059
CLASSIC BIPARTITE NL	4.277004288613059
NATURAL AUTOANTIBODY	4.277004288613059
ASP355-ARG356-PRO357	4.277004288613059
INHIBITOR ENDOSTATIN	4.277004288613059
SPHERICAL CAP DOMAIN	4.277004288613059
AVM AVERAGE POSITION	4.277004288613059
ENDOGENOUS MHCA GENE	4.277004288613059
TRAPPING/DEGRADATION	4.277004288613059
CARBOXYTERMINUS DFZ2	4.277004288613059
VARIABLE COPY NUMBER	4.277004288613059
hydrostatic pressure	4.277004288613059
MOMENTUM COEFFICIENT	4.277004288613059
EUCARYOTIC ORGANELLE	4.277004288613059
ANTI-RABBIT IGG FITC	4.277004288613059
STATISTICAL APPROACH	4.277004288613059
SUGGESTED CONVENTION	4.277004288613059
GENERATED TRANSCRIPT	4.277004288613059
TRAFFICKING ACTIVITY	4.277004288613059
PERMISSIVE SELECTION	4.277004288613059
intensity difference	4.277004288613059
MATHEMATICAL AVERAGE	4.277004288613059
NON-NEURAL STRUCTURE	4.277004288613059
TECHNICAL DIFFICULTY	4.277004288613059
PROTEASOMES ASSEMBLY	4.277004288613059
VARIABLE RELIABILITY	4.277004288613059
protein phosphatases	4.277004288613059
HIGH-WEIGHT CATEGORY	4.277004288613059
CORRESPONDING DOMAIN	4.277004288613059
SELECTED REPLACEMENT	4.277004288613059
ANGIOGENIC CHEMOKINE	4.277004288613059
PROCESSED IMAGE FILE	4.277004288613059
CONCORDANCE INCREASE	4.277004288613059
TETRAODON COMPARISON	4.277004288613059
SPHERICAL CELL SHAPE	4.277004288613059
capillary regression	4.277004288613059
THCENTURY LITERATURE	4.277004288613059
RESULTING SORT ORDER	4.277004288613059
EXPRESSED DELTA GENE	4.277004288613059
MIGRATING MESENCHYME	4.277004288613059
EFFICACIOUS APPROACH	4.277004288613059
VASCULAR ENDOTHELIAL	4.277004288613059
VARYING HERITABILITY	4.277004288613059
CROSS-VALIDATIONSFOR	4.277004288613059
NEGATIVE NM-MYOSINII	4.277004288613059
POTENTIAL IMPORTANCE	4.277004288613059
CYCLIN CO-EXPRESSION	4.277004288613059
STABILIZED Β-CATENIN	4.277004288613059
FLUORESCENT EMISSION	4.277004288613059
SMAD1-REGULATED GENE	4.277004288613059
SEQUENCE CORRELATION	4.277004288613059
COMPARATIVE APPROACH	4.277004288613059
EXTENSIVE INHIBITION	4.277004288613059
disassembling myosin	4.277004288613059
BACKGROUND SECTORING	4.277004288613059
ACTIVATING LEUKOCYTE	4.277004288613059
STORM PHOSPHORLMAGER	4.277004288613059
CONDITIONAL DELETION	4.277004288613059
INITIATED EXPERIMENT	4.277004288613059
INCREASED CELL DEATH	4.277004288613059
FUNDAMENTAL QUESTION	4.277004288613059
REFINED PROGRAM CODE	4.277004288613059
MOLECULAR DIFFERENCE	4.277004288613059
INCREASED PROBE PAIR	4.277004288613059
COLLAGEN-RICH MATRIX	4.277004288613059
ENVIRONMENTAL STRESS	4.277004288613059
BPSEQ DISPLAY FORMAT	4.277004288613059
HISTOLOGICAL SECTION	4.277004288613059
DECREASED PROBE PAIR	4.277004288613059
EXPERIMENTAL DATASET	4.277004288613059
ENDOCYTIC/PHAGOCYTIC	4.277004288613059
COORDINATE SUMMATION	4.277004288613059
CELLULAR ENVIRONMENT	4.277004288613059
APPLYING SCFG METHOD	4.277004288613059
BRUSHBORDER MEMBRANE	4.277004288613059
IDENTITY OBJECT EDGE	4.277004288613059
LITERATURE REFERENCE	4.277004288613059
SYSTEMATIC ISOLATION	4.277004288613059
MEDIATED DEGRADATION	4.277004288613059
PRACTICAL EXPERIENCE	4.277004288613059
CONSIDERING TRADEOFF	4.277004288613059
culture supernatants	4.277004288613059
CLUSTERING TECHNIQUE	4.277004288613059
COLL INCREASED LEVEL	4.277004288613059
LABORATORY PROCEDURE	4.277004288613059
ADDITIONAL MECHANISM	4.277004288613059
TRUNK-TAIL OUTGROWTH	4.277004288613059
SENSITIVITY DECREASE	4.277004288613059
HUMAN LUNG REPLICATE	4.277004288613059
MEC-3GFP FUSION GENE	4.277004288613059
OBSERVED MORPHOLOGIC	4.277004288613059
BIOCHEMICAL SNAPSHOT	4.277004288613059
COVERSLIP-CONTAINING	4.277004288613059
MULTI LOCUS SEQUENCE	4.277004288613059
CARBOXYLTERMINAL SSV	4.277004288613059
BIOPHYSICAL PROPERTY	4.277004288613059
THICKENED PROTRUSION	4.277004288613059
REPLICATE EXPERIMENT	4.277004288613059
FREEZE DRYER ES-2030	4.277004288613059
MULTICOPY SUPPRESSOR	4.277004288613059
PROPRIETARY SOFTWARE	4.277004288613059
INDIVIDUAL PRECURSOR	4.277004288613059
BRING NOVEL APPROACH	4.277004288613059
RULE GENE EXPRESSION	4.2765224483517255
EXPRESSION VARIATION	4.276281528221059
EXPRESSION INTENSITY	4.276281528221059
NO-CHANGE EXPRESSION	4.276281528221059
BONA-FIDE EXPRESSION	4.276281528221059
EXTENSIVE EXPRESSION	4.276281528221059
EXPRESSION THRESHOLD	4.276281528221059
PATTERNED EXPRESSION	4.276281528221059
THEBINARY EXPRESSION	4.276281528221059
LOCALIZED EXPRESSION	4.276281528221059
RESULTING EXPRESSION	4.276281528221059
GENERATED EXPRESSION	4.276281528221059
DISPLAYED EXPRESSION	4.276281528221059
EXAMINING EXPRESSION	4.276281528221059
MYOSIN-II MOBILIZATION	4.276233644089118
PREDICTIVE CAPABILITY	4.276116926784543
OTHER EUKARYOTIC CELL	4.276116926784543
DISCRMINANT ANALYSIS	4.275675098860857
PROTEOLYSIS ANALYSIS	4.275675098860857
PULSE-CHASE ANALYSIS	4.275675098860857
MICRO-ARRAY ANALYSIS	4.275675098860857
DICRIMINANT ANALYSIS	4.275675098860857
CONTROL PP5 ACTIVITY	4.275310297494868
EXHIBIT FRAGMENTATION	4.275280391979909
TRANSCRIPTION FACTORS	4.275243577579346
lysates	4.275110550253928
REGULATING MYOSIN II	4.275028903621414
apoptotic	4.274940067111671
REPLICATION MACHINERY	4.274793735779201
RRNA POSITION NUMBER	4.274743486778515
DOCUMENTED RRNA GENE	4.274743486778515
REPEATING MICROARRAY	4.274729068399468
MICROARRAY DETECTION	4.274729068399468
MICROARRAY TECHNIQUE	4.274729068399468
CYCLOHEXIMIDE TREATMENT	4.274667146309376
APPLYING FOLD CHANGE	4.274567440734022
POSITIVE FOLD CHANGE	4.274567440734022
AVERAGE RATIO CHANGE	4.274567440734022
KEY ACTIVATION DOMAIN	4.274474521940841
HOUSEKEEPING CONTROL	4.274463301935772
XENOPUS NOCTURNIN KDA	4.274433311511177
KKTK STRIKING EFFECT	4.274419110863124
EXPECTED EFFECT SIZE	4.274419110863124
DATABASE PROJECT HTTP	4.274274819452684
DOSE-DEPENDENT STUDY	4.27426002300159
ALGORITHM COMPARISON	4.274089627424407
IDENTFYING ALGORITHM	4.274089627424407
AFFYMETRIX ALGORITHM	4.274089627424407
IN VIVO P53 FUNCTION	4.274041211125592
DISCUSSING RISK GROUP	4.2739628496626105
CURRENT RNA DATA SET	4.273958228764263
SHOW NB LOCALIZATION	4.273955104600315
PB HUMAN T LYMPHOCYTE	4.273946077093252
CONCENTRATION GRADIENT	4.273766286213239
FIBRONECTIN TYPE III	4.27360662642743
NMR STRUCTURAL ANALYSIS	4.27358641880513
TARGET GENE PROMOTER	4.273485999367585
ROSA26 GENOMIC LOCUS	4.2734650571696955
RAW GENOMIC SEQUENCE	4.2734650571696955
PHYSIOLOGICAL CHANGE	4.273349016794504
MORPHOGENETIC CHANGE	4.273349016794504
DESTABILIZING EFFECT	4.273126521988157
RECEPTOR BMP TYPE II	4.273126521988157
CONSOLIDATION EFFECT	4.273126521988157
hydroxide	4.273053729055283
MEROPENEM	4.273053729055283
CEFOXITIN	4.273053729055283
EXTRACELLULAR REGION	4.273022653239276
HYBRIDIZED RNA PROBE	4.272942875481331
FUNCTIONAL RNA CLASS	4.272942875481331
INDEPENDENT RNA GENE	4.272942875481331
SEPHAROSE A/G AGAROSE	4.272870201847138
MMP-1 DECREASED LEVEL	4.272802961981571
BY/SNJ- CORN1 STRAIN	4.27278733199969
MORPHOLOGIC RESPONSE	4.27247694686825
SYNERGISTIC RESPONSE	4.27247694686825
LOCALIZATION DYNAMIC	4.272430512593943
SPATIAL LOCALIZATION	4.272430512593943
ALTERED LOCALIZATION	4.272430512593943
COMPLEX LOCALIZATION	4.272430512593943
CHANGED LOCALIZATION	4.272430512593943
ENVIRONMENTAL FACTOR	4.2724226807856915
TGF-Β-INDUCED FACTOR	4.2724226807856915
ANTIAPOPTOTIC FACTOR	4.2724226807856915
MORPHOGENETIC FACTOR	4.2724226807856915
STEADY-STATE EQUILIBRIUM	4.272364446353262
G PROTEIN ASSOCIATION	4.272313255120379
OVARIAN CANCER OPTIMUM	4.27226397958633
MOLLUSK MITOCHONDRIA	4.272260212423019
MITOCHONDRIA DISPLAY	4.272260212423019
LABELED MITOCHONDRIA	4.272260212423019
ACTIN REDISTRIBUTION	4.2720630901436545
MITOCHONDRIAL INTRON	4.27203556257558
INTRON DISSEMINATION	4.27203556257558
EUKARYOTIC RNASEP RNA	4.2719971071524325
HYBRIDIZATION METHOD	4.271936752682789
FIBRONECTIN FRAGMENT	4.271907795334616
COUPLING FIBRONECTIN	4.271907795334616
EFFECT SIZE CONSIDERATION	4.271887337863883
TOLL RECEPTOR FAMILY	4.271833933113189
HAVING CD14 RECEPTOR	4.271833933113189
SIMILAR CRE REPORTER	4.271742422396378
REPORTER GENE FUSION	4.271742422396378
DYNAMIC CYTOSKELETON	4.271598916954105
PHAGOCYTE RECOGNITION	4.271582027580475
PHYLOGENETIC DIVISION	4.271582027580475
CYTOPLASMIC CYLINDER	4.271565957370818
RELATING CYTOPLASMIC	4.271565957370818
MI OOCYTE ACTIVATION	4.271524188313658
C-FOS SRE ACTIVATION	4.271524188313658
IMPAIRED RT FUNCTION	4.271498817478938
RED BASE PAIR SYMBOL	4.271498817478938
CD9 PROTEIN FRAGMENT	4.271437609783475
ADAPTOR PROTEIN P130	4.271437609783475
FROG DELTA-1 PROTEIN	4.271437609783475
ASSEMBLED HA PROTEIN	4.271437609783475
TGF-Β FAMILY PROTEIN	4.271437609783475
NOVEL MATRIX PROTEIN	4.271437609783475
RRNA INTRON POSITION	4.27143100275353
BLOCKS PROLIFERATION	4.271429999089762
USING FLOW CYTOMETRY	4.271394940665087
SUBCELLULAR MEMBRANE	4.271250183298688
INCLUDED CONTROL RNA	4.27124888436314
COSTIMULATORY SIGNAL	4.271231561598642
GABA-MEDIATED SIGNAL	4.271231561598642
ALA MUTANT MYOSIN-II	4.271223543922233
DEFECTIVE MUTANT TAG	4.271223543922233
DFZ2 DELETION MUTANT	4.271223543922233
CDC42 MUTANT VERSION	4.271223543922233
MRNA INCREASED LEVEL	4.271212818978465
MRNA SAMPLE FRAGMENT	4.271212818978465
NEURON DISTINCT TYPE	4.2711462503619755
G418-RESISTANT CLONE	4.271097756667844
HUMAN PP5 CDNA PROBE	4.270663864510731
GENOME SEQUENCE HOLD	4.2705878402409185
ENTERED QUERY GENOME	4.2705878402409185
DNA SEQUENCE LIBRARY	4.2703098160364625
DNA ARRAY TECHNOLOGY	4.2703098160364625
FLANKED DNA SEQUENCE	4.2703098160364625
NEUTRALIZING SPECTRUM	4.270295096725268
CDNA CLONE HOMOLOGOUS	4.270294850155372
ADULT SKIN FIBROBLAST	4.269993661869407
LOCALIZATION CONTROL	4.269889525916658
ONE-MINUTE TREATMENT	4.2697235839295695
SAMPLED SYMBOL INDEX	4.269663660434232
KINASE RECEPTOR GENE	4.269542638768353
MYOSIN MOTOR PROTEIN	4.26946222479183
BASE OLIGONUCLEOTIDE	4.2693813285812
COLD OLIGONUCLEOTIDE	4.2693813285812
HETEROMERIC COMPLEX	4.269246991986539
RRNAS, REAL TIME PCR	4.269111489288037
LEXAOP-LACZ REPORTER	4.269111489288037
NONSPECIFIC INCLUSION	4.268936669711437
BDU AXON GUIDANCE CUE	4.268936669711437
structure predictions	4.268936669711437
IMMUNOBLOTTING PROTEIN	4.268892799999321
INCREASED TEST ERROR	4.268803035061542
LOCALIZED ACTIVATION	4.268784138163958
INCREASED ACTIVATION	4.268784138163958
MITOGENIC ACTIVATION	4.268784138163958
INCLUDING ACTIVATION	4.268784138163958
PHEROMONE ACTIVATION	4.268784138163958
BIMODAL DISTRIBUTION	4.268784138163958
DISTRIBUTION PATTERN	4.268784138163958
DENSITY DISTRIBUTION	4.268784138163958
AZ IMMUNOPRECIPITATE	4.268746081911878
ARTERIAL FLOW CHALLENGE	4.26866786347661
CONVENTIONAL PROTEIN	4.268654270368683
LAMININ-LIKE PROTEIN	4.268654270368683
BIFUNCTIONAL PROTEIN	4.268654270368683
MULTI-DOMAIN PROTEIN	4.268654270368683
PROTEIN CHEMOATTRACT	4.268654270368683
SEQUESTERING PROTEIN	4.268654270368683
DISCOIDEUM CELLS USE	4.268629769141439
RECOGNITION ALGORITHM	4.268625451138608
MAMMALIAN EXPRESSION	4.268525994971255
PURIFIED FLAG-MHCK C	4.268510133148988
AMINOTERMINAL MUTANT	4.26833317157682
LYMPHOBLASTOID ADHESION	4.268176660849332
LOCATING DAMAGE SITE	4.268129797829701
CONSERVATION ENTROPY	4.2680854253757845
FIBROBLAST CHEMOTAXI	4.26794960512344
ACTIVATED FIBROBLAST	4.26794960512344
T-STRAND	4.267913366377269
AFFYMETRIX CHIP TYPE	4.267856736574829
AFFYMETRIX CHIP USER	4.267856736574829
GENERATION GENE CHIP	4.267856736574829
GROWING PRIMARY CELL	4.267749955811737
NF-ΚB REDISTRIBUTION	4.2676160115211905
LACZ REPORTER STRAIN	4.267525465783009
Z/AP REPORTER STRAIN	4.267525465783009
DNA RESPONSE ELEMENT	4.267291588206589
OCL CLOSE APPOSITION	4.267256897096912
CLASSIFICATION ABILITY	4.267206046083264
PHOSPHORYLATION DATA	4.267176340142233
ADDITION CYTOCHROME C	4.267056478684046
CDNA MICROARRAY DATA	4.267033576334228
POTENTIAL RELATIONSHIP	4.266971093582611
DNA MICROARRAY STUDY	4.2669634921530895
PERI-CENTROMERIC DNA	4.2669625797481645
INDIVIDUAL TRANSGENE	4.26686921675252
EXPRESSING TRANSGENE	4.26686921675252
ANTI-CLEAVED CASPASE	4.26686921675252
MUSTARD CYTOTOXICITY	4.26686921675252
ADENO-ΒGAL INFECTION	4.2667527216736625
T CELL FRAGMENTATION	4.2667527216736625
MASTER TRANSCRIPTION	4.266705370325213
C/EBPΒ TRANSCRIPTION	4.266705370325213
MAKING TRANSCRIPTION	4.266705370325213
DEPENDENT RETRACTION	4.266693464061296
ANTISENSE STRAND RNA	4.266684024086752
MUTANT PHENOTYPE	4.266637089358072
PHYLOGENY SORT ORDER	4.26638659428297
MICROARRAY DATA CHIP	4.2663399230991015
EGF RECEPTOR PROTEIN	4.266267254283605
HIV-1 GP120 SEQUENCE	4.266094364163793
PROCESSOR INSTRUCTION	4.265980093269569
PALMITOYL TRANSFERASE	4.265980093269569
RECEPTOR NEURON FATE	4.265975894862106
DEPENDENT EXPRESSION	4.265970703669296
RABBIT ARP3 ANTIBODY	4.265820761042809
RABBIT VASP ANTIBODY	4.265820761042809
Γ-AMINO BUTYRIC ACID	4.265732423542254
activation of caspase	4.26558588307732
IN VITRO DEVELOPMENT	4.265458834584225
MACROPHAGE CELL TYPE	4.264869780807243
MACROPHAGE CELL LINE	4.264869780807243
CONTAINING HOMOLOGOUS	4.264697722764663
UNKNOWN MECHANISM	4.264572283875798
ENO GROWTH POTENTIAL	4.264565148812118
GROWTH CONE INTERIOR	4.264565148812118
GROWTH PLATEAU PHASE	4.264565148812118
IN VITRO INTERACTION	4.2645390709509
HYBRIDIZATION SUBJECT	4.264484776199266
CELLULAR PROCESS	4.264448470989265
NO-CHANGE CALCULATION	4.264367415210369
MOESIN IDENTIFICATION	4.264367415210369
REPRESENTATIVE GENOME	4.264199766304214
EXCITATION	4.264190116337394
C-TERMINAL MAPK SITE	4.264174574630868
GROWTH FACTOR ABSENCE	4.264093275333225
PROTEIN LOCALIZATION	4.264080494349567
SINGLE PRO-HSN3 FORM	4.26387452149194
SINGLE HUMAN PATIENT	4.26387452149194
SELECTED SINGLE BASE	4.26387452149194
NORTHERN BLOT RESULT	4.263791157891171
MITOCHONDRIAL DAMAGE	4.263692552438022
PROTEOLYSIS REACTION	4.263592464196105
GLUCOKINASE REACTION	4.263592464196105
BIOCHEMICAL REACTION	4.263592464196105
GENOME SEQUENCE	4.263559202404462
POLYCLONAL ANTI-SERA	4.263282960555713
POLYCLONAL ANTI-RHOA	4.263282960555713
SITE INFORMATION	4.26326150436004
PRIMARY PHYLOGENETIC	4.263122789411075
PRIMARY KERATINOCYTE	4.263122789411075
POST-MITOTIC PRIMARY	4.263122789411075
ONCOGENE SCIENCE	4.263076085846328
SURFACTANT PROTEIN C	4.262943454319403
MURINE MUSCLE TISSUE	4.262676797468843
MURINE SARCOMA VIRUS	4.262676797468843
CYTOLYTIC LYMPHOCYTE	4.262619025327132
MOUSE ACTIN ANTIBODY	4.262526628729873
NOVEL PROMOTER MOTIF	4.262475057099345
NEUROTOXIN	4.261941233230502
S PHASE PROLONGATION	4.261887571261746
JH10 ΜG/ML THYMIDINE	4.261439082265285
PRODUCED LEVEL ΜG/ML	4.261439082265285
PROTEASOME COMPONENT	4.26120586904827
FINAL GENERALIZATION	4.261077747117926
CHARGED PHOSPHOLIPID	4.261077747117926
CONTAINING WILD-TYPE	4.261077747117926
UNDERLYING PHYLOGENY	4.261077747117926
FINAL REPRESENTATION	4.261077747117926
POPULATIONOF SOLUTION	4.261000596104319
RESISTANCE SELECTABLE	4.2608299278547035
ESSENTIAL DETERMINANT	4.2608299278547035
GLACTOSE TRANSPORTER	4.260788173636196
GFP-BLM ACCUMULATION	4.260589202900284
PRODUCED GENE SUBSET	4.260487875210699
REPORTER LYSIS BUFFER	4.260235130382002
ANTIBODY COMBINATION	4.260228997257683
ANTI-III1-C ANTIBODY	4.260228997257683
GENERAL PRESENTATION	4.260176244769144
DEXAMETHASONE ABSENCE	4.2601152110216205
D. DISCOIDEUM ENZYME	4.259946353459801
DEVELOPMENT PROCEEDS	4.259686107569807
METAZOAN DEVELOPMENT	4.259686107569807
DEVELOPMENT PROGRESS	4.259686107569807
TEMPORAL DEVELOPMENT	4.259686107569807
PRESUMED COMMON NAME	4.259601628637889
DIRECTIONAL MOTILITY	4.259516321481148
TNF CYTOTOXIC EFFECT	4.259423563680219
positive localization	4.258884309809088
MACROPHAGE PRECURSOR	4.2588025269043355
SRC WT KINASE DOMAIN	4.258573526684017
NEURAL CREST CONTRIBUTION	4.258492349449008
GROWTH NON-ESSENTIAL	4.258345578911648
P53-REGULATED GROWTH	4.258345578911648
INTERACTION PROPERTY	4.258306462119821
P53-MDM2 INTERACTION	4.258306462119821
POSITIVE INTERACTION	4.258306462119821
NUMEROUS INTERACTION	4.258306462119821
CELL-ECM INTERACTION	4.258306462119821
REPORTED INTERACTION	4.258306462119821
MDM2-P53 INTERACTION	4.258306462119821
SINGLE OUTPUT NEURON	4.258016483240856
HUMAN IL-8 ORTOLOGUE	4.257823937565156
PROBLOTT PVDF MEMBRANE	4.257708543076104
two-hybrid experiments	4.257708543076103
PUNCTUATED EQUILIBRIUM	4.257708543076103
SINGLE NON-CONSENSUS	4.25730963793138
OBSERVATIONS SUPPORT	4.257184592530226
EXCESS GANGLION CELL	4.257184592530226
PURE TOTAL RNA ATLAS	4.25706644233003
VISUALIZATION PURPOSE	4.2568045112086015
PAC-1 OVER-EXPRESSION	4.2568045112086015
DIMETHYL SULFOXIDE ΜL	4.256677694220767
ECL DETECTION REAGENT	4.2563712198335
HNF3ΑLOXPNEO ES CELL	4.25614145063113
AQUEOUS PRIMARY ACCESS	4.25603124793799
LFC MODEL VALIDATION	4.255768899952881
mammalian development	4.255709880366241
GENERAL LOCALIZATION	4.25560246875003
ALIGNMENT ALGORITHM RUN	4.25559897548685
MUTANT IDENTIFICATION	4.255571600295814
ORF SEQUENCE FRACTION	4.2554517966717
MULTIPLE GENE SYMBOL	4.255379194788947
TIME-DEPENDENT MANNER	4.255336418078847
LOAD-DEPENDENT MANNER	4.255336418078847
EXPANDING COLLECTION	4.255250963644096
POST TNF STIMULATION	4.254849878010866
FRACTIONATION RESULT	4.254707130519872
UBIQUITIN EXPRESSION	4.254703633292169
STRIKING PERTURBATION	4.254576155565224
EUKARYOTIC CHROMOSOME	4.254576155565224
G418 SELECTION LEVEL	4.254566896821173
LINKED TN PRODUCTION	4.254566896821173
ACCESSORY PROTEIN	4.254476572566821
BLM PUBLISHED REPORT	4.254135408517483
NCBI SCIENTIFIC NAME	4.254135408517483
GFP-PROTEIN MOLECULE	4.253987867355576
IMMUNOGLOBULIN ΜG/ML	4.253656479091398
XENOPUS EMBRYOGENESI	4.253533595883389
TRANSFECTION CONTROL	4.253395121060321
PRELIMINARY OBSERVATION	4.25333537704682
MODIFYING ENZYME DNA	4.253251880883204
ΜM Β-MERCAPTOETHANOL	4.253017125872223
MEASUREMENT VARIANCE	4.252899252836641
susceptibility genes	4.252305898109837
PROTEIN P105 SUBUNIT	4.252257258735573
REVIEW BOARD APPROVAL	4.252182736540855
FIBROSARCOMA PAI-1 UG	4.252182736540855
BIPARTITE NLS VARIANT	4.252182736540855
ADDRESS GENE FUNCTION	4.252182736540855
HYAL-2 TRANSLOCATION	4.252056419417885
NEUROBLAST FORMATION	4.251998130003877
INDICATING FORMATION	4.251998130003877
INHIBITORY PROTEIN IΚB	4.251985164881328
JM-1 ES CELL ES CELL	4.251968883034744
PROTEASE SUBSTITUTION	4.251745082776399
ENZYME PHOSPHORYLATE	4.2514173858831725
KINASE INHIBITOR P21	4.251395704759008
PRODUCT AMPLIFICATION	4.2513450398823265
MOUSE ASTROCYTE LINE	4.251152511113712
COMMON NORMALIZATION	4.250900298650304
SODIUM PENTOBARBITOL	4.250772337915192
PHYSICAL ASSOCIATION	4.250772337915192
ANTINEOPLASTIC AGENT	4.250772337915192
SKP-ΔF OVEREXPRESSION	4.250659651707166
OVEREXPRESSION SYSTEM	4.250659651707166
TOTAL ELEMENT SIGNAL	4.250633422024471
PREVENTING TRANSPORT	4.250512615631055
MULTIPLE CYTOPLASMIC	4.250139258902891
RELATIVE INFORMATION	4.250093925397144
DATABASE INFORMATION	4.250093925397144
TEMPORAL INFORMATION	4.250093925397144
EXPANDED INFORMATION	4.250093925397144
INFORMATION POSITION	4.250093925397144
VALUABLE INFORMATION	4.250093925397144
GENETIC DEMONSTRATION	4.249605208360766
SIMILAR DEMONSTRATION	4.249605208360766
POTENTIAL PHYSIOLOGIC	4.249605208360766
MM/L TRIS-ACETATE PH	4.249536775020003
P VALUE DETERMINATION	4.249380260446867
PERFORMANCE DECREASE	4.249132840996576
SIGNIFICANCE PROBLEM	4.249132840996576
IMPROVED PERFORMANCE	4.249132840996576
SOFTWARE PERFORMANCE	4.249132840996576
ARCHAEAL RRNA INTRON	4.248562122657954
KDA MOLECULAR WEIGHT	4.248520893044916
stress fiber formation	4.2484459925695965
REGULATION ASSOCIATE	4.248233762041205
SIGNALING REGULATION	4.248233762041205
REGULATION MECHANISM	4.248233762041205
SENSITIVE REGULATION	4.248233762041205
LIVER TISSUE EXHIBIT	4.248140653540973
PRIMARY T LYMPHOCYTE	4.247908213348389
CDNA/CRNA PREPARATION	4.247773806759123
DUPLICATE OBSERVATION	4.247538081800496
REGRESSION MEASUREMENT	4.2474803985013505
ROL-6(SU1006) ALLELE	4.24727474448881
CYSTEINE RESIDUE	4.246944675153343
TARGET CONCENTRATION	4.246770853910433
expression fold changes	4.24647081502234
NUCLEAR ACCUMULATION	4.246432277126831
TRANSLOCATION SIGNAL	4.246283692403468
ΜG/ML CREATINE KINASE	4.2462541231792015
VALIDATION TECHNIQUE	4.2451512056227925
cytoplasmic localization	4.244707818718745
PREPARATION TOTAL RNA	4.2446159354430275
ADULT TM EM ANALYSIS	4.244486610746692
SUBJECT POOLED GROUP	4.244423966285114
LUCIFERASE REAGENT ΜL	4.244112244342831
NOVEL TUMOR REJECTION	4.243805769955564
AGRIS ONLINE RESOURCE	4.243805769955564
TRANSGENIC ARABIDOPSI	4.243805769955564
ECFP REPORTER STRAIN	4.24374183048361
RECEPTOR-REGULATED SMAD	4.243550150752042
QUANTITATIVE ASSESSMENT	4.243550150752042
ANTIGEN PRESENTATION	4.24334820092523
INCREASED PRODUCTION	4.24334820092523
ORGANIZED PRODUCTION	4.24334820092523
INCREASES PRODUCTION	4.24334820092523
PERCENTAGE IDENTITY	4.243242804553396
MEAN PIXEL INTENSITY	4.243165783105784
IMPORTIN-Β AGGREGATE	4.242700968469695
FEATURE DIFFERENTIAL	4.242367926526556
INDICATING CONFIDENCE	4.242201669971147
BIOCHEMICAL FRACTION	4.242198968662719
NUCLEOPLASM FRACTION	4.242198968662719
PROTEIN DETERMINATION	4.24218955325229
FACTOR CONCENTRATION	4.242189246083066
GRANULATED CYTOPLASM	4.2420283543492365
C-FO SERUM INDUCTION	4.241497805423191
SMG EPITHELIA NUCLEUS	4.240944073295993
FIBROBLAST MONOLAYER	4.2409227468286685
FRAP STUDIES SUPPORT	4.240007522591772
DEPHOSPHORYLATING CA	4.239602604069649
HELIOTHIS	4.238781749176886
lymphocyte activation	4.238779590004389
SIMULATION RESULT	4.2386779737235285
sequence analysis	4.2386779737235285
VCAM-1 ADHERENT CELL	4.238643586517254
CO-TRANSFECTED GSK3Β	4.238226622364039
SHOW CO-LOCALIZATION	4.238226622364039
EXTERNAL CUE ABSENCE	4.238173863634448
SPONTANEOUS APOPTOSI	4.23754029198795
OPERCULUM FLAP REACH	4.237364896447394
ALTERNATIVE STATISTICS	4.237330931961788
SUPPRESSION	4.2373133910179295
STOCK	4.237235284303603
PROMOTER/CMV ENHANCER	4.236951888203962
DIAGNOSTIC EVALUATION	4.236951888203962
CONTINUOUS EVALUATION	4.236951888203962
STIMULATED NEUTROPHIL	4.236951888203962
NEURONAL GROWTH CONE	4.236909758929096
MACROPHAGE SECRETION	4.2367806423678545
RELEASED NF-ΚB DIMER	4.236768815362196
FUNCTIONAL REPRESSOR	4.236464001170901
MEDIATED SUPPRESSION	4.236464001170901
ADHESIVE GUIDANCE CUE	4.235881612374884
PCR AMPLIFICATION	4.235832218469793
MULTIPLE HYBRID FORM	4.235692964673003
IΚBΑ PHOSPHORYLATION	4.235323257151967
COMPOUND HETEROZYGOTE	4.234381682547112
EXHIBIT INFILTRATION	4.23370883600493
CRANIOFACIAL MORPHOGENESI	4.233653384885467
ONE-TO-ONE CORRESPONDENCE	4.233653384885467
TRANSGENE INTEGRATION	4.233524947328162
N-TERMINAL PH DOMAIN	4.233278430577054
CHIMERIC GST PROTEIN	4.23307690768767
FUNCTIONAL CHANGE	4.233009720932741
TRACHEAL EPITHELIAL	4.23284689578625
BIOLOGICAL VARIANCE	4.23284689578625
RECOMBINATION EVENT	4.23284689578625
LIGNIN BIOSYNTHESIS	4.23284689578625
FUNCTIONAL LOCATION	4.23284689578625
CAPILLARY SEQUENCER	4.23284689578625
IDENTICAL STRUCTURE	4.23284689578625
SELECTED GQ-COUPLED	4.23284689578625
PERIPHERAL MEMBRANE	4.23284689578625
INTERSECTING STREET	4.23284689578625
EMISSION FILTER SET	4.23284689578625
original population	4.23284689578625
SEQUENCES SELECTION	4.23284689578625
SENSITIVE STRUCTURE	4.23284689578625
STRUCTURAL CATEGORY	4.23284689578625
ECTOPIC DEGRADATION	4.23284689578625
NORMAL GFP-BLM GENE	4.23284689578625
CHOMSKY NORMAL FORM	4.23284689578625
SMG EXPLANTS RESULT	4.23284689578625
MNOCIN BALB/C MOUSE	4.23284689578625
ATTACHED FILOPODIUM	4.23284689578625
BINDING DYE HOECHST	4.23284689578625
MOLECULAR MASS FORM	4.23284689578625
REQUIRING AGREEMENT	4.23284689578625
RELATIONAL DATABASE	4.23284689578625
SCIENTIFIC ENDEAVOR	4.23284689578625
CELLULAR RETRACTION	4.23284689578625
MODERATE REACTIVITY	4.23284689578625
MICROSCOPIC SECTION	4.23284689578625
TRANSCRIPTS DISPLAY	4.23284689578625
PHYLOGENETIC BRANCH	4.23284689578625
PHENOTYPIC VARIANCE	4.23284689578625
CD4-INDUCED EPITOPE	4.23284689578625
OSTEOBLAST FUNCTION	4.23284689578625
BRDU-LABELED EMBRYO	4.23284689578625
DOTMAC/PFA FIXATION	4.23284689578625
MASK MICROSATELLITE	4.23284689578625
CYTOKINESIS PROCESS	4.23284689578625
ANTI-HA ANTI-MAB414	4.23284689578625
ANTI-PHOSPHO-MOESIN	4.23284689578625
BACTERIAL ENDOTOXIN	4.23284689578625
TUMOR CELL INVASION	4.23284689578625
NORMAL HPB-ALL CELL	4.23284689578625
BIBILIOGRAPHIC DATA	4.23284689578625
ROUTINE HEMATOXYLIN	4.23284689578625
INTERGENIC SEQUENCE	4.23284689578625
DISRUPTED EXTENSION	4.23284689578625
INTERESTING PORTION	4.23284689578625
INTRIGUING PARALLEL	4.23284689578625
INCLUDED PROKARYOTE	4.23284689578625
LABORATORY MUTATION	4.23284689578625
DORSAL-VENTRAL AXIS	4.23284689578625
STATISTICAL MEASURE	4.23284689578625
CELLULAR LOCOMOTION	4.23284689578625
PARACRINE MECHANISM	4.23284689578625
FOLLICULAR LYMPHOMA	4.23284689578625
EMISSION WAVELENGTH	4.23284689578625
EXCESSIVE VARIATION	4.23284689578625
AML/ALL DISTINCTION	4.23284689578625
SPECIFIED PARAMETER	4.23284689578625
QUASISPECIES--A SET	4.23284689578625
EXPLOREWHETHER GPNN	4.23284689578625
EXPONENTIAL PORTION	4.23284689578625
EXPRESSING ARP3-GFP	4.23284689578625
FILAMENT ELONGATION	4.23284689578625
ANTI-MITOTIC ACTION	4.23284689578625
STRAND-BREAK REPAIR	4.23284689578625
RGS3 TRUNCATED FORM	4.23284689578625
TRAINING EXPERIMENT	4.23284689578625
DELTA-NOTCH PATHWAY	4.23284689578625
CELLULAR SLIME MOLD	4.23284689578625
PREDICTED GSK3 SITE	4.23284689578625
dimerization domain	4.23284689578625
CHR-ASSOCIATED GENE	4.23284689578625
CHARACTERISTIC PEAK	4.23284689578625
FUNCTIONAL PROPERTY	4.23284689578625
PROPORTIONAL HAZARD	4.23284689578625
WEIGHT MATRIX SCORE	4.23284689578625
POST-TRANSCIPTIONAL	4.23284689578625
INTRANUCLEAR DOMAIN	4.23284689578625
MTT OPTICAL DENSITY	4.23284689578625
GFP-EXPRESSING CELL	4.23284689578625
MATHEMATICAL METHOD	4.23284689578625
POST-ORAL VIBRISSAE	4.23284689578625
NETWORK PERSPECTIVE	4.23284689578625
CONVENTIONAL MARKOV	4.23284689578625
GAD2 KNOCKOUT MOUSE	4.23284689578625
TRAFFICKING PATHWAY	4.23284689578625
INTRODUCING TENSION	4.23284689578625
AMINO-TERMINAL SITE	4.23284689578625
CONFOCAL MICROSCOPE	4.23284689578625
DECREASED STABILITY	4.23284689578625
LYSINE-RICH HISTONE	4.23284689578625
RESULTING TREE DATA	4.23284689578625
STATISTICAL PACKAGE	4.23284689578625
IDENTIFYING RESIDUE	4.23284689578625
REPORTED GENERATION	4.23284689578625
EXTRACTION FIXATION	4.23284689578625
INTEGRATED APPROACH	4.23284689578625
AUTOMATIC GATHERING	4.23284689578625
EXPRESSING CELL ΔN1	4.23284689578625
BMP-RESPONSIVE GENE	4.23284689578625
MECHANOTRANSDUCTION	4.23284689578625
PROMOTED GLIOGENESI	4.23284689578625
HIRUDIN-INACTIVATED	4.23284689578625
ADENO-RGS3 TITERING	4.23284689578625
POSITION EQUIVALENT	4.23284689578625
COAGULATION PROCESS	4.23284689578625
SRE TRANSACTIVATION	4.23284689578625
BOC-VAL-GLY-ARG-ΒNA	4.23284689578625
SPECIFIED THRESHOLD	4.23284689578625
CONTINUING BLOCKAGE	4.23284689578625
SELECTED TARGET SET	4.23284689578625
ZETA PROBE MEMBRANE	4.23284689578625
INDIVIDUAL POSITION	4.23284689578625
DYNAMIC PROGRAMMING	4.23284689578625
CELLULAR TRANSCRIPT	4.23284689578625
ITERATIVE OPERATION	4.23284689578625
MOLEGOS DISTINCTIVE	4.23284689578625
BLM REGULATORY SITE	4.23284689578625
CONTAINING DELETION	4.23284689578625
MORULA VEGETAL HALF	4.23284689578625
RECOVERING SEQUENCE	4.23284689578625
SELECTED TRANSCRIPT	4.23284689578625
SECTION OFTHE PAPER	4.23284689578625
MODERATE PERCENTAGE	4.23284689578625
INTER-PATIENT NOISE	4.23284689578625
HOMEO-DOMAIN FAMILY	4.23284689578625
METAL CHELATE RESIN	4.23284689578625
NAMED HNF3ΑΔPGK-NEO	4.23284689578625
SPONTANEOUS PROCESS	4.23284689578625
GENOME-WIDE DISPLAY	4.23284689578625
BETTER PRESERVATION	4.23284689578625
EXTRACTION APPROACH	4.23284689578625
COUNTERACTED HYAL-1	4.23284689578625
EMBRYONIC STEM CELL	4.23284689578625
INTERNAL EE EPITOPE	4.23284689578625
FUNDAMENTAL PROBLEM	4.23284689578625
DIETARY RESVERATROL	4.23284689578625
NEGATIVE PROBE PAIR	4.23284689578625
MEIOTIC PROGRESSION	4.23284689578625
P1 POSITION DISPLAY	4.23284689578625
CHARACTERISTIC TIME	4.23284689578625
COMPATIBILITY ISSUE	4.23284689578625
ALTERED SPECIFICITY	4.23284689578625
GERMLINE COMPETENCY	4.23284689578625
SHOW SLIGHT CLOSURE	4.23284689578625
POSSIBLE COMPARISON	4.23284689578625
TGF-Β FAMILY TYPE I	4.23284689578625
METHYL METHACRYLATE	4.23284689578625
UTR SEQUENCE RESULT	4.23284689578625
ENCODING RAT C/EBPΑ	4.23284689578625
OSTEOCLAST FUNCTION	4.23284689578625
REFERENCE STRUCTURE	4.23284689578625
LANGUAGE ANNOTATION	4.23284689578625
DISEASE-ASSOCIATION	4.23284689578625
CONTAINING FRAGMENT	4.23284689578625
ANDROGEN MIBOLERONE	4.23284689578625
DOSAGE COMPENSATION	4.23284689578625
SMALL-CELL BLASTULA	4.23284689578625
UNDERLYING QUANTITY	4.23284689578625
DIFFERING STABILITY	4.23284689578625
PRACTICAL ADVANTAGE	4.23284689578625
HIDDEN MARKOV MODEL	4.23284689578625
VOLUME SEGMENTATION	4.23284689578625
BMP-RESPONSIVE CELL	4.23284689578625
NEO GENE TRUNCATION	4.23284689578625
VIRAL SUBPOPULATION	4.23284689578625
VARYINGHERITABILITY	4.23284689578625
RESISTED DETACHMENT	4.23284689578625
EXPERIMENTAL FORMAT	4.23284689578625
IDENTIFIED MUTATION	4.23284689578625
QUANTITATIVE DEGREE	4.23284689578625
PARAFORMALDEHYDE/PB	4.23284689578625
OTHER MACROMOLECULE	4.23284689578625
SPLITTING PROCEDURE	4.23284689578625
SUBVENTRICULAR ZONE	4.23284689578625
VASCULAR THROMBOSIS	4.23284689578625
REMAINING BASE PAIR	4.23284689578625
BIOLOGICAL QUESTION	4.23284689578625
POLYAMINE SYNTHESIS	4.23284689578625
RSV-TRANSFORMED CEF	4.23284689578625
SMAD1 LINKER REGION	4.23284689578625
CORRESPONDING MATCH	4.23284689578625
WORST-CASE SCENARIO	4.23284689578625
LIVER MITOCHONDRION	4.23284689578625
AD LIBITUM QUANTITY	4.23284689578625
POLY-GLN HUNTINGTIN	4.23284689578625
SPREAD HPB-ALL CELL	4.23284689578625
BASE PAIR FREQUENCY	4.23284689578625
ROBUSTNESS PROPERTY	4.23284689578625
VIDEO CAMERA SYSTEM	4.23284689578625
MULTIVALENT VACCINE	4.23284689578625
RAB24 RAB24 PORTION	4.23284689578625
OVARIAN CANCER DATA	4.23284689578625
DISTORTION ARTIFACT	4.23284689578625
PARALLEL EXPERIMENT	4.23284689578625
MISMATCHED SEQUENCE	4.23284689578625
PROBE SET INTENSITY	4.23284689578625
INPUT WEIGHT MATRIX	4.23284689578625
ENDOTHELIAL CHANNEL	4.23284689578625
RELATIVE DIFFERENCE	4.23284689578625
CELL-MATRIX LINKAGE	4.23284689578625
MM CALCIUM CHLORIDE	4.23284689578625
NON-SPECIFIC DNASE1	4.23284689578625
BIOLOGICAL DATA SET	4.23284689578625
TELANGIECTASIA GENE	4.23284689578625
CHH CRITICAL REGION	4.23284689578625
OCCURRING FILOPODIA	4.23284689578625
INCREASING INTEREST	4.23284689578625
IMPORT/LOCALIZATION	4.23284689578625
ECORI CUT PGEX-4T-1	4.23284689578625
TREE-LIKE STRUCTURE	4.23284689578625
BINDING ELEMENT LEF	4.23284689578625
MATRIX GLYCOPROTEIN	4.23284689578625
INTEGRATED MEC-3GFP	4.23284689578625
LUMBRICUS TERRESTRI	4.23284689578625
DISSIMILAR SEQUENCE	4.23284689578625
NIDDK-ANTI-RLH-S-11	4.23284689578625
BIOLOGICAL STANDARD	4.23284689578625
radical nephrectomy	4.23284689578625
PCMV-Β-GALATOSIDASE	4.23284689578625
BIOLOGICAL MODIFIER	4.23284689578625
STATISTICAL OUTLIER	4.23284689578625
V-CRK CO-EXPRESSION	4.23284689578625
ALTERED PSEUDOPODIA	4.23284689578625
SOFTWARE PROGRAM SA	4.23284689578625
EPITHELIAL COVERING	4.23284689578625
ELONGATED HYPOCOTOL	4.23284689578625
PLATFORM LIMITATION	4.23284689578625
HYALOID VASCULATURE	4.23284689578625
LOWER-THAN-EXPECTED	4.23284689578625
HUMAN MUSCLE BIOPSY	4.23284689578625
GANGLION CELL DEATH	4.23284689578625
SIGNALING INHIBITOR	4.23284689578625
CORRESPONDING ENTRY	4.23284689578625
TRANSGENIC APPROACH	4.23284689578625
DIFFERENTIATING ALM	4.23284689578625
LOW-WEIGHT CATEGORY	4.23284689578625
PRINCETON INTRUMENT	4.23284689578625
INCREASED VARIATION	4.23284689578625
PROPAGATION NETWORK	4.23284689578625
SCAFFOLDING NETWORK	4.23284689578625
TARGETING MECHANISM	4.23284689578625
HOMOGENEOUS CULTURE	4.23284689578625
NORMAL PSEUDOPODIAL	4.23284689578625
ELECTRON MICROSCOPE	4.23284689578625
OCL SNUG APPOSITION	4.23284689578625
STANDARDIZED MEDIAN	4.23284689578625
TRANSFORMANT COLONY	4.23284689578625
INCREASED STABILITY	4.23284689578625
TRANSGENIC CELLULAR	4.23284689578625
IN VIVO UTILIZATION	4.23284689578625
WEIGHT MATRIX MATCH	4.23284689578625
ACHIEVED CONFLUENCE	4.23284689578625
OUTPUTTING SEQUENCE	4.23284689578625
ANT-PHOSPHOTYROSINE	4.23284689578625
TRUNK-TAIL BUD RISE	4.23284689578625
GROUPING EFFICIENCY	4.23284689578625
GOAT-ANTI MOUSE IGG	4.23284689578625
UVEOSCLERAL OUTFLOW	4.23284689578625
PREDICTED STRUCTURE	4.23284689578625
ITERATIVE TECHNIQUE	4.23284689578625
ESP ELITE CYTOMETER	4.23284689578625
SPREADING CONDITION	4.23284689578625
filament elongation	4.23284689578625
ENDOSOME POPULATION	4.23284689578625
REPORTED DIFFERENCE	4.23284689578625
STORM PHOSPORIMAGER	4.23284689578625
BINDING CAPACITY WG	4.23284689578625
MEDIOLATERAL EXTENT	4.23284689578625
MEASURE SENSITIVITY	4.23284689578625
ORIGINAL MOTIVATION	4.23284689578625
WORD REPRESENTATION	4.23284689578625
TREE REPRESENTATION	4.23284689578625
HORIZONTAL DISTANCE	4.23284689578625
LISTERIA COMET TAIL	4.23284689578625
AGAROSE-COATED WELL	4.23284689578625
PRINCIPAL PARAMETER	4.23284689578625
ANALYZABLE MUTATION	4.23284689578625
SCANNING MICROSCOPE	4.23284689578625
RAC1 MICROINJECTION	4.23284689578625
LIMITED PROTEOLYSIS	4.23284689578625
DETAILED COMPARISON	4.23284689578625
OUTPUT ERROR CUTOFF	4.23284689578625
STRUCTURE LINK NAME	4.23284689578625
YIELDED RATIO IMAGE	4.23284689578625
EXPERIMENTAL METHOD	4.23284689578625
RESVERATROL-INDUCED	4.23284689578625
AUTOINHIBITORY ROLE	4.23284689578625
BINDING DOMAIN GAL4	4.23284689578625
LIKELIHOOD LOCATION	4.23284689578625
TECHNICAL DUPLICATE	4.23284689578625
STRUCTURE CONSENSUS	4.23284689578625
DORSAL LIP OVERHANG	4.23284689578625
TEMPERATURE READING	4.23284689578625
ENCOUNTERED PROBLEM	4.23284689578625
BACTERIAL DIVERSITY	4.23284689578625
INHIBITING THROMBIN	4.23284689578625
SCORING SYSTEM GIVE	4.23284689578625
OPERATING PARAMETER	4.23284689578625
TEMPERATURE REGIMEN	4.23284689578625
TENTATIVE BASE PAIR	4.23284689578625
DEREPLICATE LIBRARY	4.23284689578625
INVADING EPITHELIUM	4.23284689578625
EMBRYONIC CELL LINE	4.23284689578625
ARRESTED LNCAP CELL	4.23284689578625
LENS VASCULAR TUNIC	4.23284689578625
substrate selection	4.23284689578625
ENABLING RESEARCHER	4.23284689578625
MONOCLONAL EE MOUSE	4.23284689578625
HUAPE1 CONTACT PLOT	4.23284689578625
FEED-FORWARDNETWORK	4.23284689578625
ENHANCED PROPORTION	4.23284689578625
HUMAN TISSUE BIOPSY	4.23284689578625
SEGMENTATION SYSTEM	4.23284689578625
IN-FRAME METHIONINE	4.23284689578625
GROUP/CELL LOCATION	4.23284689578625
GNRH-RESPONSIVENESS	4.23284689578625
AVERAGE PATH LENGTH	4.23284689578625
KLEBSIELLA AEROGENE	4.23284689578625
LANCET OVARIAN DATA	4.23284689578625
VIMENTIN TRANSCRIPT	4.23284689578625
DELTA LEARNING RULE	4.23284689578625
POLYTOMA LEUCOPLAST	4.23284689578625
PRONUCLEAR EXCHANGE	4.23284689578625
ACTIVATING MUTATION	4.23284689578625
structural analysis	4.23284689578625
EUCARYOTIC SEQUENCE	4.23284689578625
expression analysis	4.23284689578625
TRANSGENIC SEQUENCE	4.23284689578625
CALLED HNF3ΑLOXPNEO	4.23284689578625
APPLYING NOCODAZOLE	4.23284689578625
CONSENSUS ALIGNMENT	4.23284689578625
RELATIVE PROPORTION	4.23284689578625
ETEC AUTOSCAN SCOPE	4.23284689578625
ABLATION EXPERIMENT	4.23284689578625
PHYSIOLOGICAL RANGE	4.23284689578625
COMPREHENSIVE MODEL	4.23284689578625
OSCILLATORY FEATURE	4.23284689578625
WEIGHTED CONNECTION	4.23284689578625
NORMALIZATION CURVE	4.23284689578625
COMPLEX BOOKKEEPING	4.23284689578625
BOEHRINGER MANNHEIN	4.23284689578625
GLANDULAR STRUCTURE	4.23284689578625
ANALYTICAL STRATEGY	4.23284689578625
INFECTED EPITHELIAL	4.23284689578625
SUBMENTAL VIBRISSAE	4.23284689578625
length polymorphism	4.23284689578625
BLM OLIGOMERIZATION	4.23284689578625
MARKOV CHAIN THEORY	4.23284689578625
AFFYMETRIX PROTOCOL	4.23284689578625
CELLULAR CONSTRAINT	4.23284689578625
PERMUTATION PROCESS	4.23284689578625
PROTEIN-FREE MEDIUM	4.23284689578625
ENTERING EPITHELIUM	4.23284689578625
POTENTIAL BIOMARKER	4.23284689578625
B6 EYE CILIARY BODY	4.23284689578625
PROBE SETS INCREASE	4.23284689578625
OBSERVED RAW NUMBER	4.23284689578625
ENDONUCLEASES SHARE	4.23284689578625
POLARIZED MIGRATION	4.23284689578625
DIAGNOSTIC SPECIMEN	4.23284689578625
SEVEN-TRANSMEMBRANE	4.23284689578625
POTENTIAL BIPARTITE	4.23284689578625
PROPERTY SIMILARITY	4.23284689578625
PERIVITELLINE JELLY	4.23284689578625
PRECIPITOUS DECLINE	4.23284689578625
SEQUENCE EQKLISEEDL	4.23284689578625
TLX ULTRACENTRIFUGE	4.23284689578625
RCCA TUMOR SUB-TYPE	4.23284689578625
SYMMETRIC PLACEMENT	4.23284689578625
MOLECULAR CHAPERONE	4.23284689578625
FUNCTIONAL CATEGORY	4.23284689578625
POST-CLOACAL SOMITE	4.23284689578625
NOVEL BMP-REGULATED	4.23284689578625
RIO OUTPUTS WARNING	4.23284689578625
COAT COLOR MUTATION	4.23284689578625
COORDINATED PROCESS	4.23284689578625
LFC MODEL CRITERION	4.23284689578625
CROSS-HYBRIDIZATION	4.23284689578625
SUSPENDED PRECURSOR	4.23284689578625
MULTIFURCATION LOOP	4.23284689578625
TRANSIENT CHARACTER	4.23284689578625
MISMATCH PROBE PAIR	4.23284689578625
BLASTODERM OVERHANG	4.23284689578625
TECHNICAL PROCEDURE	4.23284689578625
SELECTED GOAL POINT	4.23284689578625
OCL PLASMA MEMBRANE	4.23284689578625
FIBRINOLYTIC SYSTEM	4.23284689578625
COORDINATE POSITION	4.23284689578625
ASSOCIATED DISTANCE	4.23284689578625
CONTROLLED VARIABLE	4.23284689578625
HYAL-1 HYALURONIDAS	4.23284689578625
DETERMINING RESIDUE	4.23284689578625
SURVIVING DIFF CALL	4.23284689578625
CONCERTED HIERARCHY	4.23284689578625
THEFITNESS FUNCTION	4.23284689578625
INDIVIDUAL VARIANCE	4.23284689578625
SUBSELECTION CHOICE	4.23284689578625
DIAGNOSING LYMPHOMA	4.23284689578625
CELLULAR PROTRUSION	4.23284689578625
FIXATION/EXTRACTION	4.23284689578625
SMAD1 HOMO-OLIGOMER	4.23284689578625
COLOR NEGATIVE FILM	4.23284689578625
UNDERLYING SEQUENCE	4.23284689578625
WNT/WG TRANSDUCTION	4.23284689578625
BASE-PAIR FREQUENCY	4.23284689578625
TECHNICAL REPLICATE	4.23284689578625
SIMULATED ALIGNMENT	4.23284689578625
INTRINSIC STIFFNESS	4.23284689578625
CONTAINING D-VALINE	4.23284689578625
SELECTIVE CRITERION	4.23284689578625
POSTERIOR VIBRISSAE	4.23284689578625
NUMERICAL PROCEDURE	4.23284689578625
ANTI-MOUSE IGG FITC	4.23284689578625
DORSOVENTRAL EXTENT	4.23284689578625
IMPORTANT MECHANISM	4.23284689578625
STUDYING CYTOKINESI	4.23284689578625
EQUIVALENT FUNCTION	4.23284689578625
PREVIOUS EXPERIMENT	4.23284689578625
THEORETICAL CONTEXT	4.23284689578625
GC CONTENT SEQUENCE	4.23284689578625
IMPROVED INHIBITION	4.23284689578625
BONE MARROW STROMAL	4.23284689578625
CONSIDERED VARIABLE	4.23284689578625
GFP-MHCK-C PUNCTATE	4.23284689578625
IN VITRO EQUIVALENT	4.23284689578625
keratinocyte marker	4.23284689578625
EXPERIMENTAL SCREEN	4.23284689578625
COMPRESSED TAR FILE	4.23284689578625
NOMINAL DESCRIPTION	4.23284689578625
SODIUMORTHOVANADATE	4.23284689578625
CONSTRICTING FURROW	4.23284689578625
PECTORAL FIN FLANGE	4.23284689578625
TISSUE-SPECIFIC CRE	4.23284689578625
ALGEBRAIC OPERATION	4.23284689578625
LRP CARBOXYTERMINUS	4.23284689578625
VIEW ANTIGENIC SITE	4.23284689578625
ARR-SPECIFIC DSRNAI	4.23284689578625
STANDARD AFFYMETRIX	4.23284689578625
ENDOGENOUS FUNCTION	4.23284689578625
TPA VARIABLE REGION	4.23284689578625
POSTPROCESSING STEP	4.23284689578625
NON-SIMILAR SEGMENT	4.23284689578625
RHOA REDISTRIBUTION	4.23284689578625
TEMPORARY STRUCTURE	4.23284689578625
REPROGRAMMING EVENT	4.23284689578625
NOMARSKI MICROSCOPY	4.23284689578625
CONTAINING EGF-LIKE	4.23284689578625
VENTRAL SPINAL CORD	4.23284689578625
INDICATED REFERENCE	4.23284689578625
CONSENSUS NODE TYPE	4.23284689578625
VARIABLE PROPORTION	4.23284689578625
ARTIFICIAL LIPOSOME	4.23284689578625
DESIRED BLAST MATCH	4.23284689578625
WG-FRIZZLED COMPLEX	4.23284689578625
LFC SELECTION MODEL	4.23284689578625
INCREASED SYNTHESIS	4.23284689578625
human keratinocytes	4.23284689578625
LEUCINE-RICH DOMAIN	4.23284689578625
SIGNALING CIRCUITRY	4.23284689578625
PENETRANCE FUNCTION	4.23284689578625
SMOOTH MUSCLE CELLS	4.23284689578625
UNIVERSAL DAKO LSAB	4.23284689578625
dendritic formation	4.23284689578625
HEMAGGLUTININ QUASI	4.23284689578625
TORTUOUS PROJECTION	4.23284689578625
likelihood position	4.23284689578625
PERIPHERAL LOCATION	4.23284689578625
EXPRESSING GFP-MHCK	4.23284689578625
PRODELHB-EGF REGION	4.23284689578625
UNDERLYING PROPERTY	4.23284689578625
MISCELLANEOUS NOISE	4.23284689578625
ERASE-A-BASE SYSTEM	4.23284689578625
PROGRAMMING PROBLEM	4.23284689578625
FLUORESCEIN-12-DUTP	4.23284689578625
COMPARING THOUSANDS	4.23284689578625
SELECTIVE CONDITION	4.23284689578625
POOLED TUMOR SAMPLE	4.23284689578625
CURRENT FORMULATION	4.23284689578625
TUNEL-POSITIVE CELL	4.23284689578625
LUPUS ANTICOAGULANT	4.23284689578625
MEMBRANE BOUND FORM	4.23284689578625
BEVELED GLASS SLIDE	4.23284689578625
PEARSON CORRELATION	4.23284689578625
SECONDARY MECHANISM	4.23284689578625
EMBRYONIC STRUCTURE	4.23284689578625
GAP GENE EXPRESSION	4.232372307193837
EXPRESSION DATA SET	4.232372307193837
ENO PEAK EXPRESSION	4.232372307193837
MODIFIED EXPRESSION	4.23213501289763
GENECHIP EXPRESSION	4.23213501289763
EXTERNAL EXPRESSION	4.23213501289763
RELATING EXPRESSION	4.23213501289763
HINDLIMB EXPRESSION	4.23213501289763
ANALYTIC EXPRESSION	4.23213501289763
EXPRESSION CASSETTE	4.23213501289763
MEC-3GFP EXPRESSION	4.23213501289763
RELATIVE EXPRESSION	4.23213501289763
EXAMINED EXPRESSION	4.23213501289763
GENE ARRAY ANALYSIS	4.231974105438951
FILTRATION ANALYSIS	4.231537710265302
CYTOMETRIC ANALYSIS	4.231537710265302
ANALYSIS EXPERIMENT	4.231537710265302
POPULATION ANALYSIS	4.231537710265302
MUTATIONAL ANALYSIS	4.231537710265302
BIOLOGICAL ANALYSIS	4.231537710265302
RAW MICROARRAY DATA	4.231352910268298
MICROARRAY DATA SET	4.231352910268298
CONTROL BGJB MEDIUM	4.23117839913942
MEASUREMENT ACCURACY	4.231145927867678
PSI ALGORITHM START	4.230933031985475
REGULATED MYOSIN II	4.230901240227986
GFP-3XASP MYOSIN II	4.230901240227986
INFORMATION TRANSFER	4.230705092272634
OTHER RRNA SEQUENCE	4.230620118892572
RRNA SEQUENCE RATIO	4.230620118892572
RRNA POSITIONS FALL	4.230620118892572
RRNA SEQUENCE COUNT	4.230620118892572
GENECHIP MICROARRAY	4.230605917509322
UNIGEM-V MICROARRAY	4.230605917509322
HAND REGIONS CHANGE	4.2304467223311795
CONTROL ENGINEERING	4.230344150816006
CONTROL SPECIFICITY	4.230344150816006
COORDINATED CONTROL	4.230344150816006
DOXYCYCLINE CONTROL	4.230344150816006
'-CYCLIC AMP DEPENDENT	4.230263552384568
EMBRYOLOGICAL STUDY	4.230143931218386
LAYER CHROMATOGRAPHY	4.230062903153718
RESIN CHROMATOGRAPHY	4.230062903153718
CONSTITUTIVE FASHION	4.230062903153718
VARIABLE CONFORMATION	4.230001472906564
ALGORITHM SENSITIVE	4.229976100085087
COMPARING ALGORITHM	4.229976100085087
DETECTION ALGORITHM	4.229976100085087
STRUCTURE ALGORITHM	4.229976100085087
NETSEARCH ALGORITHM	4.229976100085087
SENSITIVE ALGORITHM	4.229976100085087
TRANSFORMING MYOSIN	4.229928412448855
MYOSIN II-DEPENDENT	4.229928412448855
SN50 PEPTIDE ABSENCE	4.229877246669542
SΑ I2 REACH FRACTION	4.22987208451364
RING ACTIN FILAMENT	4.22960233997995
COMPARE INTRON TYPE	4.229584264460137
VECTOR PFLAG-CMV II	4.229538182096774
PGK PROMOTER RESULT	4.229381556596681
ANALYSIS MICROARRAY	4.2292967319883745
INTERMINGLED CHANGE	4.229246635603644
INVESTIGATED EFFECT	4.229027489331659
CCAF-INDUCED EFFECT	4.229027489331659
UN-DESCRIBED EFFECT	4.229027489331659
INFLAMMATORY EFFECT	4.229027489331659
ZEBRAFISH EST CLONE	4.228968469805872
TYROSINE PHOSPHATAS	4.228907597649228
ENDOGENOUS TYROSINE	4.228907597649228
DESIGNED RNA SAMPLE	4.228846606694465
STRUCTURAL RNA GENE	4.228846606694465
INDIVIDUAL RNA TYPE	4.228846606694465
HR POST-TRANSFECTION	4.228794217060224
IN VIVO RT FUNCTION	4.2287799352096025
INTRON RRNA GROUP I	4.2287298396214075
MECHANICAL SEPARATION	4.228727230102041
POSSIBLE DISADVANTAGE	4.228727230102041
MONOMERIC POLYPEPTIDE	4.228727230102041
CHROMOSOME SEPARATION	4.228727230102041
BIOINFORMATIC DATABASE	4.228597670055652
BIOINFORMATIC APPROACH	4.228597670055652
LOW-OXYGEN RESPONSE	4.228387690280891
GR-GFP LOCALIZATION	4.22834195483981
C/EBPΑ LOCALIZATION	4.22834195483981
LOCALIZATION STATUS	4.22834195483981
INFLAMMATORY FACTOR	4.228334240899833
OTHER SRC SUBSTRATE	4.228123973826272
CCAF TREATMENT LEAD	4.228066142128803
NON-ARCHAEAL INTRON	4.227952948797081
GP120 SELECTION MAP	4.227925531727114
ARRAY HYBRIDIZATION	4.227855625987638
MATCH HYBRIDIZATION	4.227855625987638
REPORTER GENE Β-GAL	4.227664220361142
PROMOTER ANNOTATION	4.227648887001896
COMPARATIVE GENOMIC	4.227617946473418
CELL CYCLE G1 PHASE	4.227586635399688
FITC-LABELED MONOMER	4.227455048405978
ELK-1 PROTEIN LEVEL	4.227363995160975
PROAPOPTOTIC SIGNAL	4.227161047989772
SIGNAL TRANSMISSION	4.227161047989772
CONSTITUTIVE SIGNAL	4.227161047989772
MAKE MUTANT VERSION	4.2271531509789435
IL-1BETA MRNA LEVEL	4.227142587444979
MIDDLE LAYER NEURON	4.227077020682435
OTHER INTRACELLULAR	4.2270292568156815
P53 TRANSACTIVATION	4.2270099291114605
P53 PHSOPHORYLATION	4.2270099291114605
RNA MODEL ALGORITHM	4.22693274289369
SEQUENTIAL INCUBATION	4.226880878283242
AZ MAPPING ANALYSIS	4.226551491336755
QUERY GENOME NUMBER	4.226527014602396
WHOLE GENOME SCREEN	4.226527014602396
SRC KINASES CONTROL	4.226455477179443
CATABOLITE REPRESSION	4.226346408019905
GENOMICS DNA SAMPLE	4.226253174646629
DNA ETHYLATION DATA	4.226253174646629
INSERT DNA SEQUENCE	4.226253174646629
COGNATE DNA ELEMENT	4.226253174646629
MEASURE DNA CONTENT	4.226253174646629
TRANSFECTED 3T3 CELL	4.226044098517334
CYTOLYTIC COMPONENT	4.225983899813158
CANDIDATE COMPONENT	4.225983899813158
OCCURRING COMPONENT	4.225983899813158
INACTIVE GFP FUSION	4.22587496336914
GELDING HORSE SERUM	4.225762512846284
PROTEIN SYNTHESIS	4.225729548389862
CONTROL PROTEIN III	4.225695498514145
N-PEPTIDE TREATMENT	4.22567576530008
INHIBITOR TREATMENT	4.22567576530008
PROLONGED TREATMENT	4.22567576530008
EXOENZYME TREATMENT	4.22567576530008
iterative comparisons	4.225607532201312
MYOSIN LOCALIZATION	4.225423471502415
MM SODIUM PYROPHOSPHATE	4.225338950007828
END CUT GENOMIC DNA	4.2252871302751185
EXPRESSING RECEPTOR	4.225208082877069
RECEPTOR RADIOASSAY	4.225208082877069
AMINO ACIDS CONTRIBUTION	4.225106708722698
C/EBP-TATA REPORTER	4.225072882648588
MHCK-B DISTRIBUTION	4.224750458140575
MODERATE ACTIVATION	4.224750458140575
CAUCHY DISTRIBUTION	4.224750458140575
CELLULAR ACTIVATION	4.224750458140575
CHANCE DISTRIBUTION	4.224750458140575
SHOWED DISTRIBUTION	4.224750458140575
PHOSPHORIMAGER	4.224720861753443
AZ CO-TRANSLOCATION	4.224712974632955
PREEXISTING PROTEIN	4.224622544848337
RAS-RELATED PROTEIN	4.224622544848337
FLUORESCENT PROTEIN	4.224622544848337
INTERACTIVE PROTEIN	4.224622544848337
GFP-LABELED PROTEIN	4.224622544848337
HOMEODOMAIN PROTEIN	4.224622544848337
P53-BINDING PROTEIN	4.224622544848337
HYDROPHOBIC MEMBRANE	4.224540387217326
DEPOSITING CDNA TAG	4.224520227686195
ENCODING RAB24 CDNA	4.224520227686195
PROTEASOME ASSEMBLY	4.224149237523322
PROTEASOME ANTI-26S	4.224149237523322
NOTCH RNA TREATMENT	4.224065853037019
FIBROBLAST INGROWTH	4.223928484775532
FIBROBLAST MOVEMENT	4.223928484775532
RESIDENT FIBROBLAST	4.223928484775532
HIGH-AFFINITY LIGAND	4.223757343912912
cell-surface receptors	4.223745857885577
BLOCKING MAB ANTI-Β1	4.2237400615550085
PRIMARY FUTURE GOAL	4.223731840174776
NF-ΚB RESPONSE GENE	4.2237094360840395
CONSENSUS MAPK SITE	4.223696234488794
LEUCINE ZIPPER MOTIF	4.223522569024463
GENOME CO-LINEARITY	4.223367074010468
GENOME INTERMEDIATE	4.223367074010468
CAS PHOSPHORYLATION	4.223166857388941
RB1 PHOSPHORYLATION	4.223166857388941
NUCLEOTIDE EXCHANGE	4.223122207765337
POSSIBLE NUCLEOTIDE	4.223122207765337
SINGLE-STRANDED DNA	4.22295631407682
MM MAGNESIUM SULFATE	4.222950572023516
CLONTECH ATLAS IMAGE	4.222950572023516
GAD1-LACZ TRANSGENE	4.222864356189025
TARGETING TRANSGENE	4.222864356189025
PARAMETER DEPENDENT	4.222691248565952
PROCESSES DEPENDENT	4.222691248565952
ANCHORAGE DEPENDENT	4.222691248565952
ANTISENSE RNA PROBE	4.222681950662495
COMPREHENSIVE TABLE	4.222512031262064
DYE EXCLUSION ASSAY	4.222426213881674
BEARING SUBSTITUTION	4.2223990034868875
GΑ CAUSE C-TERMINUS	4.222388997160586
OTHER WILD-TYPE RAB	4.222388997160586
FINAL NETWORK MODEL	4.222388997160586
ENVIRONMENTAL CYCLE	4.222326375013127
TEST DENSITY EFFECT	4.222222799671182
N(T)KXD MOTIF CAUSE	4.222001667581858
RAB24 N(T)KXD MOTIF	4.222001667581858
DME MEDIUM ANTIBODY	4.221831679678968
CRITICAL AMINO ACID	4.221744671652844
SCORING MATRIX ACID	4.221744671652844
DRIVE S PHASE ENTRY	4.221679987084269
WEEK OLD SPRAGUE-DAWLEY	4.221436549848352
STEADY-STATE MEASURE	4.221261393380092
OVEREXPRESSED HYAL-1	4.221261393380092
OVEREXPRESSED LRP6ΔN	4.221261393380092
PROTEIN DNA COMPLEX	4.220770274021355
COLLAGEN EXPRESSION	4.220726396215088
MAXIMAL GROWTH RATE	4.220594964341958
SURROUNDING PEPTIDE	4.220589265769193
THESEAPPROACHES USE	4.220474170651662
BASELINE INFORMATION	4.220364381272895
OKADAIC ACID ABILITY	4.220327301607037
C/EBP-TATA VECTOR ΜG	4.220131838666897
WTPAI-1 CONSTRUCTION	4.220075374332583
GFP-BLM CONSTRUCTION	4.220075374332583
PROTEIN PHOSPHATASE 5 LOCALIZATION	4.219985325424586
SINGLE GENE PRODUCT	4.21991473092423
Q-WAVE	4.219885136125976
PREP81	4.219885136125976
MODE BOOTSTRAP MODE	4.219832621940979
BIOLOGICAL REACTION	4.219636918574885
QUALITATIVE SOLUTION	4.219631484162754
PROGRAMMING SOLUTION	4.219631484162754
PROTEIN FIBRONECTIN	4.219602753508019
INCREASED RESISTANCE	4.219463235469352
STATISTICAL TEST	4.219405689837248
T CELL CYTOSKELETON	4.219200266942228
GABA RECEPTOR SUBUNIT	4.219104879985136
ANTI-MOUSE FITC	4.218948163822638
SEQUENCE LENGTH	4.218948163822638
PHARYNGEAL ARCH	4.218948163822638
TRANSMISSION EM	4.218948163822638
FRAGMENTED CRNA	4.218948163822638
REGULATORY STEP	4.218948163822638
MOUNTING MEDIUM	4.218948163822638
MISLOCALIZATION	4.218948163822638
CELLULAR DEBRIS	4.218948163822638
UNDERESTIMATION	4.218948163822638
emission filter	4.218948163822638
MACROPHAGE-LIKE	4.218948163822638
MOLECULAR LEVEL	4.218948163822638
TISSUE-SPECIFIC	4.218948163822638
REGULATORY SITE	4.218948163822638
ORAL EPITHELIUM	4.218948163822638
CONTROL CELL GROWTH	4.218926467695128
FINAL CONTROL STUDY	4.21891852413518
MULTIPLE PROBE PAIR	4.218777410548119
MULTIPLE RDNA LOCUS	4.218777410548119
SOLUBILITY CONSTRAINT	4.218674870199692
pair frequency tables	4.218674870199692
INCLUDING RA ONCOGENE	4.218674870199692
CRW SITE COLLECTION	4.218562936687782
MG/ML BOVINE TYPE I	4.218445855055827
DROSOPHILA SEQUENCE	4.218445855055827
DROSOPHILA ORTHOLOG	4.218445855055827
WTPAI-1 PURIFICATION	4.218327556788884
GFP-BLM PURIFICATION	4.218327556788884
CELL DEATH EFFECTOR	4.218205837710321
PRACTICAL IMPLICATION	4.217826709630357
PEAK EXPRESSION	4.2178205369056485
TGF-Β GROWTH FACTOR	4.2175865277510125
GENETIC MANIPULATION	4.217545200364562
MYOSIN-II ENRICHMENT	4.217545200364562
FUNCTIONAL HOMOLOGUE	4.217545200364562
DNA DAMAGE INCREASE	4.2175122444520445
WILD-TYPE GFP-RAB24	4.217160047847754
PHYLOGENY OPERATION	4.217160047847754
BRYOPHYTA PHYLOGENY	4.217160047847754
ACTIVATION RECEPTOR	4.217111645231394
ADHESIVE ORGAN WRAP	4.217018724893353
FUNGI S. CEREVISIAE	4.217018724893353
ELONGATED PHENOTYPE	4.21697104967982
ANALYSIS METHOD	4.2168744058262675
SAMPLE BUFFER	4.216714624451344
GR-GFP ACCUMULATION	4.216678856193199
TRANSLATION PRODUCT	4.216579053479662
YEAST NITROGEN BASE	4.216579053479662
GFP REPORTER STRAIN	4.216538796291287
ANTISENSE TREATMENT	4.216428781252125
BODY AXIS FORMATION	4.216427017570254
RIBOSYLATION BUFFER	4.2163885635229095
ANTIBODY REACTIVITY	4.216324071625326
ANTI-SNIP1 ANTIBODY	4.216324071625326
CONJUGATED ANTIBODY	4.216324071625326
GENERAL DESCRIPTION	4.216272113058783
GENERAL CONSISTENCY	4.216272113058783
GENERAL GENEFINDING	4.216272113058783
GLYCINE-SERINE ACID	4.216193559586141
PROTEIN KINASE CHIP	4.2160973027746955
ARR PLASMID ADDITION	4.216016891395232
COMMON MOLEGOS FORM	4.215706144868089
MM SODIUM MOLYBDATE	4.215622121579274
ANEUPLOID DERIVATIVE	4.215494886976682
statistical analyses	4.2150677383542074
MACROPHAGE FUNCTION	4.2149190695708265
REPORTED MACROPHAGE	4.2149190695708265
OBSERVED MACROPHAGE	4.2149190695708265
MACROPHAGE ACTIVITY	4.2149190695708265
BIOCHEMICAL BEHAVIOR	4.21477966137626
MICROTUBULE BEHAVIOR	4.21477966137626
PERMEABILIZATION BSA	4.21477966137626
CONTROLLING BEHAVIOR	4.21477966137626
PIP SLIGHT AFFINITY	4.214687443909129
BURST	4.214523745520019
GROWTH POLARIZATION	4.214468998619811
INTERACTION NETWORK	4.214430470533508
STUDIED INTERACTION	4.214430470533508
COMPLEX INTERACTION	4.214430470533508
PAIRWISE SIMILARITY	4.214156183348893
WNT-DEPENDENT MANNER	4.21404760693818
RING FINGER SUBUNIT	4.2139552079463405
IN VITRO REGULATION	4.2139552079463405
TOUCH RECEPTOR AXON	4.213810489012578
INTRODUCTION CIRCADIAN	4.2137114281701935
ACTIVATED PRIMARY T	4.213634558743101
BOOTSTRAP ORTHOLOGY	4.213325485018344
BLM MISSENSE ALLELE	4.213325485018344
PROTEOLYSIS SUPPORT	4.213325485018344
BLM DELETION ALLELE	4.213325485018344
BOOTSTRAP ITERATION	4.213325485018344
CELLULAR CHANGE	4.21324532933262
RELATIVE CHANGE	4.21324532933262
INDUCER CONCENTRATION	4.21313755330433
RESVERATROL ADDITION	4.212641358034788
SMCS ERK ACTIVATION	4.212622882764141
COMPOSITIONAL VARIATION	4.212591109486877
CHARACTERIZATION	4.212385803715351
MULTIPLE DNA REPAIR	4.212183689408499
TOTAL SΑ I2 PROTEIN	4.21209715432192
TRANSFECTION METHOD	4.212095789851862
STABLE TRANSFECTION	4.212095789851862
SENSITIVE PCR ASSAY	4.212060863031458
DNA-BINDING COMPLEX	4.211931098534922
CONTROL INTERACTION	4.211927725563264
MICROARRAY PAIRWISE	4.211915205071965
MULTIPLE CHROMOSOME	4.211742667929054
IDENTIFIED MULTIPLE	4.211742667929054
MULTIPLE NON-MUSCLE	4.211742667929054
MULTIPLE ENDOGENOUS	4.211742667929054
MULTIPLE TRANSCRIPT	4.211742667929054
UBIQUITIN PRECURSOR	4.2115937469663525
HA-TAGGED UBIQUITIN	4.2115937469663525
METABOLIC MACHINERY	4.211420957138548
SEQUENCE COLLECTION	4.211420957138548
MOLECULAR MACHINERY	4.211420957138548
VECTORIAL SECRETION	4.211156439377466
NORMAL AXON GUIDANCE	4.210938635003617
GUIDANCE SYSTEMS ACT	4.210938635003617
MONOCYTIC CELLS LEAD	4.210938635003617
COLLOIDAL GOLD PROBE	4.210938635003617
RESULTING TOTAL CY3	4.210663474459084
POLYMERASE PROMOTER	4.210535961978082
MUCIN-LIKE MOLECULE	4.210176870378359
EQUIVALENT MOLECULE	4.210176870378359
SYSTEM AMPLIFICATION	4.2101128143335
PROTEIN PURIFICATION	4.209977538544508
CONTAINING P21 GENE	4.209880530176949
HYAL-2 UPREGULATION	4.209729435666362
CCR4 HOMOLOGY DOMAIN	4.209692113237401
TOTAL PHOSPHOTYROSINE	4.209536361197556
CDC42 OVEREXPRESSION	4.20943714287613
ΜM PHALLOIDIN-TRITC	4.209220738499909
ADPASE	4.20917085041169
COMPLEX MEASUREMENT	4.209104639446905
TRANSFORMING ABILITY	4.208896605710234
WEB SERVER SOFTWARE	4.208445132326368
ONE-STEP RT-PCR KIT	4.208445132326368
PHYSIOLOGIC ACTIVITY	4.208397648326331
MUTAGENESIS APPROACH	4.208397648326331
LAMIN IMMUNOREACTIVE	4.208397648326331
PHYSIOLOGIC FUNCTION	4.208397648326331
POLYCLONAL ANTI GFAP	4.208397648326331
FILOPODIA FORMATION	4.208217078462257
FRACTIONATION STUDY	4.208182344104492
CRE REPORTER ALLELE	4.2081428095932365
RESPONSE STRATIFICATION	4.207876534674924
CELL CYCLE EXIT	4.20783845032512
POISSON PROBABILITY	4.207384186088981
HIV ANTIGENIC DRIFT	4.207384186088981
ASTROCYTE CELL LINE	4.207384186088981
CYTOSOLIC COMPONENT	4.207293187375801
COMMON DINUCLEOTIDE	4.207135769409008
EXCESS TRITON X-100	4.207095247539225
PRELIMINARY ANALYSIS	4.207068458574129
ACTIVITY TAKES PLACE	4.207052420085415
LAMININ BINDING SITE	4.207052420085415
SIMILAR ASSOCIATION	4.207009734475786
INDUCED ASSOCIATION	4.207009734475786
REDUCED ASSOCIATION	4.207009734475786
LACKING CSN SUBUNIT	4.206983275529232
SPECIMEN PREPARATION	4.2065922104240485
COMPARTMENTALIZATION	4.20648942560379
MOTIF IDENTIFICATION	4.206434158621155
ORIGINAL OBSERVATION	4.206359827327716
PM-ONLY INFORMATION	4.206341532028102
INFORMATION CONTENT	4.206341532028102
SPATIAL INFORMATION	4.206341532028102
DESIRED INFORMATION	4.206341532028102
LIMITED INFORMATION	4.206341532028102
CONTENT INFORMATION	4.206341532028102
GR-REPORTER PLASMID	4.206136857404487
PJC10-PJC15 PLASMID	4.206136857404487
CELL ACTIVATION	4.206123356305918
SELF-ASSOCIATION SITE	4.206109420321756
IMMUNOLOGICAL SYNAPSE	4.206109420321756
RESULTING SUPERNATANT	4.206109420321756
ALLOWED INVESTIGATION	4.206109420321756
NORMAL LYSOSOMAL PH	4.205792766732902
AFFINITY BIOREAGENT	4.205607717970567
ONCOGENE EXPRESSION	4.205514907305032
INDICATED PLASMID ΜG	4.205412332357098
SIGNIFICANCE CUTOFF	4.205394911893882
OPTIMAL PERFORMANCE	4.205394911893882
SINGLE DISTRIBUTION	4.205352210847545
RHYTHMIC REGULATION	4.204509364026387
NEGATIVE REGULATION	4.204509364026387
P21 GENE ACTIVATION	4.204482905079832
LNCAP CELLS EXHIBIT	4.204417656803863
MATHEMATICAL RESEARCH	4.204314356053479
CYTOSKELETAL RESEARCH	4.204314356053479
ACTIVATED NF-ΚB	4.204300883658805
CONTAINING BUFFER ΜL	4.204229991849211
NUCLEATION ACTIVITY	4.203564779634392
FILAMENT NUCLEATION	4.203564779634392
EXCESS CROSSLINKING	4.203564779634392
PERFORMED JNK ASSAY	4.203534526041765
FOCAL CONCENTRATION	4.20306847258097
POLAR CONCENTRATION	4.20306847258097
REPLICATION PROTEIN	4.202932088439553
DROSOPHILA HOMOLOGUE	4.202924113090341
BASELINE EXPRESSION	4.202852896745772
GRADIENT SDS-PAGE GEL	4.2027321158170095
METABOLIC HOMEOSTASI	4.202680428302437
INTEGRATION POSITION	4.202680428302437
ROOT TRANSFORMATION	4.202202820743607
AGAR TRANSFORMATION	4.202202820743607
IN VIVO EXAMINATION	4.202023615626398
GOAT ANTI-NF-ΚB P65	4.202023615626398
EXAMPLE WOUND FLUID	4.202023615626398
MEMBRANE DESTABILIZATION	4.200552172881662
ORGANISM LIFE CYCLE	4.200409703094652
CONTINUING PRESENCE	4.200311211173074
ENDOTHELIAL ANTIGEN	4.199697330331316
IL-1BETA PRODUCTION	4.199697330331316
REACTIVE	4.199519417688961
MEAN STANDARD ERROR	4.1995176578898255
FIGURE 3(TOP PANEL)	4.199381620184126
CONTAINING CDNA	4.199163922843052
PROTEIN ASSOCIATION	4.1987853835378735
MICROSOMAL FRACTION	4.198565393949927
RECIPIENT CYTOPLASM	4.198397347372299
EGFP FUSION PROTEIN	4.198081879009116
NUC	4.19789622055417
SEA	4.19789622055417
IOD	4.19789622055417
ACO	4.19789622055417
9-C	4.19789622055417
PSI	4.19789622055417
GSΑ	4.19789622055417
ΔN4	4.19789622055417
PMT	4.19789622055417
OPG	4.19789622055417
RAD	4.19789622055417
LIF	4.19789622055417
PGK	4.19789622055417
CRW	4.19789622055417
SVJ	4.19789622055417
A/T	4.19789622055417
PP4	4.19789622055417
MYB	4.19789622055417
gar	4.19789622055417
E16	4.19789622055417
RRA	4.19789622055417
MPF	4.19789622055417
JYJ	4.19789622055417
JAW	4.19789622055417
MES	4.19789622055417
MH2	4.19789622055417
EAR	4.19789622055417
CHH	4.19789622055417
O.D	4.19789622055417
FSC	4.19789622055417
S22	4.19789622055417
XTH	4.19789622055417
FTP	4.19789622055417
CHP	4.19789622055417
IGY	4.19789622055417
p38	4.19789622055417
E13	4.19789622055417
BTX	4.19789622055417
BAC	4.19789622055417
LAG	4.19789622055417
EMS	4.19789622055417
R.J	4.19789622055417
S.R	4.19789622055417
GAM	4.19789622055417
R_I	4.19789622055417
ΔC2	4.19789622055417
CUT	4.19789622055417
CHL	4.19789622055417
5-B	4.19789622055417
RIO	4.19789622055417
ASP	4.19789622055417
5-M	4.19789622055417
PP6	4.19789622055417
JEF	4.19789622055417
HYH	4.19789622055417
p14	4.19789622055417
S67	4.19789622055417
PKB	4.19789622055417
SMC	4.19789622055417
LPA	4.19789622055417
N(0	4.19789622055417
ZT0	4.19789622055417
HFF	4.19789622055417
AVE	4.19789622055417
PCD	4.19789622055417
BIF	4.19789622055417
7-M	4.19789622055417
CD8	4.19789622055417
P57	4.19789622055417
ΔC1	4.19789622055417
BME	4.19789622055417
GUT	4.19789622055417
SCN	4.19789622055417
GRE	4.19789622055417
P63	4.19789622055417
S17	4.19789622055417
AER	4.19789622055417
PFA	4.19789622055417
ACTIVATED GR LIGAND	4.197883175007911
SINGLE MRNA SPECIES	4.197596455971976
PRELIMINARY DATA	4.196895939413569
inhibition experiments	4.196575709733155
INCLUDING NEUTROPHIL	4.195923713728744
INTENSITY SATURATION	4.195923713728744
HIV QUASISPECIATION	4.194652831240347
AMINO ACIDS ABSENCE	4.194600866526679
proteinase inhibitors	4.194410553194023
PROTEIN COMPOSITION	4.194330700553311
APOPTOSI POTENTIATE	4.1939768300979425
COX HAZARD ANALYSIS	4.19293128390314
SUITE DOCUMENTATION	4.1929167373973515
INDUCED SUPPRESSION	4.1929167373973515
POTENTIAL MODULATOR	4.1929167373973515
PENICILLIN G SODIUM	4.19280488821419
ACID STARVATION	4.192569175849858
SERUM CONCENTRATION	4.192441898171022
AGELLON	4.192289466726838
PEITSCH	4.192289466726838
PEM-BAL	4.192289466726838
REJECT	4.192107143723648
EXTENT	4.192107143723648
LINKER	4.192107143723648
RECEPTOR PRODUCTION	4.192058517422136
LATER-BORN NEURONAL	4.191988129062726
RETICULOCYTE LYSATE	4.191668919947698
CUSTOMIZED GIBBS FIND	4.191259343193286
RIBOSOMAL PROTEIN	4.191153206366056
TOLERANCE INDUCTION	4.191015301283595
lumen	4.190672859405572
ORGAN	4.190672859405572
nerve	4.190672859405572
GENUS	4.190672859405572
NIKON	4.190672859405572
ECOR1	4.190672859405572
GENERAL ASSOCIATION	4.190434951748319
FIBROBLASTS EXHIBIT	4.19020303731267
TRANSCRIPTS EXHIBIT	4.19020303731267
RHYTHMICITY EXHIBIT	4.19020303731267
F-BOX OVEREXPRESSION	4.19004830975162
QUANTITATE DIFFERENCE	4.189953841907267
WEEK OLD BALB/C MOUSE	4.189953841907267
ΜG/ML LATRUNCULIN B	4.189628215252966
MEASUREMENT SUPPORT	4.189583228678999
EMPTY VECTOR PLASMID	4.18950058764879
STAINING INTENSITY	4.189442315876413
FATTY ACID SYNTHASE	4.189208987039668
REPRESENTATIVE GENE	4.188923721558462
THERAPEUTIC AGONIST	4.188923721558462
SETS REPRESENTATIVE	4.188923721558462
ENHANCED PROTECTION	4.188923721558462
REPRESENTATIVE LINE	4.188923721558462
RISK/LOW RISK GROUP	4.188923721558462
GENERAL PERFORMANCE	4.188820129166415
COLLAGEN PRODUCTION	4.188288713648773
SINGLE MUTATION	4.18822121963037
CANCER CELL ABILITY	4.188125118390684
OPPOSITE DNA STRAND	4.188059110100727
ENCODING TERMINATION	4.187815656240313
POLY-GLN POLYPEPTIDE	4.187815656240313
PRIMARY NEURON BIRTH	4.187568057250031
DIVISION GINGLYMODI	4.186611975546473
SYMMETRICAL FASHION	4.186611975546473
EXTERNAL APPEARANCE	4.186611975546473
VASCULAR APPEARANCE	4.186611975546473
DIAGNOSTIC DIVISION	4.186611975546473
ROUND-ROBIN FASHION	4.186611975546473
INDEPENDENT FASHION	4.186611975546473
IMMUNOHISTOLOGICAL	4.186534648984291
HUAPE1 CONCENTRATE	4.186534648984291
androgen-sensitive	4.186534648984291
CRISTAE DISTENSION	4.186534648984291
GENETIC DEFICIENCY	4.186534648984291
SEQUENCER SOFTWARE	4.186534648984291
ROUND-ROBIN SERIES	4.186534648984291
LINGERING QUESTION	4.186534648984291
C/EBPΑ ENHANCEMENT	4.186534648984291
COMPUTATIONAL COST	4.186534648984291
EMPIRICAL APPROACH	4.186534648984291
SLOWED DEGRADATION	4.186534648984291
BACKBONE DEVIATION	4.186534648984291
TAXONOMY SIGNATURE	4.186534648984291
embryo development	4.186534648984291
III1-C-COATED WELL	4.186534648984291
INTERMEDIATE RATIO	4.186534648984291
AUTOIMMUNE DISEASE	4.186534648984291
TREE VIEW SOFTWARE	4.186534648984291
SUBINTESTINAL VEIN	4.186534648984291
POB1 FUNCTION LEAD	4.186534648984291
HUMAN FIBROSARCOMA	4.186534648984291
SMAD1-BINDING SITE	4.186534648984291
SELECTED GENE LIST	4.186534648984291
UNCLASSIFIED GROUP	4.186534648984291
UNTRANSFORMED CELL	4.186534648984291
GNRH-TREATED GROUP	4.186534648984291
HERITABILITY FROM0	4.186534648984291
OXIDATION ACTIVITY	4.186534648984291
CDK2 INHIBITOR P27	4.186534648984291
LINOLEOYL COENZYME	4.186534648984291
INPUT/OUTPUT LEVEL	4.186534648984291
POSITIVE INTENSITY	4.186534648984291
FINDING APE MOLEGO	4.186534648984291
SEQUENCE DIVERSITY	4.186534648984291
GOSSYPIUM HIRSUTUM	4.186534648984291
CELLULAR STRUCTURE	4.186534648984291
TESTING CORRECTION	4.186534648984291
TRAINING ITERATION	4.186534648984291
length restriction	4.186534648984291
SELECTION DETECTOR	4.186534648984291
CONTAINING GFP-BLM	4.186534648984291
BASE PAIR CATEGORY	4.186534648984291
LIQUID LIGHT-GUIDE	4.186534648984291
A-C ANTIGENIC SITE	4.186534648984291
MOLECULAR APPROACH	4.186534648984291
STANDARD CONDITION	4.186534648984291
COLLECTIVE DYNAMIC	4.186534648984291
NEGATIVE INTENSITY	4.186534648984291
muscular dystrophy	4.186534648984291
MYOSIN-II INCREASE	4.186534648984291
STUDYING MECHANISM	4.186534648984291
PFA-BASED FIXATIVE	4.186534648984291
PROTEOMICS EXPLOIT	4.186534648984291
HUGENEFL PROBE SET	4.186534648984291
TRYPANOSOMA BRUCEI	4.186534648984291
PROGNOSTIC NETWORK	4.186534648984291
SANTA CRUZ SC-8432	4.186534648984291
GLYOXYLATE BY-PASS	4.186534648984291
CATALYTIC SUB-UNIT	4.186534648984291
DIFFERENTIATED MDC	4.186534648984291
MYOSIN-II DECREASE	4.186534648984291
PREOVULATORY SURGE	4.186534648984291
mitogenic response	4.186534648984291
stiffness increase	4.186534648984291
PEGFP-N346 ΔRINGWA	4.186534648984291
DOCUMENT SELECTION	4.186534648984291
WEB-FORMATTED LIST	4.186534648984291
MEMBRANE STRUCTURE	4.186534648984291
POLY-ALA INCLUSION	4.186534648984291
PADDLEFISH DISPLAY	4.186534648984291
DISCUSSION ADAPTOR	4.186534648984291
FUNCTIONAL PARTNER	4.186534648984291
INSERTION POSITION	4.186534648984291
ASYNCHRONOUS LNCAP	4.186534648984291
TAGGING EXPERIMENT	4.186534648984291
INCLUDING SELF IGG	4.186534648984291
EXPERIMENTAL MEANS	4.186534648984291
TRANSITIONAL STAGE	4.186534648984291
BS CELL RDNA LOCUS	4.186534648984291
DIFFERING ACTIVITY	4.186534648984291
INDIVIDUAL HELICAS	4.186534648984291
EXPRESSING NLS-GFP	4.186534648984291
AGING BALB/C MOUSE	4.186534648984291
PRE-ASSEMBLED HSN3	4.186534648984291
NEOVASCULARIZATION	4.186534648984291
PHAGOCYTOSIS EVENT	4.186534648984291
PHOSPHODEOXYRIBOSE	4.186534648984291
chromatid exchange	4.186534648984291
STATISTICAL THEORY	4.186534648984291
IMAGEQUANT PROGRAM	4.186534648984291
PROPOSED RECURSION	4.186534648984291
RESULTING MUTATION	4.186534648984291
PTX-MKC2 CELL LINE	4.186534648984291
ANCESTRAL SEQUENCE	4.186534648984291
INHIBITED THROMBIN	4.186534648984291
SUB-UNIT HYPERCUBE	4.186534648984291
TELEOSTEAN FEATURE	4.186534648984291
PROMOTERINFO STORE	4.186534648984291
BIASED EXPECTATION	4.186534648984291
GR-RESPONSIVE GENE	4.186534648984291
BODIPY FLUOROPHORE	4.186534648984291
STUDIED BACKGROUND	4.186534648984291
REPORTED PROCEDURE	4.186534648984291
MIB-ARRESTED LNCAP	4.186534648984291
POTENTIAL INTEREST	4.186534648984291
CONSTRAINED INSUCH	4.186534648984291
MOLECULAR SCAFFOLD	4.186534648984291
CONSERVED MUTATION	4.186534648984291
EXTERNAL PARAMETER	4.186534648984291
RAS PROTO-ONCOGENE	4.186534648984291
WEB IMPLEMENTATION	4.186534648984291
COMPUTING DISTANCE	4.186534648984291
FEEDBACK MECHANISM	4.186534648984291
GENERATED MUTATION	4.186534648984291
UNDERGOING SUICIDE	4.186534648984291
REMAINING POSITION	4.186534648984291
ANSWERING QUESTION	4.186534648984291
CRITICAL SUBSTRATE	4.186534648984291
HUMAN AUTO-ANTIGEN	4.186534648984291
NON-SYNONYMOUS SNP	4.186534648984291
PROTEINS ASSOCIATE	4.186534648984291
LOCALIZED FUNCTION	4.186534648984291
ALGORITHMPARAMETER	4.186534648984291
SEMI-THICK SECTION	4.186534648984291
BIOLOGICAL SCIENCE	4.186534648984291
IN-FRAME INSERTION	4.186534648984291
SIMULATED DATA SET	4.186534648984291
BRASSICA CAMPESTRI	4.186534648984291
LABELING PROCEDURE	4.186534648984291
CELLULAR VIABILITY	4.186534648984291
SCANNING PARAMETER	4.186534648984291
SALI-XBAI FRAGMENT	4.186534648984291
EQUIVALENT BOOLEAN	4.186534648984291
PAIRING CONSTRAINT	4.186534648984291
INSECT HIGH-5 CELL	4.186534648984291
OCL PRECURSOR CELL	4.186534648984291
EMBRYOS EXPERIMENT	4.186534648984291
TTT POINT MUTATION	4.186534648984291
SEMI-AUTOMATICALLY	4.186534648984291
MOLECULAR SEQUENCE	4.186534648984291
REDUCED GENE PANEL	4.186534648984291
NEURITE RETRACTION	4.186534648984291
INVASIVE CARCINOMA	4.186534648984291
SPINAL HEMISEGMENT	4.186534648984291
CARBOXYFLUORESCEIN	4.186534648984291
TARGET SPECIFICITY	4.186534648984291
INFECTED CELL STOP	4.186534648984291
VCA-ACTIVATED ARP2	4.186534648984291
SUBCONFLUENT HUVEC	4.186534648984291
TARGETING FUNCTION	4.186534648984291
OTHER PP5 SEQUENCE	4.186534648984291
ROBUSTNESS MEASURE	4.186534648984291
ELECTRO NEUTRALITY	4.186534648984291
SCREENING APPROACH	4.186534648984291
TRANSWELL MEMBRANE	4.186534648984291
MOLECULAR IDENTITY	4.186534648984291
CULTURE MATURATION	4.186534648984291
ECTOPIC PROTEOLYSI	4.186534648984291
INTENTIONAL SEARCH	4.186534648984291
PUTATIVE ANTIGENIC	4.186534648984291
ACKAB GENE PRODUCT	4.186534648984291
CROSSLINKED MOESIN	4.186534648984291
MONOCLONAL Β-ACTIN	4.186534648984291
MEMBRANE POTENTIAL	4.186534648984291
OBSERVED INTENSITY	4.186534648984291
KERATINOCYTE HACAT	4.186534648984291
TELEOSTEAN PATTERN	4.186534648984291
GENE CLUSTER GROUP	4.186534648984291
STEPDISC PROCEDURE	4.186534648984291
CELLQUEST SOFTWARE	4.186534648984291
UREA/LICL PROTOCOL	4.186534648984291
MYR-TAGGED VERSION	4.186534648984291
MECHANICAL PROCESS	4.186534648984291
INTERACTING REGION	4.186534648984291
DFZ2 AMINOTERMINUS	4.186534648984291
QUALITATIVE RESULT	4.186534648984291
SCIENTIFIC JOURNAL	4.186534648984291
POSITIVE FREQUENCY	4.186534648984291
LEF/TCF-RESPONSIVE	4.186534648984291
ISOLATEDPOPULATION	4.186534648984291
PATHOPHYSIOLOGICAL	4.186534648984291
SHOW FRAGMENTATION	4.186534648984291
BIFURCATION THEORY	4.186534648984291
PROGRAM WCONSENSUS	4.186534648984291
average difference	4.186534648984291
SIGNALING FUNCTION	4.186534648984291
SWISSPROT DATABASE	4.186534648984291
ECONOMIC FRAMEWORK	4.186534648984291
DETAILED MECHANISM	4.186534648984291
GPNN FALL THEPOWER	4.186534648984291
COCLUSTERING RATIO	4.186534648984291
TNF-MEDIATED DEATH	4.186534648984291
REMODELING COMPLEX	4.186534648984291
REGULATORY PATHWAY	4.186534648984291
RUNNING GENEORDER2	4.186534648984291
BOOLEAN EQUIVALENT	4.186534648984291
TARGETING STRATEGY	4.186534648984291
FLUORESCENCE LEVEL	4.186534648984291
AMERSHAM/PHARMACIA	4.186534648984291
PHYLOGENETIC MEANS	4.186534648984291
GENEFINDER CRITICA	4.186534648984291
PROFILE COMPARISON	4.186534648984291
PECTORAL FIN LEVEL	4.186534648984291
PARACRINE MEDIATOR	4.186534648984291
HEMATOPOIETIC CELL	4.186534648984291
CONTAINING CLUSTER	4.186534648984291
NEGATIVE DIRECTION	4.186534648984291
REFERENCE POSITION	4.186534648984291
SURGICAL PROCEDURE	4.186534648984291
lung melanoma line	4.186534648984291
VAL-355 TRANSITION	4.186534648984291
NOMINAL TRAJECTORY	4.186534648984291
TRANSMEMBRANE PORE	4.186534648984291
CYTOKINESI BIOLOGY	4.186534648984291
CURRENT LIMITATION	4.186534648984291
WD40 REPEAT DOMAIN	4.186534648984291
CONTAINING INSULIN	4.186534648984291
PHASE PROLONGATION	4.186534648984291
PHENOTYPIC OUTCOME	4.186534648984291
CYTOLYTIC ACTIVITY	4.186534648984291
CULTURE SUBSTRATUM	4.186534648984291
BDU CELL MIGRATION	4.186534648984291
LABELED PHALLOIDIN	4.186534648984291
CONSTANT THICKNESS	4.186534648984291
VARIABLE SELECTION	4.186534648984291
GRK2 CO-EXPRESSION	4.186534648984291
PHYLOGENETIC POINT	4.186534648984291
GENOME-WIDE SEARCH	4.186534648984291
DISCREPANT FINDING	4.186534648984291
DIAGNOSTIC NETWORK	4.186534648984291
BIOLOGICAL MEANING	4.186534648984291
CONTAINING COMPLEX	4.186534648984291
MACVECTOR SOFTWARE	4.186534648984291
D. DISCOIDEUM MHCK	4.186534648984291
BLOTTING ISOLATION	4.186534648984291
OTHER ANTI-RT DRUG	4.186534648984291
REPETITIVE STRETCH	4.186534648984291
P-PHENYLENEDIAMINE	4.186534648984291
COMPLEX BACKGROUND	4.186534648984291
ADJOINING SEQUENCE	4.186534648984291
PROBE SET SEQUENCE	4.186534648984291
MAXIMAL DISRUPTION	4.186534648984291
CORRECTED METAPHAS	4.186534648984291
COMPUTATIONAL TOOL	4.186534648984291
PULMONARY FIBROSIS	4.186534648984291
PRODUCING HUNDREDS	4.186534648984291
GENETIC DISRUPTION	4.186534648984291
PERINUCLEAR REGION	4.186534648984291
DESCRIBING PATIENT	4.186534648984291
INSULATING NETWORK	4.186534648984291
XVOXTRACE SOFTWARE	4.186534648984291
SNP BEINGIMPORTANT	4.186534648984291
INSTABILITY RESULT	4.186534648984291
OTHER PHYLOGENETIC	4.186534648984291
PREDICTION ERROR(I	4.186534648984291
INCLUDING MEMBRANE	4.186534648984291
POSSIBLE REGULATOR	4.186534648984291
INTERMEDIATE SHAPE	4.186534648984291
NUMERICAL APERTURE	4.186534648984291
MUTATIONS INCREASE	4.186534648984291
CRYOSTAT MICROTOME	4.186534648984291
lipopolysaccharide	4.186534648984291
CDP-STAR SUBSTRATE	4.186534648984291
QUADRANT FREQUENCY	4.186534648984291
CORTICAL HALF-LIFE	4.186534648984291
astrocyte-specific	4.186534648984291
GR-TRANSACTIVATION	4.186534648984291
RESULTING DATA SET	4.186534648984291
MEASURED PARAMETER	4.186534648984291
5'CATGAATCTGGCTG3'	4.186534648984291
EXPERIMENTAL MODEL	4.186534648984291
ENHANCERS/PROMOTER	4.186534648984291
LABELING TECHNIQUE	4.186534648984291
REMAINING SEQUENCE	4.186534648984291
INTERNAL STRUCTURE	4.186534648984291
PHOSPHOR SCREEN GP	4.186534648984291
N-1 DUMMY VARIABLE	4.186534648984291
HUGENEFL CHIP-PAIR	4.186534648984291
SEQUENCES INCREASE	4.186534648984291
POSTERIOR POSITION	4.186534648984291
RELEASING ACTIVITY	4.186534648984291
PROGRAMMING MATRIX	4.186534648984291
CIVILIAN PERSONNEL	4.186534648984291
DETAIL ENHANCEMENT	4.186534648984291
PORCINE TETRAPLOID	4.186534648984291
E3 LIGASE ACTIVITY	4.186534648984291
CD14 PRIMITIVE MDC	4.186534648984291
NON-REGULATED GENE	4.186534648984291
AVIDITY/CLUSTERING	4.186534648984291
SPAWNING CONDITION	4.186534648984291
METABOLIC ACTIVITY	4.186534648984291
ENDOTHELIAL LINING	4.186534648984291
THEEPISTASIS MODEL	4.186534648984291
EXPRESSION/DENSITY	4.186534648984291
pheromone exposure	4.186534648984291
INVOLVING MUTATION	4.186534648984291
FORM COMPLEX ARRAY	4.186534648984291
IMMORTAL CELL LINE	4.186534648984291
DISCOVERING MODULE	4.186534648984291
ALTERNATING STRIPE	4.186534648984291
CONTINUED EXPOSURE	4.186534648984291
AUTOPHAGIC PROCESS	4.186534648984291
DESCRIPTIVE LETTER	4.186534648984291
TAILBUD MESENCHYME	4.186534648984291
DEFINED IVM SYSTEM	4.186534648984291
OBSERVED REDUCTION	4.186534648984291
INDEPENDENT ACTION	4.186534648984291
GSK3 PHOSPHORYLATE	4.186534648984291
CG-7 FRAME GRABBER	4.186534648984291
BINDING SITE SMAD1	4.186534648984291
EXECUTABLE VERSION	4.186534648984291
FIBROUS PROJECTION	4.186534648984291
DEVELOPING PROCESS	4.186534648984291
POSITIVE REGULATOR	4.186534648984291
ORIGINAL PROPONENT	4.186534648984291
FUNCTIONAL CLUSTER	4.186534648984291
ARTIFICIAL NETWORK	4.186534648984291
LRP6 AMINOTERMINUS	4.186534648984291
MONOCLONAL ANTI-RA	4.186534648984291
NON-ELONGATED CELL	4.186534648984291
SAMPLING FREQUENCY	4.186534648984291
PROGRAMMING METHOD	4.186534648984291
POLYMORPHISM (SNP)	4.186534648984291
FUNCTIONAL PATTERN	4.186534648984291
ALTERED RETRACTION	4.186534648984291
PCNA-POSITIVE CELL	4.186534648984291
POSTERIOR MESHWORK	4.186534648984291
DETERMINING REGION	4.186534648984291
PRESERVE STRUCTURE	4.186534648984291
FILAMENT STRUCTURE	4.186534648984291
DEVELOPED FIXATIVE	4.186534648984291
RECEPTORS FUNCTION	4.186534648984291
SELECTED VARIATION	4.186534648984291
SANTA CRUZ SC-7164	4.186534648984291
CELLULAR CLEARANCE	4.186534648984291
FLANKING NONCODING	4.186534648984291
SN50-TREATED GLAND	4.186534648984291
EXPERIMENTAL ERROR	4.186534648984291
ANALYTICAL CONCEPT	4.186534648984291
BOILING WATER BATH	4.186534648984291
INHIBITORY ELEMENT	4.186534648984291
LIMITING CONDITION	4.186534648984291
NORMAL MALE BIOPSY	4.186534648984291
SPREAD BS-C-1 CELL	4.186534648984291
AFFYMETRIX SCANNER	4.186534648984291
BALB/C MOUSE LIVER	4.186534648984291
HOMOGENEOUS TISSUE	4.186534648984291
NUMERICAL DISTANCE	4.186534648984291
INTRUDING ANTERIAD	4.186534648984291
VARIABLE THICKNESS	4.186534648984291
A-ALTERNATIVE UNIT	4.186534648984291
NOTI-PSTI FRAGMENT	4.186534648984291
VIRTUAL GASTROCOEL	4.186534648984291
cellular membranes	4.186534648984291
TARGETED INSERTION	4.186534648984291
DEPC-TREATED WATER	4.186534648984291
AMORPHOUS FILAMENT	4.186534648984291
TGFΒ FAMILY MEMBER	4.186534648984291
NIGHTTIME INCREASE	4.186534648984291
LIMITED CAPABILITY	4.186534648984291
GTPASE CONSTITUENT	4.186534648984291
QUANTUM SPECIATION	4.186534648984291
ETHANE-1-HYDROXY-1	4.186534648984291
PRESUMPTIVE FURROW	4.186534648984291
INDUCED MP-RELEASE	4.186534648984291
NEGATIVE FREQUENCY	4.186534648984291
ENDOTHELIAL ORIGIN	4.186534648984291
immunoprecipitates	4.186534648984291
CELLULAR MECHANISM	4.186534648984291
PRINCIPLE ENVELOPE	4.186534648984291
SELECTED EPISTASIS	4.186534648984291
CANDIDATE SEQUENCE	4.186534648984291
CONTAINING P50-LUC	4.186534648984291
matrix contraction	4.186534648984291
ADDITIONAL EXAMPLE	4.186534648984291
HARRIS HEMATOXYLIN	4.186534648984291
MODERN BIOPHYSICAL	4.186534648984291
UNDERSTANDING GENE	4.186534648984291
COELOMYOCTE SYSTEM	4.186534648984291
MEASUREMENTS SPLIT	4.186534648984291
UNDERLYING PREMISE	4.186534648984291
DUCHENNE DYSTROPHY	4.186534648984291
INDUCED POPULATION	4.186534648984291
ORIGINAL ALIGNMENT	4.186534648984291
EPIDERMAL COVERING	4.186534648984291
CORRESPONDING LOSS	4.186534648984291
BOI1-PH(TK) COLONY	4.186534648984291
MATURING RECIPIENT	4.186534648984291
EXPRESSED MEC-3GFP	4.186534648984291
MESENCHYMAL-NEURAL	4.186534648984291
HYAL-2 ENHANCEMENT	4.186534648984291
BIOCHEMICAL RESULT	4.186534648984291
EXCLUSIVE FUNCTION	4.186534648984291
CELLULAR ORGANELLE	4.186534648984291
POST-HYBRIDIZATION	4.186534648984291
DOUBLE-LABEL IMAGE	4.186534648984291
FUNCTIONAL ELEMENT	4.186534648984291
FOLLOWED PROCEDURE	4.186534648984291
TISSUE DYSFUNCTION	4.186534648984291
UNDERSTANDING CELL	4.186534648984291
NUTRITIONAL STATUS	4.186534648984291
QUALITATIVE NATURE	4.186534648984291
SECONDARY CATEGORY	4.186534648984291
OSTEOBLAST PROGENY	4.186534648984291
PROTEINS INFLUENCE	4.186534648984291
GFP-TAGGED VARIANT	4.186534648984291
MINUTE HAND REGION	4.186534648984291
NETWORK PREDICTION	4.186534648984291
COST-EFFECTIVENESS	4.186534648984291
BLM ACIDIC CLUSTER	4.186534648984291
SCALE INDEPENDENCE	4.186534648984291
INCREASED DISTANCE	4.186534648984291
DIETARY INGREDIENT	4.186534648984291
RNASE-FREE DNASE I	4.186534648984291
COMPARATIVE METHOD	4.186534648984291
COCLUSTERING SCORE	4.186534648984291
SUBSEQUENT NETWORK	4.186534648984291
MISMATCH PROBE SET	4.186534648984291
DOTMAC/PFA-TREATED	4.186534648984291
TECHNOLOGIES SHARE	4.186534648984291
OUTBRED POPULATION	4.186534648984291
5'TTAGACCGACAGCT3'	4.186534648984291
INDUCED CELL DEATH	4.186534648984291
FISSION YEAST POB1	4.186534648984291
TRAVEL ARRANGEMENT	4.186534648984291
methyltransferases	4.186534648984291
FIXATION TECHNIQUE	4.186534648984291
COVARIATION METHOD	4.186534648984291
MILLIGEN BIOSEARCH	4.186534648984291
EVOLUTIONARY MODEL	4.186534648984291
FATE SPECIFICATION	4.186534648984291
ZIPPER-LIKE DOMAIN	4.186534648984291
BLASTOCYST-DERIVED	4.186534648984291
RING-FINGER DOMAIN	4.186534648984291
POSSIBLE EXCEPTION	4.186534648984291
DEVELOPING STOMACH	4.186534648984291
PRE-ANALYTIC CAUSE	4.186534648984291
DESIRED GOAL POINT	4.186534648984291
NI-NTA SPIN COLUMN	4.186534648984291
INCREASED OXYBURST	4.186534648984291
N-DIMENSIONAL CUBE	4.186534648984291
estradiol exposure	4.186534648984291
SDS-STABLE COMPLEX	4.186534648984291
RESULTING SEQUENCE	4.186534648984291
INCREASED PPP FLUX	4.186534648984291
FIXATION PROCEDURE	4.186534648984291
DIAGNOSTIC PURPOSE	4.186534648984291
CHAPERONE FUNCTION	4.186534648984291
CORRESPONDING LIST	4.186534648984291
EXISTING PROBE SET	4.186534648984291
NON-LINEAR DYNAMIC	4.186534648984291
MUTATIONAL HISTORY	4.186534648984291
CIRCADIAN FUNCTION	4.186534648984291
DELETIONS APPROACH	4.186534648984291
EXAMINED CELL LINE	4.186534648984291
TERTIARY BASE-BASE	4.186534648984291
RESECTION SPECIMEN	4.186534648984291
MOLECULAR ACTIVITY	4.186534648984291
DSP-TSB-FIXED CELL	4.186534648984291
ELEMENTAL PARTICLE	4.186534648984291
ANTERIOR-POSTERIOR	4.186534648984291
CELLULAR DIVERSITY	4.186534648984291
INDUCED INHIBITION	4.186534648984291
VARIANCE PARAMETER	4.186534648984291
DISCUSSION SECTION	4.186534648984291
TECHNICAL FEASIBLE	4.186534648984291
OVERREPRESENTATION	4.186534648984291
CGR REPRESENTATION	4.186534648984291
BACTERIAL ANCESTOR	4.186534648984291
CRITICAL RELEVANCE	4.186534648984291
developmental time	4.186534648984291
PROGNOSTIC OUTCOME	4.186534648984291
WITHTWO FUNCTIONAL	4.186534648984291
CELL TYPE-SPECIFIC	4.186534648984291
AUTOMATED APPROACH	4.186534648984291
TPR DOMAIN REMOVAL	4.186534648984291
PROLONGED EXPOSURE	4.186534648984291
V3 REGION INCREASE	4.186534648984291
CO-TRANSLATIONALLY	4.186534648984291
NEGATIVE LOGARITHM	4.186534648984291
BIDIRECTIONAL GENE	4.186534648984291
TET-RESPONSIVENESS	4.186534648984291
ALA MYOSIN-II SHOW	4.186534648984291
PERMUTATIONTESTING	4.186534648984291
TEMPORAL FRAMEWORK	4.186534648984291
ΔN4 SHOW NUCLEOLAR	4.186534648984291
TRADITIONAL METHOD	4.186534648984291
FURROW PROGRESSION	4.186534648984291
INTERLEUKIN-1-BETA	4.186534648984291
DYSLEXIC RENDERING	4.186534648984291
NONTRANSFORMED RAT	4.186534648984291
ROUS SARCOMA VIRUS	4.186534648984291
PROPRIETARY METHOD	4.186534648984291
CONSTRUCTING MODEL	4.186534648984291
MATCHED PROBE PAIR	4.186534648984291
BAYESIAN TECHNIQUE	4.186534648984291
YEAST TRANSFORMANT	4.186534648984291
ESTIMATEDTHE POWER	4.186534648984291
DOCUMENTED PATHWAY	4.186534648984291
OTH-GENERATED DATA	4.186534648984291
MESENCHYMAL ORIGIN	4.186534648984291
CONSPICUOUS NUMBER	4.186534648984291
IN SITU GENERATION	4.186534648984291
THICKNESS EXCISION	4.186534648984291
PROMISING APPROACH	4.186534648984291
GENE PANEL NETWORK	4.186534648984291
PROFILING PROCEEDS	4.186534648984291
STRIKING BEGINNING	4.186534648984291
LONGNOSE GAR SPAWN	4.186534648984291
MATCHING PARAMETER	4.186534648984291
COMPAQ ARMADA E700	4.186534648984291
TYPE GFP-MYOSIN-II	4.186534648984291
DEFAULT SORT ORDER	4.186534648984291
IN VITRO CONDITION	4.186534648984291
TIMESEACH VARIABLE	4.186534648984291
CELLULAR SYNTHESIS	4.186534648984291
BLASTODERM SURFACE	4.186534648984291
INPUT DATA EXAMPLE	4.186534648984291
ECM MOLECULES PLAY	4.186534648984291
POWER THANTHE BPNN	4.186534648984291
POTENTIAL INCREASE	4.186534648984291
AVERAGE DIVERGENCE	4.186534648984291
URCHIN COELOMOCYTE	4.186534648984291
INTERACTIVE DOMAIN	4.186534648984291
EXPERIMENTAL SETUP	4.186534648984291
DISCUSSED CATEGORY	4.186534648984291
CLUSTALW ALIGNMENT	4.186534648984291
RESAMPLED DATA SET	4.186534648984291
ENCODING PROHB-EGF	4.186534648984291
INCLUDING METHANOL	4.186534648984291
IMMUNOFLOURESCENCE	4.186534648984291
SEASONAL INFLUENZA	4.186534648984291
IMPOSED CONSTRAINT	4.186534648984291
NORMALIZATION MAS4	4.186534648984291
c-terminal portion	4.186534648984291
HIERARCHICAL MATCH	4.186534648984291
CELLULAR EXTENSION	4.186534648984291
MODE BOOTSTRAP MEAN	4.186503384044555
POLYPEPTIDE ANALYSIS	4.186486466488111
STATISTICAL EVIDENCE	4.186303984505182
FN GENE EXPRESSION	4.186067665937841
EXPRESSION READOUT	4.185834174414617
SURFACE EXPRESSION	4.185834174414617
AVERAGE EXPRESSION	4.185834174414617
MINIMUM EXPRESSION	4.185834174414617
MAXIMAL EXPRESSION	4.185834174414617
COMPLEX EXPRESSION	4.185834174414617
SHOWING EXPRESSION	4.185834174414617
MULTIPLE OUTPUT	4.185518935821097
RESEARCH EFFORTS FOCUS	4.185442077595508
scintillation spectroscopy	4.18542806406009
REACTIVITY SPECTRUM	4.18536238310756
DARWINIAN EVOLUTION	4.18536238310756
ALIGNMENT ANALYSIS	4.1852464438889445
IMPROVING ANALYSIS	4.1852464438889445
ANALYSIS TECHNIQUE	4.1852464438889445
PROTEOMIC ANALYSIS	4.1852464438889445
GENEORDER ANALYSIS	4.1852464438889445
EPISTASIS ANALYSIS	4.1852464438889445
INITIATED ANALYSIS	4.1852464438889445
CYTOMETRY ANALYSIS	4.1852464438889445
CONTROL CELLS SHOW	4.184892890923555
ERROR RATE CONTROL	4.184892890923555
pairwise comparisons	4.184740186158494
SUBSET DETERMINATION	4.184662522772589
TEMPORAL MYOSIN II	4.184620173637718
FILAMENT MYOSIN II	4.184620173637718
AFFECTED MYOSIN II	4.184620173637718
R177 ALANINE MUTANT	4.184560982030786
THREONINE	4.1843894840699
RRNA GENE SEQUENCE	4.1843435574279475
EUCARYA RRNA ENTRY	4.1843435574279475
MICROARRAY SURFACE	4.184329583629757
MICROARRAY DATASET	4.184329583629757
SIMPLE FOLD CHANGE	4.184172939642822
ENDOGENOUS CONTROL	4.184072011893187
BACKGROUND CONTROL	4.184072011893187
CONTROL POPULATION	4.184072011893187
AFFYMETRIX CONTROL	4.184072011893187
CONTROL INDIVIDUAL	4.184072011893187
NON-CANCER CONTROL	4.184072011893187
EXPERIMENTAL STUDY	4.183875000925899
CYTOCHEMICAL STUDY	4.183875000925899
LONGITUDINAL STUDY	4.183875000925899
ALGORITHM DECREASE	4.183709859379789
MOBYDICK ALGORITHM	4.183709859379789
GROUPING ALGORITHM	4.183709859379789
EXISTING ALGORITHM	4.183709859379789
STANDARD ALGORITHM	4.183709859379789
DISTANCE ALGORITHM	4.183709859379789
MYOSIN SEDIMENTING	4.183662935964432
PHOSPHATE BUFFER PH	4.183612079711335
UM RHODAMINE ACTIN	4.183342088988067
SYNTHASE EXPRESSION	4.183331485977867
ROSA26 GENOMIC ARM	4.1831045473216815
GEOMETRICAL CHANGE	4.182992084972088
QUALITATIVE CHANGE	4.182992084972088
GENOME-WIDE CHANGE	4.182992084972088
COORDINATED CHANGE	4.182992084972088
INDEPENDENT EFFECT	4.182776450640911
MORPHOLOGIC EFFECT	4.182776450640911
UNDESIRABLE EFFECT	4.182776450640911
CONFOUNDING EFFECT	4.182776450640911
WEAKGENETIC EFFECT	4.182776450640911
SNIP1 LENGTH CLONE	4.182718376935825
REGULATED GENE P53	4.182705698291145
TARGETING TYROSINE	4.182658480289325
NONCODING RNA GENE	4.18259846674851
CAS ANTI-SENSE RNA	4.18259846674851
ARR INHIBITORY RNA	4.18259846674851
GENERAL APPLICATION	4.182485055960484
YEAST STRAIN EGY48	4.1824477193437355
STUDIED RAT STRAIN	4.1824477193437355
POLAR LOCALIZATION	4.182101902220304
ARP-3 LOCALIZATION	4.182101902220304
DEPOLYMERIZE ACTIN	4.181745808989956
SPLICESOMAL INTRON	4.1817191302156145
PLASMA FIBRONECTIN	4.181595302590134
FIBRONECTIN III1-C	4.181595302590134
FIBRONECTIN REPEAT	4.181595302590134
FIBRONECTIN COLUMN	4.181595302590134
FIBRONECTIN ELUTION	4.1815921842061545
INTERLEUKIN 2 CYTOLYTIC ACTIVITY	4.181467476041248
PROLACTIN PROMOTER	4.181419941179691
C-TERMINAL RESIDUE	4.181389496490377
GENOMIC TECHNOLOGY	4.181389496490377
C-TERMINAL PORTION	4.181389496490377
C-TERMINAL F-ACTIN	4.181389496490377
CYTOPLASMIC GR-GFP	4.181264004966136
TCF RAS ACTIVATION	4.181223523829283
E-VALUE	4.1812129270191285
AZ FUNCTIONAL ROLE	4.181198935286899
ΔC2 FUSION PROTEIN	4.181139614888859
HUMAN APE1 PROTEIN	4.181139614888859
QUERY PROTEIN MEET	4.181139614888859
ΔH1 FUSION PROTEIN	4.181139614888859
NORMAL BLM PROTEIN	4.181139614888859
PROLIFERATION TANG	4.181132238865682
CONSTANT FLOW RATE	4.181098261443552
RADIOACTIVE SIGNAL	4.18093992005887
INDEPENDENT SIGNAL	4.18093992005887
SIGNAL QUANTITATION	4.180926127749996
REVEALED MNOC MRNA	4.180921755354567
P53 UBIQUITINATION	4.180791222944573
DOTMAC LYSIS BUFFER	4.180776967397555
PROTEIN CONFORMATION	4.180721815916679
RIBOREGULATORY RNA	4.18063037563062
IFN-Γ	4.180467467930574
ENGINEERING STRAIN	4.180404254523458
DIFFERENTIAL GROWTH	4.180353911840947
TOPOISOMERASE II-Α	4.180084010036698
BINDING REGION DNA	4.180046595890635
BIND DNA SUBSTRATE	4.180046595890635
HOMOLOGOUS NEMATODE	4.179927408764819
FRAGMENT HOMOLOGOUS	4.179927408764819
CELLULAR COMPONENT	4.179781636336029
VASCULAR COMPONENT	4.179781636336029
NUMEROUS COMPONENT	4.179781636336029
BINDING SITE TABLE	4.179755153933487
ANTISERUM PRODUCTION	4.179642034944697
MEIOTIC CELL CYCLE	4.179633366597245
SPIKING CALCULATION	4.179606684601053
PM-ONLY CALCULATION	4.179606684601053
OMIM IDENTIFICATION	4.179606684601053
SHANNON CALCULATION	4.179606684601053
TREATMENT STRATEGY	4.179478439849781
COLCEMID TREATMENT	4.179478439849781
ESTROGEN TREATMENT	4.179478439849781
MAP KINASE PATHWAY	4.1794715086684935
E. COLI FBA RESULT	4.179331435492812
PCR PRODUCT CLONING	4.179100632118466
SUBSTITUTION MATRIX	4.17906341713998
MAKING SUBSTITUTION	4.17906341713998
ASSAY YEAST CYTOSOL	4.1790453010641055
MAMMALIAN SEQUENCE	4.1790182522975305
ACTIVATED RECEPTOR	4.1790182522975305
PHEROMONE RECEPTOR	4.1790182522975305
SIGNALING RECEPTOR	4.1790182522975305
ATR PROTEIN KINASE	4.1789189710379215
TN ANTISENSE STUDY	4.178695686285872
TEST INPUT EXAMPLE	4.1785862754764524
SEQUENCE TEST CASE	4.1785862754764524
ACTIVATION PRODUCT	4.17856796125178
OXIDASE ACTIVATION	4.17856796125178
PROBE DISTRIBUTION	4.17856796125178
POLAR DISTRIBUTION	4.17856796125178
WHOLE GENOME STUDY	4.178542948703319
PROTEIN DIFFERENCE	4.178442097841143
NTERACTING PROTEIN	4.178442097841143
PROTEIN DEPOSITION	4.178442097841143
ASSOCIATED PROTEIN	4.178442097841143
PROTEIN GENEFINDER	4.178442097841143
GFP-HYAL-2 PROTEIN	4.178442097841143
P35-C/EBPΒ PROTEIN	4.178442097841143
CONTAINING PROTEIN	4.178442097841143
GST-FUSION PROTEIN	4.178442097841143
CELL-CYCLE PROTEIN	4.178442097841143
Β-COATOMER PROTEIN	4.178442097841143
USE AD-HOC MEASURE	4.178418352092484
MOUSE Β-ACTIN CDNA	4.17834142036839
DELETERIOUS MUTANT	4.178130899910899
SYMPATHETIC NEURON	4.178018534511606
PRESUMPTIVE NEURON	4.178018534511606
ROHON-BEARD NEURON	4.178018534511606
PROTEASOME COMPLEX	4.177976375529068
ZIPPER DIMERIZATION	4.177942928001515
TERM ADMINISTRATION	4.177942928001515
DIMERIZATION DOMAIN	4.177942928001515
ANTI-MHCK-C ANTISERA	4.177905808198896
CASSETTE COATING IRE	4.177905808198896
ILLUSTRATION PURPOSE	4.177905808198896
GRANULAR LYMPHOCYTIC	4.177905808198896
GFP-NFAT TRANSLOCATE	4.177905808198896
FIBROBLAST CULTURE	4.177759160466753
PORCINE FIBROBLAST	4.177759160466753
RNASE PROTECTION	4.1775650763710805
MAPK FAMILY MEMBER	4.177530632119942
ANTISENSE SEQUENCE	4.177435852995054
CHIMERIC ANTISENSE	4.177435852995054
NF-ΚB TRANSREPRESS	4.177435852995054
TRANSREPRESS NF-ΚB	4.177435852995054
AFFINITY REGULATION	4.177270186210705
GENOME DUPLICATION	4.177206746621224
DROSOPHILA FZ GENE	4.177087811618417
BINDING FACTOR DNA	4.17708637116811
GR PHOSPHORYLATION	4.177009738582335
CURRENT NUCLEOTIDE	4.176965804493765
ALIGNED NUCLEOTIDE	4.176965804493765
E. COLI METABOLISM	4.176930364328986
EXPRESSED INTEGRIN	4.176822451018252
IODIDE-STAINED DNA	4.176802569343807
GRE-CONTAINING DNA	4.176802569343807
INSERTED TRANSGENE	4.176712085132274
PATHOGEN INFECTION	4.176599182099492
MNOC TRANSCRIPTION	4.176553290797484
TAG-DOSE DEPENDENT	4.176541751655072
SEQUENCE DEPENDENT	4.176541751655072
MOID ALGORITHM USE	4.176535159022816
TRANSFACINFO TABLE	4.1763654064080855
SINGLEBEST SOLUTION	4.176337548826523
EXPRESSHYB SOLUTION	4.176337548826523
SOLUTION TRANSITION	4.176337548826523
FILTER PAPER ASSAY	4.176280964298912
M/Z DISCRIMINATION	4.176244343996464
TOTAL PROTEIN ΜG	4.1762115908730255
QUALITATIVE INDICATION	4.176198098618839
DENSITY/CELL CYCLE	4.176182725403723
INDUCING RESISTANCE	4.176171832266523
SN50 SMG PHENOTYPE	4.176120364418297
TUMOR CELL NUCLEUS	4.175796939431776
CYTOPLASMIC SIGNAL	4.175669276040715
FIBRILLAR COLLAGEN	4.175308861724843
PURIFICATION SCHEME	4.175053245486529
TENSOR	4.174885136125976
LIPID-BINDING ANALYSIS	4.174831492806403
DNA REPAIR PROTEIN	4.174651561795203
DOSE-RESPONSE TEST	4.174612088722532
CDNA LIBRARY CLONE	4.174525148319925
ACTIVATING PEPTIDE	4.174473454300885
HEAT SHOCK FACTOR-1	4.174282663482533
DISPLAYS ENRICHMENT	4.174282663482533
DATABASE ACCESSION	4.173823095764034
SINGLE LIVING CELL	4.17380972925171
CAG CODON EXPANSION	4.173585470240822
CDNA-CRNA REACTION	4.173536368999667
DIGESTION REACTION	4.173536368999667
AFFECTING ADHESION	4.173437897181602
GNRH RECEPTOR CDNA	4.173330489243884
MONOCLONAL PRIMARY	4.173081176315381
PRIMARY IMPORTANCE	4.173081176315381
MAPK PHOSPHATASE-1	4.173028623687768
BACTERIAL TOXIN C3	4.172814242333855
BOTULINUM TOXIN C3	4.172814242333855
PLAY MULTIPLE ROLE	4.172690635066734
MULTIPLE CELL TYPE	4.172690635066734
E3 UBIQUITIN LIGAS	4.172592945452396
CALCULATED P-VALUE	4.17236439293548
RNA LOADING BUFFER	4.171802081187511
OTHER ECM MOLECULE	4.171663498550269
MAJOR ECM MOLECULE	4.171663498550269
NON-FLUORESCENT BSA	4.171558745700964
INTEGRATED BEHAVIOR	4.171558745700964
SINGLE FOLD CHANGE	4.171448019910241
POOL CANCER SUBTYPE	4.171200335466548
MULTIPROTEIN ASSAY	4.171154121956222
QUANTITATIVE ASSAY	4.171154121956222
IGNORING PHYLOGENY	4.171099191502551
S. CEREVISIAE CELL	4.170960133327039
LH RIA MEASUREMENT	4.170960133327039
S. CEREVISIAE GPA1	4.170960133327039
STELLATE PHENOTYPE	4.1709132221353
OBSERVED PHENOTYPE	4.1709132221353
PHENOTYPE RELATION	4.1709132221353
NON-SPECIFIC MANNER	4.1708377086411375
QUANTITATIVE MANNER	4.1708377086411375
AR-DEPENDENT MANNER	4.1708377086411375
SINGLE INTRON TYPE	4.170599383405926
EXPERIMENTAL MOTIF	4.170527507892115
RESTRICTION DIGEST	4.170527507892115
SUBSTITUTION MUTANT	4.17052279992902
DISRUPTING NUCLEUS	4.170428084655518
STABILIZING BUFFER	4.170340070642792
ANTI-EGFP ANTIBODY	4.170276612263711
PURIFYING ANTIBODY	4.170276612263711
INDICATED ANTIBODY	4.170276612263711
BINARY ENVIRONMENT	4.1702254863620745
GENERAL POPULATION	4.1702254863620745
OTHER FISH SPECIES	4.170186930422069
INTERACTING VEHICLE	4.170099504032267
ALIGNMENT RETRIEVAL	4.170099504032267
LEUCINE RICH-REGION	4.170099504032267
RECENT DEVELOPMENT	4.16975046220803
NEURAL DEVELOPMENT	4.16975046220803
B-CELL DEVELOPMENT	4.16975046220803
NORMAL DEVELOPMENT	4.16975046220803
RODENT DEVELOPMENT	4.16975046220803
OCULAR DEVELOPMENT	4.16975046220803
TISSUE DEVELOPMENT	4.16975046220803
PROBE PAIRS COMMON	4.169668588126194
DISPLAYED MOTILITY	4.169585911357282
MM SODIUM PYRUVATE	4.169585911357282
MIGRATING CELL	4.169563017106283
CAENORHABDITIS	4.169563017106283
NITROCELLULOSE	4.169563017106283
PHALLOIDIN ADDITION	4.169452623704907
NOCODAZOLE ADDITION	4.169452623704907
LYSATE CENTRIFUGATION	4.169086219788551
BAIT PLASMID PGBT9	4.169013318869883
PRODUCE MACROPHAGE	4.1688941261480155
BRDU INCORPORATION	4.1688941261480155
RESTING MACROPHAGE	4.1688941261480155
PFU DNA POLYMERASE	4.168820808631188
GTP RAB24 AFFINITY	4.168666212416281
CONTRAST TRANSFECTION	4.168582683059753
CELLFECTIN REAGENT	4.168526615255593
LUCIFERASE REAGENT	4.168526615255593
INDEPENDENT GROWTH	4.1684512678341346
C/EBPΒ INTERACTION	4.168413357181828
LTBP-3 INTERACTION	4.168413357181828
GASTRULATION MOVEMENT	4.168413070687947
C-TERMINAL PEPTIDE	4.168363039956606
IN VIVO REGULATION	4.167945710941765
BASAL JNK ACTIVITY	4.167945710941765
AVM TOUCH RECEPTOR	4.167803311209348
ALM TOUCH RECEPTOR	4.167803311209348
PLM TOUCH RECEPTOR	4.167803311209348
CAPILLARY TRANSFER	4.16774365726739
OTHER RNA MOLECULE	4.167727316314489
MG/ML HYALURONIDASE	4.167442169135582
BOOTSTRAP ESTIMATE	4.16732607967368
COLI MUTANT STRAIN	4.167240935306169
MAMMALIAN HOMOLOGUE	4.166643850573353
BRANCHED DENDRITIC	4.16643265784528
CONTROL PS VESICLE	4.166303952881029
GENE OVEREXPRESSION	4.166296631804753
PTEN OVEREXPRESSION	4.166296631804753
BOI1 OVEREXPRESSION	4.166296631804753
SUBSEQUENT CONFIRMATION	4.16615254758913
V-CRK TRANSFECTION	4.166116091055689
DNA SEQUENCING KIT	4.1659915451755545
MULTIPLE ATTRIBUTE	4.165768628107955
MULTIPLE CONDITION	4.165768628107955
MULTIPLE FILOPODIA	4.165768628107955
MULTIPLE PARAMETER	4.165768628107955
MULTIPLE MECHANISM	4.165768628107955
RESVERATROL ABILITY	4.165764229692901
SUPERCRIPT GIBCO/BRL	4.165518498147127
OBSERVED DISCREPANCY	4.165518498147127
ISTHE INTERPRETATION	4.165518498147127
IL-1BETA SECRETION	4.165191794194723
CYTOLYTIC EFFECTOR	4.164925008509854
MONKEY CD9 ANTIGEN	4.164789098821336
PRIMARY FIBROBLAST	4.164305687797843
GEL ELECTROPHORESIS	4.16426006825144
ELECTROPHORESIS GEL	4.16426006825144
PRODUCING MOLECULE	4.164227923333259
CANDIDATE MOLECULE	4.164227923333259
DETERGENT SOLUBILITY	4.163970084390655
DMEM MEDIUM	4.163953507800293
CLONING HOST STRAIN	4.163622034907152
TRANSFECTION STUDY	4.163456442997297
ΜG/ML SN50 PEPTIDE	4.163408588672186
SIMILAR OBSERVATION	4.163265629682823
MECHANOSENSITIVE K	4.163172875498414
MEASUREMENT SYSTEM	4.163172875498414
POTENTIAL ADHESIVE	4.163172875498414
T-TEST MEASUREMENT	4.163172875498414
RNASE MRP SEQUENCE	4.163172875498414
P53 BEARING SERINE	4.162834764521548
PHARMACIA BIOTECH AB	4.162729187771832
INFORMATIVE SUBSET	4.162523937346028
PRIMARY DETERMINANT	4.162499248849314
HSN3 TRANSLOCATION	4.162356030271634
MESODERM FORMATION	4.162299538171839
BIOLOGICAL SPECIES	4.162013071140958
CHK2 PROTEIN KINAS	4.161931045578249
COFACTOR UTILIZATION	4.161922182325645
NF-ΚB P105 SUBUNIT	4.16187984694894
PROFILED HIV VIRUS	4.1614799933617554
NEURON DEVELOPMENT	4.161234347735345
FIXED POINT NUMBER	4.161204667475793
SODIUM BOROHYDRIDE	4.161111542543777
SHOWED ASSOCIATION	4.161111542543777
SODIUM BICARBONATE	4.161111542543777
PROTEIN SUBUNIT	4.161033914548041
ELECTRON TRANSPORT	4.160859828618624
MEMBRANE TRANSPORT	4.160859828618624
ALLOWED INVESTIGATOR	4.1606712898659985
VOLUME INFORMATION	4.160454048411695
SAMPLE INFORMATION	4.160454048411695
LTBP-3 INFORMATION	4.160454048411695
RECESSIVE ONCOGENE	4.160341145378913
ACTIVATED ONCOGENE	4.160341145378913
GENOMIC SEQUENCING	4.160306920417756
CONTAINING PLASMID	4.1602526538126785
DECREASED AFFINITY	4.159731994132276
DENSITY IMPROVEMENT	4.159641605406604
TOTAL ERK1 PROTEIN	4.159311695217711
TOTAL ERK2 PROTEIN	4.159311695217711
EUKARYOTIC CELL	4.15914741548548
INSTRUCTION	4.159139078089051
C-TERMINUS PEPTIDE	4.159037996819143
MULTIPLE COMPONENT	4.159015615459694
SIGNIFICANCE	4.158740123104966
SPATIAL REGULATION	4.158651241920501
GΑ-PROTEIN SUBUNIT	4.158651241920501
MG/ML STREPTOMYCIN	4.158194136886669
POSTOPERATIVE COURSE	4.158086112116064
NUCLEATION COMPLEX	4.157721795018375
CONVENTIONAL KINAS	4.157721795018375
DELETERIOUS ALLELE	4.157721795018375
GENE CONCENTRATION	4.157233441561326
RTNF CONCENTRATION	4.157233441561326
BOI1 CONCENTRATION	4.157233441561326
MONOCLONAL AB FAIL	4.156983003891044
MACROPHAGE ABUNDANCE	4.156872661335482
CONFORMATION	4.1568282144845305
DOMAIN COMPOSITION	4.1567282483298955
THE FINE STRUCTURE	4.156205329020168
FACTOR INFORMATION	4.1560137113279065
phylogenetic analyses	4.155847620810011
FUNCTIONAL CONSEQUENCE	4.155820487504522
INTRON INFORMATION	4.155638529643018
VECTOR TRANSFECTED	4.155589236454677
NN MODEL EVOLUTION	4.155385617669787
SKP2 OVEREXPRESSION	4.155315838247806
receptor activation	4.154761252714628
SPLEEN RNA EXHIBIT	4.1546248221214075
TREATED HUVEC DMSO	4.15452036679994
SPREADING 3T3 CELL	4.15452036679994
RPMB ESTIMATE TAKE	4.15452036679994
SHED GP120 MONOMER	4.15452036679994
PLASMIN INHIBITION	4.1545203667999395
CONTINUED PRESENCE	4.1545203667999395
REGULATING RELEASE	4.154281454246325
IMMUNOBLOTTING WELL	4.154178524034989
IMMUNOBLOTTING CELL	4.154178524034989
PROPIDIUM IODIDE ΜL	4.153838747022851
TOTAL FLUORESCENCE	4.153792769477568
MEAN GLEASON SCORE	4.153739530649102
COMPARE FIGURE 4TO	4.153605673023244
S PHASE REGULATION	4.153295107230282
REQUIRED EVALUATION	4.152986579008454
PREDICTING ENHANCER	4.152986579008454
MINISCULE FRACTION	4.152802527268097
NYLON MEMBRANE WWW	4.152637173730272
COMMON PRODUCT ION	4.152206252389275
NG/ML AMPHOTERICIN	4.151959224225192
CYK DP CALCULATION	4.151609977510454
MG ASCORBIC ACID/ML	4.15150768425331
RESIN MG PROTEIN/ML	4.15150768425331
MM ELECTROPORATION	4.151253603311741
C3 ELECTROPORATION	4.151253603311741
RNASE TREATMENT	4.151177226340943
CHELATION CHROMATOGRAPHY	4.151073860059125
MOLECULAR MASS	4.1506238372132795
metabolic functions	4.150490944109148
ONLINE BIOINFORMATIC	4.149591956651993
PARTICULAR ATTENTION	4.149591956651993
E. COLI STRAIN DH5Α	4.149205957629079
MEMBRANE REGRESSION	4.149183706780939
MEDIATED REGRESSION	4.149183706780939
NON-COGNATE PROTEAS	4.149183706780939
NOVEX	4.148941804026361
GLUTATHIONE AGAROSE	4.148417911000571
DNASE-FREE RNASE ΜL	4.148397813278418
SIMULATED FLOW MIN	4.148377039274058
APOPTOSI SEQUELLAE	4.148287497702102
EXTENSIVE APOPTOSI	4.148287497702102
MPF ACTIVITY REACH	4.14811751036307
POOLED MACROPREP Q	4.14811751036307
SECRETED PROTEIN	4.14809185087364
TOTAL RNA NORTHERN	4.147964834203622
DOCUMENTATION FILE	4.147244393576224
gene transcription	4.147244393576224
GENERAL OBSERVATION	4.146690846955357
E. COLI TRNA MG/ML	4.146370187727099
STANDARD INDUCTION	4.145373429032983
SOMATIC CELL ADULT	4.145373429032983
PREDICTIVE MEASURE	4.145373429032983
POLYPEPTIDE PATTERN	4.145000547330675
ALCOHOL CONSUMPTION	4.145000547330675
ORJALE	4.144885136125976
MDCK-D	4.144885136125976
diacid	4.144885136125976
EXHIBIT DIMINUTION	4.144574182043637
FIBRONECTIN PROTEAS	4.144163915440621
CAUSAL RELATIONSHIP	4.144113210477587
MECHANICAL CONSIDERATION	4.143822728007546
COMPELLING EVIDENCE	4.143511626170411
C/EBPΑ STABILIZATION	4.14322134005394
NON EGF-LIKE DOMAIN	4.142748076857455
CONFORMATION CHANGE	4.1426375596615275
NM ARGON-ION LASER	4.14220718134442
CYCLIN E IMMUNOCOMPLEX	4.1412650509942965
BIOLOGY	4.14121725245012
CELL CYCLE S-PHASE	4.141216227976025
BROOM-LIKE FASHION	4.141040669038108
MAPK IMMUNOBLOTTING	4.140452532088805
CELLULAR EVOLUTION	4.139811102012536
SEQUENCE EVOLUTION	4.139811102012536
NEUTROPHIL ADHESION	4.139676526212154
INDIVIDUAL SUBJECT	4.1391710534238815
GST PULLDOWN ASSAY	4.139103088213859
OXYGEN UPTAKE RATE	4.138513225707764
COOMASSIE BLUE DYE	4.138513225707764
NONSPECIFIC SOURCE	4.138513225707764
structure definitions	4.138255990980901
EDEMA	4.137931787293338
A-2-Z	4.137931787293338
WATSON-CRICK BASE	4.137846399018326
AMMONIUM CHLORIDE	4.137846399018326
TARGETING CLUSTER	4.137846399018326
ATTENUATING V-CRK	4.137846399018326
MEDIA CYBERNETICS	4.137846399018326
NEURAL PROGENITOR	4.137846399018326
MOLECULAR NETWORK	4.137846399018326
purpose estimator	4.137846399018326
LEUKOCYTE EXTRACT	4.137846399018326
INTERESTING TWIST	4.137846399018326
TELENCEPHALON LIE	4.137846399018326
REDUCING VARIANCE	4.137846399018326
OUTPUT FIELD SORT	4.137846399018326
PHYLOGENETIC NODE	4.137846399018326
ACTIN-RICH CORTEX	4.137846399018326
MORPHOGENIC EVENT	4.137846399018326
SEA URCHIN EMBRYO	4.137846399018326
MOLECULAR CLUSTER	4.137846399018326
NEUROSPORA CRASSA	4.137846399018326
HYPOTHETICAL TERM	4.137846399018326
NCRNA GENEFINDING	4.137846399018326
APE1 CONTACT PLOT	4.137846399018326
TRANSFORMED VALUE	4.137846399018326
POSSIBLE MEDIATOR	4.137846399018326
INTERPRETING DATA	4.137846399018326
INTRONIC SEQUENCE	4.137846399018326
INFLUENZA VACCINE	4.137846399018326
WHT4-1 YEAST CELL	4.137846399018326
XK PROTEINS SHARE	4.137846399018326
OTHER PHOSPHATASE	4.137846399018326
PROCESSING SYSTEM	4.137846399018326
PUBMED IDENTIFIER	4.137846399018326
MINIMUM INTENSITY	4.137846399018326
DIMENSIONAL SPACE	4.137846399018326
EMBRYO GERM LAYER	4.137846399018326
C/EBPΑ-GFP FUSION	4.137846399018326
BI-DIMENSIONALITY	4.137846399018326
MICROSCOPIC IMAGE	4.137846399018326
CAUSES ALTERATION	4.137846399018326
THROMBIN CLEAVAGE	4.137846399018326
DERIVED STATISTIC	4.137846399018326
VECTORIAL COMPLEX	4.137846399018326
FIBROSARCOMA CELL	4.137846399018326
OSCILLATORY MODEL	4.137846399018326
DISCUSSION C/EBPΑ	4.137846399018326
NON-PROLIFERATING	4.137846399018326
REGULATORY SYSTEM	4.137846399018326
GROWING CELL LINE	4.137846399018326
GNRH MAXIMAL DOSE	4.137846399018326
PLATELET FACTOR-4	4.137846399018326
MICROSCOPIC FIELD	4.137846399018326
REPRESENTING RGS3	4.137846399018326
LEFT-MOST BIT SET	4.137846399018326
INTUITED MUTATION	4.137846399018326
TRABECULAR ANLAGE	4.137846399018326
PRESSING QUESTION	4.137846399018326
CYCLING MECHANISM	4.137846399018326
EXPRESSED GFP-BLM	4.137846399018326
RHYTHMIC MOVEMENT	4.137846399018326
ESTIMATE VARIANCE	4.137846399018326
CAPILLARY NETWORK	4.137846399018326
REPRESENTING TERM	4.137846399018326
PHYLOGENETIC DATA	4.137846399018326
2-D WESTERN ARRAY	4.137846399018326
REVEALED FUNCTION	4.137846399018326
PERSONAL COMPUTER	4.137846399018326
SCHEMATIC VERSION	4.137846399018326
OSCILLATORY CURVE	4.137846399018326
AFFYMETRIX SYSTEM	4.137846399018326
IN SILICO BIOLOGY	4.137846399018326
SAMPLE SIZE OF200	4.137846399018326
NUMEROUS REVISION	4.137846399018326
HERITABILITYVALUE	4.137846399018326
LAYER GLASS PLATE	4.137846399018326
NEGATIVE FEEDBACK	4.137846399018326
DONKEY ANTI-MOUSE	4.137846399018326
RADIOACTIVE PROBE	4.137846399018326
CONTAINING DOMAIN	4.137846399018326
PROMOTING COMPLEX	4.137846399018326
OBSERVED MUTATION	4.137846399018326
ETHNIC BACKGROUND	4.137846399018326
GADFLY ANNOTATION	4.137846399018326
IMPAIRED FUNCTION	4.137846399018326
UNDERLYING CORTEX	4.137846399018326
S1 MICROINJECTION	4.137846399018326
PERIODIC EXCHANGE	4.137846399018326
GFP-LABELLED MHCK	4.137846399018326
SORVAL SS34 ROTOR	4.137846399018326
CELLULAR IDENTITY	4.137846399018326
SELECTED MYCRAB24	4.137846399018326
OOCYTE MATURATION	4.137846399018326
immuno-isolate sα	4.137846399018326
MEMBRANOUS STRAND	4.137846399018326
CCAF CHEMOATTRACT	4.137846399018326
THUSFOUR NN INPUT	4.137846399018326
PROSPECTIVE TRUNK	4.137846399018326
comparative study	4.137846399018326
REGULATED PROCESS	4.137846399018326
LABELING SEQUENCE	4.137846399018326
MSN50-TREATED SMG	4.137846399018326
INTEGRATED SYSTEM	4.137846399018326
NETWORK MODELLING	4.137846399018326
KM/CAS(SD) FUSION	4.137846399018326
TARGETING PATHWAY	4.137846399018326
CRANIAL CARTILAGE	4.137846399018326
CURED/FATAL CLASS	4.137846399018326
CURRENT ALIGNMENT	4.137846399018326
INTEGER ORDER ORD	4.137846399018326
SCORING PARAMETER	4.137846399018326
ADE3 COLOR MARKER	4.137846399018326
ADESKTOP COMPUTER	4.137846399018326
5'GTAACTGGTCCGC3'	4.137846399018326
METASTATIC BREAST	4.137846399018326
COMPUTER HARDWARE	4.137846399018326
EXPRESSING TISSUE	4.137846399018326
GR-MEDIATED EVENT	4.137846399018326
LOCALIZED PATTERN	4.137846399018326
MARGINAL INCREASE	4.137846399018326
TECHNICAL CONCERN	4.137846399018326
DIGESTED PEGFP-N1	4.137846399018326
NEIGHBORING NOTCH	4.137846399018326
TRITON-EXTRACTION	4.137846399018326
LEUKEMIA LGL CELL	4.137846399018326
CIRCADIAN PATTERN	4.137846399018326
FASTA FORMAT FILE	4.137846399018326
IMPORTIN-Β FAMILY	4.137846399018326
IMAGING TECHNIQUE	4.137846399018326
DYNAMIC PSEUDOPOD	4.137846399018326
VOLUME ASSUMPTION	4.137846399018326
RETURNED ESTROGEN	4.137846399018326
CELL LINE UNDERGO	4.137846399018326
CONSERVED PROLINE	4.137846399018326
PRESUMPTIVE ACINI	4.137846399018326
INCLUDING Β-ACTIN	4.137846399018326
CASEIN ZYMOGRAPHY	4.137846399018326
RECEPTOR-SPECIFIC	4.137846399018326
CIRCULAR EXCISION	4.137846399018326
IMMUNIZING RABBIT	4.137846399018326
DEPHOSPHORYLATING	4.137846399018326
AFFYMETRIX YG_S98	4.137846399018326
YOLK PLUG CLOSURE	4.137846399018326
EXAMPLE FREQUENCY	4.137846399018326
COMPARATIVE MODEL	4.137846399018326
UVEOSCLERAL ROUTE	4.137846399018326
PROBE SPECIFICITY	4.137846399018326
NIKON DIAPHOT-TMD	4.137846399018326
UNDERLYING TISSUE	4.137846399018326
BIOLOGICAL TISSUE	4.137846399018326
USER-ENTERED TEXT	4.137846399018326
QUANTITATIVE TERM	4.137846399018326
ANALYZED DATA SET	4.137846399018326
SCALE INDEPENDENT	4.137846399018326
FIXED-ANGLE ROTOR	4.137846399018326
NUMEROUS BLM BODY	4.137846399018326
EXPERIMENTAL STEP	4.137846399018326
IMAGEPRO SOFTWARE	4.137846399018326
STATISTICAL ISSUE	4.137846399018326
FASTA FILE FORMAT	4.137846399018326
REPEATED DOUNCING	4.137846399018326
CELLULAR GROUPING	4.137846399018326
QUALITATIVE SHIFT	4.137846399018326
HL-60 CELL SYSTEM	4.137846399018326
BOOLEAN USM IMAGE	4.137846399018326
ANALOG ASPARAGINE	4.137846399018326
MOLECULAR PATTERN	4.137846399018326
ST-138 CONTROLLER	4.137846399018326
molecule approach	4.137846399018326
RECOGNIZING GP120	4.137846399018326
RHOGTPASE PATHWAY	4.137846399018326
BAYESIAN APPROACH	4.137846399018326
CONSERVED ELEMENT	4.137846399018326
INACTIVATED PAI-1	4.137846399018326
VON HIPPEL-LINDAU	4.137846399018326
PRODUCING WTPAI-1	4.137846399018326
OLFACTORY PLACODE	4.137846399018326
SKOTOMORPHOGENESI	4.137846399018326
POST-TRANSFECTION	4.137846399018326
SEQUESTERED HSP70	4.137846399018326
INTERNAL STANDARD	4.137846399018326
SPREAD MORPHOLOGY	4.137846399018326
TRIMMING STRATEGY	4.137846399018326
SYNERGISTIC EVENT	4.137846399018326
METASTATIC LESION	4.137846399018326
STATISTICAL SCORE	4.137846399018326
CHAPERONE COMPLEX	4.137846399018326
SURROUNDING POINT	4.137846399018326
EXPERIMENTAL UNIT	4.137846399018326
BIDIMENSIONAL CGR	4.137846399018326
CONNECTING REGION	4.137846399018326
PHYLOGENETIC BIAS	4.137846399018326
MOUSE MYOBLAST L6	4.137846399018326
INCREASE/DECREASE	4.137846399018326
TECHNICAL PROBLEM	4.137846399018326
BINDING SITE GAL4	4.137846399018326
QIAAMP TISSUE KIT	4.137846399018326
BINDING SITE NAME	4.137846399018326
MENOPAUSAL STATUS	4.137846399018326
INVERTED POSITION	4.137846399018326
GENOME-WIDE LEVEL	4.137846399018326
HANDLING MM PROBE	4.137846399018326
PHYLOGENETIC PATH	4.137846399018326
DT-SENSITIVE CELL	4.137846399018326
POST-IMPLANTATION	4.137846399018326
SPECIFIED FEATURE	4.137846399018326
TEXAS RED-DEXTRAN	4.137846399018326
LITERATURE SURVEY	4.137846399018326
POTENTIAL PROBLEM	4.137846399018326
receptor subunits	4.137846399018326
RHYTHMIC INCREASE	4.137846399018326
OBSERVED DECREASE	4.137846399018326
IMMUNOFLOURESCENT	4.137846399018326
E-VALUE THRESHOLD	4.137846399018326
STRAND GAD1 PROBE	4.137846399018326
SEQUENCE POSITION	4.137846399018326
IMAGE ACQUISITION	4.137846399018326
BRANCHING NETWORK	4.137846399018326
OVERDETERMINATION	4.137846399018326
DEFINED MMCOP1 NL	4.137846399018326
NEUROGENIC DOMAIN	4.137846399018326
MM OCTYLGLUCOSIDE	4.137846399018326
ATRADITIONAL BPNN	4.137846399018326
NERVE CELL SYNAPS	4.137846399018326
COMPARING PROCESS	4.137846399018326
PRO-SEQUENCE FORM	4.137846399018326
SEGMENT STRUCTURE	4.137846399018326
CONTRACTED TYPE I	4.137846399018326
ROUTINE STATISTIC	4.137846399018326
ANDROGEN ACTIVITY	4.137846399018326
NUMEROUS CELLULAR	4.137846399018326
FINGERNAIL POLISH	4.137846399018326
HELICASE DELETION	4.137846399018326
REPLICATE CULTURE	4.137846399018326
OBSERVATIONS SHOW	4.137846399018326
ENDOGENOUS UNC-86	4.137846399018326
AHAB SUCCESS RATE	4.137846399018326
constructionstill	4.137846399018326
LIMITING QUANTITY	4.137846399018326
MODELED LFC CURVE	4.137846399018326
ADDITIONAL DETAIL	4.137846399018326
MITOCHONDRIA-LIKE	4.137846399018326
NORMAL HUMAN SERA	4.137846399018326
MUTUAL INHIBITION	4.137846399018326
AMPLIFIED PRODUCT	4.137846399018326
TAXONOMICAL GROUP	4.137846399018326
INTUITIVE EXAMPLE	4.137846399018326
PREDICTED PATHWAY	4.137846399018326
METABOLISM RESULT	4.137846399018326
MINUTE TIME POINT	4.137846399018326
PUTATIVE FILAMENT	4.137846399018326
final enlargement	4.137846399018326
CAUSES RETRACTION	4.137846399018326
EXTENSIVE CONTACT	4.137846399018326
KODAK BIOMAX FILM	4.137846399018326
ANTI-CLEAVED PARP	4.137846399018326
RESULTS HIGHLIGHT	4.137846399018326
LRP FAMILY MEMBER	4.137846399018326
HA-TAGGED CHIMERA	4.137846399018326
SCALED DIFFERENCE	4.137846399018326
SCALING AVERAGE D	4.137846399018326
PREDICTION TARGET	4.137846399018326
POTENTIAL EXAMPLE	4.137846399018326
MIB-TREATED LNCAP	4.137846399018326
BRIDGED BIPARTITE	4.137846399018326
HELICASE MUTATION	4.137846399018326
QUALITY REFERENCE	4.137846399018326
DEDIFFERENTIATION	4.137846399018326
C/EBPΑ SGRAI SITE	4.137846399018326
ELLIPSOIDAL SHAPE	4.137846399018326
CELL DESQUAMATION	4.137846399018326
integrin function	4.137846399018326
CALCIUM-DEPENDENT	4.137846399018326
HOMOZYGOUS C/EBPΑ	4.137846399018326
ESSENTIAL ELEMENT	4.137846399018326
BOI1-PH PELLETING	4.137846399018326
PRINCIPAL FINDING	4.137846399018326
NEURAL PLATE CELL	4.137846399018326
GFP-HYAL-2 FUSION	4.137846399018326
POSSIBLE STRENGTH	4.137846399018326
INTENSITY PROFILE	4.137846399018326
DISTANCE PROPERTY	4.137846399018326
TPA RATE CONSTANT	4.137846399018326
SELECTING OUTLIER	4.137846399018326
FORMED BLASTOCYST	4.137846399018326
EXPERIMENTAL COST	4.137846399018326
SIMILAR STRUCTURE	4.137846399018326
DESIRED SELECTION	4.137846399018326
SN50-SUPPLEMENTED	4.137846399018326
RATTUS NORVEGICUS	4.137846399018326
MG/L L-METHIONINE	4.137846399018326
EPIDERMAL PLACODE	4.137846399018326
Β-ACTIN/CRE MOUSE	4.137846399018326
SEQUENCE VARIANCE	4.137846399018326
ROSEMARIE DALCHAU	4.137846399018326
NIDOGEN DOMAIN G2	4.137846399018326
DIGESTED PEGFP-C1	4.137846399018326
EXPRESSING HYAL-1	4.137846399018326
TWO-HYBRID SCREEN	4.137846399018326
CONTINUOUS NATURE	4.137846399018326
HOLLIDAY JUNCTION	4.137846399018326
MOUNTING QUANTITY	4.137846399018326
MICROSCOPY AMIEVA	4.137846399018326
OTHER DMD PATIENT	4.137846399018326
AVERAGE CELL SIZE	4.137846399018326
AD HOC ESTIMATION	4.137846399018326
CRE MODIFIED FORM	4.137846399018326
MOLECULAR BIOLOGY	4.137846399018326
POSSIBLE APPROACH	4.137846399018326
ONLINE REPOSITORY	4.137846399018326
MHCK-B COLOCALIZE	4.137846399018326
LOWERING VARIANCE	4.137846399018326
POSITIVE TENDENCY	4.137846399018326
MEC-3GFP DELETION	4.137846399018326
SEEDLINGS DISPLAY	4.137846399018326
ORIGINAL LOCATION	4.137846399018326
FULL LENGTH SMAD1	4.137846399018326
DIAPHYSEAL CORTEX	4.137846399018326
INITIATE MOVEMENT	4.137846399018326
FIRST-PASS METHOD	4.137846399018326
TNF-MEDIATED WOX1	4.137846399018326
CALLIPHORA VICINA	4.137846399018326
LRP AMINOTERMINUS	4.137846399018326
INHERITED DISEASE	4.137846399018326
NONLINEAR DYNAMIC	4.137846399018326
LABELING PROTOCOL	4.137846399018326
ENDOCYTIC PATHWAY	4.137846399018326
DIVERSE STRUCTURE	4.137846399018326
DUCKBILL PLATYPUS	4.137846399018326
REGIONAL INCREASE	4.137846399018326
NONSTOCHASTIC CFG	4.137846399018326
JANDEL SCIENTIFIC	4.137846399018326
STATISTICAL GROUP	4.137846399018326
INDUCED EXTENSION	4.137846399018326
MINIMUM HFC VALUE	4.137846399018326
MESSAGE STABILITY	4.137846399018326
CUSTOM MUSCLECHIP	4.137846399018326
INTERSTITIAL COLL	4.137846399018326
PHENOL-CHLOROFORM	4.137846399018326
POSSIBLE VARIABLE	4.137846399018326
SAMPLE DENDROGRAM	4.137846399018326
CANDIDATE PATHWAY	4.137846399018326
NEUROGENIC REGION	4.137846399018326
FEEDING CONDITION	4.137846399018326
TETRAPLOID EMBRYO	4.137846399018326
CELL VOLUME RATIO	4.137846399018326
PREDICTIVEABILITY	4.137846399018326
DESIRED END POINT	4.137846399018326
APOPTOTIC PATHWAY	4.137846399018326
DIMINISHED AMOUNT	4.137846399018326
DIETARY CONDITION	4.137846399018326
WEIGHT GENERATION	4.137846399018326
POTENTIAL PARTNER	4.137846399018326
DEVELOPMENTAL CUE	4.137846399018326
INTERMEDIATE STEP	4.137846399018326
Y190 TRANSFORMANT	4.137846399018326
CYLINDRICAL PRIOR	4.137846399018326
METHODS ASSOCIATE	4.137846399018326
ENVIRONMENTAL CUE	4.137846399018326
ELECTRONIC FORMAT	4.137846399018326
PATHWAY INCLUSION	4.137846399018326
CASP5 COMPETITION	4.137846399018326
SUBJECTIVE NATURE	4.137846399018326
EXPRESSING NORMAL	4.137846399018326
PRODUCE CHEMOKINE	4.137846399018326
REDUCED MIGRATION	4.137846399018326
CONTIGUOUS REGION	4.137846399018326
EXPRESSED VARIANT	4.137846399018326
EXAMPLE CONSENSUS	4.137846399018326
INCLUDING BIOLOGY	4.137846399018326
INCORPORATED HSN3	4.137846399018326
BMP FAMILY MEMBER	4.137846399018326
BRIEF DESCRIPTION	4.137846399018326
PROCESSING METHOD	4.137846399018326
TRANS-RESVERATROL	4.137846399018326
DIFFERENCE RESULT	4.137846399018326
TEN-FOLD DECREASE	4.137846399018326
INTRAGENIC MODULE	4.137846399018326
ALLOWED ISOLATION	4.137846399018326
INFLUENTIAL INPUT	4.137846399018326
THREE-STAGE MODEL	4.137846399018326
EXPECTATION VALUE	4.137846399018326
INDUCED CELL LINE	4.137846399018326
SYNCHRONIZABILITY	4.137846399018326
INDIVIDUAL FAMILY	4.137846399018326
INTERGENIC MODULE	4.137846399018326
VENTRAL MIGRATION	4.137846399018326
RE-ADMINISTRATION	4.137846399018326
RING-LIKE PATTERN	4.137846399018326
MATRIX DEPOSITION	4.137846399018326
COREGENE COREGENE	4.137846399018326
SEQUENCE MGXXXS/T	4.137846399018326
SUBSTRATE/PRODUCT	4.137846399018326
COALESCING VENULE	4.137846399018326
ACTIVATED PATHWAY	4.137846399018326
DISCRIM PROCEDURE	4.137846399018326
DEVELOPING CORNEA	4.137846399018326
IDENTIFYING NOVEL	4.137846399018326
METHODOLOGY PAPER	4.137846399018326
PRESCRIBED METHOD	4.137846399018326
CALCIUM BUFFERING	4.137846399018326
calcium ionophore	4.137846399018326
VARIABLESAS INPUT	4.137846399018326
RAB PROTEINS PLAY	4.137846399018326
CURRENT KNOWLEDGE	4.137846399018326
APPEARED NEGATIVE	4.137846399018326
polymorphonuclear	4.137846399018326
GUTELL LABORATORY	4.137846399018326
COMPLEMENT SEARCH	4.137846399018326
UNTREATED HPB-ALL	4.137846399018326
FOLLOWINGQUESTION	4.137846399018326
MARROW MATURATION	4.137846399018326
DOMINANT-NEGATIVE	4.137846399018326
BIDIRECTIONAL USM	4.137846399018326
CODING ANNOTATION	4.137846399018326
LEPISOSTEUS RAISE	4.137846399018326
NEURAL EPITHELIUM	4.137846399018326
MEMBRANE BLEBBING	4.137846399018326
PRENATAL B6 STAGE	4.137846399018326
ALIGNED BASE PAIR	4.137846399018326
GFP-TAGGED C/EBPΑ	4.137846399018326
RESULTING CHIMERA	4.137846399018326
membrane blebbing	4.137846399018326
ANTI-FLAG EPITOPE	4.137846399018326
genome annotation	4.137846399018326
NUMEROUS MEMBRANE	4.137846399018326
OTHER DMD PROFILE	4.137846399018326
CHLOROPLAST GROUP	4.137846399018326
CYTOSKELETAL CORE	4.137846399018326
SNP SIGNIFICANTIN	4.137846399018326
STRATACLEAN RESIN	4.137846399018326
MITOGENIC PATHWAY	4.137846399018326
PIGMENTED LAB RAT	4.137846399018326
POLY-GLN DISORDER	4.137846399018326
TWOFUNCTIONAL SNP	4.137846399018326
EXPRESSING MARKER	4.137846399018326
experimental data	4.137846399018326
DORSAL FIN ANLAGE	4.137846399018326
SYSTEMIC PROPERTY	4.137846399018326
COMPLEMENT SYSTEM	4.137846399018326
LTR-TAG CELL LINE	4.137846399018326
FIXATION PROTOCOL	4.137846399018326
TRANSGENIC EMBRYO	4.137846399018326
FEDERAL GUIDELINE	4.137846399018326
TRANSFERRED VIRUS	4.137846399018326
CELL-FREE EXTRACT	4.137846399018326
HUMAN AUTOANTIGEN	4.137846399018326
PIVOTAL ORGANELLE	4.137846399018326
PREDICTED OUTCOME	4.137846399018326
IMPLYING GFP-N200	4.137846399018326
TEMPORAL SEQUENCE	4.137846399018326
FORTHIS STATISTIC	4.137846399018326
POLY-ALA DISORDER	4.137846399018326
SMAD1 DEGRADATION	4.137846399018326
POSITIVE HIT RATE	4.137846399018326
HAMMAMATSU-ORCAER	4.137846399018326
PRODUCE MELATONIN	4.137846399018326
LIFTING TECHNIQUE	4.137846399018326
QUANTATIVE ASPECT	4.137846399018326
SPURIOUS ARTIFACT	4.137846399018326
RAISING ESTRADIOL	4.137846399018326
DATA INPUT/OUTPUT	4.137846399018326
METHODTO OVER-FIT	4.137846399018326
RESULTING PROFILE	4.137846399018326
TRANSITIONAL STEP	4.137846399018326
RHYTHMIC FUNCTION	4.137846399018326
TWO-HYBRID FUSION	4.137846399018326
PHOTOLITHOGRAPHIC	4.137846399018326
ROL-6 MARKER GENE	4.137846399018326
IMPLEMENTATIONARE	4.137846399018326
SITE ARCHITECTURE	4.137846399018326
PRO-HSN3 ASSEMBLY	4.137846399018326
HERITABILITIESARE	4.137846399018326
BACTERIAL LINEAGE	4.137846399018326
BINDING SITE DATA	4.137846399018326
GAMMA SUBDIVISION	4.137846399018326
MECHANISTIC THEME	4.137846399018326
ABLETO MODEL DATA	4.137846399018326
EXPENSIVE DYNAMIC	4.137846399018326
ACTIVATED NK CELL	4.137846399018326
CONTINUOUS DOMAIN	4.137846399018326
MYCRAB24-POSITIVE	4.137846399018326
SV40 TRANSDUCTION	4.137846399018326
CATALYTIC SURFACE	4.137846399018326
glycosaminoglycan	4.137846399018326
TWO-SAMPLE T-TEST	4.137846399018326
REPORTED INCREASE	4.137846399018326
SIMILARITY LENGTH	4.137846399018326
LACTOPEROXIDASE-H	4.137846399018326
BANDPASS DICHROIC	4.137846399018326
VIRAL ONCOPROTEIN	4.137846399018326
COMPREHENSIVE SET	4.137846399018326
LITERATURE RESULT	4.137846399018326
STRUCTURE ELEMENT	4.137846399018326
GOLGI/ER MEMBRANE	4.137846399018326
MARKOV TRANSITION	4.137846399018326
DIAGNOSTIC MARKER	4.137846399018326
REMODELING SYSTEM	4.137846399018326
NI-AGAROSE COLUMN	4.137846399018326
ACCEPTOR MEMBRANE	4.137846399018326
ANALYTICAL METHOD	4.137846399018326
LEICA MICROSYSTEM	4.137846399018326
CLONAL POPULATION	4.137846399018326
BIOLOGICAL SOURCE	4.137846399018326
LPA FAMILY MEMBER	4.137846399018326
BOVINE Α-THROMBIN	4.137846399018326
GHFT1-5 CELL LINE	4.137846399018326
RATIOMETRIC IMAGE	4.137846399018326
INFECTING SF9 CELL	4.137491493297626
FOLLOW-UP	4.137466460373348
WILD-TYPE FRACTION	4.1373670697863565
FORCED EXPRESSION	4.1371579180599065
BIOPSY EXPRESSION	4.1371579180599065
HB-EGF EXPRESSION	4.1371579180599065
LENGTH EXPRESSION	4.1371579180599065
NEURAL EXPRESSION	4.1371579180599065
EXPRESSION RESULT	4.1371579180599065
PROTEOME ANALYSIS	4.136580250728178
ANALYSIS STRATEGY	4.136580250728178
RHYTHMIC ANALYSIS	4.136580250728178
ABSOLUTE ANALYSIS	4.136580250728178
BLOTTING ANALYSIS	4.136580250728178
ANALYSIS APPROACH	4.136580250728178
TAXONOMY ANALYSIS	4.136580250728178
ANALYSES ANALYSIS	4.136580250728178
DATABASE ANALYSIS	4.136580250728178
ANALYSIS SOFTWARE	4.136580250728178
CLUSTALX ANALYSIS	4.136580250728178
MHC KINASE ISOFORM	4.136292581856827
DRIVING MYOSIN II	4.1359647035527916
MICROARRAY SYSTEM	4.135679089062487
FUTURE MICROARRAY	4.135679089062487
MUSCLE MICROARRAY	4.135679089062487
MESSENGER CONTROL	4.135425927500695
INDICATED CONTROL	4.135425927500695
X-100 LYSIS BUFFER	4.135299170137796
REACHING CONFLUENCY	4.135239841946722
TRANSLATIONAL LEVEL	4.135239841946722
MECHANISTIC STUDY	4.1352322897792835
NUTRITIONAL STUDY	4.1352322897792835
COMPARATIVE STUDY	4.1352322897792835
HOMOLOGOUS GENE	4.135123367704317
SANKOFF ALGORITHM	4.135069975806925
MAPPING ALGORITHM	4.135069975806925
SAMPLER ALGORITHM	4.135069975806925
ALGORITHM ATTEMPT	4.135069975806925
DEVISED ALGORITHM	4.135069975806925
RNA TYPE CRW RDBM	4.134944809186738
OTHER INTRON TYPE	4.134691021106761
NANOMOLAR CONCENTRATION	4.134668776810996
HTK PROMOTER SHOW	4.134494976916989
COMPLEX HOMOLOGOUS	4.134463226154323
REVERSIBLE CHANGE	4.134364491220421
ALLOSTERIC CHANGE	4.134364491220421
BIOLOGICAL CHANGE	4.134364491220421
SURPRISING CHANGE	4.134364491220421
TRANSCRIPT CHANGE	4.134364491220421
MATCH CELL SIGNAL	4.13418044215667
CONTROLLED EFFECT	4.134152549006636
POSITIONAL EFFECT	4.134152549006636
COLLECTIVE EFFECT	4.134152549006636
CYTOPATHIC EFFECT	4.134152549006636
DISRUPTIVE EFFECT	4.134152549006636
PROTECTIVE EFFECT	4.134152549006636
BIOLOGICAL EFFECT	4.134152549006636
EST IDENTIFICATION	4.134147641773535
RG MOLECULAR LOCUS	4.134147641773535
METRIC CALCULATION	4.134147641773535
CHICKEN EST CLONE	4.134095469646631
CREATING TYROSINE	4.134036598557838
CELLULAR TYROSINE	4.134036598557838
TESTED RNA SAMPLE	4.133977612576209
RNA SAMPLES SPLIT	4.133977612576209
POOLED RNA SAMPLE	4.133977612576209
NEW NONCODING RNA	4.133977612576209
RNASEP RNA FAMILY	4.133977612576209
YEAST STRAIN Y312	4.133829446286937
MUTANT BMP TYPE I	4.133716469491366
RESPONSE STRENGTH	4.133533782253409
SHOW LOCALIZATION	4.133489550286589
DUAL LOCALIZATION	4.133489550286589
VASP LOCALIZATION	4.133489550286589
TRAP LOCALIZATION	4.133489550286589
INHIBITORY FACTOR	4.1334820899291715
CONCLUSIVE FACTOR	4.1334820899291715
FACTOR EXTRACTION	4.1334820899291715
CONTROLLING ACTIN	4.133139554128084
DOCUMENTED INTRON	4.133113332150979
GFP-HYAL-2 VECTOR	4.1330464809240395
C/EBP-TATA VECTOR	4.1330464809240395
EXPRESSING VECTOR	4.1330464809240395
VECTOR PK7-GR-GFP	4.1330464809240395
GFP-C/EBPΑ VECTOR	4.1330464809240395
C/EBPΑ-GFP VECTOR	4.1330464809240395
MHCK DOMAIN ORGANIZATION	4.133017119460095
HUMAN FIBRONECTIN	4.132991624717247
RAT GNRH RECEPTOR	4.132921265669406
RECEPTOR FZ CLASS	4.132921265669406
NEURITE OUTGROWTH	4.132881647330201
STATISTICAL MODEL	4.132881647330201
PROMOTER STRENGTH	4.132819265866321
PERKIN ELMER LIFE	4.132789342454703
GENOMIC TECHNIQUE	4.132789342454703
GENOMIC STRUCTURE	4.132789342454703
CYTOSKELETON PLAY	4.132697395971727
CYTOPLASMIC SMAD1	4.132665999611687
CYTOPLASMIC LEVEL	4.132665999611687
AZ TARGETING ROLE	4.132602044063457
FZ PROTEIN FAMILY	4.132543739356528
MDM2 PROTEIN BIND	4.132543739356528
NB MARKER PROTEIN	4.132543739356528
D BINDING PROTEIN	4.132543739356528
P27 PROTEIN LEVEL	4.132543739356528
RB FAMILY PROTEIN	4.132543739356528
RRNA INTRON GROUP	4.1325374456880315
SMC PROLIFERATION	4.132536489626521
OVEREXPRESSED WOX1	4.132510547798199
OVEREXPRESSED ALK3	4.132510547798199
EXOFISH VERTEBRATE	4.132510547798199
BACTERIAL RIBOSOME	4.132510547798199
FLOW CHAMBER SLIT	4.132503093969969
STUDIES SUPPORT	4.1323664632986485
BACKGROUND SIGNAL	4.132347463725842
SIGNAL INTEGRATOR	4.132347463725842
SIGNAL TRANSDUCER	4.132347463725842
DLA MUTANT EMBRYO	4.132339826315714
CONSTRUCTED CLONE	4.132220004960784
INDEPENDENT CLONE	4.132220004960784
detergent extraction	4.132072761007346
COMPLEMENTARY RNA	4.132043219355151
CONTAMINATING RNA	4.132043219355151
INDIVIDUAL STRAIN	4.131820969921242
DISCARDING STRAIN	4.131820969921242
EXPRESSING STRAIN	4.131820969921242
VESSEL WALL INJURY	4.1316530223825465
patient populations	4.131485724491355
DNA RANDOM PRIMER	4.131469435163275
WG PLASMID ABSENCE	4.131380203485829
GENETIC COMPONENT	4.13120901227857
NETWORK COMPONENT	4.13120901227857
NORMAL GOAT SERUM	4.130994903028901
STRUCTURE SOLUTION	4.130930895716734
ANTI-RT TREATMENT	4.130911007159642
CHANGE CALCULATION	4.130605077761333
CD3 T CELL MARKER	4.130522386064112
HUMAN T CELL LINE	4.130522386064112
THROMBIN RECEPTOR	4.130458698994945
ESTROGEN RECEPTOR	4.130458698994945
LIGANDED RECEPTOR	4.130458698994945
MEMBRANE RECEPTOR	4.130458698994945
CORTICAL RECEPTOR	4.130458698994945
RECEPTOR MOVEMENT	4.130458698994945
RIBONUCLEASE INHIBITOR	4.130348473611627
GRANT 1-T15-LM07438-01	4.130348473611627
IMPORTIN-Α ABSENCE	4.130084975908211
TESTING TEST CASE	4.130034118533832
ACTIVATION DOMAIN	4.130016117887554
CALLED ACTIVATION	4.130016117887554
RHOA DISTRIBUTION	4.130016117887554
ACIDIC ACTIVATION	4.130016117887554
MHCK-A ACTIVATION	4.130016117887554
TRANSLATION LYSATE	4.130009432002546
PROTEIN NETSEARCH	4.129892409525628
ANALYZING PROTEIN	4.129892409525628
REFERENCE PROTEIN	4.129892409525628
INCLUDING PROTEIN	4.129892409525628
PI/MIN/MG PROTEIN	4.129892409525628
LYSOSOMAL PROTEIN	4.129892409525628
INNOCUOUS PROTEIN	4.129892409525628
APOPTOTIC PROTEIN	4.129892409525628
D-BINDING PROTEIN	4.129892409525628
PROTEIN ALIGNMENT	4.129892409525628
CHAPERONE PROTEIN	4.129892409525628
PRO-DEATH PROTEIN	4.129892409525628
TNF-ALPHA PROTEIN	4.129892409525628
SHUTTLING PROTEIN	4.129892409525628
PRECISION PROTEIN	4.129892409525628
TARGETING PROTEIN	4.129892409525628
CV-1 CDNA LIBRARY	4.129793455864878
FUNCTIONAL SUBGROUP	4.129498250544397
DEVELOPING NEURON	4.129476098499225
PROTEASOME SYSTEM	4.1294346613679425
GROWTH SUPPRESSION	4.129161012426068
GENOME REFINEMENT	4.128678210140389
ADENOVIRAL GENOME	4.128678210140389
GENOME COMPARISON	4.128678210140389
ADENOVIRUS GENOME	4.128678210140389
GENOME ANNOTATION	4.128678210140389
PAIRED NUCLEOTIDE	4.128441393453506
ENDING NUCLEOTIDE	4.128441393453506
GASTRULATION PRODUCE	4.1283565679918155
RQ1 RNASE-FREE DNASE	4.1283565679918155
GASTRULATION PATTERN	4.1283565679918155
PPACPL VECTOR DNA	4.128269489767084
GLYCINE RESIDUE	4.128198710633674
ACTIVATED HUMAN T	4.128081048412708
T CELL MORPHOLOGY	4.128081048412708
BINDINGSITE TABLE	4.127851275457282
EC GROWTH MODULATION	4.1277453113370814
BS CELL PHENOTYPE	4.127610429106413
RING FINGER MOTIF	4.127357689108589
GIBBS MOTIF MATCH	4.127357689108589
A549 CELL NUCLEUS	4.127292541842069
MM TRIS-CL BUFFER	4.127234870491378
RGS3 ACID VARIANT	4.127109141480396
VISUALIZATION TOOL	4.1269218476755
MODIFIED TYRODE ΜL	4.126800683445198
BINDING SITE P300	4.126740706172722
ANTIBODY INCUBATION	4.126684940548209
POSSIBLE VALUE	4.1265184871344
CHIMERIC MOUSE	4.1265184871344
bi-directional	4.1265184871344
ISOTHIOCYANATE	4.1265184871344
NEGATIVE VALUE	4.1265184871344
MOLECULAR DATA	4.1265184871344
microfilaments	4.1265184871344
IMMUNORESEARCH	4.1265184871344
COMPLEX SYSTEM	4.1265184871344
INPUT SEQUENCE	4.1265184871344
mismatch probe	4.1265184871344
CELLULAR EVENT	4.1265184871344
SIGNALING PLAY	4.1265184871344
FUSION PARTNER	4.1265184871344
HUMAN PLATELET	4.1265184871344
PROBE SEQUENCE	4.1265184871344
SECONDARY PEAK	4.1265184871344
DORSAL PORTION	4.1265184871344
representation	4.1265184871344
RRNA CONSERVATION	4.126120180863344
GFP REPORTER GENE	4.126091353082824
MMCOP1 CDNA CLONE	4.126042526493184
MONKEY CDNA CLONE	4.126042526493184
RAPID CELL GROWTH	4.125997228827409
SYNTHETIC PEPTIDE	4.12599171758546
INVESTIGATORS USE	4.12588040602271
DEPENDENT CONTROL	4.125604129781749
COORDINATED MANNER	4.125519193527057
SINGLE FASTA FILE	4.125339356917756
EXPERIMENTAL CONDITION	4.125295549433855
MRNA LOCALIZATION	4.125214366818842
CUMULATIVE DAMAGE	4.12516601838118
STIMULATORY EFFECT	4.125150742709079
SF9 CELL	4.124981136914583
CELLULAR ADHESION	4.1249738914018295
ADHESION CATEGORY	4.1249738914018295
CONTROLS ADHESION	4.1249738914018295
EUKARYOTIC SRP-RNA	4.124792819057329
BRANCHING TOPOLOGY	4.124792819057329
EXPERIMENTAL CHIP	4.124775852823115
MOESIN POLYCLONAL	4.124775852823115
PRIMARY SUBSTRATE	4.12462327835391
DETERGENT SAPONIN	4.124571625538815
DETERGENT EXTRACT	4.124571625538815
ACTIVATION SIGNAL	4.124517182595071
ARRAY ANALYSIS	4.124489103062265
INFORMATION SERVER	4.1244379809543
CYTOSKELETON MRNA	4.12442221250398
NUCLEAR INCLUSION	4.124360914848664
INTEGRIN MAB 33B6	4.124312964755612
CHEMOKINE ADDITION	4.124156305346741
CYTOTOXIC KILLING	4.124143407039475
P-VALUE THRESHOLD	4.123918767826707
FREQUENCIES CLOSE	4.123918767826707
MONKEY DT RECEPTOR	4.123898009927952
HEAT SHOCK PROTEIN	4.123513906957027
ACTIVATED PROTEIN	4.123137316505539
INCREASED ADHERENCE	4.123038960216781
CLEARED SUPERNATANT	4.123038960216781
T3 RNA POLYMERASE	4.122944034619213
T7 RNA POLYMERASE	4.122944034619213
HA T-CELL EPITOPE	4.122941390199226
T CELL ACTIVATION	4.122860860992194
SINGLE-STEP ASSAY	4.122729219255181
PHOSPHATASE ASSAY	4.122729219255181
RADIATION THERAPY	4.122675229327456
FINAL DEGRADATION	4.122675229327456
POSITIONAL CLONING	4.12250608461559
MAMMALIAN PROTEIN	4.122504709502248
SPINDLE PHENOTYPE	4.122492444150457
BODY ACCUMULATION	4.122209856024055
HIV-1 RT SEQUENCE	4.1222095608501395
TRANSLATION START	4.1221133341537195
BAMH1 RESTRICTION	4.1221133341537195
USE WILCOXON TEST	4.122056789870088
CURRENT STUDY	4.122033150667747
EMBRYONIC NUCLEUS	4.122015613253939
CONTAINING BUFFER	4.121929106227904
FILTRATION BUFFER	4.121929106227904
BLOCKING ANTIBODY	4.121866734390951
ANTIBODY ANTI-19S	4.121866734390951
BERKELEY ANTIBODY	4.121866734390951
GENERAL ALIGNMENT	4.121816483873255
BINARY EQUIVALENT	4.121816483873255
EXPRESSION CLONING	4.121805610045915
MRNA DISTRIBUTION	4.121740934419807
AMPLIFICATION STEP	4.121705727560981
GENOME CODON BIAS	4.121620159972455
PHOSPHATE PATHWAY	4.121586389397489
BIOLOGICAL RESEARCH	4.121295977112504
PROBE SETS COMMON	4.121269120917082
LISTERIA MOTILITY	4.121187859749919
IMPAIRED MOTILITY	4.121187859749919
CELLULAR MOTILITY	4.121187859749919
USE HUGENEFL CHIP	4.121155372891108
BINARY EXPRESSION	4.121128002914837
CO-TRANSFECTED JNK	4.121069258486698
ACTIVATED CASPASE	4.121054188964187
AS3 OVEREXPRESSION	4.121050889970846
GENOME ACTIVATION	4.120847929009618
PROTEIN N-TERMINUS	4.1208163899093115
PARALLEL MANNER	4.1207252262534055
EXPRESSION RESEARCH	4.120584094223884
MURINE TISSUE RNA	4.12032965269366
EXCITATION SPECTRUM	4.120291013881208
LIPID CARDIOLIPIN	4.120268767928215
LIPID ENVIRONMENT	4.120268767928215
ANTI-FADE REAGENT	4.120146701045644
SECONDARY REAGENT	4.120146701045644
POPULATION GROWTH	4.120072643731951
GROWTH SIMULATION	4.120072643731951
PRELIMINARY SEARCH	4.120043447524485
MUTAGENESIS SYSTEM	4.120043447524485
MUTAGENESIS RESULT	4.120043447524485
ZYMED MOUSE PCNA KIT	4.119862412527745
CYTOSOLIC ADAPTOR	4.119770111727076
ANALYZED PAIRWISE	4.119770111727076
PAIRWISE IDENTITY	4.119770111727076
CHARGED SIDE CHAIN	4.119528011854254
DMORC	4.119216087812954
SINGLE METABOLITE	4.1190858358674705
SINGLE COMPARISON	4.1190858358674705
SINGLE EXPERIMENT	4.1190858358674705
TECHNICAL SUPPORT	4.118966721180799
INHIBITED SUPPORT	4.118966721180799
SUPPORT MIGRATION	4.118966721180799
DECREASED SUPPORT	4.118966721180799
DIEGO CALIFORNIA USA	4.118446719950399
STORAGE REQUIREMENT	4.11842518141134
FINANCIAL CONSEQUENCE	4.1181512711762025
DENDRITIC PROCESS	4.118088596630216
DENDRITIC NETWORK	4.118088596630216
HNF3ΑLACZ ES CELL	4.117973053926192
RNA SPECIES FAVOR	4.117909801650654
MAXIMUM INTENSITY	4.117856151896238
MAXIMUM ESTIMATOR	4.117856151896238
MAXIMUM FREQUENCY	4.117856151896238
GENE TRANSFECTION	4.117777450135915
SOLVENT	4.117453609487308
REPEATED MULTIPLE	4.117435936491269
MULTIPLE NUCLEOLI	4.117435936491269
MULTIPLE MUTATION	4.117435936491269
MULTIPLE LOCATION	4.117435936491269
UBIQUITIN POLYMER	4.11729191105005
RNA EXTRACTION	4.117217143470446
TISSUE COLLECTION	4.117124801391771
TOTAL CELL VOLUME	4.1163922196575
TOTAL CORTEX GAIN	4.1163922196575
P53 EXPRESSION	4.11636703741078
MURINE HYAL2 CDNA	4.1161454959823285
RNA EXPRESSION	4.116113645324253
ENZYMATIC COMPLEX	4.116062155359641
MOLECULE APPROACH	4.1159216118521655
ANALYSIS ACCURACY	4.115858653101625
SELECTING ARCHAEA	4.115488885789675
DRUG TREATMENT	4.115402432339275
CELL CYCLE SUBSET	4.1153302163677825
P VALUE THRESHOLD	4.115190785613294
TAIR WEBSITE HTTP	4.115190785613294
MEASUREMENT LEVEL	4.114884628675387
SDS-PAGE PREPARATION	4.114780382981516
WILD-TYPE PROTEIN	4.114721239834759
RASMCS PRODUCE PGE	4.1145025140695015
P35-C/EBPΒ ISOFORM	4.1145025140695015
BINDING SRC KINAS	4.114399057187848
AQUEOUS FORMATION	4.1140262447373335
SEGMENT FORMATION	4.1140262447373335
MICROBIAL SPECIES	4.113744682629993
KK VERSION ABILITY	4.1137167089613405
MULTIPLE TYROSINE	4.113626136030781
PARAMETRIC METHOD	4.113572527512934
MUTANT BLM ALLELE	4.113460148478186
BLM MUTANT ALLELE	4.113460148478186
NEOMYCIN RESISTANCE	4.113424440512541
PROBABILITY LEVEL	4.113220732273725
PCDNA3 BAMH1 SITE	4.113220732273725
JOINT PROBABILITY	4.113220732273725
exposed cytoplasmic	4.113056420619556
COMMON OCCURRANCE	4.112980481866461
COMMON COMPARISON	4.112980481866461
TUMOR ASSOCIATION	4.112858590115716
SODIUM CACODYLATE	4.112858590115716
BINDING ABILITY ZINC	4.112680990180848
BUDDING TRANSPORT	4.112611186067175
MACROPHAGE ABSENCE	4.112444453071936
EFFECTOR RESPONSE	4.1122941446861905
TRANSFECTED V-CRK	4.112230755721178
PROBE INFORMATION	4.11221235367858
MODEL INFORMATION	4.11221235367858
INFORMATION SCORE	4.11221235367858
INFORMATION OTHER	4.11221235367858
PLASMID SELECTION	4.11201440738252
PLASMID PROSA26-1	4.11201440738252
GENERATED PLASMID	4.11201440738252
PLASMID PROSA26-5	4.11201440738252
LYSOSOMAL LUMEN PH	4.1118926541088205
CYTOSOLIC PROTEIN	4.111816122234379
DIGOXYGENIN SENSE	4.111705306627904
PH DOMAIN PORTION	4.111681628102188
FIBROBLAST GROWTH	4.111447410202116
PERFORMANCE RATIO	4.111296852059303
U/ML HEPARITINASE	4.111296852059303
clonal	4.110949339356238
URANYL ACETATE	4.110866570899884
BALANCED P2 SIGNAL	4.110772694785887
ΜG/ML FIBRONECTIN	4.110751166531679
G PROTEIN COMPLEX	4.1104765834425345
MUTUAL REGULATION	4.110440415060625
BUFFER PH MM HEPE	4.110264174436011
PRESENTED CONSIDERATION	4.110106007367711
TIME COURSE DESIGN	4.109700371741849
Z1 COULTER COUNTER	4.109700371741849
TET CONCENTRATION	4.109046890452607
TAG CONCENTRATION	4.109046890452607
AMERSHAM HYBOND N	4.108982276170568
MOTOR NEURON BIRTH	4.108825104421045
RAB24 MYC EPITOPE	4.108800740806746
SUPERNATANT SOLUTION	4.108145693696822
CREST	4.108141114549341
G418-SENSITIVE ES	4.108036381380125
VERTEBRATE SPECIES	4.107988969954866
OTHER HIV PROTEIN	4.107918072611927
REPORTER PLASMID	4.1075077209465025
matrix accumulation	4.107352112278285
CDNA SYNTHESIS	4.107157586010189
DECREASED SURVIVAL	4.106745207232524
BACTERIAL SURVIVAL	4.106745207232524
TRANSFECTED CLONE	4.106604361663637
TRANSFER REACTION	4.106601427114932
N-TERMINAL GLYCINE	4.106526129564671
POSSIBLE PRESENCE	4.106380269289113
MAMMALIAN SPECIES	4.106356982606613
CDNA TRANSFECTION	4.1056980354057435
DIAGNOSIS NETWORK	4.105170033530298
POSITIVE FRACTION	4.104691842815839
REMOVED CYTOPLASM	4.104529320481514
UNC-40 GUIDE CELL	4.104529320481514
B DNA SYNTHESIZER	4.1044984668239515
ENDOTHELIAL INJURY	4.104212209081674
RNA MOTIF PROJECT	4.103958201455237
molecular signals	4.103862978910777
CULTURED MONOCYTE	4.103862978910777
SERUM STIMULATION	4.1036371690429565
BMP7 TREATMENT HR	4.102607110655286
EXOGENOUS HEPARIN	4.102447003072962
EXOGENOUS PEPTIDE	4.102392120288551
SEDIMENT MYOSIN II	4.102297733735102
BDM TREATMENT MIN	4.101061839044404
HTK-TAG ASTROCYTE	4.100907898901425
CO-TRANSFECTED WG	4.100907898901425
IGF-II P3 PROMOTER	4.100802403878608
SV GENOMIC LIBRARY	4.100782107419065
INITIATE APOPTOSI	4.100254120138294
BEHAVIORAL PROCESS	4.100096087086544
WILDTYPE CONDITION	4.100096087086544
BIOSCALE Q COLUMN	4.1000870433432715
NUCLEASE RECJ ACT	4.1000870433432715
MURINE MACROPHAGE	4.100035979547792
DISEASE SAMPLES RUN	4.099746367823257
RELEASE COMPONENT	4.099508060685707
genomic variation	4.098784996595856
PRESENTED EVIDENCE	4.098631026715395
NUTRIENT DEPRIVATION	4.098627023867567
correlations	4.098530677035144
COMPOUND TREATMENT	4.098442288070642
LIPID MEMBRANE	4.098345037912272
TRYPSIN TREATMENT	4.098234641671615
WHOLE-CELL LYSATE	4.098022078579792
T7 TAG AB AGAROSE	4.09759290530119
CORONARY ARTERY BYPASS GRAFT	4.0975105338496105
SUBTILISIN MM PMSF	4.0973520057564565
IONOPHORE IONOMYCIN	4.09704577740082
DISTAL C-TERMINUS	4.096930214094464
EXHIBIT SUBSTRATE	4.096604384324698
FIBULIN-1 EXHIBIT	4.096604384324698
SINGLE OUTLIER	4.096449032917302
PHARMACIA HI-TRAP	4.095367123883889
MEC-3 HETERODIMER	4.095367123883889
STARTING POINT	4.0951892388494935
PRELIMINARY RESEARCH	4.095142242138717
P21 TRANSCRIPTION	4.094718864330373
OTHER TCF ABILITY	4.0945947734269
MAXIMUM LENGTH	4.094478093901391
TOTAL CI FRACTION	4.094289182189175
ITERATIVE FASHION	4.093131372561024
AUTOMATED FASHION	4.093131372561024
CLEAVAGE DIVISION	4.093131372561024
JUSTIFIED FASHION	4.093131372561024
COMMON OBSERVATION	4.092769370055366
GROWTH REGULATION	4.092666659774251
ACTIVITY SPECTRUM	4.091922858332449
NETWORK EVOLUTION	4.091922858332449
EMISSION SPECTRUM	4.091922858332449
COMPLEX FORMATION	4.091818545419654
OPPOSITE	4.091780867314679
SINGLE CELL ZYGOTE	4.091487289349094
REPORT LYMPHOCYTE	4.091467041551448
ΓL109	4.091142538592378
ASCVD	4.091142538592378
actions	4.090650619680476
resulting plasmid	4.090647204424508
NEURAL TUBE LUMEN	4.090647204424508
GLYCOGEN SYNTHASE	4.090647204424508
MYOSIN-II MONOMER	4.090647204424508
RETROVIRAL SYSTEM	4.090647204424508
FIBRILLIN MONOMER	4.090647204424508
E17 SMG HOMOGENATE	4.090491802431239
COLUMNAR EPITHELIA	4.090491802431238
ELEVATED INCIDENCE	4.090491802431238
STABLE EQUILIBRIUM	4.090491802431238
INCLUDING FAILURE	4.089756653583115
INFECTED SF9 CELL	4.0896429662416605
PROTEIN INDUCTION	4.089435957016642
INTERFERENCE CONTRAST	4.089430242883777
UNDERLYING FIGURE	4.089298656007542
ADDITIONAL FIGURE	4.089298656007542
HOMOLOGY MODELLING	4.088679673250992
AGONIST TREATMENT	4.088431732025207
AXIS FORMATION	4.088339513889459
BONE FORMATION	4.088339513889459
RELEASE CYTOSOLIC	4.088069160134214
FIND OVERREPRESENTED	4.087816280549658
MNOCMRNA ABUNDANCE	4.0877477211011515
RUNNING WINDOW	4.087612295351461
FUNCTIONAL CLASS III NEW YORK HEART CLASSIFICATION	4.087352620956746
MM STOCK SOLUTION	4.0872521746379356
GLYCOSYLATION	4.087044315753658
ACIDIFIED ETHANOL	4.086871268857003
protein homologous	4.086797846794583
DOMAIN HOMOLOGOUS	4.086666549458764
WU-BLAST PACKAGE	4.08652510223667
ASPIRATED OOCYTE	4.08652510223667
LYSOSOMAL MARKER	4.08652510223667
ECTOPIC INVASION	4.08652510223667
DECREASING NOISE	4.08652510223667
PARALLEL PATHWAY	4.08652510223667
NEIGHBORING BAND	4.08652510223667
PERCENTAGE LIMIT	4.08652510223667
DESCRIPTIVE TERM	4.08652510223667
TRANSIENT NATURE	4.08652510223667
MICROBIAL SYSTEM	4.08652510223667
NON-MODIFIED RAB	4.08652510223667
HOMOSCEDASTICITY	4.08652510223667
VIRAL POPULATION	4.08652510223667
PGEX-5X-1 SYSTEM	4.08652510223667
linkage analysis	4.08652510223667
SORTING FUNCTION	4.08652510223667
INDEPENDENT LINE	4.08652510223667
IGG AUTOANTIBODY	4.08652510223667
WHERETHE DATASET	4.08652510223667
IMMUNODEFICIENCY	4.08652510223667
spectral overlap	4.08652510223667
NORMALIZED VALUE	4.08652510223667
AGONIST-BOUND GR	4.08652510223667
N-ACETYLCYSTEINE	4.08652510223667
CONSCIOUS EFFORT	4.08652510223667
PROPOSED MHB-EGF	4.08652510223667
EMPIRICAL RESULT	4.08652510223667
ACTIVATED RAW265	4.08652510223667
TESTICULAR PH-20	4.08652510223667
CULINARIS LECTIN	4.08652510223667
DHT-TREATED CELL	4.08652510223667
OBSERVED SYNERGY	4.08652510223667
MG/LITER GLUCOSE	4.08652510223667
TRIMMED DATA SET	4.08652510223667
GRAPHICAL FORMAT	4.08652510223667
GTPAS RHO FAMILY	4.08652510223667
HUMAN U95 SERIES	4.08652510223667
FOLD-CHANGE UNIT	4.08652510223667
ALIGNMENT COLUMN	4.08652510223667
CELL LINE SAOS-2	4.08652510223667
TOPIIIΑ FUNCTION	4.08652510223667
FORT TICONDEROGA	4.08652510223667
ARABIDOPSIS ROOT	4.08652510223667
SYMBOLS INCREASE	4.08652510223667
IDENTICAL RESULT	4.08652510223667
REGION-DEPENDENT	4.08652510223667
CRITICAL FEATURE	4.08652510223667
ORDER INHIBITION	4.08652510223667
TRANSPORTABILITY	4.08652510223667
PROGNOSTIC INDEX	4.08652510223667
CAUSE RETRACTION	4.08652510223667
ACIDIC SUBSTRATE	4.08652510223667
PROPOSED PATHWAY	4.08652510223667
level/pixel area	4.08652510223667
CLINICAL SETTING	4.08652510223667
KIDNEY MESANGIAL	4.08652510223667
CURATED DATABASE	4.08652510223667
SPECIATION EVENT	4.08652510223667
CO-SEDIMENTATION	4.08652510223667
PANCREATIC ISLET	4.08652510223667
MATRIX SYNTHESIS	4.08652510223667
ORIGINAL PURPOSE	4.08652510223667
HU-POSITIVE CELL	4.08652510223667
DIBAEIS BAEOMYCE	4.08652510223667
MINIMUM SEQUENCE	4.08652510223667
EXTENSIVE SEARCH	4.08652510223667
TPR DOMAIN CAUSE	4.08652510223667
BACT517 POSITION	4.08652510223667
SPARC-NULL WOUND	4.08652510223667
GENE REPLACEMENT	4.08652510223667
WHITE BLASTODISC	4.08652510223667
NON-TREATED CELL	4.08652510223667
STIPULATION LEAD	4.08652510223667
ASSEMBLY DYNAMIC	4.08652510223667
TERTIARY COMPLEX	4.08652510223667
MAPK/ERK CASCADE	4.08652510223667
CHROMOSOMAL SITE	4.08652510223667
USING ZYMOGRAPHY	4.08652510223667
SEGMENT POLARITY	4.08652510223667
COUPLING DISPLAY	4.08652510223667
MG/L L-HISTIDINE	4.08652510223667
POSTMITOTIC CELL	4.08652510223667
PROPRIETARY MAS4	4.08652510223667
FEMALE PRONUCLEI	4.08652510223667
ATTACHED PORTION	4.08652510223667
EPITOPE SEQUENCE	4.08652510223667
INTERPHASE LEVEL	4.08652510223667
RECTANGULAR SLAB	4.08652510223667
GENE STAGING SET	4.08652510223667
CONTAINING X-GAL	4.08652510223667
PRESSING URGENCY	4.08652510223667
CANCER CELL LINE	4.08652510223667
EXAMPLE FUNCTION	4.08652510223667
BLUE FLUOROPHORE	4.08652510223667
SOFTWARE PACKAGE	4.08652510223667
NEO-TPA CASSETTE	4.08652510223667
DUPLICATED ENTRY	4.08652510223667
INFORMATIVE GENE	4.08652510223667
GRAPHICAL METHOD	4.08652510223667
CALCIUM IONPHORE	4.08652510223667
LENGTH INSERTION	4.08652510223667
AQUEOUS MOVEMENT	4.08652510223667
THROMBIN WTPAI-1	4.08652510223667
ANTI-TAG ISOTYPE	4.08652510223667
nickel chelation	4.08652510223667
WORST-CASE ARRAY	4.08652510223667
ANTI-HUMAN PAI-1	4.08652510223667
MHCK-C COLOCALIZ	4.08652510223667
OXIDATIVE STRESS	4.08652510223667
ROD-LIKE ELEMENT	4.08652510223667
LONGER-TERM RATE	4.08652510223667
ORIGINAL LIBRARY	4.08652510223667
NUMBERING SYSTEM	4.08652510223667
PROHIBITIVE COST	4.08652510223667
G/KG BODY WEIGHT	4.08652510223667
SEALING PODOSOME	4.08652510223667
GENETIC APPROACH	4.08652510223667
FREQUENCY WEIGHT	4.08652510223667
GFP-C/EBPΑ BOUND	4.08652510223667
CLASSIFICATIONOF	4.08652510223667
REPEATED SETBACK	4.08652510223667
MUTATIONAL SPACE	4.08652510223667
LAMINAR ARTERIAL	4.08652510223667
SEQUENCE QUALITY	4.08652510223667
NESTED BASE PAIR	4.08652510223667
UNDERLINED VALUE	4.08652510223667
PROGRAM MODELLER	4.08652510223667
STRUCTURED NCRNA	4.08652510223667
PROTEASES DOMAIN	4.08652510223667
GENETIC SEQUENCE	4.08652510223667
ENDOGENOUS NOTCH	4.08652510223667
BASE PAIR CUTTER	4.08652510223667
NONPSEUDOKNOTTED	4.08652510223667
CALLED PSALEOTPA	4.08652510223667
INHIBITING LEVEL	4.08652510223667
FORM BLUE COLONY	4.08652510223667
DESULFUROCOCCALE	4.08652510223667
ARANGE NN METHOD	4.08652510223667
DESIGNATED PROBE	4.08652510223667
DETAILED ACCOUNT	4.08652510223667
PHARYNX SIDEWALL	4.08652510223667
VENTRAL FIN FOLD	4.08652510223667
'-DIDEOXYINOSINE	4.08652510223667
INDEPENDENT TYPE	4.08652510223667
HERITABILITYVARY	4.08652510223667
COVARIANCE MODEL	4.08652510223667
REDUCED FUNCTION	4.08652510223667
CARDIOLIPIN-RICH	4.08652510223667
clonal selection	4.08652510223667
CARBOXY TERMINAL	4.08652510223667
MESODERM-DERIVED	4.08652510223667
VARIABLE SCANNER	4.08652510223667
ACTIN-CONTAINING	4.08652510223667
FOUNDER SEQUENCE	4.08652510223667
MECHANICAL MODEL	4.08652510223667
CO-PRECIPITATION	4.08652510223667
ANCESTRAL MEMBER	4.08652510223667
OTHER GΑ-PROTEIN	4.08652510223667
DIMENSIONAL DATA	4.08652510223667
CONTAINING HSP70	4.08652510223667
EXPRESSED HYAL-1	4.08652510223667
PROMISING TARGET	4.08652510223667
SIMPLIFIED MODEL	4.08652510223667
INCLUDING SAMPLE	4.08652510223667
NON-SPECIFICALLY	4.08652510223667
ELUDICATING ROLE	4.08652510223667
Γ-PROTEOBACTERIA	4.08652510223667
THETWO NN METHOD	4.08652510223667
VASCULAR CHANNEL	4.08652510223667
TRANSDUCING STEP	4.08652510223667
EXPRESSING WTP53	4.08652510223667
TRAFFICKING STEP	4.08652510223667
SYNTHETIC WEIGHT	4.08652510223667
INCLUDING MOLEGO	4.08652510223667
HSN3 PROSEQUENCE	4.08652510223667
PERMITS RECOVERY	4.08652510223667
STOCHASTIC MODEL	4.08652510223667
MUTATION PATTERN	4.08652510223667
BLM N2-N4 REGION	4.08652510223667
GFP-N346 NLSMUT4	4.08652510223667
DIGESTED EE-Α I2	4.08652510223667
LIPID-STIMULATED	4.08652510223667
base composition	4.08652510223667
PS-BASED VESICLE	4.08652510223667
EXOCYTIC PATHWAY	4.08652510223667
CLOCK() FUNCTION	4.08652510223667
MILLION-YEAR AGE	4.08652510223667
SHAM-TRANSFECTED	4.08652510223667
NETWORK PROPERTY	4.08652510223667
BACTERIAL EXOIII	4.08652510223667
CIRCULAR PATTERN	4.08652510223667
REDUCED DIAMETER	4.08652510223667
SEARCH CRITERION	4.08652510223667
T-TEST DETECTION	4.08652510223667
SKP2-INDEPENDENT	4.08652510223667
BASE-2 LOGARITHM	4.08652510223667
SPINAL CORD GLIA	4.08652510223667
TEMPORAL PATTERN	4.08652510223667
CORONAL CRYOSTAT	4.08652510223667
WASP/WAVE FAMILY	4.08652510223667
FIELD SORT ORDER	4.08652510223667
AUTOFLUORESCENCE	4.08652510223667
FILE SUPPLEMENT1	4.08652510223667
HNF3ΑLACZ EMBRYO	4.08652510223667
RESULTING PELLET	4.08652510223667
FUNCTIONAL STATE	4.08652510223667
MACROPINOCYTOTIC	4.08652510223667
CLASS ASSIGNMENT	4.08652510223667
SCANNING VERSION	4.08652510223667
CORRESPONDING CI	4.08652510223667
FEED-FORWARDBPNN	4.08652510223667
EQUAL PROPORTION	4.08652510223667
GRENANDER METHOD	4.08652510223667
SIGNALING RESULT	4.08652510223667
DISSECTING SCOPE	4.08652510223667
ENDOGENOUS LEVEL	4.08652510223667
AGING EPITHELIAL	4.08652510223667
RING FINGER PLAY	4.08652510223667
POSITION DISPLAY	4.08652510223667
ATTENUATION RGS3	4.08652510223667
CELLULAR NETWORK	4.08652510223667
BEARING MUTATION	4.08652510223667
CLONAL SELECTION	4.08652510223667
FACTORIAL DESIGN	4.08652510223667
CD4-BINDING SITE	4.08652510223667
CONFOCAL SECTION	4.08652510223667
REGULATORY DEPOT	4.08652510223667
PERVASIVE ENTITY	4.08652510223667
CHELATING COLUMN	4.08652510223667
STRESS CONDITION	4.08652510223667
SELECTIVE MEDIUM	4.08652510223667
G418-SENSITIVITY	4.08652510223667
INCLUDED LACTATE	4.08652510223667
ERROR ESTIMATION	4.08652510223667
KR WEIGHT MATRIX	4.08652510223667
DESIRED MUTATION	4.08652510223667
DEMARCATION LINE	4.08652510223667
CELLULAR PATHWAY	4.08652510223667
PROTEOMIC METHOD	4.08652510223667
MARKOV MODEL FIT	4.08652510223667
CULTURED EXPLANT	4.08652510223667
ORIGINAL DATASET	4.08652510223667
SILICON GENETICS	4.08652510223667
THROUGHEVOLUTION	4.08652510223667
LISTERIA EXPLOIT	4.08652510223667
TRANSFERRED LRP6	4.08652510223667
RADIOIMMUNOASSAY	4.08652510223667
NON-CONSERVATIVE	4.08652510223667
GENERIC PROTOCOL	4.08652510223667
TRAINING/TESTING	4.08652510223667
INSENSITIVE FORM	4.08652510223667
GΑ REASSOCIATION	4.08652510223667
BRANCHED NETWORK	4.08652510223667
ELEGANS PROTEOME	4.08652510223667
GENOTOXIC STRESS	4.08652510223667
NATIONAL HORMONE	4.08652510223667
EQUIVALENT POWER	4.08652510223667
DIVERSE MUTATION	4.08652510223667
QUALITY SEQUENCE	4.08652510223667
ETCHED COVERSLIP	4.08652510223667
TAXONOMY BROWSER	4.08652510223667
MHC PRESENTATION	4.08652510223667
CUCURBITA MAXIMA	4.08652510223667
CARBOXYLTERMINAL	4.08652510223667
mitogenic factor	4.08652510223667
COLD SENSITIVITY	4.08652510223667
PHOSPHOSUBSTRATE	4.08652510223667
AUTORADIOGRAPHIC	4.08652510223667
OBSERVED PATTERN	4.08652510223667
FINGERS FUNCTION	4.08652510223667
distance measure	4.08652510223667
micrographs show	4.08652510223667
IU/ML PORCINE LH	4.08652510223667
CYTOKINETIC CELL	4.08652510223667
PURIFIED GFP-BLM	4.08652510223667
EXPRESSED GR-GFP	4.08652510223667
LUCIFERASE PLATE	4.08652510223667
PRACTICAL METHOD	4.08652510223667
PEG202 NOT1 SITE	4.08652510223667
ABI PRISM BIGDYE	4.08652510223667
CLINICAL UTILITY	4.08652510223667
MODEL REFINEMENT	4.08652510223667
DISTANCE MEASURE	4.08652510223667
WNT DEREGULATION	4.08652510223667
TESTED CELL LINE	4.08652510223667
POOLING STRATEGY	4.08652510223667
NETSEARCH OUTPUT	4.08652510223667
LOWERCASE LETTER	4.08652510223667
TORTUOUS PROCESS	4.08652510223667
DEFINING FEATURE	4.08652510223667
BLM TOPIIIΑ BIND	4.08652510223667
AD-HOC PARAMETER	4.08652510223667
INTERNAL SEGMENT	4.08652510223667
MEDIATED PROCESS	4.08652510223667
LABIAL VIBRISSAE	4.08652510223667
PROTECTING TGF-Β	4.08652510223667
MICROPIPETTE TIP	4.08652510223667
CYLINDRICAL FORM	4.08652510223667
BIOLOGICAL EVENT	4.08652510223667
RESVERATROL SIZE	4.08652510223667
WHEEL CONTROLLER	4.08652510223667
HITRAP SP COLUMN	4.08652510223667
DORSAL MIGRATION	4.08652510223667
LUMEN-CONTAINING	4.08652510223667
CONTAINING PGBT9	4.08652510223667
TREE FORM TOLOOK	4.08652510223667
LMB-TREATED N200	4.08652510223667
VENTRICULAR ZONE	4.08652510223667
receptor neurons	4.08652510223667
EPITHELIAL LAYER	4.08652510223667
SOFTWARE PROGRAM	4.08652510223667
CONTAINING RAB24	4.08652510223667
HALLMARK FEATURE	4.08652510223667
CIRCADIAN RHYTHM	4.08652510223667
SIMILAR MUTATION	4.08652510223667
IMPEDED INGROWTH	4.08652510223667
TERMED PSEUDOPOD	4.08652510223667
INFLUENTIAL GENE	4.08652510223667
PECTORAL FIN BUD	4.08652510223667
APPENDING C/EBPΑ	4.08652510223667
RESULTING OUTPUT	4.08652510223667
GTPASES FUNCTION	4.08652510223667
CYCLICAL PROCESS	4.08652510223667
HUMAN ECTOCERVIX	4.08652510223667
INCREASED AMOUNT	4.08652510223667
TIME LAPSE MOVIE	4.08652510223667
INDIVIDUAL SCORE	4.08652510223667
PHARYNGEAL POUCH	4.08652510223667
DUPLICATED PROBE	4.08652510223667
SHOW CONCORDANCE	4.08652510223667
OSMOTIC PRESSURE	4.08652510223667
REPRESENTED GENE	4.08652510223667
SEQUENTIAL ORDER	4.08652510223667
HAVING SWISSPROT	4.08652510223667
PFA/TRITON X-100	4.08652510223667
ZYGOTIC GAP GENE	4.08652510223667
YEAST TWO-HYBRID	4.08652510223667
TRANSFORMED GENE	4.08652510223667
N-UNIT HYPERCUBE	4.08652510223667
VARIABLEENCODING	4.08652510223667
ATCISDB DATABASE	4.08652510223667
OSTEOCLAST DEATH	4.08652510223667
POTENTIAL SOURCE	4.08652510223667
TRANSLATED ELK-1	4.08652510223667
ESTIMATED LENGTH	4.08652510223667
ANALYTICAL MODEL	4.08652510223667
TISSUE VARIATION	4.08652510223667
PREFERRED PBS(+)	4.08652510223667
BIOLOGICAL MODEL	4.08652510223667
METHYLENE BRIDGE	4.08652510223667
REDUCED GENE SET	4.08652510223667
EMBRYONIC LETHAL	4.08652510223667
EQUIMOLAR AMOUNT	4.08652510223667
INTRON/RRNA GENE	4.08652510223667
CELL DESTRUCTION	4.08652510223667
HUMAN FIBULIN-1C	4.08652510223667
HALF-SAMPLE MODE	4.08652510223667
OUTPUT TEXT FILE	4.08652510223667
DEVELOPED METHOD	4.08652510223667
TUBULIN FILAMENT	4.08652510223667
ALTERNATING CELL	4.08652510223667
NATIONAL LIBRARY	4.08652510223667
POLAR PROTRUSION	4.08652510223667
RATIOMETRIC DATA	4.08652510223667
NUMBERING METHOD	4.08652510223667
SIGNALING FAMILY	4.08652510223667
RHINAL VIBRISSAE	4.08652510223667
CRITICAL PROCESS	4.08652510223667
DIFFERING RESULT	4.08652510223667
protein antizyme	4.08652510223667
CODING STRUCTURE	4.08652510223667
CAUSE ALTERATION	4.08652510223667
SUPEROXIDE ANION	4.08652510223667
PROTEINS BEARING	4.08652510223667
GENERATED FUSION	4.08652510223667
WOUND SITE PRIOR	4.08652510223667
ANTI-HU LABELING	4.08652510223667
GENERATED BYGPNN	4.08652510223667
DORSAL LIP RAISE	4.08652510223667
PULLING FILAMENT	4.08652510223667
PERCENTAGE VALUE	4.08652510223667
PROCESS SEQUENCE	4.08652510223667
MUSTELA PUTORIUS	4.08652510223667
BACKGROUND WOUND	4.08652510223667
CONTAINING PROBE	4.08652510223667
BENCHMARK METHOD	4.08652510223667
CANCER DETECTION	4.08652510223667
non-conservative	4.08652510223667
DMEM/F-12 MEDIUM	4.08652510223667
SENSITIZING CELL	4.08652510223667
SPREADSHEET FORM	4.08652510223667
NUCLEOLAR REGION	4.08652510223667
RED/GREEN MATRIX	4.08652510223667
SIMILARITY RANGE	4.08652510223667
CREST DERIVATION	4.08652510223667
BINDING CAPACITY	4.08652510223667
DIAGNOSTIC VALUE	4.08652510223667
OTHER INTERACTOR	4.08652510223667
ENDOGENOUS HNF3Α	4.08652510223667
CYTOKINESIS CELL	4.08652510223667
ungapped segment	4.08652510223667
SCE FREQUENCY BS	4.08652510223667
OPTIMAL RELATION	4.08652510223667
ENDOGENOUS SMAD1	4.08652510223667
CAUSING MUTATION	4.08652510223667
MOLECULAR DEVICE	4.08652510223667
ANECDOTAL RESULT	4.08652510223667
base pair symbol	4.08652510223667
KIDNEY CELL LINE	4.08652510223667
MICROPHOTOGRAPHY	4.08652510223667
MYELOID LEUKEMIA	4.08652510223667
POSTERIOR ASPECT	4.08652510223667
IMPROVED PROGRAM	4.08652510223667
PARAMETERIZATION	4.08652510223667
DESIGNATED SAR11	4.08652510223667
CARDIOPROTECTION	4.08652510223667
MOLECULAR DETAIL	4.08652510223667
import machinery	4.08652510223667
X-100 EXTRACTION	4.08652510223667
DIVERSE STIMULUS	4.08652510223667
RATIO GENERATION	4.08652510223667
DIG1Δ DIG2Δ CELL	4.08652510223667
GRADUAL INCREASE	4.08652510223667
CELLULAR TROPISM	4.08652510223667
TARGETING MMCOP1	4.08652510223667
GENERATION ARRAY	4.08652510223667
CROSS-GENE MODEL	4.08652510223667
CONSIDERING GPNN	4.08652510223667
BURGEONING FIELD	4.08652510223667
SPINAL CORD CELL	4.08652510223667
PERCENT IDENTITY	4.08652510223667
ADP/ATP EXCHANGE	4.08652510223667
CONTAMINANT DATA	4.08652510223667
PERIPHERAL NERVE	4.08652510223667
CELLULAR SURFACE	4.08652510223667
GENETIC DISORDER	4.08652510223667
PREVAILING MODEL	4.08652510223667
SECTORING COLONY	4.08652510223667
ABLATED POSITION	4.08652510223667
EXAMPLE DATA SET	4.08652510223667
STANDARD DYNAMIC	4.08652510223667
ASSEMBLY PATHWAY	4.08652510223667
CONTACT ASSEMBLY	4.08652510223667
UPREGULATE DELTA	4.08652510223667
INDIVIDUAL VALUE	4.08652510223667
SIMPLIFIED INPUT	4.08652510223667
LENGTH VARIATION	4.08652510223667
ENVIRONMENTAL LP	4.08652510223667
NEURAL KEEL PUSH	4.08652510223667
PROTEOMICS OFFER	4.08652510223667
EQUATOR DIAMETER	4.08652510223667
CLINICAL OUTCOME	4.08652510223667
MAPK/ERK PATHWAY	4.08652510223667
GENE DUPLICATION	4.08652510223667
INCLUDING KIDNEY	4.08652510223667
DIVERSE DATA SET	4.08652510223667
BIOCHEMICAL DATA	4.08652510223667
REDUCED CAPACITY	4.08652510223667
CUTOFF CRITERION	4.08652510223667
BRDU BRIEF PULSE	4.08652510223667
COOPERATIVE ROLE	4.08652510223667
DOWNREGULATE P27	4.08652510223667
RETAINED HORMONE	4.08652510223667
ENDOSTEAL MARGIN	4.08652510223667
MIB-EXPOSED CELL	4.08652510223667
NEGATIVE VERSION	4.08652510223667
LABELING QUALITY	4.08652510223667
BARRIER PROPERTY	4.08652510223667
CODING SELECTION	4.08652510223667
PRE-GENOMICS ERA	4.08652510223667
JUDICIOUS CHOICE	4.08652510223667
POPULATION MEANS	4.08652510223667
BASE PAIR REGION	4.08652510223667
RHODAMINE FILTER	4.08652510223667
HOMOZYGOUS MOUSE	4.08652510223667
EMPIRICAL CUTOFF	4.08652510223667
GALACTO-STAR KIT	4.08652510223667
BONDING DISTANCE	4.08652510223667
ELECTRONIC IMAGE	4.08652510223667
SOFTWARE LIBRARY	4.08652510223667
VARYING STRENGTH	4.08652510223667
AUTOMATIC METHOD	4.08652510223667
CELLULAR SYSTEMS	4.08652510223667
DRIVE BLASTODERM	4.08652510223667
AVERAGE DIAMETER	4.08652510223667
STRAINS FUNCTION	4.08652510223667
ANCHORED ADAPTOR	4.08652510223667
INCLUDING MODULE	4.08652510223667
MUSCLE MYOSIN-II	4.08652510223667
DIAMINOBENZIDINE	4.08652510223667
REGULATORY LOCUS	4.08652510223667
TIME-LAPSE MOVIE	4.08652510223667
DRIVING FILAMENT	4.08652510223667
BRIEF DISCUSSION	4.08652510223667
TANGLED TELOMERE	4.08652510223667
DIFFERENT C/EBPΑ	4.08652510223667
SERUM-STARVATION	4.08652510223667
non-specifically	4.08652510223667
TUNEL-POSITIVITY	4.08652510223667
PREFERRED CHOICE	4.08652510223667
DATA ACQUISITION	4.08652510223667
ADDING SUBSTRATE	4.08652510223667
MUTATIONAL EVENT	4.08652510223667
PORCINE MYOSINVI	4.08652510223667
OTHER IG-RELATED	4.08652510223667
BREAST CARCINOMA	4.08652510223667
CHALLENGING AREA	4.08652510223667
ASCORBIC ACID/ML	4.08652510223667
DORSAL CUTANEOUS	4.08652510223667
OVERLAPPING QRNA	4.08652510223667
REMAINING CANCER	4.08652510223667
H. BRDU-POSITIVE	4.08652510223667
RECENT DISCOVERY	4.08652510223667
MOLECULAR METHOD	4.08652510223667
TYPICALSTRUCTURE	4.08652510223667
MINIMUM VARIANCE	4.08652510223667
MAKE ENDOTHELIAL	4.08652510223667
LENGTHS INCREASE	4.08652510223667
CELL MANIPULATOR	4.08652510223667
LENGTH HUMAN BID	4.08652510223667
EXCISED SPECIMEN	4.08652510223667
STIMULATING CELL	4.08652510223667
AXONAL OUTGROWTH	4.08652510223667
FAMILY MEMBER ET	4.08652510223667
CORRELATION PLOT	4.08652510223667
MICROSCOPY SLIDE	4.08652510223667
EMPLOYED NETWORK	4.08652510223667
GARPIKE CLEAVAGE	4.08652510223667
KINASES FUNCTION	4.08652510223667
ACIDIC ACTIVATOR	4.08652510223667
CODON-BIAS MODEL	4.08652510223667
SIGNALING CENTER	4.08652510223667
NEURAL CELL TYPE	4.08652510223667
FIBRILLAR MATRIX	4.08652510223667
VASCULAR NETWORK	4.08652510223667
PPC GENE PRODUCT	4.08652510223667
MICROENVIRONMENT	4.08652510223667
DISPLAY PUNCTATE	4.08652510223667
FEMALE-TO-FEMALE	4.08652510223667
DLA DX2 MUTATION	4.08652510223667
SEQUENCE FEATURE	4.08652510223667
POPULATION TRIAL	4.08652510223667
EXCESSIVE AMOUNT	4.08652510223667
BACTERIAL MEMBER	4.08652510223667
IU/ML PENICILLIN	4.08652510223667
JAVA ACCELERATOR	4.08652510223667
REPEATED ATTEMPT	4.08652510223667
DIFFERING EXTENT	4.08652510223667
MASSON TRICHROME	4.08652510223667
SYNERGY SOFTWARE	4.08652510223667
SPATIAL PROPERTY	4.08652510223667
RING/FURROW ZONE	4.08652510223667
pathophysiologic	4.08652510223667
MM TRIETHYLAMINE	4.08652510223667
ASSEMBLY COMPLEX	4.08652510223667
TRIMERIC COMPLEX	4.08652510223667
C/EBPΑ NOTI SITE	4.08652510223667
ZEBRAFISH DELTAA	4.08652510223667
SEQUENCES RESULT	4.08652510223667
CELLULAR CONTENT	4.08652510223667
TRIMMING SECTION	4.08652510223667
PIP BOI1-PH BIND	4.08652510223667
CONSERVED DOMAIN	4.08652510223667
MDM2 RING FINGER	4.08652510223667
HUMAN OSTEOCLAST	4.08652510223667
ligand-dependent	4.08652510223667
SELECTED PORTION	4.08652510223667
anti-β1 integrin	4.08652510223667
BINDING CASSETTE	4.08652510223667
GENE FAMILY PAGE	4.08652510223667
RNASE-FREE DNASE	4.08652510223667
AVIAN OSTEOCLAST	4.08652510223667
SYSTEMATIC MEANS	4.08652510223667
SEQUENTIAL IMAGE	4.08652510223667
CDC42-GST FUSION	4.08652510223667
MICROMANIPULATOR	4.08652510223667
selection aswell	4.08652510223667
CO-TRANSLOCATION	4.08652510223667
PROTEOLYTIC SITE	4.08652510223667
INCLUDINGBOOLEAN	4.08652510223667
name information	4.08652510223667
ANIMAL XENOGRAFT	4.08652510223667
DEHYDRATED WOUND	4.08652510223667
DISC CONTRACTION	4.08652510223667
POSSIBLE OSMOTIC	4.08652510223667
MM POLY-L-LYSINE	4.08652510223667
IN VIVO PROPERTY	4.08652510223667
FEMORAL METAPHYS	4.08652510223667
UNC-129 FUNCTION	4.08652510223667
GBROWSE SOFTWARE	4.08652510223667
LYSOPHOSPHOLIPID	4.08652510223667
DATABASE ATCISDB	4.08652510223667
LYSOSOMAL HYAL-2	4.08652510223667
REGULATORY INPUT	4.08652510223667
IN SILICO RESULT	4.08652510223667
physical properties	4.086436315026957
BASIS FOREVALUATING	4.086436315026957
RELATIVE DEPENDENCE	4.086436315026957
XK IDENTIFICATION	4.086356368552343
EXPRESSION RANGE	4.085849263500617
EXPRESSION ARRAY	4.085849263500617
TGF-Β EXPRESSION	4.085849263500617
DELTA EXPRESSION	4.085849263500617
BRAIN EXPRESSION	4.085849263500617
H-RAS EXPRESSION	4.085849263500617
CASES EXPRESSION	4.085849263500617
INTAG EXPRESSION	4.085849263500617
DRIVE EXPRESSION	4.085849263500617
PAC-1 EXPRESSION	4.085849263500617
SMAD7 EXPRESSION	4.085849263500617
RETROVIRAL VECTOR	4.085847286330221
KKTK SUBSTITUTION	4.085830960078201
NETWORK ANALYSIS	4.085282203577522
BINDING ANALYSIS	4.085282203577522
MAPPING ANALYSIS	4.085282203577522
ANALYSIS PURPOSE	4.085282203577522
ONE-WAY ANALYSIS	4.085282203577522
VERTEBRATE SYSTEM	4.084747305100281
phenol extraction	4.084747305100281
HPA1	4.084493316471294
MICROARRAY PROBE	4.084397589480832
AFFINITY RESIN	4.084294713106403
FEEDBACK CONTROL	4.084149076594823
ANALYZED CONTROL	4.084149076594823
CLEAVAGE CONTROL	4.084149076594823
TEMPORAL CONTROL	4.084149076594823
TWO-HYBRID STUDY	4.083958994543475
SIMULATION STUDY	4.083958994543475
ADDITIONAL STUDY	4.083958994543475
TRUNCATION STUDY	4.083958994543475
STUDY DIFFERENCE	4.083958994543475
ENUMERATED STUDY	4.083958994543475
SEARCH ALGORITHM	4.083799661059257
ALGORITHM RECORD	4.083799661059257
MYOSIN HALF-LIFE	4.083754387949997
YEAST ACTIN GENE	4.083444825227295
GROUP IIB INTRON	4.083427664909694
SPLICESOMAL RRNA	4.083354056608196
POTENTIAL KINASE	4.083311287206657
SIGNALING KINASE	4.083311287206657
SOLUTION PROTOCOL	4.083194700014958
STANDARD SOLUTION	4.083194700014958
ALKALINE SOLUTION	4.083194700014958
MOUNTING SOLUTION	4.083194700014958
LIFESTYLE CHANGE	4.083107130924012
PRINCIPAL CHANGE	4.083107130924012
PARAMETER CHANGE	4.083107130924012
INDUCTIVE EFFECT	4.0828990804962855
SMOOTHING EFFECT	4.0828990804962855
MOUSE EMBRYO RNA	4.082727356333717
OPPOSITE QUADRANT	4.082438648842975
CHANGE MYOSIN II	4.082399311837117
GENETIC RESPONSE	4.082291675839267
DIVERSE RESPONSE	4.082291675839267
BLM LOCALIZATION	4.0822482560813445
SOLVATION FACTOR	4.08224093271464
SELECTIVE FACTOR	4.08224093271464
REMAINING FACTOR	4.08224093271464
MUTANT TRANSLOCATE	4.082088053357846
PRE-FORMED ACTIN	4.0819046867226065
ACTIN MONOCLONAL	4.0819046867226065
CATALYTIC INTRON	4.0818789462462055
ITERATED CGR MAP	4.081852917361105
PFLAG-CMV VECTOR	4.081813322574024
MM HYBRIDIZATION	4.081786551098667
CRYPTIC PROMOTER	4.081590279749756
ΜG PROTEIN SAMPLE	4.081568609195204
C-TERMINAL C-BOX	4.0815609058063815
MOSQUITO GENOMIC	4.0815609058063815
GENOMIC APPROACH	4.0815609058063815
CYTOPLASMIC SMAD	4.081439827844667
CYTOPLASMIC LOOP	4.081439827844667
CYTOPLASMIC POOL	4.081439827844667
GR PROTEIN LEVEL	4.081319812591803
OTHER GΑ PROTEIN	4.081319812591803
HUMAN XK PROTEIN	4.081319812591803
ΔN1 PROTEIN SHOW	4.081319812591803
RESPIRATORY BURST	4.081207365505745
PROXIMAL HINDLIMB	4.081207365505745
PROXIMAL FORELIMB	4.081207365505745
CHROMA FILTER SET	4.081207365505745
C/EBPΒ N-TERMINUS	4.081207365505745
SPECIFICITY REACH	4.081207365505745
CHICKEN HOMOLOGUE	4.081207365505745
SUBCELLULAR SITE	4.081144553847713
MITOGENIC SIGNAL	4.0811271410697545
SUSTAINED SIGNAL	4.0811271410697545
SIGNAL DETECTION	4.0811271410697545
INCREASED SIGNAL	4.0811271410697545
HA ESCAPE MUTANT	4.081119643901467
P27 POINT MUTANT	4.081119643901467
MOUSE BRAIN MRNA	4.08110961522181
NEURON CELL FATE	4.0810473682446275
HIGH-QUALITY RNA	4.08082848338224
RESULTING STRAIN	4.080610315000582
BL21(DE3) STRAIN	4.080610315000582
GENERATED STRAIN	4.080610315000582
RELATIVE LEVEL	4.080524533918147
GENOMIC ANALYSIS	4.080318007147233
BLM DNA HELICASE	4.080265235294894
OTHER DNA REPAIR	4.080265235294894
NYLON FILTER DNA	4.080265235294894
LABELING KIT DNA	4.080265235294894
OUTPUT COMPONENT	4.080009594421917
YELLOW GFP EX500	4.079906173662952
SRC KM/CAS(3'SD)	4.079799416750473
DONOR CALF SERUM	4.079799416750473
SRC KM/CAS(5'SD)	4.079799416750473
DSRNAI TREATMENT	4.0797170614179885
GNRH-A TREATMENT	4.0797170614179885
N POSSIBLE VALUE	4.079575227234266
HORMONE RECEPTOR	4.079273058755901
RECEPTOR COMPLEX	4.079273058755901
MAMMALIAN SYSTEM	4.079273058755901
HISTONE H1 KINASE	4.0790247437904235
SIGNED RANK TEST	4.078856274647811
RAPID ACTIVATION	4.078838604538159
SMAD1 ACTIVATION	4.078838604538159
NB-ΚB ACTIVATION	4.078838604538159
3-D DISTRIBUTION	4.078838604538159
ACTIVATION PULSE	4.078838604538159
MEC-3 ACTIVATION	4.078838604538159
alanine substitution	4.078807327784735
AZ CO-EXPRESSION	4.078803018900666
GFP-NFAT PROTEIN	4.07871716776937
DRIFTING PROTEIN	4.07871716776937
MEMBRANE PROTEIN	4.07871716776937
POLY-GLN PROTEIN	4.07871716776937
ALIGNING PROTEIN	4.07871716776937
CHIMERIC PROTEIN	4.07871716776937
STARTING PROTEIN	4.07871716776937
RELATIVE PROTEIN	4.07871716776937
NUMEROUS PROTEIN	4.07871716776937
PROTEIN FUNCTION	4.07871716776937
PROTEIN RECOVERY	4.07871716776937
JUNCTION PROTEIN	4.07871716776937
CORTICAL PROTEIN	4.07871716776937
DEFINING PROTEIN	4.07871716776937
UNTAGGED PROTEIN	4.07871716776937
CENTRIPETAL FLOW	4.078657319215081
IMAGE MOUSE CDNA	4.078620031143888
COLOR CDNA ARRAY	4.078620031143888
ANTIGENIC SITE C	4.078582387948209
CELLULAR BEHAVIOR	4.078572991853997
GLYCOSYLATION SITE	4.078486446612106
PROLINE RESIDUE	4.078474663728325
MUTANT INHIBITOR	4.078416914733865
INDICATED MUTANT	4.078416914733865
MRNA DEGRADATION	4.07840187171438
GFP CONTROL CELL	4.078322156568388
SPECIFIED NEURON	4.078308501248606
NEURON MIGRATION	4.078308501248606
TETRASPANIN PROTEIN	4.0782119640890455
UBIQUITOUS MANNER	4.077875657652063
INHIBITING NF-ΚB	4.07774631275995
BACTERIAL GENOME	4.077525264104061
NONSPECIFIC MANNER	4.077497770250531
MAXIMUM INDUCTION	4.077399699387252
BOUND NUCLEOTIDE	4.077292795960414
VIRAL NUCLEOTIDE	4.077292795960414
E. COLI POSITION	4.0772586022334645
EUKARYOTIC RNASEP	4.077161720254846
THREONINE RESIDUE	4.077161720254846
NON-SPECIFIC DNA	4.077135301824006
DNA DENATURATION	4.077135301824006
LETHAL TRANSGENE	4.077047999960665
ISL1 GENOMIC DNA	4.076955771008035
COMMITTED T CELL	4.076939067750596
ACETATE PROTOCOL	4.076939067750596
SCATTERED T CELL	4.076939067750596
PELVIC INFECTION	4.076939067750596
CONTINUED RESEARCH	4.076771395780802
ANNOTATION TABLE	4.076713513997983
AFFYMETRIX TABLE	4.076713513997983
RT SELECTION MAP	4.076704861803768
LH CONTENT ASSAY	4.076632041735028
SΑ I2 C-TERMINUS	4.076596709376093
FINAL STATE TYPE	4.076596709376093
CONSTITUTIVE GFP	4.076596709376093
RNA LOCALIZATION	4.076551637226915
LIGHT-DARK CYCLE	4.076537257921839
ADDITION SEQUENCE	4.076536105009861
TOTAL RNA MICROGRAM	4.076520446914596
THIAMINE RESPONSIVE         MEGALOBLASTIC ANEMIA	4.076390448332967
MG/ML COLLAGENASE	4.07600771652754
ACID CORE DOMAIN	4.075985007446294
H1 FUSION PROTEIN	4.075904705843946
INVERSE RELATIONSHIP	4.075428970497888
COGNATE PROTEASE	4.0754053022328245
SUFFICIENCY TEST	4.075021860853381
ONE-MAN-OUT TEST	4.075021860853381
METABOLIC COFACTOR	4.075001020729133
AXON GUIDANCE CUE	4.074914139559902
BDU AXON GUIDANCE	4.074914139559902
TERMINAL PEPTIDE	4.074888102232645
ILLUMINATING USE	4.074778834626973
PHYLOBROWSER USE	4.074778834626973
PHARMACIA BIOTECH UK	4.0743028514022726
SINGLE BASE PAIR	4.074247720528954
SINGLE YOLK CELL	4.074247720528954
SINGLE IG DOMAIN	4.074247720528954
CEE AMPLIFICATION	4.074127486316672
POTENTIAL DAMAGE	4.074077564918932
REACTION OUTCOME	4.0739839744127835
COMPLEX REACTION	4.0739839744127835
INDUCED ADHESION	4.0738889658686634
DEVELOPMENT REVIEW	4.0737076156549765
PRIMARY NEONATAL	4.073544790948134
PURIFIED PRIMARY	4.073544790948134
DETERGENT DOTMAC	4.073494086607163
TOUCH OTHER CELL	4.073287245089234
AMMONIUM SULFATE	4.073262193793503
GENE DESCRIPTION	4.073262193793503
WD REPEAT DOMAIN	4.073262193793503
MURINE L929 CELL	4.073127752834446
MURINE DATA SHOW	4.073127752834446
SECTORING ABILITY	4.072968960631187
C-PEPTIDES CLOSE	4.072853216986039
DROSOPHILA ARROW	4.072853216986039
ORIGINAL P-VALUE	4.072853216986039
WILCOXON P-VALUE	4.072853216986039
CLOSE APPOSITION	4.072853216986039
BIPHASIC RESPONSE	4.072849103489928
DM AUTHOR CONTRIBUTION	4.072789325799921
sonication buffer	4.07249366804227
CONSENSUS MITOGEN	4.07249366804227
PRELIMINARY MODEL	4.07249366804227
S POINT MUTATION	4.07238976324873
PROTEIN KINASE N	4.072227394236058
ACR5	4.072183971229764
ETAT	4.072183971229764
COLLAGEN SOLUTION	4.072161122057961
CAUSE DNA DAMAGE	4.071966877083068
COACTIVATOR	4.071792408838456
HISTOCOMPATIBILITY	4.0717814526059115
DEGENERATIVE PCR	4.071764305771388
KINETIC ANALYSIS	4.071739534538372
TWO-HYBRID ASSAY	4.0716855114842065
PHYLOGENY BUTTON	4.071632512945805
SYNONYMOUS CODON	4.071632512945805
PHYLOGENY COLUMN	4.071632512945805
INDIVIDUAL CODON	4.071632512945805
PAC-1 C-TERMINUS	4.071632512945805
NOVEL C-TERMINUS	4.071632512945805
ROLLER PHENOTYPE	4.071453084159168
NEURAL PHENOTYPE	4.071453084159168
REPORTER PROTEIN	4.071336769536729
STANDARD INJECTION	4.071283233120628
PATTERN STATISTICS	4.071283233120628
A-D ANTIGENIC SITE	4.071283233120628
BLM ACCUMULATION	4.071175685053447
MOTIF DEFINITION	4.0710809355646616
FUNCTIONAL MOTIF	4.0710809355646616
EXPRESSION ASSAY	4.071009672748154
STAINING NUCLEUS	4.070985009063593
FUSIFORM NUCLEUS	4.070985009063593
ISOLATION BUFFER	4.070900090521664
HYPOTONIC BUFFER	4.070900090521664
STRIPPING BUFFER	4.070900090521664
H DLA DX2 MUTANT	4.070887883481261
ANTI-FN ANTIBODY	4.07083886398673
ANTI-TN ANTIBODY	4.07083886398673
BINARY LOGARITHM	4.070789536193492
GENERAL ACTIVITY	4.070789536193492
GENERAL PROTOCOL	4.070789536193492
GENERAL VALIDITY	4.070789536193492
GENERAL APPROACH	4.070789536193492
GENERAL INTEREST	4.070789536193492
BINARY OPERATION	4.070789536193492
PROBE PREPARATION	4.070773859332374
BPAEC PREPARATION	4.070773859332374
ACID COUNTERPART	4.070714960051107
ACID REPLACEMENT	4.070714960051107
ACID PHOSPHATASE	4.070714960051107
OTHER PPP ENZYME	4.070574569444267
SINGLE EST CLONE	4.070565667547547
DNA FINAL AMOUNT	4.070336842434317
RULE DEVELOPMENT	4.070331218735923
VEHICLE TREATMENT	4.070226328396163
DC EXHIBIT SUICIDE	4.069906069077447
BACULOVIRUS LYSATE	4.06974725377318
PRIMARY RESPONSE	4.069311364550731
ACTIVATING LIPID	4.069270240161736
ANTIFADE REAGENT	4.06915041473066
REAGENT PROTOCOL	4.06915041473066
GROWTH POTENTIAL	4.069077717293397
ANAEROBIC GROWTH	4.069077717293397
SIMULATED GROWTH	4.069077717293397
INTERACTION SITE	4.069041139966472
SHOW INTERACTION	4.069041139966472
USER INTERACTION	4.069041139966472
INTERACTION LINE	4.069041139966472
CELL INTERACTION	4.069041139966472
CDNA START CODON	4.068691638283312
F-BOX DEPENDENCY	4.0683949935347465
ΜG/ML TORULA RNA	4.068172644286798
SINGLE CONDITION	4.068109029675095
SINGLE SUBSTRATE	4.068109029675095
CONSENSUS SINGLE	4.068109029675095
SINGLE EXCEPTION	4.068109029675095
P27 INACTIVATION	4.06799210223026
BOOTSTRAP METHOD	4.06799210223026
ONTOGENY SUPPORT	4.06799210223026
EXCESS HAIR CELL	4.06799210223026
SINGLE DNA PROBE	4.067987853587177
CYTOTOXIC T CELL	4.067971487102333
CDNA	4.06786303935062
QIAGEN MINIPREP KIT	4.067665727750125
CRW SITE PROJECT	4.067353033264522
ANTIBODY SOLUTION	4.0672150353875836
HRM MODE ESTIMATE	4.067047607127599
ΜM CPT TREATMENT	4.067033132068759
ES CELL GENOTYPE	4.067016681177291
GENOTYPE ES CELL	4.067016681177291
EMISSION MAXIMUM	4.066901925759295
MAXIMUM DISTANCE	4.066901925759295
MAXIMUM SEQUENCE	4.066901925759295
DISTENDING TOXIN	4.066668316515516
H ALLN TREATMENT	4.066542241685541
MULTIPLE EXAMPLE	4.066489426554065
MULTIPLE PROFILE	4.066489426554065
MULTIPLE PICTURE	4.066489426554065
MULTIPLE SECTION	4.066489426554065
MURINE IL-1-BETA	4.066429078133334
TARGETED BAND KB	4.066307284047859
SEQUENCING POWER	4.066184004668659
EXTREME ACCURACY	4.066184004668659
SEQUENCING ERROR	4.066184004668659
EXCESS MYOSIN II	4.066144959372478
HLA-DR SECRETION	4.065932880007325
LIMITED EFFECTOR	4.065675477229458
P53 ACCUMULATION	4.065634256480101
RNA ACCUMULATION	4.065479066199018
S ULTRAMICROTOME	4.06532209375476
PROTEASE ADDITION	4.065208298307345
UNKNOWN STRUCTURE	4.06502478450215
ADAPTOR MOLECULE	4.065002908680839
CAS(SD) MOLECULE	4.065002908680839
ΜG/ML DOTMA/DOPE	4.064693034166291
ΜG/ML NOCODAZOLE	4.064693034166291
CYTOSOLIC FACTOR	4.064496571006376
TSA201	4.064312377203099
GIBBS SAMPLER FIND	4.06429829882586
MEASUREMENT FALL	4.063984967093739
MEASUREMENT UNIT	4.063984967093739
ATM PROTEIN KINASE	4.063667555174258
QIAGEN RNA MINIPREP	4.063665438658341
SRC FAMILY KINAS	4.063508311906128
associated genes	4.063430132997913
PJC4 PLASMID DNA	4.063360133937695
MOLECULAR SUBSET	4.0633588522286574
GR TRANSLOCATION	4.06319685048035
COLONY FORMATION	4.063142345219236
BORDER FORMATION	4.063142345219236
ANLAGE FORMATION	4.063142345219236
MYOSIN-II TURNOVER	4.0630509891303666
PDGF STIMULATION	4.063032567017276
denaturing polyacrylamide	4.062644272965552
MODIFYING ENZYME	4.062599303048066
YEAST SACCHAROMYCE	4.062368583544271
ECORI CUT PCDNA3	4.062351623967439
IE UP/DOWN STREAM	4.062327687668217
CALIBRATION BUFFER	4.062291868270608
COMMON STRUCTURE	4.062115785155057
LOW-LEVEL COMMON	4.062115785155057
COMMON EARTHWORM	4.062115785155057
COMMON MECHANISM	4.062115785155057
COMMON ATTRIBUTE	4.062115785155057
UBIQUITOUS AGENT	4.06199613163995
TBID ASSOCIATION	4.06199613163995
SODIUM MOLYBDATE	4.06199613163995
CELL ASSOCIATION	4.06199613163995
ADP RIBOSYLATION	4.06199613163995
SINGLE COMPONENT	4.061593521860342
INFORMATION LINK	4.061361761710725
PEYFP-N1 PLASMID	4.061167450200872
EPISOMAL PLASMID	4.061167450200872
PTX-MKC2 PLASMID	4.061167450200872
IMAGES EVALUATION	4.060611353319351
CHEMOKINES ACTING	4.060611353319351
MAGNESIUM SULFATE	4.060611353319351
QRNA PERFORMANCE	4.060463070977655
PERFORMANCE GAIN	4.060463070977655
ANTIGENIC SITE B	4.060049387941798
EST	4.060008185658283
JNK MAPK PATHWAY	4.059902597187139
KDA TPR FRAGMENT	4.059890850730452
G PROTEIN FAMILY	4.059657864532363
PHASE REGULATION	4.059622360291881
RED WINE EXHIBIT	4.059535296402092
DEPENDENT GROWTH	4.059436272203357
SURVIVAL CATEGORY	4.059423121847059
DEVELOPING HEART	4.059329939183786
P53 UPREGULATION	4.059036699971523
KB CDNA FRAGMENT	4.058402212955077
EFFECTOR PROTEIN	4.057867542762159
INVOLVING SERINE	4.0577669987784475
REMAINING SERINE	4.0577669987784475
COMPLEX ORGANISM	4.0577669987784475
INCLUDING SERINE	4.0577669987784475
HSP70 SEQUESTRATION	4.057154198875099
NON-OVERLAPPING SET	4.057154198875099
EMBRYONIC LETHALITY	4.057154198875099
DIASTOLIC	4.05705107985946
LINEAR REGRESSION	4.0569334940003525
CASPASE EFFECTOR	4.056198374953453
MAJOR HISTOCOMPATIBILITY         COMPLEX TYPE I	4.055956153784209
myc epitope tags	4.055636768892653
PLASMIN ACTIVITY	4.055636768892653
MUTANT PH DOMAIN	4.05543532324041
NUCLEAR TRANSFER	4.055157136387311
NADPH PRODUCTION	4.055053970150313
G418 SENSITIVITY	4.055053970150313
ACR3	4.054950887891623
ARSA	4.054950887891623
ARSD	4.054950887891623
NFΚ B ACTIVATION	4.054925056142791
REPLICATING HELA	4.0544487560717295
PATHOLOGY REPORT	4.0544487560717295
neuron specification	4.054032707681194
HETEROTRIMERIC G	4.05403218014751
BOI1-PH FRACTION	4.053979346127852
osteoclast development	4.0539324319329415
STRUCTURE DIAGRAM HELP	4.0539324319329415
LACK RADIAL GLIA	4.053819808107711
INFORMATION FLOW	4.0534939786891355
INCLUDING RETINA	4.053165702225131
ZEBRAFISH RETINA	4.053165702225131
NG/ML NOCODAZOLE	4.053165702225131
ICE COLD ETHANOL	4.053165702225131
factory synthesis	4.052887848749454
CONIFERYL ALCOHOL	4.052887848749454
POLYVINYL ALCOHOL	4.052887848749454
protein synthesis	4.052887848749454
DNASE-FREE RNASE	4.052714899522273
SACCHAROMYCE	4.052169919716819
SV40 RELATIONSHIP	4.052029681575021
PROTEIN KINASE MG	4.051695793318177
MYOSIN-II CONTRIBUTION	4.051651356061936
CA PHOSPHORYLATE	4.051551537708444
STRONGER EVIDENCE	4.051447873321168
CELLULAR EVIDENCE	4.051447873321168
INCUBATION MEDIUM	4.051154000784783
MINUTE INCUBATION	4.051154000784783
MUTANT T ANTIGEN	4.050552854691155
TEST ASSOCIATION	4.0504928902566615
HIV BREAKTHROUGH	4.050264884832824
POSTERIOR END	4.049717089825474
investigation	4.049717089825474
DEFAULT VALUE	4.049717089825474
PHYSICAL LINK	4.049717089825474
PRIMARY OBJECTIVE	4.049104567003802
HEPARIN AFFINITY	4.049081977223719
HYBRID TECHNIQUE	4.048616693132649
N-TERMINAL MOTIF	4.048276658213024
pheromone detection	4.047907214827144
UNINFECTED	4.047265653617461
CYCLIN INDUCTION	4.046811530794362
HYAL-2 INDUCTION	4.046811530794362
P53 KEY FUNCTION	4.046727569755372
KDA GLYCOPROTEIN	4.046573724977343
N-TERMINAL LIPID	4.046465962810099
SEQUENCE EXHIBIT	4.046040393484803
EXPLANTS EXHIBIT	4.046040393484803
MHCK-B SUBDOMAIN	4.045842907100647
cell shape changes	4.045188572925081
MORPHOLINO OLIGO	4.044825852222247
INTRALYSOSOMAL O	4.044825852222247
HYBRID RESISTANCE	4.044416908253438
UNITS/ML RNASE T1	4.044085836784661
NM PHORBOL ESTER	4.043756640683416
PRESENCE	4.043520444842574
ORGANIC SYNTHESIS	4.043448009830691
TEST APPLICATION	4.04294551468844
FOLLICULAR FLUID	4.0426311548530665
EXPECTED FASHION	4.0426311548530665
RESISTED ELUTION	4.0426311548530665
length limitations	4.042470379154712
GIVE YES/NO ANSWER	4.042470379154712
ASPARTATE POSITION	4.042470379154712
ENVELOPE BREAKDOWN	4.042470379154712
HOMOLOGY SEQUENCE	4.041666908147905
DIVERSE SPECTRUM	4.041444831950807
INTRACELLULAR IP	4.041288451322253
TRIZOL REAGENT	4.04022978028099
AMPLITUDE RHYTHM	4.040192602220644
DOUBLING TIME	4.039431599219467
CONTROL SPECTRUM	4.03906880630896
A PRIORI UNKNOWN	4.038868816505901
SURVIVAL ACCURACY	4.038701524220505
RT-PCR TOTAL RNA	4.038500879045693
IN VITRO STUDY	4.038172715441346
EXPERIMENTS LEAD	4.037467161043231
EXPERIMENTS TIME	4.037467161043231
STORAGE LOCATION	4.037467161043231
ETHANOL FIXATION	4.0364860022193625
CALCULATION SHOW	4.035980556764642
RANK CALCULATION	4.035980556764642
OTH SUBSTITUTION	4.03546479609656
FORCE PRODUCTION	4.03470731227679
TOTAL COLLECTION	4.034593663748641
RECENT STUDY	4.03406933764327
FIXED PREPARATION	4.033429441631771
ΔC2 CONSTRUCTION	4.033292017111875
ΔN2 CONSTRUCTION	4.033292017111875
MIN FLOW CHALLENGE	4.0331256234103945
LDL	4.033119611507316
LOGICAL SOLUTION	4.032876944323378
SOLE DETERMINANT	4.032719618347092
POTENTIAL FORCE	4.032269605998298
CELL DEATH GENE	4.032269605998298
NUMERICAL VALUE	4.032269605998298
INDICATING MODE	4.032269605998298
RESOLVING POWER	4.032269605998298
IMAGING CHAMBER	4.032269605998298
DIFFERENTIATIVE	4.032269605998298
SEALING PATTERN	4.032269605998298
EPITHELIUM SHOW	4.032269605998298
DEFINETHE INPUT	4.032269605998298
GABAERGIC INPUT	4.032269605998298
COOPERATIVE SET	4.032269605998298
EOSIN HISTOLOGY	4.032269605998298
MOUSE-EAR CRESS	4.032269605998298
POTENTIAL MODEL	4.032269605998298
REMOVE PLATELET	4.032269605998298
TAKES ADVANTAGE	4.032269605998298
ANTI-CHICKEN TN	4.032269605998298
HUMAN CHEMOKINE	4.032269605998298
BEGR START NODE	4.032269605998298
LENGTH FUNCTION	4.032269605998298
STAINING EMBRYO	4.032269605998298
PROGRAM DISPLAY	4.032269605998298
ALLELEFREQUENCY	4.032269605998298
DISTANCE RESULT	4.032269605998298
NORMAL POSITION	4.032269605998298
CELL LINE LNCAP	4.032269605998298
SPARC-NULL LENS	4.032269605998298
TUMOR METASTASI	4.032269605998298
HEWLETT-PACKARD	4.032269605998298
IDENTIFYING SET	4.032269605998298
ADVANCED CANCER	4.032269605998298
ONLINE APPENDIX	4.032269605998298
VIRAL DIVERSITY	4.032269605998298
CAUSE SECTORING	4.032269605998298
INDIVIDUAL TERM	4.032269605998298
GROUP PRECURSOR	4.032269605998298
SWISSPDB VIEWER	4.032269605998298
GSK3 INHIBITION	4.032269605998298
GAL4-SRF FUSION	4.032269605998298
MATRIX EQUATION	4.032269605998298
STIMULATED ERK1	4.032269605998298
COMPLEX PATHWAY	4.032269605998298
Β-GLUCURONIDASE	4.032269605998298
GAPPY ALIGNMENT	4.032269605998298
ESTIMATED VALUE	4.032269605998298
MOLECULAR MOTOR	4.032269605998298
LINKER-TKT LINE	4.032269605998298
PROBE SYNTHESIS	4.032269605998298
PHOSPHORYLATING	4.032269605998298
REQUIRED C/EBPΑ	4.032269605998298
PREDICTED START	4.032269605998298
PATHWAY LEADING	4.032269605998298
CAPTURING IMAGE	4.032269605998298
BINDING ELEMENT	4.032269605998298
SITE OCCURRENCE	4.032269605998298
QRNA ANNOTATION	4.032269605998298
PROINFLAMMATORY	4.032269605998298
NOISE TOLERANCE	4.032269605998298
MATRIX FUNCTION	4.032269605998298
RESULTING MOUSE	4.032269605998298
STANDARD FORMAT	4.032269605998298
TESTING PURPOSE	4.032269605998298
RELATIVE IMPACT	4.032269605998298
NON-NULL NUMBER	4.032269605998298
ABLATION RESULT	4.032269605998298
SMAD-RESPONSIVE	4.032269605998298
MISMATCHED BASE	4.032269605998298
JACOBIAN MATRIX	4.032269605998298
TRABECULAR CELL	4.032269605998298
INCREASED PROBE	4.032269605998298
GENEPIX SCANNER	4.032269605998298
SILASTIC TUBING	4.032269605998298
CELLULAR ORIGIN	4.032269605998298
FIBULIN-1C BIND	4.032269605998298
tissue meshwork	4.032269605998298
AD HOC APPROACH	4.032269605998298
REGULATORY ROLE	4.032269605998298
REDOX POTENTIAL	4.032269605998298
BIOLOGICAL DATA	4.032269605998298
EQUIVALENT SIZE	4.032269605998298
destabilization	4.032269605998298
CANDIDATE PAPER	4.032269605998298
ENDOGENOUS GENE	4.032269605998298
LOUSY BASE-PAIR	4.032269605998298
QUALITY SECTION	4.032269605998298
MULTI-STEM LOOP	4.032269605998298
WEIGHT EXPONENT	4.032269605998298
SYSTEM LOCATION	4.032269605998298
MICE HOMOZYGOUS	4.032269605998298
C3-TREATED CELL	4.032269605998298
GENE-TRAP LOCUS	4.032269605998298
CONSISTENCYTHAT	4.032269605998298
SUPER-ORTHOLOGY	4.032269605998298
CASEIN ZYMOGRAM	4.032269605998298
MYC-EPITOPE TAG	4.032269605998298
DISTANCE METRIC	4.032269605998298
HYDROPATHY PLOT	4.032269605998298
INHIBITORY ROLE	4.032269605998298
MCLEOD SYNDROME	4.032269605998298
BLUE IDENTIFIER	4.032269605998298
APOPTOTIC INDEX	4.032269605998298
CDK2 INHIBITION	4.032269605998298
SOLUTIONINSTEAD	4.032269605998298
OBTAINED RESULT	4.032269605998298
LRP FLY HOMOLOG	4.032269605998298
OUTPUT CLUSTALX	4.032269605998298
TRUNCATED SMAD1	4.032269605998298
DESIRED OUTCOME	4.032269605998298
USEDTHE FORMULA	4.032269605998298
STRUCTURAL DATA	4.032269605998298
stock solutions	4.032269605998298
GENE ANNOTATION	4.032269605998298
THRESHOLD SCORE	4.032269605998298
NEWER ALIGNMENT	4.032269605998298
UNIGENE CLUSTER	4.032269605998298
INTERRELATEDNES	4.032269605998298
PHENYLKETONURIA	4.032269605998298
LRP HOMOLOG ARR	4.032269605998298
SHIFT OPERATION	4.032269605998298
RAS/ERK PATHWAY	4.032269605998298
AMPLIFIED VIRUS	4.032269605998298
INCREASING TIME	4.032269605998298
HORIZONTAL AXIS	4.032269605998298
CANDIDA ALBICAN	4.032269605998298
CASTRATION LEAD	4.032269605998298
EAR SKIN BIOPSY	4.032269605998298
error rate area	4.032269605998298
CANCER INVASION	4.032269605998298
DIFFERENCE GIVE	4.032269605998298
PROTRUDING EDGE	4.032269605998298
MEMBRANE RESULT	4.032269605998298
STANDARD MITOSI	4.032269605998298
splice acceptor	4.032269605998298
COLORING SCHEME	4.032269605998298
HETEROCHROMATIN	4.032269605998298
cell monolayers	4.032269605998298
PIRIFORM CORTEX	4.032269605998298
CONTEXTUAL MENU	4.032269605998298
STUDIED PROBLEM	4.032269605998298
MODEL SELECTION	4.032269605998298
CHANGING LENGTH	4.032269605998298
ELK-1 SYNERGISM	4.032269605998298
DIFFERENT VALUE	4.032269605998298
DRAWING PATHWAY	4.032269605998298
ENDOGENOUS MHCK	4.032269605998298
COMPUTER SYSTEM	4.032269605998298
TUMOR CELL LINE	4.032269605998298
OTHER ADENOSINE	4.032269605998298
CHARLOTTESVILLE	4.032269605998298
RESPONSIVE GENE	4.032269605998298
UPPER PARABASAL	4.032269605998298
STATE STIFFNESS	4.032269605998298
BLASTOMERE SIZE	4.032269605998298
GENERATIVE MODE	4.032269605998298
HEPARAN-SULFATE	4.032269605998298
METAMORPH IMAGE	4.032269605998298
SHOWEDTHAT GPNN	4.032269605998298
COMPLEMENTATION	4.032269605998298
ANTI-ANGIOGENIC	4.032269605998298
SPARC-DEFICIENT	4.032269605998298
LABELING PERIOD	4.032269605998298
SUCCEEDING UNIT	4.032269605998298
CRYOMOLD BIOPSY	4.032269605998298
GLOBULAR DOMAIN	4.032269605998298
BLAST TECHNIQUE	4.032269605998298
AMOUNT DECREASE	4.032269605998298
MOREFLEXIBILITY	4.032269605998298
MOLEGO BUILDING	4.032269605998298
PAIRING PARTNER	4.032269605998298
REPETITIVE STEP	4.032269605998298
NAIVE INTUITION	4.032269605998298
INCLUDED10 DEME	4.032269605998298
INCREASED ERROR	4.032269605998298
BLASTODERM REST	4.032269605998298
P53-INDEPENDENT	4.032269605998298
IN SILICO MODEL	4.032269605998298
ZT20 REFERENCED	4.032269605998298
GALAPAGOS FINCH	4.032269605998298
PHASE-DEPENDENT	4.032269605998298
MEC-3GFP FUSION	4.032269605998298
CONTAINING LACZ	4.032269605998298
SUPPRESSOR GENE	4.032269605998298
SOLID OUTGROWTH	4.032269605998298
SYSTEMATIC DATA	4.032269605998298
PROBE SELECTION	4.032269605998298
CARCINOGENICITY	4.032269605998298
PRONEPHRIC DUCT	4.032269605998298
membrane damage	4.032269605998298
BIOPSY FRAGMENT	4.032269605998298
INCLUDING HUMAN	4.032269605998298
THROMBIN PAI-1S	4.032269605998298
CONTIGUOUS CELL	4.032269605998298
CONTROLLED GENE	4.032269605998298
LEVELS/ACTIVITY	4.032269605998298
SYNCHRONIZATION	4.032269605998298
DIGOXYGENIN-UTP	4.032269605998298
SHARED FUNCTION	4.032269605998298
EXTRACT FEATURE	4.032269605998298
LOCUS PRESENTIN	4.032269605998298
ALLOWING GAPPED	4.032269605998298
INCREASED COUNT	4.032269605998298
GAPPED POSITION	4.032269605998298
thrombotic plug	4.032269605998298
ATXGXXXX FORMAT	4.032269605998298
CORTICAL REGION	4.032269605998298
MODELING METHOD	4.032269605998298
THEOBROMA CACAO	4.032269605998298
APICAL ECTODERM	4.032269605998298
LEVEL SIGNATURE	4.032269605998298
AVERAGE MEASURE	4.032269605998298
FORMAL LANGUAGE	4.032269605998298
NEURON-SPECIFIC	4.032269605998298
ERKKI RUOSLAHTI	4.032269605998298
CELL POPULATION	4.032269605998298
NON-TRANSFORMED	4.032269605998298
DALENIUS METHOD	4.032269605998298
SF900-II MEDIUM	4.032269605998298
INTENSITY LEVEL	4.032269605998298
SCIENTIFIC NAME	4.032269605998298
ASN-ALA-PRO-GLN	4.032269605998298
INTRA-MOLECULAR	4.032269605998298
MEMBRANE REFORM	4.032269605998298
FITNESS MEASURE	4.032269605998298
I/V)(D/N)(E/D)C	4.032269605998298
SECONDARY QUERY	4.032269605998298
GP OPTIMIZATION	4.032269605998298
MEMBRANE FUSION	4.032269605998298
EVENTUAL EXTENT	4.032269605998298
FILE GENERATION	4.032269605998298
SUPPRESSOR PTEN	4.032269605998298
TERMED TKT LINE	4.032269605998298
ENABLING ESCAPE	4.032269605998298
NUMEROUS TISSUE	4.032269605998298
INHIBITING ERK1	4.032269605998298
TERMINAL REPEAT	4.032269605998298
RING CHROMOSOME	4.032269605998298
MRNAS ASSOCIATE	4.032269605998298
rapid cessation	4.032269605998298
NETWORK FITNESS	4.032269605998298
AVERAGE ENTROPY	4.032269605998298
DUAL LUCIFERASE	4.032269605998298
MATCH INTENSITY	4.032269605998298
MNOC TRANSCRIPT	4.032269605998298
OTHER FASTGROUP	4.032269605998298
M-CSF PRECURSOR	4.032269605998298
PROCESSED IMAGE	4.032269605998298
BIOPSIED TISSUE	4.032269605998298
CONSIDERA LOCUS	4.032269605998298
TOOTH PRIMORDIA	4.032269605998298
HALF-RANGE MODE	4.032269605998298
ACTIN-MYOSIN-II	4.032269605998298
SYSTEM FUNCTION	4.032269605998298
BECOMING BETTER	4.032269605998298
CELLULAR VOLUME	4.032269605998298
exchange factor	4.032269605998298
WNT TARGET GENE	4.032269605998298
ENDOGENOUS COPY	4.032269605998298
TRADITIONALBPNN	4.032269605998298
MUSCULOSKELETAL	4.032269605998298
BEARING VESICLE	4.032269605998298
ALIGNMENT SCORE	4.032269605998298
CUCUMIS SATIVUS	4.032269605998298
APPROACHES WORK	4.032269605998298
ANALYTICAL TOOL	4.032269605998298
COUNTERSTAINING	4.032269605998298
EXPECTED NUMBER	4.032269605998298
MITOTIC SPINDLE	4.032269605998298
DENSITY PATTERN	4.032269605998298
genome analysis	4.032269605998298
SCORE THRESHOLD	4.032269605998298
POSITIVE NUMBER	4.032269605998298
OLIGO-DT PRIMER	4.032269605998298
AXON PROJECTION	4.032269605998298
CURRENT DATASET	4.032269605998298
SPARC INFLUENCE	4.032269605998298
SPAWNING SEASON	4.032269605998298
POLYNOMIAL TIME	4.032269605998298
MYR-BOI1-PH(KK)	4.032269605998298
BETTER THROMBIN	4.032269605998298
tumor biomarker	4.032269605998298
THROMBIN GLU192	4.032269605998298
ROSETTA PROGRAM	4.032269605998298
CD68 MUCIN-LIKE	4.032269605998298
DISCUSSING GENE	4.032269605998298
CONTRACTIBILITY	4.032269605998298
COMPLEX UNDERGO	4.032269605998298
ORDER EPISTASIS	4.032269605998298
ANDCOORDINATION	4.032269605998298
NOCTURNIN SERVE	4.032269605998298
GENETIC CIRCUIT	4.032269605998298
EMBRYONIC MUCIN	4.032269605998298
NOMARSKI OPTICS	4.032269605998298
EXCHANGEINCREAS	4.032269605998298
HYAL-1-PEGFP-N1	4.032269605998298
SUPERIMPOSITION	4.032269605998298
PROSITE PATTERN	4.032269605998298
SPATIAL CONTEXT	4.032269605998298
NOTATION SYSTEM	4.032269605998298
ENCODING MHCK-C	4.032269605998298
RGS3 SYSTEM ACT	4.032269605998298
frame proteomic	4.032269605998298
STUDIED NETWORK	4.032269605998298
CHECK ALIGNMENT	4.032269605998298
POSTERIOR SHIFT	4.032269605998298
ASSUMPTION MAKE	4.032269605998298
LFC MODEL LIMIT	4.032269605998298
BODY COLORATION	4.032269605998298
structure helix	4.032269605998298
SRC/CAS CHIMERA	4.032269605998298
GENETIC VARIANT	4.032269605998298
INCREASING BMP1	4.032269605998298
INTERNALIZATION	4.032269605998298
TREATED HBP-ALL	4.032269605998298
NEAREST CONTACT	4.032269605998298
MULTI-FACTORIAL	4.032269605998298
SHMUEL SHALTIEL	4.032269605998298
POSITION GLU351	4.032269605998298
CELLULAR MATRIX	4.032269605998298
INFLUENCED PATH	4.032269605998298
isl1 expression	4.032269605998298
SCORING/PARSING	4.032269605998298
BLUE-CELL TUMOR	4.032269605998298
DELETION REMOVE	4.032269605998298
IDENTITY OBJECT	4.032269605998298
IDENTIFIED GENE	4.032269605998298
GTPASE ACTIVITY	4.032269605998298
WAVE PROCEEDING	4.032269605998298
OTHER RAB GTPAS	4.032269605998298
QUICKCHANGE KIT	4.032269605998298
MIGRATION PRIOR	4.032269605998298
DILUTED WTPAI-1	4.032269605998298
ACTIVATED CDC42	4.032269605998298
DISEASE PROCESS	4.032269605998298
MONOMERIC STATE	4.032269605998298
PGST-P35-C/EBPΒ	4.032269605998298
DOCKING COMPLEX	4.032269605998298
VARYING FITNESS	4.032269605998298
ALTERTHE RESULT	4.032269605998298
PROCEDURE YIELD	4.032269605998298
MALE PRONUCLEUS	4.032269605998298
EXPERIMENTSWERE	4.032269605998298
SPECIFICITY APE	4.032269605998298
INBOTH TRAINING	4.032269605998298
AUTOFLUORESCENT	4.032269605998298
RESULTS SESSION	4.032269605998298
CANCERS DISPLAY	4.032269605998298
oligomerization	4.032269605998298
MICROCENTRIFUGE	4.032269605998298
SELECTIVE EVENT	4.032269605998298
EVOLVER PROGRAM	4.032269605998298
B-CELL LYMPHOMA	4.032269605998298
THRESHOLD VALUE	4.032269605998298
FUNCTION METHOD	4.032269605998298
TPR DOMAIN BIND	4.032269605998298
BLASTODERM FORM	4.032269605998298
NOTED EXCEPTION	4.032269605998298
BREEDING COLONY	4.032269605998298
PROCESSED SLIDE	4.032269605998298
CANDIDATE LOCUS	4.032269605998298
LUCIFERASE GENE	4.032269605998298
ELITE CYTOMETER	4.032269605998298
temporal myosin	4.032269605998298
cellular plasma	4.032269605998298
THESECOND LAYER	4.032269605998298
CHROMATOGRAPHED	4.032269605998298
PROSTATE BIOPSY	4.032269605998298
HARVESTING TIME	4.032269605998298
HETERO-OLIGOMER	4.032269605998298
NON-TRANSCRIBED	4.032269605998298
MODIFIED TYRODE	4.032269605998298
DEATH GENE CED9	4.032269605998298
MIGRATING FRONT	4.032269605998298
INITIATE REPAIR	4.032269605998298
EGF-LIKE REGION	4.032269605998298
INTENSITY VALUE	4.032269605998298
TIRF MICROSCOPY	4.032269605998298
ACTIVATED C-RAF	4.032269605998298
PROMISING FIELD	4.032269605998298
DIFFERENT PROBE	4.032269605998298
WHEEL SELECTION	4.032269605998298
DFZ2 CRD DOMAIN	4.032269605998298
LFC GENE FILTER	4.032269605998298
STATISTIC EVENT	4.032269605998298
MUCOR RACEMOSUS	4.032269605998298
DENSITY LINKAGE	4.032269605998298
SUBSEQUENT WORK	4.032269605998298
COST-EFFICIENCY	4.032269605998298
BACKGROUND CELL	4.032269605998298
AUTO-ACTIVATION	4.032269605998298
KEYWORDS/PHRASE	4.032269605998298
DEGLYCOSYLATION	4.032269605998298
DETECTGENE-GENE	4.032269605998298
CHICKEN MYOSINV	4.032269605998298
BOI1-PH SEGMENT	4.032269605998298
GFP-MHCK-A CELL	4.032269605998298
IN VITRO RESULT	4.032269605998298
OPERATION YIELD	4.032269605998298
PREPARED FUSION	4.032269605998298
DIVERSE PATHWAY	4.032269605998298
MOTHER/BUD NECK	4.032269605998298
MODEL PARAMETER	4.032269605998298
GROUP HOMINIDAE	4.032269605998298
OBSERVED NUMBER	4.032269605998298
NEGATIVE NATURE	4.032269605998298
ACTIVATED SMAD1	4.032269605998298
ROBOTIC PRINTER	4.032269605998298
INDIVIDUAL RANK	4.032269605998298
VARIABLE IMPACT	4.032269605998298
MMP-2 GELATINAS	4.032269605998298
RSV-TRANSFORMED	4.032269605998298
PEROXIDASE/FITC	4.032269605998298
CODING CAPACITY	4.032269605998298
BIDIRECTIONAL D	4.032269605998298
PREDICTIONERROR	4.032269605998298
DIRICHLET PRIOR	4.032269605998298
BEFOREBEGINNING	4.032269605998298
STANDARD T-TEST	4.032269605998298
SIMPLE GEOMETRY	4.032269605998298
MASIA CRITERION	4.032269605998298
CRW SITE METHOD	4.032269605998298
INCLUDING NFATC	4.032269605998298
NON-INTERACTING	4.032269605998298
COMPETING FORCE	4.032269605998298
NETWORK ELEMENT	4.032269605998298
IMMUNO-STAINING	4.032269605998298
EXPRESSING LINE	4.032269605998298
BASAL FREQUENCY	4.032269605998298
FORMING SPECKLE	4.032269605998298
GP-OPTIMIZED NN	4.032269605998298
CONSTANT AMOUNT	4.032269605998298
THR-SER-THR-PRO	4.032269605998298
DATABASE ATTFDB	4.032269605998298
MMCOP1 DELETION	4.032269605998298
PSEUDOGLANDULAR	4.032269605998298
RELATIVE WEIGHT	4.032269605998298
LOCATING MODULE	4.032269605998298
GALACTOSE PLATE	4.032269605998298
PSEUDOBACTERIAL	4.032269605998298
VASCULAR SUPPLY	4.032269605998298
AVERAGE DENSITY	4.032269605998298
POST-GENOME ERA	4.032269605998298
COMPLEX NETWORK	4.032269605998298
nucleotide base	4.032269605998298
SER/THR RESIDUE	4.032269605998298
INTERESTING HIT	4.032269605998298
DESIGNATED NAME	4.032269605998298
INCLUDING SMAD4	4.032269605998298
INTERACTING SNP	4.032269605998298
DIFFERING TREND	4.032269605998298
SUPPRESSED GNRH	4.032269605998298
UNIT INEQUALITY	4.032269605998298
OBLIGATORY STEP	4.032269605998298
AVERAGE ERRORIN	4.032269605998298
BACKPROPAGATION	4.032269605998298
POINT PARAPLAST	4.032269605998298
LABELING SYSTEM	4.032269605998298
STRUCTURE FIELD	4.032269605998298
HPB-ALL WESTERN	4.032269605998298
THR-ALA-VAL-THR	4.032269605998298
T-BUTYLALCHOHOL	4.032269605998298
POLAR PSEUDOPOD	4.032269605998298
ABLETO OPTIMIZE	4.032269605998298
LIMITED SUCCESS	4.032269605998298
PRACTICAL LEVEL	4.032269605998298
IMPROVED RESULT	4.032269605998298
IN SILICO ACNAB	4.032269605998298
JAVA TECHNOLOGY	4.032269605998298
MAINTAINABILITY	4.032269605998298
SIMULATING DATA	4.032269605998298
ENTERING MITOSI	4.032269605998298
YOLKY MACROMERE	4.032269605998298
LYSOSOMAL PROBE	4.032269605998298
LEU-PRO-SER-SER	4.032269605998298
RESULTING MATCH	4.032269605998298
COMPLEX PROBLEM	4.032269605998298
STANDARD MEDIUM	4.032269605998298
CONTACT SURFACE	4.032269605998298
PHSOPHORYLATION	4.032269605998298
GAUCHER DISEASE	4.032269605998298
GDP-BOUND STATE	4.032269605998298
MODELS INCREASE	4.032269605998298
TRANSGENIC LINE	4.032269605998298
BLASTOMERE FATE	4.032269605998298
SPECIFIED ENTRY	4.032269605998298
regulatory gene	4.032269605998298
STAINING SYSTEM	4.032269605998298
DATABASE SYSTEM	4.032269605998298
STRUCTURAL UNIT	4.032269605998298
STORMO/HAUSSLER	4.032269605998298
INCREASING DOSE	4.032269605998298
LABELING MEDIUM	4.032269605998298
EMBRYONIC STAGE	4.032269605998298
HISTORICAL DATA	4.032269605998298
CANDIDATE SMAD1	4.032269605998298
FIBULIN-1C GENE	4.032269605998298
SAMPLING THEORY	4.032269605998298
MYC-TAGGED TBID	4.032269605998298
TRAPPED GARPIKE	4.032269605998298
CYTOCHALASIN B.	4.032269605998298
OUTLINE DRAWING	4.032269605998298
FLANKING REGION	4.032269605998298
EQUIPROBABILITY	4.032269605998298
LIMITED TRYPTIC	4.032269605998298
LEVELS DECREASE	4.032269605998298
AFFYMETRIX DATA	4.032269605998298
COMPLEX PROCESS	4.032269605998298
SOMITE BOUNDARY	4.032269605998298
OTHER CHEMOKINE	4.032269605998298
PGST-P20-C/EBPΒ	4.032269605998298
LENGTH INTERVAL	4.032269605998298
UM BLEBBISTATIN	4.032269605998298
CONTAINING HALF	4.032269605998298
VIRAL VARIATION	4.032269605998298
X-RAY STRUCTURE	4.032269605998298
INCLUDING YEAST	4.032269605998298
SNUG APPOSITION	4.032269605998298
PRODUCING FORCE	4.032269605998298
ARCHITECTUREFOR	4.032269605998298
CONTAINING P107	4.032269605998298
gel contraction	4.032269605998298
INCOMPATIBILITY	4.032269605998298
LOGIC OPERATION	4.032269605998298
NGN1 TRANSCRIPT	4.032269605998298
PUTATIVE MODULE	4.032269605998298
INACTIVE C/EBPΑ	4.032269605998298
internal herpes	4.032269605998298
REPLACING SMAD1	4.032269605998298
non-overlapping	4.032269605998298
WASHED PLATELET	4.032269605998298
SCANNING SYSTEM	4.032269605998298
LIMITING AMOUNT	4.032269605998298
NOISE-TOLERANCE	4.032269605998298
MAKING EXCISION	4.032269605998298
DEVELOPSTRATEGY	4.032269605998298
STABLE GFP-NFAT	4.032269605998298
CRE-RECOMBINASE	4.032269605998298
CELLULAR TISSUE	4.032269605998298
LINEAR INCREASE	4.032269605998298
IMMUNOCHEMISTRY	4.032269605998298
TARGETING TGF-Β	4.032269605998298
DECREASED PROBE	4.032269605998298
MOLECULAR CAUSE	4.032269605998298
REJOINING EVENT	4.032269605998298
WERNER SYNDROME	4.032269605998298
RGS3 INHIBITION	4.032269605998298
RESERVE PATIENT	4.032269605998298
FUNCTIONAL SNPS	4.032269605998298
INNOVATIVE LOOK	4.032269605998298
RESVERATROL ACT	4.032269605998298
NYTRAN MEMBRANE	4.032269605998298
POOLING EXAMPLE	4.032269605998298
AHAB PREDICTION	4.032269605998298
PRO-RICH REGION	4.032269605998298
ACCURATELYMODEL	4.032269605998298
PRINCIPAL LAYER	4.032269605998298
TPR DOMAIN PLAY	4.032269605998298
C. SONNENSCHEIN	4.032269605998298
USING CONDITION	4.032269605998298
MOUSE FOREBRAIN	4.032269605998298
REMAINING VALUE	4.032269605998298
GALLIUM NITRATE	4.032269605998298
biological data	4.032269605998298
ISOLATED BIOPSY	4.032269605998298
CONSENSUS ORDER	4.032269605998298
MOLECULAR ARRAY	4.032269605998298
MINIMIZING COST	4.032269605998298
BENDING MODULUS	4.032269605998298
CHANGING GLYCINE	4.032134776130901
ORTHOLOG ABSENCE	4.03206077568722
THROMBIN ABSENCE	4.03206077568722
MANUAL INSPECTION	4.031648211182236
AFFYMETRIX MANUAL	4.031648211182236
CARBOXYLATE GROUP	4.031648211182236
NGN1 EXPRESSION	4.031607132280105
GFAP EXPRESSION	4.031607132280105
BMP6 EXPRESSION	4.031607132280105
EXPRESSION GENE	4.031607132280105
BLOT EXPRESSION	4.031607132280105
NM COLLOIDAL GOLD	4.031345652242532
INDUCER	4.0311699113760815
HAZARD ANALYSIS	4.031051286224453
HYAL-2 HOMOLOGUE	4.030926102217439
two-hybrid tests	4.030926102217439
REACH MATURATION	4.030926102217439
PROXIMAL ELEMENT	4.030926102217439
L00 MM IMIDAZOLE	4.030926102217439
CLONE HOMOLOGOUS	4.03076196250622
MAKE MICROARRAY	4.0301841657731705
HUFL MICROARRAY	4.0301841657731705
P164 RHO KINASE	4.030169432412556
GENOMICS RESEARCH	4.029962525661028
CRITICAL RESEARCH	4.029962525661028
CONTROL CULTURE	4.029940567342315
MATCHED CONTROL	4.029940567342315
CONTROL EXPLANT	4.029940567342315
CONTROL HPB-ALL	4.029940567342315
KINASES CONTROL	4.029940567342315
INITIATED STUDY	4.029754244249837
PROTEOMIC STUDY	4.029754244249837
CONDUCTED STUDY	4.029754244249837
EXTENSIVE STUDY	4.029754244249837
INHIBITOR STUDY	4.029754244249837
STUDY CONDITION	4.029754244249837
V-SRC	4.029646185023305
BLAST ALGORITHM	4.0295980616576115
ALGORITHM OFFER	4.0295980616576115
MEANS ALGORITHM	4.0295980616576115
NOVEL ALGORITHM	4.0295980616576115
MYOSIN FILAMENT	4.029553683844644
MYOSIN FUNCTION	4.029553683844644
GAP GENE FACTOR	4.02946997391525
DOCUMENTED RRNA	4.029161269236891
POLYMORPHA RRNA	4.029161269236891
ENRICHED KINASE	4.029119345619685
TERMINAL KINASE	4.029119345619685
YAOI	4.029101262884411
ONE-BASE CHANGE	4.028919226620224
PROPOSED CHANGE	4.028919226620224
ADDITIVE EFFECT	4.028715290484167
POSSIBLE EFFECT	4.028715290484167
OBSERVED EFFECT	4.028715290484167
SYSTEMIC EFFECT	4.028715290484167
RELATIVE EFFECT	4.028715290484167
MOUSE EST CLONE	4.028660367286378
RNA GENE FAMILY	4.028546962244882
STATE RNA LEVEL	4.028546962244882
POOL RNA SAMPLE	4.028546962244882
LEUCINE PHENYLALANINE	4.028398057762373
DEFINED BEHAVIOR	4.028340102216545
COMPLEX BEHAVIOR	4.028340102216545
BINDING BEHAVIOR	4.028340102216545
demonstration	4.028121590560846
downregulates	4.028121590560846
DIGITAL IMAGE	4.028121590560846
lamellipodium	4.028121590560846
FUNCTIONALITY	4.028121590560846
CELL FUNCTION	4.028121590560846
ONE-WAY ANOVA	4.028121590560846
CELLULAR TASK	4.028121590560846
PHOSPHOIMAGER	4.028121590560846
JUXTAPOSITION	4.028121590560846
REARRANGEMENT	4.028121590560846
RUNNING WATER	4.028121590560846
TRANSCRIPTASE	4.028121590560846
EXTRAVASATION	4.028121590560846
SELF-ASSEMBLY	4.028121590560846
HEMATOPOIETIC	4.028121590560846
NON-LINEARITY	4.028121590560846
VARYING LEVEL	4.028121590560846
OPTIC VESICLE	4.028121590560846
CLARIFICATION	4.028121590560846
applicability	4.028121590560846
GRADED SERIES	4.028121590560846
RESPONSE SETTLE	4.028119897530024
HU LOCALIZATION	4.028077336417529
MATERNAL FACTOR	4.028070157873726
CONSTANT FACTOR	4.028070157873726
SYSTEMIC FACTOR	4.028070157873726
NECROSIS FACTOR	4.028070157873726
phosphatidylinositol-specific phospholipase	4.028016847268341
SODIUM PYROPHOSPHATE	4.027800756983328
CROSSLINK ACTIN	4.0277405612988515
RHODAMINE ACTIN	4.0277405612988515
AFFECTING ACTIN	4.0277405612988515
INCLUDING ACTIN	4.0277405612988515
NON-RRNA INTRON	4.027715329852058
PEGFP-N1 VECTOR	4.027651003917789
VECTOR PTX-FLAG	4.027651003917789
MODIFIED VECTOR	4.027651003917789
FIBRONECTIN ING	4.027598219894013
GENOMIC CONTENT	4.027403578806333
papers	4.027170292600448
allele	4.027170292600448
INVESTIGATOR WISH	4.027030898667623
OBTAINED SIGNAL	4.026978391964318
PPT1 MRNA LEVEL	4.026961212697973
MNOC MRNA LEVEL	4.026961212697973
OTHER EUKARYOTIC	4.026954745073208
UNINFECTED GROUP	4.026954745073208
COMPLEX TOPOLOGY	4.026954745073208
BAG CELL NEURON	4.026900196683027
CONFIRMATORY STUDY	4.026713979293631
RNA GENEFINDING	4.026685640368175
INDEPENDENT RNA	4.026685640368175
RNA DEGRADATION	4.026685640368175
USE COMMITTEE	4.026536235346191
ISOGENIC STRAIN	4.026471786365319
DELETION STRAIN	4.026471786365319
KNOCKOUT STRAIN	4.026471786365319
HIRUDIN ADDITION	4.026340617679771
ANALYSIS TOOL	4.0261394451742705
C/EBPΑ BZIP DNA	4.026133530767489
ABASIC DNA SITE	4.026133530767489
PHYSIOLOGICAL SIGNIFICANCE	4.026061006857686
RNA PURIFICATION	4.025961049152737
SHARE COMPONENT	4.025882945308845
TABLE 2(THE RAW	4.025857899580651
GFP FUSION GENE	4.025781569742345
HOUR DARK CYCLE	4.025742719225843
TGF-Β TREATMENT	4.025596197277889
MAP KINASE PLAY	4.0255896421142365
MAMMALIAN BRAIN	4.025160974970037
MAMMALIAN WNT-1	4.025160974970037
TNF SENSITIVITY	4.024837855377843
FOLD ACTIVATION	4.024735112281708
CV DISTRIBUTION	4.024735112281708
RAC1 ACTIVATION	4.024735112281708
GAD1 ACTIVATION	4.024735112281708
PROTEIN PATTERN	4.024616076980158
Β-ACTIN PROTEIN	4.024616076980158
P53-GST PROTEIN	4.024616076980158
PROTEIN CONTACT	4.024616076980158
PATHWAY PROTEIN	4.024616076980158
EXTRACT PROTEIN	4.024616076980158
CARRIER PROTEIN	4.024616076980158
ENCODED PROTEIN	4.024616076980158
PROTEIN EXTRACT	4.024616076980158
BETTER STATISTICS	4.024568331993163
BINDING SITE ZINC	4.024568331993163
HUMAN RGS3 CDNA	4.0245208612755485
PPT1 CDNA PROBE	4.0245208612755485
CONTROL STATE	4.024332361061153
CONTROL LEVEL	4.024332361061153
INACTIVE MUTANT	4.024321761584756
PREPARED MUTANT	4.024321761584756
MUTANT GENOTYPE	4.024321761584756
MRNA EXPERIMENT	4.0243070160478105
POSITIVE NEURON	4.024215492025391
TN AMPLIFICATION	4.0239762272150355
FIBROBLAST LINE	4.02397018906175
L929 FIBROBLAST	4.02397018906175
LUNG FIBROBLAST	4.02397018906175
MRNA EXPRESSION	4.023644542329618
METAZOAN GENOME	4.023447743750995
STANDARD GENOME	4.023447743750995
STRATAGENE CROSSLINKER	4.023366015261467
BIND NUCLEOTIDE	4.023219872770437
NUCLEOTIDE TYPE	4.023219872770437
DNA SYNTHESIZER	4.023065493152084
DNA PRECIPITATE	4.023065493152084
MOTILE FIBROBLAST	4.023022977652401
GENOMIC DNA ARM	4.022889512639513
T CELL FUNCTION	4.022873139696573
ATG START CODON	4.022537551614369
OTHER TTT CODON	4.022537551614369
NM DEXAMETHASONE	4.022372409906788
SYMBOL SEQUENCE	4.022177105155705
NON-TAIL SYMBOL	4.022177105155705
MAXIMAL RATIO R	4.022177105155705
ELIMINATING MAB	4.0219215988052595
DIGEST COLLAGEN	4.021652819397648
PHOSPHATIDYLINOSITOL	4.021380387435274
RNA MODIFICATION	4.021258126218779
TYROSINE KINAS	4.021063436109354
NOVEX SDS-PAGE GEL	4.021008154974942
FUNCTIONAL TEST	4.0209938464362285
DEPOSITING CDNA	4.020646488914174
GFP-C/EBPΑ CDNA	4.020646488914174
AZ LOCALIZATION	4.020507960785584
ADHESIVE GUIDANCE	4.020486239487752
OBSERVATION LEAD	4.0204668843920395
cytotoxic effects	4.020350531625205
LOCATING DAMAGE	4.020068224382626
DNA MICROARRAY	4.019920418316652
EXPERIMENT CHIP	4.019692797255989
GROWING PRIMARY	4.019545986258998
TYROSINE ABILITY	4.019099131891294
AGONIST AFFINITY	4.018965852213302
MIGRATION ASSAY	4.017723474890646
SCREENING ASSAY	4.017723474890646
EXEMPLARY CODON	4.017671524422404
WILD-TYPE WOUND	4.017671524422404
PHYLOGENY FIELD	4.017671524422404
WILD-TYPE RAB24	4.017671524422404
WILD-TYPE YIELD	4.017671524422404
WILD-TYPE ELK-1	4.017671524422404
MICROARRAY CHIP	4.017607357030862
KCL CONCENTRATION	4.017553067086129
OTHER PHENOTYPE	4.01749564392149
GR ACCUMULATION	4.017223730509033
MOTIF DISCOVERY	4.0171308547344085
RESULTING MOTIF	4.0171308547344085
FIBRILLIN MOTIF	4.0171308547344085
REMAINING MOTIF	4.0171308547344085
CONSENSUS MOTIF	4.0171308547344085
SOMATIC NUCLEUS	4.017036825223452
ARCUATE NUCLEUS	4.017036825223452
ACCESSORY REGION	4.017026352212631
CUSTOM SEQUENCED	4.017026352212631
STARTING BUFFER	4.016953585984245
ANTIBODY AP-101	4.016893570231839
GENERAL EXAMPLE	4.0168452179181084
GENERAL PATTERN	4.0168452179181084
GENERAL DYNAMIC	4.0168452179181084
KINASE REACTION	4.0168262242926165
PHOSPHORIC ACID	4.0167721165528
ADHESION KINASE	4.016733094585593
SINGLE RNA GENE	4.016512371334787
FOCUSED ATTENTION	4.016477041491366
CONSTANT ROTATION	4.016477041491366
OCL DEVELOPMENT	4.016395963896355
POLYMERASE MOVE	4.016344426097323
MM SODIUM AZIDE	4.016240339954179
TERNARY MIXTURE	4.016240339954179
P300 INTERACTOR	4.016240339954179
RGS3 IMMUNOBLOT	4.016240339954179
CUL1 ACCUMULATION	4.016011668187965
END CUT PLASMID	4.015698810695932
CD68 MACROPHAGE	4.015586084197277
OTHER ATHEROSCLEROTIC CARDIOVASCULAR DISEASE	4.015433335231237
POSSIBLE CONTRIBUTION	4.015377143816367
EXTRACTED LIPID	4.015355966655194
CELLULAR GROWTH	4.015167251013987
INVASIVE GROWTH	4.015167251013987
MRNA SEQUENCE	4.015166854641438
ODC INTERACTION	4.015131397020309
UNKNOWN VARIABLE	4.015040673640516
UNKNOWN IDENTITY	4.015040673640516
UNKNOWN ETIOLOGY	4.015040673640516
UNKNOWN FUNCTION	4.015040673640516
ASSAY MAKES USE	4.014896198703524
BLASTN PAIRWISE	4.01487614709936
C-TERMINAL MAPK	4.014630257427426
SIGNAL ADHESION	4.014592140930225
ATTACHED CAS SD	4.014546189884475
SINGLE POSITION	4.014217719633155
EMITTING SINGLE	4.014217719633155
SINGLE SEQUENCE	4.014217719633155
ABLATING SINGLE	4.014217719633155
BOOTSTRAP VALUE	4.01410310448163
GOLGI APPARATUS	4.01369022944716
truncation mutants	4.013657525188797
PROBE SET SIZE HELP	4.013231024647312
COOMASSIE BLUE	4.013042094434158
CONJUGATING ENZYME UBIQUITIN	4.012875630697756
MULTIPLE ANIMAL	4.012630144899197
MURINE SEQUENCE	4.012570989895887
UBIQUITIN CHAIN	4.012491559992248
SITE COLLECTION	4.012330762870248
DATA COLLECTION	4.012330762870248
CYTOSKELETAL ORGANIZATION	4.0123051735778565
HIGHER-ORDER ORGANIZATION	4.0123051735778565
AROMATIC HYDROGEN	4.011981880101478
SECONDARY STOCK	4.011832291792047
H MUTANT EMBRYO	4.011832291792047
CARBOXYL DOMAIN	4.01130825809445
FINAL COMPONENT	4.011284863732951
HLA-DR MOLECULE	4.011173023591845
ΜG/ML THYMIDINE	4.010869276986516
plasminogen activator	4.010773790401112
RENAMED ARCHAEA	4.010756643675928
SCORE EVALUATION	4.010708284028628
HUMAN NEUTROPHIL	4.010708284028628
ENHANCER ELEMENT	4.010708284028628
P27 STABILIZATION	4.010408573615019
TAG MEASUREMENT	4.01017521226181
CEREVISIAE GPA1	4.01017521226181
MICROTITER PLATE	4.009951691333822
TRAINING SUBSET	4.009561479102463
EXOGENOUS SPARC	4.009561479102463
CREATING SUBSET	4.009561479102463
SURVIVAL PATTERN	4.0095418714408115
SURVIVAL OUTCOME	4.0095418714408115
CAUSE FORMATION	4.009349253617455
TUMOR FORMATION	4.009349253617455
FIBER FORMATION	4.009349253617455
CLIPPED SPECIES	4.009078327466382
IDENTITY WINDOW	4.008912675476868
WINDOW SEQUENCE	4.008912675476868
SCANNING WINDOW	4.008912675476868
MATCHING WINDOW	4.008912675476868
VARIABLE WINDOW	4.008912675476868
ENZYME FUNCTION	4.00881695035178
KDA PROTEOGLYCAN	4.008665315873322
COMMON STRATEGY	4.008342994244638
COMMON FUNCTION	4.008342994244638
COMMON INTEREST	4.008342994244638
inactive fusions	4.008339008459627
FIXED BL6 MOUSE	4.008313779822472
SODIUM PYRUVATE	4.00822570693212
SODIUM CHLORIDE	4.00822570693212
CAUSATIVE AGENT	4.00822570693212
GENOTOXIC AGENT	4.00822570693212
MULTIPLE INTRON	4.008075868752957
BLASTP ALGORITHM	4.007982842851215
TOTAL RNA LEVEL	4.0079032105213965
MAPK PREPARATION	4.0076531655317575
EST INFORMATION	4.00760388195627
3-D INFORMATION	4.00760388195627
PLASMID PSAΒGEO	4.007413413044749
ΜM OKADAIC ACID	4.007280377907084
QUALIFIED SENSE	4.007115988513681
PI INTEGRINS ACT	4.007097959352055
SLIGHT AFFINITY	4.0069209992308545
SHOWS ASSOCIATION	4.006660402279627
XENOPUS LAEVI	4.006405493298392
STUDYING GENE B	4.006317460974487
C/EBPΒ KDA FORM	4.006162058908476
GAD1 REGULATION	4.005898877990232
linkages	4.005685713969225
MG/ML LEUPEPTIN	4.005466570973706
MG/ML APROTININ	4.005466570973706
NUCLEATION ARP2	4.005019853723296
EXCESS FIBROSIS	4.005019853723296
MULTIPLE CLONING	4.00471275986603
RCL CONFORMATION	4.004301228968794
ONCOGENE RESEARCH	4.004217510428036
FOLDING PROJECT	4.004080207093124
MULTIPLE GENOME	4.003808282651895
analytic solution	4.003701319646423
HNF3ΑLOXPNEO ES	4.0035856562351375
UG/ML GENTAMICIN	4.003126602207824
CINNAMYL ALCOHOL	4.003126602207824
SMAD1 SUBCLONING	4.003126602207824
SUBCLONING SMAD1	4.003126602207824
ACID IDENTITY	4.002907949719282
BP MEC-3 REGION	4.002810414349647
CALIBRATION CURVE	4.002779605304043
LACZ INTRODUCTION	4.00268506904512
T7 POLYMERASE	4.002212118722031
COMPLEX FACTORS	4.001992103470518
TNF STIMULATION	4.001809895708827
GROWING EVIDENCE	4.00171306830903
GENETIC EVIDENCE	4.00171306830903
SURFACE ANTIGEN	4.001420829837918
HLA-ABC ANTIGEN	4.001420829837918
IL-2 PRODUCTION	4.001420829837918
TOTAL LYSOSOMAL	4.001303978413069
USM APPLICATION	4.0008275841425265
PREVIOUS REPORT	4.0008275841425265
MOESIN FRACTION	4.000367456993417
PELLET FRACTION	4.000367456993417
GUIDE TREE DEAL	4.0002110739100605
MAX ADI/MIN ADI	4.0002110739100605
CYTOPLASM BOUND	4.0002110739100605
EXOGENOUS	3.999918494154206
LIGAND BOUND GR	3.999732588356505
IMPORT RECEPTOR	3.999614332212223
element signals	3.9995699032682963
CHEMOKINE NG/ML	3.9995699032682963
COMMON STANDARD DEVIATION	3.999425590671458
TRANSFER BUFFER	3.9991820084135923
ECFP EXPRESSION	3.9989074295501026
PEDF-RECEPTOR INTERACTION POSITIVE MODULATOR	3.998860260524349
SINGLE SAMPLE	3.99875207358688
ONE-STEP RT-PCR	3.9982074156545457
TRANSPORT CYCLE	3.998197318366841
KEY PATH MEMBER	3.9968803173294645
ENZYMATIC ASSAY	3.996762126986799
CYTOMETRY FIXED	3.9963358667345594
BLOCK NF-ΚB P50	3.9962553135178864
ASPARTATE RESIDUE	3.9962488152368736
HITRAP Q COLUMN	3.9959366029649623
PP5 SUPPRESSION	3.995110852896023
RB1 SUPPRESSION	3.995110852896023
LYAPINA	3.9946964140806736
TRIS-ACETATE PH	3.99450500366066
AMINOMETHANE PH	3.99450500366066
ACTIVATED ERK	3.994450209436985
TOXIC INTERACTION	3.9941708632736233
NM CONCENTRATION	3.994101731930909
GAPDH TRANSCRIPT	3.993860102204619
NEO RESULT '-END	3.993860102204619
PHOSPHORYLASE B	3.993341388462581
SINGLE MOLECULE	3.993121137226702
Y. L. CONTRIBUTION	3.993015480556499
EXHIBIT SUICIDE	3.992585500743441
FLUCTUATING EXTRACELLULAR THIAMINE LEVEL	3.992510274470894
CYTOSOL FRACTION	3.9922026794398184
MEASURE HOMOLOGY	3.992111705977599
K PBLUESCRIPT II	3.992071202590101
NEUTRALIZING AB	3.990346910190603
genome sequencing	3.9900923985507233
goat anti-mouse	3.989243681353558
OPTIMAL FASHION	3.989243681353558
complex factors	3.989243681353558
FINE FILOPODIAL	3.989243681353558
DIVISION FURROW	3.989243681353558
COMMON DENOMINATOR	3.988358433901651
TIME POINT	3.988154588784401
CANCER SPECTRUM	3.988080818525322
ADULT GAD1 MRNA	3.9880329951622557
PLACE EXPRESSION	3.9877333811137405
NETWORK SUBJECT	3.9874754926695277
BINDING SITE INTERACTION	3.987268659627736
PH DISTRIBUTION	3.986970509944069
FINAL INCUBATION	3.986532002712288
ALIQUOT TITRATION	3.9861347021096267
WD	3.9860855124605927
EX	3.9860855124605927
EE	3.9860855124605927
DI	3.9860855124605927
N3	3.9860855124605927
RN	3.9860855124605927
NV	3.9860855124605927
HU	3.9860855124605927
ET	3.9860855124605927
NE	3.9860855124605927
GG	3.9860855124605927
PA	3.9860855124605927
ΚB	3.9860855124605927
S2	3.9860855124605927
S1	3.9860855124605927
GT	3.9860855124605927
IM	3.9860855124605927
LO	3.9860855124605927
TK	3.9860855124605927
DB	3.9860855124605927
COHORT	3.9860006416333245
ACID PRODUCTION	3.98592334039242
RT-PCR REACTION	3.985914294327477
NON-NORMAL MEAN	3.9857456386995147
MEAN DIFFERENCE	3.9857456386995147
ARITHMETIC MEAN	3.9857456386995147
MEAN CHROMOSOME	3.9857456386995147
MG/ML UBIQUITIN	3.985688524967656
PREPARED FIGURE	3.985555744955438
MEAN EXPRESSION	3.985083164981322
NF-ΚB INDUCTION	3.984736203533633
P20-C/EBPΒ LACK	3.984181807865942
SECONDARY GUIDE	3.984181807865942
LACK GENERALITY	3.984181807865942
BINDING ACTIVITY ARS CONSENSUS SEQUENCE	3.9838355381733304
NORMAL LD CYCLE	3.9838200234181476
CO-RECEPTOR MODEL	3.9833763076203774
CHILLED ETHANOL	3.9832200519032948
CELL SUPERNATANT	3.982276977200613
CALIBRATION TIME	3.982276977200613
SUBFRAGMENT	3.981746188001315
PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C	3.981647420484418
E. COLI ABILITY	3.9815685517654162
MULTIPLE REPORT	3.981188123043426
SODIUM VANADATE	3.980778235848027
COLI STRAIN DH5Α	3.980650410710689
CURRENT RESEARCH	3.9806222450571833
ENZYMATIC	3.9800865267434347
GEL MOBILITY SHIFT ASSAY	3.9799055853098793
SIMPLE INTERPOLATION	3.979708847370573
COGNITIVE IMPAIRMENT	3.979708847370573
NONFUNCTIONAL SNPSIN	3.979708847370573
CYSTEINE-RICH DOMAIN	3.979708847370573
VCAM-1 ADHERENT	3.979528149982165
DRUG RESISTANCE	3.979528149982165
PURIFIED RNA ΜG	3.979497408149879
KEY CONSTITUENT	3.979185672995047
STEROID ABSENCE	3.978882336235029
LIGAND	3.9787292930327904
mutant phenotype	3.9784784625231855
HUMAN HOMOLOGUE	3.9777701014482942
MOUSE HOMOLOGUE	3.9777701014482942
CALCIUM-FREE PB	3.9777701014482942
CORTEX PROXIMAL	3.9777701014482942
GPA1 N-TERMINUS	3.9777701014482942
ALEXA-CALMODULIN FLUORESCENCE INTENSITY	3.9775693954778704
GENOMIC RESOURCE	3.977312780770324
NEURONAL GROWTH	3.977144340862822
RECENT REPORT	3.9769669923149817
LIPID CATABOLISM	3.9766052401296856
PH DOMAINS BIND	3.975950630411299
GTP	3.9758397532877505
MULTIPLE HYBRID	3.975471391796922
BILIRUBIN-ALBUMIN COMPLEX SEDIMENTATION	3.975331487372349
GLASS COVER SLIP	3.9753271021982086
RRNAS, INJECTION	3.9753271021982086
POTENTIAL TRANSLATIONAL INHIBITORY EFFECT	3.9751145762139592
MEGABASE-SIZED	3.974723940890715
AB-6 NEOMARKER	3.974723940890715
GENE DISCOVERY	3.974723940890715
BOUNDED LENGTH	3.974723940890715
WG COMBINATION	3.974723940890715
CELLULAR SLIME	3.974723940890715
VALUE INCREASE	3.974723940890715
EXTERNAL PROBE	3.974723940890715
DP MATRIX FILL	3.974723940890715
MASIA PRINTOUT	3.974723940890715
EMERGING THEME	3.974723940890715
PIP MASS RATIO	3.974723940890715
FILAMENTS MOVE	3.974723940890715
INCYTE GEMTOOL	3.974723940890715
OTH ANNOTATION	3.974723940890715
METABOLIC GENE	3.974723940890715
DORSAL HINDGUT	3.974723940890715
GENOMES-GENOME	3.974723940890715
flow cytometer	3.974723940890715
IDENTITY RANGE	3.974723940890715
SPIKING SAMPLE	3.974723940890715
IMAGING SYSTEM	3.974723940890715
HUVEC MP COUNT	3.974723940890715
STRUCTURE CORE	3.974723940890715
F-ACTIN BUNDLE	3.974723940890715
LOGP CRITERION	3.974723940890715
BLAST APPROACH	3.974723940890715
OTHER BH3-ONLY	3.974723940890715
DISCUSSION PP5	3.974723940890715
LIGAND-BINDING	3.974723940890715
RETINOBLASTOMA	3.974723940890715
EXPRESSED NGN1	3.974723940890715
CILIARY MUSCLE	3.974723940890715
RING STRUCTURE	3.974723940890715
MESANGIAL CELL	3.974723940890715
viral proteins	3.974723940890715
USING NETSCAPE	3.974723940890715
RED IDENTIFIER	3.974723940890715
PREPARING CELL	3.974723940890715
SAMPLE BIOLOGY	3.974723940890715
INCLUDING RANK	3.974723940890715
REPAIR DEFICIT	3.974723940890715
GRAPHIC FORMAT	3.974723940890715
ENDOGENOUS FAK	3.974723940890715
SET SIMULATION	3.974723940890715
ESTIMATED SIZE	3.974723940890715
MULTIPLICATION	3.974723940890715
UMBILICAL CORD	3.974723940890715
discrimination	3.974723940890715
PROTEOMIC DATA	3.974723940890715
SPARSE CULTURE	3.974723940890715
molecular mass	3.974723940890715
DLBCL LYMPHOMA	3.974723940890715
GRAPHICAL VIEW	3.974723940890715
SELECTED GP120	3.974723940890715
SIMPLIFICATION	3.974723940890715
SCE CORRECTION	3.974723940890715
HYBRIDIZED O/N	3.974723940890715
GENE VARIATION	3.974723940890715
JUN-N-TERMINAL	3.974723940890715
DETAILED RATIO	3.974723940890715
EXISTING PROBE	3.974723940890715
INPUTRELEVANCE	3.974723940890715
INTENSITY DATA	3.974723940890715
overestimation	3.974723940890715
STRUCTURE FILE	3.974723940890715
INFRAME FUSION	3.974723940890715
INVASIVE EVENT	3.974723940890715
POSITIVE SCORE	3.974723940890715
PELVIC FIN MAT	3.974723940890715
INTERFERON-Γ10	3.974723940890715
EXPRESSING TAG	3.974723940890715
DEFINED CUTOFF	3.974723940890715
ATGTTCCACTGCAT	3.974723940890715
ROD-LIKE SHAPE	3.974723940890715
METHOD COMPARE	3.974723940890715
INACTIVE STATE	3.974723940890715
REPLICATE SPOT	3.974723940890715
implementation	3.974723940890715
EXPECTED VALUE	3.974723940890715
FIBRILLAR FORM	3.974723940890715
EMPIRICAL RULE	3.974723940890715
PROPER SEALING	3.974723940890715
PRECURSOR POOL	3.974723940890715
MEDICAL BIOPSY	3.974723940890715
operculum flap	3.974723940890715
SYSTEM UNDERGO	3.974723940890715
DISTINCTIONCAN	3.974723940890715
CD8 SUPPRESSOR	3.974723940890715
HEXA-HISTIDINE	3.974723940890715
EMPIRICAL DATA	3.974723940890715
MM BENZAMIDINE	3.974723940890715
ACTIVATED ALK3	3.974723940890715
PAI-1 ACTIVITY	3.974723940890715
PREDICTED BASE	3.974723940890715
CONTAINING NEO	3.974723940890715
SYSTEM PACKAGE	3.974723940890715
KLENOW FILLING	3.974723940890715
MATCHING INPUT	3.974723940890715
POSSIBLE HELIX	3.974723940890715
CASE DUPLICATE	3.974723940890715
SURVIVING DIFF	3.974723940890715
BLM-CONTAINING	3.974723940890715
BI-DIMENSIONAL	3.974723940890715
AGAROSE-COATED	3.974723940890715
CURRENT METHOD	3.974723940890715
APLYSIA SYSTEM	3.974723940890715
VIEW ANTIGENIC	3.974723940890715
NUCLEOLUS FAIL	3.974723940890715
ANGULAR RECESS	3.974723940890715
POSSIBLE INPUT	3.974723940890715
POUCH ENDODERM	3.974723940890715
SMAD4 FUNCTION	3.974723940890715
ARCHAEBACTERIA	3.974723940890715
ASSEMBLY LEVEL	3.974723940890715
neo expression	3.974723940890715
OPTIMAL METHOD	3.974723940890715
T-RFLP PATTERN	3.974723940890715
PIGMENTED CELL	3.974723940890715
CLOACAL REGION	3.974723940890715
COMFOR EXAMPLE	3.974723940890715
FORMED ELEMENT	3.974723940890715
COMPUTER MODEL	3.974723940890715
INVOLVING GENE	3.974723940890715
VENTRAL FUSION	3.974723940890715
EXPRESSING CD8	3.974723940890715
RAPID DOWNLOAD	3.974723940890715
ATTRIBUTE NAME	3.974723940890715
CORTICAL LAYER	3.974723940890715
KINASES/STRESS	3.974723940890715
COMMUNICATIONS	3.974723940890715
STRAIGHTFOWARD	3.974723940890715
FOURIER SERIES	3.974723940890715
AXON EXTENSION	3.974723940890715
INCLUDED GROUP	3.974723940890715
AB-1 NEOMARKER	3.974723940890715
MOLECULAR SITE	3.974723940890715
CODING DENSITY	3.974723940890715
ONLINE EXAMPLE	3.974723940890715
SEVERITY PRIOR	3.974723940890715
BASAL ACTIVITY	3.974723940890715
TF TARGET GENE	3.974723940890715
INCLUDING ADH2	3.974723940890715
LINEAR PATHWAY	3.974723940890715
repair pathway	3.974723940890715
SYSTEM E15 SMG	3.974723940890715
ADRENAL CORTEX	3.974723940890715
ADDED STRENGTH	3.974723940890715
PHOSPHODIESTER	3.974723940890715
PATTERNED GENE	3.974723940890715
CGAP-GAI GROUP	3.974723940890715
CATALYTIC CORE	3.974723940890715
MODIFIED PCMV6	3.974723940890715
NEGATIVE DONOR	3.974723940890715
CYCLICAL MODEL	3.974723940890715
TISSUE FILLING	3.974723940890715
P27 PROTEOLYSI	3.974723940890715
PREPARED SLIDE	3.974723940890715
C-RAF FUNCTION	3.974723940890715
UNWOUNDED SKIN	3.974723940890715
AVERAGE LENGTH	3.974723940890715
TRUNCATED FORM	3.974723940890715
MAJOR CLUSTALX	3.974723940890715
INHIBITOR LLNL	3.974723940890715
SEARCH PROGRAM	3.974723940890715
MODELNONLINEAR	3.974723940890715
INCLUDING DATA	3.974723940890715
STANDING WATER	3.974723940890715
INACTIVE C-SRC	3.974723940890715
BRASSICA NAPUS	3.974723940890715
TIME-VARIATION	3.974723940890715
NEGATIVE SLOPE	3.974723940890715
SMADS FUNCTION	3.974723940890715
CAUDAL PORTION	3.974723940890715
EXPRESSED FLAG	3.974723940890715
PS-EXPOSING MP	3.974723940890715
PRODUCED LEVEL	3.974723940890715
DESIGNING DRUG	3.974723940890715
MEDAKA CHORION	3.974723940890715
protein netrin	3.974723940890715
CHR COMPARISON	3.974723940890715
DEPOLYMERIZING	3.974723940890715
CONSENSUS TREE	3.974723940890715
POSITIVE VALUE	3.974723940890715
BOS TAURUS EST	3.974723940890715
CRE- LOXP SITE	3.974723940890715
POWER INCREASE	3.974723940890715
SEQUENCE MGCTV	3.974723940890715
BLASTULA PHASE	3.974723940890715
POLY-GLN TRACT	3.974723940890715
GROUPS THOUGHT	3.974723940890715
ACTIVATED ERK2	3.974723940890715
SIDEWALLS FACE	3.974723940890715
C/EBPΑ PORTION	3.974723940890715
SCORING METHOD	3.974723940890715
ESCAPE VARIANT	3.974723940890715
ERROR ESTIMATE	3.974723940890715
HALOBACTERIALE	3.974723940890715
CANDIDATE GENE	3.974723940890715
RELATIVE ERROR	3.974723940890715
USING EQUATION	3.974723940890715
DT-SENSITIVITY	3.974723940890715
MG/L L-LEUCINE	3.974723940890715
ENHANCED WOUND	3.974723940890715
RAT EPITHELIAL	3.974723940890715
SEGMENTAL RMSD	3.974723940890715
MEMBRANE SPACE	3.974723940890715
POTENTIAL LOSS	3.974723940890715
FN DEGRADATION	3.974723940890715
EXTRACTABILITY	3.974723940890715
SAW BOI1-S-GFP	3.974723940890715
INVERTED NIKON	3.974723940890715
ENCODING RAB24	3.974723940890715
EGF-RESPONSIVE	3.974723940890715
INTERMEDIATETO	3.974723940890715
MODELGENE-GENE	3.974723940890715
BEAMS INCREASE	3.974723940890715
INTEREST LEVEL	3.974723940890715
PLATE MESODERM	3.974723940890715
SIMULATION SET	3.974723940890715
NEUROENDOCRINE	3.974723940890715
MOLEGO CONCEPT	3.974723940890715
CHR-ASSOCIATED	3.974723940890715
IN VIVO TISSUE	3.974723940890715
SEQUENCE RATIO	3.974723940890715
ANNEXIN V-FITC	3.974723940890715
CARBON DIOXIDE	3.974723940890715
SELF-ASSOCIATE	3.974723940890715
CONSERVED AREA	3.974723940890715
SUICIDAL STATE	3.974723940890715
QUASI SOFTWARE	3.974723940890715
BLOOD PLATELET	3.974723940890715
interpretation	3.974723940890715
POLYPTERIFORME	3.974723940890715
SELF-ACTIVATOR	3.974723940890715
MATCHING VALUE	3.974723940890715
EXPRESSED ISL1	3.974723940890715
SEMI-CONSERVED	3.974723940890715
TRACTION FORCE	3.974723940890715
LIMB OUTGROWTH	3.974723940890715
INHIBITED ERK1	3.974723940890715
IPLAB SOFTWARE	3.974723940890715
INFLUENZA A--I	3.974723940890715
POSSIBLE NOISE	3.974723940890715
COMPARING PHPP	3.974723940890715
GARPIKE EMBRYO	3.974723940890715
YEAR PROGNOSIS	3.974723940890715
PAI-1 SEQUENCE	3.974723940890715
RHO-TYPE GTPAS	3.974723940890715
analysis ideas	3.974723940890715
NEGATIVE PROBE	3.974723940890715
STRIKING ARRAY	3.974723940890715
LOGODDSPOSTOTH	3.974723940890715
SLIGHT CLOSURE	3.974723940890715
GFP-BLM FUSION	3.974723940890715
PIP PROTEOLYSI	3.974723940890715
CHEMOKINE CCAF	3.974723940890715
GAD1 GENE LEAD	3.974723940890715
FLANKING STATE	3.974723940890715
FRACTAL MEMORY	3.974723940890715
EMBRYONIC AXIS	3.974723940890715
LENGTH ADAPTOR	3.974723940890715
POSTMENOPAUSAL	3.974723940890715
CELLULAR BLOOD	3.974723940890715
DISCUSSION BDM	3.974723940890715
OUTPUT PATHWAY	3.974723940890715
DODECYLSULFATE	3.974723940890715
correspondence	3.974723940890715
CUT PRF4 SMA I	3.974723940890715
PHOTOBLEACHING	3.974723940890715
FORMALDE-FRESH	3.974723940890715
SHARED FEATURE	3.974723940890715
phosphoprotein	3.974723940890715
SIGNALING NODE	3.974723940890715
MUTATIONS LEAD	3.974723940890715
REMAINING STEP	3.974723940890715
adult meshwork	3.974723940890715
ORYZIAS LATIPE	3.974723940890715
IMAGING DEVICE	3.974723940890715
RIBOREGULATORY	3.974723940890715
ACIDIC CLUSTER	3.974723940890715
VARYING RESULT	3.974723940890715
MISCALLED BASE	3.974723940890715
ISOPRENYLATION	3.974723940890715
INCREASED CHK1	3.974723940890715
CRNA SYNTHESIS	3.974723940890715
C/EBPΑ DIMERIZ	3.974723940890715
FILE FIBULIN-1	3.974723940890715
OPTIC SWELLING	3.974723940890715
BDM INHIBITION	3.974723940890715
GROWTH/DENSITY	3.974723940890715
PERFORMED RGS3	3.974723940890715
reorganization	3.974723940890715
TUMOR NECROSIS	3.974723940890715
OBSERVED TREND	3.974723940890715
FILAMENT-STATE	3.974723940890715
FN CELLULAR FN	3.974723940890715
DISEASE STATUS	3.974723940890715
CELL HARVESTER	3.974723940890715
GENBANK NUMBER	3.974723940890715
VARYING AMOUNT	3.974723940890715
DIVERSE FAMILY	3.974723940890715
ANALYZING DATA	3.974723940890715
RAS STIMULTION	3.974723940890715
DETECTION RATE	3.974723940890715
ATTEMPT RESULT	3.974723940890715
OBSERVED COUNT	3.974723940890715
DEFINED MMCOP1	3.974723940890715
POSITIONED ALM	3.974723940890715
ULTRASTRUCTURE	3.974723940890715
RGS3 BOUND GQΑ	3.974723940890715
AMOUNT COMPLEX	3.974723940890715
RESIDUAL PAI-1	3.974723940890715
POSITIONS FALL	3.974723940890715
DISTANCE RATIO	3.974723940890715
VENTRAL REGION	3.974723940890715
SPARC FUNCTION	3.974723940890715
PRECALCULATION	3.974723940890715
LOG-ODDS SCORE	3.974723940890715
LIMIT FUNCTION	3.974723940890715
BACTERIAL STAB	3.974723940890715
T7-TRANSCRIBED	3.974723940890715
RE-TRYPSINIZED	3.974723940890715
GROUP VARIABLE	3.974723940890715
gene selection	3.974723940890715
PAIR-RULE GENE	3.974723940890715
DECREASED GENE	3.974723940890715
PUBLISHED WORK	3.974723940890715
FORMATTED FILE	3.974723940890715
CELL PERIMETER	3.974723940890715
BRIDGING SHEET	3.974723940890715
CRITICAL ANGLE	3.974723940890715
ELK-1 DELETION	3.974723940890715
RESULTING SKIN	3.974723940890715
OBSERVED DRIFT	3.974723940890715
POOLING DESIGN	3.974723940890715
SUCCESSFULWITH	3.974723940890715
DME-H21 MEDIUM	3.974723940890715
BINDING RESULT	3.974723940890715
RESULTING LINE	3.974723940890715
BLOCKED HYAL-1	3.974723940890715
REVEALING GENE	3.974723940890715
EXPANDED MODEL	3.974723940890715
OPERCULAR FLAP	3.974723940890715
CONTINUESUNTIL	3.974723940890715
INCREASE SPEED	3.974723940890715
ANTI-SENSE AS3	3.974723940890715
EXTENSIVE BODY	3.974723940890715
ACTIVITY STATE	3.974723940890715
INCLUDING DFZ2	3.974723940890715
MHCK-C DISPLAY	3.974723940890715
DENUDED OOCYTE	3.974723940890715
STRESS LEADING	3.974723940890715
WASHED HISTONE	3.974723940890715
OPERATIVE MODE	3.974723940890715
OLSEN APPROACH	3.974723940890715
GENE PREDICTOR	3.974723940890715
SHOWED ANNEXIN	3.974723940890715
RESULTING CELL	3.974723940890715
ACTIVATED GPCR	3.974723940890715
PROCEEDED GAD1	3.974723940890715
MEGABASE RANGE	3.974723940890715
LIMITED AMOUNT	3.974723940890715
DRAINAGE ROUTE	3.974723940890715
MINIMUM WEIGHT	3.974723940890715
NEGATIVE LEVEL	3.974723940890715
PHOSPHORLMAGER	3.974723940890715
OBSERVED ERROR	3.974723940890715
FMC BIOPRODUCT	3.974723940890715
SALIVARY GLAND	3.974723940890715
OPERCULAR EDGE	3.974723940890715
NOCTURNIN PLAY	3.974723940890715
CLIPPED MHCK-C	3.974723940890715
INCLUDING HSN3	3.974723940890715
DATABASE QUERY	3.974723940890715
REMAINING BASE	3.974723940890715
INTERNAL ERROR	3.974723940890715
OLFACTORY BULB	3.974723940890715
LYSOSOMOTROPIC	3.974723940890715
ACTINOPTERYGII	3.974723940890715
CITRUS SINENSI	3.974723940890715
POTENTIAL AREA	3.974723940890715
WEREIDENTIFIED	3.974723940890715
COMPENDIUM SET	3.974723940890715
PATTERN SEARCH	3.974723940890715
LANDMARK PAPER	3.974723940890715
PAPERS MENTION	3.974723940890715
FORMED BIPOLAR	3.974723940890715
PARSIMONIOUS(I	3.974723940890715
POSITIVE IMAGE	3.974723940890715
VASCULAR TUNIC	3.974723940890715
ANGIOTENSIN II	3.974723940890715
CANDIDATE LIST	3.974723940890715
FILOPODIA-LIKE	3.974723940890715
LAMININ-COATED	3.974723940890715
HIGH-SCORE HIT	3.974723940890715
CALLED PARSING	3.974723940890715
EXPOSURE PRIOR	3.974723940890715
AQUEOUS MEDIUM	3.974723940890715
EXCISION EVENT	3.974723940890715
CELL METASTASI	3.974723940890715
OCTYLGLUCOSIDE	3.974723940890715
STAGE-SPECIFIC	3.974723940890715
OBTAIN/DEVELOP	3.974723940890715
MOLECULAR LEGO	3.974723940890715
SCORING SYSTEM	3.974723940890715
METHOXYFLURANE	3.974723940890715
SPECIFIED TIME	3.974723940890715
VALUABLE MODEL	3.974723940890715
DISREGARD DATA	3.974723940890715
ATTACHED BPAEC	3.974723940890715
TABULAR FORMAT	3.974723940890715
CURRENT THEORY	3.974723940890715
OCL MORPHOLOGY	3.974723940890715
BACKGROUND RAB	3.974723940890715
ASKED QUESTION	3.974723940890715
INDICATED TIME	3.974723940890715
ATTRIBUTE LINK	3.974723940890715
TGF-Β INCREASE	3.974723940890715
CONTAINED GFAP	3.974723940890715
BLASTN PROGRAM	3.974723940890715
fly annotation	3.974723940890715
FUSION MACHINE	3.974723940890715
DISTANCE VALUE	3.974723940890715
PRODUCED FORCE	3.974723940890715
MULTI-STRANDED	3.974723940890715
PRE-IMMUNE EGG	3.974723940890715
GRAPHICAL FORM	3.974723940890715
PREFERRED FATE	3.974723940890715
LABEL LYSOSOME	3.974723940890715
centrifugation	3.974723940890715
NACALAI TESQUE	3.974723940890715
DESCRIBEDABOVE	3.974723940890715
TUMOR INVASION	3.974723940890715
HUMAN ORTHOLOG	3.974723940890715
NT WORKSTATION	3.974723940890715
AB-2 NEOMARKER	3.974723940890715
POSTNATAL YEAR	3.974723940890715
REMAINING TERM	3.974723940890715
MISSING MODULE	3.974723940890715
OBSERVED RATIO	3.974723940890715
FALCIPARUM PP5	3.974723940890715
BACTERIAL LAWN	3.974723940890715
ENDOGENOUS BLM	3.974723940890715
ACIDIC SURFACE	3.974723940890715
EMBRYONIC STEM	3.974723940890715
MOLECULAR TIME	3.974723940890715
ELECTROBLOTTED	3.974723940890715
UP/DOWN STREAM	3.974723940890715
FAILED ATTEMPT	3.974723940890715
AUTORADIOGRAPH	3.974723940890715
TBID ASSOCIATE	3.974723940890715
INDIVIDUAL RED	3.974723940890715
PROTEINS SHARE	3.974723940890715
AFFYMETRIX LIM	3.974723940890715
GTP BOUND FORM	3.974723940890715
NONLYTIC STATE	3.974723940890715
AVERAGE OUTPUT	3.974723940890715
SEQUENCE SPACE	3.974723940890715
MOLECULES PLAY	3.974723940890715
INDIVIDUAL SET	3.974723940890715
downregulation	3.974723940890715
MAPPING METHOD	3.974723940890715
SHEARING FORCE	3.974723940890715
ANDROGEN LEVEL	3.974723940890715
SCHEMA ATCISDB	3.974723940890715
ZEITGEBER TIME	3.974723940890715
OTHER EGF-LIKE	3.974723940890715
CINNAMALDEHYDE	3.974723940890715
MHCK-A DISPLAY	3.974723940890715
PATIENT PLASMA	3.974723940890715
ADP-RIBOSYLATE	3.974723940890715
NEGATIVE SCORE	3.974723940890715
SELECTION UNIT	3.974723940890715
PUBLIC LICENSE	3.974723940890715
ACTIVATED ERK1	3.974723940890715
RENAL NEOPLASM	3.974723940890715
HERPES SIMPLEX	3.974723940890715
RANK CANDIDATE	3.974723940890715
DISSOLVING PFA	3.974723940890715
PRENATAL STAGE	3.974723940890715
DECREASE NOISE	3.974723940890715
MOLLUSK EMBRYO	3.974723940890715
ECHINODERM EGG	3.974723940890715
ENDOTHELIAL MP	3.974723940890715
ANTINEOPLASTIC	3.974723940890715
DOSE-DEPENDENT	3.974723940890715
NEW YORK STATE	3.974723940890715
DOMAIN PORTION	3.974723940890715
CENTROMERIC G1	3.974723940890715
MEMBRANE-BOUND	3.974723940890715
OTHER GELATION	3.974723940890715
STATE VARIABLE	3.974723940890715
NETSEARCH PATH	3.974723940890715
SPREADING CELL	3.974723940890715
ENDOGENOUS CRK	3.974723940890715
DIAGONAL ENTRY	3.974723940890715
PROBE PROPERTY	3.974723940890715
HIS-P35-C/EBPΒ	3.974723940890715
DENDRITIC-LIKE	3.974723940890715
PP5 TPR DOMAIN	3.974723940890715
SPRAGUE DAWLEY	3.974723940890715
NANOGRAM LEVEL	3.974723940890715
SPHERICAL BODY	3.974723940890715
AVERAGE WEIGHT	3.974723940890715
SEM MICROGRAPH	3.974723940890715
OMIM REFERENCE	3.974723940890715
MASS-SPEC DATA	3.974723940890715
THERMOPROTEALE	3.974723940890715
STANDARD STATE	3.974723940890715
TARGETING N346	3.974723940890715
MCP-1 INCREASE	3.974723940890715
BOARD APPROVAL	3.974723940890715
GUIDING THEORY	3.974723940890715
COLOR MUTATION	3.974723940890715
RETURNED BLAST	3.974723940890715
DISCOIDEUMCELL	3.974723940890715
DOMAIN COGNATE	3.974723940890715
ARRESTED LNCAP	3.974723940890715
PRE-HYBRIDIZED	3.974723940890715
HUGENEFL PROBE	3.974723940890715
P53-REGULATORY	3.974723940890715
TARGETING SITE	3.974723940890715
MULTIFURCATION	3.974723940890715
EXPRESSING ΔN2	3.974723940890715
DBD SGRAI SITE	3.974723940890715
STUDENT T-TEST	3.974723940890715
INTRODUCED TAG	3.974723940890715
POSSIBLEALLELE	3.974723940890715
redistribution	3.974723940890715
TRUNK-TAIL BUD	3.974723940890715
FBA SIMULATION	3.974723940890715
CHR TUMOR TYPE	3.974723940890715
THROMBOSPONDIN	3.974723940890715
GFP-N346 ΔRING	3.974723940890715
EXPRESSING DBD	3.974723940890715
P53-GST FUSION	3.974723940890715
GENETIC SWITCH	3.974723940890715
CCAAT-ENHANCER	3.974723940890715
MAXIMAL LENGTH	3.974723940890715
likelihood fit	3.974723940890715
SPECIMENS SHOW	3.974723940890715
RETINAL TISSUE	3.974723940890715
COMPLEX TISSUE	3.974723940890715
RARELYCONSIDER	3.974723940890715
SOLUBILIZATION	3.974723940890715
INCLUDING LIM1	3.974723940890715
MAXIMAL TYPE I	3.974723940890715
CONTACT REGION	3.974723940890715
TOOVER-FITTING	3.974723940890715
TEMPORAL ORDER	3.974723940890715
PROTO-ONCOGENE	3.974723940890715
ADDITONAL FILE	3.974723940890715
COMPLEX MEDIUM	3.974723940890715
ACTIVATED CHK2	3.974723940890715
IMMUNOCHEMICAL	3.974723940890715
EMBRYONIC CELL	3.974723940890715
TRANSWELL UNIT	3.974723940890715
PARALLEL TRACK	3.974723940890715
NETSEARCH DRAW	3.974723940890715
NOCTURNIN SHOW	3.974723940890715
SEQUENCE COUNT	3.974723940890715
SYMBOLS RESULT	3.974723940890715
FALSE-NEGATIVE	3.974723940890715
OXIDOREDUCTASE	3.974723940890715
PROBE SET SIZE	3.974723940890715
ALIGNMENT NAME	3.974723940890715
HUMIDIFIED AIR	3.974723940890715
ECORV FRAGMENT	3.974723940890715
CO-PRECIPITATE	3.974723940890715
PRONEURAL GENE	3.974723940890715
BEINGIMPORTANT	3.974723940890715
INFECTED GROUP	3.974723940890715
YR OLD PATIENT	3.974723940890715
MICROCYSTIN-LR	3.974723940890715
DOMAIN REMOVAL	3.974723940890715
ASSOCIATED GAP	3.974723940890715
CAS(SD) FUSION	3.974723940890715
HIND III/ECORV	3.974723940890715
trypsinization	3.974723940890715
ANTI-UBIQUITIN	3.974723940890715
FIXATIVES STOP	3.974723940890715
PRINCIPLE QRNA	3.974723940890715
SEARCH ATCISDB	3.974723940890715
REPAIR COMPLEX	3.974723940890715
NAMED ANTIZYME	3.974723940890715
SPRAGUE-DAWLEY	3.974723940890715
clinical outcomes	3.974464571578188
DBD EXPRESSION	3.9740756426735353
AER EXPRESSION	3.9740756426735353
NAC EXPRESSION	3.9740756426735353
BLM EXPRESSION	3.9740756426735353
DLB EXPRESSION	3.9740756426735353
NEO EXPRESSION	3.9740756426735353
LFC REQUIREMENT	3.973877279694723
MASIA ANALYSIS	3.9735316905181377
MEIER ANALYSIS	3.9735316905181377
BLAST ANALYSIS	3.9735316905181377
CONTROL REGION	3.972444738611513
CONTROL REGIME	3.972444738611513
CONTROL TARGET	3.972444738611513
CYCLES CONTROL	3.972444738611513
CONTROL SYSTEM	3.972444738611513
ORGANIC MOLECULE	3.972337908648788
STUDY RELATIVE	3.9722624024291773
PROTOCOL STUDY	3.9722624024291773
NUMEROUS STUDY	3.9722624024291773
ALIZADEH STUDY	3.9722624024291773
ABLATION STUDY	3.9722624024291773
MUTATION STUDY	3.9722624024291773
DETAILED STUDY	3.9722624024291773
PURSUING STUDY	3.9722624024291773
BLOCKING STUDY	3.9722624024291773
ALGORITHM AHAB	3.972109561805748
AHAB ALGORITHM	3.972109561805748
ALGORITHM MAKE	3.972109561805748
PORCINE CLONING	3.971714600942738
VECTOR PEGFP I	3.9717107582165156
RRNA ALIGNMENT	3.9716821157956583
BACTERIAL RRNA	3.9716821157956583
kinase pathways	3.971631420990739
STUDIED CHANGE	3.971445252366125
REGIONS CHANGE	3.971445252366125
PROTEIN KINAS	3.9713356961866473
TCA PRECIPITATION	3.9712610063342635
DENSITY EFFECT	3.9712456800211506
POOLING EFFECT	3.9712456800211506
DISCUSSING RISK	3.970957663379544
GENETIC FACTOR	3.9706143518496195
FACTOR LEF/TCF	3.9706143518496195
THEORETICAL GROUND	3.9704382442399235
roller peristaltic	3.9704382442399235
BIBLIOGRAPHIC DATA	3.9704382442399235
PURIFIED ACTIN	3.9702918079267264
ORIENTED ACTIN	3.9702918079267264
COMPARE INTRON	3.970267116378181
PRC/CMV VECTOR	3.9702041668794164
VECTOR PMEXNEO	3.9702041668794164
VECTOR MACHINE	3.9702041668794164
HTK-TAG VECTOR	3.9702041668794164
MEC-3 PROMOTER	3.9699902130800644
C-FOS PROMOTER	3.9699902130800644
GAL10 PROMOTER	3.9699902130800644
VIRAL PROMOTER	3.9699902130800644
CELERA GENOMIC	3.9699620361288104
C-TERMINAL END	3.9699620361288104
GENOMIC REGION	3.9699620361288104
C-TERMINAL BLM	3.9699620361288104
INCYTE GENOMIC	3.9699620361288104
C-TERMINAL CRK	3.9699620361288104
PORCINE ABILITY	3.969842900786475
reporter gene	3.969559368371473
SIGNAL DYNAMIC	3.969545947363207
P27 MRNA LEVEL	3.9695291356959106
NM CAMPTOTHECIN	3.9693855622867553
AA IDENTITY DROP	3.969348715099367
ANTI-SENSE RNA	3.969259460016399
FUNCTIONAL RNA	3.969259460016399
TRANSGENIC RNA	3.969259460016399
RNA TYPE/CLASS	3.969259460016399
ORGANIZING RNA	3.969259460016399
TELOMERASE RNA	3.969259460016399
KDA N-TERMINAL TRANSESTERIFICATION DOMAIN	3.969067274259231
COMPONENT UNIT	3.9684739408907155
CYAN GFP EX436	3.968374734541509
CONTROL FACTOR	3.9683351495704176
BMP7 TREATMENT	3.968193328645817
CEES TREATMENT	3.968193328645817
ML-7 TREATMENT	3.968193328645817
N TERMINAL END	3.9680572742240483
CONNECTION MAP	3.968001251815085
MAB F7-26 BIND	3.9679728860383947
ATM PHOSPHORYLATE	3.9679292984805827
VECTOR CONTROL	3.9679249646002135
THY-1 RECEPTOR	3.9677674191515853
RECEPTOR RAB24	3.9677674191515853
TRAIL RECEPTOR	3.9677674191515853
MAMMALIAN LRP6	3.9677674191515853
Β-GAL REPORTER	3.967644294873016
REACTION MIX ΜL	3.967580802917443
SEM OBSERVATION	3.9675177194042335
RECIPIENT ZYGOTE	3.9673843879097475
MEDLINE ABSTRACT	3.9673843879097475
SRE ACTIVATION	3.967350669001315
BMP ACTIVATION	3.967350669001315
TCF ACTIVATION	3.967350669001315
RAS ACTIVATION	3.967350669001315
PKC ACTIVATION	3.967350669001315
WNT ACTIVATION	3.967350669001315
AZ PRECIPITATE	3.967316533483308
MUTANT BEHAVIOR	3.967287396358008
MARKER PROTEIN	3.9672341807970937
SIMPLE PROTEIN	3.9672341807970937
C/EBPΒ PROTEIN	3.9672341807970937
PROTEIN DOMAIN	3.9672341807970937
NORMAL PROTEIN	3.9672341807970937
PROTEIN TARGET	3.9672341807970937
HYAL-2 PROTEIN	3.9672341807970937
CYCLIN PROTEIN	3.9672341807970937
III1-C PROTEIN	3.9672341807970937
FAMILY PROTEIN	3.9672341807970937
ENDING PROTEIN	3.9672341807970937
PROTEIN III1-C	3.9672341807970937
PROTEIN ACTION	3.9672341807970937
HYAL-1 PROTEIN	3.9672341807970937
EXTENT PROTEIN	3.9672341807970937
USE ARRAY DATA	3.967212203801514
SIMULATED FLOW	3.967176771079395
PP5 CDNA PROBE	3.9671410025020895
SKP2-ΔF MUTANT	3.966946163112938
MUTANT SKP2-ΔF	3.966946163112938
ORIENTING MRNA	3.9669317330985074
LOCALIZED MRNA	3.9669317330985074
GENOMIC CLONING	3.9668485737507733
LATERAL NEURON	3.9668421674917007
EAR FIBROBLAST	3.966602113479548
U95 HUMAN CHIP	3.9665188126855875
ANTISENSE XBAI	3.9663028882591367
COMPLEX GENOME	3.966090847365536
ALIGNED GENOME	3.966090847365536
QUERIED GENOME	3.966090847365536
HIGH-GC GENOME	3.966090847365536
LYSIS BUFFER SD	3.9660902435242273
ΜL FINAL VOLUME	3.9660441627515595
E. COLI COLONY	3.9658350520018266
OTHER INTEGRIN	3.965735176845772
REGULATORY DNA	3.965716776100541
DNA EXTRACTION	3.965716776100541
COPY TRANSGENE	3.9656330317998063
TRANSGENE COPY	3.9656330317998063
INDUCIBLE CLONE	3.9655438053116625
GENE DEPENDENT	3.9654753859774208
DETAILED TABLE	3.9653121761848333
WHOLE CELL PCR	3.9652844128671165
SERUM PROTEOME	3.9650465215358763
CURRENT SYMBOL	3.9648473976808387
SAMPLED SYMBOL	3.9648473976808387
ENCODED SYMBOL	3.9648473976808387
MM RIPA BUFFER	3.9647317472919643
GFP EXPRESSION	3.964551833149726
COLLAGEN LEVEL	3.964334330501105
OTHER PROTEASE	3.9640572742240487
UNIV	3.96403204505905
NACI	3.96403204505905
EXIT	3.96403204505905
AX70	3.96403204505905
APAI	3.96403204505905
COIL	3.96403204505905
TEST FASTGROUP	3.963689458132095
GEM CDNA CLONE	3.9636089936720675
GRGDSP PEPTIDE	3.963561150193041
NETWORKCAN USE	3.9634563352569123
USE CONVENTION	3.9634563352569123
USE PENETRANCE	3.9634563352569123
DUPLICATE CDNA	3.963349533307777
PREPARING CDNA	3.963349533307777
AMPLIFIED CDNA	3.963349533307777
EMBRYONIC CDNA	3.963349533307777
OXIDANT DAMAGE	3.9627836423832528
GAIN CONFIDENCE	3.9626957704025485
COLOR REACTION	3.9626938657027453
TUNEL REACTION	3.9626938657027453
USING REACTION	3.9626938657027453
TRANSFECTION BHK	3.9625765441229324
PRIMARY DEFECT	3.962272579023011
PRIMARY SOURCE	3.962272579023011
NF-ΚB RESPONSE	3.9622419745535526
TRANSFECTED 3T3	3.96220533507346
SNPSARE UNKNOWN	3.962198814434007
RNA PREPARATION	3.9621467534010644
NE-PER NUCLEAR	3.9620255281923025
REMAINED CLOSE	3.9616091867923546
RESIDUES CLOSE	3.9616091867923546
DROSOPHILA RRP	3.9616091867923546
PLATELET GLYCOPROTEIN IIB/IIIA INHIBITOR	3.961570406103974
POLYPOSIS COLI	3.9613906075573824
INTERNATIONAL CONFERENCE ON HARMONIZATION	3.9612212413347705
MUTANT E. COLI	3.960649866816641
DIAGNOSTIC PCR	3.9605646488553172
PCR EXPERIMENT	3.9605646488553172
LABELING ASSAY	3.9604890654458758
PULLDOWN ASSAY	3.9604890654458758
STARTING CODON	3.960438226605001
OBSERVED CODON	3.960438226605001
WILD-TYPE LENS	3.960438226605001
WILD-TYPE TBID	3.960438226605001
WILD-TYPE PHPP	3.960438226605001
SELECTED CODON	3.960438226605001
CANCER THERAPY	3.960438226605001
AMINO ACIDS ΜM	3.9603800126103565
MOTIF FUNCTION	3.959909126075901
SEQUENCE MOTIF	3.959909126075901
HELICASE MOTIF	3.959909126075901
IMAGING BUFFER	3.9597356504925894
TRIS-CL BUFFER	3.9597356504925894
LOADING BUFFER	3.9597356504925894
ANTIBODY PROBE	3.959676918947142
ANTIBODY ZRF-1	3.959676918947142
BOUND ANTIBODY	3.959676918947142
ANTIBODY AP-PH	3.959676918947142
GENERAL DEFECT	3.9596296012680736
GENERAL BELIEF	3.9596296012680736
GENERAL METHOD	3.9596296012680736
INHIBITING CBP	3.9596296012680736
SNIP1-FREE CBP	3.9596296012680736
OBJECTIVE MEANS	3.959603599931626
ORIGINAL SET IE	3.959603599931626
cell activation	3.959603599931626
COLD PHOSPHATE	3.9594129361060264
S PHASE KINASE	3.9591093844316405
OPTIMIZE	3.959063793268907
EXON STRUCTURE	3.9590376663809113
ANTISENSE MRNA	3.958510680466929
DP ALGORITHM RUN	3.9583467777716588
MICROSOFT ACCESS	3.9582197175769083
REAGENT FUGENE	3.9580572742240485
AEROBIC GROWTH	3.957987539217075
MITOTIC GROWTH	3.957987539217075
N3 INTERACTION	3.957952452421114
PROTEINS ACTING	3.9579520997937467
UPSTATE BIOTECH	3.9579520997937467
CYTOSOLIC WOX1	3.957702664294971
CONTROL BUFFER	3.9574564482133874
SINGLE NETWORK	3.95705832574876
SINGLE LINKAGE	3.95705832574876
BEARING SINGLE	3.95705832574876
SINGLE RESIDUE	3.95705832574876
CHANGED SINGLE	3.95705832574876
BOOTSTRAP MODE	3.956946163112938
INDUCER ADDITION	3.9568418676557333
MAXIMUM CONTRIBUTION	3.9565046641164403
TYROSINE MOTIF	3.9563216821297122
ES CELL MEDIUM	3.956010490598318
ES CELL COLONY	3.956010490598318
MAXIMUM NUMBER	3.9559004114789507
MAXIMUM WEIGHT	3.9559004114789507
IP3	3.9557220083444036
GROWTH CONTROL	3.955708336937873
MODEL MULTIPLE	3.9555047216714967
MULTIPLE LAYER	3.9555047216714967
MULTIPLE MATCH	3.9555047216714967
MULTIPLE PROBE	3.9555047216714967
MULTIPLE LEF-1	3.9555047216714967
MULTIPLE ARRAY	3.9555047216714967
ADDED ACCURACY	3.9552117457687648
ΜL TOTAL VOLUME	3.9551324654120026
CD68 SECRETION	3.9549708544709623
HOST CELL TYPE	3.9549708544709623
DEATH EFFECTOR	3.9547239408907156
UNKNOWN PROTEIN	3.954545285415867
CATHETER INJURY	3.954413170926864
PRIMARY NEURON	3.9543908056239965
COMPOUND ABSENCE	3.9538746819101775
COPPER-PHENANTHROLINE FOOTPRINT ASSAY	3.953830519770286
ΜG/ML BESTATIN	3.953781532513752
XENOPUS TISSUE	3.9536713093117686
ΜM LACTACYSTIN	3.9532080484701777
RNASE MRP GENE	3.9531023192690937
ADHESIVE STATE	3.9531023192690937
N-TERMINAL BLM	3.9528489408907155
N-TERMINAL END	3.9528489408907155
TCA CYCLE FLUX	3.95265044083201
MAXIMUM CHANGE	3.9526217229543605
ACID MAMMALIAN	3.952601542374334
receptor genes	3.952570094736869
promoter genes	3.952570094736869
EXOGENOUS GENE	3.952501718668494
LIMITED SUBSET	3.952501718668494
EXOGENOUS DFZ2	3.952501718668494
FORMATION RATE	3.9522940343486597
LIVING SPECIES	3.952028905429723
RESEARCH PROJECT	3.951864141598961
ENZYME MIXTURE	3.9517731212185843
MOLEGOS COMMON	3.9513093067443745
DICTATE COMMON	3.9513093067443745
FEATURE COMMON	3.9513093067443745
SODIUM CITRATE	3.95119452912601
SODIUM CHOLATE	3.95119452912601
TOTAL PROTEIN	3.95106170208095
GIBCO/BRL	3.9509418279579887
PURE TOTAL RNA	3.9508789334391508
SINAPYL ALCOHOL	3.9505203491732916
CELL SEPARATION	3.9505203491732916
PLASMID PPD118	3.9503996165663913
PPB900 PLASMID	3.9503996165663913
LYSOSOMAL PH I	3.9500862597312953
PH DOMAIN BIND	3.9500862597312953
AFFINITY C/EBP	3.949917739340328
RAB24 AFFINITY	3.949917739340328
ACTIN MOLECULE	3.949646646636404
THIAMINE CONCENTRATION EXPANDED RANGE	3.9496143915509143
NFΚ B FUNCTION	3.9493271154938907
FOLLOW-UP STUDY	3.94926734235843
SHOWED EVIDENCE	3.9491347685491394
GAINED EVIDENCE	3.9491347685491394
HELA CELL MRNA	3.94901631518309
RHO REGULATION	3.9489174892778123
FINGER SUBUNIT	3.9489174892778123
P65 HETERODIMER	3.948369052941055
ADHESION ASSAY	3.948367853324664
EC CYTOSKELETON	3.9482029215604615
TERMINAL KINAS	3.9480572742240487
CAUSING EXCESS	3.9480572742240487
BASELINE GROUP	3.9480572742240487
BASELINE LEVEL	3.9480572742240487
P53 N-TERMINAL	3.9475333262727754
GARPIKE YSL MARK	3.9475276021885946
INDIVIDUAL BASIS	3.9475276021885946
CASSETTE COATING	3.9475276021885946
RG DETERMINATION	3.9475276021885946
FUNCTIONAL BASIS	3.9475276021885946
ORGANISM GENUS	3.9471377339941642
MODEL ORGANISM	3.9471377339941642
BEARING SERINE	3.9471377339941642
ACTIN MONOMER	3.946863085929604
GENES FUNCTION	3.9466537654521194
UBIQUITYLATION REACTION	3.9466194155964622
FACTOR KAPPA B	3.9465873894664933
L00 BP OVERLAP	3.9458951120618866
G418 SELECTION	3.944535261645433
ECM PRODUCTION	3.944535261645433
MIN TIME POINT	3.944440029218792
INCREASE TOTAL	3.9444209105876857
CURRENT REPORT	3.9439547101214854
REPORT FINDING	3.9439547101214854
INCLUDING HELA	3.9439547101214854
AMERSHAM COROP	3.9439547101214854
AA STIMULATION	3.9435865790854763
PHASE FRACTION	3.943504428695594
BAND INTENSITY	3.943383867207713
CYTOPLASM FORM	3.9433513918711083
CONTAINING P21	3.9433513918711083
P21 INHIBITION	3.9433513918711083
CELL CYTOPLASM	3.9433513918711083
N-TERMINAL GFP	3.9433251313669064
SUBTYPE	3.943100743057293
CONTAINING PMA	3.942723940890716
HUMAN MONOCYTE	3.942723940890716
GTP HYDROLYSI	3.9423138773742346
EMPTY STRUCTURE	3.9414370984149585
AXONAL GUIDANCE	3.9414370984149585
RECEPTOR KINAS	3.9411007524849193
SUPPORT GROWTH	3.9402097614392977
INDUCIBLE CAMP EARLY         REPRESSOR	3.94006374511479
TRNA STRUCTURE	3.9399413321950636
HIV QUASISPECY	3.9399413321950636
TRNA ALIGNMENT	3.9399413321950636
HOMOLOGY DOMAIN	3.9397232775171593
HOMOLOGY SEARCH	3.9397232775171593
B4	3.9392463923753165
BINDING FACTOR	3.93834926222029
QIAGEN MAXIPREP	3.9379435404309833
deviations	3.9378499928617168
C/EBPΑ CONTRIBUTION	3.9378405017190206
EGFP N-TERMINUS	3.936895473035791
GENE CHIP TAKE	3.9368891830559583
ADULT B6 MOUSE	3.936628702795478
B RAISES/LOWER	3.9366287027954776
FOLD INDUCTION	3.9366287027954776
PEROXIDASE KIT	3.9366287027954776
GENE INDUCTION	3.9366287027954776
limits	3.9360246589368484
CULLIN SUBUNIT	3.9360142634713613
PHOSPHOLIPID PC	3.935922267597398
EXHIBIT DEFECT	3.9358889894344053
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA	3.935357751965466
G2 PHASE	3.935184434539914
dynamic motility	3.9348914658205874
DMEM ABBREVIATION	3.934257528557434
FOLLOW-UP GROUP	3.9341704978082905
FOLLOW-UP DONOR	3.9341704978082905
FINAL ASSESSMENT	3.932635012897729
FINE STRUCTURE	3.932618677732821
SIGNAL CONTRIBUTION	3.932154653922543
POST INFECTION	3.9321186974274247
INTRACELLULAR THIAMINE CONCENTRATION	3.931573129887346
BINDING PROTEIN POLYHEDRIN PROMOTER	3.931135365654098
PLASMID DNA REPLICATION INTERMEDIATE	3.9303606413320256
focal contacts	3.9302794964462713
OXIDE SYNTHASE	3.9302794964462713
U BASE-PAIRING	3.9302794964462713
RECRUIT DSH FZ	3.9302794964462713
STRUCTURE LINKS	3.9300830349670406
TUMOR REJECTION	3.9300830349670406
CYTOKINE IL-1Β	3.92900965517643
QUALITY FIGURE	3.92900965517643
TRIS PH	3.928714052470869
BIOMOL RESEARCH	3.9284610259030526
C3 TRANSFERASE	3.927665117361304
ΜL LYSIS BUFFER	3.9273202707752404
PURIFIED C3 ΜG	3.9267239408907164
ETHANOL SERIES	3.926723940890716
HOMOLOGOUS EST	3.9265311698063785
DP CALCULATION	3.9262390924058677
C2	3.925913059041983
E6	3.925913059041983
VALINE DISADVANTAGE	3.925384676191737
MMP PRODUCTION	3.924535261645433
DMSO TREATMENT	3.9237488842013737
COULTER COUNTER	3.9232705968982904
PREVIOUS AUTHOR	3.9232705968982904
CELLS ADHERENT	3.92311103766491
LABELED BAND	3.9229334901774595
lamellipodia	3.9229334901774595
RECONSTITUTE	3.9229334901774595
LABELING MIX	3.9229334901774595
proline-rich	3.9229334901774595
CONDENSATION	3.9229334901774595
ANTIPARALLEL	3.9229334901774595
INPUT/OUTPUT	3.9229334901774595
CELL LINEAGE	3.9229334901774595
GAIN INSIGHT	3.9229334901774595
conformation	3.9229334901774595
CYCLING CELL	3.9229334901774595
LEUCINE-RICH	3.9229334901774595
ORIGINAL SET	3.9229334901774595
VARIOUS LINE	3.9229334901774595
expectations	3.9229334901774595
STRESS FIBER	3.9229334901774595
condensation	3.9229334901774595
EXPERIMENTER	3.9229334901774595
HUMAN PLASMA	3.9229334901774595
UNRESPONSIVE	3.9229334901774595
PREREQUISITE	3.9229334901774595
melanogaster	3.9229334901774595
counterparts	3.9229334901774595
DEGENERATION	3.9229334901774595
DIMERIC FORM	3.9229334901774595
LEAD CITRATE	3.9229334901774595
DELIVERY VEHICLE	3.9227066200371516
III1-C ABSENCE	3.922479042931532
MHCK-C ABSENCE	3.922479042931532
3T3 FIBROBLAST	3.922157669035104
GENERATING COMBINATORIAL DIVERSITY	3.922111493221552
STOICHIOMETRIC-TITRATION CONDITION	3.922111493221552
ENDONUCLEASE G	3.9219334881002634
MODELING SERVER SWISS-MODEL PROTEIN	3.9218235962012353
LABELING KIT	3.9215995793313296
enhancements	3.9215995793313296
GENE CLUSTER	3.9215995793313296
SURVEILLANCE	3.9215995793313296
NON-SPECIFIC	3.9215995793313296
inactivation	3.9215995793313296
FASTA FORMAT	3.9215995793313296
NUCLEASE DNASE	3.921390607557383
S-PHASE ARREST	3.921390607557383
XNOC HOMOLOGUE	3.921390607557383
DECLINING PCNA	3.921390607557383
BLM N-TERMINUS	3.921390607557383
ACTIVITY REACH	3.921390607557383
GLYCEROL GRADIENT SEDIMENTATION ANALYSIS	3.9213462744924548
ΜG/ML GENETICIN	3.9200367694031764
MYOSIN ABSENCE	3.919821235622562
EXPERIMENTAL ONE	3.9197281021789787
UNPROCESSED FORM	3.9197281021789787
SPECIFICITY DROP	3.9197281021789787
MM TRIS BUFFER	3.919534007178971
APROTININ/ML MG	3.9187289715191227
FLUCTUATING EXTRACELLULAR THIAMINE	3.918580561096633
LPS STIMULATION	3.9184091387459423
DESIRED MANNER	3.918253352655422
ICE-COLD REAGENT	3.9175167783145777
ATP PRODUCTION	3.9174166175776364
BURST RESPONSE	3.9173296938517987
EE ANTIBODY ΜG	3.9166925929283334
NEO ABBREVIATION	3.9159372612685766
TPA ABBREVIATION	3.9159372612685766
PCDNA3 PLASMID	3.9156170078707397
KEY ACTIVATION	3.915402617053263
GENOMIC DATA	3.9152184026366625
output	3.91516905730148
PROTEIN A/G ΜL	3.9144462146494394
site mutations	3.91434658240015
HYAL-1 ABILITY	3.913633031799807
III1-C ABILITY	3.913633031799807
C/EBPΑ ABILITY	3.913633031799807
SLIGHT ABILITY	3.913633031799807
HYAL-2 ABILITY	3.913633031799807
investigators	3.9134631525732777
ΔN1 CELL LINE	3.9134631525732777
FBOOTH SAMPLE	3.9134631525732777
TARGETING CRE	3.9134631525732777
MISEXPRESSION	3.9134631525732777
ABSOLUTE CALL	3.9134631525732777
BPNN APPROACH	3.9134631525732777
SOMITE BORDER	3.9134631525732777
FACT THATGPNN	3.9134631525732777
CONSENSUS GRE	3.9134631525732777
VARIANCE DATA	3.9134631525732777
NORMAL RHYTHM	3.9134631525732777
FUNCTIONAL FA	3.9134631525732777
B. VOGELSTEIN	3.9134631525732777
KNOWLEDGE GAP	3.9134631525732777
FILAMENT FORM	3.9134631525732777
MATCHING STEP	3.9134631525732777
IN VITRO FAIL	3.9134631525732777
X. LAEVIS BLM	3.9134631525732777
STANFORD TYPE	3.9134631525732777
LEADER REGION	3.9134631525732777
LINKING RAB24	3.9134631525732777
INPUT LIBRARY	3.9134631525732777
PROTEINS SHOW	3.9134631525732777
NEGATIVE RATE	3.9134631525732777
UNTRANSFORMED	3.9134631525732777
MAJORITY POLL	3.9134631525732777
NEURAL GROOVE	3.9134631525732777
INTERNAL NODE	3.9134631525732777
CYTOMETER SET	3.9134631525732777
STRUCTURETHAT	3.9134631525732777
BMP-REGULATED	3.9134631525732777
ANTI-COLL III	3.9134631525732777
GLUCOSE/LITER	3.9134631525732777
SEALED MARGIN	3.9134631525732777
INCREASED OCL	3.9134631525732777
GFP-N280 MASK	3.9134631525732777
AMIA CLEAVAGE	3.9134631525732777
ADDED BENEFIT	3.9134631525732777
IGG RHODAMINE	3.9134631525732777
FOUNDER MOUSE	3.9134631525732777
compositional	3.9134631525732777
BIGT SEQUENCE	3.9134631525732777
PHYSICAL STEP	3.9134631525732777
THISCRITERION	3.9134631525732777
NEGATIVE CELL	3.9134631525732777
NEW BASE PAIR	3.9134631525732777
LACKING THY-1	3.9134631525732777
RELEASABLE LH	3.9134631525732777
DENUDED SPACE	3.9134631525732777
THROMBIN PLAY	3.9134631525732777
BLOTTING STEP	3.9134631525732777
SCANNING CRNA	3.9134631525732777
RPMB ESTIMATE	3.9134631525732777
IAP INSERTION	3.9134631525732777
MACHINE NOISE	3.9134631525732777
SPHINGOMYELIN	3.9134631525732777
CAMERA LUCIDA	3.9134631525732777
C/EBPΑ ARREST	3.9134631525732777
KODAK WRATTEN	3.9134631525732777
STEP FUNCTION	3.9134631525732777
COMPUTER TOOL	3.9134631525732777
STARRED VALUE	3.9134631525732777
Β-BARREL CORE	3.9134631525732777
PROCESS IMAGE	3.9134631525732777
THEREFOREHAVE	3.9134631525732777
FLEXION POINT	3.9134631525732777
FLANKING KPNI	3.9134631525732777
PARAMETER SET	3.9134631525732777
REPORTS SCORE	3.9134631525732777
ALLOWED SMAD1	3.9134631525732777
AVERAGE LEVEL	3.9134631525732777
GENETICFACTOR	3.9134631525732777
YIELDED RATIO	3.9134631525732777
INCLUDING ROW	3.9134631525732777
MATCHED PROBE	3.9134631525732777
LINE-1 REPEAT	3.9134631525732777
DNASE-TREATED	3.9134631525732777
SEQUENCE MAPS	3.9134631525732777
MARTINS-GREEN	3.9134631525732777
NONSTRUCTURAL	3.9134631525732777
RAB24 CHIMERA	3.9134631525732777
ANION RADICAL	3.9134631525732777
MISMATCH CELL	3.9134631525732777
IN SILICO NUO	3.9134631525732777
GLUCOSE RATIO	3.9134631525732777
FLANKING PEAK	3.9134631525732777
DISTINCT TYPE	3.9134631525732777
DEGRANULATION	3.9134631525732777
CRINKLED EDGE	3.9134631525732777
DEVELOPING CN	3.9134631525732777
BDM PHENOCOPY	3.9134631525732777
CHAMBER SLIDE	3.9134631525732777
RAB STRUCTURE	3.9134631525732777
LENS CELL-ECM	3.9134631525732777
FOCUSED SIGHT	3.9134631525732777
CELL INGROWTH	3.9134631525732777
CAUSED ARREST	3.9134631525732777
CURRENT STAGE	3.9134631525732777
SUBSEQUENTIAL	3.9134631525732777
DATA TOSELECT	3.9134631525732777
NON-SECTORING	3.9134631525732777
SEQUENCES FIT	3.9134631525732777
FINITE-LENGTH	3.9134631525732777
ERRONEOUS RIO	3.9134631525732777
PUBLIC DOMAIN	3.9134631525732777
p53-dependent	3.9134631525732777
UNGAPPED CASE	3.9134631525732777
ORDER PATHWAY	3.9134631525732777
IMMUNOTHERAPY	3.9134631525732777
RELEVANT GENE	3.9134631525732777
POWDERED DIET	3.9134631525732777
TIME CATEGORY	3.9134631525732777
RANDOM PRIMER	3.9134631525732777
glycosylation	3.9134631525732777
CELLULAR MASS	3.9134631525732777
HUVEC CULTURE	3.9134631525732777
SUBCONFLUENCE	3.9134631525732777
TRYPINIZATION	3.9134631525732777
SAMPLE T-TEST	3.9134631525732777
MARKOV FORMAT	3.9134631525732777
G/L RAFFINOSE	3.9134631525732777
DESIRED BLAST	3.9134631525732777
ARCHITECTUREI	3.9134631525732777
NASAL OPENING	3.9134631525732777
USER FEEDBACK	3.9134631525732777
CURRENT UNMET	3.9134631525732777
QUIKCHANGE XL	3.9134631525732777
TIME ESTIMATE	3.9134631525732777
RANK RELATIVE	3.9134631525732777
solutionsfrom	3.9134631525732777
INCREASING TN	3.9134631525732777
PLATORHYNCHUS	3.9134631525732777
ΔC2 CELL LINE	3.9134631525732777
GENE ONTOLOGY	3.9134631525732777
POMPANO BEACH	3.9134631525732777
NUMERIC ORDER	3.9134631525732777
SPATIAL POINT	3.9134631525732777
SEQUENCE COST	3.9134631525732777
PRE-REQUISITE	3.9134631525732777
GENE KNOCKOUT	3.9134631525732777
RE-INSPECTION	3.9134631525732777
GQΑ RGS3 BIND	3.9134631525732777
INCREASED PPP	3.9134631525732777
PLATING RASMC	3.9134631525732777
MORPHOLOGCIAL	3.9134631525732777
DEREPLICATION	3.9134631525732777
REASSOCIATION	3.9134631525732777
phenylalanine	3.9134631525732777
DEVELOPING SC	3.9134631525732777
LINEAL SISTER	3.9134631525732777
PUNCTATE BODY	3.9134631525732777
COREGENES FIT	3.9134631525732777
keratinocytes	3.9134631525732777
TRANSMEMBRANE	3.9134631525732777
CHARGE STATUS	3.9134631525732777
PRE-FILTERING	3.9134631525732777
ACTIVATED PKB	3.9134631525732777
DSP-TSB-FIXED	3.9134631525732777
THEBPNN MODEL	3.9134631525732777
TIRF-RESOLVED	3.9134631525732777
E-VALUE SCORE	3.9134631525732777
VENDORS OFFER	3.9134631525732777
CELL INVASION	3.9134631525732777
ΔN4 CELL LINE	3.9134631525732777
PYKNOTIC CELL	3.9134631525732777
THEPROPORTION	3.9134631525732777
HEALING EVENT	3.9134631525732777
DFZ2 ACTIVITY	3.9134631525732777
THREE-MYC BID	3.9134631525732777
PP5 INFLUENCE	3.9134631525732777
SAMPLING BIAS	3.9134631525732777
SECRETED CD68	3.9134631525732777
PP1 STRUCTURE	3.9134631525732777
CUT PGEX-4T-1	3.9134631525732777
FALL RELATIVE	3.9134631525732777
GP120 RESIDUE	3.9134631525732777
SAMPLE MEDIAN	3.9134631525732777
TRIETHYLAMINE	3.9134631525732777
NUMBEROF NODE	3.9134631525732777
MG/L L-LYSINE	3.9134631525732777
CRITICAL SITE	3.9134631525732777
SIGNIFICANTIN	3.9134631525732777
FBA METABOLIC	3.9134631525732777
nonfunctional	3.9134631525732777
TARGET C/EBPΑ	3.9134631525732777
GP120 SURFACE	3.9134631525732777
NUMERICAL USM	3.9134631525732777
NON-COAGULANT	3.9134631525732777
CED8 FUNCTION	3.9134631525732777
TESTING ERROR	3.9134631525732777
OVER-TRAINING	3.9134631525732777
DIETARY GROUP	3.9134631525732777
FAMILIAR TERM	3.9134631525732777
FRAME GRABBER	3.9134631525732777
MEMORY LENGTH	3.9134631525732777
depolymerizes	3.9134631525732777
QUASI MEASURE	3.9134631525732777
M2 MONOCLONAL	3.9134631525732777
INDUCING TRAF	3.9134631525732777
OPTIONALINPUT	3.9134631525732777
STANDARD RDBM	3.9134631525732777
GRAVID FEMALE	3.9134631525732777
FORMALIZATION	3.9134631525732777
POSITIVE CALL	3.9134631525732777
BRACKETS LINK	3.9134631525732777
BULGING LIVER	3.9134631525732777
NON-ELONGATED	3.9134631525732777
WITHINA RANGE	3.9134631525732777
IIVX COMPUTER	3.9134631525732777
EXPANDED LIST	3.9134631525732777
INTERNAL VIEW	3.9134631525732777
CLONAL EMBRYO	3.9134631525732777
NLS-GFP IMAGE	3.9134631525732777
DISEASE MODEL	3.9134631525732777
V/CAPACITANCE	3.9134631525732777
DOMAIN SEARCH	3.9134631525732777
NIDDK-RLH-L-9	3.9134631525732777
MASSIVE ARRAY	3.9134631525732777
GOAT SERUM/PB	3.9134631525732777
COMPLETE FILE	3.9134631525732777
GENBANK ENTRY	3.9134631525732777
OCL PRECURSOR	3.9134631525732777
SSV STABILITY	3.9134631525732777
sphingomyelin	3.9134631525732777
CITRUS UNSHIU	3.9134631525732777
ECTOPIC UNC-6	3.9134631525732777
SEQUENCE LIST	3.9134631525732777
SHOW MODERATE	3.9134631525732777
CONTRIBUTIONS	3.9134631525732777
THERMODYNAMIC	3.9134631525732777
TOLUDINE BLUE	3.9134631525732777
VENTRAL TRUNK	3.9134631525732777
PENTOBARBITOL	3.9134631525732777
III1-C-COATED	3.9134631525732777
UNIX COMPUTER	3.9134631525732777
DISSEMINATION	3.9134631525732777
TOP-LEVEL GUI	3.9134631525732777
G/L GALACTOSE	3.9134631525732777
VARYINGDEGREE	3.9134631525732777
PATHWAYS FALL	3.9134631525732777
PHOSPORIMAGER	3.9134631525732777
NONSTOCHASTIC	3.9134631525732777
CAUSE VESICLE	3.9134631525732777
PICKED ROLLER	3.9134631525732777
NIKON ECLIPSE	3.9134631525732777
(GFP)-LABELED	3.9134631525732777
RESULTING GAP	3.9134631525732777
MINIMUM RANGE	3.9134631525732777
ADEASY SYSTEM	3.9134631525732777
PHARYNX FLOOR	3.9134631525732777
CLINICAL DATA	3.9134631525732777
GROUP PATIENT	3.9134631525732777
WORKING MODEL	3.9134631525732777
E15 PRIMORDIA	3.9134631525732777
ORIGINAL SIZE	3.9134631525732777
MUTATING F266	3.9134631525732777
PANEL NETWORK	3.9134631525732777
rearrangement	3.9134631525732777
DRIED EXUDATE	3.9134631525732777
MODIFIED GENE	3.9134631525732777
DDHL-5 MEDIUM	3.9134631525732777
REPEATABILITY	3.9134631525732777
ELEMENT IMAGE	3.9134631525732777
OPTIMAL STAGE	3.9134631525732777
OTHER HOMOLOG	3.9134631525732777
GENETICEFFECT	3.9134631525732777
INCLUDED PER1	3.9134631525732777
GAL4-SRF BIND	3.9134631525732777
DELTA/EPSILON	3.9134631525732777
cysteine-rich	3.9134631525732777
SEQUENCE BIAS	3.9134631525732777
ACCOMMODATION	3.9134631525732777
PBS/EDTA/PMSF	3.9134631525732777
HOMO-OLIGOMER	3.9134631525732777
C/EBPΑ FUSION	3.9134631525732777
IMPORT/EXPORT	3.9134631525732777
CELL LINE AX2	3.9134631525732777
EXPRESSED TAG	3.9134631525732777
MUSCULAR DISC	3.9134631525732777
discrepancies	3.9134631525732777
PROTEINS PLAY	3.9134631525732777
RECRUITING E2	3.9134631525732777
GENECHIP DATA	3.9134631525732777
C/EBPΒ RESULT	3.9134631525732777
THY-1 VESICLE	3.9134631525732777
COMPATIBILITY	3.9134631525732777
produced gene	3.9134631525732777
TRUE-POSITIVE	3.9134631525732777
MNOCIN BALB/C	3.9134631525732777
OLYMPUS IMT-2	3.9134631525732777
IN SITU INDEX	3.9134631525732777
REDUCED YIELD	3.9134631525732777
DRIVING FORCE	3.9134631525732777
ROTATING OVEN	3.9134631525732777
OPTIMAL INPUT	3.9134631525732777
REORIENTATION	3.9134631525732777
FLANKING BASE	3.9134631525732777
MAJORITY VOTE	3.9134631525732777
TGF-Β/ACTIVIN	3.9134631525732777
GALACTOSIDASE	3.9134631525732777
TARGETED BAND	3.9134631525732777
SEQUENCE YQXP	3.9134631525732777
LACKING DELTA	3.9134631525732777
YIELD INSIGHT	3.9134631525732777
GRANULE LAYER	3.9134631525732777
MITOTIC PHASE	3.9134631525732777
FEEDING HABIT	3.9134631525732777
3-D PLACEMENT	3.9134631525732777
MM BACITRACIN	3.9134631525732777
SEQUENCE LINE	3.9134631525732777
GENETIC DRIFT	3.9134631525732777
COLOR VARIANT	3.9134631525732777
POSSIBLE PATH	3.9134631525732777
PSI PARAMETER	3.9134631525732777
PML-DEPENDENT	3.9134631525732777
BACTERIAL XTH	3.9134631525732777
CO-OCCURRENCE	3.9134631525732777
GIVING ORIGIN	3.9134631525732777
TM CELL DEATH	3.9134631525732777
DELAYED WOUND	3.9134631525732777
EXPRESSED CRE	3.9134631525732777
REQUIRED TIME	3.9134631525732777
TERTIARY-LIKE	3.9134631525732777
PATTERNS SHOW	3.9134631525732777
CIRCUMFERENCE	3.9134631525732777
learning rule	3.9134631525732777
CAENORHABDITI	3.9134631525732777
GASTROCNEMIUS	3.9134631525732777
SHARE PROFILE	3.9134631525732777
EXCHANGE FLUX	3.9134631525732777
HEMOCYTOMETER	3.9134631525732777
F266 MUTATION	3.9134631525732777
HEMISPHERICAL	3.9134631525732777
STRIPE MODULE	3.9134631525732777
insensitivity	3.9134631525732777
SPREAD BS-C-1	3.9134631525732777
APPROACH WORK	3.9134631525732777
GENUS/SPECIES	3.9134631525732777
CONSTANT TERM	3.9134631525732777
PUTATIVE GENE	3.9134631525732777
INACTIVE FORM	3.9134631525732777
REUTILIZATION	3.9134631525732777
PREDICTEDFROM	3.9134631525732777
PVL1393-PAI-1	3.9134631525732777
TARGETING PP5	3.9134631525732777
III1-C RESULT	3.9134631525732777
PISUM SATIVUM	3.9134631525732777
'-EXONUCLEASE	3.9134631525732777
CHIMERAS SHOW	3.9134631525732777
FLANKING LOXP	3.9134631525732777
TUBULIN LEVEL	3.9134631525732777
BOI1-KKTK-GFP	3.9134631525732777
ENTERED QUERY	3.9134631525732777
VALUABLE TOOL	3.9134631525732777
FLEXIBLE-BETA	3.9134631525732777
IN SILICO PTA	3.9134631525732777
BPSEQ DISPLAY	3.9134631525732777
Ρ-INDEPENDENT	3.9134631525732777
STANDARD ROOM	3.9134631525732777
RECRUITING TF	3.9134631525732777
CARBOXYKINASE	3.9134631525732777
WHATMAN PAPER	3.9134631525732777
PARALLEL GENE	3.9134631525732777
neutral drift	3.9134631525732777
JUSTIFICATION	3.9134631525732777
UNGAPPED SEED	3.9134631525732777
forevaluating	3.9134631525732777
MFOLD PROGRAM	3.9134631525732777
MACROMOLECULE	3.9134631525732777
ELECTROFUSION	3.9134631525732777
CRANIAL LEVEL	3.9134631525732777
EOSIN SECTION	3.9134631525732777
ΔN3 CELL LINE	3.9134631525732777
neuroectoderm	3.9134631525732777
SMG DYSPLASIA	3.9134631525732777
MEMORY-SAVING	3.9134631525732777
visualization	3.9134631525732777
ELECTROPORATE	3.9134631525732777
WAVE FUNCTION	3.9134631525732777
TN DEPOSITION	3.9134631525732777
PREPROCESSING	3.9134631525732777
DISEASE STATE	3.9134631525732777
LINEAL MOTHER	3.9134631525732777
CHOOSING GENE	3.9134631525732777
INDIVIDUAL TF	3.9134631525732777
SAMPLES SPLIT	3.9134631525732777
MARGINALIZING	3.9134631525732777
RHODAMINE-IGG	3.9134631525732777
C-TYPE LECTIN	3.9134631525732777
MUSCLE TISSUE	3.9134631525732777
NIDDK-RLH-RP3	3.9134631525732777
MATLAB FORMAT	3.9134631525732777
MANUFACTURERS	3.9134631525732777
translocation	3.9134631525732777
GENETIC MODEL	3.9134631525732777
normalization	3.9134631525732777
NON-REDUNDANT	3.9134631525732777
SΑ I2 DISPLAY	3.9134631525732777
disadvantages	3.9134631525732777
EXPECTED SIZE	3.9134631525732777
MAXIMUMNUMBER	3.9134631525732777
AQUEOUS HUMOR	3.9134631525732777
MODEL FITTING	3.9134631525732777
FINDS PORTION	3.9134631525732777
APE1 ACTIVITY	3.9134631525732777
BONE RESORBED	3.9134631525732777
MOUNTAIN VIEW	3.9134631525732777
EXPOSURE TIME	3.9134631525732777
ENRICHED HL-5	3.9134631525732777
GOLD-STANDARD	3.9134631525732777
RNEASY COLUMN	3.9134631525732777
LABELED PROBE	3.9134631525732777
STRATEGY MAKE	3.9134631525732777
PLL COVERSLIP	3.9134631525732777
MUTATING TBID	3.9134631525732777
BRIEF MENTION	3.9134631525732777
DIPHOSPHANATE	3.9134631525732777
CELLS DISPLAY	3.9134631525732777
establishment	3.9134631525732777
APPLYING SCFG	3.9134631525732777
WALLAC VICTOR	3.9134631525732777
PELLUCID AREA	3.9134631525732777
PHTOTOGRAPHED	3.9134631525732777
AFFYMETRIX MA	3.9134631525732777
TRAINING TIME	3.9134631525732777
MELANOMA LINE	3.9134631525732777
GNRH-RECEPTOR	3.9134631525732777
NON-REGULATED	3.9134631525732777
BOVINE EMBRYO	3.9134631525732777
TERTIARY BASE	3.9134631525732777
CELL LINE FLG	3.9134631525732777
INSENSITIVITY	3.9134631525732777
INCLUDED HUGO	3.9134631525732777
NEEDS/CONCERN	3.9134631525732777
FUSION MEDIUM	3.9134631525732777
FEMALE BIOPSY	3.9134631525732777
CASCADE CDC42	3.9134631525732777
PARP CLEAVAGE	3.9134631525732777
interpolation	3.9134631525732777
STAT3 PATHWAY	3.9134631525732777
DIAGONAL LINE	3.9134631525732777
DBD NOTI SITE	3.9134631525732777
ACTIN-BINDING	3.9134631525732777
MINIMUM SCORE	3.9134631525732777
VARIABLE GENE	3.9134631525732777
BLOCKED V-CRK	3.9134631525732777
DEHANASEKARAN	3.9134631525732777
T-TEST METHOD	3.9134631525732777
ANTICIPATETHI	3.9134631525732777
TISSUE BIOPSY	3.9134631525732777
PAIR-HMM IDEA	3.9134631525732777
POOLING SERVE	3.9134631525732777
EASTMAN KODAK	3.9134631525732777
HETEROCOMPLEX	3.9134631525732777
ALTHOUGHTHERE	3.9134631525732777
LENGTH FUSION	3.9134631525732777
GAP FREQUENCY	3.9134631525732777
COLD METHANOL	3.9134631525732777
CARBON SOURCE	3.9134631525732777
BASIDIOMYCOTA	3.9134631525732777
REDUCING CELL	3.9134631525732777
MARGINAL CELL	3.9134631525732777
MUTATION LEAD	3.9134631525732777
COLLAGEN/CELL	3.9134631525732777
MUTATION DATA	3.9134631525732777
DIFFERENT RAB	3.9134631525732777
SIMILARRESULT	3.9134631525732777
ACHIEVED RATE	3.9134631525732777
CONDITION SET	3.9134631525732777
POLYGLUTAMINE	3.9134631525732777
SAMPLING TIME	3.9134631525732777
GDP-BOUND RAB	3.9134631525732777
DEGRADED WOX1	3.9134631525732777
RAB24 PORTION	3.9134631525732777
SUBMANDIBULAR	3.9134631525732777
COSTIMULATORY	3.9134631525732777
YEAST BIOLOGY	3.9134631525732777
STREAM TARGET	3.9134631525732777
VARIABLE COPY	3.9134631525732777
POB1 FUNCTION	3.9134631525732777
CHRIS MUNGALL	3.9134631525732777
POSSIBLE FORM	3.9134631525732777
DE-EMPHASIZED	3.9134631525732777
POSSIBLE CASE	3.9134631525732777
SONY DKC-5000	3.9134631525732777
POSTERODORSAL	3.9134631525732777
integrins act	3.9134631525732777
FOLD INCREASE	3.9134631525732777
REPLACING S67	3.9134631525732777
PATHWAY MODEL	3.9134631525732777
P53-DEPENDENT	3.9134631525732777
TGF-Β PATHWAY	3.9134631525732777
TF COMPLEMENT	3.9134631525732777
CED7 FUNCTION	3.9134631525732777
HYOMANDIBULAR	3.9134631525732777
SIMULATEDDATA	3.9134631525732777
dinucleotides	3.9134631525732777
PUBMED SEARCH	3.9134631525732777
PINEAL TISSUE	3.9134631525732777
NON-EXCLUSIVE	3.9134631525732777
ADDING S-2238	3.9134631525732777
TNF-RESISTANT	3.9134631525732777
KARYOPHERIN-Β	3.9134631525732777
DIVERSE VIRUS	3.9134631525732777
HISTOCHEMICAL	3.9134631525732777
K-MEAN METHOD	3.9134631525732777
PASSAGE NUMBER	3.9131854793522542
N5 EXPRESSION	3.912829945021315
TIRF ANALYSIS	3.9122986546312184
TREE ANALYSIS	3.9122986546312184
FLUX ANALYSIS	3.9122986546312184
MASS ANALYSIS	3.9122986546312184
CELL SURFACE RECEPTOR	3.912213620451482
SEQUENCE MAP	3.9120416018845696
STATISTICS TEST	3.91199483733622
RRNAS, LNCAP M	3.9119788428515
cell suspensions	3.9117698085324313
BOOTSTRAP MEAN	3.9114177078283854
INFECTED SF9 INSECT CELL BACULOVIRUS	3.9113847593539597
CONTROL FEMUR	3.911237004085752
C/EBP CONTROL	3.911237004085752
CONTROL VALUE	3.911237004085752
CONTROL MOUSE	3.911237004085752
TOXIC MISFOLDED	3.9111595958871783
SIMILAR STUDY	3.91105891220675
CYK ALGORITHM	3.9109096293081738
HMM ALGORITHM	3.9109096293081738
RESCUE MYOSIN	3.9108672119781893
MYOSIN TARGET	3.9108672119781893
INDUCER ABSENCE	3.910757955547524
DISULFIDE BOND	3.910723940890716
BINDING ACTIVITY ATP DEPENDENT DNA	3.9103823903372716
MUTANT MOUSE	3.9103321805274915
ORIGIN CHANGE	3.910260783232615
VOLUME CHANGE	3.910260783232615
MAKING CHANGE	3.910260783232615
HYAL-2 EFFECT	3.9100658564031834
P27 RNA LEVEL	3.9099049644169854
HUMAN E1	3.9097716387193726
FIND CORRELATION	3.909619193084573
LABELED ACTIN	3.909134187924404
PQE-12 VECTOR	3.909048586928522
FINAL SOLUTION	3.908976238300908
BFGF PROMOTER	3.908839613406877
PROMOTER SHOW	3.908839613406877
TLX2 PROMOTER	3.908839613406877
GAL1 PROMOTER	3.908839613406877
ALANINE MUTANT	3.90876434493112
SΑ I2 PROTEIN	3.9085862070277555
MATING SIGNAL	3.9084056890190917
WNT/WG SIGNAL	3.9084056890190917
SIGNAL SENSOR	3.9084056890190917
MUTANT TYPE I	3.9083986647641558
FN MRNA LEVEL	3.9083892686828774
P53 STABILITY	3.9082712713831
ACTIVATED P53	3.9082712713831
NONCODING RNA	3.90812587033884
CONSERVED RNA	3.90812587033884
MESSENGER RNA	3.90812587033884
C-MYC ISO-FORM	3.908057274224049
BY/SNJ STRAIN	3.907921463785181
plasmid	3.9071700017150457
SRC KM/CAS(SD	3.9071617161287477
SRC SUBSTRATE	3.9071617161287477
W TAIL SYMBOL	3.907032056942646
PIGMENT EPITHELIUM-DERIVED FACTOR	3.9069848113917183
CONSENSUS MAP	3.906896949891583
PROHB-EGF MAP	3.906896949891583
RECEPTOR AXON	3.906668560233089
MAMMALIAN APE	3.906668560233089
CELL RECEPTOR	3.906668560233089
DFZ2 RECEPTOR	3.906668560233089
MGSA RECEPTOR	3.906668560233089
LEU2 REPORTER	3.906548301961581
REPORTER LINE	3.906548301961581
CELLULAR LIFE	3.906486562223977
GENOMIC STUDY	3.9064078519738823
TEST DATA SET	3.906278066420435
AZ INTERACTOR	3.9062281699888173
UNKNOWN MEMBER	3.906152512319287
UNKNOWN REASON	3.906152512319287
UNC-6 PROTEIN	3.9061477342549935
MEC-3 PROTEIN	3.9061477342549935
PROTEIN HSC73	3.9061477342549935
BOUND PROTEIN	3.9061477342549935
TGF-Β PROTEIN	3.9061477342549935
WTP53 PROTEIN	3.9061477342549935
WHOLE PROTEIN	3.9061477342549935
SPARC PROTEIN	3.9061477342549935
MAJOR PROTEIN	3.9061477342549935
HUMAN PROTEIN	3.9061477342549935
QUERY PROTEIN	3.9061477342549935
LEAVE PROTEIN	3.9061477342549935
CORTICAL FLOW	3.90609166088345
GLU351 MUTANT	3.905866420859595
C/EBPΑ MUTANT	3.905866420859595
ESCAPE MUTANT	3.905866420859595
MUTANT FUSION	3.905866420859595
IL-1BETA MRNA	3.9058523267376763
ATPASE	3.9055744823198966
INDUCED NF-ΚB	3.9052381197404173
GENOME CENTER	3.905031014597144
GENOME SCREEN	3.905031014597144
E-COLI GENOME	3.905031014597144
TARGET GENOME	3.905031014597144
divergence times	3.9047591406353397
DNA POLYMERAS	3.904665650720321
NONCODING DNA	3.904665650720321
DNA HISTOGRAM	3.904665650720321
DNA TITRATION	3.904665650720321
DNA SYNTHETIC	3.904665650720321
DNA SEQUENCER	3.904665650720321
DNA STABILITY	3.904665650720321
T CELL MARKER	3.9044817948822237
MTT ASSAY RAW	3.904194135739094
S2 CELL ASSAY	3.904194135739094
JELLYFISH GFP	3.9041610321075435
ESTROUS CYCLE	3.904105330787389
SERUM PROFILE	3.904010997906483
CLOSED SYMBOL	3.9038165091273305
PIPERAZINE- N	3.9036959260842563
GENOMIC CLONE	3.903637402809803
C-MYC PROMOTER	3.9033235464133984
BEAM COLLAGEN	3.903315384792476
COLLAGEN DISC	3.903315384792476
BIND COLLAGEN	3.903315384792476
COLLAGEN DISK	3.903315384792476
MOUSE EXON II	3.9032490595128637
sample solution	3.9031918320640777
PRIMARY GOAL	3.90276018734705
STANDARD TEST	3.9026855233440125
SEQUENCE TEST	3.9026855233440125
USE SELECTION	3.902457826951845
ANION-EXCHANGE COLUMN CHROMATOGRAPHY	3.902445912076565
UNKNOWN FACTOR	3.9020429232781915
RNA COMPONENT	3.9020213537832014
RNA TREATMENT	3.9017472734480503
ΜG CELL LYSATE	3.901723940890716
REACTION RATE	3.9017131056691916
GLYCOSAMINOGLYCAN	3.9015891281725854
SECRETION	3.9015115597892205
OPTIMIZING VIRAL MRNA TRANSLATION	3.901494051594527
UNIGEM-V CHIP	3.9014419507406357
PRIMARY EVENT	3.901301625427415
PRIMARY MEANS	3.901301625427415
PRIMARY FIELD	3.901301625427415
FUNCTIONAL PARTNERSHIP	3.9011003485755698
CEE CYTOTOXIC	3.900860279684218
COMPLEX CLOSE	3.900653675210627
DROSOPHILA FZ	3.900653675210627
COLI SEROTYPE	3.9004401839212495
WILD-TYPE TAG	3.899509971874676
FINAL VERSION	3.899509971874676
P53 DEPENDENT	3.89923799832967
EXAMPLE MOTIF	3.898993187404357
RELA ANTIBODY	3.898766385442462
FLAG ANTIBODY	3.898766385442462
GSK3 ANTIBODY	3.898766385442462
ANTIBODY 3G10	3.898766385442462
BINARY NUMBER	3.8987201691936226
GENERAL TREND	3.8987201691936226
GENERAL MODEL	3.8987201691936226
MYRISTIC ACID	3.898650297234478
SULFURIC ACID	3.898650297234478
SV BAC LIBRARY	3.8985334647002396
INTERNET INTERFACE	3.8984061093251343
DECADES-OLD PUZZLE	3.8984061093251343
MONOCYTIC	3.89820524945275
PHORBOL ESTER	3.898196531166854
NON-RRNA EXON	3.898142012982656
EXON SEQUENCE	3.898142012982656
FLANKING EXON	3.898142012982656
HETEROOLIGOMERIZING F-BOX PROTEIN	3.898106246724392
PCR ANALYSIS	3.8980614065290635
NON-STEROIDAL ANTI-INFLAMMATORY DRUG	3.8977918795795836
TM MACROPHAGE	3.8975166603463043
LIPID VESICLE	3.89729670872938
FINAL CONTROL	3.8972838233871494
GROWTH DEFECT	3.89711632999751
TISSUE GROWTH	3.89711632999751
BETTER GROWTH	3.89711632999751
PRIMARY CELL	3.8966360048507105
SINGLE C/EBPΑ	3.896208746157341
SINGLE MASTER	3.896208746157341
ANTI-RABBIT HRP	3.896020844623288
CELL HOMOGENATE	3.896020844623288
CELLS GROWTH	3.895817701331145
RECEPTOR CDNA	3.895558918728989
DEPENDENT MANNER	3.895167816983867
MAXIMUM SCORE	3.895077785064532
KINASE ASSAY	3.8948758562829755
MULTIPLE STEP	3.894691305867651
MULTIPLE STEM	3.894691305867651
MULTIPLE COPY	3.894691305867651
MULTIPLE SITE	3.894691305867651
PLAY MULTIPLE	3.894691305867651
MULTIPLE CELL	3.894691305867651
MULTIPLE RDNA	3.894691305867651
MULTIPLE GENE	3.894691305867651
MULTIPLE PAIR	3.894691305867651
MURINE HYAL-2	3.894634764160707
MURINE SPLEEN	3.894634764160707
ΜL CELL LYSATE	3.8944393880451873
OPG SECRETION	3.894169865681384
STOCK CULTURE	3.893928699595235
ERK1 EFFECTOR	3.893928699595235
STUDY SUPPORT	3.8936949540040446
INCREASED ERK	3.893681428038551
MOLECULE BIND	3.893298555950782
HRS INCUBATION	3.893091287829492
HELPER T-CELL	3.892900570491128
ΜM PHALLOIDIN	3.8924480931347967
ΜM NIGERICINE	3.8924480931347967
ADHESIVE SITE	3.892344825029448
SINGLE FACTOR	3.8921948174632224
MURINE T CELL	3.89192953594051
NITROGEN BASE	3.8917582048198973
ES CELL CLONE	3.891735508813184
CYTOSOLIC RNA	3.891500803974548
SPECIES GROUP	3.8912963974208887
OUTPUT WINDOW	3.8911380634555144
ENZYME MHCK-C	3.8910465671886385
ENZYME MHCK-A	3.8910465671886385
ENZYME FAMILY	3.8910465671886385
RPM MODE METHOD	3.8909745942019907
COMMON METHOD	3.8905935490867884
COMMON DOMAIN	3.8905935490867884
POOLED STOCK	3.8905301225061133
WARFARE AGENT	3.890481443187345
RRNA MOLECULE	3.890327536486441
acid sequencing	3.89009698543307
DISTAL REGION	3.889785027751408
RNAS CONSERVE	3.889785027751408
RNAS POSSIBLE	3.889785027751408
PLASMID PGBT9	3.889705034086469
PJC10 PLASMID	3.889705034086469
PBIGT PLASMID	3.889705034086469
PLASMID PJC10	3.889705034086469
PLASMID PBIGT	3.889705034086469
RESOLVING GEL	3.8896648342243934
ΜM OLEIC ACID	3.88957787605509
MM K-PIPES PH	3.8893989713684425
GOLGI PROTEIN	3.8883891406385915
G1 REGULATION	3.888257406795158
PERFORMED JNK	3.888257406795158
GAMMA SUBUNIT	3.888257406795158
SMALL SUBUNIT	3.888257406795158
MG/ML HOECHST	3.8878441978479756
EXCESS NUMBER	3.8874172152692212
HIV STRAIN RF	3.8871200522472504
COMMON FACTOR	3.886579620392671
TRANSFER RNA	3.885903269578939
DETECTING EYFP	3.885835052001827
BEGR HEAD NODE	3.885835052001827
SIMILAR REVIEW	3.885835052001827
MONOCYTIC LINE	3.885835052001827
MORPHOLOGICAL CHANGE	3.8857100184043727
MRNA MOLECULE	3.8856877301151815
OXYGEN SPECIES	3.885362238763056
HOMOLOGY MODEL	3.884157903154867
NEURON SUBSET	3.884059898227565
FN PRODUCTION	3.8839771858139684
IMMUNOPRECIPITATION EXPERIMENT	3.8839268906384565
WNT CO-RECEPTOR	3.8836345935891963
MHZ	3.8835818628273078
kinase domain	3.8834101479916736
PEAK ABUNDANCE	3.883295369462145
MAINTAINING G	3.883019849230874
FRACTION PEAK	3.8829703479246263
PEAK FRACTION	3.8829703479246263
DATA FRACTION	3.8829703479246263
INHIBITOR P21	3.882820873392035
P21 INHIBITOR	3.882820873392035
EPITOPE TAG	3.8826225303267883
CD14 MONOCYTE	3.8822080278084092
CALCULATING P	3.8822080278084092
CORIMBIA HTTP	3.8822080278084092
NG/ML PDGF-BB	3.8822080278084092
ΜG/ML HEPARIN	3.88215575411225
ORGANIC SOLVENT	3.8819956048872526
IL-8 RECEPTOR	3.881462814454969
3T3 CLONE A31	3.881073429215032
REACTIVE SITE	3.8809057309432067
RT-PCR RESULT	3.8809057309432067
MAJOR SUBGROUP	3.8806062938318924
EC INTERACTION	3.8805330975824046
PLAY KEY ROLE	3.8796372599706066
growth hormone	3.879201552831015
XENOPUS CODON	3.8789473897925255
Y-79 CELL CELL-SURFACE RECEPTOR	3.8786221233697353
TRNA ANALYSIS	3.878325692930275
STERIC HINDRANCE	3.878028852164556
BIORAD MACROPREP	3.878028852164556
NEURONAL FATE	3.877119984242036
WEEK OLD BALB/C	3.876556735855429
MYOSIN ATPASE	3.87639464789929
ENO INDUCTION	3.876254670710339
CELLS EXHIBIT	3.8755321759168844
RAB24 EXHIBIT	3.8755321759168844
BINDING FUNCTION DNA	3.875384106802688
ECFP REPORTER	3.8752931771967134
PRIMARY KINAS	3.8752556881233575
weight markers	3.874723940890716
MANUAL BINNING	3.874723940890716
PHOSPHATASE T1	3.874723940890716
CDK INHIBITION	3.874723940890716
CROSS SECTION	3.874394246617192
TOTAL LENGTH	3.8738374785542082
ANTI-ELK-1 AB	3.873392479797806
MONOCLONAL AB	3.873392479797806
RESEARCH GROUP	3.8731366393034143
RESEARCH PAPER	3.8731366393034143
NON-Q-WAVE MYOCARDIAL INFARCTION	3.8727374918180453
PRESERVE FINE	3.8723379884089777
endothelial injury	3.8722126057197563
P53 INDUCTION	3.8710627895201624
MITOCHONDRIAL FOLATE TRANSPORTER	3.8709663766652027
SUBJECT LEVEL	3.870647913169349
CHO CELL LINE	3.870053257066516
SPREADING 3T3	3.870053257066516
PCR REACTION	3.869092855470338
MEAN DISTANCE	3.868994479127327
Β-STRAND MOLEGO	3.868771092348285
CAUSE LETHALITY	3.868771092348285
actin	3.8685868005138118
edges	3.8685868005138118
CHARACTERIZED METALLO-Β-LACTAMAS	3.8682076248852586
MAX OPERATION	3.867499733801413
PEDF-AFFINITY COLUMN CHROMATOGRAPHY	3.867222595975295
HOST CELL TRANSLATION APPARATUS	3.866803132317132
HUMAN RETINOBLASTOMA Y-79 CELL	3.866210912548574
EXPORT SIGNAL	3.866021968662627
sp	3.8659130590419832
RNA EVOLUTION	3.8658892152511806
KINETIC STUDY PRE-STEADY STATE	3.8654416817793433
CBP REPRESSOR	3.863202981960818
LINK SOLUTION	3.863199063039133
BRDU SOLUTION	3.863199063039133
KEY CANDIDATE	3.862724313669271
BL21-CODONPLUS(DE3)-RIL STRAIN	3.862664813257794
ELK-1 ABSENCE	3.862434377446962
GSK3Β ABSENCE	3.862434377446962
ANTISENSE-TRANSFECTED AGGREGATE	3.8614138223605528
PROXIMAL GENE	3.861371277965164
NUCLEASE AREA	3.861371277965164
CEREVISIAE	3.8610155980276315
SERUM ALBUMIN	3.8606380887728204
FASL INITIATOR	3.8604382266050017
PBLUESCRIPT II	3.8604382266050017
THREONINE OPERON	3.8601577450155173
TOTAL PLASMID	3.8601073780591317
PORCINE ADULT	3.8576504297788707
ADULT ANATOMY	3.8576504297788707
AA ABBREVIATION	3.8562649743687025
TOXIC EXPOSURE	3.8562054223721978
ΜG/ML HYGROMYCIN	3.8561967840941773
B. MORI CADHERIN-LIKE RECEPTOR	3.855650247368344
ACID SYNTHASE	3.855240401727716
RISK/LOW RISK	3.85485979363915
RISK OMISSION	3.85485979363915
MG/L L-TRYPTOPHAN	3.8546512314554207
CONTAINING INTEIN ENDONUCLEASE	3.853834900172562
PH-20 ABILITY	3.853794278022166
SMAD4 ABILITY	3.853794278022166
BPAEC ABILITY	3.853794278022166
GPNN CANBE RUN	3.8535118196785945
GRADIENT SEDIMENTATION ANALYSIS	3.8522299911561104
CBP H1 DOMAIN	3.8515426223787275
TRANSPORT	3.851337680348978
RHABDOMYOSARCOMA CELL LINE RD	3.8511427776384344
BRUSH BORDER MEMBRANE VESICLE	3.8511427776384344
SERUM-FREE RPMI	3.850604590831617
SYMPTOMATIC MYOCARDIAL ISCHEMIA	3.8498236357715796
GENETICS FOCUS	3.848408151417032
EST SEQUENCED	3.8483483093131357
LDL OXIDATION	3.8483483093131357
ECL TECHNIQUE	3.8483483093131357
RESIDUAL PMSF	3.8483483093131357
MAXIMAL SIZE	3.8479742380292805
COHESIVE END	3.8479742380292805
OUTPUT ENTRY	3.8479742380292805
CV-1 LIBRARY	3.8479742380292805
STRIP-EZ KIT	3.8479742380292805
HETEROZYGOTE	3.8479742380292805
GROUP T-TEST	3.8479742380292805
PRE-ANALYTIC	3.8479742380292805
STREPTAVIDIN	3.8479742380292805
DEGRADING FN	3.8479742380292805
nonconserved	3.8479742380292805
CED-4 ELEGAN	3.8479742380292805
NEO FRAGMENT	3.8479742380292805
CONSTITUTION	3.8479742380292805
REPERCUSSION	3.8479742380292805
EXTRACT CELL	3.8479742380292805
SLIDE SAMPLE	3.8479742380292805
RECENT PAPER	3.8479742380292805
distinctions	3.8479742380292805
USM POSITION	3.8479742380292805
MODULE SCORE	3.8479742380292805
NON-ADHERENT	3.8479742380292805
POTENTIATING	3.8479742380292805
TRAFFIC GRID	3.8479742380292805
CO-REPRESSOR	3.8479742380292805
misalignment	3.8479742380292805
BRDU-LABELED	3.8479742380292805
FORM SPECKLE	3.8479742380292805
ERROR CUTOFF	3.8479742380292805
LRP/ARR FORM	3.8479742380292805
STUDIED CASE	3.8479742380292805
HFC APPROACH	3.8479742380292805
ENDING POINT	3.8479742380292805
DX2 MUTATION	3.8479742380292805
BPA SEQUENCE	3.8479742380292805
LEAVING OUTA	3.8479742380292805
BIOPSY SPLIT	3.8479742380292805
REVERSE BUSM	3.8479742380292805
BOI1-S-P-GFP	3.8479742380292805
PROCOAGULANT	3.8479742380292805
PIONEER WORK	3.8479742380292805
PLACING CCAF	3.8479742380292805
TOPIIIΑ BIND	3.8479742380292805
ALPHA-FACTOR	3.8479742380292805
PGK/LOXP-NEO	3.8479742380292805
ISOLATED DBD	3.8479742380292805
SINGLET/PAIR	3.8479742380292805
SMG CELLULAR	3.8479742380292805
EACHDATA SET	3.8479742380292805
MOUSE DERMAL	3.8479742380292805
TABULAR FORM	3.8479742380292805
MACRO OUTPUT	3.8479742380292805
SEMI-RELATED	3.8479742380292805
AVERAGE SIZE	3.8479742380292805
ENCODING TAG	3.8479742380292805
EXOENZYME C3	3.8479742380292805
BLOCK MITOSI	3.8479742380292805
TIP DIAMETER	3.8479742380292805
VIDEO IMAGES	3.8479742380292805
CHRONDROSTEI	3.8479742380292805
PAML PACKAGE	3.8479742380292805
MISSING CELL	3.8479742380292805
PREDOMINANCE	3.8479742380292805
VALUESTESTED	3.8479742380292805
LINKER HELIX	3.8479742380292805
MASIA RESULT	3.8479742380292805
SUBCULTURING	3.8479742380292805
FITC-LABELED	3.8479742380292805
GROWING LINE	3.8479742380292805
RUNNING TIME	3.8479742380292805
BRIEF README	3.8479742380292805
ratio change	3.8479742380292805
AQUEOUS VEIN	3.8479742380292805
EXAMPLE CASE	3.8479742380292805
craniofacial	3.8479742380292805
F-ACTIN-RICH	3.8479742380292805
SHIFTED BAND	3.8479742380292805
WHOLE EMBRYO	3.8479742380292805
NUMEROUS BLM	3.8479742380292805
POLAR RUFFLE	3.8479742380292805
RAB MUTATION	3.8479742380292805
GNU COMPILER	3.8479742380292805
BRIEF PERIOD	3.8479742380292805
PURIFIED PP5	3.8479742380292805
EST SEQUENCE	3.8479742380292805
MAIN EFFECTS	3.8479742380292805
MASTER PLATE	3.8479742380292805
T7-ΔN3 PCMV6	3.8479742380292805
PGK-NEOMYCIN	3.8479742380292805
COREGULATION	3.8479742380292805
RE-SEQUENCED	3.8479742380292805
NT ALIGNMENT	3.8479742380292805
DM515 BAR535	3.8479742380292805
N2-N4 REGION	3.8479742380292805
INCLUDINGTHE	3.8479742380292805
RABBIT WAVE1	3.8479742380292805
HTK TAG LINE	3.8479742380292805
HEPTAHELICAL	3.8479742380292805
neural crest	3.8479742380292805
KINASES LEAD	3.8479742380292805
IMAGING CELL	3.8479742380292805
upregulation	3.8479742380292805
HYPOTHALAMUS	3.8479742380292805
SCRAPE WOUND	3.8479742380292805
EMBEDDED USM	3.8479742380292805
TRANSCRPTION	3.8479742380292805
LTBP-3 PROBE	3.8479742380292805
UPREGULATING	3.8479742380292805
AMPHIREGULIN	3.8479742380292805
COMPLICATION	3.8479742380292805
PROGRAM XRNA	3.8479742380292805
RAB24 FUSION	3.8479742380292805
IAP SEQUENCE	3.8479742380292805
LENS PLACODE	3.8479742380292805
AFFECTED ALM	3.8479742380292805
K. B. HENDIL	3.8479742380292805
MATCHING END	3.8479742380292805
ALKALIZATION	3.8479742380292805
MP DETECTION	3.8479742380292805
BLM UNITS/NG	3.8479742380292805
partnerships	3.8479742380292805
EXTERNAL CUE	3.8479742380292805
PHILADELPHIA	3.8479742380292805
AUGMENTED WG	3.8479742380292805
BY/SNJ MOUSE	3.8479742380292805
DURCUPAN ACM	3.8479742380292805
REACTIVATION	3.8479742380292805
PATH-DRAWING	3.8479742380292805
POSTFIXATION	3.8479742380292805
APROTININ/ML	3.8479742380292805
TUMOR/NORMAL	3.8479742380292805
WESTGROVE PA	3.8479742380292805
dimerization	3.8479742380292805
SEVERAL-FOLD	3.8479742380292805
ENTRY NUMBER	3.8479742380292805
STROMAL CELL	3.8479742380292805
RENAL CORTEX	3.8479742380292805
DLA MUTATION	3.8479742380292805
VARYING SIZE	3.8479742380292805
NON-ORTHOLOG	3.8479742380292805
INCREASE TAG	3.8479742380292805
LONDON RESIN	3.8479742380292805
subcomplexes	3.8479742380292805
contaminants	3.8479742380292805
site epitope	3.8479742380292805
LEUKEMIA LGL	3.8479742380292805
PAIRING TERM	3.8479742380292805
spliceosomal	3.8479742380292805
WOUNDS SHIFT	3.8479742380292805
GENBANK FILE	3.8479742380292805
SCORE MATRIX	3.8479742380292805
denaturation	3.8479742380292805
GROWING LIST	3.8479742380292805
ALTERED GENE	3.8479742380292805
SPHINGOLIPID	3.8479742380292805
PAI-1 SAMPLE	3.8479742380292805
MOVAND FILE2	3.8479742380292805
WALKERSVILLE	3.8479742380292805
MATINSPECTOR	3.8479742380292805
MNOC/Β-ACTIN	3.8479742380292805
TLA100 ROTOR	3.8479742380292805
COMPOSED OF2	3.8479742380292805
BDM ACTIVITY	3.8479742380292805
CED9 HOMOLOG	3.8479742380292805
UNCOMPRESSED	3.8479742380292805
MYR-BOI1(PH)	3.8479742380292805
MG/L ADENINE	3.8479742380292805
NON-TUMOROUS	3.8479742380292805
BESTSOLUTION	3.8479742380292805
diencephalon	3.8479742380292805
POLAROID CCD	3.8479742380292805
WOUNDED AREA	3.8479742380292805
FORM COMPLEX	3.8479742380292805
BOI1 HOMOLOG	3.8479742380292805
SCORE BETTER	3.8479742380292805
INTERRUPTION	3.8479742380292805
MATRIX MATCH	3.8479742380292805
THEEPISTASIS	3.8479742380292805
EXCELLENTWAY	3.8479742380292805
METHACRYLATE	3.8479742380292805
MOUSE OOCYTE	3.8479742380292805
illumination	3.8479742380292805
OPTIMAL DOSE	3.8479742380292805
MUSCLE GROUP	3.8479742380292805
polarization	3.8479742380292805
TARGET LOCUS	3.8479742380292805
RESUSPENSION	3.8479742380292805
GENETIC LOAD	3.8479742380292805
HYALURONIDAS	3.8479742380292805
CURRENT DATA	3.8479742380292805
NON-ADHESIVE	3.8479742380292805
verification	3.8479742380292805
WORK PRESENT	3.8479742380292805
NEO SEQUENCE	3.8479742380292805
PFLAG-CMV II	3.8479742380292805
REASSESSMENT	3.8479742380292805
PROMOTERINFO	3.8479742380292805
TISSUE/ORGAN	3.8479742380292805
BIOWHITTAKER	3.8479742380292805
RETURNED HIT	3.8479742380292805
POSITIVE HIT	3.8479742380292805
CODING MODEL	3.8479742380292805
PRIMED PROBE	3.8479742380292805
PL07 COMPLEX	3.8479742380292805
RECLUSTERING	3.8479742380292805
BIOSYNTHESIS	3.8479742380292805
AVERAGE AREA	3.8479742380292805
PKC ACTIVITY	3.8479742380292805
BPNN WOULDBE	3.8479742380292805
SCORING PEAK	3.8479742380292805
PAIRED RATIO	3.8479742380292805
MISALIGNMENT	3.8479742380292805
FLAG-EPITOPE	3.8479742380292805
BREAKTHROUGH	3.8479742380292805
TRACE AMOUNT	3.8479742380292805
PLEASANT GAP	3.8479742380292805
ION-EXCHANGE	3.8479742380292805
CALLED PBIGT	3.8479742380292805
COMPONENTSOF	3.8479742380292805
VESICULATION	3.8479742380292805
ANOVA METHOD	3.8479742380292805
CD68 EPITOPE	3.8479742380292805
SONNENSCHEIN	3.8479742380292805
NEURAL FIELD	3.8479742380292805
micropipette	3.8479742380292805
HFC EQUATION	3.8479742380292805
RDBMS RESULT	3.8479742380292805
ANTI-PLASMIN	3.8479742380292805
PROGRAM TRIM	3.8479742380292805
TREE PROGRAM	3.8479742380292805
CAS ACTIVITY	3.8479742380292805
MM THYMIDINE	3.8479742380292805
SEARCH SPACE	3.8479742380292805
GENOTYPE FBA	3.8479742380292805
CENTRIFUGING	3.8479742380292805
COLOR MARKER	3.8479742380292805
CRYPTIC SITE	3.8479742380292805
LACKING PPT1	3.8479742380292805
BEM1-BINDING	3.8479742380292805
ALIGNED BASE	3.8479742380292805
TRAP NET SET	3.8479742380292805
MATERNAL/GAP	3.8479742380292805
MOLEGO BLOCK	3.8479742380292805
NON-MODIFIED	3.8479742380292805
HBP-ALL CELL	3.8479742380292805
AZ-BOUND ODC	3.8479742380292805
PATHOBIOLOGY	3.8479742380292805
AMPHOTERICIN	3.8479742380292805
DECISIONTHAT	3.8479742380292805
CRYPTOCOCCUS	3.8479742380292805
COMPARE GPNN	3.8479742380292805
UNWINDING G4	3.8479742380292805
NIEMANN-PICK	3.8479742380292805
DORSOVENTRAL	3.8479742380292805
OUTPUT LAYER	3.8479742380292805
TERMED SΑ I2	3.8479742380292805
GPNN OPTIMIZ	3.8479742380292805
PRESERVATIVE	3.8479742380292805
ENHANCED CEE	3.8479742380292805
MM PEPSTATIN	3.8479742380292805
PPT1 MESSAGE	3.8479742380292805
DM455 BAR480	3.8479742380292805
HA VARIATION	3.8479742380292805
ITERATED CGR	3.8479742380292805
AUTOANTIBODY	3.8479742380292805
GENERALIZETO	3.8479742380292805
N/T POSITION	3.8479742380292805
EQUAL AMOUNT	3.8479742380292805
POWER MAC G3	3.8479742380292805
INFILTRATION	3.8479742380292805
VAGINAL PLUG	3.8479742380292805
COMPLEX FORM	3.8479742380292805
WORD PROGRAM	3.8479742380292805
TGF-Β FAMILY	3.8479742380292805
T-LYMPHOCYTE	3.8479742380292805
CDK2 PATHWAY	3.8479742380292805
PROPORTIONOF	3.8479742380292805
KM/CAS(5'SD)	3.8479742380292805
OUTPUT POINT	3.8479742380292805
SCFG DYNAMIC	3.8479742380292805
LOXP-FLANKED	3.8479742380292805
MUS MUSCULUS	3.8479742380292805
INPUT WEIGHT	3.8479742380292805
DIVERSE TYPE	3.8479742380292805
P5-6 GLUCOSE	3.8479742380292805
biogeography	3.8479742380292805
infiltration	3.8479742380292805
MUSCLE LAYER	3.8479742380292805
MICROANATOMY	3.8479742380292805
INACTIVE MDC	3.8479742380292805
T7 SEQUENASE	3.8479742380292805
AVERAGE RANK	3.8479742380292805
ECTOPIC SITE	3.8479742380292805
POPULATIONOF	3.8479742380292805
N346 RINGMUT	3.8479742380292805
REPOPULATING	3.8479742380292805
ΜCI/ML 35S04	3.8479742380292805
THCOORDINATE	3.8479742380292805
CPT ANALOGUE	3.8479742380292805
JUNKRAT CELL	3.8479742380292805
BENCHMARKING	3.8479742380292805
PATH DRAWING	3.8479742380292805
RUNNING AHAB	3.8479742380292805
NEGATIVE ADI	3.8479742380292805
CHANCE LEVEL	3.8479742380292805
OPTIMAL STEP	3.8479742380292805
WHOLE-GENOME	3.8479742380292805
PERMEABILIZE	3.8479742380292805
RAS INCREASE	3.8479742380292805
histological	3.8479742380292805
THANTHE BPNN	3.8479742380292805
SEQUENCE TAG	3.8479742380292805
FLANKING ARM	3.8479742380292805
IMPORTANCEOF	3.8479742380292805
COUNTERSTAIN	3.8479742380292805
VEGETAL HALF	3.8479742380292805
ORGANOGENESI	3.8479742380292805
ABLATED CELL	3.8479742380292805
MIDDLE LAYER	3.8479742380292805
LPA INCREASE	3.8479742380292805
MS-JAB11-PX1	3.8479742380292805
POOLED GROUP	3.8479742380292805
ILLUMINATION	3.8479742380292805
PLUG CLOSURE	3.8479742380292805
UNSURPRISING	3.8479742380292805
IN VIVO WORK	3.8479742380292805
TARGET SMAD1	3.8479742380292805
SELF-ANTIGEN	3.8479742380292805
PROTEINS ACT	3.8479742380292805
CAMP PATHWAY	3.8479742380292805
HELIX REGION	3.8479742380292805
HYPERFILM MP	3.8479742380292805
OFGENERATION	3.8479742380292805
LABELED DUTP	3.8479742380292805
IMAGING MAKE	3.8479742380292805
SHOWED TREND	3.8479742380292805
SPECIFIC/ALL	3.8479742380292805
MICROPIPETTE	3.8479742380292805
AMEBOID CELL	3.8479742380292805
END SEQUENCE	3.8479742380292805
BIT POSITION	3.8479742380292805
FORELIMB BUD	3.8479742380292805
COLOR SQUARE	3.8479742380292805
BAND PATTERN	3.8479742380292805
BEPREVENTING	3.8479742380292805
LYMPHOPOIESI	3.8479742380292805
SCORING PATH	3.8479742380292805
SHOW FEATURE	3.8479742380292805
MHC MUTATION	3.8479742380292805
MAXIMAL DOSE	3.8479742380292805
HYPOTONICITY	3.8479742380292805
CELLS DIVIDE	3.8479742380292805
PEOPLE-POWER	3.8479742380292805
NIH-3T3 CELL	3.8479742380292805
gene profile	3.8479742380292805
NK CYTOLYTIC	3.8479742380292805
WATSON-CRICK	3.8479742380292805
V-CRK RESULT	3.8479742380292805
DESQUAMATION	3.8479742380292805
FISH GELATIN	3.8479742380292805
HYSTERECTOMY	3.8479742380292805
ACTIVATED NK	3.8479742380292805
PROTOTYPICAL	3.8479742380292805
SDC MUTATION	3.8479742380292805
GENE PROFILE	3.8479742380292805
IAP POSITION	3.8479742380292805
COMBINATORIC	3.8479742380292805
ACANTHOMOEBA	3.8479742380292805
NON-GAUSSIAN	3.8479742380292805
DEREGULATION	3.8479742380292805
AQUEOUS PASS	3.8479742380292805
MASIA PACKET	3.8479742380292805
APE FUNCTION	3.8479742380292805
TRANSVERSING	3.8479742380292805
NEPHROCYSTIN	3.8479742380292805
transporters	3.8479742380292805
TRANSMISSION	3.8479742380292805
polymorphism	3.8479742380292805
DIVERSE DATA	3.8479742380292805
BURN PATIENT	3.8479742380292805
GUANINE RING	3.8479742380292805
NON-SURVIVAL	3.8479742380292805
TGF-Β REPEAT	3.8479742380292805
TRYPSIN-EDTA	3.8479742380292805
filter paper	3.8479742380292805
TERMINAL END	3.8479742380292805
BETTER THANA	3.8479742380292805
KM/CAS(3'SD)	3.8479742380292805
DHANASEKARAN	3.8479742380292805
KBP SEQUENCE	3.8479742380292805
FAMILY SERVE	3.8479742380292805
GENE/PROTEIN	3.8479742380292805
PUBMED ENTRY	3.8479742380292805
CUTOFF VALUE	3.8479742380292805
duplications	3.8479742380292805
optimization	3.8479742380292805
WOUND BIOPSY	3.8479742380292805
subdivisions	3.8479742380292805
PURIFIED TAG	3.8479742380292805
SAPONIN G/ML	3.8479742380292805
ALM/BDU CELL	3.8479742380292805
SCREENED SET	3.8479742380292805
LATENT TGF-Β	3.8479742380292805
improvements	3.8479742380292805
PM INTENSITY	3.8479742380292805
KALEIDAGRAPH	3.8479742380292805
DATA SET CHR	3.8479742380292805
DOWNREGULATE	3.8479742380292805
CO-MIGRATION	3.8479742380292805
GENERATED DE	3.8479742380292805
KILL TM CELL	3.8479742380292805
PROMYELOCYTE	3.8479742380292805
AGING BALB/C	3.8479742380292805
EXPLANT SIZE	3.8479742380292805
MRL- FAS LPR	3.8479742380292805
MAXIMIZATION	3.8479742380292805
SIMILAR TYPE	3.8479742380292805
ROUS SARCOMA	3.8479742380292805
CO-LINEARITY	3.8479742380292805
GΑ STRUCTURE	3.8479742380292805
TRANSRIPTION	3.8479742380292805
OBSERVATIONS	3.8479742380292805
SUCCESS RATE	3.8479742380292805
RESUSPENDING	3.8479742380292805
ion exchange	3.8479742380292805
FUNCTION SET	3.8479742380292805
PET-GST-PPT1	3.8479742380292805
TRUNK SOMITE	3.8479742380292805
VASODILATION	3.8479742380292805
CONNECTED NN	3.8479742380292805
ENDOMETRIOSI	3.8479742380292805
MUTATION SET	3.8479742380292805
OUTPUT VALUE	3.8479742380292805
GR ASSOCIATE	3.8479742380292805
ACTIVATED GR	3.8479742380292805
RESIDUAL PIP	3.8479742380292805
HYAL-2 CAUSE	3.8479742380292805
TARGET ORGAN	3.8479742380292805
SANTA CLAITA	3.8479742380292805
SPATIAL POOL	3.8479742380292805
THEI THINPUT	3.8479742380292805
ASCARIS SUUM	3.8479742380292805
COLOR SCHEME	3.8479742380292805
DEFINING SMG	3.8479742380292805
crosslinkers	3.8479742380292805
EXPRESSION/G	3.8479742380292805
PHYLOGENOMIC	3.8479742380292805
MARKOV CHAIN	3.8479742380292805
INFECTING SF9	3.8469628871161117
SCE ANALYSIS	3.84683940794819
ECM ANALYSIS	3.84683940794819
WEIGHT MODIFICATION INTERVENTION	3.8465317180428387
SPATIAL ORGANIZATION	3.846438477158424
COMPLEX ORGANIZATION	3.846438477158424
S CALCULATION	3.8462413575281387
RRNA GROUP I	3.8460440200713295
CONTROL SKIN	3.845804805025259
RATE CONTROL	3.845804805025259
CONTROL DATA	3.845804805025259
CONTROL WING	3.845804805025259
CONTROL BONE	3.845804805025259
MTT ABSORBANCE	3.8456916828262
SCREEN STUDY	3.8456312503849377
CANCER STUDY	3.8456312503849377
EUCARYA RRNA	3.8450789110923544
OTHER KINASE	3.8450398604400258
PHASE KINASE	3.8450398604400258
LEVEL CHANGE	3.844853455306282
NOISE EFFECT	3.8446634946187954
PH-20 EFFECT	3.8446634946187954
RNA WEB PAGE	3.8445067016703938
OCL RESPONSE	3.844108903083029
OTHER FACTOR	3.844062572013468
FACTOR MATCH	3.844062572013468
MINOR FACTOR	3.844062572013468
SCALE FACTOR	3.844062572013468
MAJOR FACTOR	3.844062572013468
INTACT ACTIN	3.8437555622153665
LACKED ACTIN	3.8437555622153665
KNIRP INTRON	3.843732059843144
QUERY INTRON	3.843732059843144
ALGAL INTRON	3.843732059843144
VECTOR PROBE	3.8436721420721534
PEGFP VECTOR	3.8436721420721534
GENOMIC SITE	3.843441672645879
GENOMIC COPY	3.843441672645879
SMAD4 SIGNAL	3.8430456232434453
MATCH SIGNAL	3.8430456232434453
UNC-6 SIGNAL	3.8430456232434453
SMAD1 SIGNAL	3.8430456232434453
LENGTH CLONE	3.84293138382788
POOLED CLONE	3.84293138382788
P53 MUTATION	3.842914630159436
P53 FUNCTION	3.842914630159436
RNA BACKBONE	3.8427729334909504
INCLUDED RNA	3.8427729334909504
POSITIVE RNA	3.8427729334909504
TEC1Δ STRAIN	3.8425737345937376
STRAIN EGY48	3.8425737345937376
STRAIN EA489	3.8425737345937376
STRAIN EA363	3.8425737345937376
STRAIN 129X1	3.8425737345937376
MOUSE STRAIN	3.8425737345937376
IN VITRO UBIQUITYLATION ASSAY	3.8423893434382754
HEPATOCYTE CANALICULAR MEMBRANE	3.842097400884602
SRC ACTIVITY	3.841833342993704
DD TREATMENT	3.841758148360615
MAP DISTANCE	3.8415753221938895
SURVIVAL DATA	3.8413359415774284
APE1 PROTEIN	3.84084519428991
PROTEIN P107	3.84084519428991
PROTEIN TBID	3.84084519428991
PROTEIN TRAP	3.84084519428991
CED7 PROTEIN	3.84084519428991
PROTEIN AREA	3.84084519428991
CONT PROTEIN	3.84084519428991
LTBP PROTEIN	3.84084519428991
PROTEIN FORM	3.84084519428991
PROTEIN UMP1	3.84084519428991
AQUEOUS FLOW	3.840790549497096
FLOW CHAMBER	3.840790549497096
SPATIAL RESOLUTION	3.8407804013933027
PAG-3 MUTANT	3.8405710479030573
POINT MUTANT	3.8405710479030573
SPLICED MRNA	3.8405573128564408
POLY(A) MRNA	3.8405573128564408
ALEXA-CALMODULIN CONCENTRATION	3.8404898301816397
TERTBUTYLDIMETHYL SILYSPIRO AMINO	3.8403509749387115
LEAD COMPOUND	3.840208953905618
GENOME SCALE	3.839756925247861
DRAFT GENOME	3.839756925247861
TYPHI GENOME	3.839756925247861
VIRUS GENOME	3.839756925247861
ACCESSORY DNA	3.8395508074601787
BL21 E. COLI	3.839513449313597
REPEATED DNA	3.839400869729867
DNA PROTOCOL	3.839400869729867
DNA BACKBONE	3.839400869729867
PRIMARY ACCESS	3.8391956559460887
LB AGAR PLATE	3.8390461888474015
ADHERENT CELL	3.839009307837225
INACTIVE GFP	3.8389091072624764
RABBIT SERUM	3.838762895475915
CARDIOVASCULAR HEALTH STUDY	3.8383727582690006
BLOCKING MAB	3.8383353648088816
SCHEFFE TEST	3.837471189968432
TEST PATIENT	3.837471189968432
TESTING TEST	3.837471189968432
BIND HEPARIN	3.837398252134676
PEPTIDE FMLP	3.837349061502608
PEPTIDE MH-1	3.837349061502608
PEPTIDE LOOP	3.837349061502608
USE HUGENEFL	3.8372492945868646
Β-ACTIN CDNA	3.8371476363551826
NEW YORK HEART CLASSIFICATION	3.837023580836563
REACTION MIX	3.8365235465343703
SMC ADHESION	3.8364367988715298
RIBOSOMAL DATABASE PROJECT II	3.8364083144739216
PRIMARY TOOL	3.8361225495559497
PRIMARY LINE	3.8361225495559497
REVERSE MAPK	3.8360762538978506
C/EBPΑ CLOSE	3.8354911071372886
CLOSE ANALOG	3.8354911071372886
LEVELS CLOSE	3.8354911071372886
PEAKED CLOSE	3.8354911071372886
CHROMA FILTER	3.8353253406611074
NF-ΚB SIGNAL	3.8350301391970083
LTR TAG LINE	3.834957640005152
FRACTIONATION	3.834595641059459
PCR FRAGMENT	3.8344968754733246
PCR APPROACH	3.8344968754733246
FINAL FILTER	3.8343765418790747
FINAL RESULT	3.8343765418790747
FINAL AMOUNT	3.8343765418790747
AB PROTECTION	3.8343235738417203
BS PHENOTYPE	3.8342127142146145
EVIDENCE LEAD	3.834000970967681
MOTIF LENGTH	3.833872923503141
MOTIF SEARCH	3.833872923503141
IGM ANTIBODY	3.833651899764487
ACID VARIANT	3.8335387691304836
MM PHOSPHATE	3.833400630672122
AFFINITY THIAMINE TRANSPORTER	3.832987326992471
FARNESOID X         RECEPTOR	3.832735944131531
GFP REPORTER	3.832170425984499
GROWTH PHASE	3.8320438827068637
GROWTH CURVE	3.8320438827068637
RAPID GROWTH	3.8320438827068637
CAS SD BLOCK	3.8314653819986786
OTHER SUBTYPE	3.8312128242446777
TUMOR SUBTYPE	3.8312128242446777
SINGLE BATCH	3.831159421338805
SINGLE ARRAY	3.831159421338805
SINGLE VIRUS	3.831159421338805
SINGLE POINT	3.831159421338805
SINGLE SLIDE	3.831159421338805
POSSIBLE INVOLVEMENT	3.83106112674933
WORK SUPPORT	3.8310526605979134
JM-1 ES CELL	3.8301620512594203
INTEGRIN MAB	3.8297795110514485
MURINE ARRAY	3.829625539609726
MURINE RAB24	3.829625539609726
E3 UBIQUITIN	3.82955155292255
PKC RELATED KINASE 2	3.829342655990703
RHO EFFECTOR	3.8289374634189928
TOTAL TYPE I	3.8287451727663635
FUNCTIONAL GROUP INTERACTION	3.8287225301360346
P53 ANTIBODY	3.828592291894643
HORIZONTAL TRANSFER SCENARIO	3.8284690827440455
IGM MOLECULE	3.8283233739154348
ADSORBED III1-C	3.827896463935782
EXOGENOUS WG	3.8268222662400717
AXON GUIDANCE	3.8266433615597553
clock studies	3.8266433615597553
SMG EPITHELIA	3.8266433615597553
PAIRWISE RNA	3.826571423184322
ACID PROTEIN	3.8264097253911133
SPECIES TREE	3.82637222428711
eyes	3.8263131533877304
WINDOW SLIDE	3.8262179241889513
MAJOR ENZYME	3.826128758968294
ENZYME DNASE	3.826128758968294
AREAS COMMON	3.8256872823879675
PAIRS COMMON	3.8256872823879675
COMMON ORGAN	3.8256872823879675
SODIUM AZIDE	3.8255780326054123
TCA FIXATION	3.8255780326054123
FIGURE LEGEND	3.8255097996155456
TEST P-VALUE	3.82498805907644
RAS ONCOGENE	3.82489935971378
ION EXCHANGE	3.82489935971378
ENZYME CONFORMATIONAL CHANGE	3.824855074465028
PJC8 PLASMID	3.824821404043795
PJC1 PLASMID	3.824821404043795
PLASMID P102	3.824821404043795
PLASMID PJC4	3.824821404043795
PTD1 PLASMID	3.824821404043795
LRP6 PLASMID	3.824821404043795
GEL DIAMETER	3.824782228351772
MAKING SENSE	3.8245443615858488
GTP AFFINITY	3.824362734636675
IGM AFFINITY	3.824362734636675
PIP AFFINITY	3.824362734636675
P27 ABUNDANCE	3.824162796102226
KB DNA PROBE	3.8237987565106044
QIAGEN RNEASY	3.8233041388284654
TESTED KINAS	3.8225918718822296
EXCESS RESIN	3.8225918718822296
CONSENSUS SEQUENCE AR B2 BOX	3.822198089492741
NON-TREATED M	3.8215363150295483
HNF3ΑLACZ ES	3.82125595787449
S PROTEASOME	3.8210754895448664
MOTIF TRIGGER	3.8208553754921866
IΚBΑ COMPLEX	3.820778845728869
AUTHOR CONTRIBUTION	3.8207120371115866
MYOCARDIAL ISCHEMIA REDUCTION	3.8207052316791947
tissue growth	3.8201642726781486
growth arrest	3.8201642726781486
ASSAY BUFFER	3.8201584969516995
PERIPHERAL ARTERIAL DISEASE	3.8194906255302903
OPTIMAL HYDROLYTIC ACTIVITY	3.8194906255302903
LYSIS BUFFER	3.8194853135850977
ANTISENSE ΜM	3.819479094255394
M/Z MOLECULE	3.8192582431486306
NUCLEAR LOCALIZATION SIGNALS	3.819089118025673
IGY FRACTION	3.8182582971741965
WEBSITE HTTP	3.8175153986528194
MOUSE RETINA	3.8175153986528194
ECFP OVERLAP	3.8175153986528194
PUBGENE HTTP	3.8175153986528194
PMA INITIATE	3.8175153986528194
E. COLI TRNA	3.817441826577031
BINDING ACTIVITY SHOWED DNA	3.8167558358196247
cloning	3.815883628576705
FLYBASE LINKS	3.8157908876830646
HRM ESTIMATOR	3.8157908876830646
links	3.814992762084488
ALIGNED TRNA	3.814866803924432
PROFILED HIV	3.814866803924432
AGAROSE BEAD	3.814866803924432
KODAK MICROMAX	3.8147239408907163
FIXED LENGTH	3.814502985967236
THALIANA COP1	3.8143753476121924
ERK ANTIBODY	3.814374153323689
DIURETIC	3.8143709870371536
BLAST SEARCH	3.814197597129803
CATALYTIC FUNCTION	3.8138789367488934
DMSO ADDITION	3.813665145377321
OUTPATIENT REVASCULARIZATION	3.8132764702279984
FINAL SUBSET	3.813224570089866
TEST SUBUNIT	3.8129076098261248
ENZYME ASSAY	3.812579453195847
CONSTRUCTED ALANINE MUTATION	3.8117895336838745
PRESCRIBED OPEN-LABEL DIURETIC	3.8115153501130736
KDA POSITION	3.8114965860814234
AGGREGATE	3.811290492874192
BODY MASS INDEX RELATIONSHIP	3.8107982426544584
NON-FATAL MYOCARDIAL INFARCTION	3.810715565342289
TARGET CELL	3.8099467910285596
DIAGNOSTICS	3.8099467910285596
vasculature	3.8099467910285596
supernatant	3.8099467910285596
contraction	3.8099467910285596
assignments	3.8099467910285596
AUXOTROPHIC	3.8099467910285596
STATE LEVEL	3.8099467910285596
projections	3.8099467910285596
BRIEF PULSE	3.8099467910285596
POSTMITOTIC	3.8099467910285596
NEUROGENESI	3.8099467910285596
proportions	3.8099467910285596
COVER GLASS	3.8099467910285596
BENCHMARKED	3.8099467910285596
GNRH AGONIST	3.809900688808704
BIND AGONIST	3.809900688808704
SUBSTRATE Β-LACTAM CARBONYL	3.8096765225098306
P53 APOPTOSI	3.809221223769546
DOMAIN ORGANIZATION	3.8087610756558874
FINE PATTERN	3.8078968177970953
ELUTION LANE	3.8078968177970953
APOPTOTIC CELL DEATH	3.8075748079234093
STEROID RECEPTOR COACTIVATOR	3.80757240261559
DGW CONTRIBUTION	3.806455512587561
JEF CONTRIBUTION	3.806455512587561
JYJ CONTRIBUTION	3.806455512587561
M.S CONTRIBUTION	3.806455512587561
W.L CONTRIBUTION	3.806455512587561
noise effects	3.8054002212053826
EDTA SOLUTION	3.8053192023634512
FIND VARIATION	3.8050269711937466
MG PROTEIN/ML	3.804938413806375
MG SUBSECTION	3.804938413806375
FAILURE RATE	3.8048721068361755
MIN EXPOSURE	3.8047361379680584
DOMAINS BIND	3.804461610348622
CANDIDATE RECEPTOR FRACTION	3.804035754920128
LYSINE FIXABLE	3.8032953694621447
TYPE CULTURE COLLECTION	3.8032324253817658
UNC-40 GUIDE	3.803181827181544
MEMBRANE WWW	3.803181827181544
STORAGE SIZE	3.803181827181544
CTA	3.8029462464954706
CONSENSUS SEQUENCE YEAST AR	3.802929326683264
MODIFIED SVEDBERG EQUATION	3.802836061117856
PHARMACOLOGICAL INHIBITION	3.802836061117856
RT-PCR ASSAY	3.80269697457302
THY-1 LIGAND	3.8025132837360553
COLD ETHANOL	3.802285978964589
TURNOVER RATE	3.801837706984463
BULK TURNOVER	3.801837706984463
QIAGEN MINIPREP	3.801694779055972
RPMI MEDIUM ΜL	3.800920869526669
DNA INJECTION	3.800481901504094
INTRACELLULAR CONCENTRATION	3.799805687386379
GENES COMMON	3.7989690022331772
CONSTANT OFFSET	3.7987003007839943
KEY QUESTION	3.7985280702103505
KEY FUNCTION	3.7985280702103505
MOLECULAR-MASS DETERMINATION	3.7984071047867602
LRP6 ABSENCE	3.7982455206799566
COLI	3.798024551048858
T-RFLP RESOLUTION	3.79801219794284
excisions	3.79689337328124
NEUROPEPTIDE Y-LIKE RECEPTOR	3.796388606386283
GENOME DATA	3.796352499821458
PLASMA LEVEL	3.7961399646873315
HETEROOLIGOMERIZATION PARTNER	3.796096151967469
coli strains	3.7954589977250377
SPECIES D1 SIGNAL INTENSITY	3.795356803775471
ADULT SD RAT	3.795204858931463
COHORT CONTROL	3.794666960833736
ΜM IONOPHORE	3.7943871441969828
SOUND MANNER	3.7942233450119964
EXTRACELLULAR SOLUTION FLOW	3.7941560171312387
ΜG/ML BOVINE SERUM ALBUMIN	3.7936360373954168
LH ANTISERUM	3.7935834534284574
DEX ADDITION	3.7930227236903047
SIMULATION RUN	3.792905759072534
SUPERNATANT ΜL	3.791797111622423
CLONING SITE	3.7915689799247234
GFP CONTROL	3.7913609180615864
PROJECT HTTP	3.7912577785006984
EFFORTS FOCUS	3.790087660080377
BOI1 ABILITY	3.789825544674219
APE1 ABILITY	3.789825544674219
LRP6 ABILITY	3.789825544674219
PURIFIED RNA	3.789767913003351
DNA OPPOSITE	3.7897397185725943
PASSAGE CELL	3.789399546920702
NM THICKNESS	3.789399546920702
REAL-TIME PCR	3.7880080057610703
TOBACCO BUDWORM ION CHANNEL	3.7878401432893076
SIZE-EXCLUSION PURIFICATION	3.7875302242465563
FINAL STAGE	3.7874514758168085
TRANSCRIPTION FACTORS BIND	3.787265236861427
BILIRUBIN-ALBUMIN COMPLEX	3.785575745016045
BIO-RAD	3.78531693173225
BOVINE SERUM	3.784855266705056
HYDROXYL ION	3.7848219394815947
GENE ISOFORM	3.7845183226616537
GSK3 ISOFORM	3.7845183226616537
CONCENTRATE	3.783983493850674
SOURCE CODE	3.783983493850674
MORPHOLOGIC	3.783983493850674
DISLOCATION	3.783983493850674
PROBLOTT PVDF	3.7832334660529936
INFECTED SF9	3.7831681968027677
EPITHELIUM-DERIVED FACTOR	3.783133165819728
UNKNOWN ROLE	3.7827052965082926
UNKNOWN GENE	3.7827052965082926
SINGLE BAND	3.7821292403566154
NA OIL IMMERSION OBJECTIVE	3.781470039242045
CDNA CLONING	3.780742378250626
NA OBJECTIVE	3.780287928303812
GENOMIC DNA FRAGMENTATION	3.7801198802885785
ΜG TOTAL RNA	3.779589377342785
E-TP-DNTP TERNARY COMPLEX	3.7793602057975306
MM MAGNESIUM	3.7787496030827787
SUBUNIT CSN5	3.778618247039237
PRIMARY FOCUS	3.777926132934514
UBIQUITIN LIGASE ACTIVITY	3.7779065716254587
ENTERING SC	3.7776300046207343
CHROMOPHORE	3.7776300046207343
aa identity	3.7776300046207343
BOI1 ACTION	3.7776300046207343
CH-OH GROUP	3.7776300046207343
manner show	3.7776300046207343
BESPECIFIED	3.7776300046207343
MMP-2 LEVEL	3.7776300046207343
FORMAL LINK	3.7776300046207343
TILT SERIES	3.7776300046207343
DEI-470 CCD	3.7776300046207343
BRATTELBORO	3.7776300046207343
mononuclear	3.7776300046207343
PRENYLATION	3.7776300046207343
DIAPHOT-TMD	3.7776300046207343
AZ-INVOLVED	3.7776300046207343
BOTTLE-NECK	3.7776300046207343
WEB-VERSION	3.7776300046207343
MYC-TAGGING	3.7776300046207343
STATE SPACE	3.7776300046207343
WNT/WINGLES	3.7776300046207343
CHICKEN IGY	3.7776300046207343
BRUSHBORDER	3.7776300046207343
BLUEBAC KIT	3.7776300046207343
HOG NETWORK	3.7776300046207343
MITHRAMYCIN	3.7776300046207343
PLEIOTROPIC	3.7776300046207343
TELEOST YSL	3.7776300046207343
heterodimer	3.7776300046207343
WEB BROWSER	3.7776300046207343
DORSAL SITE	3.7776300046207343
PAI-1 SHARE	3.7776300046207343
NKG2 FAMILY	3.7776300046207343
INPUT DATUM	3.7776300046207343
time course	3.7776300046207343
OSTEONECTIN	3.7776300046207343
SMALL-WORLD	3.7776300046207343
SEQUENCE W.	3.7776300046207343
INTERLEUKIN	3.7776300046207343
formulation	3.7776300046207343
MOUSE LEF-1	3.7776300046207343
ARP COMPLEX	3.7776300046207343
INSERT SIZE	3.7776300046207343
PROPOSITION	3.7776300046207343
YPAD MEDIUM	3.7776300046207343
FEEDER CELL	3.7776300046207343
RIO OUTPUTS	3.7776300046207343
SKIN BIOPSY	3.7776300046207343
PH-20 BLOCK	3.7776300046207343
INPUT ELK-1	3.7776300046207343
NORMAL FATE	3.7776300046207343
centromeric	3.7776300046207343
ANTIOXIDANT	3.7776300046207343
FLY HOMOLOG	3.7776300046207343
GANCYCLOVIR	3.7776300046207343
ENGRAILED-1	3.7776300046207343
BZIP FAMILY	3.7776300046207343
COOPERATIVE	3.7776300046207343
ENGLER-BLUM	3.7776300046207343
FEWER SPACE	3.7776300046207343
DEFRANCESCO	3.7776300046207343
MARKED LOSS	3.7776300046207343
COUNTERPART	3.7776300046207343
DORSAL FACE	3.7776300046207343
SUBCORTICAL	3.7776300046207343
MMG INITIAL	3.7776300046207343
INACTIVE GR	3.7776300046207343
ARESELECTED	3.7776300046207343
NONFAT MILK	3.7776300046207343
HUMAN HDAC1	3.7776300046207343
HIDDENLAYER	3.7776300046207343
GFP-PROTEIN	3.7776300046207343
INPUT SPACE	3.7776300046207343
KRUPPEL CD2	3.7776300046207343
DIGOXYGENIN	3.7776300046207343
CD8 EPITOPE	3.7776300046207343
neural tube	3.7776300046207343
TYPE NUMBER	3.7776300046207343
FINGER-LIKE	3.7776300046207343
SIZES MATCH	3.7776300046207343
NESTED BASE	3.7776300046207343
ARMADA E700	3.7776300046207343
SPECIFIEDBY	3.7776300046207343
QJL INITIAL	3.7776300046207343
RESEQUENCED	3.7776300046207343
G/L GLUCOSE	3.7776300046207343
APE1 MOLEGO	3.7776300046207343
RT220 COLOR	3.7776300046207343
JAVA APPLET	3.7776300046207343
CBA/J MOUSE	3.7776300046207343
GQΑ ACCOUNT	3.7776300046207343
HRP-LABELED	3.7776300046207343
SCATTERPLOT	3.7776300046207343
OSTEOCLASTS	3.7776300046207343
GRIOT MELLE	3.7776300046207343
DANIO RERIO	3.7776300046207343
OLIGOMERIZE	3.7776300046207343
WOESE MODEL	3.7776300046207343
CRE SV40 PA	3.7776300046207343
ANTEROGRADE	3.7776300046207343
INPUT POWER	3.7776300046207343
DEGRADATIVE	3.7776300046207343
CORE DOMAIN	3.7776300046207343
CONSUMPTION	3.7776300046207343
ADI/MIN ADI	3.7776300046207343
AVERAGE ALM	3.7776300046207343
HYPERLINKED	3.7776300046207343
ACCELERATOR	3.7776300046207343
ORIENTATION	3.7776300046207343
T-RFLP DATA	3.7776300046207343
stimulators	3.7776300046207343
PRE-ALIGNED	3.7776300046207343
CURED/FATAL	3.7776300046207343
GCC VERSION	3.7776300046207343
EXPECTATION	3.7776300046207343
GIVE YES/NO	3.7776300046207343
EVENTS LEAD	3.7776300046207343
NEURAL FATE	3.7776300046207343
GR-FUNCTION	3.7776300046207343
SΑ I2 SERVE	3.7776300046207343
HYAL-2 PLAY	3.7776300046207343
MULTIVALENT	3.7776300046207343
CCAF RESULT	3.7776300046207343
ARTIFACTUAL	3.7776300046207343
ANTI-COLL I	3.7776300046207343
INHERITANCE	3.7776300046207343
AVERAGE AGE	3.7776300046207343
IL-1 ACTION	3.7776300046207343
discussions	3.7776300046207343
NOISE LEVEL	3.7776300046207343
DHT-TREATED	3.7776300046207343
SYSTEM STEM	3.7776300046207343
NEWMAN-KEUL	3.7776300046207343
TIME PERMIT	3.7776300046207343
UNIT-SQUARE	3.7776300046207343
MG/L URACIL	3.7776300046207343
SPARSER USM	3.7776300046207343
CALLED QRNA	3.7776300046207343
INTERNEURON	3.7776300046207343
P14 ARFGENE	3.7776300046207343
CTL EPITOPE	3.7776300046207343
PROTOSTOMIA	3.7776300046207343
CO-SEDIMENT	3.7776300046207343
DORSAL AXON	3.7776300046207343
FUSION GENE	3.7776300046207343
CITED PAPER	3.7776300046207343
DIVERSE SET	3.7776300046207343
PRIMER BORE	3.7776300046207343
L. GUARENTE	3.7776300046207343
THESERESULT	3.7776300046207343
PROTEOLYZED	3.7776300046207343
GR-REPORTER	3.7776300046207343
ENHANCEMENT	3.7776300046207343
MORPHOGENIC	3.7776300046207343
MEASURE ARR	3.7776300046207343
FZ-MEDIATED	3.7776300046207343
METHOD WORK	3.7776300046207343
TF FUNCTION	3.7776300046207343
PERIOD GENE	3.7776300046207343
REACHING G2	3.7776300046207343
GENE FILTER	3.7776300046207343
EXPECTED FZ	3.7776300046207343
CAPACITANCE	3.7776300046207343
FITC FILTER	3.7776300046207343
CDC42 GTPAS	3.7776300046207343
RAT UNIGENE	3.7776300046207343
SN50 RESULT	3.7776300046207343
SUB-SECTION	3.7776300046207343
BER-PATHWAY	3.7776300046207343
GSK3Β YIELD	3.7776300046207343
SUB-NETWORK	3.7776300046207343
pigmentosum	3.7776300046207343
VIDEO IMAGE	3.7776300046207343
HOG PATHWAY	3.7776300046207343
MODE METHOD	3.7776300046207343
HUMAN RAB11	3.7776300046207343
PROTEIN/DNA	3.7776300046207343
LUMINOMETER	3.7776300046207343
COINJECTION	3.7776300046207343
BASEPAIRING	3.7776300046207343
C3 EXOTOXIN	3.7776300046207343
MICROVESSEL	3.7776300046207343
NEW NETWORK	3.7776300046207343
NIKON TE300	3.7776300046207343
TPR REMOVAL	3.7776300046207343
GROUP CLASS	3.7776300046207343
BOUND SMAD1	3.7776300046207343
gene inputs	3.7776300046207343
BAM HI SITE	3.7776300046207343
BEDIFFICULT	3.7776300046207343
OVARIECTOMY	3.7776300046207343
INDEL SCORE	3.7776300046207343
EGF EPITOPE	3.7776300046207343
TRP RESIDUE	3.7776300046207343
SUPERFAMILY	3.7776300046207343
COMPUTIONAL	3.7776300046207343
PACKED MASS	3.7776300046207343
SEARCH PATH	3.7776300046207343
INTEL/LINUX	3.7776300046207343
SORT BUTTON	3.7776300046207343
COMPETITION	3.7776300046207343
DISTINCTION	3.7776300046207343
AGAR COLONY	3.7776300046207343
SPATIAL CUE	3.7776300046207343
GFP-LABELED	3.7776300046207343
ROUND-ROBIN	3.7776300046207343
alpha helix	3.7776300046207343
NON-DENSITY	3.7776300046207343
RGS3 ACTION	3.7776300046207343
TARGET BOI1	3.7776300046207343
GR FUNCTION	3.7776300046207343
CURRENT SET	3.7776300046207343
denominator	3.7776300046207343
PRE-COMPUTE	3.7776300046207343
RABBIT ARP3	3.7776300046207343
BINNED DATA	3.7776300046207343
SHOW DEFECT	3.7776300046207343
PRE-CHILLED	3.7776300046207343
RECENT YEAR	3.7776300046207343
THDIMENSION	3.7776300046207343
GROUPS/CELL	3.7776300046207343
FAS/CASPASE	3.7776300046207343
SGAL-LEU ML	3.7776300046207343
ADDED SPARC	3.7776300046207343
SPIKING SET	3.7776300046207343
DMD PROFILE	3.7776300046207343
ELUDICATING	3.7776300046207343
PRENATAL B6	3.7776300046207343
VIEWED FACE	3.7776300046207343
P14 ARFBIND	3.7776300046207343
collagenase	3.7776300046207343
NORMAL AXON	3.7776300046207343
RE-LIGATING	3.7776300046207343
JURKAT CELL	3.7776300046207343
LAYERS SHOW	3.7776300046207343
CANCER CASE	3.7776300046207343
STANDARD GP	3.7776300046207343
END PRODUCT	3.7776300046207343
PFF PRESENT	3.7776300046207343
ENTRY FIELD	3.7776300046207343
EXPLANATION	3.7776300046207343
BOI1-TK-GFP	3.7776300046207343
IMMIGRATION	3.7776300046207343
GNRH ACTION	3.7776300046207343
DISHEVELLED	3.7776300046207343
BMP TYPE II	3.7776300046207343
STAT FAMILY	3.7776300046207343
CONCEPT AID	3.7776300046207343
THREE-LAYER	3.7776300046207343
INLET VALVE	3.7776300046207343
cell zygote	3.7776300046207343
CELL MARKER	3.7776300046207343
ANALYZED TM	3.7776300046207343
BIOCHEMICAL	3.7776300046207343
OTHER SMAD1	3.7776300046207343
TBID HARBOR	3.7776300046207343
KBP SEGMENT	3.7776300046207343
OTHER GTPAS	3.7776300046207343
ACQUISITION	3.7776300046207343
RAS/RAF/ERK	3.7776300046207343
MALADAPTIVE	3.7776300046207343
DOWNINGTOWN	3.7776300046207343
STUDIED EYE	3.7776300046207343
HAND REGION	3.7776300046207343
METHOD QRNA	3.7776300046207343
INPUT LAYER	3.7776300046207343
ANDTHE USER	3.7776300046207343
lymphocytic	3.7776300046207343
HOMOLOG ARR	3.7776300046207343
alterations	3.7776300046207343
C. LAWRENCE	3.7776300046207343
GPNN MODELI	3.7776300046207343
XE ARC LAMP	3.7776300046207343
NEOPTERYGII	3.7776300046207343
PJC10-PJC15	3.7776300046207343
GΒΓ COMPLEX	3.7776300046207343
FOCAL PLANE	3.7776300046207343
PERINUCLEAR	3.7776300046207343
ELK-1 BOUND	3.7776300046207343
PROBE LEVEL	3.7776300046207343
PENTIUM BIT	3.7776300046207343
RABBIT VASP	3.7776300046207343
ADVANCEMENT	3.7776300046207343
RECALCULATE	3.7776300046207343
CONTACT PIP	3.7776300046207343
PAUL PREDKI	3.7776300046207343
ACTIVATABLE	3.7776300046207343
SEGREGATION	3.7776300046207343
ATLAS IMAGE	3.7776300046207343
WORK BETTER	3.7776300046207343
autoantigen	3.7776300046207343
COAGULATION	3.7776300046207343
RADIO-LABEL	3.7776300046207343
METABOLOMIC	3.7776300046207343
PATHOGENESI	3.7776300046207343
LTBP-3 GENE	3.7776300046207343
MARGINALIZE	3.7776300046207343
CALCINEURIN	3.7776300046207343
PHOTOMETRIC	3.7776300046207343
TRYPAN BLUE	3.7776300046207343
coagulation	3.7776300046207343
SEARCHSPACE	3.7776300046207343
IMAGES SHOW	3.7776300046207343
ANTI-III1-C	3.7776300046207343
CROSSBRIDGE	3.7776300046207343
NON-POOLING	3.7776300046207343
MS EXPOSURE	3.7776300046207343
VARIABLESAS	3.7776300046207343
ANTI-TIMP-2	3.7776300046207343
SCALABILITY	3.7776300046207343
TN TENASCIN	3.7776300046207343
CERAMIC CUP	3.7776300046207343
MAIN MEMORY	3.7776300046207343
ANALYZED MP	3.7776300046207343
MASIA MASIA	3.7776300046207343
SUBDIVISION	3.7776300046207343
ABC1 MEMBER	3.7776300046207343
ONLINE TOOL	3.7776300046207343
OSTEOPOROSI	3.7776300046207343
POLYSCIENCE	3.7776300046207343
HAVING CD14	3.7776300046207343
TRANSPORTIN	3.7776300046207343
COEXPRESSED	3.7776300046207343
APPELLATION	3.7776300046207343
INOCULATION	3.7776300046207343
NES-MUTATED	3.7776300046207343
COARSE DATA	3.7776300046207343
IMPROVEUPON	3.7776300046207343
BIOPSY SIZE	3.7776300046207343
SUPERNATENT	3.7776300046207343
RESEMBLANCE	3.7776300046207343
DEFORMATION	3.7776300046207343
VASCULATURE	3.7776300046207343
CONSISTANCY	3.7776300046207343
RECEIVED AD	3.7776300046207343
INCREASE FN	3.7776300046207343
terminators	3.7776300046207343
unprocessed	3.7776300046207343
DOMAIN COPY	3.7776300046207343
RPA CLUSTER	3.7776300046207343
CURVED MASS	3.7776300046207343
GTPASE RHOA	3.7776300046207343
PROKARYOTIC	3.7776300046207343
RECENT WORK	3.7776300046207343
BLASTN-TYPE	3.7776300046207343
TANSFECTION	3.7776300046207343
fluorescein	3.7776300046207343
PUTATIVE CI	3.7776300046207343
MIB-EXPOSED	3.7776300046207343
PARATHYROID	3.7776300046207343
PATHFINDING	3.7776300046207343
LGL LIBRARY	3.7776300046207343
COILED-COIL	3.7776300046207343
BRDU RESULT	3.7776300046207343
DUMMYCODING	3.7776300046207343
CAUSE RAB24	3.7776300046207343
HALECOSTOMI	3.7776300046207343
OUTPUT VIEW	3.7776300046207343
MHCK-B PLAY	3.7776300046207343
AML PATIENT	3.7776300046207343
GR MOVEMENT	3.7776300046207343
BIOMAX FILM	3.7776300046207343
JOAN BRUGGE	3.7776300046207343
MODEL TREND	3.7776300046207343
TIME-SERIES	3.7776300046207343
PAIRED GENE	3.7776300046207343
MUSCLE CELL	3.7776300046207343
THUSFOUR NN	3.7776300046207343
TRANSITIONS	3.7776300046207343
CARBON FLUX	3.7776300046207343
CARPENTERIA	3.7776300046207343
OSTEOMETRIC	3.7776300046207343
garpike ysl	3.7776300046207343
SPURR RESIN	3.7776300046207343
TF SEQUENCE	3.7776300046207343
COUNT MATCH	3.7776300046207343
MYOBLAST L6	3.7776300046207343
point dryer	3.7776300046207343
NONADAPTIVE	3.7776300046207343
PROTOTHERIA	3.7776300046207343
PHENOCOPIED	3.7776300046207343
YEAST APEII	3.7776300046207343
PUTATIVE TF	3.7776300046207343
LINE WINNER	3.7776300046207343
PENTIUM III	3.7776300046207343
LEITZ DM RB	3.7776300046207343
BOI1-KK-GFP	3.7776300046207343
LACKING PML	3.7776300046207343
INFERTILITY	3.7776300046207343
AHAB RESULT	3.7776300046207343
HYPOTHESIZE	3.7776300046207343
FAMILY NAME	3.7776300046207343
RESULTSFROM	3.7776300046207343
MOID RESULT	3.7776300046207343
DECAPRIMEII	3.7776300046207343
DYSFUNCTION	3.7776300046207343
RV INCREASE	3.7776300046207343
TGF-Β2 SHOW	3.7776300046207343
BINDING PIP	3.7776300046207343
SYSTEMS ACT	3.7776300046207343
TRNASCAN-SE	3.7776300046207343
LEXA-FUSION	3.7776300046207343
POLY-LYSINE	3.7776300046207343
COLONY LIFT	3.7776300046207343
BOROHYDRIDE	3.7776300046207343
HEADER LINE	3.7776300046207343
SAS VERSION	3.7776300046207343
PRE-CLEANED	3.7776300046207343
DEMARCATION	3.7776300046207343
PHOSPHO-P44	3.7776300046207343
CD4-BINDING	3.7776300046207343
SCANNING EM	3.7776300046207343
MM MIMOSINE	3.7776300046207343
HMM VITERBI	3.7776300046207343
PAC-1 PROBE	3.7776300046207343
U. SCHIBLER	3.7776300046207343
DIG1Δ DIG2Δ	3.7776300046207343
NON-INTEGER	3.7776300046207343
DEFINED SET	3.7776300046207343
OVERWRITING	3.7776300046207343
EYCLESHYMER	3.7776300046207343
CO-INCIDENT	3.7776300046207343
MITOCHONDRIAL TRANSPORTER	3.7769304950121114
INTERMEDIATE ACCUMULATION	3.7768244183249466
EXPRESSING WILD-TYPE CPLA	3.776807395047069
NN ANALYSIS	3.77652704196257
EM ANALYSIS	3.77652704196257
NTPDAS CATALYTIC MECHANISM	3.776128533773092
ΜM DIAMETER	3.776066316284211
E15 CONTROL	3.7755214919608244
CONTROL SET	3.7755214919608244
P27 CONTROL	3.7755214919608244
TAG CONTROL	3.7755214919608244
FEWER STUDY	3.775352810948032
AVIAN STUDY	3.775352810948032
STUDY RAISE	3.775352810948032
STUDY CLICK	3.775352810948032
HETEROOLIGOMERIZING F-BOX	3.77523903305482
EXOGENOUS AR	3.774903790030195
FUNGAL RRNA	3.774815982021387
CHK2 KINASE	3.7747780279593535
PAKA KINASE	3.7747780279593535
GENE CHANGE	3.774596857310782
EFFECT MOID	3.7744122309527848
RNAI EFFECT	3.7744122309527848
RGS3 EFFECT	3.7744122309527848
TRANSLOCATE	3.7741254252402245
FACTOR HPRT	3.7738281829925073
OTHER ACTIN	3.773529794406727
MOUSE ACTIN	3.773529794406727
MNOC INTRON	3.773506952009992
BASE VECTOR	3.7734487168036255
HISC VECTOR	3.7734487168036255
SECONDARY PREVENTION STATIN	3.7733847873820885
TK PROMOTER	3.773250786019384
SCD39 NUCLEOTIDASE ACTIVITY	3.773118988758618
ARP3 SIGNAL	3.772839791393367
MEC-3 CLONE	3.7727287599609447
LABELED RNA	3.772574759104148
RNA PROFILE	3.772574759104148
RNA CLUSTER	3.772574759104148
ENCODED RNA	3.772574759104148
QUALITY RNA	3.772574759104148
BOI1 STRAIN	3.7723811539567045
TYPE STRAIN	3.7723811539567045
STRAIN Y312	3.7723811539567045
JH10 STRAIN	3.7723811539567045
BINDING SRC	3.771661553462442
CD98-INTEGRIN ASSOCIATION	3.7715907817743877
CONTACT MAP	3.7714107782036903
FZ RECEPTOR	3.771194457284836
SENSE PROBE	3.7711856325098503
INDUCED TNF	3.7709019324059323
RENDERED RT	3.7707773384760284
RT SEQUENCE	3.7707773384760284
RT FUNCTION	3.7707773384760284
RT MUTATION	3.7707773384760284
CD9 PROTEIN	3.770701153188287
CRC PROTEIN	3.770701153188287
PROTEIN CIZ	3.770701153188287
PROTEIN L16	3.770701153188287
PROTEIN PDI	3.770701153188287
CAS PROTEIN	3.770701153188287
RHO PROTEIN	3.770701153188287
RAS PROTEIN	3.770701153188287
WNT PROTEIN	3.770701153188287
GQΑ PROTEIN	3.770701153188287
ΔN2 PROTEIN	3.770701153188287
PROTEIN S16	3.770701153188287
PROTEIN A/G	3.770701153188287
LRP PROTEIN	3.770701153188287
SRF PROTEIN	3.770701153188287
INDUCTION HR	3.770553121210091
APE1 MUTANT	3.7704347051687925
MUTANT LRP6	3.7704347051687925
MUTANT TBID	3.7704347051687925
MUTANT CELL	3.7704347051687925
GAD1 MUTANT	3.7704347051687925
MAKE MUTANT	3.7704347051687925
C/EBPΒ MRNA	3.7704213558191606
TARGET MRNA	3.7704213558191606
MMCOP1 MRNA	3.7704213558191606
OOCYTE MRNA	3.7704213558191606
CELL NEURON	3.770338497786958
E. COLI FBA	3.769406805247087
COGNATE DNA	3.7692973870363833
DNA MIXTURE	3.7692973870363833
BINDING DNA	3.7692973870363833
DNA MUTAGEN	3.7692973870363833
AT-RICH DNA	3.7692973870363833
FLANKED DNA	3.7692973870363833
ΜL RPMI-1640	3.7690412701329645
PLACING GFP	3.7688194338632552
PRODUCE GFP	3.7688194338632552
LACKING CSN	3.7688194338632552
SHEEP SERUM	3.768677327883296
SYMBOL CODE	3.768493116427793
PAIR SYMBOL	3.768493116427793
N PROCESSOR	3.768378905325381
REMAINING N	3.768378905325381
XNOC EXON I	3.7679556524164433
OTHER KINAS	3.767955535966624
RCCA SUBTYPE	3.76781939756491
SEDIMENT	3.767762523409721
IDO-TRANSFECTED RAW CELL	3.767663944413583
STOICHIOMETRIC TITRATION	3.767663944413583
PHARMACOLOGICAL ACTIVITY	3.767663944413583
MITOCHONDRIAL SUSPENSION	3.767663944413583
YORK HEART CLASSIFICATION	3.7675075086610583
TEST RESULT	3.767421895053448
MHCK-A CDNA	3.767107427223176
oligonucleotide	3.7671001229553345
DAMAGE SITE	3.766583915909865
CELL DAMAGE	3.766583915909865
CEM	3.766539123933679
ANALYTICAL ULTRACENTRIFUGATION	3.766210912548574
MAPK MODULE	3.7660661305015433
SENSE TRANSFECTED CONTROL	3.7653614542725493
REACTION	3.765138551479251
STUDIES FOCUS	3.764917720849493
SCATTERED T	3.764869867661627
COMMITTED T	3.764869867661627
TUNEL ASSAY	3.764461180001015
OTHER CODON	3.7644141484845157
JOINT CODON	3.7644141484845157
FINAL POINT	3.7644141484845157
START CODON	3.7644141484845157
MODAL CODON	3.7644141484845157
FINAL MODEL	3.7644141484845157
GIBBS MOTIF	3.7639246723313224
ALPHA MOTIF	3.7639246723313224
MOTIF MATCH	3.7639246723313224
MOTIF MODEL	3.7639246723313224
MASIA MOTIF	3.7639246723313224
RIPA BUFFER	3.763764188346669
NB ANTIBODY	3.7637098552107986
EE ANTIBODY	3.7637098552107986
FREEING CBP	3.7636660811560505
GENERAL CRE	3.7636660811560505
CDNA NKG2 C	3.763566496416379
KINASE CHIP	3.7633920595958426
GUIDANCE CUE	3.7633663508724444
IDO ANTISENSE EXPRESSION	3.7625601494309677
L929 GROWTH	3.7621469932477583
CALIFORNIA USA	3.7613906075573826
SINGLE UNIT	3.761287368641562
SINGLE SPOT	3.761287368641562
SINGLE PAIR	3.761287368641562
SINGLE PEAK	3.761287368641562
SINGLE COIL	3.761287368641562
SINGLE NODE	3.761287368641562
PRIMARY EFFICACY ENDPOINT	3.761134778827133
HORIZONTAL GENE TRANSFER	3.7608517129380163
LEUCINE TRNA	3.760476019323609
FACS ANALYSIS	3.760135534295775
ADDING SORBITOL	3.7597720832482766
TRANSFECT COS-1	3.7597720832482766
CD39 CATALYTIC MECHANISM	3.759629004724453
TITER STOCK	3.759127806030029
G BASE PAIR	3.758406941149871
G QΑ MEMBER	3.758406941149871
RAB SUBGROUP	3.7583894163338076
IC1 SUBGROUP	3.7583894163338076
ΜG/ML TAXOL	3.7582559746828226
ΜG/ML MSN50	3.7582559746828226
WL CONTRIBUTION	3.757738519645664
XP CONTRIBUTION	3.757738519645664
JM CONTRIBUTION	3.757738519645664
JY CONTRIBUTION	3.757738519645664
ΜM MONENSIN	3.7577254388996817
INCREASED K	3.757627627765917
COLI GENOME	3.7573086450175133
ARGUMENT HOLD	3.757187528748937
growth yield	3.75705232944283
tumor growth	3.75705232944283
LPA SPECIES	3.756634601964614
MM SODIUM CITRATE BUFFER	3.756348310844977
COMMON RULE	3.755968894075518
COMMON SITE	3.755968894075518
SETS COMMON	3.755968894075518
CONTAINING ALLELE INTRON	3.7554727699047556
GENERAL DNA	3.7553334635717004
BLOTTED GEL	3.7550892550686052
ANOVA	3.754579256055552
MAPKS	3.754579256055552
CHAIN KINAS	3.7529604064997937
EEF-2 KINAS	3.7529604064997937
BIRTH DEFECT	3.75279036497784
CDK ACTIVITY	3.75279036497784
DNA PASSING SINGLE-STRAND	3.7525031094426793
CRW PROJECT	3.7521097307025197
GENES SHARE	3.751662006598691
GENOTYPE ES	3.751662006598691
RNA SPECIES	3.751579356448028
DMSO VEHICLE	3.7512795098500398
RESEARCH LAB	3.7512795098500398
IL-8	3.7512244564964448
H TREATMENT	3.751030471952917
KB FRAGMENT	3.7507177157615263
T. ACIDOPHILUM CYTOPLASM	3.7505542493108477
NAD COFACTOR	3.7497199174600517
CELLS TOTAL	3.7495963703923927
MAKES TOTAL	3.7495963703923927
SINGLE GENE	3.7495604990686457
CASE REPORT	3.749165083711956
H INCUBATION	3.749121145381753
VENTRICULAR HYPERTROPHY	3.749049543558158
ACUTE CORONARY SYNDROME	3.749049543558158
CYCLIC REINVASION MODEL	3.749049543558158
HOSPITALIZED NONFATAL HF	3.748878700041566
INVARIANT G	3.7487954094144396
LH FRACTION	3.748748523893779
TH FRACTION	3.748748523893779
AMP DEPENDENT	3.748154255695507
IMMOBILON P	3.748026486875605
BOVINE-BRAIN CALMODULIN	3.7474482138375462
ANTISENSE-EXPRESSING AGGREGATE	3.746980143317805
REACTIVE OH	3.7467930069695585
MM CYSTEINE	3.7467930069695585
TEMECULA CA	3.7465940585976147
POSTNATAL WEEK	3.746152512319288
ESTIMATED INTRACELLULAR	3.745974142107976
INTRACELLULAR TARGETING	3.745974142107976
HIV VACCINE	3.7454522679412463
TRNA RECORD	3.7454522679412463
TGF-Β-INDUCED FACTOR 2	3.745127879943732
FIXED POINT	3.745098666439274
LABELED OLIGONUCLEOTIDE	3.74508043570365
HOST STRAIN	3.744970489377881
SΑ I2 REACH	3.744737207126146
EXPRESSED IDO ANTISENSE	3.744258071303987
INCLUDING RA	3.7441372856095274
MOLECULAR WEIGHT PRODUCT	3.743995569010595
FAS RECEPTOR ACTIVATION	3.7435040851548202
CELLULAR PH	3.7434411593987784
PH ACTIVITY	3.7434411593987784
MAKE LYSATE	3.7429383822631612
OTHER METALLO-Β-LACTAMAS	3.7429247880023144
ΜM IONOMYCIN	3.742886691144996
CELLULAR IP	3.742387721590819
recombination events	3.741872494376584
PP5 EXHIBIT	3.741703405415481
RAS EXHIBIT	3.741703405415481
P21 PROTEIN	3.7416780965754155
CD39 CATALYTIC ACTIVITY	3.7411113278491412
EXPERIMENTAL APPROACH	3.7408912032322537
TOTAL SERUM	3.7406436936549543
REQUIRING O	3.7406256074393234
SURFACE PLASMON RESONANCE	3.7402911021382974
NITROCEFIN CONCENTRATION	3.7402657633363656
KINETIC CONSTANT	3.740176981315993
BINDING FUNCTION	3.740176981315993
CYTOSINE	3.7398588715546888
CONGESTIVE HEART FAILURE	3.7397080888298895
AB IMMUNITY	3.739676776742364
FINE VESSEL	3.7386780075876693
CLINICAL TRIAL PRACTITIONER	3.738524275611497
COP1 MUTANT	3.7382569684893054
ΜM NON-RADIOACTIVE THDP	3.7376578994314418
BP SEQUENCE	3.7376252509111003
HYBRID MRNA	3.7367809947451507
B TREATMENT	3.7363461873571193
MEAN NUMBER	3.735511178560591
PHPP FIGURE	3.7353392649848356
TRANSCRIPTIONAL RESPONSE	3.7339619600751632
INTERLEUKIN 2	3.7338517250887033
FORM STABLE HETERODIMER	3.7335700229255755
ALGORITHM RUN	3.7333236931441505
THDP COMPARTMENTALIZATION	3.7333190605863273
MEAN SIGNAL	3.7307209653332247
LIGAND STRUCTURAL CLASS	3.730566533847612
BILE ACID CONCENTRATION	3.7302860150571933
NN SOLUTION	3.730022008246989
MODIFIED HILL EQUATION	3.7296751643430675
MOLECULAR ARCHITECTURE	3.7296751643430675
KEY ELEMENT	3.729572345943577
KEY PATHWAY	3.729572345943577
CEE ABSENCE	3.729297730751136
BMP ABSENCE	3.729297730751136
PLASMID DNA REPLICATION	3.7285064490017996
ORF FEATURE	3.728290808378853
CELLS REACH	3.728290808378853
RAT LIVER MITOCHONDRIA	3.7280492911158616
ΜG/ML RNASE	3.725898920241652
B. MORI MIDGUT RECEPTOR	3.725696520931578
APPLIED PHOTOPHYSICS SX	3.725234896431108
ADULT ANGLE	3.724766580075861
P53 ABSENCE	3.724380202886497
ELIGIBILITY RISK FACTOR	3.724239900900457
WG ADDITION	3.7242215963176664
BSA CONTROL	3.7238874493821115
UM TRIS-HCL	3.7234772282576936
GST PROTEIN	3.7229535439219505
SAMPLE BUFFER SD	3.7227160230157037
OIL IMMERSION OBJECTIVE	3.7215303957669
PIP ABILITY	3.721114198016397
WOX1 PARTICIPATION	3.7210962387656528
VIRAL MRNA TRANSLATION	3.721037468434221
PRIMARY ENDPOINT	3.721012152308572
NM DIAMETER	3.720700162803179
HUMAN MMP-1	3.720700162803179
MMP-1 LEVEL	3.720700162803179
MM NA-ACETATE	3.7181186227928515
KD	3.7174578979628734
INTERMEDIATE FORMATION	3.716820129294317
CANAL LUMEN	3.715956009318382
SRC ABILITY	3.715145746858105
CODING GENE	3.7144217498667254
ALEXA FLUOR	3.7144217498667254
MHC CLASS I	3.7144217498667254
ELISA READER	3.713597005486071
HELIOTHIS VIRESCEN	3.7112517686020023
RPM ESTIMATOR	3.710883640208391
DRAW NJ TREE	3.709524968136277
SIZE-EXCLUSION COLUMN	3.7094760996308156
HEPES BUFFERED SALINE	3.7094760996308156
CD98-INTEGRIN COMPLEX	3.7094760996308156
INHIBITION EXPERIMENT	3.7094760996308156
INTEGRIN-CD98 COMPLEX	3.7094760996308156
HEPES-BUFFERED SALINE	3.7094760996308156
EXTRA-CELLULAR MATRIX	3.7094760996308156
Β-LACTAMASE INHIBITOR	3.7094760996308156
BACILLUS THURINGIENSI	3.7094760996308156
LID SUBCOMPLEX	3.708057274224049
MM SODIUM PHOSPHATE PH	3.70795478186042
WALL INJURY	3.7071454385609037
TRANSCRIPTIONAL LEVEL	3.7068461217493867
CYTOPLASMIC SUBSTRATE	3.706717830145415
COX PROTEIN EXPRESSION	3.7061881622134423
LABELED DNA SUBSTRATE	3.706080727299418
L CONTRIBUTION	3.7060672244728057
ANTISENSE ORIENTATION	3.704714455466545
PH ELEVATION	3.704016020091233
PC SOFTWARE	3.7036212102579116
LISTERIA UL	3.7036212102579116
INDIVIDUAL IQ PEPTIDE	3.7025265823198894
EJECTION FRACTION DATA	3.7024635982818768
CLINICAL HEART FAILURE	3.702406109273151
E. COLI TOPOISOMERASE	3.702199391343294
GR-COMPLEX	3.7016524444797017
BMP R-SMAD	3.7016524444797017
MODEL GENE	3.7016524444797017
MBN-2 CELL	3.7016524444797017
MAXISCRIPT	3.7016524444797017
GROUP GENE	3.7016524444797017
FLOOR CELL	3.7016524444797017
FILTER SET	3.7016524444797017
GENE INPUT	3.7016524444797017
CELL LAYER	3.7016524444797017
NORVEGICUS	3.7016524444797017
BEGR START	3.7016524444797017
DISCUSSION	3.7016524444797017
CALCITONIN	3.7016524444797017
ANTI-MMP-1	3.7016524444797017
TRP1 MET14	3.7016524444797017
BACITRACIN	3.7016524444797017
HIGHLIGHTS	3.7016524444797017
ISL1 LOCUS	3.7016524444797017
ANASTELLIN	3.7016524444797017
pronucleus	3.7016524444797017
EN-1 LOCUS	3.7016524444797017
P1 GLUCOSE	3.7016524444797017
PVUI-ECONI	3.7016524444797017
CHAOS GAME	3.7016524444797017
LYSED-CELL	3.7016524444797017
HUMAN LRP5	3.7016524444797017
JAVA-BASED	3.7016524444797017
FL PATIENT	3.7016524444797017
BAMH1 SITE	3.7016524444797017
HERNIATION	3.7016524444797017
NERVE CELL	3.7016524444797017
PRONEPHRIC	3.7016524444797017
TERMINATOR	3.7016524444797017
NEUROSPORA	3.7016524444797017
ingression	3.7016524444797017
MOTHER/BUD	3.7016524444797017
DEATH GENE	3.7016524444797017
DIAPHYSEAL	3.7016524444797017
SUS SCROFA	3.7016524444797017
PITTSBURGH	3.7016524444797017
HACAT CELL	3.7016524444797017
COLORATION	3.7016524444797017
PEROXISOME	3.7016524444797017
GQ-COUPLED	3.7016524444797017
BIND WNT-1	3.7016524444797017
INFLECTION	3.7016524444797017
GROUP MAKE	3.7016524444797017
DSH DSRNAI	3.7016524444797017
DISTORTION	3.7016524444797017
WNT TARGET	3.7016524444797017
OTHER QRNA	3.7016524444797017
SEARCHABLE	3.7016524444797017
PEGFP-N346	3.7016524444797017
PAPER GIVE	3.7016524444797017
processors	3.7016524444797017
replicates	3.7016524444797017
IMPAIRMENT	3.7016524444797017
BIND SMAD4	3.7016524444797017
GROUP_FILE	3.7016524444797017
SOLUTIONIN	3.7016524444797017
SERUM/CELL	3.7016524444797017
VIRAL DOSE	3.7016524444797017
MODEL NODE	3.7016524444797017
KARYOTYPIC	3.7016524444797017
ZYGOMYCOTA	3.7016524444797017
ETIOLATION	3.7016524444797017
PRODUCE TN	3.7016524444797017
OVEREXPRES	3.7016524444797017
QUADRAPLEX	3.7016524444797017
CONTROLLER	3.7016524444797017
RAB INSERT	3.7016524444797017
sonication	3.7016524444797017
SUB-SAMPLE	3.7016524444797017
MM TRIS-PH	3.7016524444797017
CRITERIAWE	3.7016524444797017
AHAB SCORE	3.7016524444797017
TIME-BOUND	3.7016524444797017
ATLASIMAGE	3.7016524444797017
N-DISTANCE	3.7016524444797017
PJC4 ARRAY	3.7016524444797017
SUBPROBLEM	3.7016524444797017
CODE OTHER	3.7016524444797017
AMIA CALVA	3.7016524444797017
OBSERVABLE	3.7016524444797017
HRD DOMAIN	3.7016524444797017
LAEVIS BLM	3.7016524444797017
BPNN MODEL	3.7016524444797017
RHO TARGET	3.7016524444797017
LH CONTENT	3.7016524444797017
SΑ I2 SHOW	3.7016524444797017
OUTPUT)AND	3.7016524444797017
BRIMACOMBE	3.7016524444797017
HYPOPLASIA	3.7016524444797017
cataloging	3.7016524444797017
NULL-MODEL	3.7016524444797017
START NODE	3.7016524444797017
NEURALWORK	3.7016524444797017
IPP DOMAIN	3.7016524444797017
THESEMODEL	3.7016524444797017
TLL MATRIX	3.7016524444797017
PORCINE LH	3.7016524444797017
ANTIPORTER	3.7016524444797017
RGS ACTION	3.7016524444797017
WOX1 BLOCK	3.7016524444797017
IAN MACARA	3.7016524444797017
ΒACTIN-CRE	3.7016524444797017
BASAL FISH	3.7016524444797017
SELECTABLE	3.7016524444797017
INVOLUTION	3.7016524444797017
CYTOLETHAL	3.7016524444797017
SONNHAMMER	3.7016524444797017
T7-EPITOPE	3.7016524444797017
SYNDECAN-2	3.7016524444797017
NALGE NUNC	3.7016524444797017
INPUT SIZE	3.7016524444797017
TITRATABLE	3.7016524444797017
REFERREDTO	3.7016524444797017
VALUE ROSE	3.7016524444797017
CAAATCAAAT	3.7016524444797017
PDF FORMAT	3.7016524444797017
PREFERENCE	3.7016524444797017
AHAB TALLY	3.7016524444797017
VSM SAMPLE	3.7016524444797017
ZETA PROBE	3.7016524444797017
BMP FAMILY	3.7016524444797017
guarantees	3.7016524444797017
ANTI-PAC-1	3.7016524444797017
FIBROGENIC	3.7016524444797017
CYTOMETRIC	3.7016524444797017
HYALURONIC	3.7016524444797017
MAS4 SERVE	3.7016524444797017
G. R. POST	3.7016524444797017
TRAJECTORY	3.7016524444797017
GIOVANNONI	3.7016524444797017
NEN-DUPONT	3.7016524444797017
RESULTSARE	3.7016524444797017
test error	3.7016524444797017
CAUSE CELL	3.7016524444797017
PLACED ARR	3.7016524444797017
MH1 DOMAIN	3.7016524444797017
YEAST POB1	3.7016524444797017
MEASURE WG	3.7016524444797017
ANEUPLOIDY	3.7016524444797017
cover slip	3.7016524444797017
ANTI-HSP90	3.7016524444797017
ANTI-SSDNA	3.7016524444797017
TILT ANGLE	3.7016524444797017
valueswill	3.7016524444797017
P0-13D TKT	3.7016524444797017
CONSONANCE	3.7016524444797017
MATCH CELL	3.7016524444797017
PERMAFLUOR	3.7016524444797017
QUANTATIVE	3.7016524444797017
allosteric	3.7016524444797017
CATALOGING	3.7016524444797017
K-A31 CELL	3.7016524444797017
P27 EXPORT	3.7016524444797017
SHED GP120	3.7016524444797017
DABCO/DAPI	3.7016524444797017
luciferase	3.7016524444797017
ACETYL-COA	3.7016524444797017
PRE-COATED	3.7016524444797017
CLASSIFIER	3.7016524444797017
DNA-DAMAGE	3.7016524444797017
GFP-MMCOP1	3.7016524444797017
ALLOSTERIC	3.7016524444797017
PFLAG-N280	3.7016524444797017
LP PROBLEM	3.7016524444797017
MOTIVATION	3.7016524444797017
DICKKOPF-1	3.7016524444797017
RAY-FINNED	3.7016524444797017
ACKAB GENE	3.7016524444797017
DOMAIN B42	3.7016524444797017
COMPENDIUM	3.7016524444797017
FOLD MESAD	3.7016524444797017
P1 RESIDUE	3.7016524444797017
ECHINODERM	3.7016524444797017
IVM MEDIUM	3.7016524444797017
DISTENSION	3.7016524444797017
PROCEEDING	3.7016524444797017
organelles	3.7016524444797017
ARTHROPODA	3.7016524444797017
C-FOS GENE	3.7016524444797017
DRAFT FUGU	3.7016524444797017
ALPHABETIC	3.7016524444797017
INCLUDED10	3.7016524444797017
MM GLUCOSE	3.7016524444797017
HOG MUCOSA	3.7016524444797017
AVERAGE-GC	3.7016524444797017
PROGRAMING	3.7016524444797017
VI-470 CCD	3.7016524444797017
THEYSELECT	3.7016524444797017
ACTIN-RICH	3.7016524444797017
MIDVENTRAL	3.7016524444797017
POB1 CAUSE	3.7016524444797017
BLM DOMAIN	3.7016524444797017
WILMINGTON	3.7016524444797017
PEPRO-TECH	3.7016524444797017
RE-LIGATED	3.7016524444797017
DD-BROTH20	3.7016524444797017
ARITHMETIC	3.7016524444797017
STABLE P27	3.7016524444797017
INVAGINATE	3.7016524444797017
C3-TREATED	3.7016524444797017
ENDOSIALIN	3.7016524444797017
NMRI MOUSE	3.7016524444797017
NEO RESULT	3.7016524444797017
CLAI-AVRII	3.7016524444797017
EXECUTABLE	3.7016524444797017
NIGERICINE	3.7016524444797017
UNCHECKING	3.7016524444797017
ANTI-HSP70	3.7016524444797017
BOS TAURUS	3.7016524444797017
occurrance	3.7016524444797017
hygromycin	3.7016524444797017
INDEX PAGE	3.7016524444797017
DUAL-COLOR	3.7016524444797017
PHAGOCYTIC	3.7016524444797017
AGAR PLATE	3.7016524444797017
PEGFP-N200	3.7016524444797017
CELL-CYCLE	3.7016524444797017
TISSUE-TEK	3.7016524444797017
WOUND AREA	3.7016524444797017
SUB-SECOND	3.7016524444797017
GENE Β-GAL	3.7016524444797017
RASMC HSPG	3.7016524444797017
CONJECTURE	3.7016524444797017
PRE-IMMUNE	3.7016524444797017
MM MG(OAC)	3.7016524444797017
RAS RESULT	3.7016524444797017
MONOCLONAL	3.7016524444797017
SN50 BLOCK	3.7016524444797017
CONNECTION	3.7016524444797017
SARAN WRAP	3.7016524444797017
RE-PLATING	3.7016524444797017
TILT IMAGE	3.7016524444797017
OPTIC LOBE	3.7016524444797017
TERMED TKT	3.7016524444797017
OSTEOPENIA	3.7016524444797017
PFLAG-COP1	3.7016524444797017
INSPECTION	3.7016524444797017
STATE TYPE	3.7016524444797017
LGL SAMPLE	3.7016524444797017
PRSETA-LIP	3.7016524444797017
NONTRIVIAL	3.7016524444797017
REFINEMENT	3.7016524444797017
COMPLEX TM	3.7016524444797017
HYDROLYSED	3.7016524444797017
STIMULATOR	3.7016524444797017
DONOR POOL	3.7016524444797017
DARK-FIELD	3.7016524444797017
PTB DOMAIN	3.7016524444797017
CASTRATION	3.7016524444797017
validation	3.7016524444797017
FIRSTLAYER	3.7016524444797017
GENE PANEL	3.7016524444797017
FITC-ACTIN	3.7016524444797017
TYPE/STAGE	3.7016524444797017
MID-MITOSI	3.7016524444797017
CRNA PROBE	3.7016524444797017
LP PACKAGE	3.7016524444797017
MEC-3 GENE	3.7016524444797017
adenosines	3.7016524444797017
CATARRHINI	3.7016524444797017
MASIA TOOL	3.7016524444797017
ETS DOMAIN	3.7016524444797017
INPUTSMUST	3.7016524444797017
GENE ATLAS	3.7016524444797017
INPUT FILE	3.7016524444797017
PHYSIOLOGY	3.7016524444797017
LINE LNCAP	3.7016524444797017
methionine	3.7016524444797017
uninfected	3.7016524444797017
XNR/SIAMOI	3.7016524444797017
PERFECTHYB	3.7016524444797017
GENERATION	3.7016524444797017
LPA FAMILY	3.7016524444797017
SBD DOMAIN	3.7016524444797017
QUASI SHOW	3.7016524444797017
RECQ4 GENE	3.7016524444797017
TARGET BLM	3.7016524444797017
SPM METHOD	3.7016524444797017
PRE-WASHED	3.7016524444797017
IDENTFYING	3.7016524444797017
GASTROCOEL	3.7016524444797017
WORK SHEET	3.7016524444797017
ANTI-C-CRK	3.7016524444797017
LINKER-TKT	3.7016524444797017
MORPHOLINO	3.7016524444797017
ISOPENTANE	3.7016524444797017
RDP/RDP II	3.7016524444797017
GLIAL CELL	3.7016524444797017
FMOL/GLAND	3.7016524444797017
BAMHI SITE	3.7016524444797017
FORMULA NV	3.7016524444797017
SCREENSHOT	3.7016524444797017
CCAF PROBE	3.7016524444797017
RIBOSYLATE	3.7016524444797017
GRAINYHEAD	3.7016524444797017
MEC-3 FORM	3.7016524444797017
SEA-KEM LE	3.7016524444797017
FLUX SPACE	3.7016524444797017
TWO-HYBRID	3.7016524444797017
BURN WOUND	3.7016524444797017
BOI1-P-GFP	3.7016524444797017
GOLD PROBE	3.7016524444797017
ODC RESULT	3.7016524444797017
NET RESULT	3.7016524444797017
BIND SMAD2	3.7016524444797017
protrusion	3.7016524444797017
DENATURING	3.7016524444797017
radioassay	3.7016524444797017
DISCREPANT	3.7016524444797017
FBA PRIMER	3.7016524444797017
EGF FAMILY	3.7016524444797017
leukocytes	3.7016524444797017
RELATIONAL	3.7016524444797017
B42-FUSION	3.7016524444797017
GENE PROBE	3.7016524444797017
FIB-LC EGF	3.7016524444797017
PSEUDOMONA	3.7016524444797017
HUMAN SERA	3.7016524444797017
MODEL SHOW	3.7016524444797017
MASS RATIO	3.7016524444797017
DATABASING	3.7016524444797017
CYCLOSTOME	3.7016524444797017
ARR RESULT	3.7016524444797017
RHO RESULT	3.7016524444797017
NTERACTING	3.7016524444797017
KLEBSIELLA	3.7016524444797017
HEAT BLOCK	3.7016524444797017
ADENOVIRAL	3.7016524444797017
EMBRYOLOGY	3.7016524444797017
BINDING WG	3.7016524444797017
AVERAGE CV	3.7016524444797017
OMIM ENTRY	3.7016524444797017
ANTIBODIES	3.7016524444797017
DYE YOYO-1	3.7016524444797017
ELONGATION	3.7016524444797017
ECORI SITE	3.7016524444797017
HA VARIANT	3.7016524444797017
PSEUDOGENE	3.7016524444797017
PPT1 PROBE	3.7016524444797017
HSM METHOD	3.7016524444797017
MHCK-C ACT	3.7016524444797017
TAG RESULT	3.7016524444797017
HALF-RANGE	3.7016524444797017
WEIGHT RAC	3.7016524444797017
BASE LEVEL	3.7016524444797017
OUTPUTTING	3.7016524444797017
LENGTH BID	3.7016524444797017
TYPE/CLASS	3.7016524444797017
CRW METHOD	3.7016524444797017
YOLKY CELL	3.7016524444797017
BRIDGED NL	3.7016524444797017
ΔC2 FUSION	3.7016524444797017
SUB-CLONED	3.7016524444797017
SNSG MOUSE	3.7016524444797017
PM PARTNER	3.7016524444797017
PARALOGOUS	3.7016524444797017
FUGENE KIT	3.7016524444797017
MATCH (PM)	3.7016524444797017
TESTED AGE	3.7016524444797017
ECORI-SMAI	3.7016524444797017
CYTOMATION	3.7016524444797017
REFLECTION	3.7016524444797017
USM RESULT	3.7016524444797017
SΑ I2 FAIL	3.7016524444797017
PRE-WARMED	3.7016524444797017
HYAL1 GENE	3.7016524444797017
BLASTOCOEL	3.7016524444797017
filopodium	3.7016524444797017
E3 COMPLEX	3.7016524444797017
ACTOMYOSIN	3.7016524444797017
P8 SECTION	3.7016524444797017
INTRAGENIC	3.7016524444797017
AREPRESENT	3.7016524444797017
ATROPHIN-1	3.7016524444797017
GFP-MYOSIN	3.7016524444797017
IMPORTIN-Α	3.7016524444797017
AMINO-ACID	3.7016524444797017
ADENO-RSG3	3.7016524444797017
ANTI-RAB24	3.7016524444797017
IMPERFECTA	3.7016524444797017
PFA/DOTMAC	3.7016524444797017
DYNACORTIN	3.7016524444797017
BEDNARCZUK	3.7016524444797017
NAPERVILLE	3.7016524444797017
DIMINUTION	3.7016524444797017
phalloidin	3.7016524444797017
PIXEL SIZE	3.7016524444797017
LIST FRAME	3.7016524444797017
PYRIMIDINE	3.7016524444797017
AFFYMETIRX	3.7016524444797017
CARL WOESE	3.7016524444797017
RGS DOMAIN	3.7016524444797017
VOGELSTEIN	3.7016524444797017
HPRT LOCUS	3.7016524444797017
CELLS SHOW	3.7016524444797017
QUASISPECY	3.7016524444797017
INPUT CELL	3.7016524444797017
EGF REPEAT	3.7016524444797017
QUERY GENE	3.7016524444797017
PROTEIN/ML	3.7016524444797017
MM/L MGOAC	3.7016524444797017
STIMULTION	3.7016524444797017
THREE-HOUR	3.7016524444797017
DOTMA/DOPE	3.7016524444797017
SEQUENCE W	3.7016524444797017
AHAB MODEL	3.7016524444797017
DONOR TYPE	3.7016524444797017
PP5 RESULT	3.7016524444797017
ACETYLCHOLINE RECEPTOR	3.701556858846654
TTB	3.7010063033224547
POTENTIAL INTERACTION	3.6999927412323728
MEASURING INTERACTION	3.6999927412323728
FORM MACROSCOPIC FOCI	3.699748009402736
CONTROL V.	3.6996097308040774
STUDY NOTE	3.6994463137100273
STUDY RNOC	3.6994463137100273
STUDY GIVE	3.6994463137100273
TIRF STUDY	3.6994463137100273
CHROMA SPIN-200 COLUMN	3.699108747671593
RRNA MODEL	3.698926237254819
OTHER RRNA	3.698926237254819
QUERY RRNA	3.698926237254819
RHO KINASE	3.6988894676005333
TYPE IA TOPOISOMERASE	3.6988486047091778
SEDIMENTATION PATTERN	3.698705714021156
NET EFFECT	3.6985350857834227
FACTOR LIF	3.697969263828276
TCF FACTOR	3.697969263828276
EDGE ACTIN	3.697680186861174
RING ACTIN	3.697680186861174
ACTIN GENE	3.697680186861174
IIB INTRON	3.697658057292269
PHOSPHO-SPECIFIC ANTIBODY	3.6973842579069522
CY5 SIGNAL	3.6970117163234284
SIGNAL SET	3.6970117163234284
MNOC CLONE	3.6969041497767603
EYFP-CPLA DISTRIBUTION	3.6967933768234946
TARGET RNA	3.6967549547246183
EMBRYO RNA	3.6967549547246183
RNA FAMILY	3.6967549547246183
TORULA RNA	3.6967549547246183
SPLEEN RNA	3.6967549547246183
TISSUE RNA	3.6967549547246183
ZWF STRAIN	3.6965673912871897
HEJ STRAIN	3.6965673912871897
UREA BUFFER	3.696483466198649
SERUM	3.6963744398794907
Α4Β1-CD98 ASSOCIATION	3.6961715056424125
BCD	3.695972856795899
GUI	3.695972856795899
PKC	3.695972856795899
E18	3.695972856795899
TRP	3.695972856795899
CYK	3.695972856795899
MIP	3.695972856795899
RPA	3.695972856795899
NON-FAT MILK	3.6956800411469763
NLS VARIANT	3.695398010884265
GAPDH PROBE	3.695398010884265
SODIUM CITRATE BUFFER	3.6949563319526053
SEQUENCE DETERMINATION	3.694940599943665
GR PROTEIN	3.6949398172109436
FN PROTEIN	3.6949398172109436
MUTANT P27	3.6946816840616328
RAB MUTANT	3.6946816840616328
MUTANT TAG	3.6946816840616328
UPA MUTANT	3.6946816840616328
MUTANT BLM	3.6946816840616328
MUTANT LRP	3.6946816840616328
DLA MUTANT	3.6946816840616328
BRAIN MRNA	3.694668751296479
PVD NEURON	3.6945884789610397
FLP NEURON	3.6945884789610397
NMR ANALYSIS	3.6945452110658863
searches	3.694452953100891
S. POMBE	3.693996300629257
INSERT DNA	3.6935798574770544
COLONY DNA	3.6935798574770544
DNA STRAND	3.6935798574770544
CD3 T CELL	3.693411151374596
KDA C-TERMINAL REGION	3.693234530113654
SITE TABLE	3.693217238595652
GOAT SERUM	3.6929791481069896
COOMASSIE BRILLIANT BLUE	3.6928093592592877
SYMBOL SET	3.692800685218662
N MUTATION	3.6926900382278993
FLANKING N	3.6926900382278993
FLOW STUDY	3.6926822335199874
variables	3.6919264710937796
TEST DONOR	3.6917628927535744
TEST SCORE	3.6917628927535744
DORSAL SIDE	3.691573266989546
C/EBPΑ USE	3.6915539585621775
MODELS USE	3.6915539585621775
FUSED CDNA	3.6914582383165135
MOUSE CDNA	3.6914582383165135
HYAL1 CDNA	3.6914582383165135
COLOR CDNA	3.6914582383165135
RAB24 CDNA	3.6914582383165135
YEAST MAPK	3.6904494366649483
EXPRESSION PATTERN	3.690304474110203
WEEK INTERVAL	3.690212261395648
SUBUNIT RIBOSOMAL RNA	3.690148829659919
FALL CLOSE	3.689898469067501
ΜL REACTION	3.689784429430313
DIFFERENTIAL RESPONSE	3.6896126443903303
VECTOR DNA	3.6895290523914936
NUMEROUS T	3.689290504822043
PCR METHOD	3.688962311733786
SRC MUTANT	3.688899486479825
FINAL WASH	3.6888490069771263
FINAL CELL	3.6888490069771263
CODON BIAS	3.6888490069771263
FINAL RULE	3.6888490069771263
FINAL RANK	3.6888490069771263
FINAL LIST	3.6888490069771263
CONTAINING INSERTION	3.6883790093257542
OLIGOMERIC STRUCTURE	3.6883790093257542
TRANSDUCTION CHANNEL	3.6883790093257542
FUNCTIONAL CLASS III	3.6883790093257542
DLYDDDDK EPITOPE TAG	3.6883790093257542
FUNCTIONAL RELEVANCE	3.6883790093257542
YXXP MOTIF	3.688374805588142
POSSIBLE R	3.688374805588142
R EQUATION	3.688374805588142
R LANGUAGE	3.688374805588142
TKXD MOTIF	3.688374805588142
PXXP MOTIF	3.688374805588142
KGB BUFFER	3.688219329722901
MES BUFFER	3.688219329722901
FATTY ACID	3.688060169595451
COVALENT CROSSLINKING	3.687935328411496
OSMOLARITY	3.687911859183255
GENTAMICIN	3.687911859183255
ENGULFMENT	3.687911859183255
ASPIRATION	3.687911859183255
COMPLEMENT	3.687911859183255
FIBRINOGEN	3.687911859183255
APPROACHES	3.687911859183255
UPREGULATE	3.687911859183255
starvation	3.687911859183255
MINNEAPOLI	3.687911859183255
SECTIONING	3.687911859183255
speciation	3.687911859183255
parametric	3.687911859183255
SOLUBILIZE	3.687911859183255
RHO FAMILY	3.687911859183255
POSSIBLITY	3.687911859183255
MALIGNANCY	3.687911859183255
EQKLISEEDL	3.687911859183255
topologies	3.687911859183255
REANALYZED	3.687911859183255
PEPTIDE CONCENTRATION	3.68783004438977
Β-SCINTILLATION COUNTER	3.6871314610278283
BIND LIPID	3.6868181168905108
TPI GROWTH	3.6866526013804504
FIND HOMOLOG	3.686450089820776
FIND PIGMENT	3.686450089820776
TRANSLATIONAL MACHINERY	3.686124662937904
PHOSPHATIDYLINOSITOL-SPECIFIC	3.6860029006255384
GLYCINE MAX	3.6858288146821954
SINGLE EYE	3.685819802520681
SINGLE CHR	3.685819802520681
SINGLE ROW	3.685819802520681
assumptions	3.6857620182011153
FN SUPPORT	3.6857192778098304
THDP UPTAKE CAPACITY	3.6854354901055317
USER MANUAL	3.685119011667207
PRODUCE PGE	3.685119011667207
ACIDOPHILUM CYTOPLASM	3.68477731489337
cells growth	3.684752697041387
MONOMERIC CONFORMATION	3.684471308702155
RAT MURINE	3.684375516765383
NEUROTROPHIC ACTIVITY	3.6843451998749432
LAMININ MAP	3.6843416083650764
NON-RADIOACTIVE THDP	3.6839637304954205
AA PEPTIDE	3.683938301190317
BROAD OVERVIEW	3.683814849981625
S BLOCKAGE	3.6834238215946793
S BOUNDARY	3.6834238215946793
EXPECTED S	3.6834238215946793
PRODUCTIVE INFECTION	3.683253225856056
ANTISENSE TRANSFECTANT	3.6831674107472354
SN50 ΜG/ML	3.6828830073031513
TCA PRECIPITATION ASSAY	3.6828368148736765
ORG(UPDATED APRIL 17	3.682413406128086
GROWTH MID-LOG PHASE	3.6821594394252837
FINAL FLOW	3.6820849267870863
P66 POLYMERASE CLEFT	3.681540724757208
ENZYME MIB	3.681082987508351
COMMON SET	3.680667298134017
tyrosine	3.6806427388586984
KDA ISOFORM	3.6805026946535575
ATP DEPENDENT FASHION	3.679894845936645
SILICA GEL	3.6798151094499283
MURINE RNA	3.6794780270103
VIRAL PROTEIN TAX	3.6794314712558798
TRANSFECTED RAW CELL	3.6794153276802524
LTR VECTOR	3.67921721631352
UV RADIATION	3.678758463715609
GΑ SUBUNIT	3.678523654152469
HUMAN IL-8	3.678523654152469
SD CHIMERA	3.6783356152067186
OVER-EXPRESSION LEVEL	3.6782791206235257
MAPK ASSAY	3.6776915629969014
OVEREXPRESSED PROTEIN	3.6769687881780215
RNA SUBSET	3.6768384963872784
CONTROL PS	3.676480940476844
KB HINDIII	3.6755799899290023
RELEASE MP	3.674898992981783
LH RELEASE	3.674898992981783
REPLICATION INITIATION	3.674687959748881
ANION-EXCHANGE COLUMN	3.674679469199608
TOTAL CELL	3.674493637656057
TRAP	3.6741552773735164
agar	3.6741552773735164
DAKO	3.6741552773735164
XBAI	3.6741552773735164
STANDARD G	3.6737176717468096
CYCLE EXIT	3.6732959808881365
NG/ML BMP7	3.6729727444739324
BASELINE LIPID LEVEL	3.6723182211207
POP2 DELETION STRAIN	3.672113605245618
P3 SEQUENCE	3.6719031555309884
hybrids	3.6718088632171835
RRNA TOTAL	3.671767430431174
SDS-PAGE GEL	3.671697163030294
TERMINATION	3.671056657171849
CUT PCDNA3	3.6704788575169096
TRANSFECTED K562 CELL	3.670226433077423
RUBBER POLICEMAN	3.66953260209244
TOPOISOMERASE I PMOLE	3.6695292216606603
ACTIN MRNA	3.669263232549495
users	3.6687869788115473
EOSIN	3.6687869788115473
K-PIPES PH	3.668530508331735
AVERAGE PH	3.668530508331735
CYTOPLASMIC FRACTION	3.6682571837294637
SS	3.667611006088263
P3 PROMOTER	3.667523936929638
B FUNCTION	3.6675099444728336
PASSING SINGLE-STRAND	3.6673736831566917
KDA REGION	3.667305498365008
RT-PCR RNA	3.6668802672186085
CONNECTION SUBDOMAIN	3.666625684356792
ΜM 3(APPROXIMATELY 3	3.666421964300863
DIASTOLIC DYSFUNCTION	3.666394557192177
BINDING SPECIFICITY	3.6663003129123495
BURIED SURFACE AREA	3.6663003129123495
SUBSTRATE SELECTION	3.6663003129123495
GRADUAL WEIGHT GAIN	3.6663003129123495
KK VERSION	3.6658028194724905
FUNCTIONAL ANALYSIS	3.665645720151876
SINGLE CELL	3.6654774818021796
HYBRID TOPOISOMERASE	3.6647809315609163
acetylcholine receptor	3.6641757000470507
REPORT USE	3.663977323941246
start codons	3.663706548806693
COOMASSIE BLUE STAIN	3.6636043892222134
HEART CLASSIFICATION	3.6629607219978904
HUMAN SERUM ALBUMIN	3.662758121442367
SWISS-MODEL PROTEIN	3.6621881374433936
MODEL TAKE	3.6618195278050227
PB HUMAN T	3.661544818034852
MIN SAMPLE	3.6609399365850765
MEAN PIXEL	3.6608479932519815
FIGURE 5(C	3.6606814444714604
FIGURE 4TO	3.6606814444714604
WEB FIGURE	3.6606814444714604
FIGURE 1WE	3.6606814444714604
FIGURE 5-C	3.6606814444714604
FIGURE 7-C	3.6606814444714604
EG HB MATCH	3.660607551995759
DIMERIZATION PROCESS	3.660507561709271
DNA PROTEIN COMPLEX	3.6602620020299024
GUIDE CELL	3.6594764150594528
DETERGENT CONDITION	3.659437316939258
BACULOVIRUS	3.659354783201023
PROTEINASE K	3.6581781668396225
HBAB PROTEIN ABUNDANCE	3.6579177424306106
OTHER F-BOX PROTEIN	3.657193185175395
BINDING INTERACTION	3.657092100285979
ATORVASTATIN EVALUATION	3.655234266997052
KEY TARGET	3.6550944899248816
DOXAZOSIN TREATMENT	3.6550759347600845
IDO-EXPRESSING CELL	3.65503796054625
FZ ABSENCE	3.6548284444702825
WG ABSENCE	3.6548284444702825
MOLAR BASIS	3.6542820140160313
FIBROBLASTIC CELL LINE	3.6532591226643816
NUCLEOTIDASE ACTIVITY	3.652931575180103
INCLUDING CHD DEATH	3.650888672832424
KEY SIGNAL	3.6504537617686084
ADULT AXON	3.6504386944694
ANISOMYCIN TREATMENT	3.650435336840646
RECEPTOR COACTIVATOR	3.6501979225574885
BILE ACID TRANSPORT	3.6497816110980783
MEAN BLOOD PRESSURE	3.6496356939641377
STRAIN DH5Α	3.6490331633520006
THERMOPLASMA INTEIN	3.648553575850617
AZ ABSENCE	3.6481896250245027
PROTEIN IΚB	3.6473531625835838
IΚB PROTEIN	3.6473531625835838
NM BANDPAS	3.646499175237838
EVENT DOCUMENTATION	3.6463352337179007
MISSING DATA MODEL	3.64314418951137
ESSENTIAL MEDIATOR	3.64314418951137
COORDINATED ACTION	3.64314418951137
GLASS-FIBER FILTER	3.64314418951137
BIOCHEMICAL EVIDENCE	3.643028857271816
MULTIPLE PREPARATION	3.6424596209972857
TUBE LUMEN	3.641903069467683
C-MYC ORIGIN REGION	3.6418985494524674
COOMASSIE BLUE R250	3.6418985494524674
GROWTH MEDIUM	3.641738315353899
DEMONSTRATION	3.6417337301860715
LABELED CALMODULIN	3.6416538694786507
REMODELLING FACTOR	3.640924020969476
OPEN-LABEL MEDICINE	3.6404631516018866
CANDIDATE RECEPTOR	3.6393859911679898
CHEMOKINE RECEPTOR	3.6393859911679898
HAIR-CELL RECEPTOR	3.6393859911679898
P38 KINASE	3.639140092588514
ENZYME MAX	3.638906958088102
FUNCTIONAL RIBOSOME	3.6388483290199822
SODIUM PHOSPHATE PH	3.6385566285258517
SOLVING EQ	3.6364713081029536
BINDING SITE TOXIN	3.6362839861861525
ENZYME CDC34	3.635761012865414
statistics	3.635346798213451
MICROGRAPH	3.635346798213451
directions	3.635346798213451
SUPPRESSOR	3.635346798213451
ECORV SITE	3.635346798213451
VICE VERSA	3.635346798213451
RAS GTPASE	3.635346798213451
CONSTRUCTED ALANINE	3.6343561862012312
INTERNET ACCESS	3.6340039958251893
NUCLEOTIDE SOLUTION	3.6331832954220302
COP9 SUBUNIT	3.633042911784093
SEDIMENTATION DATA	3.632853884523543
SEDIMENTATION PEAK	3.632853884523543
SHOW SEDIMENTATION	3.632853884523543
REPLICATION REGION	3.6324727621165867
GROWING EC	3.6322660734980023
OTHER LGIC RECEPTOR	3.631218357329447
TRANSLOCATION RATE	3.631054880155042
TRANSPORT FUNCTION	3.6303067793285364
XENOPUS CALMODULIN	3.630280374492105
GENUS THERMOPLASMA	3.6300474377086815
HEAT SHOCK	3.6299531944652785
PETRI PLATE	3.6296124158950906
SUBSTRATE SPECIFICITY	3.6291127754178887
PH DOMAINS	3.627559508323493
ANTI-T7 ΜL	3.6273300511720685
IMMERSION OBJECTIVE	3.6272574913765383
PRODUCED AGGREGATE	3.626521389146419
CLINICAL DIAGNOSIS	3.626521389146419
MM TRIS PH7	3.626174468134357
CALMODULIN RELEASE	3.6255272721096676
LAEMMLI SAMPLE BUFFER	3.624766696043793
ATP ABSENCE	3.624475845697674
POSITIVE MODULATOR	3.623499061807337
K1 PROTEIN	3.6232405671965204
FOLDED CONFORMATION	3.6229957749412915
F MUTATION	3.621986611130343
MM SODIUM CARBONATE	3.621085280619039
divisions	3.6191351493365405
RAPAMYCIN	3.6190601344450766
GERM LINE	3.6190601344450766
3-D LOCUS	3.6190601344450766
androgens	3.6190601344450766
FINE-TUNE	3.6190601344450766
MAJOR ECM	3.6190601344450766
FOUR-FOLD	3.6190601344450766
DD SAMPLE	3.6190601344450766
RAJARAMAN	3.6190601344450766
BOUND GDP	3.6190601344450766
JAVA LANG	3.6190601344450766
CLONALITY	3.6190601344450766
FN PURITY	3.6190601344450766
MID-BRAIN	3.6190601344450766
SHOW DATA	3.6190601344450766
DSP PRIOR	3.6190601344450766
HEAD/NECK	3.6190601344450766
STOP CELL	3.6190601344450766
monolayer	3.6190601344450766
ttt codon	3.6190601344450766
PP5 LEVEL	3.6190601344450766
AGEI-NHEI	3.6190601344450766
XHO1 SITE	3.6190601344450766
TOOLMAKER	3.6190601344450766
oncogenes	3.6190601344450766
INCUBATOR	3.6190601344450766
RGS3 BIND	3.6190601344450766
GENOTYPIC	3.6190601344450766
CATCH-ALL	3.6190601344450766
LIVING D.	3.6190601344450766
SOM CLASS	3.6190601344450766
HA TRIMER	3.6190601344450766
TYPE HSN3	3.6190601344450766
NULLSPACE	3.6190601344450766
POWERTHAN	3.6190601344450766
SOLUBILIZ	3.6190601344450766
BOUND GQΑ	3.6190601344450766
PRINCETON	3.6190601344450766
PAIR-WISE	3.6190601344450766
LINK OPEN	3.6190601344450766
DIRICHLET	3.6190601344450766
N1 REGION	3.6190601344450766
BIOSEARCH	3.6190601344450766
CD14 CELL	3.6190601344450766
RED/WHITE	3.6190601344450766
SOLVATION	3.6190601344450766
P0-3D TKT	3.6190601344450766
PFA-BASED	3.6190601344450766
HIS3 TRP1	3.6190601344450766
IL-1ALPHA	3.6190601344450766
ORTOLOGUE	3.6190601344450766
NOTREDAME	3.6190601344450766
relations	3.6190601344450766
RPA BOUND	3.6190601344450766
DURLON-UV	3.6190601344450766
RESECTION	3.6190601344450766
DUAL ROLE	3.6190601344450766
GENENTECH	3.6190601344450766
PGAL4-SRF	3.6190601344450766
END POINT	3.6190601344450766
REPULSION	3.6190601344450766
DOTMAC- A	3.6190601344450766
CASPASE-8	3.6190601344450766
PSI VALUE	3.6190601344450766
LRP6 FORM	3.6190601344450766
EQUIMOLAR	3.6190601344450766
RMS ERROR	3.6190601344450766
THEMETHOD	3.6190601344450766
MM BIOPSY	3.6190601344450766
threonine	3.6190601344450766
STRESSGEN	3.6190601344450766
MODEL LIE	3.6190601344450766
PBS-MYBAM	3.6190601344450766
LINEARITY	3.6190601344450766
APE1 MAKE	3.6190601344450766
LEU2 HIS3	3.6190601344450766
B/MIN ADI	3.6190601344450766
DECAPRIME	3.6190601344450766
specimens	3.6190601344450766
COLUMN F.	3.6190601344450766
N.(ORD+1)	3.6190601344450766
HINDBRAIN	3.6190601344450766
NODE NAME	3.6190601344450766
AMIIFORME	3.6190601344450766
MOUSE IGG	3.6190601344450766
PENETRANT	3.6190601344450766
BIN WIDTH	3.6190601344450766
cytometer	3.6190601344450766
CAS(3'SD)	3.6190601344450766
USM SPACE	3.6190601344450766
AEBERSOLE	3.6190601344450766
B. HENDIL	3.6190601344450766
MICROPYLE	3.6190601344450766
BASE LINE	3.6190601344450766
MUCOLIPID	3.6190601344450766
EXAMPLEOF	3.6190601344450766
METAMORPH	3.6190601344450766
CHH LOCUS	3.6190601344450766
PUSH-PULL	3.6190601344450766
NEOCORTEX	3.6190601344450766
MOUSE EST	3.6190601344450766
PPAI-1-AI	3.6190601344450766
NIGERICIN	3.6190601344450766
E3 LIGASE	3.6190601344450766
REACHABLE	3.6190601344450766
LUMBRICUS	3.6190601344450766
LANGERHAN	3.6190601344450766
DEFINETHE	3.6190601344450766
USER WANT	3.6190601344450766
stretches	3.6190601344450766
MCDERMOTT	3.6190601344450766
GAD1-LACZ	3.6190601344450766
VERYSMALL	3.6190601344450766
MET14 GAL	3.6190601344450766
HFC VALUE	3.6190601344450766
CYCLIN B1	3.6190601344450766
AMBIGUOUS	3.6190601344450766
PERCENTOF	3.6190601344450766
HA ESCAPE	3.6190601344450766
BP741-759	3.6190601344450766
BUFFERING	3.6190601344450766
QUESTIONS	3.6190601344450766
EACHINPUT	3.6190601344450766
UROKINASE	3.6190601344450766
GENERATOR	3.6190601344450766
RIECHMANN	3.6190601344450766
GUANIDINE	3.6190601344450766
ABILITYTO	3.6190601344450766
PIPETTING	3.6190601344450766
SIMPLE RN	3.6190601344450766
HL60 CELL	3.6190601344450766
T. BRUCEI	3.6190601344450766
NCOI-SALI	3.6190601344450766
INTUITION	3.6190601344450766
PALMITOYL	3.6190601344450766
TYPE DFZ2	3.6190601344450766
MATΑ BOI1	3.6190601344450766
CODE LOOK	3.6190601344450766
NF-KAPPAB	3.6190601344450766
THETWO NN	3.6190601344450766
USER MOVE	3.6190601344450766
SCREEN GP	3.6190601344450766
CLEARANCE	3.6190601344450766
INCLUSION	3.6190601344450766
PEN-STREP	3.6190601344450766
Α-TOPIIIA	3.6190601344450766
VECTORIAL	3.6190601344450766
FROG-LIKE	3.6190601344450766
LOG-PHASE	3.6190601344450766
CHECK BOX	3.6190601344450766
endocytic	3.6190601344450766
MM/L KOAC	3.6190601344450766
HYPOCHORD	3.6190601344450766
STYI SITE	3.6190601344450766
CONTORTUS	3.6190601344450766
ALML/BDUL	3.6190601344450766
GPNN FALL	3.6190601344450766
HUMAN BID	3.6190601344450766
SOLUTIONS	3.6190601344450766
ALMR/BDUR	3.6190601344450766
IGG TRITC	3.6190601344450766
HEXAMERIC	3.6190601344450766
SUMMATION	3.6190601344450766
ED PERIOD	3.6190601344450766
LRP6 PLAY	3.6190601344450766
P150 ROKΑ	3.6190601344450766
ACTIVATOR	3.6190601344450766
MONOMERIC	3.6190601344450766
DAND DATA	3.6190601344450766
RAB24 LIE	3.6190601344450766
C3 RESULT	3.6190601344450766
TIME SHOW	3.6190601344450766
HYPERLINK	3.6190601344450766
SC MEDIUM	3.6190601344450766
OVULATION	3.6190601344450766
MCF7 CELL	3.6190601344450766
OTHER PPP	3.6190601344450766
ISL1 MOVE	3.6190601344450766
LFC CURVE	3.6190601344450766
personnel	3.6190601344450766
residents	3.6190601344450766
BUSM FORM	3.6190601344450766
NEW GROUP	3.6190601344450766
ROOM TEMP	3.6190601344450766
CELL LINE	3.6190601344450766
ORNITHINE	3.6190601344450766
NM-MYOSIN	3.6190601344450766
LOW-POWER	3.6190601344450766
CCAAT-DR1	3.6190601344450766
QRNA WORK	3.6190601344450766
NDEI SITE	3.6190601344450766
OTH PHASE	3.6190601344450766
DOMAIN G3	3.6190601344450766
PREDICTOR	3.6190601344450766
ANTI-PCNA	3.6190601344450766
TGF-Β/BMP	3.6190601344450766
F15-42-01	3.6190601344450766
ANEUPLOID	3.6190601344450766
TPA- LOXP	3.6190601344450766
ADE2 ADE3	3.6190601344450766
UTR PROBE	3.6190601344450766
GERM RING	3.6190601344450766
RACEMOSUS	3.6190601344450766
GENE LEAD	3.6190601344450766
DIHYDRO-2	3.6190601344450766
SUBREGION	3.6190601344450766
END STATE	3.6190601344450766
forebrain	3.6190601344450766
KM/CAS(SD	3.6190601344450766
OTHERDEME	3.6190601344450766
DESICCANT	3.6190601344450766
OCCURENCE	3.6190601344450766
DGGE DATA	3.6190601344450766
ACONITASE	3.6190601344450766
SEQUENASE	3.6190601344450766
GTP-BOUND	3.6190601344450766
C-REL P75	3.6190601344450766
ALEXA-DYE	3.6190601344450766
EARLY/MID	3.6190601344450766
ENDOTOXIN	3.6190601344450766
HIGHLIGHT	3.6190601344450766
ERYTHROSE	3.6190601344450766
NEISSERIA	3.6190601344450766
SHOW GOOD	3.6190601344450766
CASPASE-3	3.6190601344450766
HINDRANCE	3.6190601344450766
CY5 RATIO	3.6190601344450766
CHIP-PAIR	3.6190601344450766
NEOPLASIA	3.6190601344450766
chelation	3.6190601344450766
METHOD X.	3.6190601344450766
FRAME/SEC	3.6190601344450766
HMM STATE	3.6190601344450766
IG DOMAIN	3.6190601344450766
FACTORIAL	3.6190601344450766
PARAPLAST	3.6190601344450766
orthologs	3.6190601344450766
XENOGRAFT	3.6190601344450766
Α-TUBULIN	3.6190601344450766
OLFACTORY	3.6190601344450766
ACID-RICH	3.6190601344450766
circuitry	3.6190601344450766
BALB/CBYJ	3.6190601344450766
ENDOCYTIC	3.6190601344450766
STRAND 4A	3.6190601344450766
KNAGARAJU	3.6190601344450766
PANASONIC	3.6190601344450766
CRNA STEP	3.6190601344450766
MOUSE PP5	3.6190601344450766
PROBATIVE	3.6190601344450766
A875 CELL	3.6190601344450766
NOT1 SITE	3.6190601344450766
INPUTTING	3.6190601344450766
TYPE ALK3	3.6190601344450766
transgene	3.6190601344450766
DONOR SET	3.6190601344450766
SP COLUMN	3.6190601344450766
AMINOACID	3.6190601344450766
POLYAMINE	3.6190601344450766
SECRETORY	3.6190601344450766
SELECTEDI	3.6190601344450766
PRIMER F1	3.6190601344450766
GENE ABC3	3.6190601344450766
MID-STAGE	3.6190601344450766
HAMAMATSU	3.6190601344450766
GENE TREE	3.6190601344450766
CASE UNIT	3.6190601344450766
Α-ACTININ	3.6190601344450766
FRIZZLEDS	3.6190601344450766
ORDER ORD	3.6190601344450766
URA3 LEU2	3.6190601344450766
gene fall	3.6190601344450766
SET SERVE	3.6190601344450766
PROSA26-1	3.6190601344450766
ROUBINIAN	3.6190601344450766
PERFUSATE	3.6190601344450766
GP MUSTBE	3.6190601344450766
TYPE BAND	3.6190601344450766
MM S-2444	3.6190601344450766
MAS4 USES	3.6190601344450766
FLAVONOID	3.6190601344450766
incubator	3.6190601344450766
MI OOCYTE	3.6190601344450766
RUOSLAHTI	3.6190601344450766
PREWARMED	3.6190601344450766
MID-TRUNK	3.6190601344450766
transfect	3.6190601344450766
CRL-10995	3.6190601344450766
FIRMICUTE	3.6190601344450766
ANTI-COLL	3.6190601344450766
LOWERCASE	3.6190601344450766
SALI-PVUI	3.6190601344450766
GLYCOLYSI	3.6190601344450766
PDGF LANE	3.6190601344450766
DP MATRIX	3.6190601344450766
PRIMER F2	3.6190601344450766
GATHERING	3.6190601344450766
β-strands	3.6190601344450766
GDP STATE	3.6190601344450766
ARR LEVEL	3.6190601344450766
XHOI SITE	3.6190601344450766
PAIRED G.	3.6190601344450766
PHYLOTYPE	3.6190601344450766
NCOI SITE	3.6190601344450766
H. BOURNE	3.6190601344450766
rhodamine	3.6190601344450766
CCAF PLAY	3.6190601344450766
GENE LOSS	3.6190601344450766
GENEORDER	3.6190601344450766
LFC-MODEL	3.6190601344450766
MICROTOME	3.6190601344450766
ML/G CELL	3.6190601344450766
AMPHIBIAN	3.6190601344450766
DIFF CALL	3.6190601344450766
ABI MODEL	3.6190601344450766
DOMAIN G1	3.6190601344450766
MNOC GENE	3.6190601344450766
OLIGO-TEX	3.6190601344450766
TPI BLOCK	3.6190601344450766
ANAMNIOTE	3.6190601344450766
PEROXIDAS	3.6190601344450766
SC-LEU ML	3.6190601344450766
HOMINIDAE	3.6190601344450766
SPORULATE	3.6190601344450766
TREE DATA	3.6190601344450766
GALAPAGOS	3.6190601344450766
SEQUELLAE	3.6190601344450766
GROΑ/MGSA	3.6190601344450766
DECEPRIME	3.6190601344450766
SUBICULUM	3.6190601344450766
SUBBRANCH	3.6190601344450766
BLUE FONT	3.6190601344450766
ANTI-SERA	3.6190601344450766
VIEWPOINT	3.6190601344450766
XBAI SITE	3.6190601344450766
breakdown	3.6190601344450766
USM IMAGE	3.6190601344450766
MHCA GENE	3.6190601344450766
DAKO LSAB	3.6190601344450766
BIND BEM1	3.6190601344450766
DYSPLASIA	3.6190601344450766
MATR NODE	3.6190601344450766
nematodes	3.6190601344450766
REPLATING	3.6190601344450766
SMAI-CLAI	3.6190601344450766
ANTI-BRDU	3.6190601344450766
IMMUNOGEN	3.6190601344450766
L. OSSEUS	3.6190601344450766
MODEL FIT	3.6190601344450766
RAC GTPAS	3.6190601344450766
INCREASES	3.6190601344450766
FLOWCHART	3.6190601344450766
GPNN STOP	3.6190601344450766
FORM PLAY	3.6190601344450766
AHAB CODE	3.6190601344450766
PROTEIN-1	3.6190601344450766
Β-BINDING	3.6190601344450766
TRICHROME	3.6190601344450766
INPUT BIT	3.6190601344450766
RATE AREA	3.6190601344450766
T7 PRIMER	3.6190601344450766
PVDF-PLUS	3.6190601344450766
THERESULT	3.6190601344450766
PROPONENT	3.6190601344450766
HUNCHBACK	3.6190601344450766
REGION V3	3.6190601344450766
GENE POOL	3.6190601344450766
DEFINEDBY	3.6190601344450766
HYPOBLAST	3.6190601344450766
TIMEPOINT	3.6190601344450766
GELATINAS	3.6190601344450766
GFP-ΔRING	3.6190601344450766
PRONEPHRO	3.6190601344450766
NON-EQUAL	3.6190601344450766
SUBCORTEX	3.6190601344450766
XMNI-AHDI	3.6190601344450766
RAFFINOSE	3.6190601344450766
EPPENDORF	3.6190601344450766
NON-PARAMETRIC METHOD	3.619004860509675
COLLAGEN-COATED PLATE	3.619004860509675
QIAGEN KIT	3.618922540616906
SPATIAL STRUCTURE	3.618800064528388
SENSITIVE MEASURE	3.618800064528388
SVEDBERG EQUATION	3.618800064528388
SECONDARY OUTCOME	3.618800064528388
BINDING SITE LOOP	3.618800064528388
Y-79 CELL CULTURE	3.618800064528388
survival analysis	3.618800064528388
CONTACT INTERFACE	3.618800064528388
SIDE CHAIN	3.618281223532698
ISCHEMIA REDUCTION	3.6177210830708564
ZD DOMAIN ADDITION	3.6175492659712014
STEADY-STATE K CAT	3.617348897954047
STUDY RHO	3.6169312534489917
AFFINITY TRANSPORT	3.616905451902529
EXTRACELLULAR TAT	3.6169036683170295
FIND INTRON	3.616518600331279
RRNA TYPE	3.616429387967025
TARGET DNA	3.6162697308097735
WG EFFECT	3.6160519330375656
REGULATORY SIGNAL	3.6160505968821464
FACTOR NF	3.6155059238779836
CELLULAR RECEPTOR	3.615106214516698
PURIFIED RECEPTOR	3.615106214516698
PMOLES/MG PROTEIN	3.6148230697820396
REPORTED HF EVENT	3.6146957867376215
P1 SIGNAL	3.6145819058125364
PM SIGNAL	3.6145819058125364
CONTAINING INTEIN	3.614509228656223
CLONE NA1	3.61447810581112
BAC CLONE	3.61447810581112
CLONE A31	3.61447810581112
P53 POSSE	3.614462883124628
RNA VIRUS	3.6143341349660636
LIVER RNA	3.6143341349660636
STATE RNA	3.6143341349660636
NOVEL RNA	3.6143341349660636
STRAIN B6	3.6141531392413357
STRAIN RF	3.6141531392413357
SARCOPHAGA FALCULATA	3.6140551490151327
HYPERTENSIVE PATIENT	3.6140551490151327
RADIOCHEMICAL PURITY	3.6140551490151327
VOLTAGE DEPENDENT	3.613889165668916
OTHER SRC	3.6134804060279193
IN VITRO MOTILITY	3.613247218105586
SITES MAP	3.6132459636574508
RPMI MEDIUM	3.6131660171477966
LIFE SPAN	3.612882577983224
MOUSE TNF	3.6127702587748267
heart failure	3.6126391160218887
IDO ANTISENSE RNA	3.612482713268446
CLEAVAGE REACTION	3.6124122036059165
MUTANT N3	3.6123334618532814
GR MUTANT	3.6123334618532814
DFZ1 MRNA	3.612320981941237
CELL MRNA	3.612320981941237
SHOWS AREA	3.612028381961673
ENDONUCLEASE ACTIVITY	3.6118772010914895
NF-ΚB P52	3.6117771205111033
GAPDH	3.6115665405892328
DNA ARRAY	3.611270216777725
DNA LEVEL	3.611270216777725
GFP EX436	3.6108233924959396
GFP EX500	3.6108233924959396
OTHER GFP	3.6108233924959396
GFP PRIOR	3.6108233924959396
CHENODEOXYCHOLIC ACID	3.6104293876071973
WEIGHT CHANGE	3.6101677356769923
POLAR INTERACTION	3.6098945561144604
RANK TEST	3.609516874807456
TEST MODE	3.609516874807456
SAMPLES RUN	3.6094281992506847
USE DELTA	3.6093152566460978
MAKES USE	3.6093152566460978
QUASI USE	3.6093152566460978
OLSEN USE	3.6093152566460978
USE COUNT	3.6093152566460978
CELLS USE	3.6093152566460978
ACT1 CDNA	3.6092228881361548
CCAF CDNA	3.6092228881361548
WOX1 CDNA	3.6092228881361548
UBIQUITIN-CONJUGATING	3.608952500607326
MULTIPLE FUNCTION	3.60859483326486
MM GLYCINE	3.608318869771792
IDO OVEREXPRESSION	3.6082627416408424
MAPK SITE	3.6082494106368346
GENETICIN	3.6080068938535237
CALIBRATION PROTEIN	3.607284169658659
AGGRESSIVE CHOLESTEROL	3.6068636687880367
PCD ASSAY	3.6067489898947658
ASSAY E15	3.6067489898947658
RPA ASSAY	3.6067489898947658
CTG CODON	3.606705021521372
FINAL TAG	3.606705021521372
INFECTION THERAPY	3.6063318043801442
BUFFER B.	3.606097393016927
ACID RGS3	3.6059438060331814
EXON GENE	3.605493735940616
tags	3.604939692793932
CONTAINING ALLELE	3.604640306150243
CIRCULAR DICHROISM	3.6038539341033036
HETEROMERIC RECEPTOR	3.603420667816538
EXCESS CALMODULIN	3.6031755035594
QUIESCED MDCK CELL	3.602897663336758
ATP DEPENDENT DNA	3.6027378138393082
PROTEIN C	3.6026984658851418
HISTONE MG	3.602070152793003
RNA MOTIF	3.601521425267407
VIRAL LTR	3.601319459477706
MAPK PHOSPHATASE 1	3.601273552801628
CONTROL AGGREGATE	3.6012516460255584
HA T-CELL	3.6008525996101435
P GENEN X	3.6006098324790106
III1-C ΜM	3.6004519448093744
MEDICAL MANAGEMENT	3.5999249085624965
NEUROBLASTOMA CELL	3.5999249085624965
BIOTECH AB	3.599702461941711
APPLICATION	3.5994049272956667
DMSO MOLE FRACTION	3.598944270220121
TEST CHIP	3.598872469827034
LERISETRON ABILITY	3.5987668799820485
localization	3.59866910030261
MM TES PH	3.5977520411418755
GRANISETRON BOUND	3.597015820869703
ASSAY USE	3.597004112095787
PRIMARY T	3.5963624011629935
MULTICELLULAR FOCI	3.595956885249573
DBA	3.595147893088362
U95	3.595147893088362
QUIESCED OVERNIGHT	3.595122766234844
ARLINGTON HT	3.594150576558773
P-TYPE STATE	3.594150576558773
INCREASED KM	3.594150576558773
INSECT CELL GENE	3.59313941613756
dialysis buffers	3.59313941613756
ACTIVITY PROFILE	3.59313941613756
AVERAGE INCREASE	3.59313941613756
FRICTIONAL RATIO	3.59313941613756
RAREST ESSENTIAL	3.59313941613756
MODELED POSITION	3.59313941613756
PRE-STEADY STATE	3.59313941613756
ARTERIAL DISEASE	3.59313941613756
SΑ I2 MIN	3.592868854051608
TOTAL IOD	3.5928523191523696
TOTAL CY3	3.5928523191523696
SUBSTITUTION RATE	3.5927923450583257
EFFICACY ENDPOINT	3.5926589721379663
RESOLVE GDP	3.5926080187136797
HELA CELL	3.5924491219940204
DECATENATION LOOP	3.5922505175693655
MINIMUM G	3.592103524429721
AVERAGE G	3.592103524429721
MICROARRAY SLIDE	3.592075659759641
GLASS MICROARRAY	3.592075659759641
IE SUBGROUP	3.591882442298358
P66 INSOR P66 IN	3.591671132686348
SD STRAIN	3.591652770990036
P53 KINAS	3.5914000056670456
ECFP LINE	3.5913846814959776
NONIDET P	3.5913846814959776
TYROSINE RESIDUE	3.5912694946122494
CONVERT THIAMINE	3.59072905486505
SENSE TRANSFECTANT	3.5905556938113423
TCA CYCLE	3.590424472931171
COX-1 PROTEIN LEVEL	3.5903535722200663
STEROID RECEPTOR	3.589513394397175
OTHER HIV	3.588978120369969
ANTI-Α4 INTEGRIN	3.588454107147175
EMPTY TARGET SITE	3.5873339347991764
KDA SERVE	3.5859158794162163
PROTEIN G	3.58562594620875
TRANSLATION GENE	3.5854173328015557
DISULFIDE LINKAGE	3.5848166444208394
RADICAL O	3.5844658182587033
INTEGRATION POINT	3.583400668583025
MOUSE P65	3.58264506477521
PERCENT NC	3.5821536944556636
GENE BASIS	3.5821536944556636
ECFP CDNA	3.5815474351870566
REGULATORY PROTEIN	3.5813947574662413
ENZYME MECHANISM	3.581176516543258
MOID TAKE	3.580622005349106
MOUSE P50	3.580622005349106
TAKE NOTE	3.580622005349106
U PAIRING	3.580622005349106
MUTANT PH	3.5803713218984807
ΜM RESOLUTION	3.5798968454861155
MIN PULSE	3.5797732138548737
MIN BOUND	3.5797732138548737
MODE MEAN	3.5796844900053024
FIGURE 4I	3.5795237730892215
FIGURE 3I	3.5795237730892215
MW EXCLUSION LIMIT	3.5791156251426686
BP CHANGE	3.578825274015644
IA TOPOISOMERASE	3.578444406804119
COLI TRNA	3.5774466816411783
FORMED AGGREGATE	3.5771012430550897
ΜL VEHICLE	3.576116301161766
BINDING CYSTEINE	3.5757647286315506
CEREVISIAE SACCHAROMYCE	3.5755639862831
KODAK	3.5754435823048984
KEY EVENT	3.5741324510861503
MMP-1	3.5738536850588316
COVALENT COMPLEX	3.573282630416406
JAW REACH	3.5729343795299124
PHOSPHATE BUFFER	3.572517840618407
DISRUPTION	3.5723138017765494
EYFP FLUORESCENCE	3.5716008699345703
RR	3.570679734217403
ALLHAT CRITERION	3.5705992809946285
HF HOSPITALIZATION	3.570389324145931
CHIP TAKE	3.569977600368684
ADULT EYE	3.5696396827502577
ADULT AGE	3.5696396827502577
PEM BUFFER	3.5687205796988626
CD98 HETERODIMER	3.568599592014028
PLATELET FACTOR 4	3.5685465244997454
SELECTIVE LIGAND	3.5682443415020835
FOLDING PATTERN	3.566011668018374
COGNATE HORMONE	3.566011668018374
DROPOUT PROBLEM	3.566011668018374
DROPOUT PROCESS	3.566011668018374
ORIGIN FUNCTION	3.566011668018374
MULTIMERIC FORM	3.566011668018374
DICHROIC MIRROR	3.566011668018374
IMPROVED HEALTH	3.566011668018374
CELLULAR UPTAKE	3.566011668018374
BINDING CONTACT	3.566011668018374
UCB-HSA COMPLEX	3.566011668018374
EXCLUSION LIMIT	3.566011668018374
quality control	3.566011668018374
CELL LINE MOLT4	3.566011668018374
INSECTOTOXIN II	3.566011668018374
DROPOUT PATTERN	3.566011668018374
CORONARY ARTERY	3.566011668018374
THERMOCOCCUS SP	3.566011668018374
NM PHOTON	3.5658381095429643
STUDY CRITERION	3.5647539871441434
BIND CALMODULIN	3.5646021980731155
PYRUVATE KINASE	3.5644365378290677
Y-LIKE RECEPTOR	3.5624573525042433
LIFE EXPECTANCY	3.5623621476244005
DISCHARGE SUMMARY	3.562161031015807
INTEIN EXCISION	3.561882917673677
ELIGIBILITY RISK	3.5618649786267427
NUCLEOTIDE BASE	3.5614868014044436
EXPRESSING ASBT	3.56025467810112
CULLIN FUNCTION	3.5594189860163574
CHRONIC THERAPY	3.558712627230427
QUINOLINIC ACID	3.5582629232956244
COVER SLIP	3.5582539444508554
OTHER ZINC	3.5582539444508554
FLACCID PARALYSIS	3.5581153857649084
RRNAS, ΜG	3.556790365309605
liver mitochondria	3.556705627613623
MAXIMUM ENTROPY	3.5563941083919026
MAPK ACTIVATION	3.555857760470625
ECL REAGENT	3.5553118665155843
APROTININ	3.5552523356698313
KNOWLEDGE	3.5552523356698313
LACZ GENE	3.5552523356698313
mediators	3.5552523356698313
VORTEXING	3.5552523356698313
ASTRONOMY	3.5552523356698313
EUCARYOTE	3.5552523356698313
aspartate	3.5552523356698313
disorders	3.5552523356698313
PEPSTATIN	3.5552523356698313
CELL-TYPE	3.5552523356698313
THYMIDINE	3.5552523356698313
GALACTOSE	3.5552523356698313
minipreps	3.5552523356698313
TETROXIDE	3.5552523356698313
HYPERCUBE	3.5552523356698313
sequencer	3.5552523356698313
SULFOXIDE	3.5552523356698313
SURVIVAL PATHWAY	3.5546478007396307
REGRESSION MODEL	3.5534258446952522
RK CONTRIBUTION	3.5533653775831473
LM CONTRIBUTION	3.5533653775831473
MG/ML GLUTAMINE	3.552610150506078
EC NUMBER	3.552103393439193
PIPERAZINE RING	3.5519169685657865
TERMINATION RATE	3.551440166123137
POLYHEDRIN PROMOTER	3.5504961189645243
SV(X)T K1	3.5498715020723304
H1 DOMAIN	3.5498715020723304
ANTI GFAP	3.5498715020723304
CAG CODON	3.5490478278774167
GSTCDC6 PROTEIN	3.5489995395052705
MODELING SERVER	3.5489805728464976
MG/ML BSA	3.5481041980811088
PBS(+) ΜL	3.5473402106440592
ΜL MEDIUM	3.5473402106440592
RNA PROBE	3.5472079950781077
H1 KINASE	3.5472052734645176
RETINOBLASTOMA-DERIVED	3.546276664314221
washes	3.545115726026875
ACID TRYPTOPHAN	3.5448614057833283
SURROGATE ENDPOINT	3.544515574012659
ELUTION PROFILE	3.544498705696004
S. POMBE GENOME	3.5442781146658233
PI	3.542729539713167
DIMER STABILITY	3.5426547374969437
ΜG/ML STREPTOMYCIN	3.542439742550124
9E10 MOUSE	3.5423207777809838
2IN GROWTH MEDIUM	3.5420766875422034
DNA PROBE	3.541992759324988
E3 UBIQUITIN LIGASE	3.5417041511131955
AQUEOUS SOLUTION	3.5409924575658533
NEDD8 MODIFICATION	3.5402411396330997
CONJUGATING ENZYME	3.539495857156599
CATENATION ASSAY	3.5393871207453023
MM PHENYLMETHYLSULFONYL FLUORIDE	3.539048577053328
SIDE VIEW	3.5386082363372324
EC GROWTH	3.5376287841561918
COMMON ONE	3.537268798105171
INSERTION SITE	3.5372388354645823
CELLULAR STATE	3.5372388354645823
receptor class	3.5372388354645823
CORONARY EVENT	3.5372388354645823
EXPRESSING TAT	3.5372388354645823
LABELLED PROBE	3.5372388354645823
acid transport	3.5372388354645823
EXPANDED RANGE	3.5372388354645823
MIGRATING BAND	3.5372388354645823
INTEGRIN LIGAND	3.5370162499092195
NON-TAGGED P66	3.535830384760357
TAR RNA REGION	3.53541734183981
PHOTOPHYSICS SX	3.5345696461626024
GENDER DIFFERENCE	3.5338415142595165
RECORDING BUFFER	3.533202847762028
DNA TEMPLATE	3.5327542013898254
TIME DEPENDENT	3.532614558007935
CSN DEFICIENCY	3.5324769307026775
ENDONUCLEASE DOMAIN	3.5323214625120682
CARBONYL OXYGEN	3.531949477674621
LOW-DOSE DIURETIC	3.5316057629366515
DIMER FORMATION	3.531194561306522
PELVIC PAIN	3.5309340234113273
GHZ PENTIUM	3.5309340234113273
BILE ACID EFFLUX	3.530115368722396
CITRATE BUFFER	3.5297446902655194
REFERENCE ACID	3.529655897075957
ASCIDIAN	3.5285904948163083
CAUSE G1	3.5285904948163083
MANNHEIN	3.5285904948163083
SHOULDBE	3.5285904948163083
PANEL C.	3.5285904948163083
J. WRANA	3.5285904948163083
RULE SET	3.5285904948163083
GENECORE	3.5285904948163083
PM PROBE	3.5285904948163083
SUPPORTS	3.5285904948163083
OTHER GΑ	3.5285904948163083
OFTHE GP	3.5285904948163083
ROCKLAND	3.5285904948163083
LEGENDRE	3.5285904948163083
ONTOGENY	3.5285904948163083
TYPE TAG	3.5285904948163083
PYKNOTIC	3.5285904948163083
DAY-TIME	3.5285904948163083
NEONATAL	3.5285904948163083
UNTAGGED	3.5285904948163083
longnose	3.5285904948163083
formulae	3.5285904948163083
PHENOMIC	3.5285904948163083
DITHIOBI	3.5285904948163083
RD LOCUS	3.5285904948163083
RECJ ACT	3.5285904948163083
MGXXXS/T	3.5285904948163083
PG/GLAND	3.5285904948163083
HOMEOTIC	3.5285904948163083
MENASCHE	3.5285904948163083
SELF IGG	3.5285904948163083
MAKEFILE	3.5285904948163083
PLUG DAY	3.5285904948163083
R. N. D.	3.5285904948163083
BIOPSIED	3.5285904948163083
ANTI-FAK	3.5285904948163083
compiler	3.5285904948163083
RE-SCALE	3.5285904948163083
BDM LEAD	3.5285904948163083
P27 KIP1	3.5285904948163083
nucleoli	3.5285904948163083
3-D TOOL	3.5285904948163083
NECROSIS	3.5285904948163083
MIDBRAIN	3.5285904948163083
ANTI-GAG	3.5285904948163083
PUTORIUS	3.5285904948163083
RE-ENTER	3.5285904948163083
PEYFP-N1	3.5285904948163083
SECAUCUS	3.5285904948163083
FOLLICLE	3.5285904948163083
OCL SEAL	3.5285904948163083
dichroic	3.5285904948163083
GNRH RRA	3.5285904948163083
MAXIPREP	3.5285904948163083
EPISTASI	3.5285904948163083
HENIKOFF	3.5285904948163083
H3 VIRUS	3.5285904948163083
PCDNAP53	3.5285904948163083
A-FACTOR	3.5285904948163083
RETINOID	3.5285904948163083
EM GRADE	3.5285904948163083
HARDOUIN	3.5285904948163083
PTX-MKC2	3.5285904948163083
GELATION	3.5285904948163083
sorbitol	3.5285904948163083
CUT PRF4	3.5285904948163083
SHMOOING	3.5285904948163083
MAPK/ERK	3.5285904948163083
SCE DATA	3.5285904948163083
SC DRAIN	3.5285904948163083
stilbene	3.5285904948163083
A126-153	3.5285904948163083
supplies	3.5285904948163083
GFP-BEX1	3.5285904948163083
PROMMP-9	3.5285904948163083
PEBG-JNK	3.5285904948163083
BIGLYCAN	3.5285904948163083
GAPPINES	3.5285904948163083
LINE AX2	3.5285904948163083
thrombin	3.5285904948163083
SRCK295M	3.5285904948163083
MOSQUITO	3.5285904948163083
JNK/SAPK	3.5285904948163083
ΔPGK-NEO	3.5285904948163083
NON-TAIL	3.5285904948163083
RHO-TYPE	3.5285904948163083
9E3 GENE	3.5285904948163083
GENECARD	3.5285904948163083
N-METRIC	3.5285904948163083
GUARENTE	3.5285904948163083
SERUMLES	3.5285904948163083
proceeds	3.5285904948163083
GRIDDING	3.5285904948163083
MOID LAY	3.5285904948163083
intronic	3.5285904948163083
BH3-ONLY	3.5285904948163083
7WE SHOW	3.5285904948163083
MARLBORO	3.5285904948163083
PEGFP-CL	3.5285904948163083
SRE BIND	3.5285904948163083
ANTI-26S	3.5285904948163083
TOPHI11Α	3.5285904948163083
LR WHITE	3.5285904948163083
GROUP G1	3.5285904948163083
ARPPPAPP	3.5285904948163083
GRENOBLE	3.5285904948163083
AXON PLM	3.5285904948163083
MIDSHAFT	3.5285904948163083
CELL-ECM	3.5285904948163083
TFS BIND	3.5285904948163083
BUD RISE	3.5285904948163083
FRIZZLED	3.5285904948163083
ungapped	3.5285904948163083
LPA BAND	3.5285904948163083
ANATOMIC	3.5285904948163083
ZYMOLASE	3.5285904948163083
E3 LIGAS	3.5285904948163083
NON-NULL	3.5285904948163083
GENE A20	3.5285904948163083
FRUCTOSE	3.5285904948163083
EQUATION	3.5285904948163083
PARTICLE	3.5285904948163083
SUPERSET	3.5285904948163083
TAXONOMY	3.5285904948163083
IONPHORE	3.5285904948163083
PTX-FLAG	3.5285904948163083
HIRSUTUM	3.5285904948163083
BDU CELL	3.5285904948163083
PERLECAN	3.5285904948163083
TYPE SRE	3.5285904948163083
NUMBEROF	3.5285904948163083
ISO-FORM	3.5285904948163083
HUMAN TM	3.5285904948163083
ZYMOGRAM	3.5285904948163083
PCMV-GAL	3.5285904948163083
ANTIPAIN	3.5285904948163083
MYOSINVI	3.5285904948163083
ARP3-GFP	3.5285904948163083
GIRASOLE	3.5285904948163083
REFOLDED	3.5285904948163083
CHORDATE	3.5285904948163083
TAILLESS	3.5285904948163083
wildtype	3.5285904948163083
VITROGEN	3.5285904948163083
NEW BASE	3.5285904948163083
DH1 CELL	3.5285904948163083
HFC GENE	3.5285904948163083
DIALIGN2	3.5285904948163083
T7-PCMV6	3.5285904948163083
ectoderm	3.5285904948163083
ontogeny	3.5285904948163083
B2 CHAIN	3.5285904948163083
HOLLIDAY	3.5285904948163083
BIND GQΑ	3.5285904948163083
CGAP-GAI	3.5285904948163083
ANTI-RAN	3.5285904948163083
THATGPNN	3.5285904948163083
CODE BIT	3.5285904948163083
neomycin	3.5285904948163083
Α-TOPIII	3.5285904948163083
silastic	3.5285904948163083
GROUP ID	3.5285904948163083
BPNNWHEN	3.5285904948163083
NATUREOF	3.5285904948163083
ARR WORK	3.5285904948163083
CLONETIC	3.5285904948163083
ISL1-CRE	3.5285904948163083
rotation	3.5285904948163083
GLYPICAN	3.5285904948163083
BLM BODY	3.5285904948163083
CENTROID	3.5285904948163083
PREBOUND	3.5285904948163083
METASTAS	3.5285904948163083
P27 GENE	3.5285904948163083
EXOCYTIC	3.5285904948163083
ZWF CODE	3.5285904948163083
PENTAMAX	3.5285904948163083
ASTERISK	3.5285904948163083
POLYODON	3.5285904948163083
EXPORTIN	3.5285904948163083
BESTATIN	3.5285904948163083
ARTIFACT	3.5285904948163083
WT-PAI-1	3.5285904948163083
CASPASE3	3.5285904948163083
PP5 PLAY	3.5285904948163083
EE MOUSE	3.5285904948163083
BETHESDA	3.5285904948163083
MODELLER	3.5285904948163083
ANATINUS	3.5285904948163083
NON-CELL	3.5285904948163083
WHERETHE	3.5285904948163083
ANTI-GFP	3.5285904948163083
TRAP NET	3.5285904948163083
FZ CLASS	3.5285904948163083
SCHIBLER	3.5285904948163083
CHANGETO	3.5285904948163083
ACROLEIN	3.5285904948163083
ENDODERM	3.5285904948163083
PARALKAR	3.5285904948163083
R. H. K.	3.5285904948163083
PROMMP-2	3.5285904948163083
VINELAND	3.5285904948163083
proteome	3.5285904948163083
TREEVIEW	3.5285904948163083
ANTI-JNK	3.5285904948163083
EPIBLAST	3.5285904948163083
NNCHOSEN	3.5285904948163083
MOUSE TM	3.5285904948163083
STILBENE	3.5285904948163083
anteriad	3.5285904948163083
OBJECTIV	3.5285904948163083
SANDIEGO	3.5285904948163083
HEDGEHOG	3.5285904948163083
EPIPHYSI	3.5285904948163083
ZWF PHPP	3.5285904948163083
ACCESSTO	3.5285904948163083
L. STEIN	3.5285904948163083
TOSELECT	3.5285904948163083
PBIG-ALA	3.5285904948163083
HIS- NOT	3.5285904948163083
FUKUHARA	3.5285904948163083
exotoxin	3.5285904948163083
MUSCULUS	3.5285904948163083
ADH_ZINC	3.5285904948163083
PREPULSE	3.5285904948163083
OLKKONEN	3.5285904948163083
MODFITLT	3.5285904948163083
ALTERTHE	3.5285904948163083
TITERING	3.5285904948163083
AQUACIDE	3.5285904948163083
FBS-DMEM	3.5285904948163083
RGS GENE	3.5285904948163083
TN LEVEL	3.5285904948163083
S. TYPHI	3.5285904948163083
RESORBED	3.5285904948163083
OMISSION	3.5285904948163083
CARNOSUS	3.5285904948163083
PEGFP-C1	3.5285904948163083
EIF3-P44	3.5285904948163083
PLANT TF	3.5285904948163083
TEMECULA	3.5285904948163083
BOI1(KK)	3.5285904948163083
BLM SHOW	3.5285904948163083
JAK/STAT	3.5285904948163083
RC20-HRP	3.5285904948163083
meshwork	3.5285904948163083
5-M(TOP)	3.5285904948163083
FUSIFORM	3.5285904948163083
TOOL SET	3.5285904948163083
RAD LANE	3.5285904948163083
DEFRANCO	3.5285904948163083
REDIRECT	3.5285904948163083
P0-3DTKT	3.5285904948163083
GFP-VEX1	3.5285904948163083
TET-FREE	3.5285904948163083
ANTI-19S	3.5285904948163083
SV40 TAG	3.5285904948163083
EFFECTOF	3.5285904948163083
POLYTOMA	3.5285904948163083
GΑ CAUSE	3.5285904948163083
TAR FILE	3.5285904948163083
BIND ODC	3.5285904948163083
TELOMERE	3.5285904948163083
datasets	3.5285904948163083
FLATWORM	3.5285904948163083
BRIGGSAE	3.5285904948163083
GOJOBORI	3.5285904948163083
DAY CCAF	3.5285904948163083
ARPPAAPP	3.5285904948163083
LIGANDED	3.5285904948163083
ALUMINUM	3.5285904948163083
BLEBBING	3.5285904948163083
MRP GENE	3.5285904948163083
UNTANGLE	3.5285904948163083
ANTI-20S	3.5285904948163083
INTRONIC	3.5285904948163083
LRP6 LRP	3.5285904948163083
RESIDUAL	3.5285904948163083
VELOCITY	3.5285904948163083
ALLINPUT	3.5285904948163083
ATAXIN-3	3.5285904948163083
PGADA424	3.5285904948163083
PS-BASED	3.5285904948163083
BCIP-NBT	3.5285904948163083
antisera	3.5285904948163083
TRP-PLIK	3.5285904948163083
KILOBYTE	3.5285904948163083
VESICANT	3.5285904948163083
MRC-1024	3.5285904948163083
ADDITIVE	3.5285904948163083
ACCEPTOR	3.5285904948163083
FORM LFC	3.5285904948163083
artifact	3.5285904948163083
METAFANE	3.5285904948163083
purposes	3.5285904948163083
switches	3.5285904948163083
P24 GAG ANTIGEN	3.5284789903565783
RESULT SUPPORT	3.528349946575694
RIBOSOMAL GENE	3.5272388354645825
ELECTROPHORESIS	3.5270834504826563
SCD39 BOUND VO	3.5264644246901717
MONOCYTE	3.5264261002758484
SURVIVAL FACTOR	3.5261815177291616
OTHER NITROGEN	3.526127724353471
NEW RRNA	3.5260643137555574
DUPONT NEN	3.5251884141642638
INTRON I	3.524889182175765
CYTOSOLIC THDP	3.524767801127106
NATIONAL HEART	3.524195357203713
POOL RNA	3.524052341681216
DFZ2 RNA	3.524052341681216
TERM PERSISTENCE	3.5236406661135216
SRC GENE	3.5232325462761676
M. SEXTA APN-1	3.523203747745284
MYC ANTIBODY	3.523187972950549
IE INTRON	3.522954104705403
AZ SMAD1	3.5224387761220726
OPG MRNA	3.5221192063197746
BLM MRNA	3.5221192063197746
MRNA UTR	3.5221192063197746
ARR MRNA	3.5221192063197746
MRNA KIT	3.5221192063197746
NEUROMODULIN IQ	3.521421164295643
BZIP DNA	3.5211102063733684
LEXA DNA	3.5211102063733684
GLYCOSYL-PHOSPHATIDYLINOSITOL	3.520863023612643
BEX1 GFP	3.5206811422094333
W SYMBOL	3.5203882032239937
LENGTH N	3.52028567457909
LB MEDIUM	3.520219231055439
3G10 MAB	3.52018055027229
MAB 19H8	3.52018055027229
MAB 3G10	3.52018055027229
THIAMINE-RESPONSIVE	3.519889732153058
SUM TEST	3.5194265552442054
USER USE	3.519232950887048
USE GPNN	3.519232950887048
GPNN USE	3.519232950887048
TRANSFERASE	3.5191874230637663
GQΑ CDNA	3.519144253788193
GEM CDNA	3.519144253788193
CD9 CDNA	3.519144253788193
A20 CDNA	3.519144253788193
ALLHAT ENDPOINT	3.5187636567972684
U95 CHIP	3.5183691776012704
PASSING STRAND	3.5181912164169633
KINASE N	3.5177254217121243
SC CLOSE	3.5176989272920878
T HELPER	3.5171355703511793
CELL PCR	3.516831457312282
HA CODON	3.5167264659059967
G2 MOTIF	3.516287057427837
ACID BLM	3.515995506778821
NEW ENGLAND BIOLAB	3.515752500478631
BASELINE LIPID	3.5156296400622837
perturbations	3.5152644203124748
FINAL W/V	3.514453511691044
HS-LIKE MOLECULE	3.5128795693356056
COLUMN E	3.512771789602559
REDUCED EXPRESSION	3.511863625350268
SIGMA GENOSY	3.5118293890548253
S BUTTON	3.511699335011796
LTR LINE	3.511554966124578
GFP CDNA	3.511234901181318
RUN COUNTER	3.5107498067669214
ΜM MG132	3.5107219329367183
MUTANT T	3.510676265722232
RT CODON	3.51057474721176
MEAN VALUE	3.5103665757110236
RNAASE H	3.510135338733601
ANTISENSE-EXPRESSING	3.5100017445802623
MICROARRAY RESULT	3.5086297932587605
PH MM ME	3.5081293435072194
BIOCHEMICAL STUDY	3.5080236669072185
PH MEASUREMENT	3.5079497637842065
RISK REDUCTION	3.5072388354645825
MG/ML GENETICIN	3.507193896714407
monomeric	3.5069338834822945
SLOT BLOT ASSAY	3.506663453099152
ENZYMES SHARE	3.5066084413058634
HILL EQUATION	3.5066084413058634
BINDING CLEFT	3.5066084413058634
TYPE RAW CELL	3.5066084413058634
PLASMA VOLUME	3.5066084413058634
ORIGIN REGION	3.5066084413058634
MID-LOG PHASE	3.5066084413058634
DEATH PATHWAY	3.5066084413058634
INCLUDING TAT	3.5066084413058634
STRAND PASSAGE	3.5064696046953516
SSC	3.5063389484324823
fractionation	3.5038054348137084
BEGR HEAD	3.5037457471571667
H MUTANT	3.503676034104653
TOTAL CI	3.503424372885344
INDIVIDUAL IQ	3.503056722582583
K SYMBOL	3.502431835143522
ETHYL ACETATE	3.5021177624603363
UG/ML BSA	3.501600363207624
STEADY-STATE K	3.5014280246537717
MURINE T	3.501126278327626
LEUCINE-P-NITROANILIDE	3.5004270393070094
OTHER TYPE IA	3.4993734587214034
STUDY THERAPY	3.498429730773298
intracellular	3.4981241868377495
DEPENDENT DNA	3.49769305385267
RNA PBMC	3.4974769169221176
approaches	3.4974543630925616
ΜM LIPID	3.496976023578564
ICE-COLD PB	3.4969210714759504
VACUOLAR ATPASE	3.4968854582031113
KDA FORM	3.496763638817387
P21 MRNA	3.4960648683206577
ENZYME ACTION	3.4954001486135438
PBI EGFP	3.4953712138674344
P51 INSSUBUNIT	3.4952186334443804
POLYACRYLAMIDE	3.495133572306688
ELK-1 AB	3.4945194374328485
MB LOW-GC	3.493262621040084
MEMORY MB	3.493262621040084
BIOTECH UK	3.4930728080741074
MONOCYTIC CELL	3.492794391020138
MM SALT ELUATE	3.492483590709338
penicillin/streptomycin	3.492129184931994
PEPTIDE TOXIN	3.4918548455904426
MIN WASH	3.4908651284390384
AFFINITY THDP	3.4906258433516126
LACK PML	3.4895089878176337
SEQUESTRATION	3.489315265505029
POP2 DELETION	3.488004200374394
THUMB SUBDOMAIN	3.4876804985867476
transfection	3.4872845969610866
PLAY KEY	3.4854485715060823
KEY IDEA	3.4854485715060823
KEY STEP	3.4854485715060823
COMBINATION	3.4849032673943303
Q COLUMN	3.48429812021781
MEANS PB	3.48429812021781
SUBSTRATE DECAY	3.484262411193367
TAUROCHENODEOXYCHOLIC	3.483298001827965
GLYCOCHENODEOXYCHOLIC	3.483298001827965
ENDPOINT FORM	3.4825660376405803
RELB P68	3.48113437917506
ADULT B6	3.48113437917506
ADULT TM	3.48113437917506
NF-ΚB P65	3.480871822240671
DIFFERENTIAL	3.4802677176583106
1MM EDTA	3.479376745262422
BUFFER PH	3.4787836334424793
PKK-RT66 CLONE	3.4774469716992087
principles	3.4751663301043374
PREP81 PLASMID	3.4750766733024205
DEUBIQUITYLATING	3.4739987018106366
OPTIMAL SIZE	3.4738639840338648
GAUGE NEEDLE	3.4738639840338648
CELL LINE RD	3.4738639840338648
BINDING STEP	3.4738639840338648
GENE LIST	3.4737695111065183
evolution	3.4737695111065183
PERIMETER	3.4737695111065183
radiation	3.4737695111065183
neighbors	3.4737695111065183
HEALTH STUDY	3.4726924902116934
CM-IV FRACTION	3.4716290793670215
TYR228 MUTANT	3.470252653818951
CHAIN MUTANT	3.470162388970753
IDO PROMOTER	3.469726282129584
LD CYCLE	3.4695271947413877
PUTATIVE CSN	3.4693314186504627
ADSORBED	3.4691480544443873
INCREASED K M	3.4689267196100104
PGEM1 ΜG	3.468795789108336
HAMSTER ASBT	3.4685015123126566
OTHER CULLIN	3.4677230889982877
HUMAN CULLIN	3.4677230889982877
STARTING MATERIAL	3.4673016044643092
ATORVASTATIN-TREATED	3.4654074283938896
TEST COMPOUND	3.464592527357401
INJURY	3.4643823654287633
MMP ACTIVITY	3.464345596728721
ERK ACTIVITY	3.4642251108134654
APN RECEPTOR	3.4642076490866174
SOLUBLE CD39	3.4641015355157685
NHLBI GUIDELINE	3.4638250969871156
ANSWER QUESTION	3.4638250969871156
SER224 MUTANT	3.4637411694929368
UCB SEDIMENTED	3.4623670405927878
SENSE PRIMER	3.462149045812149
LIGAND SPECIFICITY	3.4619735294178398
CANBE RUN	3.4618132426888355
RUN PRIOR	3.4618132426888355
RESIDUAL UCB	3.4611728009603393
POSSIBLE EXPLANATION	3.461101889423001
PASSAGE	3.4606524498131392
M/L NACL	3.4598609480255353
G/L NACL	3.4598609480255353
AMPA RECEPTOR	3.459801249629008
FACTORS BIND	3.4597626695077253
ADULT SD	3.459528342785549
ELECTROSPRAY IONIZATION MASS SPECTROMETRY	3.459360424580418
TRUNCATION MUTANT	3.459206366293793
PENICILLIN G	3.4590301336881857
CYSTEINE BOX	3.458000005191958
INCREASED CA	3.457897656941365
SUBFRAGMENT D	3.457772308860757
MYOSIN-I CLASS	3.4572388354645827
STOCK BUFFER	3.4572123790761538
RNA TEMPLATE	3.4550618214580715
BBMV PROTEIN	3.4544354833222726
PHOSPHO-SPECIFIC	3.454141916089483
S. POMBE CSN	3.453337193676849
ALLHAT TRIAL	3.4532836871578776
ALLHAT EVENT	3.4532836871578776
MODULATOR	3.4531562044981956
QUIESCED MDCK	3.4520360012402205
METAL LIGAND	3.451133506887252
cytometry	3.4509919286299353
GAG SULFATION	3.450795718511456
PHOSPHATE PH	3.4489888559870847
TOTAL CELL LYSATE	3.4464482704521706
ACS SEQUENCE	3.445661354981586
RISK PATIENT	3.4453088221184327
CD4 RECEPTOR	3.445170874476329
VERIFICATION	3.4446485046406363
LIQUID NITROGEN	3.4434891935176575
LUMEN PH	3.442533299604552
CONCLUSION STAY	3.4418583067065835
PDB HTTP	3.4416163774228936
GROUP IE	3.4400057456193123
VIEW	3.439895998640803
SEQUENCING GEL	3.438783241107698
GAIN WEIGHT	3.4386918673295916
weight gain	3.4386918673295916
P66 INSBIND	3.4373888955978518
LYMPHOBLASTOID	3.4372388354645826
POINT MUTATION	3.4372181826203683
6B12 ANTIGEN	3.4371004015456283
TSA201 CELL	3.4363834220044374
OPPOSITE SIDE	3.435699759616103
BOMBYX MORI	3.4355290983397273
KD VALUE	3.433678263533812
TAT PEPTIDE	3.4335284630717204
STOP BUFFER	3.431758959192559
SIMVASTATIN MG	3.431683279909027
MCNTCP CELL	3.431139949537467
LIPID LEVEL	3.431035785154127
MICROTITER	3.430964166332253
OTHER F-BOX	3.4306474331597197
BIND ZN(II)	3.4303762724573645
X-RAY FILM	3.429945677554559
NONHYDROLYSABLE	3.429762906643363
EXHIBITED K	3.4286906789021834
non-fat	3.4285809480686877
FOUNDER	3.4285809480686877
WINVIEW	3.4285809480686877
hindgut	3.4285809480686877
JUNKRAT	3.4285809480686877
SHATKAY	3.4285809480686877
GNF-HS1	3.4285809480686877
M-PHASE	3.4285809480686877
MENTION	3.4285809480686877
KILL TM	3.4285809480686877
HI-TRAP	3.4285809480686877
SRC/CAS	3.4285809480686877
ELASTIN	3.4285809480686877
ANTI-CA	3.4285809480686877
COMALSO	3.4285809480686877
NLM/NIH	3.4285809480686877
TRYPTIC	3.4285809480686877
TRIS-CL	3.4285809480686877
KAWECKI	3.4285809480686877
ADENINE	3.4285809480686877
WG FORM	3.4285809480686877
SCHUELL	3.4285809480686877
SYNAPSE	3.4285809480686877
exploit	3.4285809480686877
BAYLINK	3.4285809480686877
GRAPHED	3.4285809480686877
CARRIER	3.4285809480686877
PM SITE	3.4285809480686877
WS CELL	3.4285809480686877
WARRANT	3.4285809480686877
SOLUBLE	3.4285809480686877
GFP-346	3.4285809480686877
URONATE	3.4285809480686877
EXUDATE	3.4285809480686877
FUGENE6	3.4285809480686877
SKP2-ΔF	3.4285809480686877
DALCHAU	3.4285809480686877
EXPLOIT	3.4285809480686877
FILLING	3.4285809480686877
ANY/ALL	3.4285809480686877
DIET D.	3.4285809480686877
operons	3.4285809480686877
FIBULIN	3.4285809480686877
oocytes	3.4285809480686877
lesions	3.4285809480686877
DEALING	3.4285809480686877
FOREACH	3.4285809480686877
PBPAASC	3.4285809480686877
QINTRON	3.4285809480686877
HELICAL	3.4285809480686877
ERROR(I	3.4285809480686877
UTILITY	3.4285809480686877
MG(OAC)	3.4285809480686877
AGASSIZ	3.4285809480686877
E17 SMG	3.4285809480686877
DEMARZO	3.4285809480686877
LINKED2	3.4285809480686877
DECLINE	3.4285809480686877
ethanol	3.4285809480686877
STUDENT	3.4285809480686877
GAPPING	3.4285809480686877
ROSIDAE	3.4285809480686877
STOMACH	3.4285809480686877
NODESIN	3.4285809480686877
DP FILL	3.4285809480686877
P5'-P11	3.4285809480686877
CLOSETO	3.4285809480686877
CHALFIE	3.4285809480686877
AGP/EBP	3.4285809480686877
TR TECH	3.4285809480686877
F132-62	3.4285809480686877
P18-P21	3.4285809480686877
CELTRIX	3.4285809480686877
degrees	3.4285809480686877
BIOCHEM	3.4285809480686877
PREMISE	3.4285809480686877
IMAGEPC	3.4285809480686877
SIGMOID	3.4285809480686877
CATALYZ	3.4285809480686877
NON-RNA	3.4285809480686877
CHOLATE	3.4285809480686877
CYCLINE	3.4285809480686877
carrier	3.4285809480686877
GLY-247	3.4285809480686877
TRAFFIC	3.4285809480686877
RPM-BMO	3.4285809480686877
VALUETO	3.4285809480686877
THINPUT	3.4285809480686877
OUTLINE	3.4285809480686877
GRAVITY	3.4285809480686877
NK CELL	3.4285809480686877
BIND GR	3.4285809480686877
t-tests	3.4285809480686877
kappa b	3.4285809480686877
DIBAEIS	3.4285809480686877
VACUOLE	3.4285809480686877
ELKHART	3.4285809480686877
MANASSA	3.4285809480686877
PRELUDE	3.4285809480686877
M2 BEAD	3.4285809480686877
AVERTIN	3.4285809480686877
SATIVUM	3.4285809480686877
STRDIAG	3.4285809480686877
QUANTIX	3.4285809480686877
BIM ASH	3.4285809480686877
SERVLET	3.4285809480686877
CLOACAL	3.4285809480686877
PRONASE	3.4285809480686877
GCACCAG	3.4285809480686877
ACTIVIN	3.4285809480686877
SIMPLEX	3.4285809480686877
DMGRASP	3.4285809480686877
PEGFP I	3.4285809480686877
L6 CELL	3.4285809480686877
END LAY	3.4285809480686877
MG/L KH	3.4285809480686877
sorting	3.4285809480686877
MM ETGA	3.4285809480686877
BALANCE	3.4285809480686877
WETZLAR	3.4285809480686877
SORTING	3.4285809480686877
BASEDON	3.4285809480686877
C/D BOX	3.4285809480686877
AWEIGHT	3.4285809480686877
P16-P10	3.4285809480686877
NLSMUT4	3.4285809480686877
UNIGENE	3.4285809480686877
HORMONE	3.4285809480686877
ANTI-HI	3.4285809480686877
PROGENY	3.4285809480686877
MODULUS	3.4285809480686877
POWERPC	3.4285809480686877
WICKING	3.4285809480686877
MYSOSIN	3.4285809480686877
PLACODE	3.4285809480686877
KERATIN	3.4285809480686877
GP TREE	3.4285809480686877
PHARYNX	3.4285809480686877
MYOSINV	3.4285809480686877
ARFGENE	3.4285809480686877
AMMONIA	3.4285809480686877
ILE-355	3.4285809480686877
PBIGMYD	3.4285809480686877
READOUT	3.4285809480686877
BCR-ABL	3.4285809480686877
ANTI-TN	3.4285809480686877
NUCLEAS	3.4285809480686877
ΜL/WELL	3.4285809480686877
ONETHAT	3.4285809480686877
G/MOUSE	3.4285809480686877
KILOBAS	3.4285809480686877
CYSTINE	3.4285809480686877
ENTROPY	3.4285809480686877
COVANCE	3.4285809480686877
FORM NB	3.4285809480686877
SHANDON	3.4285809480686877
ARG-247	3.4285809480686877
OPENLAB	3.4285809480686877
TENSION	3.4285809480686877
vessels	3.4285809480686877
UDAGAWA	3.4285809480686877
BIOCOAT	3.4285809480686877
OCI LY1	3.4285809480686877
ORYZIAS	3.4285809480686877
SCHLIWA	3.4285809480686877
STEROID	3.4285809480686877
WEWOULD	3.4285809480686877
EN1-CRE	3.4285809480686877
CAS ACT	3.4285809480686877
AMEBOID	3.4285809480686877
WRATTEN	3.4285809480686877
RINGMUT	3.4285809480686877
SARCOMA	3.4285809480686877
MATREYA	3.4285809480686877
OSMOTIC	3.4285809480686877
DIPLOID	3.4285809480686877
ERRORIN	3.4285809480686877
GENSCAN	3.4285809480686877
BROWSER	3.4285809480686877
MEGABAS	3.4285809480686877
caspase	3.4285809480686877
F-PCMV6	3.4285809480686877
DSP-TSB	3.4285809480686877
WASALSO	3.4285809480686877
BCL-X L	3.4285809480686877
HELIX-5	3.4285809480686877
MS-1061	3.4285809480686877
CATALYS	3.4285809480686877
STELLAR	3.4285809480686877
IGFBP-2	3.4285809480686877
p-value	3.4285809480686877
HEMO-DE	3.4285809480686877
CHOROID	3.4285809480686877
HIGH-GC	3.4285809480686877
MUTATOR	3.4285809480686877
5ΜM CPT	3.4285809480686877
DIMMOCK	3.4285809480686877
PMEXNEO	3.4285809480686877
OVIDUCT	3.4285809480686877
CHASMAN	3.4285809480686877
SDHABCD	3.4285809480686877
MM LICI	3.4285809480686877
HRM-BMO	3.4285809480686877
EPIPHYS	3.4285809480686877
ELUTENT	3.4285809480686877
REPORTS	3.4285809480686877
MINEOLA	3.4285809480686877
DATA DE	3.4285809480686877
SUICIDE	3.4285809480686877
ISOTYPE	3.4285809480686877
RNAEASY	3.4285809480686877
GLY-284	3.4285809480686877
THEGPNN	3.4285809480686877
WOULDBE	3.4285809480686877
HIALEAH	3.4285809480686877
FIXABLE	3.4285809480686877
LITHIUM	3.4285809480686877
ARG-450	3.4285809480686877
MYOTUBE	3.4285809480686877
SATIVUS	3.4285809480686877
ADHEREN	3.4285809480686877
MALE RJ	3.4285809480686877
GLU-284	3.4285809480686877
T7 (DT)	3.4285809480686877
FORMATE	3.4285809480686877
neurons	3.4285809480686877
FEMORAL	3.4285809480686877
NEO-TPA	3.4285809480686877
GPNNARE	3.4285809480686877
heparin	3.4285809480686877
FIBROID	3.4285809480686877
INGRESS	3.4285809480686877
SUBTREE	3.4285809480686877
PANGAEA	3.4285809480686877
MT-MMP1	3.4285809480686877
SYNTENY	3.4285809480686877
THEDATA	3.4285809480686877
PHYSICO	3.4285809480686877
SIEMANN	3.4285809480686877
SET CHR	3.4285809480686877
DME-H21	3.4285809480686877
PDXA-3C	3.4285809480686877
OBTAINA	3.4285809480686877
MINIMUM	3.4285809480686877
MUNGALL	3.4285809480686877
PANVERA	3.4285809480686877
WEBEGAN	3.4285809480686877
BINNING	3.4285809480686877
readout	3.4285809480686877
STRAINS	3.4285809480686877
MERIDEN	3.4285809480686877
CYS-450	3.4285809480686877
KJOLLER	3.4285809480686877
BALB/CJ	3.4285809480686877
SMAD/AZ	3.4285809480686877
EQUALTO	3.4285809480686877
COGNATE	3.4285809480686877
PSAΒGEO	3.4285809480686877
GENESIS	3.4285809480686877
GC-RICH	3.4285809480686877
BLM ASH	3.4285809480686877
REDMONT	3.4285809480686877
NONSELF	3.4285809480686877
MISFOLD	3.4285809480686877
LINK TF	3.4285809480686877
OXYANION HOLE	3.428470629393693
SUPRAPHYSIOLOGICAL	3.427047784767002
BINDING REACTION	3.426398034444233
ANTI-PHOSPHO-ERK	3.4263424160798674
CHENODEOXYCHOLIC	3.4263424160798674
NON-HOSPITALIZED	3.4263424160798674
POLYETHYLENIMINE	3.4263424160798674
FRACTION IV	3.424251126966114
RNA OTH	3.4242504494328374
7SL RNA	3.4242504494328374
DLD RNA	3.4242504494328374
P27 RNA	3.4242504494328374
EPR FEATURE	3.423890108457027
USM MAP	3.423253343024247
FN MRNA	3.42240576949445
H COURSE	3.4215505895366043
SRF DNA	3.421442938853567
BAC DNA	3.421442938853567
GFP TAG	3.4210335075890628
N LEVEL	3.420656135565082
CYTOSOLIC PLA	3.4201580962115474
GABA	3.4199636119280727
HSM USE	3.4196515818674422
USE PIP	3.4196515818674422
SPM USE	3.4196515818674422
POTENTIAL ROLE	3.4191676772605994
LEVEL EXPRESSION	3.418943672519753
RNASE T1	3.4186077403234156
HEAD END	3.417859558320063
HUMAN T	3.417650172201645
POP2 MUTANT	3.4174730760886636
SCORE R	3.4168404851003826
RATIO R	3.4168404851003826
ΜG/ML PI	3.416285969843303
EXON II	3.416149869631659
DOXAZOSIN ARM	3.415616386193984
NEUTROPHIL	3.4146427482835024
ANTIGEN	3.413909651958679
DEPENDENT FASHION	3.413851711689096
E STATE	3.4134860671094387
COMPOSITION	3.413171593411377
TETRASPANIN	3.4121976576390094
ΜM BRDU	3.4115300067406364
ΜM CAMP	3.4115300067406364
ΜM E-64	3.4115300067406364
K VALUE	3.411446218331162
T. VOLCANIUM	3.410408068666238
MICROTIP	3.40994026871648
CHEMICON	3.40994026871648
sessions	3.40994026871648
NEMATODE	3.40994026871648
internet	3.40994026871648
LIGATING	3.40994026871648
LINESCAN	3.40994026871648
criteria	3.40994026871648
metazoan	3.40994026871648
NANOGRAM	3.40994026871648
CEL FILE	3.40994026871648
OLIGOMER	3.40994026871648
PROBABLE	3.40994026871648
INVASION	3.40994026871648
attempts	3.40994026871648
PROTOZOA	3.40994026871648
GIBCOBRL	3.40994026871648
ANTI-MYC	3.40994026871648
MEGABASE	3.40994026871648
CRESCENT	3.40994026871648
PROSTATE	3.40994026871648
ITT PRINCIPLE	3.4089361764156503
PRE-SPECIFIED	3.4089361764156503
PS BIND	3.408129819027124
DSRNAI HELP	3.4075860328066243
ONLINE HELP	3.4075860328066243
FOOD INTAKE	3.4075860328066243
KIND GIFT	3.406632710210667
ACTIVATION FUNCTION 2	3.405125848209468
POLYCLONAL ANTIBODY	3.4042232692596794
LIGAND-INDUCED	3.4039055021312494
P STATE	3.4032215480571493
COLLAGEN-COATED	3.40251315436836
NON-OVERLAPPING	3.40251315436836
HETEROPOLYMERIC	3.40251315436836
Q SEPHAROSE	3.4016874701481803
HIV TET	3.4010163828387547
HOMOGENATE ΜL	3.4009953418717305
VERTEBRATE	3.4009400906210505
TYPE LEVEL	3.4007030872590756
RD-A3 CELL	3.4007030872590756
TAT-TAF II	3.4007030872590756
PH UNIT	3.3992935975118836
NM AFFINITY	3.398752714736655
EXCESS RISK	3.398603770383063
IMAGE B	3.3983911861501896
IDO EFFECT	3.397369673999688
GAL4 DNA	3.397207726483548
THDP ENTRY	3.3971536194365797
NF- K B	3.3970312869646717
DNA CIRCLE	3.3966667937577517
KB CDNA	3.39651294331476
MRNA TRANSLATION	3.3965083480663765
NEED ASSISTANCE	3.396442052914913
MYC TAG	3.396068896771843
HYBOND N	3.3958042530783272
RAF PLAY	3.395713371020814
MAS4 AIM	3.395713371020814
HF PATIENT	3.3955074894319437
1CM	3.3954311707929206
cysteines	3.395283470220678
UNTRANSFECTED	3.3949829957170485
NIKON E600 EPIFLUORESCENCE MICROSCOPE	3.394327701511628
BP STEP	3.394311488593636
amplification	3.3933440501845085
MAX ADI	3.3912877127576015
CO-IMMUNOPRECIPITATE	3.3910835680832676
NCOA FACTOR	3.390535460038714
EXCEPTION	3.390168440494568
GLUTAMINE	3.390168440494568
NEUROPEPTIDE	3.389256096877029
MG/ML CHAP	3.388949111846875
metalloproteinases	3.3884931532450326
NEUROTOXIN P2	3.3867379343951476
P42	3.386674675671402
KDA BAND	3.3861242883965113
MONONUCLEAR	3.3858284427847187
RA RECEPTOR	3.3850135520506277
CARBOXYPEPTIDASE	3.384643166065444
HELP ADDRESS	3.3826308586666842
6AA SUBUNIT	3.3804994685362435
NM LINE	3.3798128711234217
MM SALT	3.3798128711234217
dimeric	3.3793724217545056
PROTΑ MRNA	3.3792864281638586
MATTEK PLATE	3.3786801109824247
NUCLEOTIDASE	3.3786801109824247
U/ML PENICILLIN	3.3780672000675023
ΜL LYSATE	3.377970274793992
RUN AHAB	3.377593763230519
RUN TIME	3.377593763230519
RNASE P	3.3775194534508604
GROWTH/TROPHIC	3.3772388354645826
INTEGRATION	3.3770178720272397
IQ DOMAINS	3.3769585304361174
SOLUTION ΜL	3.376529652552232
DENEDDYLATING	3.3763787547855793
HARMONIZATION	3.3763787547855793
ECL KIT	3.3757488647113156
HB SITE	3.3757488647113156
STRUCTURAL FEATURE	3.3748152967270704
PROBABILITY	3.3736341424897063
MESOBILIRUBIN-XIIIΑ	3.3734791513937656
INVERTED MICROSCOPE	3.3727964750697836
BUFFER C	3.372597351527168
ΜG CCAF	3.371522298042726
BINDING AFFINITY	3.3713273716781993
MM UREA	3.370945948042464
MARKED DECREASE	3.3691835739275433
INDIVIDUAL STEP	3.3691835739275433
HYPERTENSIVE	3.3684925220185686
HUMAN CDC6	3.3681125190707015
ML	3.367894925237633
EM	3.367894925237633
OS	3.367894925237633
HH	3.367894925237633
UU	3.367894925237633
FC	3.367894925237633
SUPERFECT REAGENT	3.366689358630747
K1 DATA	3.3651824480398416
LACK CA	3.3647012450035696
R ANTAGONIST	3.3632595497229585
CA ABSENCE	3.3622573735416643
NON-CONDITIONED	3.361638525955857
MG ADDITION	3.360592667092765
G/L KCL	3.360305640345315
BLUE R250	3.359406932241763
RISE TIME	3.359406932241763
MHC CLASS	3.359406932241763
CD87 GENE	3.359406932241763
ADDITIONAL INFORMATION	3.35930759869912
CYTOKINE	3.3591371473857254
explanations	3.357969903012533
LYMPHOCYTIC	3.356459873593123
DIPHOSPHATE	3.356459873593123
PEPTIDE I	3.354579818355292
HF STATUS	3.354393263229245
LNCAP M	3.3539944774465154
HIV-1 TAT	3.3530593512901348
populations	3.3524377996958195
aggregation	3.351752839193466
definitions	3.351752839193466
ASBT MRNA	3.351164917090354
HIV-1 RNA	3.3506963515506283
PHARMACOPHORE	3.350332817481523
COMPOSITIONAL	3.350332817481523
GCDCA-INDUCED	3.350332817481523
BILE ACID	3.350167038098887
ORDER IQ3	3.349232133363418
COX-2 RNA	3.348395353455663
IDO SENSE	3.3470499373511235
GASTRULATION	3.3469521532986115
UTR	3.3458978026811415
E14	3.3458978026811415
FCS	3.3458978026811415
BRIJ	3.3444118343617415
AR B2 BOX	3.3436822430661386
EYFP	3.343291800914875
HELP FRAME	3.343156194407586
HELP POINT	3.343156194407586
letters	3.342165785032481
PAN- RA	3.342128448029352
FATAL CHD	3.3411993974068293
HRM USE	3.3404034568313836
calibration	3.339781140118121
LB AGAR	3.3380116623131935
BMI GROUP	3.3363440547841807
R AGONIST	3.335703419299248
HEXAHISTIDINE-TAG	3.3356048969654823
YEAST ACS	3.3337815128444492
B SUBUNIT	3.3317739915091757
MEAN EC	3.3311471137731097
EG POLY	3.3310447941781547
interference	3.3297057814199356
PDB ENTRY	3.3279575538905144
POP1 POP2	3.326459964445217
AMPLITUDE	3.3263182910049527
C2 DOMAIN	3.32481261605539
TRIS PH7	3.324645380139608
CULTURE COLLECTION	3.324138550604773
PERKIN-ELMER	3.3215697871515606
kinase	3.3199825702555037
BOVINE SERUM ALBUMIN	3.31837278651225
EXCRETION	3.3183073949692576
THANOR	3.316779786722732
AUREUS	3.316779786722732
HSP110	3.316779786722732
BYGPNN	3.316779786722732
TYR204	3.316779786722732
E15-18	3.316779786722732
KR-730	3.316779786722732
NOTCH1	3.316779786722732
NISSUI	3.316779786722732
MOVFOR	3.316779786722732
BIOMOL	3.316779786722732
TNT T7	3.316779786722732
VICTOR	3.316779786722732
RPMI-0	3.316779786722732
FRCOP1	3.316779786722732
TAURUS	3.316779786722732
GPGKAF	3.316779786722732
KNOBBY	3.316779786722732
(SNPS)	3.316779786722732
BTCOP1	3.316779786722732
VCAM-1	3.316779786722732
GRADSP	3.316779786722732
DNA-PK	3.316779786722732
VICINA	3.316779786722732
GPGRVF	3.316779786722732
BIOMAS	3.316779786722732
ΜCI/ML	3.316779786722732
SNIP-1	3.316779786722732
LO TPI	3.316779786722732
ABLATE	3.316779786722732
PLASMA	3.316779786722732
LAMP-1	3.316779786722732
V. TAG	3.316779786722732
BLOSUM	3.316779786722732
readme	3.316779786722732
E9-E10	3.316779786722732
RAT LH	3.316779786722732
LUCA-1	3.316779786722732
NOTCH5	3.316779786722732
SQUIRM	3.316779786722732
LOOP-8	3.316779786722732
RN AID	3.316779786722732
GPGRAF	3.316779786722732
FZ CRD	3.316779786722732
E-1030	3.316779786722732
NJPLOT	3.316779786722732
CLAITA	3.316779786722732
AND-34	3.316779786722732
D-LOOP	3.316779786722732
WINNER	3.316779786722732
S-4200	3.316779786722732
CORPET	3.316779786722732
AGCOP1	3.316779786722732
FUNGAL	3.316779786722732
PREDKI	3.316779786722732
BSA/TB	3.316779786722732
SNPSIN	3.316779786722732
LAMBDA	3.316779786722732
PPB900	3.316779786722732
HSP-90	3.316779786722732
CHANCE	3.316779786722732
SCROFA	3.316779786722732
GRGDSP	3.316779786722732
ARG346	3.316779786722732
STREAM	3.316779786722732
N-UNIT	3.316779786722732
METRIC	3.316779786722732
MMP-10	3.316779786722732
THESNP	3.316779786722732
KAYTOR	3.316779786722732
RETEST	3.316779786722732
ΑLLBΒ3	3.316779786722732
FEEDER	3.316779786722732
ERK1/2	3.316779786722732
BELIEF	3.316779786722732
NETRIN	3.316779786722732
DOG TM	3.316779786722732
AP-DNA	3.316779786722732
IGFBP3	3.316779786722732
CELERA	3.316779786722732
MUTATE	3.316779786722732
MS-870	3.316779786722732
LUCIDA	3.316779786722732
t test	3.316779786722732
HIS309	3.316779786722732
S-2444	3.316779786722732
UNSHIU	3.316779786722732
BAR535	3.316779786722732
ELEGAN	3.316779786722732
RIBOSE	3.316779786722732
ATAXIA	3.316779786722732
INSUCH	3.316779786722732
SER331	3.316779786722732
GALETO	3.316779786722732
TK SET	3.316779786722732
MEDAKA	3.316779786722732
COS(Θ)	3.316779786722732
PILEUP	3.316779786722732
SDS-12	3.316779786722732
maxima	3.316779786722732
MINIMA	3.316779786722732
RNCOP1	3.316779786722732
GOVAND	3.316779786722732
pixels	3.316779786722732
HSCOP9	3.316779786722732
INSTAT	3.316779786722732
MICHOT	3.316779786722732
PCDNAI	3.316779786722732
ESI-MS	3.316779786722732
JURKAT	3.316779786722732
SAMENN	3.316779786722732
Y-AXIS	3.316779786722732
LECTIN	3.316779786722732
FORALL	3.316779786722732
X-OMAT	3.316779786722732
SULFUR	3.316779786722732
THYMUS	3.316779786722732
MAC G3	3.316779786722732
YG_S98	3.316779786722732
RBP-JΚ	3.316779786722732
MM PLL	3.316779786722732
GLU192	3.316779786722732
5- E14	3.316779786722732
GPGRTF	3.316779786722732
THR202	3.316779786722732
VERTEX	3.316779786722732
CRASSA	3.316779786722732
BIGDYE	3.316779786722732
TOMTEC	3.316779786722732
MYELIN	3.316779786722732
CERVIX	3.316779786722732
SD/MAE	3.316779786722732
MACARA	3.316779786722732
MUCOSA	3.316779786722732
Α- 35S	3.316779786722732
DELTA1	3.316779786722732
KNIRPS	3.316779786722732
TESQUE	3.316779786722732
USEDNN	3.316779786722732
THMOST	3.316779786722732
GPGKVF	3.316779786722732
MCP444	3.316779786722732
APICAL	3.316779786722732
MODFIT	3.316779786722732
LABILE	3.316779786722732
AMIEVA	3.316779786722732
TASKED	3.316779786722732
CONTIG	3.316779786722732
HB-EGF	3.316779786722732
GLU350	3.316779786722732
N2 VAR	3.316779786722732
PVU II	3.316779786722732
NF-IL6	3.316779786722732
GPGKTF	3.316779786722732
COMMUN	3.316779786722732
DOTMAC	3.316779786722732
DALTON	3.316779786722732
FKBP51	3.316779786722732
PRO-N3	3.316779786722732
YUMURA	3.316779786722732
TRAVEL	3.316779786722732
ARANGE	3.316779786722732
NDMOST	3.316779786722732
GOLETA	3.316779786722732
IGF-1R	3.316779786722732
EVE3-7	3.316779786722732
BAR480	3.316779786722732
TFII-I	3.316779786722732
PPACSA	3.316779786722732
RAW265	3.316779786722732
LRP5ΔN	3.316779786722732
MUSTBE	3.316779786722732
B-SKP2	3.316779786722732
CUSTOM	3.316779786722732
FKBP52	3.316779786722732
ASCITE	3.316779786722732
LO ZWF	3.316779786722732
VIEWER	3.316779786722732
MEC-17	3.316779786722732
INLIER	3.316779786722732
E.COLI	3.316779786722732
WEHAVE	3.316779786722732
ISLET1	3.316779786722732
INFILE	3.316779786722732
GRAVID	3.316779786722732
T-RFLP	3.316779786722732
WHICHI	3.316779786722732
BOTHOF	3.316779786722732
FIBRIN	3.316779786722732
DIABLO	3.316779786722732
S-2288	3.316779786722732
10E-15	3.316779786722732
BRUGGE	3.316779786722732
RB-012	3.316779786722732
R-SMAD	3.316779786722732
YES/NO	3.316779786722732
GSK-3Β	3.316779786722732
MAIZEL	3.316779786722732
NCO I.	3.316779786722732
SENSOR	3.316779786722732
TARGET	3.316779786722732
GR ACT	3.316779786722732
ΜM/SEC	3.316779786722732
EACHOF	3.316779786722732
SKP-ΔF	3.316779786722732
MG-ATP	3.316779786722732
SYNAPS	3.316779786722732
KR-CD2	3.316779786722732
HOXC-8	3.316779786722732
trends	3.316779786722732
AP-101	3.316779786722732
immunofluorescence	3.3161239902872715
PERSISTENCE	3.3153438767248886
HEMODYNAMIC	3.3153438767248886
SIOUX	3.315177390957132
AUTORADIOGRAPHED	3.315144416041406
R5 VIRUS	3.3141721124273786
TYPE P66	3.313002419436221
APPEARANCE	3.312508291288264
P51 WTWA	3.312494370965314
CELLULAR RESPONSE	3.3118841787033606
INTEGRIN-LIKE	3.311263911525437
LIPODYSTROPHY	3.311263911525437
OTHER IQ	3.311152177795663
B3 DNA	3.3100244131301015
P35 FORM	3.309138888041186
ANSI C	3.3082083581513033
NKG2 C	3.3082083581513033
IR STATE	3.307128621823817
COLD HBS	3.307128621823817
FIND GENE	3.3054389951122993
PROTEASE INHIBITOR COCKTAIL TABLET	3.3051488877521646
interactions	3.304931227509966
CO-RECEPTOR	3.3048454472214535
MM Β-MERCAPTOETHANOL	3.3044399158196898
SITE E	3.302494072437018
dehydrogenases	3.3012675627774843
HYDROGEN BOND	3.3008523063087307
H LANE	3.3001131200560656
SYSTOLIC BLOOD PRESSURE	3.299775007291199
CYCLIN B	3.298353407213629
BINDING MOTIF	3.297701852706907
INCREASED LEVEL	3.2976944870234073
SD RAT	3.297267591600781
memories	3.296781618037178
BASEPAIR	3.296781618037178
skeletal	3.296781618037178
CRYOSTAT	3.296781618037178
SERINE/THREONINE	3.2938578126881346
OVER-ADJUSTMENT	3.293514145268351
RAS/RAF/MEK/ERK	3.293514145268351
G SPIN	3.293403163346109
HSA STOCK	3.2931011595512145
YEAST AR	3.29152260268951
UNPROCESSED	3.290674278603948
INFECTIVITY	3.290674278603948
EGFP-TAGGED	3.290674278603948
NON-HEPATIC	3.290674278603948
DMSO/BUFFER	3.290674278603948
SOLVENT B	3.2897114234413776
TES PH	3.289062395418384
GENE B	3.2882083581513037
ZONE B	3.2882083581513037
SITE B	3.2882083581513037
DIET B	3.2882083581513037
ATTENTION	3.288035213238271
MEDICATION	3.286290562161649
BUFFER Q	3.285802172257146
BP GAP	3.2843473542903
BT TOXIN	3.284116572521255
PEDF-BINDING	3.2834962379309847
TUBOCURARINE	3.2834962379309847
superhelical	3.2834962379309847
INDOMETHACIN	3.2834962379309847
COLLOIDAL	3.2825306740498226
PYROCOCCAL	3.281204337235037
N-BENZYL	3.2792044482706695
BN CLONE	3.278752879097785
RNA POLYMERASE	3.276745354417493
OXYGEN	3.2746951778274522
PROOF AID	3.2731169725813465
HELP SORT	3.2731169725813465
TRICHLOROACETIC ACID	3.2720581028867515
BROMOPHENOL BLUE	3.2716891463994275
NM TPA	3.2706259405688862
epitope-tagged	3.2705721687979157
IMMUNOPURIFIED	3.2705721687979157
CYTOPROTECTION	3.2705721687979157
ANTERIOR-POSTERIOR AXIS	3.268296722452807
BOUND MG	3.2680342222206096
LINE RD	3.2641673390535684
SIGNALS	3.263247374913545
REAL-TIME	3.2605660288521254
MEAN G	3.259256821882694
ΜG RNA	3.2586814260669947
DESTAINING	3.2573045872302293
SYNTHETASE	3.2573045872302293
GPI-ANCHOR	3.2573045872302293
STM UL	3.2567797867227317
UL STM	3.2567797867227317
ΜG DNA	3.2560244131301013
NJ TREE	3.2556759479900164
RPM USE	3.2552851003111734
WL	3.2549381617107715
μl	3.2549381617107715
KGB ΜL	3.2545846647715124
GLYCOCHOLIC	3.2536698814225367
TAUROCHOLIC	3.2536698814225367
CULLIN 1	3.250192413157475
WHATMAN	3.24930523123211
ELECTRO	3.24930523123211
MEETING	3.24930523123211
rollers	3.24930523123211
USEABLE	3.24930523123211
HYCLONE	3.24930523123211
ML/WELL	3.24930523123211
ANLAGEN	3.24930523123211
PARADOX	3.24930523123211
F-ACTIN	3.24930523123211
PIGMENT	3.24930523123211
UNDERGO	3.24930523123211
TOPSHAM	3.24930523123211
ONE-WAY	3.24930523123211
choices	3.24930523123211
GELATIN	3.24930523123211
KILLING	3.24930523123211
CATALYZED	3.2476723042636224
SELF-DIMERIZE	3.2461490682652956
STROMELYSIN-1	3.2461490682652956
ascertainment	3.2461490682652956
CELL LYSI	3.246003529791514
ANTISENSE RNA	3.245478513656383
MUTAGENESIS STUDY	3.2452225890163864
PEM	3.244518961701514
SURROGATE	3.244092544953853
VOLCANIUM	3.244092544953853
HOMOMERIC	3.244092544953853
ASPARTATE	3.244092544953853
FALCULATA	3.244092544953853
WD-REPEAT	3.244092544953853
KDA APN	3.243698861249844
GAG ORF	3.2430345057106194
PERIPHERAL BLOOD MONONUCLEAR CELL	3.2427625929734107
SRP RNA	3.241934090775266
QUIESCED	3.240351488096548
SKELETAL	3.240351488096548
GPI ANCHOR	3.2393797747266238
SET IE	3.236779786722732
ATHEROSCLEROTIC	3.2356502815833603
N NAOH	3.234279786722732
BN CELL	3.2324680890391453
CATIONIC	3.2311239100551945
BIOPESTICIDE	3.228574957129818
FISSION YEAST	3.227281132825569
UBIQUITIN-DEPENDENT DEGRADATION	3.2245313979391423
VOID VOLUME	3.2225640468995698
DELIVERY	3.221632381051769
FOLLOW-UP DATA	3.2216166823613515
MYOCARDIUM	3.2214549622230177
HYDROLYZED	3.2214549622230177
HS/HEPARIN	3.2214549622230177
PPARGAMMA	3.221029667496271
PARTITION	3.221029667496271
NECK-TAIL	3.221029667496271
ENDOTHELIN-1	3.220040322563358
INSOLUBILITY	3.220040322563358
HOMODIMERIZE	3.220040322563358
cytosolic	3.2185344183275486
2-D GEL	3.2164381765250454
PROXIMAL	3.210363840474745
MB RAM	3.207688877631823
HORMONES	3.203441175931133
ZINC	3.202216761664863
COMPARABILITY	3.201376682023957
UBIQUITIN ATP-DEPENDENT ACTIVATION	3.199923776575151
KB IDO	3.1958725189566484
POLYACRYLAMIDE GEL ELECTROPHORESI	3.1956031420781694
LANE B	3.1939810440948766
TACHYCARDIA	3.191995886120185
MILLISECOND	3.191995886120185
Β-STRUCTURE	3.191995886120185
PERSON-YEAR	3.191995886120185
IBERIOTOXIN	3.191995886120185
synthase	3.190650771254851
ESTER	3.190030083861297
CED-4	3.190030083861297
0-E14	3.190030083861297
CD4BS	3.190030083861297
CANAL	3.190030083861297
FILE2	3.190030083861297
ABD-A	3.190030083861297
PJC16	3.190030083861297
FACIT	3.190030083861297
NN/ΜM	3.190030083861297
SAP-1	3.190030083861297
CXCR2	3.190030083861297
I. E.	3.190030083861297
CDC24	3.190030083861297
quasi	3.190030083861297
0-E12	3.190030083861297
exons	3.190030083861297
ETS-1	3.190030083861297
LHP-K	3.190030083861297
CTK-1	3.190030083861297
FROMA	3.190030083861297
COS-1	3.190030083861297
HDAC1	3.190030083861297
PBDTX	3.190030083861297
GLIAL	3.190030083861297
MEC-7	3.190030083861297
MULTI	3.190030083861297
COP10	3.190030083861297
USF-2	3.190030083861297
OF200	3.190030083861297
COVER	3.190030083861297
fasta	3.190030083861297
LEAVE	3.190030083861297
DLBCL	3.190030083861297
SGRAI	3.190030083861297
THAT1	3.190030083861297
THISI	3.190030083861297
NFATC	3.190030083861297
HSB-1	3.190030083861297
MOFLO	3.190030083861297
ELUTE	3.190030083861297
PECAM	3.190030083861297
ZRF-1	3.190030083861297
G1-G3	3.190030083861297
CASP1	3.190030083861297
HSP40	3.190030083861297
WUSTL	3.190030083861297
PLAYS	3.190030083861297
LEGOS	3.190030083861297
WRANA	3.190030083861297
GP130	3.190030083861297
SNRNA	3.190030083861297
FOXC1	3.190030083861297
SAR11	3.190030083861297
G6PDH	3.190030083861297
PRK-2	3.190030083861297
PAI-1	3.190030083861297
mucin	3.190030083861297
H. LH	3.190030083861297
FILE1	3.190030083861297
SHP-2	3.190030083861297
M-CSF	3.190030083861297
PGEM1	3.190030083861297
KNI64	3.190030083861297
helix	3.190030083861297
MKP-1	3.190030083861297
GLU39	3.190030083861297
coats	3.190030083861297
SUCHA	3.190030083861297
HCRY2	3.190030083861297
KONTE	3.190030083861297
KRT12	3.190030083861297
PJC15	3.190030083861297
PBS(+	3.190030083861297
Y. L.	3.190030083861297
ARROW	3.190030083861297
SC-61	3.190030083861297
LOGIC	3.190030083861297
FROM0	3.190030083861297
JILKA	3.190030083861297
AGRIS	3.190030083861297
ATLAS	3.190030083861297
SER15	3.190030083861297
LINDO	3.190030083861297
NMOLE	3.190030083861297
AGTII	3.190030083861297
SAP-2	3.190030083861297
RDBMS	3.190030083861297
MELLE	3.190030083861297
COROP	3.190030083861297
NAHCO	3.190030083861297
ΔRING	3.190030083861297
UBA52	3.190030083861297
IGF-1	3.190030083861297
E. G.	3.190030083861297
K-A31	3.190030083861297
BMAL1	3.190030083861297
MATDB	3.190030083861297
P50-2	3.190030083861297
ABD-B	3.190030083861297
1E-15	3.190030083861297
IL-6R	3.190030083861297
TE300	3.190030083861297
U-TUM	3.190030083861297
SETUP	3.190030083861297
STAT1	3.190030083861297
LAPSE	3.190030083861297
PITX2	3.190030083861297
WAYTO	3.190030083861297
WTPAI	3.190030083861297
CAPS2	3.190030083861297
ICAM1	3.190030083861297
STE18	3.190030083861297
OVOID	3.190030083861297
RPA70	3.190030083861297
RCCMV	3.190030083861297
FEMUR	3.190030083861297
LUMAT	3.190030083861297
PGAL4	3.190030083861297
V. P.	3.190030083861297
SIGHT	3.190030083861297
datum	3.190030083861297
NERVE	3.190030083861297
FINDS	3.190030083861297
DM RB	3.190030083861297
LABEL	3.190030083861297
PUPIL	3.190030083861297
Β-GAL	3.190030083861297
GAMMA	3.190030083861297
TRITC	3.190030083861297
INDEX	3.190030083861297
PONGO	3.190030083861297
NAPUS	3.190030083861297
RPIAB	3.190030083861297
VAN'T	3.190030083861297
SB/LE	3.190030083861297
TX100	3.190030083861297
GRIOT	3.190030083861297
GRB-2	3.190030083861297
BULUS	3.190030083861297
MCP-1	3.190030083861297
MG132	3.190030083861297
F. E.	3.190030083861297
PBSTX	3.190030083861297
K1-30	3.190030083861297
DTREX	3.190030083861297
KYOTO	3.190030083861297
notes	3.190030083861297
X. M.	3.190030083861297
MBP-1	3.190030083861297
CD105	3.190030083861297
STE20	3.190030083861297
TMRNA	3.190030083861297
SETDB	3.190030083861297
MM KH	3.190030083861297
KI-67	3.190030083861297
UBA80	3.190030083861297
DIG2Δ	3.190030083861297
MEC-4	3.190030083861297
DERMI	3.190030083861297
looks	3.190030083861297
DICOT	3.190030083861297
Α-BLM	3.190030083861297
STEP1	3.190030083861297
KPN I	3.190030083861297
FRONT	3.190030083861297
EGILE	3.190030083861297
AORTA	3.190030083861297
RAD51	3.190030083861297
unmet	3.190030083861297
ALGAL	3.190030083861297
axons	3.190030083861297
PEROU	3.190030083861297
TRACE	3.190030083861297
WIDTH	3.190030083861297
TEC1Δ	3.190030083861297
CFI-S	3.190030083861297
MUNIT	3.190030083861297
QRRNA	3.190030083861297
XHO I	3.190030083861297
J. M.	3.190030083861297
THANA	3.190030083861297
TNFR1	3.190030083861297
SMA I	3.190030083861297
KU/ML	3.190030083861297
ISL-1	3.190030083861297
PT-PD	3.190030083861297
CBA/J	3.190030083861297
SELDI	3.190030083861297
MKCD9	3.190030083861297
PM-MM	3.190030083861297
35S04	3.190030083861297
CALVA	3.190030083861297
PJM17	3.190030083861297
GAD65	3.190030083861297
VALVE	3.190030083861297
CASP3	3.190030083861297
GDVTK	3.190030083861297
DIFCO	3.190030083861297
BM-40	3.190030083861297
PIM-1	3.190030083861297
DUMMY	3.190030083861297
ABPNN	3.190030083861297
MGOAC	3.190030083861297
PJC11	3.190030083861297
T. T.	3.190030083861297
V-MIN	3.190030083861297
C. G.	3.190030083861297
INPUT	3.190030083861297
LYZED	3.190030083861297
ΣMOST	3.190030083861297
HACAT	3.190030083861297
RERIO	3.190030083861297
TAXON	3.190030083861297
MESAD	3.190030083861297
BRN-2	3.190030083861297
SABRY	3.190030083861297
BSM I	3.190030083861297
PRSET	3.190030083861297
T. W.	3.190030083861297
I-III	3.190030083861297
TWIST	3.190030083861297
TKTAB	3.190030083861297
ACINI	3.190030083861297
MOLAR	3.190030083861297
VIRAL GENOME	3.189854718495038
MITOGEN	3.189444545651537
ANTI-Β1	3.189444545651537
BIOLOGICAL ROLE	3.1883439977437127
indicators	3.1869701818382685
CHLAMYDIA	3.1864353513098975
ZN-RIBBON	3.1864353513098975
AGITATION	3.1864353513098975
MICROFUGE	3.1864353513098975
CFP/YFP	3.1849192140175107
SERVER	3.183266758380591
FURA2-AM	3.181294988631884
CHELATOR	3.181294988631884
FURIOSUS	3.181294988631884
TYRAMIDE	3.181294988631884
transduction pathways	3.181101666467897
REGULATED TRANSCRIPTION FACTOR	3.180632766820623
GP RUN	3.1804161503590955
ACCESSORY	3.180196389251839
PROTEIN TAX	3.1786307982857123
COLD PB	3.1773629003733133
P44 ERK	3.1768940874315805
HETEROGENEITY	3.1736810759901473
CULLIN/F-BOX PROTEIN COMPLEX UBC	3.1724952816295096
CONFLUENCY	3.1723029838801953
IMMUNOSTAINING	3.1722500864250516
ΜM AA	3.1688920748259553
INDIRECT IMMUNOFLUORESCENCE	3.1681553173385377
P TPI	3.1675712444848365
LOG P	3.1675712444848365
LPS TREATMENT	3.167429605996823
MULTIPLE SEQUENCE ALIGNMENT	3.1659731580679575
NFΚ B	3.1632933703178914
sedimented	3.1617055872109985
expectancy	3.1617055872109985
E-NTPDASE1	3.1617055872109985
PECFP-CPLA	3.1617055872109985
E-DNA-DNTP	3.1617055872109985
TOXOPLASMA	3.1617055872109985
COMPARATIVE SEQUENCE ANALYSIS	3.1598676520727804
TOPOLOGY	3.1596776847773995
CF	3.159055403745262
DIDEOXY	3.1585031723388246
HS-LIKE	3.1585031723388246
CATION	3.1582667583805906
E. COLI	3.155539968430407
IMMUNOPRECIPITATION CELL LYSATE	3.1550834259363376
U RNA	3.15500206707424
TRIGGER	3.1535974571528462
BINARY	3.1513186903570847
LIFE CYCLE	3.1502067309474455
CHROMA	3.148266758380591
CM-IV-6A	3.1480757076830104
BIAPENEM	3.1480757076830104
SUBCLONE	3.1480757076830104
CONTACTS	3.1480757076830104
DIMERIZE	3.1480757076830104
therapies	3.147037671973944
LYMPHOCYTE	3.146317917368388
GENETIC DATA	3.1450241300197437
POST-TRANSLATIONAL MODIFICATION	3.142757162507269
PCR	3.1389451772400534
IMMUNOREACTIVE	3.1385329060013936
HEPATIC	3.137370338995876
ELUTING	3.137370338995876
NICOTINIC ACETYLCHOLINE RECEPTOR	3.1364845801875023
ΜL TB	3.131828823282054
PRAVASTATIN	3.1317691646122636
TEST	3.130676116230827
UREA	3.130323185444541
PUROMYCIN	3.1287781576659426
CAPTOPRIL	3.1287781576659426
PCIP/ACTR	3.1287781576659426
RECOGNISE	3.1287781576659426
CLONIDINE	3.1287781576659426
EPIDIDYMI	3.1287781576659426
AGGRASTAT	3.1287781576659426
ATM	3.1281443262642292
F EXP	3.1276444189266837
GENERAL ROLE	3.1255333963309644
INSTAR	3.122552472666305
DEPENDENT	3.120967789448232
experiments	3.1203489189178364
MMHG	3.1172218478072633
HYBRID	3.1122335751373966
STROKE	3.1082667583805907
APYRASE	3.105671088981453
H. CELL	3.10113057932062
CITRATE	3.10113057932062
associations	3.100752498007713
CATALASE	3.0927102394348878
DEMENTIA	3.0927102394348878
SUPEROSE	3.0927102394348878
pyruvate	3.0927102394348878
CYS-X-CY	3.0927102394348878
IMIPENEM	3.0927102394348878
PHOTONIC	3.0927102394348878
CEFACLOR	3.0927102394348878
genomes	3.0925591270296304
ANIMAL CARE	3.091152424269542
DIRECTED MUTAGENESIS STUDY	3.0883385459871993
ANCHOR	3.0882667583805907
EXTEIN	3.0882667583805907
ENZYMATIC ACTIVITY	3.087431353108977
IONIZATION MASS SPECTROMETRY	3.0864110389210264
PHARMACIA	3.0854626714243873
NUCLEASE	3.084368168399399
FURA2	3.08250624201526
LYASE	3.074708033898433
PERIPHERAL BLOOD MONONUCLEAR	3.07462656814506
lipoprotein	3.0741618107139153
E1	3.0732301149712367
ATENOLOL	3.0726427175030655
HEK293	3.0697305373388892
MATLAB	3.0697305373388892
INCYTE	3.0697305373388892
gapped	3.0697305373388892
X-AXIS	3.0697305373388892
ACCORD	3.0697305373388892
MAXIMA	3.0697305373388892
wounds	3.0697305373388892
offers	3.0697305373388892
subset	3.0697305373388892
ARCSIN	3.0697305373388892
TROPIX	3.0697305373388892
IMPACT	3.0697305373388892
APAF-1	3.0697305373388892
helper	3.0697305373388892
READER	3.0697305373388892
K CAT	3.067794700915797
MANIPULATION	3.066997757619779
PHYLOGENETIC CLASSIFICATION	3.0663076035390073
SALT BUFFER	3.0631490020880157
PISCATAWAY	3.0626986259388156
ADOBE PHOTOSHOP	3.0591624944900806
MISSENSE MUTATION	3.0589258812579305
CHOLIC	3.058266758380591
TYR319	3.058266758380591
POST-TRANSCRIPTIONAL LEVEL	3.057531286381317
TRIS BUFFER	3.057474912220898
EG HB	3.0568606837124106
GLUTATHIONE	3.0561823368781056
N HCL	3.0554046546444438
subtype	3.052839005624081
HIGH-CA	3.052839005624081
TRMA	3.052583139799371
ADPNP	3.051313409547953
EXCITATION WAVELENGTH	3.046301059754786
BLASTP	3.045410636213414
DATP	3.0437082903117183
N226	3.0437082903117183
WORD	3.0437082903117183
PHEM	3.0437082903117183
IMDM	3.0437082903117183
EN-1	3.0437082903117183
AGEI	3.0437082903117183
YKVP	3.0437082903117183
THOF	3.0437082903117183
PER1	3.0437082903117183
DFZ1	3.0437082903117183
MATL	3.0437082903117183
LEGO	3.0437082903117183
PF-4	3.0437082903117183
CGMP	3.0437082903117183
HPRT	3.0437082903117183
WD40	3.0437082903117183
L453	3.0437082903117183
SR-2	3.0437082903117183
JAK1	3.0437082903117183
ABC3	3.0437082903117183
GMOD	3.0437082903117183
BOXY	3.0437082903117183
RHOB	3.0437082903117183
TGFA	3.0437082903117183
ALON	3.0437082903117183
TIMP	3.0437082903117183
NKG2	3.0437082903117183
TRAF	3.0437082903117183
FLAP	3.0437082903117183
PER3	3.0437082903117183
p105	3.0437082903117183
MOSM	3.0437082903117183
NFΚB	3.0437082903117183
LANG	3.0437082903117183
NF-M	3.0437082903117183
T387	3.0437082903117183
B.IL	3.0437082903117183
IEEE	3.0437082903117183
RHOC	3.0437082903117183
Y215	3.0437082903117183
I424	3.0437082903117183
NICO	3.0437082903117183
H333	3.0437082903117183
(DT)	3.0437082903117183
TC10	3.0437082903117183
JH10	3.0437082903117183
ΑVΒ3	3.0437082903117183
EEA1	3.0437082903117183
ADH2	3.0437082903117183
SALK	3.0437082903117183
TRP1	3.0437082903117183
ABP1	3.0437082903117183
ECOR	3.0437082903117183
CSN2	3.0437082903117183
PAC1	3.0437082903117183
ACOH	3.0437082903117183
DFZ4	3.0437082903117183
DEPC	3.0437082903117183
R177	3.0437082903117183
NDEI	3.0437082903117183
RAB9	3.0437082903117183
ETGA	3.0437082903117183
PTEN	3.0437082903117183
SIP4	3.0437082903117183
Y312	3.0437082903117183
KLOK	3.0437082903117183
DNOC	3.0437082903117183
D123	3.0437082903117183
H-2A	3.0437082903117183
ACCI	3.0437082903117183
MATR	3.0437082903117183
1JK7	3.0437082903117183
SNSG	3.0437082903117183
GRKS	3.0437082903117183
CRM1	3.0437082903117183
HMDS	3.0437082903117183
H-3B	3.0437082903117183
1IT6	3.0437082903117183
ZT18	3.0437082903117183
SNPS	3.0437082903117183
PER2	3.0437082903117183
IRIX	3.0437082903117183
SYNU	3.0437082903117183
IIIΑ	3.0437082903117183
RAB1	3.0437082903117183
KPN1	3.0437082903117183
HEPE	3.0437082903117183
SPAN	3.0437082903117183
EHDP	3.0437082903117183
3G10	3.0437082903117183
FUS1	3.0437082903117183
URA3	3.0437082903117183
(PM)	3.0437082903117183
CD4I	3.0437082903117183
NNIN	3.0437082903117183
H-3A	3.0437082903117183
FAQS	3.0437082903117183
ROKΑ	3.0437082903117183
GROΑ	3.0437082903117183
EGFR	3.0437082903117183
ATH1	3.0437082903117183
AB-2	3.0437082903117183
TCFS	3.0437082903117183
UCSF	3.0437082903117183
HIS3	3.0437082903117183
PAX6	3.0437082903117183
HUGO	3.0437082903117183
N116	3.0437082903117183
ROOT	3.0437082903117183
R356	3.0437082903117183
AB-1	3.0437082903117183
T330	3.0437082903117183
SLPL	3.0437082903117183
VSMC	3.0437082903117183
DFZ3	3.0437082903117183
W210	3.0437082903117183
CKS1	3.0437082903117183
V-MO	3.0437082903117183
ESCH	3.0437082903117183
FACT	3.0437082903117183
V270	3.0437082903117183
Y-AX	3.0437082903117183
STYI	3.0437082903117183
CHK2	3.0437082903117183
P130	3.0437082903117183
Α5-C	3.0437082903117183
STE4	3.0437082903117183
OUTA	3.0437082903117183
RNOC	3.0437082903117183
urea	3.0437082903117183
33B6	3.0437082903117183
T-PA	3.0437082903117183
IGFR	3.0437082903117183
KOAC	3.0437082903117183
RAB4	3.0437082903117183
C-19	3.0437082903117183
fugu	3.0437082903117183
STE5	3.0437082903117183
HES1	3.0437082903117183
PSTI	3.0437082903117183
WISC	3.0437082903117183
NHEI	3.0437082903117183
CRP2	3.0437082903117183
ND10	3.0437082903117183
LANL	3.0437082903117183
APEX	3.0437082903117183
ZOOM	3.0437082903117183
S/HE	3.0437082903117183
FMLP	3.0437082903117183
PP1Α	3.0437082903117183
IL-1	3.0437082903117183
ORCA	3.0437082903117183
ML/G	3.0437082903117183
PP1Δ	3.0437082903117183
HFCS	3.0437082903117183
P(X)	3.0437082903117183
WWOX	3.0437082903117183
CL-2	3.0437082903117183
N-Α1	3.0437082903117183
ZT16	3.0437082903117183
TUK4	3.0437082903117183
STAB	3.0437082903117183
KNOB	3.0437082903117183
BIME	3.0437082903117183
MOID	3.0437082903117183
SLP1	3.0437082903117183
LICI	3.0437082903117183
VOTE	3.0437082903117183
SUUM	3.0437082903117183
FRAP	3.0437082903117183
N200	3.0437082903117183
FAR1	3.0437082903117183
F337	3.0437082903117183
CSN6	3.0437082903117183
TEM1	3.0437082903117183
RSG3	3.0437082903117183
PL07	3.0437082903117183
P105	3.0437082903117183
NABH	3.0437082903117183
RGS1	3.0437082903117183
NIS0	3.0437082903117183
ZN-8	3.0437082903117183
A549	3.0437082903117183
A875	3.0437082903117183
I225	3.0437082903117183
I345	3.0437082903117183
P200	3.0437082903117183
BALB	3.0437082903117183
HSF1	3.0437082903117183
D.L6	3.0437082903117183
KIP1	3.0437082903117183
EXP1	3.0437082903117183
H-1B	3.0437082903117183
AGLT	3.0437082903117183
SDQR	3.0437082903117183
D355	3.0437082903117183
RANA	3.0437082903117183
MATP	3.0437082903117183
DGGE	3.0437082903117183
MEOH	3.0437082903117183
NOT1	3.0437082903117183
N295	3.0437082903117183
NOBE	3.0437082903117183
PN X	3.0437082903117183
thei	3.0437082903117183
SPH1	3.0437082903117183
OVUM	3.0437082903117183
MTPB	3.0437082903117183
DK25	3.0437082903117183
BCLI	3.0437082903117183
19H8	3.0437082903117183
p130	3.0437082903117183
XRNA	3.0437082903117183
LUMP	3.0437082903117183
TCUS	3.0437082903117183
GPA1	3.0437082903117183
T120	3.0437082903117183
BUD6	3.0437082903117183
XHO1	3.0437082903117183
CED4	3.0437082903117183
NKXD	3.0437082903117183
IGF2	3.0437082903117183
INSR	3.0437082903117183
D214	3.0437082903117183
RHOG	3.0437082903117183
SCOP	3.0437082903117183
ORFS	3.0437082903117183
AB-6	3.0437082903117183
ZNSO	3.0437082903117183
C-20	3.0437082903117183
POLL	3.0437082903117183
F215	3.0437082903117183
BLAT	3.0437082903117183
cdks	3.0437082903117183
MC57	3.041319686637187
STORAGE	3.0410107988
DISCHARGE	3.038806524702166
SIGNALOSOME	3.0376467124758335
TN C	3.0363226831668007
GROWTH RATE	3.0350690455426976
COFACTOR	3.0345878521429857
R 2I	3.034134355123862
TIME PERIOD	3.0335830569270756
MCPBG	3.0325977100675687
COMPOUND	3.0263866256074152
INDIVIDUAL MUTATION	3.0254703105447818
SEQUENCE COMPARISON	3.0254703105447818
G QΑ	3.023565725371034
B CELL	3.0210977976102136
COOMASSIE	3.019372082712891
B EM	3.0190895998286593
MOLECULAR WEIGHT FRACTION	3.0177233996500417
FLUORESCENCE SIGNAL	3.01648810400483
TABLE	3.015627883921857
HBAB	3.0142873990479466
AMPA	3.0142873990479466
conformational	3.013707318506001
INTRACELLULAR ENVIRONMENT	3.0134200724891693
P VALUE	3.01336151057649
HSP90	3.0126742049352586
titration	3.0096916371071236
CONSTITUTIVE OVEREXPRESSION	3.009673460065582
RESULTING PLASMID	3.009452452469738
KEY ROLE	3.009445144616274
CYCLOHEXIMIDE	3.008892862359602
MCNTPC	3.0082667583805907
SANKYO	3.0082667583805907
PRO198	3.0082667583805907
NCOA-1	3.0082667583805907
ILE135	3.0082667583805907
ILE164	3.0082667583805907
SEARLE	3.0082667583805907
FICOLL	3.0082667583805907
ENHANCER	3.0074192075087116
AMPCP	3.004524160846993
DNMT1	3.004524160846993
CDC10	3.004524160846993
CD147	3.004524160846993
ΕP121	3.004524160846993
ILEUM	3.004524160846993
ΜG/ΜL	3.004524160846993
ΓY111	3.004524160846993
ARS1	2.9978749387259076
BP P	2.995083049757612
entries	2.9946081862960487
RESULTS SUPPORT	2.9926865274102035
FETAL           BOVINE SERUM	2.9916887247072594
T CELL PROLIFERATION MACROPHAGE-INDUCED INHIBITION	2.9910692731423745
RECRUIT	2.99041892565678
CONFIDENCE INTERVAL	2.9904068616006105
N-TERMINAL SEQUENCE	2.987523996587918
NEURONAL DIFFERENTIATION	2.98734639844452
UBIQUITIN/PROTEASOME-DEPENDENT PROTEOLYSIS SYSTEM	2.987209773291834
BINDING COMPLEX PIGMENT EPITHELIUM DERIVED FACTOR	2.9862384675825924
DTTP	2.9855655934843783
LOCF	2.9855655934843783
AGE GROUP	2.9851664202690777
SODIUM DEOXYCHOLATE	2.9846541072970623
DENATURING POLY ACRYLAMIDE-UREA GEL ELECTROPHORESI	2.982355473027106
ELECTROPHORETIC MOBILITY	2.982206820282051
HUMAN BILE ACID           BINDER LEVEL EXPRESSION	2.982006333351047
phylogenetic	2.9819009805492334
VELOCITY SEDIMENTATION CLASSIC HYDRODYNAMIC METHOD	2.9806322947496393
CONDITIONED MEDIA HUMAN RETINOBLASTOMA Y-79 CELL	2.9778113199531338
ECTO-NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASES	2.9778113199531338
INCLUDING PROLIFERATION DIVERSE CELLULAR PROCESS	2.97640035590569
INDIVIDUAL IQ PEPTIDE CALMODULIN BINDING AFFINITY	2.9763375443106246
COVALENT ENZYME-DNA COMPLEX CONFORMATIONAL CHANGE	2.9754752477990754
REPORTER GENE EXPRESSION	2.9753368202662593
REGULATORY PROTEIN POST-TRANSLATIONAL MODIFICATION	2.973398574659669
GIBCO-BRL	2.9728408548708605
EXPRESSING CELL HUMAN BILE ACID           BINDER	2.9727865413671384
LYSYLENDOPEPTIDASE-DIGESTED B. MORI APN FRAGMENT	2.9721192256762667
RESEMBLING TOPOISOMERASE III RELAXATION ACTIVITY	2.9712188857275694
glycine	2.970094220453017
DENATURING POLYACRYLAMIDE-UREA GEL ELECTROPHORESI	2.9697083975143364
NORMAL LYMPHOBLAST THIAMINE MITOCHONDRIAL UPTAKE	2.969223987022206
CELLULAR DNA CONTENT FLOW CYTOMETRIC MEASUREMENT	2.9688338363352
HELICOBACTER PYLORI TOPOISOMERASE I ZN(II) MOTIF	2.9686959061489886
DMUT	2.968332510146237
HOLE	2.968332510146237
CY-3	2.968332510146237
CHRONIC           OBSTRUCTIVE PULMONARY DISEASE	2.9682229860821145
GLASS SLIDE MICROARRAY GENE EXPRESSION ANALYSIS	2.9673149553402776
BIND DNA	2.9659822563959786
antagonists	2.9645511093059533
T. MARITIMA TOPOISOMERASE I DECATENATION ACTIVITY	2.9645271271793487
IMMUNOPRECIPITATION IMMUNOPRECIPITATION EXPERIMENT	2.962893722466552
R	2.962309582002633
MMP EXPRESSION TRYPTOPHAN-REVERSIBLE INHIBITION	2.9609770983781005
ESTABLISHMENT	2.9603351097655217
TYPE IA DNA TOPOISOMERASE REPRESENTATIVE EXAMPLE	2.959657024927995
ALANINE SUBSTITUTION	2.9593696661268174
CONTAINING SUB FRAGMENT ARS CONSENSUS SEQUENCE	2.958436940738043
PRE-RANDOMIZATION CORONARY ARTERY BYPASS GRAFT	2.958436940738043
ALTERED ADIPOCYTE FUNCTION POTENTIAL MECHANISM	2.958436940738043
GRIP1	2.957734912146033
EMESI	2.957734912146033
IHARA	2.957734912146033
ZOCOR	2.957734912146033
P/CAF	2.957734912146033
ΓL119	2.957734912146033
ΓY117	2.957734912146033
ORI-Β	2.957734912146033
VYDAC	2.957734912146033
EDF-1	2.957734912146033
LQH-8	2.957734912146033
DOUNCE HOMOGENIZER	2.95751900374379
STANDARD TECHNIQUE	2.95751900374379
JUN N TERMINAL           KINASE DOWN-REGULATION	2.957063885495978
DT	2.9560693905204376
TREATMENT OF MILD HYPERTENSION           STUDY	2.955925899513229
CULTURE MEDIUM IDO ANTISENSE-TRANSFECTED CLONE	2.9558515473044915
ESTIMATED CONCENTRATION	2.9556401324726345
FORM INCLUSION BODY CATALYTIC V-ATPASE SUBUNIT	2.9524316047157617
BINDING PROTEIN TYPE CYTOPLASMIC RETINOIC ACID	2.952029665660147
HTTP	2.9512032697447026
ENCODING P110 PITSLREAND P58 PITSLRE HOST MRNA	2.9509726707841484
CARDIOLOGY/AMERICAN HEART ASSOCIATION GUIDELINE	2.9508116416166676
FORMALDEHYDE-AGAROSE GEL	2.9497161232270503
BASELINE CHARACTERISTIC BASELINE CHARACTERISTIC	2.949507286601731
CHARACTERISTIC ELECTROPHORETIC MOBILITY SHIFT	2.9484448583235756
ANTERIOR-POSTERIOR AXIS ALTERED SPECIFICATION	2.9484448583235756
IMMUNOFLUORESCENCE INDIRECT IMMUNOFLUORESCENCE	2.9479487482484252
BINDING B. MORI BRUSH BORDER MEMBRANE VESICLE	2.947088426369564
determination	2.946886462336249
REVEALED CO-PRECIPITATION ENDOGENOUS PROMOTER	2.946801488840831
EXPRESSION VECTOR PCDNA3	2.9466914011436827
LDH	2.9465012337619307
BINDING CYSTEINE MOTIFS RANGE POTENTIAL ZN(II)	2.9464965558660268
UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR	2.9460298196924115
ESTIMATED INTRACELLULAR THIAMINE CONCENTRATION	2.945507426258094
TX	2.944143123002367
mg	2.944143123002367
KY	2.944143123002367
FL	2.944143123002367
CELLULAR THIAMINE/THIAMINE PHOSPHATE DERIVATIVE	2.943488989573638
PERIPHERAL ALPHA-1 ANTAGONIST POSITIVE EFFECT	2.943206082215973
ARSB	2.9424828851390257
HEME	2.9424828851390257
CY-5	2.9424828851390257
LPNA	2.9424828851390257
CDK9	2.9424828851390257
PLANT PHOTOMORPHOGENESI	2.9423422929923913
MATRIX METALLOPROTEINAS	2.9423422929923913
PHYSIOLOGICAL MECHANISM	2.9423422929923913
ELECTROSTATIC REPULSION	2.9423422929923913
CONTAINING CDK7 CAK TRIMERIC ENZYME HUMAN HOMOLOG	2.94204292045178
HOMOLOGOUS SEQUENCE	2.9418708581096946
BUDDING YEAST F-BOX PROTEIN TRUNCATION MUTANT	2.9408862566194256
STREPTAVIDIN-CONJUGATED HORSERADISH PEROXIDASE	2.940706901053214
TYROSINE KINAS RECEPTOR-ASSOCIATED JAK FAMILY	2.940042401047197
INDUCIBLE CAMP EARLY         REPRESSOR INDUCTION	2.93986799240889
REMODELLING FACTOR MOLECULAR WEIGHT CHROMATIN	2.9395075902721506
UBIQUITYLATION REACTION SUBSTRATE SPECIFICITY	2.939396029367209
MAINSTREAM HUMAN IMMUNODEFICIENCY VIRUS TYPE	2.9382378760257915
ANGIOTENSIN-CONVERTING ENZYME (ACE)-INHIBITOR	2.937821327732935
SEMI-QUANTITATIVE RT-PCR	2.9377577416720846
WEIGHT MODIFICATION INTERVENTION CLINICAL TRIAL	2.9361389298300278
E. COLI TOPOISOMERASE I KDA C-TERMINAL REGION	2.936068293922062
PROSTAGLANDIN PRODUCTION PROSTAGLANDIN SYNTHESIS	2.9358077780795484
SUBCELLULAR LOCALIZATION PATTERN INDEPENDENT	2.9350397839089677
DENSITY LIPOPROTEIN-RECEPTOR-RELATED PROTEIN	2.9347903631996974
SUBCOMMITTEE QUALITY CONTROL ROUTINE ENDPOINT	2.9341390226486
ANTIHYPERTENSIVE TRIAL DOXAZOSIN TREATMENT ARM	2.9341115465393974
IONOMYCIN	2.9333276285504173
CONSTITUTIVE ACTIVATION	2.9326285962433714
LERISETRON WHOLE CELL PATCH-CLAMP EXPERIMENT	2.932423600282573
BINDING FACTOR DNA DECREASED PHOSPHORYLATION	2.9321806880439034
SUBSTRATE Β-LACTAM CARBONYL MODELED POSITION	2.9315426494123886
ABI PRISM BIGDYE TERMINATOR CYCLE SEQUENCING	2.9315421604955922
THERMOPLASMA ACIDOPHILUM A-TYPE ATPAS SUBUNIT	2.931126603406217
MOLAR EXCESS	2.9311120771523607
BILE ACID UPTAKE ACTIVITY ASSAY UPTAKE STUDY	2.9307290194385613
REGULATED TRANSCRIPTION	2.930172130206379
E. COLI TOPOISOMERASE I DNA-BINDING PROPERTY	2.9294114307773658
PYROCOCCUS INTEIN MULTIPLE SEQUENCE ALIGNMENT	2.9285193061775083
PROTOCOL-DEFINED SECONDARY CLINICAL OUTCOME	2.9278065465793235
METHANOBACTERIUM THERMOAUTOTROPHICUS BRANCH	2.9278065465793235
POLYETHYLENIMINE-TREATED GLASS-FIBER FILTER	2.9278065465793235
ATHEROSCLEROTIC         CARDIOVASCULAR DISEASE	2.927409371289592
equations	2.9265087434069805
outgrowth	2.9265087434069805
NOREPINEPHRINE LEADING INCREASED CONCENTRATION	2.9257002255148894
SCF-MEDIATED UBIQUITYLATION MAJOR DETERMINANT	2.925654383408656
REDISSOLVED	2.9252943089659516
COREPRESSOR	2.9252943089659516
ADAPTATION	2.9250343784726573
CONTAINING CELL SUSPENSION REACTION MIXTURE	2.924503176295817
PRE-TRIAL ANTIHYPERTENSIVE TREATMENT DURATION	2.9230335589851184
MAJOR HISTOCOMPATIBILITY	2.9229413821354293
CONTAINING ACS ELEMENT LABELLED DNA FRAGMENT	2.922526466744312
HUMAN THIAMINE TRANSPORTER-SPECIFIC PEPTIDE	2.922387780383994
(1-(PHENYLMETHYL)-2-PIPERIZINYL BENZIMIDAZOLE	2.921994435220349
NEVIRAPINE-BOUND HIV-1 RT CRYSTAL STRUCTURE	2.9217418090451504
EXPRESSED IDO ANTISENSE TRANSCRIPT P19 CELL	2.921383887726889
INFLAMMATORY MEDIATOR	2.9200575936460877
GENOMIC DNA FRAGMENTATION CELL VISUALIZATION	2.9191977482958116
MBR	2.9188592326323195
REAGENT	2.9185330994079655
PERIPHERAL BLOOD           MONONUCLEAR CELLS	2.9185108690398733
STRAND PASSAGE PROTEIN CONFORMATIONAL CHANGE	2.9182682911207194
CEM CDNA FILTER HYBRIDIZATION GENE EXPRESSION	2.9181598802725017
ΜM ETHYLENE GLYCOL-BIS(Β-AMINOETHYLETHER)-N	2.9179597032118214
SIGNAL TRANSDUCTION PATHWAY RESULT MODULATION	2.917382303191864
LUMEN	2.917170790905411
CELL CYCLE-DEPENDENT SUBSTRATE DEGRADATION	2.9171407857207297
LERISETRON-BINDING SITE HYPOTHETICAL MODEL	2.9171407857207297
POLYCATIONIC POLYETHYLENIMINE-COATED GLASS	2.9171407857207297
PEDF-RECEPTOR PEI-TREATED GLASS-FIBER FILTER	2.9169934069640338
SIX-PROTEIN ORIGIN RECOGNITION COMPLEX BIND	2.9162447505870506
RECEPTOR PURITY CANDIDATE RECEPTOR FRACTION	2.9154134782983165
THIAMINE-RESPONSIVE         MEGALOBLASTIC ANEMIA	2.9151018067334147
STRUCTURAL SIMILARITY	2.914090735405481
SYMPTOMATIC MYOCARDIAL ISCHEMIA REHOSPITALIZATION	2.9138019159251445
T LYMPHOCYTE ACTIVATION	2.912419640937939
INDICATED THDP UPTAKE TIME COURSE EXPERIMENT	2.911865754035376
PIGMENT EPITHELIUM DERIVED FACTOR ABBREVIATION	2.9115941979704747
PIGMENT EPITHELIUM DERIVED FACTOR AFFINITY	2.909247596649078
RETINOIC ACID (RA)-DEPENDENT TRANSCRIPTION	2.9088138722430954
TAKE PLACE	2.908459035966164
HSA	2.9078024321804747
TDO	2.9078024321804747
THIAMINE UPTAKE PHYSIOLOGICAL SIGNIFICANCE	2.9070325534065984
HEAT SHOCK PROTEIN EXPRESSION PRAZOSIN BLOCK	2.9064456208770775
HOST CELL MAPK SIGNAL TRANSDUCTION PATHWAY	2.906379421817952
PROXIMAL-TUBULE CELL BRUSH-BORDER DYNAMIC	2.906229813601605
CATABOLISM	2.9057676196659514
SLIDE MICROARRAY GENE EXPRESSION ANALYSIS	2.905176747919335
OUTCOME-CORRELATED BASELINE CHARACTERISTIC	2.905008715457091
VASCULAR SMOOTH MUSCLE CELL PROLIFERATION	2.90487324741293
REPRESENTING ENZYME-BOUND THDP TURNOVER POOL	2.904487115558795
NON-PHARMACOLOGIC LIPID-LOWERING INTERVENTION	2.9043608198181974
EXAMINING THDP UPTAKE SENSITIVE PROCEDURE	2.9040807978571688
NONSPECIFIC	2.903694708348269
PARTICIPANT TIME-FROM-EVENT-TO-DEATH ANALYSIS	2.903677353954411
REEXAMINED POTENTIAL CELL CYCLE VARIATION	2.9036304053358797
MITOCHONDRIAL THDP-UTILIZING ENZYME ACTIVITY	2.9026969240954243
CM-IV FRACTION INDIVIDUAL HPLC FRACTION BIOASSAY	2.9026582291101986
FLOW/RAPID-SCANNING UV-VISIBLE SPECTROPHOTOMETRY	2.9025599040894705
ENZYMATIC REACTION	2.9019718836557655
CDNA FILTER HYBRIDIZATION GENE EXPRESSION	2.9017346523749334
PHYSIOLOGIC	2.901611594564756
PENICILLIN/STREPTOMYCIN	2.9014906019633586
ALEXA-CALMODULIN BOUND SUBSTANTIAL AMOUNT	2.901469932237831
PERIPHERAL ALPHA-1 ANTAGONIST FLUID STATUS	2.9014476826873996
INTERNAL CAROTID ARTERY MAXIMUM THICKNESS	2.901122740891297
PHYSIOLOGICAL FUNCTION	2.900850199051847
CORRESPONDING DECREASE	2.900850199051847
TAURINE- NOR GLYCINE-CONJUGATED BILE ACID	2.900432547755441
TRMA LYMPHOBLAST THDP MITOCHONDRIAL UPTAKE	2.899846159847194
EXTRACELLULAR SOLUTION	2.899824080288803
ACE3	2.899400176793673
E174	2.899400176793673
(CR)	2.899400176793673
AIB1	2.899400176793673
UPAR	2.899400176793673
F107	2.899400176793673
aldo	2.899400176793673
NTCP	2.899400176793673
E106	2.899400176793673
ETOH	2.899400176793673
G147	2.899400176793673
PCU4	2.899400176793673
D213	2.899400176793673
D219	2.899400176793673
CAK1	2.899400176793673
UBCS	2.899400176793673
BMAX	2.899400176793673
ARSC	2.899400176793673
CD81	2.899400176793673
GUEX	2.899400176793673
csn5	2.899400176793673
DENSITOMETRIC ANALYSIS	2.8992994240734644
PERIPHERAL ALPHA-1 ANTAGONIST ROUTINE USE	2.8989987132242665
SILVER STAIN ANTI-GST POLYCLONAL ANTIBODY	2.8988081175107756
ARCHAEAL ATPASE CATALYTIC SUBUNIT PHYLOGENY	2.8986570220801835
N-TERMINAL TRANSESTERIFICATION DOMAIN TOP67	2.8983186977513746
CIRCULAR DICHROISM CIRCULAR DICHROISM SAMPLE	2.8980665163453763
CONTAINING ANTIBIOTIC DISCUSSION Β-LACTAM	2.8980082003369048
GLYCEROL GRADIENT ULTRA-CENTRIFUGATION ANALYSIS	2.897932154298225
COP9/SIGNALOSOME CULLIN DENEDDYLATING ACTIVITY	2.896221659547214
ETHYLENE GLYCOL-BIS(Β-AMINOETHYLETHER)-N	2.895062089307325
EXHIBITED ACTIN-ACTIVATED ATPASE ACTIVITY	2.894260111936821
UNCONJUGATED BILIRUBIN SEDIMENTATION DATA	2.894232969756175
REPORTED STOPPED-FLOW FLUORESCENCE STUDY	2.894232502011513
GLYCOPROTEIN IIB/IIIA INHIBITOR UTILIZATION	2.893482464727263
CYCLIN DEPENDENT KINASE POLYUBIQUITYLATION	2.8934351612274725
dissociation	2.8933427417691577
SURFACE MANNOSE RECEPTOR DECREASED LEVEL	2.8931865006385324
TEST SYSTEM UCB-DMSO-BUFFER SYSTEM PREPARATION	2.893039158424698
PHOSPHORYLATION SITE MUTANT TRANSLOCATION	2.893013186986606
RASMOL MOLECULAR PDB VISUALIZATION SOFTWARE	2.8926862321074975
EXTRACELLULAR MATRIX FUNCTIONAL MODULATOR	2.8926861738932375
SPR	2.8923229115478923
AMP	2.8923229115478923
CO-OVEREXPRESSING EPITOPE-TAGGED COMBINATION	2.892208193058649
FOUR-DISULFIDE CORE FAMILY OTHER PEPTIDE	2.8920524237690297
EXTRACELLULAR MATRIX PRINCIPAL COMPONENT	2.891752073032182
MULTIPLE PROTEIN KINAS PHYSICAL INTEGRITY	2.8917482942747017
SURROUNDING BT USE GROWING PUBLIC CONCERN	2.8916239053416875
DEPLETING CLONE TRYPTOPHAN COMMON FEATURE	2.891323279480853
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ,	2.8909669389018684
INCLUDING NF-KAPPAB TRANSCRIPTION FACTOR	2.8905637290288633
CARDIOVASCULAR DEATH ENDPOINT END-OF-OBSERVATION	2.8898974062277962
UNCONJUGATED BILIRUBIN MEASURED QUANTITY	2.8895597245902036
ILLUSTRATION	2.8894999636011764
HIV-1 RT HETERODIMER FUNCTIONAL INTEGRITY	2.889384976768796
COPPER-PHENANTHROLINE FOOTPRINTING ASSAY	2.888665508734634
FRAMINGHAM HEART STUDY LOGISTIC REGRESSION	2.8885500231742527
CATALYTIC SUBUNIT T. ACIDOPHILUM A-ATPASE	2.8884044387010728
minima	2.888028351548519
LERISETRON COMPETITIVE ANTAGONIST ACTION	2.8879669348036687
HUMAN CDC6 CDNA PLASMID CONSTRUCTION CLONING	2.8878931188683543
INTRACELLULAR BILE ACID LEVEL EXPRESSION	2.887697871873329
CARDIOVASCULAR DEATH	2.8873798796084924
CARRYING INSERTION HETERO-DIMERIC ENZYME	2.8873272077582572
PRISM BIGDYE TERMINATOR CYCLE SEQUENCING	2.887218145750895
MURINE EMBRYONIC CARCINOMA CELL LINE P19	2.8872065201820862
CELLULAR TRANSPORT GENERALIZED MECHANISM	2.8870536970952774
EXPRESSED IDO ANTISENSE RNA RESISITANT CLONE	2.88688165131236
CANDIDATE CADHERIN-LIKE RECEPTOR FRACTION	2.8864999034449936
CELL SURFACE RECEPTOR INTRINSIC AFFINITY	2.8864983549978764
SODIUM DODECYL SULFATE GEL ELECTROPHORESI	2.886452463896594
ENDOGENOUS CPLA GEL SHIFT CHARACTERISTIC	2.8863781343057764
DNA POLYMERASE ACTIVITY INSERTION MUTANT	2.8863347966108663
CALMODULIN THREE-DIMENSIONAL INTERACTION	2.886286043649972
IDO-EXPRESSING RAW CELL ALTERED ADHESION	2.8862634361699233
EXPERIMENTAL WORK	2.8860815236062325
INDIVIDUAL DOMAIN	2.8860815236062325
SELECTION PROCESS	2.8860815236062325
MODELING APPROACH	2.8860815236062325
PUTATIVE CADHERIN-LIKE RECEPTOR MATERIAL	2.885977206692861
TRANSFECTED HUMAN CD98 FUNCTIONAL EFFECT	2.8857122126502053
PLASMA MEMBRANE FOLATE TRANSPORTER ABILITY	2.885000667713211
cytoplasmic	2.8841182063878534
SUBSTRATE SELECTION POTENTIAL MECHANISM	2.883625237484314
BACKGROUND ECTO-NUCLEOSIDE TRIPHOSPHATE	2.883625237484314
IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY	2.883537355937102
EXERCISE TIME PRIMARY PRE-SPECIFIED ANALYSIS	2.8831795909867237
OTHER MAMMALIAN CELL	2.8831571220000334
LGIC	2.883011481597398
MEET ALLHAT DIAGNOSTIC CRITERION HF CASE	2.882741217796863
BOVINE	2.882411326425154
APPROX	2.882411326425154
BODY MASS INDEX YEARS OF UNHEALTHY LIFE	2.8822585150341564
CONCENTRATED CANDIDATE RECEPTOR FRACTION	2.8821960085000584
LEPIDOPTERAN SELECTIVE TOXICITY LOCALIZATION	2.8815859585277703
CAUSES ACCUMULATION PUTATIVE CSN SUBUNIT	2.881566685935755
messages	2.881561263570836
PURIFICATION N-TERMINAL HEXAHISTIDINE TAG	2.880961537143134
INTEGRIN INVOLVING CO-IMMUNOPRECIPITATION	2.8808857261815377
GLUTAMATE	2.880843824765371
COMPETING LIGAND SATURATING CONCENTRATION	2.8808349494574137
MEDICAL MANAGEMENT BASELINE CHARACTERISTIC	2.8807445749298144
SERINE/THREONINE RECEPTOR TYROSINE KINASE	2.8807381446351203
SODIUM DODECYL SULFATE	2.8804468655127216
DNA POLYMERASE ASSAY POLYMERASE ACTIVITY	2.8803920548143487
ANTISENSE-TRANSFECTED AGGREGATE MEAN SIZE	2.880354098307919
ANTIBODY DETECTION DLYDDDDK EPITOPE TAG	2.8795944773554476
REVEALED MAJOR POLYMERASE ACTIVITY PEAK	2.8794505216365596
SEDIMENTATION COEFFICIENT SUCROSE GRADIENT	2.8791795637337585
MITOGEN-ACTIVATED PROTEIN KINASE KINASE	2.8790527465376017
FUNCTIONAL INTERACTION	2.8790353141358005
COMBINATION THERAPY INCREMENTAL BENEFIT	2.878841708908762
E. COLI BL21-CODONPLUS (DE3)-RIL STRAIN	2.8785336632387906
S. CEREVISIAE ORIGIN RECOGNITION COMPLEX	2.8778803097525247
HEAT-SHOCK         TRANSCRIPTION FACTOR	2.8776660929612654
RISK FACTOR	2.8776068297381285
OPTIMIZING VIRAL MRNA TRANSLATION PRIOR	2.8775693225199785
SPECIES SELECTIVITY SODIUM CHANNEL TOXIN	2.877463704298006
MMP ACTIVITY PHARMACOLOGICAL INHIBITION	2.8769282974785413
LYSYLENDOPEPTIDASE-DIGESTED B. MORI APN	2.8768710586750728
MAXIMUM ENTROPY DECONVOLUTION ALGORITHM	2.8764468181317207
CALCIUM-DEPENDENT LIPID         BINDING	2.876235510581392
LIPID-LOWING THERAPY INPATIENT INITIATION	2.8755455783815633
BINDING ASSAY TRANSFECTED CELL RADIOLIGAND	2.8754740780216297
WEIGHT MODIFICATION BEHAVIOR CHANGE TRIAL	2.874693583985884
RABBIT POLYCLONAL IDO-SPECIFIC ANTIBODY	2.874465593473525
DIMENSIONAL GEL ELECTROPHORESIS ANALYSIS	2.8736097753745535
IMMUNOBLOTTING IMMUNOBLOTTING PROTEIN LYSATE	2.8732416591368732
QUALITY CONTROL VALIDATION DOCUMENTATION	2.8724095477974
CATION-Π INTERACTION	2.872108900835762
ANISOMYCIN-STIMULATED P38 PHOSPHORYLATION	2.8720976615633043
POSTSYNAPTIC MEMBRANE GLUTAMATE RECEPTOR	2.8719779210760312
PROTEIN-PROTEIN COMPLEX MOLECULAR SIZE	2.8719059659063455
MERCK/SER CLINICAL EPIDEMIOLOGY FELLOW	2.8719059659063455
MAJOR HISTOCOMPATIBILITY COMPLEX TYPE I	2.8717195663629402
CALMODULIN STANDARD STAINING INTENSITY	2.870988392096882
POLYACRYLAMIDE GEL ELECTROPHORESIS SYSTEM	2.870767144180712
var	2.870646340648324
IIA	2.870646340648324
3-D	2.870646340648324
BMO	2.870646340648324
PRD	2.870646340648324
FAS	2.870646340648324
AB2	2.870646340648324
CAD	2.870646340648324
p19	2.870646340648324
MDR	2.870646340648324
HS1	2.870646340648324
YPD	2.870646340648324
HA2	2.870646340648324
ecl	2.870646340648324
W.L	2.870646340648324
PAG	2.870646340648324
TCT	2.870646340648324
EMB	2.870646340648324
BH3	2.870646340648324
DOR	2.870646340648324
JAK	2.870646340648324
MIB	2.870646340648324
7-C	2.870646340648324
AX2	2.870646340648324
KP1	2.870646340648324
P56	2.870646340648324
tet	2.870646340648324
1CR	2.870646340648324
N.H	2.870646340648324
IOP	2.870646340648324
PNN	2.870646340648324
ZT6	2.870646340648324
E64	2.870646340648324
FGF	2.870646340648324
RRP	2.870646340648324
5-D	2.870646340648324
PC3	2.870646340648324
O.C	2.870646340648324
RGS	2.870646340648324
AIR	2.870646340648324
SRF	2.870646340648324
MCS	2.870646340648324
DAT	2.870646340648324
NA1	2.870646340648324
R70	2.870646340648324
IGA	2.870646340648324
N67	2.870646340648324
ABS	2.870646340648324
VSM	2.870646340648324
JHM	2.870646340648324
BCW	2.870646340648324
SP1	2.870646340648324
L.S	2.870646340648324
KGB	2.870646340648324
G.S	2.870646340648324
SVM	2.870646340648324
HEJ	2.870646340648324
JMP	2.870646340648324
A/G	2.870646340648324
L32	2.870646340648324
SSV	2.870646340648324
EGC	2.870646340648324
P70	2.870646340648324
PP1	2.870646340648324
GTT	2.870646340648324
CEF	2.870646340648324
HC9	2.870646340648324
VAP	2.870646340648324
WEB	2.870646340648324
H.M	2.870646340648324
KEV	2.870646340648324
6-H	2.870646340648324
D/N	2.870646340648324
ZT4	2.870646340648324
SUN	2.870646340648324
MZM	2.870646340648324
SEQ	2.870646340648324
PAI	2.870646340648324
MAS	2.870646340648324
P36	2.870646340648324
EVE	2.870646340648324
PAS	2.870646340648324
SBD	2.870646340648324
K/R	2.870646340648324
N.J	2.870646340648324
FZS	2.870646340648324
TTC	2.870646340648324
PDI	2.870646340648324
6OR	2.870646340648324
ZEN	2.870646340648324
BSR	2.870646340648324
LMB	2.870646340648324
C.H	2.870646340648324
HTE	2.870646340648324
KHK	2.870646340648324
SCA	2.870646340648324
2NG	2.870646340648324
UBX	2.870646340648324
CAT	2.870646340648324
M.S	2.870646340648324
TFS	2.870646340648324
GRK	2.870646340648324
1WE	2.870646340648324
PO4	2.870646340648324
SJY	2.870646340648324
ECF	2.870646340648324
NC_	2.870646340648324
P20	2.870646340648324
EXO	2.870646340648324
PGI	2.870646340648324
3NG	2.870646340648324
smg	2.870646340648324
MBP	2.870646340648324
BDU	2.870646340648324
LY1	2.870646340648324
DKW	2.870646340648324
AE2	2.870646340648324
SKP	2.870646340648324
TLA	2.870646340648324
GOΑ	2.870646340648324
JNH	2.870646340648324
S/G	2.870646340648324
DGW	2.870646340648324
O/N	2.870646340648324
CD3	2.870646340648324
PAM	2.870646340648324
SGI	2.870646340648324
SOM	2.870646340648324
IL2	2.870646340648324
PER	2.870646340648324
E.C	2.870646340648324
AML	2.870646340648324
G.C	2.870646340648324
IBI	2.870646340648324
IC2	2.870646340648324
NAD	2.870646340648324
BAX	2.870646340648324
HSG	2.870646340648324
R.L	2.870646340648324
EMC	2.870646340648324
ABL	2.870646340648324
CLW	2.870646340648324
SVH	2.870646340648324
OCT	2.870646340648324
ECO	2.870646340648324
DRP	2.870646340648324
NES	2.870646340648324
DHT	2.870646340648324
BFA	2.870646340648324
PEP	2.870646340648324
NBM	2.870646340648324
EPK	2.870646340648324
LUT	2.870646340648324
7we	2.870646340648324
PWM	2.870646340648324
PNP	2.870646340648324
LEF	2.870646340648324
VHL	2.870646340648324
H-7	2.870646340648324
GAP	2.870646340648324
BWM	2.870646340648324
GAD	2.870646340648324
FLU	2.870646340648324
NEB	2.870646340648324
Q61	2.870646340648324
LMK	2.870646340648324
P.D	2.870646340648324
PLP	2.870646340648324
MPG	2.870646340648324
AJB	2.870646340648324
A-I	2.870646340648324
HIP	2.870646340648324
JSP	2.870646340648324
SUS	2.870646340648324
BAM	2.870646340648324
LBL	2.870646340648324
CHI	2.870646340648324
ABI	2.870646340648324
bim	2.870646340648324
TH*	2.870646340648324
5(C	2.870646340648324
VCM	2.870646340648324
VIR	2.870646340648324
2-D	2.870646340648324
ACM	2.870646340648324
HSB	2.870646340648324
GNF	2.870646340648324
RHO	2.870646340648324
LWH	2.870646340648324
GAR	2.870646340648324
CBA	2.870646340648324
GΑO	2.870646340648324
5GY	2.870646340648324
ING	2.870646340648324
IID	2.870646340648324
LT1	2.870646340648324
APC	2.870646340648324
CYA	2.870646340648324
exp	2.870646340648324
L-F	2.870646340648324
AGI	2.870646340648324
OF2	2.870646340648324
min	2.870646340648324
URL	2.870646340648324
NEX	2.870646340648324
ALL	2.870646340648324
FSH	2.870646340648324
SSU	2.870646340648324
BIM	2.870646340648324
HTH	2.870646340648324
PRF	2.870646340648324
PLL	2.870646340648324
P52	2.870646340648324
TEM	2.870646340648324
XWD	2.870646340648324
MAD	2.870646340648324
L41	2.870646340648324
NBS	2.870646340648324
P75	2.870646340648324
AHB	2.870646340648324
DPC	2.870646340648324
GSK	2.870646340648324
OAZ	2.870646340648324
ISK	2.870646340648324
PTB	2.870646340648324
NLM	2.870646340648324
GΒΓ	2.870646340648324
CO2	2.870646340648324
ems	2.870646340648324
SPM	2.870646340648324
MDP	2.870646340648324
CHX	2.870646340648324
GDI	2.870646340648324
NUB	2.870646340648324
1ΜM	2.870646340648324
ZT8	2.870646340648324
IGF	2.870646340648324
CD2	2.870646340648324
T.T	2.870646340648324
MOI	2.870646340648324
P23	2.870646340648324
PWL	2.870646340648324
DFZ	2.870646340648324
B.G	2.870646340648324
ATT	2.870646340648324
NUO	2.870646340648324
XPA	2.870646340648324
GLY	2.870646340648324
6TO	2.870646340648324
SOG	2.870646340648324
S4A	2.870646340648324
GIΑ	2.870646340648324
SJM	2.870646340648324
p65	2.870646340648324
HSM	2.870646340648324
4OR	2.870646340648324
ALANINE	2.870522682585669
PROTEIN ORIGIN RECOGNITION COMPLEX BIND	2.8703398416723016
EXTRACELLULAR SIGNAL-REGULATED KINASES	2.870322058735248
POLYMERASE ACTIVITY EXHIBITED TOTAL LACK	2.8700022999093844
PREVIOUS STUDY COLIDNA TOPOISOMERASE I	2.869662324119385
PLAY MAJOR ROLE PROTEIN KINASE PATHWAY	2.8695615209309455
CULLIN UBIQUITIN LIGAS ESSENTIAL COFACTOR	2.869471245908462
CLEAVAGE PRODUCT RELATIVE DISTRIBUTION	2.8694534644801304
FXR	2.8691036305990187
ICP	2.8691036305990187
F12	2.8691036305990187
SBP	2.8691036305990187
PVP	2.8691036305990187
AUA	2.8691036305990187
IQ DOMAINS EXAMINATION SEQUENCE ANALYSIS	2.869102252813113
NEUROPEPTIDE Y-LIKE RECEPTOR UP-REGULATION	2.8683797923209657
FUNCTIONAL ROLE	2.867695643583591
SECONDARY ENDPOINT INCREASED OCCURRENCE	2.867140462085489
ALPHA-2 MACROGLOBULIN RECEPTOR PROTEIN	2.867100836334321
APICAL SODIUM/BILE ACID CO-TRANSPORTER	2.8668614842998177
MAXIMUM POSSIBLE YEARS OF HEALTHY LIFE	2.866147997484356
TUNEL	2.866145540381948
BAMHI	2.866145540381948
SPLIT	2.866145540381948
BLAST	2.866145540381948
FASTA	2.866145540381948
MIAMI	2.866145540381948
START	2.866145540381948
BRCA1	2.866145540381948
POLAR	2.866145540381948
LEICA	2.866145540381948
BAMH1	2.866145540381948
IU/ML	2.866145540381948
BRIEF	2.866145540381948
CCAAT	2.866145540381948
THAND	2.866145540381948
BCL-2	2.866145540381948
GIBCO	2.866145540381948
ug/ml	2.866145540381948
TAT TRANSCRIPTIONAL ACTIVITY VERIFICATION	2.865893377094476
QUENCHED ALEXA-CALMODULIN FLUORESCENCE	2.8656814886023834
SCF-DEPENDENT SUBSTRATE UBIQUITYLATION	2.8656814886023834
E. COLI BL21-CODONPLUS(DE3)-RIL STRAIN	2.8655838172829866
GEL RETARDATION ASSAY GEL RETARDATION ASSAY	2.86437547962364
IDO AMPLIFICATION AMPLIFICATION CONDITION	2.8641896931010664
LERISETRON AROMATIC BENZIMIDAZOLE GROUP	2.86381975075045
HETERODIMERIZING F-BOX PROTEIN PARTNER	2.8636300136637427
REPORTER GENE EXPRESSION IFN-Γ INDUCTION	2.8630990050931096
GENERALIZED INTRACELLULAR ACCUMULATION	2.8630263556557987
SIGNATURE MOTIF REVEALED MULTIPLE COPY	2.8628496318109415
P300 HARBOR TRANSCRIPTIONAL ACTIVATION	2.862688815795908
CORONARY HEART DISEASE PRIMARY OUTCOME	2.861651057938021
CONSTITUTIVE INTEGRIN-CD98 ASSOCIATION	2.8614708127791153
CADHERIN-LIKE RECEPTOR DISSOCIATION RATE	2.8614666729529574
HAMSTER ASBT PROTEIN CARBOXYL TERMINAL	2.8614563105341744
CELL-SURFACE RECEPTOR BINDING AFFINITY	2.861341032816057
MITOCHONDRIA AFFINITY UPTAKE COMPONENT	2.860160630026163
CHRONIC OBSTRUCTIVE PULMONARY DISEASE	2.8598899726030518
Α-KETOGLUTARATE DEHYDROGENASE COMPLEX	2.8598899726030518
thiamine transporter-specific peptide	2.8598899726030518
STANDARD BIMOLECULAR-BINDING ISOTHERM	2.8598899726030518
MTSV1-7 HUMAN MAMMARY EPITHELIAL CELL	2.8598899726030518
CYCLE-DEPENDENT SUBSTRATE DEGRADATION	2.8598899726030518
KEY WORD	2.858806161890018
DISULFIDE-LINKED CELL SURFACE HETERODIMER	2.8587499969979615
CELL SURFACE DISULFIDE-LINKED HETERODIMER	2.8587499969979615
INSERTION MUTATION DELETERIOUS EFFECT	2.8587409721206902
CALMODULIN TEMPERATURE-DEPENDENT LOSS	2.85867493761021
IDO RESULT PHARMACOLOGICAL INHIBITION	2.858581704727096
CONSENSUS HEAT-SHOCK RESPONSE ELEMENT	2.8585484999586703
SURROUNDING EXTRACELLULAR ENVIRONMENT	2.8583169362283902
MEASURING INTERACTION ALEXA-CALMODULIN	2.858243433962429
RECIPROCAL EXPERIMENT	2.8575919619105488
BIOLOGICAL PHENOMENON	2.8575919619105488
TRYPAN BLUE EXCLUSION	2.8575919619105488
TRANSACTIVATE LTR-DEPENDENT TRANSCRIPTION	2.856833677555145
EXPRESSING GST-CDC6 BACULOVIRUS AMPLIFICATION	2.856821370647619
CYCLIN-DEPENDENT KINAS CATALYTIC SUBUNIT	2.8566379250416185
CD39 SCD39 TRANSFECTED STABLE HIGHFIVE	2.8561586792142215
TWO-FOLD INCREASE	2.855535118462029
CONVENTIONAL AGAROSE GEL ELECTROPHORESI	2.8554485016566713
CELL MAPK SIGNAL TRANSDUCTION PATHWAY	2.855218207292286
APICAL SODIUM/BILE ACID COTRANSPORTER	2.8548801126799597
UNCONJUGATED BILIRUBIN AQUEOUS SYSTEM	2.854496705032784
LIGAND-MODULATED TRANSCRIPTION FACTOR	2.8540110794709848
RECEPTOR PROTEIN EXTRACELLULAR DOMAIN	2.853938044693735
LAI STRAIN PROVIRAL SEQUENCE SINGLE COPY	2.8538694184431415
ATP-DEPENDENT ACTIVATION	2.853843889734068
SECOND-LINE ANTI-HYPERTENSIVE THERAPY	2.8535978271044065
METALLO-Β-LACTAMAS STRUCTURAL PROPERTY	2.85323253399446
FUNCTIONAL RIBOSOME CRITICAL COMPONENT	2.8531960624477573
INFLAMMATORY RESPONSE	2.8523806168046666
CELLULAR LOCALIZATION	2.852327167111273
SIGNALOSOME-MEDIATED CULLIN DENEDDYLATION	2.8521616558307383
E. COLI DNA TOPOISOMERASE I ZD DOMAIN	2.8520290730298403
FUNCTIONAL ACTIVITY	2.8519924824258682
UNCONJUGATED BILIRUBIN COLLOIDAL SPECIES	2.851953728379335
POP1 MUTANT POLYPLOIDIZATION PHENOTYPE	2.851838688988028
ASSOCIATED T-TEST SIGNIFICANCE RESULT	2.8516315316360794
INCLUDING PROSTAGLANDIN LIPID MEDIATOR	2.8516173894526564
ENZYME CONFORMATIONAL CHANGE POSITION	2.851225378801638
CONTINUOUS EXTRACELLULAR SOLUTION FLOW	2.851090379501143
CONFORMATIONAL CHANGE	2.8502274870897284
GRADIENT ULTRA-CENTRIFUGATION ANALYSIS	2.850195406647446
losses	2.849979916201224
accumulation	2.849878734161095
REVEALED COOPERATION HUMAN SKP1-SKP2 COMPLEX	2.849860884728879
ATOMIC EMISSION SPECTROSCOPY DETECTION	2.849731265510982
IMIDAZOLE	2.8495470461142594
ENZYME DNA CLEAVAGE-RELIGATION ACTION	2.849333047478837
BINDING PROTEIN NICOTINIC ACETYLCHOLINE	2.8491599860372383
NICOTINIC ACETYLCHOLINE         RECEPTOR	2.849049840970571
DEUBIQUITYLATING ENZYME CATALYTIC CENTER	2.848810654738409
INTRACELLULAR CALCIUM RELEASE CHANNEL	2.848279014382807
MITOCHONDRIAL PROTEIN	2.8479803997257966
SHOWING BENEFIT DOXAZOSIN PROBABILITY	2.8476339674578637
CATALYTIC ACTIVITY DRASTIC REDUCTION	2.847561840923363
STOICHIOMETRIC TITRATION IMPRACTICAL	2.847561840923363
RESIDUAL PRIMER EXTENSION CAPABILITY	2.847561840923363
ENCODING P110 PITSLREAND P58 PITSLRE	2.847561840923363
REFINED STRUCTURE/FUNCTION RELATIONSHIP	2.847547446207424
CALMODULIN INTERMEDIATE CONCENTRATION	2.8467305258161706
POSSESSING POLYUBIQUITYLATION ACTIVITY	2.846563451168787
PDB	2.846555745276785
INDIVIDUAL MUTATION RESULTING EFFECT	2.8464209871160935
FORMED AGGREGATE ANTISENSE TRANSFECTANT	2.8461499795351908
DIRECTIONAL EXTRACELLULAR PROTEOLYSI	2.8459999577348385
BINDING DOMAIN PROPOSED ACETYLCHOLINE	2.8459810193955195
MECHANOELECTRICAL TRANSDUCTION ADAPTATION	2.8459379829938043
FILTER HYBRIDIZATION GENE EXPRESSION	2.845858313547047
ESTIMATED INTRACELLULAR CONCENTRATION	2.8456120498956077
similarities	2.8454141285647587
ASSAY CONDITION	2.8447996878344624
BECKMAN PHENOMENIX C18(2) HPLC COLUMN	2.844788823406302
GENE TRANSCRIPTION PHYSICAL OBSTACLE	2.844531859680036
CELLULAR GENE TRANSCRIPTION ACTIVITY	2.844531859680036
TH PROMOTER TRANSCRIPTIONAL ACTIVITY	2.844483639323521
TREATMENT EFFECT RELATIVE COMPARISON	2.8442789758861164
Q SEPHAROSE ANION-EXCHANGE CHROMATOGRAPHY	2.8439485966802267
INOSITOL	2.8433877634076112
EXTRACELLULAR NEURONAL DIFFERENTIATION	2.8429366675778405
ELECTROPHORETIC MOBILITY SHIFT ASSAY	2.8428928662672748
P53 RESPONSIVE ELEMENT TRANSCRIPTION	2.8427883621672634
PROTEASE INHIBITOR	2.842733312220657
SCREENING METHOD MONOCLONAL ANTIBODY	2.8426264858950465
LAEMMLI ELECTROPHORESIS SAMPLE BUFFER	2.8423544851478098
PROMEGA	2.8423044680511578
HIV-1RT PURPORTED DNTP-BINDING POCKET	2.842271965206844
DIFFERENTIAL SUBCELLULAR LOCALIZATION	2.8421258169687893
MONOCYTE/MACROPHAGE CELL HIV-1 INFECTION	2.8420799975781876
SEDIMENTATION COEFFICIENT MEASUREMENT	2.841977198030331
COLI BL21-CODONPLUS (DE3)-RIL STRAIN	2.841327600792145
PLASMA MEMBRANE THIAMINE TRANSPORTER	2.8412742556734156
ESCHERICHIA COLI DNA TOPOISOMERASE I	2.8401332296586426
LIQUID SCINTILLATION SOLUTION BIOSAFE II	2.840102797279003
HYPOTONIC LYSIS BUFFER	2.839171589886526
SHOW DOWN-REGULATION EXPRESSING CELL	2.8388152950676244
NACHR BINDING SITE COMPLEMENTARY FACE	2.838748363727603
RESTRICTION DIGESTION	2.8385802029131635
QUATERNARY STRUCTURE DEPENDENT MANNER	2.8381804660393466
P66 SUBUNIT ENDOPROTEOLYTIC CLEAVAGE	2.8381735108078776
CARDIOLOGY/AMERICAN HEART ASSOCIATION	2.838036434016963
NICKEL AFFINITY COLUMN CHROMATOGRAPHY	2.8377865973507714
MITOCHONDRIA FORM NORMAL LYMPHOBLAST	2.8377017163056206
NON-STEROIDAL ANTI-INFLAMMATORY DRUG PG	2.837478255931931
HUMAN C-MYC REPLICATION ORIGIN REGION	2.8370518148672272
AMINOPEPTIDASE         N H. VIRESCEN	2.8360819994877056
NUCLEAR RECEPTOR           COACTIVATOR	2.835897181309344
INCLUDING IFN-Γ INFLAMMATORY MEDIATOR	2.835865417062769
PHYSICAL ACTIVITY MARKED LIMITATION	2.834904920602746
HUMAN NEDD8-PROCESSING ISOPEPTIDASE	2.834904920602746
GLAXO SMITHKLINE/SMITHKLINE BEECHAM	2.834904920602746
SINGLE-CELL FLUORESCENCE MICROSCOPY	2.834904920602746
STOICHIOMETRIC-TITRATION EXPERIMENT	2.834904920602746
HUMAN IMMUNODEFICIENCY VIRUS TYPE-1	2.834904920602746
FLUORESCENCE-ACTIVATED CELL SORTING	2.834904920602746
GLAXO-SMITHKLINE/SMITHKLINE BEECHAM	2.834904920602746
INCLUDING HERPES SIMPLEX VIRUS TYPE	2.834904920602746
P-TEFB-MEDIATED TAT TRANSACTIVATION	2.834904920602746
INCIDENCE	2.834478226763724
LIPID-LOWERING THERAPY IN-HOSPITAL INITIATION	2.83437740869091
MHC-I MOLECULE SELECTIVE INTERNALIZATION	2.8341810861469194
ANALYTICAL ULTRACENTRIFUGATION EXPERIMENT	2.833879616872244
POPULATION-BASED LONGITUDINAL STUDY	2.833836314784155
MICROARRAY GENE EXPRESSION ANALYSIS	2.8336411837573463
EXTRACELLULAR DIFFERENTIATION SIGNAL	2.8330035217381835
RAT HEPATOMA-HUMAN FIBROBLAST HYBRID	2.8329708103426077
HELICOBACTER PYLORI TOPOISOMERASE I	2.8329610947200488
COLLECTED PEAK JUDGE PROTEIN PURITY	2.832954042806372
CHARACTERISTIC C-TERMINAL EXTENSION	2.8328376772036865
UBIQUITIN CONJUGATING	2.8327540187042874
ACTIN/HEAT SHOCK PROTEIN/SUGAR KINASE	2.8324445795783237
ENHANCED CELL CYCLE GENE EXPRESSION	2.832240510113818
UNCONJUGATED BILIRUBIN SEDIMENTATION	2.832091759817974
MAX	2.8310423630429
PCDNA-3 MAMMALIAN EXPRESSION VECTOR	2.83095726392453
IDO EXPRESSION ANTISENSE INHIBITION	2.830662554428941
DIRECTED MUTAGENESIS STUDY GUIDE SITE	2.8305404449877227
BPH	2.8304048290175627
MSR	2.8304048290175627
TFA	2.8304048290175627
D62	2.8304048290175627
TS2	2.8304048290175627
ASN	2.8304048290175627
DE3	2.8304048290175627
Y93	2.8304048290175627
NEF	2.8304048290175627
PRECIPITATED SCD39 AMMONIUM SULFATE	2.8301690539067197
PERKIN-ELMER GP-100 GRAPHICS INTEGRATOR	2.830049717438133
EXTENSIVE TRANSLOCATION STUDIES SHOW	2.829726227136415
M. SEXTA CADHERIN-LIKE RECEPTOR BT-R	2.829440278868933
P2	2.8292946812965987
ASYNCHRONOUS POPULATION SINGLE CELL	2.829153158211673
METALLO-Β-LACTAMAS BINDING INHIBITOR	2.8291480601744383
BINDING SITE STRUCTURAL PERTURBATION	2.828819242661065
BINDING CONDITION NON-LABELED TOXIN	2.8287031904055686
ENZYME PROTEIN VARYING CONCENTRATION	2.82868267627283
INCREASED UBIQUITIN LIGASE ACTIVITY	2.8286031624991623
LERISETRON DISTAL PIPERAZINE NITROGEN	2.8284737119577907
N-BENZYL GROUP POTENTIAL INTERACTION	2.8282505331253556
CARBOXYL GROUP PROBABLE COMBINATION	2.828226134236555
T CELL RECEPTOR SIGNAL TRANSDUCTION	2.8281514845738878
SUCROSE DENSITY GRADIENT LOCALIZATION	2.828075748378404
ARTHROPOD MUSCLE EXTRAJUNCTIONAL CHANNEL	2.82765812152259
LDH ACTIVITY TIME DEPENDENT INCREASE	2.827641961922431
BINDING DOMAIN NUCLEOTIDE PHOSPHATE	2.827036336492335
SUPEROSE-12HR GEL FILTRATION COLUMN	2.82697174288859
U G	2.8267541934000926
COLI BL21-CODONPLUS(DE3)-RIL STRAIN	2.8266535405673525
UNKNOWN STOICHIOMETRY HETEROMERIC RECEPTOR	2.8265732713570944
HETERODIMERIC ENZYME RNASE H ACTIVITY	2.8261676597457632
COMPLEX FORMATION COMPLEX-FORMATION ASSAY	2.8259669532781833
ORDERED CHROMATIN STRUCTURE PRESENT	2.8257655287332213
ELEVATED PLASMA NOREPINEPHRINE LEVEL	2.825695476284015
ELECTRICAL CONDUCTIVITY MEASUREMENT	2.825518518142153
SEPHAROSE ANION-EXCHANGE CHROMATOGRAPHY	2.825446512611853
S. CEREVISIAE DNA TOPOISOMERASE III	2.8253718981736853
HIV-1 RT RESULTING MUTANT DERIVATIVE	2.8252485720323404
CLINICAL HEART FAILURE RISK REDUCTION	2.8251728146322317
crosslinking	2.824760911736097
LEUKOTRIENE B4 RECEPTOR DOWN-REGULATION	2.824743929220999
BINDING TRANSCRIPTION FACTOR ZN(II)	2.8247057901534376
SODIUM-INDEPENDENT TRANSPORT SYSTEM	2.8245891713638764
TOTAL CELL LYSATE SIZE FRACTIONATION	2.824522643998814
RECEPTOR SUBUNIT COMPLEMENTARY FACE	2.8242375967404483
NEW YORK HEART ASSOCIATION CLASS IV	2.824135164071075
OVEREXPRESSING PROTΑ SHOW HL-60 CELL	2.8239461671128674
PROTEIN LYSATE IMMUNOLOGICAL TECHNIQUE	2.823679398549269
FORMED AGGREGATE ANTISENSE CLONE D3	2.8233169352681067
STRUCTURE-ACTIVITY RELATIONSHIP STUDY	2.8232138533987636
MAINTAINING DIASTOLIC BLOOD PRESSURE	2.8225717099069656
E-TP-DNTP TERNARY COMPLEX FORMATION	2.82249464137365
MAPK PATHWAY MEMBER DOWN-REGULATION	2.8221526128848
SUBSTRATE-SPECIFIC POLYUBIQUITYLATION	2.8221370996111785
LIGAND-DEPENDENT TRANSCRIPTION FACTOR	2.8219783387506077
MM PHENYL METHYL SULFONYL FLUORIDE	2.8219011925325357
VIRUS TYPE-1 REVERSE TRANSCRIPTASE	2.8219011925325357
TERMINAL DISEASE PROGRESSION STAGE	2.8219011925325357
BARNSTEAD NANOPURE ULTRAPURE WATER	2.8219011925325357
Α-SPECIFIC INHIBITOR PYRROLIDINE-1	2.8219011925325357
BACKGROUND WHOLE-GENOME EXPRESSION	2.82162188810242
LYSATE SIZE EXCLUSION CHROMATOGRAPHY	2.8214516752520367
HUMAN ALDO KETO REDUCTASE GENE FAMILY	2.820738845055924
OTHER SEQUENCED VERTEBRATE CALMODULIN	2.820439305179216
SIGNAL TRANSDUCTION PATHWAY RESULT	2.8202280776453375
DIRECTED MUTAGENESIS	2.8200775154501105
IDO ANTISENSE TRANSFECTED P19 CLONE	2.8199313003787907
CONTROLLING INTRACELLULAR PATHOGEN	2.81961866493808
IMMORTALIZED MOUSE LUNG FIBROBLAST	2.819276865120636
SURGICAL CORONARY REVASCULARIZATION	2.819118698282658
CODON USAGE TABULATED FROM GENBANK	2.818208388960077
POTENTIAL APPLICATION	2.8181060009159795
NON-HYDROLYSABLE NUCLEOTIDE ANALOG	2.818085749727043
GENE EXPRESSION GENERAL SUPPRESSION	2.817939595257772
EXPRESSED IDO ANTISENSE TRANSCRIPT	2.817900494967584
INTRINSIC RECEPTOR TYROSINE KINASE	2.817498091059492
RECEPTOR PURITY CANDIDATE RECEPTOR	2.81740560557476
PLASMID DNA	2.817123497031797
ARACHIDONIC ACID CONTROLLING LEVEL	2.817000789687567
MAXIMAL RELAXATION ACTIVITY EXHIBIT	2.8165981670067723
overexpressed	2.8159440220694103
BILE ACID TRANSPORTER TRANSLOCATION	2.81592606668368
CYTOSINE CLEAVAGE SEQUENCE PREFERENCE	2.8158449541125328
ADHERENCE	2.815642202575555
PREFERENTIAL CELLULAR ACCUMULATION	2.8155577262730973
PRE-TRIAL ANTIHYPERTENSIVE TREATMENT	2.8155506730975963
CALCIUM PHOSPHATE CO-PRECIPITATION	2.815304796996405
PHOSPHOINOSITOL PHOSPHATE STANDARD	2.815304796996405
PROTEIN KINASE PATHWAY ESTABLISHMENT	2.8149389193212677
REGULATORY PROTEIN PHOSPHORYLATION	2.814876476333013
SPECIFIC CD98-INTEGRIN INTERACTION	2.814675581070003
CODON USAGE COMPARISON CODON USAGE	2.814515585387618
CALCULATED CALMODULIN STOICHIOMETRY	2.814413073391843
DIOXYGENASE IFN-Γ INTERFERON GAMMA LP	2.814243317076514
CARRYING INSERTION HIV-1 RT MUTANT	2.8141814387374837
Β-LACTAM CARBONYL MODELED POSITION	2.8140679728333806
NOVEL LEPIDOPTERAN-SELECTIVE TOXIN	2.813694962371516
FUNCTIONAL CAPACITY CLASSIFICATION	2.813494810416369
INTEIN MULTIPLE SEQUENCE ALIGNMENT	2.8130799991776314
C4	2.812628014629932
CORRECTED FLUORESCENCE MEASUREMENT	2.812586012349757
BIGDYE TERMINATOR CYCLE SEQUENCING	2.8125006424714933
TRANSMEMBRANE DOMAIN	2.8124105167095657
DORSAL ROOT GANGLION	2.8124105167095657
UNDERLYING PRINCIPLE	2.8124105167095657
IMMOBILON-P MEMBRANE	2.8124105167095657
TRIS-BUFFERED SALINE	2.8124105167095657
EXTRACT BILE ACID SINUSOIDAL MEMBRANE	2.8119599825047303
CIRCULAR DICHROISM CIRCULAR DICHROISM	2.811840861522486
CONTAINING YEAST AR BP DNA FRAGMENT	2.811723751196631
HEART FAILURE CLINICAL PRESENTATION	2.811667510696587
DENATURING POLYACRYLAMIDE-UREA GEL	2.811403882884937
RELAXATION ACTIVITY PARTIAL RESTORATION	2.8108324113346117
9E10 MONOCLONAL ANTIBODY	2.8107891266667435
COATED COVERSLIP	2.8107807247063716
IMMUNOLOGICAL TECHNIQUE	2.8106002808338086
YEARS OF UNHEALTHY LIFE MEAN VALUE	2.8105550785751507
CHARACTERISTIC APN ENZYME ACTIVITY	2.8101770456713413
CONVENTIONAL LAST-OBSERVATION-CARRIED-FORWARD	2.809580137031635
AA RELEASE INVESTIGATING MECHANISM	2.80947628049649
TRANSFECTED CHO CELL FLOW CYTOMETRY	2.8092914867640273
DOSE-DEPENDENTLY CATALYZES RELEASE	2.809040682578699
LEIURUS QUINQUESTRIATUS HAEBRAEUS	2.808531114475628
INCLUDING TUMOR NECROSIS FACTOR-Α	2.808531114475628
TREATING NON-CARDIOVASCULAR DEATH	2.808531114475628
STANDARD TISSUE CULTURE SUBSTRATE	2.808531114475628
HEPARAN SULFATE Y-79 CELL CULTURE	2.808531114475628
CELLULAR GENE BIOLOGICAL FUNCTION	2.808531114475628
RE-IMMUNOPRECIPITATION EXPERIMENT	2.808531114475628
PUTATIVE TETRAHEDRAL INTERMEDIATE	2.808531114475628
ISOLATED MITOCHONDRIAL SUSPENSION	2.808531114475628
TE102 RECTANGULAR STANDARD CAVITY	2.808531114475628
REVEALED CO-ELUTION IMMUNOPRECIPITATION	2.8083393759815105
lysis buffer	2.807820432108646
TIME-FROM-EVENT-TO-DEATH ANALYSIS	2.8077666907771266
HAMSTER OVARY CELL LINE DERIVATIVE	2.8076393304595912
BINDING PROPERTY SINGLE-STRAND DNA	2.807240965081251
EXTRACELLULAR HEPARIN/HS-LIKE GAG	2.8070045421491563
MAMMALIAN EXPRESSION VECTOR PCDNA3	2.8067445225452534
HYPERTHERMOPHILIC TOPOISOMERASE I	2.8059792323776453
STRAND DISPLACEMENT DNA SYNTHESIS	2.8056435958888115
ATLAS HUMAN CDNA EXPRESSION ARRAY	2.805447721441715
CONTAINING ETHANOLAMINE BLANK FLOWCELL	2.8053818647202533
MITOCHONDRIAL TRANSPORTER AFFINITY	2.8049474333076976
MC57 MURINE FIBROSARCOMA CELL LINE	2.8047536028750235
EMBRYONIC CARCINOMA CELL LINE P19	2.8045081474035145
OPEN-LABEL BETA-BLOCKER USE POST-EVENT	2.8041242350299838
INDUCED GENOMIC DNA FRAGMENTATION	2.80411702356234
BASELINE CHARACTERISTIC COMPARABILITY	2.804099615848395
PLASMA MEMBRANE FOLATE TRANSPORTER	2.8035961949197734
HARBOR TRANSCRIPTIONAL ACTIVATION	2.8033913870928786
POST-DIAGNOSIS PHARMACOLOGIC MANAGEMENT	2.8032619574150424
REMODELLING FACTORS BIND CHROMATIN	2.8032572134825
NON-STRINGENT DETERGENT CONDITION	2.8031881113329775
OTHER MULTIDRUG RESISTANCE PROTEIN	2.802803921485852
CAK TRIMERIC ENZYME HUMAN HOMOLOG	2.802645051997167
S-PHASE GENE OBSERVED UP-REGULATION	2.8022181543870346
REDUCED TAT-DEPENDENT TRANSLATION	2.8021986663065603
BINDING TETRACYSTEINE MOTIF ZN(II)	2.802073311511458
protein expression	2.8017962831966012
MONOCYTE HOMOTYPIC CELL AGGREGATION	2.801503131376066
CASPASE GCDCA-MEDIATED ACTIVATION	2.8014936608181107
ACID/FUNCTIONAL GROUP INTERACTION	2.801362305227627
HTTP RIBOSOMAL DATABASE PROJECT II	2.8013284564923135
MDCK CELL SIDE-BY-SIDE COMPARISON	2.8012035673085642
ALDO KETO REDUCTASE SUPERGENE FAMILY	2.8009135963594205
EXPRESSING F-BOX-DELETED MUTANT STRAIN	2.8009076077965083
INFLAMMATION	2.8006878348513204
VELOCITY SEDIMENTATION EXPERIMENT	2.8003893954011123
CADHERIN-LIKE RECEPTOR PURIFICATION	2.800354045687304
IQ PEPTIDE-BOUND ALEXA-CALMODULIN	2.7994232966783947
P35-DNA PROTEIN COMPLEX FORMATION	2.7989394621039385
DIAGNOSTIC CRITERION HEART FAILURE	2.7988401037750767
PURIFIED PROTEIN	2.7984461560464196
BLOCKED MONOCYTE CELL-CELL FUSION	2.7982725484417386
ALEXA-CALMODULIN BOUND IQ PEPTIDE	2.7981216815809975
ACID (RA)-DEPENDENT TRANSCRIPTION	2.798099968557167
ZN(II) COORDINATION NUMEROUS EXAMPLE	2.7979325638767527
SURFACE PLASMON RESONANCE TECHNIQUE	2.797694539419682
DNA DEPENDENT POLYMERASE ACTIVITY	2.7976826375241743
BLINDED QUALITY CONTROL EVALUATION	2.7976650768821587
Β-LACTAM ANTIBIOTIC EXTENSIVE USE	2.7971473024021694
PARTICIPANT ANTIHYPERTENSIVE TREATMENT	2.7970798045884773
CALMODULIN-IQ PEPTIDE INTERACTION	2.7965908791653526
REGULATING AA RELEASE INDEPENDENT	2.796203877566825
SCD39 TRANSFECTED STABLE HIGHFIVE	2.796135542452038
MM DITHIOTHREITOL	2.795631951936707
LIGAND INFLUENCE INTEGRIN AFFINITY	2.795548740740795
INTRINSIC AFFINITY	2.7954243502044993
OPEN-LABEL LIPID-LOWERING COMPONENT	2.7952244875641883
CONTAINING P35 PROTEIN PREPARATION	2.795156890370378
CELLULAR RNA NORTHERN BLOTS TOTAL	2.7947986674118814
TRYPTOPHAN-REVERSIBLE INHIBITION	2.7947734444133494
AHA MEDICAL/SCIENTIFIC STATEMENT	2.7947734444133494
MTSV1-7 HUMAN MAMMARY EPITHELIAL	2.7947734444133494
OBSERVED T701-CALMODULIN COMPLEX	2.7947734444133494
ORDINARY PHYSICAL ACTIVITY CAUSE	2.7947734444133494
PET-28A-RT66 EXPRESSION CASSETTE	2.7944985949891863
EXPRESSING IDO BLOTTING RAW CELL	2.7937660260289436
glutamine	2.793749381127797
MUTANT ENZYME POLYMERASE ACTIVITY	2.7936840800243465
COMPARING OVERWEIGHT EFFECT SIZE	2.793667474230469
PROTEIN EXPRESSION CONFIRMATORY TEST	2.793564902371664
INTEGRATED TAT EXPRESSION VECTOR	2.793130170949394
HIV-RNA EXPRESSION CLONE PHIV-PB	2.792882717000442
INSERTION MUTANT RNASE H ACTIVITY	2.7925194337065165
SCD39 BOUND VO EPR CHARACTERISTIC	2.7920345113181004
QIAGEN QIAQUICK GEL EXTRACTION KIT	2.791741614429627
S. POMBE CSN COMPLEX GENERAL ROLE	2.7914782653340313
INITIATOR	2.7914244571907663
EPR MEASUREMENT CW-EPR EXPERIMENT	2.791341084905326
QIAGEN SUPERFECT TRANSFECTION REAGENT	2.7912220280427045
PREVENTED STABLE DIMERIZATION P51	2.7912068315585477
PUTATIVE INTERACTION	2.7911928976916887
DOXAZOSIN BASELINE CHARACTERISTIC	2.791185712969051
SILVER STAIN ANTI-GST POLYCLONAL	2.7908600114585416
MOLECULAR WEIGHT SPECIES REACTIVE	2.790569529442887
AFFINITY THDP TRANSPORT MECHANISM	2.7904217416320125
INFECTED T HOMOGENOUS POPULATION	2.7903877005846853
IN VITRO UBIQUITYLATION ACTIVITY	2.790310757710498
MITOGEN-ACTIVATED PROTEIN KINASE	2.790291130303483
GENUS THERMOPLASMA LACK CELL WALL	2.790244900511475
REDUCED GLUTATHIONE ELUTION BUFFER	2.789848039867363
PRODUCTION PROSTAGLANDIN SYNTHESIS	2.789747221524264
HIV-1 TAT PROTEIN IN VIVO EFFECT	2.7893368713831284
MAPK SIGNAL TRANSDUCTION PATHWAY	2.7891524359646582
INTEGRATED WILD-TYPE SINGLE-COPY	2.7887169410309087
P51 RESIDUAL POLYMERASE ACTIVITY	2.7885334106253796
cell receptor signal transduction	2.7884162791150597
NATIONAL AMBULATORY MEDICAL CARE SURVEY	2.7883798685133256
PLUTELLA XYLOSTELLA APN RECEPTOR	2.78832195167988
TRITON X-100 DETERGENT CONDITION	2.7880927668126385
CRITICAL DISULFIDE LOOP STRUCTURE	2.7880139824078483
PHYTOHEMAGGLUTININ-ACTIVATED PBMC	2.7880139824078483
CARRYING INSERTION P51 INSMUTANT	2.7877075238005014
EUKARYTOTIC TYPE IA TOPOISOMERAS	2.7877075238005014
TREATED IDO TRANSFECTED RAW CELL	2.787630392451556
IDO TRANSCRIPTION TRANSIENT BURST	2.787202400108069
ΜM PARTICLE SIZE PROTEIN C4 COLUMN	2.7869311766307963
UBIQUITIN LIGAS CULLIN/RING FAMILY	2.7869254454349646
PHYSIOLOGIC STUDY CELLULAR EFFECT	2.7868989208824257
POP2 DISRUPTANT POLYPLOIDY PHENOTYPE	2.7865919429616692
MULTIPLE CULLIN NEDDYLATION STATE	2.7865758335901734
CALMODULIN MEASURING INTERACTION	2.7864935523605756
SURFACE DISULFIDE-LINKED HETERODIMER	2.7863360199331884
SURVIVAL ANALYSIS SURVIVAL ANALYSIS	2.7860412871766584
REPLICATION BIOCHEMICAL ANALYSIS	2.785893559194311
CULLIN/RING ENZYME STUDIED EXAMPLE	2.7857635109423082
SYSTEMIC TRYPTOPHAN CONCENTRATION	2.7857279668593127
IN VITRO POLYUBIQUITYLATION ASSAY	2.785648827503746
mammalian	2.7856204798299977
F-BOX PROTEIN HETEROOLIGOMERIZATION	2.7855149817457314
FINAL DMSO/AQUEOUS BUFFER SYSTEM	2.7854652937231226
synthesis	2.7850623955963743
Y152 FUNCTIONAL GROUP INTERACTION	2.7848356396219667
CARDIAC BETA RECEPTOR STIMULATION	2.784828640766993
MITOCHONDRIAL TRANSPORT CAPACITY	2.784699260569289
IN VITRO ASSAY SUBSTRATE-INDEPENDENT	2.7845825605623458
COLLAGENASE I REDUCED EXPRESSION	2.7843923816627263
VOLTAGE DEPENDENT SODIUM CHANNEL	2.78435115144547
RAW CELL MACROSCOPIC FOCI GROWTH	2.7839516851505466
T-TAILED CLONING VECTOR PGEM T-EASY	2.783562536522159
PYROCOCCUS FURIOSUS A-ATPASE SEQUENCE	2.783241515137942
ALTERED BIOPHYSICAL/ENZYMATIC PROPERTY	2.7832071643248892
NON-CONJUGATED BILE ACID ADDITION	2.783173418420009
EXTRACELLULAR MATRIX MODIFICATION	2.7825793849256093
MAPK PATHWAY TAT DOWN-REGULATION	2.782319759333205
BACKGROUND PHYSIOLOGIC LITERATURE	2.7822270990041154
CLEAVED DNA GATE STRAND HYDROXYL	2.781771815517755
mitogen-activated protein kinase	2.781728667897323
THERMOPLASMA ACIDOPHILUM A-ATPASE	2.7811166682569377
MEET ALLHAT DIAGNOSTIC CRITERION	2.7810235448424026
truncation	2.780842699605031
structure/function relationship	2.780605037515223
BINDING SITE STRUCTURAL FEATURE	2.780605037515223
REMODELLING ACTIVITIES INCREASE	2.780605037515223
MEMBRANE-PHOSPHOLIPID SUBSTRATE	2.780605037515223
MODERATE ESSENTIAL HYPERTENSION	2.780605037515223
NON-ATTACHED SUSPENSION CULTURE	2.780605037515223
BINDING SITE COMPLEMENTARY FACE	2.780605037515223
CASPASE-DEPENDENT DEATH PATHWAY	2.780605037515223
GENOME-WIDE FUNCTIONAL ANALYSIS	2.7801038557845366
THDP SUBMICROMOLAR CONCENTRATION	2.7799182919653282
PHARMACOLOGIC TREATMENT LINE AGENT	2.779876156919071
PERFORMED MICROARRAY EXPERIMENT	2.779747147358869
SIGNALING CASCADE	2.7796076310069635
ENTROPY DECONVOLUTION ALGORITHM	2.779506040975057
CONCENTRATION DEPENDENT DECREASE	2.7793553799586275
IDO EXPRESSION VARYING CAPACITY	2.779152033127295
ARCHAEAL ATPASE CATALYTIC SUBUNIT	2.7790794766593865
MITOGEN ACTIVATED         PROTEIN	2.7790256740666814
TRANSFECTED P19 CELL	2.7788373820354018
COVALENT CROSSLINKING EXPERIMENT	2.7786227687268403
INVADING PATHOGEN PROLIFERATION	2.778503206632157
PEDF LIGAND-RECEPTOR INTERACTION	2.778496484334255
RECIPROCAL CO-IMMUNOPRECIPITATION	2.7783588614347754
BL21-CODONPLUS (DE3)-RIL STRAIN	2.7782199811940127
CONTAMINATING TOPOISOMERASE III	2.7780953886996214
NON-Q WAVE MYOCARDIAL INFARCTION	2.778088754450109
TRITC-LABELED ANTI MOUSE ANTIBODY	2.7780609222589803
CONTAINING INSERTION HETERODIMER	2.777815234942515
HIV-1RT INSERTION MUTANTS RESULT	2.777815234942515
CATALYTIC SUBUNIT WHOLE A-ATPASE	2.7777963715281984
CONCENTRATED CANDIDATE RECEPTOR	2.777680751069218
THDP INTRACELLULAR CONCENTRATION	2.7776721715056154
NONSYNAPTIC INFORMATION TRANSFER	2.7771669075939296
HIV-1 GAG IRE POSSIBLE FUNCTION	2.7769027299046845
AGONIST BINDING SITE INTERACTION	2.7767220170363762
F-BOX PROTEIN COMPARTMENTALIZATION	2.7767155894297253
UBIQUITYLATION ASSAY	2.7766461712161243
BINDING MOTIF T. MARITIMA ZN(II)	2.7762570274305878
SCD39 NUCLEOTIDASE ACTIVITY COFACTOR	2.776133853909375
molecular weight	2.776124797224605
PERFORMING CELL MIGRATION ASSAY	2.776117142391238
PRESCRIBED OPEN-LABEL ACE-INHIBITOR	2.775887148268823
SOLUTION CAPILLARY ELECTROPHORESI	2.7758481829714587
OPEN-LABEL DIURETIC POST-EVENT USE	2.7758446069225124
NEUROPEPTIDE Y-LIKE RECEPTOR MRNA	2.7753069472206597
INCREASED COX PROTEIN EXPRESSION	2.7752276056140066
TOTAL CELL FLUORESCENCE FRACTION	2.7752113413596873
ADDED OPEN-LABEL DRUG TOTAL DOSE	2.7750946665782097
EXTRACELLULAR STIMULATION ABSENCE	2.775040513460635
HEAT-SHOCK TRANSCRIPTION FACTOR	2.7749942149674323
EXTRACELLULAR SOLUTION FLOW RATE	2.774874918828789
WILD-TYPE L1 MULTIPLE PREPARATION	2.774871425199902
VENTRICULAR SYSTOLIC DYSFUNCTION	2.774822609741779
POLAR FIBROBLAST-LIKE PHENOTYPE	2.774527454238887
SCD39 BOUND VO EQUATORIAL LIGAND	2.774402117251641
PULSING IDO-EXPRESSING RAW CELL	2.774137865567327
POP2 DELETION STRAIN CELL LYSATE	2.7741007943042413
SECONDARY ENDPOINT	2.7738707323173806
H. TAURINE-CONJUGATED BILE ACID	2.7738684297692116
CASPASE TCA-MEDIATED ACTIVATION	2.773684052705462
BINDING PROTEIN MAJOR BILE ACID	2.7733266862298303
FIRST-LINE BLOOD PRESSURE AGENT	2.7731868108691073
PRESENTED HEART PROTECTION STUDY	2.772977324347658
INCUBATING RECEPTOR-BOUND TOXIN	2.7725980627225906
CELL CULTURE NORMAL LYMPHOBLAST	2.77246891796787
PURIFIED RABBIT ANTISERA AFFINITY	2.7720827209443653
CHRONIC CONGESTIVE HEART FAILURE	2.7720801883023576
SECONDARY PREVENTION STATIN TRIAL	2.772020593000846
M. SEXTA APN-1 HOMOLOGOUS REGION	2.771804049721084
SUSTAINED INCREASE SUPRAPHYSIOLOGICAL	2.771799935622014
QUATTRO-BD MASS SPECTROMETER VG/FISON	2.771799935622014
BACTERIAL TYPE IA TOPOISOMERASE	2.771716697959968
MURINE MACROPHAGE CELL LINE RAW	2.7716250981436574
PURIFIED CSN ENZYMATIC ACTIVITY	2.77113525002009
MEDIATED CYTOTOXICITY BILE ACID	2.7710022967468486
GEL ELECTROPHORESI DENATURING SD	2.770804581079044
PRELIMINARY ANALYSIS HYBRID TOXIN	2.7706571403147087
NON-PHARMACOLOGIC LIPID-LOWERING	2.770547430883586
AFFINITY-PURIFIED RABBIT ANTISERA	2.770536425461221
REGULATED KINASE EXTRACELLULAR-SIGNAL	2.7704420930481253
EXTRACELLULAR-SIGNAL REGULATED KINASE	2.7704420930481253
DEMONSTRATED SATURABLE UPTAKE COWORKER	2.770305520458496
MADIN DARBY CANINE KIDNEY SUBCLONE	2.7702019425181126
JUN N-TERMINAL           KINASE	2.7701136008457756
REDUCED AFFINITY	2.7699284420709867
COMPARING ATENOLOL CONTROLLED TRIAL	2.769786753532384
LERISETRON BENZIMIDAZOLE PORTION	2.769697395321138
COX-2 INHIBITOR FLUFENAMIC ACID	2.7695181286391444
GENE EXPRESSION RT-PCR ANALYSIS	2.769515604819732
POST-HF EVENT MEDICAL MANAGEMENT	2.7693361302070976
GENE EXPRESSION DOWN-REGULATION	2.769122750162676
IMPREGNATED TLC PLATE POTASSIUM OXALATE	2.768820551671069
IONO-STIMULATED AA RELEASE PEAK	2.7684818146076005
MEDIATED AA RELEASE INDEPENDENT	2.7684818146076005
UBIQUITIN           CONJUGATING	2.768400858194194
NORMAL LYMPHOBLAST MITOCHONDRIA	2.7679680858778455
CPLA DEMONSTRATED TRANSLOCATION	2.7679012523341515
TERMINATED TEMPLATE PRIMER DIDEOXY	2.7678186437585826
TOP67 TRANSESTERIFICATION DOMAIN	2.7676254336376713
TRANSESTERIFICATION DOMAIN TOP67	2.7676254336376713
REPORTER PLASMID ELECTROPORATION	2.7676161304287294
restrictions	2.767594505531603
RNA POLYMERASE II	2.7674365002883934
LIGAND SPECIFICITY IDENTIFICATION	2.7673916818657274
REPLICATION FACTOR CONSERVATION	2.767211046455078
COP9/SIGNALOSOME POTENTIAL ROLE	2.7671533198636
MM TRIS-HCL PH	2.7668868860947002
B. THURINGIENSIS INSECTICIDAL PROTEIN	2.7668089277589574
CONTROL SAMPLE	2.76676641440898
PEDF-RECEPTOR INTERACTION MODULATION	2.7666665179241114
CSN MUTANT CELL EXTRACT EXHIBIT	2.7664462962156486
SUBCELLULAR FRACTION	2.766385144019221
NON-HEXAHISTIDINE-TAGGED ENZYME	2.766133415041653
RESEMBLED RAW CELLS(NOT SHOWN)	2.7660006118595577
CHROMOSOME LOSS INCREASED RATE	2.7660006118595577
MECHANOELECTRICAL TRANSDUCTION	2.7660006118595577
ARS         CONSENSUS SEQUENCE	2.7660006118595577
RECEPTOR-ASSOCIATED JAK FAMILY	2.7660006118595577
CLEAVAGE PRODUCT MAXIMAL YIELD	2.7660006118595577
COLD PHOSPHATE-BUFFERED SALINE	2.7660006118595577
six-protein origin recognition	2.7660006118595577
MATRIX METALLOPROTEINASE NSAID	2.7660006118595577
ELECTROPHORETIC MOBILITY SHIFT	2.7660006118595577
EMBRYONIC KIDNEY CELL LINE HEK	2.7660006118595577
GROWING NON-HEMATOPOIETIC CELL	2.7660006118595577
PEI-TREATED GLASS-FIBER FILTER	2.7660006118595577
CONSERVED MULTIPROTEIN COMPLEX	2.7660006118595577
BASELINE ELIGIBILITY RISK FACTOR	2.7659096426770318
LYMPHOBLASTOID T CELL LINE MOLT4	2.765827535144166
SYSTEMATIC MUTATIONAL ANALYSIS	2.7655038408709833
SUBCLINICAL VENTRICULAR DYSFUNCTION	2.76544554239436
REACTION MIXTURE	2.765404131489408
EXHIBIT DIFFERENTIAL SENSITIVITY	2.765137738541988
STRUCTURAL PROPERTY	2.7651268677472203
receptor expression	2.7651268677472203
STATISTICAL CONCEPT	2.7651268677472203
INVOLVING CO-IMMUNOPRECIPITATION	2.7648471924059943
MCPBG FUNCTIONAL GROUP INTERACTION	2.7647827339212125
SINGLE SIMPLE IMPUTATION METHOD	2.764526362778834
MULTIPLE CULLIN UBIQUITIN LIGAS	2.7643755558055263
IDO-TRANSFECTED RAW CELL CLONE	2.764344982720485
TERNARY COMPLEX FORMATION ASSAY	2.764100077419338
SUBSEQUENT ANALYSIS	2.763641251244295
UNCONJUGATED BILIRUBIN SOLUBILITY	2.763557809111636
FISSION YEAST GENOME ASSOCIATE	2.763302770132939
BINDING ACTIVITY INTRINSIC DNA	2.7631858728626284
PLASMINOGEN ACTIVATOR RECEPTOR	2.76310206113492
SUBUNIT DISULFIDE LINKAGE ABSENCE	2.7629922660447397
MISSING DATA PRE-SPECIFIED MODEL	2.7629768016555345
HEAT-INACTIVE FETAL CALF SERUM	2.7629764183111707
INCLUDED STROKE SECONDARY ENDPOINT	2.7629110226442837
REPRESENTING ENZYME-BOUND THDP	2.7627002818265542
HUMAN CDNA MICROARRAY SYSTEM I	2.7626468058821905
TETRACYSTEINE MOTIF CYS-X-CYS-X	2.7623669282653376
DNA CLEAVAGE-RELIGATION ACTION	2.7622476265303186
GENOMIC DNA FRAGMENTATION CELL	2.761697777624533
CONCENTRATION CURVE CONSTRUCTION	2.761627575198808
GENERAL CONSENSUS SEQUENCE IQX	2.7612836307274824
NICOTINIC ACETYLCHOLINE	2.7612090787207006
E. COLI EXPRESSION STRAIN BL21	2.7610867642556176
EXPRESSING CLONE IDO ANTISENSE	2.76047578001074
PROTEASE-DIGESTED APN FRAGMENT	2.760445056304002
LIGAND-MODULATED TRANSCRIPTION	2.7602269398041304
NONPOLAR COBBLESTONE PHENOTYPE	2.7599765154740155
BEAR UBIQUITIN LIGASE ACTIVITY	2.7599522247627837
SODIUM/BILE ACID COTRANSPORTER	2.7596814965357033
CHLOROTOXIN STRUCTURAL COORDINATE	2.759680800028533
METALLOPROTEASE REGULATOR EMMPRIN	2.759680800028533
DENSITY PROTEIN-LIPID MICRODOMAIN	2.759680800028533
EXCHANGED HYPERVARIABLE REGION	2.759333945192891
PHENANTHROLINE FOOTPRINT ANALYSIS	2.7591711842295323
CODING GENE PROTEIN	2.758905069902319
PHOSPHORYLATION-DEPENDENT MANNER	2.7588619420045233
GEL ELECTROPHORES SD PREPARATION	2.7586716516056673
TRANSCRIPTION INITIATION COMPLEX	2.7585556474350574
HOMOLOGOUS TYPE IA TOPOISOMERAS	2.7584049763808305
AFFINITY PURIFICATION	2.758216543552735
EXPLORATORY INVESTIGATION SUPPORT	2.7581881515315385
INCLUDING CDK4 ONCOPROTEIN KINAS	2.7580306572265414
CALMODULIN ALTERED INTERACTION	2.757863066376534
BIO-RAD BICINCHONIC ACID METHOD	2.7578079280049193
TOTAL MORTALITY SECONDARY OUTCOME	2.757782299171612
PROTOCOL-REQUIRED DOCUMENTATION	2.7576759733363203
EXTRACELLULAR BACTERIUM GROWTH	2.7575390159241127
OVER-EXPRESSION DEPRESSED LEVEL	2.757412420874494
UNCONJUGATED BILIRUBIN SELF-AGGREGATION	2.7572793398697377
RECENT X-RAY CRYSTALLOGRAPHIC DATA	2.757277130014507
LERISETRON FUNCTIONAL ACTIVITY	2.7572286820349965
P66 SUBUNIT CATALYTIC FUNCTION	2.7570558140403847
PROTEIN ACID TOPOISOMERASE III	2.757055053695619
UNCONJUGATED BILIRUBIN ABBREVIATION	2.756779228508434
SODIUM CITRATE-SODIUM CHLORIDE	2.7561966902909303
CADHERIN-LIKE RECEPTOR FRACTION	2.756149800559761
SUBCELLULAR FRACTIONATION CELL	2.755516740891816
orientation	2.755249891983904
PHOSPHATE SYSTEM IONIC STRENGTH	2.7547595572784775
EGFP-TAGGED CPLA MOLECULAR WEIGHT	2.7547239298861075
CD3-MEDIATED T-CELL ACTIVATION	2.7541564854144127
APOPTOTIC CELL DEATH INDUCTION	2.754095849954796
COMMON SUBCELLULAR COMPARTMENT	2.7540939766641737
TRANSFECTED CELL BINDING ASSAY	2.754014524840834
BINDING ASSAY TRANSFECTED CELL	2.754014524840834
CELLULAR RESPONSE SIGNIFICANCE	2.7538918978155644
AFFINITY THDP UPTAKE COMPONENT	2.7538203013503093
IDO CONSTITUTIVE OVEREXPRESSION	2.7534634829976223
UNDERGOING AGGREGATION P19 CELL	2.753404873146133
REPLICATION REGION C-MYC ORIGIN	2.7533590816236257
MURINE MONOCYTIC CELL LINE P388	2.7533234414747834
PIPERAZINE NITROGEN SUBSTITUTION	2.752891745599032
CLINICAL EVENT CHARACTERIZATION	2.752580625741009
EMISSION SPECTROSCOPY DETECTION	2.752580625741009
BILE ACID SYNTHESIS TAKES PLACE	2.7514774260508443
BINDING PROTEIN DNA	2.751422753008365
RADIOACTIVE THDP CONCENTRATION	2.751400846798306
ENZYME DNA POLYMERASE ACTIVITY	2.7511436118449577
HOSPITALIZED NONFATAL HF EVENT	2.751013787090124
T. ACIDOPHILUM A-ATPASE INTEIN	2.751008515832979
SUPERNATANT PROTEIN CONCENTRATION	2.7509940643586925
CORONARY ARTERY BYPASS GRAFTS	2.750932476949418
BRUSH BORDER MEMBRANE SURFACE	2.750932476949418
GAG-POL POLYPROTEIN PRECURSOR	2.750932476949418
NEDD8-PROCESSING ISOPEPTIDASE	2.750932476949418
CORRELATION COEFFICIENT LIMIT	2.750932476949418
DIFFERENT FLUORESCENT-PROTEIN	2.750932476949418
MACROPHAGE-INDUCED INHIBITION	2.750932476949418
TCA-CONTAINING CULTURE MEDIUM	2.750932476949418
PURPORTED DNTP-BINDING POCKET	2.750932476949418
OBSTRUCTIVE PULMONARY DISEASE	2.750932476949418
COMPETITIVE ANTAGONIST ACTION	2.750932476949418
MEASURED HYDRODYNAMIC PROPERTY	2.7508490967080426
CHS PARTICIPANT POTENTIAL LIMITATION	2.750631836477297
CLINICAL TRIAL SAFETY ENDPOINT	2.7506159964749424
REDUCED FOLATE CARRIER PROTEIN	2.7505021670934586
CUL1 SUBUNIT COVALENT MODIFICATION	2.7504772094576944
PIPERAZINE RING OTHER NITROGEN	2.750435477759941
ULTRA-CENTRIFUGATION ANALYSIS	2.7501941466498074
ENZYME-DNA COMPLEX DISSOCIATION	2.750032951943353
SUBUNIT RIBOSOMAL RNA SEQUENCE	2.7499784454573013
SEPARATED CALMODULIN STANDARD	2.7497935812458807
indices	2.749601609495052
ECFP/EYFP FLUORESCENCE CHANGE	2.7495788714001317
CONFORMATIONAL CHANGE LEADING	2.7495788714001317
HETERODIMER CATALYTIC FUNCTION	2.749333945192891
RIBOSOMAL PROTEIN UP-REGULATION	2.7492673344456784
CONSENSUS HEAT-SHOCK RESPONSE	2.7492559299746677
IDO SENSE TRANSFECTED P19 CELL	2.748904947314591
HYBRIDIZATION GENE EXPRESSION	2.748788237718276
μm	2.748627270619087
MOTILE	2.748595690806391
POLYPREP CHROMATOGRAPHY COLUMN	2.748456752210435
INDIVIDUAL HPLC FRACTION BIOASSAY	2.7481458705958275
BINDING ACTIVITY REPORTED DNA	2.74814352303876
BIOPESTICIDE SCORPION TOXINS OFFER	2.7480451210833596
RAT HEPATOMA-HUMAN FIBROBLAST	2.7475793829999176
HF CHEST X-RAY CHARACTERISTIC	2.747342479623051
SUBCELLULAR LOCALIZATION DATA	2.7471078974983336
PRIMARY ENDPOINT CHLORTHALIDONE	2.7470329345070357
ATPASE CATALYTIC SUBUNIT GROUP	2.7469066839658196
BASELINE COVARIATE	2.7467182254088036
PROTEIN-BOUND OLIGONUCLEOTIDE	2.7466981211285746
PROTEASE INHIBITION POTENTIAL	2.746528746895741
HYDROPHOBIC AMINO-ACID RESIDUE	2.746392768722303
DISCUSSION TRYPTOPHAN CATABOLISM	2.745968397120237
SHIFTING REACTION TEMPERATURE	2.7459658641069247
GE	2.745961347963265
COLLECTED VO PARALLEL PORTION	2.7454278143823214
candidates	2.7453935445170976
KINETIC PARAMETER STEADY-STATE	2.745167278526224
MURINE FIBROSARCOMA CELL LINE	2.744963565732084
STRUCTURAL HOMOLOGUE	2.744938488232717
CEREVISIAE V-ATPASE SACCHAROMYCE	2.744907141969382
CM-IV HPLC FRACTION ADMINISTRATION	2.7448814692423205
INTERMEDIATE ADP SCD39 RELEASE	2.7447738579286773
UNDETECTABLE	2.744509117232311
GLYCINE- CONJUGATED BILE ACID	2.7443163251480085
E. COLI DNA TOPOISOMERASE III	2.743919651710369
INCREASED RELATIVE RISK TWO-FOLD	2.7438988160008457
ENZYME ACTION INDIVIDUAL STEP	2.743826047815666
IMMOBILON-P TRANSFER MEMBRANE	2.7437524822966832
RESULTING RELAXATION ACTIVITY	2.7437524822966832
PEDF-RECEPTOR INTERACTION COFACTOR	2.743690672034484
HOST TRANSCRIPTIONAL MACHINERY	2.7435868670502748
DNA DECREASED PHOSPHORYLATION	2.743574425409854
CELL MIGRATION ASSAY P19 CELL	2.7435207144140263
SELECTIVE CHANNEL INTEGRAL ION	2.743273339132285
SIGNALING PATHWAY ESTABLISHMENT	2.7432391551496043
CYSTEINE PROTEAS CASPASE FAMILY	2.7432088256996323
PROMOTER ACTIVITY	2.743179283114555
UCB-HSA COMPLEX SEDIMENTATION	2.743068673282137
MEMBRANE THIAMINE TRANSPORTER	2.7430182589864245
IDO-EXPRESSING RAW CELL CLONE	2.74294048086372
CATALYZED CATENANE FAVOR FORMATION	2.7428491202103777
PREVENTING RIBOSOMAL MOVEMENT	2.742675483098773
ATP-SULFURYLASE COMPETITIVE INHIBITOR	2.742436589961668
TOTAL IQ PEPTIDE CONCENTRATION	2.7422952392529236
EYFP-CPLA RESTING DISTRIBUTION	2.742095081905641
FUNCTIONING ENDONUCLEASE GENE	2.742005997110883
TRUNCATED N-TERMINAL FRAGMENT	2.741901389925275
LIQUID NITROGEN FLOW CRYOSTAT	2.7417147636884778
NON-NUCLEOSIDE RT INHIBITOR TSAO	2.7415435091298965
mammalian expression	2.741387328839198
ENZYME PREPARATION	2.741327550827558
FURA2-AM DE-ESTERIFICATION MIN INCUBATION	2.741048033374011
CALMODULIN TOTAL CONCENTRATION	2.74092548891769
F-BOX PROTEIN OLIGOMERIZATION	2.740660337144891
CELL CYCLE ANALYSIS HELA CELL	2.740642036658457
SUBCELLULAR COMPARTMENTALIZATION	2.7406165819097166
BINDING CYSTEINE MOTIFS RANGE	2.740611234636112
COPPER-PHENANTHROLINE REAGENT	2.740611234636112
HOST PROTEIN INTEIN-FREE HOMOLOG	2.74057520099208
SF9-CELL EXTRACT CENTRIFUGATION	2.7405701635520603
THREE-DIMENSIONAL INTERACTION	2.740546321162443
G418 RESISTANCE PERIODIC CHECK	2.740437617337342
ENSURING HETERODIMER FORMATION	2.7399881508003676
CLEAVAGE PRODUCT	2.7398613286491647
ENZYMATIC DIGESTION TREATMENT	2.7397676040503773
EQUILIBRIUM DISSOCIATION CONSTANT	2.7394498617221603
ION CHANNEL FUNCTION MODULATION	2.739332721993199
CPLA PREVENTING TRANSLOCATION	2.7384558456270396
ALL-CAUSE MORTALITY	2.738387668350497
PNEUMOCYSTIS CARINII PHAGOCYTOSI	2.7382460795105676
HARMONIZATION (ICH)-E9 GUIDELINE	2.7382460795105676
SQUAMOUS EPITHELIA BASAL LAYER	2.73822283408178
ELEVATED PLASMA NOREPINEPHRINE	2.73822283408178
AFFINITY COLUMN CHROMATOGRAPHY	2.7381208348977735
APN-CONTAINING FRACTION PRIOR	2.738043510938655
PLASMA VOLUME FLUID EXPANSION	2.7378951182378732
N-TERMINAL FRAGMENT	2.7378692868322236
HOMOLOGOUS REGION	2.7378077781471535
DNA SYNTHESIS TEMPLATE PRIMER	2.7376026798251707
HETERODIMERIC ENZYME PREPARATION	2.737069442169515
REPLACING WILD-TYPE UBIQUITIN	2.7370439849886563
ARACHIDONIC ACID TOTAL AMOUNT	2.7368536087185147
F-BOX INDEPENDENT INTERACTION	2.7368283784387004
ANGIOTENSIN-CONVERTING ENZYME	2.7367196186819145
NUMEROUS DEUBIQUITYLATING ENZYME	2.7365912971656385
INTRACELLULAR CALCIUM RELEASE	2.7364213223913016
SPECIES D2 EXPERIMENTAL VALUE	2.7363988900943177
TRANSLATION GENE UPREGULATION	2.736124612733837
EMPTY TARGET SITE DISTRIBUTION	2.7359186866163423
BINDING AFFINITY TEMPLATE-PRIMER	2.735804698302142
DENEDDYLATION CRITICAL ACTIVITY	2.735765978676481
DESENSITIZED STATE DESTABILIZATION	2.7357357758418304
MORPHOLOGICAL DIFFERENTIATION	2.735735555751912
OPTIMAL SUPERHELICAL DENSITY	2.7353702177008388
COMMERCIAL COMPUTER SOFTWARE	2.7353702177008388
POROUS TISSUE CULTURE INSERT	2.7353702177008388
DROPOUT PROBLEM MIRROR IMAGE	2.7353702177008388
MEDICAL/SCIENTIFIC STATEMENT	2.7353702177008388
ESTABLISHED CORONARY DISEASE	2.7353702177008388
AMPLIFIED CHORION GENE LOCUS	2.7353702177008388
CLEAVAGE SEQUENCE PREFERENCE	2.7353702177008388
PERMEABILIZING CELL MEMBRANE	2.7353702177008388
MOLECULAR STRUCTURE FACILITY	2.7353702177008388
EXCESSIVE NEGATIVE SUPERCOIL	2.7353702177008388
BIMOLECULAR-BINDING ISOTHERM	2.7353702177008388
QUATTRO-BD MASS SPECTROMETER	2.7353702177008388
ENDOGENOUS RA-INDUCIBLE GENE	2.7353702177008388
IP/IMMUNOBLOTTING EXPERIMENT	2.7353702177008388
INCREMENTAL CLINICAL BENEFIT	2.7353702177008388
CATALYTIC BASE ATTACK RESULT	2.7353702177008388
TOPOISOMERASE III BETA FAMILY	2.7353222398188457
S. POMBE GENOME DATABASE PSH1	2.7351272265024877
BAC-TO-BAC EXPRESSION SYSTEM	2.7351051236654196
METALLOPROTEINASE EXPRESSION	2.7349725766477095
CONDUCT SENSITIVITY ANALYSIS	2.7348826975224374
BINDING MOTIF MULTIPLE ZN(II)	2.734827758876181
IDO ANTISENSE TRANSFECTED P19	2.7347730261315557
LYMPHOBLASTOID CELL LINE MOLT4	2.7347506118595577
TOTAL RNA IMMUNOBLOT ANALYSIS	2.7346313020991926
SUBCOMMITTEE QUALITY CONTROL	2.7344382346817295
CALMODULIN DETAILED ANALYSIS	2.733754676695861
SIZE EXCLUSION CHROMATOGRAPHY	2.733549332000692
TAT TRANSCRIPTIONAL ACTIVITY	2.7334683221211455
CM-FRACTION CHROMATOGRAPHIC ANALYSIS	2.733335341170988
SWISS-PROT PROTEIN DATA BANK	2.7330732531154163
CONSERVED TETRACYSTEINE MOTIF	2.7330204797072786
RESEMBLING TOPOISOMERASE III	2.732928978598546
PROTEIN HYDRODYNAMIC PROPERTY	2.732827615705544
ORGANIZED RAFT-TYPE MICRODOMAIN	2.732563188759428
TFIID COMPLEX BIND KDA COMPONENT	2.732560552071338
SIGNALING CASCADE ACTIVATION	2.732355231159758
AMMONIUM ACETATE	2.7320321764637785
ZWITTERIONIC DETERGENT MG/ML CHAP	2.7319991637233114
IN VITRO FOOT PRINTING ASSAY	2.7318777688783413
WHOLE CELL PATCH CLAMP ASSAY	2.7318777688783413
THIAMINE MITOCHONDRIA UPTAKE	2.7317392836111103
BB	2.7317361276234884
P68 KINASE STEADY-STATE AMOUNT	2.7315550778656132
VENTRICULAR SYSTOLIC FUNCTION	2.731504256124371
CALMODULIN STOICHIOMETRY LEAD	2.7314447060222258
CO-OVEREXPRESSING EPITOPE-TAGGED	2.73118015889772
DECREASED LEVEL	2.731174743025136
USAGE COMPARISON CODON USAGE	2.730989065383331
Β-LACTAMAS BACTERIAL PRODUCTION	2.730548855478262
PREVENTED STABLE DIMERIZATION	2.7302899923228057
SODIUM CHLORIDE CONCENTRATION	2.7300224426716135
BINDING TRANSCRIPTION FACTOR	2.7299123387679205
SPODPTERA FRUGIPERDA SF9 CELL	2.7298507905222396
(RA)-DEPENDENT TRANSCRIPTION	2.729704062278658
STRUCTURE-ACTIVITY RELATIONSHIP	2.729651561562107
DENSITY GRADIENT LOCALIZATION	2.729520540350884
CTD KINASE RNA POLYMERASE II	2.729449625311324
KDA TRANSESTERIFICATION DOMAIN	2.7291992146539688
SARCOPHAGA FALCULATA INSTAR LARVA	2.729149353499099
CONCOMITANT ALPHA-1 BLOCKADE	2.729079332321853
ELECTROPHORESIS SAMPLE BUFFER	2.729016958532406
RESIDUAL POLYMERASE ACTIVITY	2.7289976325117364
IMPAIRED POLYMERASE ACTIVITY	2.7289976325117364
HEART FAILURE REFERENCE POINT	2.7288336726526756
CADHERIN-LIKE RECEPTOR ALLELE	2.728794160103486
PERSONAL COMMUNICATION	2.7285705406230494
TRANSPORTER-SPECIFIC PEPTIDE	2.728523393613943
CANDIDATE RECEPTOR FRACTION ΜL	2.7281559671087625
DIASTOLIC HF MAJOR RISK FACTOR	2.728027044827027
MYOSIN LEVER ARM STABILIZATION	2.7276700470755046
DISCONTINUOUS SUCROSE GRADIENT	2.7275815958286014
CASPASE ACTIVATION TIME COURSE	2.7275222219698776
STIMULATING MULTIPLE PATHWAY	2.727511333864028
FATAL CORONARY HEART DISEASE	2.727369852599303
MULTIPLE CD98 CHARACTERIZATION	2.727264973566397
AFFECTING RIBOSOMAL FIDELITY	2.7271920667081577
CADHERIN-LIKE RECEPTOR ISOFORM	2.7269909500238088
COX-2 PROTEIN REDUCED AMOUNT	2.726939639870906
INSERTION MUTANT CONSTRUCTION	2.7266397373581
SYNCYTIUM-INDUCING PHENOTYPE	2.726502343130462
N-TERMINAL HEXAHISTIDINE TAG	2.726425365052594
AMPA RECEPTOR OBSERVED DISTURBANCE	2.7263075309720506
PEPTIDE TOXIN MOLECULAR MASS	2.7261052692340475
EXPRESSING GSTCDC6 BACULOVIRUS	2.7258361589816325
UCB-DMSO-BUFFER SYSTEM PREPARATION	2.725758727593433
HYDROPHOBIC EXTRACTION BUFFER	2.725316345041921
PLASMID TRANSIENT EXPRESSION	2.7251587238094563
HOMEOSTASI	2.725002172120498
AMMONIUM SULPHATE PRECIPITATION	2.7245562139667956
IIB/IIIA INHIBITOR UTILIZATION	2.724333945192891
RECOMMENDED CHOLESTEROL TARGET	2.724333945192891
PLATELET GLYCOPROTEIN IIB/IIIA	2.724333945192891
CONSERVED GLYCINE SUBSTITUTION	2.723853318159469
POP1 MAJOR PHENOTYPIC DEFECT	2.7236871448541518
LEPIDOPTERAN-SELECTIVE TOXIN	2.7236871448541518
HEAT SHOCK PROTEIN EXPRESSION	2.7236416492439153
GEL FILTRATION CHROMATOGRAPHY	2.723490050152191
ACTIVATED K CONDUCTANCE CALCIUM	2.723344347511694
METAL AFFINITY CHROMATOGRAPHY	2.723308099317722
HIGH-RISK HYPERTENSIVE PARTICIPANT	2.723303949553122
HOSPITAL DISCHARGE	2.7231860527547034
SPECTROPOLARIMETER JASCO J-810 CD	2.723043064193212
TOTAL CELLULAR RADIOACTIVITY	2.72297907983314
ISOLATABLE MUTANT TOTAL AMOUNT	2.722850359334305
FUSION PROTEIN OVEREXPRESSION	2.722819138310823
CONCENTRATION RESPONSE CURVE	2.722620661133053
BOMBYX MORI AMINOPEPTIDASE N	2.72253943272995
COMMON CALMODULIN-BINDING MOTIF	2.7224980525600713
TAG CGG CCG CGT AGA CAG CAA TGG CAC TC	2.7224977623535818
REMODELLING FACTOR CHROMATIN	2.722211669059647
RECEPTOR-BINDING MEASUREMENT	2.722108351226221
DIFFERENTIAL F-BOX REQUIREMENT	2.7219997274196692
THDP CHARACTERISTIC AFFINITY	2.7219879029288716
P66 SUBUNIT POLYMERASE CLEFT	2.721812549949308
PEDF MOLECULE OPPOSITE REGION	2.721690117733623
SINGLE PARAMETER MANIPULATION	2.7216205829012825
ZINTEROL-INDUCED STIMULATION	2.7215479906709557
P66 WT SEDIMENTATION PATTERN	2.72144877650635
REPORT CONFORMATIONAL CHANGE	2.7214477664522647
COPPER PHENANTHROLINE FOOTPRINT ANALYSIS	2.7213357886894847
EYFP-CPLA RAPID TRANSLOCATION	2.7210513978046023
PPARGAMMA PROMOTER TRANSCRIPTION	2.7210172722299646
SODIUM-INDEPENDENT TRANSPORT	2.720795295139625
UNKNOWN CYTOPLASMIC SUBSTRATE	2.7206088828080257
SUCROSE-GRADIENT CENTRIFUGATION	2.720552726570479
INTERNAL RIBOSOME ENTRY SITE	2.720036184589562
DUAL CFP/YFP IMAGING APPROACH	2.7199687500095
UBIQUITIN-RELATED PEPTIDE NEDD8	2.7198637543208806
AROMATIC BENZIMIDAZOLE GROUP	2.7197927872385894
INCREASED P38 PHOSPHORYLATION	2.7197697177885822
ZINTEROL-MEDIATED AA RELEASE	2.7196465378914474
extracellular differentiation	2.7194772622802947
PERIPHERAL VASCULAR DISEASE	2.719280324841274
PRODUCED INTERMEDIATE LEVEL	2.719280324841274
BINDING DOMAIN PUTATIVE GAG	2.719280324841274
POTTER-ELVEHJAM HOMOGENIZER	2.719280324841274
AUTOMATED EDMAN DEGRADATION	2.719280324841274
COUPLED PLASMA SPECTROMETER	2.719280324841274
DIMENSIONAL MODEL STRUCTURE	2.719280324841274
OTHER PHENOTYPIC ALTERATION	2.719280324841274
ORDER NUCLEOPROTEIN COMPLEX	2.719280324841274
CARDIOVASCULAR COMPLICATION	2.719280324841274
murine macrophage cell line	2.719280324841274
CHICKEN GIZZARD ECTO-ATPASE	2.719280324841274
MICROBIAL PATHOGEN OUTBREAK	2.719280324841274
LC-235 DIODE ARRAY DETECTOR	2.719280324841274
SOMETIMES-DISCREPANT RESULT	2.719280324841274
MMTV-CDC37 TRANSGENIC MOUSE	2.719280324841274
PHYLOGENETIC RECONSTRUCTION	2.719280324841274
P110 PITSLREAND P58 PITSLRE	2.719280324841274
POST-RETROVIRAL INOCULATION	2.719280324841274
CRITICAL STRUCTURAL ELEMENT	2.719280324841274
BRIDGING HYDROXIDE FUNCTION	2.719280324841274
GENE EXPRESSION MHC CLASS I	2.719122853820362
RA- INDUCED GENE EXPRESSION	2.719083486065134
ENDOGENOUS EXPRESSION LEVEL	2.7190178731397543
EXPRESSING EGFP FLUORESCENCE	2.7190139157154767
MOTIF	2.7187714420144284
CHOLESTEROL SIDE CHAIN HYDROXYLATION	2.7186519935727866
PRIMARY PRE-SPECIFIED ANALYSIS	2.71864910675944
DELETION MUTANT	2.7186191519109904
MRNA TRANSCRIPT	2.7185958576788676
STRUCTURE-FUNCTION ANALYSIS	2.7185563336348464
PHOSPHODIESTER BOND RELIGATION	2.7183815642405103
POSITIVE CONTROL IQ-PEPTIDE	2.718357631394906
GLUTATHIONE S-TRANSFERASE HA	2.7181530577162474
NON-SIGNIFICANT EFFECT SIZE	2.7178722144079037
SUPERFECT TRANSFECTION REAGENT	2.7178488183337484
CD87 GENE PROMOTER ACTIVITY	2.717843052357508
A-ATPASE INTEIN DISTRIBUTION	2.7177707194626053
CONFIRMATORY EVENT DOCUMENTATION	2.7176906740913744
TOTAL ALEXA-CALMODULIN BOUND	2.717240026504943
TERMED FARNESOID X RECEPTOR	2.7171681591912185
SERIOUS SUPERSATURATION EFFECT	2.716932288878191
MEK INHIBITION RESULTS EFFECT	2.7168275023489286
VAB- 8	2.716779786722732
EXTRACELLULAR RECORDING BUFFER	2.7166007289555765
BINDING ACTIVITY NORMAL DNA	2.7165455351306083
ALEXA-CALMODULIN INTERACTION	2.7164746553278123
RECEPTOR TERTIARY STRUCTURE	2.716464103974533
ACCELERATED CELL CYCLE SHOW	2.7163713541855086
CONTROL SIGNAL TRANSDUCTION	2.7162614152157785
OTHER TRANSMEMBRANE PROTEIN	2.7162482321585335
ANTISENSE-TRANSFECTED CLONE	2.7160631188842355
BT TOXIN RECEPTOR CLASS PLAY	2.71590520241888
THERMOPLASMA COMMON ANCESTOR	2.715882886732322
INTRACELLULAR RECORDING BUFFER	2.715881318674908
HUMAN CDNA EXPRESSION ARRAY	2.715629945073337
BINDING ACTIVITY SHOWED P35	2.7156000362086012
Γ-AMINO BUTYRIC ACID TYPE A	2.715596547783357
CELLULAR GENE TRANSCRIPTION	2.715540539625625
IMAGING EXPERIMENT	2.71553580540733
BLOTTING TECHNIQUE	2.71553580540733
REDUCING CONDITION	2.71553580540733
WORKING HYPOTHESIS	2.71553580540733
SUSTAINED INCREASE	2.71553580540733
RECEPTOR LEADING CONFORMATION	2.7154976864378937
E. COLI BL21(DE3)PLYSS CELL	2.715232007345334
APN X-RAY CRYSTAL STRUCTURE	2.715232007345334
affinity	2.715047039249757
PK DETERMINATION PH MEASUREMENT	2.715004869640346
CM-52 CATION EXCHANGE COLUMN	2.7149248402191364
LIGAND-DEPENDENT TRANSCRIPTION	2.714772394349585
SPATIAL EXPRESSION	2.714740932133882
CHLOROFORM	2.7145964106480585
MCNTCP DIFFERENTIAL RESPONSE	2.714329713929409
HISTIDINE	2.713927671959441
NON-HYDROLYSABLE NUCLEOTIDE	2.71390248610128
EXPRESSED IDO ANTISENSE RNA	2.713861875680497
ZYGOTE	2.7137117803606015
LTR-DEPENDENT TRANSCRIPTION	2.7136706470178007
CEREVISIAE INTEIN SACCHAROMYCE	2.7136245994835453
CLINICAL HEART FAILURE EVENT	2.713482426385317
C-TERMINAL C-MYC EPITOPE TAG	2.7134644561133006
E3 UBIQUITIN LIGASE COMPLEX	2.713403734927813
LEPIDOPTERAN SELECTIVE TOXICITY	2.7133464492571098
COLI EXPRESSION STRAIN BL21	2.71331248027305
INCREASED ATPASE ACTIVITY ACR5	2.713304533428185
BALB 3T3 CELL TRANSFORMATION	2.713181435937751
PIG CSN PURIFIED PREPARATION	2.7130801445065016
SINGLE-STRAND CHARACTERISTIC	2.713066169538982
POLYMERASE ACTIVITY PROFILE	2.7129712586138353
NON-BILE ACID METABOLIZING CELL	2.712768694796362
CONTROL EXPERIMENT	2.7127412936710473
MUTANT OVEREXPRESSION PLASMID	2.712657940480124
PHOSPHORYLATION SITE MUTANT	2.71256286872083
IDO ACTIVITY PROXIMAL INDUCER	2.712549718406074
MAXIMAL RELAXATION ACTIVITY	2.712239772674422
COMPLEMENTARY SINGLE STRAND	2.7121287229557023
Α-DNP-HORSERADISH PEROXIDASE	2.7120040720074647
ZN(II) NEAR-WILD-TYPE LEVEL	2.7120024506912697
INTEGRIN-DEPENDENT ADHESION	2.711919747575929
NON-DENATURING POLYACRYLAMIDE GEL	2.711728402128048
BUDDING YEAST F-BOX PROTEIN	2.71172584120408
CHROMATIN IMMUNOPRECIPITATION	2.7116925835725145
TRANSLATION INITIATION FACTOR	2.7116643279670263
EJECTION FRACTION INFORMATION	2.7115641858314152
SHARED THIAMINE TRANSPORTER	2.7115198086956154
LERISETRON FUNCTIONAL GROUP	2.7107575511656115
LERISETRON BINDING LOCATION	2.7107575511656115
SCF-MEDIATED UBIQUITYLATION	2.710757551165611
OTHER TYPE IA TOPOISOMERASE	2.710720449538914
MOLECULAR MASS DETERMINATION	2.710587941965442
REQUIRED HETEROOLIGOMERIZATION	2.7104450563040023
TOLUIDINE BLUE-O PRECIPITATION	2.7104450563040023
METAL-ATP COMPLEX COORDINATION	2.7104450563040023
ALPHA-1 RECEPTOR INHIBITION	2.710235923211549
HOMODIMER PREDICTED POSITION	2.7102066761848973
transmembrane	2.710099263677143
COMMON INTERMEDIATE PATHWAY	2.7098013375337078
receptor signal transduction	2.7097132734100753
MUTANT OVER-EXPRESSION LEVEL	2.7096294091165958
EUKARYOTIC TOPOISOMERASE III	2.709562832905172
TRANSFECTED STABLE HIGHFIVE	2.709515538921419
GEL ELECTROPHORESIS ANALYSIS	2.709342037424435
FORM HYDROPHOBIC INTERACTION	2.7092695212289457
LIGAND/RECEPTOR INTERACTION	2.709095878310608
LIGAND-RECEPTOR INTERACTION	2.709095878310608
TAA GAT CTT ACA CTA AGG CCA ACT CAG	2.7090327669711467
NON-STEROIDAL ANTI-INFLAMMATORY	2.7085422643815305
NUCLEATION COMPLEX KINETICS	2.708484811518768
IMMUNOBLOTTING STABLE EGFP-CPLA	2.7084526340666875
ATP NON-HYDROLYZABLE ANALOG	2.7083018367166916
CALMODULIN BINDING AFFINITY	2.7081212096265905
ATOMIC EMISSION SPECTROSCOPY	2.7081097143919024
ERK CONSTITUTIVE ACTIVATION	2.708096266239646
VEGF-INDUCED ERK ACTIVATION	2.708096266239646
RELAXED CHROMATIN STRUCTURE	2.7079166266070573
THIAMINE TRANSPORT CAPACITY	2.707788506161104
VARYING CONCENTRATION	2.707660433036857
BINDING PROTEIN	2.707557771042358
STEROID RECEPTOR HORMONES ACT	2.7074935093003734
FLOW CYTOMETRIC MEASUREMENT	2.707471871971934
RECEPTOR FIXED CONCENTRATION	2.707057458566817
CHARACTERIZED PEPTIDE TOXIN	2.707050191808136
INFECTED CD4 LYMPHOCYTIC CELL	2.7068951764126457
PYROCOCCUS CATALYTIC SUBUNIT	2.7066440959344327
ENDOGENOUS PROTEIN	2.706352670292664
REMODELING FACTOR CHROMATIN	2.706252934485438
practices	2.70618262648057
ALEXA-CALMODULIN IQ PEPTIDE	2.706135192729537
CALMODULIN TRIGGERS RELEASE	2.706079017762389
NON-SMOKING POPULATION-BASED STUDY	2.7059534728420687
POST-RANDOMIZATION STRATIFICATION	2.705945454136729
MORI CADHERIN-LIKE RECEPTOR	2.7055993886435497
INFLUENCE INTEGRIN AFFINITY	2.705599049791848
MUTANT CELL EXTRACT EXHIBIT	2.7051275902943845
MOUSE LEUKOTRIENE B4 RECEPTOR	2.704741178016825
DUAL CFP/YFP DICHROIC MIRROR	2.704702151478285
STABILIZATION	2.7046893574206674
DNA SUBSTRATE CONCENTRATION	2.7046554504358045
MAXIMUM RELAXATION ACTIVITY	2.704619410329124
CHONDROITINASE ABC REACTION	2.704596065434721
CLASSIC HYDRODYNAMIC METHOD	2.704559170310584
anion-exchange chromatography	2.704486886539541
OVEREXPRESSING IDO MC57 CELL	2.7043895765459065
FLUID	2.704238342204976
DEPENDENT DECREASE	2.7041962259918932
BINDING MOTIF SINGLE ZN(II)	2.703960087263548
COVALENT ENZYME-DNA COMPLEX	2.70385816295198
PEPTIDE BOUND CONCENTRATION	2.703782784628201
USE SUBSTRATE CONCENTRATION	2.7037403522142247
SUBDOMAIN RELATIVE POSITION	2.703482012661997
GAGS/POLYANIONS PURIFICATION	2.7030880427297297
OUTCOME-CORRELATED BASELINE	2.703087054857515
INCREASED TOTAL BODY SODIUM	2.7029355135608757
SUBMICROMOLAR CONCENTRATION	2.702812592654401
CD98 MICRODOMAIN ALLOWED MAINTENANCE	2.702796002309787
IMMUNOBLOTTING PROTEIN LYSATE	2.702781176922372
UNCONVENTIONAL MYOSIN ISOZYME	2.702652380015415
SEEDING SUSPENSION CULTURE	2.7026257604288397
GP-100 GRAPHICS INTEGRATOR	2.7026257604288397
TEMPERATURE-DEPENDENT LOSS	2.7026257604288397
protein origin recognition	2.7026257604288397
CONTAINING CELL SUSPENSION	2.7026257604288397
PUMPING ATPASES/ATPSYNTHAS	2.7026257604288397
POST-TRANSCRIPTIONAL EVENT	2.7026257604288397
CHEST X-RAY CHARACTERISTIC	2.7026257604288397
ALTERED ADIPOCYTE FUNCTION	2.7026257604288397
TCDCA- MEDIATED CELL DEATH	2.7026257604288397
CONSTITUTIVE INTEGRIN-CD98	2.7026257604288397
RECOMBINATION INTERMEDIATE	2.7026257604288397
BIOCHEMICAL CHARACTERISTIC	2.7026257604288397
quality control evaluation	2.7026257604288397
WERNIKE-KORSAKOFF SYNDROME	2.7026257604288397
CLEAVAGE-RELIGATION ACTION	2.7026257604288397
INHIBITED DOSE-DEPENDENTLY	2.7026257604288397
DIVERSE PATIENT POPULATION	2.7026257604288397
ordinary physical activity	2.7026257604288397
CALMODULIN-PEPTIDE COMPLEX	2.7026257604288397
CONDENSED MESENCHYMAL CELL	2.7026257604288397
SHIMADZU SPECTROPHOTOMETER	2.7026257604288397
FOUR-DISULFIDE CORE FAMILY	2.7026257604288397
WITHIN-SUBJECT VARIABILITY	2.7026257604288397
OTHER INDIVIDUAL ORGANELLE	2.7026257604288397
embryonic kidney cell line	2.7026257604288397
HEK293 CELL LINE DERIVATIVE	2.7025286662373853
NONFATAL HEART FAILURE EVENT	2.7023304023043884
ACTIVATING ENZYME UBIQUITIN	2.7021536511408417
AVANTI POLAR LIPID	2.702006514104774
BINDING TETRACYSTEINE MOTIF	2.701716196022911
transduction	2.701500709499223
DERIVED CELL LINE NON-HEPATIC	2.701390513845549
YELLOW CHROMOPHORIC CHANGE	2.701312275477458
ENDOTOXIN TOLERANCE EFFECT	2.7012323242195477
AGGRESSIVE TREATMENT STRATEGY	2.70105349368838
SINGLE-STRAND DNA SUBSTRATE	2.700912784029697
REACTION MECHANISM	2.7007858261677016
TRUNCATED CYTOPLASMIC TAIL	2.7006715511109305
SENSE-TRANSFECTED AGGREGATE	2.7005957825523215
SIGNAL TRANSDUCTION MEMBER	2.700551389372936
GEL FILTRATION SCALE LYSATE	2.7004964912822262
MURINE IDO CDNA BP FRAGMENT	2.700369381600385
STABLE RECEPTOR CONFORMATION	2.7002737803727874
SYNTHETIC TAT MRNA INJECTION	2.700267894284202
TREATMENT GROUP DIFFERENCE	2.7000095128522097
LIGAND CYSTEINE-LOOP FAMILY	2.699945077099472
CONTAINING AC DNA FRAGMENT	2.6999194705546006
ACIDOPHILUM A-ATPASE INTEIN	2.699858640154808
Y-79 CELL-SURFACE RECEPTOR	2.6998388880102557
RECEPTOR FUNCTIONAL DOMAIN	2.6998388880102557
SIGNALING PATHWAY RECEPTOR	2.6998388880102557
MRNA CAP MANNER INDEPENDENT	2.6997686097290634
IDO GENE BP RT-PCR FRAGMENT	2.6997179707225483
DERIVED MACROPHAGE MONOCYTE	2.6997162109017125
CELL CYCLE GENE EXPRESSION	2.6995523173103066
CONTAINING ENDOGENOUS CPLA	2.6994836983882795
12CA5 TISSUE CULTURE SUPERNATANT	2.6993835161399056
MOTILE CELL LAMELLOPODIA DYNAMIC	2.6993835161399056
INCREASED PLASMA CATECHOLAMINE	2.699333945192891
TAURINE BIOLOGICAL ACTIVITY	2.6990387373615756
INTEGRIN ΑVΒ3-CD47 COMPLEX	2.6990247455059504
SECONDARY PREVENTION SETTING	2.6990228799555904
DISPLACEMENT DNA SYNTHESIS	2.699017373929854
SCT1 TRANSCRIPTION COMPLEX	2.6989249483256392
CELL CYCLE PHASE-DEPENDENT	2.698787552906239
SKELETAL MUSCLE	2.6986960243117517
THIAMINE DIPHOSPHATE ABBREVIATION	2.6986150547296663
BACKGROUND SEQUENCE HOMOLOGY	2.6983370811302083
MUTANT ENZYME OVEREXPRESSION	2.698022786478509
SPECIES V EQUATORIAL LIGAND	2.6978881358503446
THIAMINE AFFINITY TRANSPORT	2.69774616818668
AFFINITY THIAMINE TRANSPORT	2.69774616818668
QUANTIFYING SYSTOLIC FAILURE	2.6976109411974507
TRANSCRIPTION FACTOR MEP-1	2.697278593900277
P66 IN POLYMERASE ACTIVITY	2.697096906565215
BINDING ASSAY IN VITRO DNA	2.697039123602717
N-TERMINAL CYSTEINE RESIDUE	2.6969302386657734
FINAL MOLECULAR-MASS VALUE	2.696902718854962
FINAL MITOCHONDRIAL PELLET	2.696902718854962
DUPLICATE CONTROL REACTION	2.696893279140265
DMSO-AQUEOUS BUFFER SYSTEM	2.6966212577939515
RABBIT ANTI-MOUSE ANTIBODY	2.696597729178611
INNER-EAR HAIR CELL STEREOCILIA	2.6965318021925815
PENTAMERIC QUATERNARY STRUCTURE	2.6965318021925815
T. ACIDOPHILUM INTEIN SHOW	2.696499838072838
CELL CYCLE-DEPENDENT MANNER	2.6964192378053795
MEMBRANE FOLATE TRANSPORTER	2.696346315677673
PRODUCTIVE TERNARY COMPLEX	2.696341636347719
'-ATA AAC AAT GAG ACA ATA-3	2.6961470820073328
UCB-DMSO-WATER SYSTEM PREPARATION	2.6960468377882383
CASPASE CASCADE ACTIVATION	2.696029996972728
Β-TRCP PROTEIN DIMERIZATION	2.6960066446788353
OTHER TYPE IA TOPOISOMERAS	2.695948878592649
GROWTH MEDIUM SUPPLEMENTED	2.695920941848564
INDIVIDUAL ALANINE MUTATION	2.6957264775921703
PROJECT	2.695272683779544
HUMAN THIAMINE TRANSPORTER	2.6949461183042707
BETTER REPLICATION PROFILE	2.6947124189933542
REGENERATED CELLULOSE SPECTRA/POR	2.6945470474324065
DNA-PROTEIN COMPLEX FORMATION	2.6944894749263186
PAROXYSMAL NOCTURNAL DYSPNEA	2.6944794627374344
MMP-1 DIMINISHED EXPRESSION	2.694105150087818
ΜM NITROCELLULOSE MEMBRANE	2.694006216151312
POLYPLOIDIZATION PHENOTYPE	2.6939377696058444
TAURINE CYTOTOXIC POTENTIAL	2.6938151018829437
RESULTING MUTANT DERIVATIVE	2.6937960886503585
kb	2.693630477341137
INCLUDING P21 MER OLIGO PROBE	2.6936192255155302
TOTAL CONTACT SURFACE AREA	2.6935209215613063
CHD EVENT OTHER RISK FACTOR	2.6934808381721247
ENZYME CATALYTIC MECHANISM	2.693431365769167
COMMON PRACTICE	2.693376726570009
STRUCTURAL CHANGE COMPACT-TO-OPEN	2.693145603985154
LABELED OLIGONUCLEOTIDE '-END	2.69306294739789
PRODUCTIVE HIV-1 INFECTION	2.693061407074119
FUNCTIONAL HOMOMERIC RECEPTOR	2.6930138534173587
affinity chromatography	2.6929734842636464
ΜM BOVINE-BRAIN CALMODULIN	2.69290107708877
CORRESPONDING F-BOX MUTANT	2.6925427011921568
TOTAL RNA PURIFICATION CELL	2.692440256102996
CATALYTIC V-ATPASE SUBUNIT	2.692287362746996
QUANTITATION SCINTILLATION COUNTER	2.692156374618311
OTHER MAMMALIAN	2.6920368102403462
NUCLEATION KINETIC PROCESS	2.6919427494909343
LEUKOTRIENE FAMILY MEMBER B4	2.6917534124065408
DENEDDYLATION VARYING DEGREE	2.6917534124065408
ANTISERUM ANTI-CYTOCHROME C	2.691520433440545
MOLECULAR WEIGHT CHROMATIN	2.69138048575736
problems	2.6910848915093744
DEMONSTRATED SATURABLE UPTAKE	2.690881612581092
TOTAL SURFACE AREA	2.6907662695630044
EXHIBITED K S VALUE MUTANT	2.690670257544471
CADHERIN-LIKE GLYCOPROTEIN	2.690607373123696
CULLIN DENEDDYLATING ACTIVITY	2.690558758471585
MENTIONED EJECTION FRACTION	2.6904484051140938
QUALITY CONTROL VALIDATION	2.690266599423143
MOLECULAR-MASS MEASUREMENT	2.6896329092881435
HEMATOPOIETIC CELL SURVIVAL	2.68938505717895
ARS1 DNA FRAGMENT B1-B2 BOX	2.6893326016720125
DEMONSTRATED TRANSLOCATION	2.6891786137937137
HUMAN THP-1 PROMONOCYTIC CELL	2.689005023069582
TERMINATED TEMPLATE PRIMER	2.6889878741251305
LIVER TRANSAMINASE ELEVATION	2.6886379263140907
RELAXATION ACTIVITY ZN(II)	2.6884565495366
CONSERVED NEDDYLATION SITE	2.6880580182407865
MMP-3	2.6878871496342365
SQUARED EFFECT SIZE INVERSE	2.6878618607966986
DETERGENT-FREE PURIFICATION	2.68731992355754
CLEAVED DNA HYDROXYL GROUP	2.687268536549186
AGONIST-INDUCED AA RELEASE	2.687221033534749
IONO-STIMULATED AA RELEASE	2.687221033534749
ENZYME POLYMERASE ACTIVITY	2.6871880476885726
BINDING SITE OPPOSITE FACE	2.686949603074304
HOST TRANSLATIONAL APPARATUS	2.6869071007071743
DETERMINATION PH MEASUREMENT	2.6866348969016856
PHARMACIA PERISTALTIC PUMP	2.6866012440219813
MUTANT HETERODIMERIC ENZYME	2.6865988254933604
CD98 CO-IMMUNOPRECIPITATION	2.686404867820629
SURVIVAL PATHWAY ACTIVATION	2.686400122619732
INTERMEDIATE CONCENTRATION	2.6863296420489835
REPLICATION FACTOR	2.686277969346464
ROOM TEMPERATURE INCUBATION	2.686232835078501
LABELED DNA SUBSTRATE PMOLE	2.686183153911061
BINDING SITE DIVALENT CATION	2.6860607778920276
OVARY CELL LINE DERIVATIVE	2.6860486744907104
ADMISSION LDL CHOLESTEROL LEVEL	2.6860226477772513
BINDING AFFINITY DATA DNTP	2.68592758367214
BIO-RAD DC PROTEIN ASSAY KIT	2.68582425997485
LAYER CHROMATOGRAPHY PLATE	2.6857578484216202
BINDING SITE ACETYLCHOLINE	2.6857578484216202
MITOCHONDRIAL SUSPENSION ΜL	2.6857089114603108
CONVERTER-DOMAIN MOVEMENT	2.6853654443270285
SERINE-PROTEASE INHIBITOR	2.6853654443270285
JUGULAR VENOUS DISTENTION	2.6853654443270285
MADIN DARBY CANINE KIDNEY	2.6853654443270285
PEPTIDE-DERIVATIZED PLATE	2.6853654443270285
MYOSIN-CALMODULIN COMPLEX	2.6853654443270285
MADIN-DARBY CANINE KIDNEY	2.6853654443270285
PHOTODIODE ARRAY DETECTOR	2.6853654443270285
BACKGROUND SCORPION VENOM	2.6853654443270285
MATRIX METALLOPROTEINASES	2.6853654443270285
EXCLUDING MAJOR VARIATION	2.6853654443270285
SELECTIVE INTERNALIZATION	2.6853654443270285
CHAMELEON-MUTAGENESIS KIT	2.6853654443270285
MOLECULAR POROUS MEMBRANE	2.6853654443270285
FISSION YEAST COUNTERPART	2.6853654443270285
CELLULAR REPAIR MECHANISM	2.6853654443270285
ubiquitin-related peptide	2.6853654443270285
INTERPHOTORECEPTOR MATRIX	2.6853654443270285
CURRENT CIGARETTE SMOKING	2.6853654443270285
QUINQUESTRIATUS HAEBRAEUS	2.6853654443270285
CELLULAR MICROENVIRONMENT	2.6853654443270285
monocyte cell-cell fusion	2.6853654443270285
PERFORMING CELL MIGRATION	2.6853654443270285
MEDICARE ELIGIBILITY LIST	2.6853654443270285
REVEALED CO-PRECIPITATION	2.6853654443270285
FLUOROGENIC-LEAVING GROUP	2.6853654443270285
PHARMACOLOGICAL INHIBITOR	2.6853654443270285
ADJUSTED MEAN LDL CHOLESTEROL	2.6852289588086165
HIV-1 CORECEPTOR UP-REGULATION	2.684721005215677
LAI STRAIN PROVIRAL SEQUENCE	2.684561279618651
INTRACELLULAR SIGNIFICANCE	2.68441909754108
EXTRACELLULAR FLUID VOLUME	2.6843270880281507
C-TERMINAL MYC EPITOPE-TAG	2.684282678461282
PRODUCED AGGREGATE CLONE C2	2.6840395457426407
SENSE-TRANSFECTED CONTROL	2.684010775522993
CYTOSOL THDP-UTILIZING ENZYME	2.683964095736963
ALTERED RESPONSE KINETICS	2.6837563453415245
INHIBITING IDO EXPRESSION	2.6835392924334553
ENDOGENOUS IDO EXPRESSION	2.6835392924334553
CONTAINING AR DNA FRAGMENT	2.6835307605930407
POMBE GENOME DATABASE PSH1	2.6834547779500317
DNTP COMPLEMENTARY ADDITION	2.6834522334418396
MUSCLE CELL PROLIFERATION	2.683384241201127
EXPRESSION VECTOR PET-11A	2.6833176441562387
EXPRESSION VECTOR PET-28A	2.6833176441562387
PBK-CMV EXPRESSION VECTOR	2.6833176441562387
SENSE TRANSFECTED P19 CELL	2.6832694679919595
DIRECTIONAL EXTRACELLULAR	2.683242726692134
EXTRACELLULAR ENVIRONMENT	2.683242726692134
PRELIMINARY CALIBRATION STUDY	2.6832251273741305
BACTERIAL TOPOISOMERASE I	2.68299982865431
BINDING ACTIVITY SHOW DNA	2.682688690871358
LIGAND-INDUCED TRANSACTIVATION	2.6826672785262247
FLOW CYTOMETRY EXPERIMENT	2.6823749490426487
CARRYING INSERTION MUTANT	2.6822835727978487
EXHIBITED DECREASE MUTANT	2.6822835727978487
COLLAGEN FIBRILLAR TYPE I	2.682277855039909
MITOCHONDRIAL THDP UPTAKE	2.68222690472164
THDP MITOCHONDRIAL UPTAKE	2.68222690472164
INTRACELLULAR COMPARTMENT	2.68221651220639
CONTROLLING INTRACELLULAR	2.68221651220639
MICROMOLAR FINAL CONCENTRATION	2.6820821292122616
HEPARIN Y-79 CELL CULTURE	2.6820634391171927
COVALENT ATTACHMENT	2.68205614495866
OTHER MULTIDRUG RESISTANCE	2.681948965065151
INITIATOR CASPASE ACTIVATION	2.6819055984127007
DNA DECATENATING ACTIVITY	2.681796439719468
MEASURED CASPASE ACTIVITY	2.6817632568253895
BINDING CONTACT SUBSTRATE-ENZYME	2.681718714607786
PROTEIN COMPARTMENTALIZATION	2.681707382573909
TARGET GENE TRANSCRIPTION	2.6817050228473027
WAVE MYOCARDIAL INFARCTION	2.68160435180909
MULTIPLE SIMPLE IMPUTATION	2.681572529413823
BIAPENEM REDUCED K CAT VALUE	2.6809965651549064
B. MORI RECEPTOR CRY TOXIN	2.6809963637969862
WILCOXON SIGNED-RANK TEST	2.6809931339802113
GCDCA-MEDIATED ACTIVATION	2.680983059532408
Γ-AMINO BUTYRIC ACID TYPE	2.6808584419553094
EQUATORIAL COORDINATION SITE	2.680849211082966
BACKGROUND GLYCOSAMINOGLYCAN	2.680849211082966
STENOTROPHOMONAS MALTOPHILIA	2.680849211082966
PLASMID CONSTRUCTION CLONING	2.6803118738348157
transcriptional machinery	2.68030705336728
MITOCHONDRIA MITOCHONDRIA	2.68030705336728
SUBSTRATE PHOSPHORYLATION	2.680125898870099
DECREASED PHOSPHORYLATION	2.680125898870099
STAT TRANSCRIPTION FACTOR	2.680076636716425
BONDING INTERACTION HYDROGEN	2.680049112453354
TOP67 CATENATING ACTIVITY	2.6798041723946735
CALCIUM-DEPENDENT LIPID-BINDING	2.6797171551280536
S-ADENOSYLMETHIONINE SYNTHETASE	2.6797171551280536
E. COLI TOPOISOMERASE III	2.679628826320687
UNCONJUGATED BILIRUBIN S O	2.6795908645250686
P19 CELL DECREASED ABILITY	2.679557312211052
LOW-DOSE CHLORTHALIDONE ARM	2.6795332076084115
ADRENERGIC RECEPTOR EXPRESSION	2.6794986035444284
BICINCHONINIC ACID METHOD	2.679356107831403
BILE ACID UPTAKE CAPACITY	2.6790154623033082
PRIMARY RESPONSE VARIABLE	2.6788226099307195
PHOSPHOTYROSINE PHOSPHATASE	2.678797149881877
REFERENCE REAGENT PROGRAM	2.678761433907357
HEAT/STRESS INDUCIBLE GENE	2.678588985818552
CALCIUM IMAGING MDCK CELL	2.6785727478953665
BOUND VO SIGNAL INTENSITY	2.6785434374469017
HIV-1 RT KINETIC ANALYSIS	2.6784475118836433
BOUND NON-HYDROLYSABLE VO	2.6783211665460454
SERUM TRYPTOPHAN HOMEOSTASI	2.6777552772317676
RAW CELL MACROSCOPIC FOCI	2.6776962709364422
CYTOPLASMIC RETINOIC ACID	2.6774232267329627
DOXAZOSIN TREATMENT GROUP	2.6772648374023134
IDO PHARMACOLOGIC INHIBITOR	2.677193855824079
MEASURED COX-2 EXPRESSION	2.677183749732544
E. COLI DNA TOPOISOMERASE	2.6769520728650167
CARDIOVASCULAR RISK FACTOR	2.6769426313931897
ALEXA-CALMODULIN BOUND IQ	2.6769224223933623
ANTI-HYPERTENSIVE THERAPY	2.6768745737874506
MISSING EXERCISE TIME DATA	2.6768720733463884
ORIGINAL MEASUREMENT UNIT	2.6767980794582655
FIBROBLAST-LIKE PHENOTYPE	2.6767722741423956
MULTIPLE ENZYME PREPARATION	2.6766402331894557
TAT-DEPENDENT TRANSLATION	2.6765600971007997
ANALYZING OBSERVATIONAL STUDY	2.676520730657795
HS-PEDF COMPLEX FORMATION	2.6764778041360686
ANTI-PHOSPHO-P38 ANTIBODY	2.676422082253994
MCNTCP EXTENDED TREATMENT	2.676308515751479
STRUCTURE DEPENDENT MANNER	2.6762978232381083
ABOLISHED ENZYME FUNCTION	2.676271397191743
CHO CELL ADHESIVE FUNCTION	2.6760986893499186
MEDICAL MANAGEMENT BASELINE	2.676098271551251
SCD39 HYDROLYSI CONFORMATION	2.6760657026670525
CELL-TO-CELL HETEROGENEITY	2.6759182330840754
ENERGY PREVENTING COUPLING	2.6759182330840754
HOSPITALIZED HF PARTICIPANT	2.6759161279131036
OBSERVED CD98 INTERACTION	2.675914655886521
TRANSCRIPTIONAL REPRESSION	2.675794012026658
GEL FILTRATION EXPERIMENT	2.6757108504140064
CD98-INTEGRIN INTERACTION	2.6753971267124297
BINDING AFFINITY TYPE DNA	2.675316772263353
P66 WTHOMODIMERIC SPECIES	2.67525657851232
CARRIED INSERTION SUBUNIT	2.6751398798062467
OTHER REPLICATION PROTEIN	2.674570721792878
POMBE ORC4 SUBUNIT SACCHAROMYCE	2.6743641495775887
HOMOTYPIC CELL AGGREGATION	2.674347202063795
TYPE IA DNA TOPOISOMERASE	2.674310468697148
CALMODULIN SUPPLEMENTATION	2.6742605244902626
COMMERCIAL DNA SEQUENCING	2.6740649153257063
REPRODUCTION	2.6740068693451096
TYPE P51 SPECIES SEDIMENTED	2.673793724201234
DOXAZOSIN HEMODYNAMIC EFFECT	2.6737377754371567
PROTEIN COMPLEX FORMATION	2.6735100569141212
MIDGUT EPITHELIAL RECEPTOR	2.6731313606654914
BINDING MODE DIFFERENTIAL	2.6730550559719126
HIV-1RT ENZYMATIC ACTIVITY	2.6730420378315625
HYDROLYTIC ACTIVITY OPTIMUM	2.673013839173392
pressures	2.6729771238499
REMAINING BOUND LABELED TP	2.6725797921659797
CIRCULAR DICHROISM SPECTRUM	2.672331777959615
MCNTCP CYTOTOXIC RESPONSE	2.672174328384313
CRITICAL CYSTEINE RESIDUE	2.6721574234876857
INCREASED APOPTOSI	2.6721343178216976
ANALYSIS SURVIVAL ANALYSIS	2.6720867760487392
KDA S. FRUGIPERDA PROTEIN	2.6717506818095775
AFFINITY BILE ACID BINDER	2.671643543695303
ENZYME REACTION MECHANISM	2.671504592678296
AMINOPEPTIDASE N ACTIVITY	2.671497022445718
STAINING SOLUTION COOMASSIE	2.6714580947722792
INCREASED ATPASE ACTIVITY	2.671380481085371
INTEGRIN-CD98 ASSOCIATION	2.671380481085371
PROTEIN COMPLEX UBC	2.670296298927855
BENZIMIDAZOLE N1 POSITION	2.6702705633677795
ADDED C-TERMINAL CYSTEINE	2.6702705633677795
BINDING ASSAY TRANSFECTED	2.6701674455629827
T CELL ACTIVATION ANTIGEN	2.6701037251264386
RELATIONSHIP	2.6700596381306614
CELL-DEPENDENT REGULATION	2.670027097545856
DETAILED PHARMACOPHORE MODEL	2.6699450097593918
CLEAVAGE REVERSAL EXPERIMENT	2.6699450097593918
ELEVATED CATECHOLAMINE LEVEL	2.6699450097593918
EXTRACELLULAR STIMULATION	2.669848677390265
ACID SYNTHESIS TAKES PLACE	2.6697904675405177
SHOCK PROTEIN/SUGAR KINASE	2.6693416974488904
SODIUM FRACTIONAL EXCRETION	2.6692716969502546
TOXIN N-TERMINAL SEQUENCE	2.669150240171585
AMINOPEPTIDASE N RECEPTOR	2.6687405659227252
INTERSTITIAL FLUID VOLUME	2.6686816285299635
FUNCTIONAL GROUP N-BENZYL	2.6686816285299635
SEQUENCED METALLO-Β-LACTAMAS	2.6686537227605474
NICOTINIC ACHR E LOOP REGION	2.6685430410177893
ASSEMBLED COMPLEX CONFIGURATION	2.668507390418368
N'-BIS(2-ETHANESULFONIC ACID)	2.66836253844297
APPROACHING GDCA-TREATED CELL	2.66836253844297
OTHER TETRACYSTEINE MOTIF	2.668174052123439
DISULFIDE BRIDGE FORMATION	2.668000824043179
CONTAINING AMPICILLIN LB BROTH	2.667786326145272
NTPDAS ENZYMATIC MECHANISM	2.6677005323626095
BLOOD-PRESSURE REDUCTION	2.6674536437245666
SEPHADEX G10 SPIN COLUMN	2.6674536437245666
BOVINE INTESTINAL MUCOSA	2.6674536437245666
MATERNAL-FETAL INTERFACE	2.6674536437245666
TRANSACTIVATION ACTIVITY	2.6674536437245666
MOLECULAR WEIGHT COMPLEX	2.6674536437245666
HETEROOLIGOMERIC COMPLEX	2.6674536437245666
PHAGE DISPLAY TECHNOLOGY	2.6674536437245666
CRITICAL REGULATORY STEP	2.6674536437245666
DIVERSE CELLULAR PROCESS	2.6674536437245666
BLAST SEQUENCE ALIGNMENT	2.6674536437245666
SUPER-INFECTION IMMUNITY	2.6674536437245666
CELL-DEPENDENT VARIATION	2.6674536437245666
ENGINEERED V-ATPASE GENE	2.6674536437245666
eukaryotic topoisomerase	2.6674536437245666
DIRECTED EXPERIMENTATION	2.6674536437245666
ENDOPROTEOLYTIC CLEAVAGE	2.6674536437245666
MISSING VISIT TIME-POINT	2.6674536437245666
NON-LINEAR CURVE FITTING	2.6674536437245666
NON-CARDIOVASCULAR DEATH	2.6674536437245666
BIOLOGICAL ACTIVITY DATA	2.6674536437245666
CHEMOMECHANICAL COUPLING	2.6674536437245666
ΜM MILLIPORE MEMBRANE FILTER	2.667435577119828
TOP67 RELIGATION CAPABILITY	2.667331990056284
GST FUSION PROTEIN	2.6672256026670023
CELLULAR GENE EXPRESSION	2.667199703167131
ENDOGENOUSIDO EXPRESSION	2.6670727328884127
SECONDARY PREVENTION TRIAL	2.6670157239691537
LIQUID SCINTILLATION SOLUTION	2.666775981562729
PHARMACOLOGICAL ANALYSIS	2.6667531310989125
DNA PASSING DOUBLE-STRAND	2.6667015587602187
DNA REPLICATION MACHINERY	2.6662379400135032
SIMILAR SELECTIVE EFFECT	2.6660911974294534
SECONDARY PREVENTION STUDY	2.666029599882578
STRUCTURE-FUNCTION STUDY	2.666007354580523
SEMI-OBSERVATIONAL STUDY	2.666007354580523
ULTRACENTRIFUGATION EXPERIMENT	2.6660006118595576
EIGHT-WEEK DOUBLE-BLIND PERIOD	2.6660006118595576
CULLIN NEDDYLATION RESULT	2.665843912060082
TRYPTOPHAN COMMON FEATURE	2.665694418328474
THIAMINE UPTAKE PROPERTY	2.665642298939156
THIAMINE CELLULAR UPTAKE	2.665642298939156
RELIGATION CLEAVED DNA END	2.665581221111332
PRAZOSIN VOLUME EXPANSION	2.665553413068014
P66 INSSUBUNIT DIMERIZATION	2.6655118262684416
MRNA	2.665438237438753
EXPRESSED COX-2 MC57 CELL	2.6654368717076666
INTERMEDIATE-TERM EFFECT	2.665409974281897
HIV-RNA EXPRESSION CLONE	2.665124453843448
IDO SENSE TRANSFECTED P19	2.665043453905518
EXPRESSING BTR175 SF9 CELL	2.6649998062516413
MULTIPLE CULLIN UBIQUITIN	2.664968053237151
CTC	2.6649447947346347
SURFACE MANNOSE RECEPTOR	2.6647287511343403
PURIFIED RECEPTOR SAMPLE	2.6647287511343403
STEROID HORMONE RECEPTOR	2.6647287511343403
CONSERVED GLYCINE RESIDUE	2.6646920204045785
ADJUSTED YOL PLOTTED MEAN	2.664405764915815
SCALE IMMUNOPRECIPITATION	2.6643879994645427
LIGAND GATED ION CHANNELS	2.6639673752874415
COMPLEMENTARY DNA STRAND	2.6639255074639356
TRANSCRIPTION START SITE	2.663835137398053
PUTATIVE CSN HOLOCOMPLEX	2.6637231360117566
FRACTIONAL AMOUNT	2.6634005235755676
POSITION RELATIVE	2.6634005235755676
SUBCONFLUENT CELL	2.6634005235755676
RESIDUAL ACTIVITY	2.6634005235755676
INVADING PATHOGEN	2.6634005235755676
MARGINAL DECREASE	2.6634005235755676
FUNCTIONAL DOMAIN	2.6634005235755676
RESTRICTIVE MODEL	2.6634005235755676
NON-ADHERENT CELL	2.6634005235755676
STRUCTURAL DETAIL	2.6634005235755676
PROPOSED FUNCTION	2.6634005235755676
TESTING PROCEDURE	2.6634005235755676
RECEPTOR DOWN-MODULATION	2.6633663048392267
BILIRUBIN COLLOID SUSPENSION	2.6632689681327135
INTEGRAL MEMBRANE PROTEIN	2.6631860304296735
PURIFIED GSTCDC6 FRACTION	2.662769440776228
MOLECULAR CHAPERONE HSP90	2.662723122888155
SCREENING OTHER CRY TOXIN	2.662723122888155
REGULATING CELL ADHESION	2.6627057248173536
APN STRUCTURAL ALIGNMENT	2.6622309329266325
ENCODING HUMAN CD98 CDNA	2.6620322583179954
POTENTIATE TRANSCRIPTION	2.6620258842347964
KEY VARIABLE DISTRIBUTION	2.6618599258831535
E. COLI TOPOISOMERASE I.	2.661782715208899
OPEN-LABEL MEDICINE PRESCRIPTION	2.661767879936216
STRUCTURES REPRESENTATIVE	2.661591006816211
GENERAL COMPUTER PROGRAM	2.6615411409344523
DIFFERENTIAL CYTOTOXICITY	2.6614965805418964
TYPE POLYMERASE ACTIVITY	2.66134917655815
MM SODIUM CARBONATE BUFFER	2.6610067755985525
ANTI-LIGHT CHAIN REAGENT	2.6609252552271485
NEGATIVE-CONTROL PEPTIDE	2.660894890629486
CGG CCG CGT AGA CAG CAA TGG CAC TC	2.660633573145981
TOTAL LIGAND CONCENTRATION	2.660488145418662
FILTRATION CHROMATOGRAPHY	2.660339720631431
LERISETRON N-BENZYL GROUP	2.660339720631431
WEIGHT-AVERAGE AGGREGATION	2.660207922881273
AMINOPEPTIDASE         N MG	2.6601299080950445
IN VIVO STUDY	2.6599803813679297
REVIEWED DISCHARGE SUMMARY	2.659893716677217
NUCLEAR HORMONE RECEPTOR	2.659754740850593
BOUND SUBSTRATE MOLECULE	2.6593668657148615
INCREASED MMP EXPRESSION	2.6593656369702288
INDUCED COX-2 EXPRESSION	2.6593656369702288
SUBSTRATE UBIQUITYLATION	2.6592072582541437
SPECTROPHOTOMETRIC ASSAY	2.659089871984102
NON-CONJUGATED BILE ACID	2.659083951781222
RETINOBLASTOMA-DERIVED HEPARIN	2.6590561674151134
MAB 6B12 CO-IMMUNOPRECIPITATED	2.6588400261062692
LP	2.6588356325547484
nm	2.6588356325547484
SL	2.6588356325547484
NW	2.6588356325547484
rd	2.6588356325547484
th	2.6588356325547484
XL	2.6588356325547484
RD	2.6588356325547484
KC	2.6588356325547484
QI	2.6588356325547484
JM	2.6588356325547484
MS	2.6588356325547484
GO	2.6588356325547484
AU	2.6588356325547484
RJ	2.6588356325547484
G3	2.6588356325547484
OD	2.6588356325547484
LF	2.6588356325547484
6I	2.6588356325547484
UA	2.6588356325547484
PT	2.6588356325547484
IB	2.6588356325547484
QΑ	2.6588356325547484
E3	2.6588356325547484
XE	2.6588356325547484
E7	2.6588356325547484
SR	2.6588356325547484
XP	2.6588356325547484
JJ	2.6588356325547484
FG	2.6588356325547484
ED	2.6588356325547484
AD	2.6588356325547484
VT	2.6588356325547484
F1	2.6588356325547484
HV	2.6588356325547484
MH	2.6588356325547484
ie	2.6588356325547484
ΔC	2.6588356325547484
YM	2.6588356325547484
MQ	2.6588356325547484
RM	2.6588356325547484
kd	2.6588356325547484
PV	2.6588356325547484
BD	2.6588356325547484
NO	2.6588356325547484
VA	2.6588356325547484
LY	2.6588356325547484
FD	2.6588356325547484
RV	2.6588356325547484
PL	2.6588356325547484
ME	2.6588356325547484
TU	2.6588356325547484
QE	2.6588356325547484
WB	2.6588356325547484
AJ	2.6588356325547484
UT	2.6588356325547484
B1	2.6588356325547484
DL	2.6588356325547484
F2	2.6588356325547484
NH	2.6588356325547484
NA	2.6588356325547484
LE	2.6588356325547484
MZ	2.6588356325547484
HW	2.6588356325547484
GB	2.6588356325547484
G4	2.6588356325547484
TL	2.6588356325547484
FT	2.6588356325547484
ZP	2.6588356325547484
CV	2.6588356325547484
WA	2.6588356325547484
KO	2.6588356325547484
E2	2.6588356325547484
LW	2.6588356325547484
JY	2.6588356325547484
VN	2.6588356325547484
UB	2.6588356325547484
HOMOLOGOUS SCORPION TOXIN	2.6587220701037757
CARDIAC RECEPTOR ALPHA-1	2.6587025463674925
CELL MIGRATION ASSAY P19	2.6586634836208627
ANTIHYPERTENSIVE TREATMENT	2.658640098046748
CALMODULIN-BINDING PROPERTY	2.658555562402179
G/L PENICILLIN/STREPTOMYCIN	2.658555562402179
AP-1 FUNCTIONAL INTERACTION	2.6585131272083014
LOWERING TREATMENT LIPID	2.658412216164455
BINDING ZD DOMAIN ZN(II)	2.6582552176843843
ACTIVATED PROTEIN MITOGEN	2.658013658632448
MISSING DATA INFORMATION	2.6579987362455473
CPLA ANALYZING GEL SHIFT	2.657991476580205
TYRAMIDE SIGNAL AMPLIFICATION	2.6579678115565595
ACRYLAMIDE CRITERION GEL	2.6579096036877323
GEL SHIFT CHARACTERISTIC	2.6579096036877323
F-BOX PROTEIN DEPENDENCY	2.6577076484303825
HIV-1 PROTEASE INHIBITOR	2.657525701730695
NORMAL HUMAN LYMPHOBLAST	2.657345171212435
IDO-EXPRESSING RAW CLONE	2.657343454711754
ERK MAPK PATHWAY CONTROL	2.657161923193492
CDNA MONOCLONAL ANTIBODY	2.657104282328193
BACKBONE CONTROL PLASMID	2.6570329543004134
ORIGINAL BASELINE WEIGHT	2.6570082221286975
MOUSE MODEL AMPA RECEPTOR	2.6568820602560974
DIMINISHED ADPASE ACTIVITY	2.6568414278378154
IQ1 BINDING STOICHIOMETRY	2.6568239740075286
DECREASED ERK ACTIVATION	2.6566322771293014
REDUCED GLUTATHIONE ELUATE	2.6566223640455138
TYPE HETERODIMERIC ENZYME	2.656459365932729
HIV-1 RT TERNARY COMPLEX	2.6563569099753126
FUNCTIONAL PEDF RECEPTOR	2.6562594903809327
NUCLEOPHILIC SUBSTITUTION	2.656253888191334
DE-ESTERIFICATION MIN INCUBATION	2.6561152718875443
FIBROBLAST GROWTH FACTOR	2.65610685348566
BETA RECEPTOR STIMULATION	2.656068927150332
AFFINITY THIAMINE UPTAKE	2.6559256276871848
THIAMINE AFFINITY UPTAKE	2.6559256276871848
REMODELLING FACTORS BIND	2.6558476197291565
CAUSE NEUROHORMONAL CHANGE	2.655527942886433
STOICHIOMETRY DETERMINATION	2.655488655208285
CELL CYCLE ANALYSIS HELA	2.6552494456997073
ATCC	2.6551259193122623
AMBULATORY MEDICAL CARE SURVEY	2.6548895007484465
EXCITATORY MECHANICAL STIMULUS	2.6548895007484465
QUANTITATIVE MEASUREMENT	2.654749752594456
UNCONJUGATED BILIRUBIN NM	2.6545121711575743
SINUSOIDAL MEMBRANE VESICLE	2.6545072449062395
MUTANT TOXIN CONSTRUCTION	2.6545025684792303
stimulatory	2.6544729541097203
SIGNALING PROTEIN	2.654374623223499
PROTEIN STRUCTURE	2.654374623223499
REGULATING TRANSLOCATION	2.6543055605968995
PREVENTING TRANSLOCATION	2.6543055605968995
DNA DEPENDENT POLYMERASE	2.654198350726697
SUBGROUP	2.654188212576724
HEPARIN DEGRADING ENZYME	2.6541114726970565
TAT-TIP60 INTERACTIONS CONTROL	2.6539398331321125
HOST SIGNAL TRANSDUCTION	2.653819382526075
UBIQUITIN ANTIBODY	2.653768873351124
EXPRESSING GST BACULOVIRUS	2.6536704067001065
ERYTHROLEUKEMIA K562 CELL	2.6536661943126054
CONSTITUTIVE ASSOCIATION	2.6536288210241517
APOPTOSI EXECUTION PHASE	2.653588039836245
ESSENTIAL CA EGTA CHELATE	2.6534498842938965
GRAPHPAD PRISM	2.6532757775919715
CLINICAL EVENT	2.6532757775919715
CYCLOOXYGENASES 1 PHARMACOLOGICAL INHIBITOR	2.6532138917628396
GRANULOCYTE CHEMOTACTIC FACTOR	2.6531771719813233
BLOOD PRESSURE ABBREVIATION	2.6530351294531704
ENDPOINT SURVIVAL ANALYSIS	2.6528419252086324
RIBOSOMAL RRNA PHYLOGENY	2.652832323000746
CAPILLARY ELECTROPHORESI	2.6527647696053758
POP1 DELETION BACKGROUND	2.652531612873325
PASSING SINGLE-STRAND DNA	2.652292808753663
NEUROBLASTOMA MITOCHONDRIA	2.6519951075263184
BASELINE CHOLESTEROL LEVEL	2.6518814584737878
PCDNA3 EXPRESSION VECTOR	2.6518048297760193
CELL SURFACE HETERODIMER	2.6517855113307633
CELLULAR DOWN-REGULATION	2.6517855113307633
DMUT OLIGONUCLEOTIDE RESULT	2.651739164567135
SATURATING CONCENTRATION	2.6515199497647663
INCREASING CONCENTRATION	2.6515199497647663
ONCOGENIC TRANSFORMATION	2.651056760986865
BASELINE ELIGIBILITY RISK	2.6510245901447367
ACTING	2.6505288168167707
LYMPHOBLAST MITOCHONDRIA	2.6497907010637416
OVEREXPRESSING PROTΑ SHOW	2.6497037880608025
CHRONIC SODIUM HOMEOSTASI	2.649626093820571
IQ PEPTIDE CONCENTRATION	2.649609927676985
STRESS SIGNAL INTRODUCTION	2.649564291714749
DISULFIDE-LINKED HETERODIMER	2.6494996322776894
INDIVIDUAL P19 AGGREGATE	2.6492568685462428
EVENT ASCERTAINMENT METHOD	2.649210705739311
INCLUDING PHOTORECEPTOR	2.6488392428691414
METALLOPROTEINASE NSAID	2.6488392428691414
SIDE-BY-SIDE COMPARISON	2.6488392428691414
DOSE-DEPENDENT DECREASE	2.6488392428691414
CLEAVAGE SITE SELECTION	2.6488392428691414
CONTAINING SUB FRAGMENT	2.6488392428691414
LERISETRON-BINDING SITE	2.6488392428691414
IN VITRO RECONSTITUTION	2.6488392428691414
YEAST CANDIDA TROPICALI	2.6488392428691414
NUCLEOTIDE-BINDING SITE	2.6488392428691414
EXAMINING HEALTH STATUS	2.6488392428691414
PATHLENGTH OPTICAL CELL	2.6488392428691414
MECHANICAL COMPLICATION	2.6488392428691414
MAJOR PHENOTYPIC DEFECT	2.6488392428691414
DOSE-DEPENDENT INCREASE	2.6488392428691414
LOWERING BLOOD PRESSURE	2.6488392428691414
TWO-WEEK WASHOUT PERIOD	2.6488392428691414
EXTRAPOLATION PROCEDURE	2.6488392428691414
BIOISOSTERIC EQUIVALENT	2.6488392428691414
NON-ATTACHED SUSPENSION	2.6488392428691414
CORONARY ARTERY DISEASE	2.6488392428691414
THERMOLYNE AMPLITRON II	2.6488392428691414
POTENTIAL CLEAVAGE SITE	2.6488392428691414
DUAL IMAGING MICROSCOPY	2.6488392428691414
INTERESTING POSSIBILITY	2.6488392428691414
SURROUNDING ENVIRONMENT	2.6488392428691414
HUMAN SKP1-SKP2 COMPLEX	2.6488392428691414
VENTRICULAR DYSFUNCTION	2.6488392428691414
PHYSIOLOGICAL RELEVANCE	2.6488392428691414
ASYNCHRONOUS POPULATION	2.6488392428691414
PRE-CYCLED CM-52 COLUMN	2.6488392428691414
CEREBROVASCULAR DISEASE	2.6488392428691414
HEPARIN/HS-PEDF COMPLEX	2.6488392428691414
ELECTRICAL CONDUCTIVITY	2.6488392428691414
X-RAY CRYSTAL STRUCTURE	2.6488392428691414
NON-DESENSITIZING PHASE	2.6488392428691414
T701-CALMODULIN COMPLEX	2.6488392428691414
CERVICAL ADIPOSE TISSUE	2.6488392428691414
PROTEIN-PROTEIN COMPLEX	2.6488392428691414
DOCUMENTED LUNG DISEASE	2.6488392428691414
INTERNAL CAROTID ARTERY	2.6488392428691414
ANTIBIOTIC G418-SULFATE	2.6488392428691414
NON-HYDROLYZABLE ANALOG	2.6488392428691414
INVESTIGATING MECHANISM	2.6488392428691414
ANTIRETROVIRAL STRATEGY	2.6488392428691414
STRAND ABUNDANCE ANALYSIS	2.6486653119918286
WHOLE-GENOME EXPRESSION	2.6484629174080574
GIVE THIAMINE DIPHOSPHATE	2.648311728831685
VO POSSIBLE METAL LIGAND	2.6481997695888975
DOXAZOSIN ARM TERMINATION	2.6481532812666186
LONGITUDINAL STUDY CASE	2.6478866569840593
MILD HYPERTENSION STUDY	2.6478866569840593
MITOCHONDRIAL PREPARATION	2.6478268587836324
RECEPTOR DOWN-REGULATION	2.647698172445423
CHANGE CURRENT PRACTICE	2.647570429702536
DECONVOLUTION ALGORITHM	2.647321642807124
OBSERVED IDO EXPRESSION	2.6470557334232128
GLYCINE CONSERVED NATURE	2.6470169492978664
CRITICAL GLYCINE RESIDUE	2.6470169492978664
TRANS-INHIBITORY EFFECT	2.646820174960544
EXTRACELLULAR BACTERIUM	2.6467660927844205
GENETIC SCREEN	2.6467412850347727
IMMUNOPRECIPITATION STEP	2.6467164096739446
ΔPOP1 POP2-13MYC STRAIN	2.646643566183669
DISTAL OXYGEN SUBSTITUTION	2.6465845481339816
MEMBRANE PROXIMAL REGION	2.6465628005328288
RELEASE INTERMEDIATE ADP	2.6465444591428446
COLIDNA TOPOISOMERASE I	2.646528866655323
SUPERNATANT FRACTION	2.6464046417680507
CLEAVED DNA GATE STRAND	2.646224994246443
LEPTIN RECEPTOR VARIANT	2.6461471523243443
BINDING REGION RECEPTOR	2.6461471523243443
TRANSCRIPTIONAL OUTCOME	2.6461393264797373
AFFINITY THIAMINE IMPORT	2.6461330449410574
SEIKAGAKU	2.646117984882032
ENDOGENOUS HAMSTER CD98	2.6460995047040825
PRIMARY MOUSE HEPATOCYTE	2.646083633128062
BCA PROTEIN ASSAY	2.64594696982537
F-BOX/WD REPEAT PROTEIN	2.6459407954715837
PROTEIN A-SEPHAROSE 4CL	2.6459407954715837
INCLUDING PROLIFERATION	2.6459368327505324
INHIBITED PROLIFERATION	2.6459368327505324
COMPOUND BINDING AFFINITY	2.6458181726278327
C4 GUARD COLUMN CARTRIDGE	2.6457413818089996
DETAILED CHARACTERIZATION	2.645741381808999
ANTIHYPERTENSIVE EFFICACY	2.645741381808999
IMMUNOSTAINING EXPERIMENT	2.645741381808999
DIVERSE INTEIN SEQUENCE	2.645712066983771
ENCODING PORTION INTEIN	2.645712066983771
R ANTAGONIST GRANISETRON	2.6455807523486015
BINDING SITE NUCLEOTIDE	2.6454120427290864
POLYPEPTIDE CHARACTERIZATION	2.645410556781349
TIME DEPENDENT INCREASE	2.6452601629540933
NON-CALMODULIN RECEPTOR	2.644801107051946
PHOSPHOTYROSINE-CONTAINING PROTEIN	2.6447301719057723
CONTINUOUS DISTRIBUTION	2.6445591910813304
TCA-MEDIATED ACTIVATION	2.6445591910813304
PROTEIN OLIGOMERIZATION	2.6444915717728046
POLY(A)-BINDING PROTEIN	2.6444915717728046
CALMODULIN-LIKE PROTEIN	2.6444915717728046
ELECTROPHORESIS ANALYSIS	2.6443700848220497
CARCINOMA CELL LINE P19	2.6442864426830877
IDO OVEREXPRESSING CLONE	2.6442419286716192
HIV-1RT EXPRESSION CLONE	2.64423361065171
P35 BINDING SPECIFICITY	2.6441484790410863
CYCLIN DEPENDENT KINASE	2.644067136315744
PNEUMOCYSTIS CARINII	2.643730445517444
DNA CLEAVAGE-RELIGATION	2.643610745623745
GAT CTT ACA CTA AGG CCA ACT CAG	2.6434855941913917
INCLUDING TRANSCRIPTION	2.6434768223266762
ACTIVATED TRANSCRIPTION	2.6434768223266762
CALMODULIN PEPTIDE BIND	2.6434518234990207
CLONING VECTOR PGEM T-EASY	2.6434014413168625
COX STIMULATORY CO-FACTOR	2.643099777641131
STIMULATED FOCUS FORMATION	2.6430363142724937
CLOSED POLYMERASE CLEFT	2.642808260804499
EXCLUSION CHROMATOGRAPHY	2.642714487313298
CELL EXTRACT PREPARATION	2.642714487313298
ENDOTHELIAL CELL GROWTH	2.642362455993584
GSTCDC6 PROTEIN FRACTION	2.6421826211352397
F-BOX SIGNATURE RESIDUE	2.642109016507149
HF RECOGNIZED TREATMENT	2.6418251566197726
BINDING DOMAIN ACID DNA	2.641823234824856
NON-STRINGENT DETERGENT	2.6415832175726184
FUNCTIONAL ASBT PROTEIN	2.6415803671243774
1IN MULTIPLE EXPERIMENT	2.6414016353579908
U937 MONOCYTIC CELL LINE	2.641340089734894
MONOCYTIC CELL LINE P388	2.641340089734894
LIPID-LOWERING TREATMENT	2.6412335038002426
P66 WT ACTIVITY PROFILE	2.64119246227496
XYLOSTELLA APN RECEPTOR	2.6409873121134835
IDO-EXPRESSING MC57 CELL	2.64098560710155
DOXAZOSIN TREATMENT ARM	2.64092779310484
CONSTANT CARBOXYL GROUP	2.6409010271601248
SPODPTERA FRUGIPERDA SF9	2.6407844822031987
ENZYME PROTEIN INDUCTION	2.6406079370254765
TARGET UNKNOWN SUBSTRATE	2.640593988192332
LIFE-PROLONGING THERAPY	2.640546642530258
INSERTION MUTANT ABILITY	2.640477551133417
PEDF NEUROTROPHIC EFFECT	2.640212900682931
VIRAL PROGENY FORMATION	2.640159137841525
INFECTIOUS HIV-1 GENOME	2.6398177811051853
HIGH-DENSITY LIPOPROTEIN	2.6398039983237367
DIMINISHED PG SYNTHESIS	2.639733642497034
INHIBITING PG SYNTHESIS	2.639733642497034
LOCF LAST-OBSERVATION-CARRIED-FORWARD	2.639664880150458
EXCHANGED HYPERVARIABLE	2.639551530489592
HEART FAILURE OCCURRENCE	2.6394977881408725
C-TERMINAL C-MYC EPITOPE	2.639474835878489
DISULFIDE LINKAGE ABSENCE	2.6393044932856626
CALCIUM-DEPENDENT LIPID	2.6392312645454696
INDEPENDENT INTERACTION	2.6391036953014795
CONTROLLING INTERACTION	2.6391036953014795
BIOCHEMICAL INTERACTION	2.6391036953014795
PURIFIED CSN PREPARATION	2.6389839796004875
NEGATIVE SUPERHELICAL TURN	2.638527694801405
EXTENSIVE BASELINE DATA	2.63851956244742
BASELINE PULSE PRESSURE	2.63851956244742
NONHYDROLYSABLE ATP ANALOG	2.638346626819407
ATP NONHYDROLYSABLE ANALOG	2.638346626819407
CD98 MOLECULE ASSOCIATE	2.638110074700169
OVEREXPRESSED GFP-FUSION	2.638075895486185
CELLULAR HOST CELL MRNA	2.6379778909101326
B. THURINGIENSIS INSECTICIDAL	2.6376937041405752
VELOCITY-SEDIMENTATION EXPERIMENT	2.637555013910796
EXCESS CALMODULIN BLOCK	2.637452009300345
MEASUREMENT VALUE	2.637344334890287
PLASMID PURIFICATION KIT	2.637309761700926
PFIZER ADVISORY BOARD MEMBER	2.637232405788668
UV-VISIBLE SPECTROPHOTOMETRY	2.637232405788668
ISOPYCNIC FRACTIONATION	2.6372296023947044
TOTAL CELL FLUORESCENCE	2.637112333299003
INSERTION MUTANT ENZYME	2.6369476439132367
CHANGE NMR CHEMICAL SHIFT	2.6368422071123274
SUCROSE GRADIENT FRACTION	2.6364593854628073
WATER MOLECULE	2.6364143621788947
STOP CODON	2.6363979778555784
MRNA ACCUMULATION	2.63626635895412
EVENT MEDICAL MANAGEMENT	2.6361173789369596
HUMAN NEUROBLASTOMA CELL	2.6361173789369596
POLYPEPTIDE COMPLEX BIND	2.6361173789369596
TRYPTOPHAN CONCENTRATION	2.6361086720003697
REVERSED PHASE HPLC ION-PAIR	2.6360640985039994
MAJOR BILE ACID SPECIES	2.6360505091315334
EXTENSIVE TRANSLOCATION	2.635849435345296
MAJOR POLYANIONIC COMPONENT	2.6357837764875187
LABELED TEMPLATE PRIMER	2.6356651827563056
P66 IN RNASE H ACTIVITY	2.6354947608011594
CO-IMMUNOPRECIPITATED INTEGRIN	2.6353826343314677
PROGRESSIVE ASSOCIATION	2.6351808423109806
LERISETRON INHIBITION NM	2.635102439186754
BIDIRECTIONAL TRANSPORT	2.635045610622286
TRANSCELLULAR TRANSPORT	2.635045610622286
MITOCHONDRIAL TRANSPORT	2.635045610622286
TARGET PROTEIN	2.634909351697184
DESCRIPTIVE INFORMATION	2.6348276078137864
VERSA	2.6344478886502016
OVARY	2.6344478886502016
moves	2.6344478886502016
NADPH	2.6344478886502016
EXTENSIVE NEURONAL LOSS	2.6344396887923205
P51 HOMODIMER PREPARATION	2.6343547099358475
CELL ACTIVATION ANTIGEN	2.6343032179294066
HPAI RESTRICTION ENZYME	2.63422439491306
HEALTH EVENT PREDICTIVE	2.634096842266682
IONO-INDUCED AA RELEASE	2.633958432631753
ACID TRANSPORT ACTIVITY	2.633774475475788
ACID TRANSPORT FUNCTION	2.633774475475788
REPLICATION C-MYC ORIGIN	2.6336027404046205
ORDERED LIPID MICRODOMAIN	2.6335223359290554
AMINOPEPTIDASE         N MW	2.6331411247887804
SUBSTRATE CONCENTRATION	2.6330973574800747
INCREASED CONCENTRATION	2.6330973574800747
SHOCK PROTEIN EXPRESSION	2.632929674560906
INDIVIDUAL HPLC FRACTION	2.632841811189126
BINDING DOMAIN HEPARIN/H	2.6326355717383363
PURIFIED RABBIT ANTISERA	2.6326355717383363
H1-CONTAINING CHROMATIN	2.632545010624318
TERMINATED PRIMER DIDEOXY	2.632533360969657
CONSERVED TETRACYSTEINE	2.6322540421913745
STRUCTURAL DETERMINATION	2.6318442519204677
TRANSCRIPTION HORMONAL-REGULATION	2.6316320543069334
HYDROPHOBIC ORGANIC ANION	2.6314974377665705
SUCROSE DENSITY GRADIENT	2.6313363899478053
REDUCED DIMER STABILITY	2.63114836214619
STAT	2.6311239093877443
NUNC	2.6311239093877443
IL-2	2.6311239093877443
NFAT	2.6311239093877443
FLAG	2.6311239093877443
SMAC	2.6311239093877443
HMMS	2.6311239093877443
P100	2.6311239093877443
DUTP	2.6311239093877443
java	2.6311239093877443
ANTI-INFLAMMATORY DRUG PG	2.63075749262151
MEDLINE	2.630615720838658
EQUATORIAL METAL LIGAND	2.6303562331585955
POST-THERAPY OBSERVATION	2.6302224380363204
PLXIZ RETROVIRAL VECTOR	2.6298906771230426
COP9/SIGNALOSOME ABBREVIATION	2.6297798580863208
INTERNAL RIBOSOME ENTRY	2.629489842078413
CHOLESTATIC LIVER CELL	2.629464863654051
MOLECULAR WEIGHT RANGE	2.629464863654051
FIBROSARCOMA CELL LINE	2.629464863654051
VGMCA ACQUISITION MODE	2.629464863654051
STATISTICAL LITERATURE	2.629464863654051
NON-ESSENTIAL FUNCTION	2.629464863654051
MICROPLATE FLUOROMETER	2.629464863654051
PITSLREAND P58 PITSLRE	2.629464863654051
BIND METAL-ADP COMPLEX	2.629464863654051
GROWING PUBLIC CONCERN	2.629464863654051
VENTRICULAR ARRHYTHMIA	2.629464863654051
COMPETITIVE ANTAGONIST	2.629464863654051
QUENCHING FLUORESCENCE	2.629464863654051
CONSENSUS SEQUENCE IQX	2.629464863654051
competitive antagonist	2.629464863654051
CARDIOVASCULAR OUTCOME	2.629464863654051
CELLULAR RADIOACTIVITY	2.629464863654051
NON-ADHERENT CELL LINE	2.629464863654051
LOWERED BLOOD PRESSURE	2.629464863654051
RESTRICTIVE ASSUMPTION	2.629464863654051
INTEREST CORRESPONDING	2.629464863654051
NUMEROUS VALUABLE CROP	2.629464863654051
ENGLISH-LANGUAGE PAPER	2.629464863654051
sodium dodecyl sulfate	2.629464863654051
COMPUTER PROGRAM QPOWA	2.629464863654051
TERMINALLY-BOUND WATER	2.629464863654051
INCLUDING D-TRYPTOPHAN	2.629464863654051
CHRONIC VOLUME LOADING	2.629464863654051
SPECTROSCOPIC PROPERTY	2.629464863654051
translation initiation	2.629464863654051
COMPARE NIFEDIPINE-GIT	2.629464863654051
VOLUME-TO-VOLUME RATIO	2.629464863654051
CHENG-PRUSOFF EQUATION	2.629464863654051
fibrosarcoma cell line	2.629464863654051
MATERNAL IMMUNE SYSTEM	2.629464863654051
ATPASE/ADPASE ACTIVITY	2.629464863654051
PATHOLOGICAL CONDITION	2.629464863654051
LIQUID SCINTILLATION COUNTER	2.629443690557544
ZN(II) DEPENDENT ENZYME	2.6294213828631015
COMPROMISED EXPRESSION	2.629093310777169
CONCLUSIONS EXPRESSION	2.629093310777169
CALMODULIN IQ3 AFFINITY	2.629066386632079
IQ3 CALMODULIN AFFINITY	2.629066386632079
BINDING CYSTEINE ZN(II)	2.628982554417233
HYDROLYSI OBSERVED RATE	2.628865667859358
CENTRIFUGATION EXPERIMENT	2.6287596407298444
GLASS MICROARRAY SLIDE	2.6286851081267173
COGNATE HORMONE ABSENCE	2.628621093471483
P66 CATALYTIC FUNCTION	2.6283885813768864
RANDOMIZATION ASSIGNMENT	2.6282833127400576
DESENSITIZATION KINETICS	2.6282833127400576
CFP/YFP IMAGING APPROACH	2.6282833127400576
DENATURING TRIS/TRICINE SD	2.6281052451058873
POPULATION-BASED STUDY	2.6280541059615214
INDUCED ALTERATION IDO	2.6279516747099185
DMSO CONCENTRATION	2.627792873348617
SINGLE-STRAND SUBSTRATE	2.6277308056428925
ALTERED IDO EXPRESSION	2.6277039727919975
C-TERMINAL EPITOPE TAG	2.627645434090273
NON-SIGNIFICANT EFFECT	2.627471401697216
P53 RESPONSIVE ELEMENT	2.6274338725130892
GEL FILTRATION FRACTION	2.627328516166145
CHO CELL FLOW CYTOMETRY	2.6272993438756895
SOLVENT B GRADIENT ELUTION	2.6271987768289
WEIGHT SPECIES REACTIVE	2.6271569356000986
MONOCLONAL MYC ANTIBODY	2.627139794285246
ALTERED BIOPHYSICAL/ENZYMATIC	2.627077569189746
EXPRESSION STRAIN BL21	2.6270493307665217
THIAMINE MONOPHOSPHATE	2.6268145963125935
RECEPTOR FAMILY MEMBER	2.6268069143782706
MANNOSE RECEPTOR LEVEL	2.6268069143782706
RABBIT ANTISERA ANTIBODY	2.626741603439727
NEUROTROPHIC OPPOSITE SIDE	2.6266528818343633
PROTEIN BAND INTENSITY	2.626603174556663
INITIATE PROLIFERATION	2.6265992620911
INTRACELLULAR PATHOGEN	2.626428464646951
INTEIN SPLICING DOMAIN	2.6263773468185487
CLINICAL TRIAL TWO-COMPONENT	2.6263282044650937
FLUOROSTAR BMG LABTECHNOLOGY	2.6263282044650937
YEAST GENOME ASSOCIATE	2.62616632948087
RING DOMAIN PROTEIN HRT1	2.6260829898760947
DISCONTINUED TREATMENT	2.6257220371228502
HYALURONIDASE TREATMENT	2.6256989390663525
EUKARYOTIC VACUOLAR ATPASE	2.6255330239336585
B. TAMULUS INSECT TOXIN	2.625449857297932
TAT PEPTIDE ANTAGONIST	2.625199782258031
APPLIED PHOTOPHYSICS PD	2.6250245957420915
PROTΑ MRNA ACCUMULATION	2.6246462481492996
IL-8 PROTEIN PRODUCTION	2.6242713508854973
TRANSCRIPTION ACTIVITY	2.624170449680932
PRIMER EXTENSION ASSAY	2.624025999477632
COMPARISON CODON USAGE	2.624006574962716
ATP-DEPENDENT TRANSPORTER	2.623888110965723
CATENANE FAVOR FORMATION	2.623849703106297
ACID SEQUENCE IDENTITY	2.6236702822945297
EQUILIBRIUM ULTRACENTRIFUGATION	2.6236683315796263
MM POTASSIUM PHOSPHATE	2.623614831755204
STABLE TERNARY COMPLEX	2.6234714486204287
HUMAN BILE ACID BINDER	2.6233418103860684
LIPID METABOLITES PLAY	2.6231407774461597
ELEVATED IONIC STRENGTH	2.6230400418148374
CELLULAR IONIC STRENGTH	2.6230400418148374
INCREASING LDH ACTIVITY	2.6230400418148374
TYR228 AROMATIC PORTION	2.6230400418148374
INCLUDING PROSTAGLANDIN	2.6230400418148374
CELL CULTURE MDCK CELL	2.6229149172244495
CELLULAR DEFENSE MECHANISM	2.6225031783945467
HIV-1 RT MUTANT ABILITY	2.62244037356292
CSN FUNCTION DIVERSIFICATION	2.6224338468495314
TOXIN MOLECULAR WEIGHT	2.622187145398938
REVEALED MULTIPLE COPY	2.6221215803696127
TERTBUTYLDIMETHYL SILYSPIRO	2.6221207049387223
SYNGENEIC MURINE FETUS	2.622099462046467
CCG CGT AGA CAG CAA TGG CAC TC	2.6217876488965945
LIPOPROTEIN SUBFRACTION	2.6215224417528193
TRITON X-100 DETERGENT	2.621437114594721
ACID TOPOISOMERASE III	2.6213892064235242
HF DIAGNOSIS VALIDATION	2.6213883012791106
BINDING ASSAY RECEPTOR	2.6213680502018515
P51 PLAY THUMB SUBDOMAIN	2.6212276074650527
PEDF SPATIAL STRUCTURE	2.621203669959058
BRADFORD PROTEIN ASSAY	2.6211643103802444
ANTI-HUMAN TRANSPORTER	2.6211285681981944
RETINOIC ACID RECEPTOR	2.6210123330187494
IQ4 CALMODULIN AFFINITY	2.62097251963465
BILIRUBIN-IXΑ CLOSE ANALOGUE	2.62096548250268
HEPARIN SULFATE ABILITY	2.6208979263333587
CAUSE MINOR SIDE EFFECT	2.6208305450208034
INDUCING APOPTOSI	2.6207421615686926
CASPASE ACTIVITY ASSAY	2.6205525430376917
SHARED COMMON ANCESTOR	2.620518595359961
alanine	2.6202633424325557
REMAINING SURVIVAL TIME	2.6202616663166816
EXPRESSING TAT PLASMID	2.6201710207471836
HBAB-EXPRESSING MCNTCP	2.6201077973260487
P66 N-TERMINAL PORTION	2.62003057681828
AFFINITY UPTAKE SYSTEM	2.6199869049962294
INTEIN INTEGRATION SITE	2.619912865929467
ANTIHYPERTENSIVE THERAPY	2.619889670386234
METALLO-Β-LACTAMASE IMI	2.6198151416830493
INTEGRIN-LIKE PROTEIN BAND	2.6195026838069544
MONOLAYER ADHERENT CELL	2.619484140203247
CIRCUMSTANTIAL SUPPORT	2.619276058096893
PHOSPHORYLATE CPLA ERK	2.618729822802689
BT TOXIN SILKWORM RECEPTOR	2.618696111608445
DRUG TARGET VALIDATION	2.6185482862713814
INCREASE SEDIMENTATION	2.6185482862713814
AMICON YM30 ULTRAFILTRATION	2.618522200497887
AMICON ULTRAFILTRATION CELL	2.618522200497887
AA RELEASE ASSAYS SHOW	2.618445795535242
SRC-1 COACTIVATOR PROTEIN	2.6183895961144192
TOP67 CATENANE FORMATION	2.6183521127926817
WILD-TYPE CELL NUCLEUS	2.618310969371758
TSA201 CELL TRANSFECTION	2.6182696900684275
ELIMINATING EXCESS P66	2.618199775819728
NITROGEN FLOW CRYOSTAT	2.6180905681421294
LOWERING THERAPY LIPID	2.6176824887548253
TRANSFECTED HUMAN CD98	2.617543866001682
NUMEROUS DEUBIQUITYLATING	2.6174384800104074
HOST CELL CYCLE CHANGE	2.617289164332992
BUTAIT STRUCTURE MODEL	2.617238296985461
CULLIN UBIQUITIN LIGAS	2.61713969564136
CONTROL AGGREGATE SIZE	2.6168377114678294
FOLDED CONFORMATION P51	2.616752656496012
INDUCIBLE ENZYME SYSTEM	2.6167382697540322
OTHER ORC BINDING SITE	2.6167288567076032
STANDARD RT-PCR METHOD	2.6167288567076032
CONSERVED CYSTEINE BOX	2.6167288567076032
CA DIFFERING CONDITION	2.616646688920852
PROTEIN LYSATE	2.6165315243693628
NON-BILE ACID METABOLIZING	2.61642753236351
ENZYME (ACE)-INHIBITOR	2.616311282709359
NON-FUNCTIONING ENZYME	2.616311282709359
MULTIFUNCTIONAL ENZYME	2.616311282709359
STOCK UCB/DMSO SOLUTION ΜL	2.616176854282489
MULTIPLE CSN COMPONENT	2.616094719939597
FASL-INDEPENDENT MANNER	2.616059081529555
A-ATPASE INTEIN SPREAD	2.61583720313873
STRUCTURAL PERTURBATION	2.6156688415136076
LABELED RNA-DNA HYBRID	2.61557103789429
T. ACIDOPHILUM SUBUNIT	2.6149022036021328
DETERMINING AA RELEASE	2.6147727728289722
TOP67 BINDING AFFINITY	2.61462437575562
DELAYED STATIN THERAPY	2.6144545697528807
CALCIUM INDICATOR FURA2	2.614440308130069
BINDING DOMAIN AGONIST	2.6141816553183137
DISADVANTAGE	2.6140334898856086
AMPLIFICATION CONDITION	2.6140103214458312
CHLORIDE CONCENTRATION	2.6139226178888944
AMINO-ACID COMPOSITION	2.613654648134323
ENCOMPASSING CHD DEATH	2.6133772759322222
VOLUME FLUID EXPANSION	2.6133772759322222
PENICILLIN G K S VALUE	2.6127000776024882
ATORVASTATIN-TREATED PATIENT	2.612697952810626
ANTI-PHOSPHO-ERK IMMUNOBLOT	2.6125952520070994
LEUCINE-PHENYLALANINE DIPEPTIDE	2.612458566869941
HISTONE ACETYLATION/METHYLATION	2.612458566869941
DIFFERENTIATION SIGNAL	2.6124329482355244
INVOLVING HOSPITALIZATION	2.612213328909129
PO	2.612179370141453
BIOCHEMICAL OBSERVATION	2.612056223544193
COMMON CALMODULIN-BINDING	2.612012606641214
NON-OVERLAPPING INTERACTION	2.6119362584080568
INFECTED CD4 LYMPHOCYTIC	2.6117447285465984
MONOCHROMATOR POLYCHROME IV	2.6113251916162166
COATED COVERSLIP POLYLYSINE	2.6113251916162166
KYNURENINE STANDARD MIXTURE	2.6113251916162166
IQ DOMAIN PERMIT ACCESS	2.6110064284559416
MULTIPLE FREEZE/THAW CYCLE	2.610965503529311
NEUROMODULIN IQ PEPTIDE	2.6107458770840974
KD C-TERMINAL ZD DOMAIN	2.6104168612989813
HAMSTER OVARY K1 SUBLINE	2.610376875718568
DECREASE UCB SATURATION	2.6103749794790883
OMAPATRILAT TITRATION STUDY	2.610328682694139
RANDOMIZATION MECHANISM	2.6101404412876854
CFP/YFP DICHROIC MIRROR	2.6101404412876854
CORRESPONDING GAG LYASE	2.6101404412876854
RECEPTOR CONCENTRATION	2.609935693975224
HOST PROTEIN PHYLOGENY	2.6098239908018193
RNASE H ACTIVITY ASSAY	2.6097238691416456
LIPOPOLYSACCHARIDE MMP	2.6096661619463912
ELECTROPHYSIOLOGICAL PROPERTY	2.6093840109383644
HEART FAILURE DIAGNOSIS	2.6093125941408366
SILVER STAIN PROTOCOL	2.609265798941799
SCORPION TOXINS OFFER	2.609265798941799
TAT-RESPONSIVE REGION	2.609265798941799
COMPETITIVE INHIBITOR	2.609265798941799
ADVISORY BOARD MEMBER	2.609265798941799
DIVERSE PHYSIOLOGICAL	2.609265798941799
ESTIMATED GAG CONTENT	2.609265798941799
POPULATION DIFFERENCE	2.609265798941799
CONDENSED MESENCHYMAL	2.609265798941799
INACTIVE INTERMEDIATE	2.609265798941799
DECATENATING ACTIVITY	2.609265798941799
FUNCTIONAL CONNECTION	2.609265798941799
EVOLUTIONARY ANCESTOR	2.609265798941799
INSTRUMENTAL ACTIVITY	2.609265798941799
biological activities	2.609265798941799
BIOCHEMICAL MECHANISM	2.609265798941799
GEOGRAPHICAL LOCATION	2.609265798941799
TRANSFORMING ACTIVITY	2.609265798941799
heterodimer formation	2.609265798941799
POTENTIOMETRIC METHOD	2.609265798941799
penicillin resistance	2.609265798941799
STRUCTURAL COORDINATE	2.609265798941799
OVERWHELMING MAJORITY	2.609265798941799
IQ3-DERIVATIZED PLATE	2.609265798941799
ALTERED SPECIFICATION	2.609265798941799
PARALLEL GROUPS TRIAL	2.609265798941799
SUBSTRATE DEGRADATION	2.609265798941799
STRUCTURAL CLASS SHOW	2.609265798941799
EXPRESSING CELLS HOLD	2.609265798941799
CLINICAL PRESENTATION	2.609265798941799
TEMPORALLY CORRELATED	2.609265798941799
CONCLUSIONS DOMAIN II	2.609265798941799
CUMULATIVE EVENT RATE	2.609265798941799
myocardial infarction	2.609265798941799
GENERALIZED MECHANISM	2.609265798941799
FUNCTIONAL DIFFERENCE	2.609265798941799
AMMONIUM SULPHATE CUT	2.609265798941799
POSTSYNAPTIC MEMBRANE	2.609265798941799
BINDING SITE LOCATION	2.609265798941799
POLYPROTEIN PRECURSOR	2.609265798941799
DISCOVERED CONNECTION	2.609265798941799
MIKROLITER CENTRIFUGE	2.609265798941799
CATALYTIC BASE ATTACK	2.609265798941799
TOXIN/AGGLUTININ FOLD	2.609265798941799
STRUCTURAL PREDICTION	2.609265798941799
AMINE-COUPLING METHOD	2.609265798941799
MMTV-CDC37 TRANSGENIC	2.609265798941799
HOMOGENOUS POPULATION	2.609265798941799
GLOBULAR MOTOR DOMAIN	2.609265798941799
REGENERATED CELLULOSE	2.609265798941799
'-UNTRANSLATED REGION	2.609265798941799
PROSTATIC HYPERTROPHY	2.609265798941799
INFLUENCE COX ACTIVITY	2.6090872525397346
MULTIPLE PROTEIN KINAS	2.6090710857150667
PEDF RECEPTOR AFFINITY	2.609067762025456
ENDOGENOUS EXPRESSION	2.608899221797872
DIMINISHED EXPRESSION	2.608899221797872
FOLD EXCESS PIPERAZINE	2.6087359144170743
ERRONEOUS INTERPRETATION	2.6086981472478032
SINGLE-STRAND SCISSION	2.6086241250144093
RPMI-1640 MEDIUM	2.6084457804177505
DIVERSE FUNCTION	2.6084457804177505
CHEMOKINE FAMILY	2.6084457804177505
PERIPHERAL BLOOD	2.6084457804177505
UNDERLYING CAUSE	2.6084457804177505
MILLIMOLAR RANGE	2.6084457804177505
CATALYTIC CENTER	2.6084457804177505
NUMEROUS EXAMPLE	2.6084457804177505
OTHER PHENOTYPIC	2.6084457804177505
STATISTICAL TERM	2.6084457804177505
ANALYTICAL GRADE	2.6084457804177505
BINDING PROPERTY	2.6084457804177505
CELLULAR CONTEXT	2.6084457804177505
IN VIVO FUNCTION	2.6084457804177505
PERISTALTIC PUMP	2.6084457804177505
EXTRACELLULAR CYSTEINE	2.608313994975129
BRUSH-BORDER MYOSIN I	2.6082639026060166
HPLC GRADIENT SYSTEM-II	2.608242632254906
ANTIHYPERTENSIVE EFFECT	2.608121373379088
COMPARING FOLD CHANGE	2.608029853052166
CHROMATOGRAPHIC ANALYSIS	2.6079976346221487
CONTROL PROLIFERATIVE	2.6079770348517544
A-SUBUNIT MONOMER AGGREGATE	2.6078650911923367
BACULOVIRUS AMPLIFICATION	2.6077488983358306
P51 PROPOSED FUNCTION	2.6077427141081095
VON WILLEBRAND FACTOR	2.6077166338883546
DEPICTED TREE TOPOLOGY	2.607631708888712
INCLUDING GABA RECEPTOR	2.6074483507428883
PIMOBENDAN TREATMENT EFFECT	2.6072732820018243
CELL LYSATE PREINCUBATION	2.607107920853921
PROTEIN COMPLEX	2.6069105925380844
EYFP-CPLA TRANSLOCATION	2.606825334159204
CONTAINING ACS ELEMENT	2.606823073527033
POTENTIAL BOMBYX MORI	2.6066882707617096
HORMONE RECEPTOR GENE	2.6066434441846646
ASYMMETRIC HETERODIMER	2.606540051150445
REPRESENTATIVE EXAMPLE	2.606540051150445
CLINICAL TRIAL IMPLICATION	2.606478661987688
SYNTHETIC TAT PROTEIN	2.606442432790174
DEFECTIVE SUBCELLULAR	2.606347371873375
CO-STIMULATORY SIGNAL	2.6063379271255807
INDICATED THDP UPTAKE	2.6062799494658537
EXAMINING THDP UPTAKE	2.6062799494658537
INTRACELLULAR VESICLE	2.606270062547059
B. MORI MIDGUT PROTEIN	2.6062552007272695
Β-SHEET N-TERMINAL STRAND	2.6062549028413806
IDO STIMULATORY EFFECT	2.6062450889577122
INTEIN OCCURRING LOSS	2.6062196292744204
matrix metalloproteinases	2.606117319290971
ISOELECTRIC PRECIPITATION	2.606117319290971
PHYSICOCHEMICAL CONDITION	2.606117319290971
VIRAL GENOME SEQUENCE	2.6060114378223336
ANTAGONIST GRANISETRON	2.6059522354452245
PRIMARY ENDPOINT EVENT	2.6058973421497953
ESSENTIAL DNA ELEMENT	2.6058704266104016
LABELLED DNA FRAGMENT	2.6058704266104016
STRANDED PROVIRAL DNA	2.6058704266104016
BINDING MODEL	2.6058317345175896
HUMAN HOMOLOG	2.6058317345175896
3-D STRUCTURE	2.6058317345175896
N-TERMINAL PURIFICATION	2.6055895131411817
TEMPERATURE TREATMENT	2.605573095304201
CYCLE GENE EXPRESSION	2.60540978786696
PROPOSED ACETYLCHOLINE	2.605333482071308
COMPLEMENT ACTIVATION	2.6050966174154793
RELATIVE DISTRIBUTION	2.6050966174154793
NON-DENATURED PROTEIN	2.605030749714361
TRANSMEMBRANE PROTEIN	2.605030749714361
GCDCA-INDUCED CELL DEATH	2.604781114149352
EJECTION FRACTION REVIEW	2.604738653085954
CHANGE MUTAGENESIS KIT	2.604699513450492
ALTERED CELL ADHESION	2.6046965444407313
ATPΓS INCREASING AMOUNT	2.6046120410617633
PHOSPHORYLATION EVENT	2.604281157667907
MEDIATED CYTOTOXICITY	2.604125387628098
OBSERVED CYTOTOXICITY	2.604125387628098
CELLULAR CYTOTOXICITY	2.604125387628098
PROTEIN KINASE KINASE	2.604118187726047
T CELL CO-STIMULATION	2.604066302440584
BINDING TRANSCRIPTION	2.604042286290463
DOXAZOSIN GAIN WEIGHT	2.60402108942753
STANDARD ECL TECHNIQUE	2.6039928497611555
CODON USAGE FREQUENCY	2.6038806061369693
ANTI-Α4-ALEXA-488 MAB	2.603539771149322
STABLE DIMER FORMATION	2.603428316475946
P51 INSSUBUNIT SEDIMENTED	2.603297145144388
HEART PROTECTION STUDY	2.6032738404057842
BILE ACID EXPORT PUMP	2.603224743902941
SERINE RESIDUE	2.6031620305650764
DECREASED K CAT VALUE	2.60315287737956
CTT ACA CTA AGG CCA ACT CAG	2.6030633191755235
RESEMBLING LIPID RAFT	2.603026403140341
CYTOPLASMIC COMPONENT	2.6029734966782287
CALMODULIN-IQ PEPTIDE	2.6029538520263706
CHARACTERIZED PEPTIDE	2.6029538520263706
MAP KINASE ACTIVATION	2.6027900136801123
HOSPITALIZED/FATAL HF	2.6027099120489625
OVER-EXPRESSION PLASMID	2.602692815447452
SUBSTRATE-INDEPENDENT ASSAY	2.6026810973188366
CYTOPLASMIC TAIL	2.6026751944787963
HIV-1 RT DIMER SUBUNIT	2.602640814547484
INDIVIDUAL ORC SUBUNIT	2.6026233866486344
OBSERVED UP-REGULATION	2.60249449600275
HYDROPHOBIC EXTRACTION	2.60249449600275
BINDING DOMAIN ZN(II)	2.602488927097519
REACTION INTERMEDIATE	2.6024634501356982
HF ACCEPTED TREATMENT	2.602433405254843
P66 POLYMERASE DOMAIN	2.6023291741509427
LOWERING LDL CHOLESTEROL	2.6021697587503847
CA POSSIBLE COORDINATION	2.6020855214794505
EXPRESSING LYMPHOCYTE	2.601969731270739
P51 POLYMERASE DOMAIN	2.6018679583210225
E-TP COMPLEX FORMATION	2.6017908298685457
PROTEASE-DIGESTED APN	2.6017265290150373
RADIOLIGAND CONCENTRATION	2.6013202172912093
IQ PEPTIDE CALMODULIN	2.6012763823306297
COMPLEMENTATION ASSAY	2.6012167563153628
MAJOR DETERMINANT	2.601201879617156
MEMBRANE PHOSPHOLIPID	2.6011880097345546
COBBLESTONE PHENOTYPE	2.6010906869730213
DUAL F-BOX REQUIREMENT	2.600986835699261
WILD-TYPE MUTANT BIND	2.6009486678321174
CELLULAR ACCUMULATION	2.600940224789547
HUMIDIFIED ATMOSPHERE	2.6009332154458473
DECATENATION MECHANISM	2.6008088480245437
STEADY-STATE CONDITION	2.6008088480245437
WILD-TYPE CELL GENOME	2.6006262450175037
STABLE DIMERIC ENZYME	2.6006141777143674
IFN-Γ RESPONSE ELEMENT	2.6001256173796317
CCR5 VIRUS REPLICATION	2.6000844455130396
GEL FILTRATION COLUMN	2.6000809015690947
CALMODULIN-BINDING MOTIF	2.5999936292512458
BINDING AFFINITY DATA	2.5999147664744977
PROGNOSTIC DETERMINANT	2.599884460423592
TIME-DEPENDENT GROWTH	2.599802280205278
EVIDENCE POINT ABUNDANCE	2.5997733817619864
COMPOSITION REQUIREMENT	2.599655544307488
pathways	2.5996363982297055
ALLOGENEIC MATERNAL REJECTION	2.5995542563542635
ENCODING GENE SUBUNIT	2.5995377087137195
LYMPHOBLAST CELL LINE	2.5995377087137195
CELL MACROSCOPIC FOCI	2.5995377087137195
RELAXATION EFFICIENCY	2.5994319686025444
MG/ML BROMPHENOL BLUE	2.5993782318247343
ISOPROPYL THIO-Β-D-GALACTOSIDE	2.5993339451928907
UNINFECTED BYSTANDER CELL	2.5993246228593083
SECONDARY PURIFICATION	2.5993006366756224
INCLUDING PURIFICATION	2.5993006366756224
ASSAYING MUTANT TOXIN	2.599153603563841
B. MORI CADHERIN-LIKE	2.599149000834948
HIV-1 VIRION INFECTIVITY	2.599031340793828
INSECT-SPECIFIC TOXIN	2.5984954133321394
DOMAIN-SWITCHED TOXIN	2.5984954133321394
BEARING PEDF RECEPTOR	2.598492882101679
P66 CATALYTIC SUBUNIT	2.59847583970995
TOTAL CHOLESTEROL LEVEL	2.598413531717547
CD4 RECEPTOR DISAPPEARANCE	2.598350284100151
PYROCOCCAL ATPASE INTEIN	2.598236433773331
CLASSIFICATION SCHEME	2.5982327210001963
ADHERENT P19 PHENOTYPE	2.5982271285944343
TRANSFECTED TSA201 CELL	2.5982261368812
BACKGROUND CYTOSOLIC PLA	2.5981138237690105
HOST EXPRESSION LEVEL	2.5978521253987936
ADRENERGIC ALPHA-ANTAGONIST	2.5978307999630843
EXTRACELLULAR ATP ACT	2.597696761856847
ENZYMATIC DEGRADATION	2.5976669221313964
DROSOPHILA ORC SUBUNIT	2.5976124986697045
T-CELL CO-STIMULATION	2.5973616885311226
EJECTION FRACTION TWO-THIRDS	2.597206008247255
BUTAIT MOLECULAR MASS	2.5972029670589802
CYCLE-DEPENDENT MANNER	2.59710042247249
CSN-INDEPENDENT MANNER	2.59710042247249
GLUTATHIONE TRANSFERASE	2.597081093385584
CYSTEINE MOTIFS RANGE	2.596700349063863
COMPARE TRANSLOCATION	2.596612478784996
TRANSLOCATION PROCESS	2.596612478784996
SUPPORT PROLIFERATION	2.5963862128169146
MOUSE NACHR RECEPTOR ΔT119	2.59637624947032
HETERO-DIMERIC ENZYME	2.5962883671006516
NEUROMODULIN IQ DOMAIN	2.5961196818306247
COMMON CHARACTERISTIC	2.596026105411876
POTENTIAL ASSOCIATION	2.595961204953396
STABILIZING ROLE LEVER-ARM	2.595795651049782
TOTAL RNA PURIFICATION	2.59568932087741
INTRON TERM PERSISTENCE	2.5955161030855938
concentration dependent	2.5952562868332794
INDUCIBLE PREP81 PLASMID	2.595253195801769
PEPTIDE SEQUENCE	2.595240532594656
SODIUM CARBONATE BUFFER	2.5952345521539546
PURIFICATION BACULOVIRUS	2.5950552301092356
TOTAL PROTEIN CONTENT	2.5950192965375045
ANION-EXCHANGE FRACTION	2.5949949065599336
C-JUN N-TERMINAL KINASE	2.5949536515774705
ENZYME BINARY COMPLEX	2.594924162675302
GROUP B STREPTOCOCCUS	2.5949052847955865
COLD TRANSPORT BUFFER	2.594658212161355
FINGER SUBDOMAIN MOVE	2.5945550283529957
CHROMATOGRAPHIC SEPARATION	2.5944602746825436
GST-CDC6 FUSION PROTEIN	2.5943423933629752
SK-N-SH THRICE-CLONED SUBLINE	2.5936564036038026
HBAB EXPRESSION VECTOR	2.5935275603494743
MORI AMINOPEPTIDASE N	2.5934945483898764
N-BENZYL GROUP ABSENCE	2.593415534432484
TOTAL REACTION VOLUME	2.5933077634850625
SURPRISING OBSERVATION	2.5931483289948734
IQ DOMAINS EXAMINATION	2.593131986967999
BINDING TETRACYSTEINE	2.5931102205273096
KDA C-TERMINAL DOMAIN	2.5930242294246377
ALLHAT CLINICAL TRIAL	2.592964674775828
FOLLOW-UP CLINIC VISIT	2.5927851636482817
CLEAVED GPI-ANCHOR ISOZYME	2.5927433622103804
PROTEIN TRANSLOCATION	2.5923774295575583
REPORT CONFORMATIONAL	2.5918674837261952
PHOSPHOLIPID HYDROLYSI	2.59169702738659
SUBSTRATE-INDEPENDENT	2.591657124767772
TRANSFECTED MDCK CELL	2.5915569036077253
ADDED OPEN-LABEL DRUG	2.5915263402905953
T. ACIDOPHILUM ATPASE	2.591321654229235
INSTAR HELIOTHIS VIRESCEN	2.591312724504015
BINDING DOMAIN LIGAND	2.5912615722510246
POSSIBLE METAL LIGAND	2.5912615722510246
CULTURING MEDIA RESULT	2.5912568428147082
OTHER ANTIHYPERTENSIVE	2.591256842814708
SPECTROSCOPY DETECTION	2.591256842814708
ANTIHYPERTENSIVE TRIAL	2.591256842814708
NOREPINEPHRINE LEADING	2.591256842814708
OVEREXPRESSED PAIRWISE	2.591053608661307
ventricular dysfunction	2.590791040496957
ACHIEVING COMPARABILITY	2.590791040496957
PHARMACOLOGIC INHIBITOR	2.590791040496957
RAT HEPATOCYTE CYTOSOL	2.590735485805204
SCD39 ATPASE ACTIVITY	2.5904780995521146
BOUND ADP CONFORMATION	2.5903388373430087
GEL-FILTRATION EXPERIMENT	2.590267694283759
OTHER S. POMBE CULLIN	2.590019275602624
WILD-TYPE CELL LYSATE	2.589744475024291
HUMAN THP-1 PROMONOCYTIC	2.5891129817555485
CEREBELLAR PURKINJE CELL	2.5891129817555485
RECEPTOR-REGULATED STORE	2.5891129817555485
MONOCYTE/MACROPHAGE CELL	2.5891129817555485
PRAZOSIN RENAL EFFECT	2.5891064467463276
UNDERGOING AGGREGATION	2.5890093121770996
TIME COURSE EXPERIMENT	2.5887096414254183
MEASURED HYDRODYNAMIC	2.588704153686994
CONSERVED NEDDYLATION	2.588704153686994
HYDRODYNAMIC PROPERTY	2.588704153686994
HEPARITINASE REACTION	2.58832731902302
NONFATAL HEART FAILURE	2.5883019828243734
DOXAZOSIN PROBABILITY	2.588286960884723
TEMPORAL CORRELATION	2.5881687086367378
NON-COVALENTLY BOUND	2.5881687086367378
INHIBITORY INFLUENCE	2.5881687086367378
information transfer	2.5881687086367378
LINEWEAVER-BURK PLOT	2.5881687086367378
POTENTIAL USEFULNESS	2.5881687086367378
CONFERRING STABILITY	2.5881687086367378
COTRANSLATIONAL ROLE	2.5881687086367378
ANTI-APOPTOTIC STATE	2.5881687086367378
INTERMEDIATE PRODUCT	2.5881687086367378
ACTIVE-CONTROL TRIAL	2.5881687086367378
MISSING DATA PROBLEM	2.5881687086367378
VANADATE SENSITIVITY	2.5881687086367378
ULTRACENTRIFUGE TUBE	2.5881687086367378
CATEGORICAL VARIABLE	2.5881687086367378
BRISTOL-MYERS SQUIBB	2.5881687086367378
UNDERLYING CONDITION	2.5881687086367378
SPECIALIZED FUNCTION	2.5881687086367378
BACKGROUND MYOSIN-1C	2.5881687086367378
COMPARING OVERWEIGHT	2.5881687086367378
DIAGNOSTIC CRITERION	2.5881687086367378
ACRYLAMIDE CRITERION	2.5881687086367378
INTERMEDIATE PATHWAY	2.5881687086367378
COMPOSITE COMPARISON	2.5881687086367378
PROXIMAL-TUBULE CELL	2.5881687086367378
CARDIOVASCULAR CAUSE	2.5881687086367378
MOLECULAR WEIGHT GAG	2.5881687086367378
INCREASE SAMPLE SIZE	2.5881687086367378
CYSTEINE-LOOP FAMILY	2.5881687086367378
FUNCTIONAL INTEGRITY	2.5881687086367378
PROBABLE COMBINATION	2.5881687086367378
RESULTING SUSPENSION	2.5881687086367378
PROLIFERATING TISSUE	2.5881687086367378
INCREASED OCCURRENCE	2.5881687086367378
TRANSMEMBRANE REGION	2.5881687086367378
KIDNEY CELL LINE HEK	2.5881687086367378
STRUCTURAL TECHNIQUE	2.5881687086367378
QUENCHING CORRECTION	2.5881687086367378
PROGRESSIVE INCREASE	2.5881687086367378
DEAE-SEPHACEL COLUMN	2.5881687086367378
REGULATORY POTENTIAL	2.5881687086367378
BRUSH-BORDER DYNAMIC	2.5881687086367378
NEAR-WILD-TYPE LEVEL	2.5881687086367378
INCLUDING INTERFERON	2.5881687086367378
SUGGESTING MECHANISM	2.5881687086367378
PROMOTED CELL FUSION	2.5881687086367378
DIODE ARRAY DETECTOR	2.5881687086367378
BIOLOGICAL CHEMISTRY	2.5881687086367378
ELIMINATIVE CLEAVAGE	2.5881687086367378
CONTACT SURFACE AREA	2.5881687086367378
molecular chaperones	2.5881687086367378
STUDY GUIDELINES CAUTION	2.588148788992853
CD87 GENE EXPRESSION	2.587927788506071
MICROBORE HPLC SYSTEM	2.5877250277224797
PASSING DOUBLE-STRAND	2.5877250277224797
BENZIMIDAZOLE PORTION	2.5877250277224797
COVALENT INTERMEDIATE	2.5877250277224797
OPEN-LABEL ACE-INHIBITOR	2.5875768903443914
SINGLE PARAMETER	2.5875478855978162
ANALYSIS TEMPERATURE	2.587504113760637
FRACTION DISTRIBUTION	2.587443692708915
VA COOPERATIVE STUDY	2.587253953432915
PERFORMED MICROARRAY	2.5870310985299425
PHARMACOLOGIC TREATMENT	2.587000137484896
BEHAVIOR CHANGE TRIAL	2.586990030000738
INTERACTIONS CONTROL	2.5868982152980946
REPRESENTATIVE MEMBER	2.5866479891615137
HAMSTER OVARY K1 CELL	2.5866479891615137
REMAINING CALMODULIN	2.5866309735958284
SEPARATED CALMODULIN	2.5866309735958284
KDA N-TERMINAL DOMAIN	2.5865732172105185
SDS-PAGE ELECTROPHORESI	2.586522790322532
PROTEIN/SUGAR KINASE	2.5864502378781107
MORPHOGENETIC EFFECT	2.586229825324287
DISTINCTIVE RESPONSE	2.585905037764333
BLOTTING ASSAY LIGAND	2.585895543833401
ENZYME PROTEIN MICROGRAM	2.5858938239042573
DIASTOLIC HYPERTENSION	2.5857985541233734
PCU3 CHROMOSOMAL LOCUS	2.5857985541233734
GENERAL RESPONSE	2.585785688137594
RADIOACTIVE THIAMINE	2.585591002498797
CD3 SURFACE RECEPTOR	2.585583530886803
EXPRESSED HUMAN CD98	2.585537775528397
PROKARYOTIC PROMOTER	2.5855299917026326
C-TERMINAL EXTENSION	2.5855142850542157
COLUMN CHROMATOGRAPHY	2.585457578120446
SUBSTRATE RECOGNITION	2.585457578120446
QUANTITATION STANDARD	2.585457578120446
JUDGE PROTEIN PURITY	2.5853853692219455
BINDING PROTEIN TYPE	2.5853853692219455
FISSION YEAST MUTANT	2.5852783362913248
EXAMINED THDP UPTAKE	2.5852251894165152
SENSE TRANSFECTED P19	2.5849809577633964
GENOME DATABASE PSH1	2.5849604844506677
CELLULAR DNA CONTENT	2.5848214723484397
PURIFIED CSN COMPLEX	2.5846294771933747
RECOGNIZED TREATMENT	2.584528356294993
TIME DEPENDENT MANNER	2.584492080964164
IQ DOMAIN CALMODULIN	2.584440866113321
CALMODULIN IQ DOMAIN	2.584440866113321
WILD-TYPE L1 SPECTRUM	2.584438119501514
ubiquitin ligases	2.584375570804597
CD98 IMMUNOPRECITATE	2.5842223089742267
NORMAL IONIC STRENGTH	2.5841348991859268
BINDING STOICHIOMETRY	2.5841348991859268
CERTAIN PROSTAGLANDIN	2.5841348991859268
SELECTIVE ACTIVATION	2.5840586334121873
RESTING DISTRIBUTION	2.5840586334121873
CUL1-RELATED PROTEIN	2.5839936995145494
P68 KINASE ACTIVATION	2.5837834508395363
ANTISENSE INHIBITION	2.5834745700908037
FISSION YEAST CULLIN	2.583373620874762
EXTRACELLULAR SIGNAL	2.5832915274426376
RECOGNIZING INTEGRIN	2.583158111312426
QUANTITATE	2.5830451178847778
T CELL COSTIMULATION	2.5830429251670397
SCD39 CATALYTIC SITE	2.5827633369777834
HIV-1 TAT LITERATURE	2.582713746412105
TEMPERATURE INCUBATION	2.582679532014039
MAPK PATHWAY CONTROL	2.5826764718082287
SYSTOLIC HYPERTENSION	2.582656610964993
MM CACODYLATE BUFFER	2.5825987706275106
B. MORI APN SEQUENCE	2.582546775613242
cytometric measurements	2.5824984401580737
SERIOUS SUPERSATURATION	2.5824984401580737
REDISSOLVED PRECIPITATE	2.5824984401580737
HIV-INFECTED INDIVIDUAL	2.5824984401580737
IQ CONSENSUS MOTIF RG	2.5824595058688686
INCLUDING CARBOXYPEPTIDASE	2.5824418873773998
CHRONIC HEART FAILURE	2.5823619234853483
HEART FAILURE FINDING	2.5823619234853483
CLEAVED DNA RELIGATION	2.5823570947233097
MBR DIANION SELF-ASSOCIATION	2.5823219634092394
UNKNOWN UBIQUITYLATION	2.5821213912155265
HIV-1 RT DIMERIZATION	2.5820918928092387
P66 RNASE H SUBDOMAIN	2.5819842119650427
SCALE GROWTH CULTURE	2.581949138736267
MM MAGNESIUM CHLORIDE	2.581850271935393
MOLECULE OPPOSITE END	2.5818156660808267
REACTION TEMPERATURE	2.581462796428261
COMPETITION REACTION	2.581462796428261
C-TERMINAL ZD DOMAIN	2.581444168894348
DNMT1 REPLICATION ORIGIN	2.5813756324252752
ANTI-PHOSPHO-ERK ANTIBODY	2.581324332210724
DEGRADING ENZYME	2.5812956465738193
KINAS	2.581252181537928
HAMSTER ASBT PROTEIN	2.581198109486136
ATP-DEPENDENT CHROMATIN	2.58094660851571
COX-2 ACTIVITY OTHER	2.580736322605676
HIV-1 RNA TRANSCRIPT	2.580683039846241
ELECTROPHYSIOLOGICAL METHOD	2.580480867837629
RATIONAL CONSTRUCTION	2.5803919992222863
WILD-TYPE BACKGROUND	2.580205437889171
HYPERTENSION THERAPY	2.580205437889171
LIPID-LOWING THERAPY	2.580205437889171
NEUROTROPHIC RECEPTOR	2.580201367050225
THERMOPLASMA A-ATPASE	2.579959545934951
GRADIENT LOCALIZATION	2.5799396835435573
UNTRANSFECTED P19 CELL	2.5798051390897507
CALCIUM IMAGING MDCK	2.5796745531726666
TYPE L1 WILD-TYPE L1	2.5795418319935406
BLOOD PRESSURE AGENT	2.5794247250707825
L1 MUTANT PREPARATION	2.57938427734611
ION CHANNEL FUNCTION	2.5791597558718142
SER224 CATALYTIC ROLE	2.579108719234752
STIMULATORY CO-FACTOR	2.579108719234752
GCDCA-TREATED MCNTCP	2.5790678277823758
COMPACT P51 MOLECULE	2.5789950760900893
CYCLIN-DEPENDENT KINAS	2.578912713005074
SERINE/THREONINE KINAS	2.578912713005074
CPLA PHOSPHORYLATION	2.578882742618347
CELLULAR INTERACTION	2.578819795390119
MEASURED INTERACTION	2.578819795390119
NON-HOSPITALIZED PARTICIPANT	2.578642667333641
A-TYPE ATPAS SUBUNIT	2.5785785331127866
'- 32P-LABELED DIDEOXY	2.5785208358682605
RECEIVED ACE-INHIBITOR	2.57852083586826
TOXIN RECEPTOR CLASS	2.5785050680000774
IONIC STRENGTH BUFFER	2.5784848608333184
IMMOBILON-P TRANSFER	2.5784742920744828
ALKALINE AQUEOUS UCB	2.5782588605953216
P24 GAG ANTIGEN LEVEL	2.5781129666029154
HIV-1 RT HELP P51 SUBUNIT	2.5779208771026125
ANTIHYPERTENSIVE AGENT	2.5777716589890574
SEDIMENTATION RESULT	2.577551014306649
DNA-BINDING PROPERTY	2.577551014306649
DNA-BINDING ACTIVITY	2.577551014306649
STIMULATING MULTIPLE	2.5774553594027743
CAMP-DEPENDENT MANNER	2.577334773369632
HOST GENE EXPRESSION	2.576916846237831
IONOPHORE STIMULATION	2.576855710218059
MM EDTA CONCENTRATION	2.576704482497279
BOUND MG CONCENTRATION	2.576650009989121
displays	2.576598788750662
DNA DAMAGE/REPAIR ENZYME	2.5765949334656857
ALEXA-488-CONJUGATED ANTIBODY	2.5764743623621267
CONCERN BUTAIT OFFER	2.5762768909870384
THDP AFFINITY UPTAKE	2.5760067261221744
BINDING MOTIF ZN(II)	2.575982441070202
TRUNCATED N-TERMINAL	2.5759749503045266
FURA2 DICHROIC MIRROR	2.5757579326006357
proliferation of smcs	2.5757579326006357
ANISOMYCIN-TREATED MACROPHAGE	2.575681995221447
OSTEOCLAST FORMATION	2.575665629332147
DNA ENZYMES AFFINITY	2.575603009054099
RECEPTOR PURIFICATION	2.575571990779406
SENSITIVE ELISA METHOD	2.575524128351449
HEAT/STRESS INDUCIBLE	2.5753390842713713
RETAINED ASSOCIATION	2.5750527332878046
PUTATIVE CSN SUBUNIT	2.5750393016694235
B. MORI BBMV PROTEIN	2.5748849815288515
ATORVASTATIN TREATMENT	2.5747780093370594
NUCLEOTIDE PHOSPHATE	2.574697271112261
THERMOPLASMA LINEAGE	2.574655279489352
BIOSYNTHETIC PATHWAY	2.574655279489352
NON-DENATURATING GEL	2.5745866834023095
DIFFERENTIATION GENE	2.5744894705427583
IA DNA TOPOISOMERASE	2.5743446429514196
baseline	2.574327720200844
INFERIOR PERFORMANCE	2.574232984828496
SINGLE AC INTRODUCTION	2.5740867915800507
POP1 MUTANTS DISPLAY	2.5740117828632862
AA RELEASE REDUCTION	2.5738788699828903
INHIBITED AA RELEASE	2.5738788699828903
LIGAND-DEPENDENT MANNER	2.5738422070770577
SYNTHESIS TAKES PLACE	2.573786881639391
CELL EXTRACT EXHIBIT	2.573736891100695
NON-DENATURING CONDITION	2.5734448493617452
ANTAGONIST PHARMACOPHORE	2.5734448493617452
COMPOSITIONAL DIFFERENCE	2.5734448493617452
EMPIRICAL OBSERVATION	2.5734356052304563
GLYCOCHENODEOXYCHOLIC ACID	2.573328418330845
TAUROCHENODEOXYCHOLIC ACID	2.573328418330845
SHOW DOWN-REGULATION	2.5733039365746135
AMPA RECEPTOR DENSITY	2.573135577843501
PLASMA CONCENTRATION	2.573051991285425
EQUILIBRIUM DISSOCIATION	2.572495265580302
P51 SPECIES SEDIMENTED	2.5722245249402143
FORCE-FEEDING BIOASSAY	2.5721528323950364
P66 RNASE H ACTIVITY	2.5721505539942315
PUBLISHED REPORT	2.572046699879733
DEOXYNUCLEOTIDE TRIPHOSPHATE	2.5718071978472214
INTENSIVE DIETARY COUNSELING	2.5718071978472214
HYPERCHOLESTEROLEMIC PATIENT	2.5718071978472214
KING PHARMACEUTICALS/MONARCH	2.5718071978472214
IQ4 HILL COEFFICIENT	2.571652295234377
CGT AGA CAG CAA TGG CAC TC	2.5716316977378524
ANTIHYPERTENSIVE DRUG	2.5715694493079906
PLASMA NOREPINEPHRINE	2.5715694493079906
ELEVATED PGE RELATIVE	2.5715694493079906
LIPOPROTEIN SECRETION	2.571487322184605
PRE-SPECIFIED ANALYSIS	2.5714695294888186
EQUATORIAL COORDINATION	2.5714416397062294
EFFICIENT AUTOCATALYTIC	2.5714416397062294
PRONOUNCED INFLAMMATION	2.5714416397062294
BACTERIAL PRODUCTION	2.571340664792823
NITROCEFIN K S VALUE	2.57103534944365
CONCENTRATION FACTOR	2.5707611873717413
MULTIPLE SUBSTITUTION	2.57070310554917
ARCHAEAL ATP SYNTHASE	2.57069025007707
TRYPTOPHAN CATABOLITE	2.5706262274448495
MUTANT OVEREXPRESSION	2.570598482726514
ACTIVATING KINASE CDK	2.570407326775927
NORTHERN BLOTS TOTAL	2.5703009523196387
S. POMBE CSN COMPLEX	2.5701369346451215
PRINCIPAL INVESTIGATOR	2.5696610049489923
STOCK UCB/DMSO SOLUTION	2.569585907700569
DEUBIQUITYLATING ENZYME	2.56917590190872
CLEAVED DNA HYDROXYL	2.569174343861993
MMTV-CYCLIN D1 MOUSE	2.5689883575888355
PURIFIED ORC PROTEIN	2.5688689558195854
SUCROSE CONCENTRATION	2.5688007908603097
MUTANT CONCENTRATION	2.5687164327673053
ACTIVATED STAT5 PROTEIN	2.5685431923086717
B. MORI CRY RECEPTOR	2.568397543821189
INTRINSIC HAT ACTIVITY	2.568332030311102
ENDPOINT END-OF-OBSERVATION	2.567935532300761
FUNCTIONAL MODULATOR	2.567898564915659
CLASSIC HYDRODYNAMIC	2.567898564915659
EPITOPE-TAGGED PROTEIN	2.567860298748955
HF ALLHAT DEFINITION	2.5677900552025683
LACK ENDOGENOUS CPLA	2.5677660803161753
CELL LINE DERIVATIVE	2.5676655747579455
REDISSOLVED UCB SEDIMENT	2.5674760370212484
intracellular accumulation	2.5671804431803915
ALLHAT DOXAZOSIN ARM	2.5669283292859233
MM LEUCINE-P-NITROANILIDE	2.5664932567729415
TETRASODIUM PYROPHOSPHATE	2.5664932567729415
AFFINITY TRANSPORTER	2.5662329562067954
ULTRACENTRIFUGATION	2.566196567142604
INDOMETHACIN CONCENTRATION	2.5661457689975435
CONTAINING MUTATION	2.566090012223333
FORM HETEROOLIGOMER	2.566090012223333
PRESCRIBED PROTOCOL	2.566090012223333
ANTI-UBIQUITIN BLOT	2.566090012223333
PURIFIED POPULATION	2.566090012223333
INCLUDING ESSENTIAL	2.566090012223333
AVERAGE WEIGHT GAIN	2.566090012223333
acidophilum subunit	2.566090012223333
SENSITIVE PROCEDURE	2.566090012223333
GRAPHICS INTEGRATOR	2.566090012223333
HEIGHTENED INTEREST	2.566090012223333
INCREASING ACTIVITY	2.566090012223333
EXTENSIVE VORTEXING	2.566090012223333
mutational analysis	2.566090012223333
EXPERIMENTAL ASPECT	2.566090012223333
EMERGING DIFFERENCE	2.566090012223333
CONTAINING YEAST AC	2.566090012223333
YEAST CAKS FUNCTION	2.566090012223333
INTERESTING FEATURE	2.566090012223333
TAT TRANSACTIVATION	2.566090012223333
PHOSPHODIESTER BOND	2.566090012223333
NEIGHBORING RESIDUE	2.566090012223333
MULTIFUNCTIONAL SET	2.566090012223333
DIAGNOSTIC VALIDITY	2.566090012223333
INCLUDING NF-KAPPAB	2.566090012223333
HYDROLYTIC ACTIVITY	2.566090012223333
SUBMICROMOLAR RANGE	2.566090012223333
RELATIVE COMPARISON	2.566090012223333
DETECTED DIFFERENCE	2.566090012223333
MECHANICAL STIMULUS	2.566090012223333
BOOTSTRAPPED SAMPLE	2.566090012223333
CONTINUOUS VARIABLE	2.566090012223333
RAS-RAF-MEK PATHWAY	2.566090012223333
MAMMARY GLAND TUMOR	2.566090012223333
FUNCTIONAL CAPACITY	2.566090012223333
PULMONARY PATHOLOGY	2.566090012223333
COMPUTATIONAL MODEL	2.566090012223333
INNER-EAR HAIR CELL	2.566090012223333
HEPARIN/HS-LIKE GAG	2.566090012223333
SPECTROSCOPIC GRADE	2.566090012223333
CLINICAL TRIAL DATA	2.566090012223333
ASSESSED DIFFERENCE	2.566090012223333
DIFFERING CONDITION	2.566090012223333
chromophoric change	2.566090012223333
CLINICAL SITE STAFF	2.566090012223333
PLASMA SPECTROMETER	2.566090012223333
SYMPTOMATIC EPISODE	2.566090012223333
SHORTER/LONGER FORM	2.566090012223333
NHEI/BSRGI FRAGMENT	2.566090012223333
THEORETICAL CONCERN	2.566090012223333
INTERVENING RESIDUE	2.566090012223333
COMMERCIAL SUPPLIER	2.566090012223333
OTHER TRANSMEMBRANE	2.566090012223333
INITIATE CELL DEATH	2.566090012223333
telephone interview	2.566090012223333
POTENTIAL INHIBITOR	2.566090012223333
SUTTER FILTER WHEEL	2.566090012223333
FORM INCLUSION BODY	2.566090012223333
OBSERVED INHIBITION	2.566090012223333
SEQUENCE PREFERENCE	2.566090012223333
PREVENTING COUPLING	2.566090012223333
TAILORING PESTICIDE	2.566090012223333
SINGLE-CELL IMAGING	2.566090012223333
PHYSICAL DIFFERENCE	2.566090012223333
CATENATING ACTIVITY	2.566090012223333
ACTIVITIES INCREASE	2.566090012223333
TILLVISION SOFTWARE	2.566090012223333
DIAGNOSTIC STANDARD	2.566090012223333
INTEGRIN-BASED CELL	2.566090012223333
HISTONE ACETYLATION	2.566090012223333
LIMITED DEGRADATION	2.566090012223333
IMPARTING STABILITY	2.566090012223333
CHIMERIC HETERODIMER	2.565871550543551
UCB DIACID SOLUBILITY	2.565705572698287
N-TERMINAL	2.565640519261475
HIV-1 RT HETERODIMER	2.5650962387829206
SQUARED EFFECT SIZE	2.56481687673847
FLASH CHROMATOGRAPHY	2.5646980159070676
DIAGNOSTICS DIVISION	2.5646980159070676
KDA POLYPEPTIDE CHAIN	2.5646622139858675
CONVENTIONAL MYOSIN	2.564630770554636
CALMODULIN STANDARD	2.5645754200085817
RELEASED CALMODULIN	2.5645754200085817
BULLFROG CALMODULIN	2.5645754200085817
IDO GENE EXPRESSION	2.5644031082166387
FLUORESCENCE CHANGE	2.5642898821320306
INNER-FILTER EFFECT	2.564180308996038
QUANTITATIVE EFFECT	2.564180308996038
BACILLUS THURINGIENSIS	2.5639653993580342
STABLE SUPERSATURATION	2.5639653993580342
TRANSAMINASE ELEVATION	2.5639653993580342
TAT PROTEIN ADDITION	2.563931059029189
PROCESSIVITY FACTOR	2.563833684780125
NORMAL MITOCHONDRIA	2.5637536731686636
MITOCHONDRIA UPTAKE	2.5637536731686636
COX-2 MRNA INDUCTION	2.563683662014927
BACKGROUND THIAMINE	2.5635511004182585
THIAMINE DEFICIENCY	2.5635511004182585
RECEPTOR CLASS PLAY	2.5635437412536066
ENCODING HUMAN CD98	2.5634986745107793
ENDOGENOUS PROMOTER	2.5634910078311566
CELL CYCLE G2 PHASE	2.5634598820300525
CYTOPLASMIC TUBULIN	2.5634117698923706
COOMASSIE BLUE G-250	2.563394088533197
CONFIDENCE	2.5632609872082077
SUBSEQUENT INCUBATION	2.5631070034718295
ALPHA-ADRENERGIC BLOCKER	2.5629994277658756
S. POMBE CSN SUBUNIT	2.562944303002158
ENZYME TRANSLOCATION	2.562901322674208
MIN POST-STIMULATION	2.5628470149031504
P35-ACS DNA COMPLEX	2.562793151653523
MM AMMONIUM ACETATE	2.562724251746108
CYSTEINE SUBSTITUTION	2.562722346842913
PRINCIPAL COMPONENT	2.5626585142367873
HS-LIKE MOLECULE ΜG/ML	2.5626310485832073
ACTIVATION FUNCTION	2.5620417934004958
SYSTOLIC DYSFUNCTION	2.5619367579388714
RECEPTOR EXPRESSION	2.5619146643244335
THDP CHARACTERISTIC	2.561741183091869
PHARMACOLOGIC MANAGEMENT	2.561693750066392
DEMONSTRATED INTEIN	2.5616533279579
P35 MULTIMERIC FORM	2.5616533279579
MAPK PATHWAY MEMBER	2.561514681574605
ΜG INTERNAL STANDARD	2.561412118924914
TRANSFORMED E. COLI	2.561209659531357
COMBATING INFECTION	2.5610413715074953
BACTERIAL INFECTION	2.5610413715074953
VIRAL TRANSCRIPTION	2.5610180521508403
TOP67 CLEAVAGE SITE	2.560952798863358
MINUTE ASSAY PERIOD	2.5608796712710453
MURINE MHC CLASS II	2.56079806352119
AROMATIC AMINO ACID	2.5605389001566303
RETINOBLASTOMA-DERIVED H	2.5603880723669086
DIMERIZATION PARTNER	2.5602972610202546
THERMOPLASMA SUBUNIT	2.5602700162034253
CHLORTHALIDONE MM HG	2.560176605402867
REDUCED K CAT VALUE	2.560154448138497
BINDING PROTEIN TATA-BOX	2.5600656639472583
BLOCKED TOXIN BTR175	2.5598548570898343
METALLO-Β-LACTAMASE CCRA	2.559735233517167
BUDDING YEAST F-BOX	2.559724334799016
EXAMPLE CONSTRUCTION	2.5597042514964996
EXHIBITED TOTAL LACK	2.559419550548672
BACTERIAL RESISTANCE	2.5593981820648843
INDICATED DETERGENT	2.5592270162502415
GEL FILTRATION ELUTING	2.559022461781719
GENERATION CARBAPENEM	2.5590039994300544
NEGATIVE INTERFERENCE	2.5590039994300544
S PHASE PROGRESSION	2.558645406422013
MICROCOCCAL NUCLEASE	2.5584391645124893
RETROVIRAL INFECTION	2.5582683050634993
COMBINATION THERAPY	2.5582465882540855
RESULTING PHYLOGENY	2.5582465882540855
YEAST S. CEREVISIAE	2.558175926776885
FLATTENED PHENOTYPE	2.5581520891701186
DISPERSED PHENOTYPE	2.5581520891701186
MOLECULAR PHENOTYPE	2.5581520891701186
CAUSES ACCUMULATION	2.558005992426808
RECOGNIZED IQ MOTIF	2.5580053875618773
EUKARYTOTIC TYPE IA	2.5579560910700394
DMSO-AQUEOUS BUFFER	2.557860846091663
ACTIVATING ANTIBODY	2.5578286001428716
ETHANESULFONIC ACID	2.5577633441232788
N'-TETRAACETIC ACID	2.5577633441232788
TRIFLUROACETIC ACID	2.5577633441232788
INTEIN TERM SURVIVAL	2.557723068267072
CAK TRIMERIC ENZYME	2.5576894051305867
INTEIN DISTRIBUTION	2.5576051091350624
'-TAT TTG TTA CTC TGT TAT-5	2.557347625003688
OVEREXPRESSING CLONE	2.5573439950476473
FRACTION INFORMATION	2.5573108670536104
preliminary analyses	2.557200433507312
ANALYZING GEL SHIFT	2.557171601212615
VENT DNA POLYMERASE	2.557088843312252
SINGLE PROTEIN BAND	2.556882479479686
FORMING INTERACTION	2.5568817995969626
INTERACTION PARTNER	2.5568817995969626
ALTERED INTERACTION	2.5568817995969626
P35-ACS INTERACTION	2.5568817995969626
BONDING INTERACTION	2.5568817995969626
CRITICAL STEP	2.5568568395741664
PREVIOUS WORK	2.5568568395741664
REDUCED LEVEL	2.5568568395741664
ALLHAT FOLLOW-UP FORM	2.5567761791273718
ALLELE	2.556696427772575
NONPRODUCTIVE MANNER	2.556690367799298
NATIONAL HEART LUNG	2.5565414960868575
RECEPTOR HORMONES ACT	2.55638164467292
NON-HYDROLYSABLE VO	2.5563293068393804
GENETIC PERTURBATION	2.556315625646471
CARBOXYL-TERMINAL	2.5562806367583035
COX-2 PROTEIN LEVEL	2.556028032872731
POLYETHYLENIMINE FILTER	2.555962119073647
DENATURING TRIS/TRICINE	2.555962119073647
MUTANT HETERODIMERIC	2.555961702502135
BILE ACID TREATMENT	2.555878591843267
filters	2.55587343883378
MOUSE NACHR RECEPTOR	2.5558539867625543
DMEM CULTURE MEDIUM	2.555815585503383
CHOLESTEROL SIDE CHAIN	2.555714497847877
USE REGRESSION MODEL	2.5556675973540246
MULTIPLE TIME-POINT	2.5555378982947357
SEQUENCING FACILITY	2.5553770428994826
N-BENZYL INTERACTION	2.5553491026604487
GEL-FILTRATION ANALYSIS	2.5552700391645895
PAIRED DNA MOLECULE	2.5552364765175595
HYDROPHOBIC SUBSTITUENT	2.555181639041752
RELEASE ASSAYS SHOW	2.5551638494801026
PRELIMINARY CALIBRATION	2.5550690698063825
MM PHOSPHATE BUFFER	2.5549996687125502
ENZYMATIC DIGESTION	2.5548276598572337
ENZYMATIC MECHANISM	2.5548276598572337
ARCHAEAL TYPE ATPAS	2.5548276598572337
VOLTAGE DEPENDENT K	2.554790711036786
AMPLIFICATION DOMAIN	2.554722971496958
EXHIBITED K S VALUE	2.554570993787507
R. SEQUENCE HOMOLOGY	2.554512620948909
PURITY DETERMINATION	2.5543851357682734
B. MORI APN RESEARCH	2.5542329240663384
CEREVISIAE V-ATPASE	2.554218884053661
H POST-TRANSFECTION	2.5538891304933924
EQUATORIAL NITROGEN	2.5538891304933924
CO-ACTIVATOR PATHWAY	2.553865388493374
LIPID-LOWERING AGENT	2.553817344627627
RAPID TRANSLOCATION	2.5538038096421336
SPECIES SELECTIVITY	2.5536295372650955
CD98 OVER-EXPRESSION	2.553467608156039
PG E SIMILAR EFFECT	2.553446920969238
SUBUNIT CSN COMPLEX	2.5531582020948242
MISSING CSN SUBUNIT	2.5531582020948242
KB IDO PCR FRAGMENT	2.5531297666938566
GENETIC STUDY	2.5530587457248686
HIGH-RISK HYPERTENSIVE	2.553048821975365
NONHYDROLYSABLE ANALOG	2.553048821975365
POLYPEPTIDE N-TERMINUS	2.553048821975365
TRANSPORT MECHANISM	2.553043524828941
ISOLATING TOTAL RNA	2.5529981570138585
PURIFIED PREPARATION	2.5529626695422327
CENSORED OBSERVATION	2.552846477994066
INTEGRIN-ASSOCIATED PROTEIN	2.5527994859795777
DISCUSSION Β-LACTAM	2.552779959427034
Β-LACTAM ANTIBIOTIC	2.552779959427034
SUBSTRATE CARBOXYLATE	2.5527212744910863
INVARIANT CARBOXYLATE	2.5527212744910863
replication machinery	2.5527212744910863
ELECTRODE CALIBRATION	2.5527212744910863
S-PHASE UP-REGULATION	2.552499531257946
DETERMINED AFFINITY	2.552470423315492
SIGNIFICANCE RESULT	2.5523640202771496
MUTANT TOTAL AMOUNT	2.5521514291560976
REDUCING AA RELEASE	2.5520152348401175
CRITICAL REGULATION	2.551921246343402
SIGNAL AMPLIFICATION	2.5518366079897494
HUMAN MONOCYTE CD98	2.551785828050036
DEPLETED TRYPTOPHAN	2.551688971492911
SYSTEMIC TRYPTOPHAN	2.551688971492911
BODY MASS INDEX BMI	2.551448954147404
PROTΑ PUTATIVE ROLE	2.551448954147404
TAT DOWN-REGULATION	2.551448954147404
RESISTANCE PHENOTYPE	2.5513389682962626
CONCENTRATION CURVE	2.5512008006206934
ULTRAFILTRATION ASSAY	2.5509549568036185
POLYMERASE REACTION	2.5509285611057444
COMBAT PENICILLIN RESISTANCE	2.550702292059658
OTHER TETRACYSTEINE	2.5504031642848375
DODECYL SULFATE	2.5503491022810945
BINDING COMPLEX	2.5503491022810945
SIZE DIFFERENCE	2.5503491022810945
DNA TEMPLATE PRIMER	2.5503326766952856
CLINICAL INVESTIGATOR	2.550262816906273
MASS SCALE SPECTRUM	2.5502618413304368
ERK PHOSPHORYLATION	2.5501302020809353
EXPRESSING F-BOX-DELETED	2.5499426507710394
APPROACHING GDCA-TREATED	2.5499426507710394
RELAXATION REACTION	2.5499365074811755
NEUROPEPTIDE Y RECEPTOR	2.549830135054943
REMODELLING FACTORS	2.549822169916745
BINDING AFFINITY DTTP	2.549652966962753
EPITOPE-TAGGED STRAIN	2.5495130745222516
POLYCLONAL ANTISERUM	2.5494549616177986
CYCLIN B ACTIVATION	2.5494473348405564
PARTICIPANT CASE-FATALITY	2.5493425431457353
TRITON X-100 LYSATE	2.5492489015375903
HEPARIN/HS DEPLETION	2.5488207825899383
AGGREGATION FUNCTION	2.5488207825899383
CHF AVERAGE INCIDENCE	2.5483424055942296
fibroblast growth	2.5482866153540296
MM ATP	2.5478043440196156
WILD-TYPE UBIQUITIN	2.5476200138441367
HIGH-DOSE STATIN THERAPY	2.547611083450533
TITRATION STUDY	2.5474947605055784
PRELIMINARY	2.546672748414351
sequence alignments	2.546568601455428
COX ACTIVITY RESULT	2.546568601455428
layer chromatography	2.546361537212013
CELLULAR EFFECT	2.546315793250474
CONTAINING YEAST AR	2.546124933028884
CORE ACS SEQUENCE T	2.546035689379867
HF ALLHAT CRITERION	2.546018056380892
S. POMBE EQUIVALENT	2.5458954493599824
INPATIENT INITIATION	2.5456979313163823
ANALYZING OBSERVATIONAL	2.5456424386519254
CALCIUM-CHANNEL BLOCKER	2.5456424386519254
CA OBSERVED EVIDENCE	2.5454680457529757
UNKNOWN STOICHIOMETRY	2.5453615109911523
REVERSED PHASE HPLC	2.545174214972006
C-TERMINAL CYSTEINE	2.545174214972006
BENZIMIDAZOLE GROUP	2.545174214972006
SCREENING OTHER CRY	2.545174214972006
HPLC GRADE METHANOL	2.545174214972006
LIGANDED RA RECEPTOR	2.545043243444646
ACA CTA AGG CCA ACT CAG	2.545028171960156
MM SULFATE ADDITION	2.5449585881962187
C-TERMINAL TAIL	2.5448273101558403
THRICE-CLONED SUBLINE	2.5446434852838418
RELIGATION CAPABILITY	2.5446434852838418
ANTISENSE AGGREGATE	2.5445729916502065
GSTCDC6 PURIFICATION	2.5444450794387232
P35 CHARACTERIZATION	2.544250063907734
KDA POLYPEPTIDE BIND	2.5441974667284177
SURFACE HETERODIMER	2.5441284251094394
THERMOTOGA MARITIMA	2.5441284251094394
COMPLEMENTARY OLIGO	2.5441284251094394
CELLULAR P68 KINASE	2.544045809725306
polymerase	2.5440144827688584
TRANSFER	2.5437181348134024
RT DIMERIZATION P51	2.5435984878221793
ERYTHROLEUKEMIA K562	2.5435743924503647
SCD39 CONCENTRATION	2.5432147689429137
MOLECULE LERISETRON	2.5431962694594437
LERISETRON MOLECULE	2.5431962694594437
USE LOW-DOSE DIURETIC	2.543116948791205
DIFFERING EFFICACY	2.5429338888223536
XBAI/PSTI FRAGMENT	2.5429338888223536
(ICH)-E9 GUIDELINE	2.5429338888223536
INSERTION MUTATION	2.5429338888223536
footprint analysis	2.5429338888223536
PREFERRED APPROACH	2.5429338888223536
MECHANISTIC ASPECT	2.5429338888223536
EXPERIMENTAL VALUE	2.5429338888223536
DIFFUSION CONSTANT	2.5429338888223536
PHYSICAL INTEGRITY	2.5429338888223536
OVERLAPPING REGION	2.5429338888223536
STRUCTURAL BARRIER	2.5429338888223536
SURPRISING FINDING	2.5429338888223536
HHBSS SUPPLEMENTED	2.5429338888223536
AMINOACID SEQUENCE	2.5429338888223536
EXHIBITED DECREASE	2.5429338888223536
ORIENTATION RESULT	2.5429338888223536
PREDICTED POSITION	2.5429338888223536
IN VITRO CELL LINE	2.5429338888223536
IN VITRO SUBSTRATE	2.5429338888223536
CELL COSTIMULATION	2.5429338888223536
GENETIC EXPERIMENT	2.5429338888223536
DISCOURAGING TRIAL	2.5429338888223536
GIVE SUBMICROMOLAR	2.5429338888223536
ribosomal movement	2.5429338888223536
UNSPECIFIC EPITOPE	2.5429338888223536
SEEDING SUSPENSION	2.5429338888223536
lipid microdomains	2.5429338888223536
METHYLENE CHLORIDE	2.5429338888223536
NITRIC OXIDE DONOR	2.5429338888223536
TERMED FARNESOID X	2.5429338888223536
LABELED TOP STRAND	2.5429338888223536
SELECTIVE TOXICITY	2.5429338888223536
ENGINEERED VARIANT	2.5429338888223536
REGARDING QUESTION	2.5429338888223536
AMINO-ACID RESIDUE	2.5429338888223536
MAIL QUESTIONNAIRE	2.5429338888223536
USING DENSITOMETRY	2.5429338888223536
CLINICAL INHIBITOR	2.5429338888223536
INDUCED ALTERATION	2.5429338888223536
KINETIC DIFFERENCE	2.5429338888223536
ELECTRIC POTENTIAL	2.5429338888223536
BURYING DYE MOIETY	2.5429338888223536
INTERACTING SPHERE	2.5429338888223536
CATALYTIC V-ATPASE	2.5429338888223536
SUBSTANTIAL AMOUNT	2.5429338888223536
EXCESSIVE NEGATIVE	2.5429338888223536
DESENSITIZED STATE	2.5429338888223536
PHOTORECEPTOR CELL	2.5429338888223536
TIME-TO-EVENT DATA	2.5429338888223536
NORMAL-WEIGHT PEER	2.5429338888223536
OPERATIONAL ASPECT	2.5429338888223536
ACIDIC ENVIRONMENT	2.5429338888223536
GROOVE-LIKE REGION	2.5429338888223536
PROPOSED MECHANISM	2.5429338888223536
HYPOTHETICAL MODEL	2.5429338888223536
PRACTICAL QUESTION	2.5429338888223536
REGULATORY PROCESS	2.5429338888223536
HOSPITALIZED EVENT	2.5429338888223536
ADDITIONAL CONTACT	2.5429338888223536
SPECIFYING RESIDUE	2.5429338888223536
FUNCTIONAL CHANNEL	2.5429338888223536
PUTATIVE SUBSTRATE	2.5429338888223536
INDEPENDENT METHOD	2.5429338888223536
SOURCE TEMPERATURE	2.5429338888223536
PROPOSED INHIBITOR	2.5429338888223536
adipocyte function	2.5429338888223536
PEPTIDE-FREE STATE	2.5429338888223536
MOLECULAR PROPERTY	2.5429338888223536
peptide antagonist	2.5429338888223536
ENZYME-DNA COMPLEX	2.5429338888223536
INCLUDING PLACENTA	2.5429338888223536
RECOMMENDED TARGET	2.5429338888223536
BINDING CAPABILITY	2.5429338888223536
BEING ENZYME-BOUND	2.5429338888223536
INVESTIGATION SUPPORT	2.5426689145887376
HDAC CONCOMITANT DISMISSAL	2.5423805963602533
INTER-CELLULAR ADHESIVENES	2.5423805963602533
SN-2 ARACHIDONATE HYDROLYZ	2.5423805963602533
ELEMENTAL ANALYSIS	2.5422897862746807
SECONDARY ANALYSIS	2.5422897862746807
SCATCHARD ANALYSIS	2.5422897862746807
SCINTILLATION COUNTING	2.5421322445926955
DIGESTED PKK-RT66 HPA1	2.5421322445926955
P66 BAND INTENSITY	2.541919351710878
NIACIN TREATMENT EFFECT	2.5417691247048197
OTHER PROSTAGLANDIN	2.541688248763451
ENGINEERED CHO CELL	2.541688248763451
HYPERTENSION STUDY	2.5416040647931575
INSECT CELL FACTOR	2.541453776461091
CALMODULIN COMPLEX	2.541443568789634
CALMODULIN MIXTURE	2.541443568789634
C-TERMINAL 3HA TAG	2.541218837991049
DELETERIOUS EFFECT	2.5410547896506634
BTR175 CDNA VARIANT	2.5410108809219785
LOOP RNA STRUCTURE	2.5409657977044633
TOXIN CONCENTRATION	2.5407429019950296
INHIBITED RESPONSE	2.5407400166929692
APOPTOTIC RESPONSE	2.5407400166929692
ELIGIBILITY FACTOR	2.5407137202804595
CHEMOTACTIC FACTOR	2.5407137202804595
ΜM DTTP CONCENTRATION	2.5406705545126296
YEAST MITOCHONDRIA	2.5406349908995414
HUMAN MITOCHONDRIA	2.5406349908995414
DEPLETING THIAMINE	2.5404356644900488
BINDING ABILITY DNA	2.5404322629557403
LAST-OBSERVATION-CARRIED-FORWARD	2.5404003023508324
ENDOGENOUS GENOMIC	2.540361312575397
REVERSE IDO EFFECT	2.540254777132023
HYDROPHOBIC RESIDUE	2.54025285091287
SYNTHETIC TAT MRNA	2.540127442007492
THDP UPTAKE SYSTEM	2.540081131003946
STOICHIOMETRY FINE-TUNING	2.540077215094256
IL-8 MRNA INDUCTION	2.5398481492985248
HUMAN IDO PROMOTER	2.5398026073116164
NEUROTROPHIC EFFECT	2.539778545536156
DNA SEQUENCES PLAY	2.539689862275526
INDEX HOSPITALIZATION	2.5396725380793836
C-JUN PHOSPHORYLATION	2.5396588440099497
CRITICAL COMPONENT	2.539557382498223
MIRACL TRIAL RESULT	2.539469906630735
GENE IDENTIFICATION	2.539469906630735
NEUROTROPHIC FACTOR	2.5394319213202428
ACCEPTED TREATMENT	2.539405784255099
LOWERING TREATMENT	2.539405784255099
EXTENDED TREATMENT	2.539405784255099
ANTI-HIV TREATMENT	2.539405784255099
ASSIGNED TREATMENT	2.539405784255099
MAP KINASE KINASES	2.539402318664455
ECO RI CLONING SITE	2.5393642712910816
RECEPTOR Γ-SUBUNIT	2.5391756904789733
DNA-BOUND RECEPTOR	2.5391756904789733
MAMMALIAN TOXICITY	2.5391756904789733
ALLHAT EVENT REPORT	2.5389994889643375
GAMMA DISTRIBUTION	2.5389505449560983
BACKGROUND PROTEIN	2.53888761325078
MEMBRANOUS PROTEIN	2.53888761325078
PROTEIN DEPENDENCY	2.53888761325078
HUMAN CDNA LIBRARY	2.5388372745144037
INCREASED HF EVENT	2.5387581128852648
PHOSPHORYLATE CPLA	2.5386967044156017
MITOCHONDRIAL THDP	2.5386547520947427
STABLE DIMERIZATION	2.5386380283309657
EXTENSIVE EYFP-CPLA	2.5386380283309657
TAURINE COUNTERPART	2.5386380283309657
RECRUITING RIBOSOME	2.5386380283309657
STEADY-STATE AMOUNT	2.5386380283309657
YM30 ULTRAFILTRATION	2.5386194684296566
IMPROVED LOCF METHOD	2.5386194684296566
ESTIMATED SOLUBILITY	2.5386194684296566
TOTAL CELL LYSATE MG	2.538302747434015
PURIFIED ZD DOMAIN	2.538131746494701
ZD DOMAIN INCREASE	2.538131746494701
CD39 ADPASE ACTIVITY	2.538074971284524
ANTISENSE CLONE D3	2.537992820801709
STAT TRANSCRIPTION	2.5379432097289505
DEPENDENT INCREASE	2.537937440157744
GENERAL SUPPRESSION	2.5378375416651506
REVERSE PCR PRIMER	2.537834268651395
ELEVATED CATECHOLAMINE	2.537765613639628
UCB-DMSO-BUFFER SYSTEM	2.537765613639628
TREATED ONE HEPARINASE	2.537765613639628
SUBSTRATE HYDROLYSI	2.53775248046347
SAN DIEGO CA	2.5377263819834703
INCUBATION TIME	2.5375961360882786
EXPRESSED IDO CDNA	2.5374108956051997
INCLUDING COLLAGEN	2.53732099519263
BIDING PROTEIN DNA	2.53699234522781
INDIVIDUAL PEPTIDE	2.5369032914806504
CONJUGATED PEPTIDE	2.5369032914806504
EMPHASIZING MORTALITY	2.536888807644887
CYTOMEGALOVIRUS COX	2.536807896071475
bile acid synthesis	2.536807896071475
EXTENSIVE COVARIATE	2.536807896071475
receptor inhibition	2.536807896071475
COMPARING REACTION	2.536434748830042
CATALYTIC REACTION	2.536434748830042
HIV-1RT P66 SUBUNIT	2.536091697107591
TOXIN BLOT OVERLAY	2.536073685497136
INTRACELLULAR THDP	2.535792548058393
N-TERMINAL CYSTEINE	2.535778446675511
CD98 IDENTIFICATION	2.535582900061904
glutathione elution buffer	2.535532512425698
FOOTPRINTING ASSAY	2.5352436253083193
BB METALLO-Β-LACTAMAS	2.5351957786087014
ΜM ETHYLENE GLYCOL	2.5351847104941125
PRECIPITATED SCD39	2.5350758377407403
MUTANT K CAT VALUE	2.5349925081825364
IQ CONSENSUS MOTIF	2.534978824764424
TRIS-BORATE BUFFER	2.5348365996516047
TRICINE/SDS BUFFER	2.5348365996516047
ANTI-ASBT ANTIBODY	2.534804870462064
ANTIBODY DETECTION	2.534804870462064
WILD-TYPE L1 LEVEL	2.5347873973736577
ACID COTRANSPORTER	2.5347406602064537
EXERCISE TIME VALUE	2.534716316346342
DNA CLEAVAGE ASSAY	2.534563019932836
MM SODIUM CHLORIDE	2.5344595200088493
MM SODIUM FLUORIDE	2.5344595200088493
PG RELATIVE AMOUNT	2.5344595200088493
DERIVED MACROPHAGE	2.534113627404216
PREFORMED E-TP COMPLEX	2.5339448115556937
DOMAIN INTERACTION	2.5338732429211226
PERMIT INTERACTION	2.5338732429211226
KV ELECTRIC POTENTIAL	2.533873099674182
POSSIBLE COORDINATION	2.533873099674182
NEUROTOXIN PURIFICATION	2.533853808505102
GRANISETRON SUPPORT	2.5338046021071814
CYTOTOXIC RESPONSE	2.5337691649270218
HYDROLYZE NUCLEOTIDE	2.533682828261423
OTHER CORE SUBUNIT	2.5336394198010908
MONOCYTIC CELL LINE	2.533554327610157
PARTIAL RELAXATION	2.533538392963903
BILE ACID WITHDRAWAL	2.5332867748184102
IN VITRO STUDY SCCDC6	2.5331771670655576
P66 INSOR P66 WTAND	2.5331697257045183
CARDIOVASCULAR RISK	2.5331476315524926
CHLORTHALIDONE ARM	2.533111324970337
ACID SIMILARITY	2.5327631102992414
CONTAINING ETHANOLAMINE	2.5327428381247734
TUBOCURARINE INHIBITION	2.5327428381247734
EXTRAJUNCTIONAL CHANNEL	2.5327428381247734
PEROXISOME PROLIFERATOR	2.5327428381247734
PHOSPHATE GROUP	2.5325948232946303
systolic dysfunction	2.5324258134037714
FRACTIONAL EXCRETION	2.5324258134037714
CHROMATOGRAPHIC PEAK	2.5324258134037714
DIVERSE COLLECTION	2.5323926007860433
CELLULAR MACHINERY	2.5323926007860433
IMMUNOREACTIVE BAND	2.532302955125035
REPLICATION ORIGIN	2.53226246142757
FINAL MOLE FRACTION	2.5322091214247515
SIZE FRACTIONATION	2.5321290685851356
FIXED CONCENTRATION	2.531893910850237
IDO-EXPRESSING RAW	2.5318520219123863
SMRT RECEPTOR COREPRESSOR	2.531660178211544
EXTRACT PREPARATION	2.531413822043501
N-TERMINAL PORTION	2.531116116687896
TRI CATIONIC SPECIES	2.5301855552029195
TRANSPORT CAPACITY	2.53009647863952
CELLULAR TRANSPORT	2.53009647863952
ISOLATED TOTAL RNA	2.530051837868889
WEIGHT INFORMATION	2.529893588536056
MUTANT P66 SUBUNIT	2.5298236329984842
EVOLUTIONARY SENSE	2.529635648530393
PHOTOGRAPHED SENSE	2.529635648530393
DIFFERING AFFINITY	2.5295325613963464
INCREASED AFFINITY	2.5295325613963464
RANDOMIZATION GROUP	2.5294873670335103
RANDOMIZATION VISIT	2.5294873670335103
ENERGY MINIMIZATION	2.5294873670335103
CONVERTED CD39 ACR1	2.5292996611607417
INDIVIDUAL SUBUNIT	2.528992185290459
EXPRESSING GSTCDC6	2.528992185290459
IDO-EXPRESSING MC57	2.5289904985467704
CULTURE TRYPTOPHAN	2.528763632773543
PUTATIVE TURN REGION	2.5287096203882404
SUBSTRATE DECAY RATE	2.5287096203882404
BACTERIAL PETRI DISH	2.5287096203882404
ICE-COLD STOP BUFFER	2.5285450540379677
BOUND DNA FRACTION	2.5284458217034613
CONCENTRATION DATA	2.5282832851108714
ELUTE BBMV PROTEIN	2.528231015955506
COACTIVATOR PROTEIN	2.5281907796560787
UBIQUITIN LIGAS	2.5279056891268348
HYDROLYZE NITROCEFIN	2.5277428059451754
PM	2.527739675135793
OVEREXPRESSED COX-2	2.527657234774019
CULLIN MODIFICATION	2.527631933406376
LYSIS BUFFER ICE-COLD	2.5276218436240647
THYMOSIN FAMILY MEMBER	2.5275768080824697
BINDING MODEL LANGMUIR	2.5275768080824697
P66 RNASE H DOMAIN	2.527409643021977
PROTEIN PREPARATION	2.5273016465745446
GAG LYASE TREATMENT	2.527096990204787
STATIN-MEDIATED REDUCTION	2.5268691942549126
GAG-PEDF-RECEPTOR COMPLEX	2.5268691942549126
ENTEROHEPATIC CIRCULATION	2.5268691942549126
LABELED CDNA	2.5267739660614663
ΜM SODIUM VANADATE	2.526710341680608
CONSTRUCTION CLONING	2.526671424691779
PYROCOCCUS A-ATPASE	2.5265423266159384
CONFLICTING REPORT	2.5263110884574025
DNTP COMPLEMENTARY	2.5263110884574025
CONTROL VALIDATION	2.526267112795061
P19 CELL AGGREGATE	2.5262024427033833
ANALYZING FRACTION	2.526067827964257
ENZYME DIMERIZATION	2.5260371176918466
CALMODULIN CONSEQUENCE	2.5259957865304967
PASSING DNA STRAND	2.52596945562509
DNA PASSING STRAND	2.52596945562509
DISTAL SUBSTITUTION	2.525888220103899
VECTOR END RE-LIGATION	2.5258498918863412
BINDING ASSAY BBMV	2.5258016906605327
UNKNOWN CYTOPLASMIC	2.525763334839981
S. CEREVISIAE SWI/SNF	2.5257225375911965
EPR CHARACTERISTIC	2.5256461764428044
INCLUDING MONOCYTE	2.5256461764428044
SURVIVAL DIFFERENCE	2.5255455437053755
MEAN WEIGHT CHANGE	2.5253554749840252
SHOWED DNA GSTORC4	2.525283435292568
PROMOTER CHROMATIN	2.525211874937993
TWO-THIRDS ASN233 MUTANT	2.5251347744808506
SINGLE EPR FEATURE	2.525046287369697
HERPES SIMPLEX VIRUS TYPE 1	2.524961085036171
PARTIAL IMPUTATION	2.5249258550936564
NM ALEXA-CALMODULIN	2.5245971350850724
COMPLEX-FORMATION ASSAY	2.5244797488191244
AROMATIC SUBSTITUENT	2.524462542656205
INCREASING ATTENTION	2.524462542656205
HIV-INFECTED PATIENT	2.524462542656205
LYSINE Ε-AMINO GROUP	2.5244625426562046
LIPOFECTAMINE REAGENT	2.52444901226573
DH5Α E. COLI STRAIN	2.524269543144748
THDP CONCENTRATION	2.52400414838326
CASPASE TIME COURSE	2.523719677488447
REPRESSOR SEQUENCE	2.5232887611183203
ENDONUCLEASE MOTIF	2.5232494315333276
IMPREGNATED TLC PLATE	2.523102714064523
TRYPTOPHAN DEPRIVATION	2.5227329497028372
ACTIVATION ANTIGEN	2.5226413823338816
PROTEIN PRODUCTION	2.5225784506285636
INCLUDING MAB 6B12	2.5223379544907982
PHYSICAL SEPARATION	2.5221668379955458
HUMAN NEUROBLASTOMA	2.5221668379955458
BOVINE NEUROMODULIN	2.5221668379955458
HIV-1 DNA TEMPLATE	2.522142311158279
MULTIPLE UBIQUITIN	2.5220946007352647
T. MARITIMA ZN(II)	2.5220526631953697
HEALTH RELATIONSHIP	2.521723169569002
YEAST ACS SEQUENCE	2.5215910340327867
CULLIN DENEDDYLATION	2.5215169887452773
ENZYME INTERACTION	2.521474268878413
INCUBATION BUFFER ΜL	2.521445290740275
SUPERFECT REAGENT ΜL	2.521428299113907
HISTOLOGIC EVIDENCE	2.5214223774154134
ENDOGENOUS AGONIST	2.521324248347917
MENTIONED EJECTION	2.521324248347917
REDUCED PROTECTION	2.521324248347917
STABLE HETERODIMER	2.521324248347917
COMMON INTERACTION	2.5212236972775495
RECEPTOR COREPRESSOR	2.520584776031303
ADP SCD39 AFFINITY	2.5202866010037686
GLUTATHIONE COLUMN	2.5201868988492624
ROUNDED APPEARANCE	2.5201868988492624
BUFFER COMPOSITION	2.519933399324407
B MAX VALUES RANGE	2.5199320306142696
SURROUNDING BT USE	2.5196671710658394
BUTAIT PURIFICATION	2.519623917382358
GROWTH/TROPHIC CO-RECEPTOR	2.519072208859368
PYROCOCCUS HOMOLOG	2.5189231771840905
COMPELLING INDICATION	2.518794559820659
POLYETHYLENIMINE BIND	2.518794559820659
GEL-FILTRATION MATRIX	2.518794559820659
MYC EPITOPE TAG	2.5186341936642487
phase progression	2.5185897638393717
LONGITUDINAL DATA	2.5185897638393717
CONDITIONING TIME	2.5185897638393717
Β-LACTAMASE GROUP	2.5185897638393717
DERIVED CELL LINE	2.5185897638393717
CRYSTALLINE STATE	2.5185897638393717
CONTROLLING LEVEL	2.5185897638393717
MISSING AT RANDOM	2.5185897638393717
TERMINATED PRIMER	2.5185897638393717
MODELED STRUCTURE	2.5185897638393717
COMPELLING REASON	2.5185897638393717
STRONG BAND SHIFT	2.5185897638393717
IN VITRO ACTIVITY	2.5185897638393717
DRUG REGISTRATION	2.5185897638393717
INVASIVE STRATEGY	2.5185897638393717
NUMEROUS VALUABLE	2.5185897638393717
SELECTIVE CHANNEL	2.5185897638393717
ADJUSTED VARIABLE	2.5185897638393717
SCREENING PROCESS	2.5185897638393717
SIGNATURE RESIDUE	2.5185897638393717
EXPLANATORY TRIAL	2.5185897638393717
ASSOCIATED T-TEST	2.5185897638393717
BLOTTING RAW CELL	2.5185897638393717
VENOUS DISTENTION	2.5185897638393717
APOPTOTIC CASCADE	2.5185897638393717
VARIABLE SEQUENCE	2.5185897638393717
ANTAGONIST ACTION	2.5185897638393717
SPECIFYING REGION	2.5185897638393717
phosphate buffers	2.5185897638393717
mass spectrometer	2.5185897638393717
IDENTIFIED DOMAIN	2.5185897638393717
SOUTHERN BLOTTING	2.5185897638393717
PROTONATION STATE	2.5185897638393717
SIGNALING COMPLEX	2.5185897638393717
B-COMPLEX VITAMIN	2.5185897638393717
LIPOPHILIC REGION	2.5185897638393717
ASSEMBLED COMPLEX	2.5185897638393717
HEXAHISTIDINE TAG	2.5185897638393717
SKP1-SKP2 COMPLEX	2.5185897638393717
ESTIMATED CONTENT	2.5185897638393717
LITERATURE SEARCH	2.5185897638393717
MEMBRANE PROPERTY	2.5185897638393717
POLAR ENVIRONMENT	2.5185897638393717
VARYING HALF-LIFE	2.5185897638393717
CRITICAL ACTIVITY	2.5185897638393717
PRODUCED INCREASE	2.5185897638393717
'- 32P-RNA STRAND	2.5185897638393717
BINDING INHIBITOR	2.5185897638393717
Α-THYMOSIN FAMILY	2.5185897638393717
YEAST COUNTERPART	2.5185897638393717
PHYSICAL ACTIVITY	2.5185897638393717
SEQUENCE ANALYZER	2.5185897638393717
TECHNICAL FINDING	2.5185897638393717
endonuclease gene	2.5185897638393717
PATHOGEN OUTBREAK	2.5185897638393717
BLOCKING ACTIVITY	2.5185897638393717
catalytic subunit	2.5185897638393717
COARSE SUSPENSION	2.5185897638393717
INTESTINAL MUCOSA	2.5185897638393717
BINDING SUBSTRATE	2.5185897638393717
PHYSICAL OBSTACLE	2.5185897638393717
CLINICAL PRACTICE	2.5185897638393717
ORDERED MECHANISM	2.5185897638393717
BINDING CONDITION	2.5185897638393717
MEASURED QUANTITY	2.5185897638393717
PULMONARY DISEASE	2.5185897638393717
CELLULAR MEMBRANE	2.5185897638393717
MIMICKED PROPERTY	2.5185897638393717
CARRIED INSERTION	2.5185897638393717
BIOSUPPORT MEDIUM	2.5185897638393717
NON-MEDICAL STAFF	2.5185897638393717
CAPILLARY VOLTAGE	2.5185897638393717
PHYSICAL PARTICLE	2.5185897638393717
COMPARATIVE TRIAL	2.5185897638393717
NON-TARGET INSECT	2.5185897638393717
SURPRISING RESULT	2.5185897638393717
PRINCIPAL RESPECT	2.5185897638393717
REVEALED INCREASE	2.5185897638393717
MARKED LIMITATION	2.5185897638393717
REMAINING PATIENT	2.5185897638393717
CLASSICAL PATHWAY	2.5185897638393717
BMG LABTECHNOLOGY	2.5185897638393717
EDMAN DEGRADATION	2.5185897638393717
stress	2.518063896967885
SPECTRAL ANALYSIS	2.517956689694298
DOMAINS EXAMINATION	2.517873595401852
HOMOLOGOUS TYPE IA	2.5175731773329435
GCDCA-INDUCED APOPTOSI	2.5174781689461714
SPHERICAL CONTROL	2.5173795280805558
DUPLICATE CONTROL	2.5173795280805558
CATENATION ACTIVITY	2.5172864853035692
INCREASED INCIDENCE	2.5172864853035692
CULLIN/RING COMPLEX	2.5172864853035692
COOPERATIVE STUDY	2.5172827092198506
ACIDOPHILUM ATPASE	2.517217438845988
JOHNSON ALGORITHM	2.5172015522336713
IDO GENE FRAGMENT	2.5171878075643077
GRADIENT SYSTEM-II	2.5171313330319816
BOVINE CALMODULIN	2.517124961248529
ASSOCIATED KINASE	2.516952797552881
ACTIVATING KINASE	2.516952797552881
LABORATORY CHANGE	2.5168488099404196
DIFFERENTIAL F-BOX	2.5167542061876413
FUNCTIONAL EFFECT	2.5167428388335265
EXTRACELLULAR GAG	2.516693367628013
TYROSINE MUTATION	2.516684863609128
GROWTH/TROPHIC FACTOR	2.5164708122404926
RESPONSE VARIABLE	2.5164334554569128
ASSOCIATED FACTOR	2.5164076092947947
WILLEBRAND FACTOR	2.5164076092947947
REMODELING FACTOR	2.5164076092947947
MEASURING ABSORBANCE	2.516242392207104
INTEGRATED VECTOR	2.5161898047922286
THIAMINE MOVEMENT	2.5161343144096353
CLASSIC IQ DOMAIN	2.5160152623160728
PROTEIN S. LECTIN	2.5159384340084725
CONTAINING STRAIN	2.51557704929083
TRIS-HCL PH	2.5155597264113077
BP RT-PCR FRAGMENT	2.5153540173459707
CSN SUBUNITS SHOW	2.5152183927969562
T CELL LINE MOLT4	2.514927757362265
ANTI-LDL RECEPTOR	2.5148959138276816
RECEPTOR FUNCTION	2.5148959138276816
NON-CONDITIONED MEDIUM	2.514840801136022
CYSTEINYL LEUKOTRIENES	2.514840801136022
sulphate precipitation	2.514840801136022
LIPODYSTROPHY SYNDROME	2.514840801136022
POMBE SKP1 HOMOLOGUE	2.5148130518703926
REMAINING PROTEIN	2.514612769093023
MONOMERIC PROTEIN	2.514612769093023
PROTEIN DETECTION	2.514612769093023
DOMAIN PROTEIN HRT1	2.5145450349909315
HF OUTCOME STATUS	2.514485486048605
ENZYME-BOUND THDP	2.51438389501418
T. VOLCANIUM INTEIN	2.5143286957932807
ENDONUCLEASE ACTING	2.514288725664763
CLINICAL COVARIATE	2.514121034856438
DETAILED COVARIATE	2.514121034856438
MAP KINASE KINASE	2.5140273507999926
PREVENTED DNA P51	2.5139710032877916
BINDING ZD DOMAIN	2.51386984437999
COMPLEX COORDINATION	2.513844848326116
FUNCTIONAL HOMOMERIC	2.513844848326116
BLUE-O PRECIPITATION	2.513844848326116
DNA COMPLEMENTARY	2.513807040948084
HIV-1RT EXPRESSION	2.5137707975716013
IONOMYCIN TREATMENT	2.5137009200604843
ENZYME DISSOCIATION	2.513558943195316
PRIMARY HEPATOCYTE	2.513460162514807
CRYSTALLOGRAPHIC STUDY	2.5134300434434924
BINDING STUDY P35	2.513427558220859
CDC2 PROTEIN KINASE	2.5134166297442317
anti-mouse	2.5133462141075515
CARBAPENEM SUBSTITUENT	2.513021371572244
PROTEIN HOMOLOGOUS	2.5128519018357958
MANN-WHITNEY TEST	2.512730553476001
INSERTION PEPTIDE	2.5126624231229386
SCINTILLATION SOLUTION	2.512638333769343
ANTI-CYTOCHROME C	2.512521295963024
MANNER INDEPENDENT	2.512426161093737
SPECTROPHOTOMETRY DMSO	2.5122935997467324
ANTISENSE IDO RNA	2.5122724125794296
PARALLEL REACTION	2.5122019029169
SEQUENCE RETRIEVAL	2.5120629738588724
EUKARYOTIC HOMOLOG	2.5120629738588724
SOLVAY	2.5117758964608163
IDO TRANSCRIPTION	2.511581601351206
C-TERMINAL WD-REPEAT	2.511190424743594
RECORDING PROCEDURE	2.5111860444385985
SERIOUS DISCREPANCY	2.5111860444385985
PRE-SPECIFIED MODEL	2.5111860444385985
replication profile	2.5111860444385985
CULTURE SUPERNATANT	2.5111860444385985
TRANSESTERIFICATION	2.5111860444385985
BIOCHEMICAL ASSAY	2.5110311739577993
EXTRACT BILE ACID	2.51102582369395
BINDING BILE ACID	2.51102582369395
GCDCA CYTOTOXICITY	2.5110105563032996
RECEIVING THERAPY	2.511004178993937
TERMED PEDF BOUND	2.5109358403917255
ROUNDED PHENOTYPE	2.5109127864054375
POLVINYLIDENE DIFLUORIDE	2.5107723197865304
FLAVOBACTERIUM HEPARINUM	2.5107723197865304
PEPTIDE-CONJUGATED PLATE	2.5107723197865304
ATHEROGENIC DYSLIPIDEMIA	2.5107723197865304
SYNTHASE-EXPRESSING CELL	2.5107723197865304
HIV-1 TAT PROTEIN	2.5107421924018136
VIRAL TRANSLATION	2.5107232314070687
DNA TOPOISOMERASE	2.510636945788798
SUSPENSION BUFFER	2.510631117444161
CELL CULTURE MDCK	2.510498473337574
IDO-ANTISENSE EXPRESSION	2.5103914089503765
TUMOR DEVELOPMENT	2.510341360900646
RT-PCR ANALYSIS	2.5103140520734004
E-TP-DNTP TERNARY	2.5102604942051685
PG RELATIVE LEVEL	2.5102604942051685
ENZYME CONFORMATION	2.510184563613156
HEMAGGLUTININ SCF	2.510178026188988
POSITIVE ION MODE	2.5100080920950414
NUCLEOTIDE ABSENCE	2.509924630039051
PROTECTING MCNTCP	2.5099205240160174
UBIQUITYLATION REACTION VITROUBIQUITYLATION ASSAY	2.5097807078002425
POINT INTERACTION	2.509684255425444
FUNCTIONAL COFACTOR	2.5094149487036073
HYDROPHOBIC BUFFER	2.5094134932110905
CHROMATIN TEMPLATE	2.5093780454577934
BINDING ASSAY ELISA	2.5092053486501187
ANTISENSE CLONE E6	2.509179966835793
SITE SERINE GROUP	2.508824413233754
P19 CELL ADHESION	2.5087460815444045
EXPRESSING CELL IDO-A	2.5087421999183097
MICROCON RETENATE CUP	2.5087421999183097
YM-10 DIAFLO MEMBRANE	2.5087421999183097
MAXIMUM THICKNESS	2.508594640278328
NM TEMPLATE PRIMER	2.508509366080752
P51 THUMB SUBDOMAIN	2.5084955638670663
NON-LABELED TOXIN	2.508475650712125
REVEALED MULTIPLE	2.5083845325758434
RECEPTOR ANTISERUM	2.508304775515492
OTHER REPLICATION	2.5081010539296344
CARBOXYL TERMINAL	2.507697642010029
ZWITTERIONIC DETERGENT	2.5076767972286453
WHATMAN GF/B FILTER	2.5075257799196162
ADHESIVE FUNCTION	2.5071088786679026
N-TERMINAL FUSION	2.506974337044799
N-TERMINAL STRAND	2.506974337044799
NCOA FAMILY MEMBER	2.506917821364959
PROGENY FORMATION	2.5066796866988756
PRODUCT FORMATION	2.5066796866988756
MONOMERIC SPECIES	2.5065389056452054
ENDOGENOUS ENZYME	2.5064030865467055
ACTIVATING ENZYME	2.5064030865467055
THERAPEUTIC AGENT	2.506095859388067
OTHER CSN SUBUNIT	2.506083064811056
POLYPLOIDY PHENOTYPE	2.5057856345574945
GEL ELECTROPHORES	2.50565191354462
MM SODIUM CHLORATE	2.5056466660429333
SENSE ORIENTATION	2.5055192176441605
MM TRIS-BORATE PH	2.5055073783813024
AFFINITY KINETICS	2.505417895580632
OBSERVED AFFINITY	2.505417895580632
N-TERMINAL KINASE	2.5053373707583084
TOXIN CONSTRUCTION	2.5050568087607776
SUBUNIT INTERFACE	2.504886771860521
HUMAN LYMPHOBLAST	2.504886771860521
CONTAINED GSTCDC6	2.504886771860521
BACULOVIRUS SYSTEM	2.504799229161583
ONCOPROTEIN KINAS	2.5044300054612263
BENZIMIDAZOLE HETEROCYCLE	2.504226872816039
TOXIN PURIFICATION	2.5042098463681626
EXPRESSING EGFP	2.5039660484289574
IL-8 UP-REGULATION	2.5035690788499454
SALT STEP GRADIENT	2.5035684511421703
T-CELL ACTIVATION	2.5034958666596605
TARGET VALIDATION	2.503418594148502
NEUROHORMONAL LEVEL	2.503342620469351
CAUSE NEUROHORMONAL	2.503342620469351
VALIDATION EXERCISE	2.503342620469351
DNA-PROTEIN COMPLEX	2.503342620469351
PEDF-AFFINITY RESIN	2.503342620469351
HR INCREASED RATE	2.5032819169440796
SURVIVAL TECHNIQUE	2.5030391679464703
CEREVISIAE INTEIN	2.502818042795737
ASSAY DEVELOPMENT	2.5027827710190738
CATALYZES RELEASE	2.50273928804294
RELEASE REDUCTION	2.50273928804294
OXYGEN SUBSTITUTION	2.502595627710375
ligases	2.5025942991860948
CONTROL EVALUATION	2.5024123148687347
BACULOVIRUS VECTOR	2.502357461876336
THIAMINE DEPLETION	2.502301004829278
WILD-TYPE LAI VIRUS	2.5022968306067845
EXTRACELLULAR ATP	2.502293613345153
LITERATURE REPORT	2.502251581095358
PEDF GAG AFFINITY	2.5021545948858988
BLOTTING FRACTION	2.5020124857381285
MONOLAYER ADHERENT	2.5019537299558756
OTHER LGIC SUBUNIT	2.50162513761674
DENEDDYLATING ENZYME	2.501051396961173
ALDO KETO REDUCTASE	2.501018642996981
SIMPLE IMPUTATION	2.50089006586669
LIGAND BLOT STUDY	2.500811219910164
DENATURING GEL SD	2.5007549313644017
PREPARATION BUFFER	2.5007161146919676
INTEGRIN AFFINITY	2.5006449433183358
BUTAIT TOXIN SHOW	2.5005192150520243
CM-IV FRACTIONATION	2.5002052508816517
EXOGENOUS ADDITION	2.4997393611844476
DISCUSSION VANADYL	2.4997146078734804
TOTAL BODY SODIUM	2.4995334045247555
NEDDYLATION STATE	2.499281002414628
SUPPRESSION LEVEL	2.499281002414628
TENTATIVE EVIDENCE	2.498982077687906
MANDUCA SEXTA APN	2.4989648355608893
SALT FRACTIONATION	2.4988834678552325
INCUBATION MIXTURE	2.4988325817316666
MYOCARDIAL DAMAGE	2.4980898151426536
EXHIBIT REDUCTION	2.497968756492558
HIV IDENTIFICATION	2.4979493935000745
INDUCED DNA GCDCA	2.497701583939165
CORE ACS SEQUENCE	2.497612344019897
LIPID ASSOCIATION	2.497307043843011
HBAB MRNA ABUNDANCE	2.4972368978373978
CM-IV HPLC FRACTION	2.497144402503409
LIGAND BLOT ASSAY	2.496643529735463
ELECTROCARDIOGRAPHIC Q-WAVE	2.4966228625645934
EDTA CONCENTRATION	2.49626900292652
MEK	2.496268032292278
UCB-DMSO-WATER SYSTEM	2.4961767500403735
HYBRIDOMA SUPERNATANT	2.4961767500403735
CONTAINING AMPICILLIN	2.4961767500403735
CONCOMITANT DISMISSAL	2.4961767500403735
OTHER RISK FACTOR	2.495895356575769
MAJOR RISK FACTOR	2.495895356575769
DECREASED MORTALITY	2.495812933458873
INCREASED MORTALITY	2.495812933458873
ALLHAT DEFINITION	2.4956279934964334
ALLHAT POPULATION	2.4956279934964334
ZD DOMAIN ABSENCE	2.4953754660901675
SURVIVING SUBJECT	2.495313448697215
DMUT OLIGONUCLEOTIDE	2.4951685962480625
SQUAMOUS EPITHELIA	2.4949124655458275
INDEPENDENT REVIEW	2.4949124655458275
PRODUCE Β-LACTAMAS	2.4949124655458275
POST TRANSLATIONAL	2.4949124655458275
FURA2 FLUORESCENCE	2.4949124655458275
CULLIN/RING FAMILY	2.4949124655458275
DNA SINGLE-STRAND	2.4944982795233406
INSSUBUNIT SEDIMENTED	2.4944369185188133
DIMER INSTABILITY	2.49431589233398
SUBUNIT RIBOSOMAL	2.4942669530769126
UBIQUITIN-LIKE MODIFIER	2.4940440365433174
RIBONUCLEOTIDE REDUCTAS	2.4940440365433174
GUANIDINE HYDROCHLORIDE	2.4940440365433174
M. THERMOLITHOTROPHICUS	2.4940440365433174
HYPERNEGATIVE SUPERCOIL	2.4940440365433174
HUMAN CUL3 HOMOLOGUE	2.494025152243284
ADJUSTED MEAN YOL	2.493623116699044
HYDROPHOBIC FORCE	2.493601954936762
PROLONGED STORAGE	2.493601954936762
EXPERIMENTS LIMIT	2.493601954936762
LIPOPROTEIN LEVEL	2.493601954936762
SYSTOLIC FUNCTION	2.493601954936762
CELL LYSIS BUFFER	2.4934106544837644
TOXIN DISSOCIATION	2.4933533284264597
VECTOR PGEM T-EASY	2.4932846206889963
GRADIENT SYSTEM-I	2.4932290025650814
WAF1 GENE PROMOTER	2.4932075629442942
HEK293 CELL LINE	2.4929291154485433
CHANNEL FUNCTION	2.4929291154485433
COMPLEX KINETICS	2.4929291154485433
HALOBACTERIUM SP	2.4929291154485433
EMBRYO STRUCTURE	2.4929291154485433
MONITORING BOARD	2.4929291154485433
VIRAL MATURATION	2.4929291154485433
VALIDATED METHOD	2.4929291154485433
TYPE COUNTERPART	2.4929291154485433
systolic failure	2.4929291154485433
VENTRICULAR MASS	2.4929291154485433
FOLDED STRUCTURE	2.4929291154485433
ARTHROPOD MUSCLE	2.4929291154485433
ANTI-HLA CLASS I	2.4929291154485433
BINDING STRENGTH	2.4929291154485433
FIBRILLAR TYPE I	2.4929291154485433
CUMULATIVE EVENT	2.4929291154485433
PUBLISHED RESULT	2.4929291154485433
bile acid binder	2.4929291154485433
VARYING CAPACITY	2.4929291154485433
SURVIVING COLONY	2.4929291154485433
MISSING DATA SET	2.4929291154485433
DROPOUT CATEGORY	2.4929291154485433
AROMATIC PORTION	2.4929291154485433
CALLED MYOSIN-IΒ	2.4929291154485433
OUTCOME VARIABLE	2.4929291154485433
WEIGHT-LOSS DRUG	2.4929291154485433
CELL-CELL FUSION	2.4929291154485433
STABILIZING ROLE	2.4929291154485433
ETHIDIUM BROMIDE	2.4929291154485433
AD HOC COMMITTEE	2.4929291154485433
ORGAN TRANSPLANT	2.4929291154485433
BIOCHEMICAL LINK	2.4929291154485433
receptor variant	2.4929291154485433
PATHOGEN CAPTURE	2.4929291154485433
CLASS PREDICTION	2.4929291154485433
STANDARD MIXTURE	2.4929291154485433
AKTA-FPLC SYSTEM	2.4929291154485433
MOLECULAR SWITCH	2.4929291154485433
STATISTICAL TOOL	2.4929291154485433
ENCODING PORTION	2.4929291154485433
USING PROPORTION	2.4929291154485433
ICH-E9 GUIDELINE	2.4929291154485433
ΔPOP2 POP1-13MYC	2.4929291154485433
ONSET ALCOHOLISM	2.4929291154485433
INFECTIOUS VIRUS	2.4929291154485433
MAXIMAL ACTIVITY	2.4929291154485433
SHAPE MORPHOLOGY	2.4929291154485433
BA ENZYMES SHARE	2.4929291154485433
SCREENING METHOD	2.4929291154485433
POPULAR PRACTICE	2.4929291154485433
S-TRANSFERASE HA	2.4929291154485433
PROGRESSIVE RISE	2.4929291154485433
CRITICAL ELEMENT	2.4929291154485433
METABOLITES PLAY	2.4929291154485433
PARALLEL PORTION	2.4929291154485433
CHEMICAL LIBRARY	2.4929291154485433
POPULAR APPROACH	2.4929291154485433
AGGREGATING CELL	2.4929291154485433
CONSENSUS BETTER	2.4929291154485433
CONSERVED NATURE	2.4929291154485433
PHYLOGENIES SHOW	2.4929291154485433
EQUATORIAL METAL	2.4929291154485433
BINDING LOCATION	2.4929291154485433
OVERWEIGHT GROUP	2.4929291154485433
IMPUTED DATA SET	2.4929291154485433
CURRENT PRACTICE	2.4929291154485433
VASCULAR HORMONE	2.4929291154485433
WEIGHT GUIDELINE	2.4929291154485433
IMAGING APPROACH	2.4929291154485433
BEING OVERWEIGHT	2.4929291154485433
NON-ENZYME BOUND	2.4929291154485433
ALIGNED POSITION	2.4929291154485433
OBSERVED OUTCOME	2.4929291154485433
THEORETICAL FEAR	2.4929291154485433
ALIGNED DATA SET	2.4929291154485433
CLINICAL PICTURE	2.4929291154485433
ETHER EXTRACTION	2.4929291154485433
IN VIVO ASSEMBLY	2.4929291154485433
IN VIVO ACTIVITY	2.4929291154485433
ΜG/G BODY WEIGHT	2.4929291154485433
MM NON-ESSENTIAL	2.4929291154485433
SF9-CELL EXTRACT	2.4929291154485433
NUMBERING SCHEME	2.4929291154485433
VASCULAR DISEASE	2.4929291154485433
ABUNDANCE ANALYSIS	2.492896322333111
ICP DETECTION LIMIT	2.492884721843687
REVEALED CO-ELUTION	2.492884721843687
EVENT ASCERTAINMENT	2.492884721843687
EXPRESSING GST-CDC6	2.492884721843687
HEMODYNAMIC MEASURE	2.492884721843687
INTEGRAL MEMBRANE	2.4928447486063803
VO PROTEIN LIGAND	2.49273803387977
COMPLIMENTARY SIDE	2.4926789109748264
ANALYSIS PROGRAM	2.4923076661189696
FP IMAGING STUDY	2.4920737462174785
MYOSIN LEVER ARM	2.4920055440196527
P66 INS(PANEL B)	2.491950259814402
OTHER MICROARRAY	2.4918653590706246
ST-T WAVE CHANGE	2.4917897916776575
COMPUTER CONTROL	2.49174110262762
STUDY POPULATION	2.4916460616019456
ANALYTICAL STUDY	2.4916460616019456
STUDY LIMITATION	2.4916460616019456
PHYSIOLOGY STUDY	2.4916460616019456
CRY TOXIN VARIANT	2.4916187955000475
P51 INS(PANEL F)	2.4915251002965424
SINGLE IMPUTATION	2.4915097842912624
CALMODULIN RATIO	2.4914912102756324
MG/ML PROTEINASE K.	2.4914179491766997
REGULATED KINASE	2.491322207933537
STAINING SOLUTION	2.491263914337688
TOLERANCE EFFECT	2.491116104578351
RESULTING EFFECT	2.491116104578351
BINDING RESPONSE	2.490812402249842
INDUCED RESPONSE	2.490812402249842
RESPONSE PROFILE	2.490812402249842
RESPONSE ELEMENT	2.490812402249842
IMAC PURIFICATION	2.4906428723035585
CYTOKINE RECEPTOR	2.49062204232229
B. MORI ACTIVITY	2.490553089806696
RAT FAS RECEPTOR	2.4905117676216206
IQ PEPTIDES BIND	2.4904018881749423
EXPRESSING CLONE	2.490167575712489
TRANSCRIBING RNA	2.4900808060213286
UCB CONCENTRATION	2.4900302511783665
BACTERIAL STRAIN	2.4899717218304995
OVEREXPRESSED IDO	2.4899372824677535
MCNTCP PREINCUBATION	2.48987919540963
EXCESS PIPERAZINE	2.4897819795528
PROTEIN A-SEPHAROSE-4CL	2.4896963654469806
TREATMENT PERIOD	2.4895250950392027
RECEPTOR VARIANT	2.4893030937081586
CARDIAC RECEPTOR	2.4893030937081586
RECEPTOR LEADING	2.4893030937081586
RECEPTOR SURFACE	2.4893030937081586
BINDING POCKET NNRTI	2.489070228222576
NUMBERING SCHEME BBL	2.489070228222576
INTERNAL PROTEIN	2.4890251482148935
GLOBULAR PROTEIN	2.4890251482148935
ENCODING PROTEIN	2.4890251482148935
EXTERNAL PROTEIN	2.4890251482148935
MATERNAL REJECTION	2.4889097876362616
GLYCOSYLATION PLAY	2.4889097876362616
MANGANESE CHLORIDE	2.4889097876362616
DMSO-WATER MIXTURE	2.4889097876362616
EXERTIONAL DYSPNEA	2.4889097876362616
HF OUTCOME GROUP	2.4889002024036717
GENERATED MUTANT	2.488875021697141
RESULTING MUTANT	2.488875021697141
REMAINING MUTANT	2.488875021697141
RADIOACTIVE THDP	2.488800476833254
REMAINING CELL	2.4887293178222705
BLUE EXCLUSION	2.4887293178222705
RESULTING DATA	2.4887293178222705
VARYING DEGREE	2.4887293178222705
EPPENDORF TUBE	2.4887293178222705
GLYCINE HOMOLOGOUS	2.4887116898320176
ANTISENSE PRIMER	2.488539720710183
ANTISENSE STRAND	2.488539720710183
GENOME ASSOCIATE	2.488429196382239
EGTA CONCENTRATION	2.488388564234988
EXPRESSING BTR175	2.4882474244576316
ANTI-Α6 INTEGRIN	2.4882438064581587
ANTI-Α5 INTEGRIN	2.4882438064581587
ANTI-Α2 INTEGRIN	2.4882438064581587
ANTI-Α3 INTEGRIN	2.4882438064581587
CASPASE ACTIVITY	2.488190564310541
VIRAL RNA GENOME	2.4880302964528638
ACID EXPORT PUMP	2.4876590680533557
LIPID MICRODOMAINS HELP	2.4876387176608694
IMAGE ANALYSIS	2.4873763951075136
ENCODED PROTEASE	2.4873692154466203
SIGNED-RANK TEST	2.487177494756899
ESSENTIAL COFACTOR	2.487167074694775
DETECTED HEPARIN	2.4871375529465403
ATTACHED PEPTIDE	2.487110615446531
AGRICULTURAL USE	2.487055981643695
CCR5 UP-REGULATION	2.4866398674183587
ALTERED ADHESION	2.48661104726454
POMBE CSN SUBUNIT	2.486552363599821
ADDED IQ PEPTIDE	2.4865228881736003
OTHER IQ PEPTIDE	2.4865228881736003
RAT ASBT PROTEIN	2.4864110480895447
COMPETING ABILITY	2.4861510446458026
DECREASED ABILITY	2.4861510446458026
ESCHERICHIA COLI	2.4859792404461394
CLINICAL STUDY	2.4859360527711876
ONE-TO-ONE RELATIONSHIP	2.4858351998442205
PRIMARY ANALYSIS	2.485817510474701
CD39 FAMILY GIVE	2.485801038523001
BIOLOGICAL ASSAY	2.4855093200723117
WILD-TYPE SAMPLE	2.4854828208031106
LOWERING THERAPY	2.4854828208031106
RNASE H SUBDOMAIN	2.4854279478178967
TRANSPORTER GENE	2.4853474336277395
REVIEWED DISCHARGE	2.4853081808905224
ZINC RIBBON FAMILY	2.4853081808905224
HIV-1 INHIBITION	2.485277876913787
BUFFER CONDITION	2.4851166095910404
THERMOPOL BUFFER	2.4851166095910404
BUFFER FLOW RATE	2.4850981838696784
GENERAL CATEGORY	2.485061332426954
GENERAL COMPUTER	2.485061332426954
SODIUM/BILE ACID	2.485024044355762
PHOSPHATE SYSTEM	2.484948397742434
HIV-1 EXPRESSION	2.4849399575457607
ALPHA-1 BLOCKADE	2.4849100289073083
BINDING SITE ADP	2.4847527919163035
IDO AMPLIFICATION	2.484627373075949
PHYSIOLOGIC STUDY	2.484606343731823
CONCLUSION RECOMMENDATION	2.4846035275690155
PREVIOUS NMR STUDY	2.484421631537725
LIPID METABOLISM	2.4843016844110766
RESEMBLING LIPID	2.4843016844110766
SITE INTERACTION	2.4841871343134443
CD86 INTERACTION	2.4841871343134443
BOOTSTRAP SAMPLE	2.4836626154453385
POTENTIAL ZN(II)	2.483558497467774
PEDF NEUROTROPHIC	2.483509281370994
BINDING SITE ATP	2.48350555612325
ACTIVATED PBMC PHA	2.4833873239594615
PEAK WT RESPONSE	2.483341649783836
CDK INHIBITOR P27	2.4831903678940086
P27 CDK INHIBITOR	2.4831903678940086
CYCLIN T1 COMPLEX	2.4831903678940086
MAXIMUM POSSIBLE	2.483117527209856
HF INCIDENCE RATE	2.483019356319393
ZN(II) COORDINATION	2.4830143456127236
IDO SENSE PRIMER	2.4829992102661294
TYPE P66 SUBUNIT	2.482982679166139
MULTIPLE WASHING	2.4829112776072404
SYNGENEIC MURINE	2.4828811033968754
CATENANE FORMATION	2.482794910139601
POSITIVE CLONE	2.4827173235070257
HAVING SECRETION	2.482633004333871
CULLIN/RING ENZYME	2.482513491503118
COX-2 TRANSCRIPT	2.4825043029449376
EXPRESSING COX-2	2.4825043029449376
wt	2.482246382462066
PEDF-BINDING AFFINITY	2.482150201339422
RNA GEL ANALYSIS	2.482149090149211
ACETONITRILE GRADIENT	2.4817358598821486
RECOMBINANT PEDF	2.481659047877078
N-TERMINAL PIECE	2.4815269767727246
ANISOMYCIN ABSENCE	2.4814634515544114
BRIDGE FORMATION	2.4812377369398266
MAGNETIC RESONANCE	2.4811920588953917
SUBSTRATE TURNOVER	2.4811920588953917
HIV-INFECTED BRAIN	2.4811920588953917
MODIFIED SPECIES	2.4810995409763668
CONFIRMATORY EVIDENCE	2.4810168929457297
MAXIMUM RESPONSE	2.481000814011154
BACTERIAL ENZYME	2.4809662158542416
METABOLIC ENZYME	2.4809662158542416
PRODUCING ENZYME	2.4809662158542416
PRIMITIVE ENZYME	2.4809662158542416
LOW-DOSE IONOPHORE	2.480923616156579
GLUTATHIONE ELUATE	2.4808966434411954
P53 INACTIVATION	2.4808919011586656
OBJECTIVE MEASURE	2.4808304081643175
ADP INTERMEDIATE	2.4806646301501836
TRANSFECTED LINE	2.48035647725324
DATA INFORMATION	2.480347445185571
MAP KINASE KINAS	2.4802552513308846
TRIS-GLYCINE GEL	2.4802288362563334
ENZYMES AFFINITY	2.479999115444071
DISSOCIATION RATE	2.4799722409898846
GROWTH RETARDATION	2.4798680970611837
MANUAL MODIFICATION	2.4798123485616075
BINDING PROTEIN ACH	2.479685372905386
matches	2.4793284701758314
PRECIPITATED UCB	2.479029365443736
F-BOX REQUIREMENT	2.4790127994284066
MUTAGENESIS KIT	2.4789905578931912
ANTISERUM SUPPORT	2.4788075855388683
MUTANT UBIQUITIN	2.4787864934678456
SURVIVAL ANALYSIS	2.478745051108665
ZN(II) DEPENDENT	2.478737774922754
WEIGHT CHROMATIN	2.478297799654009
DMSO/BUFFER MIXTURE	2.478243663767758
REVERSAL EXPERIMENT	2.478243663767758
CONDUCTANCE CALCIUM	2.478243663767758
COMPELLING ARGUMENT	2.478243663767758
extract preparation	2.478243663767758
PERKIN-ELMER SERIES	2.478243663767758
SINUSOIDAL MEMBRANE	2.478243663767758
LEPIDOPTERAN INSECT	2.478243663767758
FAILURE DIAGNOSIS	2.4782067083777526
AFFECTED CD39 ACR3	2.4779202696172105
PYROCOCCAL A-ATPASE	2.477738799696174
WT RECEPTOR	2.4776004070840343
TRIGGERS RELEASE	2.4773696938013705
ΜG LYSATE PROTEIN	2.4771760954483
LAMELLOPODIA DYNAMIC	2.4766829181708054
BIBLIOGRAPHIC SEARCH	2.4766829181708054
OBSERVED DISTURBANCE	2.4766829181708054
optimal superhelical	2.4766829181708054
CONTINUOUS AGITATION	2.4766829181708054
HETERODUPLEX SUBSTRATE	2.476632780296679
NON-CLINICAL INHIBITOR	2.476632780296679
CANDESARTAN CILTEXETIL	2.476632780296679
IDO-INDUCED ALTERATION	2.476632780296679
MYCOBACTERIUM SMEGMATI	2.476632780296679
CHARGED POLYSACCHARIDE	2.476632780296679
NON-REDUCING CONDITION	2.476632780296679
DEACETYLATION ACTIVITY	2.476632780296679
MAX VALUES RANGE	2.476576468384064
ACID INTERACTION	2.476282063220663
NON-SPHERICAL AGGREGATE	2.47618305119803
CULLIN UBIQUITIN	2.4761149017330504
midgut epithelial	2.476110488704936
POLYPEPTIDE BOUND	2.476110488704936
EUKARYOTIC ENZYME	2.476060747164966
RECEPTOR SUBUNIT	2.475851722735764
MORI APN RESEARCH	2.475488081743259
OBSERVED EVIDENCE	2.475390500990793
INCUBATION PERIOD	2.4752435647226005
HETEROPOLYMERIC RNA	2.4752434469489204
EUKARYOTIC MRNA	2.475051936936716
ARS1 DNA FRAGMENT	2.47494482940286
RT CONCENTRATION	2.4749327347926013
FAMILY MEMBER B4	2.4743961154421332
NORMAL BMI GROUP	2.4743961154421332
E. COLI STRAIN	2.4743502760994973
SERUM TRYPTOPHAN	2.474212966083265
OBJECTIVE ASSESSMENT	2.474205456160451
RNASE H FUNCTION	2.4739369645410734
PHENANTHROLINE MONOHYDRATE	2.473704097473716
NEURONAL LINEAGE	2.473534115441835
characterization	2.473476757478529
BACTERIAL LYSATE	2.473382592004283
HETEROPOLYMERIC DNA	2.473298372913043
ABSORBANCE READING	2.47322537116288
MORTALITY ANALYSIS	2.4731389367564827
EXERCISE CAPACITY	2.4730762547667617
INTRACELLULAR CA	2.472680793448376
FINGER SUBDOMAIN	2.472588017880532
TRANSFECTED TSA201	2.4722772419109624
CYTOSOLIC ENZYME	2.4720940350001093
AGONIST ACTIVITY	2.472079490441332
NON-HOSPITALIZED HF	2.4718779863434412
PROTΑ EXPRESSION	2.4717415710733057
AVERAGE INCIDENCE	2.471390569245554
IN-HOSPITAL INITIATION	2.4711744916053444
HDL CHOLESTEROL RATIO	2.471045850284501
GLUTATHIONE BEAD	2.4709821417567417
ENCOMPASSING CHD	2.4709821417567417
HUMAN HEPATOCYTE	2.4709821417567417
TFIID COMPLEX BIND	2.4709017539075644
PROTECTION STUDY	2.470796436594734
AGONIST RESPONSE	2.4699627772426305
CHO CELL EXTRACT	2.4697628654405306
GROWTH CULTURE	2.4697374529352003
LINKED CY-3 TYRAMIDE	2.469250532139743
DIMER ASYMMETRIC	2.469100972583159
HEMODYNAMIC EFFECT	2.4690226547358742
IONO STIMULATION	2.4689183625404874
PROTEIN C4 COLUMN	2.468739239414655
TOTAL RNA	2.4687282489084623
S PERFUSION TIME	2.468486758448564
REDUCTASE INHIBITOR	2.468482958383805
TRANSFECTED MDCK	2.468442405820548
FORM HYDROPHOBIC	2.468400144851824
PROCEDURAL GUIDE	2.468400144851824
COMPETING LIGAND	2.468034040813067
ALLHAT PARTICIPANT	2.4679670037557315
INCUBATION BUFFER	2.46728491832739
ROUTINE ENDPOINT	2.4672680385165906
HOMOMERIC RECEPTOR	2.467143555564184
UNINFECTED BYSTANDER	2.4671269932737254
ANTI GST ANTIBODY	2.4666730362354894
INDICATING RETENTION	2.466547846310266
ADHERENT CULTURE	2.4660263735037544
MULTIPLE FREEZE/THAW	2.465969568936842
MYOSIN-1A IQ DOMAIN	2.4658209478245454
A-SEPHAROSE 4CL	2.4658013673293575
L. DISPAR APN-1	2.4658013673293575
CALCIUM GREEN-2	2.4658013673293575
DEPRESSED LEVEL	2.4658013673293575
CLASS DISCOVERY	2.4658013673293575
S. FLUORESCENCE	2.4658013673293575
STANDARD NORMAL	2.4658013673293575
MM PIPERAZINE-N	2.4658013673293575
STEROID HORMONE	2.4658013673293575
SCHEDULED VISIT	2.4658013673293575
YEAR EQUIVALENT	2.4658013673293575
WEIGHT STANDARD	2.4658013673293575
POSSIBLE METHOD	2.4658013673293575
THYROID HORMONE	2.4658013673293575
SHOWING BENEFIT	2.4658013673293575
regulatory step	2.4658013673293575
SUPPORTIVE ROLE	2.4658013673293575
BRADFORD METHOD	2.4658013673293575
BINDING RESIDUE	2.4658013673293575
EMISSION FILTER	2.4658013673293575
focus formation	2.4658013673293575
INHIBITED TNF-Α	2.4658013673293575
GEL-LOADING DYE	2.4658013673293575
TRIAL PROCEDURE	2.4658013673293575
LOSING ACTIVITY	2.4658013673293575
rabbit antisera	2.4658013673293575
ABSORBENCY PEAK	2.4658013673293575
CLINICAL CENTER	2.4658013673293575
PRACTICAL USAGE	2.4658013673293575
EXECUTION PHASE	2.4658013673293575
FLATBED SCANNER	2.4658013673293575
CELLULAR REPAIR	2.4658013673293575
CONTAINING CELL	2.4658013673293575
BINDING EPITOPE	2.4658013673293575
PCU3-13MYC CELL	2.4658013673293575
CHROMOSOME LOSS	2.4658013673293575
INDIVIDUAL CASE	2.4658013673293575
DIVERSE PATIENT	2.4658013673293575
GROUPING SCHEME	2.4658013673293575
AQUEOUS AMMONIA	2.4658013673293575
MEASURED WEIGHT	2.4658013673293575
EMISSION PHOTON	2.4658013673293575
PACKAGED VIRION	2.4658013673293575
PEAK WAVELENGTH	2.4658013673293575
SUBSTRATES BIND	2.4658013673293575
REFERENCE POINT	2.4658013673293575
MEMBRANE SYSTEM	2.4658013673293575
INDIVIDUAL PEAK	2.4658013673293575
SPLICED MESSAGE	2.4658013673293575
F-BOX/WD REPEAT	2.4658013673293575
CUPRIC SULPHATE	2.4658013673293575
NOVEL MYOGLOBIN	2.4658013673293575
POSITIVE RESULT	2.4658013673293575
DRIVE CATALYSIS	2.4658013673293575
SELECTIVE ENTRY	2.4658013673293575
CARDIAC DISEASE	2.4658013673293575
KINETIC PROCESS	2.4658013673293575
RELATIVE AMOUNT	2.4658013673293575
REMAINING BOUND	2.4658013673293575
POSITIVE ACTION	2.4658013673293575
MUTANTS DISPLAY	2.4658013673293575
MEMBRANE FILTER	2.4658013673293575
protein content	2.4658013673293575
DOT-BLOT METHOD	2.4658013673293575
MECHANICAL WORK	2.4658013673293575
CONSIDERING GAP	2.4658013673293575
INTESTINAL CELL	2.4658013673293575
open-label drug	2.4658013673293575
PRAGMATIC TRIAL	2.4658013673293575
BINDING SEGMENT	2.4658013673293575
surface mannose	2.4658013673293575
SUSPENSION CELL	2.4658013673293575
MEMBRANE DOMAIN	2.4658013673293575
SPLICING DOMAIN	2.4658013673293575
OPTIMAL OUTCOME	2.4658013673293575
FORMING COMPLEX	2.4658013673293575
POSSIBLE REASON	2.4658013673293575
RESULTING IMAGE	2.4658013673293575
PROBE SUBSTRATE	2.4658013673293575
MAKING MUTATION	2.4658013673293575
MEASURED HEIGHT	2.4658013673293575
OPPOSITE SURFACE	2.465733952395659
NOCTURNAL DYSPNEA	2.465490669921327
CARBOXYLATE TRIAD	2.465490669921327
RECORDING CHAMBER	2.465490669921327
EVENTUAL DELIVERY	2.465490669921327
DMSO-WATER SYSTEM	2.465490669921327
MAPK HOMOLOG P38	2.465419193564028
HAMSTER OVARY K1	2.465129615438928
DISEASE CONTROL	2.464636848001366
SINGLE B SUBUNIT	2.4645849867989864
STUDY PROCEDURE	2.464543686455127
STUDY SUBSTRATE	2.464543686455127
STUDY GUIDELINE	2.464543686455127
WEAK CALMODULIN	2.464391897384099
OTHER BETA-BLOCKER	2.46435337800622
P51 CONSTRUCTION	2.4642065501581447
SPECIES SEDIMENTED	2.464181898440882
KDA APN FRACTION	2.4641301543242258
POSSIBLE CHANGE	2.4641261776403205
NUISANCE EFFECT	2.464024209572292
MYOCARDIAL INJURY	2.4639735529522397
MEDICATION ADHERENCE	2.4638191731170442
IMPLICATING P51	2.463736992157009
SPECIES REACTIVE	2.463724853470357
TORPEDO NACHR ΓY111	2.463602605691829
SPLICING INTRON	2.4635242292562376
PKK223-3 VECTOR	2.463492066289103
VECTOR PEGFP-C3	2.463492066289103
OTHER IQ DOMAIN	2.4633241171225393
PEAK MRNA LEVEL	2.463147170679195
RABBIT ANTISERUM	2.4631439368668127
DEPLETING CLONE	2.4630944382954167
HETERODIMERIC RT	2.4630060425215268
CLEAVED DNA END	2.462733329713953
DNA GATE STRAND	2.462733329713953
BEING COMPONENT	2.462608036984631
CELL CYCLE SHOW	2.4625379239431298
CATALYZE CATENATION	2.4623825175188347
STABLE RECEPTOR	2.462247051815227
RECEPTOR PURITY	2.462247051815227
PROTEIN SOLUTION	2.462201069258247
COMMON PROBLEM	2.4621592356290427
BB ENZYMES SHARE	2.4620407821045265
MOUSE MODEL AMPA	2.4620407821045265
FURA2 IMAGE PAIR	2.4620407821045265
ASSAYING MUTANT	2.4618274451225863
REPORTED INTEIN	2.4616726169846603
V-ATPASE INTEIN	2.4616726169846603
INTEIN SEQUENCE	2.4616726169846603
ADDITION CONTROL	2.46164886034917
PRIMARY CONSEQUENCE	2.4616466666752
CM5 SENSOR CHIP	2.461609097748588
CASPAS ACTIVATION	2.461575529355941
BULLFROG GENOME	2.461390436205706
P51 WTAND P66 IN	2.461356783777206
CA CONCENTRATION	2.4613069941964905
INDUCED E. COLI	2.4612597419501907
ZD DOMAIN PRIOR	2.4612597419501907
STUDY TREATMENT	2.4612069820949225
SIGNAL RESPONSE	2.4610809060782297
CSN HOLOCOMPLEX	2.460935340137393
transport buffer	2.4608527692836026
MUTAGENESIS DATA	2.4608527692836026
HIV-1 TAT CLADE	2.4608014127834856
SIGNALING PATHWAY	2.460729537580386
SCINTILLATION VIAL	2.4606114489197375
CAUSE MINOR SIDE	2.460604115437363
CADHERIN MOLECULE	2.4604281756624737
TRNA COMPOSITION	2.460419955017509
BEAD BEATER LYSI	2.4602238213195844
HEPARIN SULFATE	2.460124335605399
ASBT EXPRESSION	2.4597131405530073
REACTION VOLUME	2.459654806665823
HPA1 SITE ABSENCE	2.4596389330405626
PRIMARY OUTCOME	2.4594395574597074
MAPK STIMULATOR	2.4594147066399037
COLLOIDAL SPECIES	2.459339711051388
RT INHIBITOR TSAO	2.4593285528493563
INSECT TOXIN I5	2.4593133310734046
Α- INSECT TOXIN	2.4593133310734046
NUCLEAR HORMONE	2.4593133310734046
SCINTILLATION FLUID	2.4593093630981353
E. COLI PROTEIN	2.4587085656108107
MAJOR BILE ACID	2.4585231536169045
PHARMACOPHORIC REGION	2.458480400406565
COGNITIVE ABNORMALITY	2.458480400406565
INCLUDING NONINVASIVE	2.458480400406565
PREPARATIVE CONDITION	2.458480400406565
CORONARY VASODILATORY	2.458480400406565
PEROXISOMAL ACTIVATOR	2.458480400406565
APN GLYCOSYLATION	2.458410790732254
SCD39 CATALYSIS	2.4583696167089024
COMPARING HIV-1	2.45830143551055
SIGNATURE MOTIF	2.4582319916974127
CADHERIN AFFINITY	2.4582187009868144
MOLECULAR OXYGEN	2.458179740436524
IONIC PHENOMENON	2.458179740436524
STRENGTH BUFFER	2.458143357322331
CARDIOVASCULAR DISEASE	2.45812147732511
IODOACETIC ACID	2.4580526226066084
CLAVULANIC ACID	2.4580526226066084
DIGESTED PKK-RT66	2.457905085075892
PLASMON RESONANCE	2.457905085075892
REGULATOR EMMPRIN	2.457905085075892
CONTROL GENE	2.4573415493095854
GROWTH PROPERTY	2.457250189837202
CONSERVED F-BOX	2.456915578544031
FILTRATION ELUTING	2.456495326924607
DMSO/BUFFER SYSTEM	2.456495326924607
CLEAVED GPI-ANCHOR	2.456495326924607
TOLERABILITY TRIAL	2.456495326924607
COLLOID SUSPENSION	2.456495326924607
NECK-TAIL FRAGMENT	2.456495326924607
NON-HEPATIC TISSUE	2.456495326924607
CEREBELLAR PURKINJE	2.4562820766538644
ZN-RIBBON STRUCTURE	2.4562820766538644
PARTIAL RESTORATION	2.4562820766538644
NEUROTOXIC ACTIVITY	2.4562820766538644
DTTP CONCENTRATION	2.4562511501960818
ANTI-Β1 INTEGRIN	2.456167460293218
POMBE ORC4 SUBUNIT	2.4561427780996623
CELL AGGREGATION	2.456135659553464
BINDING SITE TC	2.455708866486764
hormone receptors	2.455657504380948
COX-2 SYNTHESIS	2.4555827102262318
EXPRESSED COX-2	2.4555827102262318
L1 WILD-TYPE L1	2.455258308413434
TARGET MOLECULE	2.455253076126131
SATURATION LIMIT	2.4550207063445226
RAW TRANSFECTANT	2.4550207063445226
FUNCTIONAL PEDF	2.4547541704611135
HUMAN PEDF CDNA	2.4545621970558202
TARGET ANTIGEN	2.4544722936108765
FAVOR FORMATION	2.454341191138936
MG PEDF/ML RESIN	2.454318698768522
PAF STIMULATION	2.4542873874948494
PARAMETRIC CASE	2.4541229020686424
MURINE IDO CDNA	2.4540117919631363
PPARGAMMA PROMOTER	2.4539379730223065
COMMON ANCESTOR	2.4538380614525273
enzyme functions	2.453836068560022
RIBOSOME SUBUNIT	2.4534157132171344
PFB-GST PLASMID	2.453373270852583
PLASMID EXPRESS	2.453373270852583
REGRESSION	2.4533316964084553
ISOLATABLE ENZYME	2.4533039926286606
primer extension	2.4532155440062358
AFFINITY MATRIX	2.4531270639456357
INITIATOR CASPASE	2.453077894719706
HMG COA ABBREVIATION	2.4530344171628804
IDO TRANSFECTANT	2.452956387036878
KB DNA FRAGMENT	2.4528243288866793
INTEIN TRANSFER	2.4527868281993337
HIV-1 RNAS POSE	2.452543912094091
MAMMALIAN TOXIN	2.4525149974312974
HEART MYOGLOBIN	2.4524726841513673
PENTAMERIC RECEPTOR	2.452462670199274
BLOOD MONOCYTE	2.4524168721581927
BASELINE WEIGHT	2.4521764911918567
UNPROCESSED INTEIN	2.452129742990377
CONCENTRATION L	2.451945561087831
FATAL HF REPORT	2.4513714539172886
CDC37 EXPRESSION	2.4508919460660943
ΜM WILD-TYPE L1	2.4507680400449727
THIAMINE IMPORT	2.4506653506664904
RELEASE CALCIUM	2.4505496403097666
BRANCHING EUKARYOTE	2.4505027116238924
CONTAINING G418	2.4503769792491674
P66 CONFORMATION	2.450348895363393
HOST EXPRESSION	2.450331379206371
EXCEPTING TOTAL	2.450318553536743
REDUCED SDS-PAGE	2.4500034169042846
UNTRANSFECTED P19	2.4495758154416887
NG/ML APROTININ	2.4494515159643564
PURIFIED BUTAIT	2.4494515159643564
MONOCYTE FUSION	2.4494515159643564
immunodeficiency	2.449140576594966
IL-8 ACTIVATION	2.448848756467029
MRNA REGULATION	2.44863470835008
P24 GAG ANTIGEN NG	2.4483407456134985
EXERCISE PROGRAM	2.448251347575947
NM TEMPLATE-PRIMER	2.4479464581654886
HUMAN GENOME	2.447787423481061
ASYMPTOMATIC HYPERTENSIVE	2.447621069218855
MEK1 ACTIVATION	2.447436038895168
S. POMBE ORIGIN	2.4470084347259076
MULTIPLE ZN(II)	2.4467963270241886
TECHNICAL REVIEW	2.446596615432518
LYMPHOCYTIC CELL	2.446596615432518
POP2 BACKGROUND	2.4463372585614986
POP2 DISRUPTANT	2.4463372585614986
INSECTICIDAL TOXIN	2.4462050219367795
GRADIENT ELUTION	2.4460870671212653
CYSTEINYL LEUKOTRIENE	2.4459149505286293
TRANSFECTED P19	2.445462725740714
POP INTERACTING PROTEIN 1	2.4453952588023946
PREVENTION STUDY	2.44531356158592
FLUID EXPANSION	2.4442884050069873
BLINDED FASHION	2.4442884050069873
NG/ML ANISOMYCIN	2.4441730692778334
NON-DENATURING GEL	2.4433320941483
P51 HETERODIMER	2.4432996779507574
MOLECULE COMMON	2.443289770249301
control plasmid	2.443093240433522
BBMV PREPARATION	2.4426339674048316
SF9 INSECT CELL	2.4426100887974407
DISTAL NITROGEN	2.442061052847348
ANTI-CD98 MAB 4F2	2.4420608050560704
BN CLONE ABILITY	2.4420598798499733
BIPHASIC FASHION	2.441196963175011
MASS CALIBRATION	2.4408050529305148
SHOWED ADHERENCE	2.4408050529305148
KAPLAN-MEIER METHOD	2.440595228715369
MUTANT ENZYME	2.440556922421777
RESEARCH PRODUCT	2.4399776868588
PEDF POLYPEPTIDE	2.4399597978626546
PKK-RT66 TEMPLATE	2.4398287977846427
METALLOTHIONEIN GENE	2.4395209880154947
PREVENTED ADSORPTION	2.4395209880154947
DIMITRIOS MOSKIPHIDI	2.4395209880154947
MEASURING ABSORPTION	2.4395209880154947
MULTIUBIQUITIN CHAIN	2.4395209880154947
IDA-SEPHAROSE COLUMN	2.4395209880154947
ASSOCIATED PEPTIDASE	2.4395209880154947
NORMOTENSIVE PATIENT	2.4395209880154947
putative tetrahedral	2.4395209880154947
DNA SEQUENCING	2.43918675710934
OPPOSITE REGION	2.439144000973377
GENERAL GUIDANCE	2.4387288324109284
CELL PROTEIN ΜG	2.4387254139424757
cacodylate buffer	2.4387142037575265
TRANSIENT BURST	2.4385516150543554
NUCLEIC ACID	2.4379643039493444
CA IQ3 AFFINITY	2.437909883247988
MANGANESE ABSENCE	2.437749102486593
OPPOSITE EFFECT	2.437366843216312
IL-8 PRODUCTION	2.4371916152451343
ATP ANALOG ADPNP	2.4371730561072247
HUMAN CDC6 CDNA	2.437154492899799
POTENTIAL BIAS	2.437028534775566
CLEAR-CUT SIGN	2.437028534775566
BINDING METHOD	2.437028534775566
BEING POST-HOC	2.437028534775566
REMAINING LOOP	2.437028534775566
FORM INCLUSION	2.437028534775566
REGULATED STEP	2.437028534775566
REDUCED AMOUNT	2.437028534775566
INCLUDING IL-1	2.437028534775566
MONOMERIC FORM	2.437028534775566
ALARMING GROUP	2.437028534775566
PREDICTED SIZE	2.437028534775566
OBSERVED VALUE	2.437028534775566
diverse intein	2.437028534775566
ALBUMIN UPTAKE	2.437028534775566
SEQUENCES PLAY	2.437028534775566
CARDIAC MUSCLE	2.437028534775566
CATALYTIC ROLE	2.437028534775566
DECREASED RATE	2.437028534775566
YIELDED RESULT	2.437028534775566
VARIOUS AMOUNT	2.437028534775566
REPORTED VALUE	2.437028534775566
BLANK FLOWCELL	2.437028534775566
CURRENT SMOKER	2.437028534775566
BIND DOMAIN II	2.437028534775566
SUBSTRATE BIND	2.437028534775566
CAUSE INCREASE	2.437028534775566
MM NA-PYRUVATE	2.437028534775566
COUNTING DEATH	2.437028534775566
QUANTITY PRIOR	2.437028534775566
XBAI/PSTI SITE	2.437028534775566
GEORGE PAVLAKI	2.437028534775566
CARBONYL GROUP	2.437028534775566
OPTIMAL WEIGHT	2.437028534775566
CAROTID ARTERY	2.437028534775566
PHOSPHORYL END	2.437028534775566
BL21(DE3) PLYS	2.437028534775566
public concern	2.437028534775566
OCCURRING LOSS	2.437028534775566
ADJUSTED VALUE	2.437028534775566
STAIN PROTOCOL	2.437028534775566
BACTERIAL CELL	2.437028534775566
DIABETES TRIAL	2.437028534775566
FORCED DROPOUT	2.437028534775566
CELL LINE P388	2.437028534775566
INCLUDING CELL	2.437028534775566
ionic strength	2.437028534775566
CURRENT POLICY	2.437028534775566
OLYMPUS SYSTEM	2.437028534775566
STRAND OPENING	2.437028534775566
DIETARY INTAKE	2.437028534775566
COMPARING DATA	2.437028534775566
CELLULAR DEATH	2.437028534775566
COLLECTED PEAK	2.437028534775566
REPORTED EVENT	2.437028534775566
point mutation	2.437028534775566
CANCER HISTORY	2.437028534775566
AQUEOUS SYSTEM	2.437028534775566
JASCO J-810 CD	2.437028534775566
PERIODIC CHECK	2.437028534775566
mobility shift	2.437028534775566
BIND SUBSTRATE	2.437028534775566
END TIME-POINT	2.437028534775566
ICE/WATER BATH	2.437028534775566
ANCESTRAL GENE	2.437028534775566
TYPE STRUCTURE	2.437028534775566
IN VITRO MODEL	2.437028534775566
HEALTH MEASURE	2.437028534775566
EXTERNAL FORCE	2.437028534775566
CHEMICAL PROBE	2.437028534775566
PRINCIPAL FACE	2.437028534775566
UCB-HSA SYSTEM	2.437028534775566
CHAPERONE HSP90	2.4366052041775697
INDIVIDUAL HPLC	2.4366052041775697
USING ANTISERUM	2.4366052041775697
BIPHASIC NATURE	2.4366052041775697
EUKARYOTIC GENE	2.4366052041775697
IDO STIMULATORY	2.4365281185982908
RT DIMERIZATION	2.4364700367555705
ECFP BLEACH VALUE	2.436463165246129
CCR5 EXPRESSION	2.4362739673184732
R. OTHER STUDY	2.436208021955053
MARITIMA ZN(II)	2.436178743367487
TAT MICROARRAY	2.436008126612301
MEDICAL CARE SURVEY	2.4359472737706294
IN VIVO EFFECT	2.435869114485711
CYSTEINE PROTEAS	2.435840856500226
POSITIVE STUDY	2.435797765544797
NEGATIVE STUDY	2.435797765544797
HAVING ASP P51	2.4356817334287646
BEHAVIOR CHANGE	2.435608995026946
CONFIRMATORY TEST	2.435495507777027
NONRIBOSOMAL PROTEIN	2.4353459788933063
DRASTIC EFFECT	2.4352894043407836
SIMILAR EFFECT	2.4352894043407836
MAXIMAL EFFECT	2.4352894043407836
RESULTS EFFECT	2.4352894043407836
IDO INHIBITION	2.435048336755764
RESPONSE CURVE	2.4349980779227742
COMPARING ATENOLOL	2.43488568645017
HOMING ENDONUCLEAS	2.43488568645017
GUIDELINES CAUTION	2.43488568645017
HYDROLYZED PRODUCT	2.43488568645017
NEUROTOXIC PROCESS	2.43488568645017
PRODUCE HS/HEPARIN	2.43488568645017
VISITING PROFESSOR	2.43488568645017
TRNA REGULATION	2.4348444257546706
anion	2.4348407637157403
THIAMINE ENTRY	2.4347163960472424
HUMAN THIAMINE	2.4347163960472424
CD98 TYPE FORM	2.434668652769666
CREB PHOSPHORYLATION	2.4346070137800817
REDUCED ABILITY	2.4345880147234458
NOSOCOMIAL INFECTION	2.4343952045457966
SELECTED CLONE	2.4343795281530496
PHOTOPHYSICS PD	2.434359345473586
TREATMENT CODE	2.433763228653117
HAART-TREATED SUBJECT	2.4336937595514585
PUTATIVE Β-STRAND	2.4336312135705
VIRUS INFECTIVITY	2.4336312135705
ADOMET SYNTHETASE	2.4336312135705
DRIED CM-FRACTION	2.4336312135705
HISTIDINE RESIDUE	2.4336312135705
SUPERHELICAL TURN	2.4336312135705
PROSTATISM EVIDENCE	2.4335760289598385
OTHER RECEPTOR	2.433550273906001
CROSSLINK CD98	2.4334887117667163
CAUSES PARALYSIS	2.433358758285082
NON-ST ELEVATION	2.433358758285082
RESULTS CONTRAST	2.433358758285082
BIDING PROTEIN	2.433283654728755
CALLED PROTEIN	2.433283654728755
Β-TRCP PROTEIN	2.433283654728755
PROTEIN PURITY	2.433283654728755
NDE	2.4332224559869564
BINDING MUTANT	2.433139645886677
MRNA STABILITY	2.433132430879462
CARBONATE BUFFER	2.4329925470730114
SPLICED INTEIN	2.432988130735162
CYSTEINE-BASED PROTEAS	2.4329664707660013
MONOCYTE/MACROPHAGE	2.43284397659298
TRIGGER APOPTOSI	2.4327788698525175
COMPETITOR DNA	2.432524952380479
CASPASE FAMILY	2.4324830802301114
CONTROL MUTANT	2.4320000447470758
SCD39 HYDROLYSI	2.4319988887008357
CLOSE HOMOLOGUE	2.4318508562982073
GENETIC ISOFORM	2.4317391769856047
CHEMICAL ENERGY	2.4317391769856047
CONTINUING USE	2.4313947319586644
POST-EVENT USE	2.4313947319586644
GSTCDC6 ELUTION	2.431103041002954
CARDIAC DAMAGE	2.4310583855218346
CONTAINING P35	2.43096792871496
ATP CD39 HYDROLYZ	2.430929721207177
CLOSE ANALOGUE	2.4304711577263856
MCNTCP PRE-TREATMENT	2.4304201071611327
PROXIMAL INDUCER	2.430380240426909
BLOTTING ASSAY	2.429911097053146
BIND BILE ACID	2.42990605905395
F-BOX DISPENSIBILITY	2.4298265714532397
K CERENKOV CPM	2.4298213275683587
TYPE PHENOTYPE	2.429799619112915
PURIFIED SCD39	2.429755807502839
CD98 MICRODOMAIN	2.429668559168761
KINETIC BUFFER	2.429534389576503
RUNNING BUFFER	2.429534389576503
AQUEOUS BUFFER	2.429534389576503
PROTEIN TURNOVER	2.429454791051432
ACID INSERTION	2.4294455963869406
INDIVIDUAL P19	2.429185397520664
PYROCOCCAL ATPASE	2.4290501152716883
HEPATIC ENZYME TDO	2.4290207749188566
CATIONIC SPECIES	2.4289754784583377
CYCLIN-DEPENDENT	2.428776423118662
LIPID MEDIATOR	2.4287526727066004
RNAZOL REAGENT	2.4286952014422325
INCLUDING IFN-Γ	2.4286426142270816
SODIUM CARBONATE	2.428540567632155
ΜM LEUPEPTIN	2.4284160057301283
RRNA PHYLOGENY	2.4283647650851803
TRIS-HCL BUFFER	2.4282350926302554
MEAN BASELINE PP	2.428128190339022
HOMOLOGOUS ACHBP	2.4280955138770652
ZN(II) CONTENT	2.428039770730622
ATP BOUND FORM	2.427988986752967
CHONDROITIN ABC	2.427868473537451
MAPK COMPONENT	2.427653534775566
PURIFIED TOXIN	2.4275047252517563
STUDY MEDICATION	2.427493369272064
HIV-1 PROMOTER	2.4273222213289563
SCD39 GLUTAMATE	2.4269275948531304
CELLULAR INJURY	2.42687314979364
REGRESSION LINE	2.42687314979364
CONVERTED CD39	2.4267721245191556
CLINICAL COURSE	2.426660958675395
XENOPUS EMBRYO	2.4265022189860925
CPLA GEL SHIFT	2.4262923282794313
ACID TREATMENT	2.4261802902644916
INSOR P66 WTAND	2.4259136514740978
SPACED SPECIES	2.4256810170450693
SLIDING WINDOW	2.4255999633469947
COMMON THEME	2.4255609336708326
DIMERIC ENZYME	2.4255531249395004
OVARY K1 SUBLINE	2.4254160439966204
PRESSURE AGENT	2.425263828893213
SODIUM SULFATE	2.425263828893213
CHRONIC SODIUM	2.425263828893213
SPECIFIC RETENTION	2.425063122598153
ACETATE BUFFER	2.4249366884270773
ARM TERMINATION	2.424926738916854
UG/ML APROTININ	2.424926738916854
UG/ML LEUPEPTIN	2.424926738916854
UG/ML PEPSTATIN	2.424926738916854
MCARDLE RH-7777	2.424926738916854
MONOVALENT ION	2.424907322654354
DENATURING GEL	2.4248457936588146
P66 N-TERMINAL	2.4246825840713404
ANTIBODY SERUM	2.42466631412636
PPAR DOWN-REGULATION	2.4246562159533704
ENZYME ADDITION	2.4245778849816113
SOLUTION VANADYL	2.424405786477474
HIV-1 PROTEASE	2.4243557519009484
KD PROTEIN BAND	2.42432197345426
HIV-1 ACCESSORY	2.4242392451667967
PROSTAGLANDIN TDO	2.4241913746517363
CHEMOKINE IL-8	2.4241253089691144
TERM INCUBATION	2.4240925628268033
G418 RESISTANCE	2.424006251241101
BASELINE VALUE	2.4236952014422326
WD-REPEAT DOMAIN	2.423430365424505
HYPERTENSIVE MAN	2.423430365424505
WD-REPEAT REGION	2.423430365424505
STIMULATING AP-1	2.423430365424505
WHOLE A-ATPASE	2.4232354313272904
CEREVISIAE SWI/SNF	2.423204799707231
SYSTEM EMPLOY	2.423131386773234
MODIFIED FORM	2.423131386773234
FAMILY MEMBER	2.423131386773234
VALUABLE CLUE	2.423131386773234
CLEAVAGE RATE	2.423131386773234
QUANTUM YIELD	2.423131386773234
CURRENT MODEL	2.423131386773234
ICER OVEREXPRESSION	2.423006944663116
CHROMATIN POOL	2.4229934470562675
MEK1 INHIBITOR	2.4227428204898516
ARCHAEAL ATPSYNTHASE	2.4223693279438128
CDK9 STABILIZATION/FOLDING	2.422196723308813
FORM AGGREGATE	2.4216439193909505
STATE FRACTION	2.421418778678005
TRANSPORT THDP	2.42118695061715
BUTAIT LEADING	2.421028534775566
CONCERN BUTAIT	2.421028534775566
INCLUDING PBMC	2.421028534775566
ACTIVATED PBMC	2.421028534775566
COLLAGENASE I.	2.421028534775566
COLLAGENASE IV	2.421028534775566
MG CONCENTRATION	2.4208781514405713
SODIUM ACETATE	2.4206661277437878
INCREASED RISK	2.420643482202125
UCB/DMSO SOLUTION	2.4204651224469615
CHELATOR AFFINITY	2.42045934531176
VO EPR FEATURE	2.4204359421829733
IMAGING STUDY	2.4204031415334546
CADHERIN REPEAT	2.4203851135376873
INDICATOR FURA2	2.4203851135376873
DEFINED OBESITY	2.4203851135376873
UNINFECTED PBMC	2.420255352812568
PROTEIN MICROGRAM	2.4202143799053877
W89 INTERACTION	2.420073509738087
TGAGTCATTATTGGATAAAGAATCGTAAAAACTGCTTTAAACGATAAAA	2.4199672390946847
MICHROM BIORESOURCE	2.4196794314640413
HIV-1-INFECTED CELL	2.4196794314640413
HAMMERHEAD RIBOZYME	2.4196794314640413
VENTRICULAR MYOCYTE	2.4196794314640413
LURIA-BERTANI BROTH	2.4196794314640413
NMOL/MG PROTEIN/MIN	2.4196794314640413
DOSE IONOPHORE	2.41963723042774
COX-2 ANTIBODY	2.419505023803779
KAPLAN-MEIER CURVE	2.4194502289684294
MASS INDEX BMI	2.4192507569977884
RNA-DNA HYBRID	2.4188467165937477
RNASE H DOMAIN	2.4188103165573476
OTHER S. POMBE	2.4186377301778648
TRIS-BORATE PH	2.4185502739060007
EPIDEMIOLOGIC RESEARCH	2.4184110342557754
MONOCYTIC CLONE	2.4176781845037465
TOXINS EXHIBIT	2.4176110590474105
HF ASCERTAINMENT	2.417386995857197
SCD39 AFFINITY	2.417352706727645
NEUROTOXIN BT-II	2.4171122972405015
PEPTIDES CROSS	2.417028534775566
sample buffer	2.4168278317966787
NM ALEXA FLUOR	2.4165157142627454
MMP INHIBITOR GM	2.416480490422101
PBMC INFECTION	2.4164308336261406
RAT HEPATOCYTE	2.4159759031966184
CD98 PRE-CLUSTERING	2.4157924248952103
HIV-1 CORECEPTOR	2.4157791268897486
CD98 KD SUBUNIT	2.415671424622072
KDA C-TERMINAL	2.4154859057479072
BROAD SPECTRUM	2.4154069131539444
SINGLE SUBUNIT	2.4152925013981363
TOXIN AFFINITY	2.415101624476563
NONIDET P-40	2.4148365201449415
MOTOR PROTEIN	2.414830113954713
VIRAL PROTEIN	2.414830113954713
INDIVIDUAL ORC	2.4148063125533437
DMSO-WATER SHOW	2.4147080818137283
LYSATE PROTEIN	2.414533654728755
HIV-1 RT DIMER	2.414428337374145
FINAL FRACTION	2.4142759215351477
C-TERMINAL MYC	2.414134761881793
IDO CATABOLITE	2.4139957051768164
SURVEY RESEARCH	2.4138970772817343
CELL CULTURE ACH	2.413501972563928
RT HETERODIMER	2.4133248310718622
myristate	2.413305387021445
induction	2.413305387021445
AMICON YM10 FILTER	2.4132760459757328
CATALYZE CHANGE	2.4130328921246913
OTHER ENDPOINT	2.4124131501601815
STERIC CONSTRAINT	2.412391576003282
POTASSIUM OXALATE	2.412391576003282
ACETYLTRANSFERASE	2.412391576003282
MAJOR POLYANIONIC	2.412391576003282
SN-2 ARACHIDONATE	2.412391576003282
PREP81 PROMOTER	2.4122894647478996
DRUG PERFUSION	2.412028534775566
PRAZOSIN BLOCK	2.412028534775566
PERFUSION TIME	2.412028534775566
DOUBLE-BLIND STUDY	2.4119462219465366
LIGAND ADDITION	2.4119014495735254
CA INTERACTION	2.411868596992378
RADIOISOTOPIC ASSAY	2.4118639200356093
platelets	2.4116417324706596
EXPRESSING GST	2.411222083162663
MMTV-CYCLIN D1	2.411222083162663
KEY ASSUMPTION	2.41105450880154
HPLC SUPERNATANT	2.4110198743487836
EPR SPECIES D2	2.4107160482077603
ICE-COLD ADDITION	2.410699571136165
EXTENSIVE USE	2.410642940253117
TRANSLATED ORF	2.4103618681088994
COVARIATE DATA	2.4103618681088994
COX EXPRESSION	2.4100377190003095
ΜG/ML CYSTEINE	2.4098906639204176
REVEALED COOPERATION	2.4097914438912458
INDUCED REVERSAL	2.409530615419697
cell aggregation	2.409530615419697
NECK-TAIL REGION	2.409530615419697
PRODUCING EFFLUX	2.409530615419697
EFFLUX MECHANISM	2.409530615419697
PROTEIN LIGAND	2.4094030577138295
IFN-Γ INDUCTION	2.4091785054592227
SILKWORM RECEPTOR	2.408697725991592
BUDDING YEAST	2.4086350756618886
ELUTION BUFFER	2.4084817579975555
DROSOPHILA ORC	2.4082489355041634
BIPHASIC MANNER	2.4077525252981555
DNA DAMAGE/REPAIR	2.4076088531119946
ADPASE ACTIVITY	2.4074090410257813
DIALYSIS TUBING	2.4074090410257813
CONTAINING ACS	2.4073989051459366
INDUCIBLE CAMP	2.407028534775566
FUNCTIONAL NL	2.406398140616847
RESIDUES LINE	2.406398140616847
RETARDED BAND	2.406398140616847
ANION CHANNEL	2.406398140616847
K. SIMULATION	2.406398140616847
LOG-LOG SCALE	2.406398140616847
ACTIVITY PEAK	2.406398140616847
BUTHOID VENOM	2.406398140616847
DEPICTED TREE	2.406398140616847
BIASED RESULT	2.406398140616847
SITE LOCATION	2.406398140616847
INO80 COMPLEX	2.406398140616847
RETAINED FORM	2.406398140616847
Ε-AMINO GROUP	2.406398140616847
REMOVING CELL	2.406398140616847
T-RICH STRAND	2.406398140616847
P300-/- MOUSE	2.406398140616847
GLYOXALASE II	2.406398140616847
survival time	2.406398140616847
PUTATIVE ROLE	2.406398140616847
METHOXY GROUP	2.406398140616847
gene promoter	2.406398140616847
CALCIUM ENTRY	2.406398140616847
CELL LINE HEK	2.406398140616847
B-TYPE PESTLE	2.406398140616847
HAMSTER OVARY	2.406398140616847
CANINE KIDNEY	2.406398140616847
PRIMERS MATCH	2.406398140616847
ENCODING GENE	2.406398140616847
CAKS FUNCTION	2.406398140616847
SCHEDULED END	2.406398140616847
POLYCHROME IV	2.406398140616847
CARDIAC EVENT	2.406398140616847
HEALTH STATUS	2.406398140616847
TIME INTERVAL	2.406398140616847
STARTING TREE	2.406398140616847
PEPTIDES BIND	2.406398140616847
INTRODUCED LY	2.406398140616847
OBSERVED RATE	2.406398140616847
CONFINED AREA	2.406398140616847
INVASIVE TOOL	2.406398140616847
XYLENE CYANOL	2.406398140616847
PROGRAM QPOWA	2.406398140616847
PROTHYMOSIN Α	2.406398140616847
CONTAINING AC	2.406398140616847
DETECTION TAG	2.406398140616847
BOVINE KIDNEY	2.406398140616847
MAXIMAL YIELD	2.406398140616847
OTHER LINEAGE	2.406398140616847
ALKYL BROMIDE	2.406398140616847
EMISSION LINE	2.406398140616847
SUBUNITS SHOW	2.406398140616847
LISTED REASON	2.406398140616847
BUTHUS TAMULUS	2.406259304006335
STORAGE BUFFER	2.4060049778117967
EGFP-TAGGED CPLA	2.4054424536535772
CATALYTIC P66	2.4050224749141678
CAUSED CHANGE	2.4047969559465154
P68 ACTIVATION	2.404770470259437
SITE TYROSINE	2.4046461717398926
BP MEASUREMENT	2.4045961023431337
EFFECTOR CASPAS	2.4044894247106026
IDO SYNTHESIS	2.404464036361595
IDO SUBSTRATE	2.404464036361595
FRACTION REVIEW	2.4044340390352468
YEARS OF LIFE	2.4040726105004135
STRESS SIGNAL	2.403869408839754
CCR5 INFECTION	2.403859405054712
RNA POLYMERAS	2.403729499499628
ENGINEERED CHO	2.4036952014422326
REPLACING LYSINE	2.4035735797033513
CONSERVED LYSINE	2.4035735797033513
TREATMENT ARM	2.403208842171452
'-END	2.403019462816008
TYPE RECEPTOR	2.4030008444467525
RECEPTOR OPEN	2.4030008444467525
RECEPTOR GENE	2.4030008444467525
DISTINCT CD98	2.4029407153109985
CD98 MUTATION	2.4029407153109985
RECOGNIZED IQ	2.4028464218935666
TARGET UNKNOWN	2.4027428204898515
FLOW CRYOSTAT	2.402712394771933
HF EVENT RATE	2.40262336709452
RR RELATIVE RISK	2.402580740417293
AFFECTED CPLA	2.4025678557191914
CALLED INTEIN	2.4024517864798685
INTEIN SPREAD	2.4024517864798685
HARBOR INTEIN	2.4024517864798685
MICROMOLAR FINAL	2.4020843207742644
E. COLI HB101	2.402057151066171
E. COLI JM109	2.402057151066171
E. COLI BL-21	2.402057151066171
INTRINSIC DNA	2.4019993896903684
PREVENTED DNA	2.4019993896903684
HIV-1 GAG IRE	2.401619069551882
EPR SPECIES D1	2.4015925552132997
P19 CELL LINE	2.40129109408664
PROTEASE GENE	2.4011889531560358
OTHER PEPTIDE	2.4009466653671607
PEPTIDE BOUND	2.4009466653671607
ASBT ACTIVITY	2.4008954778061304
STEP REACTION	2.400523117164804
CHLAMYDIA SPECIES	2.4003407178091156
PARALLEL Β-SHEET	2.4002641154164923
P38 ACTIVATION	2.400008565497532
ABSORBANCE DATA	2.399874547309191
OTHER COMPOUND	2.399528534775566
PCR TECHNIQUE	2.39948329000515
INCREASED K D	2.399358698102237
HIV-1 RT SHOW	2.3992074086903954
STUDY CONCLUSION	2.3989810615698945
NA- PHOSPHATE	2.3989208380415197
MODFIT LT SOFTWARE	2.398869618992775
TUMORIGENESIS BEAR	2.398869618992775
NERUOBLASTOMA CELL	2.398869618992775
RECEIVED HONORARIA	2.398869618992775
BUFFER/DMSO SYSTEM	2.398869618992775
Q-SEPHAROSE COLUMN	2.398869618992775
TRIGLYCERIDE LEVEL	2.398869618992775
G2-TO-M TRANSITION	2.398869618992775
HISTAMINE RELEASER	2.398869618992775
EGFP-POSITIVE CELL	2.398869618992775
TOXIN ADDITION	2.398638745870313
IFN-Γ RESPONSE	2.3986344415591376
LIPID PROFILE	2.398314918694898
REAGENT GRADE	2.398258785209329
GROWTH PERIOD	2.398224729328963
WILD-TYPE P66	2.398045884564867
LACKING F-BOX	2.397904900191611
DOUBLE-BLIND	2.3977230605036173
EXTREMITY EDEMA	2.397676986641852
INCLUDED STROKE	2.397676986641852
MER OLIGO PROBE	2.397676986641852
ZN(II) DOMAIN	2.397618611188513
ANTI-INFLAMMATORY	2.397220406312412
BLOCKED TOXIN	2.3970960201511122
CYCLOOXYGENASE IDO	2.3967300506289693
COX-2 MESSAGE	2.3966309141278255
VO PREPARATION	2.396560698518256
AFFECTED CD39	2.3963804724229787
EVIDENCE POINT	2.396350568673871
SCFV MOLECULE	2.396315842305599
HS PROTEOGLYCAN	2.3961287052625906
OTHER ARCHAEA	2.396116849575772
Q SEPHAROSE HR	2.3959474536944847
FRACTION CM-IV-6A	2.3958142979020387
P66 INSSUBUNIT	2.3956200840713406
ACID RECEPTOR	2.3955944167773526
EXOGENOUS TAT	2.3955456667401567
DNA-PROTEIN GEL	2.394959915620958
GPI-LINKED PROTEIN	2.3948233434212014
NET TRANSPORT	2.3947935150853366
OTHER SUBUNIT	2.39452881571103
ESTIMATED YOL	2.39418910750557
PREDICTED YOL	2.39418910750557
REGRESSED YOL	2.39418910750557
CASPASE Z-IETD-AFC	2.3939583370667665
HUMAN SUBUNIT	2.393795267727787
REDISSOLVED UCB	2.39378416488828
DENATURING SD	2.3936928053465754
MULTIPLE CD98	2.393554791958185
NACHR RECEPTOR	2.393550273906001
UCB OXIDATION	2.3933751719648186
UNCHARGED UCB	2.3933751719648186
USE REGRESSION	2.3932994938634264
INHIBITED ATP	2.393154443682581
PRECIPITATION	2.393108102800306
COX-2 PROTEIN	2.3929732049686834
CD98 MOLECULE	2.392858416999751
EXHIBITED K S	2.392736849635104
BLINDED REVIEW	2.3925840903311215
INCLUDING CDK4	2.3925840903311215
REVIEW ATTEMPT	2.3925840903311215
ACH2 CELL LINE	2.3925840903311215
SD PREPARATION	2.392441457325844
MIN INCUBATION	2.3924312491742263
INFECTED HOST	2.3919281754479265
BALB 3T3 CELL	2.3919281754479265
TC INHIBITION	2.3919281754479265
P19 PHENOTYPE	2.3916769251668217
MIN TTBS WASH	2.391608649403187
REDUCED TOTAL	2.3915993126031783
MMHG DIFFERENCE	2.391483861124806
IL-8 PROMOTER	2.391483498144587
REPORT RESULT	2.391371638326045
ΜCI/NMOL DNTP	2.391371638326045
EPR PARAMETER	2.3907705782344126
INFECTED PBMC	2.3907705782344126
HEPARIN ΜG/ML	2.390744441386333
THDP AFFINITY	2.390415542662596
ALLOWED MAINTENANCE	2.3903973153121827
HOST RESPONSE	2.389944982252186
LIGAND-INDUCED RA	2.3898646876744145
TEMPLATE BASE	2.3897730742525556
ORDER IQ3 IQ1	2.389756213130482
KDA ZD DOMAIN	2.3895800553516526
A-TYPE ATPASE	2.3891618585773977
V-TYPE ATPASE	2.3891618585773977
SINGLE ZN(II)	2.3889914079805448
A-SUBUNIT MONOMER	2.388791978706373
CONTACTS ACCOUNT	2.3886809904124857
LEAVE MYOCARDIUM	2.3886809904124857
ADDING SEROTONIN	2.3886809904124857
ISOLEUCINE GROUP	2.3886809904124857
RECEPTOR-REGULATED	2.3885779322622307
differences	2.388519203477209
INCLUDING P21	2.3883596337172217
NEURONAL LOSS	2.388226556451226
C-MYC	2.3880059268752785
SATURABLE MANNER	2.387677532524438
UCB SATURATION	2.3873315650785965
CCR5 CO-RECEPTOR	2.387327118658771
CO-RECEPTOR CCR5	2.387327118658771
CPLA FRACTION	2.3873214533948657
MONOCYTE CD98	2.3873131529285647
INCLUDING GABA	2.387028534775566
RETINA NEURON	2.386921424938247
RESEARCH TOPIC	2.386234883981915
RESISITANT CLONE	2.385919450676431
IDO INDUCTION	2.385859795430126
W	2.3857641361437345
L	2.3857641361437345
D	2.3857641361437345
PEDF MOLECULE	2.385756678533684
HUMAN SUBJECT	2.3849905209148825
SCD39 RELEASE	2.384716753186672
BRAUN-SONIC U	2.384693192863466
KDA COMPONENT	2.3846302387672504
HIV-1 GAG ORF	2.384255111349178
activity results	2.384148463237005
TURN COORDINATE	2.3840521105043506
BACTERIAL PETRI	2.3840521105043506
CM-FRACTION III	2.3840521105043506
DIALYZED SAMPLE	2.3840521105043506
HF PARTICIPANT	2.38347023929644
P42 ACTIVATION	2.3833418988308654
ELISA ASSAY	2.3832117335894787
CO-IMMUNOPRECIPITATED	2.3830877011389484
BIOPHYSICAL/ENZYMATIC	2.3830877011389484
STEP GRADIENT	2.383073420643065
PARTITION STUDY	2.38279442963012
HF MANIFESTATION	2.382637620845178
CHELATOR ABSENCE	2.382298452144972
HYALUROLYTICUS STREPTOMYCE	2.382135432291667
PHOSPHOTYROSINE-CONTAINING	2.382135432291667
FRACTION COLLECTOR	2.382003558134678
PALO ALTO	2.381789658313701
CATALYZE	2.3816540996765307
BETA RECEPTOR	2.3812958966933717
SIGNALOSOME GST	2.3810383130177146
OPPOSITE FACE	2.380918419341139
TAUROCHOLIC ACID	2.3807759193197042
GLYCOCHOLIC ACID	2.3807759193197042
LDL CHOLESTEROL	2.3806458914699755
ΜM UBIQUITIN	2.380397661214503
COX INHIBITOR	2.38035220331279
HIV-1 EXHIBIT	2.380264045691203
PG D ADDITION	2.3799415335918046
FLOW INJECTION	2.3799216165365724
INCLUDING W183	2.379885677632709
CONTAINING AR	2.3797602501922435
VECTOR PCDNA3	2.3795706054945156
CLONE E6 CELL	2.3786273068025876
MYOSIN ISOZYME	2.378556773978224
H. SUBTILISIN	2.3784917792196434
DRUG ADDITION	2.3782040847722494
SCD39 COFACTOR	2.3781429042770323
SOLUTION FLOW	2.3775803500048607
POSITION Y142	2.377458210279006
AGONIST FLUMAZENIL	2.3772599785183384
BACTERIAL F-ATPAS	2.3769921800579183
RESULTING ARSDMUT	2.3769921800579183
GAMMA IRRADIATION	2.3769921800579183
NON-CARDIAC CAUSE	2.3769921800579183
OTHER LGIC	2.3767277062067276
MICROMOLAR K D	2.3764879942350254
LAT	2.376331167587759
POU	2.376331167587759
TPL	2.376331167587759
PG-INDUCED CHANGE	2.3752512261589662
images	2.3751125717777946
ADDRESS OBESITY	2.3749688597460166
NMR SPECTROSCOPY	2.3747812404076782
TEP BUFFER ΜL	2.374519502267462
SINGLE LIGAND	2.3744462174350964
P51 HOMODIMER	2.3743719589667536
SALT BUFFER H	2.3742480207445933
CHAIN ISOFORM	2.373840718986776
SAY KAPLAN-MEIER	2.37378840112162
HEME DISSOCIATION	2.3737740531537947
HEALTH STATE	2.3736536833448483
MOTIFS RANGE	2.3736536833448483
V-TYPE ATPAS	2.3736536833448483
optical cell	2.3736536833448483
TOXINS OFFER	2.3736536833448483
INDUCED BAND	2.3736536833448483
SULPHATE CUT	2.3736536833448483
SENSORY CELL	2.3736536833448483
SEQUENCE IQX	2.3736536833448483
groups trial	2.3736536833448483
MIRROR IMAGE	2.3736536833448483
TREATING GAP	2.3736536833448483
LYS MUTATION	2.3736536833448483
BLINDED DRUG	2.3736536833448483
ARS FUNCTION	2.3736536833448483
A-TYPE ATPAS	2.3736536833448483
NET INCREASE	2.3736536833448483
WEIGHT RANGE	2.3736536833448483
USING METHOD	2.3736536833448483
T-RNA PRIMER	2.3736536833448483
BEING NORMAL	2.3736536833448483
VARIANT FORM	2.3736536833448483
DATA PROBLEM	2.3736536833448483
VALUES RANGE	2.3736536833448483
MHC CLASS II	2.3736536833448483
CERENKOV CPM	2.3736536833448483
CLEAVED GENE	2.3736536833448483
MUTANTS BIND	2.3736536833448483
NI-NTA RESIN	2.3736536833448483
STABLE NF-KB	2.3736536833448483
CLINIC VISIT	2.3736536833448483
HEALTH EVENT	2.3736536833448483
HAVING VALUE	2.3736536833448483
ALA MUTATION	2.3736536833448483
nitric oxide	2.3736536833448483
GENETIC WORK	2.3736536833448483
BINDING MODE	2.3736536833448483
PUTATIVE GAG	2.3736536833448483
POWER OUTPUT	2.3736536833448483
TRIAL RESULT	2.3736536833448483
MOTOR DOMAIN	2.3736536833448483
KEEPING GENE	2.3736536833448483
KINETIC DATA	2.3736536833448483
SHEP PARTICIPANT	2.373640216153552
MORTALITY RATE	2.3730285347755657
EXTEIN RELIGATION	2.37294653480702
FINAL DIALYSIS	2.3727428204898517
CASE CONTROL	2.3725689668428376
STUDY SAMPLE	2.372482189522677
RENAL EFFECT	2.3719983116396057
IDO ACTIVITY	2.371768854175513
PUC18 VECTOR	2.371502635366285
KPSKKKPTDGDKSEEPSNVESRGTGGTNPMTELRSVKDTTEK	2.371197623857
MEAN BASELINE	2.3711408352418433
COLUMN ELUATE	2.370880953384042
BIOTECH GRADE	2.370880953384042
IN VITRO DNA	2.3707958939117106
CONTAINING HSA	2.3703618681088994
TERM SURVIVAL	2.3703345351189222
CELL SURVIVAL	2.3703345351189222
HAMSTER CD98	2.370284342705859
ATP Γ-PHOSPHATE	2.3701963042628242
CONSENSUS IQ	2.3701924515975232
CELL PROTEIN	2.370089161475163
PROTEIN LOSS	2.370089161475163
MEASURE CPLA	2.3699209824408705
CARRY INTEIN	2.3698078702922647
OTHER INTEIN	2.3698078702922647
HEALTH CARE COST	2.369375782072475
REPORTED DNA	2.3693669991951416
PROVIRAL DNA	2.3693669991951416
STRANDED DNA	2.3693669991951416
ISOLATED DNA	2.3693669991951416
INSTAR HELIOTHIS	2.3692060659552
ACHBP DISPLAY	2.3691896587539087
CSN INCREASE	2.369121117961446
EXHIBITED K M	2.368716418920994
ESTIMATED K M	2.368716418920994
DIFFERING K M	2.368716418920994
PEPTIDE BIND	2.368341095081512
CLINICAL USE	2.3682912116236405
SOLVENT PARTITION	2.3682784825944445
CDNA VARIANT	2.3682403825077993
CDNA QUALITY	2.3682403825077993
MOLE FRACTION	2.3681700289065883
INCREASED HF	2.3681357776607066
HIV-1 RNA U-5PB	2.368107583323437
COVALENT LINKS	2.367980915727947
YEAST CULLIN	2.3675127883092717
TORPEDO NACHR	2.3673292346607617
DOMAIN TOP67	2.3669741133061506
P51 WTAND P66	2.366957096906463
ADHERENT	2.3669018290830426
ASSAY SYSTEM	2.366879030458625
FINAL SAMPLE	2.3668548352697454
ΜM PORE SIZE	2.366827130102365
CD98 PROTEIN	2.366719820836174
HIV-1 VIRION	2.366667711010798
ACID SEGMENT	2.36643594889545
SKP1 HOMOLOGUE	2.3659174236644547
SCALE GROWTH	2.36568850568364
MIN TREATMENT	2.3655454417327344
DOSE DIURETIC	2.365272976452547
SINGLE VALUE	2.3652462749996106
ASPARTATE SIDE-CHAIN	2.365197127704873
SINGLE-CELL DILUTION	2.365197127704873
EXTRACELLULAR-SIGNAL	2.365197127704873
COLLECTED VO	2.365192894629165
VEGETATIVE CELL	2.364816886872546
MAXIMUM DOSE	2.364695201175301
1IN MULTIPLE	2.3645068847332986
MURINE TUMOR	2.364479334135071
COX-2 INDUCER	2.3640734924977544
GEL PRE-TREATMENT	2.3640543297631664
HIV-1 STRAIN	2.3639674592930264
NON-FATAL STROKE	2.3638600082610433
ACTIVATED STAT5	2.363614796298099
CONTAINING CDK7	2.363614796298099
SUGGESTING ICER	2.363614796298099
INCLUDING CD147	2.363614796298099
ΜM PEPSTATIN	2.3634138534811235
PEDF COMPLEX	2.363363534906855
BEARING PEDF	2.363363534906855
ORGANIC PHASE	2.3629882451100856
ADDRESS ISSUE	2.3629882451100856
ORGANIC LAYER	2.3629882451100856
EQUILIBRIUM L	2.3629882451100856
ZD DOMAIN ΜM	2.3625967357445234
HIV-1 GENOME	2.362559054620088
TCA INCREASE	2.3624555806329144
STACKING GEL	2.362057678506094
P51 MOLECULE	2.3619053447616336
OBSERVED YOL	2.3617556992134183
F-BOX MUTANT	2.361675229755525
GEL ANALYSIS	2.3614902634655492
CORE SUBUNIT	2.3613718932736947
maximum	2.361323678717568
ACID PEPTIDE	2.3611233606321136
ACHBP SUPPORT	2.360507679652556
UCB/DMSO STOCK	2.360361868108899
MULTIPLE CSN	2.3599743193498965
SCOP RELEASE	2.3594471351282156
ASN233 MUTANT	2.3591898792532437
SIXTH REPORT	2.3590100105677037
EVENT REPORT	2.3590100105677037
CALCULATED G	2.358819832999169
SINGLE ASSAY	2.3584716221133872
ZN(II) MOTIF	2.358047172324346
ESSENTIAL CA	2.357687356252349
INCLUDING P42	2.3575620081717403
STOCK VANADYL	2.3575620081717403
DNA AFFINITY	2.3575612474988388
HEPATIC TISSUE	2.357028534775566
SPR TECHNOLOGY	2.357028534775566
INHIBITOR TSAO	2.357028534775566
NMR COORDINATE	2.357028534775566
ATP DEPENDENCE	2.356802546075001
SCALE LYSATE	2.3558067071477033
GELATINASE B	2.3555234218112404
APN AFFINITY	2.355502340111783
COMMON MOTIF	2.355459548261122
KDA ASSEMBLY	2.3554148573709197
BT ABBREVIATION	2.3549444205742347
POTENTIAL UBC	2.3543062660087335
HEPARIN-LIKE GAG	2.3539316154004664
GOVERNMENTAL BAN	2.3539316154004664
REGION HOMOLOGUS	2.3539316154004664
ALIREZA SENEJANI	2.3539316154004664
MATRIGEL COATING	2.3539316154004664
OLGA ZHAXYBAYEVA	2.3539316154004664
AEROMONAS SOBRIA	2.3539316154004664
UBIQUITYL MOIETY	2.3539316154004664
FLUID STATUS	2.3536149732287557
PYROCOCCUS ABYSII	2.3533925827610096
THR	2.353152318920969
CTP	2.353152318920969
ROS	2.353152318920969
SAM	2.353152318920969
GOV	2.353152318920969
A-C	2.353152318920969
UTP	2.353152318920969
H.S	2.353152318920969
ATG	2.353152318920969
EQN	2.353152318920969
IHC	2.353152318920969
PIR	2.353152318920969
W.G	2.353152318920969
TAG SEQUENCE	2.353005986517643
JAVA PROGRAM	2.353005986517643
BASAL LAMINA	2.353005986517643
PURIFIED ORC	2.3525017115556395
ATPASE CYCLE	2.352296822783465
B ACTIVATION	2.352014338933768
PLOTTED MEAN	2.351985809804683
STABLE DIMER	2.351897369504519
HYDROLYZE ADP	2.3514973904171192
INTEINS LACK	2.35125747792098
SALT SOLUTION	2.3512130912681704
UCB MOLECULE	2.3511370682144
OTHER LIGAND	2.3509232061982357
ARS1 FRAGMENT	2.3505854178224395
TURNOVER POOL	2.3505854178224395
TRYPTOPHAN INGESTION	2.3505760404306524
MYOSIN-I ISOZYME	2.349960258256236
PRAZOSIN ARM	2.3498577150819884
HYDROLYZE ATP	2.3497445481758192
CALIBRATION	2.349522319917455
IMPREGNATED TLC	2.349016714722205
KEY VARIABLE	2.3489305994353833
SERUM CREATININE	2.3488873512858186
OPPOSITE END	2.348823107766212
INFECTION HR	2.3486971164435078
SPECTROPHOTOMETRY	2.348672663301628
BMI CATEGORY	2.348271317197798
S-PHASE GENE	2.348271317197798
G/ML	2.3481951075323235
http	2.3481951075323235
STRAND Β-SHEET	2.3481396458866772
DISPLAYING GLU	2.3481396458866772
'-GCCTGAGACAAACTCCAGCTGGACCAGCGATTGCC-3	2.3478700370225054
'-GGCAATCGCTGGTCCAGCTGGAGTTTGTCTCAGGC-3	2.3478700370225054
HYBRID TOXIN	2.347282393841419
CELLULAR RNA	2.347103733754192
EGTA GRADIENT	2.3470098151451397
MHC-I MOLECULE	2.346705954130405
PEDF-RECEPTOR	2.346292131453639
PERMIT ACCESS	2.346292131453639
ARCHAEAL ATP	2.3461037226963217
DEOXYCHOLIC ACID	2.346026544307685
PROTEIN BAND	2.344916204848183
POMBE GENOME	2.343287406802017
CD39 MONOMER	2.3427392630375428
SINGLE-STRAND	2.342524141052478
STANDARD ECL	2.341925725661035
DNA ADDITION	2.3418912420256537
GST-CDC6 BEAD	2.341283297356705
NON-REDUCING GEL	2.3412313362082564
CPLA ABILITY	2.3408466357633393
HF MEDICATION	2.340629971170148
SEPHAROSE HR	2.3403822033953356
CONDUCTANCE CA	2.340254341227179
ATP SYNTHASE	2.3395954236842575
ACETYLATION/METHYLATION	2.339248830217493
PHARMACEUTICALS/MONARCH	2.339248830217493
ADJUSTED YHL	2.3390413658715974
MIRACL TRIAL	2.3390413658715974
W89 RELATIVE	2.3390413658715974
INTEGRAL ION	2.3390413658715974
LDL RECEPTOR	2.33861498225055
EGTA CHELATE	2.338508868679701
DOTTED LINE	2.338481566640575
H. VIRESCEN	2.338481566640575
acid binder	2.338481566640575
S300 COLUMN	2.338481566640575
ASSAYS SHOW	2.338481566640575
STATED SIGN	2.338481566640575
total cells	2.338481566640575
HEALTH DATA	2.338481566640575
N1 POSITION	2.338481566640575
FATAL EVENT	2.338481566640575
health care	2.338481566640575
VIRAL TITER	2.338481566640575
host signal	2.338481566640575
TESTED GENE	2.338481566640575
PUTATIVE NL	2.338481566640575
TARGET PEST	2.338481566640575
BEAD BEATER	2.338481566640575
CELL FUSION	2.338481566640575
GAG CONTENT	2.338481566640575
CHEST X-RAY	2.338481566640575
CHAINS BIND	2.338481566640575
RESULT MAKE	2.338481566640575
EXPORT PUMP	2.338481566640575
HLA CLASS I	2.338481566640575
LIVING CELL	2.338481566640575
GROUP SERVE	2.338481566640575
KIMAX GLASS	2.338481566640575
PHE158 MUTANT	2.3374849314998634
ACHBP RESULT	2.337393160277633
UV MEASUREMENT	2.3373288350758665
SEROTONIN TYPE	2.337028534775566
TERMINAL ILEUM	2.337028534775566
POTATO APYRASE	2.337028534775566
MICROFUGE TUBE	2.337028534775566
OBSERVED K M	2.3369319771543617
AMPLIFICATION	2.3368466240363728
REVERSE IDO	2.33664966579001
MARKING IDO	2.33664966579001
IDO CATALYZ	2.33664966579001
OTHER ALIQUOT	2.3366322371238377
P51 INSFAIL	2.3366126576920188
CELL FACTOR	2.3365806558264617
ALLHAT MANUAL	2.3364436806279105
VECTOR COPY	2.3363909227320208
PDOI VECTOR	2.3363909227320208
TH PROMOTER	2.3362919573399
SPLICED RNA	2.335953943882282
RNA STAT-60	2.335953943882282
PEPTIDE NEDD8	2.3358318221070187
BASELINE BMI	2.3355801341242723
KNOW HUMAN GENE	2.335476465144564
MMHG DECREASE	2.3353637661512376
P 2Y2 RECEPTOR	2.3351541386403003
TCA ADDITION	2.3349798234634265
MUTANT BIND	2.3348839169146047
THDP UPTAKE	2.3348177649394453
G418 ABSENCE	2.334421947605818
P24 GAG ELISA	2.3343887845409252
INDUCED DNA	2.3343152578483997
LABELED DNA	2.3343152578483997
ANTI-Α3 MAB	2.3337974657315357
TEST SYSTEM	2.333377511856932
ROUTINE USE	2.3332696797136157
FLUID RETENTION	2.33281214570016
growth factors	2.3325544238624705
REVERSE PCR	2.3319321158120068
LOWRY ASSAY	2.3318971543307154
DIASTOLIC HF	2.3318752545934918
FINAL VISIT	2.331873638572466
K CAT VALUE	2.3318141076889694
OTHER HIV-1	2.3316917689926098
HIV-1 CLADE	2.3316917689926098
HIV-1 VIRUS	2.3316917689926098
CD98 MUTANT	2.3316091915003203
EMPTY TARGET	2.3313497397664302
MAPK KINASE	2.3312736412502892
S CHECKPOINT	2.3310376016557135
LIPID TRIAL	2.3308254844651106
CASPAS	2.330791870960836
NOVEL TOXIN	2.329670995883096
MURINE CELL	2.329564844428187
IQ4-COATED WELL	2.3295526059543463
MULTIWELL PLATE	2.3295526059543463
MOLECULAR RULER	2.3295526059543463
FAMILY BUTHIDAE	2.3295526059543463
RECOGNIZED CD63	2.3295526059543463
INTRONLESS GENE	2.3295526059543463
DENSITY ERK	2.329113364822496
AFFINITY K M	2.3290614760234933
CALLED CD39	2.3289932596709826
ACTIVATED K	2.3284803782131664
H59 SUBSTITUTION	2.3284014623304117
AWAS DIALYZED	2.3282603287046766
TERMED EXTEIN	2.3282603287046766
PATIENTS DROP	2.3282603287046766
ARSD FRAGMENT	2.3282603287046766
SYBYL ALGORITHM	2.328216833784003
RETENTION TIME	2.327937625684657
ENZYME BIND	2.3278655510557438
HBAB PROTEIN	2.327785217896745
COMMON LINK	2.327651011367967
HYDROLYZE AA	2.3272558097427125
SPECTROMETRY	2.3271095683385807
DNA CATENANE	2.3270630556167236
END-OF-OBSERVATION	2.326837484077986
DIETARY COUNSELING	2.326837484077986
SENSE STRAND	2.326418607915513
ΜM THIAMINE	2.3263903012840137
NACHR SUBTYPE	2.3262040704964617
AQUEOUS UCB	2.326146767580105
DUAL CFP/YFP	2.326061746819128
SHOWS RESULT	2.326061746819128
MM MANGANESE	2.326061746819128
hormones	2.3259844712861684
ADDING PG E	2.325352088649038
TARGET IΚBΑ	2.325265710504357
PCEP4 DERIVATIVE	2.3251735119422436
PEDF MUTANT	2.324882728487196
KB IDO CDNA	2.32478201065461
GAG ANTIGEN	2.324517643175892
BLOTS TOTAL	2.3244647495264044
DEPENDENT K	2.324202413221096
HRT1	2.324150464325992
VELOCITY-SEDIMENTATION	2.323800696939307
CUL1	2.3237897069336197
PBMC SAMPLE	2.3236798077680105
IMPORT THDP	2.3232538908202542
EXCITATION LIGHT	2.3230432820564495
ACETATE ION	2.3230147339628693
HYDROLYZE VO	2.322888951050747
DROSOPHILA NURF	2.3228518471981983
ZD MOLECULE	2.3227646452570725
OBSERVATIONAL	2.322200225561211
B AMPLIFIER	2.3208604251256175
ACTIVATED B	2.3208604251256175
KDA COMPLEX	2.3207549093081625
PROTΑ BOUND	2.3199793680498697
INTERLEUKIN-8	2.319578349603324
ATP-DEPENDENT	2.319578349603324
ALPHA BLOCKER	2.319578349603324
INSTAR LARVA	2.3192628987440256
APN RESEARCH	2.318960727718465
B. MORI CRY	2.318751912465708
STUDIES SHOW	2.318442394334874
ADDING DMSO	2.317923568206458
BETA FAMILY	2.317923568206458
POMBE FISSION YEAST SCHIZOSACCHAROMYCE	2.3176624830892165
AGAROSE	2.317033864608204
LIGAND BLOT	2.316389389218837
NONFATAL HF	2.316298429990322
P51 MONOMER	2.316054659257902
ASBT LYSATE	2.315923868534829
MEAN CHANGE	2.315905579955528
ATP Β-PHOSPHATE	2.3156967997128195
TOXIC EFFECT	2.3155930535350486
BRIEF TELEPHONE INTERVIEW	2.315540860825425
CO-ACTIVATOR	2.31507899223627
ASPECT	2.3148134820444293
CHS PARTICIPANT	2.3148092698354086
CSN5 MUTANT	2.313838212731158
RESTING CD4	2.3138119685196346
MARKER PCNA	2.3138119685196346
CUL1 SUBUNIT	2.313779956747975
EGTA ABSENCE	2.313644510005039
FOCUS NUMBER	2.31353755299657
EPR SPECIES	2.313182106439951
NEUROPEPTIDE Y	2.3125840903311214
CA HOMOTETRAMER	2.312411632749103
BTR175 GENE	2.3120498543681385
PREVENTION	2.3116626436749983
SUB CLONING	2.311070902061752
ADDING EDTA	2.311070902061752
RISK NATURE	2.310728268754517
NICOTINIC ACHR	2.3103618681088993
ANALOG ADPNP	2.3101977679772214
HORMONES ACT	2.3101977679772214
H SUBDOMAIN	2.3101516419691697
salt buffer	2.3100166457317974
inhibitor p27	2.308725875726634
PHARMACOLOGIC	2.308725875726634
FETAL DEFENSE	2.308725875726634
HORMONAL FORM	2.308725875726634
CDC10 HOMOLOG	2.308725875726634
HDAC ACTIVITY	2.308725875726634
SELF DIMERIZE	2.308725875726634
CTC PHYSICIAN	2.308725875726634
QUESTION MARK	2.308725875726634
STABILIZATION/FOLDING	2.3076950018713314
HOMOLOG P38	2.307644568989399
CLONING DNA	2.306904593269577
PROTEIN HRT1	2.3066332461075363
DE-ESTERIFICATION	2.306193388167192
COMPLEX-FORMATION	2.306193388167192
DNA PASSAGE	2.3058503369396224
FOCUS GROWTH	2.305572375335362
PVDF MEMBRANE	2.305473392645801
epitope tags	2.3050009973749086
'-CGAGCGCCGCGTTCTCGCGAGCTACCGGCG-3	2.304908692388304
WORSE EVGFP	2.3048412055665652
DEFINED YHL	2.3048412055665652
MM TRIS BASE	2.3041873534911335
T BUFFER ΜL	2.3040341045025263
CONSULTANT FEE	2.3036952014422325
STATED SYMPTOM	2.3036952014422325
APN-SIZED BAND	2.3036952014422325
MCAR CONDITION	2.3036952014422325
GAUSSIAN CURVE	2.3036952014422325
ISCHEMIC EVENT	2.3036952014422325
UNREACTED SITE	2.3036952014422325
YM30 CENTRICON	2.3036952014422325
MICHAEL LEFFAK	2.3036952014422325
DUAL EYFP/ECFP	2.3036952014422325
JEFFREY LEIDEN	2.3036952014422325
BMI SUBGROUP	2.303478906350061
HEPARIN ΜG/ΜL	2.303299638788289
M. SEXTA ΜG	2.3032949293207072
BUFFER SALT	2.303083737594765
OBSERVED EC	2.3026708596908225
PLOIDY CONTROL	2.3025556003026315
ECG ABNORMALITY	2.302302853679344
UCB-DMSO-BUFFER	2.302302853679344
BYSTANDER CD4	2.3022143914006197
IDO AXPRESSION	2.3017150034224305
INORGANIC PYROPHOSPHATE	2.300550028636037
VIRAL GENE	2.3004927865700586
MM SULFATE	2.3004927865700586
FETAL LOSS	2.3004927865700586
LINE MOLT4	2.3004927865700586
CESD SCORE	2.3004927865700586
BIOSAFE II	2.3004927865700586
Γ- 32P-ATP	2.3004927865700586
T162 FLASK	2.3004927865700586
FIT BETTER	2.3004927865700586
HAVING ASP	2.3004927865700586
VALUE SHOW	2.3004927865700586
ACR REGION	2.3004927865700586
CHAIN BIND	2.3004927865700586
TIME SCALE	2.3004927865700586
SW48 ROTOR	2.3004927865700586
DTT ADDITION	2.300227090909148
GLUR-A PROTEIN	2.2999503213954218
BIOCHEMICAL ACTIVITY	2.2997755141371345
EXAMINATION	2.2995295696075106
FACE STUDY	2.2993897211852214
STUDY LEAD	2.2993897211852214
STUDY SHOW	2.2993897211852214
CTD KINASE	2.2991112981304744
IDO RESULT	2.2987180526588107
CD39 HYDROLYZ	2.298708207532766
N HCL/METHANOL	2.2986952014422326
ETAT PLASMID	2.298621350984479
VECTOR END	2.2984673840272785
PREVIOUS NMR	2.297506584903696
WHATMAN GF/B	2.297506584903696
POSSIBLE AIM	2.297506584903696
LGIC FAMILY	2.2973655697723405
REPORTED PK	2.2973655697723405
FURA2 IMAGE	2.2973655697723405
CULLIN 1 ACCUMULATION	2.2972805739891236
CLASSIC IQ	2.2972337297512215
THDP SERVE	2.2969433187475627
DNA PRIMER	2.2964564930687352
PAIRED DNA	2.2964564930687352
CYCLE SHOW	2.296199418305722
N TERMINAL	2.2960115834441575
CHAIN CDNA	2.2953956834884646
TREATED HF	2.2952971887429268
SHOWED P35	2.29506102520533
TRIS/HCL PH	2.2949554317571605
LIPOPROTEIN	2.294946981721268
BIOINFORMATIC	2.294772695028032
COLI HB101	2.294517849068857
COLI JM109	2.294517849068857
INFECTED T	2.2943118167412293
RNA GENOME	2.2941753771233935
FINAL WORD	2.294091067818771
ACID CHAIN	2.2936966491279334
P300 LEVEL	2.2934634483333505
EUKARYOTIC	2.2932627818510474
DNA T-STRAND	2.2932199007539897
ASBT CLONE	2.2930693962598254
SDS-POLYACRYLAMIDE GEL ELECTROPHORESI	2.292589501053869
MOTILE CELL	2.2922260701638115
ligand	2.2919123191478485
PLASMID PJW312	2.2915330392800706
THERMOLITHOTROPHICUS	2.290873267394251
ALEXA-488-CONJUGATED	2.290873267394251
ELECTROCARDIOGRAPHIC	2.290873267394251
THIO-Β-D-GALACTOSIDE	2.290873267394251
HYPERCHOLESTEROLEMIC	2.290873267394251
FRAGILI BACTEROIDE	2.290821416620591
NEUROTOXIC SYMPTOM	2.290821416620591
PEDF BOUND	2.290803698730272
STORE PEDF	2.290803698730272
R RECEPTOR	2.2907366084279994
HIV-1 MRNA	2.2904230271330874
PG PROFILE	2.2899487792149964
TCA UPTAKE	2.2899487792149964
IQ3 REGION	2.2899487792149964
LINE AGENT	2.2899487792149964
STIMULATORY	2.289142370398694
NEN WEBSITE	2.289142370398694
INTERFERENCE	2.2890457961880126
MUTANT CUL1	2.2886284204378406
ADDING ATP	2.2883403713133768
ATP ANALOG	2.2883403713133768
CALLED K S	2.2879571870485265
COHORT STUDY	2.2878743023658408
ΜL CHLOROFORM	2.2877620725306858
PCNA PROTEIN	2.287310217876901
EXCESS P66	2.2872806008279642
L-LYSINE HCL	2.287122889661721
COLLOIDAL H	2.287086570555282
TOTAL DOSE	2.2869133831582364
RESEARCH GRANT	2.286234883981915
ΜM PEPTIDE	2.285848804876091
PCU3 RESULT	2.2856181420957022
ELUTE BBMV	2.285555442817054
BINDING CA	2.285459072857357
ORC4 SUBUNIT	2.285224794832543
DIEGO CA	2.2850081332148995
HELP DESCRIPTION	2.284432865376428
CRYSTALLOGRAPHIC	2.284432865376428
RELEASE AA	2.283261262433227
PROTΑ SHOW	2.282567974066453
BIACORE AB	2.2821083634894377
AP-1	2.2815656468364813
ADDED DMSO	2.280576328232719
TOTAL LYSATE	2.27977110251296
AFFINITY K	2.279687535937338
APN ISOZYME	2.279450742565467
GUIDE SITE	2.279404771859934
INHIBITOR GM	2.2784698102934082
BLEACH VALUE	2.2784698102934082
ANALOG AMPCP	2.2784698102934082
BASES MATCH	2.2776815204183767
BODY WEIGHT	2.2776815204183767
dorsal root	2.2776815204183767
GENE FAMILY	2.2776815204183767
FINE COLLOID	2.2774678747876034
GST FUSION	2.2773639962428254
GST MOIETY	2.2773639962428254
NON-PARAMETRIC	2.277028534775566
GEL-FILTRATION	2.277028534775566
NON-DENATURING	2.277028534775566
STRATIFICATION	2.277028534775566
ANKLE EDEMA	2.2768075713382236
ADPNP SERVE	2.2768075713382236
KILLER CELL	2.2768075713382236
A-2-Z TRIAL	2.2768075713382236
LOCF METHOD	2.2768075713382236
PGEM T-EASY	2.2768075713382236
M. JANNASCHII	2.2761684540965628
DAUCUS CAROTA	2.2761684540965628
EXAMPLE FAZAL	2.2761684540965628
TEFLON PESTEL	2.2761684540965628
SCD CATALYSIS	2.2761684540965628
ÄKTA EXPLORER	2.2761684540965628
T701 FRAGMENT	2.2761684540965628
CASE-FATALITY	2.2761684540965628
P. HORIKOSHII	2.2761684540965628
PKK223-3 RT66	2.2761684540965628
VIRAL LATENCY	2.2761684540965628
P. AERUGINOSA	2.2761684540965628
ELASTASE GENE	2.2761684540965628
3-(N-MORPHOLINO)PROPANESULFONIC	2.2761656255793774
Q CONTRIBUTION	2.276033509899944
leads	2.275671852413718
A-2-Z STUDY	2.2756689745018726
MYOSIN HEAD	2.2755781893720637
NECROTIC CELL	2.2753514362851814
RECEPTOR FXR	2.275159066882923
CCR5 VIRUS	2.274885911564908
PHASE HPLC	2.274885911564908
TO ALANINE	2.2744203320193597
HYGROMYCIN ΜG	2.273563860366157
BASELINE PP	2.273283343035232
SYNTHASE-EXPRESSING	2.273268850704749
HORMONAL-REGULATION	2.273268850704749
INTEGRIN-ASSOCIATED	2.273268850704749
CSN1 MUTANT	2.2732099216122528
elution buffer	2.272925970673002
PBLUESCRIPT K	2.272498541488115
SOLUTION C	2.272310249283688
SALT	2.271883204054683
ADULT LIFE	2.2716850521892638
bases	2.270834662388696
C-MYC GENE	2.270618099064049
VO ABSENCE	2.2691142032304135
HIV-1 RT HELP	2.2689777221701117
TAURINE ΜM	2.268445062503404
DAMAGED DNA	2.2682259665661495
CLOSE PROXIMITY	2.268083975320522
VG BIOTECH	2.2679022183816846
CODING YHL	2.2679022183816846
BETA BLOCKER	2.267893824398804
GLYCINE ΜM	2.2674708879108167
TEST SAMPLE	2.266097725918532
HIV-1RT WT	2.2660490292101887
TOTAL LACK	2.265825368448112
BASELINE SBP	2.2657786272198828
ATP HYDROLYZ	2.2655635224220263
HISTONE H1	2.264643161562847
TREATED ONE	2.2644727722777533
P. FURIOSUS	2.2644727722777533
MHC-I CHAIN	2.2644727722777533
LINKED CY-3	2.2644727722777533
GF/B FILTER	2.2644727722777533
CATABOLITE	2.2627563391940466
FINAL IMAGE	2.2626846436105423
CEM T CELL	2.2622296400106374
EPITOPE-TAGGED	2.261776532421785
FORMIC ACID	2.2617606654185907
EXTRAJUNCTIONAL	2.2614282252668407
DESTABILIZATION	2.2614282252668407
THDP EFFLUX	2.2608089705766234
HUMAN UBC3	2.2606598698953793
SOLUTION B	2.260360374281284
HYGROMYCIN B	2.2603395487598004
SET PRIOR	2.2591966315527463
ST-T WAVE	2.2591966315527463
H. MEDIUM	2.2591966315527463
WD REPEAT	2.2591966315527463
ERROR BAR	2.2591966315527463
PC12 CELL	2.2591966315527463
host gene	2.2591966315527463
FUME HOOD	2.2591966315527463
NED8 GENE	2.2591966315527463
TYPE SIZE	2.2591966315527463
S. LECTIN	2.2591966315527463
TYPE FORM	2.2591966315527463
TRIAL ARM	2.2591966315527463
IMAGO CCD	2.2591966315527463
M1 REGION	2.2591966315527463
COLD D-PB	2.2591966315527463
TRIAL SET	2.2591966315527463
B1-B2 BOX	2.2591966315527463
U973 CELL	2.2591966315527463
SINGLE TYPE	2.25913648663708
OPEN-LABEL	2.2583167571498097
P66 INSWA	2.257978521827874
P51 BOUND	2.2574494438665655
P51 SHARE	2.2574494438665655
LPS EXPOSURE	2.256996008232174
RAW CLONE	2.256905617235768
NG/ML PMSF	2.2562782490611646
EQUILIBRIUM	2.2562495729041063
LEUKOTRIENE	2.2562495729041063
lines	2.256135631676389
LIFE DATA	2.25610785332182
PEAK MRNA	2.2558270553008266
FORM THDP	2.255771451732313
LABELED TP	2.2556807553110443
TRITON XI	2.2555163851499405
BOUND DNA	2.2553016727190704
OTHER CSN	2.255078260578178
MOLECULAR WEIGHT SPECIES	2.255065805580258
PEPTIDE-CONJUGATED	2.2548053491631963
ANISOMYCIN-TREATED	2.2548053491631963
SPECTROPOLARIMETER	2.2548053491631963
ΜM FURA2-AM	2.254520489417227
CONTRIBUTIONS AUTHOR	2.2544656814355357
TEST CELL	2.254425001733936
P35 BOUND	2.253955068494205
T RESIDUE	2.253232094279234
BCA ASSAY	2.253041059277591
RGD MOTIF	2.252790276703418
BUFFER P.	2.252715260838672
P300 GENE	2.252413432300516
UCB DIANION	2.2521379732172826
TRI	2.2516988486676803
SINGLE AC	2.2515575081046513
CATECHOLAMINE	2.2501225167925063
ACTIVATED TCR	2.2501225167925063
recombination	2.2501225167925063
EBV ORI P	2.2499714805697133
ΜM FILTER	2.249892536734895
SPECIES V	2.2493826411452646
YEAST ARS1	2.2492790365597566
MBR SYSTEM	2.2492790365597566
ZN CONTENT	2.2492790365597566
LYSED CELL	2.2492790365597566
E3 ENZYME	2.2492720326468194
DERIVATIVE TΑ	2.2492243810234007
P300 MRNA	2.249043856048597
BOUND ADP	2.2490218326744014
CELL FOCI	2.2480371747184322
IL-8 GENE	2.2480371747184322
UCB BOUND	2.247665192823955
APPROXIMATION	2.2468652750966602
SERIOUS HARM	2.2467418526095946
MARKED DELAY	2.2467418526095946
RTK FUNCTION	2.2467418526095946
BENZYL GROUP	2.2467418526095946
ANGINAL PAIN	2.2467418526095946
UNLYSED CELL	2.2467418526095946
BUTHID VENOM	2.2467418526095946
MM HEPES/KOH	2.2467418526095946
ΜM MUTANT	2.246529200438998
trichloroacetic	2.246393750711362
HOST GENE	2.2463839218540893
SITE TYR319	2.245970573687048
GROUND RULE	2.245970573687048
RETARDATION	2.245970573687048
KD PROTEIN	2.2459227229253775
PEDF CDNA	2.2449281932127794
PHENYLMETHYLSULFONYLFLUORIDE	2.244681158139987
GAGGTGAACATATGGGAAAGATAATCAG	2.244681158139987
MODULATION	2.2443779743063983
CY-5 SIGNAL	2.243575467073364
HOST MRNA	2.24301434560217
DNA G-STRAND	2.242455168459888
S O VALUE	2.241801749402536
PHYSICOCHEMICAL	2.241128743266846
CHD EVENT	2.240989096717813
PVP PEPTIDE	2.2408071694291762
ICE COLD PB	2.2403559603633236
HUMAN ORC	2.239977567004761
YEAST ORC	2.239977567004761
OTHER ORC	2.239977567004761
ΜM ENZYME	2.2399679378289687
MEAN SIZE	2.2395088093328592
WT ENZYME	2.2390972337684745
CHOLIC ACID	2.238955522088676
ERK KINAS	2.2389071380932277
STANDARD PROTOCOL	2.2383903466207986
KD SUBUNIT	2.23771464139614
UCB-DMSO-WATER	2.237028534775566
ΜM MDL-72222	2.2365020227458703
MEMBER B4	2.2361337540951642
INDEX BMI	2.2361337540951642
GAG-PEDF-RECEPTOR	2.2353945962764654
SEXTA APN	2.2352233773534174
SD ADDITION	2.2351636005205013
FIXING SOLUTION	2.2351346046506104
HPLC STEP	2.234486405705337
MG/ML ZEOCIN	2.2342587217176026
CF CONTRIBUTION	2.234209758585725
RECRUIT HAT	2.2336357746265776
LIGAND CONCENTRATION	2.233634781756489
ATGGATCCTTCTCAACGAAGAGCAGTG	2.2334822253285163
ISOPROPYL-Β-THIOGALACTOSIDE	2.2334822253285163
COMPETING INTEREST	2.2327719505481145
STRUCTURAL ANALYSIS	2.232764237006447
CULTURE ACH	2.2327547175508293
MICRODOMAIN	2.2327547175508293
L-GLUTAMINE	2.2327547175508293
STRUCTURAL CHANGE	2.230811164713719
ENZYME TDO	2.230458683072364
PERTURBATION	2.2295645858648974
ASTROCYTE	2.2291146174776393
COX	2.228942333308001
DMORC BIND	2.2287935365556355
SPR METHOD	2.2287935365556355
YHL RANGE	2.227747253201498
CAUSE CHF	2.227747253201498
CYCLE	2.227652915759823
ACS MOTIF	2.2271648573061045
Y RECEPTOR	2.2256761778593566
IL-8 ELISA	2.225664347276069
KEY KINAS	2.2252013511444924
FISSION YEAST SCHIZOSACCHAROMYCE	2.225009345524776
ΜL SAMPLE	2.223336669652238
ΜL VOLUME	2.223336669652238
CDC6 CDNA	2.2228286300470375
LEPIDOPTERAN	2.221359486462544
TRIS/TRICINE	2.221359486462544
INSECTICIDAL	2.221359486462544
REACTION CONDITION	2.219546884529238
TOXIC SYMPTOM	2.218288593420881
HBAB MRNA	2.217388926204857
descriptions	2.2173275440278704
INTEIN-FREE	2.215133576035872
MM MANNITOL	2.2151335760358717
MM TRIS/HCI	2.2151335760358717
INDOLE RING	2.2151335760358717
HCTZ PERIOD	2.2151335760358717
RAT MYOCYTE	2.2151335760358717
PARA-FORMALDEHYDE	2.2150160350764434
SUBSTRATE-ENZYME	2.2149341153523894
SELF-AGGREGATION	2.2149341153523894
STROMELYSIN S- 1	2.2149341153523894
CYCLIN D	2.213961811738362
I-BGL II	2.213961811738362
SKD CONTRIBUTION	2.2138968205759113
EMA CONTRIBUTION	2.2138968205759113
MORTALITY	2.213479156936918
K1 SUBLINE	2.213429411552545
P51 PLAY	2.2122840702762976
CLONE D3	2.211761859357642
LOOP RNA	2.211692735170816
MBR DIANION	2.2116093477328804
specification	2.2110536108364207
F-BOX-DELETED	2.2110536108364207
BIBLIOGRAPHIC	2.2110536108364207
DAMAGE/REPAIR	2.2110536108364207
FIV-1 RT	2.2108859523912443
F12 MEDIUM	2.21086872405203
MEM MEDIUM	2.21086872405203
ARSA OLIGO	2.21086872405203
HUMAN CUL3	2.21086872405203
B. FRAGILI	2.21086872405203
TAT MRNA	2.2107261674900953
MRNA CAP	2.2107261674900953
RESPONSE	2.210589295905989
TYPE DNA	2.210221667516892
DNA NICK	2.210221667516892
SHOW DNA	2.210221667516892
DNA GATE	2.210221667516892
CTENEYFLDYIRYSFLMTLYRNQPK	2.2098766941106818
SVLDKSWPVPPPSLREASELLREMC	2.2098766941106818
HPA1 SITE	2.209776179857928
RETRIEVAL	2.209776179857928
IDO MRNA	2.20908164863124
BIND P35	2.2089285873521693
MAPK ACT	2.2087712990901007
MBR STUDY	2.2087117393598854
P66 WTAND	2.2085580701330554
LXXLL MOTIF	2.208280909891166
P51 THUMB	2.208028992171747
TAT EXON	2.207448227238583
RNA U5-PB	2.2074131801184214
REGENERATING SYSTEM ATP	2.2073103914745666
Β- TOXIN	2.2060524591314876
TOXIN I5	2.2060524591314876
MMP GENE	2.2056569915011437
S BORDER	2.205516231836106
PEDF GAG	2.204983627698126
IQ MOTIF	2.2047901584124108
H DOMAIN	2.2047342336970086
CYCLIN H	2.2047342336970086
LPNA ASSAY	2.2044897872180065
POLYBRENE UG	2.204437909031177
ADDED PG	2.2041914349886933
IONO ACT	2.2041914349886933
OTHER PG	2.2041914349886933
ACID DNA	2.2039241734981485
CDNA PCR	2.2033591724722914
PEDF MAP	2.202192091483935
T BUFFER	2.2020105966348145
ETAT CELL	2.2015394379087914
IMMUNOLOGICAL	2.2014614610411556
FULGID P	2.2006740993588125
LIFE YOL	2.200614779214261
TOP67 ΜM	2.199199586772449
GAG ELISA	2.1981478382826762
AGGRESSIVE	2.198065286549454
KDA BIND	2.1980483837389015
CRKHSIATFLQARWRGYHQRQKFL	2.1974096719104574
CHMKHSAVEIQSWWRGTIGRRKAA	2.1974096719104574
'-ATTTGCTGGGTTGAAAAATG-3	2.1974096719104574
TREE-BRANCH-RECONNECTION	2.1974096719104574
KAHKAATKIQASFRGHITRKKLKC	2.1974096719104574
CKRKWAVDVVRRFIKGFIYRNQPR	2.1974096719104574
IRES	2.197117526642204
TIF2	2.197117526642204
RANK ORDER	2.1963248991881734
RDNA LOCUS	2.1963248991881734
NET CHARGE	2.1963248991881734
PEAK LEVEL	2.1963248991881734
MM TRIS-CL	2.1963248991881734
MAGNESIUM	2.19629787485025
ORC BIND	2.1955066556556546
MICROGRAM	2.1951209655460446
BUFFER P	2.1944503464878293
COMPACT-TO-OPEN	2.1933038445793347
STATIN-MEDIATED	2.1933038445793347
DIVERSIFICATION	2.1933038445793347
ATP-SULFURYLASE	2.1933038445793347
PHOTOMULTIPLIER	2.1933038445793347
STROMELYSI N- 2	2.1933038445793347
A-SEPHAROSE-4CL	2.1933038445793347
DEOXYNUCLEOTIDE	2.1933038445793347
METALLOTHIONEIN	2.1933038445793347
KINETIC PARAMETER	2.193176228686862
OLIGO ARSB	2.192943911548424
CD39 ACR5	2.192669100425106
RT DIMER	2.191903506134745
ER FUNCTION	2.1904639779149315
CONDUCTANCE	2.1904639779149315
CM-FRACTION	2.1904639779149315
SUBCLINICAL	2.1904639779149315
FACS DATA	2.19000799918
SLOT BLOT	2.19000799918
RECOGNITION	2.1892788781827233
denaturing	2.1886411194628828
WG320 NM	2.188408518700767
NORMAL DNA	2.1871644186599806
DUTY CYCLE	2.186580980324761
IMINODIACETIC-SEPHAROSE	2.184453623891669
ILE-ASN-ASN-GLU-THR-ILE	2.184453623891669
'-GAAGAAAAACTCTCTTTTC-3	2.184453623891669
PENICILLIN-STREPTOMYCIN	2.184453623891669
PDB FILE	2.1837624654212044
MGSO	2.183500986887441
GDCA-TREATED	2.183285937241968
PROLIFERATOR	2.183285937241968
LAMELLOPODIA	2.183285937241968
ZWITTERIONIC	2.183285937241968
RIBONUCLEASE	2.183285937241968
FIBROBLASTIC	2.183285937241968
CRANIOFACIAL	2.183285937241968
PROMONOCYTIC	2.183285937241968
METABOLIZING	2.183285937241968
ETHANOLAMINE	2.183285937241968
PRACTITIONER	2.183285937241968
ARACHIDONATE	2.183285937241968
POLYACRYLAMIDE GEL	2.181956182206197
FINAL STEP	2.181796020168621
JOSMAN LCC	2.18099403654602
STATUS QUO	2.18099403654602
MELTRI N-Β	2.18099403654602
ASSESSMENT	2.18099403654602
PMI METHOD	2.18099403654602
PAUL INSEL	2.18099403654602
BC ENZYME	2.1800834002740737
ΜL PULSE	2.1795271912425784
P51 GLU138	2.179183449424444
HYDROPHOBIC	2.1788785673314703
SYNTHASE	2.177051499572947
DNA GYRASE	2.1769577430446967
PGE	2.1758437974687506
STRUCTURAL HOMOLOGY	2.175509808517134
MEAN BMI	2.1729103425982905
REJECTION	2.172710841086814
HYBRIDOMA	2.172710841086814
CARBONATE	2.172710841086814
RECORDING	2.172710841086814
RAT ΕP121	2.172710841086814
DNASE RQ1	2.172710841086814
MER OLIGO	2.172710841086814
Y140 LIE	2.1724377105522703
AMICON YM10	2.171961779324226
CALBIOCHEM-NOVABIOCHEM	2.1709686135819353
FLUORESCENCE-INTENSITY	2.1709686135819353
BUFFER F	2.1708277467019634
DISPENSIBILITY	2.170361868108899
MULTIUBIQUITIN	2.170361868108899
UBIQUITIN-LIKE	2.170361868108899
CYSTEINE-BASED	2.170361868108899
HYALUROLYTICUS	2.170361868108899
RIBONUCLEOTIDE	2.170361868108899
PRE-CLUSTERING	2.170361868108899
POLYSACCHARIDE	2.170361868108899
HIV-1-INFECTED	2.170361868108899
CYCLOOXYGENASE	2.170361868108899
PHARMACOPHORIC	2.170361868108899
AG	2.1697117181937755
VEHICLE	2.1688020078790244
MG LARVA	2.167823921531593
CLOSE	2.1672785950405156
CODON AUA	2.1665332846249616
LB BROTH	2.166505696097114
COMPLEX UBC	2.165704840253216
TAKE YHL	2.1653073093384965
ATTACHMENT	2.165174303018469
LIPOFECTAMINE	2.164218340180729
MODEL L	2.163957038364552
3HA TAG	2.163957038364552
CO-PURIFICATION	2.163709436182925
TAR RNA	2.1617917890466267
IQ SITE	2.1610752883632407
RT SHOW	2.1610219226224756
L1 GENE	2.160655033154716
unknown	2.1606338338713424
MUTAGENESI	2.1604228824370066
ELEVATION	2.160355728163109
RESONANCE	2.160355728163109
IDO RNA	2.1602225192439324
PIG CSN	2.1601833181247394
HF RATE	2.159362944159563
ANTI GST	2.159310736628925
POMBE	2.1587194902927167
BTR175 MW	2.157610147513397
PH7	2.1573899741590865
MICROMOLAR	2.1570942865412124
SINUSOIDAL	2.1570942865412124
CHLOROPHENYLBIGUANIDE	2.1569096033360977
MALEIMIDE-DERIVATIZED	2.1569096033360977
CALBIOCHEM-BOEHRINGER	2.1569096033360977
S PRIOR	2.155897907004953
DRUG PG	2.1546337295367803
PEAK WT	2.1546337295367803
CELLULAR REGULATORY MECHANISM	2.154592113560996
DISTURBANCE	2.15345958073352
IN-HOSPITAL	2.15345958073352
FREEZE/THAW	2.15345958073352
POLYANIONIC	2.15345958073352
ENDONUCLEAS	2.15345958073352
RESTORATION	2.15345958073352
STRUCTURAL INFORMATION	2.153386798620533
SDS-POLYACRYLAMIDE GEL	2.153057164075078
KB ZONE	2.152430038359307
schemes	2.1523930924821757
ALPHA-1	2.151765019128235
NEUROTOXIC	2.148999987345675
HYGROMYCIN	2.148999987345675
GROUP B	2.148862157405303
LOW-DOSE	2.147523249840615
ACHBP M114	2.146851536539152
HAART-TREATED	2.145938767576279
TWO-COMPONENT	2.145938767576279
IDO-ANTISENSE	2.145938767576279
LURIA-BERTANI	2.145938767576279
EPIDEMIOLOGIC	2.145938767576279
RADIOISOTOPIC	2.145938767576279
BILIRUBIN-IXΑ	2.145938767576279
NERUOBLASTOMA	2.145938767576279
MONOCHROMATOR	2.145938767576279
TUMORIGENESIS	2.145938767576279
HYPERNEGATIVE	2.145938767576279
IDA-SEPHAROSE	2.145938767576279
CYSTEINE-RICH	2.145938767576279
NONFUNCTIONAL	2.145938767576279
EGFP-POSITIVE	2.145938767576279
INTERPOLATION	2.145938767576279
DEACETYLATION	2.145938767576279
MYCOBACTERIUM	2.145938767576279
CONFIGURATION	2.145938767576279
NON-SPHERICAL	2.145938767576279
HYDROCHLORIDE	2.145938767576279
ENZYME NG	2.145489084087701
CASE DGTP	2.1438822442648364
9SF9 CELL	2.1438822442648364
ANTI-CD98	2.1438822442648364
HDL LEVEL	2.1438822442648364
IQ3 IQ1	2.143702953669738
HIPPOCAMPUS	2.1434603620851997
PBS WASH	2.14277763827649
PREINCUBATION	2.1423901303828417
BP CDNA	2.142315306255307
O HIV-1	2.142291037207905
POST-HOSPITALIZATION	2.142225546773008
CTGCTGCTCCTGTTGCTGCT	2.142225546773008
GATGTACCCAGTCTACAGGT	2.142225546773008
TGCATCAGTGGTCAGCCTCA	2.142225546773008
TGTCTTGTCTCATCATTACT	2.142225546773008
CTTTCTCTGCGGCCATTCTG	2.142225546773008
CCATAGTCTGGTTAACATCA	2.142225546773008
DERMATAN	2.140141187407532
MM MAGNESIUM ACETATE	2.140077813430303
ΜM MCPBG	2.13858896890082
BUFFER GF	2.1374008735507615
BUFFER H*	2.1374008735507615
AMMO ACID	2.137324080058889
KB	2.1364805419759314
G TENSOR	2.134580672847547
IQ2 IQ4	2.1336666439063254
PROTECTION	2.1328123758797957
activation	2.132329820043702
IIB/IIIA	2.130913609366178
PHA	2.130744410451342
F VALUE	2.1287356494596374
ASCERTAINMENT	2.1275714857971297
ACIDOPHILUMA-ATPASE	2.126858269945457
5-HYDROXYTRYPTAMINE	2.126858269945457
AGGTCACATTGCCGAACCT	2.126858269945457
ACCTTGGAAGAACCAAATC	2.126858269945457
GATTGTGAACTATACTCCT	2.126858269945457
TTCAGTTTACACATCAGAC	2.126858269945457
CHONDROITIN-SULFATE	2.126858269945457
REDUCTASE	2.126681321668681
1MM DTT	2.1256993228299033
STRAIN RELIEF	2.124563682250761
MM NAOH	2.124332975846523
P27 CDK	2.124332975846523
RESISITANT	2.121244661534001
PENTAMERIC	2.121244661534001
ATMOSPHERE	2.121244661534001
ADRENERGIC	2.121244661534001
GUIDELINES	2.121244661534001
SILYSPIRO	2.1208193668072544
BYSTANDER	2.1208193668072544
films	2.1203476355372457
NONRIBOSOMAL	2.1198300218743413
HETERODUPLEX	2.1198300218743413
spectroscopy	2.1198300218743413
HEPARIN-LIKE	2.1198300218743413
NON-CLINICAL	2.1198300218743413
L-TRYPTOPHAN	2.1198300218743413
NORMOTENSIVE	2.1198300218743413
VASODILATORY	2.1198300218743413
PRESCRIPTION	2.1198300218743413
DYSLIPIDEMIA	2.1198300218743413
HOMOTETRAMER	2.1198300218743413
HCL/METHANOL	2.1198300218743413
TRIGLYCERIDE	2.1198300218743413
ASYMPTOMATIC	2.1198300218743413
DIALYSIS	2.119049580455866
CONTRAST	2.119049580455866
PKK-RT66	2.119049580455866
NONFATAL MYOCARDIAL INFARCTION	2.1157890418299856
REPRESSION	2.114963176678678
ΜL DMSO	2.113487365238607
CONFIRMATORY	2.112865884445907
R91 Y140	2.1120390179179545
GLYCOSAMINOGLYCANS	2.1107410793336174
SPECTROFLUOROMETRY	2.1107410793336174
GTATGGAGCGACGTCACT	2.1107410793336174
ACTGCGAAGATCCACTGA	2.1107410793336174
NON-DISCRIMINATORY	2.1107410793336174
CGCTCCAGAGTGCTGGCA	2.1107410793336174
GATGACAGGGAAGCTGGA	2.1107410793336174
Α-STREPTAVIDIN-HRP	2.1107410793336174
TGCAGTGGCAAAGTGGAG	2.1107410793336174
phenotypic	2.110367285547917
TAF II	2.108056457691574
BAIE D	2.108056457691574
'- 32P	2.108056457691574
RAF	2.107574251389714
HOMOGENATE	2.1065085966204378
STRAIN	2.1038011385426376
UCB/DMSO	2.103230875242117
GST-CDC6	2.103230875242117
MINIPREP	2.103230875242117
TYPE A/E	2.1032308752421165
MM CACL2	2.1032308752421165
RNA LEVEL	2.102522323118076
PH MM HEPE	2.102333149684843
P66 INSP	2.102061182250959
P66 L289	2.102061182250959
ΜM UBIQUITIN ALDEHYDE	2.1019922167319
INJECTION	2.10113193971617
E LOOP	2.100913600548717
LOOP E	2.100913600548717
MEAN PP	2.1006321719013603
MICROCENTRIFUGATION	2.10056108543874
ubiquitin-dependent	2.10056108543874
immunoprecipitation	2.10056108543874
PLYS S	2.100429339047506
T TEST	2.0987461128639877
Q-SEPHAROSE	2.0976689097276915
CFP	2.0956132072090536
YFP	2.0956132072090536
RELATIVE POSITION	2.0951804853356673
DIMETHYLSULFOXIDE	2.093797012495013
PHENOL/CHLOROFORM	2.093797012495013
CD98-TRANSFECTION	2.093797012495013
LOST-TO-FOLLOW-UP	2.093797012495013
MACROPHAGE-TROPIC	2.093797012495013
spectrophotometer	2.093797012495013
PFBGSTBACULOVIRUS	2.093797012495013
hyperthermophilic	2.093797012495013
CCATCCACAGTCTTCTG	2.093797012495013
LOSS-TO-FOLLOW-UP	2.093797012495013
IMMUNOSUPPRESSION	2.093797012495013
DEOXYCHOLIC	2.0917855854311687
PEROXISOMAL	2.0917855854311687
ATPSYNTHASE	2.0917855854311687
CIRCULATION	2.0917855854311687
PROTEIN/MIN	2.0917855854311687
NONINVASIVE	2.0917855854311687
tetrahedral	2.0917855854311687
NON-SMOKING	2.0917855854311687
IRRADIATION	2.0917855854311687
RE-LIGATION	2.0917855854311687
STREPTOMYCE	2.0917855854311687
GRANULOCYTE	2.0917855854311687
IDO-INDUCED	2.0917855854311687
Β-PHOSPHATE	2.0917855854311687
ADHESIVENES	2.0917855854311687
SPECTRA/POR	2.0917855854311687
PREPARATIVE	2.0917855854311687
ZHAXYBAYEVA	2.0917855854311687
MONOHYDRATE	2.0917855854311687
NON-CARDIAC	2.0917855854311687
OMAPATRILAT	2.0917855854311687
BUFFER/DMSO	2.0917855854311687
HETEROCYCLE	2.0917855854311687
STEREOCILIA	2.0917855854311687
POTENTIAL LIMITATION	2.091407044678139
ΜM TCA	2.0911644686221074
stocks	2.089309793632454
HELP RESOLVE	2.088102064190528
PROFESSOR	2.0862250506208815
CYSTEINYL	2.0862250506208815
A-SUBUNIT	2.0862250506208815
DISMISSAL	2.0862250506208815
CHELATION	2.0862250506208815
ACR4 G221	2.0862250506208815
terms	2.086171863186042
REPORT	2.084979534614651
HMG COA	2.084708913328494
H9 CELL	2.084708913328494
influences	2.083966002977344
BT USE	2.083831105578898
HYDROLYSI	2.0829213496648866
dithiothreitol	2.08127252847671
MYOSIN-I	2.0810846879428677
REVERSAL	2.0810846879428677
P66 ΜG	2.080000119663405
P51 ΜG	2.0795413061764223
5HT Y152	2.079502817421493
SODIUM-DEPENDENT	2.0759366153043124
CHYMOTRYPSINOGEN	2.0759366153043124
OXATHIOLEDIOSIDE	2.0759366153043124
PRE-EQUILIBRATED	2.0759366153043124
GENERALIZABILITY	2.0759366153043124
GLYCOSAMINGLYCAN	2.0759366153043124
PHOSPHOCELLULOSE	2.0759366153043124
IMMUNOREGULATION	2.0759366153043124
CONTRAINDICATION	2.0759366153043124
MAP KINAS	2.0751165841789216
INVESTIGATOR	2.0744582157897753
SUBLINE	2.073387752609057
ISOZYME	2.073387752609057
DEPLETION	2.073122147211676
HS GAG	2.070556457691574
ACR1 G64	2.070011594293243
MR	2.068766886191657
LIPID-BINDING	2.0684595056019086
BP REGION	2.065445884859284
MIN PRIOR	2.063303836557121
TEMPLATE	2.0630661593429958
FIGURE 1I	2.062438668762891
ICN	2.062061220670356
PHOTOSHOP	2.0615674318792627
GPI-LINKED	2.0614952865219816
SIDE-CHAIN	2.0614952865219816
AERUGINOSA	2.0614952865219816
SUBCOMPLEX	2.0614952865219816
BACTEROIDE	2.0614952865219816
HAMMERHEAD	2.0614952865219816
HORIKOSHII	2.0614952865219816
POLYLYSINE	2.0614952865219816
DIFLUORIDE	2.0614952865219816
NOSOCOMIAL	2.0614952865219816
CONSULTANT	2.0614952865219816
INTRONLESS	2.0614952865219816
JANNASCHII	2.0614952865219816
KYNURENINE	2.0614952865219816
PIMOBENDAN	2.0614952865219816
ADSORPTION	2.0614952865219816
EXCITATORY	2.0614952865219816
IQ4-COATED	2.0614952865219816
PG-INDUCED	2.0614952865219816
FLUMAZENIL	2.0614952865219816
Z-IETD-AFC	2.0614952865219816
FLUOROSTAR	2.0614952865219816
osteoclast	2.0614952865219816
CILTEXETIL	2.0614952865219816
ABSORPTION	2.0614952865219816
ALLOGENEIC	2.0614952865219816
AXPRESSION	2.0614952865219816
CREATININE	2.0614952865219816
MAB P3	2.061401846480001
DISCREPANCY	2.0586600675367364
MG/ML BOVINE SERUM ALBUMIN	2.0586382646863863
MM NAC1	2.058292871649808
COATING	2.058292871649808
ENERGY	2.058056457691574
contribution	2.057583380426494
CDK	2.0572492809745615
OSTEO-ARTHRITIS	2.0570550832043235
DESULFUROCOCCUS	2.0570550832043235
ANTIBODY-ENZYME	2.0570550832043235
experimentation	2.0570550832043235
HEPTANUCLEOTIDE	2.0570550832043235
LOW-TEMPERATURE	2.0570550832043235
INCOMPARABILITY	2.0570550832043235
OVER-CORRECTION	2.0570550832043235
CATHETERIZATION	2.0570550832043235
TRANSMEMBRANE-4	2.0570550832043235
ACTR/PCIP/AIB-1	2.0570550832043235
HEPATOCARCINOMA	2.0570550832043235
internalization	2.0570550832043235
EPIDEMIOLOGICAL	2.0570550832043235
ultrafiltration	2.0570550832043235
DISCONTINUATION	2.0570550832043235
DNA-REPLICATION	2.0570550832043235
CRYSTALLIZATION	2.0570550832043235
GCDCA-TREATMENT	2.0570550832043235
MM CREATINE PHOSPHATE	2.057050426127369
SIMILAR RESULT	2.0518724266156827
SATURATION	2.0483944946254544
SILKWORM	2.047865406993994
PURKINJE	2.047865406993994
HORMONAL	2.047865406993994
RESISTANCE	2.047283359884258
HETEROMERIC	2.045663772582291
POLYUBIQUITYLATION ACTIVITY	2.0446882893493696
MM PM	2.044681606260857
TRIS BASE	2.0413489760194303
IMAGEQUANT SOFTWARE	2.039575354277327
REGENERATING SYSTEM	2.039575354277327
PBLUESCRIPT	2.037731491493032
COLLOID	2.0371600383068595
DIANION	2.0371600383068595
photoreceptors	2.037028534775566
POST-INJECTION	2.037028534775566
IMMOBILIZATION	2.037028534775566
METHANOSARCINA	2.037028534775566
AMINOGYLCOSIDE	2.037028534775566
PHENYL-AGAROSE	2.037028534775566
HYPERLIPIDEMIA	2.037028534775566
IDO-EXPRESSION	2.037028534775566
INTEGRIN-CD147	2.037028534775566
TRANSPEPTIDASE	2.037028534775566
P-GLYCOPROTEIN	2.037028534775566
POST-INFECTION	2.037028534775566
HISTOPATHOLOGY	2.037028534775566
PEDF-HEPARIN/H	2.037028534775566
LIFETECHNOLOGY	2.037028534775566
MOLECULE	2.0362929483261065
VITROUBIQUITYLATION ASSAY	2.0348772728534485
ORI P	2.0334521865726263
6OF H9	2.0330564576915737
ELECTROSTATIC INTERACTION	2.0323110092887715
measures	2.031032782138659
ng/ml	2.030266039277831
UBC	2.0295438463629445
HONORARIA	2.0285678569769265
MULTIWELL	2.0285678569769265
DIPEPTIDE	2.0285678569769265
APN-SIZED	2.0285678569769265
POLYBRENE	2.0285678569769265
UNREACTED	2.0285678569769265
TAT-TIP60	2.0285678569769265
HISTAMINE	2.0285678569769265
HIGH-DOSE	2.0285678569769265
UBIQUITYL	2.0285678569769265
DIMITRIOS	2.0285678569769265
HOMOLOGUS	2.0285678569769265
HEPARINUM	2.0285678569769265
TRANSFECT	2.0285678569769265
LEVER-ARM	2.0285678569769265
CENTRICON	2.0285678569769265
EYFP/ECFP	2.0285678569769265
MDL-72222	2.0285678569769265
HEPES/KOH	2.0285678569769265
PEPTIDASE	2.0285678569769265
COLLECTOR	2.0285678569769265
MYOSIN-1A	2.0285678569769265
IMMUNOPRECIPITATION BUFFER	2.0255705255426255
NM ENZYME	2.0249666292081234
PHARMACOLOGICAL PROPERTY	2.0205086591277377
GLASS TISSUE HOMOGENIZER	2.0205086591277377
SEPARATION	2.019545630894442
PB	2.0190731963042623
T4 POLYNUCLEOTIDE KINASE	2.018453210405889
ENDOGENOUS GENOMIC LOCUS	2.0173337249413112
connections	2.017075818466967
hypertrophy	2.017075818466967
CHOLANGIOCYTE	2.015709081055995
presentations	2.015709081055995
CHARYBDOTOXIN	2.015709081055995
LACTOBACILLUS	2.015709081055995
SIGMA-ALDRICH	2.015709081055995
CYCLOOXYGENAS	2.015709081055995
INTEGRIN-CD81	2.015709081055995
DINITROPHENYL	2.015709081055995
ANTI-PARALLEL	2.015709081055995
STROMELYSIN-3	2.015709081055995
STROMELYSIN-2	2.015709081055995
THIAMINE/THDP	2.015709081055995
EURYARCHAEOTE	2.015709081055995
triphosphates	2.015709081055995
lipofectamine	2.015709081055995
PRE-INCUBATED	2.015709081055995
DISENGAGEMENT	2.015709081055995
LUND-JOHANSEN	2.015709081055995
THYROGLOBULIN	2.015709081055995
hemagglutinin	2.015709081055995
TRANSKETOLASE	2.015709081055995
BIAEVALUATION	2.015709081055995
stoichiometry	2.015709081055995
NEUROTOXICITY	2.015709081055995
comparability	2.015709081055995
nitrocellulose	2.0148420952241732
identification	2.0148420952241732
ΜCI	2.01342331265809
NK	2.0129425875433786
T7	2.0129425875433786
KH	2.0129425875433786
MK	2.0129425875433786
μg	2.0129425875433786
AC	2.0129425875433786
CM	2.0129425875433786
MIX	2.009629927356049
HIN FI	2.008056457691574
MM KOH	2.008056457691574
KILLER	2.008056457691574
T-EASY	2.008056457691574
mitochondria	2.007370064689955
REACH	2.0072502073000886
FRAGILI	2.0054607882924365
RESOLVE	2.0054607882924365
DEFENSE	2.0054607882924365
OXALATE	2.0054607882924365
SWI/SNF	2.0054607882924365
TABLE 2I	2.0021408486726595
ATPΓ S	2.000429339047506
BLOCKER	2.0001803028563163
CROSSLINKER	1.9977398200054748
GIBCO BRL	1.9964061834398648
bootstrapped	1.9929181911390876
PET-28A-RT51	1.9929181911390876
RAMIFICATION	1.9929181911390876
SIZE-PURIFED	1.9929181911390876
UNISOLATABLE	1.9929181911390876
COEXPRESSION	1.9929181911390876
zwitterionic	1.9929181911390876
RESIDUE-TURN	1.9929181911390876
CRENARCHEOTE	1.9929181911390876
hemodynamics	1.9929181911390876
MOLAR-EXCESS	1.9929181911390876
MICROCON-100	1.9929181911390876
NON-MEMBRANE	1.9929181911390876
dependencies	1.9929181911390876
FLOCCULATION	1.9929181911390876
INDUCIBILITY	1.9929181911390876
MUKHOPADHYAY	1.9929181911390876
CO-ORDINATED	1.9929181911390876
HALF-CYSTINE	1.9929181911390876
INTERFERON-Γ	1.9929181911390876
SUMO-PROTEIN	1.9929181911390876
VERAPAMIL-SR	1.9929181911390876
processivity	1.9929181911390876
densitometry	1.9929181911390876
consequences	1.9929181911390876
BEATS/MINUTE	1.9929181911390876
METAL-LIGAND	1.9929181911390876
certificates	1.9929181911390876
OVER-EXPRESS	1.9929181911390876
PRO-THYMOSIN	1.9929181911390876
coordination	1.9929181911390876
percutaneous	1.9929181911390876
TATA-BOX	1.9924999387458713
ISCHEMIC	1.9924999387458713
MANNITOL	1.9924999387458713
G-STRAND	1.9924999387458713
SENEJANI	1.9924999387458713
GAUSSIAN	1.9924999387458713
EXPLORER	1.9924999387458713
TRIS/HCI	1.9924999387458713
BUTHIDAE	1.9924999387458713
SORBITOL	1.9924999387458713
ELASTASE	1.9924999387458713
MICROCON	1.9924999387458713
THYMOSIN	1.9924999387458713
VG/FISON	1.9924999387458713
ION-PAIR	1.9924999387458713
LANGMUIR	1.9924999387458713
AMPICILLIN	1.9908891195020197
NDE I	1.9885345078197045
OPERON	1.9880564576915738
glycoprotein	1.9860640365135316
PP	1.9807716415167476
DISAPPEARANCE	1.9797915353090771
precipitation	1.9797915353090771
HYDROXYLATION	1.9797915353090771
MANIFESTATION	1.9797915353090771
NORTHERN	1.9775029129198876
GLU R	1.9770971359150256
CHEMICAL TREATMENT	1.9762966831660722
BIRTH	1.9744977332094167
CM-IV	1.9744977332094167
signatures	1.972714394102922
CO-EXPOSURE	1.9684375948264656
CDC37-HSP90	1.9684375948264656
SUB-CULTURE	1.9684375948264656
CYS20-CYS34	1.9684375948264656
BASOLATERAL	1.9684375948264656
AAAAGAAAAAA	1.9684375948264656
FRACTIONATE	1.9684375948264656
AAAAGATAAAG	1.9684375948264656
PFB-GSTCDC6	1.9684375948264656
inoculation	1.9684375948264656
CYSL6-CYS32	1.9684375948264656
NEUROPHYSIN	1.9684375948264656
ISOPROPANOL	1.9684375948264656
CEPHALOTHIN	1.9684375948264656
LOOP-SEARCH	1.9684375948264656
HYDROLYZING	1.9684375948264656
INDOLEAMINE	1.9684375948264656
AFFILIATION	1.9684375948264656
FISHERBRAND	1.9684375948264656
acetylation	1.9684375948264656
CROSS-LINKS	1.9684375948264656
ADDRESSABLE	1.9684375948264656
CARDIOTOXIC	1.9684375948264656
RAS/RAF/MEK	1.9684375948264656
oncoprotein	1.9684375948264656
NOXIUSTOXIN	1.9684375948264656
occurrences	1.9684375948264656
prokaryotic	1.9684375948264656
TREE-PUZZLE	1.9684375948264656
HYDROPHILIC	1.9684375948264656
fluorometer	1.9684375948264656
DEMOGRAPHIC	1.9684375948264656
HIRABAYASHI	1.9684375948264656
HYDROXYUREA	1.9684375948264656
DENEDDYLATE	1.9684375948264656
BIOISOSTERE	1.9684375948264656
NUCLEOPHILE	1.9684375948264656
ACHIEVEMENT	1.9684375948264656
MEAN AGE	1.9681044418180988
GENERAL	1.9659138102379865
HOMOLOGUE	1.9650211344290924
WTAND	1.9644714656306395
C-JUN	1.9644714656306395
XIIIΑ	1.9644714656306395
THUMB	1.9644714656306395
GAITHERSBURG	1.9641613999619556
PG D	1.9639178786015932
CHIP	1.9635669787146175
INTRACELLULAR TRANSPORT	1.961896707276313
ADULT	1.9609562539066545
UBIQUITIN ALDEHYDE	1.958785055337383
MATTEK	1.958056457691574
GROUND	1.958056457691574
BLEACH	1.958056457691574
STERIC	1.958056457691574
EVALUATION	1.956367484080855
SYSTEMATIC APPROACH	1.9546912490341426
BINDING STUDY RECEPTOR	1.953366098828925
SK-N-SH	1.9526287049350644
LATENCY	1.9526287049350644
MICHROM	1.9526287049350644
ARSDMUT	1.9526287049350644
G2-TO-M	1.9526287049350644
F-ATPAS	1.9526287049350644
UNLYSED	1.9526287049350644
PROTEIN KINASE PATHWAY	1.9526152290174017
NEDD8	1.9511031088589363
RD A3	1.9511031088589363
INCREASED RELATIVE RISK	1.951087660012918
limitations	1.9509297412046644
TURN BIND	1.9508596884954432
TOXIC	1.9508035693613195
EFFLUX	1.9477102546507332
MAUROTOXIN	1.9419965364979432
METAL-FREE	1.9419965364979432
QIAGEN-TIP	1.9419965364979432
E-NTPDASE3	1.9419965364979432
SELF-IMAGE	1.9419965364979432
LONG-CHAIN	1.9419965364979432
EUBACTERIA	1.9419965364979432
hybridomas	1.9419965364979432
KALIOTOXIN	1.9419965364979432
RETAINMENT	1.9419965364979432
CATABOLIZE	1.9419965364979432
E-NTPDASE2	1.9419965364979432
arthropods	1.9419965364979432
PTCA/STENT	1.9419965364979432
crosslinks	1.9419965364979432
PERIYANNAN	1.9419965364979432
DIMETHYL-1	1.9419965364979432
MICROLITER	1.9419965364979432
LOFTSTRAND	1.9419965364979432
AGGLUTININ	1.9419965364979432
ANTI-CD147	1.9419965364979432
PEDF-RESIN	1.9419965364979432
LOVASTATIN	1.9419965364979432
E-NTPDASES	1.9419965364979432
DEPRESSANT	1.9419965364979432
NENLIFESCI	1.9419965364979432
isoleucine	1.9419965364979432
CYS5-CYS27	1.9419965364979432
PRECIPIATE	1.9419965364979432
PEDFRANGED	1.9419965364979432
(D)DROPOUT	1.9419965364979432
LISINOPRIL	1.9419965364979432
TUTTLINGEN	1.9419965364979432
ALTRINCHAM	1.9419965364979432
SUPERSHIFT	1.9419965364979432
TAZOBACTAM	1.9419965364979432
AMLODIPINE	1.9419965364979432
destaining	1.9419965364979432
MATRILYSIN	1.9419965364979432
guidelines	1.9419965364979432
MARGATOXIN	1.9419965364979432
INHALATION	1.9419965364979432
ANTI-XPRES	1.9419965364979432
HYDROXAMIC	1.9419965364979432
absorbance	1.9419965364979432
TORUS-LIKE	1.9419965364979432
HYALURONAN	1.9419965364979432
DEPRIVATION	1.9417514799228943
F IQ	1.940448938012752
communication	1.9396665890632483
ACETIC ACID	1.936787807499395
contents	1.9359217708534726
SEROTONIN	1.935242951498825
PETRI	1.9323874093785525
DECAY	1.9323874093785525
MHC-I	1.9323874093785525
ACKNOWLEDGEMENT	1.9319083842525977
PHOTOMICROGRAPH	1.9319083842525977
DIVISION	1.931650417750519
DRASTIC REDUCTION	1.928064324726487
POSSIBLE FUNCTION	1.928064324726487
PHYSIOLOGICAL PROCESS	1.9270475153491113
RAPID PERFUSION SYSTEM	1.926973380377103
catalysis	1.925763730328209
DEPENDENCE	1.9251191574898554
CORECEPTOR	1.9251191574898554
FITC	1.9245368116567856
POLYNUCLEOTIDE KINASE	1.9240803622107916
APPRECIATION	1.9209610842330327
REACTION PRODUCT	1.9207197477146782
K562	1.919821459471644
FIXED	1.918178942797951
injection	1.9132534696890164
CYANINE-3	1.9132534696890164
CYANINE-5	1.9132534696890164
MICRO-TIP	1.9132534696890164
SDS-2XSSC	1.9132534696890164
PEL-FREEZ	1.9132534696890164
ANTI-BT-R	1.9132534696890164
MELTRIN-Β	1.9132534696890164
NON-LIVER	1.9132534696890164
NUMERATOR	1.9132534696890164
ECTOKINAS	1.9132534696890164
OVALBUMIN	1.9132534696890164
ENALAPRIL	1.9132534696890164
LIFE-YEAR	1.9132534696890164
RESTENOSI	1.9132534696890164
EPIZOOTIC	1.9132534696890164
FOUR-WEEK	1.9132534696890164
SULBACTAM	1.9132534696890164
obstacles	1.9132534696890164
myoglobin	1.9132534696890164
ALPHAGENE	1.9132534696890164
CD3-GAMMA	1.9132534696890164
BIOSOURCE	1.9132534696890164
MILLIUNIT	1.9132534696890164
ANTI-CD71	1.9132534696890164
homomeric	1.9132534696890164
PAROMYCIN	1.9132534696890164
HEMOSTASI	1.9132534696890164
CAUCASIAN	1.9132534696890164
vortexing	1.9132534696890164
OCCUPANCY	1.9132534696890164
resources	1.9132534696890164
EVALUABLE	1.9132534696890164
hydrolyze	1.9132534696890164
DIALYZING	1.9132534696890164
SIX-MONTH	1.9132534696890164
repressor	1.9132534696890164
CSNMUTANT	1.9132534696890164
COELUTING	1.9132534696890164
amplifier	1.9132534696890164
POLYANION	1.9132534696890164
NAGAMATSU	1.9132534696890164
G-PROTEIN	1.9132534696890164
MELTRIN-Α	1.9132534696890164
ALEXA-488	1.9132534696890164
IINCREASE	1.9132534696890164
PYROCOCCI	1.9132534696890164
CO-WORKER	1.9132534696890164
DILTIAZEM	1.9132534696890164
histories	1.9132534696890164
DIALYSATE	1.9132534696890164
RFNAHGDVN	1.9132534696890164
ORTHOPNEA	1.9132534696890164
aminoacid	1.9132534696890164
BENZYL	1.908056457691574
PLOIDY	1.908056457691574
BUTHID	1.908056457691574
DIAFLO	1.908056457691574
PUZZLE	1.908056457691574
SCCDC6	1.908056457691574
NIACIN	1.908056457691574
CAROTA	1.908056457691574
INDOLE	1.908056457691574
GENOSY	1.908056457691574
ABYSII	1.908056457691574
LEFFAK	1.908056457691574
MELTRI	1.908056457691574
GYRASE	1.908056457691574
GLU138	1.908056457691574
P-TYPE	1.908056457691574
GLUR-A	1.908056457691574
LEIDEN	1.908056457691574
injury	1.908056457691574
PESTEL	1.908056457691574
ZEOCIN	1.908056457691574
PJW312	1.908056457691574
SOBRIA	1.908056457691574
variants	1.9069009747536991
LERISETRON INHIBITION	1.9067849827334773
STAT5	1.9043138601579763
TFIID	1.9043138601579763
CDC34	1.9043138601579763
COX-1	1.9043138601579763
12CA5	1.9043138601579763
NHLBI	1.9043138601579763
DNASE I	1.9039204805540773
P	1.898751333879776
reticulum	1.8960537370525903
outcomes	1.8953552815783916
RECOMMENDATION	1.893850712172407
BINDING SITE RESIDUE	1.8931614314483736
POTENTIAL DIFFERENCE	1.8931614314483736
VENTRICULAR FUNCTION	1.8931614314483736
DAPI	1.8925103650326416
CHROMATOGRAPHY	1.889349894042745
MM POTASSIUM ACETATE	1.887344877269335
PANEL E	1.8867913541591257
POSITIVE CHANGE	1.886715359312134
ΜG/ML PEPSTATIN	1.8857649568264345
THALIANA	1.8853570332045213
HEAD	1.885355292795362
DH5Α	1.885355292795362
SHEP	1.885355292795362
reconstruction	1.8835218900876431
APPROPRIATENES	1.8835218900876431
NON-RESPONSIVE	1.8835218900876431
EPITHELIA	1.8820059291991638
AGITOXIN	1.881769002249626
CAVEOLAE	1.881769002249626
cofactor	1.881769002249626
PEDFWERE	1.881769002249626
TESTABLE	1.881769002249626
ARGININE	1.881769002249626
ADEQUACY	1.881769002249626
NU-PHARM	1.881769002249626
SEC/SCAN	1.881769002249626
PREITSCH	1.881769002249626
ALDOLASE	1.881769002249626
ANATRACE	1.881769002249626
OCCURING	1.881769002249626
COPLANAR	1.881769002249626
C-EXTEIN	1.881769002249626
PEPTIDAS	1.881769002249626
BERIBERI	1.881769002249626
AXOPATCH	1.881769002249626
APOPTOSE	1.881769002249626
FUGENE-6	1.881769002249626
STRIATUM	1.881769002249626
SCHAGGER	1.881769002249626
CAVEOLIN	1.881769002249626
TEL-TEST	1.881769002249626
FERRITIN	1.881769002249626
DAB/UREA	1.881769002249626
LYSOZYME	1.881769002249626
SARKOSYL	1.881769002249626
ERK/MAPK	1.881769002249626
INVIABLE	1.881769002249626
ILEOCYTE	1.881769002249626
MCMANNUS	1.881769002249626
solvents	1.881769002249626
T-TROPIC	1.881769002249626
AA/AA/AC	1.881769002249626
HESPERIA	1.881769002249626
DIALYSED	1.881769002249626
ECDYSONE	1.881769002249626
MCI/MMOL	1.881769002249626
flowcell	1.881769002249626
barriers	1.881769002249626
PEDF-GAG	1.881769002249626
NOVOZYME	1.881769002249626
CM-IV-6B	1.881769002249626
OAKVILLE	1.881769002249626
D-DOMAIN	1.881769002249626
KUWABARA	1.881769002249626
PCU3-MYC	1.881769002249626
NA-AZIDE	1.881769002249626
cadherin	1.881769002249626
T CELL PROLIFERATION	1.8812738488449634
NUCLEAR	1.8810816453608084
algorithm	1.8786194594804206
observations	1.8756024126181834
K S	1.8728110462959366
INDICATION	1.8708780091501915
VEGETATIVE	1.8708780091501915
TSAO	1.868122209457221
GF/B	1.868122209457221
SLOT	1.868122209457221
FACS	1.868122209457221
DROP	1.868122209457221
ORC4	1.868122209457221
SLIP	1.868122209457221
EPR	1.8664143098952712
RECEPTOR STIMULATION	1.8651789260681255
LETHALITY	1.864921473679049
MG/ML CREATINE KINASE	1.861574104891562
TUMORIGENESI	1.8593025840611586
IE	1.859269102279105
peristaltic	1.8577689697990234
FINE-TUNING	1.8577689697990234
plasminogen	1.8577689697990234
PUBLISHED PROCEDURE	1.857698694726615
POTENTIAL MECHANISM	1.857698694726615
U-5PB	1.8575246114570163
INSEL	1.8575246114570163
NNRTI	1.8575246114570163
DELAY	1.8575246114570163
FAZAL	1.8575246114570163
PIT-1	1.8575246114570163
LIGHT	1.8575246114570163
IDO-A	1.8575246114570163
RULER	1.8575246114570163
SYBYL	1.8575246114570163
ΔT119	1.8575246114570163
CACL2	1.8575246114570163
LXXLL	1.8575246114570163
DISSOCIATION CONSTANT	1.8570496754041932
fibroblasts	1.856435315604281
DESCRIPTIVE STATISTICS	1.8554341921555413
BINDING REGION	1.8553518696820437
F T	1.855187209298536
CRITICAL ROLE	1.8537741696202916
CULTURING	1.851644650907191
SPECTRUM	1.8514961652773558
PRIMARY SEQUENCE	1.8514191892331682
UG	1.8497082188340237
PROTEAS	1.849047893741635
reasons	1.8469645382203206
NEURONE	1.8469645382203206
GSK/SKB	1.8469645382203206
OVERUSE	1.8469645382203206
CHIRARA	1.8469645382203206
PKKRT66	1.8469645382203206
capture	1.8469645382203206
KDALTON	1.8469645382203206
CM-IV-6	1.8469645382203206
VOLCANI	1.8469645382203206
HIS-TAG	1.8469645382203206
A5-PUJ2	1.8469645382203206
ANIONIC	1.8469645382203206
A3-IIF5	1.8469645382203206
JANRRNA	1.8469645382203206
EMPHAZE	1.8469645382203206
cations	1.8469645382203206
RAR/PML	1.8469645382203206
LEDERLE	1.8469645382203206
MI-110K	1.8469645382203206
BIOVAIL	1.8469645382203206
SPCH2_2	1.8469645382203206
ICP-AES	1.8469645382203206
ANTI-CD	1.8469645382203206
GSTORC2	1.8469645382203206
PERNIXL	1.8469645382203206
G1-TO-S	1.8469645382203206
tubulin	1.8469645382203206
BLOWFLY	1.8469645382203206
Β-TRCP1	1.8469645382203206
THLITHO	1.8469645382203206
records	1.8469645382203206
A4-PUJ1	1.8469645382203206
YHL/YOL	1.8469645382203206
INVASIN	1.8469645382203206
chorion	1.8469645382203206
DATAPAC	1.8469645382203206
SALINA2	1.8469645382203206
A-ATPAS	1.8469645382203206
FURIOS2	1.8469645382203206
ΜL/LANE	1.8469645382203206
GAINIED	1.8469645382203206
scanner	1.8469645382203206
A2-2E10	1.8469645382203206
TAUTOT2	1.8469645382203206
ANXIETY	1.8469645382203206
surveys	1.8469645382203206
HIS-UBC	1.8469645382203206
NOVARTI	1.8469645382203206
ATLANTA	1.8469645382203206
CAG	1.846290933072914
RNASE	1.8444368228316088
MM TRIS	1.8429524035550968
YM10	1.8422725844500094
ICER	1.8422725844500094
CUL3	1.8422725844500094
HDAC	1.8422725844500094
CDK7	1.8422725844500094
MARK	1.8422725844500094
ACHR	1.8422725844500094
UL	1.8391460518995717
DIRECTED MUTAGENESI	1.8377206763977
LPS	1.833391332545762
monophosphate	1.832011584821025
LINEARIZATION	1.832011584821025
baculoviruses	1.832011584821025
randomization	1.832011584821025
MISCONCEPTION	1.832011584821025
proliferative	1.832011584821025
INITIATION	1.8319322683943189
CDNA ΜG	1.8289436153604783
BINDING SITE LIGAND	1.8279420179068322
MONOMER	1.8239845573776363
TWO-FOLD	1.8225302970349535
NATIONAL COMMITTEE	1.8205053979716976
TISSUE HOMOGENIZER	1.8205053979716976
BECKMAN JA20 ROTOR	1.8205053979716976
COMPLEMENTARY FACE	1.8205053979716976
longitudinal study	1.8205053979716976
NORMALIZED CURRENT	1.8205053979716976
UG TOTAL CELL LYSATE	1.8188247949606526
ACA	1.8186489319433026
CREATINE KINASE	1.8163190638301179
MAXIMAL ACTIVATION	1.8137251655792879
MAXENT	1.808056457691574
F-TYPE	1.808056457691574
SPORC4	1.808056457691574
WOBURN	1.808056457691574
GM-CSF	1.808056457691574
M-BLTR	1.808056457691574
FIG- 1	1.808056457691574
MAZEI5	1.808056457691574
zeocin	1.808056457691574
CD-EPR	1.808056457691574
AVENTI	1.808056457691574
LYS-94	1.808056457691574
HEXOSE	1.808056457691574
LYS224	1.808056457691574
ASTHMA	1.808056457691574
ABYSSI	1.808056457691574
SOLFA4	1.808056457691574
cyanol	1.808056457691574
DEMARK	1.808056457691574
ACIDOP	1.808056457691574
DNASEI	1.808056457691574
MOBILI	1.808056457691574
SINNET	1.808056457691574
LYS-75	1.808056457691574
INFACT	1.808056457691574
RAHWAY	1.808056457691574
NEPEAN	1.808056457691574
UVASOL	1.808056457691574
1(IQ4)	1.808056457691574
BARKE2	1.808056457691574
EVEREX	1.808056457691574
NCOA-2	1.808056457691574
issues	1.808056457691574
X-BAND	1.808056457691574
REFLUX	1.808056457691574
ACALDA	1.808056457691574
MPS101	1.808056457691574
BIOTIN	1.808056457691574
CAC	1.807592131491458
CCA	1.807592131491458
CGT	1.807592131491458
AGG	1.807592131491458
TGG	1.807592131491458
AGA	1.807592131491458
CAA	1.807592131491458
HEART ATTACK TRIAL	1.8045128933069918
CREATINE	1.804210252823937
TOTAL CONCENTRATION	1.8040355197973332
MOLECULAR BASIS	1.8025453607809188
MCAR	1.7991898761046567
CREB	1.7991898761046567
G221	1.7991898761046567
HARM	1.7991898761046567
PPAR	1.7991898761046567
HCTZ	1.7991898761046567
T701	1.7991898761046567
AMMO	1.7991898761046567
NAC1	1.7991898761046567
L289	1.7991898761046567
SMRT	1.7991898761046567
NURF	1.7991898761046567
M114	1.7991898761046567
ATPΓ	1.7991898761046567
DGTP	1.7991898761046567
9SF9	1.7991898761046567
CD63	1.7991898761046567
RT66	1.7991898761046567
INSP	1.7991898761046567
motility	1.7953614564940668
CCG	1.7921126108588756
AIM	1.7921126108588756
LAI	1.7921126108588756
MER	1.7921126108588756
PLA	1.7921126108588756
AGONIST APPLICATION	1.7915616192757229
ISOLEUCINE	1.789516286640696
NA-ACETATE	1.789516286640696
MM MGCL	1.7864636138458376
CLOSED CONFORMATION	1.7839880533790193
COUNTER	1.7836916261949234
proximal	1.7832131490392689
AMICON	1.7826474111300084
HOLDING POTENTIAL	1.7814039365978753
OBSERVED INCREASE	1.7814039365978753
NC	1.7773564045760912
quantitation	1.7769461168048295
deoxycholate	1.7769461168048295
determinant	1.7729804276339869
discoveries	1.7729804276339869
CALBIOCHEM	1.7726524155732186
REACTION BUFFER	1.7692465121719687
surface receptors	1.7689969496675744
P44	1.768893329910002
ITT	1.768893329910002
RQ1	1.768893329910002
CHS	1.768893329910002
CGG	1.768893329910002
2IN	1.768893329910002
GAT	1.768893329910002
COA	1.768893329910002
GPI	1.768893329910002
BINDING ASSAY DNA	1.7673994600513794
OFFSET	1.764926329424241
PPARΓ	1.7639461140550963
ΓN107	1.7639461140550963
ORALE	1.7639461140550963
SCORC	1.7639461140550963
ΓS111	1.7639461140550963
WYETH	1.7639461140550963
RAF-1	1.7639461140550963
ESI-M	1.7639461140550963
lysed	1.7639461140550963
PUC19	1.7639461140550963
CDC45	1.7639461140550963
EGR-1	1.7639461140550963
TIP60	1.7639461140550963
PAUP*	1.7639461140550963
ERK-2	1.7639461140550963
BAL-I	1.7639461140550963
CDC53	1.7639461140550963
VIM-1	1.7639461140550963
AXIAL	1.7639461140550963
PIPLC	1.7639461140550963
SPORC	1.7639461140550963
phage	1.7639461140550963
REUSE	1.7639461140550963
THAN1	1.7639461140550963
VACUO	1.7639461140550963
CYS-X	1.7639461140550963
YRNQP	1.7639461140550963
VO(OH	1.7639461140550963
PLYSS	1.7639461140550963
A6-BB	1.7639461140550963
G/MOL	1.7639461140550963
NCOAS	1.7639461140550963
D-MEM	1.7639461140550963
FRP-1	1.7639461140550963
PSATY	1.7639461140550963
HSV-1	1.7639461140550963
GYRAS	1.7639461140550963
HXB-2	1.7639461140550963
IIIC4	1.7639461140550963
WIF-B	1.7639461140550963
ΓS115	1.7639461140550963
TOMHS	1.7639461140550963
CABGS	1.7639461140550963
ΔR113	1.7639461140550963
CYSLT	1.7639461140550963
PRELIMINARY RESULT	1.7639165353119688
BREAKDOWN	1.7605608160312705
GLUTAMATE RECEPTOR	1.7575195334460865
factors	1.7520523107711155
MUTAGENESIS	1.7496736244603235
MM L-GLUTAMINE	1.7449915583575994
ROC1	1.7435922549185228
RBX1	1.7435922549185228
RAISING QUESTION	1.7401878792295125
BINDING CONSTANT	1.7401878792295125
PHARMINGEN	1.7400822805870761
PCEP4	1.7398500854525958
H1	1.7390843806075824
K1	1.7390843806075824
DETAILED ANALYSIS	1.738479742656855
TAKE TIME	1.7372829522217612
INCREASED RATE	1.73659213386932
5HT	1.7301945283285458
QUO	1.7301945283285458
EMA	1.7301945283285458
KOH	1.7301945283285458
SCD	1.7301945283285458
BBL	1.7301945283285458
2Y2	1.7301945283285458
H59	1.7301945283285458
RTK	1.7301945283285458
HBS	1.7301945283285458
GHZ	1.7301945283285458
SKD	1.7301945283285458
LCC	1.7301945283285458
BAN	1.7301945283285458
PMI	1.7301945283285458
G64	1.7301945283285458
A/E	1.7301945283285458
T1	1.7290843806075824
RECEPTOR PROTEIN	1.727370739441822
protocols	1.7267077172634682
BINDING ABILITY	1.7252441313698181
ANTIPARALLEL Β-SHEET	1.7244813602562523
PROTEINASE INHIBITOR	1.7244813602562523
LB	1.7219415234647253
CHAIN REACTION	1.7213885443400425
preparation	1.7208832958112792
macrophages	1.717798119592572
C-FOS/C-JUN	1.717798119592572
carboxylate	1.717798119592572
RANDOMIZING	1.717798119592572
corrections	1.717798119592572
Α-HELIX	1.7169806106430705
PREFORMED	1.7153213959697697
NANOMOLAR	1.7153213959697697
AGTX	1.7130244594139514
AF-2	1.7130244594139514
W143	1.7130244594139514
12D7	1.7130244594139514
EBNA	1.7130244594139514
MAT1	1.7130244594139514
MNKI	1.7130244594139514
CDK6	1.7130244594139514
K153	1.7130244594139514
CUTG	1.7130244594139514
CD71	1.7130244594139514
HFBA	1.7130244594139514
R91A	1.7130244594139514
PTCA	1.7130244594139514
PCU1	1.7130244594139514
L102	1.7130244594139514
PIP1	1.7130244594139514
CYS2	1.7130244594139514
KMI6	1.7130244594139514
MKKS	1.7130244594139514
CD80	1.7130244594139514
C816	1.7130244594139514
IL-3	1.7130244594139514
TRAN	1.7130244594139514
ERST	1.7130244594139514
CUL4	1.7130244594139514
GLYR	1.7130244594139514
FUJI	1.7130244594139514
MWCO	1.7130244594139514
IKBA	1.7130244594139514
V/CM	1.7130244594139514
D206	1.7130244594139514
CAA1	1.7130244594139514
ECFV	1.7130244594139514
PMOL	1.7130244594139514
TA-4	1.7130244594139514
C109	1.7130244594139514
BRG1	1.7130244594139514
MGTX	1.7130244594139514
CALB	1.7130244594139514
TA-5	1.7130244594139514
aids	1.7130244594139514
MOPS	1.7130244594139514
MMPS	1.7130244594139514
XBRA	1.7130244594139514
SWAP	1.7130244594139514
COPD	1.7130244594139514
T142	1.7130244594139514
URFE	1.7130244594139514
CDT1	1.7130244594139514
ISCO	1.7130244594139514
GAGS	1.7130244594139514
FHHL	1.7130244594139514
FLAW	1.7130244594139514
NCOR	1.7130244594139514
DSMB	1.7130244594139514
NAPA	1.7130244594139514
ISW1	1.7130244594139514
GDCA	1.7130244594139514
ERKS	1.7130244594139514
MIDI	1.7130244594139514
CHTX	1.7130244594139514
5-HT	1.7130244594139514
STU1	1.7130244594139514
caps	1.7130244594139514
UCSD	1.7130244594139514
RAC3	1.7130244594139514
P154	1.7130244594139514
IBTX	1.7130244594139514
HCLO	1.7130244594139514
VP26	1.7130244594139514
KXTX	1.7130244594139514
EC50	1.7130244594139514
HSTF	1.7130244594139514
CSN3	1.7130244594139514
MICROMAX	1.7094421719297317
ARGUMENT	1.7094421719297317
SUBCLINICAL DISEASE	1.708171393707207
NEURONAL CELL	1.7072803189722887
TRANSFECTION	1.7062596150538116
REVIEW	1.7040602809867125
ISOFORM	1.7012380819610977
UK	1.6990843806075824
OPTIMUM	1.6983709638146576
FASTPREP DEVICE	1.6966153706270208
DISRUPTING CELL	1.6966153706270208
PLAY MAJOR ROLE	1.6966153706270208
STUDIED EXAMPLE	1.6966153706270208
CYSTIC FIBROSIS	1.6966153706270208
DETECTION LIMIT	1.6966153706270208
INTEGRAL	1.693095251984466
MONITOR	1.6927290128230699
CHOLESTEROL LEVEL	1.6910215320958084
RECEPTOR FAMILY	1.6905654070810898
PROTEIN CONTENT	1.6901016591439821
MEASUREMENT	1.689908155326628
OBSERVATIONAL STUDY	1.6892568291338117
GLYCINE RECEPTOR	1.6877257261931962
GLYCEROL	1.6839140457779291
SERUM CHOLESTEROL	1.6822748477891567
complement	1.67974539593838
carcinomas	1.67974539593838
GM	1.6790843806075824
H9	1.6790843806075824
rises	1.6787077811136157
usage	1.6787077811136157
MRNA INDUCTION	1.6785996541118107
SCINTILLATION COUNTER	1.6777218759262584
GST	1.6755096112905914
COMMUNICATION	1.6745904192694399
CYSTEINE	1.6701682636363258
strengths	1.6648564501177772
CARINII	1.6641127110247542
DESTAINING SOLUTION	1.6600778173559352
AMERSHAM PHARMACIA BIOTECH	1.6571392029527203
MITOGENESI	1.653913415791537
HKY	1.6527969251656338
Q55	1.6527969251656338
HB6	1.6527969251656338
DCO	1.6527969251656338
PHU	1.6527969251656338
W53	1.6527969251656338
WCC	1.6527969251656338
TSA	1.6527969251656338
LVH	1.6527969251656338
1MG	1.6527969251656338
CKS	1.6527969251656338
1in	1.6527969251656338
BRD	1.6527969251656338
CUL	1.6527969251656338
POL	1.6527969251656338
1TO	1.6527969251656338
1EQ	1.6527969251656338
RGX	1.6527969251656338
HC1	1.6527969251656338
LTE	1.6527969251656338
SPB	1.6527969251656338
JDO	1.6527969251656338
RBI	1.6527969251656338
BAL	1.6527969251656338
GSC	1.6527969251656338
CRM	1.6527969251656338
CV1	1.6527969251656338
CGL	1.6527969251656338
LCK	1.6527969251656338
DNP	1.6527969251656338
7DA	1.6527969251656338
RDP	1.6527969251656338
8G6	1.6527969251656338
DTC	1.6527969251656338
VPR	1.6527969251656338
MSU	1.6527969251656338
VMA	1.6527969251656338
JLC	1.6527969251656338
CDC	1.6527969251656338
ACE	1.6527969251656338
BMS	1.6527969251656338
C37	1.6527969251656338
NCI	1.6527969251656338
PGG	1.6527969251656338
JTW	1.6527969251656338
2AT	1.6527969251656338
3IN	1.6527969251656338
AKT	1.6527969251656338
ICH	1.6527969251656338
LJH	1.6527969251656338
RAR	1.6527969251656338
CVD	1.6527969251656338
PRS	1.6527969251656338
R.B	1.6527969251656338
5E9	1.6527969251656338
MCM	1.6527969251656338
PIL	1.6527969251656338
MOL	1.6527969251656338
JTT	1.6527969251656338
MT2	1.6527969251656338
MAR	1.6527969251656338
LTC	1.6527969251656338
(D)	1.6527969251656338
DMF	1.6527969251656338
JEW	1.6527969251656338
PH8	1.6527969251656338
NTX	1.6527969251656338
CME	1.6527969251656338
DJF	1.6527969251656338
MG2	1.6527969251656338
VPU	1.6527969251656338
AFC	1.6527969251656338
CA2	1.6527969251656338
DAB	1.6527969251656338
E-H	1.6527969251656338
GEL	1.6509418250250736
ARRAY DETECTOR	1.6504005322829025
BINDING POCKET	1.6504005322829025
MOBILITY SHIFT	1.6504005322829025
antiserum	1.6503819131850495
SHARE HOMOLOGUE	1.6502323167748836
MM NAF	1.6480323467183058
A3	1.645751047274249
HP	1.645751047274249
HT	1.645751047274249
IR	1.645751047274249
TΑ	1.645751047274249
H*	1.645751047274249
FI	1.645751047274249
GF	1.645751047274249
NECROTIC	1.6423012904382133
antisense	1.642019936616999
TOTAL AMOUNT	1.6390260198199376
BINDING BUFFER	1.6376444038294795
E	1.6350011919224507
ZYMED	1.634517861604646
U	1.624937937949618
kinase kinases	1.6242136724290004
ADDRESS	1.6228532855653306
Q	1.6214157990591265
ROTATION	1.6204736539967775
S. POMBE CELL	1.6192820763138256
MONOCLONAL MYC	1.6154847191443664
homologue	1.613599330571671
COOPERATION	1.6055955003447786
MAINTENANCE	1.6055955003447786
SEQUENCE HOMOLOGY	1.6024485193307236
WI	1.5952596357440267
DM	1.5952596357440267
SM	1.5952596357440267
SP	1.5952596357440267
DE	1.5952596357440267
INVERSE	1.595032826674056
CABG	1.594448719197127
KEY COMPONENT	1.5928460369787043
E LOOP REGION	1.5906463732469784
ACID POSITION	1.5885952635753433
RETINOIC ACID	1.5885952635753433
MG/ML	1.5880510388334859
lipids	1.5868398759307396
classes	1.586519546774582
CROSS	1.5847669847370955
languages	1.5844667890110626
guanidine	1.5844667890110626
ALABASTER	1.5844667890110626
lethality	1.5844667890110626
eppendorf	1.5844667890110626
cognitive	1.5844667890110626
Y	1.579150132373229
rr	1.5790843806075823
HZ	1.5790843806075823
BV	1.5790843806075823
FS	1.5790843806075823
IZ	1.5790843806075823
QC	1.5790843806075823
SY	1.5790843806075823
KW	1.5790843806075823
SB	1.5790843806075823
MC	1.5790843806075823
KN	1.5790843806075823
KI	1.5790843806075823
OM	1.5790843806075823
CP	1.5790843806075823
MΩ	1.5790843806075823
FK	1.5790843806075823
WK	1.5790843806075823
KA	1.5790843806075823
CZ	1.5790843806075823
OTHER MUTANT	1.5784579315188005
TIME COURSE	1.5765942189411228
EUKARYOTE	1.5712190922087172
reports	1.5710124420013278
POSITIVE EFFECT	1.5707751202267628
lists	1.5639778626101717
SPECIES	1.5621918576249545
TOTAL MORTALITY	1.5589420335113588
INVOLVEMENT	1.5562563041028974
ATTACK TRIAL	1.548608033804432
CELLULAR PROTEIN	1.546667626840189
PROTEIN PEAK	1.5425406975523368
HEART DISEASE	1.5355921554301133
CHOLESTEROL	1.5351982677263076
TOTAL VOLUME	1.5240600279928065
SYMPTOM	1.5221454357030915
HYDROGEN	1.52105298679295
INGESTION	1.519466887344598
AGAROSE GEL	1.5185822516364635
ABBOTT	1.5132668655547143
GENDER	1.5118606754780146
BOUND LIGAND	1.5099174455401385
run	1.5092322061405916
gains	1.5091381706977003
pictures	1.5083966161871145
MULTIMER	1.5083966161871145
analyzer	1.5083966161871145
COWORKER	1.5057924917185677
SHOW CHANGE	1.5014111332604863
DILUTION	1.4984772423850041
DISSOCIATION	1.4934492786348978
GRADIENT	1.4929149882861235
SHOWS	1.4891964318617854
MW	1.4889771184509222
NON-FUNCTIONAL	1.4838324579450806
PROXIMITY	1.4815774575493506
reductions	1.4810352100672086
HA ANTIBODY	1.4802676216733237
CARDIOVASCULAR EVENT	1.4759387027866653
NON	1.4720643705482073
accounts	1.467374317790847
DENATURE	1.467374317790847
stops	1.4672127064630343
X-RAY CRYSTALLOGRAPHY	1.460871381420815
ELECTROPHYSIOLOGICAL	1.4594126769543472
BP FRAGMENT	1.4580677206662511
TAKES PLACE	1.4580650517911669
QS	1.4566091372232726
relationships	1.4491576462551579
ONE	1.4474240511816867
NON-FAT	1.4448023486611743
VALINE	1.443774839857869
AGENT	1.4432294886703891
faces	1.4407919960305546
NOVAGEN	1.4402342547060152
EG	1.4388163995988603
PREVIOUS STUDY	1.4363099146126304
ACID)	1.4361016802643911
FIGURE	1.4353051042855693
TRANSFECTANT	1.4307776059086292
TAKE	1.4266146615806699
proline	1.4243049414954307
website	1.4243049414954307
lactate	1.4243049414954307
fitting	1.4243049414954307
PROOF	1.419928650255318
TBE BUFFER	1.419664657767354
BORIC ACID	1.4195292008889182
KM	1.4163793576446202
EXHIBIT	1.4061939064218762
WEBPAGE	1.4048314885556383
leaders	1.4048314885556383
PHENYLALANINE	1.4035236961157085
AUTORADIOGRAPHY	1.4008077627877191
ΜL/MIN	1.393981077024143
GUIDE	1.3910540386480656
PROTEIN CONCENTRATION	1.388070241908265
agarose	1.3865897385147545
stores	1.3826688793463031
ADVICE	1.3826688793463031
CI/MMOL	1.3803877499759825
ACCOMPLISHMENT	1.3769152378972673
BIOLOGICAL ACTIVITY	1.3764055699699358
OBSERVED CHANGE	1.3721490229786824
PHOSPHATE	1.3483135416636753
CHICAGO	1.3446486966525861
receptors	1.3383868167927915
PHOSPHATE BUFFERED SALINE	1.3372858322803367
T	1.3312322581345926
markers	1.330863766772881
cullin	1.3302984471576262
lamina	1.3302984471576262
W/V	1.3284257003548807
yields	1.318119940265298
AGGREGATION	1.3134161151795984
RETENTION	1.3106126110753935
ΜG/ML BSA	1.3082703865061065
DERIVATIVE	1.3057085260153238
areas	1.3015876496537928
ATP	1.297003530346009
LT	1.296687494623642
efforts	1.2957178229289394
BEAD LYSI	1.2954914881607145
COP9	1.29518645541551
BUFFER ΜL	1.2926963312422581
USE	1.2916410352959176
representatives	1.2890764838413744
TWO-THIRDS	1.2865839132077272
IN VITRO ASSAY	1.2757903091977765
ION	1.2745477481869936
LINKS	1.2736592760978378
bonds	1.269980790967186
PYROPHOSPHATE	1.2686971953980073
MAX VALUE	1.2676804529277668
profiles	1.2639688642406888
COMMON FEATURE	1.2529979228004047
TS	1.2410686310011068
experiences	1.2304708199003223
tables	1.227291227374301
OUGHT	1.2237226738748126
MMP-7	1.2237226738748126
titer	1.2237226738748126
DOUBT	1.2237226738748126
MMP-9	1.2237226738748126
oligo	1.2237226738748126
RDDAY	1.2237226738748126
FASHION	1.2220158272073558
ECL	1.2186571975742615
agents	1.2074531246659772
slides	1.2074531246659772
MOLECULAR SIZE	1.2019010836427204
STANDARD CURVE	1.2019010836427204
properties	1.1940716834351381
BETA	1.1899689245267222
subcellular	1.189555060791909
NEGATIVE CHARGE	1.1802085249568393
KAPLAN-MEIER	1.1782838318461948
HRM	1.174743193521401
INHIBITORY EFFECT	1.169870142163128
GUIDANCE	1.1664579507348067
PROTEINASE	1.1598914766090116
PRE-TREATMENT	1.157862232531968
STRATAGENE	1.1576885972577649
MM PMSF	1.1559920642155501
STATISTICS	1.148720150562089
UNITED STATE	1.1316554838812671
CTT	1.1308291894685403
IΚB	1.1308291894685403
FINAL VOLUME	1.1287647257129505
enzymatic	1.1241451101344055
CATALYTIC ACTIVITY	1.1241045729298271
events	1.1189596056955637
ANTI	1.117371781864656
NON-REDUCING	1.116563131519822
hydrophobic	1.1162155187818792
INTERPRETATION	1.1105867646403587
albumin	1.1090191459620478
SEDIMENTED	1.1017736892947656
CD28	1.1006899728615198
ML/H	1.1006899728615198
TATA	1.1006899728615198
HAT	1.0956979862262517
NAF	1.0956979862262517
SODIUM	1.0919686887292004
PHOSPHORIMAGING	1.070145550700406
Β-STRAND	1.0659351728634983
serum albumin	1.065574275147065
studies	1.0624082344078651
GLU	1.060648446163472
plots	1.051913613502963
ABSORBANCE	1.0492481230202269
ASSAY	1.0440866369463437
p27	1.0430011813628186
TTG	1.0430011813628186
TGT	1.0430011813628186
TTA	1.0430011813628186
MEM	1.0430011813628186
clones	1.0381159235881987
CT	1.0363100502642437
KK	1.0342881610148258
SCINTILLATION	1.0278856698972734
EQUIPMENT	1.020701560406657
ILE	1.0155608804260656
CONCLUSION	1.0133361981412525
LACK	1.0120680200547716
HYDROLYZ	1.009391110310887
deaths	1.0075187210150305
IMMUNOCOMPLEX	1.0063483102891895
MM MGCL2	1.0030109272510184
HIV-1	1.0026781776451517
BINDING DATA	0.9999378340757877
significance	0.9969872717122423
JNC VI	0.9943456155973743
BIOSYNTHESI	0.9882196234867581
Β-SHEET	0.9719861348024345
HOMOGENIZATION	0.9695421760814472
PLACE	0.9626585932701435
ΜG/ML APROTININ	0.9622854230802862
β-sheet	0.9610458450076889
ELISA	0.9599183435966573
TWEEN	0.9565770675989393
RELIEF	0.9556992282926523
REV	0.9551731732570973
DBP	0.9551731732570973
hrp	0.9551731732570973
CAM	0.9551731732570973
M.W	0.9551731732570973
PHE	0.9551731732570973
HPO	0.9551731732570973
ARG	0.9551731732570973
SV	0.9499914121517886
P3	0.9499914121517886
NP	0.9499914121517886
3T3	0.9452789965022211
non-essential	0.93619230679989
COLLABORATION	0.93619230679989
G BEAD	0.9347577807162516
modification	0.9275451087206471
ΜG/ML LEUPEPTIN	0.9267362238306012
emissions	0.9233316351518448
ROOM TEMPERATURE	0.9224566921510444
SUBSTITUTION	0.9163037165894155
NP40	0.9085235490063595
ICE-COLD	0.9075962148979101
REQUIREMENT	0.9060865626025983
antiparallel	0.900540680377517
PRETREATMENT	0.900540680377517
TURNOVER	0.896470295951374
VACUUM	0.8846539436612506
PHENOTYPE	0.8835557957696469
PC	0.8775660002332082
RUN	0.8771538183732204
FINE	0.876002713765273
polypeptide	0.8622458583009521
derivatives	0.8622458583009521
construction	0.8587947103900135
LM	0.8527259326944377
RK	0.8527259326944377
KV	0.8527259326944377
MYOCYTE	0.8520822500377726
REGULATION	0.839033129715336
HOMOLOGY	0.8346040538037904
combinations	0.817937434222077
non-adherent	0.817937434222077
MOLECULAR WEIGHT	0.8147676273352022
CONFIRMATION	0.8097975800949284
products	0.8076915183231739
NMR	0.7958127558050714
V/V	0.7896679627358622
ASSISTANCE	0.7841918156561261
transfected	0.7781235952896814
PHARMACIA BIOTECH	0.7777786054260303
GA	0.7770750042276094
CE	0.7770750042276094
RL	0.7770750042276094
OC	0.7770750042276094
C	0.7769968236238557
ZYMOLYASE	0.7759217252364358
MANUAL	0.7747313625174636
homogenizer	0.7569868647683333
max	0.7502624776459976
DIALYZED	0.7485882555987924
MILLIPORE	0.744479241933996
A-D	0.7333465713305399
CONSIDERATION	0.7309425143508146
BIORAD	0.7292130196558178
TURN	0.7267039115012337
SUPERDEX	0.726670797547832
PFIZER	0.7134915436642738
NAOH	0.7126954553180803
F	0.7073383762843855
9E10	0.7071484301780848
positions	0.7061184251179169
drugs	0.7056484510241561
MM ME	0.7016662055287679
CHO	0.6978464420968958
BINDING ASSAY	0.6922138769027968
CEREBELLUM	0.6911552346273565
REF	0.6868476872957663
MM EGTA	0.6746451441683865
PURIFICATION	0.6734048415340483
RISK	0.6721756270504042
suspensions	0.6717851477360688
EDU	0.6599853472326503
FBS	0.6599853472326503
NAH	0.6599853472326503
S	0.658653579110086
locations	0.6401397550784955
N	0.6353950865547564
ABUNDANCE	0.6321433131929304
movements	0.6278996454492694
FOCUS	0.6271502335735806
NLS	0.6255826124927852
BRL	0.6255826124927852
sequenced	0.6195921784223972
AMBIGUITY	0.6195921784223972
weights	0.6155001811854497
shares	0.6136665264902093
checks	0.6113627902340558
counts	0.6113627902340558
Β-TURN	0.6113627902340558
PAIN	0.6093710235623397
ACCESS	0.593372119129359
TRIS-HCL	0.5851325767570831
HOMOGENIZED	0.5838130529279586
goals	0.5423612945301253
ACH	0.5378739987614747
TLC	0.5378739987614747
AUTHOR	0.5316909940820603
HRP	0.5267613559557407
BINDING STUDY	0.515258047002632
WWW	0.5151631049342837
LYSINE	0.5068992268073955
OVERVIEW	0.5009253931430653
FORMATION	0.5008708141992555
HDL	0.5002334238590224
bovine serum	0.4983142300482948
QIAGEN	0.4891768591429284
DC	0.4888651430717834
exhibits	0.4838676013381774
homology	0.4838676013381774
BC	0.4632540730888416
R104	0.462704913638722
MGCL2	0.46072999664387293
NEN	0.4555605093530124
charges	0.45454929834295976
ECG	0.4475366189955896
TCR	0.4475366189955896
MANUFACTURER	0.43444692273136454
sequencing	0.4290798209725626
PVDF	0.4259799601387484
ranges	0.4244300406094208
purification	0.4200125117833099
COORDINATION	0.4144031220468025
MN	0.4000641541077815
PE	0.4000641541077815
CLONING	0.39393287795023557
MM TRI	0.38174199982653745
1AT	0.3684914117004402
LYSED	0.36087834724008117
organization	0.353380450260385
elution	0.3478817009700239
sources	0.34493759203633645
INVESTIGATION	0.33930451115683846
successes	0.33895190580816803
ER	0.3212692400068097
exposures	0.31080676131791407
concerns	0.3032959805833765
tfs	0.2990022844212339
MB	0.2965428504767772
LYSI	0.29239265939181597
BIOTECH	0.2835187994730729
codons	0.27041623511543667
results	0.2675459465637886
AP	0.253183404386664
ug	0.253183404386664
SW	0.253183404386664
mixtures	0.24518922621839434
ML/MIN	0.24480292531273884
pharmacologic	0.24107625530830196
ends	0.23300949436538887
BP	0.21821510032625113
MM KCL	0.2171089505518755
causes	0.18045217174339978
NUCLEUS	0.1794221609852258
inhibitors	0.16417194728522455
CHROMATOGRAM	0.14929165698485325
SE	0.14309889747753307
WEEK	0.1359347710856803
polyacrylamide	0.13551939786612555
OBJECTIVE	0.13198156162288788
BINDING DOMAIN	0.12170736957119477
RPMI	0.1198185409777962
INCUBATION	0.10373790825581386
placements	0.10169981028115532
homolog	0.09785258452235446
RA	0.0944058319096921
averages	0.08796651921593579
COURSE	0.057510457982343555
peptides	0.0551026053180359
infection	0.04735212095602265
INVITROGEN	0.03717412979492951
SUPERNATANT	0.026844912898926765
NJ	-0.00017888759489703698
parallel	-0.007046423044381411
PH6	-0.02887955420731253
G	-0.03101605830215659
cases	-0.04265651776551305
applications	-0.060698916038331996
RESOLUTION	-0.06644752270814921
interests	-0.09876394990840365
HCL	-0.13815691176494482
CARLSBAD	-0.1393571209844508
visits	-0.1515554821878995
CONSEQUENCE	-0.15694742380150362
portions	-0.18442736216492106
packages	-0.19341990727899433
FINAL MANUSCRIPT	-0.2043776056258313
pepstatin	-0.21160341229744217
extracts	-0.21890524201881367
bp	-0.2200935398696865
IMPLICATION	-0.23300753289038567
peaks	-0.27794903495765544
epitopes	-0.2937208121934023
detection	-0.3025156946139276
uses	-0.3187838985070859
VI	-0.398515332426123
FINAL	-0.40824827243938344
NIH	-0.40829900350176374
IL	-0.4249495204534155
PBS	-0.42999356386270327
LYSATE	-0.5194756621391132
HELP	-0.5467059690900085
DETERMINATION	-0.5916964480077045
solution	-0.6012094934687036
lives	-0.6233114152801
inhibition	-0.6278923172051822
UV	-0.6293498017659668
KEY	-0.6467895800050125
permits	-0.6546720261740866
examples	-0.6708077842906444
LYSIS	-0.733881035983114
COM	-0.7339859338417043
MM DTT	-0.7516113073839303
mg/ml	-0.7836387486247656
ANTIBODY	-0.7907355793202484
KCL	-0.8092146549346113
ALIQUOT	-0.8387665973144651
INDIANAPOLI	-0.8574284101247424
USA	-0.8820329404944631
plays	-0.8889928215976602
M	-0.9043866193142744
BASIS	-0.9163461896448912
growth	-0.9302400118553651
responses	-1.013195048610502
IDENTIFICATION	-1.0498093030335713
FIND	-1.0499928026207481
EVIDENCE	-1.0610843593951675
NG	-1.075138384735697
KDA	-1.0854092497811294
TRIS	-1.0910288313471228
ENZYME	-1.0930664315596097
NY	-1.1310794472716128
MM TRIS-HCL	-1.146257421691347
CY	-1.1733481484141017
PARTICIPATION	-1.2534562355878516
aprotinin	-1.2801669616605902
PMSF	-1.2914063376343723
KS	-1.402192587477299
RESEARCH	-1.417019363496791
leupeptin	-1.4708593676323478
ORGANIZATION	-1.514633667277486
reactions	-1.6748316579086788
decreases	-1.6974141860089675
RPM	-1.7115193154137507
proteases	-1.7673245997431808
MANNER	-2.2251131739703243
ABBREVIATION	-2.2722723671772247
μg/ml	-2.291630133034306
gifts	-2.3797916445735643
shows	-2.4448985107789065
MM HEPE	-2.4821291875457376
SDS-PAGE	-2.5873353895046414
UNKNOWN	-2.6442710757780836
steps	-2.7157298713492084
TOTAL	-2.7896545099315553
SIGMA	-3.0476005701615954
ST	-3.0992616066683887
MM NACL	-3.113982505855577
B	-3.1166132991229047
works	-3.1179501849583886
MM EDTA	-3.2094647174184883
PREPARATION	-3.2322631139547155
DTT	-3.3033073724070117
RESUSPENDED	-3.3566414384474745
MG	-3.4227922654135647
targets	-3.7639159010138217
changes	-3.962241447238327
MGCL	-4.23943220702496
EDTA	-4.30096864618886
OBSERVATION	-4.351907163776526
SOLUTION	-4.555242115912929
signals	-4.568858797507595
CENTRIFUGATION	-4.5901257069069
GENE EXPRESSION	-4.700928241283531
increases	-4.72520392694269
supports	-4.758047652663642
BINDING SITE	-4.824209529692226
buffer	-4.888735247957058
KNOW	-5.033558526625912
SINGLE	-5.192162472334555
ΜG/ML	-5.333056721781791
PLASMID	-5.643599000954957
TRANSFECTED	-5.686140193069569
LOCALIZATION	-5.778452393738171
HR	-5.8983945581161485
FRACTION	-6.205805558912745
TRANSCRIPTION	-6.588055001872277
effects	-7.083058741637453
NACL	-7.297502579492526
ΜG	-7.385169455824174
standards	-7.606118691317075
times	-8.227800402486373
GROWTH	-8.79071499651929
CA	-9.806474292160217
BUFFER	-10.099897767190035
CONTRIBUTION	-10.72211093570858
treatments	-10.77231232816601
INTERACTION	-11.761602894124486
AFFINITY	-11.831443870780749
MULTIPLE	-13.194690758457648
functions	-13.749960509277944
ABILITY	-15.64502438044067
ΜL	-16.347770530351927
PH	-18.153789647561148
controls	-18.271294483635295
MUTANT	-20.442105202475076
NM	-22.0705239120598
ABSENCE	-24.462240171784103
CONCENTRATION	-26.104946249960452
PROTEIN	-27.23015409603497
genes	-28.280397050985613
ACTIVATION	-28.32273318791009
domains	-31.227099009046185
analyses	-32.02146997916644
ΜM	-34.49765450091918
RECEPTOR	-36.13089822594628
DNA	-40.04370966917256
ADDITION	-40.08880095180207
MIN	-45.634298752570075
expressions	-60.62885441767741
